1000003 26.05.2002 1 A1 SN NYNNY 2001.12.202300051.0000018.9500000.00 5001.12.2023Professional attendance at consulting rooms (other than a service to which 5001.12.2023another item applies) by a general practitioner for an obvious problem 5001.12.2023characterised by the straightforward nature of the task that requires a short 5001.12.2023patient history and, if required, limited examination and management-each 5001.12.2023attendance 1000004 26.05.2002 1 A1 SD NYNNY 3001.12.2023The fee for item 3, plus $29.00 divided by the number of patients seen, up to 3001.12.2023a maximum of six patients. For seven or more patients - the fee for item 3 3001.12.2023plus $2.30 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms or a residential aged care facility or a service to which 5001.12.2023another item in the table applies) that requires a short patient history and, 5001.12.2023if necessary, limited examination and management-an attendance on one or more 5001.12.2023patients at one place on one occasion-each patient 1000023 26.05.2002 1 A1 SN NYNYY 2001.12.202300102.0000041.4000000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in this Schedule applies), lasting at 5001.12.2023least 6 minutes and less than 20 minutes and including any of the following 5001.12.2023that are clinically relevant:(a) taking a patient history;(b) performing a 5001.12.2023clinical examination;(c) arranging any necessary investigation;(d) 5001.12.2023implementing a management plan;(e) providing appropriate preventive health 5001.12.2023care;for one or more health-related issues, with appropriate documentation 1000024 26.05.2002 1 A1 SD NYNYY 3001.12.2023The fee for item 23, plus $29.00 divided by the number of patients seen, up to 3001.12.2023a maximum of six patients. For seven or more patients - the fee for item 23 3001.12.2023plus $2.30 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms or a residential aged care facility or a service to which 5001.12.2023another item in this Schedule applies), lasting at least 6 minutes and less 5001.12.2023than 20 minutes and including any of the following that are clinically 5001.12.2023relevant:(a) taking a patient history;(b) performing a clinical 5001.12.2023examination;(c) arranging any necessary investigation;(d) implementing a 5001.12.2023management plan;(e) providing appropriate preventive health care;for one or 5001.12.2023more health-related issues, with appropriate documentationan attendance on one 5001.12.2023or more patients at one place on one occasioneach patient 1000036 26.05.2002 1 A1 SN NYNNY 2001.12.202300188.0000080.1000000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in the table applies), lasting at least 5001.12.202320 minutes and including any of the following that are clinically relevant: 5001.12.2023(a) taking a detailed patient history; (b) performing a clinical examination; 5001.12.2023(c) arranging any necessary investigation; (d) implementing a management plan; 5001.12.2023(e) providing appropriate preventive health care; for one or more 5001.12.2023health-related issues, with appropriate documentation-each attendance 1000037 26.05.2002 1 A1 SD NYNNY 3001.12.2023The fee for item 36, plus $29.00 divided by the number of patients seen, up to 3001.12.2023a maximum of six patients. For seven or more patients - the fee for item 36 3001.12.2023plus $2.30 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms or a residential aged care facility or a service to which 5001.12.2023another item in the table applies), lasting at least 20 minutes and including 5001.12.2023any of the following that are clinically relevant: (a) taking a detailed 5001.12.2023patient history; (b) performing a clinical examination; (c) arranging any 5001.12.2023necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation-an attendance on one or more patients at one 5001.12.2023place on one occasion-each patient 1000044 26.05.2002 1 A1 SN NYNNY 2001.12.202300285.0000118.0000000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in the table applies), lasting at least 5001.12.202340 minutes and including any of the following that are clinically relevant: 5001.12.2023(a) taking an extensive patient history; (b) performing a clinical 5001.12.2023examination; (c) arranging any necessary investigation; (d) implementing a 5001.12.2023management plan; (e) providing appropriate preventive health care; for one or 5001.12.2023more health-related issues, with appropriate documentation-each attendance 1000047 26.05.2002 1 A1 SD NYNNY 3001.12.2023The fee for item 44, plus $29.00 divided by the number of patients seen, up to 3001.12.2023a maximum of six patients. For seven or more patients - the fee for item 44 3001.12.2023plus $2.30 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms or a residential aged care facility or a service to which 5001.12.2023another item in the table applies), lasting at least 40 minutes and including 5001.12.2023any of the following that are clinically relevant: (a) taking an extensive 5001.12.2023patient history; (b) performing a clinical examination; (c) arranging any 5001.12.2023necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation-an attendance on one or more patients at one 5001.12.2023place on one occasion-each patient 1000052 26.05.2002 1 A2 1 SN NNNNY 2001.12.202300051.0000011.0000000.00 5001.12.2023Professional attendance at consulting rooms of not more than 5 minutes in 5001.12.2023duration (other than a service to which any other item applies)-each 5001.12.2023attendance, by: (a) a medical practitioner (who is not a general 5001.12.2023practitioner); or (b) a Group A1 disqualified general practitioner, as defined 5001.12.2023in the dictionary of the General Medical Services Table (GMST). 1000053 26.05.2002 1 A2 1 SN NNNNY 2001.12.202300102.0000021.0000000.00 5001.12.2023Professional attendance at consulting rooms of more than 5 minutes in duration 5001.12.2023but not more than 25 minutes (other than a service to which any other item 5001.12.2023applies)-each attendance, by: (a) a medical practitioner (who is not a general 5001.12.2023practitioner); or (b) a Group A1 disqualified general practitioner, as defined 5001.12.2023in the dictionary of the General Medical Services Table (GMST). 1000054 26.05.2002 1 A2 1 SN NNNNY 2001.12.202300188.0000038.0000000.00 5001.12.2023Professional attendance at consulting rooms of more than 25 minutes in 5001.12.2023duration but not more than 45 minutes (other than a service to which any other 5001.12.2023item applies)-each attendance, by: (a) a medical practitioner (who is not a 5001.12.2023general practitioner); or (b) a Group A1 disqualified general practitioner, as 5001.12.2023defined in the dictionary of the General Medical Services Table (GMST). 1000057 26.05.2002 1 A2 1 SN NYNYY 2001.12.202300285.0000061.0000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 45 minutes, but 5001.12.2023not more than 60 minutes (other than a service to which any other item 5001.12.2023applies) by:(a) a medical practitioner who is not a general practitioner; 5001.12.2023or(b) a Group A1 disqualified general practitioner 1000058 26.05.2002 1 A2 1 SD NNNNY 3001.12.2023An amount equal to $8.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $8.50 plus $.70 per patient 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item in the 5001.12.2023table applies), not more than 5 minutes in duration-an attendance on one or 5001.12.2023more patients at one place on one occasion-each patient, by: (a) a medical 5001.12.2023practitioner (who is not a general practitioner); or (b) a Group A1 5001.12.2023disqualified general practitioner, as defined in the dictionary of the General 5001.12.2023Medical Services Table (GMST). 1000059 26.05.2002 1 A2 1 SD NNNNY 3001.12.2023An amount equal to $16.00, plus $17.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $16.00 plus $.70 per patient 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item in the 5001.12.2023table applies) of more than 5 minutes in duration but not more than 25 5001.12.2023minutes-an attendance on one or more patients at one place on one 5001.12.2023occasion-each patient, by: (a) a medical practitioner (who is not a general 5001.12.2023practitioner); or (b) a Group A1 disqualified general practitioner, as defined 5001.12.2023in the dictionary of the General Medical Services Table (GMST). 1000060 26.05.2002 1 A2 1 SD NNNNY 3001.12.2023An amount equal to $35.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $35.50 plus $.70 per patient 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item in the 5001.12.2023table applies) of more than 25 minutes in duration but not more than 45 5001.12.2023minutes-an attendance on one or more patients at one place on one 5001.12.2023occasion-each patient, by: (a) a medical practitioner (who is not a general 5001.12.2023practitioner); or (b) a Group A1 disqualified general practitioner, as defined 5001.12.2023in the dictionary of the General Medical Services Table (GMST). 1000065 26.05.2002 1 A2 1 SD NYNYY 3001.12.2023An amount equal to $57.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $57.50 plus $0.70 per patient 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item in this 5001.12.2023Schedule applies) lasting more than 45 minutes but not more than 60 minutes an 5001.12.2023attendance on one or more patients at one place on one occasioneach patient, 5001.12.2023by:(a) a medical practitioner who is not a general practitioner; or(b) a Group 5001.12.2023A1 disqualified general practitioner 1000104 26.05.2002 1 A3 SN NYNNY 2001.12.202300205.0000095.6000000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist in the 5001.12.2023practice of the specialist's specialty after referral of the patient to the 5001.12.2023specialist-each attendance, other than a second or subsequent attendance, in a 5001.12.2023single course of treatment, other than a service to which item 106, 109 or 5001.12.202316401 applies 1000105 26.05.2002 1 A3 SN NYNNY 2001.12.202300110.0000048.0500000.00 5001.12.2023Professional attendance by a specialist in the practice of the specialist's 5001.12.2023specialty following referral of the patient to the specialist-an attendance 5001.12.2023after the first in a single course of treatment, if that attendance is at 5001.12.2023consulting rooms or hospital, other than a service to which item 16404 applies 1000106 26.05.2002 1 A3 SN NYNNY 2001.12.202300205.0000079.3000000.00 5001.12.2023Professional attendance by a specialist in the practice of the specialist's 5001.12.2023specialty of ophthalmology and following referral of the patient to the 5001.12.2023specialist-an attendance (other than a second or subsequent attendance in a 5001.12.2023single course of treatment) at which the only service provided is refraction 5001.12.2023testing for the issue of a prescription for spectacles or contact lenses, if 5001.12.2023that attendance is at consulting rooms or hospital (other than a service to 5001.12.2023which any of items 104, 109 and 10801 to 10816 applies) 1000107 26.05.2002 1 A3 SN NYNNY 2001.12.202300280.0000140.2500000.00 5001.12.2023Professional attendance by a specialist in the practice of the specialist's 5001.12.2023specialty following referral of the patient to the specialist-an attendance 5001.12.2023(other than a second or subsequent attendance in a single course of 5001.12.2023treatment), if that attendance is at a place other than consulting rooms or 5001.12.2023hospital 1000108 26.05.2002 1 A3 SN NYNNY 2001.12.202300182.0000088.8000000.00 5001.12.2023Professional attendance by a specialist in the practice of the specialist's 5001.12.2023specialty following referral of the patient to the specialist-each attendance 5001.12.2023after the first in a single course of treatment, if that attendance is at a 5001.12.2023place other than consulting rooms or hospital 1000109 01.05.2006 1 A3 SN NYNNY 2001.12.202300320.0000215.4000000.00 5001.12.2023Professional attendance by a specialist in the practice of the specialist's 5001.12.2023specialty of ophthalmology following referral of the patient to the 5001.12.2023specialist-an attendance (other than a second or subsequent attendance in a 5001.12.2023single course of treatment) at which a comprehensive eye examination, 5001.12.2023including pupil dilation, is performed on: (a) a patient aged 9 years or 5001.12.2023younger; or (b) a patient aged 14 years or younger with developmental delay; 5001.12.2023(other than a service to which any of items 104, 106 and 10801 to 10816 5001.12.2023applies) 1000110 26.05.2002 1 A4 SN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Professional attendance at consulting rooms or hospital, by a consultant 5001.12.2023physician in the practice of the consultant physician's specialty (other than 5001.12.2023psychiatry) following referral of the patient to the consultant physician by a 5001.12.2023referring practitioner-initial attendance in a single course of treatment 1000111 01.11.2017 1 A3 SN NYNYY 2001.12.202300110.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or in hospital by a specialist in 5001.12.2023the practice of the specialist's specialty following referral of the patient 5001.12.2023to the specialist by a referring practitioner-an attendance after the first 5001.12.2023attendance in a single course of treatment, if: (a) during the attendance, the 5001.12.2023specialist determines the need to perform an operation on the patient that had 5001.12.2023not otherwise been scheduled; and (b) the specialist subsequently performs the 5001.12.2023operation on the patient, on the same day; and (c) the operation is a service 5001.12.2023to which an item in Group T8 applies; and (d) the amount specified in the item 5001.12.2023in Group T8 as the fee for a service to which that item applies is $330.20 or 5001.12.2023more For any particular patient, once only on the same day 1000115 01.04.2019 1 A3 SN NYNYY 2001.12.202300110.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or in hospital on a day by a 5001.12.2023medical practitioner (the attending practitioner) who is a specialist or 5001.12.2023consultant physician in the practice of the attending practitioners specialty 5001.12.2023after referral of the patient to the attending practitioner by a referring 5001.12.2023practitioneran attendance after the initial attendance in a single course of 5001.12.2023treatment, if: (a) the attending practitioner performs a scheduled operation 5001.12.2023on the patient on the same day; and (b) the operation is a service to which an 5001.12.2023item in Group T8 applies; and (c) the amount specified in the item in Group T8 5001.12.2023as the fee for a service to which that item applies is $330.20 or more; and 5001.12.2023(d) the attendance is unrelated to the scheduled operation; and (e) it is 5001.12.2023considered a clinical risk to defer the attendance to a later day For any 5001.12.2023particular patient, once only on the same day 1000116 26.05.2002 1 A4 SN NYNNY 2001.12.202300180.0000084.3500000.00 5001.12.2023Professional attendance at consulting rooms or hospital, by a consultant 5001.12.2023physician in the practice of the consultant physician's specialty (other than 5001.12.2023psychiatry) following referral of the patient to the consultant physician by a 5001.12.2023referring practitioner-each attendance (other than a service to which item 119 5001.12.2023applies) after the first in a single course of treatment 1000117 01.11.2017 1 A4 SN NYNYY 2001.12.202300163.0000084.3500000.00 5001.12.2023Professional attendance at consulting rooms or in hospital, by a consultant 5001.12.2023physician in the practice of the consultant physician's specialty (other than 5001.12.2023psychiatry) following referral of the patient to the consultant physician by a 5001.12.2023referring practitioner-an attendance after the first attendance in a single 5001.12.2023course of treatment, if: (a) the attendance is not a minor attendance; and (b) 5001.12.2023during the attendance, the consultant physician determines the need to perform 5001.12.2023an operation on the patient that had not otherwise been scheduled; and (c) the 5001.12.2023consultant physician subsequently performs the operation on the patient, on 5001.12.2023the same day; and (d) the operation is a service to which an item in Group T8 5001.12.2023applies; and (e) the amount specified in the item in Group T8 as the fee for a 5001.12.2023service to which that item applies is $330.20 or more For any particular 5001.12.2023patient, once only on the same day 1000119 26.05.2002 1 A4 SN NYNNY 2001.12.202300093.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or hospital, by a consultant 5001.12.2023physician in the practice of the consultant physician's specialty (other than 5001.12.2023psychiatry) following referral of the patient to the consultant physician by a 5001.12.2023referring practitioner-each minor attendance after the first in a single 5001.12.2023course of treatment 1000120 01.11.2017 1 A4 SN NYNYY 2001.12.202300093.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or in hospital by a consultant 5001.12.2023physician in the practice of the consultant physicians specialty (other than 5001.12.2023psychiatry) following referral of the patient to the consultant physician by a 5001.12.2023referring practitionerminor attendance, if: (a) during the attendance, the 5001.12.2023consultant physician determines the need to perform an operation on the 5001.12.2023patient that had not otherwise been scheduled; and (b) the consultant 5001.12.2023physician subsequently performs the operation on the patient, on the same day; 5001.12.2023and (c) the operation is a service to which an item in Group T8 applies; and 5001.12.2023(d) the amount specified in the item in Group T8 as the fee for a service to 5001.12.2023which that item appliesis $330.20 or more For any particular patient, once 5001.12.2023only on the same day 1000122 26.05.2002 1 A4 SN NYNNY 2001.12.202300470.0000204.5000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital, by 5001.12.2023a consultant physician in the practice of the consultant physician's specialty 5001.12.2023(other than psychiatry) following referral of the patient to the consultant 5001.12.2023physician by a referring practitioner-initial attendance in a single course of 5001.12.2023treatment 1000123 01.11.2023 1 A1 SN YNNYN 2001.12.202300370.0000191.2000000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in this Schedule applies), lasting at 5001.12.2023least 60 minutes and including any of the following that are clinically 5001.12.2023relevant:(a) taking an extensive patient history;(b) performing a clinical 5001.12.2023examination;(c) arranging any necessary investigation;(d) implementing a 5001.12.2023management plan;(e) providing appropriate preventive health care;for one or 5001.12.2023more health related issues, with appropriate documentation 1000124 01.11.2023 1 A1 SD NNNYY 3001.12.2023The fee for item 123, plus $29.00 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023123 plus $2.30 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms or a residential aged care facility or a service to which 5001.12.2023another item in this Schedule applies), lasting at least 60 minutes and 5001.12.2023including any of the following that are clinically relevant:(a) taking an 5001.12.2023extensive patient history;(b) performing a clinical examination;(c) arranging 5001.12.2023any necessary investigation;(d) implementing a management plan;(e) providing 5001.12.2023appropriate preventive health care;for one or more health related issues, with 5001.12.2023appropriate documentationan attendance on one or more patients at one place on 5001.12.2023one occasioneach patient 1000128 26.05.2002 1 A4 SN NYNNY 2001.12.202300250.0000123.7000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital, by 5001.12.2023a consultant physician in the practice of the consultant physician's specialty 5001.12.2023(other than psychiatry) following referral of the patient to the consultant 5001.12.2023physician by a referring practitioner-each attendance (other than a service to 5001.12.2023which item 131 applies) after the first in a single course of treatment 1000131 26.05.2002 1 A4 SN NYNNY 2001.12.202300173.0000089.1500000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital, by 5001.12.2023a consultant physician in the practice of the consultant physician's specialty 5001.12.2023(other than psychiatry) following referral of the patient to the consultant 5001.12.2023physician by a referring practitioner-each minor attendance after the first in 5001.12.2023a single course of treatment 1000132 01.11.2007 1 A4 SN NYNNY 2001.12.202300680.0000294.8500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty (other than psychiatry) of at least 45 5001.12.2023minutes in duration for an initial assessment of a patient with at least 2 5001.12.2023morbidities (which may include complex congenital, developmental and 5001.12.2023behavioural disorders) following referral of the patient to the consultant 5001.12.2023physician by a referring practitioner, if: (a) an assessment is undertaken 5001.12.2023that covers: (i) a comprehensive history, including psychosocial history and 5001.12.2023medication review; and (ii) comprehensive multi or detailed single organ 5001.12.2023system assessment; and (iii) the formulation of differential diagnoses; and 5001.12.2023(b) a consultant physician treatment and management plan of significant 5001.12.2023complexity is prepared and provided to the referring practitioner, which 5001.12.2023involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment 5001.12.2023options and decisions; and (iii) medication recommendations; and (c) an 5001.12.2023attendance on the patient to which item 110, 116 or 119 applies did not take 5001.12.2023place on the same day by the same consultant physician; and (d) this item has 5001.12.2023not applied to an attendance on the patient in the preceding 12 months by the 5001.12.2023same consultant physician 1000133 01.11.2007 1 A4 SN NYNNY 2001.12.202300340.0000147.6500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty (other than psychiatry) of at least 20 5001.12.2023minutes in duration after the first attendance in a single course of treatment 5001.12.2023for a review of a patient with at least 2 morbidities (which may include 5001.12.2023complex congenital, developmental and behavioural disorders) if: (a) a review 5001.12.2023is undertaken that covers: (i) review of initial presenting problems and 5001.12.2023results of diagnostic investigations; and (ii) review of responses to 5001.12.2023treatment and medication plans initiated at time of initial consultation; and 5001.12.2023(iii) comprehensive multi or detailed single organ system assessment; and (iv) 5001.12.2023review of original and differential diagnoses; and (b) the modified consultant 5001.12.2023physician treatment and management plan is provided to the referring 5001.12.2023practitioner, which involves, if appropriate: (i) a revised opinion on the 5001.12.2023diagnosis and risk assessment; and (ii) treatment options and decisions; and 5001.12.2023(iii) revised medication recommendations; and (c) an attendance on the patient 5001.12.2023to which item 110, 116 or 119 applies did not take place on the same day by 5001.12.2023the same consultant physician; and (d) item 132 applied to an attendance 5001.12.2023claimed in the preceding 12 months; and (e) the attendance under this item is 5001.12.2023claimed by the same consultant physician who claimed item 132 or a locum 5001.12.2023tenens; and (f) this item has not applied more than twice in any 12 month 5001.12.2023period 1000141 01.11.2007 1 A28 SN NYNNY 2001.12.202300890.0000505.7000000.00 5001.12.2023Professional attendance of more than 60 minutes in duration at consulting 5001.12.2023rooms or hospital by a consultant physician or specialist in the practice of 5001.12.2023the consultant physician's or specialist's specialty of geriatric medicine, 5001.12.2023if: (a) the patient is at least 65 years old and referred by a medical 5001.12.2023practitioner practising in general practice (including a general practitioner, 5001.12.2023but not including a specialist or consultant physician) or a participating 5001.12.2023nurse practitioner; and (b) the attendance is initiated by the referring 5001.12.2023practitioner for the provision of a comprehensive assessment and management 5001.12.2023plan; and (c) during the attendance: (i) the medical, physical, psychological 5001.12.2023and social aspects of the patient's health are evaluated in detail using 5001.12.2023appropriately validated assessment tools if indicated (the assessment); and 5001.12.2023(ii) the patient's various health problems and care needs are identified and 5001.12.2023prioritised (the formulation); and (iii) a detailed management plan is 5001.12.2023prepared (the management plan) setting out: (A) the prioritised list of health 5001.12.2023problems and care needs; and (B) short and longer term management goals; and 5001.12.2023(C) recommended actions or intervention strategies to be undertaken by the 5001.12.2023patient's general practitioner or another relevant health care provider that 5001.12.2023are likely to improve or maintain health status and are readily available and 5001.12.2023acceptable to the patient and the patient's family and carers; and (iv) the 5001.12.2023management plan is explained and discussed with the patient and, if 5001.12.2023appropriate, the patient's family and any carers; and (v) the management plan 5001.12.2023is communicated in writing to the referring practitioner; and (d) an 5001.12.2023attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not 5001.12.2023been provided to the patient on the same day by the same practitioner; and (e) 5001.12.2023an attendance to which this item or item 145 applies has not been provided to 5001.12.2023the patient by the same practitioner in the preceding 12 months 1000143 01.11.2007 1 A28 SN NYNNY 2001.12.202300595.0000316.1500000.00 5001.12.2023Professional attendance of more than 30 minutes in duration at consulting 5001.12.2023rooms or hospital by a consultant physician or specialist in the practice of 5001.12.2023the consultant physician's or specialist's specialty of geriatric medicine to 5001.12.2023review a management plan previously prepared by that consultant physician or 5001.12.2023specialist under item 141 or 145, if: (a) the review is initiated by the 5001.12.2023referring medical practitioner practising in general practice or a 5001.12.2023participating nurse practitioner; and (b) during the attendance: (i) the 5001.12.2023patient's health status is reassessed; and (ii) a management plan prepared 5001.12.2023under item 141 or 145 is reviewed and revised; and (iii) the revised 5001.12.2023management plan is explained to the patient and (if appropriate) the patient's 5001.12.2023family and any carers and communicated in writing to the referring 5001.12.2023practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 5001.12.2023or 119 applies was not provided to the patient on the same day by the same 5001.12.2023practitioner; and (d) an attendance to which item 141 or 145 applies has been 5001.12.2023provided to the patient by the same practitioner in the preceding 12 months; 5001.12.2023and (e) an attendance to which this item or item 147 applies has not been 5001.12.2023provided to the patient in the preceding 12 months, unless there has been a 5001.12.2023significant change in the patient's clinical condition or care circumstances 5001.12.2023that requires a further review 1000145 01.11.2007 1 A28 SN NYNNY 2001.12.202301080.0000613.1500000.00 5001.12.2023Professional attendance of more than 60 minutes in duration at a place other 5001.12.2023than consulting rooms or hospital by a consultant physician or specialist in 5001.12.2023the practice of the consultant physician's or specialist's specialty of 5001.12.2023geriatric medicine, if: (a) the patient is at least 65 years old and referred 5001.12.2023by a medical practitioner practising in general practice (including a general 5001.12.2023practitioner, but not including a specialist or consultant physician) or a 5001.12.2023participating nurse practitioner; and (b) the attendance is initiated by the 5001.12.2023referring practitioner for the provision of a comprehensive assessment and 5001.12.2023management plan; and (c) during the attendance: (i) the medical, physical, 5001.12.2023psychological and social aspects of the patient's health are evaluated in 5001.12.2023detail utilising appropriately validated assessment tools if indicated (the 5001.12.2023assessment); and (ii) the patient's various health problems and care needs are 5001.12.2023identified and prioritised (the formulation); and (iii) a detailed management 5001.12.2023plan is prepared (the management plan) setting out: (A) the prioritised list 5001.12.2023of health problems and care needs; and (B) short and longer term management 5001.12.2023goals; and (C) recommended actions or intervention strategies, to be 5001.12.2023undertaken by the patient's general practitioner or another relevant health 5001.12.2023care provider that are likely to improve or maintain health status and are 5001.12.2023readily available and acceptable to the patient, the patient's family and any 5001.12.2023carers; and (iv) the management plan is explained and discussed with the 5001.12.2023patient and, if appropriate, the patient's family and any carers; and (v) the 5001.12.2023management plan is communicated in writing to the referring practitioner; and 5001.12.2023(d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies 5001.12.2023has not been provided to the patient on the same day by the same practitioner; 5001.12.2023and (e) an attendance to which this item or item 141 applies has not been 5001.12.2023provided to the patient by the same practitioner in the preceding 12 months 1000147 01.11.2007 1 A28 SN NYNNY 2001.12.202300725.0000383.3000000.00 5001.12.2023Professional attendance of more than 30 minutes in duration at a place other 5001.12.2023than consulting rooms or hospital by a consultant physician or specialist in 5001.12.2023the practice of the consultant physician's or specialist's specialty of 5001.12.2023geriatric medicine to review a management plan previously prepared by that 5001.12.2023consultant physician or specialist under items 141 or 145, if: (a) the review 5001.12.2023is initiated by the referring medical practitioner practising in general 5001.12.2023practice or a participating nurse practitioner; and (b) during the attendance: 5001.12.2023(i) the patient's health status is reassessed; and (ii) a management plan that 5001.12.2023was prepared under item 141 or 145 is reviewed and revised; and (iii) the 5001.12.2023revised management plan is explained to the patient and (if appropriate) the 5001.12.2023patient's family and any carers and communicated in writing to the referring 5001.12.2023practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 5001.12.2023or 119 applies has not been provided to the patient on the same day by the 5001.12.2023same practitioner; and (d) an attendance to which item 141 or 145 applies has 5001.12.2023been provided to the patient by the same practitioner in the preceding 12 5001.12.2023months; and (e) an attendance to which this item or 143 applies has not been 5001.12.2023provided by the same practitioner in the preceding 12 months, unless there has 5001.12.2023been a significant change in the patient's clinical condition or care 5001.12.2023circumstances that requires a further review 1000151 01.11.2023 1 A2 1 SN YNNYN 2001.12.202300191.0000098.4000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 60 minutes 5001.12.2023(other than a service to which any other item applies) by:(a) a medical 5001.12.2023practitioner who is not a general practitioner; or(b) a Group A1 disqualified 5001.12.2023general practitioner 1000160 26.05.2002 1 A5 SN NYNNY 2001.12.202300405.0000243.8500000.00 5001.12.2023Professional attendance by a general practitioner, specialist or consultant 5001.12.2023physician for a period of not less than 1 hour but less than 2 hours (other 5001.12.2023than a service to which another item applies) on a patient in imminent danger 5001.12.2023of death 1000161 26.05.2002 1 A5 SN NYNNY 2001.12.202300655.0000406.3500000.00 5001.12.2023Professional attendance by a general practitioner, specialist or consultant 5001.12.2023physician for a period of not less than 2 hours but less than 3 hours (other 5001.12.2023than a service to which another item applies) on a patient in imminent danger 5001.12.2023of death 1000162 26.05.2002 1 A5 SN NYNNY 2001.12.202300890.0000568.6500000.00 5001.12.2023Professional attendance by a general practitioner, specialist or consultant 5001.12.2023physician for a period of not less than 3 hours but less than 4 hours (other 5001.12.2023than a service to which another item applies) on a patient in imminent danger 5001.12.2023of death 1000163 26.05.2002 1 A5 SN NYNNY 2001.12.202301105.0000731.5000000.00 5001.12.2023Professional attendance by a general practitioner, specialist or consultant 5001.12.2023physician for a period of not less than 4 hours but less than 5 hours (other 5001.12.2023than a service to which another item applies) on a patient in imminent danger 5001.12.2023of death 1000164 26.05.2002 1 A5 SN NYNNY 2001.12.202301310.0000812.7500000.00 5001.12.2023Professional attendance by a general practitioner, specialist or consultant 5001.12.2023physician for a period of 5 hours or more (other than a service to which 5001.12.2023another item applies) on a patient in imminent danger of death 1000165 01.11.2023 1 A2 1 SD NNNYY 3001.12.2023An amount equal to $88.20, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $88.20 plus $0.70 per patient 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item in this 5001.12.2023Schedule applies) lasting more than 60 minutesan attendance on one or more 5001.12.2023patients at one place on one occasioneach patient, by:(a) a medical 5001.12.2023practitioner who is not a general practitioner; or(b) a Group A1 disqualified 5001.12.2023general practitioner 1000170 26.05.2002 1 A6 SN NYNNY 2001.12.202300350.0000129.4000000.00 5001.12.2023Professional attendance for the purpose of group therapy of not less than 1 5001.12.2023hour in duration given under the direct continuous supervision of a general 5001.12.2023practitioner, specialist or consultant physician (other than a consultant 5001.12.2023physician in the practice of the consultant physician's specialty of 5001.12.2023psychiatry) involving members of a family and persons with close personal 5001.12.2023relationships with that family-each group of 2 patients 1000171 26.05.2002 1 A6 SN NYNNY 2001.12.202300360.0000136.3500000.00 5001.12.2023Professional attendance for the purpose of group therapy of not less than 1 5001.12.2023hour in duration given under the direct continuous supervision of a general 5001.12.2023practitioner, specialist or consultant physician (other than a consultant 5001.12.2023physician in the practice of the consultant physician's specialty of 5001.12.2023psychiatry) involving members of a family and persons with close personal 5001.12.2023relationships with that family-each group of 3 patients 1000172 26.05.2002 1 A6 SN NYNNY 2001.12.202300450.0000165.9000000.00 5001.12.2023Professional attendance for the purpose of group therapy of not less than 1 5001.12.2023hour in duration given under the direct continuous supervision of a general 5001.12.2023practitioner, specialist or consultant physician (other than a consultant 5001.12.2023physician in the practice of the consultant physician's specialty of 5001.12.2023psychiatry) involving members of a family and persons with close personal 5001.12.2023relationships with that family-each group of 4 or more patients 1000177 01.04.201901.12.20221 A7 5 DN NYNYY 2001.12.202300124.0000064.1000000.00 5001.12.2023Professional attendance on a patient who is 30 years of age or overfor a heart 5001.12.2023health assessment by amedical practitioner at consulting rooms(other than a 5001.12.2023specialist or consultant physician) lasting at least 20 minutes and including: 5001.12.2023(a) collection of relevant information, including taking a patient history; 5001.12.2023and (b) a basic physical examination, which must include recording blood 5001.12.2023pressure and cholesterol; and (c) initiating interventions and referrals as 5001.12.2023indicated; and (d) implementing a management plan; and (e) providing the 5001.12.2023patient with preventative health care advice and information. 1000179 01.07.2018 1 A7 2 SN NYNYY 2001.12.202300029.0000015.1500000.00 5001.12.2023Professional attendance at consulting rooms lasting not more than 5 minutes 5001.12.2023(other than a service to which any other item applies) by a prescribed medical 5001.12.2023practitioner in an eligible areaeach attendance 1000181 01.07.2018 1 A7 2 SD NYNYY 3001.12.2023The fee for item 179, plus $23.20 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023179 plus $1.85 per patient. 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item applies) 5001.12.2023lasting not more than 5 minutesan attendance on one or more patients at one 5001.12.2023place on one occasion by a prescribed medical practitioner in an eligible 5001.12.2023areaeach patient 1000185 01.07.2018 1 A7 2 SN NYNYY 2001.12.202300064.0000033.1000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 5 minutes but 5001.12.2023not more than 25 minutes (other than a service to which any other item 5001.12.2023applies) by a prescribed medical practitioner in an eligible areaeach 5001.12.2023attendance 1000187 01.07.2018 1 A7 2 SD NYNYY 3001.12.2023The fee for item 185, plus $23.20 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023185 plus $1.85 per patient. 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item applies) 5001.12.2023lasting more than 5 minutes but not more than 25 minutesan attendance on one 5001.12.2023or more patients at one place on one occasion by a prescribed medical 5001.12.2023practitioner in an eligible areaeach patient 1000189 01.07.2018 1 A7 2 SN NYNYY 2001.12.202300124.0000064.1000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 25 minutes but 5001.12.2023not more than 45 minutes (other than a service to which any other applies) by 5001.12.2023a prescribed medical practitioner in an eligible areaeach attendance 1000191 01.07.2018 1 A7 2 SD NYNYY 3001.12.2023The fee for item 189, plus $23.20 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023189 plus $1.85 per patient. 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item applies) 5001.12.2023lasting more than 25 minutes but not more than 45 minutesan attendance on one 5001.12.2023or more patients at one place on one occasion by a prescribed medical 5001.12.2023practitioner in an eligible areaeach patient 1000193 26.05.2002 1 A7 1 SN NYNNY 2001.12.202300095.0000040.7500000.00 5001.12.2023Professional attendance by a medical practitioner who holds endorsement of 5001.12.2023registration for acupuncture with the Medical Board of Australia or is 5001.12.2023registered by the Chinese Medicine Board of Australia as an acupuncturist, at 5001.12.2023a place other than a hospital, for treatment lasting less than 20 minutes and 5001.12.2023including any of the following that are clinically relevant: (a) taking a 5001.12.2023patient history; (b) performing a clinical examination; (c) arranging any 5001.12.2023necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation, at which acupuncture is performed by the 5001.12.2023medical practitioner by the application of stimuli on or through the skin by 5001.12.2023any means, including any consultation on the same occasion and another 5001.12.2023attendance on the same day related to the condition for which the acupuncture 5001.12.2023is performed 1000195 26.05.2002 1 A7 1 SD NYNNY 3001.12.2023The fee for item 193, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023193 plus $2.25 per patient. 5001.12.2023Professional attendance by a medical practitioner who holds endorsement of 5001.12.2023registration for acupuncture with the Medical Board of Australia or is 5001.12.2023registered by the Chinese Medicine Board of Australia as an acupuncturist, on 5001.12.2023one or more patients at a hospital, for treatment lasting less than 20 minutes 5001.12.2023and including any of the following that are clinically relevant: (a) taking a 5001.12.2023patient history; (b) performing a clinical examination; (c) arranging any 5001.12.2023necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation, at which acupuncture is performed by the 5001.12.2023medical practitioner by the application of stimuli on or through the skin by 5001.12.2023any means, including any consultation on the same occasion and another 5001.12.2023attendance on the same day related to the condition for which the acupuncture 5001.12.2023is performed 1000197 01.05.2003 1 A7 1 SN NYNNY 2001.12.202300174.0000078.9500000.00 5001.12.2023Professional attendance by a medical practitioner who holds endorsement of 5001.12.2023registration for acupuncture with the Medical Board of Australia or is 5001.12.2023registered by the Chinese Medicine Board of Australia as an acupuncturist, at 5001.12.2023a place other than a hospital, for treatment lasting at least 20 minutes and 5001.12.2023including any of the following that are clinically relevant: (a) taking a 5001.12.2023detailed patient history; (b) performing a clinical examination; (c) arranging 5001.12.2023any necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation, at which acupuncture is performed by the 5001.12.2023medical practitioner by the application of stimuli on or through the skin by 5001.12.2023any means, including any consultation on the same occasion and another 5001.12.2023attendance on the same day related to the condition for which the acupuncture 5001.12.2023is performed 1000199 01.05.2003 1 A7 1 SN NYNNY 2001.12.202300265.0000116.2000000.00 5001.12.2023Professional attendance by a medical practitioner who holds endorsement of 5001.12.2023registration for acupuncture with the Medical Board of Australia or is 5001.12.2023registered by the Chinese Medicine Board of Australia as an acupuncturist, at 5001.12.2023a place other than a hospital, for treatment lasting at least 40 minutes and 5001.12.2023including any of the following that are clinically relevant: (a) taking an 5001.12.2023extensive patient history; (b) performing a clinical examination; (c) 5001.12.2023arranging any necessary investigation; (d) implementing a management plan; (e) 5001.12.2023providing appropriate preventive health care; for one or more health-related 5001.12.2023issues, with appropriate documentation, at which acupuncture is performed by 5001.12.2023the medical practitioner by the application of stimuli on or through the skin 5001.12.2023by any means, including any consultation on the same occasion and another 5001.12.2023attendance on the same day related to the condition for which the acupuncture 5001.12.2023is performed 1000203 01.07.2018 1 A7 2 SN NYNYY 2001.12.202300183.0000094.4000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 45 minutes but 5001.12.2023not more than 60 minutes (other than a service to which any other item 5001.12.2023applies) by a prescribed medical practitioner in an eligible areaeach 5001.12.2023attendance 1000206 01.07.2018 1 A7 2 SD NYNYY 3001.12.2023The fee for item 203, plus $23.20 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023203 plus $1.85 per patient. 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item applies) 5001.12.2023lasting more than 45 minutes but not more than 60 minutesan attendance on one 5001.12.2023or more patients at one place on one occasion by a prescribed medical 5001.12.2023practitioner in an eligible areaeach patient 1000214 01.07.2018 1 A7 3 SN NYNYY 2001.12.202300378.0000195.1000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner for a period of 5001.12.2023not less than one hour but less than 2 hours (other than a service to which 5001.12.2023another item applies) on a patient in imminent danger of death 1000215 01.07.2018 1 A7 3 SN NYNYY 2001.12.202300630.0000325.1000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner for a period of 5001.12.2023not less than 2 hours but less than 3 hours (other than a service to which 5001.12.2023another item applies) on a patient in imminent danger of death 1000218 01.07.2018 1 A7 3 SN NYNYY 2001.12.202300881.0000454.9000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner for a period of 5001.12.2023not less than 3 hours but less than 4 hours (other than a service to which 5001.12.2023another item applies) on a patient in imminent danger of death 1000219 01.07.2018 1 A7 3 SN NYNYY 2001.12.202301134.0000585.2000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner for a period of 5001.12.2023not less than 4 hours but less than 5 hours (other than a service to which 5001.12.2023another item applies) on a patient in imminent danger of death 1000220 01.07.2018 1 A7 3 SN NYNYY 2001.12.202301259.0000650.2000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner for a period of 5 5001.12.2023hours or more (other than a service to which another item applies) on a 5001.12.2023patient in imminent danger of death 1000221 01.07.2018 1 A7 4 SN NYNYY 2001.12.202300200.0000103.5000000.00 5001.12.2023Professional attendance for the purpose of Group therapy lasting at least one 5001.12.2023hour given under the direct continuous supervision of a prescribed medical 5001.12.2023practitioner, involving members of a family and persons with close personal 5001.12.2023relationships with that familyeach Group of 2 patients 1000222 01.07.2018 1 A7 4 SN NYNYY 2001.12.202300211.0000109.1000000.00 5001.12.2023Professional attendance for the purpose of Group therapy lasting at least one 5001.12.2023hour given under the direct continuous supervision of a prescribed medical 5001.12.2023practitioner, involving members of a family and persons with close personal 5001.12.2023relationships with that familyeach Group of 3 patients 1000223 01.07.2018 1 A7 4 SN NYNYY 2001.12.202300257.0000132.7000000.00 5001.12.2023Professional attendance for the purpose of Group therapy lasting at least one 5001.12.2023hour given under the direct continuous supervision of a prescribed medical 5001.12.2023practitioner, involving members of a family and persons with close personal 5001.12.2023relationships with that familyeach Group of 4 or more patients 1000224 01.07.2018 1 A7 5 SN NYNYY 2001.12.202300101.0000052.2500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner to perform a 5001.12.2023brief health assessment, lasting not more than 30 minutes and including:(a) 5001.12.2023collection of relevant information, including taking a patient history; and(b) 5001.12.2023a basic physical examination; and(c) initiating interventions and referrals as 5001.12.2023indicated; and(d) providing the patient with preventive health care advice and 5001.12.2023information 1000225 01.07.2018 1 A7 5 SN NYNYY 2001.12.202300235.0000121.4500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner to perform a 5001.12.2023standard health assessment, lasting more than 30 minutes but less than 45 5001.12.2023minutes, including:(a) detailed information collection, including taking a 5001.12.2023patient history; and(b) an extensive physical examination; and(c) initiating 5001.12.2023interventions and referrals as indicated; and(d) providing a preventive health 5001.12.2023care strategy for the patient 1000226 01.07.2018 1 A7 5 SN NYNYY 2001.12.202300325.0000167.5500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner to perform a long 5001.12.2023health assessment, lasting at least 45 minutes but less than 60 minutes, 5001.12.2023including:(a) comprehensive information collection, including taking a patient 5001.12.2023history; and(b) an extensive examination of the patients medical condition and 5001.12.2023physical function; and(c) initiating interventions and referrals as indicated; 5001.12.2023and(d) providing a basic preventive health care management plan for the 5001.12.2023patient 1000227 01.07.2018 1 A7 5 SN NYNYY 2001.12.202300458.0000236.7000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner to perform a 5001.12.2023prolonged health assessment, lasting at least 60 minutes, including:(a) 5001.12.2023comprehensive information collection, including taking a patient history; 5001.12.2023and(b) an extensive examination of the patients medical condition, and 5001.12.2023physical, psychological and social function; and(c) initiating interventions 5001.12.2023and referrals as indicated; and(d) providing a comprehensive preventive health 5001.12.2023care management plan for the patient 1000228 01.07.2018 1 A7 5 SN NYNYY 2001.12.202300362.0000186.9000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner at consulting 5001.12.2023rooms or in a place other than a hospital or a residential aged care facility, 5001.12.2023for a health assessment of a patient who is of Aboriginal or Torres Strait 5001.12.2023Islander descentapplicable not more than once in a 9 month period and only if 5001.12.2023the following items are not applicable within the same 9 month period:(a) item 5001.12.2023715;(b) item 92004 or 92011 of the Telehealth and Telephone Determination 1000229 01.07.201801.12.20221 A7 6 SN NYNYY 2001.12.202300246.0000127.0500000.00 5001.12.2023Attendance by a prescribed medical practitioner, for preparation of a GP 5001.12.2023management plan for a patient (other than a service associated with a service 5001.12.2023to which any of items 235 to 240 and 735 to 758 apply) 1000230 01.07.201801.12.20221 A7 6 SN NYNYY 2001.12.202300195.0000100.7000000.00 5001.12.2023Attendance by a prescribed medical practitioner, to coordinate the development 5001.12.2023of team care arrangements for a patient (other than a service associated with 5001.12.2023a service to which any of items 235 to 240 and 735 to 758 apply) 1000231 01.07.201801.12.20221 A7 6 SN NYNYY 2001.12.202300120.0000062.0000000.00 5001.12.2023Either:(a) contribution to a multidisciplinary care plan, for a patient, 5001.12.2023prepared by another provider; or(b) contribution to a review of a 5001.12.2023multidisciplinary care plan, for a patient, prepared by another provider;by a 5001.12.2023prescribed medical practitioner, other than a service associated with a 5001.12.2023service to which any of items 235 to 240 and 735 to 758 apply 1000232 01.07.201801.12.20221 A7 6 SN NYNYY 2001.12.202300120.0000062.0000000.00 5001.12.2023Either:(a) contribution to a multidisciplinary care plan, for a patient in a 5001.12.2023residential aged care facility, prepared by that facility, or contribution to 5001.12.2023a review of a multidisciplinary care plan, for a patient, prepared by such a 5001.12.2023facility; or(b) contribution to a multidisciplinary care plan, for a patient, 5001.12.2023prepared by another provider before the patient is discharged from a hospital 5001.12.2023or contribution to a review of a multidisciplinary care plan, for a patient, 5001.12.2023prepared by another provider;by a prescribed medical practitioner, other than 5001.12.2023a service associated with a service to which any of items 235 to 240 and 735 5001.12.2023to 758 apply 1000233 01.07.201801.12.20221 A7 6 SN NYNYY 2001.12.202300123.0000063.4500000.00 5001.12.2023Attendance by a prescribed medical practitioner:(a) to review a GP management 5001.12.2023plan prepared by a medical practitioner (or an associated medical 5001.12.2023practitioner); or(b) to coordinate a review of team care arrangements which 5001.12.2023have been coordinated by the medical practitioner (or the associated medical 5001.12.2023practitioner) 1000235 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300121.0000062.3000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate:(a) a 5001.12.2023community case conference; or(b) a multidisciplinary case conference in a 5001.12.2023residential aged care facility; or(c) a multidisciplinary discharge case 5001.12.2023conference;if the conference lasts for at least 15 minutes but less than 20 5001.12.2023minutes, other than a service associated with a service to which any of items 5001.12.2023229 to 233 and 721 to 732 apply 1000236 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300206.0000106.5000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate:(a) a 5001.12.2023community case conference; or(b) a multidisciplinary case conference in a 5001.12.2023residential aged care facility; or(c) a multidisciplinary discharge case 5001.12.2023conference;if the conference lasts for at least 20 minutes but less than 40 5001.12.2023minutes, other than a service associated with a service to which any of items 5001.12.2023229 to 233 and 721 to 732 apply 1000237 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300344.0000177.5000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate:(a) a 5001.12.2023community case conference; or(b) a multidisciplinary case conference in a 5001.12.2023residential aged care facility; or(c) a multidisciplinary discharge case 5001.12.2023conference;if the conference lasts at least 40 minutes, other than a service 5001.12.2023associated with a service to which any of items 229 to 233 and 721 to 732 5001.12.2023apply 1000238 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300089.0000045.7500000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in:(a) a community case 5001.12.2023conference; or(b) a multidisciplinary case conference in a residential aged 5001.12.2023care facility; or(c) a multidisciplinary discharge case conference;if the 5001.12.2023conference lasts for at least 15 minutes but less than 20 minutes, other than 5001.12.2023a service associated with a service to which any of items 229 to 233 and 721 5001.12.2023to 732 apply 1000239 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300152.0000078.4000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in:(a) a community case 5001.12.2023conference; or(b) a multidisciplinary case conference in a residential aged 5001.12.2023care facility; or(c) a multidisciplinary discharge case conference;if the 5001.12.2023conference lasts for at least 20 minutes but less than 40 minutes, other than 5001.12.2023a service associated with a service to any of items 229 to 233 and 721 to 732 5001.12.2023apply 1000240 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300253.0000130.5000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in:(a) a community case 5001.12.2023conference; or(b) a multidisciplinary case conference in a residential aged 5001.12.2023care facility; or(c) a multidisciplinary discharge case conference;if the 5001.12.2023conference lasts for at least 40 minutes, other than a service associated with 5001.12.2023a service to which any of items 229 to 233 and 721 to 732 apply 1000243 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300118.0000061.0000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a case 5001.12.2023conference team, to lead and coordinate a multidisciplinary case conference on 5001.12.2023a patient with cancer, to develop a multidisciplinary treatment plan, if the 5001.12.2023case conference lasts at least 10 minutes, with a multidisciplinary team of at 5001.12.2023least 3 other medical practitioners from different areas of medical practice 5001.12.2023(which may include general practice), and, in addition, allied health 5001.12.2023providers 1000244 01.07.2018 1 A7 6 SN NYNYY 2001.12.202300055.0000028.4500000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a case 5001.12.2023conference team, to participate in a multidisciplinary case conference on a 5001.12.2023patient with cancer, to develop a multidisciplinary treatment plan, if the 5001.12.2023case conference lasts at least 10 minutes, with a multidisciplinary team of at 5001.12.2023least 4 medical practitioners from different areas of medical practice (which 5001.12.2023may include general practice), and, in addition, allied health providers 1000272 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300122.0000063.1500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner (who has not 5001.12.2023undertaken mental health skills training), lasting at least 20 minutes but 5001.12.2023less than 40 minutes, for the preparation of a GP mental health treatment plan 5001.12.2023for a patient 1000276 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300180.0000092.9500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner (who has not 5001.12.2023undertaken mental health skills training), lasting at least 40 minutes, for 5001.12.2023the preparation of a GP mental health treatment plan for a patient 1000277 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300122.0000063.1500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner to:(a) review a 5001.12.2023GP mental health treatment plan which a medical practitioner, or an associated 5001.12.2023medical practitioner, has prepared; or(b) to review a Psychiatrist Assessment 5001.12.2023and Management Plan 1000279 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300122.0000063.1500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner, in relation to a 5001.12.2023mental disorder, lasting at least 20 minutes and involving:(a) taking relevant 5001.12.2023history and identifying the presenting problem (to the extent not previously 5001.12.2023recorded); and(b) providing treatment and advice; and(c) if appropriate, 5001.12.2023referral for other services or treatments; and(d) documenting the outcomes of 5001.12.2023the consultation 1000281 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300155.0000080.1500000.00 5001.12.2023Professional attendance by a prescribed medical practitioner (who has 5001.12.2023undertaken mental health skills training), lasting at least 20 minutes but 5001.12.2023less than 40 minutes, for the preparation of a GP mental health treatment plan 5001.12.2023for a patient 1000282 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300229.0000118.1000000.00 5001.12.2023Professional attendance by a prescribed medical practitioner (who has 5001.12.2023undertaken mental health skills training), lasting at least 40 minutes, for 5001.12.2023the preparation of a GP mental health treatment plan for a patient 1000283 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300158.0000081.7000000.00 5001.12.2023Professional attendance at consulting rooms by a prescribed medical 5001.12.2023practitioner, registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialling requirements for provision of this service:(a) for providing 5001.12.2023focussed psychological strategies for mental disorders that have been assessed 5001.12.2023by a medical practitioner; and(b) lasting at least 30 minutes but less than 40 5001.12.2023minutes 1000285 01.07.2018 1 A7 9 SD NYNYY 3001.12.2023The fee for item 283, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023283 plus $1.80 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a prescribed 5001.12.2023medical practitioner, registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service:(a) for 5001.12.2023providing focussed psychological strategies for mental disorders that have 5001.12.2023been assessed by a medical practitioner; and(b) lasting at least 30 minutes 5001.12.2023but less than 40 minutes 1000286 01.07.2018 1 A7 9 SN NYNYY 2001.12.202300226.0000116.9000000.00 5001.12.2023Professional attendance at consulting rooms by a prescribed medical 5001.12.2023practitioner, registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialling requirements for provision of this service:(a) for providing 5001.12.2023focussed psychological strategies for mental disorders that have been assessed 5001.12.2023by a medical practitioner; and(b) lasting at least 40 minutes 1000287 01.07.2018 1 A7 9 SD NYNYY 3001.12.2023The fee for item 286, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023286 plus $1.80 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a prescribed 5001.12.2023medical practitioner, registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service:(a) for 5001.12.2023providing focussed psychological strategies for mental disorders that have 5001.12.2023been assessed by a medical practitioner; and(b) lasting at least 40 minutes 1000289 01.07.2008 1 A8 SN NYNYY 2001.12.202300571.0000294.8500000.00 5001.12.2023Professional attendance lasting at least 45 minutes, by a consultant physician 5001.12.2023in the practice of the consultant physicians specialty of psychiatry, 5001.12.2023following referral of the patient to the consultant psychiatrist by areferring 5001.12.2023practitioner, for a patient aged under 25, if the consultant psychiatrist: (a) 5001.12.2023undertakes, or has previously undertaken in prior attendances, a comprehensive 5001.12.2023assessment in relation to which a diagnosis of a complex neurodevelopmental 5001.12.2023disorder (such as autism spectrum disorder) is made (if appropriate, using 5001.12.2023information provided by an eligible allied health provider); and (b) develops 5001.12.2023a treatment and management plan, which must include: (i) documentation of the 5001.12.2023confirmed diagnosis; and (ii) findings of any assessments performed for the 5001.12.2023purposes of formulation of the diagnosis or contribution to the treatment and 5001.12.2023management plan; and (iii) a risk assessment; and (iv) treatment options 5001.12.2023(which may include biopsychosocial recommendations); and (c) provides a copy 5001.12.2023of the treatment and management plan to: (i) the referring practitioner; and 5001.12.2023(ii) one or more allied health providers, if appropriate, for the treatment of 5001.12.2023the patient; (other than attendance on a patient for whom payment has 5001.12.2023previously been made under this item or item 135, 137, 139, 92140, 92141, 5001.12.202392142 or 92434) Applicable only once per lifetime 1000291 01.05.2005 1 A8 SN NYNNY 2001.12.202300890.0000505.7000000.00 5001.12.2023Professional attendance of more than 45 minutes in duration at consulting 5001.12.2023rooms by a consultant physician in the practice of the consultant physician's 5001.12.2023specialty of psychiatry, if: (a) the attendance follows referral of the 5001.12.2023patient to the consultant for an assessment or management by a medical 5001.12.2023practitioner in general practice (including a general practitioner, but not a 5001.12.2023specialist or consultant physician) or a participating nurse practitioner; and 5001.12.2023(b) during the attendance, the consultant: (i) uses an outcome tool (if 5001.12.2023clinically appropriate); and (ii) carries out a mental state examination; and 5001.12.2023(iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is 5001.12.2023clinically appropriate for the patient to be managed by the referring 5001.12.2023practitioner without ongoing treatment by the consultant; and (d) within 2 5001.12.2023weeks after the attendance, the consultant: (i) prepares a written diagnosis 5001.12.2023of the patient; and (ii) prepares a written management plan for the patient 5001.12.2023that: (A) covers the next 12 months; and (B) is appropriate to the patient's 5001.12.2023diagnosis; and (C) comprehensively evaluates the patient's biological, 5001.12.2023psychological and social issues; and (D) addresses the patient's diagnostic 5001.12.2023psychiatric issues; and (E) makes management recommendations addressing the 5001.12.2023patient's biological, psychological and social issues; and (iii) gives the 5001.12.2023referring practitioner a copy of the diagnosis and the management plan; and 5001.12.2023(iv) if clinically appropriate, explains the diagnosis and management plan, 5001.12.2023and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), 5001.12.2023if the patient agrees 1000293 01.05.2005 1 A8 SN NYNNY 2001.12.202300595.0000316.1500000.00 5001.12.2023Professional attendance of more than 30 minutes but not more than 45 minutes 5001.12.2023in duration at consulting rooms by a consultant physician in the practice of 5001.12.2023the consultant physician's specialty of psychiatry, if: (a) the patient is 5001.12.2023being managed by a medical practitioner or a participating nurse practitioner 5001.12.2023in accordance with a management plan prepared by the consultant in accordance 5001.12.2023with item 291; and (b) the attendance follows referral of the patient to the 5001.12.2023consultant for review of the management plan by the medical practitioner or a 5001.12.2023participating nurse practitioner managing the patient; and (c) during the 5001.12.2023attendance, the consultant: (i) uses an outcome tool (if clinically 5001.12.2023appropriate); and (ii) carries out a mental state examination; and (iii) makes 5001.12.2023a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 5001.12.20232 weeks after the attendance, the consultant: (i) prepares a written diagnosis 5001.12.2023of the patient; and (ii) revises the management plan; and (iii) gives the 5001.12.2023referring practitioner a copy of the diagnosis and the revised management 5001.12.2023plan; and (iv) if clinically appropriate, explains the diagnosis and the 5001.12.2023revised management plan, and gives a copy, to: (A) the patient; and (B) the 5001.12.2023patient's carer (if any), if the patient agrees; and (e) in the preceding 12 5001.12.2023months, a service to which item 291 applies has been provided; and (f) in the 5001.12.2023preceding 12 months, a service to which this item applies has not been 5001.12.2023provided 1000294 01.11.2022 1 A8 SD NNNYY 3001.12.202350% of the fee for item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 3001.12.2023316, 318, 319, 348, 350 or 352 5001.12.2023Professional attendance on a patient by a consultant physician practising in 5001.12.2023the consultant physicians specialty of psychiatry if: (a) the attendance is by 5001.12.2023video conference; and (b) except for the requirement for the attendance to be 5001.12.2023at consulting roomsitem 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 5001.12.2023316, 318, 319, 348, 350 or 352 would otherwise apply to the attendance; and 5001.12.2023(c) the patient is not an admitted patient; and (d) the patient is bulkbilled; 5001.12.2023and (e) the patient: (i) is located: (A) within a Modified Monash 2, 3, 4, 5, 5001.12.20236 or 7 area; and (B) at the time of the attendanceat least 15 km by road from 5001.12.2023the physician; or (ii) is a care recipient in a residential aged care 5001.12.2023facility; or (iii) is a patient of: (A) an Aboriginal medical service; or (B) 5001.12.2023an Aboriginal community controlled health service; for which a direction made 5001.12.2023under subsection19(2) of the Act applies 1000296 01.11.2006 1 A8 SN NYNNY 2001.12.202300485.0000290.8500000.00 5001.12.2023Professional attendance of more than 45 minutes in duration by a consultant 5001.12.2023physician in the practice of the consultant physician's speciality of 5001.12.2023psychiatry following referral of the patient to him or her by a referring 5001.12.2023practitioner-an attendance at consulting rooms if the patient: (a) is a new 5001.12.2023patient for this consultant psychiatrist; or (b) has not received a 5001.12.2023professional attendance from this consultant psychiatrist in the preceding 24 5001.12.2023months; other than attendance on a patient in relation to whom this item, or 5001.12.2023item 297 or 299 or any of items 300 to 308, has applied in the preceding 24 5001.12.2023months 1000297 01.11.2006 1 A8 SN NYNNY 2001.12.202300485.0000290.8500000.00 5001.12.2023Professional attendance of more than 45 minutes by a consultant physician in 5001.12.2023the practice of the consultant physician's speciality of psychiatry following 5001.12.2023referral of the patient to him or her by a referring practitioner-an 5001.12.2023attendance at hospital if the patient: (a) is a new patient for this 5001.12.2023consultant psychiatrist; or (b) has not received a professional attendance 5001.12.2023from this consultant psychiatrist in the preceding 24 months; other than 5001.12.2023attendance on a patient in relation to whom this item, or item 296 or 299 or 5001.12.2023any of items 300 to 308, has applied in the preceding 24 months (H) 1000299 01.11.2006 1 A8 SN NYNNY 2001.12.202300575.0000347.7500000.00 5001.12.2023Professional attendance of more than 45 minutes by a consultant physician in 5001.12.2023the practice of the consultant physician's speciality of psychiatry following 5001.12.2023referral of the patient to him or her by a referring practitioner-an 5001.12.2023attendance at a place other than consulting rooms or a hospital if the 5001.12.2023patient: (a) is a new patient for this consultant psychiatrist; or (b) has not 5001.12.2023received a professional attendance from this consultant psychiatrist in the 5001.12.2023preceding 24 months; other than attendance on a patient in relation to whom 5001.12.2023this item, or item 296 or 297 or any of items 300 to 308, has applied in the 5001.12.2023preceding 24 months 1000300 26.05.2002 1 A8 SN NYNNY 2001.12.202300108.0000048.4000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to him or her by a referring practitioner-an attendance of not more 5001.12.2023than 15 minutes in duration at consulting rooms, if that attendance and 5001.12.2023another attendance to whichitem 296 or any of items 300 to 308 applies have 5001.12.2023not exceeded 50 attendances in a calendar year for the patient 1000301 01.11.2023 1 A7 2 SN YNNYN 2001.12.202300296.0000152.9500000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 60 minutes 5001.12.2023(other than a service to which any other item in this Schedule applies) by a 5001.12.2023prescribed medical practitioner in an eligible areaeach attendance 1000302 26.05.2002 1 A8 SN NYNNY 2001.12.202300215.0000096.6000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to him or her by a referring practitioner-an attendance of more than 5001.12.202315 minutes, but not more than 30 minutes, in duration at consulting rooms, if 5001.12.2023that attendance and another attendance to whichitem 296 or any of items 300 to 5001.12.2023308 applies have not exceeded 50 attendances in a calendar year for the 5001.12.2023patient 1000303 01.11.2023 1 A7 2 SD NNNYY 3001.12.2023The fee for item 301, plus $23.20 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023301 plus $1.85 per patient. 5001.12.2023Professional attendance (other than an attendance at consulting rooms or a 5001.12.2023residential aged care facility or a service to which any other item applies) 5001.12.2023lasting more than 60 minutesan attendance on one or more patients at one place 5001.12.2023on one occasion by a prescribed medical practitioner in an eligible areaeach 5001.12.2023patient 1000304 26.05.2002 1 A8 SN NYNNY 2001.12.202300325.0000148.7000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to him or her by a referring practitioner-an attendance of more than 5001.12.202330 minutes, but not more than 45 minutes, in duration at consulting rooms), if 5001.12.2023that attendance and another attendance to whichitem 296 or any of items 300 to 5001.12.2023308 applies have not exceeded 50 attendances in a calendar year for the 5001.12.2023patient 1000306 26.05.2002 1 A8 SN NYNNY 2001.12.202300490.0000205.2000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to him or her by a referring practitioner-an attendance of more than 5001.12.202345 minutes, but not more than 75 minutes, in duration at consulting rooms, if 5001.12.2023that attendance and another attendance to whichitem 296 or any of items 300 to 5001.12.2023308 applies have not exceeded 50 attendances in a calendar year for the 5001.12.2023patient 1000308 26.05.2002 1 A8 SN NYNNY 2001.12.202300545.0000238.1500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to him or her by a referring practitioner-an attendance of more than 5001.12.202375 minutes in duration at consulting rooms), if that attendance and another 5001.12.2023attendance to whichitem 296 or any of items 300 to 308 applies have not 5001.12.2023exceeded 50 attendances in a calendar year for the patient 1000309 01.03.2023 1 A7 9 SN YYNYN 2001.12.202300158.0000081.7000000.00 5001.12.2023Professional attendance at consulting rooms by a prescribed medical 5001.12.2023practitioner, registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialling requirements for provision of this service:(a) for providing 5001.12.2023focussed psychological strategies for assessed mental disorders to a person 5001.12.2023other than the patient, if the service is part of the patients treatment; 5001.12.2023and(b) lasting at least 30 minutes but less than 40 minutes 1000311 01.03.2023 1 A7 9 SD NYNYY 3001.12.2023The fee for item 309, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023309 plus $1.80 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a prescribed 5001.12.2023medical practitioner, registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service:(a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and(b) lasting at least 30 minutes but less than 40 minutes 1000313 01.03.2023 1 A7 9 SN YYNYN 2001.12.202300226.0000116.9000000.00 5001.12.2023Professional attendance at consulting rooms by a prescribed medical 5001.12.2023practitioner, registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialling requirements for provision of this service:(a) for providing 5001.12.2023focussed psychological strategies for assessed mental disorders to a person 5001.12.2023other than the patient, if the service is part of the patients treatment; 5001.12.2023and(b) lasting at least 40 minutes 1000315 01.03.2023 1 A7 9 SD NYNYY 3001.12.2023The fee for item 313, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023313 plus $1.80 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a prescribed 5001.12.2023medical practitioner, registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service:(a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and(b) lasting at least 40 minutes 1000319 26.05.2002 1 A8 SN NYNNY 2001.12.202300490.0000205.2000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioneran attendance 5001.12.2023of more than 45 minutes in duration at consulting rooms, if the patient has: 5001.12.2023(a) been diagnosed as suffering severe personality disorder, anorexia nervosa, 5001.12.2023bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform 5001.12.2023disorder or a pervasive development disorder; and (b) forpatients 18 years and 5001.12.2023overbeen rated with a level of functional impairment within the range 1 to 50 5001.12.2023according to the Global Assessment of Functioning Scale; if that attendance 5001.12.2023and another attendance to whichitem 296 or any of items 300 to 308 applies 5001.12.2023have not exceeded 160 attendances in a calendar year for the patient 1000320 26.05.2002 1 A8 SN NYNNY 2001.12.202300108.0000048.4000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of not more than 15 minutes in duration at hospital 1000322 26.05.2002 1 A8 SN NYNNY 2001.12.202300215.0000096.6000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 15 minutes, but not more than 30 minutes, in duration at hospital 1000324 26.05.2002 1 A8 SN NYNNY 2001.12.202300325.0000148.7000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 30 minutes, but not more than 45 minutes, in duration at hospital 1000326 26.05.2002 1 A8 SN NYNNY 2001.12.202300490.0000205.2000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 45 minutes, but not more than 75 minutes, in duration at hospital 1000328 26.05.2002 1 A8 SN NYNNY 2001.12.202300550.0000238.1500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 75 minutes in duration at hospital 1000330 26.05.2002 1 A8 SN NYNNY 2001.12.202300178.0000088.9000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of not more than 15 minutes in duration if that attendance is at a place other 5001.12.2023than consulting rooms or hospital 1000332 26.05.2002 1 A8 SN NYNNY 2001.12.202300290.0000139.2000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 15 minutes, but not more than 30 minutes, in duration if that 5001.12.2023attendance is at a place other than consulting rooms or hospital 1000334 26.05.2002 1 A8 SN NYNNY 2001.12.202300395.0000202.8500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 30 minutes, but not more than 45 minutes, in duration if that 5001.12.2023attendance is at a place other than consulting rooms or hospital 1000336 26.05.2002 1 A8 SN NYNNY 2001.12.202300565.0000245.4500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 45 minutes, but not more than 75 minutes, in duration if that 5001.12.2023attendance is at a place other than consulting rooms or hospital 1000338 26.05.2002 1 A8 SN NYNNY 2001.12.202300605.0000278.8000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner-an attendance 5001.12.2023of more than 75 minutes in duration if that attendance is at a place other 5001.12.2023than consulting rooms or hospital 1000342 26.05.2002 1 A8 SN NYNNY 2001.12.202300134.0000055.0500000.00 5001.12.2023Group psychotherapy (including any associated consultations with a patient 5001.12.2023taking place on the same occasion and relating to the condition for which 5001.12.2023group therapy is conducted) of not less than 1 hour in duration given under 5001.12.2023the continuous direct supervision of a consultant physician in the practice of 5001.12.2023the consultant physician's specialty of psychiatry, involving a group of 2 to 5001.12.20239 unrelated patients or a family group of more than 3 patients, each of whom 5001.12.2023is referred to the consultant physician by a referring practitioner-each 5001.12.2023patient 1000344 26.05.2002 1 A8 SN NYNNY 2001.12.202300174.0000073.1000000.00 5001.12.2023Group psychotherapy (including any associated consultations with a patient 5001.12.2023taking place on the same occasion and relating to the condition for which 5001.12.2023group therapy is conducted) of not less than 1 hour in duration given under 5001.12.2023the continuous direct supervision of a consultant physician in the practice of 5001.12.2023the consultant physician's specialty of psychiatry, involving a family group 5001.12.2023of 3 patients, each of whom is referred to the consultant physician by a 5001.12.2023referring practitioner-each patient 1000346 26.05.2002 1 A8 SN NYNNY 2001.12.202300260.0000108.1500000.00 5001.12.2023Group psychotherapy (including any associated consultations with a patient 5001.12.2023taking place on the same occasion and relating to the condition for which 5001.12.2023group therapy is conducted) of not less than 1 hour in duration given under 5001.12.2023the continuous direct supervision of a consultant physician in the practice of 5001.12.2023the consultant physician's specialty of psychiatry, involving a family group 5001.12.2023of 2 patients, each of whom is referred to the consultant physician by a 5001.12.2023referring practitioner-each patient 1000348 26.05.2002 1 A8 SN NYNNY 2001.12.202300325.0000141.6000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 20 minutes, but 5001.12.2023less than 45 minutes, in duration, in the course of initial diagnostic 5001.12.2023evaluation of a patient 1000350 26.05.2002 1 A8 SN NYNNY 2001.12.202300435.0000195.4500000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 45 minutes in 5001.12.2023duration, in the course of initial diagnostic evaluation of a patient 1000352 26.05.2002 1 A8 SN NYNNY 2001.12.202300220.0000141.6000000.00 5001.12.2023Professional attendance by a consultant physician in the practice of the 5001.12.2023consultant physician's specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 20 minutes in 5001.12.2023duration, in the course of continuing management of a patient-if that 5001.12.2023attendance and another attendance to which this item applies have not exceeded 5001.12.20234 in a calendar year for the patient 1000385 26.05.2002 1 A12 SN NYNNY 2001.12.202300390.0000095.6000000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a consultant 5001.12.2023occupational physician in the practice of the consultant occupational 5001.12.2023physician's specialty of occupational medicine following referral of the 5001.12.2023patient to the consultant occupational physician by a referring 5001.12.2023practitioner-initial attendance in a single course of treatment 1000386 26.05.2002 1 A12 SN NYNNY 2001.12.202300180.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a consultant 5001.12.2023occupational physician in the practice of the consultant occupational 5001.12.2023physician's specialty of occupational medicine following referral of the 5001.12.2023patient to the consultant occupational physician by a referring 5001.12.2023practitioner-each attendance after the first in a single course of treatment 1000387 26.05.2002 1 A12 SN NYNNY 2001.12.202300470.0000140.2500000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a consultant occupational physician in the practice of the consultant 5001.12.2023occupational physician's specialty of occupational medicine following referral 5001.12.2023of the patient to the consultant occupational physician by a referring 5001.12.2023practitioner-initial attendance in a single course of treatment 1000388 26.05.2002 1 A12 SN NYNNY 2001.12.202300250.0000088.8000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a consultant occupational physician in the practice of the consultant 5001.12.2023occupational physician's specialty of occupational medicine following referral 5001.12.2023of the patient to the consultant occupational physician by a referring 5001.12.2023practitioner-each attendance after the first in a single course of treatment 1000410 26.05.2002 1 A13 SN NYNNY 2001.12.202300047.0000021.8500000.00 5001.12.2023LEVEL AProfessional attendance at consulting rooms by a public health 5001.12.2023physician in the practice of his or her specialty of public health medicine 5001.12.2023for an obvious problem characterised by the straightforward nature of the task 5001.12.2023that requires a short patient history and, if required, limited examination 5001.12.2023and management. 1000411 26.05.2002 1 A13 SN NYNNY 2001.12.202300095.0000047.7500000.00 5001.12.2023LEVEL BProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine at consulting rooms lasting 5001.12.2023less than 20 minutes, including any of the following that are clinically 5001.12.2023relevant: a)taking a patient history; b)performing a clinical examination; 5001.12.2023c)arranging any necessary investigation; d)implementing a management plan; 5001.12.2023e)providing appropriate preventive health care; in relation to 1 or more 5001.12.2023health-related issues, with appropriate documentation. 1000412 26.05.2002 1 A13 SN NYNNY 2001.12.202300174.0000092.4000000.00 5001.12.2023LEVEL CProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine at consulting rooms lasting at 5001.12.2023least 20 minutes, including any of the following that are clinically relevant: 5001.12.2023a)taking a detailed patient history; b)performing a clinical examination; 5001.12.2023c)arranging any necessary investigation; d)implementing a management plan; 5001.12.2023e)providing appropriate preventive health care; in relation to 1 or more 5001.12.2023health-related issues, with appropriate documentation. 1000413 26.05.2002 1 A13 SN NYNNY 2001.12.202300265.0000136.0500000.00 5001.12.2023LEVEL DProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine at consulting rooms lasting at 5001.12.2023least 40 minutes, including any of the following that are clinically relevant: 5001.12.2023a)taking an extensive patient history; b)performing a clinical examination; 5001.12.2023c)arranging any necessary investigation; d)implementing a management plan; 5001.12.2023e)providing appropriate preventive health care; in relation to 1 or more 5001.12.2023health-related issues, with appropriate documentation. 1000414 26.05.2002 1 A13 SD NYNNY 3001.12.2023The fee for item 410, plus $28.50 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023410 plus $2.25 per patient. 5001.12.2023LEVEL AProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine other than at consulting rooms 5001.12.2023for an obvious problem characterised by the straightforward nature of the task 5001.12.2023that requires a short patient history and, if required, limited examination 5001.12.2023and management 1000415 26.05.2002 1 A13 SD NYNNY 3001.12.2023The fee for item 411, plus $28.50 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023411 plus $2.25 per patient. 5001.12.2023LEVEL BProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine other than at consulting rooms, 5001.12.2023lasting less than 20 minutes, including any of the following that are 5001.12.2023clinically relevant: a)taking a patient history; b)performing a clinical 5001.12.2023examination; c)arranging any necessary investigation; d)implementing a 5001.12.2023management plan; e)providing appropriate preventive health care; in relation 5001.12.2023to 1 or more health-related issues, with appropriate documentation. 1000416 26.05.2002 1 A13 SD NYNNY 3001.12.2023The fee for item 412, plus $28.50 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023412 plus $2.25 per patient. 5001.12.2023LEVEL CProfessional attendance by a public health physician in the practice of 5001.12.2023his or her specialty of public health medicine other than at consulting rooms 5001.12.2023lasting at least 20 minutes, including any of the following that are 5001.12.2023clinically relevant: a)taking a detailed patient history; b)performing a 5001.12.2023clinical examination; c)arranging any necessary investigation; d)implementing 5001.12.2023a management plan; e)providing appropriate preventive health care; in relation 5001.12.2023to 1 or more health-related issues, with appropriate documentation. 1000417 26.05.2002 1 A13 SD NYNYY 3001.12.2023The fee for item 413, plus $28.50 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023413 plus $2.25 per patient. 5001.12.2023LEVEL D Professional attendance by a public health physician in the practice 5001.12.2023of the public health physicians specialty of public health medicine at other 5001.12.2023than consulting rooms, lasting at least 40 minutes and including any of the 5001.12.2023following that are clinically relevant: a)taking an extensive patient history; 5001.12.2023b)performing a clinical examination; c)arranging any necessary investigation; 5001.12.2023d)implementing a management plan; e)providing appropriate preventive health 5001.12.2023care; for one or more healthrelated issues, with appropriate documentation 1000585 01.03.2018 1 A111 SN NYNNY 2001.12.202300277.0000142.9000000.00 5001.12.2023Professional attendance by a general practitioner on one patient on one 5001.12.2023occasioneach attendance (other than an attendance in unsociable hours) in an 5001.12.2023after-hours period if: (a) the attendance is requested by the patient or a 5001.12.2023responsible person in the same unbroken after-hours period; and (b) the 5001.12.2023patients medical condition requires urgent assessment; and (c) if the 5001.12.2023attendance is at consulting roomsit is necessary for the practitioner to 5001.12.2023return to, and specially open, the consulting rooms for the attendance 1000588 01.03.2018 1 A111 SN NYNNY 2001.12.202300277.0000142.9000000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) on one patient on one occasioneach attendance (other than an 5001.12.2023attendance in unsociable hours) in an after-hours period if: (a) the 5001.12.2023attendance is requested by the patient or a responsible person in the same 5001.12.2023unbroken after-hours period; and (b) the patients medical condition requires 5001.12.2023urgent assessment; and (c) the attendance is in an after-hours rural area; and 5001.12.2023(d) if the attendance is at consulting roomsit is necessary for the 5001.12.2023practitioner to return to, and specially open, the consulting rooms for the 5001.12.2023attendance 1000591 01.03.2018 1 A111 SN NYNNY 2001.12.202300192.0000099.1000000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) on one patient on one occasioneach attendance (other than an 5001.12.2023attendance in unsociable hours) in an after-hours period if: (a) the 5001.12.2023attendance is requested by the patient or a responsible person in the same 5001.12.2023unbroken after-hours period; and (b) the patients medical condition requires 5001.12.2023urgent assessment; and (c) the attendance is not in an after-hours rural area; 5001.12.2023and (d) if the attendance is at consulting roomsit is necessary for the 5001.12.2023practitioner to return to, and specially open, the consulting rooms for the 5001.12.2023attendance 1000594 01.03.2018 1 A111 SN NYNNY 2001.12.202300089.0000046.2000000.00 5001.12.2023Professional attendance by a medical practitionereach additional patient at an 5001.12.2023attendance that qualifies for item 585, 588 or 591 in relation to the first 5001.12.2023patient 1000599 01.05.2010 1 A112 SN NYNNY 2001.12.202300560.0000168.4000000.00 5001.12.2023Professional attendance by a general practitioner on not more than one patient 5001.12.2023on one occasioneach attendance in unsociable hours if: (a) the attendance is 5001.12.2023requested by the patient or a responsible person in the same unbroken 5001.12.2023after-hours period; and (b) the patients medical condition requires urgent 5001.12.2023assessment; and (c) if the attendance is at consulting roomsit is necessary 5001.12.2023for the practitioner to return to, and specially open, the consulting rooms 5001.12.2023for the attendance 1000600 01.05.2010 1 A112 SN NYNNY 2001.12.202300560.0000134.6000000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) on not more than one patient on one occasioneach attendance in 5001.12.2023unsociable hours if: (a) the attendance is requested by the patient or a 5001.12.2023responsible person in the same unbroken after-hours period; and (b) the 5001.12.2023patients medical condition requires urgent assessment; and (c) if the 5001.12.2023attendance is at consulting roomsit is necessary for the practitioner to 5001.12.2023return to, and specially open, the consulting rooms for the attendance 1000699 01.04.2019 1 A14 DN NYNNY 2001.12.202300155.0000080.1000000.00 5001.12.2023Professional attendance on a patient who is 30 years of age or over for a 5001.12.2023heart health assessment by a general practitioner at consulting roomslasting 5001.12.2023at least 20 minutes and including: collection of relevant information, 5001.12.2023including taking a patient history; and a basic physical examination, which 5001.12.2023must include recording blood pressure and cholesterol; and initiating 5001.12.2023interventions and referrals as indicated; and implementing a management plan; 5001.12.2023and providing the patient with preventative health care advice and 5001.12.2023information. 1000721 01.07.200501.12.20221 A151 SN NYNNY 2001.12.202300315.0000158.8000000.00 5001.12.2023Attendance by a general practitioner for preparation of a GP management plan 5001.12.2023for a patient (other than a service associated with a service to which any of 5001.12.2023items 735 to 758 apply) 1000723 01.07.200501.12.20221 A151 SN NYNNY 2001.12.202300275.0000125.8500000.00 5001.12.2023Attendance by a general practitioner to coordinate the development of team 5001.12.2023care arrangements for a patient (other than a service associated with a 5001.12.2023service to which any of items 735 to 758 apply) 1000729 01.07.200501.12.20221 A151 SN NYNNY 2001.12.202300126.0000077.5000000.00 5001.12.2023Contribution by a general practitioner to a multidisciplinary care plan 5001.12.2023prepared by another provider or a review of a multidisciplinary care plan 5001.12.2023prepared by another provider (other than a service associated with a service 5001.12.2023to which any of items 735 to 758 apply) 1000731 01.07.200501.12.20221 A151 SN NYNNY 2001.12.202300126.0000077.5000000.00 5001.12.2023Contribution by a general practitioner to: (a) a multidisciplinary care plan 5001.12.2023for a patient in a residential aged care facility, prepared by that facility, 5001.12.2023or to a review of such a plan prepared by such a facility; or (b) a 5001.12.2023multidisciplinary care plan prepared for a patient by another provider before 5001.12.2023the patient is discharged from a hospital, or to a review of such a plan 5001.12.2023prepared by another provider (other than a service associated with a service 5001.12.2023to which items 735 to 758 apply) 1000732 01.05.201001.12.20221 A151 SN NYNNY 2001.12.202300158.0000079.3000000.00 5001.12.2023Attendance by a general practitioner to review or coordinate a review of: (a) 5001.12.2023a GP management plan prepared by a general practitioner (or an associated 5001.12.2023general practitioner) to which item 721 applies; or (b) team care arrangements 5001.12.2023which have been coordinated by the general practitioner (or an associated 5001.12.2023general practitioner) to which item 723 applies 1000733 01.07.2018 1 A7 10 DN NYNYY 2001.12.202300049.0000025.5000000.00 5001.12.2023Professional attendance at consulting rooms of not more than 5 minutes in 5001.12.2023duration (other than a service to which another item applies) by a prescribed 5001.12.2023medical practitionereach attendance 1000735 01.05.2010 1 A152 SN NYNNY 2001.12.202300310.0000077.8500000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate: (a) a community case conference; 5001.12.2023or (b) a multidisciplinary case conference in a residential aged care 5001.12.2023facility; or (c) a multidisciplinary discharge case conference; if the 5001.12.2023conference lasts for at least 15 minutes, but for less than 20 minutes (other 5001.12.2023than a service associated with a service to which items 721 to 732 apply) 1000737 01.07.2018 1 A7 10 DN NYNYY 2001.12.202300083.0000043.1000000.00 5001.12.2023Professional attendance at consulting rooms of more than 5 minutes in duration 5001.12.2023but not more than 25 minutes in duration (other than a service to which 5001.12.2023another item applies) by a prescribed medical practitionereach attendance 1000739 01.05.2010 1 A152 SN NYNNY 2001.12.202300435.0000133.1000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate: (a) a community case conference; 5001.12.2023or (b) a multidisciplinary case conference in a residential aged care 5001.12.2023facility; or (c) a multidisciplinary discharge case conference; if the 5001.12.2023conference lasts for at least 20 minutes, but for less than 40 minutes (other 5001.12.2023than a service associated with a service to which items 721 to 732 apply) 1000741 01.07.2018 1 A7 10 DN NYNYY 2001.12.202300143.0000073.9500000.00 5001.12.2023Professional attendance at consulting rooms of more than 25 minutes in 5001.12.2023duration but not more than 45 minutes in duration (other than a service to 5001.12.2023which another item applies) by a prescribed medical practitionereach 5001.12.2023attendance 1000743 01.05.2010 1 A152 SN NYNNY 2001.12.202300560.0000221.9000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate: (a) a community case conference; 5001.12.2023or (b) a multidisciplinary case conference in a residential aged care 5001.12.2023facility; or (c) a multidisciplinary discharge case conference; if the 5001.12.2023conference lasts for at least 40 minutes (other than a service associated with 5001.12.2023a service to which items 721 to 732 apply) 1000745 01.07.2018 1 A7 10 DN NYNYY 2001.12.202300201.0000103.7000000.00 5001.12.2023Professional attendance at consulting rooms of more than 45 minutes in 5001.12.2023duration but not more than 60 minutes (other than a service to which another 5001.12.2023item applies) by a prescribed medical practitionereach attendance 1000747 01.05.2010 1 A152 SN NYNNY 2001.12.202300186.0000057.2000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in: (a) a community case conference; or (b) a 5001.12.2023multidisciplinary case conference in a residential aged care facility; or (c) 5001.12.2023a multidisciplinary discharge case conference; if the conference lasts for at 5001.12.2023least 15 minutes, but for less than 20 minutes (other than a service 5001.12.2023associated with a service to which items 721 to 732 apply) 1000750 01.05.2010 1 A152 SN NYNNY 2001.12.202300250.0000098.0000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in: (a) a community case conference; or (b) a 5001.12.2023multidisciplinary case conference in a residential aged care facility; or (c) 5001.12.2023a multidisciplinary discharge case conference; if the conference lasts for at 5001.12.2023least 20 minutes, but for less than 40 minutes (other than a service 5001.12.2023associated with a service to which items 721 to 732 apply) 1000758 01.05.2010 1 A152 SN NYNNY 2001.12.202300310.0000163.1000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in: (a) a community case conference; or (b) a 5001.12.2023multidisciplinary case conference in a residential aged care facility; or (c) 5001.12.2023a multidisciplinary discharge case conference; if the conference lasts for at 5001.12.2023least 40 minutes (other than a service associated with a service to which 5001.12.2023items 721 to 732 apply) 1000761 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 733, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023733 plus $1.80 per patient. 5001.12.2023Professional attendance by a prescribed medical practitioner (other than 5001.12.2023attendance at consulting rooms, a hospital or a residential aged care facility 5001.12.2023or a service to which another item in the table applies), lasting not more 5001.12.2023than 5 minutesan attendance on one or more patients on one occasioneach 5001.12.2023patient 1000763 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 737, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023737 plus $1.80 per patient. 5001.12.2023Professional attendance by a prescribed medical practitioner (other than 5001.12.2023attendance at consulting rooms, a hospital or a residential aged care facility 5001.12.2023or a service to which another item in the table applies), lasting more than 5 5001.12.2023minutes, but not more than 25 minutesan attendance on one or more patients on 5001.12.2023one occasioneach patient 1000766 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 741, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023741 plus $1.80 per patient. 5001.12.2023Professional attendance by a prescribed medical practitioner (other than 5001.12.2023attendance at consulting rooms, a hospital or a residential aged care facility 5001.12.2023or a service to which another item in the table applies), lasting more than 25 5001.12.2023minutes, but not more than 45 minutesan attendance on one or more patients on 5001.12.2023one occasioneach patient 1000769 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 745, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023745 plus $1.80 per patient. 5001.12.2023Professional attendance by a prescribed medical practitioner (other than 5001.12.2023attendance at consulting rooms, a hospital or a residential aged care facility 5001.12.2023or a service to which another item in the table applies), lasting more than 45 5001.12.2023minutes, but not more than 60 minutesan attendance on one or more patients on 5001.12.2023one occasioneach patient. 1000788 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 741, plus $41.15 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023741 plus $2.90 per patient. 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self-contained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex if the patient is accommodated in the residential aged 5001.12.2023care facility (other than accommodation in a self-contained unit) of more than 5001.12.202325 minutes in duration but not more than 45 minutes by a prescribed medical 5001.12.2023practitioneran attendance on one or more patients at one residential aged care 5001.12.2023facility on one occasioneach patient 1000789 01.07.2018 1 A7 10 DD NYNYY 3001.12.2023The fee for item 745, plus $41.15 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.2023745 plus $2.90 per patient. 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self-contained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex if the patient is accommodated in the residential aged 5001.12.2023care facility (other than accommodation in a self-contained unit) of more than 5001.12.202345 minutes but not more than 60 minutes in duration by a prescribed medical 5001.12.2023practitioneran attendance on one or more patients at one residential aged care 5001.12.2023facility on one occasioneach patient 1000820 26.05.2002 1 A152 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a community case conference of at least 15 minutes but less than 30 5001.12.2023minutes, with a multidisciplinary team of at least 3 other formal care 5001.12.2023providers of different disciplines 1000822 26.05.2002 1 A152 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a community case conference of at least 30 minutes but less than 45 5001.12.2023minutes, with a multidisciplinary team of at least 3 other formal care 5001.12.2023providers of different disciplines 1000823 26.05.2002 1 A152 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a community case conference of at least 45 minutes, with a 5001.12.2023multidisciplinary team of at least 3 other formal care providers of different 5001.12.2023disciplines 1000825 26.05.2002 1 A152 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a multidisciplinary case conference team 5001.12.2023of at least 2 other formal care providers of different disciplines, to 5001.12.2023participate in a community case conference (other than to organise and 5001.12.2023coordinate the conference) of at least 15 minutes but less than 30 minutes, 5001.12.2023with the multidisciplinary case conference team 1000826 26.05.2002 1 A152 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a multidisciplinary case conference team 5001.12.2023of at least 2 other formal care providers of different disciplines, to 5001.12.2023participate in a community case conference (other than to organise and 5001.12.2023coordinate the conference) of at least 30 minutes but less than 45 minutes, 5001.12.2023with the multidisciplinary case conference team 1000828 26.05.2002 1 A152 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a multidisciplinary case conference team 5001.12.2023of at least 2 other formal care providers of different disciplines, to 5001.12.2023participate in a community case conference (other than to organise and 5001.12.2023coordinate the conference) of at least 45 minutes, with the multidisciplinary 5001.12.2023case conference team 1000830 26.05.2002 1 A152 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a discharge case conference of at least 15 minutes but less than 30 5001.12.2023minutes, with a multidisciplinary team of at least 3 other formal care 5001.12.2023providers of different disciplines 1000832 26.05.2002 1 A152 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a discharge case conference of at least 30 minutes but less than 45 5001.12.2023minutes, with a multidisciplinary team of at least 3 other formal care 5001.12.2023providers of different disciplines 1000834 26.05.2002 1 A152 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to organise and 5001.12.2023coordinate a discharge case conference of at least 45 minutes, with a 5001.12.2023multidisciplinary team of at least 3 other formal care providers of different 5001.12.2023disciplines 1000835 26.05.2002 1 A152 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to participate 5001.12.2023in a discharge case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 15 minutes but less than 30 minutes, with a 5001.12.2023multidisciplinary team of at least 2 other formal care providers of different 5001.12.2023disciplines 1000837 26.05.2002 1 A152 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to participate 5001.12.2023in a discharge case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 30 minutes but less than 45 minutes, with a 5001.12.2023multidisciplinary team of at least 2 other formal care providers of different 5001.12.2023disciplines 1000838 26.05.2002 1 A152 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty, as a member of a case conference team, to participate 5001.12.2023in a discharge case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 45 minutes, with a multidisciplinary team of at least 5001.12.20232 other formal care providers of different disciplines 1000855 01.11.2002 1 A152 SN NYNNY 2001.12.202300305.0000155.3500000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a multidisciplinary case 5001.12.2023conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of at 5001.12.2023least 15 minutes but less than 30 minutes, with the multidisciplinary case 5001.12.2023conference team 1000857 01.11.2002 1 A152 SN NYNNY 2001.12.202300460.0000233.2000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a multidisciplinary case 5001.12.2023conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of at 5001.12.2023least 30 minutes but less than 45 minutes, with the multidisciplinary case 5001.12.2023conference team 1000858 01.11.2002 1 A152 SN NYNNY 2001.12.202300615.0000310.7000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a multidisciplinary case 5001.12.2023conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of at 5001.12.2023least 45 minutes, with the multidisciplinary case conference team 1000861 01.11.2002 1 A152 SN NYNNY 2001.12.202300305.0000155.3500000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a case conference team, to 5001.12.2023organise and coordinate a discharge case conference of at least 15 minutes but 5001.12.2023less than 30 minutes, with a multidisciplinary team of at least 2 other formal 5001.12.2023care providers of different disciplines 1000864 01.11.2002 1 A152 SN NYNNY 2001.12.202300460.0000233.2000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a case conference team, to 5001.12.2023organise and coordinate a discharge case conference of at least 30 minutes but 5001.12.2023less than 45 minutes, with a multidisciplinary team of at least 2 other formal 5001.12.2023care providers of different disciplines 1000866 01.11.2002 1 A152 SN NYNNY 2001.12.202300615.0000310.7000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physician's specialty of psychiatry, as a member of a case conference team, to 5001.12.2023organise and coordinate a discharge case conference of at least 45 minutes, 5001.12.2023with a multidisciplinary team of at least 2 other formal care providers of 5001.12.2023different disciplines 1000871 01.11.2006 1 A152 SN NYNNY 2001.12.202300174.0000089.7000000.00 5001.12.2023Attendance by a general practitioner, specialist or consultant physician as a 5001.12.2023member of a case conference team, to lead and coordinate a multidisciplinary 5001.12.2023case conference on a patient with cancer to develop a multidisciplinary 5001.12.2023treatment plan, if the case conference is of at least 10 minutes, with a 5001.12.2023multidisciplinary team of at least 3 other medical practitioners from 5001.12.2023different areas of medical practice (which may include general practice), and, 5001.12.2023in addition, allied health providers 1000872 01.11.2006 1 A152 SN NYNNY 2001.12.202300081.0000041.8000000.00 5001.12.2023Attendance by a general practitioner, specialist or consultant physician as a 5001.12.2023member of a case conference team, to participate in a multidisciplinary case 5001.12.2023conference on a patient with cancer to develop a multidisciplinary treatment 5001.12.2023plan, if the case conference is of at least 10 minutes, with a 5001.12.2023multidisciplinary team of at least 4 medical practitioners from different 5001.12.2023areas of medical practice (which may include general practice), and, in 5001.12.2023addition, allied health providers 1000880 01.05.2006 1 A152 SN NYNNY 2001.12.202300108.0000054.3500000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of geriatric or 5001.12.2023rehabilitation medicine, as a member of a case conference team, to coordinate 5001.12.2023a case conference of at least 10 minutes but less than 30 minutes-for any 5001.12.2023particular patient, one attendance only in a 7 day period (other than 5001.12.2023attendance on the same day as an attendance for which item 832, 834, 835, 837 5001.12.2023or 838 was applicable in relation to the patient) (H) 1000900 26.05.2002 1 A17 SN NYNYY 2001.12.202300455.0000170.4500000.00 5001.12.2023Participation by a general practitioner (not including a specialist or 5001.12.2023consultant physician) in a Domiciliary Medication Management Review (DMMR) for 5001.12.2023a patient living in a community setting, in which the general practitioner, 5001.12.2023with the patients consent:(a) assesses the patient as:(i) having a chronic 5001.12.2023medical condition or a complex medication regimen; and(ii) not having their 5001.12.2023therapeutic goals met; and(b) following that assessment:(i) refers the patient 5001.12.2023to a community pharmacy or an accredited pharmacist for the DMMR; and(ii) 5001.12.2023provides relevant clinical information required for the DMMR; and(c) discusses 5001.12.2023with the reviewing pharmacist the results of the DMMR including suggested 5001.12.2023medication management strategies; and(d) develops a written medication 5001.12.2023management plan following discussion with the patient; and(e) provides the 5001.12.2023written medication management plan to a community pharmacy chosen by the 5001.12.2023patientFor any particular patientapplicable not more than once in each 12 5001.12.2023month period, and only if item 245 does not apply in the same 12 month period, 5001.12.2023except if there has been a significant change in the patients condition or 5001.12.2023medication regimen requiring a new DMMR 1000930 01.07.2023 1 A152 SN YYNYN 2001.12.202300151.0000077.8500000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate a mental health case conference, 5001.12.2023if the conference lasts for at least 15 minutes, but for less than 20 minutes 1000933 01.07.2023 1 A152 SN YYNYN 2001.12.202300258.0000133.1000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate a mental health case conference, 5001.12.2023if the conference lasts for at least 20 minutes, but for less than 40 minutes 1000935 01.07.2023 1 A152 SN YYNYN 2001.12.202300430.0000221.9000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to organise and coordinate a mental health case conference, 5001.12.2023if the conference lasts for at least 40 minutes 1000937 01.07.2023 1 A152 SN YYNYN 2001.12.202300111.0000057.2000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in a mental health case conference, if the 5001.12.2023conference lasts for at least 15 minutes, but for less than 20 minutes 1000943 01.07.2023 1 A152 SN YYNYN 2001.12.202300190.0000098.0000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in a mental health case conference, if the 5001.12.2023conference lasts for at least 20 minutes, but for less than 40 minutes 1000945 01.07.2023 1 A152 SN YYNYN 2001.12.202300316.0000163.1000000.00 5001.12.2023Attendance by a general practitioner, as a member of a multidisciplinary case 5001.12.2023conference team, to participate in a mental health case conference, if the 5001.12.2023conference lasts for at least 40 minutes 1000946 01.07.2023 1 A152 SN YYNYN 2001.12.202300301.0000155.3500000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference of at least 15 minutes but less than 30 minutes, with 5001.12.2023the multidisciplinary case conference team 1000948 01.07.2023 1 A152 SN YYNYN 2001.12.202300452.0000233.2000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference of at least 30 minutes but less than 45 minutes, with 5001.12.2023the multidisciplinary case conference team 1000959 01.07.2023 1 A152 SN YYNYN 2001.12.202300602.0000310.7000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference of at least 45 minutes, with the multidisciplinary case 5001.12.2023conference team 1000961 01.07.2023 1 A152 SN YYNYN 2001.12.202300216.0000111.6000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference of at least 15 minutes but less than 30 minutes, with the 5001.12.2023multidisciplinary case conference team 1000962 01.07.2023 1 A152 SN YYNYN 2001.12.202300345.0000178.0000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference of at least 30 minutes but less than 45 minutes, with the 5001.12.2023multidisciplinary case conference team 1000964 01.07.2023 1 A152 SN YYNYN 2001.12.202300473.0000244.4000000.00 5001.12.2023Attendance by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry or paediatrics, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference of at least 45 minutes, with the multidisciplinary case conference 5001.12.2023team 1000969 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300121.0000062.3000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference if the conference lasts for at least 15 minutes, but 5001.12.2023for less than 20 minutes 1000971 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300206.0000106.5000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference if the conference lasts for at least 20 minutes, but 5001.12.2023for less than 40 minutes 1000972 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300344.0000177.5500000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to organise and coordinate a mental 5001.12.2023health case conference if the conference lasts for at least 40 minutes 1000973 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300089.0000045.7500000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 15 minutes, but for less than 5001.12.202320 minutes 1000975 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300152.0000078.4000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 20 minutes, but for less than 5001.12.202340 minutes 1000986 01.07.2023 1 A7 6 SN YYNYN 2001.12.202300253.0000130.5000000.00 5001.12.2023Attendance by a prescribed medical practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 40minutes 1002197 01.11.2023 1 A7 10 DN YNNYN 2001.12.202300341.0000176.2000000.00 5001.12.2023Professional attendance at consulting rooms of more than 60 minutes in 5001.12.2023duration (other than a service to which another item applies) by a prescribed 5001.12.2023medical practitionereach attendance. 1002198 01.11.2023 1 A7 10 DD NNNYY 3001.12.2023The fee for item 2197, plus $22.90 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232197 plus $1.80 per patient. 5001.12.2023Professional attendance by a prescribed medical practitioner (other than 5001.12.2023attendance at consulting rooms, a hospital or a residential aged care facility 5001.12.2023or a service to which another item in the table applies), lasting more than 60 5001.12.2023minutesan attendance on one or more patients on one occasioneach patient. 1002200 01.11.2023 1 A7 10 DD NNNYY 3001.12.2023The fee for item 2197, plus $41.15 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232197 plus $2.90 per patient. 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self-contained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex if the patient is accommodated in the residential aged 5001.12.2023care facility (other than accommodation in a self-contained unit) of more than 5001.12.202360 minutes in duration by a prescribed medical practitioneran attendance on 5001.12.2023one or more patients at one residential aged care facility on one occasioneach 5001.12.2023patient. 1002700 01.11.201101.12.20221 A201 SN NYNNY 2001.12.202300265.0000078.9500000.00 5001.12.2023Professional attendance by a general practitioner (including a general 5001.12.2023practitioner who has not undertaken mental health skills training) of at least 5001.12.202320 minutes but less than 40 minutes in duration for the preparation of a GP 5001.12.2023mental health treatment plan for a patient 1002701 01.11.201101.12.20221 A201 SN NYNNY 2001.12.202300390.0000116.2000000.00 5001.12.2023Professional attendance by a general practitioner (including a general 5001.12.2023practitioner who has not undertaken mental health skills training) of at least 5001.12.202340 minutes in duration for the preparation of a GP mental health treatment 5001.12.2023plan for a patient 1002712 01.11.200601.12.20221 A201 SN NYNNY 2001.12.202300260.0000078.9500000.00 5001.12.2023Professional attendance by a general practitioner to review a GP mental health 5001.12.2023treatment plan which he or she, or an associated general practitioner has 5001.12.2023prepared, or to review a Psychiatrist Assessment and Management Plan 1002713 01.11.200601.12.20221 A201 SN NYNNY 2001.12.202300215.0000078.9500000.00 5001.12.2023Professional attendance by a general practitioner in relation to a mental 5001.12.2023disorder and of at least 20 minutes in duration, involving taking relevant 5001.12.2023history and identifying the presenting problem (to the extent not previously 5001.12.2023recorded), providing treatment and advice and, if appropriate, referral for 5001.12.2023other services or treatments, and documenting the outcomes of the consultation 1002715 01.11.201101.12.20221 A201 SN NYNNY 2001.12.202300194.0000100.2000000.00 5001.12.2023Professional attendance by a general practitioner (including a general 5001.12.2023practitioner who has undertaken mental health skills training of at least 20 5001.12.2023minutes but less than 40 minutes in duration for the preparation of a GP 5001.12.2023mental health treatment plan for a patient 1002717 01.11.201101.12.20221 A201 SN NYNNN 2001.12.202300350.0000147.6500000.00 5001.12.2023Professional attendance by a general practitioner (including a general 5001.12.2023practitioner who has undertaken mental health skills training) of at least 40 5001.12.2023minutes in duration for the preparation of a GP mental health treatment plan 5001.12.2023for a patient 1002721 01.11.2002 1 A202 SN NYNNY 2001.12.202300198.0000102.1000000.00 5001.12.2023Professional attendance at consulting rooms by a general practitioner, for 5001.12.2023providing focussed psychological strategies for assessed mental disorders by a 5001.12.2023general practitioner registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service, and lasting at 5001.12.2023least 30 minutes, but less than 40 minutes 1002723 01.11.2002 1 A202 SD NYNNY 3001.12.2023The fee for item 2721, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232721 plus $2.25 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a general 5001.12.2023practitioner, for providing focussed psychological strategies for assessed 5001.12.2023mental disorders by a general practitioner registered with the Chief Executive 5001.12.2023Medicare as meeting the credentialling requirements for provision of this 5001.12.2023service, and lasting at least 30 minutes, but less than 40 minutes 1002725 01.11.2002 1 A202 SN NYNNY 2001.12.202300283.0000146.1000000.00 5001.12.2023Professional attendance at consulting rooms by a general practitioner, for 5001.12.2023providing focussed psychological strategies for assessed mental disorders by a 5001.12.2023general practitioner registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service, and lasting at 5001.12.2023least 40 minutes 1002727 01.11.2002 1 A202 SD NYNNY 3001.12.2023The fee for item 2725, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232725 plus $2.25 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a general 5001.12.2023practitioner, for providing focussed psychological strategies for assessed 5001.12.2023mental disorders by a general practitioner registered with the Chief Executive 5001.12.2023Medicare as meeting the credentialling requirements for provision of this 5001.12.2023service, and lasting at least 40 minutes 1002739 01.03.2023 1 A202 DN YYNYN 2001.12.202300198.0000102.1000000.00 5001.12.2023Professional attendance at consulting rooms by a general practitioner (not 5001.12.2023including a specialist or a consultant physician) registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies to a person 5001.12.2023other than the patient, if the service is part of the patients treatment; and 5001.12.2023(b) lasting at least 30 minutes, but less than 40 minutes 1002741 01.03.2023 1 A202 SD NYNYY 3001.12.2023The fee for item 2739, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232739 plus $2.25 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a general 5001.12.2023practitioner (not including a specialist or a consultant physician) registered 5001.12.2023with the Chief Executive Medicare as meeting the credentialling requirements 5001.12.2023for provision of this service: (a) for providing focussed psychological 5001.12.2023strategies to a person other than the patient, if the service is part of the 5001.12.2023patients treatment; and (b) lasting at least 30 minutes, but less than 40 5001.12.2023minutes 1002743 01.03.2023 1 A202 DN YYNYN 2001.12.202300283.0000146.1000000.00 5001.12.2023Professional attendance at consulting rooms by a general practitioner (not 5001.12.2023including a specialist or a consultant physician) registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies to a person 5001.12.2023other than the patient, if the service is part of the patients treatment; and 5001.12.2023(b) lasting at least 40 minutes 1002745 01.03.2023 1 A202 SD NYNYY 3001.12.2023The fee for item 2743, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20232743 plus $2.25 per patient. 5001.12.2023Professional attendance at a place other than consulting rooms by a general 5001.12.2023practitioner (not including a specialist or a consultant physician) registered 5001.12.2023with the Chief Executive Medicare as meeting the credentialling requirements 5001.12.2023for provision of this service: (a) for providing focussed psychological 5001.12.2023strategies to a person other than the patient, if the service is part of the 5001.12.2023patients treatment; and (b) lasting at least 40 minutes 1002801 01.05.2006 1 A241 SN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of pain medicine following referral of the patient to 5001.12.2023the specialist or consultant physician by a referring practitioner-initial 5001.12.2023attendance in a single course of treatment 1002806 01.05.2006 1 A241 SN NYNNY 2001.12.202300180.0000084.3500000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of pain medicine following referral of the patient to 5001.12.2023the specialist or consultant physician by a referring practitioner-each 5001.12.2023attendance (other than a service to which item 2814 applies) after the first 5001.12.2023in a single course of treatment 1002814 01.05.2006 1 A241 SN NYNNY 2001.12.202300093.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of pain medicine following referral of the patient to 5001.12.2023the specialist or consultant physician by a referring practitioner-each minor 5001.12.2023attendance after the first attendance in a single course of treatment 1002824 01.05.2006 1 A241 SN NYNNY 2001.12.202300470.0000204.5000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of pain medicine following referral of the 5001.12.2023patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-initial attendance in a single course of treatment 1002832 01.05.2006 1 A241 SN NYNNY 2001.12.202300250.0000123.7000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of pain medicine following referral of the 5001.12.2023patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-each attendance (other than a service to which item 2840 applies) 5001.12.2023after the first in a single course of treatment 1002840 01.05.2006 1 A241 SN NYNNY 2001.12.202300173.0000089.1500000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of pain medicine following referral of the 5001.12.2023patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-each minor attendance after the first attendance in a single 5001.12.2023course of treatment 1002946 01.05.2006 1 A242 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023community case conference of at least 15 minutes but less than 30 minutes 1002949 01.05.2006 1 A242 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023community case conference of at least 30 minutes but less than 45 minutes 1002954 01.05.2006 1 A242 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023community case conference of at least 45 minutes 1002958 01.05.2006 1 A242 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a community 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 15 minutes but less than 30 minutes 1002972 01.05.2006 1 A242 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a community 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 30 minutes but less than 45 minutes 1002974 01.05.2006 1 A242 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a community 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 45 minutes 1002978 01.05.2006 1 A242 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023discharge case conference of at least 15 minutes but less than 30 minutes, 5001.12.2023before the patient is discharged from a hospital (H) 1002984 01.05.2006 1 A242 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023discharge case conference of at least 30 minutes but less than 45 minutes, 5001.12.2023before the patient is discharged from a hospital (H) 1002988 01.05.2006 1 A242 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to organise and coordinate a 5001.12.2023discharge case conference of at least 45 minutes, before the patient is 5001.12.2023discharged from a hospital (H) 1002992 01.05.2006 1 A242 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a discharge 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 15 minutes but less than 30 minutes, before the patient is discharged 5001.12.2023from a hospital (H) 1002996 01.05.2006 1 A242 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a discharge 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 30 minutes but less than 45 minutes, before the patient is discharged 5001.12.2023from a hospital (H) 1003000 01.05.2006 1 A242 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of pain medicine, as a member 5001.12.2023of a multidisciplinary case conference team, to participate in a discharge 5001.12.2023case conference (other than to organise and coordinate the conference) of at 5001.12.2023least 45 minutes, before the patient is discharged from a hospital (H) 1003005 01.05.2006 1 A243 SN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of palliative medicine following referral of the patient 5001.12.2023to the specialist or consultant physician by a referring practitioner-initial 5001.12.2023attendance in a single course of treatment 1003010 01.05.2006 1 A243 SN NYNNY 2001.12.202300180.0000084.3500000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of palliative medicine following referral of the patient 5001.12.2023to the specialist or consultant physician by a referring practitioner-each 5001.12.2023attendance (other than a service to which item 3014 applies) after the first 5001.12.2023in a single course of treatment 1003014 01.05.2006 1 A243 SN NYNNY 2001.12.202300093.0000048.0500000.00 5001.12.2023Professional attendance at consulting rooms or hospital by a specialist, or 5001.12.2023consultant physician, in the practice of the specialist's or consultant 5001.12.2023physician's specialty of palliative medicine following referral of the patient 5001.12.2023to the specialist or consultant physician by a referring practitioner-each 5001.12.2023minor attendance after the first attendance in a single course of treatment 1003018 01.05.2006 1 A243 SN NYNNY 2001.12.202300470.0000204.5000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of palliative medicine following referral of 5001.12.2023the patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-initial attendance in a single course of treatment 1003023 01.05.2006 1 A243 SN NYNNY 2001.12.202300250.0000123.7000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of palliative medicine following referral of 5001.12.2023the patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-each attendance (other than a service to which item 3028 applies) 5001.12.2023after the first in a single course of treatment 1003028 01.05.2006 1 A243 SN NYNNY 2001.12.202300173.0000089.1500000.00 5001.12.2023Professional attendance at a place other than consulting rooms or hospital by 5001.12.2023a specialist, or consultant physician, in the practice of the specialist's or 5001.12.2023consultant physician's specialty of palliative medicine following referral of 5001.12.2023the patient to the specialist or consultant physician by a referring 5001.12.2023practitioner-each minor attendance after the first attendance in a single 5001.12.2023course of treatment 1003032 01.05.2006 1 A244 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to organise and coordinate 5001.12.2023a community case conference of at least 15 minutes but less than 30 minutes 1003040 01.05.2006 1 A244 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to organise and coordinate 5001.12.2023a community case conference of at least 30 minutes but less than 45 minutes 1003044 01.05.2006 1 A244 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to organise and coordinate 5001.12.2023a community case conference of at least 45 minutes 1003051 01.05.2006 1 A244 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to participate in a 5001.12.2023community case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 15 minutes but less than 30 minutes 1003055 01.05.2006 1 A244 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to participate in a 5001.12.2023community case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 30 minutes but less than 45 minutes, with a 5001.12.2023multidisciplinary team of at least 2 other formal care providers of different 5001.12.2023disciplines 1003062 01.05.2006 1 A244 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to participate in a 5001.12.2023community case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 45 minutes 1003069 01.05.2006 1 A244 SN NYNNY 2001.12.202300330.0000155.3500000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to organise and coordinate 5001.12.2023a discharge case conference of at least 15 minutes but less than 30 minutes, 5001.12.2023before the patient is discharged from a hospital (H) 1003074 01.05.2006 1 A244 SN NYNNY 2001.12.202300495.0000233.2000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a case conference team, to organise and coordinate a discharge case 5001.12.2023conference of at least 30 minutes but less than 45 minutes, before the patient 5001.12.2023is discharged from a hospital (H) 1003078 01.05.2006 1 A244 SN NYNNY 2001.12.202300660.0000310.7000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to organise and coordinate 5001.12.2023a discharge case conference of at least 45 minutes, before the patient is 5001.12.2023discharged from a hospital (H) 1003083 01.05.2006 1 A244 SN NYNNY 2001.12.202300205.0000111.6000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a case conference team, to participate in a discharge case 5001.12.2023conference (other than to organise and coordinate the conference) of at least 5001.12.202315 minutes but less than 30 minutes, before the patient is discharged from a 5001.12.2023hospital (H) 1003088 01.05.2006 1 A244 SN NYNNY 2001.12.202300325.0000178.0000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to participate in a 5001.12.2023discharge case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 30 minutes but less than 45 minutes, before the 5001.12.2023patient is discharged from a hospital (H) 1003093 01.05.2006 1 A244 SN NYNNY 2001.12.202300445.0000244.4000000.00 5001.12.2023Attendance by a specialist, or consultant physician, in the practice of the 5001.12.2023specialist's or consultant physician's specialty of palliative medicine, as a 5001.12.2023member of a multidisciplinary case conference team, to participate in a 5001.12.2023discharge case conference (other than to organise and coordinate the 5001.12.2023conference) of at least 45 minutes, before the patient is discharged from a 5001.12.2023hospital (H) 1005000 01.01.2005 1 A22 SN NYNNY 2001.12.202300071.0000031.9000000.00 5001.12.2023Professional attendance at consulting rooms (other than a service to which 5001.12.2023another item applies) by a general practitioner for an obvious problem 5001.12.2023characterised by the straightforward nature of the task that requires a short 5001.12.2023patient history and, if required, limited examination and management-each 5001.12.2023attendance 1005001 01.03.2020 1 A211 SN NYNNY 2001.12.202300150.0000064.6000000.00 5001.12.2023Professional attendance, on a patient aged 4 years or over but under 75 years 5001.12.2023old, at a recognised emergency department of a private hospital by a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine 5001.12.2023involving medical decisionmaking of ordinary complexity 1005003 01.01.2005 1 A22 SD NYNNY 3001.12.2023The fee for item 5000, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235000 plus $2.25 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms, a hospital or a residential aged care facility or a service 5001.12.2023to which another item in the table applies) that requires a short patient 5001.12.2023history and, if necessary, limited examination and management-an attendance on 5001.12.2023one or more patients on one occasion-each patient 1005004 01.03.2020 1 A211 SN NYNNY 2001.12.202300250.0000108.4500000.00 5001.12.2023Professional attendance, on a patient aged under 4 years, at a recognised 5001.12.2023emergency department of a private hospital by a specialist in the practice of 5001.12.2023the specialists specialty of emergency medicine involving medical 5001.12.2023decision-making of ordinary complexity 1005011 01.03.2020 1 A211 SN NYNNY 2001.12.202300250.0000108.4500000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over, at a recognised 5001.12.2023emergency department of a private hospital by a specialist in the practice of 5001.12.2023the specialists specialty of emergency medicine involving medical 5001.12.2023decision-making of ordinary complexity 1005012 01.03.2020 1 A211 SN NYNNY 2001.12.202300395.0000170.0000000.00 5001.12.2023Professional attendance, on a patient aged 4 years or over but under 75 years 5001.12.2023old, at a recognised emergency department of a private hospital by a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine 5001.12.2023involving medical decision-making of complexity that is more than ordinary but 5001.12.2023is not high 1005014 01.03.2020 1 A211 SN NYNNY 2001.12.202300495.0000213.8500000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over, at a recognised 5001.12.2023emergency department of a private hospital by a specialist in the practice of 5001.12.2023the specialists specialty of emergency medicine involving medical 5001.12.2023decision-making of complexity that is more than ordinary but is not high 1005016 01.03.2020 1 A211 SN NYNNY 2001.12.202300665.0000286.9500000.00 5001.12.2023Professional attendance, on a patient aged 4 years or over but under 75 years 5001.12.2023old, at a recognised emergency department of a private hospital by a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine 5001.12.2023involving medical decision-making of high complexity 1005019 01.03.2020 1 A211 SN NYNNY 2001.12.202300765.0000330.9000000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over, at a recognised 5001.12.2023emergency department of a private hospital by a specialist in the practice of 5001.12.2023the specialists specialty of emergency medicine involving medical 5001.12.2023decision-making of high complexity 1005020 01.01.2005 1 A22 SN NYNYY 2001.12.202300142.0000053.9000000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in this Schedule applies), lasting at 5001.12.2023least 6 minutes and less than 20 minutes and including any of the following 5001.12.2023that are clinically relevant:(a) taking a patient history;(b) performing a 5001.12.2023clinical examination;(c) arranging any necessary investigation;(d) 5001.12.2023implementing a management plan;(e) providing appropriate preventive health 5001.12.2023care;for one or more health-related issues, with appropriate documentation 1005021 01.03.2020 1 A211 SN NYNNY 2001.12.202300150.0000048.4000000.00 5001.12.2023Professional attendance, on a patient aged 4 years or over but under 75 years 5001.12.2023old, at a recognised emergency department of a private hospital by a medical 5001.12.2023practitioner (except a specialist in the practice of the specialists specialty 5001.12.2023of emergency medicine) involving medical decision-making of ordinary 5001.12.2023complexity 1005023 01.01.2005 1 A22 SD NYNYY 3001.12.2023The fee for item 5020, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235020 plus $2.25 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms, a hospital or a residential aged care facility or a service 5001.12.2023to which another item in this Schedule applies), lasting at least 6 minutes 5001.12.2023and less than 20 minutes and including any of the following that are 5001.12.2023clinically relevant:(a) taking a patient history;(b) performing a clinical 5001.12.2023examination;(c) arranging any necessary investigation;(d) implementing a 5001.12.2023management plan;(e) providing appropriate preventive health care;for one or 5001.12.2023more health-related issues, with appropriate documentationan attendance on one 5001.12.2023or more patients on one occasioneach patient 1005027 01.03.2020 1 A211 SN NYNNY 2001.12.202300250.0000081.3500000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over,at a recognised 5001.12.2023emergency department of a private hospital by a medical practitioner (except a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine) 5001.12.2023involving medical decision-making of ordinary complexity 1005030 01.03.2020 1 A211 SN NYNNY 2001.12.202300395.0000127.4500000.00 5001.12.2023Professional attendance, on a patient aged 4 years or over but under 75 years 5001.12.2023old, at a recognised emergency department of a private hospital by a medical 5001.12.2023practitioner (except a specialist in the practice of the specialists specialty 5001.12.2023of emergency medicine) involving medical decision-making of complexity that is 5001.12.2023more than ordinary but is not high 1005032 01.03.2020 1 A211 SN NYNNY 2001.12.202300495.0000160.4000000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over, at a recognised 5001.12.2023emergency department of a private hospital by a medical practitioner (except a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine) 5001.12.2023involving medical decision-making of complexity that is more than ordinary but 5001.12.2023is not high 1005033 01.03.2020 1 A211 SN NYNNY 2001.12.202300665.0000215.2000000.00 5001.12.2023Professional attendance, on a patient 4 years or over but under 75 years old, 5001.12.2023at a recognised emergency department of a private hospital by a medical 5001.12.2023practitioner (except a specialist in the practice of the specialists specialty 5001.12.2023of emergency medicine) involving medical decision-making of high complexity 1005036 01.03.2020 1 A211 SN NYNNY 2001.12.202300765.0000248.2000000.00 5001.12.2023Professional attendance, on a patient aged 75 years or over, at a recognised 5001.12.2023emergency department of a private hospital by a medical practitioner (except a 5001.12.2023specialist in the practice of the specialists specialty of emergency medicine) 5001.12.2023involving medical decision-making of high complexity 1005039 01.03.2020 1 A212 SN NYNNY 2001.12.202300360.0000156.8000000.00 5001.12.2023Professional attendance at a recognised emergency department of a private 5001.12.2023hospital by a specialist in the practice of the specialists specialty of 5001.12.2023emergency medicine for preparation of goals of care by the specialist for a 5001.12.2023gravely ill patient lacking current goals of care if: (a) the specialist takes 5001.12.2023overall responsibility for the preparation of the goals of care for the 5001.12.2023patient; and (b) the attendance is the first attendance by the specialist for 5001.12.2023the preparation of the goals of care for the patient following the 5001.12.2023presentation of the patient to the emergency department; and (c) the 5001.12.2023attendance is in conjunction with, or after, an attendance on the patient by 5001.12.2023the specialist that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5001.12.20235016, 5017 or 5019 1005040 01.01.2005 1 A22 SN NYNNY 2001.12.202300260.0000092.4500000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in the table applies), lasting at least 5001.12.202320 minutes and including any of the following that are clinically relevant: 5001.12.2023(a) taking a detailed patient history; (b) performing a clinical examination; 5001.12.2023(c) arranging any necessary investigation; (d) implementing a management plan; 5001.12.2023(e) providing appropriate preventive health care; for one or more 5001.12.2023health-related issues, with appropriate documentation-each attendance 1005041 01.03.2020 1 A212 SN NYNNY 2001.12.202300680.0000294.8500000.00 5001.12.2023Professional attendance at a recognised emergency department of a private 5001.12.2023hospital by a specialist in the practice of the specialists specialty of 5001.12.2023emergency medicine for preparation of goals of care by the specialist for a 5001.12.2023gravely ill patient lacking current goals of care if: (a) the specialist takes 5001.12.2023overall responsibility for the preparation of the goals of care for the 5001.12.2023patient; and (b) the attendance is the first attendance by the specialist for 5001.12.2023the preparation of the goals of care for the patient following the 5001.12.2023presentation of the patient to the emergency department; and (c) the 5001.12.2023attendance is not in conjunction with, or after, an attendance on the patient 5001.12.2023by the specialist that is described in item 5001, 5004, 5011, 5012, 5013, 5001.12.20235014, 5016, 5017 or 5019; and (d) the attendance is for at least 60 minutes 1005042 01.03.2020 1 A212 SN NYNNY 2001.12.202300360.0000117.7000000.00 5001.12.2023Professional attendance at a recognised emergency department of a private 5001.12.2023hospital by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) for preparation of goals of care 5001.12.2023by the practitioner for a gravely ill patient lacking current goals of care 5001.12.2023if: (a) the practitioner takes overall responsibility for the preparation of 5001.12.2023the goals of care for the patient; and (b) the attendance is the first 5001.12.2023attendance by the practitioner for the preparation of the goals of care for 5001.12.2023the patient following the presentation of the patient to the emergency 5001.12.2023department; and (c) the attendance is in conjunction with, or after, an 5001.12.2023attendance on the patient by the practitioner that is described in item 5021, 5001.12.20235022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 1005043 01.01.2005 1 A22 SD NYNNY 3001.12.2023The fee for item 5040, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235040 plus $2.25 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms, a hospital or a residential aged care facility or a service 5001.12.2023to which another item in the table applies), lasting at least 20 minutes and 5001.12.2023including any of the following that are clinically relevant: (a) taking a 5001.12.2023detailed patient history; (b) performing a clinical examination; (c) arranging 5001.12.2023any necessary investigation; (d) implementing a management plan; (e) providing 5001.12.2023appropriate preventive health care; for one or more health-related issues, 5001.12.2023with appropriate documentation-an attendance on one or more patients on one 5001.12.2023occasion-each patient 1005044 01.03.2020 1 A212 SN NYNNY 2001.12.202300680.0000221.1000000.00 5001.12.2023Professional attendance at a recognised emergency department of a private 5001.12.2023hospital by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) for preparation of goals of care 5001.12.2023by the practitioner for a gravely ill patient lacking current goals of care 5001.12.2023if: (a) the practitioner takes overall responsibility for the preparation of 5001.12.2023the goals of care for the patient; and (b) the attendance is the first 5001.12.2023attendance by the practitioner for the preparation of the goals of care for 5001.12.2023the patient following the presentation of the patient to the emergency 5001.12.2023department; and (c) the attendance is not in conjunction with, or after, an 5001.12.2023attendance on the patient by the practitioner that is described in item 5021, 5001.12.20235022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (d) the attendance is 5001.12.2023for at least 60 minutes 1005060 01.01.2005 1 A22 SN NYNNY 2001.12.202300400.0000129.6500000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in the table applies), lasting at least 5001.12.202340 minutes and including any of the following that are clinically relevant: 5001.12.2023(a) taking an extensive patient history; (b) performing a clinical 5001.12.2023examination; (c) arranging any necessary investigation; (d) implementing a 5001.12.2023management plan; (e) providing appropriate preventive health care; for one or 5001.12.2023more health-related issues, with appropriate documentation-each attendance 1005063 01.01.2005 1 A22 SD NYNNY 3001.12.2023The fee for item 5060, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235060 plus $2.25 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms, a hospital or a residential aged care facility or a service 5001.12.2023to which another item in the table applies), lasting at least 40 minutes and 5001.12.2023including any of the following that are clinically relevant: (a) taking an 5001.12.2023extensive patient history; (b) performing a clinical examination; (c) 5001.12.2023arranging any necessary investigation; (d) implementing a management plan; (e) 5001.12.2023providing appropriate preventive health care; for one or more health-related 5001.12.2023issues, with appropriate documentation-an attendance on one or more patients 5001.12.2023on one occasion-each patient 1005071 01.11.2023 1 A22 SN YNNYN 2001.12.202300427.0000220.2500000.00 5001.12.2023Professional attendance by a general practitioner at consulting rooms (other 5001.12.2023than a service to which another item in this Schedule applies), lasting at 5001.12.2023least 60 minutes and including any of the following that are clinically 5001.12.2023relevant:(a) taking an extensive patient history;(b) performing a clinical 5001.12.2023examination;(c) arranging any necessary investigation;(d) implementing a 5001.12.2023management plan;(e) providing appropriate preventive health care;for one or 5001.12.2023more health-related issues, with appropriate documentation 1005076 01.11.2023 1 A22 SD NNNYY 3001.12.2023The fee for item 5071, plus $28.60 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235071 plus $2.25 per patient. 5001.12.2023Professional attendance by a general practitioner (other than attendance at 5001.12.2023consulting rooms, a hospital or a residential aged care facility or a service 5001.12.2023to which another item in this Schedule applies), lasting at least 60 minutes 5001.12.2023and including any of the following that are clinically relevant:(a) taking an 5001.12.2023extensive patient history;(b) performing a clinical examination;(c) arranging 5001.12.2023any necessary investigation;(d) implementing a management plan;(e) providing 5001.12.2023appropriate preventive health care;for one or more health-related issues, with 5001.12.2023appropriate documentationan attendance on one or more patients on one 5001.12.2023occasioneach patient 1005077 01.11.2023 1 A22 SD NNNYY 3001.12.2023The fee for item 5071, plus $51.45 divided by the number of patients seen, up 3001.12.2023to a maximum of six patients. For seven or more patients - the fee for item 3001.12.20235071 plus $3.65 per patient. 5001.12.2023Professional attendance by a general practitioner, on care recipients in a 5001.12.2023residential aged care facility, other than a service to which another item in 5001.12.2023this Schedule applies, lasting at least 60 minutes and including any of the 5001.12.2023following that are clinically relevant:(a) taking an extensive patient 5001.12.2023history;(b) performing a clinical examination;(c) arranging any necessary 5001.12.2023investigation;(d) implementing a management plan;(e) providing appropriate 5001.12.2023preventive health care;for one or more health-related issues, with appropriate 5001.12.2023documentationan attendance on one or more patients at one residential aged 5001.12.2023care facility on one occasioneach patient 1005200 01.01.2005 1 A23 SN NNNNY 2001.12.202300071.0000021.0000000.00 5001.12.2023Professional attendance at consulting rooms of not more than 5 minutes in 5001.12.2023duration (other than a service to which another item applies) by a medical 5001.12.2023practitioner (other than a general practitioner)-each attendance 1005203 01.01.2005 1 A23 SN NNNNY 2001.12.202300142.0000031.0000000.00 5001.12.2023Professional attendance at consulting rooms of more than 5 minutes in duration 5001.12.2023but not more than 25 minutes in duration (other than a service to which 5001.12.2023another item applies) by a medical practitioner (other than a general 5001.12.2023practitioner)-each attendance 1005207 01.01.2005 1 A23 SN NNNNY 2001.12.202300260.0000048.0000000.00 5001.12.2023Professional attendance at consulting rooms of more than 25 minutes in 5001.12.2023duration but not more than 45 minutes in duration (other than a service to 5001.12.2023which another item applies) by a medical practitioner (other than a general 5001.12.2023practitioner)-each attendance 1005208 01.01.2005 1 A23 SN NYNYY 2001.12.202300400.0000071.0000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 45 minutes, but 5001.12.2023not more than 60 minutes, (other than a service to which another item applies) 5001.12.2023by a medical practitioner (other than a general practitioner) 1005209 01.11.2023 1 A23 SN YNNYN 2001.12.202300237.0000122.4000000.00 5001.12.2023Professional attendance at consulting rooms lasting more than 60 minutes 5001.12.2023(other than a service to which another item applies) by a medical practitioner 5001.12.2023(other than a general practitioner) 1005220 01.01.2005 1 A23 SD NNNNY 3001.12.2023An amount equal to $18.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $18.50 plus $.70 per patient 5001.12.2023Professional attendance by a medical practitioner who is not a general 5001.12.2023practitioner (other than attendance at consulting rooms, a hospital or a 5001.12.2023residential aged care facility or a service to which another item in the table 5001.12.2023applies), lasting not more than 5 minutes-an attendance on one or more 5001.12.2023patients on one occasion-each patient 1005223 01.01.2005 1 A23 SD NNNNY 3001.12.2023An amount equal to $26.00, plus $17.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $26.00 plus $.70 per patient 5001.12.2023Professional attendance by a medical practitioner who is not a general 5001.12.2023practitioner (other than attendance at consulting rooms, a hospital or a 5001.12.2023residential aged care facility or a service to which another item in the table 5001.12.2023applies), lasting more than 5 minutes, but not more than 25 minutes-an 5001.12.2023attendance on one or more patients on one occasion-each patient 1005227 01.01.2005 1 A23 SD NNNNY 3001.12.2023An amount equal to $45.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $45.50 plus $.70 per patient 5001.12.2023Professional attendance by a medical practitioner who is not a general 5001.12.2023practitioner (other than attendance at consulting rooms, a hospital or a 5001.12.2023residential aged care facility or a service to which another item in the table 5001.12.2023applies), lasting more than 25 minutes, but not more than 45 minutes-an 5001.12.2023attendance on one or more patients on one occasion-each patient 1005228 01.01.2005 1 A23 SD NYNYY 3001.12.2023An amount equal to $67.50, plus $15.50 divided by the number of patients seen, 3001.12.2023up to a maximum of six patients. For seven or more patients - an amount equal 3001.12.2023to $67.50 plus $0.70 per patient 5001.12.2023Professional attendance by a medical practitioner who is not a general 5001.12.2023practitioner (other than attendance at consulting rooms, a hospital or a 5001.12.2023residential aged care facility or a service to which another item in this 5001.12.2023Schedule applies), lasting more than 45 minutes, but not more than 60 5001.12.2023minutesan attendance on one or more patients on one occasioneach patient 1005261 01.11.2023 1 A23 SD NNNYY 3001.12.2023An amount equal to $112.20, plus $15.50 divided by the number of patients 3001.12.2023seen, up to a maximum of six patients. For seven or more patients - an amount 3001.12.2023equal to $112.20 plus $0.70 per patient 5001.12.2023Professional attendance by a medical practitioner who is not a general 5001.12.2023practitioner (other than attendance at consulting rooms, a hospital or a 5001.12.2023residential aged care facility or a service to which another item in this 5001.12.2023Schedule applies), lasting more than 60 minutesan attendance on one or more 5001.12.2023patients on one occasioneach patient 1005262 01.11.2023 1 A23 SD NNNYY 3001.12.2023An amount equal to $112.20, plus $27.95 divided by the number of patients 3001.12.2023seen, up to a maximum of six patients. For seven or more patients - an amount 3001.12.2023equal to $112.20 plus $1.25 per patient 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self-contained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex, if the patient is a care recipient at the facility and 5001.12.2023is not a resident of a self-contained unit, lasting more than 60 minutes by a 5001.12.2023medical practitioner (other than a general practitioner)an attendance on one 5001.12.2023or more patients at one residential aged care facility on one occasioneach 5001.12.2023patient 1006007 01.11.2006 1 A26 SN NYNNY 2001.12.202300315.0000144.7500000.00 5001.12.2023Professional attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist-an attendance (other than 5001.12.2023a second or subsequent attendance in a single course of treatment) at 5001.12.2023consulting rooms or hospital 1006009 01.11.2006 1 A26 SN NYNNY 2001.12.202300112.0000048.0500000.00 5001.12.2023Professional attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist-a minor attendance after 5001.12.2023the first in a single course of treatment at consulting rooms or hospital 1006011 01.11.2006 1 A26 SN NYNNY 2001.12.202300220.0000095.6000000.00 5001.12.2023Professional attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist-an attendance after the 5001.12.2023first in a single course of treatment, involving an extensive and 5001.12.2023comprehensive examination, arranging any necessary investigations in relation 5001.12.2023to one or more complex problems and of more than 15 minutes in duration but 5001.12.2023not more than 30 minutes in duration at consulting rooms or hospital 1006013 01.11.2006 1 A26 SN NYNNY 2001.12.202300305.0000132.4000000.00 5001.12.2023Professional attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist-an attendance after the 5001.12.2023first in a single course of treatment, involving a detailed and comprehensive 5001.12.2023examination, arranging any necessary investigations in relation to one or more 5001.12.2023complex problems and of more than 30 minutes in duration but not more than 45 5001.12.2023minutes in duration at consulting rooms or hospital 1006015 01.11.2006 1 A26 SN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Professional attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist-an attendance after the 5001.12.2023first in a single course of treatment, involving an exhaustive and 5001.12.2023comprehensive examination, arranging any necessary investigations in relation 5001.12.2023to one or more complex problems and of more than 45 minutes in duration at 5001.12.2023consulting rooms or hospital 1006018 01.11.2016 1 A311 SN NYNNY 2001.12.202300327.0000168.6000000.00 5001.12.2023Professional attendance by an addiction medicine specialist in the practice of 5001.12.2023the addiction medicine specialist's specialty following referral of the 5001.12.2023patient to the addiction medicine specialist by a referring practitioner, if 5001.12.2023the attendance: (a) includes a comprehensive assessment; and (b) is the first 5001.12.2023or only time in a single course of treatment that a comprehensive assessment 5001.12.2023is provided 1006019 01.11.2016 1 A311 SN NYNNY 2001.12.202300163.0000084.3500000.00 5001.12.2023Professional attendance by an addiction medicine specialist in the practice of 5001.12.2023the addiction medicine specialist's specialty following referral of the 5001.12.2023patient to the addiction medicine specialist by a referring practitioner, if 5001.12.2023the attendance is a patient assessment: (a) before or after a comprehensive 5001.12.2023assessment under item 6018 in a single course of treatment; or (b) that 5001.12.2023follows an initial assessment under item 6023 in a single course of treatment; 5001.12.2023or (c) that follows a review under item 6024 in a single course of treatment 1006023 01.11.2016 1 A311 SN NYNNY 2001.12.202300571.0000294.8500000.00 5001.12.2023Professional attendance by an addiction medicine specialist in the practice of 5001.12.2023the addiction medicine specialist's specialty of at least 45 minutes for an 5001.12.2023initial assessment of a patient with at least 2 morbidities, following 5001.12.2023referral of the patient to the addiction medicine specialist by a referring 5001.12.2023practitioner, if: (a) an assessment is undertaken that covers: (i) a 5001.12.2023comprehensive history, including psychosocial history and medication review; 5001.12.2023and (ii) a comprehensive multi or detailed single organ system assessment; and 5001.12.2023(iii) the formulation of differential diagnoses; and (b) an addiction medicine 5001.12.2023specialist treatment and management plan of significant complexity that 5001.12.2023includes the following is prepared and provided to the referring practitioner: 5001.12.2023(i) an opinion on diagnosis and risk assessment; (ii) treatment options and 5001.12.2023decisions; (iii) medication recommendations; and (c) an attendance on the 5001.12.2023patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies 5001.12.2023did not take place on the same day by the same addiction medicine specialist; 5001.12.2023and (d) neither this item nor item 132 has applied to an attendance on the 5001.12.2023patient in the preceding 12 months by the same addiction medicine specialist 1006024 01.11.2016 1 A311 SN NYNNY 2001.12.202300286.0000147.6500000.00 5001.12.2023Professional attendance by an addiction medicine specialist in the practice of 5001.12.2023the addiction medicine specialist's specialty of at least 20 minutes, after 5001.12.2023the first attendance in a single course of treatment for a review of a patient 5001.12.2023with at least 2 morbidities if: (a) a review is undertaken that covers: (i) 5001.12.2023review of initial presenting problems and results of diagnostic 5001.12.2023investigations; and (ii) review of responses to treatment and medication plans 5001.12.2023initiated at time of initial consultation; and (iii) comprehensive multi or 5001.12.2023detailed single organ system assessment; and (iv) review of original and 5001.12.2023differential diagnoses; and (b) the modified addiction medicine specialist 5001.12.2023treatment and management plan is provided to the referring practitioner, which 5001.12.2023involves, if appropriate: (i) a revised opinion on diagnosis and risk 5001.12.2023assessment; and (ii) treatment options and decisions; and (iii) revised 5001.12.2023medication recommendations; and (c) an attendance on the patient to which item 5001.12.2023104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on 5001.12.2023the same day by the same addiction medicine specialist; and (d) item 6023 5001.12.2023applied to an attendance claimed in the preceding 12 months; and (e) the 5001.12.2023attendance under this item is claimed by the same addiction medicine 5001.12.2023specialist who claimed item 6023 or by a locum tenens; and (f) this item has 5001.12.2023not applied more than twice in any 12 month period 1006028 01.11.2016 1 A312 SN NYNNY 2001.12.202300107.0000055.0500000.00 5001.12.2023Group therapy (including any associated consultation with a patient taking 5001.12.2023place on the same occasion and relating to the condition for which group 5001.12.2023therapy is conducted) of not less than 1 hour, given under the continuous 5001.12.2023direct supervision of an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty for a group of 2 to 9 unrelated 5001.12.2023patients, or a family group of more than 2 patients, each of whom is referred 5001.12.2023to the addiction medicine specialist by a referring practitioner-for each 5001.12.2023patient 1006029 01.11.2016 1 A313 SN NYNNY 2001.12.202300092.0000047.7000000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of less 5001.12.2023than 15 minutes, with the multidisciplinary case conference team 1006031 01.11.2016 1 A313 SN NYNNY 2001.12.202300163.0000084.3500000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of at 5001.12.2023least 15 minutes but less than 30 minutes, with the multidisciplinary case 5001.12.2023conference team 1006032 01.11.2016 1 A313 SN NYNNY 2001.12.202300245.0000126.6000000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate a community case conference of at 5001.12.2023least 30 minutes but less than 45 minutes, with the multidisciplinary case 5001.12.2023conference team 1006034 01.11.2016 1 A313 SN NYNNY 2001.12.202300327.0000168.6000000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to organise and coordinate the multidisciplinary case conference 5001.12.2023of at least 45 minutes, with the multidisciplinary case conference team 1006035 01.11.2016 1 A313 SN NYNNY 2001.12.202300074.0000038.1500000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to participate in a community case conference (other than to 5001.12.2023organise and coordinate the conference) of less than 15 minutes, with the 5001.12.2023multidisciplinary case conference team 1006037 01.11.2016 1 A313 SN NYNNY 2001.12.202300131.0000067.5000000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to participate in a community case conference (other than to 5001.12.2023organise and coordinate the conference) of at least 15 minutes but less than 5001.12.202330 minutes, with the multidisciplinary case conference team 1006038 01.11.2016 1 A313 SN NYNNY 2001.12.202300196.0000101.2500000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to participate in a community case conference (other than to 5001.12.2023organise and coordinate the conference) of at least 30 minutes but less than 5001.12.202345 minutes, with the multidisciplinary case conference team 1006042 01.11.2016 1 A313 SN NYNNY 2001.12.202300261.0000134.8500000.00 5001.12.2023Attendance by an addiction medicine specialist in the practice of the 5001.12.2023addiction medicine specialist's specialty, as a member of a multidisciplinary 5001.12.2023case conference team of at least 2 other formal care providers of different 5001.12.2023disciplines, to participate in a community case conference (other than to 5001.12.2023organise and coordinate the conference) of at least 45 minutes, with the 5001.12.2023multidisciplinary case conference team 1006051 01.11.2016 1 A321 SN NYNNY 2001.12.202300327.0000168.6000000.00 5001.12.2023Professional attendance by a sexual health medicine specialist in the practice 5001.12.2023of the sexual health medicine specialist's specialty following referral of the 5001.12.2023patient to the sexual health medicine specialist by a referring practitioner, 5001.12.2023if the attendance: (a) includes a comprehensive assessment; and (b) is the 5001.12.2023first or only time in a single course of treatment that a comprehensive 5001.12.2023assessment is provided 1006052 01.11.2016 1 A321 SN NYNNY 2001.12.202300163.0000084.3500000.00 5001.12.2023Professional attendance by a sexual health medicine specialist in the practice 5001.12.2023of the sexual health medicine specialist's specialty following referral of the 5001.12.2023patient to the sexual health medicine specialist by a referring practitioner, 5001.12.2023if the attendance is a patient assessment: (a) before or after a comprehensive 5001.12.2023assessment under item 6051 in a single course of treatment; or (b) that 5001.12.2023follows an initial assessment under item 6057 in a single course of treatment; 5001.12.2023or (c) that follows a review under item 6058 in a single course of treatment 1006057 01.11.2016 1 A321 SN NYNNY 2001.12.202300571.0000294.8500000.00 5001.12.2023Professional attendance by a sexual health medicine specialist in the practice 5001.12.2023of the sexual health medicine specialist's specialty of at least 45 minutes 5001.12.2023for an initial assessment of a patient with at least 2 morbidities, following 5001.12.2023referral of the patient to the sexual health medicine specialist by a 5001.12.2023referring practitioner, if: (a) an assessment is undertaken that covers: (i) a 5001.12.2023comprehensive history, including psychosocial history and medication review; 5001.12.2023and (ii) a comprehensive multi or detailed single organ system assessment; and 5001.12.2023(iii) the formulation of differential diagnoses; and (b) a sexual health 5001.12.2023medicine specialist treatment and management plan of significant complexity 5001.12.2023that includes the following is prepared and provided to the referring 5001.12.2023practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment 5001.12.2023options and decisions; (iii) medication recommendations; and (c) an attendance 5001.12.2023on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 5001.12.2023applies did not take place on the same day by the same sexual health medicine 5001.12.2023specialist; and (d) neither this item nor item 132 has applied to an 5001.12.2023attendance on the patient in the preceding 12 months by the same sexual health 5001.12.2023medicine specialist 1006058 01.11.2016 1 A321 SN NYNNY 2001.12.202300286.0000147.6500000.00 5001.12.2023Professional attendance by a sexual health medicine specialist in the practice 5001.12.2023of the sexual health medicine specialist's specialty of at least 20 minutes, 5001.12.2023after the first attendance in a single course of treatment for a review of a 5001.12.2023patient with at least 2 morbidities if: (a) a review is undertaken that 5001.12.2023covers: (i) review of initial presenting problems and results of diagnostic 5001.12.2023investigations; and (ii) review of responses to treatment and medication plans 5001.12.2023initiated at time of initial consultation; and (iii) comprehensive multi or 5001.12.2023detailed single organ system assessment; and (iv) review of original and 5001.12.2023differential diagnoses; and (b) the modified sexual health medicine specialist 5001.12.2023treatment and management plan is provided to the referring practitioner, which 5001.12.2023involves, if appropriate: (i) a revised opinion on diagnosis and risk 5001.12.2023assessment; and (ii) treatment options and decisions; and (iii) revised 5001.12.2023medication recommendations; and (c) an attendance on the patient, being an 5001.12.2023attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 5001.12.2023applies did not take place on the same day by the same sexual health medicine 5001.12.2023specialist; and (d) item 6057 applied to an attendance claimed in the 5001.12.2023preceding 12 months; and (e) the attendance under this item is claimed by the 5001.12.2023same sexual health medicine specialist who claimed item 6057 or by a locum 5001.12.2023tenens; and (f) this item has not applied more than twice in any 12 month 5001.12.2023period 1006062 01.11.2016 1 A322 SN NYNNY 2001.12.202300396.0000204.5000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or a hospital 5001.12.2023by a sexual health medicine specialist in the practice of the sexual health 5001.12.2023medicine specialist's specialty following referral of the patient to the 5001.12.2023sexual health medicine specialist by a referring practitioner-initial 5001.12.2023attendance in a single course of treatment 1006063 01.11.2016 1 A322 SN NYNNY 2001.12.202300240.0000123.7000000.00 5001.12.2023Professional attendance at a place other than consulting rooms or a hospital 5001.12.2023by a sexual health medicine specialist in the practice of the sexual health 5001.12.2023medicine specialist's specialty following referral of the patient to the 5001.12.2023sexual health medicine specialist by a referring practitioner-each attendance 5001.12.2023after the attendance under item 6062 in a single course of treatment 1006064 01.11.2016 1 A323 SN NYNNY 2001.12.202300092.0000047.7000000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to organise and coordinate a community 5001.12.2023case conference of less than 15 minutes, with the multidisciplinary case 5001.12.2023conference team 1006065 01.11.2016 1 A323 SN NYNNY 2001.12.202300163.0000084.3500000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to organise and coordinate a community 5001.12.2023case conference of at least 15 minutes but less than 30 minutes, with the 5001.12.2023multidisciplinary case conference team 1006067 01.11.2016 1 A323 SN NYNNY 2001.12.202300245.0000126.6000000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to organise and coordinate a community 5001.12.2023case conference of at least 30 minutes but less than 45 minutes, with the 5001.12.2023multidisciplinary case conference team 1006068 01.11.2016 1 A323 SN NYNNY 2001.12.202300327.0000168.6000000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to organise and coordinate a community 5001.12.2023case conference of at least 45 minutes, with the multidisciplinary case 5001.12.2023conference team 1006071 01.11.2016 1 A323 SN NYNNY 2001.12.202300074.0000038.1500000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to participate in a community case 5001.12.2023conference (other than to organise and coordinate the conference) of less than 5001.12.202315 minutes, with the multidisciplinary case conference team 1006072 01.11.2016 1 A323 SN NYNNY 2001.12.202300131.0000067.5000000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to participate in a community case 5001.12.2023conference (other than to organise and coordinate the conference) of at least 5001.12.202315 minutes but less than 30 minutes, with the multidisciplinary case 5001.12.2023conference team 1006074 01.11.2016 1 A323 SN NYNNY 2001.12.202300196.0000101.2500000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to participate in a community case 5001.12.2023conference (other than to organise and coordinate the conference) of at least 5001.12.202330 minutes but less than 45 minutes, with the multidisciplinary case 5001.12.2023conference team 1006075 01.11.2016 1 A323 SN NYNNY 2001.12.202300261.0000134.8500000.00 5001.12.2023Attendance by a sexual health medicine specialist in the practice of the 5001.12.2023sexual health medicine specialist's specialty, as a member of a 5001.12.2023multidisciplinary case conference team of at least 2 other formal care 5001.12.2023providers of different disciplines, to participate in a community case 5001.12.2023conference (other than to organise and coordinate the conference) of at least 5001.12.202345 minutes, with the multidisciplinary case conference team 1006082 01.07.2021 1 A33 SN NYNNY 2001.12.202300109.0000056.0500000.00 5001.12.2023Attendance at a TMVr suitability case conference, by a cardiothoracic surgeon 5001.12.2023or an interventional cardiologist, to coordinate the conference, if: (a) the 5001.12.2023attendance lasts at least 10 minutes; and (b) the surgeon or cardiologist is 5001.12.2023accredited by the TMVr accreditation committee to perform the service 5001.12.2023Applicable once each 5 years 1006084 01.07.2021 1 A33 SN NYNNY 2001.12.202300081.0000041.8000000.00 5001.12.2023Attendance at a TMVr suitability case conference, by a specialist or 5001.12.2023consultant physician, other than to coordinate the conference, if the 5001.12.2023attendance lasts at least 10 minutes Applicable once each 5 years 1010660 18.06.2021 1 A445 DN NYNYY 2001.12.202300094.0000048.6500000.00 5001.12.2023Professional attendance by a general practitioner, if all of the following 5001.12.2023apply: (a)the service is associated with a service to which item 93644, 93645, 5001.12.202393653 or 93654 applies; (b)the service requires personal attendance by the 5001.12.2023general practitioner, lasting more than 10 minutes in duration, to provide 5001.12.2023in-depth clinical advice on the individual risks and benefits associated with 5001.12.2023receiving a COVID-19 vaccine; (c)one or both of the following is undertaken, 5001.12.2023where clinically relevant: (i)a detailed patient history; (ii)complex 5001.12.2023examination and management; (d)the service is bulk-billed 1010661 18.06.2021 1 A445 DN NYNYY 2001.12.202300075.0000038.9500000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner), if all of the following apply: (a) the service is associated 5001.12.2023with a service to which item 93646, 93647, 93655 or 93656 applies; (b) the 5001.12.2023service requires personal attendance by the medical practitioner (other than a 5001.12.2023general practitioner), lasting more than 10 minutes in duration, to provide 5001.12.2023in-depth clinical advice on the individual risks and benefits associated with 5001.12.2023receiving a COVID-19 vaccine; (c)one or both of the following is undertaken, 5001.12.2023where clinically relevant: (i)a detailed patient history; (ii)complex 5001.12.2023examination and management; (d)the service is bulk-billed 1010801 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023myopia of 5.0 dioptres or greater (spherical equivalent) in one eye 1010802 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in one 5001.12.2023eye 1010803 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023astigmatism of 3.0 dioptres or greater in one eye 1010804 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023irregular astigmatism in either eye, being a condition the existence of which 5001.12.2023has been confirmed by keratometric observation, if the maximum visual acuity 5001.12.2023obtainable with spectacle correction is worse than 0.3 logMAR (6/12) and if 5001.12.2023that corrected acuity would be improved by an additional 0.1 logMAR by the use 5001.12.2023of a contact lens 1010805 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023anisometropia of 3.0 dioptres or greater (difference between spherical 5001.12.2023equivalents) 1010806 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with 5001.12.2023corrected visual acuity of 0.7 logMAR (6/30) or worse in both eyes and for 5001.12.2023whom a contact lens is prescribed as part of a telescopic system 1010807 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient for 5001.12.2023whom a wholly or segmentally opaque contact lens is prescribed for the 5001.12.2023alleviation of dazzle, distortion or diplopia caused by pathological 5001.12.2023mydriasis, aniridia, coloboma of the iris, pupillary malformation or 5001.12.2023distortion, significant ocular deformity or corneal opacity-whether 5001.12.2023congenital, traumatic or surgical in origin 1010808 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient who, 5001.12.2023because of physical deformity, are unable to wear spectacles 1010809 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the investigation and evaluation of a patient for the fitting 5001.12.2023of contact lenses, with keratometry and testing with trial lenses and the 5001.12.2023issue of a prescription-one service in any period of 36 months-patient with a 5001.12.2023medical or optical condition (other than myopia, hyperopia, astigmatism, 5001.12.2023anisometropia or a condition to which item 10806, 10807 or 10808 applies) 5001.12.2023requiring the use of a contact lens for correction, if the condition is 5001.12.2023specified on the patient's account 1010816 26.05.2002 1 A9 SN NYNNY 2001.12.202300330.0000135.9500000.00 5001.12.2023Attendance for the refitting of contact lenses with keratometry and testing 5001.12.2023with trial lenses and the issue of a prescription, if the patient requires a 5001.12.2023change in contact lens material or basic lens parameters, other than simple 5001.12.2023power change, because of a structural or functional change in the eye or an 5001.12.2023allergic response within 36 months after the fitting of a contact lens to 5001.12.2023which items 10801 to 10809 apply 1010905 26.05.2002 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023REFERRED COMPREHENSIVE INITIAL CONSULTATION Professional attendance of more 5001.12.2023than 15 minutes duration, being the first in a course of attention, where the 5001.12.2023patient has been referred by another optometrist who is not associated with 5001.12.2023the optometrist to whom the patient is referred 1010907 26.05.2002 1 A101 SN NYNNY 2001.12.202300071.0000036.8000000.00 5001.12.2023COMPREHENSIVE INITIAL CONSULTATION BY ANOTHER PRACTITIONER Professional 5001.12.2023attendance of more than 15 minutes in duration, being the first in a course of 5001.12.2023attention if the patient has attended another optometrist for an attendance to 5001.12.2023which this item or item 10905, 10910, 10911, 10912, 10913, 10914 or 10915 5001.12.2023applies, or to which old item 10900 applied: (a) for a patient who is less 5001.12.2023than 65 years of age-within the previous 36 months; or (b) for a patient who 5001.12.2023is at least 65 years or age-within the previous 12 months 1010910 01.01.2015 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023COMPREHENSIVE INITIAL CONSULTATION - PATIENT IS LESS THAN 65 YEARS OF AGE 5001.12.2023Professional attendance of more than 15 minutes in duration, being the first 5001.12.2023in a course of attention, if: (a) the patient is less than 65 years of age; 5001.12.2023and (b) the patient has not, within the previous 36 months, received a service 5001.12.2023to which: (i)this item or item 10905, 10907, 10912, 10913, 10914 or 10915 5001.12.2023applies; or (ii) old item 10900 applied 1010911 01.01.2015 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023COMPREHENSIVE INITIAL CONSULTATION - PATIENT IS AT LEAST 65 YEARS OF AGE 5001.12.2023Professional attendance of more than 15 minutes in duration, being the first 5001.12.2023in a course of attention, if: (a) the patient is at least 65 years of age; and 5001.12.2023(b) the patient has not, within the previous 12 months, received a service to 5001.12.2023which: (i)this item, or item 10905, 10907, 10910, 10912, 10913, 10914 or 10915 5001.12.2023applies; or (ii) old item 10900 applied 1010912 26.05.2002 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023OTHER COMPREHENSIVE CONSULTATIONS Professional attendance of more than 15 5001.12.2023minutes in duration, being the first in a course of attention, if the patient 5001.12.2023has suffered a significant change of visual function requiring comprehensive 5001.12.2023reassessment: (a) for a patient who is less than 65 years of age-within 36 5001.12.2023months of an initial consultation to which: (i)this item, or item 10905, 5001.12.202310907, 10910, 10913, 10914 or 10915 at the same practice applies; or (ii) old 5001.12.2023item 10900 at the same practice applied; or (b) for a patient who is at least 5001.12.202365 years of age-within 12 months of an initial consultation to which: (i)this 5001.12.2023item, or item 10905, 10907, 10910, 10911, 10913, 10914 or 10915 at the same 5001.12.2023practice applies; or (ii) old item 10900 at the same practice applied 1010913 26.05.2002 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023Professional attendance of more than 15 minutes in duration, being the first 5001.12.2023in a course of attention, if the patient has new signs or symptoms, unrelated 5001.12.2023to the earlier course of attention, requiring comprehensive reassessment: (a) 5001.12.2023for a patient who is less than 65 years of age-within 36 months of an initial 5001.12.2023consultation to which: (i)this item, or item 10905, 10907, 10910, 10912, 10914 5001.12.2023or 10915 at the same practice applies; or (ii) old item 10900 at the same 5001.12.2023practice applied; or (b) for a patient who is at least 65 years of age-within 5001.12.202312 months of an initial consultation to which: (i)this item, or item 10905, 5001.12.202310907, 10910, 10911, 10912, 10914 or 10915 at the same practice applies; or 5001.12.2023(ii) old item 10900 at the same practice applied 1010914 26.05.2002 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023Professional attendance of more than 15 minutes in duration, being the first 5001.12.2023in a course of attention, if the patient has a progressive disorder (excluding 5001.12.2023presbyopia) requiring comprehensive reassessment: (a) for a patient who is 5001.12.2023less than 65 years of age-within 36 months of an initial consultation to 5001.12.2023which: (i)this item, or item 10905, 10907, 10910, 10912, 10913 or 10915 5001.12.2023applies; or (ii) old item 10900 applied; or (b) for a patient who is at least 5001.12.202365 years of age-within 12 months of an initial consultation to which: (i)this 5001.12.2023item, or item 10905, 10907, 10910, 10911, 10912, 10913 or 10915 applies; or 5001.12.2023(ii) old item 10900 applied 1010915 01.11.2003 1 A101 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023Professional attendance of more than 15 minutes duration, being the first in a 5001.12.2023course of attention involving the examination of the eyes, with the 5001.12.2023instillation of a mydriatic, of a patient with diabetes mellitus requiring 5001.12.2023comprehensive reassessment. 1010916 26.05.2002 1 A101 SN NYNNY 2001.12.202300071.0000036.8000000.00 5001.12.2023BRIEF INITIAL CONSULTATION Professional attendance, being the first in a 5001.12.2023course of attention, of not more than 15 minutes duration, not being a service 5001.12.2023associated with a service to which item 10931, 10932, 10933, 10940, 10941, 5001.12.202310942 or 10943 applies 1010918 26.05.2002 1 A101 SN NYNNY 2001.12.202300071.0000036.8000000.00 5001.12.2023SUBSEQUENT CONSULTATION Professional attendance being the second or subsequent 5001.12.2023in a course of attention not related to the prescription and fitting of 5001.12.2023contact lenses, not being a service associated with a service to which item 5001.12.202310940 or 10941 applies 1010921 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL 5001.12.2023SUBSEQUENT CONSULTATIONS All professional attendances after the first, being 5001.12.2023those attendances regarded as a single service, in a single course of 5001.12.2023attention involving the prescription and fitting of contact lenses, being a 5001.12.2023course of attention for which the first attendance is a service to which: 5001.12.2023(a)item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 5001.12.2023applies; or (b) old item 10900 applied Payable once in a period of 36 months 5001.12.2023for -patients with myopia of 5.0 dioptres or greater (spherical equivalent) in 5001.12.2023one eye 1010922 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients with 5001.12.2023manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in one 5001.12.2023eye 1010923 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients with 5001.12.2023astigmatism of 3.0 dioptres or greater in one eye 1010924 26.05.2002 1 A101 SN NYNNY 2001.12.202300446.0000230.3000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients with 5001.12.2023irregular astigmatism in either eye, being a condition the existence of which 5001.12.2023has been confirmed by keratometric observation, if the maximum visual acuity 5001.12.2023obtainable with spectacle correction is worse than 0.3 logMAR (6/12) and if 5001.12.2023that corrected acuity would be improved by an additional 0.1 logMAR by the use 5001.12.2023of a contact lens 1010925 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients with 5001.12.2023anisometropia of 3.0 dioptres or greater (difference between spherical 5001.12.2023equivalents) 1010926 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients with 5001.12.2023corrected visual acuity of 0.7 logMAR (6/30) or worse in both eyes, being 5001.12.2023patients for whom a contact lens is prescribed as part of a telescopic system 1010927 26.05.2002 1 A101 SN NYNNY 2001.12.202300446.0000230.3000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients for whom a 5001.12.2023wholly or segmentally opaque contact lens is prescribed for the alleviation of 5001.12.2023dazzle, distortion or diplopia caused by: i.pathological mydriasis; or 5001.12.2023ii.aniridia; or iii.coloboma of the iris; or iv.pupillary malformation or 5001.12.2023distortion; or v.significant ocular deformity or corneal opacity -whether 5001.12.2023congenital, traumatic or surgical in origin 1010928 26.05.2002 1 A101 SN NYNNY 2001.12.202300354.0000182.5000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients who, because 5001.12.2023of physical deformity, are unable to wear spectacles 1010929 26.05.2002 1 A101 SN NYNNY 2001.12.202300446.0000230.3000000.00 5001.12.2023All professional attendances after the first, being those attendances regarded 5001.12.2023as a single service, in a single course of attention involving the 5001.12.2023prescription and fitting of contact lenses, being a course of attention for 5001.12.2023which the first attendance is a service to which: (a) item 10905, 10907, 5001.12.202310910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 5001.12.202310900 applied Payable once in a period of 36 months for -patients who have a 5001.12.2023medical or optical condition (other than myopia, hyperopia, astigmatism, 5001.12.2023anisometropia or a condition to which item 10926, 10927 or 10928 applies) 5001.12.2023requiring the use of a contact lens for correction, if the condition is 5001.12.2023specified on the patient's account Note: Benefits may not be claimed under 5001.12.2023Item 10929 where the patient wants the contact lenses for appearance, 5001.12.2023sporting, work or psychological reasons - see paragraph O6 of explanatory 5001.12.2023notes to this category. 1010940 01.11.2003 1 A101 SN NYNNY 2001.12.202300136.0000070.1000000.00 5001.12.2023COMPUTERISED PERIMETRY Full quantitative computerised perimetry (automated 5001.12.2023absolute static threshold), with bilateral assessment and report, where 5001.12.2023indicated by the presence of relevant ocular disease or suspected pathology of 5001.12.2023the visual pathways or brain that: (a) is not a service involving multifocal 5001.12.2023multi channel objective perimetry; and (b) is performed by an optometrist; not 5001.12.2023being a service associated with a service to which item 10916, 10918, 10931, 5001.12.202310932 or 10933 appliesTo a maximum of 2 examinations per patient (including 5001.12.2023examinations to which item 10941 applies) in any 12 month period. 1010941 01.11.2003 1 A101 SN NYNNY 2001.12.202300082.0000042.3000000.00 5001.12.2023COMPUTERISED PERIMETRY Full quantitative computerised perimetry (automated 5001.12.2023absolute static threshold) with unilateral assessment and report, where 5001.12.2023indicated by the presence of relevant ocular disease or suspected pathology of 5001.12.2023the visual pathways or brain that: (a) is not a service involving multifocal 5001.12.2023multichannel objective perimetry; and (b) is performed by an optometrist; not 5001.12.2023being a service associated with a service to which item 10916, 10918 10931, 5001.12.202310932 or 10933 appliesTo a maximum of 2 examinations per patient (including 5001.12.2023examinations to which item 10940 applies) in any 12 month period. 1010942 01.05.2005 1 A101 SN NYNNY 2001.12.202300071.0000036.8000000.00 5001.12.2023LOW VISION ASSESSMENT Testing of residual vision to provide optimum visual 5001.12.2023performance for a patient who has best corrected visual acuity of 6/15 or N.12 5001.12.2023or worse in the better eye or a horizontal visual field of less than 120 5001.12.2023degrees and within 10 degrees above and below the horizontal midline, 5001.12.2023involving 1 or more of the following: (a) spectacle correction; (b) 5001.12.2023determination of contrast sensitivity; (c) determination of glare sensitivity; 5001.12.2023(d) prescription of magnification aids; not being a service associated with a 5001.12.2023service to which item 10916, 10921, 10922, 10923, 10924, 10925, 10926, 10927, 5001.12.202310928, 10929 or 10930 appliesNot payable more than twice per patient in a 12 5001.12.2023month period. 1010944 01.09.2015 1 A101 SN NYNNY 2001.12.202300154.0000079.4000000.00 5001.12.2023CORNEA, complete removal of embedded foreign body from - not more than once on 5001.12.2023the same day by the same practitioner (excluding aftercare) The item is not to 5001.12.2023be billed on the same occasion as MBS items 10905, 10907, 10910, 10911, 10912, 5001.12.202310913, 10914, 10915, 10916 or 10918. If the embedded foreign body is not 5001.12.2023completely removed, this item does not apply but item 10916 may apply. 1010945 01.09.2015 1 A102 SN NYNNY 2001.12.202300071.0000036.8000000.00 5001.12.2023A professional attendance of less than 15 minutes (whether or not continuous) 5001.12.2023by an attending optometrist that requires the provision of clinical support to 5001.12.2023a patient who: (a)is participating in a video conferencing consultation with a 5001.12.2023specialist practising in his or her speciality ofophthalmology; and (b)is not 5001.12.2023an admitted patient 1010946 01.09.2015 1 A102 SN NYNNY 2001.12.202300142.0000073.4500000.00 5001.12.2023A professional attendance of at least 15 minutes (whether or not continuous) 5001.12.2023by an attending optometrist that requires the provision of clinical support to 5001.12.2023a patient who: (a)is participating in a video conferencing consultation with a 5001.12.2023specialist practising in his or her speciality ofophthalmology; and (b)is not 5001.12.2023an admitted patient 1011000 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300430.0000135.5000000.00 4026.05.2002(Anaes.) 5001.12.2023ELECTROENCEPHALOGRAPHY, not being a service: (a)associated with a service to 5001.12.2023which item 11003 or 11009 applies; or (b)involving quantitative topographic 5001.12.2023mapping using neurometrics or similar devices (Anaes.) 1011003 26.05.2002 2 D1 1 SN NYNYY 2001.12.202300865.0000358.4500000.00 5001.12.2023Electroencephalography, prolonged recording lasting at least 3 hours, that 5001.12.2023requires multichannel recording using: (a) for a service not associated with a 5001.12.2023service to which an item in Group T8 appliesstandard 1020 electrode placement; 5001.12.2023or (b) for a service associated with a service to which an item in Group T8 5001.12.2023applieseither standard 1020 electrode placement or a different electrode 5001.12.2023placement and number of recorded channels; other than a service: (c) 5001.12.2023associated with a service to which item 11000, 11004 or 11005 applies; or (d) 5001.12.2023involving quantitative topographic mapping using neurometrics or similar 5001.12.2023devices. 1011004 01.11.2003 2 D1 1 SN NYNNY 2001.12.202301915.0000358.4500000.00 5001.12.2023Electroencephalography, ambulatory or video, prolonged recording lasting at 5001.12.2023least 3 hours and up to 24 hours, that requires multi channel recording using 5001.12.2023standard 10-20 electrode placement, first day, other than a service:(a) 5001.12.2023associated with a service to which item 11000, 11003 or 11005 applies; or(b) 5001.12.2023involving quantitative topographic mapping using neurometrics or similar 5001.12.2023devices. 1011005 01.11.2003 2 D1 1 SN NYNNY 2001.12.202301915.0000358.4500000.00 5001.12.2023Electroencephalography, ambulatory or video, prolonged recording lasting at 5001.12.2023least 3 hours and up to 24 hours, that requires multi channel recording using 5001.12.2023standard 10-20 electrode placement, each day after the first day, other than a 5001.12.2023service:(a) associated with a service to which item 11000, 11003 or 11004 5001.12.2023applies; or(b) involving quantitative topographic mapping using neurometrics 5001.12.2023or similar devices. 1011012 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300330.0000123.2500000.00 5001.12.2023NEUROMUSCULAR ELECTRODIAGNOSISconduction studies on 1 nerve OR 5001.12.2023ELECTROMYOGRAPHY of 1 or more muscles using concentric needle electrodes OR 5001.12.2023both these examinations (not being a service associated with a service to 5001.12.2023which item 11015 or 11018 applies) 1011015 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300455.0000165.0000000.00 5001.12.2023NEUROMUSCULAR ELECTRODIAGNOSISconduction studies on 2 or 3 nerves with or 5001.12.2023without electromyography (not being a service associated with a service to 5001.12.2023which item 11012 or 11018 applies) 1011018 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300660.0000246.5500000.00 5001.12.2023NEUROMUSCULAR ELECTRODIAGNOSISconduction studies on 4 or more nerves with or 5001.12.2023without electromyography OR recordings from single fibres of nerves and 5001.12.2023muscles OR both of these examinations (not being a service associated with a 5001.12.2023service to which item 11012 or 11015 applies) 1011021 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300455.0000165.0000000.00 5001.12.2023NEUROMUSCULAR ELECTRODIAGNOSISrepetitive stimulation for study of 5001.12.2023neuromuscular conduction OR electromyography with quantitative computerised 5001.12.2023analysis OR both of these examinations 1011024 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300300.0000125.3000000.00 5001.12.2023CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised 5001.12.2023averaging techniques, not being a service involving quantitative topographic 5001.12.2023mapping of event-related potentials or multifocal multichannel objective 5001.12.2023perimetry - 1 or 2 studies 1011027 26.05.2002 2 D1 1 SN NYNNY 2001.12.202300440.0000185.8500000.00 5001.12.2023CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised 5001.12.2023averaging techniques, not being a service involving quantitative topographic 5001.12.2023mapping of event-related potentials or multifocal multichannel objective 5001.12.2023perimetry - 3 or more studies 1011200 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300106.0000044.9000000.00 5001.12.2023PROVOCATIVE TEST OR TESTS FOR OPEN ANGLE GLAUCOMA, including water drinking 1011204 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300245.0000119.1500000.00 5001.12.2023ELECTRORETINOGRAPHY of one or both eyes by computerised averaging techniques, 5001.12.2023including 3 or more studies performed according to current professional 5001.12.2023guidelines or standards,performed by or on behalf of a specialist or 5001.12.2023consultant physician in the practice of his or her speciality. 1011205 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300245.0000119.1500000.00 5001.12.2023ELECTROOCULOGRAPHY of one or both eyes performed according to current 5001.12.2023professional guidelines or standards, performed by or on behalf of a 5001.12.2023specialist or consultant physician in the practice of his or her speciality. 1011210 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300245.0000119.1500000.00 5001.12.2023PATTERN ELECTRORETINOGRAPHY of one or both eyes by computerised averaging 5001.12.2023techniques, including 3 or more studies performed according to current 5001.12.2023professional guidelines or standards 1011211 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300245.0000119.1500000.00 5001.12.2023DARK ADAPTOMETRY of one or both eyes with a quantitative (log cd/m2) 5001.12.2023estimation of threshold in log lumens at 45 minutes of dark adaptations 1011215 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300425.0000135.3500000.00 5001.12.2023RETINAL ANGIOGRAPHY, multiple exposures of 1 eye with intravenous dye 5001.12.2023injection 1011218 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300535.0000167.3000000.00 5001.12.2023RETINAL ANGIOGRAPHY, multiple exposures of both eyes with intravenous dye 5001.12.2023injection 1011219 01.11.2016 2 D1 2 SN NYNNY 2001.12.202300156.0000043.9500000.00 5001.12.2023Optical coherence tomography for diagnosis of an ocular condition for the 5001.12.2023treatment of which there is a medication that is: (a) listed on the 5001.12.2023pharmaceutical benefits scheme; and (b) indicated for intraocular 5001.12.2023administration Applicable only once in any 12 month period 1011220 01.12.2016 2 D1 2 SN NYNNY 2001.12.202300156.0000043.9500000.00 5001.12.2023OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment 5001.12.2023following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. 5001.12.2023Maximum of one service per eye per lifetime. 1011221 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300300.0000074.6500000.00 5001.12.2023Full quantitative computerised perimetry (automated absolute static 5001.12.2023threshold), other than a service involving multifocal multichannel objective 5001.12.2023perimetry, performed by or on behalf of a specialist in the practice of his or 5001.12.2023her specialty, if indicated by the presence of relevant ocular disease or 5001.12.2023suspected pathology of the visual pathways or brain with assessment and 5001.12.2023report, bilateralto a maximum of 3 examinations (including examinations to 5001.12.2023which item 11224 applies) in any 12 month period 1011224 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300166.0000044.9500000.00 5001.12.2023Full quantitative computerised perimetry (automated absolute static 5001.12.2023threshold), other than a service involving multifocal multichannel objective 5001.12.2023perimetry, performed by or on behalf of a specialist in the practice of his or 5001.12.2023her specialty, if indicated by the presence of relevant ocular disease or 5001.12.2023suspected pathology of the visual pathways or brain with assessment and 5001.12.2023report, unilateralto a maximum of 3 examinations (including examinations to 5001.12.2023which item 11221 applies) in any 12 month period 1011235 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300425.0000135.0500000.00 5001.12.2023EXAMINATION OF THE EYE BY IMPRESSION CYTOLOGY OF CORNEA for the investigation 5001.12.2023of ocular surface dysplasia, including the collection of cells, processing and 5001.12.2023all cytological examinations and preparation of report 1011237 01.11.2003 2 D1 2 SN NYNNY 2001.12.202300240.0000089.6500000.00 5001.12.2023OCULAR CONTENTS, simultaneous ultrasonic echography by both unidimensional and 5001.12.2023bidimensional techniques, for the diagnosis, monitoring or measurement of 5001.12.2023choroidal and ciliary body melanomas, retinoblastoma or suspicious naevi or 5001.12.2023simulating lesions, one eye, not being a service associated with a service to 5001.12.2023which items in Group I1 of Category 5 apply 1011240 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300240.0000089.6500000.00 5001.12.2023ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence 5001.12.2023interferometry of, for the measurement of one eye prior to lens surgery on 5001.12.2023that eye, not being a service associated with a service to which items in 5001.12.2023Group I1 of Category 5 apply. 1011241 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300360.0000114.1000000.00 5001.12.2023ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence 5001.12.2023interferometry of, for bilateral eye measurement prior to lens surgery on both 5001.12.2023eyes, not being a service associated with a service to which items in Group I1 5001.12.2023apply 1011242 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300240.0000088.2000000.00 5001.12.2023ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence 5001.12.2023interferometry of, for the measurement of an eye previously measured and on 5001.12.2023which lens surgery has been performed, and where further lens surgery is 5001.12.2023contemplated in that eye, not being a service associated with a service to 5001.12.2023which items in Group I1 apply 1011243 26.05.2002 2 D1 2 SN NYNNY 2001.12.202300240.0000088.2000000.00 5001.12.2023ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence 5001.12.2023interferometry of, for the measurement of a second eye where surgery for the 5001.12.2023first eye has resulted in more than 1 dioptre of error or where more than 3 5001.12.2023years have elapsed since the surgery for the first eye, not being a service 5001.12.2023associated with a service to which items in Group I1 apply 1011244 01.03.2013 2 D1 2 SN NYNNY 2001.12.202300240.0000084.7500000.00 5001.12.2023Orbital contents, diagnostic B-scan of, by a specialist practising in his or 5001.12.2023her speciality of ophthalmology, not being a service associated with a service 5001.12.2023to which an item in Group I1 of the diagnostic imaging services table applies. 1011300 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300520.0000211.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Brain stem evoked response audiometry if: (a) the service is not for the 5001.12.2023purposes of programming either an auditory implant or the sound processor of 5001.12.2023an auditory implant; and(b) a service to which item 82300 applies has not been 5001.12.2023performed on the patient on the same day other than a service associated with 5001.12.2023a service to which item 11340, 11341 or 11343 applies (Anaes.) 1011302 01.03.2023 2 D1 3 SN YYNYN 2001.12.202300520.0000211.9000000.00 5001.12.2023Programming an auditory implant or the sound processor of an auditory implant, 5001.12.2023unilateral, performed by or on behalf of a medical practitioner, if a service 5001.12.2023to which item 82301, 82302 or 82304 applies has not been performed on the 5001.12.2023patient on the same day Applicable up to a total of 4 services to which this 5001.12.2023item, item 11342 or item 11345 applies on the same day 1011303 26.05.2002 2 D1 3 SN NYNNY 2001.12.202300515.0000211.9000000.00 5001.12.2023ELECTROCOCHLEOGRAPHY, extratympanic method, 1 or both ears 1011304 26.05.2002 2 D1 3 SN NYNNY 2001.12.202300840.0000348.9000000.00 5001.12.2023ELECTROCOCHLEOGRAPHY, transtympanic membrane insertion technique, 1 or both 5001.12.2023ears 1011306 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300058.0000024.1000000.00 5001.12.2023Non determinate audiometry, if a service to which item 82306 applies has not 5001.12.2023been performed on the patient on the same day. 1011309 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300068.0000028.9500000.00 5001.12.2023Audiogram, air conduction, if a service to which item 82309 applies has not 5001.12.2023been performed on the patient on the same day. 1011312 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300099.0000040.8500000.00 5001.12.2023Audiogram, air and bone conduction or air conduction and speech 5001.12.2023discrimination, if a service to which item 82312 applies has not been 5001.12.2023performed on the patient on the same day. 1011315 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300130.0000054.1000000.00 5001.12.2023Audiogram, air and bone conduction and speech,if a service to which item 82315 5001.12.2023applies has not been performed on the patient on the same day 1011318 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300162.0000066.8500000.00 5001.12.2023Audiogram, air and bone conduction and speech, with other cochlear tests,if a 5001.12.2023service to which item 82318 applies has not been performed on the patient on 5001.12.2023the same day 1011324 26.05.2002 2 D1 3 SN NYNYN 2001.12.202300093.0000021.8500000.00 5001.12.2023Impedance audiogram involving tympanometry and measurement of static 5001.12.2023compliance and acoustic reflex performed by, or on behalf of, a medical 5001.12.2023practitioner, if a service to which item 82324 applies has not been performed 5001.12.2023on the patient on the same day 1011332 26.05.2002 2 D1 3 SN NYNYY 2001.12.202300315.0000064.5000000.00 5001.12.2023Oto-acoustic emission audiometry for the detection of outer hair cell 5001.12.2023functioning in the cochlea, performed by or on behalf of a specialist or 5001.12.2023consultant physician, when middle ear pathology has been excluded, if:(a) the 5001.12.2023service is performed:(i) on an infant or child who is at risk of permanent 5001.12.2023hearing impairment; or(ii) on an individual who is at risk of oto-toxicity due 5001.12.2023to medications or medical intervention; or(iii) on an individual at risk of 5001.12.2023noise induced hearing loss; or(iv) to assist in the diagnosis of auditory 5001.12.2023neuropathy; and(b) a service to which item 82332 applies has not been 5001.12.2023performed on the patient on the same day 1011340 01.03.2023 2 D1 3 SN YYNYN 2001.12.202300585.0000204.9000000.00 5001.12.2023Investigation of the vestibular function to assist in the diagnosis, treatment 5001.12.2023or management of a vestibular or related disorder, performed by or on behalf 5001.12.2023of a medical practitioner: (a) to assess one or more of the following: (i) the 5001.12.2023organs of the peripheral vestibular system (utricle, saccule, lateral, 5001.12.2023superior and posterior semicircular canals, and vestibular nerve); (ii) 5001.12.2023muscular or eye movement responses elicited by vestibular stimulation; (iii) 5001.12.2023static signs of vestibular dysfunction; (iv) the central ocularmotor function; 5001.12.2023and (b) using up to 2 clinically recognised tests; other than a service 5001.12.2023associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 5001.12.202311300 applies 1011341 01.03.2023 2 D1 3 SN YYNYN 2001.12.202301170.0000410.7500000.00 5001.12.2023Investigation of the vestibular function to assist in the diagnosis, treatment 5001.12.2023or management of a vestibular or related disorder, performed by or on behalf 5001.12.2023of a medical practitioner: (a) to assess one or more of the following: (i) the 5001.12.2023organs of the peripheral vestibular system (utricle, saccule, lateral, 5001.12.2023superior and posterior semicircular canals, and vestibular nerve); (ii) 5001.12.2023muscular or eye movement responses elicited by vestibular stimulation; (iii) 5001.12.2023static signs of vestibular dysfunction; (iv) the central ocularmotor function; 5001.12.2023and (b) using 3 or 4 clinically recognised tests; other than a service 5001.12.2023associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 5001.12.202311300 applies 1011342 01.03.2022 2 D1 3 DN NYNYY 2001.12.202300376.0000169.4500000.00 5001.12.2023Programming by telehealth of an auditory implant, or the sound processor of an 5001.12.2023auditory implant, unilateral, performed by or on behalf of a medical 5001.12.2023practitioner, if a service to which items 82301, 82302 or 82304 applies has 5001.12.2023not been performed on the patient on the same day Applicable up to a total of 5001.12.20234 services to which this item, item 11302 or item 11345 applies on the same 5001.12.2023day 1011343 01.03.2023 2 D1 3 SN YYNYN 2001.12.202301755.0000614.5500000.00 5001.12.2023Investigation of the vestibular function to assist in the diagnosis, treatment 5001.12.2023or management of a vestibular or related disorder, performed by or on behalf 5001.12.2023of a medical practitioner: (a) to assess one or more of the following: (i) the 5001.12.2023organs of the peripheral vestibular system (utricle, saccule, lateral, 5001.12.2023superior and posterior semicircular canals, and vestibular nerve); (ii) 5001.12.2023muscular or eye movement responses elicited by vestibular stimulation; (iii) 5001.12.2023static signs of vestibular dysfunction; (iv) the central ocularmotor function; 5001.12.2023and (b) using 5 or more clinically recognised tests; other than a service 5001.12.2023associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 5001.12.202311300 applies 1011345 01.03.2022 2 D1 3 DN NYNYY 2001.12.202300376.0000169.4500000.00 5001.12.2023Programming by phone of an auditory implant, or the sound processor of an 5001.12.2023auditory implant, unilateral, performed by or on behalf of a medical 5001.12.2023practitioner, if a service to which items 82301, 82302 or 82304 applies has 5001.12.2023not been performed on the patient on the same day Applicable up to a total of 5001.12.20234 services to which this item, item 11302 or item 11342 applies on the same 5001.12.2023day 1011503 26.05.2002 2 D1 4 SN NYNYY 2001.12.202300435.0000152.6000000.00 5001.12.2023Complex measurement of properties of the respiratory system, including the 5001.12.2023lungs and respiratory muscles, that is performed: (a) in a respiratory 5001.12.2023laboratory; and (b) under the supervision of a specialist or consultant 5001.12.2023physician who is responsible for staff training, supervision, quality 5001.12.2023assurance and the issuing of written reports on tests performed; and (c) using 5001.12.2023any of the following tests: (i) measurement of absolute lung volumes by any 5001.12.2023method; (ii) measurement of carbon monoxide diffusing capacity by any method; 5001.12.2023(iii) measurement of airway or pulmonary resistance by any method; (iv) 5001.12.2023inhalation provocation testing, including preprovocation spirometry and the 5001.12.2023construction of a dose response curve, using a recognised direct or indirect 5001.12.2023bronchoprovocation agent and postbronchodilator spirometry; (v) provocation 5001.12.2023testing involving sequential measurement of lung function at baseline and 5001.12.2023after exposure to specific sensitising agents, including drugs, or 5001.12.2023occupational asthma triggers; (vi) spirometry performed before and after 5001.12.2023simple exercise testing undertaken as a provocation test for the investigation 5001.12.2023of asthma, in premises equipped with resuscitation equipment and personnel 5001.12.2023trained in Advanced Life Support; (vii) measurement of the strength of 5001.12.2023inspiratory and expiratory muscles at multiple lung volumes; (viii) simulated 5001.12.2023altitude test involving exposure to hypoxic gas mixtures and oxygen saturation 5001.12.2023at rest and/or during exercise with or without an observation of the effect of 5001.12.2023supplemental oxygen; (ix) calculation of pulmonary or cardiac shunt by 5001.12.2023measurement of arterial oxygen partial pressure and haemoglobin concentration 5001.12.2023following the breathing of an inspired oxygen concentration of 100% for a 5001.12.2023duration of 15 minutes or greater; (x) if the measurement is for the purpose 5001.12.2023of determining eligibility for pulmonary arterial hypertension medications 5001.12.2023subsidised under the Pharmaceutical Benefits Scheme or eligibility for the 5001.12.2023provision of portable oxygenfunctional exercise test by any method (including 5001.12.20236 minute walk test and shuttle walk test); each occasion at which one or more 5001.12.2023tests are performed Not applicable to a service performed in association with 5001.12.2023a spirometry or sleep study service to which item 11505, 11506, 11507, 11508, 5001.12.202311512, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 5001.12.2023applies Not applicable to a service to which item 11507 applies 1011505 01.11.2018 2 D1 4 SN NYNNY 2001.12.202300110.0000045.3000000.00 5001.12.2023Measurement of spirometry, that: (a) involves a permanently recorded tracing, 5001.12.2023performed before and after inhalation of a bronchodilator; and (b) is 5001.12.2023performed to confirm diagnosis of: (i) asthma; or (ii) chronic obstructive 5001.12.2023pulmonary disease (COPD); or (iii) another cause of airflow limitation; each 5001.12.2023occasion at which 3 or more recordings are made Applicable only once in any 12 5001.12.2023month period 1011506 26.05.2002 2 D1 4 SN NYNNY 2001.12.202300055.0000022.6500000.00 5001.12.2023Measurement of spirometry, that: (a) involves a permanently recorded tracing, 5001.12.2023performed before and after inhalation of a bronchodilator; and (b) is 5001.12.2023performed to: (i) confirm diagnosis of chronic obstructive pulmonary disease 5001.12.2023(COPD); or (ii) assess acute exacerbations of asthma; or (iii) monitor asthma 5001.12.2023and COPD; or (iv) assess other causes of obstructive lung disease or the 5001.12.2023presence of restrictive lung disease; each occasion at which recordings are 5001.12.2023made 1011507 01.11.2018 2 D1 4 SN NYNYY 2001.12.202300290.0000110.3000000.00 5001.12.2023Measurement of spirometry: (a) that includes continuous measurement of the 5001.12.2023relationship between flow and volume during expiration or during expiration 5001.12.2023and inspiration, performed before and after inhalation of a bronchodilator; 5001.12.2023and (b) fractional exhaled nitric oxide (FeNO) concentration in exhaled 5001.12.2023breath; if: (c) the measurement is performed: (i) under the supervision of a 5001.12.2023specialist or consultant physician; and (ii) with continuous attendance by a 5001.12.2023respiratory scientist; and (iii) in a respiratory laboratory equipped to 5001.12.2023perform complex lung function tests; and (d) a permanently recorded tracing 5001.12.2023and written report is provided; and (e) 3 or more spirometry recordings are 5001.12.2023performed unless difficult to achieve for clinical reasons; each occasion at 5001.12.2023which one or more such tests are performed Not applicable to a service 5001.12.2023associated with a service to which item 11503 or 11512 applies 1011508 01.11.2018 2 D1 4 SN NYNNY 2001.12.202300835.0000320.1000000.00 5001.12.2023Maximal symptomlimited incremental exercise test using a calibrated cycle 5001.12.2023ergometer or treadmill, if: (a) the test is performed for the evaluation of: 5001.12.2023(i) breathlessness of uncertain cause from tests performed at rest; or (ii) 5001.12.2023breathlessness out of proportion with impairment due to known conditions; or 5001.12.2023(iii) functional status and prognosis in a patient with significant cardiac or 5001.12.2023pulmonary disease for whom complex procedures such as organ transplantation 5001.12.2023are considered; or (iv) anaesthetic and perioperative risks in a patient 5001.12.2023undergoing major surgery who is assessed as substantially above average risk 5001.12.2023after standard evaluation; and (b) the test has been requested by a specialist 5001.12.2023or consultant physician following professional attendance on the patient by 5001.12.2023the specialist or consultant physician; and (c) a respiratory scientist and a 5001.12.2023medical practitioner are in constant attendance during the test; and (d) the 5001.12.2023test is performed in a respiratory laboratory equipped with airway management 5001.12.2023and defibrillator equipment; and (e) there is continuous measurement of at 5001.12.2023least the following: (i) work rate; (ii) pulse oximetry; (iii) respired oxygen 5001.12.2023and carbon dioxide partial pressures and respired volumes; (iv) ECG; (v) heart 5001.12.2023rate and blood pressure; and (f) interpretation and preparation of a permanent 5001.12.2023report is provided by aspecialist or consultant physician who is also 5001.12.2023responsible for the supervision of technical staff and quality assurance 1011512 26.05.2002 2 D1 4 SN NYNYY 2001.12.202300164.0000068.0000000.00 5001.12.2023Measurement of spirometry: (a) that includes continuous measurement of the 5001.12.2023relationship between flow and volume during expiration or during expiration 5001.12.2023and inspiration, performed before and after inhalation of a bronchodilator; 5001.12.2023and (b) that is performed with a respiratory scientist in continuous 5001.12.2023attendance; and (c) that is performed in a respiratory laboratory equipped to 5001.12.2023perform complex lung function tests; and (d) that is performed under the 5001.12.2023supervision of a specialist or consultant physician who is responsible for 5001.12.2023staff training, supervision, quality assurance and the issuing of written 5001.12.2023reports; and (e) for which a permanently recorded tracing and written report 5001.12.2023is provided; and (f) for which 3 or more spirometry recordings are performed; 5001.12.2023each occasion at which one or more such tests are performed Not applicable for 5001.12.2023a service associated with a service to which item 11503 or 11507 applies 1011600 26.05.2002 2 D1 5 SN NYNNY 2001.12.202300162.0000076.3000000.00 5001.12.2023BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic 5001.12.2023arterial or cardiac intracavity), by indwelling catheter - once only for each 5001.12.2023type of pressure on any calendar day up to a maximum of 4 pressures (not being 5001.12.2023a service to which item 13876 applies and where not performed in association 5001.12.2023with the administration of general anaesthesia) 1011602 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000063.5500000.00 5001.12.2023Investigation of venous reflux or obstruction in one or more limbs at rest by 5001.12.2023CW Doppler or pulsed Doppler involving examination at multiple sites along 5001.12.2023each limb using intermittent limb compression or Valsalva manoeuvres, or both, 5001.12.2023to detect prograde and retrograde flow, other than a service associated with a 5001.12.2023service to which item 32500 applieshard copy trace and written report, the 5001.12.2023report component of which must be performed by a medical practitioner, maximum 5001.12.2023of 2 examinations in a 12 month period, not to be used in conjunction with 5001.12.2023sclerotherapy 1011604 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000083.3000000.00 5001.12.2023Investigation of chronic venous disease in the upper and lower extremities, 5001.12.2023one or more limbs, by plethysmography (excluding 5001.12.2023photoplethysmography)examination, hard copy trace and written report, not 5001.12.2023being a service associated with a service to which item 32500 applies 1011605 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000083.3000000.00 5001.12.2023Investigation of complex chronic lower limb reflux or obstruction, in one or 5001.12.2023more limbs, by infrared photoplethysmography, during and following exercise to 5001.12.2023determine surgical intervention or the conservative management of deep venous 5001.12.2023thrombotic diseasehard copy trace, calculation of 90% recovery time and 5001.12.2023written report, not being a service associated with a service to which item 5001.12.202332500 applies 1011607 01.11.2021 2 D1 5 SN NYNNN 2001.12.202300238.0000113.3500000.00 5001.12.2023Continuous ambulatory blood pressure recording for 24 hours or more for a 5001.12.2023patient if: (a) the patient has a clinic blood pressure measurement (using a 5001.12.2023sphygmomanometer or a validated oscillometric blood pressure monitoring 5001.12.2023device) of either or both of the following measurements: (i) systolic blood 5001.12.2023pressure greater than or equal to 140 mmHg and less than or equal to 180 mmHg; 5001.12.2023(ii) diastolic blood pressure greater than or equal to 90 mmHg and less than 5001.12.2023or equal to 110 mmHg; and (b) the patient has not commenced antihypertensive 5001.12.2023therapy; and (c) the recording includes the patients resting blood pressure; 5001.12.2023and (d) the recording is conducted using microprocessorbased analysis 5001.12.2023equipment; and (e) the recording is interpreted by a medical practitioner and 5001.12.2023a report is prepared by the same medical practitioner; and (f) a treatment 5001.12.2023plan is provided for the patient; and (g) the service: (i) is not provided in 5001.12.2023association with ambulatory electrocardiogram recording, and (ii) is not 5001.12.2023associated with a service to which any of the following items apply: (A) 177; 5001.12.2023(B) 224 to 228; (C) 229 to 244; (D) 699; (E) 701 to 707; (F) 715; (G) 721 to 5001.12.2023732; (H) 735 to 758. Applicable only once in any 12 month period 1011610 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000070.1000000.00 5001.12.2023MEASUREMENT OF ANKLE: BRACHIAL INDICES AND ARTERIAL WAVEFORM ANALYSIS, 5001.12.2023measurement of posterior tibial and dorsalis pedis (or toe) and brachial 5001.12.2023arterial pressures bilaterally using Doppler or plethysmographic techniques, 5001.12.2023the calculation of ankle (or toe) brachial systolic pressure indices and 5001.12.2023assessment of arterial waveforms for the evaluation of lower extremity 5001.12.2023arterial disease, examination, hard copy trace and report. 1011611 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000070.1000000.00 5001.12.2023MEASUREMENT OF WRIST: BRACHIAL INDICES AND ARTERIAL WAVEFORM ANALYSIS, 5001.12.2023measurement of radial and ulnar (or finger) and brachial arterial pressures 5001.12.2023bilaterally using Doppler or plethysmographic techniques, the calculation of 5001.12.2023the wrist (or finger ) brachial systolic pressure indices and assessment of 5001.12.2023arterial waveforms for the evaluation of upper extremity arterial disease, 5001.12.2023examination, hard copy trace and report. 1011612 26.05.2002 2 D1 5 SN NYNNY 2001.12.202300225.0000123.7000000.00 5001.12.2023EXERCISE STUDY FOR THE EVALUATION OF LOWER EXTREMITY ARTERIAL DISEASE, 5001.12.2023measurement of posterior tibial and dorsalis pedis (or toe) and brachial 5001.12.2023arterial pressures bilaterally using Doppler or plethysmographic techniques, 5001.12.2023the calculation of ankle (or toe) brachial systolic pressure indices for the 5001.12.2023evaluation of lower extremity arterial disease at rest and following exercise 5001.12.2023using a treadmill or bicycle ergometer or other such equipment where the 5001.12.2023exercise workload is quantifiably documented, examination and report. 1011614 01.11.2003 2 D1 5 SN NYNNY 2001.12.202300120.0000083.3000000.00 5001.12.2023Transcranial doppler, examination of the intracranial arterial circulation 5001.12.2023using CW Doppler or pulsed Doppler with hard copy recording of waveforms, 5001.12.2023examination and report, other than a service associated with a service to 5001.12.2023which item 55280 of the diagnostic imaging services table applies 1011615 26.05.2002 2 D1 5 SN NYNNY 2001.12.202300178.0000083.5000000.00 5001.12.2023MEASUREMENT OF DIGITAL TEMPERATURE, 1 or more digits, (unilateral or 5001.12.2023bilateral) and report, with hard copy recording of temperature before and for 5001.12.202310 minutes or more after cold stress testing. 1011627 26.05.2002 2 D1 5 SN NYNNY 2001.12.202300640.0000251.6500000.00 5001.12.2023PULMONARY ARTERY pressure monitoring during open heart surgery, in apatient 5001.12.2023under 12 years of age 1011704 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300130.0000034.4000000.00 5001.12.2023Twelvelead electrocardiography, trace and formal report, by a specialist or a 5001.12.2023consultant physician, if the service: (a) is requested by a requesting 5001.12.2023practitioner; and (b) is not associated with a service to which item 12203, 5001.12.202312204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies. Note: 5001.12.2023the following are also requirements of the service: a formal report is 5001.12.2023completed; and a copy of the formal report is provided to the requesting 5001.12.2023practitioner; and the service is not provided to the patient as part of an 5001.12.2023episode of hospital treatment or hospital-substitute treatment; and is not 5001.12.2023provided in association with an attendance item (Part 2 of the schedule); and 5001.12.2023the specialist or consultant physician who renders the service does not have a 5001.12.2023financial relationship with the requesting practitioner. 1011705 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300065.0000020.2500000.00 5001.12.2023Twelvelead electrocardiography, formal report only, by a specialist or a 5001.12.2023consultant physician, if the service: (a) is requested by a requesting 5001.12.2023practitioner; and (b) is not associated with a service to which item 12203, 5001.12.202312204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies 5001.12.2023Applicable not more than twice on the same day Note: the following are also 5001.12.2023requirements of the service: a formal report is completed; and a copy of the 5001.12.2023formal report is provided to the requesting practitioner; and the specialist 5001.12.2023or consultant physician who renders the service does not have a financial 5001.12.2023relationship with the requesting practitioner. 1011707 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300065.0000020.2500000.00 5001.12.2023Twelvelead electrocardiography, trace only, by a medical practitioner, if: (a) 5001.12.2023the trace: (i) is required to inform clinical decision making; and (ii) is 5001.12.2023reviewed in a clinically appropriate timeframe to identify potentially serious 5001.12.2023or lifethreatening abnormalities; and (iii) does not need to be fully 5001.12.2023interpreted or reported on; and (b) the service is not associated with a 5001.12.2023service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 5001.12.202312217 or 12250 applies Applicable not more than twice on the same day Note: 5001.12.2023the service is not provided to the patient as part of an episode of: hospital 5001.12.2023treatment; or hospital-substitute treatment. 1011713 26.05.2002 2 D1 6 SN NYNNY 2001.12.202300260.0000076.7500000.00 5001.12.2023SIGNAL AVERAGED ECG RECORDING involving not more than 300 beats, using at 5001.12.2023least 3 leads with data acquisition at not less than 1000Hz of at least 100 5001.12.2023QRS complexes, including analysis, interpretation and report of recording by a 5001.12.2023specialist physician or consultant physician 1011714 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300102.0000026.6500000.00 5001.12.2023Twelvelead electrocardiography, trace and clinical note, by a specialist or 5001.12.2023consultant physician, if the service is not associated with a service to which 5001.12.2023item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 5001.12.2023applies Applicable not more than twice on the same day Note: the service is 5001.12.2023not provided to the patient as part of an episode of: hospital treatment; or 5001.12.2023hospital-substitute treatment. 1011716 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300490.0000184.4000000.00 5001.12.2023Note:the service only applies if the patient meets one or more of the 5001.12.2023following and the requirements in Note: DR.1.1 Continuous ambulatory 5001.12.2023electrocardiogram recording for 12 or more hours, by a specialist or 5001.12.2023consultant physician, if the service: (a) is indicated for the evaluation of 5001.12.2023any of the following: (i) syncope; (ii) presyncopal episodes; (iii) 5001.12.2023palpitations where episodes are occurring more than once a week; (iv) another 5001.12.2023asymptomatic arrhythmia is suspected with an expected frequency of greater 5001.12.2023than once a week; (v) surveillance following cardiac surgical procedures that 5001.12.2023have an established risk of causing dysrhythmia; and (b) utilises a system 5001.12.2023capable of superimposition and full disclosure printout of at least 12 hours 5001.12.2023of recorded electrocardiogram data (including resting electrocardiogram and 5001.12.2023the recording of parameters) and microprocessor based scanning analysis; and 5001.12.2023(c) includes interpretation and report; and (d) is not provided in association 5001.12.2023with ambulatory blood pressure monitoring; and (e) is not associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 11717, 11723, 11735, 12203, 5001.12.202312204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies 5001.12.2023Applicable only once in any 4 week period Note: this services does not apply 5001.12.2023if the patient is being provided with the service as part of an episode of: 5001.12.2023hospital treatment; or hospitalsubstitute treatment. 1011717 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300260.0000108.3500000.00 5001.12.2023Note: the service only applies if the patient meets one or more of the 5001.12.2023following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram 5001.12.2023monitoring, by a specialist or consultant physician, if the service: (a) 5001.12.2023utilises a patient activated, single or multiple event memory recording device 5001.12.2023that: (i) is connected continuously to the patient for between 7 and 30 days; 5001.12.2023and (ii) is capable of recording for at least 20 seconds prior to each 5001.12.2023activation and for 15 seconds after each activation; and (b) includes 5001.12.2023transmission, analysis, interpretation and reporting (including the indication 5001.12.2023for the investigation); and (c) is for the investigation of recurrent episodes 5001.12.2023of: unexplained syncope; or palpitation; or other symptoms where a cardiac 5001.12.2023rhythm disturbance is suspected and where infrequent episodes have occurred; 5001.12.2023and (d) is not associated with a service to which item 11716, 11723, 11735, 5001.12.202312203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies 5001.12.2023Applicable only once in any 3 month period Note: the service does not apply if 5001.12.2023the patient is being provided with the service as part of an episode of: 5001.12.2023hospital treatment; or hospitalsubstitute treatment. 1011719 01.09.2015 2 D1 6 SN NYNNY 2001.12.202300250.0000073.5000000.00 5001.12.2023IMPLANTED PACEMAKER (including cardiac resynchronisation pacemaker) REMOTE 5001.12.2023MONITORING involving reviews (without patient attendance) of arrhythmias, lead 5001.12.2023and device parameters, if at least one remote review is provided in a 12 month 5001.12.2023period. Payable only once in any 12 month period 1011720 01.09.2015 2 D1 6 SN NYNYY 2001.12.202300250.0000073.5000000.00 5001.12.2023IMPLANTED PACEMAKER TESTING, with patient attendance, following detection of 5001.12.2023abnormality by remote monitoring involving electrocardiography, measurement of 5001.12.2023rate, width and amplitude of stimulus including reprogramming when required, 5001.12.2023not being a service associated with a service to which item 11721 applies. 1011721 26.05.2002 2 D1 6 SN NYNNY 2001.12.202300260.0000076.7500000.00 5001.12.2023IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate 5001.12.2023responsive, or antitachycardia pacemakers, including reprogramming when 5001.12.2023required, not being a service associated with a service to which Item 11704, 5001.12.202311719, 11720, 11725 or 11726 applies 1011723 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300136.0000057.2000000.00 5001.12.2023Note:the service only applies if the patient meets one or more of the 5001.12.2023following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram 5001.12.2023monitoring, by a specialist or consultant physician, if the service: (a) 5001.12.2023utilises a patient activated, single or multiple event recording, on a memory 5001.12.2023recording device that: (i) is connected continuously to the patient for up to 5001.12.20237 days; and (ii) is capable of recording for at least 20 seconds prior to each 5001.12.2023activation and for 15 seconds after each activation; and (b) includes 5001.12.2023transmission, analysis, interpretation and formal report (including the 5001.12.2023indication for the investigation); and (c) is for the investigation of 5001.12.2023recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) 5001.12.2023other symptoms where a cardiac rhythm disturbance is suspected and where 5001.12.2023infrequent episodes have occurred; and (d) is not associated with a service to 5001.12.2023which item 11716, 11717, 11735, 12203, 12204, 12205, 12207, 12208, 12210, 5001.12.202312213, 12215, 12217 or 12250 applies Applicable only once in any 3 month 5001.12.2023period Note: The service does not apply if the patient is an admitted patient. 1011724 26.05.2002 2 D1 6 SN NYNNY 2001.12.202300545.0000185.8500000.00 5001.12.2023UP-RIGHT TILT TABLE TESTING for the investigation of syncope of suspected 5001.12.2023cardiothoracic origin, including blood pressure monitoring, continuous ECG 5001.12.2023monitoring and the recording of the parameters, and involving an established 5001.12.2023intravenous line and the continuous attendance of a specialist or consultant 5001.12.2023physician - on premises equipped with a mechanical respirator and 5001.12.2023defibrillator 1011725 01.09.2015 2 D1 6 SN NYNNY 2001.12.202300710.0000208.6000000.00 5001.12.2023IMPLANTED DEFIBRILLATOR (including cardiac resynchronisation defibrillator) 5001.12.2023REMOTE MONITORING involving reviews (without patient attendance) of 5001.12.2023arrhythmias, lead and device parameters, if at least 2 remote reviews are 5001.12.2023provided in a 12 month period. Payable only once in any 12 month period 1011726 01.09.2015 2 D1 6 SN NYNNY 2001.12.202300355.0000104.3000000.00 5001.12.2023IMPLANTED DEFIBRILLATOR TESTING with patient attendance following detection of 5001.12.2023abnormality by remote monitoring involving electrocardiography, measurement of 5001.12.2023rate, width and amplitude of stimulus, not being a service associated with a 5001.12.2023service to which item 11727 applies. 1011727 01.11.2006 2 D1 6 SN NYNYY 2001.12.202300355.0000104.3000000.00 5001.12.2023IMPLANTED DEFIBRILLATOR TESTING involving electrocardiography, assessment of 5001.12.2023pacing and sensing thresholds for pacing and defibrillation electrodes, 5001.12.2023download and interpretation of stored events and electrograms, including 5001.12.2023programming when required, not being a service associated with a service to 5001.12.2023which item 11719, 11720, 11721, 11725 or 11726 applies 1011728 01.05.2018 2 D1 6 SN NYNYY 2001.12.202300089.0000038.2500000.00 5001.12.2023Implanted loop recording for the investigation of atrial fibrillation if the 5001.12.2023patient to whom the service is provided has been diagnosed as having had an 5001.12.2023embolic stroke of undetermined source, including reprogramming when required, 5001.12.2023retrieval of stored data, analysis, interpretation and report, other than a 5001.12.2023service to which item 38288 applies For any particular patientapplicable not 5001.12.2023more than 4 times in any 12 months 1011729 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300450.0000167.5500000.00 5001.12.2023Multi channel electrocardiogram monitoring and recording during exercise 5001.12.2023(motorised treadmill or cycle ergometer capable of quantifying external 5001.12.2023workload in watts) or pharmacological stress, if: (a) the patient is 17 years 5001.12.2023or more; and (b) the patient: (i) has symptoms consistent with cardiac 5001.12.2023ischemia; or (ii) has other cardiac disease which may be exacerbated by 5001.12.2023exercise; or (iii) has a first degree relative with suspected heritable 5001.12.2023arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 5001.12.2023minutes; and (ii) includes resting electrocardiogram; and (d) a written report 5001.12.2023is produced by a medical practitioner that includes interpretation of the 5001.12.2023monitoring and recording data, commenting on the significance of the data, and 5001.12.2023the relationship of the data to clinical decision making for the patient in 5001.12.2023the clinical context; and (e) the service is not a service: (i) provided on 5001.12.2023the same occasion as a service to which item 11704, 11705, 11707 or 11714 5001.12.2023applies; or (ii) performed within 24 months of a service to which item 55141, 5001.12.202355143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 5001.12.202361410 or 61414 applies Applicable only once in any 24 month period 1011730 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300450.0000167.5500000.00 5001.12.2023Multi channel electrocardiogram monitoring and recording during exercise 5001.12.2023(motorised treadmill or cycle ergometer capable of quantifying external 5001.12.2023workload in watts), if: (a) the patient is less than 17 years; and (b) the 5001.12.2023patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other 5001.12.2023cardiac disease which may be exacerbated by exercise; or (iii) has a first 5001.12.2023degree relative with suspected heritable arrhythmia; and (c) the monitoring 5001.12.2023and recording: (i) is not less than 20 minutes in duration; and (ii) includes 5001.12.2023resting electrocardiogram; and (d) a written report is produced by a medical 5001.12.2023practitioner that includes interpretation of the monitoring and recording 5001.12.2023data, commenting on the significance of the data, and the relationship of the 5001.12.2023data to clinical decision making for the patient in the clinical context; and 5001.12.2023(e) the service is not a service: (i) provided on the same occasion as a 5001.12.2023service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed 5001.12.2023within 24 months of a service to which item 55141, 55143, 55145, 55146, 61324, 5001.12.202361329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 applies 5001.12.2023Applicable only once in any 24 month period 1011731 01.08.2020 2 D1 6 SN NYNYY 2001.12.202300089.0000038.2500000.00 5001.12.2023Implanted electrocardiogram loop recording, by a medical practitioner, 5001.12.2023including reprogramming (if required), retrieval of stored data, analysis, 5001.12.2023interpretation and report, if the service is: (a) an investigation for a 5001.12.2023patient with: (i) cryptogenic stroke; or (ii) recurrent unexplained syncope; 5001.12.2023and (b) not a service to which item 38285 applies Applicable only once in any 5001.12.20234 week period 1011736 01.11.2022 2 D1 6 SN NYNYY 2001.12.202300085.0000038.2500000.00 5001.12.2023Implanted loop recording via remote monitoring (including reprogramming (if 5001.12.2023required), retrieval of stored data, analysis, interpretation and report), for 5001.12.2023the investigation of atrial fibrillation, if the service: (a) is provided to a 5001.12.2023patient who has been diagnosed as having had an embolic stroke of undetermined 5001.12.2023source; and (b) is not a service to which item 38288 applies Applicable not 5001.12.2023more than 4 times in any 12 month period 1011737 01.11.2022 2 D1 6 SN NYNYY 2001.12.202300085.0000038.2500000.00 5001.12.2023Implanted electrocardiogram loop recording via remote monitoring (including 5001.12.2023reprogramming (if required), retrieval of stored data, analysis, 5001.12.2023interpretation and report), by a medical practitioner, if the service is: (a) 5001.12.2023an investigation for a patient with: (i) cryptogenic stroke; or (ii) recurrent 5001.12.2023unexplained syncope; and (b) not a service to which item 38285 applies 5001.12.2023Applicable only once in any 4 week period 1011800 26.05.2002 2 D1 7 SN NYNNY 2001.12.202300580.0000192.0000000.00 5001.12.2023OESOPHAGEAL MOTILITY TEST, manometric 1011801 01.09.2015 2 D1 7 SN NYNNY 2001.12.202300985.0000289.5000000.00 4001.09.2015(Anaes.) 5001.12.2023CLINICAL ASSESSMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE that involves 48 hour 5001.12.2023catheter-free wireless ambulatory oesophageal pH monitoring including 5001.12.2023administration of the device and associated endoscopy procedure for placement, 5001.12.2023analysis and interpretation of the data and all attendances for providing the 5001.12.2023service, if (a)a cathetter-based ambulatory oesophageal pH-mnitoring: (i)has 5001.12.2023been attempted on the patient but failed due to clinical complications, or 5001.12.2023(ii)is not clinically appropriate for the patient due to anatomical reasons 5001.12.2023(nasopharyngeal anatomy) preventing the use of catheter-based pH monitoring; 5001.12.2023and (b)the services is performed by a specialist or consultant physician with 5001.12.2023endoscopic training that is recognised by The Conjoint Committee for the 5001.12.2023Recognition of Training in Gastrointestinal Endoscopy. Not in association with 5001.12.2023another item in Category 2, sub-group 7 (Anaes.) 1011810 26.05.2002 2 D1 7 SN NYNNY 2001.12.202300485.0000192.0000000.00 5001.12.2023CLINICAL ASSESSMENT of GASTRO-OESOPHAGEAL REFLUX DISEASE involving 24 hour pH 5001.12.2023monitoring, including analysis, interpretation and report and including any 5001.12.2023associated consultation 1011820 01.05.2004 2 D1 7 SN NYNYY 2001.12.202303000.0001353.1500000.00 5001.12.2023Capsule endoscopy to investigate an episode of obscure gastrointestinal 5001.12.2023bleeding, using a capsule endoscopy device (including administration of the 5001.12.2023capsule, associated endoscopy procedure if required for placement, imaging, 5001.12.2023image reading and interpretation, and all attendances for providing the 5001.12.2023service on the day the capsule is administered) if: (a) the service is 5001.12.2023provided to a patient who: (i) has overt gastrointestinal bleeding; or (ii) 5001.12.2023has gastrointestinal bleeding that is recurrent or persistent, and iron 5001.12.2023deficiency anaemia that is not due to coeliac disease, and, if the patient 5001.12.2023also has menorrhagia, has had the menorrhagia considered and managed; and 5001.12.2023(b)an upper gastrointestinal endoscopy and a colonoscopy have been performed 5001.12.2023on the patient and have not identified the cause of thebleeding; and (c)the 5001.12.2023service has not been provided to the same patient on more than 2 occasions in 5001.12.2023the preceding 12 months; and (d)the service is performed by a specialist or 5001.12.2023consultant physician with endoscopic training that is recognised by the 5001.12.2023Conjoint Committee for the Recognitionof Training in Gastrointestinal 5001.12.2023Endoscopy; and (e)the service is not associated with a service to which item 5001.12.202330680, 30682, 30684 or 30686 applies 1011830 26.05.2002 2 D1 7 SN NYNNY 2001.12.202300610.0000205.6000000.00 5001.12.2023DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR involving anal manometry or 5001.12.2023measurement of anorectal sensation or measurement of the rectosphincteric 5001.12.2023reflex 1011833 26.05.2002 2 D1 7 SN NYNNY 2001.12.202300685.0000274.8500000.00 5001.12.2023DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR and sphincter muscles involving 5001.12.2023electromyography or measurement of pudendal and spinal nerve motor latency 1011900 26.05.2002 2 D1 8 SN NYNNY 2001.12.202300080.0000030.3000000.00 5001.12.2023Urine flow study, including peak urine flow measurement, not being a service 5001.12.2023associated with a service to which item 11912, 11917 or 11919 applies 1011912 26.05.2002 2 D1 8 SN NYNNY 2001.12.202300570.0000217.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Cystometrography:(a) with measurement of any one or more of the following: (i) 5001.12.2023urine flow rate; (ii) urethral pressure profile; (iii) urethral sphincter 5001.12.2023electromyography; and(b) with simultaneous measurement of: (i) rectal 5001.12.2023pressure; or (ii) stomal or vaginal pressure if rectal pressure is not 5001.12.2023possible;not being a service associated with a service to which any of items 5001.12.202311012 to 11027, 11900, 11917, 11919 and 36800 or an item in Group I3 of the 5001.12.2023diagnostic imaging services table applies (Anaes.) 1011917 01.11.2002 2 D1 8 SN NYNNY 2001.12.202301225.0000471.5500000.00 4001.11.2002(Anaes.) 5001.12.2023Cystometrography, in conjunction with real time ultrasound of one or more 5001.12.2023components of the urinary tract:(a) with measurement of any one or more of the 5001.12.2023following: (i) urine flow rate; (ii) urethral pressure profile; (iii) urethral 5001.12.2023sphincter electromyography; and(b) with simultaneous measurement of: (i) 5001.12.2023rectal pressure; or (ii) stomal or vaginal pressure if rectal pressure is not 5001.12.2023possible;including all imaging associated with cystometrography, not being a 5001.12.2023service associated with a service to which any of items 11012 to 11027, 11900, 5001.12.202311912, 11919 and 36800 or an item in Group I3 of the diagnostic imaging 5001.12.2023services table applies (Anaes.) 1011919 01.05.2003 2 D1 8 SN NYNNY 2001.12.202301225.0000471.5500000.00 4001.05.2003(Anaes.) 5001.12.2023CYSTOMETROGRAPHY IN CONJUNCTION WITH CONTRAST MICTURATING CYSTOURETHROGRAPHY, 5001.12.2023with measurement of any one or more of urine flow rate, urethral pressure 5001.12.2023profile, rectal pressure, urethral sphincter electromyography, being a service 5001.12.2023associated with a service to which items 60506 or 60509 applies;other than a 5001.12.2023service associated with a service to which items 11012-11027, 11900-11917 and 5001.12.202336800 apply (Anaes.) 1012000 26.05.2002 2 D1 9 SN NYNNY 2001.12.202300122.0000042.8500000.00 5001.12.2023Skin prick testing for aeroallergens by a specialist or consultant physician 5001.12.2023in the practice of the specialist or consultant physicians specialty, 5001.12.2023including all allergens tested on the same day, not being a service associated 5001.12.2023with a service to which item 12001, 12002, 12005, 12012, 12017, 12021, 12022 5001.12.2023or 12024 applies 1012001 01.11.2018 2 D1 9 SN NYNYY 2001.12.202300122.0000042.8500000.00 5001.12.2023Skin prick testing for aeroallergens, including all allergens tested on the 5001.12.2023same day, not being a service associated with a service to which item 12000, 5001.12.202312002, 12005, 12012, 12017, 12021, 12022 or 12024 applies. Applicable only 5001.12.2023once in any 12 month period 1012002 01.11.2018 2 D1 9 SN NYNYY 2001.12.202300122.0000042.8500000.00 5001.12.2023Repeat skin prick testing of a patient for aeroallergens, including all 5001.12.2023allergens tested on the same day, if: (a) further testing for aeroallergens is 5001.12.2023indicated in the same 12 month period to which item 12001 applies to a service 5001.12.2023for the patient; and (b) the service is not associated with a service to which 5001.12.2023item 12000, 12001, 12005, 12012, 12017, 12021, 12022 or 12024 applies 5001.12.2023Applicable only once in any 12 month period 1012004 01.11.2018 2 D1 9 SN NYNNY 2001.12.202300186.0000064.8000000.00 5001.12.2023Skin testing for medication allergens (antibiotics or non general anaesthetics 5001.12.2023agents) and venoms (including prick testing and intradermal testing with a 5001.12.2023number of dilutions), including all allergens tested on the same day, not 5001.12.2023being a service associated with a service to which item 12012, 12017, 12021, 5001.12.202312022 or 12024 applies 1012005 01.11.2018 2 D1 9 SN NYNYY 2001.12.202300193.0000087.1500000.00 5001.12.2023Skin testing: (a) performed by or on behalf of a specialist or consultant 5001.12.2023physician in the practice of the specialist or consultant physicians 5001.12.2023specialty; and (b) for agents used in the perioperative period (including 5001.12.2023prick testing and intradermal testing with a number of dilutions), to 5001.12.2023investigate anaphylaxis in a patient with a history of prior anaphylactic 5001.12.2023reaction or cardiovascular collapse associated with the administration of an 5001.12.2023anaesthetic; and (c) including all allergens tested on the same day; and (d) 5001.12.2023not being a service associated with a service to which item 12000, 12001, 5001.12.202312002, 12003, 12012, 12017, 12021, 12022 or 12024 applies 1012012 26.05.2002 2 D1 9 SN NYNNY 2001.12.202300051.0000022.9000000.00 5001.12.2023Epicutaneous patch testing in the investigation of allergic dermatitis using 5001.12.2023not more than 25 allergens 1012017 01.11.2016 2 D1 9 SN NYNNY 2001.12.202300230.0000077.3000000.00 5001.12.2023Epicutaneous patch testing in the investigation of allergic dermatitis using 5001.12.2023more than 25 allergens but not more than 50 allergens 1012021 26.05.2002 2 D1 9 SN NYNNY 2001.12.202300375.0000127.1000000.00 5001.12.2023Epicutaneous patch testing in the investigation of allergic dermatitis, 5001.12.2023performed by or on behalf of a specialist, or consultant physician, in the 5001.12.2023practice of his or her specialty, using more than 50 allergens but not more 5001.12.2023than 75 allergens 1012022 01.11.2016 2 D1 9 SN NYNNY 2001.12.202300449.0000149.2500000.00 5001.12.2023Epicutaneous patch testing in the investigation of allergic dermatitis, 5001.12.2023performed by or on behalf of a specialist, or consultant physician, in the 5001.12.2023practice of his or her specialty, using more than 75 allergens but not more 5001.12.2023than 100 allergens 1012024 01.11.2016 2 D1 9 SN NYNNY 2001.12.202300515.0000170.0500000.00 5001.12.2023Epicutaneous patch testing in the investigation of allergic dermatitis, 5001.12.2023performed by or on behalf of a specialist, or consultant physician, in the 5001.12.2023practice of his or her specialty, using more than 100 allergens 1012200 26.05.2002 2 D1 10 SN NYNNY 2001.12.202300091.0000040.9000000.00 5001.12.2023COLLECTION OF SPECIMEN OF SWEAT by iontophoresis 1012201 01.05.2004 2 D1 10 SN NYNNY 2001.12.202303790.0002633.8500000.00 5001.12.2023Administration, by a specialist or consultant physician in the practice of the 5001.12.2023specialists or consultant physicians specialty, of thyrotropin alfa-rch 5001.12.2023(recombinant human thyroid-stimulating hormone), and arranging services to 5001.12.2023which both items 61426 and 66650 apply, for the detection of recurrent 5001.12.2023well-differentiated thyroid cancer in a patient if: (a) the patient has had a 5001.12.2023total thyroidectomy and 1 ablative dose of radioactive iodine; and (b) the 5001.12.2023patient is maintained on thyroid hormone therapy; and (c) the patient is at 5001.12.2023risk of recurrence; and (d) on at least 1 previous whole body scan or serum 5001.12.2023thyroglobulin test when withdrawn from thyroid hormone therapy, the patient 5001.12.2023did not have evidence of well-differentiated thyroid cancer; and (e) either: 5001.12.2023(i) withdrawal from thyroid hormone therapy resulted in severe psychiatric 5001.12.2023disturbances when hypothyroid; or (ii) withdrawal is medically 5001.12.2023contra-indicated because the patient has: (a) unstable coronary artery 5001.12.2023disease; or (b) hypopituitarism; or (c) a high risk of relapse or exacerbation 5001.12.2023of a previous severe psychiatric illness applicable once only in a 12 month 5001.12.2023period 1012203 26.05.2002 2 D1 10 SN NYNYY 2001.12.202301510.0000647.2000000.00 5001.12.2023Overnight diagnostic assessment of sleep, for at least 8 hours, for a patient 5001.12.2023aged 18 years or more, to confirm diagnosis of a sleep disorder, if: (a) 5001.12.2023either: (i) the patient has been referred by a medical practitioner to a 5001.12.2023qualified adult sleep medicine practitioner or a consultant respiratory 5001.12.2023physician who has determined that the patient has a high probability for 5001.12.2023symptomatic, moderate to severe obstructive sleep apnoea based on a STOPBang 5001.12.2023score of3 or more, an OSA50 score of 5 or more or a high risk score on the 5001.12.2023Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or 5001.12.2023(ii) following professional attendance on the patient (either facetoface or by 5001.12.2023video conference) by a qualified adult sleep medicine practitioner or a 5001.12.2023consultant respiratory physician, the qualified adult sleep medicine 5001.12.2023practitioner or consultant respiratory physician determines that assessment is 5001.12.2023necessary to confirm the diagnosis of a sleep disorder; and (b) the overnight 5001.12.2023diagnostic assessment is performed to investigate: (i) suspected obstructive 5001.12.2023sleep apnoea syndrome where the patient is assessed as not suitable for an 5001.12.2023unattended sleep study; or (ii) suspected central sleep apnoea syndrome; or 5001.12.2023(iii) suspected sleep hypoventilation syndrome; or (iv) suspected sleeprelated 5001.12.2023breathing disorders in association with nonrespiratory comorbid conditions 5001.12.2023including heart failure, significant cardiac arrhythmias, neurological 5001.12.2023disease, acromegaly or hypothyroidism; or (v) unexplained hypersomnolence 5001.12.2023which is not attributed to inadequate sleep hygiene or environmental factors; 5001.12.2023or (vi) suspected parasomnia or seizure disorder where clinical diagnosis 5001.12.2023cannot be established on clinical features alone (including associated 5001.12.2023atypical features, vigilance behaviours or failure to respond to conventional 5001.12.2023therapy); or (vii) suspected sleep related movement disorder, where the 5001.12.2023diagnosis of restless legs syndrome is not evident on clinical assessment; and 5001.12.2023(c) a sleep technician is in continuous attendance under the supervision of a 5001.12.2023qualified adult sleep medicine practitioner; and (d) there is continuous 5001.12.2023monitoring and recording, performed in accordance with current professional 5001.12.2023guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) 5001.12.2023anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) 5001.12.2023oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) 5001.12.2023position; and (e) polygraphic records are: (i) analysed (for assessment of 5001.12.2023sleep stage, arousals, respiratory events, cardiac abnormalities and limb 5001.12.2023movements) with manual scoring, or manual correction of computerised scoring 5001.12.2023in epochs of not more than 1 minute; and (ii) stored for interpretation and 5001.12.2023preparation of a report; and (f) interpretation and preparation of a permanent 5001.12.2023report is provided by a qualified adult sleep medicine practitioner with 5001.12.2023personal direct review of raw data from the original recording of polygraphic 5001.12.2023data from the patient; and (g) the overnight diagnostic assessment is not 5001.12.2023provided to the patient on the same occasion that a service described in any 5001.12.2023of items 11000, 11003, 11004, 11005, 11503, 11704, 11705,11707, 11713, 11714, 5001.12.202311716, 11717, 11723, 11735or 12250 is provided to the patient Applicable only 5001.12.2023once in any 12 month period 1012204 01.11.2018 2 D1 10 SN NYNYY 2001.12.202301510.0000647.2000000.00 5001.12.2023Overnight assessment of positive airway pressure, for at least 8 hours, for a 5001.12.2023patient aged 18 years or more, if: (a) the necessity for an intervention sleep 5001.12.2023study is determined by a qualified adult sleep medicine practitioner or 5001.12.2023consultant respiratory physician where a diagnosis of a sleeprelated breathing 5001.12.2023disorder has been made; and (b) the patient has not undergone positive airway 5001.12.2023pressure therapy in the previous 6 months; and (c) following professional 5001.12.2023attendance on the patient by a qualified adult sleep medicine practitioner or 5001.12.2023a consultant respiratory physician (either facetoface or by video conference), 5001.12.2023the qualified adult sleep medicine practitioner or consultant respiratory 5001.12.2023physician establishes that the sleeprelated breathing disorder is responsible 5001.12.2023for the patients symptoms; and (d) a sleep technician is in continuous 5001.12.2023attendance under the supervision of a qualified adult sleep medicine 5001.12.2023practitioner; and (e) there is continuous monitoring and recording, performed 5001.12.2023in accordance with current professional guidelines, of the following measures: 5001.12.2023(i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous 5001.12.2023ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory 5001.12.2023movement; (ix) position; and (f) polygraphic records are: (i) analysed (for 5001.12.2023assessment of sleep stage, arousals, respiratory events, cardiac abnormalities 5001.12.2023and limb movements) with manual scoring, or manual correction of computerised 5001.12.2023scoring in epochs of not more than 1 minute; and (ii) stored for 5001.12.2023interpretation and preparation of a report; and (g) interpretation and 5001.12.2023preparation of a permanent report is provided by a qualified adult sleep 5001.12.2023medicine practitioner with personal direct review of raw data from the 5001.12.2023original recording of polygraphic data from the patient; and (h) the overnight 5001.12.2023assessment is not provided to the patient on the same occasion that a service 5001.12.2023mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 5001.12.202311707, 11713, 11714, 11716,11717, 11723, 11735or 12250 is provided to the 5001.12.2023patient Applicable only once in any 12 month period 1012205 01.11.2018 2 D1 10 SN NYNNY 2001.12.202301510.0000647.2000000.00 5001.12.2023Followup study for a patient aged 18 years or more with a sleeprelated 5001.12.2023breathing disorder, following professional attendance on the patient by a 5001.12.2023qualified adult sleep medicine practitioner or consultant respiratory 5001.12.2023physician (either face-to-face or by video conference), if: (a) any of the 5001.12.2023following subparagraphs applies: (i) there has been a recurrence of symptoms 5001.12.2023not explained by known or identifiable factors such as inadequate usage of 5001.12.2023treatment, sleep duration or significant recent illness; (ii) there has been a 5001.12.2023significant change in weight or changes in comorbid conditions that could 5001.12.2023affect sleeprelated breathing disorders, and other means of assessing 5001.12.2023treatment efficacy (including review of data stored by a therapy device used 5001.12.2023by the patient) are unavailable or have been equivocal; (iii) the patient has 5001.12.2023undergone a therapeutic intervention (including, but not limited to, positive 5001.12.2023airway pressure, upper airway surgery, positional therapy, appropriate oral 5001.12.2023appliance, weight loss of more than 10% in the previous 6 months or oxygen 5001.12.2023therapy), and there is either clinical evidence of suboptimal response or 5001.12.2023uncertainty about control of sleepdisordered breathing; and (b) a sleep 5001.12.2023technician is in continuous attendance under the supervision of a qualified 5001.12.2023adult sleep medicine practitioner; and (c) there is continuous monitoring and 5001.12.2023recording, performed in accordance with current professional guidelines, of 5001.12.2023the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior 5001.12.2023tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen 5001.12.2023saturation; (viii) respiratory movement (chest and abdomen); (ix) position; 5001.12.2023and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, 5001.12.2023arousals, respiratory events, cardiac abnormalities and limb movements) with 5001.12.2023manual scoring, or manual correction of computerised scoring in epochs of not 5001.12.2023more than 1 minute; and (ii) stored for interpretation and preparation of a 5001.12.2023report; and (e) interpretation and preparation of a permanent report is 5001.12.2023provided by a qualifiedadult sleep medicine practitioner with personal direct 5001.12.2023review of raw data from the original recording of polygraphic data from the 5001.12.2023patient; and (f) the followup study is not provided to the patient on the same 5001.12.2023occasion that a service mentioned in any of items 11000, 11003, 11004,11005, 5001.12.202311503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735or 12250 5001.12.2023is provided to the patient Applicable only once in any 12 month period 1012207 26.05.2002 2 D1 10 SN NYNYY 2001.12.202301510.0000647.2000000.00 5001.12.2023Overnight investigation, for a patient aged 18 years or more, for a 5001.12.2023sleeprelated breathing disorder, following professional attendance by a 5001.12.2023qualified adult sleep medicine practitioner or a consultant respiratory 5001.12.2023physician (either facetoface or by video conference), if: (a) the patient is 5001.12.2023referred by a medical practitioner; and (b) the necessity for the 5001.12.2023investigation is determined by a qualified adult sleep medicine practitioner 5001.12.2023before the investigation; and (c) there is continuous monitoring and 5001.12.2023recording, in accordance with current professional guidelines, of the 5001.12.2023following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial 5001.12.2023EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen 5001.12.2023saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and 5001.12.2023(d) a sleep technician is in continuous attendance under the supervision of a 5001.12.2023qualified adult sleep medicine practitioner; and (e) polygraphic records are: 5001.12.2023(i) analysed (for assessment of sleep stage, arousals, respiratory events and 5001.12.2023assessment of clinically significant alterations in heart rate and limb 5001.12.2023movement) with manual scoring, or manual correction of computerised scoring in 5001.12.2023epochs of not more than 1 minute; and (ii) stored for interpretation and 5001.12.2023preparation of a report; and (f) interpretation and preparation of a permanent 5001.12.2023report is provided by a qualified adult sleep medicine practitioner with 5001.12.2023personal direct review of raw data from the original recording of polygraphic 5001.12.2023data from the patient; and (g) the investigation is not provided to the 5001.12.2023patient on the same occasion that a service mentioned in any of items 11000, 5001.12.202311003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 5001.12.202311723, 11735 or 12250 is provided to the patient; and (h) previous studies 5001.12.2023have demonstrated failure of continuous positive airway pressure or oxygen; 5001.12.2023and (i) if the patient has severe respiratory failurea further investigation 5001.12.2023is indicated in the same 12 month period to which items 12204 and 12205 apply 5001.12.2023to a service for the patient, for the adjustment or testing, or both, of the 5001.12.2023effectiveness of a positive pressure ventilatory support device (other than 5001.12.2023continuous positive airway pressure) in sleep Applicable only once in any 12 5001.12.2023month period 1012208 01.11.2018 2 D1 10 SN NYNYY 2001.12.202301510.0000647.2000000.00 5001.12.2023Overnight investigation, for sleep apnoea for at least 8 hours, for a patient 5001.12.2023aged 18 years or more, if: (a) a qualified adult sleep medicine practitioner 5001.12.2023or consultant respiratory physician has determined that the investigation is 5001.12.2023necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep 5001.12.2023technician is in continuous attendance under the supervision of a qualified 5001.12.2023adult sleep medicine practitioner; and (c) there is continuous monitoring and 5001.12.2023recording, in accordance with current professional guidelines, of the 5001.12.2023following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial 5001.12.2023EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen 5001.12.2023saturation; (viii) respiratory movement (chest and abdomen); (ix) position; 5001.12.2023and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, 5001.12.2023arousals, respiratory events, cardiac abnormalities and limb movements) with 5001.12.2023manual scoring, or manual correction of computerised scoring in epochs of not 5001.12.2023more than 1 minute; and (ii) stored for interpretation and preparation of a 5001.12.2023report; and (e) interpretation and preparation of a permanent report is 5001.12.2023provided by a qualified adult sleep medicine practitioner with personal direct 5001.12.2023review of raw data from the original recording of polygraphic data from the 5001.12.2023patient; and (f) a further investigation is indicated in the same 12 month 5001.12.2023period to which item 12203 applies to a service for the patient because 5001.12.2023insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or 5001.12.2023less, during the previous investigation to which that item applied; and (g) 5001.12.2023the investigation is not provided to the patient on the same occasion that a 5001.12.2023service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 5001.12.202311705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to 5001.12.2023the patient Applicable only once in any 12 month period 1012213 26.05.2002 2 D1 10 SN NYNYY 2001.12.202301630.0000695.9500000.00 5001.12.2023Overnight paediatric investigation, for at least 8 hours, for a patient aged 5001.12.2023at least 12 years but less than 18 years, if: (a) the patient is referred by a 5001.12.2023medical practitioner; and (b) the necessity for the investigation is 5001.12.2023determined by a qualified sleep medicine practitioner before the 5001.12.2023investigation; and (c) there is continuous monitoring of oxygen saturation and 5001.12.2023breathing using a multichannel polygraph, and recordings of the following are 5001.12.2023made, in accordance with current professional guidelines: (i) airflow; (ii) 5001.12.2023continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in 5001.12.2023selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen 5001.12.2023saturation; (vii) respiratory movement of rib and abdomen (whether movement of 5001.12.2023rib is recorded separately from, or together with, movement of abdomen); 5001.12.2023(viii) measurement of carbon dioxide (either endtidal or transcutaneous); and 5001.12.2023(d) a sleep technician, or registered nurse with sleep technology training, is 5001.12.2023in continuous attendance under the supervision of a qualified sleep medicine 5001.12.2023practitioner; and (e) polygraphic records are: (i) analysed (for assessment of 5001.12.2023sleep stage, and maturation of sleep indices, arousals, respiratory events and 5001.12.2023assessment of clinically significant alterations in heart rate and body 5001.12.2023movement) with manual scoring, or manual correction of computerised scoring in 5001.12.2023epochs of not more than 1 minute; and (ii) stored for interpretation and 5001.12.2023preparation of a report; and (f) interpretation and report are provided by a 5001.12.2023qualified sleep medicine practitioner based on reviewing the direct original 5001.12.2023recording of polygraphic data from the patient; and (g) the investigation is 5001.12.2023not provided to the patient on the same occasion that a service to which item 5001.12.202311704, 11705, 11707, 11714, 11716, 11717, 11723 or 11735 applies is provided 5001.12.2023to the patient For each particular patientapplicable only in relation to each 5001.12.2023of the first 3 occasions the investigation is performed in any 12 month period 1012215 26.05.2002 2 D1 10 SN NYNYY 2001.12.202301810.0000772.5500000.00 5001.12.2023Overnight paediatric investigation, for at least 8 hours, for a patient less 5001.12.2023than 12 years of age, if: (a) the patient is referred by a medical 5001.12.2023practitioner; and (b) the necessity for the investigation is determined by a 5001.12.2023qualified paediatric sleep medicine practitioner before the investigation; and 5001.12.2023(c) there is continuous monitoring of oxygen saturation and breathing using a 5001.12.2023multichannel polygraph, and recordings of the following are made, in 5001.12.2023accordance with current professional guidelines: (i) airflow; (ii) continuous 5001.12.2023EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected 5001.12.2023investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; 5001.12.2023(vii) respiratory movement of rib and abdomen (whether movement of rib is 5001.12.2023recorded separately from, or together with, movement of abdomen); (viii) 5001.12.2023measurement of carbon dioxide (either endtidal or transcutaneous); and (d) a 5001.12.2023sleep technician, or registered nurse with sleep technology training, is in 5001.12.2023continuous attendance under the supervision of a qualified paediatric sleep 5001.12.2023medicine practitioner; and (e) polygraphic records are: (i) analysed (for 5001.12.2023assessment of sleep stage, and maturation of sleep indices, arousals, 5001.12.2023respiratory events and assessment of clinically significant alterations in 5001.12.2023heart rate and body movement) with manual scoring, or manual correction of 5001.12.2023computerised scoring in epochs of not more than 1 minute; and (ii) stored for 5001.12.2023interpretation and preparation of a report; and (f) interpretation and report 5001.12.2023are provided by a qualified paediatric sleep medicine practitioner based on 5001.12.2023reviewing the direct original recording of polygraphic data from the patient; 5001.12.2023and (g) a further investigation is indicated in the same 12 month period to 5001.12.2023which item 12210 applies to a service for the patient, for a patient using 5001.12.2023Continuous Positive Airway Pressure (CPAP) or noninvasive or invasive 5001.12.2023ventilation, or supplemental oxygen, in either or both of the following 5001.12.2023circumstances: (i) there is ongoing hypoxia or hypoventilation on the third 5001.12.2023study to which item 12210 applied for the patient, and further titration of 5001.12.2023respiratory support is needed to optimise therapy; (ii) there is clear and 5001.12.2023significant change in clinical status (for example lung function or functional 5001.12.2023status) or an intervening treatment that may affect ventilation in the period 5001.12.2023since the third study to which item 12210 applied for the patient, and repeat 5001.12.2023study is therefore required to determine the need for or the adequacy of 5001.12.2023respiratory support; and (h) the investigation is not provided to the patient 5001.12.2023on the same occasion that a service to which item 11704, 11705, 11707, 11714, 5001.12.202311716, 11717, 11723 or 11735 applies is provided to the patient Applicable 5001.12.2023only once in the same 12 month period to which item 12210 applies 1012217 26.05.2002 2 D1 10 SN NYNYY 2001.12.202301630.0000695.9500000.00 5001.12.2023Overnight paediatric investigation, for at least 8 hours, for a patient aged 5001.12.2023at least 12 years but less than 18 years, if: (a) the patient is referred by a 5001.12.2023medical practitioner; and (b) the necessity for the investigation is 5001.12.2023determined by a qualified sleep medicine practitioner before the 5001.12.2023investigation; and (c) there is continuous monitoring of oxygen saturation and 5001.12.2023breathing using a multichannel polygraph, and recordings of the following are 5001.12.2023made, in accordance with current professional guidelines: (i) airflow; (ii) 5001.12.2023continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in 5001.12.2023selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen 5001.12.2023saturation; (vii) respiratory movement of rib and abdomen (whether movement of 5001.12.2023rib is recorded separately from, or together with, movement of abdomen); 5001.12.2023(viii) measurement of carbon dioxide (either endtidal or transcutaneous); and 5001.12.2023(d) a sleep technician, or registered nurse with sleep technology training, is 5001.12.2023in continuous attendance under the supervision of a qualified sleep medicine 5001.12.2023practitioner; and (e) polygraphic records are: (i) analysed (for assessment of 5001.12.2023sleep stage, and maturation of sleep indices, arousals, respiratory events and 5001.12.2023assessment of clinically significant alterations in heart rate and body 5001.12.2023movement) with manual scoring, or manual correction of computerised scoring in 5001.12.2023epochs of not more than 1 minute; and (ii) stored for interpretation and 5001.12.2023preparation of a report; and (f) interpretation and report are provided by a 5001.12.2023qualified sleep medicine practitioner based on reviewing the direct original 5001.12.2023recording of polygraphic data from the patient; and (g) a further 5001.12.2023investigation is indicated in the same 12 month period to which item 12213 5001.12.2023applies to a service for the patient, for a patient using Continuous Positive 5001.12.2023Airway Pressure (CPAP) or noninvasive or invasive ventilation, or supplemental 5001.12.2023oxygen, in either or both of the following circumstances: (i) there is ongoing 5001.12.2023hypoxia or hypoventilation on the third study to which item 12213 applied for 5001.12.2023the patient, and further titration is needed to optimise therapy; (ii) there 5001.12.2023is clear and significant change in clinical status (for example lung function 5001.12.2023or functional status) or an intervening treatment that may affect ventilation 5001.12.2023in the period since the third study to which item 12213 applied for the 5001.12.2023patient, and repeat study is therefore required to determine the need for or 5001.12.2023the adequacy of respiratory support; and (h) the investigation is not provided 5001.12.2023to the patient on the same occasion that a service to which item 11704, 11705, 5001.12.202311707, 11714, 11716, 11717, 11723 or 11735 applies is provided to the patient 5001.12.2023Applicable only once in the same 12 month period to which item 12213 applies 1012250 01.10.2008 2 D1 10 SN NYNYY 2001.12.202300865.0000369.0500000.00 5001.12.2023Overnight investigation of sleep for at least 8 hours of a patient aged 18 5001.12.2023years or more to confirm diagnosis of obstructive sleep apnoea, if: (a) 5001.12.2023either: (i) the patient has been referred by a medical practitioner to a 5001.12.2023qualified adult sleep medicine practitioner or a consultant respiratory 5001.12.2023physician who has determined that the patient has a high probability for 5001.12.2023symptomatic, moderate to severe obstructive sleep apnoea based on a STOPBang 5001.12.2023score of3 or more, an OSA50 score of 5 or more or a high risk score on the 5001.12.2023Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or 5001.12.2023(ii) following professional attendance on the patient (either facetoface or by 5001.12.2023video conference) by a qualified adult sleep medicine practitioner or a 5001.12.2023consultant respiratory physician, the qualified adult sleep medicine 5001.12.2023practitioner or consultant respiratory physician determines that investigation 5001.12.2023is necessary to confirm the diagnosis of obstructive sleep apnoea; and (b) 5001.12.2023during a period of sleep, there is continuous monitoring and recording, 5001.12.2023performed in accordance with current professional guidelines, of the following 5001.12.2023measures: (i) airflow; (ii) continuous EMG; (iii) continuous ECG; (iv) 5001.12.2023continuous EEG; (v) EOG; (vi) oxygen saturation; (vii) respiratory effort; and 5001.12.2023(c) the investigation is performed under the supervision of a qualified adult 5001.12.2023sleep medicine practitioner; and (d) either: (i) the equipment is applied to 5001.12.2023the patient by a sleep technician; or (ii) if this is not possiblethe reason 5001.12.2023it is not possible for the sleep technician to apply the equipment to the 5001.12.2023patient is documented and the patient is given instructions on how to apply 5001.12.2023the equipment by a sleep technician supported by written instructions; and (e) 5001.12.2023polygraphic records are: (i) analysed (for assessment of sleep stage, 5001.12.2023arousals, respiratory events and cardiac abnormalities) with manual scoring, 5001.12.2023or manual correction of computerised scoring in epochs of not more than 1 5001.12.2023minute; and (ii) stored for interpretation and preparation of a report; and 5001.12.2023(f) interpretation and preparation of a permanent report is provided by a 5001.12.2023qualified adult sleep medicine practitioner with personal direct review of raw 5001.12.2023data from the original recording of polygraphic data from the patient; and (g) 5001.12.2023the investigation is not provided to the patient on the same occasion that a 5001.12.2023service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 5001.12.202311705, 11707, 11714, 11716, 11717, 11723, 11735 and 12203 is provided to the 5001.12.2023patient Applicable only once in any 12 month period 1012254 01.11.2018 2 D1 10 SN NYNNY 2001.12.202302380.0001005.6500000.00 5001.12.2023Multiple sleep latency test for the assessment of unexplained hypersomnolence 5001.12.2023in a patient aged 18 years or more, if: (a) a qualified adult sleep medicine 5001.12.2023practitioner or neurologist determines that testing is necessary to confirm 5001.12.2023the diagnosis of a central disorder of hypersomnolence or to determine whether 5001.12.2023the eligibility criteria under the pharmaceutical benefits scheme for drugs 5001.12.2023relevant to treat that condition are met; and (b) an overnight diagnostic 5001.12.2023assessment of sleep is performed for at least 8 hours, with continuous 5001.12.2023monitoring and recording, in accordance with current professional guidelines, 5001.12.2023of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior 5001.12.2023tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen 5001.12.2023saturation; (viii) respiratory movement (chest and abdomen); (ix) position; 5001.12.2023and (c) immediately following the overnight investigation a daytime 5001.12.2023investigation is performed where at least 4 nap periods are conducted, during 5001.12.2023which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep 5001.12.2023technician is in continuous attendance under the supervision of a qualified 5001.12.2023adult sleep medicine practitioner; and (e) polygraphic records are: (i) 5001.12.2023analysed (for assessment of sleep stage, arousals, respiratory events, cardiac 5001.12.2023abnormalities and limb movements) with manual scoring, or manual correction of 5001.12.2023computerised scoring in epochs of not more than 1 minute; and (ii) stored for 5001.12.2023interpretation and preparation of a report; and (f) interpretation and 5001.12.2023preparation of a permanent report is provided by a qualified adult sleep 5001.12.2023medicine practitioner with personal direct review of raw data from the 5001.12.2023original recording of polygraphic data from the patient; and (g) the 5001.12.2023diagnostic assessment is not provided to the patient on the same occasion that 5001.12.2023a service described in item 11003, 12203, 12204, 12205, 12208, 12250 or 12258 5001.12.2023is provided to the patient Applicable only once in a 12 month period 1012261 01.11.2018 2 D1 10 DN NYNNY 2001.12.202302490.0001054.5000000.00 5001.12.2023Multiple sleep latency test for the assessment of unexplained hypersomnolence 5001.12.2023in a patient aged at least 12 years but less than 18 years, if: (a) a 5001.12.2023qualified sleep medicine practitioner determines that testing is necessary to 5001.12.2023confirm the diagnosis of a central disorder of hypersomnolence or to determine 5001.12.2023whether the eligibility criteria under the pharmaceutical benefits scheme for 5001.12.2023drugs relevant to treat that condition are met; and (b) an overnight 5001.12.2023diagnostic assessment of sleep is performed for at least 8 hours, with 5001.12.2023continuous monitoring of oxygen saturation and breathing using a multichannel 5001.12.2023polygraph, and recordings of the following, in accordance with current 5001.12.2023professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG 5001.12.2023(with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 5001.12.2023EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib 5001.12.2023and abdomen (whether movement of rib is recorded separately from, or together 5001.12.2023with, movement of abdomen); (viii) measurement of carbon dioxide (either 5001.12.2023endtidal or transcutaneous); and (c) immediately following the overnight 5001.12.2023investigation, a daytime investigation is performed where at least 4 nap 5001.12.2023periods are conducted, during which there is continuous recording of EEG, EMG, 5001.12.2023EOG and ECG; and (d) a sleep technician is in continuous attendance under the 5001.12.2023supervision of a qualified sleep medicine practitioner; and (e) polygraphic 5001.12.2023records are: (i) analysed (for assessment of sleep stage, and maturation of 5001.12.2023sleep indices, arousals, respiratory events and assessment of clinically 5001.12.2023significant alterations in heart rate and body movement) with manual scoring, 5001.12.2023or manual correction of computerised scoring in epochs of not more than 1 5001.12.2023minute; and (ii) stored for interpretation and preparation of a report; and 5001.12.2023(f) interpretation and preparation of a permanent report is provided by a 5001.12.2023qualified sleep medicine practitioner with personal direct review of raw data 5001.12.2023from the original recording of polygraphic data from the patient; and (g) the 5001.12.2023diagnostic assessment is not provided to the patient on the same occasion that 5001.12.2023a service described in item 11003, 12213, 12217 or 12265 is provided to the 5001.12.2023patient Applicable only once in a 12 month period 1012268 01.11.2018 2 D1 10 DN NYNNY 2001.12.202302675.0001131.0500000.00 5001.12.2023Multiple sleep latency test for the assessment of unexplained hypersomnolence 5001.12.2023for a patient less than 12 years of age, if: (a) a qualified paediatric sleep 5001.12.2023medicine practitioner determines that testing is necessary to confirm the 5001.12.2023diagnosis of a central disorder of hypersomnolence or to determine whether the 5001.12.2023eligibility criteria under the pharmaceutical benefits scheme for drugs 5001.12.2023relevant to treat that condition are met; and (b) an overnight diagnostic 5001.12.2023assessment of sleep is performed for at least 8 hours, with continuous 5001.12.2023monitoring of oxygen saturation and breathing using a multichannel polygraph, 5001.12.2023and recordings of the following, in accordance with current professional 5001.12.2023guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a 5001.12.2023minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG 5001.12.2023leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and 5001.12.2023abdomen (whether movement of rib is recorded separately from, or together 5001.12.2023with, movement of abdomen); (viii) measurement of carbon dioxide (either 5001.12.2023endtidal or transcutaneous); and (c)immediately following the overnight 5001.12.2023investigation, a daytime investigation is performed where at least 4 nap 5001.12.2023periods are conducted, during which there is continuous recording of EEG, EMG, 5001.12.2023EOG and ECG; and (d) a sleep technician is in continuous attendance under the 5001.12.2023supervision of a qualified paediatric sleep medicine practitioner; and 5001.12.2023(e)polygraphic records are: (i)analysed (for assessment of sleep stage, 5001.12.2023arousals, respiratory events, cardiac abnormalities and limb movements) with 5001.12.2023manual scoring, or manual correction of computerised scoring in epochs of not 5001.12.2023more than 1 minute; and (ii)stored for interpretation and preparation of a 5001.12.2023report; and (f)interpretation and preparation of a permanent report is 5001.12.2023provided by a qualified paediatric sleep medicine practitioner with personal 5001.12.2023direct review of raw data from the original recording of polygraphic data from 5001.12.2023the patient; and (g) the diagnostic assessment is not provided to the patient 5001.12.2023on the same occasion that a service described in item 11003, 12210, 12215 or 5001.12.202312272 is provided to the patient Applicable only once in a 12 month period 1012306 26.05.2002 2 D1 10 SN NYNYY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry, involving the 5001.12.2023measurement of 2 or more sites (including interpretation and reporting), for: 5001.12.2023(a) confirmation of a presumptive diagnosis of low bone mineral density made 5001.12.2023on the basis of one or more fractures occurring after minimal trauma; or (b) 5001.12.2023monitoring of low bone mineral density proven by bone densitometry at least 12 5001.12.2023months previously; other than a service associated with a service to which 5001.12.2023item 12312, 12315 or 12321 applies For any particular patient, once only in a 5001.12.202324 month period 1012312 26.05.2002 2 D1 10 SN NYNYY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry, involving the 5001.12.2023measurement of 2 or more sites (including interpretation and reporting) for 5001.12.2023diagnosis and monitoring of bone loss associated with one or more of the 5001.12.2023following: (a) prolonged glucocorticoid therapy; (b) any condition associated 5001.12.2023with excess glucocorticoid secretion; (c) male hypogonadism; (d) female 5001.12.2023hypogonadism lasting more than 6 months before the age of 45; other than a 5001.12.2023service associated with a service to which item 12306, 12315 or 12321 applies 5001.12.2023For any particular patient, once only in a 12 month period 1012315 26.05.2002 2 D1 10 SN NYNYY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry, involving the 5001.12.2023measurement of 2 or more sites (including interpretation and reporting) for 5001.12.2023diagnosis and monitoring of bone loss associated with one or more of the 5001.12.2023following conditions: (a) primary hyperparathyroidism; (b) chronic liver 5001.12.2023disease; (c) chronic renal disease; (d) any proven malabsorptive disorder; (e) 5001.12.2023rheumatoid arthritis; (f) any condition associated with thyroxine excess; 5001.12.2023other than a service associated with a service to which item 12306, 12312 or 5001.12.202312321 applies For any particular patient, once only in a 24 monthperiod 1012320 01.11.2017 2 D1 10 SN NYNNY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry or quantitative 5001.12.2023computed tomography, involving the measurement of 2 or more sites (including 5001.12.2023interpretation and reporting) for measurement of bone mineral density, if:(a) 5001.12.2023the patient is 70 years of age or over, and (b) either: (i) the patient has 5001.12.2023not previously had bone densitometry; or (ii) the t-score for the patient's 5001.12.2023bone mineral density is -1.5 or more; other than a service associatedwith a 5001.12.2023service to which item12306, 12312, 12315, 12321 or 12322 applies For any 5001.12.2023particular patient, once only in a 5 year period 1012321 26.05.2002 2 D1 10 SN NYNYY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry, involving the 5001.12.2023measurement of 2 or more sites at least 12 months after a significant change 5001.12.2023in therapy (including interpretation and reporting), for: (a) established low 5001.12.2023bone mineral density; or (b) confirming a presumptive diagnosis of low bone 5001.12.2023mineral density made on the basis of one or more fractures occurring after 5001.12.2023minimal trauma; other than a service associated with a service to which item 5001.12.202312306, 12312 or 12315 applies For any particular patient, once only in a 12 5001.12.2023monthperiod 1012322 01.11.2017 2 D1 10 SN NYNNY 2001.12.202300305.0000112.7000000.00 5001.12.2023Bone densitometry, using dual energy Xray absorptiometry or quantitative 5001.12.2023computed tomography, involving the measurement of 2 or more sites (including 5001.12.2023interpretation and reporting) for measurement of bone mineral density, if:(a) 5001.12.2023the patient is 70 years of age or over; and (b) the tscore for the patient's 5001.12.2023bone mineral density is less than 1.5 but more than 2.5; other than a service 5001.12.2023associated with a service to which item12306, 12312, 12315, 12320 or 12321 5001.12.2023applies For any particular patient, once only in a 2 yearperiod 1012325 01.11.2016 2 D1 10 SN NYNNY 2001.12.202300091.0000055.0000000.00 5001.12.2023Assessment of visual acuity and bilateral retinal photography with a non 5001.12.2023mydriatic retinal camera, including analysis and reporting of the images for 5001.12.2023initial or repeat assessment for presence or absence of diabetic retinopathy, 5001.12.2023in a patient with medically diagnosed diabetes, if: (a)the patient is of 5001.12.2023Aboriginal and Torres Strait Islander descent; and (b)the assessment is 5001.12.2023performed by the medical practitioner (other than an optometrist or 5001.12.2023ophthalmologist) providing the primary glycaemic management of the patient's 5001.12.2023diabetes; and (c)this item and item 12326 have not applied to the patient in 5001.12.2023the preceding 12 months; and (d)the patient does not have: (i)an existing 5001.12.2023diagnosis of diabetic retinopathy; or (ii)visual acuity of less than 6/12 in 5001.12.2023either eye; or (iii) a difference of more than 2 lines of vision between the 2 5001.12.2023eyes at the time of presentation 1012326 01.11.2016 2 D1 10 SN NYNNY 2001.12.202300091.0000055.0000000.00 5001.12.2023Assessment of visual acuity and bilateral retinal photography with a 5001.12.2023non-mydriatic retinal camera, including analysis and reporting of the images 5001.12.2023for initial or repeat assessment for presence or absence of diabetic 5001.12.2023retinopathy, in a patient with medically diagnosed diabetes, if: (a)the 5001.12.2023assessment is performed by the medical practitioner (other than an optometrist 5001.12.2023or ophthalmologist) providing the primary glycaemic management of the 5001.12.2023patient's diabetes; and (b)this item and item 12325 have not applied to the 5001.12.2023patient in the preceding 24 months; and (c)the patient does not have: (i)an 5001.12.2023existing diagnosis of diabetic retinopathy; or (ii)visual acuity of less than 5001.12.20236/12 in either eye; or (iii)a difference of more than 2 lines of vision 5001.12.2023between the 2 eyes at the time of presentation 1012500 26.05.2002 2 D2 SN NYNNY 2001.12.202300575.0000238.4500000.00 5001.12.2023BLOOD VOLUME ESTIMATION 1012524 26.05.2002 2 D2 SN NYNNY 2001.12.202300460.0000174.3000000.00 5001.12.2023RENAL FUNCTION TEST (without imaging procedure) 1012527 26.05.2002 2 D2 SN NYNNY 2001.12.202300305.0000093.5000000.00 5001.12.2023RENAL FUNCTION TEST (with imaging and at least 2 blood samples) 1012533 26.05.2002 2 D2 SN NYNNY 2001.12.202300270.0000093.1500000.00 5001.12.2023CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, performed by a 5001.12.2023specialist or consultant physician, including the measurement of exhaled 13CO2 5001.12.2023or 14CO2, for either:- (a)the confirmation of Helicobacter pylori 5001.12.2023colonisation, OR (b)the monitoring of the success of eradication of 5001.12.2023Helicobacter pylori in patients with peptic ulcer disease. not being a service 5001.12.2023to which 66900 applies 1013015 26.05.2002 3 T1 1 SN NYNNY 2001.12.202300773.0000280.4500000.00 5001.12.2023HYPERBARIC, OXYGEN THERAPY, for treatment of localised non-neurological soft 5001.12.2023tissue radiation injuries excluding radiation-induced soft tissue lymphoedema 5001.12.2023of the arm after treatment for breast cancer, performed in a comprehensive 5001.12.2023hyperbaric medicine facility, under the supervision of a medical practitioner 5001.12.2023qualified in hyperbaric medicine, for a period in the hyperbaric chamber of 5001.12.2023between 1 hour 30 minutes and 3 hours, including any associated attendance. 1013020 26.05.2002 3 T1 1 SN NYNNY 2001.12.202300785.0000284.9000000.00 5001.12.2023HYPERBARIC OXYGEN THERAPY, for treatment of decompression illness, gas 5001.12.2023gangrene, air or gas embolism; diabetic wounds including diabetic gangrene and 5001.12.2023diabetic foot ulcers; necrotising soft tissue infections including necrotising 5001.12.2023fasciitis or Fournier's gangrene; or for the prevention and treatment of 5001.12.2023osteoradionecrosis, performed in a comprehensive hyperbaric medicine facility, 5001.12.2023under the supervision of a medical practitioner qualified in hyperbaric 5001.12.2023medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes 5001.12.2023and 3 hours, including any associated attendance 1013025 26.05.2002 3 T1 1 SN NYNNY 2001.12.202300351.0000127.3500000.00 5001.12.2023HYPERBARIC OXYGEN THERAPY for treatment of decompression illness, air or gas 5001.12.2023embolism, performed in a comprehensive hyperbaric medicine facility, under the 5001.12.2023supervision of a medical practitioner qualified in hyperbaric medicine, for a 5001.12.2023period in the hyperbaric chamber greater than 3 hours, including any 5001.12.2023associated attendance - per hour (or part of an hour) 1013030 26.05.2002 3 T1 1 SN NYNNY 2001.12.202300496.0000179.8500000.00 5001.12.2023HYPERBARIC OXYGEN THERAPY performed in a comprehensive hyperbaric medicine 5001.12.2023facility where the medical practitioner is pressurised in the hyperbaric 5001.12.2023chamber for the purpose of providing continuous life saving emergency 5001.12.2023treatment, including any associated attendance - per hour (or part of an hour) 1013100 26.05.2002 3 T1 2 SN NYNNY 2001.12.202300480.0000150.4500000.00 5001.12.2023SUPERVISION IN HOSPITAL by a medical specialist ofhaemodialysis, 5001.12.2023haemofiltration, haemoperfusion or peritoneal dialysis, including all 5001.12.2023professional attendances, where the total attendance time on the patient by 5001.12.2023the supervising medical specialist exceeds 45 minutes in 1 day 1013103 26.05.2002 3 T1 2 SN NYNNY 2001.12.202300250.0000078.4000000.00 5001.12.2023SUPERVISION IN HOSPITAL by a medical specialist ofhaemodialysis, 5001.12.2023haemofiltration, haemoperfusion or peritoneal dialysis, including all 5001.12.2023professional attendances, where the total attendance time on the patient by 5001.12.2023the supervising medical specialist does not exceed 45 minutes in 1 day 1013104 01.11.2005 3 T1 2 SN NYNNY 2001.12.202300475.0000162.8000000.00 5001.12.2023Planning and management of home dialysis (either haemodialysis or peritoneal 5001.12.2023dialysis), by a consultant physician in the practice of his or her specialty 5001.12.2023of renal medicine, for a patient with end-stage renal disease, and supervision 5001.12.2023of that patient on self-administered dialysis, to a maximum of 12 claims per 5001.12.2023year 1013106 26.05.2002 3 T1 2 SN NYNNY 2001.12.202300315.0000133.5500000.00 5001.12.2023DECLOTTING OF AN ARTERIOVENOUS SHUNT 1013109 26.05.2002 3 T1 2 SN NYNNY 2001.12.202300765.0000250.6500000.00 4026.05.2002(Anaes.) 5001.12.2023INDWELLING PERITONEAL CATHETER (Tenckhoff or similar) FOR DIALYSISINSERTION 5001.12.2023AND FIXATION OF (Anaes.) 1013110 26.05.2002 3 T1 2 SN NYNNY 2001.12.202300765.0000251.5000000.00 4026.05.2002(Anaes.) 5001.12.2023INDWELLING PERITONEAL CATHETER (Tenckhoff or similar) FOR DIALYSIS , removal 5001.12.2023of (including catheter cuffs) (Anaes.) 1013200 26.05.2002 3 T1 3 SN NYNYY 2001.12.202306335.0003424.0000000.00 5001.12.2023ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO 5001.12.2023OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and 5001.12.2023including quantitative estimation of hormones, semen preparation, ultrasound 5001.12.2023examinations, all treatment counselling and embryology laboratory services but 5001.12.2023excluding artificial insemination or transfer of frozen embryos or donated 5001.12.2023embryos or ova or a service to which item 13201, 13202, 13203, 13218 applies - 5001.12.2023being services rendered during 1 treatment cycle - INITIAL cycle in a single 5001.12.2023calendar year 1013201 01.01.2010 3 T1 3 SN NYNYY 2001.12.202305930.0003202.8000000.00 5001.12.2023ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO 5001.12.2023OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and 5001.12.2023including quantitative estimation of hormones, semen preparation, ultrasound 5001.12.2023examinations, all treatment counselling and embryology laboratory services but 5001.12.2023excluding artificial insemination or transfer of frozen embryos or donated 5001.12.2023embryos or ova or a service to which item 13200, 13202, 13203, 13218 applies - 5001.12.2023being services rendered during 1 treatment cycle - each cycle SUBSEQUENT to 5001.12.2023the first in a single calendar year 1013202 01.01.2010 3 T1 3 SN NYNNY 2001.12.202300950.0000512.4000000.00 5001.12.2023ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE THAT IS 5001.12.2023CANCELLED BEFORE OOCYTE RETRIEVAL, involving the use of drugs to induce 5001.12.2023superovulation and including quantitative estimation of hormones, semen 5001.12.2023preparation, ultrasound examinations, but excluding artificial insemination or 5001.12.2023transfer of frozen embryos or donated embryos or ova or a service to which 5001.12.2023Item 13200, 13201, 13203, 13218, applies being services rendered during 1 5001.12.2023treatment cycle 1013203 26.05.2002 3 T1 3 SN NYNNY 2001.12.202301585.0000535.7000000.00 5001.12.2023Ovulation monitoring services for artificial insemination or gonadotrophin, 5001.12.2023stimulated ovulation induction, including quantitative estimation of hormones 5001.12.2023and ultrasound examinations, being services rendered during one treatment 5001.12.2023cycle but excluding a service to which item 13200, 13201, 13202, 13212, 13215 5001.12.2023or 13218 applies 1013209 26.05.2002 3 T1 3 SN NYNNY 2001.12.202300270.0000093.2000000.00 5001.12.2023PLANNING and MANAGEMENT of a referred patient by a specialist for the purpose 5001.12.2023of treatment by assisted reproductive technologies or for artificial 5001.12.2023insemination payable once only during 1 treatment cycle 1013290 26.05.2002 3 T1 3 SN NYNNY 2001.12.202300650.0000224.7500000.00 5001.12.2023SEMEN, collection of, from a patient with spinal injuries or medically induced 5001.12.2023impotence, for the purposes of analysis, storage or assisted reproduction, bya 5001.12.2023medical practitioner using a vibrator or electro-ejaculation device including 5001.12.2023catheterisation and drainage of bladder where required 1013300 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300168.0000062.6500000.00 5001.12.2023UMBILICAL OR SCALP VEIN CATHETERISATION in a NEONATE with or without infusion; 5001.12.2023or cannulation of a vein in a neonate 1013303 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300250.0000092.9000000.00 5001.12.2023UMBILICAL ARTERY CATHETERISATION with or without infusion 1013306 26.05.2002 3 T1 4 SN NYNNY 2001.12.202301215.0000367.7500000.00 5001.12.2023BLOOD TRANSFUSION with venesection and complete replacement of blood, 5001.12.2023including collection from donor 1013309 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300940.0000313.5500000.00 5001.12.2023BLOOD TRANSFUSION with venesection and complete replacement of blood, using 5001.12.2023blood already collected 1013312 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300106.0000031.3000000.00 5001.12.2023BLOOD for pathology test, collection of, BY FEMORAL OR EXTERNAL JUGULAR VEIN 5001.12.2023PUNCTURE IN INFANTS 1013318 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300695.0000250.3500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL VEIN CATHETERISATION - by open exposure in a patient under 12 years of 5001.12.2023age (Anaes.) 1013319 26.05.2002 3 T1 4 SN NYNNY 2001.12.202300620.0000250.3500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL VEIN CATHETERISATION in a neonate via peripheral vein (Anaes.) 1013400 26.05.2002 3 T1 5 SN NYNNY 2001.12.202300270.0000106.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Restoration of cardiac rhythm by electrical stimulation (cardioversion), other 5001.12.2023than in the course of cardiac surgery (H) (Anaes.) 1013506 26.05.2002 3 T1 6 SN NYNNY 2001.12.202300490.0000203.0000000.00 5001.12.2023GASTRO-OESOPHAGEAL balloon intubation, for control of bleeding from gastric 5001.12.2023oesophageal varices 1013700 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300885.0000366.9000000.00 4026.05.2002(Anaes.) 5001.12.2023HARVESTING OF HOMOLOGOUS (including allogeneic) or AUTOLOGOUS bone marrow for 5001.12.2023the purpose of transplantation (Anaes.) 1013703 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300325.0000131.5000000.00 5001.12.2023Transfusion of blood, including collection from donor, when used for 5001.12.2023intra-operative normovolaemic haemodilution 1013706 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300220.0000091.7000000.00 5001.12.2023TRANSFUSION OF BLOOD or bone marrow already collected 1013750 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300365.0000150.4500000.00 5001.12.2023THERAPEUTIC HAEMAPHERESIS for the removal of plasma or cellular (or both) 5001.12.2023elements of blood, utilising continuous or intermittent flow techniques; 5001.12.2023including morphological tests for cell counts and viability studies, if 5001.12.2023performed; continuous monitoring of vital signs, fluid balance, blood volume 5001.12.2023and other parameters with continuous registered nurse attendance under the 5001.12.2023supervision of a consultant physician, not being a service associated with a 5001.12.2023service to which item 13755 applies -payable once per day 1013755 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300365.0000150.4500000.00 5001.12.2023DONOR HAEMAPHERESIS for the collection of blood products for transfusion, 5001.12.2023utilising continuous or intermittent flow techniques; including morphological 5001.12.2023tests for cell counts and viability studies; continuous monitoring of vital 5001.12.2023signs, fluid balance, blood volume and other parameters; with continuous 5001.12.2023registered nurse attendance under the supervision of a consultant physician; 5001.12.2023not being a service associated with a service to which item 13750 applies - 5001.12.2023payable once per day 1013757 26.05.2002 3 T1 8 SN NYNNY 2001.12.202300196.0000080.3000000.00 5001.12.2023THERAPEUTIC VENESECTION for the management of haemochromatosis, polycythemia 5001.12.2023vera or porphyria cutanea tarda 1013760 26.05.2002 3 T1 8 SN NYNNY 2001.12.202302045.0000839.4000000.00 5001.12.2023In vitro processing with cryopreservation of bone marrow or peripheral blood, 5001.12.2023for autologous stem cell transplantation for a patient receiving highdose 5001.12.2023chemotherapy for management of: (a) aggressive malignancy; or (b) malignancy 5001.12.2023that has proven refractory to prior treatment 1013761 01.03.2022 3 T1 8 SN NYNYY 2001.12.202305566.0002018.7500000.00 5001.12.2023Extracorporeal photopheresis for the treatment of chronic graftversushost 5001.12.2023disease, if: (a) the person is: (i) has received allogeneic haematopoietic 5001.12.2023stem cell transplantation; and (ii) has been diagnosed with chronic graft 5001.12.2023versus host disease following the transplantation; and (iii) steroid treatment 5001.12.2023is clinically unsuitable as the disease is steroid refractory or the person is 5001.12.2023steroiddependent or steroidintolerant; and (b) the person has not previously 5001.12.2023received extracorporeal photopheresis treatment; and (c) the service is 5001.12.2023delivered using an integrated, closed extracorporeal photopheresis system; and 5001.12.2023(d) the service is provided in combination with the use of methoxsalen that is 5001.12.2023listed on the Pharmaceutical Benefits Scheme; and (e) the service is provided 5001.12.2023by, or on behalf of, a specialist or consultant physician who: (i) is 5001.12.2023practising in the speciality of haematology or oncology; and (ii) has 5001.12.2023experience with allogeneic bone marrow transplantation. Applicable once per 5001.12.2023treatment session 1013762 01.03.2022 3 T1 8 SN NYNYY 2001.12.202305566.0002018.7500000.00 5001.12.2023Extracorporeal photopheresis for the treatment of chronic graftversushost 5001.12.2023disease, if: (a) the person is: (i) has received allogeneic haematopoietic 5001.12.2023stem cell transplantation; and (ii) has been diagnosed with chronic graft 5001.12.2023versus host disease following the transplantation; and (iii) steroid treatment 5001.12.2023is clinically unsuitable as the disease is steroid refractory or the person is 5001.12.2023steroiddependent or steroidintolerant; and (b) the person has previously 5001.12.2023received an extracorporeal photopheresis treatment cycle andhad a partial or 5001.12.2023complete response in at least one organ in response to treatment; and (c) the 5001.12.2023person requires further extracorporeal photopheresis; and (d) the service is 5001.12.2023delivered using an integrated, closed extracorporeal photopheresis system; and 5001.12.2023(e) the service is provided in combination with the use of methoxsalen that is 5001.12.2023listed on the Pharmaceutical Benefits Scheme; and (f) the service is provided 5001.12.2023by, or on behalf of, a specialist or consultant physician who: (i) is 5001.12.2023practising in the speciality of haematology or oncology; and (ii) has 5001.12.2023experience with allogeneic bone marrow transplantation. Applicable once per 5001.12.2023treatment session 1013815 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300305.0000125.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Central vein catheterisation, including under ultrasound guidance where 5001.12.2023clinically appropriate, by percutaneous or open exposure other than a service 5001.12.2023to which item 13318 applies (Anaes.) No separate ultrasound item is payable 5001.12.2023with this item. (Anaes.) 1013818 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300640.0000125.1500000.00 4026.05.2002(Anaes.) 5001.12.2023RIGHT HEART BALLOON CATHETER, insertion of, including pulmonary wedge pressure 5001.12.2023and cardiac output measurement (Anaes.) 1013830 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300200.0000082.9000000.00 5001.12.2023INTRACRANIAL PRESSURE, monitoring of, by intraventricular or subdural 5001.12.2023catheter, subarachnoid bolt or similar, by a specialist or consultant 5001.12.2023physician - each day 1013832 01.03.2020 3 T1 9 SN NYNNY 2001.12.202302590.0000970.6000000.00 5001.12.2023Peripheral cannulation, including under ultrasound guidance where clinically 5001.12.2023appropriate, for veno-arterial cardiopulmonary extracorporeal life support No 5001.12.2023separate ultrasound item is payable with this item 1013834 01.03.2020 3 T1 9 SN NYNNY 2001.12.202301440.0000543.3500000.00 5001.12.2023Venoarterial cardiopulmonary extracorporeal life support, management ofthe 5001.12.2023first day 1013835 01.03.2020 3 T1 9 SN NYNNY 2001.12.202300335.0000126.4000000.00 5001.12.2023Venoarterial cardiopulmonary extracorporeal life support, management ofeach 5001.12.2023day after the first 1013837 01.03.2020 3 T1 9 SN NYNNY 2001.12.202301440.0000543.3500000.00 5001.12.2023Veno-venous pulmonary extracorporeal life support, management ofthe first day 1013838 01.03.2020 3 T1 9 SN NYNNY 2001.12.202300335.0000126.4000000.00 5001.12.2023Veno-venous pulmonary extracorporeal life support, management ofeach day after 5001.12.2023the first 1013839 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300086.0000025.4000000.00 5001.12.2023ARTERIAL PUNCTURE and collection of blood for diagnostic purposes 1013840 01.03.2020 3 T1 9 SN NYNNY 2001.12.202301735.0000650.3000000.00 5001.12.2023Peripheral cannulation, including under ultrasound guidance where clinically 5001.12.2023appropriate, for veno-venous pulmonary extracorporeal life support No separate 5001.12.2023ultrasound item is payable with this item 1013842 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300245.0000102.9500000.00 5001.12.2023Intra-arterial cannulation, including under ultrasound guidance where 5001.12.2023clinically appropriate, for the purpose of intra-arterial pressure monitoring 5001.12.2023or arterial blood sampling (or both) No separate ultrasound item is payable 5001.12.2023with this item 1013848 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300495.0000171.8500000.00 5001.12.2023Counterpulsation by intra-aortic balloon-management including associated 5001.12.2023consultations and monitoring of parameters by means of full haemodynamic 5001.12.2023assessment and management on several occasions on a day each day 1013851 26.05.2002 3 T1 9 SN NYNNY 2001.12.202301440.0000543.3500000.00 5001.12.2023Ventricular assist device, management of,for a patient admitted to an 5001.12.2023intensive care unit for implantation of the device or for complications 5001.12.2023arising from implantation or management of the device - first day 1013854 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300335.0000126.4000000.00 5001.12.2023Ventricular assist device, management of, for a patient admitted to an 5001.12.2023intensive care unit, including management ofcomplications arising from 5001.12.2023implantation or management of the device - each day after the first day 1013857 26.05.2002 3 T1 9 SN NYNNY 2001.12.202300410.0000161.1500000.00 5001.12.2023AIRWAY ACCESS, ESTABLISHMENT OF AND INITIATION OF MECHANICAL VENTILATION 5001.12.2023(other than in the context of an anaesthetic for surgery), outside an 5001.12.2023Intensive Care Unit, for the purpose of subsequent ventilatory support in an 5001.12.2023Intensive Care Unit 1013870 26.05.2002 3 T1 10 SN NYNNY 2001.12.202301050.0000398.6000000.00 5001.12.2023(Note: See para T1.8 of Explanatory Notes to this Category for definition of 5001.12.2023an Intensive Care Unit) MANAGEMENT of a patient in an Intensive Care Unit by a 5001.12.2023specialist or consultant physician who is immediately available and 5001.12.2023exclusively rostered for intensive care - including initial and subsequent 5001.12.2023attendances, electrocardiographic monitoring, arterial sampling and bladder 5001.12.2023catheterisation - management on the first day (H) 1013873 26.05.2002 3 T1 10 SN NYNNY 2001.12.202300780.0000295.6000000.00 5001.12.2023MANAGEMENT of a patient in an Intensive Care Unit by a specialist or 5001.12.2023consultant physician who is immediately available and exclusively rostered for 5001.12.2023intensive care - including all attendances, electrocardiographic monitoring, 5001.12.2023arterial sampling and bladder catheterisation - management on each day 5001.12.2023subsequent to the first day (H) 1013876 26.05.2002 3 T1 10 SN NYNNY 2001.12.202300225.0000084.6500000.00 5001.12.2023CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial 5001.12.2023pressure or cardiac intracavity pressure, continuous monitoring by indwelling 5001.12.2023catheter in an intensive care unit and managed by a specialist or consultant 5001.12.2023physician who is immediately available and exclusively rostered for intensive 5001.12.2023care - once only for each type of pressure on any calendar day (up to a 5001.12.2023maximum of 4 pressures) (H) 1013881 01.11.2005 3 T1 10 SN NYNNY 2001.12.202300425.0000161.1500000.00 5001.12.2023AIRWAY ACCESS, ESTABLISHMENT OF AND INITIATION OF MECHANICAL VENTILATION, in 5001.12.2023an Intensive Care Unit, not in association with any anaesthetic service, by a 5001.12.2023specialist or consultant physician for the purpose of subsequent ventilatory 5001.12.2023support (H) 1013882 26.05.2002 3 T1 10 SN NYNNY 2001.12.202300335.0000126.8500000.00 5001.12.2023VENTILATORY SUPPORT in an Intensive Care Unit, management of, by invasive 5001.12.2023means, or by non-invasive means where the only alternative to non-invasive 5001.12.2023ventilatory support would be invasive ventilatory support, by a specialist or 5001.12.2023consultant physician who is immediately available and exclusively rostered for 5001.12.2023intensive care, each day (H) 1013885 26.05.2002 3 T1 10 SN NYNNY 2001.12.202300480.0000169.1500000.00 5001.12.2023CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care 5001.12.2023unit, management by a specialist or consultant physician who is immediately 5001.12.2023available and exclusively rostered for intensive care - on the first day (H) 1013888 26.05.2002 3 T1 10 SN NYNNY 2001.12.202300250.0000084.6500000.00 5001.12.2023CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care 5001.12.2023unit, management by a specialist or consultant physician who is immediately 5001.12.2023available and exclusively rostered for intensive care - on each day subsequent 5001.12.2023to the first day(H) 1013899 01.03.2020 3 T1 10 SN NYNNY 2001.12.202300680.0000294.8500000.00 5001.12.2023Preparation of Goals of Care is provided outside of an intensive care unit. 5001.12.2023Refer to explanatory note TN.1.11 for further information aboutGoals of Care 5001.12.2023attendance Professional attendance, outside an intensive care unit, for at 5001.12.2023least 60 minutes spent in preparation of goals of care for a gravely ill 5001.12.2023patient lacking current goals of care, by aspecialist in the specialty of 5001.12.2023intensive care who takes overall responsibility for the preparation of the 5001.12.2023goals of care for the patient Item 13899 cannot be co-claimed with item 13870 5001.12.2023or item 13873 on the same day 1013950 01.11.2020 3 T1 11 SNS NYNNY 2001.12.202300290.0000118.9000000.00 5001.12.2023Parenteral administration of one or more antineoplastic agents, including 5001.12.2023agents used in cytotoxic chemotherapy or monoclonal antibody therapy but not 5001.12.2023agents used in anti-resorptive bone therapy or hormonal therapy, by or on 5001.12.2023behalf of a specialist or consultant physicianattendance for one or more 5001.12.2023episodes of administration Note: The fee for item 13950 contains a component 5001.12.2023which covers the accessing of a long-term drug delivery device. TN.1.27 refers 1014050 26.05.2002 3 T1 12 SN NYNNY 2001.12.202300160.0000058.1000000.00 5001.12.2023UVA or UVB phototherapy administered in a whole body cabinet or hand and foot 5001.12.2023cabinet including associated consultations other than the initial 5001.12.2023consultation, if treatment is initiated and supervised by a specialist in the 5001.12.2023specialty of dermatology Applicable not more than 150 times in a 12 month 5001.12.2023period 1014100 26.05.2002 3 T1 12 SN NYNYY 2001.12.202300780.0000167.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Laser photocoagulation using laser radiation in the treatment of vascular 5001.12.2023abnormalities of the head or neck, including any associated consultation, if: 5001.12.2023(a) the abnormality is visible from 3 metres; and (b) photographic evidence 5001.12.2023demonstrating the need for this service is documented in the patient notes; to 5001.12.2023a maximum of 4 sessions (including any sessions to which this item or any of 5001.12.2023items 14106 to 14118 apply) in any 12 month period (Anaes.) 1014106 26.05.2002 3 T1 12 SN NYNNY 2001.12.202300780.0000176.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Laser photocoagulation using laser radiation in the treatment of vascular 5001.12.2023malformations, infantile haemangiomas, caf au lait macules and naevi of Ota, 5001.12.2023other than melanocytic naevi (common moles), if the abnormality is visible 5001.12.2023from 3 metres, including any associated consultation, up to a maximum of 6 5001.12.2023sessions (including any sessions to which this item or any of items 14100 to 5001.12.202314118 apply) in any 12 month periodarea of treatment less than 150 cm2 5001.12.2023(Anaes.) 1014115 26.05.2002 3 T1 12 SN NYNNY 2001.12.202301315.0000282.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Laser photocoagulation using laser radiation in the treatment of vascular 5001.12.2023malformations, infantile haemangiomas, caf au lait macules and naevi of Ota, 5001.12.2023other than melanocytic naevi (common moles), including any associated 5001.12.2023consultation, up to a maximum of 6 sessions (including any sessions to which 5001.12.2023this item or any of items 14100 to 14118 apply) in any 12 month periodarea of 5001.12.2023treatment 150 cm2 to 300 cm2 (Anaes.) 1014118 26.05.2002 3 T1 12 SN NYNNY 2001.12.202301670.0000358.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Laser photocoagulation using laser radiation in the treatment of vascular 5001.12.2023malformations, infantile haemangiomas, caf au lait macules and naevi of Ota, 5001.12.2023other than melanocytic naevi (common moles), including any associated 5001.12.2023consultation, up to a maximum of 6 sessions (including any sessions to which 5001.12.2023this item or any of items 14100 to 14115 apply) in any 12 month periodarea of 5001.12.2023treatment more than 300 cm2 (Anaes.) 1014124 26.05.2002 3 T1 12 SN NYNYY 2001.12.202300780.0000167.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Laser photocoagulation using laser radiation in the treatment of vascular 5001.12.2023malformations, infantile haemangiomas, cafaulait macules and naevi of Ota, 5001.12.2023other than melanocytic naevi (common moles), including any associated 5001.12.2023consultation, if: (a) a seventh or subsequent session (including any sessions 5001.12.2023to which this item or any of items 14100 to 14118 apply) is indicated in a 12 5001.12.2023month period commencing on the day of the first session; and (b) photographic 5001.12.2023evidence demonstrating the need for this service is documented in the patient 5001.12.2023notes (Anaes.) 1014201 01.07.2011 3 T1 13 SN NYNNY 2001.12.202300719.0000260.7000000.00 5001.12.2023POLY-L-LACTIC ACID, one or more injections of, for the initial session only, 5001.12.2023for the treatment of severe facial lipoatrophy caused by antiretroviral 5001.12.2023therapy, when prescribed in accordance with the National Health Act 1953 - 5001.12.2023once per patient 1014202 01.07.2011 3 T1 13 SN NYNNY 2001.12.202300364.0000131.9500000.00 5001.12.2023POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the 5001.12.2023continuation of treatment of severe facial lipoatrophy caused by 5001.12.2023antiretroviral therapy, when prescribed in accordance with the National Health 5001.12.2023Act 1953 1014203 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300142.0000056.3000000.00 4026.05.2002(Anaes.) 5001.12.2023HORMONE OR LIVING TISSUE IMPLANTATION, by direct implantation involving 5001.12.2023incision and suture (Anaes.) 1014206 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300090.0000039.2000000.00 5001.12.2023HORMONE OR LIVING TISSUE IMPLANTATIONby cannula 1014212 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300570.0000203.9000000.00 4026.05.2002(Anaes.) 5001.12.2023INTUSSUSCEPTION, management of fluid or gas reduction for (Anaes.) 1014216 01.11.2021 3 T1 13 SNS NYNNY 2001.12.202300435.0000197.2000000.00 5001.12.2023Professional attendance on a patient by a psychiatrist, who has undertaken 5001.12.2023training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment 5001.12.2023mapping for rTMS, if the patient: (a) has not previously received any prior 5001.12.2023transcranial magnetic stimulation therapy in a public or private setting; and 5001.12.2023(b) is at least 18 years old; and (c) is diagnosed with a major depressive 5001.12.2023episode; and (d) has failed to receive satisfactory improvement for the major 5001.12.2023depressive episode despite the adequate trialling of at least 2 different 5001.12.2023classes of antidepressant medications, unless contraindicated, and all of the 5001.12.2023following apply: (i) the patients adherence to antidepressant treatment has 5001.12.2023been formally assessed; (ii) the trialling of each antidepressant medication 5001.12.2023has been at the recommended therapeutic dose for a minimum of 3 weeks; (iii) 5001.12.2023where clinically appropriate, the treatment has been titrated to the maximum 5001.12.2023tolerated therapeutic dose; and (e) has undertaken psychological therapy, if 5001.12.2023clinically appropriate 1014217 01.11.2021 3 T1 13 SNS NYNNY 2001.12.202300375.0000169.2500000.00 5001.12.2023Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 35 5001.12.2023services provided by, or on behalf of, a psychiatrist who has undertaken 5001.12.2023training in rTMS, if the patient has previously received a service under item 5001.12.202314216each service up to 35 services 1014218 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300280.0000107.8500000.00 5001.12.2023Implanted infusion pump, refilling of reservoir with a therapeutic agent or 5001.12.2023agents for infusion to the subarachnoid space or accessing the side port to 5001.12.2023assess catheter patency, with or without pump reprogramming, for the 5001.12.2023management of chronic pain, including cancer pain 1014219 01.11.2021 3 T1 13 SN NYNYY 2001.12.202300435.0000197.2000000.00 5001.12.2023Professional attendance on a patient by a psychiatrist, who has undertaken 5001.12.2023training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment 5001.12.2023mapping for rTMS, if the patient: (a) is at least 18 years old; and (b) is 5001.12.2023diagnosed with a major depressive episode; and (c) has failed to receive 5001.12.2023satisfactory improvement for the major depressive episode despite the adequate 5001.12.2023trialling of at least 2 different classes of antidepressant medications, 5001.12.2023unless contraindicated, and all of the following apply: (i) the patients 5001.12.2023adherence to antidepressant treatment has been formally assessed; (ii) the 5001.12.2023trialling of each antidepressant medication has been at the recommended 5001.12.2023therapeutic dose for a minimum of 3 weeks; (iii) where clinically appropriate, 5001.12.2023the treatment has been titrated to the maximum tolerated therapeutic dose; and 5001.12.2023(d) has undertaken psychological therapy, if clinically appropriate; and (e) 5001.12.2023has previously received an initial service under item 14217 and the patient: 5001.12.2023(i) has relapsed after a remission following the initial service; and (ii) has 5001.12.2023had a satisfactory clinical response to the service under item 14217 (which 5001.12.2023has been assessed by a validated major depressive disorder tool at least 4 5001.12.2023months after receiving that service) 1014220 01.11.2021 3 T1 13 SN NYNYY 2001.12.202300375.0000169.2500000.00 5001.12.2023Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 15 5001.12.2023services provided by, or on behalf of, a psychiatrist who has undertaken 5001.12.2023training in rTMS, if the patient has previously received: (a) a service under 5001.12.2023item 14217 (which was not provided in the previous 4 months); and (b) a 5001.12.2023service under item 14219 Each service up to 15 services 1014221 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300152.0000057.8000000.00 5001.12.2023LONG-TERM IMPLANTED DEVICE FOR DELIVERY OF THERAPEUTIC AGENTS, accessing of, 5001.12.2023not being a service associated with a service to which item 13950 applies 1014224 26.05.2002 3 T1 13 SN NYNNY 2001.12.202300182.0000077.4500000.00 4026.05.2002(Anaes.) 5001.12.2023ELECTROCONVULSIVE THERAPY, with or without the use of stimulus dosing 5001.12.2023techniques, including any electroencephalographic monitoring and associated 5001.12.2023consultation (Anaes.) 1014227 01.05.2006 3 T1 13 SN NYNNY 2001.12.202300280.0000107.8500000.00 5001.12.2023IMPLANTED INFUSION PUMP, REFILLING of reservoir, with baclofen, for infusion 5001.12.2023to the subarachnoid or epidural space, with or without re-programming of a 5001.12.2023programmable pump, for the management of severe chronic spasticity 1014234 01.11.2020 3 T1 13 SN NYNNY 2001.12.202301040.0000398.3000000.00 4001.11.2020(Anaes.) 5001.12.2023Infusion pump or components of an infusion pump, removal or replacement of, 5001.12.2023and connection to intrathecal or epidural catheter, and loading of reservoir 5001.12.2023with baclofen, with or without programming of the pump, for the management of 5001.12.2023severe chronic spasticity (Anaes.) 1014237 01.11.2020 3 T1 13 SN NYNNY 2001.12.202301900.0000726.3500000.00 4001.11.2020(Anaes.) 5001.12.2023Infusion pump or components of an infusion pump, subcutaneous implantation of, 5001.12.2023and intrathecal or epidural spinal catheter insertion, and connection of pump 5001.12.2023to catheter, and loading of reservoir with baclofen, with or without 5001.12.2023programming of the pump, for the management of severe chronic spasticity 5001.12.2023(Anaes.) 1014245 01.11.2006 3 T1 13 SN NYNNY 2001.12.202300330.0000107.8500000.00 5001.12.2023IMMUNOMODULATING AGENT, administration of, by intravenous infusion for at 5001.12.2023least 2 hours duration - payable once only on the same day and where the agent 5001.12.2023is provided under section 100 of the Pharmaceutical Benefits Scheme 1014247 01.11.2020 3 T1 13 DNS NYNNY 2001.12.202305616.0002036.9500000.00 5001.12.2023Extracorporeal photopheresis for the treatment of erythrodermic stage III-IVa 5001.12.2023T4 M0 cutaneous T-cell lymphoma; if the service is provided in the initial six 5001.12.2023months of treatment; and the service is delivered using an integrated, closed 5001.12.2023extracorporeal photopheresis system; and the patient is 18 years old or over; 5001.12.2023and the patient has received prior systemic treatment for this condition and 5001.12.2023experienced either disease progression or unacceptable toxicity while on this 5001.12.2023treatment; and the service is provided in combination with the use of 5001.12.2023Pharmaceutical Benefits Scheme-subsidised methoxsalen; and the service is 5001.12.2023supervised by a specialist or consultant physician in the speciality of 5001.12.2023haematology. Applicable once per treatment cycle 1014249 01.11.2020 3 T1 13 DNS NYNNY 2001.12.202305616.0002036.9500000.00 5001.12.2023Extracorporeal photopheresis for the continuing treatment of erythrodermic 5001.12.2023stage III-IVa T4 M0 cutaneous T-cell lymphoma; if in the preceding 6 5001.12.2023months:(i) a service to which item 14247 applies has been provided; and(ii) 5001.12.2023the patient has demonstrated a response to this service; and(iii)the patient 5001.12.2023requires further treatment; and the service is delivered using an integrated, 5001.12.2023closed extracorporeal photopheresis system; and the patient is 18 years old or 5001.12.2023over; and the service is provided in combination with the use of 5001.12.2023Pharmaceutical Benefits Scheme-subsidised methoxsalen; and the service is 5001.12.2023supervised by a specialist or consultant physician in the speciality of 5001.12.2023haematology. Applicable once per treatment cycle 1014255 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300400.0000163.3000000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 30 minutes but less than 1 5001.12.2023hour, by a specialist in the practice of the specialists specialty of 5001.12.2023emergency medicine at a recognised emergency department of a private hospital, 5001.12.2023in conjunction with an attendance on the patient by the specialist described 5001.12.2023in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.) 1014256 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300710.0000314.0500000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 1 hour but less than 2 hours, 5001.12.2023by a specialist in the practice of the specialists specialty of emergency 5001.12.2023medicine at a recognised emergency department of a private hospital, in 5001.12.2023conjunction with an attendance on the patient by the specialist described in 5001.12.2023item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.) 1014257 01.03.2020 3 T1 14 SN NYNNY 2001.12.202301365.0000625.4500000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 2 hours, by a specialist in 5001.12.2023the practice of the specialists specialty of emergency medicine at a 5001.12.2023recognised emergency department of a private hospital, in conjunction with an 5001.12.2023attendance on the patient by the specialist described in item 5001, 5004, 5001.12.20235011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.) 1014258 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300400.0000122.5500000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 30 minutes but less than 1 5001.12.2023hour, by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) at a recognised emergency 5001.12.2023department of a private hospital, in conjunction with an attendance on the 5001.12.2023patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5001.12.20235032, 5033, 5035 or 5036 (Anaes.) 1014259 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300710.0000235.5500000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 1 hour but less than 2 hours, 5001.12.2023by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) at a recognised emergency 5001.12.2023department of a private hospital, in conjunction with an attendance on the 5001.12.2023patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5001.12.20235032, 5033, 5035 or 5036 (Anaes.) 1014260 01.03.2020 3 T1 14 SN NYNNY 2001.12.202301365.0000469.1000000.00 4001.03.2020(Anaes.) 5001.12.2023Resuscitation of a patient provided for at least 2 hours, by a medical 5001.12.2023practitioner (except a specialist in the practice of the specialists specialty 5001.12.2023of emergency medicine) at a recognised emergency department of a private 5001.12.2023hospital, in conjunction with an attendance on the patient by the practitioner 5001.12.2023described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 5001.12.2023(Anaes.) 1014263 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300174.0000057.5000000.00 4001.03.2020(Anaes.) 5001.12.2023Minor procedure on a patient by a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine at a recognised emergency 5001.12.2023department of a private hospital, in conjunction with an attendance on the 5001.12.2023patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5001.12.20235014, 5016, 5017 or 5019 (Anaes.) 1014264 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300350.0000129.4000000.00 4001.03.2020(Anaes.) 5001.12.2023Procedure (except a minor procedure) on a patient by a specialist in the 5001.12.2023practice of the specialists specialty of emergency medicine at a recognised 5001.12.2023emergency department of a private hospital, in conjunction with an attendance 5001.12.2023on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5001.12.20235013, 5014, 5016, 5017 or 5019 (Anaes.) 1014265 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300174.0000043.1000000.00 4001.03.2020(Anaes.) 5001.12.2023Minor procedure on a patient by a medical practitioner (except a specialist in 5001.12.2023the practice of the specialists specialty of emergency medicine) at a 5001.12.2023recognised emergency department of a private hospital, in conjunction with an 5001.12.2023attendance on the patient by the practitioner described in item 5021, 5022, 5001.12.20235027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.) 1014266 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300350.0000097.0500000.00 4001.03.2020(Anaes.) 5001.12.2023Procedure (except a minor procedure) on a patient by a medical practitioner 5001.12.2023(except a specialist in the practice of the specialists specialty of emergency 5001.12.2023medicine) at a recognised emergency department of a private hospital, in 5001.12.2023conjunction with an attendance on the patient by the practitioner described in 5001.12.2023item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.) 1014270 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300455.0000145.0500000.00 4001.03.2020(Anaes.) 5001.12.2023Management, without aftercare, of all fractures and dislocations suffered by a 5001.12.2023patient that: (a) is provided by a specialist in the practice of the 5001.12.2023specialist's specialty of emergency medicine in conjunction with an attendance 5001.12.2023on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5001.12.20235013, 5014, 5016, 5017 or 5019; and (b) occurs at a recognised emergency 5001.12.2023department of a private hospital (Anaes.) 1014272 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300455.0000108.8500000.00 4001.03.2020(Anaes.) 5001.12.2023Management, without aftercare, of all fractures and dislocations suffered by a 5001.12.2023patient that: (a) is provided by a medical practitioner (except a specialist 5001.12.2023in the practice of the specialist's specialty of emergency medicine) in 5001.12.2023conjunction with an attendance on the patient by thepractitioner described in 5001.12.2023item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (b) occurs at 5001.12.2023a recognised emergency department of a private hospital (Anaes.) 1014277 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000163.3000000.00 5001.12.2023Application of chemical or physical restraint of a patient by a specialist in 5001.12.2023the practice of the specialists specialty of emergency medicine at a 5001.12.2023recognised emergency department of a private hospital 1014278 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000122.5500000.00 5001.12.2023Application of chemical or physical restraint of a patient by a medical 5001.12.2023practitioner (except a specialist in the practice of the specialists specialty 5001.12.2023of emergency medicine) at a recognised emergency department of a private 5001.12.2023hospital 1014280 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000163.3000000.00 5001.12.2023Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is 5001.12.2023managed by a specialist in the practice of the specialists specialty of 5001.12.2023emergency medicine at a recognised emergency department of a private hospital; 5001.12.2023and (b) occurs in conjunction with an attendance on the patient that is 5001.12.2023described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5001.12.20235022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia 5001.12.2023provided by a specialist anaesthetist to which an item in Group T7 or T10 5001.12.2023applies 1014283 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000122.5500000.00 5001.12.2023Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is 5001.12.2023managed by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) at a recognised emergency 5001.12.2023department of a private hospital; and (b) occurs in conjunction with an 5001.12.2023attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5001.12.20235013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 5001.12.2023or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to 5001.12.2023which an item in Group T7 or T10 applies 1014285 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000163.3000000.00 5001.12.2023Emergent intubation, airway management or both of a patient that: (a) is 5001.12.2023managed by a specialist in the practice of the specialists specialty of 5001.12.2023emergency medicine at a recognised emergency department of a private hospital; 5001.12.2023and (b) occurs in conjunction with an attendance on the patient that is 5001.12.2023described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5001.12.20235022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia 5001.12.2023provided by a specialist anaesthetist to which an item in Group T7 or T10 5001.12.2023applies 1014288 01.03.2020 3 T1 14 SN NYNNY 2001.12.202300735.0000122.5500000.00 5001.12.2023Emergent intubation, airway management or both of a patient that: (a) is 5001.12.2023managed by a medical practitioner (except a specialist in the practice of the 5001.12.2023specialists specialty of emergency medicine) at a recognised emergency 5001.12.2023department of a private hospital; and (b) occurs in conjunction with an 5001.12.2023attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5001.12.20235013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 5001.12.2023or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to 5001.12.2023which an item in Group T7 or T10 applies 1015000 26.05.2002 3 T2 1 SN NYNNY 2001.12.202300126.0000046.8500000.00 5001.12.2023(Benefits for administration of general anaesthetic for radiotherapy are 5001.12.2023payable under Group T10) RADIOTHERAPY, SUPERFICIAL (including treatment with 5001.12.2023xrays, radium rays or other radioactive substances), not being a service to 5001.12.2023which another item in this Group applies each attendance at which fractionated 5001.12.2023treatment is given - 1 field 1015003 26.05.2002 3 T2 1 SD NYNNY 3001.12.2023The fee for item 15000 plus for each field in excess of 1, an amount of $18.80 5001.12.2023Radiotherapy, superficial (including treatment with x-rays, radium rays or 5001.12.2023other radioactive substances), not being a service to which another item in 5001.12.2023this Group applies - each attendance at which fractionated treatment is given 5001.12.2023- 2 or more fields up to a maximum of 5 additional fields 1015006 26.05.2002 3 T2 1 SN NYNNY 2001.12.202300340.0000103.8500000.00 5001.12.2023RADIOTHERAPY, SUPERFICIAL, attendance at which single dose technique is 5001.12.2023applied - 1 field 1015012 26.05.2002 3 T2 1 SN NYNNY 2001.12.202300186.0000058.8500000.00 5001.12.2023RADIOTHERAPY, SUPERFICIALeach attendance at which treatment is given to an eye 1015100 26.05.2002 3 T2 2 SN NYNNY 2001.12.202300170.0000052.5000000.00 5001.12.2023RADIOTHERAPY, DEEP OR ORTHOVOLTAGE each attendance at which fractionated 5001.12.2023treatment is given at 3 or more treatments per week - 1 field 1015106 26.05.2002 3 T2 2 SN NYNNY 2001.12.202300200.0000061.9500000.00 5001.12.2023RADIOTHERAPY, DEEP OR ORTHOVOLTAGEeach attendance at which fractionated 5001.12.2023treatment is given at 2 treatments per week or less frequently - 1 field 1015112 26.05.2002 3 T2 2 SN NYNNY 2001.12.202300440.0000132.3500000.00 5001.12.2023RADIOTHERAPY, DEEP OR ORTHOVOLTAGEattendance at which single dose technique is 5001.12.2023applied 1 field 1015211 26.05.2002 3 T2 3 SN NYNNY 2001.12.202300144.0000060.2500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using cobalt unit or caesium teletherapy 5001.12.2023uniteach attendance at which treatment is given - 1 field 1015215 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300190.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator 5001.12.2023with or without electron facilities - each attendance at which treatment is 5001.12.2023given - 1 field - treatment delivered to primary site (lung) 1015218 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300190.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator 5001.12.2023with or without electron facilities - each attendance at which treatment is 5001.12.2023given - 1 field - treatment delivered to primary site (prostate) 1015221 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300190.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator 5001.12.2023with or without electron facilities - each attendance at which treatment is 5001.12.2023given - 1 field - treatment delivered to primary site (breast) 1015224 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300190.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator 5001.12.2023with or without electron facilities - each attendance at which treatment is 5001.12.2023given - 1 field - treatment delivered to primary site for diseases and 5001.12.2023conditions not covered by items 15215, 15218 and 15221 1015227 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300190.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator 5001.12.2023with or without electron facilities - each attendance at which treatment is 5001.12.2023given - 1 field - treatment delivered to secondary site 1015245 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300250.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator 5001.12.2023with a minimum higher energy of at least 10MV photons, with electron 5001.12.2023facilities - each attendance at which treatment is given - 1 field - treatment 5001.12.2023delivered to primary site (lung) 1015248 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300250.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator 5001.12.2023with a minimum higher energy of at least 10MV photons, with electron 5001.12.2023facilities - each attendance at which treatment is given - 1 field - treatment 5001.12.2023delivered to primary site (prostate) 1015251 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300250.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator 5001.12.2023with a minimum higher energy of at least 10MV photons, with electron 5001.12.2023facilities - each attendance at which treatment is given - 1 field - treatment 5001.12.2023delivered to primary site (breast) 1015254 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300250.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator 5001.12.2023with a minimum higher energy of at least 10MV photons, with electron 5001.12.2023facilities - each attendance at which treatment is given - 1 field - treatment 5001.12.2023delivered to primary site for diseases and conditions not covered by items 5001.12.202315245, 15248 or 15251 1015257 01.05.2003 3 T2 3 SN NYNNY 2001.12.202300250.0000065.6500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator 5001.12.2023with a minimum higher energy of at least 10MV photons, with electron 5001.12.2023facilities - each attendance at which treatment is given - 1 field - treatment 5001.12.2023delivered to secondary site 1015275 01.01.2016 3 T2 3 SN NYNNY 2001.12.202300350.0000201.3500000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT with IGRT imaging facilities undertaken: (a) to 5001.12.2023implement an IMRT dosimetry plan prepared in accordance with item 15565; and 5001.12.2023(b) utilising an intensity modulated treatment delivery mode (delivered by a 5001.12.2023fixed or dynamic gantry linear accelerator or by a helical non C-arm based 5001.12.2023linear accelerator), once only at each attendance at which treatment is given. 1015303 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300995.0000392.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life greater than 115 days using manual afterloading techniques (Anaes.) 1015304 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300995.0000392.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life greater than 115 days using automatic afterloading techniques 5001.12.2023(Anaes.) 1015307 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301885.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life of less than 115 days including iodine, gold, iridium or tantalum 5001.12.2023using manual afterloading techniques (Anaes.) 1015308 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302015.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life of less than 115 days including iodine, gold, iridium or tantalum 5001.12.2023using automatic afterloading techniques (Anaes.) 1015311 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300930.0000366.8000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life greater than 115 days using manual afterloading techniques (Anaes.) 1015312 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300930.0000364.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life greater than 115 days using automatic afterloading techniques 5001.12.2023(Anaes.) 1015315 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301820.0000720.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life of less than 115 days including iodine, gold, iridium or tantalum 5001.12.2023using manual afterloading techniques (Anaes.) 1015316 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301940.0000720.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a 5001.12.2023half-life of less than 115 days including iodine, gold, iridium or tantalum 5001.12.2023using automatic afterloading techniques (Anaes.) 1015319 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301130.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed 5001.12.2023sources having a half-life greater than 115 days using manual afterloading 5001.12.2023techniques (Anaes.) 1015320 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301130.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed 5001.12.2023sources having a half-life greater than 115 days using automatic afterloading 5001.12.2023techniques (Anaes.) 1015323 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302020.0000794.7000000.00 4026.05.2002(Anaes.) 5001.12.2023COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed 5001.12.2023sources having a half-life of less than 115 days including iodine, gold, 5001.12.2023iridium or tantalum using manual afterloading techniques (Anaes.) 1015324 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302140.0000794.7000000.00 4026.05.2002(Anaes.) 5001.12.2023COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed 5001.12.2023sources having a half-life of less than 115 days including iodine, gold, 5001.12.2023iridium or tantalum using automatic afterloading techniques (Anaes.) 1015327 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302195.0000864.5500000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a region, under 5001.12.2023general anaesthesia, or epidural or spinal (intrathecal) nerve block, 5001.12.2023requiring surgical exposure and using manual afterloading techniques (Anaes.) 1015328 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302320.0000864.5500000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a region, under 5001.12.2023general anaesthesia, or epidural or spinal (intrathecal) nerve block, 5001.12.2023requiring surgical exposure and using automatic afterloading techniques 5001.12.2023(Anaes.) 1015331 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302085.0000820.9000000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a site (including the 5001.12.2023tongue, mouth, salivary gland, axilla, subcutaneous sites), where the volume 5001.12.2023treated involves multiple planes but does not require surgical exposure and 5001.12.2023using manual afterloading techniques (Anaes.) 1015332 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302215.0000820.9000000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a site (including the 5001.12.2023tongue, mouth, salivary gland, axilla, subcutaneous sites), where the volume 5001.12.2023treated involves multiple planes but does not require surgical exposure and 5001.12.2023using automatic afterloading techniques (Anaes.) 1015335 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301885.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a site where the 5001.12.2023volume treated involves only a single plane but does not require surgical 5001.12.2023exposure and using manual afterloading techniques (Anaes.) 1015336 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302015.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 5001.12.2023115 days including iodine, gold, iridium or tantalum) to a site where the 5001.12.2023volume treated involves only a single plane but does not require surgical 5001.12.2023exposure and using automatic afterloading techniques (Anaes.) 1015338 26.05.2002 3 T2 4 SN NYNNY 2001.12.202302330.0001029.8000000.00 5001.12.2023Prostate, radioactive seed implantation of, radiation oncology component, 5001.12.2023using transrectal ultrasound guidance: (a) for a patient with: (i) localised 5001.12.2023prostatic malignancy at clinical stages T1 (clinically inapparent tumour not 5001.12.2023palpable or visible by imaging) or T2 (tumour confined within prostate); and 5001.12.2023(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 5001.12.20233); and (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at 5001.12.2023the time of diagnosis; and (b) performed by an oncologist at an approved site 5001.12.2023in association with a urologist; and (c) being a service associated with: (i) 5001.12.2023services to which items 37220 and 55603 apply; and (ii) a service to which 5001.12.2023item 60506or 60509 applies 1015339 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300215.0000083.8000000.00 4026.05.2002(Anaes.) 5001.12.2023REMOVAL OF A SEALED RADIOACTIVE SOURCE under general anaesthesia, or under 5001.12.2023epidural or spinal nerve block (Anaes.) 1015342 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300530.0000209.4500000.00 5001.12.2023CONSTRUCTION AND APPLICATION OF A RADIOACTIVE MOULD using a sealed source 5001.12.2023having a half-life of greater than 115 days, to treat intracavity, intraoral 5001.12.2023or intranasal site 1015345 26.05.2002 3 T2 4 SN NYNNY 2001.12.202301420.0000558.9000000.00 5001.12.2023CONSTRUCTION AND APPLICATION OF A RADIOACTIVE MOULD using a sealed source 5001.12.2023having a half-life of less than 115 days including iodine, gold, iridium or 5001.12.2023tantalum to treat intracavity, intraoral or intranasal sites 1015348 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300162.0000064.2500000.00 5001.12.2023SUBSEQUENT APPLICATIONS OF RADIOACTIVE MOULD referred to in item 15342 or 5001.12.202315345each attendance 1015351 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300425.0000128.4000000.00 5001.12.2023CONSTRUCTION WITH OR WITHOUT INITIAL APPLICATION OF RADIOACTIVE MOULD not 5001.12.2023exceeding 5 cm. diameter to an external surface 1015354 26.05.2002 3 T2 4 SN NYNNY 2001.12.202300500.0000155.7000000.00 5001.12.2023CONSTRUCTION AND INITIAL APPLICATION OF RADIOACTIVE MOULD 5 cm. or more in 5001.12.2023diameter to an external surface 1015357 26.05.2002 3 T2 4 SN NYNYY 2001.12.202300142.0000044.0000000.00 5001.12.2023SUBSEQUENT APPLICATIONS OF RADIOACTIVE MOULD, attendance upon a patient to 5001.12.2023apply a radioactive mould constructed for application to an external surface 5001.12.2023of the patient other than an attendance which is the first attendance to apply 5001.12.2023the mould each attendance 1015500 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300600.0000267.1500000.00 5001.12.2023RADIOTHERAPY PLANNINGRADIATION FIELD SETTING using a simulator or isocentric 5001.12.2023xray or megavoltage machine or CT of a single area for treatment by a single 5001.12.2023field or parallel opposed fields (not being a service associated with a 5001.12.2023service to which item 15509 applies) 1015503 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300825.0000342.9500000.00 5001.12.2023RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage 5001.12.2023machine or CT of a single area, where views in more than 1 plane are required 5001.12.2023for treatment by multiple fields, or of 2 areas (not being a service 5001.12.2023associated with a service to which item 15512 applies) 1015506 26.05.2002 3 T2 5 SN NYNNY 2001.12.202301295.0000512.1500000.00 5001.12.2023RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage 5001.12.2023machine or CT of 3 or more areas, or of total body or half body irradiation, 5001.12.2023or of mantle therapy or inverted Y fields, or of irregularly shaped fields 5001.12.2023using multiple blocks, or of offaxis fields or several joined fields (not 5001.12.2023being a service associated with a service to which item 15515 applies) 1015509 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300520.0000231.4500000.00 5001.12.2023RADIATION FIELD SETTING using a diagnostic xray unit of a single area for 5001.12.2023treatment by a single field or parallel opposed fields (not being a service 5001.12.2023associated with a service to which item 15500 applies) 1015512 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300440.0000298.4000000.00 5001.12.2023RADIATION FIELD SETTING using a diagnostic xray unit of a single area, where 5001.12.2023views in more than 1 plane are required for treatment by multiple fields, or 5001.12.2023of 2 areas (not being a service associated with a service to which item 15503 5001.12.2023applies) 1015513 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300820.0000337.4000000.00 5001.12.2023RADIATION SOURCE LOCALISATION using a simulator or x-ray machine or CT of a 5001.12.2023single area, where views in more than 1 plane are required, for brachytherapy 5001.12.2023treatment planning for I125 seed implantation of localised prostate cancer, in 5001.12.2023association with item 15338 1015515 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300770.0000432.1000000.00 5001.12.2023RADIATION FIELD SETTING using a diagnostic xray unit of 3 or more areas, or of 5001.12.2023total body or half body irradiation, or of mantle therapy or inverted Y 5001.12.2023fields, or of irregularly shaped fields using multiple blocks, or of offaxis 5001.12.2023fields or several joined fields (not being a service associated with a service 5001.12.2023to which item 15506 applies) 1015518 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300540.0000084.7500000.00 5001.12.2023RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or 5001.12.2023teletherapy radiotherapy by a single field or parallel opposed fields to 1 5001.12.2023area with up to 2 shielding blocks 1015521 26.05.2002 3 T2 5 SN NYNNY 2001.12.202301075.0000374.1500000.00 5001.12.2023RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or 5001.12.2023teletherapy radiotherapy to a single area by 3 or more fields, or by a single 5001.12.2023field or parallel opposed fields to 2 areas, or where wedges are used 1015524 26.05.2002 3 T2 5 SN NYNNY 2001.12.202302130.0000701.5000000.00 5001.12.2023RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or 5001.12.2023teletherapy radiotherapy to 3 or more areas, or by mantle fields or inverted Y 5001.12.2023fields or tangential fields or irregularly shaped fields using multiple 5001.12.2023blocks, or offaxis fields, or several joined fields 1015527 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300520.0000086.9000000.00 5001.12.2023RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage 5001.12.2023or teletherapy radiotherapy by a single field or parallel opposed fields to 1 5001.12.2023area with up to 2 shielding blocks 1015530 26.05.2002 3 T2 5 SN NYNNY 2001.12.202300850.0000387.6000000.00 5001.12.2023RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage 5001.12.2023or teletherapy radiotherapy to a single area by 3 or more fields, or by a 5001.12.2023single field or parallel opposed fields to 2 areas, or where wedges are used 1015533 26.05.2002 3 T2 5 SN NYNNY 2001.12.202301675.0000734.9500000.00 5001.12.2023RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage 5001.12.2023or teletherapy radiotherapy to 3 or more areas, or by mantle fields or 5001.12.2023inverted Y fields, or tangential fields or irregularly shaped fields using 5001.12.2023multiple blocks, or offaxis fields, or several joined fields 1015536 26.05.2002 3 T2 5 SN NYNNY 2001.12.202301075.0000293.7500000.00 5001.12.2023BRACHYTHERAPY PLANNING, computerised radiation dosimetry 1015539 26.05.2002 3 T2 5 SN NYNNY 2001.12.202302125.0000690.4500000.00 5001.12.2023BRACHYTHERAPY PLANNING, computerised radiation dosimetry for I125 seed 5001.12.2023implantation of localised prostate cancer, in association with item 15338 1015550 01.05.2006 3 T2 5 SN NYNNY 2001.12.202301255.0000724.9000000.00 5001.12.2023SIMULATION FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY without intravenous 5001.12.2023contrast medium, where: (a)treatment set up and technique specifications are 5001.12.2023in preparations for three dimensional conformal radiotherapy dose planning; 5001.12.2023and (b)patient set up and immobilisation techniques are suitable for reliable 5001.12.2023CT image volume data acquisition and three dimensional conformal radiotherapy 5001.12.2023treatment; and (c)a high-quality CT-image volume dataset must be acquired for 5001.12.2023the relevant region of interest to be planned and treated; and (d)the image 5001.12.2023set must be suitable for the generation of quality digitally reconstructed 5001.12.2023radiographic images 1015553 01.05.2006 3 T2 5 SN NYNNY 2001.12.202301355.0000782.1500000.00 5001.12.2023SIMULATION FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY pre and post 5001.12.2023intravenous contrast medium, where: (a)treatment set up and technique 5001.12.2023specifications are in preparations for three dimensional conformal 5001.12.2023radiotherapy dose planning; and (b)patient set up and immobilisation 5001.12.2023techniques are suitable for reliable CT image volume data acquisition and 5001.12.2023three dimensional conformal radiotherapy treatment; and (c)a high-quality 5001.12.2023CT-image volume dataset must be acquired for the relevant region of interest 5001.12.2023to be planned and treated; and (d)the image set must be suitable for the 5001.12.2023generation of quality digitally reconstructed radiographic images 1015555 01.01.2016 3 T2 5 SN NYNNY 2001.12.202301420.0000782.1500000.00 5001.12.2023SIMULATION FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT), with or without 5001.12.2023intravenous contrast medium, if: 1.treatment set-up and technique 5001.12.2023specifications are in preparations for three-dimensional conformal 5001.12.2023radiotherapy dose planning; and 2.patient set-up and immobilisation techniques 5001.12.2023are suitable for reliable CT-image volume data acquisition and 5001.12.2023three-dimensional conformal radiotherapy; and 3.a high-quality CT-image volume 5001.12.2023dataset is acquired for the relevant region of interest to be planned and 5001.12.2023treated; and 4.the image set is suitable for the generation of quality 5001.12.2023digitally-reconstructed radiographic images. 1015556 01.05.2006 3 T2 5 SN NYNNY 2001.12.202301365.0000731.3500000.00 5001.12.2023DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 1 COMPLEXITY 5001.12.2023where: (a)dosimetry for a single phase three dimensional conformal treatment 5001.12.2023plan using CT image volume dataset and having a single treatment target volume 5001.12.2023and organ at risk; and (b)one gross tumour volume or clinical target volume, 5001.12.2023plus one planning target volume plus at least one relevant organ at risk as 5001.12.2023defined in the prescription must be rendered as volumes; and (c)the organ at 5001.12.2023risk must be nominated as a planning dose goal or constraint and the 5001.12.2023prescription must specify the organ at risk dose goal or constraint; and 5001.12.2023(d)dose volume histograms must be generated, approved and recorded with the 5001.12.2023plan; and (e)a CT image volume dataset must be used for the relevant region to 5001.12.2023be planned and treated; and (f)the CT images must be suitable for the 5001.12.2023generation of quality digitally reconstructed radiographic images 1015559 01.05.2006 3 T2 5 SN NYNNY 2001.12.202301650.0000953.8500000.00 5001.12.2023DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 2 COMPLEXITY 5001.12.2023where: (a)dosimetry for a two phase three dimensional conformal treatment plan 5001.12.2023using CT image volume dataset(s) with at least one gross tumour volume, two 5001.12.2023planning target volumes and one organ at risk defined in the prescription; or 5001.12.2023(b)dosimetry for a one phase three dimensional conformal treatment plan using 5001.12.2023CT image volume datasets with at least one gross tumour volume, one planning 5001.12.2023target volume and two organ at risk dose goals or constraints defined in the 5001.12.2023prescription; or (c)image fusion with a secondary image (CT, MRI or PET) 5001.12.2023volume dataset used to define target and organ at risk volumes in conjunction 5001.12.2023with and as specified in dosimetry for three dimensional conformal 5001.12.2023radiotherapy of level 1 complexity. All gross tumour targets, clinical 5001.12.2023targets, planning targets and organs at risk as defined in the prescription 5001.12.2023must be rendered as volumes. The organ at risk must be nominated as planning 5001.12.2023dose goals or constraints and the prescription must specify the organs at risk 5001.12.2023as dose goals or constraints. Dose volume histograms must be generated, 5001.12.2023approved and recorded with the plan. A CT image volume dataset must be used 5001.12.2023for the relevant region to be planned and treated. The CT images must be 5001.12.2023suitable for the generation of quality digitally reconstructed radiographic 5001.12.2023images 1015562 01.05.2006 3 T2 5 SN NYNNY 2001.12.202302300.0001233.6500000.00 5001.12.2023DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 3 COMPLEXITY - 5001.12.2023where: (a)dosimetry for a three or more phase three dimensional conformal 5001.12.2023treatment plan using CT image volume dataset(s) with at least one gross tumour 5001.12.2023volume, three planning target volumes and one organ at risk defined in the 5001.12.2023prescription; or (b)dosimetry for a two phase three dimensional conformal 5001.12.2023treatment plan using CT image volume datasets with at least one gross tumour 5001.12.2023volume, and (i) two planning target volumes; or (ii) two organ at risk dose 5001.12.2023goals or constraints defined in the prescription. or (c)dosimetry for a one 5001.12.2023phase three dimensional conformal treatment plan using CT image volume 5001.12.2023datasets with at least one gross tumour volume, one planning target volume and 5001.12.2023three organ at risk dose goals or constraints defined in the prescription; or 5001.12.2023(d)image fusion with a secondary image (CT, MRI or PET) volume dataset used to 5001.12.2023define target and organ at risk volumes in conjunction with and as specified 5001.12.2023in dosimetry for three dimensional conformal radiotherapy of level 2 5001.12.2023complexity. All gross tumour targets, clinical targets, planning targets and 5001.12.2023organs at risk as defined in the prescription must be rendered as volumes. The 5001.12.2023organ at risk must be nominated as planning dose goals or constraints and the 5001.12.2023prescription must specify the organs at risk as dose goals or constraints. 5001.12.2023Dose volume histograms must be generated, approved and recorded with the plan. 5001.12.2023A CT image volume dataset must be used for the relevant region to be planned 5001.12.2023and treated. The CT images must be suitable for the generation of quality 5001.12.2023digitally reconstructed radiographic images 1015565 01.01.2016 3 T2 5 SN NYNNY 2001.12.202312215.0003647.5000000.00 5001.12.2023Preparation of an IMRT DOSIMETRY PLAN, which uses one or more CT image volume 5001.12.2023datasets, if: (a)in preparing the IMRT dosimetry plan: (i)the differential 5001.12.2023between target dose and normal tissue dose is maximised, based on a review and 5001.12.2023assessmentby a radiation oncologist; and (ii)all gross tumour targets, 5001.12.2023clinical targets, planning targets and organs at risk are rendered as volumes 5001.12.2023as defined in the prescription; and (iii)organs at risk are nominated as 5001.12.2023planning dose goals or constraints and the prescription specifies the organs 5001.12.2023at risk as dose goals or constraints; and (iv)dose calculations and dose 5001.12.2023volume histograms are generated in an inverse planned process, using a 5001.12.2023specialised calculation algorithm, with prescription and plan details approved 5001.12.2023and recorded in the plan; and (v)a CT image volume dataset is used for the 5001.12.2023relevant region to be planned and treated; and (vi)the CT images are suitable 5001.12.2023for the generation of quality digitally reconstructed radiographic images; and 5001.12.2023(b) the final IMRT dosimetry plan is validated by the radiation therapist and 5001.12.2023the medical physicist, using robust quality assurance processes that include: 5001.12.2023(i)determination of the accuracy of the dose fluence delivered by the 5001.12.2023multi-leaf collimator and gantryposition (static or dynamic); and (ii)ensuring 5001.12.2023that the plan is deliverable, data transfer is acceptable and validation 5001.12.2023checks are completed on a linear accelerator; and (iii)validating the accuracy 5001.12.2023of the derived IMRT dosimetry plan; and (c)the final IMRT dosimetry plan is 5001.12.2023approved by the radiation oncologist prior to delivery. 1015600 26.05.2002 3 T2 6 SN NYNNY 2001.12.202305220.0001873.7500000.00 5001.12.2023STEREOTACTIC RADIOSURGERY, including all radiation oncology consultations, 5001.12.2023planning, simulation, dosimetry and treatment 1015700 01.07.2008 3 T2 7 DN NYNNY 2001.12.202300174.0000050.6000000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT VERIFICATION - single projection (with single or 5001.12.2023double exposures) - when prescribed and reviewed by a radiation oncologist and 5001.12.2023not associated with item 15705 or 15710 - each attendance at which treatment 5001.12.2023is verified (ie maximum one per attendance). 1015705 01.07.2008 3 T2 7 DN NYNNY 2001.12.202300290.0000084.3000000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT VERIFICATION - multiple projection acquisition 5001.12.2023when prescribed and reviewed by a radiation oncologist and not associated with 5001.12.2023item 15700 or 15710 - each attendance at which treatment involving three or 5001.12.2023more fields is verified (ie maximum one per attendance). 1015710 01.05.2010 3 T2 7 SN NYNNY 2001.12.202300290.0000084.3000000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT VERIFICATION - volumetric acquisition, when 5001.12.2023prescribed and reviewedby a radiation oncologist and not associated with item 5001.12.202315700 or 15705 - each attendance at which treatment involving three fields or 5001.12.2023more is verified (ie maximum one per attendance). (see para T2.5 of 5001.12.2023explanatory notes to this Category) 1015715 01.01.2016 3 T2 7 SN NYNNY 2001.12.202300290.0000084.3000000.00 5001.12.2023RADIATION ONCOLOGY TREATMENT VERIFICATION of planar or volumetric IGRT for 5001.12.2023IMRT, involving the use of at least 2 planar image views or projections or 1 5001.12.2023volumetric image set to facilitate a 3-dimensional adjustment to radiation 5001.12.2023treatment field positioning, if: (a) the treatment technique is classified as 5001.12.2023IMRT; and (b) the margins applied to volumes (clinical target volume or 5001.12.2023planning target volume) are tailored or reduced to minimise treatment related 5001.12.2023exposure of healthy or normal tissues; and (c) the decisions made using 5001.12.2023acquired images are based on action algorithms and are given effect 5001.12.2023immediately prior to or during treatment delivery by qualified and trained 5001.12.2023staff considering complex competing factors and using software driven 5001.12.2023modelling programs; and (d) the radiation treatment field positioning requires 5001.12.2023accuracy levels of less than 5mm (curative cases) or up to 10mm (palliative 5001.12.2023cases) to ensure accurate dose delivery to the target; and (e) the image 5001.12.2023decisions and actions are documented in the patient's record; and (f) the 5001.12.2023radiation oncologist is responsible for supervising the process, including 5001.12.2023specifying the type and frequency of imaging, tolerance and action levels to 5001.12.2023be incorporated in the process, reviewing the trend analysis and any reports 5001.12.2023and relevant images during the treatment course and specifying action 5001.12.2023protocols as required; and (g) when treatment adjustments are inadequate to 5001.12.2023satisfy treatment protocol requirements, replanning is required; and (h) the 5001.12.2023imaging infrastructure (hardware and software) is linked to the treatment unit 5001.12.2023and networked to an image database, enabling both on line and off line 5001.12.2023reviews. 1015800 01.07.2008 3 T2 8 DN NYNNY 2001.12.202300365.0000106.0000000.00 5001.12.2023BRACHYTHERAPY TREATMENT VERIFICATION - maximum of one only for each 5001.12.2023attendance. 1015850 01.07.2008 3 T2 8 DN NYNNY 2001.12.202300630.0000219.6000000.00 5001.12.2023RADIATION SOURCE LOCALISATION using a simulator, x-ray machine, CT or 5001.12.2023ultrasound of a single area, where views in more than one plane are required, 5001.12.2023for brachytherapy treatment planning, not being a service to which Item 15513 5001.12.2023applies. 1015900 01.09.2015 3 T2 10 SN NYNNY 2001.12.202300785.0000275.1000000.00 5001.12.2023BREAST, MALIGNANT TUMOUR, targeted intraoperative radiation therapy, using an 5001.12.2023Intrabeamor Xoft Axxent device, delivered at the time of breast-conserving 5001.12.2023surgery (partial mastectomy or lumpectomy) for a patient who: a) is 45 years 5001.12.2023of age or more; and b) has a T1 or small T2 (less than or equal to 3cm in 5001.12.2023diameter) primary tumour; and c) has an histologic Grade 1 or 2 tumour; and d) 5001.12.2023has an oestrogen-receptor positive tumour; and e) has a node negative 5001.12.2023malignancy; and f) is suitable for wide local excision of a primary invasive 5001.12.2023ductal carcinoma that was diagnosed as unifocal on conventional examination 5001.12.2023and imaging; and g) has no contra-indications to breast irradiation Applicable 5001.12.2023only once per breast per lifetime (H) 1016003 26.05.2002 3 T3 SN NYNYY 2001.12.202301845.0001562.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Intra-cavitary administration of a therapeutic dose of Yttrium 90 (not 5001.12.2023including preliminary paracentesis and other than a service to which item 5001.12.202335404, 35406 or 35408 applies or a service associated with selective internal 5001.12.2023radiation therapy) (Anaes.) 1016006 26.05.2002 3 T3 SN NYNYY 2001.12.202301415.0001052.9500000.00 5001.12.2023Administration of a therapeutic dose of Iodine 131 for thyroid cancer by 5001.12.2023single dose technique 1016009 26.05.2002 3 T3 SN NYNYY 2001.12.202300965.0000510.1000000.00 5001.12.2023Administration of a therapeutic dose of Iodine 131 for thyrotoxicosis by 5001.12.2023single dose technique 1016012 26.05.2002 3 T3 SN NYNYY 2001.12.202300840.0002929.7000000.00 5001.12.2023Intravenous administration of a therapeutic dose of Phosphorous 32 1016015 26.05.2002 3 T3 SN NYNYY 2001.12.202308435.0004497.0500000.00 5001.12.2023Administration of Strontium 89 forthe relief of bone pain due to skeletal 5001.12.2023metastases (as indicated by a positive bone scan), if systemic antineoplastic 5001.12.2023therapy is unavailable or has failed to control the patients disease and 5001.12.2023either: a) the disease is poorly controlled by conventional radiotherapy; or 5001.12.2023b) conventional radiotherapy is inappropriate, due to the wide distribution of 5001.12.2023sites of bone pain. 1016018 26.05.2002 3 T3 SN NYNYY 2001.12.202305060.0004838.7500000.00 5001.12.2023Administration of153 Sm-lexidronam for the relief of bone pain due to skeletal 5001.12.2023metastases (as indicated by a positive bone scan), if systemic antineoplastic 5001.12.2023therapy is unavailable or has failed to control the patients disease, and: a) 5001.12.2023the disease is poorly controlled by conventional radiotherapy; or b) 5001.12.2023conventional radiotherapy is inappropriate, due to the wide distribution of 5001.12.2023sites of bone pain. 1016401 01.01.2010 3 T4 SN NYNNY 2001.12.202300259.0000094.1000000.00 5001.12.2023Professional attendance at consulting rooms or a hospital by a specialist in 5001.12.2023the practice of his or her specialty of obstetrics, after referral of the 5001.12.2023patient to him or her - each attendance, other than a second or subsequent 5001.12.2023attendance in a single course of treatment 1016408 01.11.2017 3 T4 SN NYNNY 2001.12.202300200.0000058.8000000.00 5001.12.2023Postnatal attendance (other than attendance at consulting rooms, a hospital or 5001.12.2023a residential aged care facility or a service to which any other item applies) 5001.12.2023if the attendance: (a) is by: (i) a midwife (on behalf of and under the 5001.12.2023supervision of the medical practitioner who attended the birth); or (ii) an 5001.12.2023obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 5001.12.2023weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a 5001.12.2023patient who was privately admitted for the birth; and (e) is for a pregnancy 5001.12.2023in relation to which a service to which item 82130, 82135 or 82140 applies is 5001.12.2023not provided Payable once only for a pregnancy 1016500 26.05.2002 3 T4 SN NYNNY 2001.12.202300128.0000051.9000000.00 5001.12.2023ANTENATAL ATTENDANCE 1016501 26.05.2002 3 T4 SN NYNNY 2001.12.202300520.0000154.7000000.00 5001.12.2023EXTERNAL CEPHALIC VERSION for breech presentation, after 36 weeks where no 5001.12.2023contraindication exists, in a Unit with facilities for Caesarean Section, 5001.12.2023including pre- and post version CTG, with or without tocolysis, not being a 5001.12.2023service to which items 55718 to 55728 and 55768 to 55774 apply - chargeable 5001.12.2023whether or not the version is successful and limited to a maximum of 2 ECV's 5001.12.2023per pregnancy 1016502 26.05.2002 3 T4 SN NYNNY 2001.12.202300128.0000051.9000000.00 5001.12.2023POLYHYDRAMNIOS, UNSTABLE LIE, MULTIPLE PREGNANCY, PREGNANCY COMPLICATED BY 5001.12.2023DIABETES OR ANAEMIA, THREATENED PREMATURE LABOUR treated by bed rest only or 5001.12.2023oral medication, requiring admission to hospitaleach attendance that is not a 5001.12.2023routine antenatal attendance, to a maximum of 1 visit per day 1016505 26.05.2002 3 T4 SN NYNNY 2001.12.202300128.0000051.9000000.00 5001.12.2023THREATENED ABORTION, THREATENED MISCARRIAGE OR HYPEREMESIS GRAVIDARUM, 5001.12.2023requiring admission to hospital, treatment ofeach attendance that is not a 5001.12.2023routine antenatal attendance 1016508 26.05.2002 3 T4 SN NYNNY 2001.12.202300128.0000051.9000000.00 5001.12.2023Pregnancy complicatedby acute intercurrent infection, fetal growth 5001.12.2023restriction, threatened premature labour with ruptured membranes or threatened 5001.12.2023premature labour treated by intravenous therapy, requiring admission to 5001.12.2023hospital - each professional attendance (other than a service to which item 5001.12.202316533 applies) that is not a routine antenatal attendance, to a maximum of one 5001.12.2023visit per day 1016509 26.05.2002 3 T4 SN NYNNY 2001.12.202300128.0000051.9000000.00 5001.12.2023Pre-eclampsia,eclampsia or antepartum haemorrhage, treatment of- each 5001.12.2023professional attendance (other than a service to which item 16534 applies) 5001.12.2023that is not a routine antenatal attendance 1016511 26.05.2002 3 T4 SN NYNNY 2001.12.202300850.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVIX, purse string ligation of (Anaes.) 1016512 26.05.2002 3 T4 SN NYNNY 2001.12.202300245.0000069.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVIX, removal of purse string ligature of (Anaes.) 1016514 26.05.2002 3 T4 SN NYNNY 2001.12.202300130.0000040.3500000.00 5001.12.2023ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (not 5001.12.2023during the course of the confinement) 1016515 26.05.2002 3 T4 SN NYNNY 2001.12.202303665.0000694.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Management of vaginal birth as an independent procedure, ifthe patient's care 5001.12.2023has been transferred by another medical practitioner for management of the 5001.12.2023birth and the attending medical practitioner has not provided antenatal care 5001.12.2023to the patient, including all attendances related to the birth (Anaes.) 1016518 26.05.2002 3 T4 SN NYNNY 2001.12.202301835.0000496.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Management of labour, incomplete, if the patient's care has been transferred 5001.12.2023to another medical practitioner for completion of the birth (Anaes.) 1016519 26.05.2002 3 T4 SN NYNNY 2001.12.202303670.0000763.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Management of labourand birth by any means (including Caesarean section) 5001.12.2023including post-partum care for 5 days (Anaes.) 1016520 26.05.2002 3 T4 SN NYNNY 2001.12.202303670.0000694.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Caesarean section and postoperative care for 7 days, if the patients care has 5001.12.2023been transferred by another medical practitioner for management of the 5001.12.2023confinement and the attending medical practitioner has not provided any of the 5001.12.2023antenatal care (Anaes.) 1016522 26.05.2002 3 T4 SN NYNNY 2001.12.202305180.0001793.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Management of labour and birth, or birth alone, (including caesarean section), 5001.12.2023on or after 23 weeks gestation, if in the course of antenatal supervision or 5001.12.2023intrapartum management one or more of the following conditions is present, 5001.12.2023including postnatal care for 7 days: (a) fetal loss; (b) multiple pregnancy; 5001.12.2023(c) antepartum haemorrhage that is: (i) of greater than 200 ml; or (ii) 5001.12.2023associated with disseminated intravascular coagulation; (d) placenta praevia 5001.12.2023on ultrasound in the third trimester with the placenta within 2 cm of the 5001.12.2023internal cervical os; (e) baby with a birth weight less than or equal to 2,500 5001.12.2023g; (f) trial of vaginal birth in a patient with uterine scar where there has 5001.12.2023been a planned vaginal birth after caesarean section; (g) trial of vaginal 5001.12.2023breech birth where there has been a planned vaginal breech birth; (h) 5001.12.2023prolonged labour greater than 12 hours with partogram evidence of abnormal 5001.12.2023cervimetric progress as evidenced by cervical dilatation at less than 1 cm/hr 5001.12.2023in the active phase of labour (after 3 cm cervical dilatation and effacement 5001.12.2023until full dilatation of the cervix); (i) acute fetal compromise evidenced by: 5001.12.2023(i) scalp pH less than 7.15; or (ii) scalp lactate greater than 4.0; (j) acute 5001.12.2023fetal compromise evidenced by at least one of the following significant 5001.12.2023cardiotocograph abnormalities: (i) prolonged bradycardia (less than 100 bpm 5001.12.2023for more than 2 minutes); (ii) absent baseline variability (less than 3 bpm); 5001.12.2023(iii) sinusoidal pattern; (iv) complicated variable decelerations with reduced 5001.12.2023(3 to 5 bpm) or absent baseline variability; (v) late decelerations; (k) 5001.12.2023pregnancy induced hypertension of at least 140/90 mm Hg associated with: (i) 5001.12.2023at least 2+ proteinuria on urinalysis; or (ii) protein-creatinine ratio 5001.12.2023greater than 30 mg/mmol; or (iii) platelet count less than 150 x 109/L; or 5001.12.2023(iv) uric acid greater than 0.36 mmol/L; (l) gestational diabetes mellitus 5001.12.2023requiring at least daily blood glucose monitoring; (m) mental health disorder 5001.12.2023(whether arising prior to pregnancy, during pregnancy or postpartum) that is 5001.12.2023demonstrated by: (i) the patient requiring hospitalisation; or (ii) the 5001.12.2023patient receiving ongoing care by a psychologist or psychiatrist to treat the 5001.12.2023symptoms of a mental health disorder; or (iii) the patient having a GP mental 5001.12.2023health treatment plan; or (iv) the patient having a management plan prepared 5001.12.2023in accordance with item 291; (n) disclosure or evidence of domestic violence; 5001.12.2023(o) any of the following conditions either diagnosed pre-pregnancy or evident 5001.12.2023at the first antenatal visit before 20 weeks gestation: (i) pre-existing 5001.12.2023hypertension requiring antihypertensive medication prior to pregnancy; (ii) 5001.12.2023cardiac disease (co-managed with a specialist physician and with 5001.12.2023echocardiographic evidence of myocardial dysfunction); (iii) previous renal or 5001.12.2023liver transplant; (iv) renal dialysis; (v) chronic liver disease with 5001.12.2023documented oesophageal varices; (vi) renal insufficiency in early pregnancy 5001.12.2023(serum creatinine greater than 110 mmol/L); (vii) neurological disorder that 5001.12.2023confines the patient to a wheelchair throughout pregnancy; (viii) maternal 5001.12.2023height of less than 148 cm; (ix) a body mass index greater than or equal to 5001.12.202340; (x) pre-existing diabetes mellitus on medication prior to pregnancy; (xi) 5001.12.2023thyrotoxicosis requiring medication; (xii) previous thrombosis or 5001.12.2023thromboembolism requiring anticoagulant therapy through pregnancy and the 5001.12.2023early puerperium; (xiii) thrombocytopenia with platelet count of less than 5001.12.2023100,000 prior to 20 weeks gestation; (xiv) HIV, hepatitis B or hepatitis C 5001.12.2023carrier status positive; (xv) red cell or platelet iso-immunisation; (xvi) 5001.12.2023cancer with metastatic disease; (xvii) illicit drug misuse during pregnancy 5001.12.2023(Anaes.) 1016527 01.11.2010 3 T4 SN NYNNY 2001.12.202303665.0000694.3500000.00 4001.11.2010(Anaes.) 5001.12.2023Management of vaginal birth, if the patient's care has been transferred by a 5001.12.2023participating midwife for management of the birth, including all attendances 5001.12.2023related to the birth.Payable once only for a pregnancy. (Anaes.) 1016528 01.11.2010 3 T4 SN NYNNY 2001.12.202303670.0000694.3500000.00 4001.11.2010(Anaes.) 5001.12.2023Caesarean section and post-operative care for 7 days, if the patient's care 5001.12.2023has been transferred by a participating midwife for management of the 5001.12.2023birth.Payable once only for a pregnancy. (Anaes.) 1017610 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300200.0000048.0500000.00 5001.12.2023ANAESTHETIST, PRE-ANAESTHESIA CONSULTATION (Professional attendance by a 5001.12.2023medical practitionerin the practice of ANAESTHESIA) -a BRIEF consultation 5001.12.2023involving a targeted history and limited examination (including the 5001.12.2023cardio-respiratory system) -AND of not more than 15 minutes s duration, not 5001.12.2023being a service associated with a service to which items 2801 - 3000 apply 1017615 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300400.0000095.6000000.00 5001.12.2023Professional attendance by a medical practitioner in the practice of 5001.12.2023anaesthesia for a consultation on a patient undergoing advanced surgery or who 5001.12.2023has complex medical problems, involving a selective history and an extensive 5001.12.2023examination of multiple systems and the formulation of a written patient 5001.12.2023management plan documented in the patient notes - and of more than 15 minutes 5001.12.2023but not more than 30 minutes duration, not being a service associated with a 5001.12.2023service to which items 2801 - 3000 applies 1017620 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300600.0000132.4000000.00 5001.12.2023Professional attendance by a medical practitioner in the practice of 5001.12.2023anaesthesia for a consultation on a patient undergoing advanced surgery or who 5001.12.2023has complex medical problems involving a detailed history and comprehensive 5001.12.2023examination of multiple systems and the formulation of a written patient 5001.12.2023management plan documented in the patient notes - and of more than 30 minutes 5001.12.2023but not more than 45 minutes duration, not being a service associated with a 5001.12.2023service to which items 2801 - 3000 apply 1017625 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300800.0000168.6000000.00 5001.12.2023Professional attendance by a medical practitioner in the practice of 5001.12.2023anaesthesia for aconsultation on a patient undergoing advanced surgery or who 5001.12.2023has complex medical problems involving an exhaustive history and comprehensive 5001.12.2023examination of multiple systems , the formulation of a written patient 5001.12.2023management plan following discussion with relevant health care professionals 5001.12.2023and/or the patient, involving medical planning of high complexity documented 5001.12.2023in the patient notes - and of more than 45 minutes duration, not being a 5001.12.2023service associated with a service to which items 2801 - 3000 apply 1017640 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300200.0000048.0500000.00 5001.12.2023ANAESTHETIST, REFERRED CONSULTATION (other than prior to anaesthesia) 5001.12.2023(Professional attendance by a specialist anaesthetist in the practice of 5001.12.2023ANAESTHESIA where the patient is referred to him or her) -a BRIEF consultation 5001.12.2023involving a short history and limited examination -AND of not more than 15 5001.12.2023minutesduration, not being a service associated with a service to which items 5001.12.20232801 - 3000 apply 1017645 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300400.0000095.6000000.00 5001.12.2023-a consultation involving a selective history and examination of multiple 5001.12.2023systems andthe formulation of a written patient management plan -AND of more 5001.12.2023than 15 minutes but not more than 30 minutes duration, not being a service 5001.12.2023associated with a service to which items 2801 - 3000 apply. 1017650 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300600.0000132.4000000.00 5001.12.2023-a consultation involving a detailed history and comprehensive examination of 5001.12.2023multiple systems and the formulation of a written patient management plan -AND 5001.12.2023of more than 30 minutes but not more than 45 minutes duration, not being a 5001.12.2023service associated with a service to which items 2801 - 3000 apply 1017655 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300800.0000168.6000000.00 5001.12.2023-a consultation involving an exhaustive history and comprehensive examination 5001.12.2023of multiple systems andthe formulation of a written patient management plan 5001.12.2023following discussion with relevant health care professionals and/or the 5001.12.2023patient, involving medical planning of high complexity, -AND of more than 45 5001.12.2023minutes duration, not being a service associated with a service to which items 5001.12.20232801 - 3000 apply. 1017680 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300400.0000095.6000000.00 5001.12.2023ANAESTHETIST, CONSULTATION, OTHER (Professional attendance by an anaesthetist 5001.12.2023in the practice of ANAESTHESIA) -a consultation immediately prior to the 5001.12.2023institution of a major regional blockade in a patient in labour, where no 5001.12.2023previous anaesthesia consultation has occurred, not being a service associated 5001.12.2023with a service to which items 2801 - 3000 apply. 1017690 01.11.2006 3 T6 1 SN NYNNY 2001.12.202300200.0000044.1500000.00 5001.12.2023-Where a pre-anaesthesia consultation covered by an itemin the range 5001.12.202317615-17625 is performed in-rooms if: (a) the service is provided to a patient 5001.12.2023prior to an admitted patient episode of care involving anaesthesia; and (b) 5001.12.2023the service is not providedto an admitted patient of a hospital; and (c) the 5001.12.2023service is not provided on the day of admission to hospital for the subsequent 5001.12.2023episode of care involving anaesthesia services; and (d) the service is of more 5001.12.2023than 15 minutes duration not being a service associated with a service to 5001.12.2023which items 2801 - 3000 apply. 1018213 26.05.2002 3 T7 SN NYNNY 2001.12.202300400.0000097.5500000.00 5001.12.2023Intravenous regional anaesthesia of limb by retrograde perfusion of local 5001.12.2023anaesthetic agent 1018216 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000209.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic 5001.12.2023substance, initial injection or commencement of, including up to 1 hour of 5001.12.2023continuous attendance by the medical practitioner Applicable once per 5001.12.2023presentation, per medical practitioner, per complete new procedure (Anaes.) 1018219 26.05.2002 3 T7 SD NYNNY 3001.12.2023The fee for item 18216 plus $20.90 for each additional 15 minutes or part 3001.12.2023thereof beyond the first hour of attendance by the medical practitioner. 4026.05.2002(Anaes.) 5001.12.2023Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic 5001.12.2023substance, initial injection or commencement of, if continuous attendance by 5001.12.2023the medical practitioner extends beyond the first hour (Anaes.) 1018222 26.05.2002 3 T7 SN NYNNY 2001.12.202300300.0000041.4500000.00 5001.12.2023Continuous infusion or injection by catheter of a therapeutic substance (not 5001.12.2023contrast agent) to maintain regional anaesthesia or analgesia, subsequent 5001.12.2023injection or revision of, if the period of continuous medical practitioner 5001.12.2023attendance is 15 minutes or less 1018225 26.05.2002 3 T7 SN NYNNY 2001.12.202300400.0000055.0500000.00 5001.12.2023Continuous infusion or injection by catheter of a therapeutic substance (not 5001.12.2023contrast agent) to maintain regional anaesthesia or analgesia, subsequent 5001.12.2023injection or revision of, if the period of continuous medical practitioner 5001.12.2023attendance is more than 15 minutes 1018226 01.11.2002 3 T7 SN NYNNY 2001.12.202301500.0000313.5000000.00 5001.12.2023Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic 5001.12.2023substance, initial injection or commencement of, including up to 1 hour of 5001.12.2023continuous attendance by the medical practitioner, for a patient in labour, 5001.12.2023where the service is provided in the after hours period, being the period from 5001.12.20238pm to 8am on any weekday, or any time on a Saturday, a Sunday or a public 5001.12.2023holiday. Applicable once per presentation, per medical practitioner, per 5001.12.2023complete new procedure 1018227 01.11.2002 3 T7 SD NYNNY 3001.12.2023The fee for item 18226 plus $31.50 for each additional 15 minutes or part 3001.12.2023there of beyond the first hour of attendance by the medical practitioner. 5001.12.2023Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic 5001.12.2023substance, initial injection or commencement of, where continuous attendance 5001.12.2023by a medical practitioner extends beyond the first hour, for a patient in 5001.12.2023labour, where the service is provided in the after hours period, being the 5001.12.2023period from 8pm to 8am on any weekday, or any time on a Saturday, a Sunday or 5001.12.2023a public holiday. 1018228 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023Interpleural block, initial injection or commencement of infusion of a 5001.12.2023therapeutic substance, not in association with a service to which an item in 5001.12.2023Group T8 applies, unless the nerve block is performed using a targeted 5001.12.2023percutaneous approach 1018230 26.05.2002 3 T7 SN NYNNY 2001.12.202302000.0000262.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Intrathecal or epidural injection of neurolytic substance (not contrast agent) 5001.12.2023by any route, including transforaminal route (Anaes.) 1018232 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000209.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Intrathecal or epidural injection (including translaminar and transforaminal 5001.12.2023approaches) of therapeutic substance or substances (anaesthetic, steroid or 5001.12.2023chemotherapeutic agents):(a) other than a service to which another item in 5001.12.2023this Group applies; and (b) not in association with a service to which an item 5001.12.2023in Group T8 applies, unless the nerve block is performed using a targeted 5001.12.2023percutaneous approach (Anaes.) 1018233 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000209.0500000.00 4026.05.2002(Anaes.) 5001.12.2023EPIDURAL INJECTION of blood for blood patch (Anaes.) 1018234 26.05.2002 3 T7 SN NYNNY 2001.12.202301000.0000137.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Trigeminal nerve, primary branch (ophthalmic, maxillary or mandibular 5001.12.2023branches, excluding infraorbital nerve), injection of an anaesthetic agent or 5001.12.2023steroid, but not in association with a service to which an item in Group T8 5001.12.2023applies, unless a targeted percutaneous technique is used (Anaes.) 1018236 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Trigeminal nerve, peripheral branch (including infraorbital nerve), injection 5001.12.2023of an anaesthetic agent, but not in association with a service to which an 5001.12.2023item in Group T8 applies, unless a targeted percutaneous technique is used 5001.12.2023(Anaes.) 1018238 26.05.2002 3 T7 SN NYNNY 2001.12.202300300.0000041.4500000.00 5001.12.2023Facial nerve, injection of an anaesthetic agent, other than a service 5001.12.2023associated with a service to which item 18240 applies, not in association with 5001.12.2023a service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach 1018240 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000103.0000000.00 5001.12.2023RETROBULBAR OR PERIBULBAR INJECTION of an anaesthetic agent 1018242 26.05.2002 3 T7 SN NYNNY 2001.12.202300300.0000041.4500000.00 4026.05.2002(Anaes.) 5001.12.2023GREATER OCCIPITAL NERVE, injection of an anaesthetic agent (Anaes.) 1018244 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000111.0000000.00 5001.12.2023Vagus nerve, injection of an anaesthetic agent, not in association with a 5001.12.2023service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach 1018248 26.05.2002 3 T7 SN NYNNY 2001.12.202300700.0000097.5500000.00 5001.12.2023PHRENIC NERVE, injection of an anaesthetic agent 1018250 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023SPINAL ACCESSORY NERVE, injection of an anaesthetic agent 1018252 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000111.0000000.00 5001.12.2023Cervical plexus, injection of an anaesthetic agent, not in association with a 5001.12.2023service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach 1018254 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000111.0000000.00 5001.12.2023Brachial plexus, injection of an anaesthetic agent, not in association with a 5001.12.2023service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach 1018256 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023SUPRASCAPULAR NERVE, injection of an anaesthetic agent 1018258 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023INTERCOSTAL NERVE (single), injection of an anaesthetic agent 1018260 26.05.2002 3 T7 SN NYNNY 2001.12.202300700.0000097.5500000.00 5001.12.2023INTERCOSTAL NERVES (multiple), injection of an anaesthetic agent 1018262 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Ilio inguinal, iliohypogastric or genitofemoral nerves, one or more of, 5001.12.2023injections of an anaesthetic agent, not in association with a service to which 5001.12.2023an item in Group T8 applies, unless the nerve block is performed using a 5001.12.2023targeted percutaneous approach (Anaes.) 1018264 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000111.0000000.00 5001.12.2023Pudendal nerve or dorsal nerve (or both), injection of an anaesthetic agent, 5001.12.2023not in association with a service to which an item in Group T8 applies, unless 5001.12.2023the nerve block is performed using a targeted percutaneous approach 1018266 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023Ulnar, radial or median nerve, main trunk of, one or more of, injections of an 5001.12.2023anaesthetic agent, not being associated with a brachial plexus block, not in 5001.12.2023association with a service to which an item in Group T8 applies, unless the 5001.12.2023nerve block is performed using a targeted percutaneous approach 1018268 26.05.2002 3 T7 SN NYNNY 2001.12.202300700.0000097.5500000.00 5001.12.2023OBTURATOR NERVE, injection of an anaesthetic agent 1018270 26.05.2002 3 T7 SN NYNNY 2001.12.202300700.0000097.5500000.00 5001.12.2023FEMORAL NERVE, injection of an anaesthetic agent 1018272 26.05.2002 3 T7 SN NYNNY 2001.12.202300500.0000068.8500000.00 5001.12.2023SAPHENOUS, SURAL, POPLITEAL OR POSTERIOR TIBIAL NERVE, MAIN TRUNK OF, 1 or 5001.12.2023more of, injection of an anaesthetic agent 1018276 26.05.2002 3 T7 SN NYNNY 2001.12.202301000.0000137.4500000.00 5001.12.2023PARAVERTEBRAL NERVES, injection of an anaesthetic agent, (multiple levels) 1018278 26.05.2002 3 T7 SN NYNNY 2001.12.202300700.0000097.5500000.00 5001.12.2023Sciatic nerve, injection of an anaesthetic agent, not in association with a 5001.12.2023service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach 1018280 26.05.2002 3 T7 SN NYNNY 2001.12.202301000.0000137.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Sphenopalatine ganglion, injection of an anaesthetic agent, not in association 5001.12.2023with a service to which an item in Group T8 applies, unless the nerve block is 5001.12.2023performed using a targeted percutaneous approach (Anaes.) 1018282 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000111.0000000.00 5001.12.2023CAROTID SINUS, injection of an anaesthetic agent, as an independent 5001.12.2023percutaneous procedure 1018284 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000162.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Cervical or thoracic sympathetic chain, injection of an anaesthetic agent 5001.12.2023(Anaes.) 1018286 26.05.2002 3 T7 SN NYNNY 2001.12.202300800.0000162.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent (Anaes.) 1018288 26.05.2002 3 T7 SN NYNNY 2001.12.202301000.0000162.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in 5001.12.2023association with a service to which an item in Group T8 applies, unless the 5001.12.2023nerve block is performed using a targeted percutaneous approach (Anaes.) 1018290 26.05.2002 3 T7 SN NYNNY 2001.12.202302000.0000274.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Cranial nerve other than trigeminal, destruction by a neurolytic agent under 5001.12.2023image guidance, other than a service associated with the injection of 5001.12.2023botulinum toxin (Anaes.) 1018292 26.05.2002 3 T7 SN NYNNY 2001.12.202301000.0000137.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve branch, destruction by a neurolytic agent under image guidance, other 5001.12.2023than a service to which another item in this Group applies or a service 5001.12.2023associated with the injection of botulinum toxin except a service to which 5001.12.2023item 18354 applies (Anaes.) 1018294 26.05.2002 3 T7 SN NYNNY 2001.12.202302000.0000193.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under 5001.12.2023image guidance (Anaes.) 1018296 26.05.2002 3 T7 SN NYNNY 2001.12.202301500.0000165.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under 5001.12.2023image guidance (Anaes.) 1018297 01.11.2019 3 T7 SN NYNNY 2001.12.202300300.0000065.3000000.00 5001.12.2023Assistance at the administration of an epidural blood patch (a service to 5001.12.2023which item 18233 applies) by another medical practitioner 1018298 26.05.2002 3 T7 SN NYNNY 2001.12.202302000.0000193.7500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL OR THORACIC SYMPATHETIC CHAIN, destruction by a neurolytic agent 5001.12.2023(Anaes.) 1018350 01.05.2003 3 T11 SN NYNNY 2001.12.202300365.0000137.4500000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for 5001.12.2023the treatment of hemifacial spasm in a patient who is at least 12 years of 5001.12.2023age, including all such injections on any one day 1018351 01.11.2005 3 T11 SN NYNNY 2001.12.202300379.0000137.4500000.00 5001.12.2023Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection 5001.12.2023of, for the treatment of hemifacial spasm in a patient who is at least 18 5001.12.2023years of age, including all such injections on any one day 1018353 01.04.2015 3 T11 DN NYNNY 2001.12.202300730.0000274.8500000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium 5001.12.2023Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA 5001.12.2023(Xeomin), injection of, for the treatment of cervical dystonia (spasmodic 5001.12.2023torticollis), including all such injections on any one day 1018354 01.05.2003 3 T11 SN NYNNY 2001.12.202300365.0000137.4500000.00 4001.05.2003(Anaes.) 5001.12.2023Botulinum Toxin Type A Purified Neurotixin Complex (Botox) or Clostridium 5001.12.2023Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the 5001.12.2023treatment of dynamic equinus foot deformity (including equinovarus and 5001.12.2023equinovalgus) due to spasticity in an ambulant cerebral palsy patient, 5001.12.2023if:(a)the patient is at least 2 years of age; and (b)the treatment is for all 5001.12.2023or any of the muscles subserving one functional activity and supplied by one 5001.12.2023motor nerve, with a maximum of 4 sets of injections for the patient on any one 5001.12.2023day (with a maximum of2 sets of injections for each lower limb), including all 5001.12.2023injections per set (Anaes.) 1018360 01.05.2003 3 T11 SN NYNNY 2001.12.202300365.0000137.4500000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), or Clostridium 5001.12.2023Botulinum Type A Toxin Haemagglutinin Complex (Dysport),injection of, for the 5001.12.2023treatment of moderate to severe focal spasticity, if: (a)the patient is at 5001.12.2023least 18 years of age; and (b)the spasticity is associated with a previously 5001.12.2023diagnosed neurological disorder; and (c)treatment is provided as: (i)second 5001.12.2023line therapy when standard treatment for the conditions has failed; or (ii)an 5001.12.2023adjunct to physical therapy; and (d)the treatment is for all or any of the 5001.12.2023muscles subserving one functional activity and supplied by one motor nerve, 5001.12.2023with a maximum of 4 sets of injections for the patient on any one day (with a 5001.12.2023maximum of 2 sets of injections for each limb), including all injections per 5001.12.2023set; and (e)the treatment is not provided on the same occasion as a service 5001.12.2023mentioned in item 18365 1018365 01.04.2015 3 T11 DN NYNNY 2001.12.202300365.0000137.4500000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium 5001.12.2023Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA 5001.12.2023(Xeomin), injection of, for the treatment of moderate to severe spasticity of 5001.12.2023the upper limb following an acute event,if: (a) the patient is at least 18 5001.12.2023years of age; and (b) treatment is provided as: (i)second line therapy when 5001.12.2023standard treatment for the condition has failed; or (ii) an adjunct to 5001.12.2023physical therapy; and (c) the patient does not have established severe 5001.12.2023contracture in the limb that is to be treated; and (d) the treatment is for 5001.12.2023all or any of the muscles subserving one functional activity and supplied by 5001.12.2023one motor nerve, with a maximum of 4 sets of injections for the patient on any 5001.12.2023one day (with a maximum of 2 sets of injections for each upper limb), 5001.12.2023including all injections per set; and (e) for a patient who has received 5001.12.2023treatment on 2 previous separate occasions - the patient has responded to the 5001.12.2023treatment 1018366 01.05.2003 3 T11 SN NYNNY 2001.12.202300475.0000172.1500000.00 4001.05.2003(Anaes.) 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for 5001.12.2023the treatment of strabismus, including all such injections on any one day and 5001.12.2023associated electromyography (Anaes.) 1018368 01.05.2003 3 T11 SN NYNNY 2001.12.202300790.0000293.9000000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for 5001.12.2023the treatment of spasmodic dysphonia, including all such injections on any one 5001.12.2023day 1018375 01.10.2013 3 T11 DN NYNNY 2001.12.202300675.0000253.0500000.00 4001.10.2013(Anaes.) 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical 5001.12.2023injection of, with cystoscopy, for the treatment of urinary incontinence, 5001.12.2023including all such injections on any one day, if: (a) the urinary incontinence 5001.12.2023is due to neurogenic detrusor overactivity as demonstrated by urodynamic study 5001.12.2023of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or 5001.12.2023(iii) spina bifida and who is at least 18 years of age; and (b) the patient 5001.12.2023has urinary incontinence that is inadequately controlled by anti-cholinergic 5001.12.2023therapy, as manifested by having experienced at least 14 episodes of urinary 5001.12.2023incontinence per week before commencement of treatment with botulinum toxin 5001.12.2023type A; and (c) the patient is willing and able to self-catheterise; and (d) 5001.12.2023the requirements relating to botulinum toxin type A under the Pharmaceutical 5001.12.2023Benefits Scheme are complied with; and (e) treatment is not provided on the 5001.12.2023same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 5001.12.202311919 For each patient - applicable not more than once except if the patient 5001.12.2023achieves at least a 50% reduction in urinary incontinence episodes from 5001.12.2023baseline at any time during the period of 6 to 12 weeks after first treatment 5001.12.2023(Anaes.) 1018377 01.03.2014 3 T11 SN NYNNY 2001.12.202300379.0000137.4500000.00 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for 5001.12.2023the treatment of chronic migraine, including all injections in 1 day, if: 5001.12.2023(a)the patient is at least 18 years of age; and (b) the patient has 5001.12.2023experienced an inadequate response, intolerance or contraindication to at 5001.12.2023least 3 prophylactic migraine medications before commencement of treatment 5001.12.2023with botulinum toxin, as manifested by an average of 15 or more headache days 5001.12.2023per month, with at least 8 days of migraine, over a period of at least 6 5001.12.2023months, before commencement of treatment with botulinum toxin; and (c)the 5001.12.2023requirements relating to botulinum toxin type A under the Pharmaceutical 5001.12.2023Benefits Scheme are complied with For each patient-applicable not more than 5001.12.2023twice except if the patient achieves and maintains at least a 50% reduction in 5001.12.2023the number of headache days per month from baseline after 2 treatment cycles 5001.12.2023(each of 12 weeks duration) 1018379 01.11.2014 3 T11 SN NYNNY 2001.12.202300675.0000253.0500000.00 4001.11.2014(Anaes.) 5001.12.2023Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical 5001.12.2023injection of, with cystoscopy, for the treatment of urinary incontinence, 5001.12.2023including all such injections on any one day, if: (a)the urinary incontinence 5001.12.2023is due to idiopathic overactive bladder in a patient: and (b)the patient is at 5001.12.2023least 18 years of age; and (c)the patient has urinary incontinence that is 5001.12.2023inadequately controlled by at least 2 alternative anti- cholinergic agents, as 5001.12.2023manifested by having experienced at least 14 episodes of urinary incontinence 5001.12.2023per week before commencement of treatment with botulinum toxin; and (d)the 5001.12.2023patient is willing and able to self-catheterise; and (e)treatment is not 5001.12.2023provided on the same occasion as a service mentioned in item 104, 105, 110, 5001.12.2023116, 119, 11900 or 11919 For each patient-applicable not more than once except 5001.12.2023if the patient achieves at least a 50% reduction in urinary incontinence 5001.12.2023episodes from baseline at any time during the period of 6 to 12 weeks after 5001.12.2023first treatment (H) (Anaes.) 1020100 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, 5001.12.2023subcutaneous tissue, muscles, salivary glands or superficial vessels of the 5001.12.2023head including biopsy, not being a service to which another item in this 5001.12.2023Subgroup applies (5 basic units) 1020102 26.05.2002 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for plastic repair of cleft lip (6 5001.12.2023basic units) 1020104 26.05.2002 3 T101 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for electroconvulsive therapy (4 basic 5001.12.2023units) 1020120 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on external, middle or 5001.12.2023inner ear, including biopsy, not being a service to which another item in this 5001.12.2023Subgroup applies (5 basic units) 1020124 26.05.2002 3 T101 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for otoscopy (4 basic units) 1020140 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on eye, not being a 5001.12.2023service to which another item in this Group applies (5 basic units) 1020142 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lens surgery (5 basic units) 1020143 26.05.2002 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for retinal surgery (6 basic units) 1020144 26.05.2002 3 T101 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for corneal transplant (7 basic units) 1020145 26.05.2002 3 T101 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vitrectomy (7 basic units) 1020146 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for biopsy of conjunctiva (5 basic 5001.12.2023units) 1020147 01.07.2008 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for squint repair (6 basic units) 1020148 26.05.2002 3 T101 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for ophthalmoscopy (4 basic units) 1020160 26.05.2002 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023Initiation of the management of anaesthesia for intranasal or accessory 5001.12.2023sinuses, not being a service to which another item in this Subgroup applies (6 5001.12.2023basic units) 1020162 26.05.2002 3 T101 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023Initiation of the management of anaesthesia for intranasal surgery for 5001.12.2023malignancy or for intranasal ablation (7 basic units) 1020164 26.05.2002 3 T101 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for biopsy of soft tissue of the nose 5001.12.2023and accessory sinuses (4 basic units) 1020170 26.05.2002 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for intraoral procedures, including 5001.12.2023biopsy, not being a service to which another item in this Subgroup applies (6 5001.12.2023basic units) 1020172 26.05.2002 3 T101 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of cleft palate (7 basic 5001.12.2023units) 1020174 26.05.2002 3 T101 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision of retropharyngeal tumour 5001.12.2023(9 basic units) 1020176 26.05.2002 3 T101 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical intraoral surgery (10 5001.12.2023basic units) 1020190 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on facial bones, not 5001.12.2023being a service to which another item in this Subgroup applies (5 basic units) 1020192 26.05.2002 3 T101 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for extensive surgery on facial bones 5001.12.2023(including prognathism and extensive facial bone reconstruction) (10 basic 5001.12.2023units) 1020210 26.05.2002 3 T101 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for intracranial procedures, not being 5001.12.2023a service to which another item in this Subgroup applies (15 basic units) 1020212 26.05.2002 3 T101 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for subdural taps (5 basic units) 1020214 26.05.2002 3 T101 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for burr holes of the cranium (9 basic 5001.12.2023units) 1020216 26.05.2002 3 T101 SN NYNNY 2001.12.202302000.0000436.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for intracranial vascular procedures 5001.12.2023including those for aneurysms or arterio-venous abnormalities (20 basic units) 1020220 26.05.2002 3 T101 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for spinal fluid shunt procedures (10 5001.12.2023basic units) 1020222 26.05.2002 3 T101 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for ablation of an intracranial nerve 5001.12.2023(6 basic units) 1020225 26.05.2002 3 T101 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for all cranial bone procedures (12 5001.12.2023basic units) 1020230 01.07.2008 3 T101 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the head or face (12 basic units) 1020300 26.05.2002 3 T102 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the neck not being a service to which another item in 5001.12.2023this Subgroup applies (5 basic units) 1020305 26.05.2002 3 T102 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for incision and drainage of large 5001.12.2023haematoma, large abscess, cellulitis or similar lesion or epiglottitis causing 5001.12.2023life threatening airway obstruction (15 basic units) 1020320 26.05.2002 3 T102 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on oesophagus, thyroid, 5001.12.2023larynx, trachea, lymphatic system, muscles, nerves or other deep tissues of 5001.12.2023the neck, not being a service to which another item in this Subgroup applies 5001.12.2023(6 basic units) 1020321 26.05.2002 3 T102 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for laryngectomy, hemi laryngectomy, 5001.12.2023laryngopharyngectomy or pharyngectomy (10 basic units) 1020330 26.05.2002 3 T102 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for laser surgery to the airway 5001.12.2023(excluding nose and mouth) (8 basic units) 1020350 26.05.2002 3 T102 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major vessels of 5001.12.2023neck, not being a service to which another item in this Subgroup applies (10 5001.12.2023basic units) 1020352 26.05.2002 3 T102 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for simple ligation of major vessels 5001.12.2023of neck (5 basic units) 1020355 01.07.2008 3 T102 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the neck (12 basic units) 1020400 26.05.2002 3 T103 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the anterior part of the chest, not being a service to 5001.12.2023which another item in this Subgroup applies (3 basic units) 1020401 26.05.2002 3 T103 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the breast, not 5001.12.2023being a service to which another item in this Subgroup applies (4 basic units) 1020402 26.05.2002 3 T103 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023Initiation of management of anaesthesia for reconstructive procedures on 5001.12.2023breast including implant reconstruction and exchange (5 basic units) 1020403 26.05.2002 3 T103 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023Initiation of management of anaesthesia for axillary dissection or sentinel 5001.12.2023node biopsy (5 basic units) 1020404 26.05.2002 3 T103 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for mastectomy (6 basic units) 1020405 26.05.2002 3 T103 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for reconstructive procedures on the 5001.12.2023breast using myocutaneous flaps (8 basic units) 1020406 26.05.2002 3 T103 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical or modified radical 5001.12.2023procedures on breast with internal mammary node dissection (13 basic units) 1020410 26.05.2002 3 T103 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for electrical conversion of 5001.12.2023arrhythmias (4 basic units) 1020420 26.05.2002 3 T103 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the posterior part of the chest not being a service to 5001.12.2023which another item in this Subgroup applies (5 basic units) 1020440 01.05.2003 3 T103 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of 5001.12.2023the sternum (4 basic units) 1020450 26.05.2002 3 T103 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on clavicle, scapula or 5001.12.2023sternum, not being a service to which another item in this Subgroup applies (5 5001.12.2023basic units) 1020452 26.05.2002 3 T103 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical surgery on clavicle, 5001.12.2023scapula or sternum (6 basic units) 1020470 26.05.2002 3 T103 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for partial rib resection, not being a 5001.12.2023service to which another item in this Subgroup applies (6 basic units) 1020472 26.05.2002 3 T103 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracoplasty (10 basic units) 1020474 26.05.2002 3 T103 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures on chest wall 5001.12.2023(13 basic units) 1020475 01.07.2008 3 T103 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the anterior or posterior thorax (10 basic units) 1020500 26.05.2002 3 T104 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the oesophagus 5001.12.2023(15 basic units) 1020520 26.05.2002 3 T104 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for all closed chest procedures 5001.12.2023(including rigid oesophagoscopy or bronchoscopy), not being a service to which 5001.12.2023another item in this Subgroup applies (6 basic units) 1020522 26.05.2002 3 T104 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for needle biopsy of pleura (4 basic 5001.12.2023units) 1020524 26.05.2002 3 T104 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for pneumocentesis (4 basic units) 1020526 26.05.2002 3 T104 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracoscopy (10 basic units) 1020528 26.05.2002 3 T104 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for mediastinoscopy (8 basic units) 1020540 26.05.2002 3 T104 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracotomy procedures involving 5001.12.2023lungs, pleura, diaphragm, or mediastinum, not being a service to which another 5001.12.2023item in this Subgroup applies (13 basic units) 1020542 26.05.2002 3 T104 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for pulmonary decortication (15 basic 5001.12.2023units) 1020546 26.05.2002 3 T104 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for pulmonary resection with 5001.12.2023thoracoplasty (15 basic units) 1020548 26.05.2002 3 T104 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for intrathoracic repair of trauma to 5001.12.2023trachea and bronchi (15 basic units) 1020560 26.05.2002 3 T104 SN NYNNY 2001.12.202302000.0000436.0000000.00 5001.12.2023Initiation of the management of anaesthesia for: (a) open procedures on the 5001.12.2023heart, pericardium or great vessels of the chest; or (b) percutaneous 5001.12.2023insertion of a valvular prosthesis (20 basic units) 1020600 26.05.2002 3 T105 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on cervical spine 5001.12.2023and/or cord, not being a service to which another item in this Subgroup 5001.12.2023applies (for myelography and discography see Items 21908 and 21914) (10 basic 5001.12.2023units) 1020604 26.05.2002 3 T105 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for posterior cervical laminectomy 5001.12.2023with the patient in the sitting position (13 basic units) 1020620 26.05.2002 3 T105 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on thoracic spine 5001.12.2023and/or cord, not being a service to which another item in this Subgroup 5001.12.2023applies (10 basic units) 1020622 26.05.2002 3 T105 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracolumbar sympathectomy (13 5001.12.2023basic units) 1020630 26.05.2002 3 T105 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures in lumbar region, not 5001.12.2023being a service to which another item in this Subgroup applies (8 basic units) 1020632 26.05.2002 3 T105 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lumbar sympathectomy (7 basic 5001.12.2023units) 1020634 26.05.2002 3 T105 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for chemonucleolysis (10 basic units) 1020670 26.05.2002 3 T105 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for extensive spine and/or spinal cord 5001.12.2023procedures (13 basic units) 1020680 26.05.2002 3 T105 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for manipulation of spine when 5001.12.2023performed in the operating theatre of a hospital (3 basic units) 1020690 26.05.2002 3 T105 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous spinal procedures, 5001.12.2023not being a service to which another item in this Subgroup applies (5 basic 5001.12.2023units) 1020700 26.05.2002 3 T106 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the upper anterior abdominal wall, not being a service 5001.12.2023to which another item in this Subgroup applies (3 basic units) 1020702 26.05.2002 3 T106 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous liver biopsy (4 basic 5001.12.2023units) 1020703 01.11.2005 3 T106 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures on the nerves, 5001.12.2023muscles, tendons and fascia of the upper abdominal wall, not being a service 5001.12.2023to which another item in this Subgroup applies (4 basic units) 1020704 01.07.2008 3 T106 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the anterior or posterior upper abdomen (10 basic units) 1020706 26.05.2002 3 T106 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023Initiation of the management of anaesthesia for laparoscopic procedures in the 5001.12.2023upper abdomen, including laparoscopic cholecystectomy, not being a service to 5001.12.2023which another item in this Subgroup applies (7 basic units) 1020730 26.05.2002 3 T106 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the upper posterior abdominal wall, not being a service 5001.12.2023to which another item in this Subgroup applies (5 basic units) 1020740 26.05.2002 3 T106 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for upper gastrointestinal endoscopic 5001.12.2023procedures (5 basic units) 1020745 26.05.2002 3 T106 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023Initiation of the management of anaesthesia for any of the following:(a) upper 5001.12.2023gastrointestinal endoscopic procedures in association with acute 5001.12.2023gastrointestinal haemorrhage;(b) endoscopic retrograde 5001.12.2023cholangiopancreatography;(c) upper gastrointestinal endoscopic ultrasound;(d) 5001.12.2023percutaneous endoscopic gastrostomy;(e) upper gastrointestinal endoscopic 5001.12.2023mucosal resection of tumour. (7 basic units) 1020750 26.05.2002 3 T106 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023Initiation of the management of anaesthesia for hernia repairs to the upper 5001.12.2023abdominal wall, other than a service to which another item in this Subgroup 5001.12.2023applies. (5 basic units) 1020752 26.05.2002 3 T106 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of incisional hernia and/or 5001.12.2023wound dehiscence (6 basic units) 1020754 26.05.2002 3 T106 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on an omphalocele (7 5001.12.2023basic units) 1020756 26.05.2002 3 T106 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for transabdominal repair of 5001.12.2023diaphragmatic hernia (9 basic units) 1020770 26.05.2002 3 T106 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major upper 5001.12.2023abdominal blood vessels (15 basic units) 1020790 26.05.2002 3 T106 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023Initiation of the management of anaesthesia for procedures within the 5001.12.2023peritoneal cavity in upper abdomen, including any of the following:(a) open 5001.12.2023cholecystectomy;(b) gastrectomy;(c) laparoscopically assisted nephrectomy;(d) 5001.12.2023bowel shunts (8 basic units) 1020791 26.05.2002 3 T106 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023Initiation of the management of anaesthesia for bariatric surgery in a patient 5001.12.2023with clinically severe obesity (10 basic units) 1020792 26.05.2002 3 T106 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for partial hepatectomy (excluding 5001.12.2023liver biopsy) (13 basic units) 1020793 26.05.2002 3 T106 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for extended or trisegmental 5001.12.2023hepatectomy (15 basic units) 1020794 26.05.2002 3 T106 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for pancreatectomy, partial or total 5001.12.2023(12 basic units) 1020798 26.05.2002 3 T106 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for neuro endocrine tumour removal in 5001.12.2023the upper abdomen (10 basic units) 1020799 01.11.2002 3 T106 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous procedures on an 5001.12.2023intra-abdominal organ in the upper abdomen (6 basic units) 1020800 26.05.2002 3 T107 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the lower anterior abdominal walls, not being a service 5001.12.2023to which another item in this Subgroup applies (3 basic units) 1020802 26.05.2002 3 T107 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lipectomy of the lower abdomen (5 5001.12.2023basic units) 1020803 01.11.2005 3 T107 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures on the nerves, 5001.12.2023muscles, tendons and fascia of the lower abdominal wall, not being a service 5001.12.2023to which another item in this Subgroup applies (4 basic units) 1020804 01.11.2008 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the anterior or posterior lower abdomen (10 basic units) 1020806 26.05.2002 3 T107 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for laparoscopic procedures in the 5001.12.2023lower abdomen (7 basic units) 1020810 26.05.2002 3 T107 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lowerintestinal endoscopic 5001.12.2023procedures (4 basic units) 1020815 26.05.2002 3 T107 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for extracorporeal shock wave 5001.12.2023lithotripsy to urinary tract (6 basic units) 1020820 26.05.2002 3 T107 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its 5001.12.2023derivatives or subcutaneous tissue of the lower posterior abdominal wall (5 5001.12.2023basic units) 1020830 26.05.2002 3 T107 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for hernia repairs in lower abdomen, 5001.12.2023not being a service to which another item in this Subgroup applies (4 basic 5001.12.2023units) 1020832 26.05.2002 3 T107 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of incisional herniae 5001.12.2023and/or wound dehiscence of the lower abdomen (6 basic units) 1020840 26.05.2002 3 T107 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023Initiation of the management of anaesthesia for all open procedures within the 5001.12.2023lower abdominal peritoneal cavity, including appendicectomy, not being a 5001.12.2023service to which another item in this Subgroup applies (6 basic units) 1020841 26.05.2002 3 T107 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bowel resection, including 5001.12.2023laparoscopic bowel resection not being a service to which another item in this 5001.12.2023Subgroup applies (8 basic units) 1020842 26.05.2002 3 T107 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for amniocentesis (4 basic units) 1020844 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for abdominoperineal resection, 5001.12.2023including pull through procedures, ultra low anterior resection and formation 5001.12.2023of bowel reservoir (10 basic units) 1020845 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical prostatectomy (10 basic 5001.12.2023units) 1020846 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical hysterectomy (10 basic 5001.12.2023units) 1020847 01.11.2005 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for ovarian malignancy (10 basic 5001.12.2023units) 1020848 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for pelvic exenteration (10 basic 5001.12.2023units) 1020850 26.05.2002 3 T107 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean section (12 basic units) 1020855 26.05.2002 3 T107 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean hysterectomy or 5001.12.2023hysterectomy within 24 hours of birth (15 basic units) 1020860 26.05.2002 3 T107 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for extraperitoneal procedures in 5001.12.2023lower abdomen, including those on the urinary tract, not being a service to 5001.12.2023which another item in this Subgroup applies (6 basic units) 1020862 26.05.2002 3 T107 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for renal procedures, including upper 5001.12.20231/3 of ureter (7 basic units) 1020863 01.07.2008 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for nephrectomy (10 basic units) 1020864 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for total cystectomy (10 basic units) 1020866 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for adrenalectomy (10 basic units) 1020867 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for neuro endocrine tumour removal in 5001.12.2023the lower abdomen (10 basic units) 1020868 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for renal transplantation (donor or 5001.12.2023recipient) (10 basic units) 1020880 26.05.2002 3 T107 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major lower 5001.12.2023abdominal vessels, not being a service to which another item in this subgroup 5001.12.2023applies (15 basic units) 1020882 26.05.2002 3 T107 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for inferior vena cava ligation (10 5001.12.2023basic units) 1020884 26.05.2002 3 T107 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous umbrella insertion (5 5001.12.2023basic units) 1020886 01.11.2002 3 T107 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous procedures on an 5001.12.2023intra-abdominal organ in the lower abdomen (6 basic units) 1020900 26.05.2002 3 T108 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the perineum not being a service to which another item 5001.12.2023in this Subgroup applies (3 basic units) 1020902 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023Initiation of the management of anaesthesia for anorectal procedures 5001.12.2023(including surgical haemorrhoidectomy, but not banding of haemorrhoids) (4 5001.12.2023basic units) 1020904 26.05.2002 3 T108 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical perineal procedures 5001.12.2023including radical perineal prostatectomy or radical vulvectomy (7 basic units) 1020905 01.07.2008 3 T108 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the perineum (10 basic units) 1020906 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vulvectomy (4 basic units) 1020910 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral procedures 5001.12.2023(including urethrocystoscopy), not being a service to which another item in 5001.12.2023this Subgroup applies (4 basic units) 1020911 01.07.2008 3 T108 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for endoscopic ureteroscopic surgery 5001.12.2023including laser procedures (5 basic units) 1020912 26.05.2002 3 T108 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral resection of bladder 5001.12.2023tumour(s) (5 basic units) 1020914 26.05.2002 3 T108 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral resection of 5001.12.2023prostate (7 basic units) 1020916 26.05.2002 3 T108 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bleeding post-transurethral 5001.12.2023resection (7 basic units) 1020920 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023Initiation of management of anaesthesia for procedures on external genitalia, 5001.12.2023not being a service to which another item in this Subgroup applies. (4 basic 5001.12.2023units) 1020924 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on undescended testis, 5001.12.2023unilateral or bilateral (4 basic units) 1020926 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical orchidectomy, inguinal 5001.12.2023approach (4 basic units) 1020928 26.05.2002 3 T108 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical orchidectomy, abdominal 5001.12.2023approach (6 basic units) 1020930 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for orchiopexy, unilateral or 5001.12.2023bilateral (4 basic units) 1020932 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis (4 5001.12.2023basic units) 1020934 26.05.2002 3 T108 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis with 5001.12.2023bilateral inguinal lymphadenectomy (6 basic units) 1020936 26.05.2002 3 T108 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis with 5001.12.2023bilateral inguinal and iliac lymphadenectomy (8 basic units) 1020938 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for insertion of penile prosthesis (4 5001.12.2023basic units) 1020940 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for per vagina and vaginal procedures 5001.12.2023(including biopsy of vagina, cervix or endometrium), not being a service to 5001.12.2023which another item in this Subgroup applies (4 basic units) 1020942 26.05.2002 3 T108 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal procedures including 5001.12.2023repair operations and urinary incontinence procedures (perineal) (5 basic 5001.12.2023units) 1020943 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for transvaginal assisted reproductive 5001.12.2023services (4 basic units) 1020944 26.05.2002 3 T108 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal hysterectomy (6 basic 5001.12.2023units) 1020946 26.05.2002 3 T108 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal birth (8 basic units) 1020948 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for purse string ligation of cervix, 5001.12.2023or removal of purse string ligature (4 basic units) 1020950 26.05.2002 3 T108 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for culdoscopy (5 basic units) 1020952 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for hysteroscopy (4 basic units) 1020954 26.05.2002 3 T108 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for correction of inverted uterus (10 5001.12.2023basic units) 1020956 26.05.2002 3 T108 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for evacuation of retained products of 5001.12.2023conception, as a complication of confinement (4 basic units) 1020958 26.05.2002 3 T108 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for manual removal of retained 5001.12.2023placenta or for repair of vaginal or perineal tear following birth (5 basic 5001.12.2023units) 1020960 26.05.2002 3 T108 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal procedures in the 5001.12.2023management of post partum haemorrhage (blood loss > 500mls) (7 basic units) 1021100 26.05.2002 3 T109 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the anterior pelvic region (anterior to iliac crest), 5001.12.2023except external genitalia (3 basic units) 1021110 26.05.2002 3 T109 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its 5001.12.2023derivatives or subcutaneous tissue of the pelvic region (posterior to iliac 5001.12.2023crest), except perineum (5 basic units) 1021112 01.05.2003 3 T109 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of 5001.12.2023the anterior iliac crest (4 basic units) 1021114 01.05.2003 3 T109 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of 5001.12.2023the posterior iliac crest (5 basic units) 1021116 01.05.2003 3 T109 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow 5001.12.2023harvesting from the pelvis (6 basic units) 1021120 26.05.2002 3 T109 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the bony pelvis (6 5001.12.2023basic units) 1021130 26.05.2002 3 T109 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for body cast application or revision 5001.12.2023when performed in the operating theatre of a hospital (3 basic units) 1021140 26.05.2002 3 T109 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for interpelviabdominal (hind-quarter) 5001.12.2023amputation (15 basic units) 1021150 26.05.2002 3 T109 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures for tumour of 5001.12.2023the pelvis, except hind-quarter amputation (10 basic units) 1021155 01.07.2008 3 T109 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the anterior or posterior pelvis (10 basic units) 1021160 26.05.2002 3 T109 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving 5001.12.2023symphysis pubis or sacroiliac joint when performed in the operating theatre of 5001.12.2023a hospital (4 basic units) 1021170 26.05.2002 3 T109 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving 5001.12.2023symphysis pubis or sacroiliac joint (8 basic units) 1021195 26.05.2002 3 T1010 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the upper leg (3 basic units) 1021199 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, 5001.12.2023tendons, fascia or bursae of the upper leg (4 basic units) 1021200 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving hip 5001.12.2023joint when performed in the operating theatre of a hospital (4 basic units) 1021202 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the hip 5001.12.2023joint (4 basic units) 1021210 26.05.2002 3 T1010 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving hip 5001.12.2023joint, not being a service to which another item in this Subgroup applies (6 5001.12.2023basic units) 1021212 26.05.2002 3 T1010 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for hip disarticulation (10 basic 5001.12.2023units) 1021214 26.05.2002 3 T1010 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023Initiation of management of anaesthesia for primary total hip replacement. (10 5001.12.2023basic units) 1021215 01.03.2022 3 T1010 SNS NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023Initiation of management of anaesthesia for revision total hip replacement (15 5001.12.2023basic units) 1021216 01.11.2005 3 T1010 SN NYNNY 2001.12.202301400.0000305.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral total hip replacement 5001.12.2023(14 basic units) 1021220 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving upper 5001.12.20232/3 of femur when performed in the operating theatre of a hospital (4 basic 5001.12.2023units) 1021230 26.05.2002 3 T1010 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving upper 5001.12.20232/3 of femur, not being a service to which another item in this Subgroup 5001.12.2023applies (6 basic units) 1021232 26.05.2002 3 T1010 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for above knee amputation (5 basic 5001.12.2023units) 1021234 26.05.2002 3 T1010 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of the upper 2/3 5001.12.2023of femur (8 basic units) 1021260 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving veins of 5001.12.2023upper leg, including exploration (4 basic units) 1021270 26.05.2002 3 T1010 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving arteries of 5001.12.2023upper leg, including bypass graft, not being a service to which another item 5001.12.2023in this Subgroup applies (8 basic units) 1021272 26.05.2002 3 T1010 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery ligation (4 basic 5001.12.2023units) 1021274 26.05.2002 3 T1010 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery embolectomy (6 5001.12.2023basic units) 1021275 01.07.2008 3 T1010 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the upper leg (10 basic units) 1021280 26.05.2002 3 T1010 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of 5001.12.2023upper leg (15 basic units) 1021300 26.05.2002 3 T1011 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the knee and/or popliteal area (3 basic units) 1021321 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, 5001.12.2023tendons, fascia or bursae of knee and/or popliteal area (4 basic units) 1021340 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower 1/3 of 5001.12.2023femur when performed in the operating theatre of a hospital (4 basic units) 1021360 26.05.2002 3 T1011 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on lower 1/3 of 5001.12.2023femur (5 basic units) 1021380 26.05.2002 3 T1011 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on knee joint 5001.12.2023when performed in the operating theatre of a hospital (3 basic units) 1021382 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of knee 5001.12.2023joint (4 basic units) 1021390 26.05.2002 3 T1011 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on upper ends of 5001.12.2023tibia, fibula, and/or patella when performed in the operating theatre of a 5001.12.2023hospital (3 basic units) 1021392 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on upper ends of 5001.12.2023tibia, fibula, and/or patella (4 basic units) 1021400 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on knee joint, not 5001.12.2023being a service to which another item in this Subgroup applies (4 basic units) 1021402 26.05.2002 3 T1011 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for knee replacement (7 basic units) 1021403 26.05.2002 3 T1011 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral knee replacement (10 5001.12.2023basic units) 1021404 26.05.2002 3 T1011 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for disarticulation of knee (5 basic 5001.12.2023units) 1021420 26.05.2002 3 T1011 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for cast application, removal, or 5001.12.2023repair involving knee joint, undertaken in a hospital (3 basic units) 1021430 26.05.2002 3 T1011 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of knee or 5001.12.2023popliteal area, not being a service to which another item in this Subgroup 5001.12.2023applies (4 basic units) 1021432 26.05.2002 3 T1011 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of arteriovenous fistula of 5001.12.2023knee or popliteal area (5 basic units) 1021440 26.05.2002 3 T1011 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of knee or 5001.12.2023popliteal area, not being a service to which another item in this Subgroup 5001.12.2023applies (8 basic units) 1021445 01.07.2008 3 T1011 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the knee and/or popliteal area (10 basic units) 1021460 26.05.2002 3 T1012 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of lower leg, ankle, or foot (3 basic units) 1021461 26.05.2002 3 T1012 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, 5001.12.2023tendons, or fascia of lower leg, ankle, or foot, not being a service to which 5001.12.2023another item in this Subgroup applies (4 basic units) 1021462 26.05.2002 3 T1012 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower leg, 5001.12.2023ankle, or foot (3 basic units) 1021464 26.05.2002 3 T1012 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedure of ankle 5001.12.2023joint (4 basic units) 1021472 26.05.2002 3 T1012 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of Achilles tendon (5 basic 5001.12.2023units) 1021474 26.05.2002 3 T1012 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for gastrocnemius recession (5 basic 5001.12.2023units) 1021480 26.05.2002 3 T1012 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on bones of lower 5001.12.2023leg, ankle, or foot, including amputation, not being a service to which 5001.12.2023another item in this Subgroup applies (4 basic units) 1021482 26.05.2002 3 T1012 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of bone 5001.12.2023involving lower leg, ankle or foot (5 basic units) 1021484 26.05.2002 3 T1012 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for osteotomy or osteoplasty of tibia 5001.12.2023or fibula (5 basic units) 1021486 26.05.2002 3 T1012 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for total ankle replacement (7 basic 5001.12.2023units) 1021490 26.05.2002 3 T1012 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lower leg cast application, 5001.12.2023removal or repair, undertaken in a hospital (3 basic units) 1021500 26.05.2002 3 T1012 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of lower 5001.12.2023leg, including bypass graft, not being a service to which another item in this 5001.12.2023Subgroup applies (8 basic units) 1021502 26.05.2002 3 T1012 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of the lower leg (6 5001.12.2023basic units) 1021520 26.05.2002 3 T1012 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of lower leg, 5001.12.2023not being a service to which another item in this Subgroup applies (4 basic 5001.12.2023units) 1021522 26.05.2002 3 T1012 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for venous thrombectomy of the lower 5001.12.2023leg (5 basic units) 1021530 26.05.2002 3 T1012 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of 5001.12.2023lower leg, ankle or foot (15 basic units) 1021532 26.05.2002 3 T1012 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of 5001.12.2023toe (8 basic units) 1021535 01.07.2008 3 T1012 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the lower leg (10 basic units) 1021600 26.05.2002 3 T1013 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the shoulder or axilla (3 basic units) 1021610 26.05.2002 3 T1013 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, 5001.12.2023tendons, fascia or bursae of shoulder or axilla including axillary dissection 5001.12.2023(5 basic units) 1021620 26.05.2002 3 T1013 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on humeral head 5001.12.2023and neck, sternoclavicular joint, acromioclavicular joint, or shoulder joint 5001.12.2023when performed in the operating theatre of a hospital (4 basic units) 1021622 26.05.2002 3 T1013 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of 5001.12.2023shoulder joint (5 basic units) 1021630 26.05.2002 3 T1013 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on humeral head 5001.12.2023and neck, sternoclavicular joint, acromioclavicular joint orshoulder joint, 5001.12.2023not being a service to which another item in this Subgroup applies (5 basic 5001.12.2023units) 1021632 26.05.2002 3 T1013 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection involving 5001.12.2023humeral head and neck, sternoclavicular joint, acromioclavicular joint or 5001.12.2023shoulder joint (6 basic units) 1021634 26.05.2002 3 T1013 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder disarticulation (9 basic 5001.12.2023units) 1021636 26.05.2002 3 T1013 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for interthoracoscapular (forequarter) 5001.12.2023amputation (15 basic units) 1021638 26.05.2002 3 T1013 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for total shoulder replacement (10 5001.12.2023basic units) 1021650 26.05.2002 3 T1013 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of shoulder 5001.12.2023or axilla, not being a service to which another item in this Subgroup applies 5001.12.2023(8 basic units) 1021652 26.05.2002 3 T1013 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures for axillary-brachial 5001.12.2023aneurysm (10 basic units) 1021654 26.05.2002 3 T1013 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bypass graft of arteries of 5001.12.2023shoulder or axilla (8 basic units) 1021656 26.05.2002 3 T1013 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for axillary-femoral bypass graft (10 5001.12.2023basic units) 1021670 26.05.2002 3 T1013 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of shoulder or 5001.12.2023axilla (4 basic units) 1021680 26.05.2002 3 T1013 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder cast application, removal 5001.12.2023or repair, not being a service to which another item in this Subgroup applies, 5001.12.2023when undertaken in a hospital (3 basic units) 1021682 26.05.2002 3 T1013 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder spica application when 5001.12.2023undertaken in a hospital (4 basic units) 1021685 01.07.2008 3 T1013 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the shoulder or the axilla (10 basic units) 1021700 26.05.2002 3 T1014 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the upper arm or elbow (3 basic units) 1021710 26.05.2002 3 T1014 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, 5001.12.2023tendons, fascia or bursae of upper arm or elbow, not being a service to which 5001.12.2023another item in this Subgroup applies (4 basic units) 1021712 26.05.2002 3 T1014 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open tenotomy of the upper arm 5001.12.2023orelbow (5 basic units) 1021714 26.05.2002 3 T1014 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for tenoplasty of the upper arm 5001.12.2023orelbow (5 basic units) 1021716 26.05.2002 3 T1014 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for tenodesis for rupture of long 5001.12.2023tendon of biceps (5 basic units) 1021730 26.05.2002 3 T1014 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the upper arm 5001.12.2023orelbow when performed in the operating theatre of a hospital (3 basic units) 1021732 26.05.2002 3 T1014 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of elbow 5001.12.2023joint (4 basic units) 1021740 26.05.2002 3 T1014 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the upper arm 5001.12.2023or elbow, not being a service to which another item in this Subgroup applies 5001.12.2023(5 basic units) 1021756 26.05.2002 3 T1014 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures on the upper 5001.12.2023arm or elbow (6 basic units) 1021760 26.05.2002 3 T1014 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for total elbow replacement (7 basic 5001.12.2023units) 1021770 26.05.2002 3 T1014 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of upper 5001.12.2023arm, not being a service to which another item in this Subgroup applies (8 5001.12.2023basic units) 1021772 26.05.2002 3 T1014 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of arteries of the 5001.12.2023upper arm (6 basic units) 1021780 26.05.2002 3 T1014 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of upper arm, 5001.12.2023not being a service to which another item in this Subgroup applies (4 basic 5001.12.2023units) 1021785 01.07.2008 3 T1014 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the upper arm or elbow (10 basic units) 1021790 26.05.2002 3 T1014 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of 5001.12.2023upper arm (15 basic units) 1021800 26.05.2002 3 T1015 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or 5001.12.2023subcutaneous tissue of the forearm, wrist or hand (3 basic units) 1021810 26.05.2002 3 T1015 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the nerves, muscles, 5001.12.2023tendons, fascia, or bursae of the forearm, wrist or hand (4 basic units) 1021820 26.05.2002 3 T1015 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the radius, 5001.12.2023ulna, wrist, or hand bones when performed in the operating theatre of a 5001.12.2023hospital (3 basic units) 1021830 26.05.2002 3 T1015 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the radius, 5001.12.2023ulna, wrist, or hand bones, not being a service to which another item in this 5001.12.2023Subgroup applies (4 basic units) 1021832 26.05.2002 3 T1015 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for total wrist replacement (7 basic 5001.12.2023units) 1021834 26.05.2002 3 T1015 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the 5001.12.2023wrist joint (4 basic units) 1021840 26.05.2002 3 T1015 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the arteries of 5001.12.2023forearm, wrist or hand, not being a service to which another item in this 5001.12.2023Subgroup applies (8 basic units) 1021842 26.05.2002 3 T1015 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of artery of forearm, 5001.12.2023wrist or hand (6 basic units) 1021850 26.05.2002 3 T1015 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the veins of 5001.12.2023forearm, wrist or hand, not being a service to which another item in this 5001.12.2023Subgroup applies (4 basic units) 1021860 26.05.2002 3 T1015 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for forearm, wrist, or hand cast 5001.12.2023application, removal, or repair when rendered to a patient as part of an 5001.12.2023episode of hospital treatment (3 basic units) 1021865 01.07.2008 3 T1015 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap 5001.12.2023surgery involving the forearm, wrist or hand (10 basic units) 1021870 26.05.2002 3 T1015 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of 5001.12.2023forearm, wrist or hand (15 basic units) 1021872 26.05.2002 3 T1015 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of a 5001.12.2023finger (8 basic units) 1021878 26.05.2002 3 T1016 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting where the area of burn involves not more than 3% 5001.12.2023of total body surface (3 basic units) 1021879 26.05.2002 3 T1016 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting,where the area of burn involves more than 3% but 5001.12.2023less than 10% of total body surface (5 basic units) 1021880 26.05.2002 3 T1016 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 10% or more but 5001.12.2023less than 20% of total body surface (7 basic units) 1021881 26.05.2002 3 T1016 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 20% or more but 5001.12.2023less than 30% of total body surface (9 basic units) 1021882 26.05.2002 3 T1016 SN NYNNY 2001.12.202301100.0000239.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 30% or more but 5001.12.2023less than 40% of total body surface (11 basic units) 1021883 26.05.2002 3 T1016 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 40% or more but 5001.12.2023less than 50% of total body surface (13 basic units) 1021884 26.05.2002 3 T1016 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 50% or more but 5001.12.2023less than 60% of total body surface (15 basic units) 1021885 26.05.2002 3 T1016 SN NYNNY 2001.12.202301700.0000370.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 60% or more but 5001.12.2023less than 70% of total body surface (17 basic units) 1021886 26.05.2002 3 T1016 SN NYNNY 2001.12.202301900.0000414.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 70% or more but 5001.12.2023less than 80% of total body surface (19 basic units) 1021887 26.05.2002 3 T1016 SN NYNNY 2001.12.202302100.0000457.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, 5001.12.2023with or without skin grafting, where the area of burn involves 80% or more of 5001.12.2023total body surface (21 basic units) 1021900 26.05.2002 3 T1017 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023hysterosalpingography (3 basic units) 1021906 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023myelography: lumbar or thoracic (5 basic units) 1021908 26.05.2002 3 T1017 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023myelography: cervical (6 basic units) 1021910 26.05.2002 3 T1017 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023myelography: posterior fossa (9 basic units) 1021912 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023discography: lumbar or thoracic (5 basic units) 1021914 26.05.2002 3 T1017 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for 5001.12.2023discography: cervical (6 basic units) 1021915 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral arteriogram (5 basic 5001.12.2023units) 1021916 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for arteriograms: cerebral, carotid or 5001.12.2023vertebral (5 basic units) 1021918 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde arteriogram: brachial 5001.12.2023or femoral (5 basic units) 1021922 26.05.2002 3 T1017 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for computerised axial tomography 5001.12.2023scanning, magnetic resonance scanning, digital subtraction angiography 5001.12.2023scanning (6 basic units) 1021925 26.05.2002 3 T1017 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde cystography, retrograde 5001.12.2023urethrography or retrograde cystourethrography (4 basic units) 1021926 26.05.2002 3 T1017 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for fluoroscopy (4 basic units) 1021930 26.05.2002 3 T1017 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for bronchography (6 basic units) 1021935 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for phlebography (5 basic units) 1021936 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for heart, 2 dimensional real time 5001.12.2023transoesophageal examination (5 basic units) 1021939 26.05.2002 3 T1017 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral venous cannulation (3 5001.12.2023basic units) 1021941 26.05.2002 3 T1017 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac catheterisation including 5001.12.2023coronary arteriography, ventriculography, cardiac mapping, insertion of 5001.12.2023automatic defibrillator or transvenous pacemaker (7 basic units) 1021942 26.05.2002 3 T1017 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac electrophysiological 5001.12.2023procedures including radio frequency ablation (10 basic units) 1021943 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for central vein catheterisation or 5001.12.2023insertion of right heart balloon catheter (via jugular, subclavian or femoral 5001.12.2023vein) by percutaneous or open exposure (5 basic units) 1021945 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for lumbar puncture, cisternal 5001.12.2023puncture, or epidural injection (5 basic units) 1021949 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for harvesting of bone marrow for the 5001.12.2023purpose of transplantation (5 basic units) 1021952 26.05.2002 3 T1017 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023Initiation of the management of anaesthesia for diagnostic muscle biopsy to 5001.12.2023assess for malignant hyperpyrexia (4 basic units) 1021955 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for electroencephalography (5 basic 5001.12.2023units) 1021959 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for brain stem evoked response 5001.12.2023audiometry (5 basic units) 1021962 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for electrocochleography by 5001.12.2023extratympanic method or transtympanic membrane insertion method (5 basic 5001.12.2023units) 1021965 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure if there is 5001.12.2023a clinical need for anaesthesia, not for headache of any etiology (5 basic 5001.12.2023units) 1021969 26.05.2002 3 T1017 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the 5001.12.2023medical practitioner is not confined in the chamber (including the 5001.12.2023administration of oxygen) (8 basic units) 1021970 26.05.2002 3 T1017 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the 5001.12.2023medical practitioner is confined in the chamber (including the administration 5001.12.2023of oxygen) (15 basic units) 1021973 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for brachytherapy using radioactive 5001.12.2023sealed sources (5 basic units) 1021976 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for therapeutic nuclear medicine (5 5001.12.2023basic units) 1021980 26.05.2002 3 T1017 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for radiotherapy (5 basic units) 1021990 26.05.2002 3 T1018 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA when no procedure ensues (3 basic 5001.12.2023units) 1021997 26.05.2002 3 T1018 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA in connection with a procedure covered 5001.12.2023by an item that does not include the word "(Anaes.)", other than a service to 5001.12.2023which item 21965 or 21992 applies, if there is a clinical need for anaesthesia 5001.12.2023(4 basic units) 1022002 26.05.2002 3 T1019 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023Administration of homologous blood or bone marrow already collected, when 5001.12.2023performed in association with the management of anaesthesia (4 basic units) 1022007 26.05.2002 3 T1019 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023ENDOTRACHEAL INTUBATION with flexible fibreoptic scope associated with 5001.12.2023difficult airway when performed in association with the administration of 5001.12.2023anaesthesia (4 basic units) 1022008 26.05.2002 3 T1019 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023DOUBLE LUMEN ENDOBRONCHIAL TUBE OR BRONCHIAL BLOCKER, insertion of when 5001.12.2023performed in association with the administration of anaesthesia (4 basic 5001.12.2023units) 1022012 26.05.2002 3 T1019 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023Central venous, pulmonary arterial, systemic arterial or cardiac intracavity 5001.12.2023blood pressure monitoring by indwelling catheteronce per day for each type of 5001.12.2023pressure for a patient:(a) when performed in association with the management 5001.12.2023of anaesthesia for the patient; and(b) other than a service to which item 5001.12.202313876 applies(c) is categorised as having a high risk of complications or 5001.12.2023during the procedure develops either complications or a high risk of 5001.12.2023complications (3 basic units) 1022014 26.05.2002 3 T1019 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023Central venous, pulmonary arterial, systemic arterial or cardiac intracavity 5001.12.2023blood pressure monitoring by indwelling catheteronce per day for each type of 5001.12.2023pressure for a patient:(a) when performed in association with the management 5001.12.2023of anaesthesia for the patient; and(b) relating to another discrete operation 5001.12.2023on the same day for the patient; and(c) other than a service to which item 5001.12.202313876 applies(d) who is categorised as having a high risk of complications or 5001.12.2023develops during the current procedure either complications or a high risk of 5001.12.2023complications (3 basic units) 1022015 26.05.2002 3 T1019 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023RIGHT HEART BALLOON CATHETER, insertion of, including pulmonary wedge pressure 5001.12.2023and cardiac output measurement, when performed in association with the 5001.12.2023administration of anaesthesia (6 basic units) 1022020 26.05.2002 3 T1019 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023CENTRAL VEIN CATHETERISATION by percutaneous or open exposure, not being a 5001.12.2023service to which item 13318 applies, when performed in association with the 5001.12.2023administration of anaesthesia (4 basic units) 1022025 26.05.2002 3 T1019 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.2023Intra-arterial cannulation when performed in association with the management 5001.12.2023of anaesthesia in a patient who:(a) is categorised as having a high risk of 5001.12.2023complications; or(b) develops a high risk of complications during the 5001.12.2023procedure (4 basic units) 1022031 01.11.2005 3 T1019 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023Intrathecal or epidural injection (initial) of a therapeutic substance or 5001.12.2023substances, with or without insertion of a catheter, in association with 5001.12.2023anaesthesia and surgery, for post-operative pain management, not being a 5001.12.2023service to which 22036 applies (5 basic units) 1022036 01.11.2005 3 T1019 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023INTRATHECAL or EPIDURAL INJECTION (subsequent) of a therapeutic substance or 5001.12.2023substances, using an in-situ catheter, in association with anaesthesia and 5001.12.2023surgery, for postoperative pain management, not being a service associated 5001.12.2023with a service to which 22031 applies (3 basic units) 1022041 01.11.2019 3 T1019 SN NYNNY 2001.12.202300200.0000043.6000000.00 5001.12.2023Perioperative introduction of a plexus or nerve block proximal to the lower 5001.12.2023leg or forearm for post operative pain management (2 basic units) 1022042 01.11.2019 3 T1019 SN NYNNY 2001.12.202300100.0000021.8000000.00 5001.12.2023Introduction of a nerve block performed via a retrobulbar, peribulbar, or sub 5001.12.2023Tenons approach, or other complex eye block, when administered by an 5001.12.2023anaesthetist perioperatively (1 basic units) 1022051 01.11.2008 3 T1019 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.2023INTRA-OPERATIVE TRANSOESOPHAGEAL ECHOCARDIOGRAPHY - Monitoring in real time of 5001.12.2023the structure and function of the heart chambers, valves and surrounding 5001.12.2023structures, including assessment of blood flow, with appropriate permanent 5001.12.2023recording during procedures on the heart, pericardium or great vessels of the 5001.12.2023chest (not in association with items 55130, 55135 or 21936) (9 basic units) 1022055 26.05.2002 3 T1019 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.2023PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent, not being a 5001.12.2023service associated with anaesthesia to which an item in Subgroup 21 applies 5001.12.2023(12 basic units) 1022065 26.05.2002 3 T1019 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.2023INDUCED CONTROLLED HYPOTHERMIA total body, being a service to which item 22060 5001.12.2023applies, not being a service associated with anaesthesia to which an item in 5001.12.2023Subgroup 21 applies (5 basic units) 1022075 26.05.2002 3 T1019 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.2023DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 5001.12.202322°c, including management of retrograde cerebral perfusion if performed, 5001.12.2023not being a service associated with anaesthesia to which an item in Subgroup 5001.12.202321 applies (15 basic units) 1022900 26.05.2002 3 T1020 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT BY A MEDICAL PRACTITIONER OF ANAESTHESIA for 5001.12.2023extraction of tooth or teeth with or without incision of soft tissue or 5001.12.2023removal of bone (6 basic units) 1022905 26.05.2002 3 T1020 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.2023INITIATION OF MANAGEMENT OF ANAESTHESIA for restorative dental work (6 basic 5001.12.2023units) 1023010 26.05.2002 3 T1021 SN NYNNY 2001.12.202300100.0000021.8000000.00 5001.12.2023ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of 5001.12.2023anaesthesia performed in association with an item in the range 20100 to 21997 5001.12.2023or 22900 to 22905; or (b) perfusion performed in association with item 22060; 5001.12.2023or (c) for assistance at anaesthesia performed in association with items 25200 5001.12.2023to 25205 For a period of: (FIFTEEN MINUTES OR LESS) (1 basic units) 1023025 01.11.2019 3 T1021 SN NYNNY 2001.12.202300200.0000043.6000000.00 5001.12.202316 MINUTES TO 30 MINUTES (2 basic units) 1023035 01.11.2019 3 T1021 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.202331 MINUTES to 45 MINUTES (3 basic units) 1023045 01.11.2019 3 T1021 SN NYNNY 2001.12.202300400.0000087.2000000.00 5001.12.202346 MINUTES to 1:00 HOUR (4 basic units) 1023055 01.11.2019 3 T1021 SN NYNNY 2001.12.202300500.0000109.0000000.00 5001.12.20231:01 HOURS to 1:15 HOURS (5 basic units) 1023065 01.11.2019 3 T1021 SN NYNNY 2001.12.202300600.0000130.8000000.00 5001.12.20231:16 HOURS to 1:30 HOURS (6 basic units) 1023075 01.11.2019 3 T1021 SN NYNNY 2001.12.202300700.0000152.6000000.00 5001.12.20231:31 HOURS to 1:45 HOURS (7 basic units) 1023085 01.11.2019 3 T1021 SN NYNNY 2001.12.202300800.0000174.4000000.00 5001.12.20231:46 HOURS to 2:00 HOURS (8 basic units) 1023091 01.11.2005 3 T1021 SN NYNNY 2001.12.202300900.0000196.2000000.00 5001.12.20232:01 HOURS TO 2:10 HOURS (9 basic units) 1023101 01.11.2005 3 T1021 SN NYNNY 2001.12.202301000.0000218.0000000.00 5001.12.20232:11 HOURS TO 2:20 HOURS (10 basic units) 1023111 01.11.2005 3 T1021 SN NYNNY 2001.12.202301100.0000239.8000000.00 5001.12.20232:21 HOURS TO 2:30 HOURS (11 basic units) 1023112 01.11.2005 3 T1021 SN NYNNY 2001.12.202301200.0000261.6000000.00 5001.12.20232:31 HOURS TO 2:40 HOURS (12 basic units) 1023113 01.11.2005 3 T1021 SN NYNNY 2001.12.202301300.0000283.4000000.00 5001.12.20232:41 HOURS TO 2:50 HOURS (13 basic units) 1023114 01.11.2005 3 T1021 SN NYNNY 2001.12.202301400.0000305.2000000.00 5001.12.20232:51 HOURS TO 3:00 HOURS (14 basic units) 1023115 01.11.2005 3 T1021 SN NYNNY 2001.12.202301500.0000327.0000000.00 5001.12.20233:01 HOURS TO 3:10 HOURS (15 basic units) 1023116 01.11.2005 3 T1021 SN NYNNY 2001.12.202301600.0000348.8000000.00 5001.12.20233:11 HOURS TO 3:20 HOURS (16 basic units) 1023117 01.11.2005 3 T1021 SN NYNNY 2001.12.202301700.0000370.6000000.00 5001.12.20233:21 HOURS TO 3:30 HOURS (17 basic units) 1023118 01.11.2005 3 T1021 SN NYNNY 2001.12.202301800.0000392.4000000.00 5001.12.20233:31 HOURS TO 3:40 HOURS (18 basic units) 1023119 01.11.2005 3 T1021 SN NYNNY 2001.12.202301900.0000414.2000000.00 5001.12.20233:41 HOURS TO 3:50 HOURS (19 basic units) 1023121 01.11.2005 3 T1021 SN NYNNY 2001.12.202302000.0000436.0000000.00 5001.12.20233:51 HOURS TO 4:00 HOURS (20 basic units) 1023170 26.05.2002 3 T1021 SN NYNNY 2001.12.202302100.0000457.8000000.00 5001.12.20234:01 HOURS TO 4:10 HOURS (21 basic units) 1023180 26.05.2002 3 T1021 SN NYNNY 2001.12.202302200.0000479.6000000.00 5001.12.20234:11 HOURS TO 4:20 HOURS (22 basic units) 1023190 26.05.2002 3 T1021 SN NYNNY 2001.12.202302300.0000501.4000000.00 5001.12.20234:21 HOURS TO 4:30 HOURS (23 basic units) 1023200 26.05.2002 3 T1021 SN NYNNY 2001.12.202302400.0000523.2000000.00 5001.12.20234:31 HOURS TO 4:40 HOURS (24 basic units) 1023210 26.05.2002 3 T1021 SN NYNNY 2001.12.202302500.0000545.0000000.00 5001.12.20234:41 HOURS TO 4:50 HOURS (25 basic units) 1023220 26.05.2002 3 T1021 SN NYNNY 2001.12.202302600.0000566.8000000.00 5001.12.20234:51 HOURS TO 5:00 HOURS (26 basic units) 1023230 26.05.2002 3 T1021 SN NYNNY 2001.12.202302700.0000588.6000000.00 5001.12.20235:01 HOURS TO 5:10 HOURS (27 basic units) 1023240 26.05.2002 3 T1021 SN NYNNY 2001.12.202302800.0000610.4000000.00 5001.12.20235:11 HOURS TO 5:20 HOURS (28 basic units) 1023250 26.05.2002 3 T1021 SN NYNNY 2001.12.202302900.0000632.2000000.00 5001.12.20235:21 HOURS TO 5:30 HOURS (29 basic units) 1023260 26.05.2002 3 T1021 SN NYNNY 2001.12.202303000.0000654.0000000.00 5001.12.20235:31 HOURS TO 5:40 HOURS (30 basic units) 1023270 26.05.2002 3 T1021 SN NYNNY 2001.12.202303100.0000675.8000000.00 5001.12.20235:41 HOURS TO 5:50 HOURS (31 basic units) 1023280 26.05.2002 3 T1021 SN NYNNY 2001.12.202303200.0000697.6000000.00 5001.12.2023(5:51 HOURS TO 6:00 HOURS (32 basic units) 1023290 26.05.2002 3 T1021 SN NYNNY 2001.12.202303300.0000719.4000000.00 5001.12.20236:01 HOURS TO 6:10 HOURS (33 basic units) 1023300 26.05.2002 3 T1021 SN NYNNY 2001.12.202303400.0000741.2000000.00 5001.12.20236:11 HOURS TO 6:20 HOURS (34 basic units) 1023310 26.05.2002 3 T1021 SN NYNNY 2001.12.202303500.0000763.0000000.00 5001.12.20236:21 HOURS TO 6:30 HOURS (35 basic units) 1023320 26.05.2002 3 T1021 SN NYNNY 2001.12.202303600.0000784.8000000.00 5001.12.20236:31 HOURS TO 6:40 HOURS (36 basic units) 1023330 26.05.2002 3 T1021 SN NYNNY 2001.12.202303700.0000806.6000000.00 5001.12.20236:41 HOURS TO 6:50 HOURS (37 basic units) 1023340 26.05.2002 3 T1021 SN NYNNY 2001.12.202303800.0000828.4000000.00 5001.12.20236:51 HOURS TO 7:00 HOURS (38 basic units) 1023350 26.05.2002 3 T1021 SN NYNNY 2001.12.202303900.0000850.2000000.00 5001.12.20237:01 HOURS TO 7:10 HOURS (39 basic units) 1023360 26.05.2002 3 T1021 SN NYNNY 2001.12.202304000.0000872.0000000.00 5001.12.20237:11 HOURS TO 7:20 HOURS (40 basic units) 1023370 26.05.2002 3 T1021 SN NYNNY 2001.12.202304100.0000893.8000000.00 5001.12.20237:21 HOURS TO 7:30 HOURS (41 basic units) 1023380 26.05.2002 3 T1021 SN NYNNY 2001.12.202304200.0000915.6000000.00 5001.12.20237:31 HOURS TO 7:40 HOURS (42 basic units) 1023390 26.05.2002 3 T1021 SN NYNNY 2001.12.202304300.0000937.4000000.00 5001.12.20237:41 HOURS TO 7:50 HOURS (43 basic units) 1023400 26.05.2002 3 T1021 SN NYNNY 2001.12.202304400.0000959.2000000.00 5001.12.20237:51 HOURS TO 8:00 HOURS (44 basic units) 1023410 26.05.2002 3 T1021 SN NYNNY 2001.12.202304500.0000981.0000000.00 5001.12.20238:01 HOURS TO 8:10 HOURS (45 basic units) 1023420 26.05.2002 3 T1021 SN NYNNY 2001.12.202304600.0001002.8000000.00 5001.12.20238:11 HOURS TO 8:20 HOURS (46 basic units) 1023430 26.05.2002 3 T1021 SN NYNNY 2001.12.202304700.0001024.6000000.00 5001.12.20238:21 HOURS TO 8:30 HOURS (47 basic units) 1023440 26.05.2002 3 T1021 SN NYNNY 2001.12.202304800.0001046.4000000.00 5001.12.20238:31 HOURS TO 8:40 HOURS (48 basic units) 1023450 26.05.2002 3 T1021 SN NYNNY 2001.12.202304900.0001068.2000000.00 5001.12.20238:41 HOURS TO 8:50 HOURS (49 basic units) 1023460 26.05.2002 3 T1021 SN NYNNY 2001.12.202305000.0001090.0000000.00 5001.12.20238:51 HOURS TO 9:00 HOURS (50 basic units) 1023470 26.05.2002 3 T1021 SN NYNNY 2001.12.202305100.0001111.8000000.00 5001.12.20239:01 HOURS TO 9:10 HOURS (51 basic units) 1023480 26.05.2002 3 T1021 SN NYNNY 2001.12.202305200.0001133.6000000.00 5001.12.20239:11 HOURS TO 9:20 HOURS (52 basic units) 1023490 26.05.2002 3 T1021 SN NYNNY 2001.12.202305300.0001155.4000000.00 5001.12.20239:21 HOURS TO 9:30 HOURS (53 basic units) 1023500 26.05.2002 3 T1021 SN NYNNY 2001.12.202305400.0001177.2000000.00 5001.12.20239:31 HOURS TO 9:40 HOURS (54 basic units) 1023510 26.05.2002 3 T1021 SN NYNNY 2001.12.202305500.0001199.0000000.00 5001.12.20239:41 HOURS TO 9:50 HOURS (55 basic units) 1023520 26.05.2002 3 T1021 SN NYNNY 2001.12.202305600.0001220.8000000.00 5001.12.20239:51 HOURS TO 10:00 HOURS (56 basic units) 1023530 26.05.2002 3 T1021 SN NYNNY 2001.12.202305700.0001242.6000000.00 5001.12.202310:01 HOURS TO 10:10 HOURS (57 basic units) 1023540 26.05.2002 3 T1021 SN NYNNY 2001.12.202305800.0001264.4000000.00 5001.12.202310:11 HOURS TO 10:20 HOURS (58 basic units) 1023550 26.05.2002 3 T1021 SN NYNNY 2001.12.202305900.0001286.2000000.00 5001.12.202310:21 HOURS TO 10:30 HOURS (59 basic units) 1023560 26.05.2002 3 T1021 SN NYNNY 2001.12.202306000.0001308.0000000.00 5001.12.202310:31 HOURS TO 10:40 HOURS (60 basic units) 1023570 26.05.2002 3 T1021 SN NYNNY 2001.12.202306100.0001329.8000000.00 5001.12.202310:41 HOURS TO 10:50 HOURS (61 basic units) 1023580 26.05.2002 3 T1021 SN NYNNY 2001.12.202306200.0001351.6000000.00 5001.12.202310:51 HOURS TO 11:00 HOURS (62 basic units) 1023590 26.05.2002 3 T1021 SN NYNNY 2001.12.202306300.0001373.4000000.00 5001.12.202311:01 HOURS TO 11:10 HOURS (63 basic units) 1023600 26.05.2002 3 T1021 SN NYNNY 2001.12.202306400.0001395.2000000.00 5001.12.202311:11 HOURS TO 11:20 HOURS (64 basic units) 1023610 26.05.2002 3 T1021 SN NYNNY 2001.12.202306500.0001417.0000000.00 5001.12.202311:21 HOURS TO 11:30 HOURS (65 basic units) 1023620 26.05.2002 3 T1021 SN NYNNY 2001.12.202306600.0001438.8000000.00 5001.12.202311:31 HOURS TO 11:40 HOURS (66 basic units) 1023630 26.05.2002 3 T1021 SN NYNNY 2001.12.202306700.0001460.6000000.00 5001.12.202311:41 HOURS TO 11:50 HOURS (67 basic units) 1023640 26.05.2002 3 T1021 SN NYNNY 2001.12.202306800.0001482.4000000.00 5001.12.202311:51 HOURS TO 12:00 HOURS (68 basic units) 1023650 26.05.2002 3 T1021 SN NYNNY 2001.12.202306900.0001504.2000000.00 5001.12.202312:01 HOURS TO 12:10 HOURS (69 basic units) 1023660 26.05.2002 3 T1021 SN NYNNY 2001.12.202307000.0001526.0000000.00 5001.12.202312:11 HOURS TO 12:20 HOURS (70 basic units) 1023670 26.05.2002 3 T1021 SN NYNNY 2001.12.202307100.0001547.8000000.00 5001.12.202312:21 HOURS TO 12:30 HOURS (71 basic units) 1023680 26.05.2002 3 T1021 SN NYNNY 2001.12.202307200.0001569.6000000.00 5001.12.202312:31 HOURS TO 12:40 HOURS (72 basic units) 1023690 26.05.2002 3 T1021 SN NYNNY 2001.12.202307300.0001591.4000000.00 5001.12.202312:41 HOURS TO 12:50 HOURS (73 basic units) 1023700 26.05.2002 3 T1021 SN NYNNY 2001.12.202307400.0001613.2000000.00 5001.12.202312:51 HOURS TO 13:00 HOURS (74 basic units) 1023710 26.05.2002 3 T1021 SN NYNNY 2001.12.202307500.0001635.0000000.00 5001.12.202313:01 HOURS TO 13:10 HOURS (75 basic units) 1023720 26.05.2002 3 T1021 SN NYNNY 2001.12.202307600.0001656.8000000.00 5001.12.202313:11 HOURS TO 13:20 HOURS (76 basic units) 1023730 26.05.2002 3 T1021 SN NYNNY 2001.12.202307700.0001678.6000000.00 5001.12.202313:21 HOURS TO 13:30 HOURS (77 basic units) 1023740 26.05.2002 3 T1021 SN NYNNY 2001.12.202307800.0001700.4000000.00 5001.12.202313:31 HOURS TO 13:40 HOURS (78 basic units) 1023750 26.05.2002 3 T1021 SN NYNNY 2001.12.202307900.0001722.2000000.00 5001.12.202313:41 HOURS TO 13:50 HOURS (79 basic units) 1023760 26.05.2002 3 T1021 SN NYNNY 2001.12.202308000.0001744.0000000.00 5001.12.202313:51 HOURS TO 14:00 HOURS (80 basic units) 1023770 26.05.2002 3 T1021 SN NYNNY 2001.12.202308100.0001765.8000000.00 5001.12.202314:01 HOURS TO 14:10 HOURS (81 basic units) 1023780 26.05.2002 3 T1021 SN NYNNY 2001.12.202308200.0001787.6000000.00 5001.12.202314:11 HOURS TO 14:20 HOURS (82 basic units) 1023790 26.05.2002 3 T1021 SN NYNNY 2001.12.202308300.0001809.4000000.00 5001.12.202314:21 HOURS TO 14:30 HOURS (83 basic units) 1023800 26.05.2002 3 T1021 SN NYNNY 2001.12.202308400.0001831.2000000.00 5001.12.202314:31 HOURS TO 14:40 HOURS (84 basic units) 1023810 26.05.2002 3 T1021 SN NYNNY 2001.12.202308500.0001853.0000000.00 5001.12.202314:41 HOURS TO 14:50 HOURS (85 basic units) 1023820 26.05.2002 3 T1021 SN NYNNY 2001.12.202308600.0001874.8000000.00 5001.12.202314:51 HOURS TO 15:00 HOURS (86 basic units) 1023830 26.05.2002 3 T1021 SN NYNNY 2001.12.202308700.0001896.6000000.00 5001.12.202315:01 HOURS TO 15:10 HOURS (87 basic units) 1023840 26.05.2002 3 T1021 SN NYNNY 2001.12.202308800.0001918.4000000.00 5001.12.202315:11 HOURS TO 15:20 HOURS (88 basic units) 1023850 26.05.2002 3 T1021 SN NYNNY 2001.12.202308900.0001940.2000000.00 5001.12.202315:21 HOURS TO 15:30 HOURS (89 basic units) 1023860 26.05.2002 3 T1021 SN NYNNY 2001.12.202309000.0001962.0000000.00 5001.12.202315:31 HOURS TO 15:40 HOURS (90 basic units) 1023870 26.05.2002 3 T1021 SN NYNNY 2001.12.202309100.0001983.8000000.00 5001.12.202315:41 HOURS TO 15:50 HOURS (91 basic units) 1023880 26.05.2002 3 T1021 SN NYNNY 2001.12.202309200.0002005.6000000.00 5001.12.202315:51 HOURS TO 16:00 HOURS (92 basic units) 1023890 26.05.2002 3 T1021 SN NYNNY 2001.12.202309300.0002027.4000000.00 5001.12.202316:01 HOURS TO 16:10 HOURS (93 basic units) 1023900 26.05.2002 3 T1021 SN NYNNY 2001.12.202309400.0002049.2000000.00 5001.12.202316:11 HOURS TO 16:20 HOURS (94 basic units) 1023910 26.05.2002 3 T1021 SN NYNNY 2001.12.202309500.0002071.0000000.00 5001.12.202316:21 HOURS TO 16:30 HOURS (95 basic units) 1023920 26.05.2002 3 T1021 SN NYNNY 2001.12.202309600.0002092.8000000.00 5001.12.202316:31 HOURS TO 16:40 HOURS (96 basic units) 1023930 26.05.2002 3 T1021 SN NYNNY 2001.12.202309700.0002114.6000000.00 5001.12.202316:41 HOURS TO 16:50 HOURS (97 basic units) 1023940 26.05.2002 3 T1021 SN NYNNY 2001.12.202309800.0002136.4000000.00 5001.12.202316:51 HOURS TO 17:00 HOURS (98 basic units) 1023950 26.05.2002 3 T1021 SN NYNNY 2001.12.202309900.0002158.2000000.00 5001.12.202317:01 HOURS TO 17:10 HOURS (99 basic units) 1023960 26.05.2002 3 T1021 SN NYNNY 2001.12.202310000.0002180.0000000.00 5001.12.202317:11 HOURS TO 17:20 HOURS (100 basic units) 1023970 26.05.2002 3 T1021 SN NYNNY 2001.12.202310100.0002201.8000000.00 5001.12.202317:21 HOURS TO 17:30 HOURS (101 basic units) 1023980 26.05.2002 3 T1021 SN NYNNY 2001.12.202310200.0002223.6000000.00 5001.12.202317:31 HOURS TO 17:40 HOURS (102 basic units) 1023990 26.05.2002 3 T1021 SN NYNNY 2001.12.202310300.0002245.4000000.00 5001.12.202317:41 HOURS TO 17:50 HOURS (103 basic units) 1024100 26.05.2002 3 T1021 SN NYNNY 2001.12.202310400.0002267.2000000.00 5001.12.202317:51 HOURS TO 18:00 HOURS (104 basic units) 1024101 26.05.2002 3 T1021 SN NYNNY 2001.12.202310500.0002289.0000000.00 5001.12.202318:01 HOURS TO 18:10 HOURS (105 basic units) 1024102 26.05.2002 3 T1021 SN NYNNY 2001.12.202310600.0002310.8000000.00 5001.12.202318:11 HOURS TO 18:20 HOURS (106 basic units) 1024103 26.05.2002 3 T1021 SN NYNNY 2001.12.202310700.0002332.6000000.00 5001.12.202318:21 HOURS TO 18:30 HOURS (107 basic units) 1024104 26.05.2002 3 T1021 SN NYNNY 2001.12.202310800.0002354.4000000.00 5001.12.202318:31 HOURS TO 18:40 HOURS (108 basic units) 1024105 26.05.2002 3 T1021 SN NYNNY 2001.12.202310900.0002376.2000000.00 5001.12.202318:41 HOURS TO 18:50 HOURS (109 basic units) 1024106 26.05.2002 3 T1021 SN NYNNY 2001.12.202311000.0002398.0000000.00 5001.12.202318:51 HOURS TO 19:00 HOURS (110 basic units) 1024107 26.05.2002 3 T1021 SN NYNNY 2001.12.202311100.0002419.8000000.00 5001.12.202319:01 HOURS TO 19:10 HOURS (111 basic units) 1024108 26.05.2002 3 T1021 SN NYNNY 2001.12.202311200.0002441.6000000.00 5001.12.202319:11 HOURS TO 19:20 HOURS (112 basic units) 1024109 26.05.2002 3 T1021 SN NYNNY 2001.12.202311300.0002463.4000000.00 5001.12.202319:21 HOURS TO 19:30 HOURS (113 basic units) 1024110 26.05.2002 3 T1021 SN NYNNY 2001.12.202311400.0002485.2000000.00 5001.12.202319:31 HOURS TO 19:40 HOURS (114 basic units) 1024111 26.05.2002 3 T1021 SN NYNNY 2001.12.202311500.0002507.0000000.00 5001.12.202319:41 HOURS TO 19:50 HOURS (115 basic units) 1024112 26.05.2002 3 T1021 SN NYNNY 2001.12.202311600.0002528.8000000.00 5001.12.202319:51 HOURS TO 20:00 HOURS (116 basic units) 1024113 26.05.2002 3 T1021 SN NYNNY 2001.12.202311700.0002550.6000000.00 5001.12.202320:01 HOURS TO 20:10 HOURS (117 basic units) 1024114 26.05.2002 3 T1021 SN NYNNY 2001.12.202311800.0002572.4000000.00 5001.12.202320:11 HOURS TO 20:20 HOURS (118 basic units) 1024115 26.05.2002 3 T1021 SN NYNNY 2001.12.202311900.0002594.2000000.00 5001.12.202320:21 HOURS TO 20:30 HOURS (119 basic units) 1024116 26.05.2002 3 T1021 SN NYNNY 2001.12.202312000.0002616.0000000.00 5001.12.202320:31 HOURS TO 20:40 HOURS (120 basic units) 1024117 26.05.2002 3 T1021 SN NYNNY 2001.12.202312100.0002637.8000000.00 5001.12.202320:41 HOURS TO 20:50 HOURS (121 basic units) 1024118 26.05.2002 3 T1021 SN NYNNY 2001.12.202312200.0002659.6000000.00 5001.12.202320:51 HOURS TO 21:00 HOURS (122 basic units) 1024119 26.05.2002 3 T1021 SN NYNNY 2001.12.202312300.0002681.4000000.00 5001.12.202321:01 HOURS TO 21:10 HOURS (123 basic units) 1024120 26.05.2002 3 T1021 SN NYNNY 2001.12.202312400.0002703.2000000.00 5001.12.202321:11 HOURS TO 21:20 HOURS (124 basic units) 1024121 26.05.2002 3 T1021 SN NYNNY 2001.12.202312500.0002725.0000000.00 5001.12.202321:21 HOURS TO 21:30 HOURS (125 basic units) 1024122 26.05.2002 3 T1021 SN NYNNY 2001.12.202312600.0002746.8000000.00 5001.12.202321:31 HOURS TO 21:40 HOURS (126 basic units) 1024123 26.05.2002 3 T1021 SN NYNNY 2001.12.202312700.0002768.6000000.00 5001.12.202321:41 HOURS TO 21:50 HOURS (127 basic units) 1024124 26.05.2002 3 T1021 SN NYNNY 2001.12.202312800.0002790.4000000.00 5001.12.202321:51 HOURS TO 22:00 HOURS (128 basic units) 1024125 26.05.2002 3 T1021 SN NYNNY 2001.12.202312900.0002812.2000000.00 5001.12.202322:01 HOURS TO 22:10 HOURS (129 basic units) 1024126 26.05.2002 3 T1021 SN NYNNY 2001.12.202313000.0002834.0000000.00 5001.12.202322:11 HOURS TO 22:20 HOURS (130 basic units) 1024127 26.05.2002 3 T1021 SN NYNNY 2001.12.202313100.0002855.8000000.00 5001.12.202322:21 HOURS TO 22:30 HOURS (131 basic units) 1024128 26.05.2002 3 T1021 SN NYNNY 2001.12.202313200.0002877.6000000.00 5001.12.202322:31 HOURS TO 22:40 HOURS (132 basic units) 1024129 26.05.2002 3 T1021 SN NYNNY 2001.12.202313300.0002899.4000000.00 5001.12.202322:41 HOURS TO 22:50 HOURS (133 basic units) 1024130 26.05.2002 3 T1021 SN NYNNY 2001.12.202313400.0002921.2000000.00 5001.12.202322:51 HOURS TO 23:00 HOURS (134 basic units) 1024131 26.05.2002 3 T1021 SN NYNNY 2001.12.202313500.0002943.0000000.00 5001.12.202323:01 HOURS TO 23:10 HOURS (135 basic units) 1024132 26.05.2002 3 T1021 SN NYNNY 2001.12.202313600.0002964.8000000.00 5001.12.202323:11 HOURS TO 23:20 HOURS (136 basic units) 1024133 26.05.2002 3 T1021 SN NYNNY 2001.12.202313700.0002986.6000000.00 5001.12.202323:21 HOURS TO 23:30 HOURS (137 basic units) 1024134 26.05.2002 3 T1021 SN NYNNY 2001.12.202313800.0003008.4000000.00 5001.12.202323:31 HOURS TO 23:40 HOURS (138 basic units) 1024135 26.05.2002 3 T1021 SN NYNNY 2001.12.202313900.0003030.2000000.00 5001.12.202323:41 HOURS TO 23:50 HOURS (139 basic units) 1024136 26.05.2002 3 T1021 SN NYNNY 2001.12.202314000.0003052.0000000.00 5001.12.202323:51 HOURS TO 24:00 HOURS (140 basic units) 1025000 26.05.2002 3 T1022 SN NYNNY 2001.12.202300100.0000021.8000000.00 5001.12.2023ANAESTHESIA, PERFUSION or ASSISTANCE AT ANAESTHESIA (a) for anaesthesia 5001.12.2023performed in association with an item in the range 20100 to 21997 or 22900 to 5001.12.202322905; or (b) for perfusion performed in association with item 22060; or (c) 5001.12.2023for assistance at anaesthesia performed in association with items 25200 to 5001.12.202325205 Where the patient has severe systemic disease equivalent to ASA physical 5001.12.2023status indicator 3 (1 basic units) 1025005 26.05.2002 3 T1022 SN NYNNY 2001.12.202300200.0000043.6000000.00 5001.12.2023Where the patient has severe systemic disease which is a constant threat to 5001.12.2023life equivalent to ASA physical status indicator 4 (2 basic units) 1025010 26.05.2002 3 T1022 SN NYNNY 2001.12.202300300.0000065.4000000.00 5001.12.2023For a patient who is not expected to survive for 24 hours with or without the 5001.12.2023operation, equivalent to ASA physical status indicator 5 (3 basic units) 1025014 01.05.2020 3 T1023 SNS NYNNY 2001.12.202300100.0000021.8000000.00 4001.05.2020(Anaes.) 5001.12.2023Anaesthesia, perfusion or assistance in the management of anaesthesia, if the 5001.12.2023patient is aged 75 years or more (Anaes.) (1 basic units) 1025020 26.05.2002 3 T1023 SN NYNNY 2001.12.202300200.0000043.6000000.00 5001.12.2023ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient 5001.12.2023requires immediate treatment without which there would be significant threat 5001.12.2023to life or body part - not being a service associated with a service to which 5001.12.2023item 25025 or 25030 or 25050 applies (2 basic units) 1025025 26.05.2002 3 T1024 SD NNNNY 3001.12.2023An additional amount of 50% of fee for the anaesthetic service.That is:(a) an 3001.12.2023anaesthesia item/s range 20100 - 21997 or 22900, plus (b)an item range 23010 - 3001.12.202324136, plus(c) if applicable,an item range 25000-25014, plus(d) where 3001.12.2023performed, any assoc therapeutic or diagnostic service range 22002-22051 5001.12.2023Anaesthesia, if the patient requires immediate treatment without which there 5001.12.2023would be significant threat to life or body part and if more than 50% of the 5001.12.2023service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, 5001.12.2023Sunday or public holiday (0 basic units) 1025030 26.05.2002 3 T1024 SD NNNNY 3001.12.202350% of the fee for assistance at anaesthesia. That is: (a) an assistant 3001.12.2023anaesthesia item in the range 25200 - 25205, plus (b) an item range 3001.12.202323010-24136, plus (c) where applicable, an item range 25000-25014, plus (d) 3001.12.2023where performed, any associated therapeutic or diagnostic service 22002 -22051 5001.12.2023Assistance in the management of anaesthesia, if the patient requires immediate 5001.12.2023treatment without which there would be significant threat to life or body part 5001.12.2023and if more than 50% of the service time occurs between 8 pm to 8 am on any 5001.12.2023weekday, or on a Saturday, Sunday or public holiday (0 basic units) 1025050 26.05.2002 3 T1025 SD NNNNY 3001.12.2023An additional amount of 50% of the fee for the perfusion service. That is: (a) 3001.12.2023item 22060, plus (b) an item range 23010 - 24136, plus (c) where applicable, 3001.12.2023an item range 25000 - 25014, plus (d) where performed, any associated 3001.12.2023therapeutic or diagnostic service in the range 22002-22051 or 22065-22075 5001.12.2023Perfusion, if the patient requires immediate treatment without which there 5001.12.2023would be significant threat to life or body part and if more than 50% of the 5001.12.2023service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, 5001.12.2023Sunday or public holiday. (0 basic units) 1025200 26.05.2002 3 T1026 SD NYNYY 3001.12.2023An amount of $109.05 (5 basic units) plus an item in the range 23010 - 24136 3001.12.2023plus, where applicable - an item in the range 25000 - 25020 plus, where 3001.12.2023performed, any associated therapeutic or diagnostic service/s in the range 3001.12.202322001 - 22051 5001.12.2023Assistance in the management of anaesthesia requiring continuous anaesthesia 5001.12.2023on a patient in imminent danger of death requiring continuous life saving 5001.12.2023emergency treatment, to the exclusion of attendance on all other patients (5 5001.12.2023basic units) 1025205 26.05.2002 3 T1026 SD NYNYY 3001.12.2023An amount of $109.05 (5 basic units) plus an item in the range 23010 - 24136 3001.12.2023plus, where applicable - an item in the range 25000 - 25020 plus, where 3001.12.2023performed, any associated therapeutic or diagnostic service/s in the range 3001.12.202322001 - 22051 5001.12.2023Assistance in the management of elective anaesthesia, if: (a)the patient has 5001.12.2023complex airway problems; or (b) the patient is a neonate; or (c) the patient 5001.12.2023is a paediatric patient and is receiving one or more of the following 5001.12.2023services: (i) invasive monitoring, either intravascular or transoesophageal; 5001.12.2023(ii) organ transplantation; (iii) craniofacial surgery; (iv) major tumour 5001.12.2023resection; (v) separation of conjoint twins; or (d) there is anticipated to be 5001.12.2023massive blood loss (greater than 50% of blood volume) during the procedure; or 5001.12.2023(e) the patient is critically ill, with multiple organ failure; or (f) the 5001.12.2023service time of the management of anaesthesia exceeds 6 hours and the 5001.12.2023assistance is provided to the exclusion of attendance on all other patients (5 5001.12.2023basic units) 1030001 26.05.2002 3 T8 1 SD NNNNY 3001.12.202350% of the fee which would have applied had the procedure not been 3001.12.2023discontinued 5001.12.2023OPERATIVE PROCEDURE, not being a service to which any other item in this Group 5001.12.2023applies, being a service to which an item in this Group would have applied had 5001.12.2023the procedure not been discontinued on medical grounds 1030003 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300086.0000040.0000000.00 5001.12.2023Burns, involving 1% or more but less than 3% of total body surface, dressing 5001.12.2023of (including redressing of any related donor site, if required), without 5001.12.2023anaesthesia, if medical practitioner is presenteach attendance at which the 5001.12.2023procedure is performedNot applicable for skin reactions secondary to 5001.12.2023radiotherapy 1030006 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300148.0000051.1500000.00 5001.12.2023Burns, involving 3% or more but less than 10% of total body surface, dressing 5001.12.2023of (including redressing of any related donor site, if required), without 5001.12.2023anaesthesia, if medical practitioner is presenteach attendance at which the 5001.12.2023procedure is performedNot applicable for skin reactions secondary to 5001.12.2023radiotherapy 1030007 01.07.2023 3 T8 1 SN YYNYN 2001.12.202300472.0000171.0500000.00 5001.12.2023Burns, involving 10% or more of total body surface, dressing of (including 5001.12.2023redressing of any related donor site, if required), without anaesthesia, if 5001.12.2023medical practitioner is presenteach attendance at which the procedure is 5001.12.2023performedNot applicable for skin reactions secondary to radiotherapy 1030010 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300245.0000081.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Burns, involving not more than 3% of total body surface, dressing of 5001.12.2023(including redressing of any related donor site, if required), in an operating 5001.12.2023theatre under general anaesthesia or intravenous sedation, if medical 5001.12.2023practitioner is present (H) (Anaes.) 1030014 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300510.0000171.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Burns, involving 3% or more but less than 20% of total body surface, dressing 5001.12.2023of (including redressing of any related donor site, if required), in an 5001.12.2023operating theatre under general anaesthesia or intravenous sedation, if 5001.12.2023medical practitioner is present (H) (Anaes.) 1030015 01.07.2023 3 T8 1 SN YYNYN 2001.12.202300707.0000256.6000000.00 4001.07.2023(Anaes.) 5001.12.2023Burns, involving 20% or more but less than 50% of total body surface, or burns 5001.12.2023of less than 20% of total body surface involving 1% or more of total body 5001.12.2023surface within the hands or face, dressing of (including redressing of any 5001.12.2023related donor site, if required), in an operating theatre under general 5001.12.2023anaesthesia or intravenous sedation, if medical practitioner is present (H) 5001.12.2023(Anaes.) (Assist.) 1030016 01.07.2023 3 T8 1 SN YYNYN 2001.12.202301061.0000384.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Burns, involving 50% or more of total body surface, dressing of (including 5001.12.2023redressing of any related donor site, if required), in an operating theatre 5001.12.2023under general anaesthesia or intravenous sedation, if medical practitioner is 5001.12.2023present (H) (Anaes.) (Assist.) 1030023 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301035.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023WOUND OF SOFT TISSUE, traumatic, deep or extensively contaminated, debridement 5001.12.2023of, under general anaesthesia or regional or field nerve block, including 5001.12.2023suturing of that wound when performed (Anaes.) (Assist.) 1030024 01.11.2005 3 T8 1 SN NYNNY 2001.12.202301035.0000358.9000000.00 4001.11.2005(Anaes.) 5001.12.2023WOUND OF SOFT TISSUE, debridement of extensively infected post-surgical 5001.12.2023incision or Fournier's Gangrene, under general anaesthesia or regional or 5001.12.2023field nerve block, including suturing of that wound when performed (Anaes.) 5001.12.2023(Assist.) 1030026 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300178.0000057.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 5001.12.2023CM LONG), superficial, not being a service to which another item in Group T4 5001.12.2023applies (Anaes.) 1030029 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300265.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 5001.12.2023CM LONG), involving deeper tissue, not being a service to which another item 5001.12.2023in Group T4 applies (Anaes.) 1030032 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300235.0000090.7500000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM 5001.12.2023LONG), superficial (Anaes.) 1030035 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300355.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM 5001.12.2023LONG), involving deeper tissue (Anaes.) 1030038 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300265.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other 5001.12.2023than wound closure at time of surgery, not on face or neck, large (MORE THAN 7 5001.12.2023CM LONG), superficial, not being a service to which another item in Group T4 5001.12.2023applies (Anaes.) 1030042 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300590.0000204.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, other than on face or neck, large (MORE THAN 5001.12.20237 CM LONG), involving deeper tissue, other than a service to which another 5001.12.2023item in Group T4 applies (Anaes.) 1030045 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300355.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM 5001.12.2023LONG), superficial (Anaes.) 1030049 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300605.0000204.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than 5001.12.2023wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM 5001.12.2023LONG), involving deeper tissue (Anaes.) 1030052 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300825.0000279.5500000.00 4026.05.2002(Anaes.) 5001.12.2023FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with 5001.12.2023accurate apposition of each layer of tissue (Anaes.) (Assist.) 1030055 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300245.0000081.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Wounds, dressing of, under general, regional or intravenous sedation, with or 5001.12.2023without removal of sutures, other than a service associated with a service to 5001.12.2023which another item in this Group applies (Anaes.) 1030058 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300460.0000158.9000000.00 4026.05.2002(Anaes.) 5001.12.2023POSTOPERATIVE HAEMORRHAGE, control of, under general anaesthesia, as an 5001.12.2023independent procedure (Anaes.) 1030061 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300071.0000025.9000000.00 4026.05.2002(Anaes.) 5001.12.2023SUPERFICIAL FOREIGN BODY, REMOVAL OF, (including from cornea or sclera), as an 5001.12.2023independent procedure (Anaes.) 1030062 01.05.2007 3 T8 1 SN NYNNY 2001.12.202300192.0000066.8500000.00 4001.05.2007(Anaes.) 5001.12.2023Etonogestrel subcutaneous implant, removal of, as an independent procedure 5001.12.2023(Anaes.) 1030064 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300320.0000120.9500000.00 4026.05.2002(Anaes.) 5001.12.2023SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and exploration, 5001.12.2023including closure of wound if performed, as an independent procedure (Anaes.) 1030068 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300890.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an 5001.12.2023independent procedure (Anaes.) (Assist.) 1030071 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300220.0000057.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Diagnostic biopsy of skin, as an independent procedure, if the biopsy specimen 5001.12.2023is sent for pathological examination (Anaes.) 1030072 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300220.0000057.5000000.00 4001.11.2016(Anaes.) 5001.12.2023Diagnostic biopsy of mucous membrane, as an independent procedure, if the 5001.12.2023biopsy specimen is sent for pathological examination (Anaes.) 1030075 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300565.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an 5001.12.2023independent procedure,if the biopsy specimen is sent for pathological 5001.12.2023examination (Anaes.) 1030078 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300144.0000053.3500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC DRILL BIOPSY OF LYMPH NODE, DEEP TISSUE OR ORGAN, as an independent 5001.12.2023procedure, where the biopsy specimen is sent for pathological examination 5001.12.2023(Anaes.) 1030081 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300320.0000120.9500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using open approach, where the 5001.12.2023biopsy specimen is sent for pathological examination (Anaes.) 1030084 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300178.0000064.7500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using percutaneous approach where 5001.12.2023the biopsy is sent for pathological examination (Anaes.) 1030087 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300089.0000032.3500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL 5001.12.2023MEMBRANE, where the biopsy is sent for pathological examination (Anaes.) 1030090 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300385.0000141.5000000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC BIOPSY OF PLEURA, PERCUTANEOUS 1 or more biopsies on any 1 5001.12.2023occasion, where the biopsy is sent for pathological examination (Anaes.) 1030093 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300390.0000188.8500000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC NEEDLE BIOPSY OF VERTEBRA, where the biopsy is sent for 5001.12.2023pathological examination (Anaes.) 1030094 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300610.0000208.5000000.00 4026.05.2002(Anaes.) 5001.12.2023DIAGNOSTIC PERCUTANEOUS ASPIRATION BIOPSY of deep organ using interventional 5001.12.2023imaging techniques - but not including imaging, where the biopsy is sent for 5001.12.2023pathological examination (Anaes.) 1030097 01.11.2006 3 T8 1 SN NYNNY 2001.12.202300300.0000106.9500000.00 5001.12.2023Personal performance of a Synacthen Stimulation Test, including associated 5001.12.2023consultation; by a medical practitioner with resuscitation training and access 5001.12.2023to facilities where life support procedures can be implemented, if: serum 5001.12.2023cortisol at 0830-0930 hours on any dayin the preceding month has been measured 5001.12.2023at greater than 100 nmol/L but less than 400 nmol/L; or in a patient who is 5001.12.2023acutely unwelland adrenal insufficiency is suspected. 1030099 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300265.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SINUS, excision of, involving superficial tissue only (Anaes.) 1030103 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300600.0000202.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SINUS, excision of, involving muscle and deep tissue (Anaes.) 1030104 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300355.0000139.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Pre-auricular sinus, excision of, on a patient 10 years of age or over 5001.12.2023(Anaes.) 1030107 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300635.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of ganglion, other than a service associated with a service to which 5001.12.2023another item in this Group applies (Anaes.) 1030166 01.07.2023 3 T8 1 SN YYNYN 2001.12.202302276.0000825.5500000.00 4001.07.2023(Anaes.) 5001.12.2023Removal of redundant abdominal skin and lipectomy, as a wedge excision, for 5001.12.2023functional problems following significant weight loss equivalent to at least 5 5001.12.2023body mass index points and if there has been a stable weight for a period of 5001.12.2023at least 6 months prior to surgery, other than a service associated with a 5001.12.2023service to which item 30175, 30176, 30177, 45530, 45531, 45564, 45565, 45567, 5001.12.202346060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 5001.12.202346088 or 46090 applies (H) (Anaes.) (Assist.) 1030169 01.07.2023 3 T8 1 SN YYNYN 2001.12.202301821.0000660.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Removal of redundant non-abdominal skin and lipectomy for functional problems 5001.12.2023following significant weight loss equivalent to at least 5 body mass index 5001.12.2023points and if there has been a stable weight for a period of at least 6 months 5001.12.2023prior to surgery, one or 2 non-abdominal areas, other than a service 5001.12.2023associated with a service to which item 30175, 30176, 45530, 45531, 45564, 5001.12.202345565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 5001.12.202346084, 46086, 46088 or 46090 applies (H) (Anaes.) (Assist.) 1030175 01.07.2022 3 T8 1 SN NYNYY 2001.12.202302944.0001067.8000000.00 4001.07.2022(Anaes.) 5001.12.2023Radical abdominoplasty, with repair of rectus diastasis, excision of skin and 5001.12.2023subcutaneous tissue, and transposition of umbilicus, not being a laparoscopic 5001.12.2023procedure, if:(a) the patient has an abdominal wall defect as a consequence of 5001.12.2023pregnancy; and(b) the patient: (i) has a diastasis of at least 3cm measured by 5001.12.2023diagnostic imaging prior to this service; and(ii) has either or both of the 5001.12.2023following: (A) at least moderately severe pain or discomfort at the site of 5001.12.2023the diastasis in the abdominal wall during functional use and the pain or 5001.12.2023discomfort has been documented in the patients records by the practitioner 5001.12.2023providing the service;(B) low back pain or urinary symptoms likely due to 5001.12.2023rectus diastasis and the pain or symptoms have been documented in the patients 5001.12.2023records by the practitioner providing the service; and (iii) has failed to 5001.12.2023respond to non-surgical conservative treatment, that must have included 5001.12.2023physiotherapy; and(iv) has not been pregnant in the last 12 months; and (c) 5001.12.2023the service is not a service associated with a service to which item 30166, 5001.12.202330169, 30176, 30177, 30179, 30651, 30655, 45530, 45531, 45564, 45565, 45567, 5001.12.202346060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 5001.12.202346088 or 46090 appliesApplicable once per lifetime (H) (Anaes.) (Assist.) 1030176 01.01.2016 3 T8 1 SN NYNYY 2001.12.202302970.0001084.9000000.00 4001.01.2016(Anaes.) 5001.12.2023Radical abdominoplasty, with excision of skin and subcutaneous tissue, repair 5001.12.2023of musculoaponeurotic layer and transposition of umbilicus, not being a 5001.12.2023service associated with a service to which item 30166, 30169, 30175, 30177, 5001.12.202330179, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 5001.12.202346070 or 46072 applies,if the patient has previously had a massive 5001.12.2023intra-abdominal or pelvic tumour surgically removed (H) (Anaes.) (Assist.) 1030180 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300400.0000150.2500000.00 4026.05.2002(Anaes.) 5001.12.2023AXILLARY HYPERHIDROSIS, partial excision for (Anaes.) 1030183 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300800.0000271.3500000.00 4026.05.2002(Anaes.) 5001.12.2023AXILLARY HYPERHIDROSIS, total excision of sweat gland bearing area (Anaes.) 1030187 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300725.0000282.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PALMAR OR PLANTAR WARTS, removal of, by carbon dioxide laser or erbium laser, 5001.12.2023requiring admission to a hospital, or when performed by a specialist in the 5001.12.2023practice of his/her specialty, (5 or more warts) (Anaes.) 1030189 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300415.0000162.1000000.00 4026.05.2002(Anaes.) 5001.12.2023WARTS or MOLLUSCUM CONTAGIOSUM (one or more), removal of, by any method (other 5001.12.2023than by chemical means), where undertaken in the operating theatre of a 5001.12.2023hospital, not being a service associated with a service to which another item 5001.12.2023in this Group applies (H) (Anaes.) 1030190 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301115.0000437.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Angiofibromas, trichoepitheliomas or other severely disfiguring tumours of the 5001.12.2023face or neck (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis 5001.12.2023papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), 5001.12.2023suitable for laser ablation as confirmed by the opinion of a specialist in the 5001.12.2023specialty of dermatologyremoval of, by carbon dioxide laser or erbium laser 5001.12.2023ablation, including associated resurfacing (10 or more tumours) (Anaes.) 1030192 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300110.0000043.5000000.00 4026.05.2002(Anaes.) 5001.12.2023PREMALIGNANT SKIN LESIONS (including solar keratoses), treatment of, by 5001.12.2023ablative technique (10 or more lesions) (Anaes.) 1030196 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300350.0000138.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Malignant neoplasm of skin or mucous membrane that has been: (a) proven by 5001.12.2023histopathology; or (b) confirmed by the opinion of a specialist in the 5001.12.2023specialty of dermatology or plastic surgerywhere a specimen has been submitted 5001.12.2023for histologic confirmation; removal of, by serial curettage, or carbon 5001.12.2023dioxide laser or erbium laser excisionablation, including any associated 5001.12.2023cryotherapy or diathermy (Anaes.) 1030202 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300134.0000053.2000000.00 5001.12.2023Malignant neoplasm of skin or mucous membrane proven by histopathology or 5001.12.2023confirmed by the opinion of a specialist in the specialty of dermatology or 5001.12.2023plastic surgeryremoval of, by liquid nitrogen cryotherapy using repeat freeze 5001.12.2023thaw cycles 1030207 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300122.0000049.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Skin lesions, multiple injections with glucocorticoid preparations (Anaes.) 1030210 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300480.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Keloid and other skin lesions, extensive, multiple injections of 5001.12.2023glucocorticoid preparations, if undertaken in the operating theatre of a 5001.12.2023hospital (H) (Anaes.) 1030216 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300074.0000030.1000000.00 4026.05.2002(Anaes.) 5001.12.2023HAEMATOMA, aspiration of (Anaes.) 1030219 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300074.0000030.1000000.00 5001.12.2023HAEMATOMA, FURUNCLE, SMALL ABSCESS OR SIMILAR LESION not requiring admission 5001.12.2023to a hospital - INCISION WITH DRAINAGE OF (excluding aftercare) 1030223 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300480.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, 5001.12.2023requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding 5001.12.2023aftercare) (Anaes.) 1030224 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300770.0000261.5000000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS DRAINAGE OF DEEP ABSCESS using interventional imaging techniques 5001.12.2023- but not including imaging (Anaes.) 1030225 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300865.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ABSCESS DRAINAGE TUBE, exchange of using interventional imaging techniques - 5001.12.2023but not including imaging (Anaes.) 1030226 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300490.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, excision of (LIMITED), or fasciotomy (Anaes.) 1030229 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300875.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, excision of (EXTENSIVE) (Anaes.) (Assist.) 1030232 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300720.0000246.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, RUPTURED, repair of (limited), not associated with external wound 5001.12.2023(Anaes.) 1030235 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300960.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, RUPTURED, repair of (extensive), not associated with external wound 5001.12.2023(Anaes.) (Assist.) 1030238 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300490.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023FASCIA, DEEP, repair of, FOR HERNIATED MUSCLE (Anaes.) 1030241 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301035.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023BONE TUMOUR, INNOCENT, excision of, not being a service to which another item 5001.12.2023in this Group applies (Anaes.) (Assist.) 1030244 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301035.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023STYLOID PROCESS OF TEMPORAL BONE, removal of (Anaes.) (Assist.) 1030246 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302280.0000759.3000000.00 4026.05.2002(Anaes.) 5001.12.2023PAROTID DUCT, repair of, using micro-surgical techniques (Anaes.) (Assist.) 1030247 26.05.2002 3 T8 1 SN NYNYY 2001.12.202302440.0000813.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Parotid gland, total extirpation of, including removal of tumour, other than a 5001.12.2023service associated with a service to which item 39321, 39324, 39327 or 39330 5001.12.2023applies (H) (Anaes.) (Assist.) 1030250 26.05.2002 3 T8 1 SN NYNYY 2001.12.202303995.0001377.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Parotid gland, total extirpation of, with preservation of facial nerve, 5001.12.2023including: (a) removal of tumour; and (b) exposure or mobilisation of facial 5001.12.2023nerve; other than a service associated with a service to which item 39321, 5001.12.202339324, 39327 or 39330 applies (H) (Anaes.) (Assist.) 1030251 26.05.2002 3 T8 1 SN NYNYY 2001.12.202305870.0002115.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Recurrent parotid tumour, excision of, with preservation of facial nerve, 5001.12.2023including: (a) removal of tumour; and (b) exposure or mobilisation of facial 5001.12.2023nerve; other than a service associated with a service to which item 39321, 5001.12.202339324, 39327 or 39330 applies (H) (Anaes.) (Assist.) 1030253 26.05.2002 3 T8 1 SN NYNYY 2001.12.202302665.0000918.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Parotid gland, superficial lobectomy of, with exposure of facial nerve, 5001.12.2023including: (a) removal of tumour; and (b) exposure or mobilisation of facial 5001.12.2023nerve; other than a service associated with a service to which item 39321, 5001.12.202339324, 39327 or 39330 applies (H) (Anaes.) (Assist.) 1030255 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303540.0001222.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling (Anaes.) 5001.12.2023(Assist.) 1030256 26.05.2002 3 T8 1 SN NYNYY 2001.12.202301120.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Submandibular gland, extirpation of, other than a service associated with a 5001.12.2023service to which item 31423, 31426, 31429, 31432, 31435 or 31438 applies on 5001.12.2023the same side (H) (Anaes.) (Assist.) 1030257 01.03.2023 3 T8 1 SNS YYNYN 2001.12.202301260.0000550.3500000.00 4001.03.2023(Anaes.) 5001.12.2023Sialendoscopy, of submandibular or parotid duct, with or without removal of 5001.12.2023calculus or treatment of stricture (Anaes.) 1030259 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300635.0000218.5500000.00 4026.05.2002(Anaes.) 5001.12.2023SUBLINGUAL GLAND, extirpation of (Anaes.) 1030262 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300192.0000064.7500000.00 4026.05.2002(Anaes.) 5001.12.2023SALIVARY GLAND, DILATATION OR DIATHERMY of duct (Anaes.) 1030266 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300480.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Salivary gland, removal of calculus from duct or meatotomy or 5001.12.2023marsupialisation, 1 or more such procedures. (Anaes.) 1030269 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300490.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023SALIVARY GLAND, repair of CUTANEOUS FISTULA OF (Anaes.) 1030272 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300960.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023TONGUE, partial excision of (Anaes.) (Assist.) 1030275 26.05.2002 3 T8 1 SN NYNYY 2001.12.202305625.0001940.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Radical excision of intra oral tumour, with or without resection of mandible, 5001.12.2023including dissection of lymph glands of neck, unilateral, other than a service 5001.12.2023associated with a service to which item 31423, 31426, 31429, 31432, 31435 or 5001.12.202331438 applies on the same side (H) (Anaes.) (Assist.) 1030278 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300148.0000051.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Tongue tie, repair of, other than: (a) a service to which another item in this 5001.12.2023Subgroup applies; or (b) a service associated with a service to which item 5001.12.202345009 applies (Anaes.) 1030281 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300375.0000131.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person 5001.12.2023aged 2 years and over, under general anaesthesia, other than a service 5001.12.2023associated with a service to which item 45009 applies (Anaes.) 1030283 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300635.0000225.3000000.00 4026.05.2002(Anaes.) 5001.12.2023RANULA OR MUCOUS CYST OF MOUTH, removal of (Anaes.) 1030286 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301285.0000437.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Branchial cyst, removal of, on a patient 10 years of age or over (Anaes.) 5001.12.2023(Assist.) 1030289 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301630.0000552.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Branchial fistula, removal of, on a patient 10 years of age or over (Anaes.) 5001.12.2023(Assist.) 1030293 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301435.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL OESOPHAGOSTOMY or CLOSURE OF CERVICAL OESOPHAGOSTOMY with or without 5001.12.2023plastic repair (Anaes.) (Assist.) 1030294 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305625.0001940.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL OESOPHAGECTOMY with tracheostomy and oesophagostomy, with or without 5001.12.2023plastic reconstruction; or LARYNGOPHARYNGECTOMY with tracheostomy and plastic 5001.12.2023reconstruction (Anaes.) (Assist.) 1030296 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303275.0001126.8000000.00 4026.05.2002(Anaes.) 5001.12.2023THYROIDECTOMY, total (Anaes.) (Assist.) 1030297 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303275.0001126.8000000.00 4026.05.2002(Anaes.) 5001.12.2023THYROIDECTOMY following previous thyroid surgery (Anaes.) (Assist.) 1030299 01.11.2005 3 T8 1 SN NYNYY 2001.12.202302045.0000781.7500000.00 4001.11.2005(Anaes.) 5001.12.2023Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection 5001.12.2023in an axilla, using preoperative lymphoscintigraphy and/or lymphotropic dye 5001.12.2023injection (H) (Anaes.) (Assist.) 1030305 01.07.2023 3 T8 1 SN YYNYN 2001.12.202302155.0000781.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection 5001.12.2023along internal mammary chain (H) (Anaes.) (Assist.) 1030306 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302620.0000879.0500000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL HEMITHYROIDECTOMY (Anaes.) (Assist.) 1030310 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302555.0000879.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Partial or subtotal thyroidectomy (Anaes.) (Assist.) 1030311 01.11.2021 3 T8 1 SN NYNYY 2001.12.202302045.0000685.1000000.00 4001.11.2021(Anaes.) 5001.12.2023Sentinel lymph node biopsy or biopsies for cutaneous melanoma, using 5001.12.2023preoperative lymphoscintigraphy and/or lymphotropic dye injection, if: (a) the 5001.12.2023primary lesion is greater than 1.0 mm in depth (or at least 0.8 mm in depth in 5001.12.2023the presence of ulceration); and (b) appropriate excision of the primary 5001.12.2023melanoma has occurred; and (c) the service is not associated with a service to 5001.12.2023which item 30075, 30078, 30299, 30305, 30329, 30332, 30618, 30820, 31423, 5001.12.202352025 or 52027 appliesApplicable to only one lesion per occasion on which the 5001.12.2023service is provided (H) (Anaes.) (Assist.) 1030314 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301850.0000503.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Thyroglossal cyst or fistula or both, radical removal of, including 5001.12.2023thyroglossal duct and portion of hyoid bone, on a patient 10 years of age or 5001.12.2023over (Anaes.) (Assist.) 1030315 26.05.2002 3 T8 1 SN NYNYY 2001.12.202303995.0001254.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Minimally invasive parathyroidectomy. Removal of 1 or more parathyroid adenoma 5001.12.2023through a small cervical incision for an image localised adenoma, including 5001.12.2023thymectomy. For any particular patient - applicable only once per occasion on 5001.12.2023which the service is provided. Not in association with a service to which item 5001.12.202330318, 30317 or 30320 applies. (Anaes.) (Assist.) 1030317 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304365.0001502.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Redo parathyroidectomy. Cervical re-exploration for persistent or recurrent 5001.12.2023hyperparathyroidism, including thymectomy and cervical exploration of the 5001.12.2023mediastinum. For any particular patient - applicable only once per occasion on 5001.12.2023which the service is provided. Not in association with a service to which item 5001.12.202330315, 30318 or 30320 applies. (Anaes.) (Assist.) 1030318 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303995.0001254.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Open parathyroidectomy, exploration and removal of 1 or more adenoma or 5001.12.2023hyperplastic glands via a cervical incision including thymectomy and cervical 5001.12.2023exploration of the mediastinum when performed. For any particular patient - 5001.12.2023applicable only once per occasion on which the service is provided. Not in 5001.12.2023association with a service to which item 30315, 30317 or 30320 applies. 5001.12.2023(Anaes.) (Assist.) 1030320 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304365.0001502.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of a mediastinal parathyroid adenoma via sternotomy or mediastinal 5001.12.2023thorascopic approach. For any particular patient - applicable only once per 5001.12.2023occasion on which the service is provided. Not in association with a service 5001.12.2023to which item 30315, 30317 or 30318 applies. (Anaes.) (Assist.) 1030323 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304365.0001502.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of phaeochromocytoma or extraadrenal paraganglioma via endoscopic or 5001.12.2023open approach. (Anaes.) (Assist.) 1030324 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304365.0001502.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of an adrenocortical tumour or hyperplasia via endoscopic or open 5001.12.2023approach. (Anaes.) (Assist.) 1030329 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300790.0000271.8000000.00 4026.05.2002(Anaes.) 5001.12.2023LYMPH NODES of GROIN, limited excision of (Anaes.) 1030330 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302300.0000791.1000000.00 4026.05.2002(Anaes.) 5001.12.2023LYMPH NODES of GROIN, radical excision of (Anaes.) (Assist.) 1030332 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300855.0000381.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of axilla, limited excision of (H) (Anaes.) (Assist.) 1030336 26.05.2002 3 T8 1 SN NYNYY 2001.12.202302735.0001145.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of axilla, complete excision of (H) (Anaes.) (Assist.) 1030382 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304180.0001438.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Enterocutaneous fistula, repair of,if dissection and resection of bowel is 5001.12.2023performed, with or without anastomosis or formation of a stoma (H) (Anaes.) 5001.12.2023(Assist.) 1030384 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304365.0001502.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Open or minimally invasive excision of a retroperitoneal mass, 4 cm or greater 5001.12.2023in largest dimension, lasting more than 3 hours, other than a service to which 5001.12.2023another item in this Group applies (H) (Anaes.) (Assist.) 1030385 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301810.0000620.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Unplanned return to theatre for laparotomy or laparoscopy for control or 5001.12.2023drainage of intra-abdominal haemorrhage following abdominal surgery (H) 5001.12.2023(Anaes.) (Assist.) 1030387 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302070.0000698.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Laparoscopy or laparotomy when an operation is performed on abdominal, 5001.12.2023retroperitoneal or pelvic viscera, excluding lymph node biopsy, other than a 5001.12.2023service to which another item in this Group applies (H) (Anaes.) (Assist.) 1030388 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303405.0001172.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Laparotomy for abdominal trauma, including control of haemorrhage (with or 5001.12.2023without packing) and containment of contamination (H) (Anaes.) (Assist.) 1030390 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300705.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Laparoscopy, diagnostic, with or without aspiration of fluid, on a patient 10 5001.12.2023years of age or over, if no other intra-abdominal procedure is performed (H) 5001.12.2023(Anaes.) (Assist.) 1030392 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301870.0000742.4500000.00 4026.05.2002(Anaes.) 5001.12.2023RADICAL OR DEBULKING OPERATION for advanced intra-abdominal malignancy, with 5001.12.2023or without omentectomy, as an independent procedure (Anaes.) (Assist.) 1030396 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303250.0001118.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Laparotomy or laparoscopy for generalised intra-peritoneal sepsis(also known 5001.12.2023asperitonitis), with or without removal of foreign material or enteric 5001.12.2023contents, with lavage of the entire peritoneal cavity, with or without closure 5001.12.2023of the abdomen when performed by laparotomy (H) (Anaes.) (Assist.) 1030397 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300745.0000255.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Laparostomy, via wound previously made and left open or closed, including 5001.12.2023change of dressings or packs, with or without drainage of loculated 5001.12.2023collections (H) (Anaes.) 1030399 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301020.0000351.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Laparostomy, final closure of wound made at previous operation, after removal 5001.12.2023of dressings or packs (Anaes.) (Assist.) 1030400 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302020.0000696.1500000.00 4026.05.2002(Anaes.) 5001.12.2023LAPAROTOMY WITH INSERTION OF PORTACATH for administration of cytotoxic therapy 5001.12.2023including placement of reservoir (Anaes.) (Assist.) 1030406 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300178.0000057.5000000.00 4026.05.2002(Anaes.) 5001.12.2023PARACENTESIS ABDOMINIS (Anaes.) 1030408 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301255.0000431.6000000.00 4026.05.2002(Anaes.) 5001.12.2023PERITONEOVENOUS shunt, insertion of (Anaes.) (Assist.) 1030409 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300630.0000192.0000000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER BIOPSY, percutaneous (Anaes.) 1030411 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300285.0000097.7500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER BIOPSY by wedge excision when performed in conjunction with another 5001.12.2023intraabdominal procedure (Anaes.) 1030412 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300168.0000057.6500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER BIOPSY by core needle, when performed in conjunction with another 5001.12.2023intra-abdominal procedure (Anaes.) 1030414 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302205.0000759.3000000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, subsegmental resection of, (local excision), other than for trauma 5001.12.2023(Anaes.) (Assist.) 1030415 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304410.0001518.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, segmental resection of, other than for trauma (Anaes.) (Assist.) 1030416 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302395.0000824.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Liver cysts, greater than 5 cm in diameter, marsupialisation of 4 or less 5001.12.2023(Anaes.) (Assist.) 1030417 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303595.0001236.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Liver cysts, greater than 5 cm in diameter, marsupialisation of 5 or more 5001.12.2023(Anaes.) (Assist.) 1030418 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305105.0001758.4500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, lobectomy of, other than for trauma (Anaes.) (Assist.) 1030419 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302605.0000899.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Liver tumour, other than a hepatocellular carcinoma, destruction of one or 5001.12.2023more, by local ablation, other than a service associated with a service to 5001.12.2023which item 50950 or 50952 applies (Anaes.) (Assist.) 1030421 26.05.2002 3 T8 1 SN NYNNY 2001.12.202306385.0002197.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, 5001.12.2023other than for trauma (Anaes.) (Assist.) 1030422 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302160.0000743.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, repair of superficial laceration of, for trauma (Anaes.) (Assist.) 1030425 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304180.0001438.5000000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, repair of deep multiple lacerations of, or debridement of, for trauma 5001.12.2023(Anaes.) (Assist.) 1030427 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304990.0001718.2000000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, segmental resection of, for trauma (Anaes.) (Assist.) 1030428 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305340.0001838.1500000.00 4026.05.2002(Anaes.) 5001.12.2023LIVER, lobectomy of, for trauma (Anaes.) (Assist.) 1030430 26.05.2002 3 T8 1 SN NYNNY 2001.12.202307430.0002557.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, 5001.12.2023for trauma (Anaes.) (Assist.) 1030431 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301775.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Liver abscess, single, open or minimally invasive abdominal drainage of, 5001.12.2023excluding aftercare (Anaes.) (Assist.) 1030433 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302320.0000799.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Liver abscess, multiple, open or minimally invasive abdominal drainage of, 5001.12.2023excluding aftercare (Anaes.) (Assist.) 1030439 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300595.0000204.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Intraoperative ultrasound of biliary tract, or operative cholangiography, if 5001.12.2023the service: (a) is performed in association with an intra-abdominal 5001.12.2023procedure; and (b) is not associated with a service to which item 30442 or 5001.12.202330445 applies (Anaes.) (Assist.) 1030440 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301690.0000579.4000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLANGIOGRAM, percutaneous transhepatic, and insertion of biliary drainage 5001.12.2023tube, using interventional imaging techniques - but not including imaging, not 5001.12.2023being a service associated with a service to which item 30451 applies (Anaes.) 5001.12.2023(Assist.) 1030441 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300435.0000150.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Intraoperative ultrasoundfor staging of intra-abdominal tumours (Anaes.) 1030442 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300595.0000204.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLEDOCHOSCOPY in conjunction with another procedure (Anaes.) 1030443 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302075.0000707.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Cholecystectomy, by any approach, without cholangiogram (Anaes.) (Assist.) 1030445 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302910.0000915.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Cholecystectomy, by any approach, with attempted or completed cholangiogram or 5001.12.2023intraoperative ultrasound of the biliary system, when performed via 5001.12.2023laparoscopic or open approach or when conversion from laparoscopic to open 5001.12.2023approach is required (Anaes.) (Assist.) 1030448 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303110.0001070.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Cholecystectomy, by any approach, involving removal of common duct calculi via 5001.12.2023the cystic duct, with or without stent insertion (Anaes.) (Assist.) 1030449 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303460.0001190.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Cholecystectomy with removal of common duct calculi via choledochotomy, by any 5001.12.2023approach, with or without insertion of a stent (Anaes.) (Assist.) 1030450 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301675.0000577.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Calculus of biliary tract, extraction of, using interventional imaging 5001.12.2023techniques (Anaes.) (Assist.) 1030451 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300865.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023BILIARY DRAINAGE TUBE, exchange of, using interventional imaging techniques - 5001.12.2023but not including imaging, not being a service associated with a service to 5001.12.2023which item 30440 applies (Anaes.) (Assist.) 1030452 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301205.0000415.5000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLEDOCHOSCOPY with balloon dilation of a stricture or passage of stent or 5001.12.2023extraction of calculi (Anaes.) (Assist.) 1030454 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304270.0001450.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Choledochotomy without cholecystectomy, with or without removal of calculi 5001.12.2023(Anaes.) (Assist.) 1030455 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304270.0001450.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Choledochotomy with cholecystectomy, with removal of calculi, including 5001.12.2023biliary intestinal anastomosis (Anaes.) (Assist.) 1030457 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304410.0001518.3500000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLEDOCHOTOMY, intrahepatic, involving removal of intrahepatic bile duct 5001.12.2023calculi (Anaes.) (Assist.) 1030458 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303285.0001116.1500000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSDUODENAL OPERATION ON SPHINCTER OF ODDI, involving 1 or more of, removal 5001.12.2023of calculi, sphincterotomy, sphincteroplasty, biopsy, local excision of 5001.12.2023peri-ampullary or duodenal tumour, sphincteroplasty of the pancreatic duct, 5001.12.2023pancreatic duct septoplasty, with or without choledochotomy (Anaes.) (Assist.) 1030460 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302760.0000949.3000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLECYSTODUODENOSTOMY, CHOLECYSTOENTEROSTOMY, CHOLEDOCHOJEJUNOSTOMY or 5001.12.2023Roux-en-Y as a bypass procedure when no prior biliary surgery performed 5001.12.2023(Anaes.) (Assist.) 1030461 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304810.0001627.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Radical resection of porta hepatis (including associated neuro-lymphatic 5001.12.2023tissue), for cancer, suspected cancer or choledochal cyst, including bile duct 5001.12.2023excision and biliary-enteric anastomoses, other than a service associated with 5001.12.2023a service to which item 30440, 30451 or 31454 applies (Anaes.) (Assist.) 1030463 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305805.0001998.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Radical resection of common hepatic duct and right and left hepatic ducts, 5001.12.2023with 2 duct anastomoses, for cancer, suspected cancer or choledochal cyst 5001.12.2023(Anaes.) (Assist.) 1030464 26.05.2002 3 T8 1 SN NYNNY 2001.12.202306965.0002397.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Radical resection of common hepatic duct and right and left hepatic ducts, for 5001.12.2023cancer, suspected cancer or choledochal cyst, involving either or both of the 5001.12.2023following:(a) more than 2 anastomoses;(b) resection of segment (or major 5001.12.2023portion of segment) of liver; (Anaes.) (Assist.) 1030469 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305500.0001894.2000000.00 4026.05.2002(Anaes.) 5001.12.2023BILIARY STRICTURE, repair of, after 1 or more operations on the biliary tree 5001.12.2023(Anaes.) (Assist.) 1030472 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304125.0001467.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair of bile duct injury, including immediate reconstruction, other than a 5001.12.2023service associated with a service to which item 30584 applies (Anaes.) 5001.12.2023(Assist.) 1030473 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300710.0000194.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophagoscopy (not being a service associated with a service to which item 5001.12.202341822 applies), gastroscopy,duodenoscopy or panendoscopy (1 or more such 5001.12.2023procedures), with or without biopsy, not being a service associated with a 5001.12.2023service to which item 30478 or 30479 applies. (Anaes.) 1030475 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301150.0000384.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Endoscopic dilatation of stricture of upper gastrointestinal tract (including 5001.12.2023the use of imaging intensification where clinically indicated) (Anaes.) 1030478 26.05.2002 3 T8 1 SN NYNYY 2001.12.202301040.0000270.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophagoscopy (other than a service associated with a service to which item 5001.12.202341822 or 41825 applies), gastroscopy, duodenoscopy, panendoscopy or push 5001.12.2023enteroscopy, one or more such procedures, if: (a) the procedures are performed 5001.12.2023using one or more of the following endoscopic procedures: (i) polypectomy; 5001.12.2023(ii) sclerosing or adrenalin injections; (iii) banding; (iv) endoscopic clips; 5001.12.2023(v) haemostatic powders; (vi) diathermy; (vii) argon plasma coagulation; and 5001.12.2023(b) the procedures are for the treatment of one or more of the following: (i) 5001.12.2023upper gastrointestinal tract bleeding; (ii) polyps; (iii) removal of foreign 5001.12.2023body; (iv) oesophageal or gastric varices; (v) peptic ulcers; (vi) neoplasia; 5001.12.2023(vii) benign vascular lesions; (viii) strictures of the gastrointestinal 5001.12.2023tract; (ix) tumorous overgrowth through or over oesophageal stents; other than 5001.12.2023a service associated with a service to which item 30473 or 30479 applies 5001.12.2023(Anaes.) 1030479 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301535.0000524.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Endoscopy with laser therapy, for the treatment of one or more of the 5001.12.2023following: (a) neoplasia; (b) benign vascular lesions; (c) strictures of the 5001.12.2023gastrointestinal tract; (d) tumorous overgrowth through or over oesophageal 5001.12.2023stents; (e) peptic ulcers; (f) angiodysplasia; (g) gastric antral vascular 5001.12.2023ectasia; (h) post-polypectomy bleeding; other than a service associated with a 5001.12.2023service to which item 30473 or 30478 applies (Anaes.) 1030481 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301135.0000392.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS GASTROSTOMY (initial procedure): (a) including any associated 5001.12.2023imaging services; and (b) excluding the insertion of a device for the purpose 5001.12.2023of facilitating weight loss (Anaes.) 1030482 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300810.0000279.4000000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS GASTROSTOMY (repeat procedure): (a) including any associated 5001.12.2023imaging services; and (b) excluding the insertion of a device for the purpose 5001.12.2023of facilitating weight loss (Anaes.) 1030483 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300565.0000194.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Gastrostomy button, caecostomy antegrade enema device (chait etc.) or stomal 5001.12.2023indwelling device: (a) non-endoscopic insertion of; or (b) non-endoscopic 5001.12.2023replacement of; on a patient 10 years of age or over, excluding the insertion 5001.12.2023of a device for the purpose of facilitating weight loss (Anaes.) 1030484 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301160.0000401.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (Anaes.) 1030485 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301810.0000620.1000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC SPHINCTEROTOMY with or without extraction of stones from common 5001.12.2023bile duct (Anaes.) 1030488 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300290.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SMALL BOWEL INTUBATIONas an independent procedure (Anaes.) 1030490 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301670.0000579.4000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL PROSTHESIS, insertion of, including endoscopy and dilatation 5001.12.2023(Anaes.) 1030491 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301765.0000611.3000000.00 4026.05.2002(Anaes.) 5001.12.2023BILE DUCT, ENDOSCOPIC STENTING OF (including endoscopy and dilatation) 5001.12.2023(Anaes.) 1030492 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302590.0000866.5500000.00 4026.05.2002(Anaes.) 5001.12.2023BILE DUCT, PERCUTANEOUS STENTING OF (including dilatation when performed), 5001.12.2023using interventional imaging techniques - but not including imaging (Anaes.) 1030494 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301345.0000462.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC BILIARY DILATATION (Anaes.) 1030495 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302590.0000866.5500000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS BILIARY DILATATION for biliary stricture, using interventional 5001.12.2023imaging techniques - but not including imaging (Anaes.) 1030515 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302250.0000775.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Gastroenterostomy (including gastroduodenostomy), enterocolostomy or 5001.12.2023enteroenterostomy, as an independent procedure or in combination with another 5001.12.2023procedure, only if required for irresectable obstruction, other than a service 5001.12.2023to which any of items 31569 to 31581 apply (Anaes.) (Assist.) 1030517 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302855.0001015.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of gastroenterostomy, pyloroplasty or gastroduodenostomy (Anaes.) 5001.12.2023(Assist.) 1030518 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303180.0001086.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Partial gastrectomy, not being a service associated with a service to which 5001.12.2023any of items 31569 to 31581 apply (Anaes.) (Assist.) 1030520 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302810.0000935.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Gastric tumour, 2 cm or greater in diameter, removal of, by local excision, by 5001.12.2023laparoscopic or open approach, including any associated anastomosis, excluding 5001.12.2023polypectomy, other than a service to which item 30518 applies (Anaes.) 5001.12.2023(Assist.) 1030521 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303995.0001590.3500000.00 4026.05.2002(Anaes.) 5001.12.2023GASTRECTOMY, TOTAL, for benign disease (Anaes.) (Assist.) 1030526 26.05.2002 3 T8 1 SN NYNNY 2001.12.202306895.0002373.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Gastrectomy, total, and removal of lower oesophagus, performed by open or 5001.12.2023minimally invasive approach, with anastomosis in the mediastinum, including 5001.12.2023any of the following (if performed):(a) distal pancreatectomy;(b) nodal 5001.12.2023dissection;(c) splenectomy (Anaes.) (Assist.) 1030529 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304180.0001438.5000000.00 4026.05.2002(Anaes.) 5001.12.2023ANTIREFLUX operation by fundoplasty, with OESOPHAGOPLASTY for stricture or 5001.12.2023short oesophagus (Anaes.) (Assist.) 1030530 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302505.0000863.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ANTIREFLUX operation by cardiopexy, with or without fundoplasty (Anaes.) 5001.12.2023(Assist.) 1030532 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302910.0000991.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophagogastric myotomy (Hellers operation) by endoscopic, abdominal or 5001.12.2023thoracic approach, whether performed by open or minimally invasive approach, 5001.12.2023including fundoplication when performed laparoscopically (Anaes.) (Assist.) 1030533 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303450.0001178.8500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic 5001.12.2023approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic 5001.12.2023hiatus, by laparoscopy or open operation (Anaes.) (Assist.) 1030559 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302715.0000935.1500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGUS, local excision for tumour of (Anaes.) (Assist.) 1030560 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303020.0001038.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophageal perforation, repair of, by abdominal or thoracic approach, 5001.12.2023including thoracic drainage (Anaes.) (Assist.) 1030562 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301905.0000654.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Enterostomy or colostomy, closure of (not involving resection of bowel), on a 5001.12.2023patient 10 years of age or over (Anaes.) (Assist.) 1030563 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301905.0000654.8500000.00 4026.05.2002(Anaes.) 5001.12.2023COLOSTOMY OR ILEOSTOMY, refashioning of, on a person 10 years of age or over 5001.12.2023(Anaes.) (Assist.) 1030565 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302785.0000959.0500000.00 4026.05.2002(Anaes.) 5001.12.2023SMALL INTESTINE, resection of, without anastomosis (including formation of 5001.12.2023stoma) (Anaes.) (Assist.) 1030574 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300200.0000067.8500000.00 4026.05.2002(Anaes.) 5001.12.2023NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item 5001.12.2023Appendicectomy, when performed in conjunction with another intra-abdominal 5001.12.2023procedure and during which a specimen is collected and sent for pathological 5001.12.2023testing (Anaes.) 1030577 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303480.0001198.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Initial pancreatic necrosectomy by open, laparoscopic or endoscopic approach, 5001.12.2023excluding aftercare (Anaes.) (Assist.) 1030583 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304960.0001710.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Distal pancreatectomy with splenic preservation, by open or minimally invasive 5001.12.2023approach (Anaes.) (Assist.) 1030584 26.05.2002 3 T8 1 SN NYNNY 2001.12.202309685.0003302.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Pancreatico duodenectomy (Whipples procedure), with or without preservation of 5001.12.2023pylorus, including any of the following (if performed):(a) cholecystectomy;(b) 5001.12.2023pancreatico-biliary anastomosis;(c) gastro-jejunal anastomosis (Anaes.) 5001.12.2023(Assist.) 1030589 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303995.0001377.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PANCREATICO-JEJUNOSTOMY for pancreatitis or trauma (Anaes.) (Assist.) 1030590 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304410.0001518.3500000.00 4026.05.2002(Anaes.) 5001.12.2023PANCREATICO-JEJUNOSTOMY following previous pancreatic surgery (Anaes.) 5001.12.2023(Assist.) 1030593 26.05.2002 3 T8 1 SN NYNNY 2001.12.202306035.0002077.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PANCREATECTOMY, near total or total (including duodenum), with or without 5001.12.2023splenectomy (Anaes.) (Assist.) 1030594 26.05.2002 3 T8 1 SN NYNNY 2001.12.202306965.0002397.6000000.00 4026.05.2002(Anaes.) 5001.12.2023PANCREATECTOMY for pancreatitis following previously attempted drainage 5001.12.2023procedure or partial resection (Anaes.) (Assist.) 1030596 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302880.0000987.6500000.00 4026.05.2002(Anaes.) 5001.12.2023SPLENORRHAPHY OR PARTIAL SPLENECTOMY (Anaes.) (Assist.) 1030599 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304180.0001438.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SPLENECTOMY, for massive spleen (weighing more than 1500 grams) or involving 5001.12.2023thoraco-abdominal incision (Anaes.) (Assist.) 1030600 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302515.0000855.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Emergency repair of diaphragmatic laceration or hernia, following recent 5001.12.2023trauma, by any approach, including when performed in conjunction with another 5001.12.2023procedure indicated as a result of abdominal or chest trauma (Anaes.) 5001.12.2023(Assist.) 1030601 26.05.2002 3 T8 1 SN NYNYY 2001.12.202303065.0001053.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Diaphragmatic hernia, congenital, or delayed presentation of traumatic 5001.12.2023rupture, repair of, by thoracic or abdominal approach, on a patient 10 years 5001.12.2023of age or over,other than a service to which any of items 31569 to 31581 apply 5001.12.2023(Anaes.) (Assist.) 1030606 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303550.0001222.6500000.00 4026.05.2002(Anaes.) 5001.12.2023PORTAL HYPERTENSION, oesophageal transection via stapler or oversew of gastric 5001.12.2023varices with or without devascularisation (Anaes.) (Assist.) 1030615 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301775.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Strangulated, incarcerated or obstructed hernia, repair of, without bowel 5001.12.2023resection, on a patient 10 years of age or over (Anaes.) (Assist.) 1030621 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301200.0000448.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair of symptomatic umbilical, epigastric or linea alba hernia requiring 5001.12.2023mesh or other repair, by open or minimally invasive approach, in a patient 10 5001.12.2023years of age or over, other than a service to which item 30651 or 30655 5001.12.2023applies (Anaes.) (Assist.) 1030628 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300104.0000039.2000000.00 5001.12.2023HYDROCELE, tapping of 1030629 01.11.2020 3 T8 1 SN NYNNY 2001.12.202301775.0000573.8000000.00 4001.11.2020(Anaes.) 5001.12.2023Orchidectomy, radical, including spermatic cord, unilateral, for tumour, 5001.12.2023inguinal approach, without insertion of testicular prosthesis, other than a 5001.12.2023service associated with a service to which item 30631, 30635, 30641, 30643 or 5001.12.202330644 applies (Anaes.) (Assist.) 1030630 01.11.2020 3 T8 1 SN NYNYY 2001.12.202301595.0000521.5000000.00 4001.11.2020(Anaes.) 5001.12.2023Insertion of testicular prosthesis,at least 6 months following orchidectomy 5001.12.2023(H) (Anaes.) (Assist.) 1030631 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300690.0000260.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Hydrocele, removal of, other than a service associated with a service to which 5001.12.2023item 30641, 30642 or 30644 applies (Anaes.) 1030635 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300960.0000321.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Varicocele, surgical correction of, including microsurgical techniques, other 5001.12.2023than a service associated with a service to which item 30390, 30627, 30641, 5001.12.202330642 or 30644 appliesone procedure (Anaes.) (Assist.) 1030640 01.05.2016 3 T8 1 SN NYNYY 2001.12.202302925.0001007.1000000.00 4001.05.2016(Anaes.) 5001.12.2023Repair of large and irreducible scrotal hernia, if surgery exceeds 2 hours, in 5001.12.2023a patient 10 years of age or over, other than a service to which item 30615, 5001.12.202330621, 30648, 30651 or 30655 applies (Anaes.) (Assist.) 1030641 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301200.0000448.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Orchidectomy, simple or subcapsular, unilateral with or without insertion of 5001.12.2023testicular prosthesis (H) (Anaes.) (Assist.) 1030642 01.05.2017 3 T8 1 SN NYNNY 2001.12.202302570.0000834.5000000.00 4001.05.2017(Anaes.) 5001.12.2023Orchidectomy, radical, including spermatic cord, unilateral, for tumour, 5001.12.2023inguinal approach, with insertion of testicular prosthesis, other than a 5001.12.2023service associated with a service to which item 30631, 30635, 30641, 30643, 5001.12.202330644 or 45051 applies (Anaes.) (Assist.) 1030644 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301775.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Exploration of spermatic cord, inguinal approach, with or without testicular 5001.12.2023biopsy, with or without excision of spermatic cord lesion, for a patient at 5001.12.2023least 10 years of age, other than a service associated with a service to which 5001.12.2023item 30629, 30630 or 30642 applies (Anaes.) (Assist.) 1030648 01.07.2021 3 T8 1 SN NYNYY 2001.12.202301435.0000511.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Femoral or inguinal hernia or infantile hydrocele, repair of, by open or 5001.12.2023minimally invasive approach, on a patient 10 years of age or over,otherthan a 5001.12.2023service to which item 30615 or 30651 applies (Anaes.) (Assist.) 1030651 01.07.2021 3 T8 1 SN NYNYY 2001.12.202301775.0000573.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Ventral hernia repair involving primary fascial closure by suture, with or 5001.12.2023without onlay mesh or insertion of intraperitoneal onlay mesh repair, without 5001.12.2023closure of the defect or advancement of the rectus muscle toward the midline, 5001.12.2023by open or minimally invasive approach, in a patient 10 years of age or over, 5001.12.2023other than a service associated with a service to which item 30175, 30621, 5001.12.202330655 or 30657 applies (H) (Anaes.) (Assist.) 1030652 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301775.0000573.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Recurrent groin hernia regardless of size of defect, repair of, with or 5001.12.2023without mesh, by open or minimally invasive approach, in a patient 10 years of 5001.12.2023age or over (Anaes.) (Assist.) 1030655 01.07.2021 3 T8 1 SN NYNYY 2001.12.202302925.0001007.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Ventral hernia, repair of,with advancement of the rectus muscles to the 5001.12.2023midline using a retro-rectus, pre-peritoneal or sublay technique,by open or 5001.12.2023minimally invasive approach, in a patient 10 years of age or over, other than 5001.12.2023aservice associated with a service to which item 30175, 30621 or 30651 applies 5001.12.2023(H) (Anaes.) (Assist.) 1030657 01.07.2021 3 T8 1 SN NYNNY 2001.12.202304200.0001434.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Unilateral abdominal wall reconstruction with component separation, including 5001.12.2023transversus abdominus release and external oblique release for abdominal wall 5001.12.2023closure by mobilising the rectus abdominis muscles to the midline, by open or 5001.12.2023minimally invasive approach (Anaes.) (Assist.) 1030661 01.11.2022 3 T8 1 SN NYNNY 2001.12.202301164.0000422.2000000.00 4001.11.2022(Anaes.) 5001.12.2023Minor surgical repair following a complication from the circumcision of a 5001.12.2023penis, when performed in conjunction with a service to which an item in Group 5001.12.2023T7 or Group T10 applies, other than a service associated with a service to 5001.12.2023which item 45206 applies (H) (Anaes.) 1030662 01.11.2022 3 T8 1 SN NYNNY 2001.12.202302328.0000844.3000000.00 4001.11.2022(Anaes.) 5001.12.2023Complex surgical repair following a complication from the circumcision of a 5001.12.2023penis, including single stage local flap, if indicated, to repair one defect, 5001.12.2023on genitals (other than a service associated with a service to which item 5001.12.202337819, 37822, 45200, 45201, 45202, 45203 or 45206 applies) (H) (Anaes.) 1030663 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300465.0000158.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Haemorrhage, arrest of, following circumcision requiring general anaesthesia, 5001.12.2023on a patient 10 years of age or over (Anaes.) 1030666 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300148.0000052.2000000.00 4026.05.2002(Anaes.) 5001.12.2023PARAPHIMOSIS or PHIMOSIS, reduction of, under general anaesthesia, with or 5001.12.2023without dorsal incision, not being a service associated with a service to 5001.12.2023which another item in this Group applies (Anaes.) 1030672 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301260.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023COCCYX, excision of (Anaes.) (Assist.) 1030676 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301230.0000417.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Pilonidal sinus or cyst, or sacral sinus or cyst, definitive excision of 5001.12.2023(Anaes.) 1030679 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300290.0000106.0000000.00 4026.05.2002(Anaes.) 5001.12.2023PILONIDAL SINUS, injection of sclerosant fluid under anaesthesia (Anaes.) 1030680 01.07.2007 3 T8 1 SN NYNNY 2001.12.202303551.0001287.8500000.00 4001.07.2007(Anaes.) 5001.12.2023Balloon enteroscopy, examination of the small bowel (oral approach), with or 5001.12.2023without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients 5001.12.2023with obscure gastrointestinal bleeding, not in association with another item 5001.12.2023in this subgroup(with the exception of item 30682 or 30686) The patient to 5001.12.2023whom the service is provided must: (i)have recurrent or persistent bleeding; 5001.12.2023and (ii)be anaemic or have active bleeding; and (iii)have had an upper 5001.12.2023gastrointestinal endoscopy and a colonoscopy performed which did not identify 5001.12.2023the cause of the bleeding. (Anaes.) 1030682 01.07.2007 3 T8 1 SN NYNNY 2001.12.202303551.0001287.8500000.00 4001.07.2007(Anaes.) 5001.12.2023Balloon enteroscopy, examination of the small bowel (anal approach), with or 5001.12.2023without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients 5001.12.2023with obscure gastrointestinal bleeding, not in association with another item 5001.12.2023in this subgroup (with the exception of item 30680 or 30684) The patient to 5001.12.2023whom the service is provided must: (i)have recurrent or persistent bleeding; 5001.12.2023and (ii)be anaemic or have active bleeding; and (iii)have had an upper 5001.12.2023gastrointestinal endoscopy and a colonoscopy performed which did not identify 5001.12.2023the cause ofthe bleeding. (Anaes.) 1030684 01.07.2007 3 T8 1 SN NYNNY 2001.12.202304369.0001584.8500000.00 4001.07.2007(Anaes.) 5001.12.2023Balloon enteroscopy, examination of the small bowel (oral approach), with or 5001.12.2023without biopsy, WITH 1 or more of the following procedures (snare polypectomy, 5001.12.2023removal of foreign body, diathermy, heater probe, laser coagulation or argon 5001.12.2023plasma coagulation), for diagnosis and management of patients with obscure 5001.12.2023gastrointestinal bleeding, not in association with another item in this 5001.12.2023subgroup (with the exception of item 30682 or 30686) The patient to whom the 5001.12.2023service is provided must: (i)have recurrent or persistent bleeding; and (ii)be 5001.12.2023anaemic or have active bleeding; and (iii)have had an upper gastrointestinal 5001.12.2023endoscopy and a colonoscopy performed which did not identify the cause of the 5001.12.2023bleeding. (Anaes.) 1030686 01.07.2007 3 T8 1 SN NYNNY 2001.12.202304369.0001584.8500000.00 4001.07.2007(Anaes.) 5001.12.2023Balloon enteroscopy, examination of the small bowel (anal approach), with or 5001.12.2023without biopsy, WITH 1 or more of the following procedures (snare polypectomy, 5001.12.2023removal of foreign body, diathermy, heater probe, laser coagulation or argon 5001.12.2023plasma coagulation), for diagnosis and management of patients with obscure 5001.12.2023gastrointestinal bleeding, not in association with another item in this 5001.12.2023subgroup (with the exception of item 30680 or 30684) The patient to whom the 5001.12.2023service is provided must: (i)have recurrent or persistent bleeding; and (ii)be 5001.12.2023anaemic or have active bleeding; and (iii)have had an upper gastrointestinal 5001.12.2023endoscopy and a colonoscopy performed which did not identify the cause of the 5001.12.2023bleeding. (Anaes.) 1030687 01.11.2012 3 T8 1 SN NYNNY 2001.12.202301445.0000524.0000000.00 4001.11.2012(Anaes.) 5001.12.2023ENDOSCOPY with RADIOFREQUENCY ABLATION of mucosal metaplasia for the treatment 5001.12.2023of Barrett's Oesophagus in a single course of treatment, following diagnosis 5001.12.2023of high grade dysplasia confirmed by histological examination (Anaes.) 1030688 01.07.2007 3 T8 1 SN NYNYY 2001.12.202301107.0000401.7000000.00 4001.07.2007(Anaes.) 5001.12.2023Endoscopicultrasound(endoscopy with ultrasound imaging), with or without 5001.12.2023biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic 5001.12.2023cancer, not in association with another item in this Subgroup (other than item 5001.12.202330484, 30485, 30491 or 30494) and other than a service associated with the 5001.12.2023routine monitoring of chronic pancreatitis. (Anaes.) 1030690 01.07.2007 3 T8 1 SN NYNYY 2001.12.202301710.0000620.1000000.00 4001.07.2007(Anaes.) 5001.12.2023Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without 5001.12.2023biopsy,with fine needle aspiration, including aspiration of the locoregional 5001.12.2023lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric 5001.12.2023or pancreatic cancer, not in association with another item in this Subgroup 5001.12.2023(other than item 30484, 30485, 30491 or 30494)and other than a service 5001.12.2023associated with the routine monitoring of chronic pancreatitis. (Anaes.) 1030692 01.07.2007 3 T8 1 SN NYNYY 2001.12.202301107.0000401.7000000.00 4001.07.2007(Anaes.) 5001.12.2023Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without 5001.12.2023biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric 5001.12.2023submucosal tumours, not in association with another item in this Subgroup 5001.12.2023(other than item 30484, 30485, 30491 or 30494)and other than a service 5001.12.2023associated with the routine monitoring of chronic pancreatitis. (Anaes.) 1030694 01.07.2007 3 T8 1 SN NYNYY 2001.12.202301710.0000620.1000000.00 4001.07.2007(Anaes.) 5001.12.2023Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without 5001.12.2023biopsy,with fine needle aspiration,for the diagnosis of 1 or more of 5001.12.2023pancreatic, biliary or gastric submucosal tumours,not in association with 5001.12.2023another item in this Subgroup (other than item 30484, 30485, 30491 or 5001.12.202330494)and other than a service associated with the routine monitoring of 5001.12.2023chronic pancreatitis. (Anaes.) 1030720 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301525.0000490.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Appendicectomy, on a patient 10 years of age or over, whether performed by:(a) 5001.12.2023laparoscopy or right iliac fossa open incision; or(b) conversion of a 5001.12.2023laparoscopy to an open right iliac fossa incision;other than a service to 5001.12.2023which item 30574 applies (Anaes.) (Assist.) 1030721 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301555.0000531.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Laparotomy or laparoscopy, or laparoscopy converted to laparotomy, with or 5001.12.2023without associated biopsies, including the division of adhesions (if 5001.12.2023performed, but only if the time taken to divide adhesions is 45 minutes or 5001.12.2023less), if no other intra-abdominal procedure is performed (Anaes.) (Assist.) 1030722 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301770.0000573.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Laparotomy or laparoscopy, on a patient 10 years of age or over, including any 5001.12.2023of the following procedures (if performed, and including division of one or 5001.12.2023more adhesions, but only if the time taken to divide the adhesions is 45 5001.12.2023minutes or less): (a) colostomy; (b) colotomy; (c) cholecystostomy; (d) 5001.12.2023enterostomy; (e) enterotomy; (f) gastrostomy; (g) gastrotomy; (h) caecostomy; 5001.12.2023(i) gastric fixation by cardiopexy; (j) reduction of intussusception; (k) 5001.12.2023simple repair of ruptured viscus (including perforated peptic ulcer); (l) 5001.12.2023reduction of volvulus; (m) drainage of pancreas (Anaes.) (Assist.) 1030723 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301770.0000573.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Laparotomy, laparoscopy or extra-peritoneal approach, for drainage of an 5001.12.2023intra-abdominal, pancreatic or retroperitoneal collection or abscess (Anaes.) 5001.12.2023(Assist.) 1030724 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302225.0000576.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Laparotomy or laparoscopy with division of adhesions, lasting more than 45 5001.12.2023minutes but less than 2 hours, performed either:(a) as a primary procedure; 5001.12.2023or(b) when the division of adhesions is performed in conjunction with another 5001.12.2023primary procedureto provide access to a surgical field (but excluding 5001.12.2023mobilisation or normal anatomical dissection of the organ or structure for 5001.12.2023which the primary procedure is being carried out) (Anaes.) (Assist.) 1030725 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302970.0001021.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Laparotomy or laparoscopy for intestinal obstruction or division of extensive, 5001.12.2023complex adhesions, lasting 2 hours or more, performed either:a) as a primary 5001.12.2023procedure; orb) when the division of adhesions is performed in conjunction 5001.12.2023with another procedureto provide access to a surgical field, but excluding 5001.12.2023mobilisation or normal anatomical dissection of the organ or structure for 5001.12.2023which the other procedure is being carried out (Anaes.) (Assist.) 1030730 01.07.2021 3 T8 1 SN NYNNY 2001.12.202303085.0001065.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Small intestine, resection of, including either of the following:(a) a small 5001.12.2023bowel diverticulum (such as Meckels procedure) with anastomosis;(b) 5001.12.2023stricturoplasty (Anaes.) (Assist.) 1030731 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302320.0000799.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Intraoperative enterotomy for visualisation of the small intestine by 5001.12.2023endoscopy, including endoscopic examination using a flexible endoscope, with 5001.12.2023or without biopsies (Anaes.) (Assist.) 1030732 01.07.2021 3 T8 1 SN NYNNY 2001.12.202312885.0004375.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Peritonectomy, lasting more than 5 hours, including hyperthermic 5001.12.2023intra-peritoneal chemotherapy (Anaes.) (Assist.) 1030750 01.07.2021 3 T8 1 SN NYNNY 2001.12.202306590.0002269.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy with colon or jejunal interposition graft, by any approach, 5001.12.2023including:(a) any gastrointestinal anastomoses (except vascular anastomoses); 5001.12.2023and(b) anastomoses in the chest or neck (if appropriate)One surgeon (Anaes.) 5001.12.2023(Assist.) 1030751 01.07.2021 3 T8 1 SN NYNNY 2001.12.202306590.0002269.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy with colon or jejunal interposition graft, by any approach, 5001.12.2023including:(a) any gastrointestinal anastomoses (except vascular anastomoses); 5001.12.2023and(b) anastomoses in the chest or neck (if appropriate)Conjoint surgery, 5001.12.2023principal surgeon (Anaes.) (Assist.) 1030752 01.07.2021 3 T8 1 SN NYNNY 2001.12.202304945.0001702.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy with colon or jejunal interposition graft, by any approach, 5001.12.2023including:(a) any gastrointestinal anastomoses (except vascular anastomoses); 5001.12.2023and(b) anastomoses in the chest or neck (if appropriate)Conjoint surgery, 5001.12.2023co-surgeon (Anaes.) (Assist.) 1030753 01.07.2021 3 T8 1 SN NYNNY 2001.12.202305500.0001894.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy, by any approach, including:(a) gastric reconstruction by 5001.12.2023abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the 5001.12.2023neck or chestOne surgeon (Anaes.) (Assist.) 1030754 01.07.2021 3 T8 1 SN NYNNY 2001.12.202305500.0001894.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy, by any approach, including:(a) gastric reconstruction by 5001.12.2023abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the 5001.12.2023neck or chestConjoint surgery, principal surgeon (Anaes.) (Assist.) 1030755 01.07.2021 3 T8 1 SN NYNNY 2001.12.202304125.0001420.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Oesophagectomy by any approach, including:(a) gastric reconstruction by 5001.12.2023abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the 5001.12.2023neck or chestConjoint surgery, co-surgeon (Anaes.) (Assist.) 1030756 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302865.0000959.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Antireflux operation by fundoplasty, with or without cardiopexy, by any 5001.12.2023approach, with or without closure of the diaphragmatic hiatus, other than a 5001.12.2023service to which item 30601 applies (Anaes.) (Assist.) 1030760 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302590.0000647.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Vagotomy, with or without gastroenterostomy, pyloroplasty or other drainage 5001.12.2023procedure (Anaes.) (Assist.) 1030761 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302445.0000835.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Bleeding peptic ulcer, control of, by laparoscopy or laparotomy, involving 5001.12.2023suture of bleeding point or wedge excision (with or without gastric 5001.12.2023resection), including either of the following (if performed):(a) vagotomy and 5001.12.2023pyloroplasty;(b) gastroenterostomy (Anaes.) (Assist.) 1030762 01.07.2021 3 T8 1 SN NYNNY 2001.12.202304810.0001830.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Gastrectomy, subtotal or total radical, for carcinoma, by open or minimally 5001.12.2023invasive approach, including all necessary anastomoses, including either or 5001.12.2023both of the following (if performed):(a) extended lymph node dissection;(b) 5001.12.2023splenectomy (Anaes.) (Assist.) 1030763 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302160.0000743.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Gastric tumour, 2cm or greater in diameter, removal of, by local excision, by 5001.12.2023endoscopic approach, including any required anastomosis, excluding 5001.12.2023polypectomy, other than a service to which item 30518 applies (Anaes.) 5001.12.2023(Assist.) 1030770 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302675.0000920.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Hydatid cyst of liver, peritoneum or viscus, complete removal of contents of, 5001.12.2023with or without suture of biliary radicles, with omentoplasty or myeloplasty 5001.12.2023(Anaes.) (Assist.) 1030771 01.07.2021 3 T8 1 SN NYNNY 2001.12.202305395.0001856.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Portal hypertension, porto-caval, meso-caval or selective spleno-renal shunt 5001.12.2023for (Anaes.) (Assist.) 1030780 01.07.2021 3 T8 1 SN NYNNY 2001.12.202304490.0001546.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Intrahepatic biliary bypass of left or right hepatic ductal system by 5001.12.2023Roux-en-Y loop to peripheral ductal system (Anaes.) (Assist.) 1030790 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302250.0000771.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Pancreatic cyst anastomosis to stomach, duodenum or small intestine, by 5001.12.2023endoscopic, open or minimally invasive approach, with or without the use of 5001.12.2023endoscopic or intraoperative ultrasound (Anaes.) (Assist.) 1030791 01.07.2021 3 T8 1 SN NYNNY 2001.12.202301395.0000479.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Pancreatic necrosectomy, by open, laparoscopic or endoscopic approach, 5001.12.2023excluding aftercare, subsequent procedure (Anaes.) (Assist.) 1030792 01.07.2021 3 T8 1 SN NYNNY 2001.12.202303810.0001314.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Distal pancreatectomy with splenectomy, by open or minimally invasive approach 5001.12.2023(Anaes.) (Assist.) 1030800 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302315.0000792.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Splenectomy, by open or minimally invasive approach, other than a service to 5001.12.2023which item 30792 applies (Anaes.) (Assist.) 1030810 01.07.2021 3 T8 1 SN NYNNY 2001.12.202303665.0001262.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Exploration of pancreas or duodenum for endocrine tumour, including associated 5001.12.2023imaging, either: (a) followed by local excision of tumour; or (b) when, after 5001.12.2023extensive exploration, no tumour is found (Anaes.) (Assist.) 1030820 01.07.2021 3 T8 1 SN NYNNY 2001.12.202300610.0000202.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Lymph node of neck, biopsy of, by open procedure, if the specimen excised is 5001.12.2023sent for pathological examination (Anaes.) 1031000 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301730.0000639.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Mohs surgery of skin tumour located on the head, neck, genitalia, hand, 5001.12.2023digits, leg (below knee) or foot, utilising horizontal frozen sections with 5001.12.2023mapping of all excised tissue, and histological examination of all excised 5001.12.2023tissue by the specialist performing the procedure, if the specialist is 5001.12.2023recognised by the Australasian College of Dermatologists as an approved Mohs 5001.12.2023surgeon6 or fewer sections (Anaes.) 1031001 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302160.0000799.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Mohs surgery of skin tumour located on the head, neck, genitalia, hand, 5001.12.2023digits, leg (below knee) or foot, utilising horizontal frozen sections with 5001.12.2023mapping of all excised tissue, and histological examination of all excised 5001.12.2023tissue by the specialist performing the procedure, if the specialist is 5001.12.2023recognised by the Australasian College of Dermatologists as an approved Mohs 5001.12.2023surgeon7 to 12 sections (inclusive) (Anaes.) 1031002 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302595.0000959.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Mohs surgery of skin tumour located on the head, neck, genitalia, hand, 5001.12.2023digits, leg (below knee) or foot, utilising horizontal frozen sections with 5001.12.2023mapping of all excised tissue, and histological examination of all excised 5001.12.2023tissue by the specialist performing the procedure, if the specialist is 5001.12.2023recognised by the Australasian College of Dermatologists as an approved Mohs 5001.12.2023surgeon13 or more sections (Anaes.) 1031003 01.11.2018 3 T8 1 SN NYNYY 2001.12.202301763.0000639.4000000.00 4001.11.2018(Anaes.) 5001.12.2023Mohs surgery of skin tumour utilising horizontal frozen sections with mapping 5001.12.2023of all excised tissue, and histological examination of all excised tissue by 5001.12.2023the specialist performing the procedure, if the specialist is recognised by 5001.12.2023the Australasian College of Dermatologists as an approved Mohs surgeon6 or 5001.12.2023fewer sections Not applicable to a service performed in association with a 5001.12.2023service to which item 31000 applies (Anaes.) 1031004 01.11.2018 3 T8 1 SN NYNYY 2001.12.202302203.0000799.2000000.00 4001.11.2018(Anaes.) 5001.12.2023Mohs surgery of skin tumour utilising horizontal frozen sections with mapping 5001.12.2023of all excised tissue, and histological examination of all excised tissue by 5001.12.2023the specialist performing the procedure, if the specialist is recognised by 5001.12.2023the Australasian College of Dermatologists as an approved Mohs surgeon7 to 12 5001.12.2023sections (inclusive) Not applicable to a service performed in association with 5001.12.2023a service to which item 31001 applies (Anaes.) 1031005 01.11.2018 3 T8 1 SN NYNYY 2001.12.202302644.0000959.0500000.00 4001.11.2018(Anaes.) 5001.12.2023Mohs surgery of skin tumour utilising horizontal frozen sections with mapping 5001.12.2023of all excised tissue, and histological examination of all excised tissue by 5001.12.2023the specialist performing the procedure, if the specialist is recognised by 5001.12.2023the Australasian College of Dermatologists as an approved Mohs surgeon13 or 5001.12.2023more sections Not applicable to a service performed in association with a 5001.12.2023service to which item 31002 applies (Anaes.) 1031206 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300320.0000105.1000000.00 4001.11.2016(Anaes.) 5001.12.2023Tumour, cyst, ulcer or scar (other than a scar removed during the surgical 5001.12.2023approach at an operation), removal of and suture, if: (a) the lesion size is 5001.12.2023not more than 10 mm in diameter; and (b) the removal is from a mucous membrane 5001.12.2023by surgical excision (other than by shave excision); and (c) the specimen 5001.12.2023excised is sent for histological examination (Anaes.) 1031211 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300405.0000135.5000000.00 4001.11.2016(Anaes.) 5001.12.2023Tumour, cyst, ulcer or scar (other than a scar removed during the surgical 5001.12.2023approach at an operation), removal of and suture, if: (a) the lesion size is 5001.12.2023more than 10 mm, but not more than 20 mm, in diameter; and (b) the removal is 5001.12.2023from a mucous membrane by surgical excision (other than by shave excision); 5001.12.2023and (c) the specimen excised is sent for histological examination (Anaes.) 1031216 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300480.0000158.0500000.00 4001.11.2016(Anaes.) 5001.12.2023Tumour, cyst, ulcer or scar (other than a scar removed during the surgical 5001.12.2023approach at an operation), removal of and suture, if: (a) the lesion size is 5001.12.2023more than 20 mm in diameter; and (b) the removal is from a mucous membrane by 5001.12.2023surgical excision (other than by shave excision); and (c) the specimen excised 5001.12.2023is sent for histological examination (Anaes.) 1031220 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300615.0000236.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Tumours (other than viral verrucae (common warts) and seborrheic keratoses), 5001.12.2023lipomas, cysts, ulcers or scars (other than scars removed during the surgical 5001.12.2023approach at an operation), removal of 4 to 10 lesions and suture, if: (a) the 5001.12.2023size of each lesion is not more than 10 mm in diameter; and (b) each removal 5001.12.2023is from cutaneous or subcutaneous tissue by surgical excision (other than by 5001.12.2023shave excision); and (c) all of the specimens excised are sent for 5001.12.2023histological examination (Anaes.) 1031221 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300615.0000236.1000000.00 4001.11.2016(Anaes.) 5001.12.2023Tumours, cysts, ulcers or scars (other than scars removed during the surgical 5001.12.2023approach at an operation), removal of 4 to 10 lesions, if: (a) the size of 5001.12.2023each lesion is not more than 10 mm in diameter; and (b) each removal is from a 5001.12.2023mucous membrane by surgical excision (other than by shave excision); and (c) 5001.12.2023each site of excision is closed by suture; and (d) all of the specimens 5001.12.2023excised are sent for histological examination (Anaes.) 1031225 26.05.2002 3 T8 1 SN NYNYY 2001.12.202301090.0000419.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Tumours (other than viral verrucae (common warts) and seborrheic keratoses), 5001.12.2023lipomas, cysts, ulcers or scars (other than scars removed during the surgical 5001.12.2023approach at an operation), removal of more than 10 lesions, if: (a) the size 5001.12.2023of each lesion is not more than 10 mm in diameter; and (b) each removal is 5001.12.2023from cutaneous or subcutaneous tissue or mucous membrane by surgical excision 5001.12.2023(other than by shave excision); and (c) each site of excision is closed by 5001.12.2023suture; and (d) all of the specimens excised are sent for histological 5001.12.2023examination (Anaes.) 1031227 01.07.2023 3 T8 1 DN YYNYN 2001.12.202300407.0000147.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Tumour, lipoma or cyst, removal of single lesion by excision and suture, where 5001.12.2023removal is from subcutaneous tissue and the specimen excised is sent for 5001.12.2023histological examination (Anaes.) 1031245 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301225.0000406.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE, extensive excision of, in the treatment of 5001.12.2023SUPPURATIVE HIDRADENITIS (excision from axilla, groin or natal cleft) or 5001.12.2023SYCOSIS BARBAE or NUCHAE (excision from face or neck) (Anaes.) 1031250 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301225.0000406.1000000.00 4026.05.2002(Anaes.) 5001.12.2023GIANT HAIRY or COMPOUND NAEVUS, excision of an area at least 1 percent of body 5001.12.2023surface where the specimen excised is sent for histological confirmation of 5001.12.2023diagnosis (Anaes.) 1031340 26.05.2002 3 T8 1 SD NNNYY 3001.12.202375% of the fee for excision of malignant tumour 4026.05.2002(Anaes.) 5001.12.2023Muscle, bone or cartilage, excision of one or more of, if clinically 5001.12.2023indicated, and if: (a) the specimen excised is sent for histological 5001.12.2023confirmation; and (b)a malignant tumour of skin covered by item 31000, 31001, 5001.12.202331002, 31003, 31004, 31005, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 5001.12.202331369, 31371,31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 5001.12.202331381, 31382 or 31383 is excised (Anaes.) 1031344 01.07.2023 3 T8 1 SN YYNYN 2001.12.202301917.0000695.3500000.00 4001.07.2023(Anaes.) 5001.12.2023Lipoma, removal of, by surgical excision or liposuction, if:(a) the lesion:(i) 5001.12.2023is subcutaneous and 150mm or more in diameter; or(ii) is submuscular, 5001.12.2023intramuscular or involves dissection of a named nerve or vessel and is 50 mm 5001.12.2023or more in diameter; and(b) a specimen of the excised lipoma is sent for 5001.12.2023histological confirmation of diagnosis (Anaes.) (Assist.) 1031345 26.05.2002 3 T8 1 SN NYNYY 2001.12.202300675.0000232.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Lipoma, removal of, by surgical excision or liposuction, if:(a) the lesion is: 5001.12.2023(i) subcutaneous and 50 mm or more in diameter but less than 150 mm in 5001.12.2023diameter; or(ii) sub fascial; and (b) the specimen excised is sent for 5001.12.2023histological confirmation of diagnosis (Anaes.) 1031346 01.05.2003 3 T8 1 SN NYNNY 2001.12.202300675.0000232.2000000.00 4001.05.2003(Anaes.) 5001.12.2023Liposuction (suction assisted lipolysis) to one regional area for contour 5001.12.2023problems of abdominal, upper arm or thigh fat because of repeated insulin 5001.12.2023injections, if: (a) the lesion is subcutaneous; and (b) the lesion is 50 mm or 5001.12.2023more in diameter; and (c) photographic and/or diagnostic imaging evidence 5001.12.2023demonstrating the need for this service is documented in the patient notes 5001.12.2023(Anaes.) 1031350 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301390.0000476.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Benign tumour of soft tissue (other than tumours of skin, cartilage and bone, 5001.12.2023simple lipomas covered by item 31345 and lipomata), removal of, by surgical 5001.12.2023excision, on a patient 10 years of age or over, if the specimen excised is 5001.12.2023sent for histological confirmation of diagnosis, other than a service to which 5001.12.2023another item in this Group applies (Anaes.) (Assist.) 1031355 26.05.2002 3 T8 1 SN NYNNY 2001.12.202302290.0000786.4500000.00 4026.05.2002(Anaes.) 5001.12.2023MALIGNANT TUMOURof SOFT TISSUE, excluding tumours of skin, cartilage and bone, 5001.12.2023removal of by surgical excision, where histological proof of malignancy has 5001.12.2023been obtained, not being a service to which another item in this Group applies 5001.12.2023(Anaes.) (Assist.) 1031356 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300735.0000243.6000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit 5001.12.2023or genitalia, or from a contiguous area; and (b) the necessary excision 5001.12.2023diameter is less than 6 mm; and (c) the excised specimen is sent for 5001.12.2023histological examination; and (d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy; not in association with item 45201 (Anaes.) 1031357 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300365.0000120.7000000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous 5001.12.2023area; and (b) the necessary excision diameter is less than 6 mm; and (c) the 5001.12.2023excised specimen is sent for histological examination; not in association with 5001.12.2023item 45201 (Anaes.) 1031358 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300900.0000298.1500000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit 5001.12.2023or genitalia, or from a contiguous area; and (b) the necessary excision 5001.12.2023diameter is 6 mm or more; and (c) the excised specimen is sent for 5001.12.2023histological examination; and (d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy (Anaes.) 1031359 01.11.2016 3 T8 1 SN NYNYY 2001.12.202301100.0000363.4000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision), if: (a) the 5001.12.2023lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia 5001.12.2023(the applicable site); and (b) the necessary excision area is at least one 5001.12.2023third of the surface area of the applicable site; and (c) the excised specimen 5001.12.2023is sent for histological examination; and (d) malignancy is confirmed from the 5001.12.2023excised specimen or previous biopsy (H) (Anaes.) 1031360 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300560.0000184.9500000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous 5001.12.2023area; and (b) the necessary excision diameter is 6 mm or more; and (c) the 5001.12.2023excised specimen is sent for histological examination (Anaes.) 1031361 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300620.0000205.5000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola 5001.12.2023complex, distal lower limb (distal to, and including, the knee) or distal 5001.12.2023upper limb (distal to, and including, the ulnar styloid); and (b) the 5001.12.2023necessary excision diameter is less than 14 mm; and (c) the excised specimen 5001.12.2023is sent for histological examination; and (d) malignancy is confirmed from the 5001.12.2023excised specimen or previous biopsy; not in association with item 45201 5001.12.2023(Anaes.) 1031362 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300450.0000147.4500000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, 5001.12.2023and including, the knee) or distal upper limb (distal to, and including, the 5001.12.2023ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; 5001.12.2023and (c) the excised specimen is sent for histological examination; not in 5001.12.2023association with item 45201 (Anaes.) 1031363 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300815.0000268.8500000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola 5001.12.2023complex, distal lower limb (distal to, and including, the knee) or distal 5001.12.2023upper limb (distal to, and including, the ulnar styloid); and (b) the 5001.12.2023necessary excision diameter is 14 mm or more; and (c) the excised specimen is 5001.12.2023sent for histological examination; and (d) malignancy is confirmed from the 5001.12.2023excised specimen or previous biopsy (Anaes.) 1031364 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300560.0000184.9500000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, 5001.12.2023and including, the knee) or distal upper limb (distal to, and including, the 5001.12.2023ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and 5001.12.2023(c) the excised specimen is sent for histological examination (Anaes.) 1031365 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300530.0000174.2000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331369, 31370, 31371, 31372, 31373, 31377, 31378 or 31379), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from any part of the body not covered by item 31356, 31358, 31359, 31361 or 5001.12.202331363; and (b) the necessary excision diameter is less than 15 mm; and (c) the 5001.12.2023excised specimen is sent for histological examination; and (d) malignancy is 5001.12.2023confirmed from the excised specimen or previous biopsy; not in association 5001.12.2023with item 45201 (Anaes.) 1031366 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300315.0000105.1000000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from any part of the body not covered by item 31357, 31360, 31362 or 31364; 5001.12.2023and (b) the necessary excision diameter is less than 15 mm; and (c) the 5001.12.2023excised specimen is sent for histological examination; not in association with 5001.12.2023item 45201 (Anaes.) 1031367 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300710.0000235.1000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from any part of the body not covered by 5001.12.2023item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision 5001.12.2023diameter is at least 15 mm but not more than 30 mm; and (c) the excised 5001.12.2023specimen is sent for histological examination; and (d) malignancy is confirmed 5001.12.2023from the excised specimen or previous biopsy; not in association with item 5001.12.202345201 (Anaes.) 1031368 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300420.0000138.2000000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from any part of the body not covered by item 31357, 31360, 31362 or 31364; 5001.12.2023and (b) the necessary excision diameter is at least 15 mm but not more than 5001.12.202330mm; and (c) the excised specimen is sent for histological examination; not 5001.12.2023in association with item 45201 (Anaes.) 1031369 01.11.2016 3 T8 1 SN NYNYY 2001.12.202300820.0000270.7000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if: (a) the lesion is excised from any part of the body not covered by 5001.12.2023item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision 5001.12.2023diameter is more than 30 mm; and (c) the excised specimen is sent for 5001.12.2023histological examination; and (d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy (Anaes.) 1031370 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300480.0000158.0500000.00 4001.11.2016(Anaes.) 5001.12.2023Non-malignant skin lesion (other than viral verrucae (common warts) and 5001.12.2023seborrheic keratoses), including a cyst, ulcer or scar (other than a scar 5001.12.2023removed during the surgical approach at an operation), surgical excision 5001.12.2023(other than by shave excision) and repair of, if: (a) the lesion is excised 5001.12.2023from any part of the body not covered by item 31357, 31360, 31362 or 31364; 5001.12.2023and (b) the necessary excision diameter is more than 30 mm; and (c) the 5001.12.2023excised specimen is sent for histological examination (Anaes.) 1031371 01.11.2016 3 T8 1 SN NYNNY 2001.12.202301190.0000392.9500000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from nose, eyelid, eyebrow, lip, 5001.12.2023ear, digit or genitalia, or from a contiguous area; and (b) the necessary 5001.12.2023excision diameter is 6 mm or more; and (c) the excised specimen is sent for 5001.12.2023histological examination; and (d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy (Anaes.) 1031372 01.11.2016 3 T8 1 SN NYNNY 2001.12.202301025.0000339.8000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from face, neck, scalp, 5001.12.2023nipple-areola complex, distal lower limb (distal to, and including, the knee) 5001.12.2023or distal upper limb (distal to, and including, the ulnar styloid); and (b) 5001.12.2023the necessary excision diameter is less than 14 mm; and (c) the excised 5001.12.2023specimen is sent for histological examination; and (d) malignancy is confirmed 5001.12.2023from the excised specimen or previous biopsy; not in association with a 5001.12.2023service to which item 45201 applies (Anaes.) 1031373 01.11.2016 3 T8 1 SN NYNNY 2001.12.202301190.0000392.7500000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from face, neck, scalp, 5001.12.2023nipple-areola complex, distal lower limb (distal to, and including, the knee) 5001.12.2023or distal upper limb (distal to, and including, the ulnar styloid); and (b) 5001.12.2023the necessary excision diameter is 14 mm or more; and (c) the excised specimen 5001.12.2023is sent for histological examination; and (d) malignancy is confirmed from the 5001.12.2023excised specimen or previous biopsy (Anaes.) 1031374 01.11.2016 3 T8 1 SN NYNNY 2001.12.202300935.0000310.3000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from any part of the body not 5001.12.2023covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter 5001.12.2023is less than 15 mm; and (c) the excised specimen is sent for histological 5001.12.2023examination; and (d) malignancy is confirmed from the excised specimen or 5001.12.2023previous biopsy; not in association with a service to which item 45201 applies 5001.12.2023(Anaes.) 1031375 01.11.2016 3 T8 1 SN NYNNY 2001.12.202301010.0000333.9000000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from any part of the body not 5001.12.2023covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter 5001.12.2023is at least 15 mm but not more than 30 mm; and (c) the excised specimen is 5001.12.2023sent for histological examination; and (d) malignancy is confirmed from the 5001.12.2023excised specimen or previous biopsy; not in association with a service to 5001.12.2023which item 45201 applies (Anaes.) 1031376 01.11.2016 3 T8 1 SN NYNNY 2001.12.202301170.0000387.0500000.00 4001.11.2016(Anaes.) 5001.12.2023Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour 5001.12.2023of skin or merkel cell carcinoma of skin, definitive surgical excision (other 5001.12.2023than by shave excision) and repair of, including excision of the primary 5001.12.2023tumour bed, if: (a) the tumour is excised from any part of the body not 5001.12.2023covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter 5001.12.2023is more than 30 mm; and (c) the excised specimen is sent for histological 5001.12.2023examination; and (d) malignancy is confirmed from the excised specimen or 5001.12.2023previous biopsy (Anaes.) 1031377 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300365.0000120.7000000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from nose, eyelid, 5001.12.2023eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the 5001.12.2023necessary excision diameter is less than 6 mm; and (c) the excised specimen is 5001.12.2023sent for histological examination; not in association with a service to which 5001.12.2023item 45201 applies (Anaes.) 1031378 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300560.0000184.9500000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from nose, eyelid, 5001.12.2023eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the 5001.12.2023necessary excision diameter is 6 mm or more; and (c) the excised specimen is 5001.12.2023sent for histological examination (Anaes.) 1031379 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300450.0000147.4500000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, 5001.12.2023nippleareola complex, distal lower limb (distal to, and including, the knee) 5001.12.2023or distal upper limb (distal to, and including, the ulnar styloid); and (b) 5001.12.2023the necessary excision diameter is less than 14 mm; and (c) the excised 5001.12.2023specimen is sent for histological examination; not in association with a 5001.12.2023service to which item 45201 applies (Anaes.) 1031380 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300560.0000184.9500000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, 5001.12.2023nippleareola complex, distal lower limb (distal to, and including, the knee) 5001.12.2023or distal upper limb (distal to, and including, the ulnar styloid); and (b) 5001.12.2023the necessary excision diameter is 14 mm or more; and (c) the excised specimen 5001.12.2023is sent for histological examination (Anaes.) 1031381 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300315.0000105.1000000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from any part of the 5001.12.2023body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary 5001.12.2023excision diameter is less than 15 mm; and (c) the excised specimen is sent for 5001.12.2023histological examination; not in association with a service to which item 5001.12.202345201 applies (Anaes.) 1031382 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300420.0000138.2000000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from any part of the 5001.12.2023body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary 5001.12.2023excision diameter is at least 15 mm but not more than 30 mm; and (c) the 5001.12.2023excised specimen is sent for histological examination; not in association with 5001.12.2023a service to which item 45201 applies (Anaes.) 1031383 01.11.2022 3 T8 1 SN NYNNY 2001.12.202300480.0000158.0500000.00 4001.11.2022(Anaes.) 5001.12.2023Clinically suspected melanoma, surgical excision (other than by shave 5001.12.2023excision) and repair of, if: (a) the lesion is excised from any part of the 5001.12.2023body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary 5001.12.2023excision diameter is more than 30 mm; and (c) the excised specimen is sent for 5001.12.2023histological examination (Anaes.) 1031386 01.07.2023 3 T8 1 SN YYNYN 2001.12.202302168.0000786.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if:(a) the lesion is excised from the head or neck; and(b) the necessary 5001.12.2023excision diameter is more than 50 mm; and(c) the excision involves at least 2 5001.12.2023critical areas (eyelid, nose, ear, mouth); and(d) the excised specimen is sent 5001.12.2023for histological examination; and(e) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy; and(f) the service is not covered by item 31387 5001.12.2023(Anaes.) (Assist.) 1031387 01.07.2023 3 T8 1 SN YYNYN 2001.12.202301951.0000707.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if:(a) the lesion is excised from the head or neck; and(b) the necessary 5001.12.2023excision diameter is more than 70 mm; and(c) the excised specimen is sent for 5001.12.2023histological examination; and(d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy; and(e) the service is not covered by item 31386 5001.12.2023(Anaes.) (Assist.) 1031388 01.07.2023 3 T8 1 SN YYNYN 2001.12.202301756.0000636.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Malignant skin lesion (other than a malignant skin lesion covered by item 5001.12.202331371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 5001.12.202331382 or 31383), surgical excision (other than by shave excision) and repair 5001.12.2023of, if:(a) the lesion is excised from the trunk or limbs; and(b) the necessary 5001.12.2023excision diameter is more than 120 mm; and(c) the excised specimen is sent for 5001.12.2023histological examination; and(d) malignancy is confirmed from the excised 5001.12.2023specimen or previous biopsy (Anaes.) (Assist.) 1031400 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300885.0000287.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR up to and including 20mm in 5001.12.2023diameter (excluding tumour of the lip), excision of, where histological 5001.12.2023confirmation of malignancy has been obtained (Anaes.) (Assist.) 1031403 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301025.0000331.6500000.00 4026.05.2002(Anaes.) 5001.12.2023MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 20mm and up to and 5001.12.2023including 40mm in diameter (excluding tumour of the lip), excision of, where 5001.12.2023histological confirmation of malignancy has been obtained (Anaes.) (Assist.) 1031406 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301705.0000552.7000000.00 4026.05.2002(Anaes.) 5001.12.2023MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 40mm in diameter 5001.12.2023(excluding tumour of the lip), excision of, where histological confirmation of 5001.12.2023malignancy has been obtained (Anaes.) (Assist.) 1031409 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305160.0001717.3000000.00 4026.05.2002(Anaes.) 5001.12.2023PARAPHARYNGEAL TUMOUR, excision of, by cervical approach (Anaes.) (Assist.) 1031412 26.05.2002 3 T8 1 SN NYNNY 2001.12.202305870.0002115.3000000.00 4026.05.2002(Anaes.) 5001.12.2023RECURRENT OR PERSISTENT PARAPHARYNGEAL TUMOUR, excision of, by cervical 5001.12.2023approach (Anaes.) (Assist.) 1031423 26.05.2002 3 T8 1 SN NYNYY 2001.12.202301219.0000442.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, selective dissection of one or 2 lymph node levels 5001.12.2023involving removal of soft tissue and lymph nodes from one side of the neck, on 5001.12.2023a patient 10 years of age or over, other than a service associated with a 5001.12.2023service to which item 30256 or 30275 applies on the same side (Anaes.) 5001.12.2023(Assist.) 1031426 26.05.2002 3 T8 1 SN NYNYY 2001.12.202302438.0000884.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, selective dissection of 3 lymph node levels involving 5001.12.2023removal of soft tissue and lymph nodes from one side of the neck,other than a 5001.12.2023service associated with a service to which item 30256 or 30275 applies on the 5001.12.2023same side(H) (Anaes.) (Assist.) 1031429 26.05.2002 3 T8 1 SN NYNYY 2001.12.202303800.0001378.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, selective dissection of 4 lymph node levels on one side 5001.12.2023of the neck with preservation of one or more of: internal jugular vein, 5001.12.2023sternocleido-mastoid muscle, or spinal accessory nerve, other than a service 5001.12.2023associated with a service to which item 30256 or 30275 applies on the same 5001.12.2023side(H) (Anaes.) (Assist.) 1031432 26.05.2002 3 T8 1 SN NYNYY 2001.12.202304064.0001474.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, bilateral selective dissection of levels I, II and III 5001.12.2023(bilateral supraomohyoid dissections),other than a service associated with a 5001.12.2023service to which item 30256 or 30275 applies on the same side(H) (Anaes.) 5001.12.2023(Assist.) 1031435 26.05.2002 3 T8 1 SN NYNYY 2001.12.202302987.0001083.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, comprehensive dissection of all 5 lymph node levels on 5001.12.2023one side of the neck,other than a service associated with a service to which 5001.12.2023item 30256 or 30275 applies on the same side(H) (Anaes.) (Assist.) 1031438 26.05.2002 3 T8 1 SN NYNYY 2001.12.202304735.0001717.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Lymph nodes of neck, comprehensive dissection of all 5 lymph node levels on 5001.12.2023one side of the neck with preservation of one or more of: internal jugular 5001.12.2023vein, sternocleido-mastoid muscle, or spinal accessory nerve,other than a 5001.12.2023service associated with a service to which item 30256 or 30275 applies on the 5001.12.2023same side(H) (Anaes.) (Assist.) 1031454 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301850.0000620.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Laparoscopy or laparotomy with drainage of bile, as an independent procedure 5001.12.2023(H) (Anaes.) (Assist.) 1031456 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300805.0000270.3500000.00 4026.05.2002(Anaes.) 5001.12.2023GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where 5001.12.2023blind insertion of the feeding tube has failed or is inappropriate due to the 5001.12.2023patient's medical condition (Anaes.) 1031458 26.05.2002 3 T8 1 SN NYNNY 2001.12.202300970.0000324.3000000.00 4026.05.2002(Anaes.) 5001.12.2023GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where 5001.12.2023blind insertion of the feeding tube has failed or is inappropriate due to the 5001.12.2023patient's medical condition, and where the use of imaging intensification is 5001.12.2023clinically indicated (Anaes.) 1031460 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301170.0000392.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS GASTROSTOMY TUBE, jejunal extension to, including any associated 5001.12.2023imaging services (Anaes.) (Assist.) 1031462 26.05.2002 3 T8 1 SN NYNNY 2001.12.202301710.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATIVE FEEDING JEJUNOSTOMY performed in conjunction with major upper 5001.12.2023gastro-intestinal resection (Anaes.) (Assist.) 1031466 26.05.2002 3 T8 1 SN NYNNY 2001.12.202303966.0001438.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ANTIREFLUX OPERATION BY FUNDOPLASTY, via abdominal or thoracic approach, with 5001.12.2023or without closure of the diaphragmatic hiatus, revision procedure, by 5001.12.2023laparoscopy or open operation (Anaes.) (Assist.) 1031468 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304715.0001580.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Para-oesophageal hiatus hernia, repair of, with complete reduction of hernia, 5001.12.2023resection of sac and repair of hiatus, with or without fundoplication, other 5001.12.2023than a service associated with a service to which item 30756 or 31466 applies 5001.12.2023(Anaes.) (Assist.) 1031472 26.05.2002 3 T8 1 SN NYNNY 2001.12.202304082.0001480.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Cholecystoduodenostomy, cholecystoenterostomy, choledochojejunostomy or 5001.12.2023Roux-en-y loop to provide biliary drainage or bypass, other than a service 5001.12.2023associated with a service to which item 30584 applies (Anaes.) (Assist.) 1031500 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300685.0000286.2000000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, BENIGN LESION up to and including 50mm in diameter, including simple 5001.12.2023cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision 5001.12.2023of, with or without frozen section histology (Anaes.) 1031503 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300910.0000381.6500000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, BENIGN LESION more than 50mm in diameter, excision of (Anaes.) 5001.12.2023(Assist.) 1031506 01.11.2002 3 T8 1 SN NYNNY 2001.12.202301025.0000429.4000000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or 5001.12.2023other localisation procedure is performed, excision biopsy of (Anaes.) 5001.12.2023(Assist.) 1031509 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300855.0000381.6500000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen 5001.12.2023section histology (Anaes.) 1031512 01.11.2002 3 T8 1 SN NYNYY 2001.12.202301600.0000715.6000000.00 4001.11.2002(Anaes.) 5001.12.2023Breast, malignant tumour, complete local excision of, with or without frozen 5001.12.2023section histology, other than a service associated with a service to which:(a) 5001.12.2023item 45523 or 45558 applies; and(b) item 31513, 31514, 45520, 45522 or 45556 5001.12.2023applies on the same side (if performed by the same medical practitioner)(H) 5001.12.2023(Anaes.) (Assist.) 1031513 01.07.2023 3 T8 1 SN YYNYN 2001.12.202302579.0000935.6000000.00 4001.07.2023(Anaes.) 5001.12.2023Breast, malignant tumour, complete local excision of, with simultaneous 5001.12.2023reshaping of the breast parenchyma using techniques such as round block or 5001.12.2023rotation flaps, other than a service associated with a service to which:(a) 5001.12.2023item 45523 or 45558 applies; and(b) item 31512, 31514, 45520, 45522 or 45556 5001.12.2023applies on the same side(H) (Anaes.) (Assist.) 1031514 01.07.2023 3 T8 1 SN YYNYN 2001.12.202303719.0001348.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Breast, malignant tumour, complete local excision of, with simultaneous 5001.12.2023ipsilateral pedicled breast reduction, including repositioning of the nipple, 5001.12.2023other than a service associated with a service to which:(a) item 45523 or 5001.12.202345558 applies; and(b) item 31512, 31513, 45520, 45522 or 45556 applies on the 5001.12.2023same side(H) (Anaes.) (Assist.) 1031515 01.11.2002 3 T8 1 SN NYNNY 2001.12.202301075.0000480.1000000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete 5001.12.2023excision of malignant tumour (Anaes.) (Assist.) 1031516 01.09.2015 3 T8 1 SN NYNYY 2001.12.202302145.0000954.3000000.00 4001.09.2015(Anaes.) 5001.12.2023BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen 5001.12.2023section histology when targeted intraoperative radiation therapy(using an 5001.12.2023Intrabeam or Xoft Axxent device) is performed concurrently, if the patient 5001.12.2023satisfies the requirements mentioned in paragraphs(a) to (g) of item 15900 5001.12.2023Applicable only once per breast per lifetime (H) (Anaes.) (Assist.) 1031519 01.07.2014 3 T8 1 SN NYNYY 2001.12.202301690.0000810.2000000.00 4001.07.2014(Anaes.) 5001.12.2023Total mastectomy (unilateral) (H) (Anaes.) (Assist.) 1031520 01.07.2023 3 T8 1 SN YYNYN 2001.12.202303909.0001417.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Total mastectomy (bilateral) (H) (Anaes.) (Assist.) 1031522 01.07.2023 3 T8 1 SN YYNYN 2001.12.202303157.0001145.0000000.00 4001.07.2023(Anaes.) 5001.12.2023Skin sparing mastectomy (unilateral) (H) (Anaes.) (Assist.) 1031523 01.07.2023 3 T8 1 SN YYNYN 2001.12.202305524.0002003.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Skin sparing mastectomy (bilateral) (H) (Anaes.) (Assist.) 1031525 01.07.2014 3 T8 1 SN NYNYY 2001.12.202301578.0000572.3500000.00 4001.07.2014(Anaes.) 5001.12.2023Mastectomy for gynaecomastia (unilateral), with or without liposuction 5001.12.2023(suction assisted lipolysis), if:(a) breast enlargement is not due to obesity 5001.12.2023and is not proportionate to body habitus; and(b) sufficient photographic 5001.12.2023evidence demonstrating the clinical need for the service is included in 5001.12.2023patient notes;not being a service associated with a service to which item 5001.12.202345585 applies (H) (Anaes.) (Assist.) 1031526 01.07.2023 3 T8 1 SN YYNYN 2001.12.202302762.0001001.6500000.00 4001.07.2023(Anaes.) 5001.12.2023Mastectomy for gynaecomastia (bilateral), with or without liposuction (suction 5001.12.2023assisted lipolysis), if:(a) breast enlargement is not due to obesity and is 5001.12.2023not proportionate to body habitus; and(b) sufficient photographic evidence 5001.12.2023demonstrating the clinical need for the service is included in patient 5001.12.2023notes;not being a service associated with a service to which item 45585 5001.12.2023applies (H) (Anaes.) (Assist.) 1031528 01.07.2023 3 T8 1 SN YYNYN 2001.12.202303157.0001145.0000000.00 4001.07.2023(Anaes.) 5001.12.2023Nipple sparing mastectomy (unilateral) (H) (Anaes.) (Assist.) 1031529 01.07.2023 3 T8 1 SN YYNYN 2001.12.202305524.0002003.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Nipple sparing mastectomy (bilateral) (H) (Anaes.) (Assist.) 1031530 01.11.2002 3 T8 1 SN NYNNY 2001.12.202301490.0000655.6500000.00 5001.12.2023Breast, biopsy of solid tumour or tissue of, using a vacuum-assisted breast 5001.12.2023biopsy device under imaging guidance, for histological examination, if imaging 5001.12.2023has demonstrated:(a) microcalcification of lesion; or(b) impalpable lesion 5001.12.2023less than one cm in diameter;including pre-operative localisation of lesion, 5001.12.2023if performed, other than a service associated with a service to which item 5001.12.202331548 applies 1031533 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300360.0000151.8000000.00 4001.11.2002(Anaes.) 5001.12.2023FINE NEEDLE ASPIRATION of an impalpable breast lesion detected by mammography 5001.12.2023or ultrasound, imaging guided - but not including imaging (Anaes.) 1031536 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300610.0000208.5000000.00 4001.11.2002(Anaes.) 5001.12.2023Breast, preoperative localisation of lesion of, by hookwire or similar device, 5001.12.2023using interventional imaging techniques, but not including imaging (Anaes.) 5001.12.2023(Anaes.) 1031548 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300440.0000220.1500000.00 4001.11.2002(Anaes.) 5001.12.2023Breast, biopsy of solid tumour or tissue of, using mechanical biopsy device, 5001.12.2023for histological examination, other than a service associated with a service 5001.12.2023to which item 31530 applies (Anaes.) (Anaes.) 1031551 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300535.0000238.5500000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, HAEMATOMA, SEROMA OR INFLAMMATORY CONDITION including abscess, 5001.12.2023granulomatous mastitis or similar, exploration and drainage of when undertaken 5001.12.2023in the operating theatre of a hospital, excluding aftercare (Anaes.) 1031554 01.11.2002 3 T8 1 SN NYNNY 2001.12.202301140.0000477.1000000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST, microdochotomy of, for benign or malignant condition (Anaes.) 5001.12.2023(Assist.) 1031557 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300855.0000381.6500000.00 4001.11.2002(Anaes.) 5001.12.2023BREAST CENTRAL DUCTS, excision of, for benign condition (Anaes.) (Assist.) 1031560 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300910.0000381.6500000.00 4001.11.2002(Anaes.) 5001.12.2023ACCESSORY BREAST TISSUE, excision of (Anaes.) (Assist.) 1031563 01.11.2002 3 T8 1 SN NYNYY 2001.12.202300535.0000285.8500000.00 4001.11.2002(Anaes.) 5001.12.2023Inverted nipple, surgical eversion of, with or without flap repair, if the 5001.12.2023nipple cannot readily be everted manually (Anaes.) 1031566 01.11.2002 3 T8 1 SN NYNNY 2001.12.202300405.0000143.0500000.00 4001.11.2002(Anaes.) 5001.12.2023ACCESSORY NIPPLE, excision of (Anaes.) 1031569 01.07.2013 3 T8 1 SN NYNNY 2001.12.202302810.0000935.1500000.00 4001.07.2013(Anaes.) 5001.12.2023Adjustable gastric band, placement of, with or without crural repair taking 45 5001.12.2023minutes or less, for a patient with clinically severe obesity (Anaes.) 5001.12.2023(Assist.) 1031572 01.07.2013 3 T8 1 SN NYNNY 2001.12.202303885.0001150.7000000.00 4001.07.2013(Anaes.) 5001.12.2023Gastric bypass by Roux-en-Y including associated anastomoses, with or without 5001.12.2023crural repair taking 45 minutes or less, for a patient with clinically severe 5001.12.2023obesity not being associated with a service to which item 30515 applies 5001.12.2023(Anaes.) (Assist.) 1031575 01.07.2013 3 T8 1 SN NYNNY 2001.12.202302810.0000935.1500000.00 4001.07.2013(Anaes.) 5001.12.2023Sleeve gastrectomy, with or without crural repair taking 45 minutes or less, 5001.12.2023for a patient with clinically severe obesity (Anaes.) (Assist.) 1031578 01.07.2013 3 T8 1 SN NYNNY 2001.12.202302810.0000935.1500000.00 4001.07.2013(Anaes.) 5001.12.2023Gastroplasty (excluding by gastric plication), with or without crural repair 5001.12.2023taking 45 minutes or less, for a patient with clinically severe obesity 5001.12.2023(Anaes.) (Assist.) 1031581 01.07.2013 3 T8 1 SN NYNNY 2001.12.202303885.0001150.7000000.00 4001.07.2013(Anaes.) 5001.12.2023Gastric bypass by biliopancreatic diversion with or without duodenal switch 5001.12.2023including gastric resection and anastomoses, with or without crural repair 5001.12.2023taking 45 minutes or less, for a patient with clinically severe obesity 5001.12.2023(Anaes.) (Assist.) 1031584 01.07.2013 3 T8 1 SN NYNNY 2001.12.202304920.0001694.1500000.00 4001.07.2013(Anaes.) 5001.12.2023Surgical reversal of previous bariatric procedure, including revision or 5001.12.2023conversion, if:a) the previous procedure involved any of the following:(i) 5001.12.2023placement of adjustable gastric banding;(ii) gastric bypass;(iii) sleeve 5001.12.2023gastrectomy;(iv) gastroplasty (excluding gastric plication);(v) 5001.12.2023biliopancreatic diversion; and(b) any of items 31569 to 31581 applied to the 5001.12.2023previous procedureother than a service associated with a service to which item 5001.12.202331585 applies (Anaes.) (Assist.) 1031585 01.07.2021 3 T8 1 SN NYNNY 2001.12.202302910.0000915.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Removal of adjustable gastric band (Anaes.) (Assist.) 1031587 01.07.2013 3 T8 1 SN NYNNY 2001.12.202300270.0000107.8500000.00 5001.12.2023Adjustment of gastric band as an independent procedure including any 5001.12.2023associated consultation 1031590 01.07.2013 3 T8 1 SN NYNNY 2001.12.202300764.0000277.1500000.00 4001.07.2013(Anaes.) 5001.12.2023Adjustment of gastric band reservoir, repair, revision or replacement of 5001.12.2023(Anaes.) (Assist.) 1032000 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303140.0001135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE INTESTINE, resection of, without anastomosis, including right 5001.12.2023hemicolectomy (including formation of stoma) (Anaes.) (Assist.) 1032003 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303280.0001187.4000000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE INTESTINE, resection of, with anastomosis, including right hemicolectomy 5001.12.2023(Anaes.) (Assist.) 1032004 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303600.0001266.2500000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse 5001.12.2023colon and splenic flexure) without anastomosis, not being a service associated 5001.12.2023with a service to which item 32000, 32003, 32005, 32006 or 32030 applies (H) 5001.12.2023(Anaes.) (Assist.) 1032005 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304075.0001430.4000000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse 5001.12.2023colon and splenic flexure) with anastomosis, not being a service associated 5001.12.2023with a service to which item 32000, 32003, 32004, 32006 or 32030 applies (H) 5001.12.2023(Anaes.) (Assist.) 1032006 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303600.0001266.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Left hemicolectomy, including the descending and sigmoid colon (including 5001.12.2023formation of stoma), other than a service associated with a service to which 5001.12.2023item 32024, 32025, 32026 or 32028 applies (H) (Anaes.) (Assist.) 1032009 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304150.0001502.0000000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY AND ILEOSTOMY (Anaes.) (Assist.) 1032012 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304585.0001659.1500000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY AND ILEORECTAL ANASTOMOSIS (Anaes.) (Assist.) 1032015 26.05.2002 3 T8 2 SN NYNNY 2001.12.202305405.0002039.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY1 surgeon (Anaes.) 5001.12.2023(Assist.) 1032018 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304785.0001729.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS 5001.12.2023OPERATION; ABDOMINAL RESECTION (including aftercare) (Anaes.) (Assist.) 1032021 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301705.0000620.1000000.00 5001.12.2023TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS 5001.12.2023OPERATION; PERINEAL RESECTION (Assist.) 1032023 01.03.2013 3 T8 2 SN NYNNY 2001.12.202301765.0000611.3000000.00 4001.03.2013(Anaes.) 5001.12.2023Endoscopic insertion of stent or stents for large bowel obstruction, stricture 5001.12.2023or stenosis, including colonoscopy and any image intensification, where the 5001.12.2023obstruction is due to: a) a pre-diagnosed colorectal cancer, or cancer of an 5001.12.2023organ adjacent to the bowel; or b) an unknown diagnosis (Anaes.) 1032024 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304150.0001502.0000000.00 4026.05.2002(Anaes.) 5001.12.2023RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS 5001.12.2023(of the rectum) greater than 10 centimetres from the anal vergeexcluding 5001.12.2023resection of sigmoid colon alone not being a service associated with a service 5001.12.2023to which item 32000, 32030, 32106 or 32232 applies (H) (Anaes.) (Assist.) 1032025 26.05.2002 3 T8 2 SN NYNNY 2001.12.202305620.0002009.1000000.00 4026.05.2002(Anaes.) 5001.12.2023RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS 5001.12.2023(of the rectum) less than 10 centimetres from the anal verge, with or without 5001.12.2023covering stoma not being a service associated with a service to which item 5001.12.202332000, 32030, 32106 or 32232 applies (H) (Anaes.) (Assist.) 1032026 26.05.2002 3 T8 2 SN NYNNY 2001.12.202306700.0002249.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Rectum, ultra-low restorative resection, with or without covering stoma and 5001.12.2023with or without colonic reservoir, if the anastomosis is sited in the 5001.12.2023anorectal region and is 6 cm or less from the anal verge, not being a service 5001.12.2023associated with a service to which item 32000, 32030, 32106, 32117 or 32232 5001.12.2023applies (H) (Anaes.) (Assist.) 1032028 26.05.2002 3 T8 2 SN NYNNY 2001.12.202307130.0002389.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Rectum, low or ultra-low restorative resection, with per anal sutured coloanal 5001.12.2023anastomosis, with or without covering stoma and with or without colonic 5001.12.2023reservoir, not being a service associated with a service to which item 32000, 5001.12.202332030, 32106, 32117 or 32232 applies (H) (Anaes.) (Assist.) 1032030 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303235.0001135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023RECTOSIGMOIDECTOMY, including formation of stoma (H) (Anaes.) (Assist.) 1032033 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304735.0001659.1500000.00 4026.05.2002(Anaes.) 5001.12.2023RESTORATION OF BOWEL continuity following rectosigmoidectomy or similar 5001.12.2023operation, including dismantling of the stoma (H) (Anaes.) (Assist.) 1032036 26.05.2002 3 T8 2 SN NYNNY 2001.12.202305825.0002104.3500000.00 4026.05.2002(Anaes.) 5001.12.2023SACROCOCCYGEAL AND PRESACRAL TUMOURexcision of (Anaes.) (Assist.) 1032039 26.05.2002 3 T8 2 SN NYNNY 2001.12.202304585.0001689.6000000.00 4026.05.2002(Anaes.) 5001.12.2023RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF1 surgeon (Anaes.) (Assist.) 1032042 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303940.0001423.4000000.00 4026.05.2002(Anaes.) 5001.12.2023RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS 5001.12.2023OPERATIONabdominal resection (Anaes.) (Assist.) 1032045 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301475.0000532.7000000.00 5001.12.2023RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS 5001.12.2023OPERATIONperineal resection (Assist.) 1032046 26.05.2002 3 T8 2 SN NYNNY 2001.12.202302345.0000823.2000000.00 5001.12.2023RECTUM and ANUS, abdomino-perineal resection of, combined synchronous 5001.12.2023operation - perineal resection where the perineal surgeon also provides 5001.12.2023assistance to the abdominal surgeon (Assist.) 1032047 26.05.2002 3 T8 2 SN NYNNY 2001.12.202302735.0000959.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PERINEAL PROCTECTOMY (Anaes.) (Assist.) 1032051 26.05.2002 3 T8 2 SN NYNNY 2001.12.202307040.0002549.8500000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with 5001.12.2023formation of ileal reservoir, with or without creation of temporary ileostomy1 5001.12.2023surgeon (Anaes.) (Assist.) 1032054 26.05.2002 3 T8 2 SN NYNNY 2001.12.202306455.0002340.3000000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with 5001.12.2023formation of ileal reservoir, with or without creation of temporary 5001.12.2023ileostomyconjoint surgery, abdominal surgeon (including aftercare) (Anaes.) 5001.12.2023(Assist.) 1032057 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301705.0000620.1000000.00 5001.12.2023TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with 5001.12.2023formation of ileal reservoirconjoint surgery, perineal surgeon (Assist.) 1032060 26.05.2002 3 T8 2 SN NYNNY 2001.12.202307040.0002549.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Restorative proctectomy, involving rectal resection with formation of ileal 5001.12.2023reservoir and ileoanal anastomosis, including ileostomy mobilisation, with or 5001.12.2023without mucosectomy or temporary loop ileostomy, 1 surgeon (H) (Anaes.) 5001.12.2023(Assist.) 1032063 26.05.2002 3 T8 2 SN NYNNY 2001.12.202306455.0002340.3000000.00 4026.05.2002(Anaes.) 5001.12.2023ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal 5001.12.2023anastomosis with formation of ileal reservoir, with or without temporary loop 5001.12.2023ileostomyconjoint surgery, abdominal surgeon (including aftercare) (Anaes.) 5001.12.2023(Assist.) 1032066 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301705.0000620.1000000.00 5001.12.2023ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal 5001.12.2023anastomosis with formation of ileal reservoir, with or without temporary loop 5001.12.2023ileostomyconjoint surgery, perineal surgeon (Assist.) 1032069 26.05.2002 3 T8 2 SN NYNNY 2001.12.202305210.0001886.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ILEOSTOMY RESERVOIR, continent type, creation of, including conversion of 5001.12.2023existing ileostomy where appropriate (Anaes.) 1032072 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300174.0000052.6500000.00 5001.12.2023SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), with or without biopsy 1032075 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300310.0000082.6000000.00 4026.05.2002(Anaes.) 5001.12.2023SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), UNDER GENERAL 5001.12.2023ANAESTHESIA, with or without biopsy, not being a service associated with a 5001.12.2023service to which another item in this Group applies (Anaes.) 1032084 26.05.2002 3 T8 2 SN NYNYY 2001.12.202300380.0000122.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Sigmoidoscopy or colonoscopy up to the hepatic flexure, with or without 5001.12.2023biopsy,other than a service associated with a service to whichany of items 5001.12.202332222 to 32228applies. (Anaes.) 1032094 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301730.0000607.4000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC DILATATION OF COLORECTAL STRICTURES including colonoscopy (Anaes.) 1032095 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300400.0000140.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC EXAMINATION of SMALL BOWEL with flexible endoscope passed by stoma, 5001.12.2023with or without biopsies (Anaes.) 1032096 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300780.0000282.8500000.00 4026.05.2002(Anaes.) 5001.12.2023RECTAL BIOPSY, full thickness, to diagnose or exclude Hirschsprung's Disease, 5001.12.2023under general anaesthesia, or under epidural or spinal (intrathecal) nerve 5001.12.2023block where undertaken in a hospital (Anaes.) (Assist.) 1032105 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301475.0000532.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ANORECTAL CARCINOMAper anal full thickness excision of (Anaes.) (Assist.) 1032106 01.05.2004 3 T8 2 SN NYNNY 2001.12.202304150.0001502.0000000.00 4001.05.2004(Anaes.) 5001.12.2023Anterolateral intraperitoneal rectal tumour, per anal excision of, using 5001.12.2023rectoscopy digital viewing system and pneumorectum, if:(a) clinically 5001.12.2023appropriate; and(b) removal requires dissection within the peritoneal 5001.12.2023cavity;excluding use of a colonoscope as the operating platform and not being 5001.12.2023a service associated with a service to which item 32024, 32025 or 32232 5001.12.2023applies (Anaes.) (Assist.) 1032108 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303045.0001100.3500000.00 4026.05.2002(Anaes.) 5001.12.2023RECTAL TUMOUR, transsphincteric excision of (Kraske or similar operation) 5001.12.2023(Anaes.) (Assist.) 1032117 26.05.2002 3 T8 2 SN NYNNY 2001.12.202303950.0001382.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Rectal prolapse, abdominal rectopexy of, excluding ventral mesh rectopexy, not 5001.12.2023being a service associated with a service to which item 32025 or 32026 applies 5001.12.2023(H) (Anaes.) (Assist.) 1032118 06.07.2022 3 T8 2 DN NYNNY 2001.12.202303950.0001382.7000000.00 4006.07.2022(Anaes.) 5001.12.2023Rectal prolapse, ventral mesh rectopexy of, not being a service associated 5001.12.2023with a service to which item 32025, 32026 or 32117 applies (H) (Anaes.) 5001.12.2023(Assist.) 1032123 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301015.0000366.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ANAL STRICTURE, anoplasty for (Anaes.) (Assist.) 1032129 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301930.0000698.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ANAL SPHINCTER, repair (H) (Anaes.) (Assist.) 1032131 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301640.0000587.3500000.00 4026.05.2002(Anaes.) 5001.12.2023RECTOCELE, transanal repair of rectocele (Anaes.) (Assist.) 1032135 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300205.0000074.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of haemorrhoids or rectal prolapse, including rubber band ligation 5001.12.2023or sclerotherapy for, not being a service to which item 32139 applies (Anaes.) 1032139 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301235.0000404.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Operative treatment of haemorrhoids involving third-degree or fourth-degree 5001.12.2023haemorrhoids, including excision of anal skin tags when performed, not being a 5001.12.2023service associated with a service to which item 32135 or 32233 applies (H) 5001.12.2023(Anaes.) (Assist.) 1032147 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300138.0000049.6000000.00 4026.05.2002(Anaes.) 5001.12.2023PERIANAL THROMBOSIS, incision of (Anaes.) 1032150 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300870.0000282.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Operation for anal fissure, including excision, injection of Botulinum toxin 5001.12.2023or sphincterotomy, excluding dilatation (Anaes.) (Assist.) 1032156 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300515.0000144.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Anal fistula, subcutaneous, excision of (Anaes.) 1032159 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301265.0000366.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a 5001.12.2023combination of both procedures, involving the lower half of the anal sphincter 5001.12.2023mechanism (Anaes.) (Assist.) 1032162 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301475.0000532.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a 5001.12.2023combination of both procedures, involving the upper half of the anal sphincter 5001.12.2023mechanism (Anaes.) (Assist.) 1032165 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301930.0000698.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Operative treatment of anal fistula, repair by mucosal advancement flap, 5001.12.2023including ligation of inter-sphincteric fistula tract (LIFT) or other complex 5001.12.2023sphincter sparing surgery (Anaes.) (Assist.) 1032166 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300645.0000227.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ANAL FISTULA - readjustment of Seton (Anaes.) 1032171 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300270.0000097.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Anorectal examination, with or without biopsy, under general anaesthetic, with 5001.12.2023or without faecal disimpaction,other than a service associated with a service 5001.12.2023to which another item in this Group applies (H) (Anaes.) 1032174 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300270.0000097.7500000.00 4026.05.2002(Anaes.) 5001.12.2023INTR-AANAL, perianal or ischiorectal abscess, drainage of (excluding 5001.12.2023aftercare) (Anaes.) 1032175 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300510.0000179.0500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRA-ANAL, PERIANAL or ISCHIO-RECTAL ABSCESS, draining of, undertaken in the 5001.12.2023operating theatre of a hospital (excluding aftercare) (Anaes.) 1032183 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301730.0000618.2000000.00 4026.05.2002(Anaes.) 5001.12.2023INTESTINAL SLING PROCEDURE prior to radiotherapy (Anaes.) (Assist.) 1032186 26.05.2002 3 T8 2 SN NYNNY 2001.12.202301725.0000618.2000000.00 4026.05.2002(Anaes.) 5001.12.2023COLONIC LAVAGE, total, intra operative (Anaes.) (Assist.) 1032212 26.05.2002 3 T8 2 SN NYNNY 2001.12.202300425.0000150.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ANO-RECTAL APPLICATION OF FORMALIN in the treatment of radiation proctitis, 5001.12.2023where performed in the operating theatre of a hospital, excluding aftercare 5001.12.2023(Anaes.) 1032213 01.11.2005 3 T8 2 SN NYNNY 2001.12.202302120.0000727.5000000.00 4001.11.2005(Anaes.) 5001.12.2023Sacral nerve lead or leads, placement of, percutaneous or open, including 5001.12.2023intraoperative test stimulation and programming, for the management of faecal 5001.12.2023incontinence (H) (Anaes.) 1032215 01.11.2005 3 T8 2 SN NYNNY 2001.12.202300400.0000138.0000000.00 5001.12.2023Sacral nerve electrode or electrodes, management, adjustment and electronic 5001.12.2023programming of the neurostimulator by a medical practitioner, to manage faecal 5001.12.2023incontinence, not being a service associated with a service to which item 5001.12.202332213, 32216, 32218 or 32237 applies. Applicable once per day for the same 5001.12.2023patient by the same practitioner 1032216 01.11.2005 3 T8 2 SN NYNNY 2001.12.202301905.0000653.3500000.00 4001.11.2005(Anaes.) 5001.12.2023Sacral nerve lead or leads, inserted for the management of faecal incontinence 5001.12.2023in a patient with faecal incontinence refractory to conservative non-surgical 5001.12.2023treatment, either:(a) percutaneous surgical repositioning of the lead or 5001.12.2023leads, using fluoroscopic guidance; or(b) open surgical repositioning of the 5001.12.2023lead or leads; to correct displacement or unsatisfactory positioning 5001.12.2023(including intraoperative test stimulation), not being a service associated 5001.12.2023with a service to which item 32213 applies (H) (Anaes.) 1032218 01.11.2005 3 T8 2 SN NYNNY 2001.12.202300500.0000172.0500000.00 4001.11.2005(Anaes.) 5001.12.2023Sacral nerve lead or leads, removal (H) (Anaes.) 1032221 01.03.2009 3 T8 2 DN NYNYY 2001.12.202302830.0000994.9500000.00 4001.03.2009(Anaes.) 5001.12.2023Removal or revision of an artificial bowel sphincter (with or without 5001.12.2023replacement) for severe faecal incontinence in the treatment of a patient for 5001.12.2023whom conservative and other less invasive forms of treatment are 5001.12.2023contraindicated or have failed. (Anaes.) (Assist.) 1032222 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, for a 5001.12.2023patient: (a) following a positive faecal occult blood test; or (b) who has 5001.12.2023symptoms consistent with pathology of the colonic mucosa; or (c) with anaemia 5001.12.2023or iron deficiency; or (d) for whom diagnostic imaging has shown an 5001.12.2023abnormality of the colon; or (e) who is undergoing the first examination 5001.12.2023following surgery for colorectal cancer; or (f) who is undergoing preoperative 5001.12.2023evaluation; or (g) for whom a repeat colonoscopy is required due to inadequate 5001.12.2023bowel preparation for the patients previous colonoscopy; or (h) for the 5001.12.2023management of inflammatory bowel disease Applicable only once on a day under a 5001.12.2023single episode of anaesthesia or other sedation (Anaes.) 1032223 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, for a 5001.12.2023patient: (a) who has had a colonoscopy that revealed: (i) 1 to 4 adenomas, 5001.12.2023each of which was less than 10 mm in diameter, had no villous features and had 5001.12.2023no high grade dysplasia; or (ii) 1 or 2 sessile serrated lesions, each of 5001.12.2023which was less than 10 mm in diameter, and without dysplasia; or (b) with a 5001.12.2023moderate risk of colorectal cancer due to family history; or (c) with a 5001.12.2023history of colorectal cancer, who has had an initial postoperative colonoscopy 5001.12.2023that did not reveal any adenomas or colorectal cancer Applicable only once in 5001.12.2023any 5 year period (Anaes.) 1032224 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, for a 5001.12.2023patient with a moderate risk of colorectal cancer due to: (a) a history of 5001.12.2023adenomas, including an adenoma that: (i) was 10 mm or greater in diameter; or 5001.12.2023(ii) had villous features; or (iii) had high grade dysplasia; or (b) having 5001.12.2023had a previous colonoscopy that revealed: (i) 5 to 9 adenomas, each of which 5001.12.2023was less than 10 mm in diameter, had no villous features and had no high grade 5001.12.2023dysplasia; or (ii) 1 or 2 sessile serrated lesions, each of which was 10 mm or 5001.12.2023greater in diameter or had dysplasia; or (iii) a hyperplastic polyp that was 5001.12.202310 mm or greater in diameter; or (iv) 3 or more sessile serrated lesions, each 5001.12.2023of which was less than 10 mm in diameter and had no dysplasia; or (v) 1 or 2 5001.12.2023traditional serrated adenomas, of any size Applicable only once in any 3 year 5001.12.2023period (Anaes.) 1032225 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, for a 5001.12.2023patient with a high risk of colorectal cancer due to having had a previous 5001.12.2023colonoscopy that: (a) revealed 10 or more adenomas; or (b) included a 5001.12.2023piecemeal, or possibly incomplete, excision of a large, sessile polyp 5001.12.2023Applicable not more than 4 times in any 12 month period (Anaes.) 1032226 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, for a 5001.12.2023patient who has a high risk of colorectal cancer due to: (a) having either: 5001.12.2023(i) a known or suspected familial condition, such as familial adenomatous 5001.12.2023polyposis, Lynch syndrome or serrated polyposis syndrome; or (ii) a genetic 5001.12.2023mutation associated with hereditary colorectal cancer; or (b) having had a 5001.12.2023previous colonoscopy that revealed: (i) 5 or more sessile serrated lesions, 5001.12.2023each of which was less than 10 mm in diameter and had no dysplasia; or (ii) 3 5001.12.2023or more sessile serrated lesions, 1 or more of which was 10 mm or greater in 5001.12.2023diameter or had dysplasia; or (iii) 3 or more traditional serrated adenomas, 5001.12.2023of any size Applicable only once in any 12 month period (Anaes.) 1032227 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301585.0000516.4000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy: (a) for the 5001.12.2023treatment of bleeding, including one or more of the following: (i) radiation 5001.12.2023proctitis; (ii) angioectasia; (iii) postpolypectomy bleeding; or (b) for the 5001.12.2023treatment of colonic strictures with balloon dilatation Applicable only once 5001.12.2023on a day under a single episode of anaesthesia or other sedation (Anaes.) 1032228 01.11.2019 3 T8 2 SN NYNNY 2001.12.202301125.0000368.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Endoscopic examination of the colon to the caecum by colonoscopy, other that a 5001.12.2023service to which item 32222, 32223, 32224, 32225, or 32226 applies. Applicable 5001.12.2023only once (Anaes.) 1032229 01.11.2019 3 T8 2 SN NYNNY 2001.12.202300790.0000296.8500000.00 4001.11.2019(Anaes.) 5001.12.2023Removal of one or more polyps during colonoscopy, in association with a 5001.12.2023service to which item 32222, 32223, 32224, 32225, 32226, or 32228 applies 5001.12.2023(Anaes.) 1032230 01.11.2021 3 T8 2 SN NYNYY 2001.12.202301960.0000735.4500000.00 4001.11.2021(Anaes.) 5001.12.2023Endoscopic mucosal resection using electrocautery of a noninvasive sessile or 5001.12.2023flat superficial colorectal neoplasm which is at least 25mm in diameter, if 5001.12.2023the service is: (a) provided by a specialist gastroenterologist or surgical 5001.12.2023endoscopist; and (b) supported by photographic evidence to confirm the size of 5001.12.2023the polyp in situ, and (c) performed within 6 months after a service to which 5001.12.2023item 32222, 32223, 32224, 32225, 32226 or 32228 applies has been performed 5001.12.2023Applicable only once per polyp (H) (Anaes.) 1032231 01.07.2022 3 T8 2 SN NYNNY 2001.12.202301050.0000366.8000000.00 4001.07.2022(Anaes.) 5001.12.2023Rectal tumour, per anal excision of (H) (Anaes.) (Assist.) 1032232 01.07.2022 3 T8 2 SN NYNNY 2001.12.202302775.0000994.5000000.00 4001.07.2022(Anaes.) 5001.12.2023Rectal tumour, per anal excision of, using a rectoscopy digital viewing system 5001.12.2023and pneumorectum if clinically appropriate and excluding use of a colonoscope 5001.12.2023as the operating platform, not being a service associated with a service to 5001.12.2023which item 32024, 32025 or 32106 applies (H) (Anaes.) (Assist.) 1032233 01.07.2022 3 T8 2 SN NYNNY 2001.12.202301945.0000706.3000000.00 4001.07.2022(Anaes.) 5001.12.2023Perineal repair of rectal prolapse, not being a service associated with a 5001.12.2023service to which item 32139 applies (H) (Anaes.) (Assist.) 1032234 01.07.2022 3 T8 2 SN NYNNY 2001.12.202300450.0000139.7000000.00 4001.07.2022(Anaes.) 5001.12.2023Rectal stricture, treatment of (H) (Anaes.) 1032235 01.07.2022 3 T8 2 SN NYNNY 2001.12.202300385.0000134.8000000.00 4001.07.2022(Anaes.) 5001.12.2023Anal skin tags or anal polyps, excision of one or more of (Anaes.) 1032236 01.07.2022 3 T8 2 SN NYNNY 2001.12.202300525.0000191.8000000.00 4001.07.2022(Anaes.) 5001.12.2023Anal warts, removal of, under general anaesthesia, or under regional or field 5001.12.2023nerve block (excluding pudendal block), not being a service associated with a 5001.12.2023service to which item 35507 or 35508 applies (H) (Anaes.) 1032237 01.07.2022 3 T8 2 SN NYNNY 2001.12.202300945.0000311.0500000.00 4001.07.2022(Anaes.) 5001.12.2023Neurostimulator or receiver, subcutaneous placement of, replacement of, or 5001.12.2023removal of, including programming and placement and connection of an extension 5001.12.2023wire or wires to sacral nerve electrode(s), for the management of faecal 5001.12.2023incontinence (H) (Anaes.) (Assist.) 1032500 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300360.0000120.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, multiple injections of sclerosant using continuous compression 5001.12.2023techniques, including associated consultation, one or both legs, if: (a) 5001.12.2023proximal reflux of 0.5 seconds or longer has been demonstrated; and (b) the 5001.12.2023service is not for cosmetic purposes; and (c) the service is not associated 5001.12.2023with: (i) any other varicose vein operation on the same leg (excluding 5001.12.2023aftercare); or (ii) a service on the same leg (excluding aftercare) to which 5001.12.2023any of the following items apply: (A) 35200; (B) 59970 to 60078; (C) 60500 to 5001.12.202360509; (D) 61109 Applicable to a maximum of 6 treatments in a 12 month period 5001.12.2023(Anaes.) 1032504 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300890.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023VARICOSE VEINS, multiple excision of tributaries, with or without division of 5001.12.20231 or more perforating veins - 1 leg - not being a service associated with a 5001.12.2023service to which item 32507, 32508, 32511, 32514 or 32517 applies on the same 5001.12.2023leg (Anaes.) 1032507 26.05.2002 3 T8 3 SN NYNYY 2001.12.202301775.0000587.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, subfascial ligation of one or more incompetent perforating 5001.12.2023veins in one leg of a patient, if the service: (a) is performed by open 5001.12.2023surgical technique (not including endoscopic ligation) and the patient has 5001.12.2023significant signs or symptoms (including one or more of the following signs or 5001.12.2023symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; 5001.12.2023(iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; 5001.12.2023(viii) discolouration; (ix) discomfort; (x) any other signs or symptoms 5001.12.2023attributable to venous dysfunction; and (b) is not associated with: (i) any 5001.12.2023other varicose vein operation on the same leg; or (ii) a service (on the same 5001.12.2023leg) to which item 35200, 60072, 60075 or 60078 applies (H) (Anaes.) (Assist.) 1032508 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301775.0000587.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, complete dissection at the saphenofemoral or saphenopopliteal 5001.12.2023junction, with or without either ligation or stripping, or both, of the great 5001.12.2023or small saphenous veins in one leg of a patient, for the first time on the 5001.12.2023same leg, including excision or injection of either tributaries or incompetent 5001.12.2023perforating veins, or both, if the patient has significant signs or symptoms 5001.12.2023(including one or more of the following signs or symptoms) attributable to 5001.12.2023venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) 5001.12.2023heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) 5001.12.2023discomfort; (j) any other signs or symptoms attributable to venous dysfunction 5001.12.2023(H) (Anaes.) (Assist.) 1032511 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302640.0000873.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, complete dissection at the saphenofemoral and saphenopopliteal 5001.12.2023junction, with or without either ligation or stripping, or both, of the great 5001.12.2023or small saphenous veins in one leg of a patient, for the first time on the 5001.12.2023same leg, including excision or injection of either tributaries or incompetent 5001.12.2023perforating veins, or both, if the patient has significant signs or symptoms 5001.12.2023(including one or more of the following signs or symptoms) attributable to 5001.12.2023venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) 5001.12.2023heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) 5001.12.2023discomfort; (j) any other signs or symptoms attributable to venous dysfunction 5001.12.2023(H) (Anaes.) (Assist.) 1032514 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303085.0001020.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, ligation of the great or small saphenous vein in the same leg 5001.12.2023of a patient, with or without stripping, by reoperation for recurrent veins in 5001.12.2023the same territoryone legincluding excision or injection of either tributaries 5001.12.2023or incompetent perforating veins, or both, if the patient has significant 5001.12.2023signs or symptoms (including one or more of the following signs or symptoms) 5001.12.2023attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin 5001.12.2023irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) 5001.12.2023discolouration; (i) discomfort; (j) any other signs or symptoms attributable 5001.12.2023to venous dysfunction (H) (Anaes.) (Assist.) 1032517 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303970.0001313.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Varicose veins, ligation of the great and small saphenous vein in the same leg 5001.12.2023of a patient, with or without stripping, by reoperation for recurrent veins in 5001.12.2023either territoryone legincluding excision or injection of either tributaries 5001.12.2023or incompetent perforating veins, or both, if the patient has significant 5001.12.2023signs or symptoms (including one or more of the following signs or symptoms) 5001.12.2023attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin 5001.12.2023irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) 5001.12.2023discolouration; (i) discomfort; (j) any other signs or symptoms attributable 5001.12.2023to venous dysfunction (H) (Anaes.) (Assist.) 1032520 01.11.2011 3 T8 3 SN NYNNY 2001.12.202301775.0000587.3500000.00 4001.11.2011(Anaes.) 5001.12.2023Varicose veins, abolition of venous reflux by occlusion of a primary or 5001.12.2023recurrent great or small saphenous vein (and major tributaries of saphenous 5001.12.2023veins as necessary) in one leg of a patient, using a laser probe introduced by 5001.12.2023an endovenous catheter, if all of the following apply: (a) it is documented by 5001.12.2023duplex ultrasound that the great or small saphenous vein (whichever is to be 5001.12.2023treated) of the patient demonstrates reflux of 0.5 seconds or longer; (b) the 5001.12.2023patient has significant signs or symptoms (including one or more of the 5001.12.2023following signs or symptoms) attributable to venous reflux: (i) ache; (ii) 5001.12.2023pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle 5001.12.2023cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any 5001.12.2023other signs or symptoms attributable to venous dysfunction; (c) the service 5001.12.2023does not include radiofrequency diathermy, radiofrequency ablation or 5001.12.2023cyanoacrylate adhesive; (d) the service is not associated with a service (on 5001.12.2023the same leg) to which any of the following items apply: (i) 32500 to 32507; 5001.12.2023(ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; 5001.12.2023(vi) 60500 to 60509; (vii) 61109 The service includes all preparation and 5001.12.2023immediate clinical aftercare (including excision or injection of either 5001.12.2023tributaries or incompetent perforating veins, or both) (Anaes.) 1032522 01.11.2011 3 T8 3 SN NYNNY 2001.12.202302640.0000873.2000000.00 4001.11.2011(Anaes.) 5001.12.2023Varicose veins, abolition of venous reflux by occlusion of a primary or 5001.12.2023recurrent great and small saphenous vein (and major tributaries of saphenous 5001.12.2023veins as necessary) in one leg of a patient, using a laser probe introduced by 5001.12.2023an endovenous catheter, if all of the following apply: (a) it is documented by 5001.12.2023duplex ultrasound that the great and small saphenous veins of the patient 5001.12.2023demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant 5001.12.2023signs or symptoms (including one or more of the following signs or symptoms) 5001.12.2023attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin 5001.12.2023irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) 5001.12.2023discolouration; (ix) discomfort; (x) any other signs or symptoms attributable 5001.12.2023to venous dysfunction; (c) the service does not include radiofrequency 5001.12.2023diathermy, radiofrequency ablation or cyanoacrylate adhesive; (d) the service 5001.12.2023is not associated with a service (on the same leg) to which any of the 5001.12.2023following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; 5001.12.2023(iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The 5001.12.2023service includes all preparation and immediate clinical aftercare (including 5001.12.2023excision or injection of either tributaries or incompetent perforating veins, 5001.12.2023or both) (Anaes.) 1032523 01.05.2013 3 T8 3 SN NYNNY 2001.12.202301775.0000587.3500000.00 4001.05.2013(Anaes.) 5001.12.2023Varicose veins, abolition of venous reflux by occlusion of a primary or 5001.12.2023recurrent great or small saphenous vein (and major tributaries of saphenous 5001.12.2023veins as necessary) in one leg of a patient, using a radiofrequency catheter 5001.12.2023introduced by an endovenous catheter, if all of the following apply: (a) it is 5001.12.2023documented by duplex ultrasound that the great or small saphenous vein 5001.12.2023(whichever is to be treated) demonstrates reflux of 0.5 seconds or longer; (b) 5001.12.2023the patient has significant signs or symptoms (including one or more of the 5001.12.2023following signs or symptoms) attributable to venous reflux: (i) ache; (ii) 5001.12.2023pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle 5001.12.2023cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any 5001.12.2023other signs or symptoms attributable to venous dysfunction; (c) the service 5001.12.2023does not include endovenous laser therapy or cyanoacrylate adhesive; (d) the 5001.12.2023service is not associated with a service (on the same leg) to which any of the 5001.12.2023following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; 5001.12.2023(iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The 5001.12.2023service includes all preparation and immediate clinical aftercare (including 5001.12.2023excision or injection of either tributaries or incompetent perforating veins, 5001.12.2023or both) (Anaes.) 1032526 01.05.2013 3 T8 3 SN NYNNY 2001.12.202302640.0000873.2000000.00 4001.05.2013(Anaes.) 5001.12.2023Varicose veins, abolition of venous reflux by occlusion of a primary or 5001.12.2023recurrent great and small saphenous vein (and major tributaries of saphenous 5001.12.2023veins as necessary) in one leg of a patient, using a radiofrequency catheter 5001.12.2023introduced by an endovenous catheter, if all of the following apply: (a) it is 5001.12.2023documented by duplex ultrasound that the great and small saphenous veins 5001.12.2023demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant 5001.12.2023signs or symptoms (including one or more of the following signs or symptoms) 5001.12.2023attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin 5001.12.2023irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) 5001.12.2023discolouration; (ix) discomfort; (x) any other signs or symptoms attributable 5001.12.2023to venous dysfunction; (c) the service does not include endovenous laser 5001.12.2023therapy or cyanoacrylate adhesive; (d) the service is not associated with a 5001.12.2023service (on the same leg) to which any of the following items apply: (i) 32500 5001.12.2023to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 5001.12.202360078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation 5001.12.2023and immediate clinical aftercare (including excision or injection of either 5001.12.2023tributaries or incompetent perforating veins, or both) (Anaes.) 1032700 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304800.0001580.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY OF NECK, bypass using vein or synthetic material (Anaes.) (Assist.) 1032703 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304105.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023INTERNAL CAROTID ARTERY, transection and reanastomosis of, or resection of 5001.12.2023small length and reanastomosis of - with or without endarterectomy (Anaes.) 5001.12.2023(Assist.) 1032708 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304850.0001564.5000000.00 4026.05.2002(Anaes.) 5001.12.2023AORTIC BYPASS for occlusive disease using a straight non-bifurcated graft 5001.12.2023(Anaes.) (Assist.) 1032710 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305390.0001738.3000000.00 4026.05.2002(Anaes.) 5001.12.2023AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both 5001.12.2023anastomoses to the iliac arteries (Anaes.) (Assist.) 1032711 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305930.0001912.1500000.00 4026.05.2002(Anaes.) 5001.12.2023AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both 5001.12.2023anastomoses to the common femoral or profunda femoris arteries (Anaes.) 5001.12.2023(Assist.) 1032712 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304210.0001382.3000000.00 4026.05.2002(Anaes.) 5001.12.2023ILIO-FEMORAL BYPASS GRAFTING (Anaes.) (Assist.) 1032715 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304210.0001382.3000000.00 4026.05.2002(Anaes.) 5001.12.2023AXILLARY or SUBCLAVIAN TO FEMORAL BYPASS GRAFTING to 1 or both FEMORAL 5001.12.2023ARTERIES (Anaes.) (Assist.) 1032718 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303970.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORO-FEMORAL OR ILIO-FEMORAL CROSS-OVER BYPASS GRAFTING (Anaes.) (Assist.) 1032721 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306300.0002077.4000000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL ARTERY, bypass grafting to (Anaes.) (Assist.) 1032724 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307170.0002358.9500000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL ARTERIES (both), bypass grafting to (Anaes.) (Assist.) 1032730 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305430.0001787.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MESENTERIC VESSEL (single), bypass grafting to (Anaes.) (Assist.) 1032733 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306300.0002077.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MESENTERIC VESSELS (multiple), bypass grafting to (Anaes.) (Assist.) 1032736 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301390.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR MESENTERIC ARTERY, operation on, when performed in conjunction with 5001.12.2023another intra-abdominal vascular operation (Anaes.) (Assist.) 1032739 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304320.0001423.6500000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when 5001.12.2023it is the ipsilateral long saphenous vein) with above knee anastomosis 5001.12.2023(Anaes.) (Assist.) 1032742 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304965.0001630.7000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when 5001.12.2023it is the ipsilateral long saphenous vein) with distal anastomosis to below 5001.12.2023knee popliteal artery (Anaes.) (Assist.) 1032745 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305660.0001862.3000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when 5001.12.2023it is the ipsilateral long saphenous vein) with distal anastomosis to tibio 5001.12.2023peroneal trunk or tibial or peroneal artery (Anaes.) (Assist.) 1032748 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306120.0002019.6000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when 5001.12.2023it is the ipsilateral long saphenous vein) with distal anastomosis within 5cms 5001.12.2023of the ankle joint (Anaes.) (Assist.) 1032751 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303970.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING using synthetic graft, with lower anastomosis 5001.12.2023above or below the knee (Anaes.) (Assist.) 1032754 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304965.0001630.7000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY BYPASS GRAFTING, using a composite graft (synthetic material 5001.12.2023and vein) with lower anastomosis above or below the knee, including use of a 5001.12.2023cuff or sleeve of vein at 1 or both anastomoses (Anaes.) (Assist.) 1032757 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301390.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMORAL ARTERY SEQUENTIAL BYPASS GRAFTING, (using a vein or synthetic 5001.12.2023material) where an additional anastomosis is made to separately revascularise 5001.12.2023more than 1 artery - each additional artery revascularised beyond a femoral 5001.12.2023bypass (Anaes.) (Assist.) 1032760 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301390.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023VEIN, HARVESTING OF, FROM LEG OR ARM for bypass or replacement graft when not 5001.12.2023performed on the limb which is the subject of the bypass or graft - each vein 5001.12.2023(Anaes.) (Assist.) 1032763 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303975.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIAL BYPASS GRAFTING, using vein or synthetic material, not being a 5001.12.2023service to which another item in this Sub-group applies (Anaes.) (Assist.) 1032766 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304505.0000869.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIAL OR VENOUS ANASTOMOSIS, not being a service to which another item in 5001.12.2023this Sub-group applies, as an independent procedure (Anaes.) (Assist.) 1032769 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300910.0000301.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item in 5001.12.2023this Sub-group applies, when performed in combination with another vascular 5001.12.2023operation (including graft to graft anastomosis) (Anaes.) (Assist.) 1033050 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304890.0001601.9000000.00 4026.05.2002(Anaes.) 5001.12.2023BYPASS GRAFTING to replace a popliteal aneurysm using vein, including 5001.12.2023harvesting vein (when it is the ipsilateral long saphenous vein) (Anaes.) 5001.12.2023(Assist.) 1033055 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303920.0001284.6000000.00 4026.05.2002(Anaes.) 5001.12.2023BYPASS GRAFTING to replace a popliteal aneurysm using a synthetic graft 5001.12.2023(Anaes.) (Assist.) 1033070 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302830.0000926.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, without 5001.12.2023bypass grafting (Anaes.) (Assist.) 1033075 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303600.0001178.9000000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM IN THE NECK, ligation, suture closure or excision of, without bypass 5001.12.2023grafting (Anaes.) (Assist.) 1033080 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304395.0001439.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or excision of, 5001.12.2023without bypass grafting (Anaes.) (Assist.) 1033100 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304800.0001580.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM OF COMMON OR INTERNAL CAROTID ARTERY, OR BOTH, replacement by graft 5001.12.2023of vein or synthetic material (Anaes.) (Assist.) 1033103 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306735.0002218.2500000.00 4026.05.2002(Anaes.) 5001.12.2023THORACIC ANEURYSM, replacement by graft (Anaes.) (Assist.) 1033109 26.05.2002 3 T8 3 SN NYNNY 2001.12.202308155.0002681.9000000.00 4026.05.2002(Anaes.) 5001.12.2023THORACO-ABDOMINAL ANEURYSM, replacement by graft including re-implantation of 5001.12.2023arteries (Anaes.) (Assist.) 1033112 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307050.0002325.8500000.00 4026.05.2002(Anaes.) 5001.12.2023SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft including 5001.12.2023re-implantation of arteries (Anaes.) (Assist.) 1033115 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304775.0001564.5000000.00 4026.05.2002(Anaes.) 5001.12.2023INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft, not being a 5001.12.2023service associated with a service to which item 33116 applies (Anaes.) 5001.12.2023(Assist.) 1033116 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304775.0001539.9000000.00 4026.05.2002(Anaes.) 5001.12.2023INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft using 5001.12.2023endovascular repair procedure, excluding associated radiological services 5001.12.2023(Anaes.) (Assist.) 1033118 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305305.0001738.3000000.00 4026.05.2002(Anaes.) 5001.12.2023INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 5001.12.2023iliac arteries (with or without excision of common iliac aneurysms) not being 5001.12.2023a service associated with a service to which item 33119 applies (Anaes.) 5001.12.2023(Assist.) 1033119 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305305.0001711.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one 5001.12.2023or both iliac arteries using endovascular repair procedure, excluding 5001.12.2023associated radiological services (Anaes.) (Assist.) 1033121 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305835.0001912.1500000.00 4026.05.2002(Anaes.) 5001.12.2023INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 1 or 5001.12.2023both femoral arteries (with or without excision or bypass of common iliac 5001.12.2023aneurysms) (Anaes.) (Assist.) 1033124 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304035.0001332.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM OF ILIAC ARTERY (common, external or internal), replacement by graft 5001.12.2023- unilateral (Anaes.) (Assist.) 1033127 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305315.0001746.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSMS OF ILIAC ARTERIES (common, external or internal), replacement by 5001.12.2023graft - bilateral (Anaes.) (Assist.) 1033130 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304620.0001523.0500000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM OF VISCERAL ARTERY, excision and repair by direct anastomosis or 5001.12.2023replacement by graft (Anaes.) (Assist.) 1033133 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303460.0001142.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM OF VISCERAL ARTERY, dissection and ligation of arteries without 5001.12.2023restoration of continuity (Anaes.) (Assist.) 1033136 26.05.2002 3 T8 3 SN NYNNY 2001.12.202308750.0002880.3000000.00 4026.05.2002(Anaes.) 5001.12.2023FALSE ANEURYSM, repair of, at aortic anastomosis following previous aortic 5001.12.2023surgery (Anaes.) (Assist.) 1033139 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305315.0001746.6000000.00 4026.05.2002(Anaes.) 5001.12.2023FALSE ANEURYSM, repair of, in iliac artery and restoration of arterial 5001.12.2023continuity (Anaes.) (Assist.) 1033142 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304965.0001630.7000000.00 4026.05.2002(Anaes.) 5001.12.2023FALSE ANEURYSM, repair of, in femoral artery and restoration of arterial 5001.12.2023continuity (Anaes.) (Assist.) 1033145 26.05.2002 3 T8 3 SN NYNNY 2001.12.202308490.0002805.9000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED THORACIC AORTIC ANEURYSM, replacement by graft (Anaes.) (Assist.) 1033148 26.05.2002 3 T8 3 SN NYNNY 2001.12.202310570.0003484.6500000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED THORACO-ABDOMINAL AORTIC ANEURYSM, replacement by graft (Anaes.) 5001.12.2023(Assist.) 1033151 26.05.2002 3 T8 3 SN NYNNY 2001.12.202310050.0003310.8500000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft (Anaes.) 5001.12.2023(Assist.) 1033154 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307445.0002450.0000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft 5001.12.2023(Anaes.) (Assist.) 1033157 26.05.2002 3 T8 3 SN NYNNY 2001.12.202308315.0002731.4000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation 5001.12.2023graft to iliac arteries (with or without excision or bypass of common iliac 5001.12.2023aneurysms) (Anaes.) (Assist.) 1033160 26.05.2002 3 T8 3 SN NYNNY 2001.12.202308750.0002731.4000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation 5001.12.2023graft to 1 or both femoral arteries (Anaes.) (Assist.) 1033163 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307015.0002317.8000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED ILIAC ARTERY ANEURYSM, replacement by graft (Anaes.) (Assist.) 1033166 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307015.0002317.8000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED ANEURYSM OF VISCERAL ARTERY, replacement by anastomosis or graft 5001.12.2023(Anaes.) (Assist.) 1033169 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305480.0001804.5000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED ANEURYSM OF VISCERAL ARTERY, simple ligation of (Anaes.) (Assist.) 1033172 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304265.0001407.1000000.00 4026.05.2002(Anaes.) 5001.12.2023ANEURYSM OF MAJOR ARTERY, replacement by graft, not being a service to which 5001.12.2023another item in this Sub-group applies (Anaes.) (Assist.) 1033175 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303960.0001296.7500000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, 5001.12.2023without bypass grafting (Anaes.) (Assist.) 1033178 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305035.0001649.0500000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED ANEURYSM IN THE NECK, ligation, suture closure or excision of, 5001.12.2023without bypass grafting (Anaes.) (Assist.) 1033181 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306155.0002016.1500000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or 5001.12.2023excision of, without bypass grafting (Anaes.) (Assist.) 1033500 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303410.0001249.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY OR ARTERIES OF NECK, endarterectomy of, including closure by suture 5001.12.2023(where endarterectomy of 1 or more arteries is undertaken through 1 5001.12.2023arteriotomy incision) (Anaes.) (Assist.) 1033506 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304225.0001398.8500000.00 4026.05.2002(Anaes.) 5001.12.2023INNOMINATE OR SUBCLAVIAN ARTERY, endarterectomy of, including closure by 5001.12.2023suture (Anaes.) (Assist.) 1033509 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304575.0001564.5000000.00 4026.05.2002(Anaes.) 5001.12.2023AORTIC ENDARTERECTOMY, including closure by suture, not being a service 5001.12.2023associated with another procedure on the aorta (Anaes.) (Assist.) 1033512 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305080.0001738.3000000.00 4026.05.2002(Anaes.) 5001.12.2023AORTO-ILIAC ENDARTERECTOMY (1 or both iliac arteries), including closure by 5001.12.2023suture not being a service associated with a service to which item 33515 5001.12.2023applies (Anaes.) (Assist.) 1033515 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305590.0001912.1500000.00 4026.05.2002(Anaes.) 5001.12.2023AORTO-FEMORAL ENDARTERECTOMY (1 or both femoral arteries) or BILATERAL 5001.12.2023ILIO-FEMORAL ENDARTERECTOMY, including closure by suture, not being a service 5001.12.2023associated with a service to which item 33512 applies (Anaes.) (Assist.) 1033518 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304225.0001398.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ILIAC ENDARTERECTOMY, including closure by suture, not being a service 5001.12.2023associated with another procedure on the iliac artery (Anaes.) (Assist.) 1033521 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304570.0001514.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ILIO-FEMORAL ENDARTERECTOMY (1 side), including closure by suture (Anaes.) 5001.12.2023(Assist.) 1033524 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305430.0001787.9000000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL ARTERY, endarterectomy of (Anaes.) (Assist.) 1033527 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306300.0002077.4000000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL ARTERIES (both), endarterectomy of (Anaes.) (Assist.) 1033530 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305430.0001787.9000000.00 4026.05.2002(Anaes.) 5001.12.2023COELIAC OR SUPERIOR MESENTERIC ARTERY, endarterectomy of (Anaes.) (Assist.) 1033533 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306125.0002077.4000000.00 4026.05.2002(Anaes.) 5001.12.2023COELIAC AND SUPERIOR MESENTERIC ARTERY, endarterectomy of (Anaes.) (Assist.) 1033536 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304505.0001481.6500000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR MESENTERIC ARTERY, endarterectomy of, not being a service associated 5001.12.2023with a service to which another item in this Sub-group applies (Anaes.) 5001.12.2023(Assist.) 1033539 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303220.0001067.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY OF EXTREMITIES, endarterectomy of, including closure by suture (Anaes.) 5001.12.2023(Assist.) 1033542 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304610.0001523.0500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTENDED DEEP FEMORAL ENDARTERECTOMY where the endarterectomy is at least 7cms 5001.12.2023long (Anaes.) (Assist.) 1033545 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300930.0000301.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material 5001.12.2023where patch is less than 3cm long (Anaes.) (Assist.) 1033548 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301865.0000612.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material 5001.12.2023where patch is 3cm long or greater (Anaes.) (Assist.) 1033551 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300920.0000301.2000000.00 4026.05.2002(Anaes.) 5001.12.2023VEIN, harvesting of from leg or arm for patch when not performed through same 5001.12.2023incision as operation (Anaes.) (Assist.) 1033554 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300875.0000299.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ENDARTERECTOMY, in conjunction with an arterial bypass operation to prepare 5001.12.2023the site for anastomosis - each site (Anaes.) (Assist.) 1033800 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303930.0001299.5000000.00 4026.05.2002(Anaes.) 5001.12.2023EMBOLUS, removal of, from artery of neck (Anaes.) (Assist.) 1033803 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303740.0001241.7000000.00 4026.05.2002(Anaes.) 5001.12.2023EMBOLECTOMY or THROMBECTOMY, by abdominal approach, of an artery or bypass 5001.12.2023graft of trunk (Anaes.) (Assist.) 1033806 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302715.0000893.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Embolectomy or thrombectomy (including the infusion of thrombolytic or other 5001.12.2023agents) from an artery or bypass graft of extremities, or embolectomy of 5001.12.2023abdominal artery via the femoral artery, item to be claimed once per 5001.12.2023extremity, regardless of the number of incisions required to access the artery 5001.12.2023or bypass graft (Anaes.) (Assist.) 1033810 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301905.0000652.1500000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR VENA CAVA OR ILIAC VEIN, closed thrombectomy by catheter via the 5001.12.2023femoral vein (Anaes.) (Assist.) 1033811 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305705.0001941.4000000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR VENA CAVA OR ILIAC VEIN, open removal of thrombus or tumour (Anaes.) 5001.12.2023(Assist.) 1033812 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303110.0001026.3000000.00 4026.05.2002(Anaes.) 5001.12.2023THROMBUS, removal of, from femoral or other similar large vein (Anaes.) 5001.12.2023(Assist.) 1033815 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302680.0000943.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of 5001.12.2023continuity, by lateral suture (Anaes.) (Assist.) 1033818 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303125.0001100.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of 5001.12.2023continuity, by direct anastomosis (Anaes.) (Assist.) 1033821 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303575.0001258.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of 5001.12.2023continuity, by interposition graft of synthetic material or vein (Anaes.) 5001.12.2023(Assist.) 1033824 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303410.0001200.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of 5001.12.2023continuity, by lateral suture (Anaes.) (Assist.) 1033827 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303740.0001407.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of 5001.12.2023continuity, by direct anastomosis (Anaes.) (Assist.) 1033830 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304585.0001613.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of 5001.12.2023continuity, by interposition graft of synthetic material or vein (Anaes.) 5001.12.2023(Assist.) 1033833 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304445.0001465.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of 5001.12.2023continuity by lateral suture (Anaes.) (Assist.) 1033836 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305315.0001746.6000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of 5001.12.2023continuity by direct anastomosis (Anaes.) (Assist.) 1033839 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306185.0002044.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of 5001.12.2023continuity by means of interposition graft (Anaes.) (Assist.) 1033842 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303065.0001009.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY OF NECK, re-operation for bleeding or thrombosis after carotid or 5001.12.2023vertebral artery surgery (Anaes.) (Assist.) 1033845 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302140.0000703.6500000.00 4026.05.2002(Anaes.) 5001.12.2023LAPAROTOMY for control of post operative bleeding or thrombosis after 5001.12.2023intra-abdominal vascular procedure, where no other procedure is performed 5001.12.2023(Anaes.) (Assist.) 1033848 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302140.0000703.6500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTREMITY, re-operation on, for control of bleeding or thrombosis after 5001.12.2023vascular procedure, where no other procedure is performed (Anaes.) (Assist.) 1034100 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302370.0000778.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERY OF NECK, elective ligation or exploration of, not being a service 5001.12.2023associated with any other vascular procedure (Anaes.) (Assist.) 1034103 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301400.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Great artery (aorta or pulmonary artery) or great vein (superior or inferior 5001.12.2023vena cava), ligation or exploration of immediate branches or tributaries, or 5001.12.2023ligation or exploration of the subclavian, axillary, iliac, femoral or 5001.12.2023popliteal arteries or veins, if the service is not associated with item 32508, 5001.12.202332511, 32520, 32522, 32523, 32526, 32528 or 32529 - for a maximum of 2 5001.12.2023services provided to the same patient on the same occasion (H) (Anaes.) 5001.12.2023(Assist.) 1034106 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300975.0000321.0500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by 5001.12.2023elective operation, or exploration of, not being a service associated with any 5001.12.2023other vascular procedure except those services to which items 32508, 32511, 5001.12.202332514 or 32517 apply (Anaes.) (Assist.) 1034109 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301040.0000372.4500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPORAL ARTERY, biopsy of (Anaes.) (Assist.) 1034112 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302865.0000943.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and ligation (Anaes.) 5001.12.2023(Assist.) 1034115 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303215.0001067.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF THE NECK, dissection and ligation (Anaes.) (Assist.) 1034118 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304620.0001523.0500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and ligation (Anaes.) 5001.12.2023(Assist.) 1034121 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303700.0001216.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and repair of, with 5001.12.2023restoration of continuity (Anaes.) (Assist.) 1034124 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304050.0001332.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF THE NECK, dissection and repair of, with restoration 5001.12.2023of continuity (Anaes.) (Assist.) 1034127 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305315.0001746.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and repair of, with 5001.12.2023restoration of continuity (Anaes.) (Assist.) 1034130 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301665.0000546.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SURGICALLY CREATED ARTERIO-VENOUS FISTULA OF AN EXTREMITY, closure of (Anaes.) 5001.12.2023(Assist.) 1034133 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301865.0000612.6500000.00 4026.05.2002(Anaes.) 5001.12.2023SCALENOTOMY (Anaes.) (Assist.) 1034136 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302985.0000984.8500000.00 4026.05.2002(Anaes.) 5001.12.2023FIRST RIB, resection of portion of (Anaes.) (Assist.) 1034139 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302985.0000984.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL RIB, removal of, or other operation for removal of thoracic outlet 5001.12.2023compression, not being a service to which another item in this Sub-group 5001.12.2023applies (Anaes.) (Assist.) 1034142 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303410.0001216.6500000.00 4026.05.2002(Anaes.) 5001.12.2023COELIAC ARTERY, decompression of, for coeliac artery compression syndrome, as 5001.12.2023an independent procedure (Anaes.) (Assist.) 1034145 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302675.0000885.6000000.00 4026.05.2002(Anaes.) 5001.12.2023POPLITEAL ARTERY, exploration of, for popliteal entrapment, with or without 5001.12.2023division of fibrous tissue and muscle (Anaes.) (Assist.) 1034148 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304800.0001580.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or 5001.12.2023reconstruction of internal or common carotid arteries, when tumour is 4cm or 5001.12.2023less in maximum diameter (Anaes.) (Assist.) 1034151 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306535.0002160.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or 5001.12.2023reconstruction of internal or common carotid arteries, when tumour is greater 5001.12.2023than 4cm in maximum diameter (Anaes.) (Assist.) 1034154 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307840.0002574.2500000.00 4026.05.2002(Anaes.) 5001.12.2023RECURRENT CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or 5001.12.2023replacement of portion of internal or common carotid arteries (Anaes.) 5001.12.2023(Assist.) 1034157 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303980.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023NECK, excision of infected bypass graft, including closure of vessel or 5001.12.2023vessels (Anaes.) (Assist.) 1034160 26.05.2002 3 T8 3 SN NYNNY 2001.12.202307445.0002450.0000000.00 4026.05.2002(Anaes.) 5001.12.2023AORTO-DUODENAL FISTULA, repair of, by suture of aorta and repair of duodenum 5001.12.2023(Anaes.) (Assist.) 1034163 26.05.2002 3 T8 3 SN NYNNY 2001.12.202309530.0003145.2500000.00 4026.05.2002(Anaes.) 5001.12.2023AORTO-DUODENAL FISTULA, repair of, by insertion of aortic graft and repair of 5001.12.2023duodenum (Anaes.) (Assist.) 1034166 26.05.2002 3 T8 3 SN NYNNY 2001.12.202309530.0003145.2500000.00 4026.05.2002(Anaes.) 5001.12.2023AORTO-DUODENAL FISTULA, repair of, by oversewing of abdominal aorta, repair of 5001.12.2023duodenum and axillo-bifemoral grafting (Anaes.) (Assist.) 1034169 26.05.2002 3 T8 3 SN NYNNY 2001.12.202305320.0001746.6000000.00 4026.05.2002(Anaes.) 5001.12.2023INFECTED BYPASS GRAFT FROM TRUNK, excision of, including closure of arteries 5001.12.2023(Anaes.) (Assist.) 1034172 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304330.0001423.6500000.00 4026.05.2002(Anaes.) 5001.12.2023INFECTED AXILLO-FEMORAL OR FEMORO-FEMORAL GRAFT, excision of, including 5001.12.2023closure of arteries (Anaes.) (Assist.) 1034175 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303980.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023INFECTED BYPASS GRAFT FROM EXTREMITIES, excision of including closure of 5001.12.2023arteries (Anaes.) (Assist.) 1034500 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301040.0000339.5000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS SHUNT, EXTERNAL, insertion of (Anaes.) (Assist.) 1034503 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301375.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, in conjunction with another 5001.12.2023venous or arterial operation (Anaes.) (Assist.) 1034506 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300695.0000231.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS SHUNT, EXTERNAL, removal of (Anaes.) (Assist.) 1034509 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303255.0001075.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, not in conjunctionwith 5001.12.2023another venous or arterial operation (Anaes.) (Assist.) 1034512 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303600.0001183.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS ACCESS DEVICE, insertion of (Anaes.) (Assist.) 1034515 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302560.0000844.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIOVENOUS ACCESS DEVICE, thrombectomy of (Anaes.) (Assist.) 1034518 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304295.0001415.2500000.00 4026.05.2002(Anaes.) 5001.12.2023STENOSIS OF ARTERIOVENOUS FISTULA OR PROSTHETIC ARTERIOVENOUS ACCESS DEVICE, 5001.12.2023correction of (Anaes.) (Assist.) 1034521 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302540.0000869.5500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRA-ABDOMINAL ARTERY OR VEIN, cannulation of, for infusion chemotherapy, by 5001.12.2023open operation (excluding aftercare) (Anaes.) (Assist.) 1034524 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301390.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTERIAL CANNULATION for infusion chemotherapy by open operation, not being a 5001.12.2023service to which item 34521 applies (excluding after-care) (Anaes.) (Assist.) 1034527 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301775.0000607.1500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with 5001.12.2023pump or access port as with central venous line catheter or other chemotherapy 5001.12.2023delivery device, including any associated percutaneous central vein 5001.12.2023catheterisation, on apatient 10 years of age or over (Anaes.) 1034528 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300885.0000299.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous 5001.12.2023tunnel with pump or access port as with central venous line catheter or other 5001.12.2023chemotherapy delivery device, on a patient 10 years of age or over (Anaes.) 1034530 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300655.0000224.7500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open 5001.12.2023surgical procedure in the operating theatre of a hospital on apatient 10 years 5001.12.2023of age or over (Anaes.) 1034533 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304130.0001365.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ISOLATED LIMB PERFUSION, including cannulation of artery and vein at 5001.12.2023commencement of procedure, regional perfusion for chemotherapy, or other 5001.12.2023therapy, repair of arteriotomy and venotomy at conclusion of procedure 5001.12.2023(excluding aftercare) (Anaes.) (Assist.) 1034538 01.05.2004 3 T8 3 SN NYNNY 2001.12.202300920.0000299.8500000.00 4001.05.2004(Anaes.) 5001.12.2023CENTRAL VEIN CATHERTERISATION by percutaneous technique, using subcutaneous 5001.12.2023tunnelled cuffed catheter or similar device, for the administration of 5001.12.2023haemodialysis or parenteral nutrition (Anaes.) 1034539 01.05.2004 3 T8 3 SN NYNNY 2001.12.202300655.0000224.7500000.00 4001.05.2004(Anaes.) 5001.12.2023TUNNELLED CUFFED CATHETER, OR SIMILAR DEVICE, removal of, by open surgical 5001.12.2023procedure (Anaes.) 1034800 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302715.0000893.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR VENA CAVA, plication, ligation, or application of caval clip (Anaes.) 5001.12.2023(Assist.) 1034803 26.05.2002 3 T8 3 SN NYNNY 2001.12.202306010.0001970.1000000.00 4026.05.2002(Anaes.) 5001.12.2023INFERIOR VENA CAVA, reconstruction of or bypass by vein or synthetic material 5001.12.2023(Anaes.) (Assist.) 1034806 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303220.0001067.7000000.00 4026.05.2002(Anaes.) 5001.12.2023CROSS LEG BYPASS GRAFTING, saphenous to iliac or femoral vein (Anaes.) 5001.12.2023(Assist.) 1034809 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303220.0001067.7000000.00 4026.05.2002(Anaes.) 5001.12.2023SAPHENOUS VEIN ANASTOMOSIS to femoral or popliteal vein for femoral vein 5001.12.2023bypass (Anaes.) (Assist.) 1034812 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303915.0001291.2000000.00 4026.05.2002(Anaes.) 5001.12.2023VENOUS STENOSIS OR OCCLUSION, vein bypass for, using vein or synthetic 5001.12.2023material, not being a service associated with a service to which item 34806 or 5001.12.202334809 applies (Anaes.) (Assist.) 1034815 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303220.0001067.7000000.00 4026.05.2002(Anaes.) 5001.12.2023VEIN STENOSIS, patch angioplasty for, (excluding vein graft stenosis)-using 5001.12.2023vein or synthetic material (Anaes.) (Assist.) 1034818 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303575.0001175.3500000.00 4026.05.2002(Anaes.) 5001.12.2023VENOUS VALVE, plication or repair to restore valve competency (Anaes.) 5001.12.2023(Assist.) 1034821 26.05.2002 3 T8 3 SN NYNNY 2001.12.202304845.0001597.5500000.00 4026.05.2002(Anaes.) 5001.12.2023VEIN TRANSPLANT to restore valvular function (Anaes.) (Assist.) 1034824 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301665.0000546.2500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL STENT, application of, to restore venous valve competency to 5001.12.2023superficial vein - 1 stent (Anaes.) (Assist.) 1034827 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302015.0000662.2500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL STENTS, application of, to restore venous valve competency to 5001.12.2023superficial vein or veins - more than 1 stent (Anaes.) (Assist.) 1034830 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302370.0000778.1000000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL STENT, application of, to restore venous valve competency to deep 5001.12.2023vein (1 stent) (Anaes.) (Assist.) 1034833 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303065.0001009.7500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL STENTS, application of, to restore venous valve competency to deep 5001.12.2023vein or veins (more than 1 stent) (Anaes.) (Assist.) 1035000 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302370.0000778.1000000.00 4026.05.2002(Anaes.) 5001.12.2023LUMBAR SYMPATHECTOMY (Anaes.) (Assist.) 1035003 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303065.0001009.7500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL OR UPPER THORACIC SYMPATHECTOMY by any surgical approach (Anaes.) 5001.12.2023(Assist.) 1035006 26.05.2002 3 T8 3 SN NYNNY 2001.12.202303590.0001266.4500000.00 4026.05.2002(Anaes.) 5001.12.2023CERVICAL OR UPPER THORACIC SYMPATHECTOMY, where operation is a reoperation for 5001.12.2023previous incomplete sympathectomy by any surgical approach (Anaes.) (Assist.) 1035009 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302985.0000984.8500000.00 4026.05.2002(Anaes.) 5001.12.2023LUMBAR SYMPATHECTOMY, where operation is following chemical sympathectomy or 5001.12.2023for previous incomplete surgical sympathectomy (Anaes.) (Assist.) 1035012 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302320.0000778.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SACRAL or PRE-SACRAL SYMPATHECTOMY (Anaes.) (Assist.) 1035100 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301135.0000405.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough 5001.12.2023in, in the operating theatre of a hospital, when debridement includes muscle, 5001.12.2023tendon or bone (Anaes.) (Assist.) 1035103 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300725.0000258.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough 5001.12.2023in, in the operating theatre of a hospital, superficial tissue only (Anaes.) 1035200 26.05.2002 3 T8 3 SN NYNNY 2001.12.202300610.0000188.8000000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATIVE ARTERIOGRAPHY OR VENOGRAPHY, 1 or more of, performed during the 5001.12.2023course of an operative procedure on an artery or vein, 1 site (Anaes.) 1035202 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302890.0000899.3500000.00 4026.05.2002(Anaes.) 5001.12.2023MAJOR ARTERIES OR VEINS IN THE NECK, ABDOMEN OR EXTREMITIES, access to, as 5001.12.2023part of RE-OPERATION after prior surgery on these vessels (Anaes.) (Assist.) 1035300 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301705.0000567.2500000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSLUMINAL BALLOON ANGIOPLASTY of 1 peripheral artery or vein of 1 limb, 5001.12.2023percutaneous or by open exposure, excluding associated radiological services 5001.12.2023or preparation, and excluding aftercare (Anaes.) (Assist.) 1035303 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302185.0000727.3000000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSLUMINAL BALLOON ANGIOPLASTY of aortic arch branches, aortic visceral 5001.12.2023branches, or more than 1 peripheral artery or vein of 1 limb, percutaneous or 5001.12.2023by open exposure, excluding associated radiological services or preparation, 5001.12.2023and excluding aftercare (Anaes.) (Assist.) 1035306 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302200.0000671.3000000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon 5001.12.2023dilatation for 1 peripheral artery or vein of 1 limb, percutaneous or by open 5001.12.2023exposure, excluding associated radiological services or preparation, and 5001.12.2023excluding aftercare. (Anaes.) (Assist.) 1035307 01.11.2005 3 T8 3 SN NYNNY 2001.12.202303895.0001234.0500000.00 4001.11.2005(Anaes.) 5001.12.2023TRANSLUMINAL STENT INSERTION, 1 or more stents (not drug-eluting), with or 5001.12.2023without associated balloon dilatation, for 1 carotid artery, percutaneous (not 5001.12.2023direct), with or without the use of an embolic protection device, in patients 5001.12.2023who: -meet the indications for carotid endarterectomy; and -have medical or 5001.12.2023surgical comorbidities that would make them at high risk of perioperative 5001.12.2023complications from carotid endarterectomy, excluding associated radiological 5001.12.2023services or preparation, and excluding aftercare (Anaes.) (Assist.) 1035309 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302515.0000839.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon 5001.12.2023dilatation for visceral arteries or veins, or more than 1 peripheral artery or 5001.12.2023vein of 1 limb, percutaneous or by open exposure, excluding associated 5001.12.2023radiological services or preparation, and excluding aftercare. (Anaes.) 5001.12.2023(Assist.) 1035312 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302865.0000951.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL ARTERIAL ATHERECTOMY including associated balloon dilatation of 1 5001.12.2023limb, percutaneous or by open exposure, excluding associated radiological 5001.12.2023services or preparation, and excluding aftercare (Anaes.) (Assist.) 1035315 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302865.0000951.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL LASER ANGIOPLASTY including associated balloon dilatation of 1 5001.12.2023limb, percutaneous or by open exposure, excluding associated radiological 5001.12.2023services or preparation, and excluding aftercare (Anaes.) (Assist.) 1035317 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301190.0000391.6000000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of 5001.12.2023thrombolytic or chemotherapeutic agents, BY CONTINUOUS INFUSION, using 5001.12.2023percutaneous approach, excluding associated radiological services or 5001.12.2023preparation, and excluding aftercare (not being a service associated with a 5001.12.2023service to which another item in Subgroup 11 of Group T1 or items 35319 or 5001.12.202335320 applies and not being a service associated with photodynamic therapy 5001.12.2023with verteporfin) (Anaes.) (Assist.) 1035319 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302130.0000701.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of 5001.12.2023thrombolytic or chemotherapeutic agents, BY PULSE SPRAY TECHNIQUE, using 5001.12.2023percutaneous approach, excluding associated radiological services or 5001.12.2023preparation, and excluding aftercare (not being a service associated with a 5001.12.2023service to which another item in Subgroup 11 of Group T1 or items 35317 or 5001.12.202335320 applies and not being a service associated with photodynamic therapy 5001.12.2023with verteporfin) (Anaes.) (Assist.) 1035320 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302865.0000942.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of 5001.12.2023thrombolytic or chemotherapeutic agents, BY OPEN EXPOSURE, excluding 5001.12.2023associated radiological services or preparation, and excluding aftercare (not 5001.12.2023being a service associated with a service to which another item in Subgroup 11 5001.12.2023of Group T1 or items 35317 or 35319 applies and not being a service associated 5001.12.2023with photodynamic therapy with verteporfin) (Anaes.) (Assist.) 1035321 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302685.0000895.2000000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude 5001.12.2023arteries, veins or arterio-venous fistulae or to arrest haemorrhage, (but not 5001.12.2023for the treatment of uterine fibroids or varicose veins) percutaneous or by 5001.12.2023open exposure, excluding associated radiological services or preparation, and 5001.12.2023excluding aftercare, not being a service associated with photodynamic therapy 5001.12.2023with verteporfin (Anaes.) (Assist.) 1035324 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301010.0000335.7000000.00 4026.05.2002(Anaes.) 5001.12.2023ANGIOSCOPY not combined with any other procedure, excluding associated 5001.12.2023radiological services or preparation, and excluding aftercare (Anaes.) 5001.12.2023(Assist.) 1035327 26.05.2002 3 T8 3 SN NYNNY 2001.12.202301315.0000449.9000000.00 4026.05.2002(Anaes.) 5001.12.2023ANGIOSCOPY combined with any other procedure, excluding associated 5001.12.2023radiological services or preparation, and excluding aftercare (Anaes.) 5001.12.2023(Assist.) 1035330 26.05.2002 3 T8 3 SN NYNNY 2001.12.202302560.0000567.2500000.00 4026.05.2002(Anaes.) 5001.12.2023INSERTION of INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, 5001.12.2023excluding associated radiological services or preparation, and excluding 5001.12.2023aftercare (Anaes.) (Assist.) 1035331 01.05.2005 3 T8 3 SN NYNNY 2001.12.202301950.0000652.1500000.00 4001.05.2005(Anaes.) 5001.12.2023RETRIEVAL OF INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, not 5001.12.2023including associated radiological services or preparation, and not including 5001.12.2023aftercare (Anaes.) 1035360 01.05.2005 3 T8 3 SN NYNNY 2001.12.202302725.0000911.6000000.00 4001.05.2005(Anaes.) 5001.12.2023Retrieval of foreign body in PULMONARY ARTERY, percutaneous or by open 5001.12.2023exposure, not including associated radiological services or preparation, and 5001.12.2023not including aftercare (foreign body does not include an instrument inserted 5001.12.2023for the purpose of a service being rendered) (Anaes.) (Assist.) 1035361 01.05.2005 3 T8 3 SN NYNNY 2001.12.202302340.0000781.8000000.00 4001.05.2005(Anaes.) 5001.12.2023Retrieval of foreign body in RIGHT ATRIUM, percutaneous or by open exposure, 5001.12.2023not including associated radiological services or preparation, and not 5001.12.2023including aftercare (foreign body does not include an instrument inserted for 5001.12.2023the purpose of a service being rendered) (Anaes.) (Assist.) 1035362 01.05.2005 3 T8 3 SN NYNNY 2001.12.202301950.0000652.1500000.00 4001.05.2005(Anaes.) 5001.12.2023Retrieval of foreign body in INFERIOR VENA CAVA or AORTA, percutaneous or by 5001.12.2023open exposure, not including associated radiological services or preparation, 5001.12.2023and not including aftercare (foreign body does not include an instrument 5001.12.2023inserted for the purpose of a service being rendered) (Anaes.) (Assist.) 1035363 01.05.2005 3 T8 3 SN NYNNY 2001.12.202301565.0000522.4500000.00 4001.05.2005(Anaes.) 5001.12.2023Retrieval of foreign body in PERIPHERAL VEIN or PERIPHERAL ARTERY, 5001.12.2023percutaneous or by open exposure, not including associated radiological 5001.12.2023services or preparation, and not including aftercare (foreign body does not 5001.12.2023include an instrument inserted for the purpose of a service being rendered) 5001.12.2023(Anaes.) (Assist.) 1035401 01.11.2021 3 T8 3 SNS NYNNY 2001.12.202302375.0000751.6000000.00 4001.11.2021(Anaes.) 5001.12.2023Vertebroplasty, for one or more fractures in one or more vertebrae, performed 5001.12.2023by an interventional radiologist, for the treatment of a painful osteoporotic 5001.12.2023thoracolumbar vertebral compression fracture of the thoracolumbar spinal 5001.12.2023segment (T11, T12, L1 or L2), if: (a) pain is severe (numeric rated pain score 5001.12.2023greater than or equal to 7 out of 10); and (b) symptoms are poorly controlled 5001.12.2023by opiate therapy; and (c) severe pain duration is 3 weeks or less; and (d) 5001.12.2023there is MRI (or SPECTCT if MRI unavailable) evidence of acute vertebral 5001.12.2023fracture Applicable only once for the same fracture, but is applicable for a 5001.12.2023new fracture of the same vertebra or vertebrae (H) (Anaes.) 1035404 01.05.2006 3 T8 3 SN NYNNY 2001.12.202301180.0000381.5000000.00 5001.12.2023DOSIMETRY, HANDLING AND INJECTION OF SIR-SPHERES for selective internal 5001.12.2023radiation therapy of hepatic metastases which are secondary to colorectal 5001.12.2023cancer and are not suitable for resection or ablation, used in combination 5001.12.2023with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not 5001.12.2023being a service to which item 35317, 35319, 35320 or 35321 applies The 5001.12.2023procedure must be performed by a specialist or consultant physician recognised 5001.12.2023in the specialties of nuclear medicine or radiation oncology on an admitted 5001.12.2023patient in a hospital. To be claimed once in the patient's lifetime only. 1035406 01.05.2006 3 T8 3 SN NYNNY 2001.12.202302775.0000895.2000000.00 4001.05.2006(Anaes.) 5001.12.2023Trans-femoral catheterisation of the hepatic artery to administer SIR-Spheres 5001.12.2023to embolise the microvasculature of hepatic metastases which are secondary to 5001.12.2023colorectal cancer and are not suitable for resection or ablation, for 5001.12.2023selective internal radiation therapy used in combination with systemic 5001.12.2023chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to 5001.12.2023which item 35317, 35319, 35320 or 35321 applies excluding associated 5001.12.2023radiological services or preparation, and excluding aftercare (Anaes.) 5001.12.2023(Assist.) 1035408 01.05.2006 3 T8 3 SN NYNNY 2001.12.202301851.0000671.5000000.00 4001.05.2006(Anaes.) 5001.12.2023Catheterisation of the hepatic artery via a permanently implanted hepatic 5001.12.2023artery port to administer SIR-Spheres to embolise the microvasculature of 5001.12.2023hepatic metastases which are secondary to colorectal cancer and are not 5001.12.2023suitable for resection or ablation, for selective internal radiation therapy 5001.12.2023used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and 5001.12.2023leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 5001.12.2023applies excluding associated radiological services or preparation, and 5001.12.2023excluding aftercare (Anaes.) (Assist.) 1035410 01.11.2006 3 T8 3 SN NYNNY 2001.12.202302780.0000895.2000000.00 4001.11.2006(Anaes.) 5001.12.2023UTERINE ARTERY CATHETERISATION with percutaneous administration of occlusive 5001.12.2023agents, for the treatment of symptomatic uterine fibroids in a patient who has 5001.12.2023been referred for uterine artery embolisation by a specialist gynaecologist, 5001.12.2023excluding associated radiological services or preparation, and excluding 5001.12.2023aftercare (Anaes.) (Assist.) 1035412 01.11.2006 3 T8 3 SN NYNNY 2001.12.202309775.0003145.2500000.00 4001.11.2006(Anaes.) 5001.12.2023Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with 5001.12.2023detachable coils, and assisted coiling (if performed), with parent artery 5001.12.2023preservation, not for use with liquid embolics only, including intraoperative 5001.12.2023imaging, but in association with preoperative diagnostic imaging under item 5001.12.202360009, 60072, 60075 or 60078, including aftercare (Anaes.) (Assist.) 1035414 01.11.2017 3 T8 3 SN NYNNY 2001.12.202313960.0003852.4500000.00 4001.11.2017(Anaes.) 5001.12.2023Mechanical thrombectomy, in a patient with a diagnosis of acute ischaemic 5001.12.2023stroke caused by occlusion of a large vessel of the anterior cerebral 5001.12.2023circulation, including intra-operative imaging and aftercare, if: (a) the 5001.12.2023diagnosis is confirmed by an appropriate imaging modality such as computed 5001.12.2023tomography, magnetic resonance imaging or angiography; and (b) the service is 5001.12.2023performed by a specialist or consultant physician with appropriate training 5001.12.2023that is recognised by the Conjoint Committee for Recognition of Training in 5001.12.2023Interventional Neuroradiology; and (c) the service is provided in an eligible 5001.12.2023stroke centre. For any particular patient - applicable once per presentation 5001.12.2023by the patient at an eligible stroke centre, regardless of the number of times 5001.12.2023mechanical thrombectomy is attempted during that presentation (Anaes.) 5001.12.2023(Assist.) 1035500 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300245.0000089.5000000.00 4026.05.2002(Anaes.) 5001.12.2023GYNAECOLOGICAL EXAMINATION UNDER ANAESTHESIA, not being a service associated 5001.12.2023with a service to which another item in this Group applies (Anaes.) 1035507 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300580.0000192.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Vulval or vaginal warts, removal of under general anaesthesia, or under 5001.12.2023regional or field nerve block (excluding pudendal block), if the time taken is 5001.12.2023less than or equal to 45 minutesother than a service associated with a service 5001.12.2023to which item 32236 applies (H) (Anaes.) 1035508 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300870.0000282.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Vulval or vaginal warts, removal of under general anaesthesia, or under 5001.12.2023regional or field nerve block (excluding pudendal block), if the time taken is 5001.12.2023greater than 45 minutesother than a service associated with a service to which 5001.12.2023item 32236 applies (H) (Anaes.) (Assist.) 1035509 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300270.0000098.5000000.00 4026.05.2002(Anaes.) 5001.12.2023HYMENECTOMY (Anaes.) 1035513 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300700.0000244.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Bartholin's abscess, cyst or gland, excision of (Anaes.) 1035517 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300460.0000160.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Bartholin's abscess, cyst or gland, marsupialisation of (Anaes.) 1035518 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300855.0000228.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Ovarian cyst aspiration, for cysts of at least 4 cm in diameter in a 5001.12.2023premenopausal patient and at least 2 cm in diameter in a postmenopausal 5001.12.2023patient, by abdominal or vaginal route, using interventional imaging 5001.12.2023techniques and not associated with services provided for assisted reproductive 5001.12.2023techniques, and not in cases of suspected or possible malignancy (Anaes.) 1035527 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300455.0000160.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Urethral caruncle, symptomatic excision of, if:(a) conservative management has 5001.12.2023failed; or(b) there is a suspicion of malignancy (Anaes.) 1035536 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301160.0000383.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Vulva, wide local excision or hemivulvectomy, one or both procedures, for 5001.12.2023suspected malignancy or vulval lesions with a high risk of malignancy (Anaes.) 5001.12.2023(Assist.) 1035539 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300910.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Colposcopically directed laser therapy for histologically-confirmed high grade 5001.12.2023intraepithelial neoplastic changes of the vagina, vulva, urethra or anal 5001.12.2023canal, including any associated biopsiesone anatomical site (Anaes.) 1035545 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300540.0000202.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Colposcopically directed laser therapy for condylomata, unsuccessfully treated 5001.12.2023by other methods (Anaes.) 1035548 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304185.0001377.0500000.00 4026.05.2002(Anaes.) 5001.12.2023VULVECTOMY, radical, for malignancy (H) (Anaes.) (Assist.) 1035551 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Pelvic lymph nodes, radical excision of,unilateral, or sentinel node 5001.12.2023dissection (including any pre-operative injection) (Anaes.) (Assist.) 1035552 01.11.2020 3 T8 4 SN NYNNY 2001.12.202304060.0001531.2000000.00 4001.11.2020(Anaes.) 5001.12.2023Pelvic lymph nodes, radical excision of, unilateral or sentinel node 5001.12.2023dissection, following similar previous dissection, radiation or chemotherapy 5001.12.2023(H) (Anaes.) (Assist.) 1035554 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300134.0000047.8500000.00 4026.05.2002(Anaes.) 5001.12.2023VAGINA, DILATATION OF, as an independent procedure including any associated 5001.12.2023consultation (Anaes.) 1035557 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300675.0000236.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Vagina, complete excision of benign tumour (including Gartner duct cyst), with 5001.12.2023histological documentation (Anaes.) 1035560 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302460.0000752.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Partial or complete vaginectomy, for either or both of the following:(a) 5001.12.2023deeply infiltrating vaginal endometriosis, if accompanied by histological 5001.12.2023confirmation from excised tissue;(b) pre-invasive or invasive lesions Not 5001.12.2023being a service associated with hysterectomy for non invasive indications (H) 5001.12.2023(Anaes.) (Assist.) 1035561 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304625.0001689.6000000.00 4026.05.2002(Anaes.) 5001.12.2023VAGINECTOMY, radical, for proven invasive malignancy - 1 surgeon (H) (Anaes.) 5001.12.2023(Assist.) 1035562 26.05.2002 3 T8 4 SN NYNNY 2001.12.202303940.0001423.4000000.00 4026.05.2002(Anaes.) 5001.12.2023VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - 5001.12.2023abdominal surgeon (including aftercare) (H) (Anaes.) (Assist.) 1035564 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301970.0000711.7000000.00 5001.12.2023VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - 5001.12.2023perineal surgeon (H) (Assist.) 1035565 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302265.0000752.8000000.00 4026.05.2002(Anaes.) 5001.12.2023VAGINAL RECONSTRUCTION for congenital absence, gynatresia or urogenital sinus 5001.12.2023(Anaes.) (Assist.) 1035566 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301240.0000437.2500000.00 4026.05.2002(Anaes.) 5001.12.2023VAGINAL SEPTUM, excision of, for correction of double vagina (Anaes.) 5001.12.2023(Assist.) 1035568 01.05.2005 3 T8 4 SN NYNNY 2001.12.202302055.0000687.4500000.00 4001.05.2005(Anaes.) 5001.12.2023Procedures for the management of symptomatic upper vaginal (vault or cervical) 5001.12.2023prolapse by sacrospinous or ilococcygeus fixation (H) (Anaes.) (Assist.) 1035569 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300525.0000177.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PLASTIC REPAIR TO ENLARGE VAGINAL ORIFICE (Anaes.) 1035570 01.05.2005 3 T8 4 SN NYNNY 2001.12.202301825.0000609.6500000.00 4001.05.2005(Anaes.) 5001.12.2023Anterior vaginal compartment repair by vaginal approach for pelvic organ 5001.12.2023prolapse: (a) involving repair of urethrocele and cystocele; and (b) using 5001.12.2023native tissue without graft; other than a service associated with a service to 5001.12.2023which item 35573, 35577 or 35578 applies (Anaes.) (Assist.) 1035571 01.05.2005 3 T8 4 SN NYNNY 2001.12.202301825.0000609.6500000.00 4001.05.2005(Anaes.) 5001.12.2023Posterior vaginal compartment repair by vaginal approach for pelvic organ 5001.12.2023prolapse: (a) involving repair of one or more of the following: (i) perineum; 5001.12.2023(ii) rectocoele; (iii) enterocoele; and (b) using native tissue without graft; 5001.12.2023other than a service associated with a service to which item 35573, 35577 or 5001.12.202335578 applies (Anaes.) (Assist.) 1035573 01.05.2005 3 T8 4 SN NYNNY 2001.12.202302735.0000914.5500000.00 4001.05.2005(Anaes.) 5001.12.2023Anterior and posterior vaginal compartment repair by vaginal approach for 5001.12.2023pelvic organ prolapse: (a) involving anterior and posterior compartment 5001.12.2023defects; and (b) using native tissue without graft; other than a service 5001.12.2023associated with a service to which item 35577 or 35578 applies (Anaes.) 5001.12.2023(Assist.) 1035577 01.05.2005 3 T8 4 SN NYNNY 2001.12.202302220.0000742.4500000.00 4001.05.2005(Anaes.) 5001.12.2023Manchester (Donald Fothergill) operation for pelvic organ prolapse, involving 5001.12.2023either or both of the following: (a) cervical amputation; (b) anterior and 5001.12.2023posterior native tissue vaginal wall repairs without graft (Anaes.) (Assist.) 1035578 01.05.2005 3 T8 4 SN NYNNY 2001.12.202302220.0000742.4500000.00 4001.05.2005(Anaes.) 5001.12.2023Colpocleisis for pelvic organ prolapse, not being a service associated with a 5001.12.2023service to which another item (other than item 35599) in this Subgroup applies 5001.12.2023(H) (Anaes.) (Assist.) 1035581 01.07.2018 3 T8 4 SN NYNNY 2001.12.202301825.0000609.6500000.00 4001.07.2018(Anaes.) 5001.12.2023Vaginal procedure for excision of graft material in symptomatic patients with 5001.12.2023graft related complications (including graft related pain or discharge and 5001.12.2023bleeding related to graft exposure), less than 2cm2 in its maximum area, 5001.12.2023either singly or in multiple pieces, other than a service associated with a 5001.12.2023service to which item 35582 or 35585 applies (Anaes.) (Assist.) 1035582 01.07.2018 3 T8 4 SN NYNNY 2001.12.202302735.0000914.5500000.00 4001.07.2018(Anaes.) 5001.12.2023Vaginal procedure for excision of graft material in symptomatic patients with 5001.12.2023graft related complications (including graft related pain or discharge and 5001.12.2023bleeding related to graft exposure),2cm2 or more in its maximum area, either 5001.12.2023singly or in multiple pieces, other than a service associated with a service 5001.12.2023to which item 35581 or 35585 applies (Anaes.) (Assist.) 1035585 01.07.2018 3 T8 4 SN NYNNY 2001.12.202304850.0001621.5000000.00 4001.07.2018(Anaes.) 5001.12.2023Abdominal procedure, by open, laparoscopic or robotassisted approach, if the 5001.12.2023service: (a) is for the removal of graft material: (i) in symptomatic patients 5001.12.2023with graft related complications (including graft related pain or discharge 5001.12.2023and bleeding related to graft exposure); or (ii) where the graft has 5001.12.2023penetrated adjacent organs such as the bladder (including urethra) or bowel; 5001.12.2023and (b) if requiredincludes retroperitoneal dissection, and mobilisation, of 5001.12.2023either or both of the bladder and bowel; other than a service associated with 5001.12.2023a service to which item 35581 or 35582 applies (Anaes.) (Assist.) 1035595 01.05.2005 3 T8 4 SN NYNNY 2001.12.202302055.0000687.4500000.00 4001.05.2005(Anaes.) 5001.12.2023Procedure for the management of symptomatic vaginal vault or cervical 5001.12.2023prolapse, by uterosacral ligament suspension, by any approach, without graft, 5001.12.2023if the uterosacral ligaments are separately identified, transfixed and then 5001.12.2023incorporated into rectovaginal and pubocervical fascia of the vaginal vault, 5001.12.2023including cystoscopy to check ureteric integrity (H) (Anaes.) (Assist.) 1035596 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Fistula between genital and urinary or alimentary tracts, repair of, other 5001.12.2023than a service to which item 35591, 35592, 37029, 37333 or 37336 applies (H) 5001.12.2023(Anaes.) (Assist.) 1035597 01.05.2005 3 T8 4 SN NYNNY 2001.12.202304850.0001621.5000000.00 4001.05.2005(Anaes.) 5001.12.2023Sacral colpopexy, by any approach where graft or mesh is secured to vault, 5001.12.2023anterior and posterior compartments and to sacrum for correction of 5001.12.2023symptomatic upper vaginal vault prolapse (H) (Anaes.) (Assist.) 1035599 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302330.0000834.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Stress incontinence, procedure using a female synthetic mid-urethral sling, 5001.12.2023with diagnostic cystoscopy to assess the integrity of the lower urinary tract, 5001.12.2023other than a service associated with a service to which item 36812 applies (H) 5001.12.2023(Anaes.) (Assist.) 1035608 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300194.0000070.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, one or more biopsies, cauterisation (other than by chemical means), 5001.12.2023ionisation, diathermy or endocervical curettage of, with or without dilatation 5001.12.2023of cervix (Anaes.) 1035611 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300194.0000070.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of cervical or vaginal polyp or polypi, with or without dilatation of 5001.12.2023cervix, not being a service associated with a service to which item 35608 5001.12.2023applies (Anaes.) 1035612 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301700.0000556.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, residual stump, removal of, by abdominal approach for non-malignant 5001.12.2023lesions (Anaes.) (Assist.) 1035614 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300245.0000070.3000000.00 5001.12.2023Examination of the lower genital tract using a colposcope in a patient who:(a) 5001.12.2023has a human papilloma virus related gynaecology indication; or(b) has symptoms 5001.12.2023or signs suspicious of lower genital tract malignancy; or(c) is undergoing 5001.12.2023follow-up treatment of lower genital tract malignancy; or(d) is undergoing 5001.12.2023assessment or surveillance of a vulvovaginal pre-malignant or malignant 5001.12.2023disease; or(e) is undergoing assessment or surveillance as part of an 5001.12.2023identified at risk population 1035615 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300215.0000077.5000000.00 5001.12.2023Vulva or vagina, biopsy of, when performed in conjunction with a service to 5001.12.2023which item 35614 applies 1035616 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301525.0000494.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Endometrial ablation by thermal balloon or radiofrequency electrosurgery, for 5001.12.2023abnormal uterine bleeding, with or without endometrial sampling, including any 5001.12.2023hysteroscopy performed on the same day (H) (Anaes.) 1035620 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300188.0000058.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Endometrial biopsy for pathological assessment in women with abnormal uterine 5001.12.2023bleeding or post-menopausal bleeding (Anaes.) 1035622 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302070.0000663.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Endometrial ablation, using hysteroscopically guided electrosurgery or laser 5001.12.2023energy for abnormal uterine bleeding, with or without endometrial sampling, 5001.12.2023not being a service associated with a service to which item 30390 applies (H) 5001.12.2023(Anaes.) 1035623 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302655.0000901.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Endometrial ablation and resection of myoma or uterine septum (or both), using 5001.12.2023hysteroscopic guided electrosurgery or laser energy, for abnormal uterine 5001.12.2023bleeding, with or without endometrial sampling (H) (Anaes.) 1035626 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300755.0000246.6500000.00 5001.12.2023Hysteroscopy for investigation of suspected intrauterine pathology, with or 5001.12.2023without local anaesthesia, including any associated endometrial biopsy, not 5001.12.2023being a service associated with a service to which item 35630 applies 1035630 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300620.0000201.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysteroscopy for investigation of suspected intrauterine pathology if 5001.12.2023performed under general anaesthesia, including any associated endometrial 5001.12.2023biopsy, not being a service associated with a service to which item 35626 5001.12.2023applies (H) (Anaes.) 1035633 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300760.0000239.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysteroscopy, under visual guidance, including any of the following:(a) 5001.12.2023removal of an intra-uterine device;(b) removal of polyps by any method;(c) 5001.12.2023division of minor intrauterine adhesions (Anaes.) 1035635 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301340.0000329.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysteroscopy involving division of:(a) a uterine septum; or(b) moderate to 5001.12.2023severe intrauterine adhesions (H) (Anaes.) 1035636 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301525.0000476.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysteroscopy, resection of myoma or myoma and uterine septum (if both are 5001.12.2023performed) (H) (Anaes.) 1035637 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301355.0000447.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Operative laparoscopy, including any of the following: (a) excision or 5001.12.2023ablation of minimal endometriosis; (b) division of pathological adhesions; (c) 5001.12.2023sterilisation by application of clips, division, destruction or removal of 5001.12.2023tubes; not being a service associated with another laparoscopic procedure (H) 5001.12.2023NOTE: Strict legal requirements apply in relation to sterilisation procedures 5001.12.2023on minors. Medicare benefits are not payable for services not rendered in 5001.12.2023accordance with relevant Commonwealth and State and Territory law. Observe the 5001.12.2023explanatory note before submitting a claim. (Anaes.) (Assist.) 1035640 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300620.0000201.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Uterus, curettage of, with or without dilation (including curettage for 5001.12.2023incomplete miscarriage), if performed under:(a) general anaesthesia; or(b) 5001.12.2023epidural or spinal (intrathecal) nerve block; or(c) sedation;including 5001.12.2023procedures (if performed) to which item 35626 or 35630 applies (Anaes.) 1035641 26.05.2002 3 T8 4 SN NYNNY 2001.12.202305000.0001367.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Severe endometriosis, laparoscopic resection of, involving 2 of the following 5001.12.2023procedures:(a) resection of the pelvic side wall including dissection of 5001.12.2023endometriosis or scar tissue from the ureter;(b) resection of the Pouch of 5001.12.2023Douglas; (c) resection of an ovarian endometrioma greater than 2 cm in 5001.12.2023diameter;(d) dissection of bowel from uterus from the level of the 5001.12.2023endocervical junction or above (H) (Anaes.) (Assist.) 1035643 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300730.0000239.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Evacuation of the contents of the gravid uterus by curettage or suction 5001.12.2023curettage, if performed under:(a) local anaesthesia; or(b) general 5001.12.2023anaesthesia; or(c) epidural or spinal (intrathecal) nerve block; or(d) 5001.12.2023sedation;including procedures (if performed) to which item 35626 or 35630 5001.12.2023applies (Anaes.) 1035644 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300690.0000224.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with 5001.12.2023colposcopy, including any local anaesthesia and biopsies, for previously 5001.12.2023biopsy confirmed HSIL (CIN 2/3) in a patient with a Type 1 or 2 (completely 5001.12.2023visible) transformation zone, if there is:(a) no evidence of invasive or 5001.12.2023glandular disease; and(b) no discordance between cytology and previous 5001.12.2023histology;not being a service associated with a service to which item 35647 or 5001.12.202335648 applies (Anaes.) 1035645 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301075.0000350.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with 5001.12.2023colposcopy, including any local anaesthesia or biopsies, in conjunction with 5001.12.2023ablative therapy of additional areas of biopsy proven high grade 5001.12.2023intraepithelial lesions of one or more sites of the vagina, vulva, urethra or 5001.12.2023anus, for previously biopsy confirmed HSIL (CIN2/3) in a patient with a Type 1 5001.12.2023of 2 (completely visible) transformation zone, if there is:(a) no evidence of 5001.12.2023invasive or glandular disease; and(b) no discordance between cytology and 5001.12.2023previous histology;not being a service associated with a service to which item 5001.12.202335647 or 35648 applies (Anaes.) 1035647 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300685.0000224.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, complete excision of the endocervical transformation zone, using large 5001.12.2023loop or laser therapy, including any local anaesthesia and biopsies (Anaes.) 1035648 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301075.0000350.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Cervix, complete excision of the endocervical transformation zone, using large 5001.12.2023loop or laser therapy, including any local anaesthesia and biopsies, in 5001.12.2023conjunction with ablative treatment of additional areas of biopsy-proven high 5001.12.2023grade intraepithelial lesions of one or more sites of the vagina, vulva, 5001.12.2023urethra or anus (Anaes.) 1035649 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301495.0000589.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Myomectomy, one or more myomas, when undertaken by an open abdominal approach 5001.12.2023(H) (Anaes.) (Assist.) 1035653 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302210.0000742.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, abdominal, with or without removal of fallopian tubes and 5001.12.2023ovaries (H) (Anaes.) (Assist.) 1035657 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302210.0000742.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, vaginal, with or without uterine curettage, inclusive of 5001.12.2023posterior culdoplasty, not being a service associated with a service to which 5001.12.2023item 35673 applies (H) (Anaes.) (Assist.) 1035658 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301360.0000458.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Uterus (at least equivalent in size to a 10 week gravid uterus), debulking of, 5001.12.2023prior to vaginal or laparoscopic removal at hysterectomy or myoma of at least 5001.12.20234 cm removed by laparoscopy when retrieved from the abdomen (H) (Anaes.) 5001.12.2023(Assist.) 1035661 26.05.2002 3 T8 4 SN NYNNY 2001.12.202306460.0001856.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, abdominal, that concurrently requires extensive retroperitoneal 5001.12.2023dissection with exposure of one or both ureters and complex side wall 5001.12.2023dissection, including when performed with one or more of the following 5001.12.2023procedures:(a) salpingectomy;(b) oophorectomy;(c) excision of ovarian cyst(H) 5001.12.2023(Anaes.) (Assist.) 1035667 26.05.2002 3 T8 4 SN NYNNY 2001.12.202306135.0001753.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Radical hysterectomy or radical trachelectomy (with or without excision of 5001.12.2023uterine adnexae) for proven malignancy, including excision of any one or more 5001.12.2023of the following:(a) parametrium;(b) paracolpos;(c) upper vagina;(d) 5001.12.2023contiguous pelvic peritoneum;utilising nerve sparing techniques and involving 5001.12.2023ureterolysis, if performed (H) (Anaes.) (Assist.) 1035668 01.03.2022 3 T8 4 SN NYNNY 2001.12.202305618.0002037.7500000.00 4001.03.2022(Anaes.) 5001.12.2023Hysterectomy, radical (with or without excision of uterine adnexae) including 5001.12.2023excision of any one or more of the following:(a) parametrium;(b) 5001.12.2023paracolpos;(c) upper vagina;(d) contiguous pelvic peritoneum;utilising nerve 5001.12.2023sparing techniques and involving ureterolysis, if performed in a patient with 5001.12.2023malignancy and previous pelvic radiation or chemotherapy treatment (H) 5001.12.2023(Anaes.) (Assist.) 1035671 01.03.2022 3 T8 4 SN NYNNY 2001.12.202304407.0001598.5000000.00 4001.03.2022(Anaes.) 5001.12.2023Hysterectomy, peripartum, for ongoing intractable haemorrhage where other 5001.12.2023haemorrhage control techniques have failed, for the purpose of providing 5001.12.2023lifesaving emergency treatment, not being a service associated with a service 5001.12.2023to which item 35667, 35668 or 35669 applies (H) (Anaes.) (Assist.) 1035680 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301795.0000640.6500000.00 4026.05.2002(Anaes.) 5001.12.2023BICORNUATE UTERUS, plastic reconstruction for (Anaes.) (Assist.) 1035691 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300565.0000174.6500000.00 4026.05.2002(Anaes.) 5001.12.2023STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in 5001.12.2023conjunction with Caesarean section NOTE:Strict legal requirements apply in 5001.12.2023relation to sterilisation procedures on minors.Medicare benefits are not 5001.12.2023payable for services not rendered in accordance with relevant Commonwealth and 5001.12.2023State and Territory law.Observe the explantory note before submitting a claim. 5001.12.2023(Anaes.) (Assist.) 1035694 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301975.0000701.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Tuboplasty (salpingostomy or salpingolysis), unilateral or bilateral, one or 5001.12.2023more procedures (H) (Anaes.) (Assist.) 1035697 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302945.0001041.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Microsurgical or laparoscopic tuboplasty (salpingostomy, salpingolysis or 5001.12.2023tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures 5001.12.2023(Anaes.) (Assist.) 1035700 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302235.0000803.6500000.00 4026.05.2002(Anaes.) 5001.12.2023FALLOPIAN TUBES, unilateral microsurgical or laparoscopic anastomosis of (H) 5001.12.2023(Anaes.) (Assist.) 1035703 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300210.0000074.3000000.00 4026.05.2002(Anaes.) 5001.12.2023HYDROTUBATION OF FALLOPIAN TUBES as a nonrepetitive procedure (Anaes.) 1035717 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302690.0000939.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Laparotomy, involving oophorectomy, salpingectomy, salpingo-oophorectomy, 5001.12.2023removal of ovarian, parovarian, fimbrial or broad ligament cystone or more 5001.12.2023such procedures, unilateral or bilateral, including adhesiolysis, for benign 5001.12.2023disease (including ectopic pregnancy by tubal removal or salpingostomy), not 5001.12.2023being a service associated with hysterectomy (H) (Anaes.) (Assist.) 1035720 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304885.0001755.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Radical debulking, involving the radical excision of a macroscopically 5001.12.2023disseminated gynaecological malignancy from the pelvic cavity, including 5001.12.2023resection of peritoneum from the following:(a) the pelvic side wall;(b) the 5001.12.2023pouch of Douglas;(c) the bladder;for macroscopic disease confined to the 5001.12.2023pelvis, not being a service associated with a service to which item 35721 5001.12.2023applies (H) (Anaes.) (Assist.) 1035721 01.03.2022 3 T8 4 SN NYNNY 2001.12.202309680.0003511.1000000.00 4001.03.2022(Anaes.) 5001.12.2023Radical debulking, involving the radical excision of a macroscopically 5001.12.2023disseminated gynaecological malignancy from the abdominal and pelvic cavity, 5001.12.2023where cancer has extended beyond the pelvis, including any of the 5001.12.2023following:(a) resection of peritoneum over any of the following: (i) the 5001.12.2023diaphragm; (ii) the paracolic gutters; (iii) the greater or lesser omentum; 5001.12.2023(iv) the porta hepatis;(b) cytoreduction of recurrent gynaecological 5001.12.2023malignancy from the abdominal cavity following previous abdominal surgery, 5001.12.2023radiation or chemotherapy;(c) cytoreduction of recurrent gynaecological 5001.12.2023malignancy from the pelvic cavity following previous pelvic surgery, radiation 5001.12.2023or chemotherapy;not being a service to which a service associated with a 5001.12.2023service to which item 35720 or 35726 applies (H) (Anaes.) (Assist.) 1035723 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304065.0001526.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Para-aortic lymph node dissection from above the level of the aortic 5001.12.2023bifurcation (unilateral), for staging or restaging of gynaecological 5001.12.2023malignancy (H) (Anaes.) (Assist.) 1035724 01.03.2022 3 T8 4 SN NYNNY 2001.12.202306333.0002296.9000000.00 4001.03.2022(Anaes.) 5001.12.2023Para-aortic lymph node dissection (pelvic or above the aortic bifurcation) 5001.12.2023after prior similar dissection, radiotherapy or chemotherapy for malignancy 5001.12.2023(H) (Anaes.) (Assist.) 1035726 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301485.0000531.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Infra-colic omentectomy, with or without multiple peritoneal biopsies, for 5001.12.2023staging or restaging of gynaecological malignancy, not being a service 5001.12.2023associated with a service to which item 35721 applies (H) (Anaes.) (Assist.) 1035729 26.05.2002 3 T8 4 SN NYNNY 2001.12.202300730.0000239.7500000.00 4026.05.2002(Anaes.) 5001.12.2023OVARIAN TRANSPOSITION out of the pelvis, in conjunction with radical 5001.12.2023hysterectomy for invasive malignancy (Anaes.) 1035730 01.05.2017 3 T8 4 SN NYNNY 2001.12.202300730.0000239.7500000.00 4001.05.2017(Anaes.) 5001.12.2023Ovarian repositioning for one or both ovaries to preserve ovarian function, 5001.12.2023prior to gonadotoxic radiotherapy when the treatment volume and dose of 5001.12.2023radiation have a high probability of causing infertility (Anaes.) 1035750 26.05.2002 3 T8 4 SN NYNNY 2001.12.202302635.0000863.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, laparoscopic assisted vaginal, by any approach, including any 5001.12.2023endometrial sampling, with or without removal of the tubes or ovarian 5001.12.2023cystectomy or removal of the ovaries and tubes due to other pathology, not 5001.12.2023being a service associated with a service to which item 35595 or 35673 5001.12.2023applies. (H) (Anaes.) (Assist.) 1035751 01.03.2022 3 T8 4 SN NYNNY 2001.12.202302381.0000863.6000000.00 4001.03.2022(Anaes.) 5001.12.2023Hysterectomy, laparoscopic, by any approach, including any endometrial 5001.12.2023sampling, with or without removal of the tubes, not being a service associated 5001.12.2023with a service to which item 35595 applies (H) (Anaes.) (Assist.) 1035753 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304425.0000954.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, complex laparoscopic, by any approach, including endometrial 5001.12.2023sampling, with either or both of the following procedures:(a) unilateral or 5001.12.2023bilateral salpingo-oophorectomy (excluding salpingectomy);(b) excision of 5001.12.2023moderate endometriosis or ovarian cyst;including any associated laparoscopy, 5001.12.2023not being a service associated with a service to which item 35595 applies (H) 5001.12.2023(Anaes.) (Assist.) 1035754 26.05.2002 3 T8 4 SN NYNNY 2001.12.202306460.0001845.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, complex laparoscopic, by any approach, that concurrently 5001.12.2023requires either extensive retroperitoneal dissection or complex side wall 5001.12.2023dissection, or both, with any of the following procedures (if performed):(a) 5001.12.2023endometrial sampling; (b) unilateral or bilateral salpingectomy, oophorectomy 5001.12.2023or salpingo-oophorectomy;(c) excision of ovarian cyst; (d) any other 5001.12.2023associated laparoscopy; not being a service associated with a service to which 5001.12.2023item 35595 or 35641 applies (H) (Anaes.) (Assist.) 1035756 26.05.2002 3 T8 4 SN NYNNY 2001.12.202304760.0001575.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterectomy, laparoscopic, by any approach, if the procedure is completed by 5001.12.2023open hysterectomy for control of bleeding or extensive pathology, including 5001.12.2023any associated laparoscopy, not being a service associated with a service to 5001.12.2023which item 35595 or 35641 applies (H) (Anaes.) (Assist.) 1035759 26.05.2002 3 T8 4 SN NYNNY 2001.12.202301845.0000620.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Procedure for the control of post operative haemorrhage following 5001.12.2023gynaecological surgery, under general anaesthesia, utilising a vaginal, 5001.12.2023abdominal or laparoscopic approach if no other procedure is performed (H) 5001.12.2023(Anaes.) (Assist.) 1036502 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302095.0000752.8000000.00 4026.05.2002(Anaes.) 5001.12.2023PELVIC LYMPHADENECTOMY, open or laparoscopic, or both, unilateral or bilateral 5001.12.2023(Anaes.) (Assist.) 1036503 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304065.0001531.2000000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL TRANSPLANT (not being a service to which item 36506 or 36509 applies) 5001.12.2023(Anaes.) (Assist.) 1036504 01.05.2019 3 T8 5 SN NYNNY 2001.12.202300855.0000324.5000000.00 4001.05.2019(Anaes.) 5001.12.2023RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to 5001.12.2023white light, including catheterisation, with biopsy of bladder, not being a 5001.12.2023service associated with a service to which item 36505, 36507, 36508, 36812, 5001.12.202336830, 36836, 36840, 36845, 36848, 36854, 37203, 37206, 37215, 37230 or 37233 5001.12.2023applies. (Anaes.) 1036505 01.05.2019 3 T8 5 SN NYNNY 2001.12.202300665.0000255.0000000.00 4001.05.2019(Anaes.) 5001.12.2023RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to 5001.12.2023white light, including catheterisation, with urethroscopy with or without 5001.12.2023urethral dilatation, not being a service associated with any other urological 5001.12.2023endoscopic procedure on the lower urinary tract except a service to which item 5001.12.202337327 applies. (Anaes.) 1036506 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL TRANSPLANT, performed by vascular surgeon and urologist operating 5001.12.2023togethervascular anastomosis including aftercare (Anaes.) (Assist.) 1036507 01.05.2019 3 T8 5 SN NYNNY 2001.12.202301125.0000427.2500000.00 4001.05.2019(Anaes.) 5001.12.2023RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to 5001.12.2023white light, including catheterisation, with resection, diathermy or visual 5001.12.2023laser destruction of bladder tumour or other lesion of the bladder, not being 5001.12.2023a service to which item 36840 or 36845 applies. (Anaes.) 1036508 01.05.2019 3 T8 5 SN NYNNY 2001.12.202302205.0000832.6000000.00 4001.05.2019(Anaes.) 5001.12.2023RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to 5001.12.2023white light, including catheterisation, with diathermy, resection or visual 5001.12.2023laser destruction of multiple tumours in more than 2 quadrants of the bladder 5001.12.2023or solitary tumour greater than 2cm in diameter, not being a service to which 5001.12.2023item 36845 applies. (Anaes.) 1036509 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302305.0000861.8500000.00 5001.12.2023RENAL TRANSPLANT, performed by vascular surgeon and urologist operating 5001.12.2023togetherureterovesical anastomosis including aftercare (Assist.) 1036516 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, complete, by open, laparoscopic or robot-assisted approach, other 5001.12.2023than a service associated with a service to which item 30390 or 30627 applies 5001.12.2023(Anaes.) (Assist.) 1036519 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, complete, by open, laparoscopic or robot-assisted approach, 5001.12.2023complicated by previous surgery on the same kidney, other than a service 5001.12.2023associated with a service to which item 30390 or 30627 applies (Anaes.) 5001.12.2023(Assist.) 1036522 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303250.0001219.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, partial,by open, laparoscopic or robot-assisted approach, other 5001.12.2023than a service associated with a service to which item 30390 or 30627 applies 5001.12.2023(Anaes.) (Assist.) 1036525 26.05.2002 3 T8 5 SN NYNYY 2001.12.202304605.0001732.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, partial, by open, laparoscopic or robotassisted approach: (a) if 5001.12.2023complicated by previous surgery or ablative procedure on the same kidney; or 5001.12.2023(b) for a patient with a solitary functioning kidney; or (c) for a patient 5001.12.2023with an estimated glomerular filtration rate (eGFR) of less than 5001.12.202360ml/min/1.73m2; other than a service associated with a service to which item 5001.12.202330390 or 30627 applies (Anaes.) (Assist.) 1036528 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, radical, by open, laparoscopic or robot-assisted approach, with 5001.12.2023or without en bloc dissection of lymph nodes, with or without adrenalectomy, 5001.12.2023for a tumour less than 10 cm in diameter, other than a service associated with 5001.12.2023a service to which item 30390 or 30627 applies (Anaes.) (Assist.) 1036529 26.05.2002 3 T8 5 SN NYNYY 2001.12.202304665.0001753.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrectomy, radical, by open, laparoscopic or robotassisted approach, with or 5001.12.2023without en bloc dissection of lymph nodes, with or without adrenalectomy: (a) 5001.12.2023for a tumour 10 cm or more in diameter; or (b) if complicated by previous open 5001.12.2023or laparoscopic surgery on the same kidney; other than a service associated 5001.12.2023with a service to which item 30390 or 30627 applies (Anaes.) (Assist.) 1036530 01.11.2022 3 T8 5 SNS NYNNY 2001.12.202302457.0000891.3500000.00 4001.11.2022(Anaes.) 5001.12.2023Renal cell carcinoma, not more than 4 cm in diameter, destruction of, by 5001.12.2023percutaneous, laparoscopic or open cryoablation (including any associated 5001.12.2023imaging services), if: (a) malignancy has previously been confirmed by 5001.12.2023histopathological examination; and (b) a multidisciplinary team has reviewed 5001.12.2023treatment options for the patient and assessed that partial nephrectomy is not 5001.12.2023suitable; and (c) the service is not a service associated with a service to 5001.12.2023which item 36522 or 36525 applies (H) (Anaes.) 1036531 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303385.0001274.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroureterectomy, complete, by open, laparoscopic or robot-assisted 5001.12.2023approach, including associated bladder repair and any associated endoscopic 5001.12.2023procedure, other than a service associated with a service to which item 30390 5001.12.2023or 30627 applies (Anaes.) (Assist.) 1036532 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304865.0001829.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroureterectomy, for tumour, by open, laparoscopic or robot-assisted 5001.12.2023approach, with or without en bloc dissection of lymph nodes, including 5001.12.2023associated bladder repair and any associated endoscopic procedures, other than 5001.12.2023a service to which item 36533 applies or a service associated with a service 5001.12.2023to which item 30390 or 30627 applies (Anaes.) (Assist.) 1036533 26.05.2002 3 T8 5 SN NYNNY 2001.12.202305750.0002162.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroureterectomy, for tumour, by open, laparoscopic or robot-assisted 5001.12.2023approach, with or without en bloc dissection of lymph nodes, including 5001.12.2023associated bladder repair and any associated endoscopic procedures, if 5001.12.2023complicated by previous open or laparoscopic surgery on the same kidney or 5001.12.2023ureter, other than a service associated with a service to which item 30390 or 5001.12.202330627 applies (Anaes.) (Assist.) 1036537 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023KIDNEY OR PERINEPHRIC AREA, EXPLORATION OF, with or without drainage of, by 5001.12.2023open exposure, not being a service to which another item in this Sub-group 5001.12.2023applies (Anaes.) (Assist.) 1036543 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrolithotomy or pyelolithotomy, or both, extended, for one or more renal 5001.12.2023stones, including one or more of nephrostomy, pyelostomy, pedicle control with 5001.12.2023or without freezing, calyorrhaphy or pyeloplasty (Anaes.) (Assist.) 1036546 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) to urinary tract and 5001.12.2023posttreatment care for 3 days, including pretreatment consultation, unilateral 5001.12.2023(Anaes.) 1036549 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Ureterolithotomy, by open, laparoscopic or robot-assisted approach (Anaes.) 5001.12.2023(Assist.) 1036552 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023NEPHROSTOMY or pyelostomy, open, as an independent procedure (Anaes.) 5001.12.2023(Assist.) 1036558 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023RENAL CYST OR CYSTS, excision or unroofing of (Anaes.) (Assist.) 1036561 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300495.0000189.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Renal biopsy, performed under image guidance (closed) (Anaes.) 1036564 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Pyeloplasty, (plastic reconstruction of the pelvi-ureteric junction) by open, 5001.12.2023laparoscopic or robot-assisted approach, with or without the use of a 5001.12.2023retroperitoneal approach (Anaes.) (Assist.) 1036567 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302980.0001118.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Pyeloplasty in a kidney that is congenitally abnormal (in addition to the 5001.12.2023presence of pelvi-ureteric junction obstruction), or in a solitary kidney, by 5001.12.2023open, laparoscopic or robot-assisted approach, with or without the use of a 5001.12.2023retroperitoneal approach (Anaes.) (Assist.) 1036570 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Pyeloplasty, complicated by previous surgery on the same kidney, by 5001.12.2023open,laparoscopic or robot-assisted approach, with or without the use of a 5001.12.2023retroperitoneal approach (Anaes.) (Assist.) 1036573 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023DIVIDED URETER, repair of (Anaes.) (Assist.) 1036576 26.05.2002 3 T8 5 SN NYNYY 2001.12.202303385.0001274.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Kidney, exposure and exploration of, including repair or nephrectomy, for 5001.12.2023trauma, by open, laparoscopic or robotassisted approach, other than a service 5001.12.2023associated with: (a) any other procedure performed on the kidney, renal pelvis 5001.12.2023or renal pedicle; or (b) a service to which item 30390 or 30627 applies 5001.12.2023(Anaes.) (Assist.) 1036579 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Ureterectomy, complete or partial: (a) for a tumour within the ureter, proven 5001.12.2023by histopathology at the time of surgery; or (b) for congenital anomaly; with 5001.12.2023or without associated bladder repair (Anaes.) (Assist.) 1036585 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, transplantation of, into skin (Anaes.) (Assist.) 1036588 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, reimplantation into bladder (Anaes.) (Assist.) 1036591 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303250.0001219.5500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, reimplantation into bladder with psoas hitch or Boari flap or both 5001.12.2023(Anaes.) (Assist.) 1036594 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, transplantation of, into intestine (Anaes.) (Assist.) 1036597 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, transplantation of, into another ureter (Anaes.) (Assist.) 1036600 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303250.0001219.5500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, transplantation of, into isolated intestinal segment, unilateral 5001.12.2023(Anaes.) (Assist.) 1036603 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023URETERS, transplantation of, into isolated intestinal segment, bilateral 5001.12.2023(Anaes.) (Assist.) 1036604 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300790.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Ureteric stent, passage of through percutaneous nephrostomy tube, using 5001.12.2023interventional radiology techniques, but not including imaging (Anaes.) 1036606 26.05.2002 3 T8 5 SN NYNNY 2001.12.202306775.0002549.0500000.00 4026.05.2002(Anaes.) 5001.12.2023INTESTINAL URINARY RESERVOIR, continent, formation of, including formation of 5001.12.2023nonreturn valves and implantation of ureters (1 or both) into reservoir 5001.12.2023(Anaes.) (Assist.) 1036607 01.05.2005 3 T8 5 SN NYNNY 2001.12.202302300.0000760.3000000.00 4001.05.2005(Anaes.) 5001.12.2023Ureteric stent insertion of, with balloon dilatation of: (a) the pelvicalyceal 5001.12.2023system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a 5001.12.2023nephrostomy tube using interventionalradiology techniques, but not including 5001.12.2023imaging (Anaes.) 1036608 01.05.2005 3 T8 5 SN NYNNY 2001.12.202300890.0000294.6500000.00 4001.05.2005(Anaes.) 5001.12.2023Ureteric stent, exchange of, percutaneously through either the ileal conduit 5001.12.2023or bladder, using interventional radiology techniques, but not including 5001.12.2023imaging, not being a service associated with a service to which items 36811 to 5001.12.202336854 apply (Anaes.) 1036609 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Intestinal urinary conduit, reservoir or ureterostomy, revision of (Anaes.) 5001.12.2023(Assist.) 1036610 01.11.2020 3 T8 5 SN NYNNY 2001.12.202305335.0001953.7500000.00 4001.11.2020(Anaes.) 5001.12.2023Intestinal urinary conduit, incontinent, formation of (including associated 5001.12.2023small bowel resection and anastomosis), including implantation of one or both 5001.12.2023ureters into reservoir (Anaes.) (Assist.) 1036611 01.11.2020 3 T8 5 SN NYNNY 2001.12.202308320.0003081.7000000.00 4001.11.2020(Anaes.) 5001.12.2023Intestinal urinary reservoir, continent, formation of (including associated 5001.12.2023small bowel resection and anastomosis), including formation of non-return 5001.12.2023valves and implantation of one or both ureters into reservoir, performed by 5001.12.2023open, laparoscopic or robot-assisted approach (Anaes.) (Assist.) 1036612 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023URETER, exploration of, with or without drainage of, as an independent 5001.12.2023procedure (Anaes.) (Assist.) 1036615 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Ureterolysis, unilateral, with or without repositioning of the ureter, for 5001.12.2023obstruction of the ureter, if: (a) the obstruction: (i) is evident either 5001.12.2023radiologically or by proximal ureteric dilatation at operation; and (ii) is 5001.12.2023secondary to retroperitoneal fibrosis; and (b) there is biopsy proven 5001.12.2023fibrosis, endometriosis or cancer at the site of the obstruction at time of 5001.12.2023surgery (Anaes.) (Assist.) 1036618 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023REDUCTION URETEROPLASTY (Anaes.) (Assist.) 1036621 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000511.3500000.00 4026.05.2002(Anaes.) 5001.12.2023CLOSURE OF CUTANEOUS URETEROSTOMY (Anaes.) (Assist.) 1036624 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301625.0000614.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrostomy, percutaneous, using interventional radiology techniques, but not 5001.12.2023including imaging (Anaes.) (Assist.) 1036627 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroscopy, percutaneous, with or without any one or more of; stone 5001.12.2023extraction, biopsy or diathermy, not being a service to which item 36639 or 5001.12.202336645 applies (Anaes.) 1036633 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroscopy, percutaneous, with incision of any one or more of; renal pelvis, 5001.12.2023calyx or calyces or ureter and including antegrade insertion of ureteric 5001.12.2023stent, not being a service associated with a service to which item 36627, 5001.12.202336639 or 36645 applies (Anaes.) (Assist.) 1036636 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301165.0000440.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroscopy, percutaneous, with incision of any one or more of; renal pelvis, 5001.12.2023calyx or calyces or ureter and including antegrade insertion of ureteric 5001.12.2023stent, being a service associated with a service to which item 36627, 36639 or 5001.12.202336645 applies (Anaes.) (Assist.) 1036639 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Nephroscopy, percutaneous, with destruction and extraction of one or two 5001.12.2023stones using ultrasound or electrohydraulic shock waves orlasers, other than a 5001.12.2023service to which item 36645 applies (Anaes.) 1036645 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303115.0001173.7000000.00 4026.05.2002(Anaes.) 5001.12.2023NEPHROSCOPY, percutaneous, with removal or destruction of a stone greater than 5001.12.20233 cm in any dimension, or for 3 or more stones (Anaes.) (Assist.) 1036649 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300790.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Nephrostomy drainage tube, exchange of, using interventional radiology 5001.12.2023techniques, but not including imaging (Anaes.) (Assist.) 1036650 01.05.2005 3 T8 5 SN NYNNY 2001.12.202300500.0000164.8000000.00 4001.05.2005(Anaes.) 5001.12.2023Nephrostomy tube, removal of, using interventionalradiology techniques, but 5001.12.2023not including imaging, if the ureter has been stented with a double J ureteric 5001.12.2023stent and that stent is left in place (Anaes.) 1036652 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301905.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023PYELOSCOPY, retrograde, of one collecting system, with or without any one or 5001.12.2023more of, cystoscopy, ureteric meatotomy, ureteric dilatation, not being a 5001.12.2023service associated with a service to which item 36803, 36812 or 36824 applies 5001.12.2023(Anaes.) (Assist.) 1036654 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023PYELOSCOPY, retrograde, of one collecting system, being a service to which 5001.12.2023item 36652 applies, plus 1 or more of extraction of stone from the renal 5001.12.2023pelvis or calyces, or biopsy or diathermy of the renal pelvis or calyces, not 5001.12.2023being a service associated with a service to which item 36656 applies to a 5001.12.2023procedure performed in the same collecting system (Anaes.) (Assist.) 1036656 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303120.0001173.7000000.00 4026.05.2002(Anaes.) 5001.12.2023PYELOSCOPY, retrograde, of one collecting system, being a service to which 5001.12.2023item 36652 applies, plus extraction of 2 or more stones in the renal pelvis or 5001.12.2023calyces or destruction of stone with ultrasound, electrohydraulic or kinetic 5001.12.2023lithotripsy, or laser in the renal pelvis or calyces, with or without 5001.12.2023extraction of fragments, not being a service associated with a service to 5001.12.2023which item 36654 applies to a procedure performed in the same collecting 5001.12.2023system (Anaes.) (Assist.) 1036663 01.05.2010 3 T8 5 SN NYNNY 2001.12.202301950.0000727.5000000.00 4001.05.2010(Anaes.) 5001.12.2023Both:(a) percutaneous placement of sacral nerve lead or leads using 5001.12.2023fluoroscopic guidance, or open placement of sacral nerve lead or leads; and 5001.12.2023(b) intraoperative test stimulation, to manage: (i) detrusor overactivity that 5001.12.2023has been refractory to at least 12 months conservative nonsurgical treatment; 5001.12.2023or (ii) nonobstructive urinary retention that has been refractory to at least 5001.12.202312 months conservative nonsurgical treatment (Anaes.) 1036664 01.05.2010 3 T8 5 SN NYNNY 2001.12.202301755.0000653.3500000.00 4001.05.2010(Anaes.) 5001.12.2023Both:(a) percutaneous repositioning of sacral nerve lead or leads using 5001.12.2023fluoroscopic guidance, or open repositioning of sacral nerve lead or leads; 5001.12.2023and (b) intraoperative test stimulation, to correct displacement or 5001.12.2023unsatisfactory positioning, if inserted for the management of: (i) detrusor 5001.12.2023overactivity that has been refractory to at least 12 months conservative 5001.12.2023nonsurgical treatment; or (ii) nonobstructive urinary retention that has been 5001.12.2023refractory to at least 12 months conservative nonsurgical treatment other than 5001.12.2023a service to which item36663 applies (Anaes.) 1036665 01.05.2010 3 T8 5 SN NYNNY 2001.12.202300370.0000138.0000000.00 5001.12.2023Sacral nerve electrode or electrodes, management and adjustment of the pulse 5001.12.2023generator by a medical practitioner, to manage detrusor overactivity or non 5001.12.2023obstructive urinary retention - each day 1036666 01.05.2010 3 T8 5 SN NYNNY 2001.12.202300985.0000367.6500000.00 4001.05.2010(Anaes.) 5001.12.2023Pulse generator, subcutaneous placement of, and placement and connection of 5001.12.2023extension wire or wires to sacral nerve electrode or electrodes, for the 5001.12.2023management of:(a) detrusor overactivity that has been refractory to at least 5001.12.202312 months conservative nonsurgical treatment; or (b) nonobstructive urinary 5001.12.2023retention that has been refractory to at least 12 months conservative 5001.12.2023nonsurgical treatment (Anaes.) 1036667 01.05.2010 3 T8 5 SN NYNNY 2001.12.202300460.0000172.0500000.00 4001.05.2010(Anaes.) 5001.12.2023Sacral nerve lead or leads, removal of, if the lead was inserted to manage:(a) 5001.12.2023detrusor overactivity that has been refractory to at least 12 months 5001.12.2023conservative nonsurgical treatment; or (b) nonobstructive urinary retention 5001.12.2023that has been refractory to at least 12 months conservative nonsurgical 5001.12.2023treatment (Anaes.) 1036668 01.05.2010 3 T8 5 SN NYNNY 2001.12.202300460.0000172.0500000.00 4001.05.2010(Anaes.) 5001.12.2023Pulse generator, removal of, if the pulse generator was inserted to manage:(a) 5001.12.2023detrusor overactivity that has been refractory to at least 12 months 5001.12.2023conservative nonsurgical treatment; or (b) nonobstructive urinary retention 5001.12.2023that has been refractory to at least 12 months conservative nonsurgical 5001.12.2023treatment (Anaes.) 1036800 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300081.0000030.3500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER, catheterisation of, where no other procedure is performed (Anaes.) 1036803 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Ureteroscopy, of one ureter, with or without any one or more of; cystoscopy, 5001.12.2023ureteric meatotomy or ureteric dilatation, not being a service associated with 5001.12.2023a service to which item 36652, 36654, 36656,36806, 36809, 36812, 36824 or 5001.12.202336848 applies (Anaes.) (Assist.) 1036806 26.05.2002 3 T8 5 SN NYNYY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Ureteroscopy, of one ureter: (a) with or without one or more of the following: 5001.12.2023(i) cystoscopy; (ii) endoscopic incision of pelviureteric junction or ureteric 5001.12.2023stricture; (iii) ureteric meatotomy; (iv) ureteric dilatation; and (b) with 5001.12.2023either or both of the following: (i) extraction of stone from the ureter; (ii) 5001.12.2023biopsy or diathermy of the ureter; other than: (c) a service associated with a 5001.12.2023service to which item 36803 or 36812 applies; or (d) a service associated with 5001.12.2023a service, performed on the same ureter, to which item 36809, 36824 or 36848 5001.12.2023applies (Anaes.) (Assist.) 1036809 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Ureteroscopy, of one ureter, with or without any one or more of, cystoscopy, 5001.12.2023ureteric meatotomy or ureteric dilatation, plus destruction of stone in the 5001.12.2023ureter with ultrasound, electrohydraulic or kinetic lithotripsy, or laser, 5001.12.2023with or without extraction of fragments, not being a service associated with a 5001.12.2023service to which item 36803 or 36812 applies, or a service associated with a 5001.12.2023service to which item 36806, 36824 or 36848 applies to a procedure performed 5001.12.2023on the same ureter (Anaes.) (Assist.) 1036811 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300945.0000355.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with insertion of one or more urethral or prostatic prostheses, 5001.12.2023other than a service associated with a service to which item 37203, 37207 or 5001.12.202337230 applies (Anaes.) 1036812 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300490.0000183.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Either or both of cystoscopy and urethroscopy, with or without urethral 5001.12.2023dilatation, other than a service associated with any other urological 5001.12.2023endoscopic procedure on the lower urinary tract (Anaes.) 1036815 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300690.0000261.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CYSTOSCOPY, with or without urethroscopy, for the treatment of penile warts or 5001.12.2023uretheral warts, not being a service associated with a service to which item 5001.12.202330189 applies (Anaes.) 1036818 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300805.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with ureteric catheterisation, unilateral or bilateral, guided by 5001.12.2023fluoroscopic imaging of the upper urinary tract, other than a service 5001.12.2023associated with a service to which item 36824 or 36830 applies (Anaes.) 1036821 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy with one or more of; ureteric dilatation, insertion of ureteric 5001.12.2023stent, or brush biopsy of ureter or renal pelvis, unilateral (Anaes.) 5001.12.2023(Assist.) 1036822 01.11.2020 3 T8 5 SN NYNYY 2001.12.202301350.0000508.0500000.00 4001.11.2020(Anaes.) 5001.12.2023Cystoscopy, with ureteric catheterisation, unilateral: (a) guided by 5001.12.2023fluoroscopic imaging of the upper urinary tract; and (b) including one or more 5001.12.2023of ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter 5001.12.2023or of renal pelvis; other than a service associated with a service to which 5001.12.2023item 36818, 36821 or 36830 applies (Anaes.) (Assist.) 1036823 01.11.2020 3 T8 5 SN NYNYY 2001.12.202301555.0000584.1500000.00 4001.11.2020(Anaes.) 5001.12.2023Cystoscopy, with removal of ureteric stent and ureteric catheterisation, 5001.12.2023unilateral: (a) guided by fluoroscopic imaging of the upper urinary tract; and 5001.12.2023(b) including either or both of the following: (i) ureteric dilatation; or 5001.12.2023(ii) insertion of ureteric stent of ureter or of renal pelvis; other than a 5001.12.2023service associated with a service to which item 36818, 36821, 36830 or 36833 5001.12.2023applies (Anaes.) (Assist.) 1036824 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300625.0000234.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with ureteric catheterisation, unilateral or bilateral,other than 5001.12.2023a service associated with a service to which item 36818 applies (Anaes.) 1036827 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with controlled hydrodilatation of the bladder,other than a 5001.12.2023service associated with a service to which item 37011 or 37245 applies 5001.12.2023(Anaes.) 1036830 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300595.0000223.7500000.00 4026.05.2002(Anaes.) 5001.12.2023CYSTOSCOPY, with ureteric meatotomy (Anaes.) 1036833 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with removal of ureteric stent or other foreign body in the lower 5001.12.2023urinary tract, unilateral (Anaes.) 1036836 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CYSTOSCOPY, with biopsy of bladder, not being a service associated with a 5001.12.2023service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203, 37206, 5001.12.202337215, 37230 or 37233applies (Anaes.) 1036840 01.05.2003 3 T8 5 SN NYNYY 2001.12.202300950.0000355.7500000.00 4001.05.2003(Anaes.) 5001.12.2023Cystoscopy, with diathermy, resection or visual laser destruction of bladder 5001.12.2023tumour or other lesion of the bladder, for: (a) a tumour or lesion in only one 5001.12.2023quadrant of the bladder; or (b) a solitary tumour of not more than 2 cm in 5001.12.2023diameter; other than a service associated with a service to which item 36845 5001.12.2023applies (Anaes.) 1036842 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000357.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with lavage of blood clots from bladder, including any associated 5001.12.2023cautery of prostate or bladder, other than a service associated with a service 5001.12.2023to which any of items 36812, 36827 to 36863, 37203, 37206, 37230 and 37233 5001.12.2023apply (Anaes.) 1036845 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with diathermy, resection or visual laser destruction of: (a) 5001.12.2023multiple tumours in 2 or more quadrants of the bladder; or (b) a solitary 5001.12.2023bladder tumour of more than 2 cm in diameter (Anaes.) 1036848 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CYSTOSCOPY, with resection of ureterocele (Anaes.) 1036851 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Cystoscopy, with injection into bladder wall, other than a service associated 5001.12.2023with a service to which item 18375 or 18379 applies (H) (Anaes.) 1036854 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023CYSTOSCOPY, with endoscopic incision or resection of external sphincter, 5001.12.2023bladder neck or both (Anaes.) 1036860 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300490.0000183.5000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC EXAMINATION of intestinal conduit or reservoir (Anaes.) 1036863 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Litholapaxy, with or without cystoscopy (Anaes.) 1037000 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER, partial excision of (Anaes.) (Assist.) 1037004 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER, repair of rupture (Anaes.) (Assist.) 1037008 26.05.2002 3 T8 5 SN NYNYY 2001.12.202301220.0000458.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Open cystostomy or cystotomy, suprapubic, other than: (a) a service to which 5001.12.2023item 37011 applies; or (b) a service associated with a service to which item 5001.12.202337245 applies; or (c) another open bladder procedure (Anaes.) (Assist.) 1037011 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300270.0000102.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Suprapubic stab cystotomy, other than a service associated with a service to 5001.12.2023which item 36827 applies (Anaes.) 1037014 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303115.0001173.7000000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER, total excision of (Anaes.) (Assist.) 1037015 01.11.2020 3 T8 5 SN NYNNY 2001.12.202303740.0001408.4000000.00 4001.11.2020(Anaes.) 5001.12.2023Bladder, total excision of, following previous open, laparoscopic or 5001.12.2023robot-assisted surgery, or radiation therapy or chemotherapy to the pelvis 5001.12.2023(Anaes.) (Assist.) 1037016 01.11.2020 3 T8 5 SN NYNNY 2001.12.202305875.0002196.1500000.00 4001.11.2020(Anaes.) 5001.12.2023Cystectomy, including prostatectomy and pelvic lymph node dissection, other 5001.12.2023than a service associated with a service to which items 37000, 37014, 37015, 5001.12.202337209, 35551 or 36502 applies (Anaes.) (Assist.) 1037018 01.11.2020 3 T8 5 SN NYNNY 2001.12.202308815.0003294.3000000.00 4001.11.2020(Anaes.) 5001.12.2023Cystectomy, including prostatectomy and pelvic lymph node dissection, 5001.12.2023following previous open, laparoscopic or robot-assisted surgery, or radiation 5001.12.2023therapy or chemotherapy to the pelvis, other than a service associated with a 5001.12.2023service to which items 37000, 37014, 37015, 37016, 37209, 35551 or 36502 5001.12.2023applies (Anaes.) (Assist.) 1037019 01.11.2020 3 T8 5 SN NYNNY 2001.12.202305905.0002193.6500000.00 4001.11.2020(Anaes.) 5001.12.2023Cystectomy, including anterior exenteration and pelvic lymph node dissection, 5001.12.2023other than a service associated with a service to which any of items 37000, 5001.12.202337014, 37015, 35551, 36502, and 35653 to 35756 apply (Anaes.) (Assist.) 1037020 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER DIVERTICULUM, excision or obliteration of (Anaes.) (Assist.) 1037021 01.11.2020 3 T8 5 SN NYNNY 2001.12.202308855.0003290.4000000.00 4001.11.2020(Anaes.) 5001.12.2023Cystectomy, including anterior exenteration and pelvic lymph node dissection, 5001.12.2023following previous open, laparoscopic or robot-assisted surgery, radiation 5001.12.2023therapy or chemotherapy to the pelvis, other than a service associated with a 5001.12.2023service to which any of items 37000, 37014, 37015, 35551, 36502 and 35653 to 5001.12.202335756 apply (Anaes.) (Assist.) 1037023 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301220.0000458.4000000.00 4026.05.2002(Anaes.) 5001.12.2023VESICAL FISTULA, cutaneous, operation for (Anaes.) 1037026 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301220.0000458.4000000.00 4026.05.2002(Anaes.) 5001.12.2023CUTANEOUS VESICOSTOMY, establishment of (Anaes.) (Assist.) 1037029 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023VESICOVAGINAL FISTULA, closure of, by abdominal approach (Anaes.) (Assist.) 1037038 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.3500000.00 4026.05.2002(Anaes.) 5001.12.2023VESICOINTESTINAL FISTULA, closure of, excluding bowel resection (Anaes.) 5001.12.2023(Assist.) 1037039 01.11.2020 3 T8 5 SN NYNNY 2001.12.202302085.0000742.4500000.00 4001.11.2020(Anaes.) 5001.12.2023Bladder stress incontinence, sling procedure for, using a non-autologous 5001.12.2023biological sling (Anaes.) (Assist.) 1037040 01.05.2016 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4001.05.2016(Anaes.) 5001.12.2023Bladder stress incontinence, sling procedure for, using a non-adjustable 5001.12.2023synthetic male sling system, other than a service associated with a service to 5001.12.2023which item 37042 applies (H) (Anaes.) (Assist.) 1037041 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300136.0000051.3000000.00 5001.12.2023BLADDER ASPIRATION by needle 1037042 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Bladder stress incontinencesling procedure for, using autologous fascial 5001.12.2023sling, including harvesting of sling, other than a service associated with a 5001.12.2023service to which item 35599 applies (H) (Anaes.) (Assist.) 1037044 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000853.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Bladder stress incontinence, suprapubic operation for (such as Burch 5001.12.2023colposuspension), open or laparoscopic route, using native tissue without 5001.12.2023graft, with diagnostic cystoscopy to assess the integrity of the lower urinary 5001.12.2023tract, not being a service associated with a service to which item 35599 or 5001.12.202336812 applies (H) (Anaes.) (Assist.) 1037045 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304180.0001572.5500000.00 4026.05.2002(Anaes.) 5001.12.2023CONTINENT CATHETERISATION BLADDER STOMAS (eg. Mitrofanoff), formation of 5001.12.2023(Anaes.) (Assist.) 1037046 01.11.2020 3 T8 5 SN NYNNY 2001.12.202302280.0000762.2000000.00 4001.11.2020(Anaes.) 5001.12.2023Suprapubic or perineal procedure for excision of graft material, either singly 5001.12.2023or in multiple pieces, for a symptomatic patient with graft related 5001.12.2023complications (including graft related pain or discharge and bleeding related 5001.12.2023to graft exposure), if not more than one service to which this item applies 5001.12.2023has been provided to the patient by the same practitioner in the preceding 12 5001.12.2023months (Anaes.) (Assist.) 1037047 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304880.0001833.8000000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER ENLARGEMENT using intestine (Anaes.) (Assist.) 1037048 01.11.2020 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4001.11.2020(Anaes.) 5001.12.2023Bladder neck closure for the management of urinary incontinence (Anaes.) 5001.12.2023(Assist.) 1037050 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER EXSTROPHY CLOSURE, not involving sphincter reconstruction (Anaes.) 5001.12.2023(Assist.) 1037053 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302445.0000942.9500000.00 4026.05.2002(Anaes.) 5001.12.2023BLADDER TRANSECTION AND RE-ANASTOMOSIS TO TRIGONE (Anaes.) (Assist.) 1037200 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302980.0001118.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatectomy, by open, laparoscopic or robot-assisted approach (Anaes.) 5001.12.2023(Assist.) 1037201 01.11.2002 3 T8 5 SN NYNNY 2001.12.202302415.0000912.3500000.00 4001.11.2002(Anaes.) 5001.12.2023PROSTATE, transurethral radio-frequency needle ablation of, with or without 5001.12.2023cystoscopy and with or without urethroscopy, in patients with moderate to 5001.12.2023severe lower urinary tract symptoms who are not medically fit for 5001.12.2023transurethral resection of the prostate (that is, prostatectomy using 5001.12.2023diathermy or cold punch) and including services to which item 36854, 37203, 5001.12.202337206, 37207, 37208, 37245, 37303, 37321 or 37324 applies (Anaes.) 1037202 01.11.2002 3 T8 5 SN NYNNY 2001.12.202301210.0000458.0000000.00 4001.11.2002(Anaes.) 5001.12.2023PROSTATE, transurethral radio-frequency needle ablation of, with or without 5001.12.2023cystoscopy and with or without urethroscopy, in patients with moderate to 5001.12.2023severe lower urinary tract symptoms who are not medically fit for 5001.12.2023transurethral resection of the prostate (that is prostatectomy using diathermy 5001.12.2023or cold punch) and including services to which item 36854, 37245, 37303, 37321 5001.12.2023or 37324 applies, continuation of, within 10 days of the procedure described 5001.12.2023by item 37201, 37203 or 37207 which had to be discontinued for medical reasons 5001.12.2023(Anaes.) 1037203 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303385.0001147.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatectomy, transurethral resection using cautery, with or without 5001.12.2023cystoscopy and with or without urethroscopy, and including services to which 5001.12.2023item 36854, 37201, 37202, 37207, 37208, 37245, 37303, 37321 or 37324 applies 5001.12.2023(Anaes.) 1037206 26.05.2002 3 T8 5 SN NYNYY 2001.12.202301625.0000614.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatectomy, endoscopic, using diathermy or other ablative techniques: (a) 5001.12.2023with or without cystoscopy and with or without urethroscopy; and (b) including 5001.12.2023services to which one or more of items 36854, 37303, 37321 and 37324 apply; 5001.12.2023continuation, within 10 days, of treatment of benign prostatic hyperplasia 5001.12.2023that had to be discontinued for medical reasons (Anaes.) 1037207 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303385.0001147.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or 5001.12.2023without cystoscopy and with or without urethroscopy, and including services to 5001.12.2023which items 36854, 37201, 37202, 37203, 37206, 37245, 37303, 37321 or 37324 5001.12.2023applies (Anaes.) 1037208 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301625.0000614.3500000.00 4026.05.2002(Anaes.) 5001.12.2023PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or 5001.12.2023without cystoscopy and with or without urethroscopy, and including services to 5001.12.2023which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 5001.12.2023days of the procedure described by items 37201, 37203, 37207 or 37245 which 5001.12.2023had to be discontinued for medical reasons (Anaes.) 1037209 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303795.0001421.1500000.00 4026.05.2002(Anaes.) 5001.12.2023PROSTATE, and/or SEMINAL VESICLE/AMPULLA OF VAS, unilateral or bilateral, 5001.12.2023total excision of, not being a service associated with a service to which item 5001.12.2023number 37210 or 37211 applies (Anaes.) (Assist.) 1037210 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304665.0001753.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatectomy, radical, involving total excision of the prostate, sparing of 5001.12.2023nerves around the prostate (where clinically indicated) with or without 5001.12.2023bladder neck reconstruction, other than a service associated with a service to 5001.12.2023which item 30390, 30627, 35551, 36502 or 37375 applies (Anaes.) (Assist.) 1037211 26.05.2002 3 T8 5 SN NYNYY 2001.12.202305665.0002130.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatectomy, radical, involving total excision of the prostate, sparing of 5001.12.2023nerves around the prostate (where clinically indicated): (a) with or without 5001.12.2023bladder neck reconstruction; and (b) with pelvic lymphadenectomy; other than a 5001.12.2023service associated with a service to which item 30390, 30627, 35551, 36502 or 5001.12.202337375 applies (Anaes.) (Assist.) 1037213 01.11.2020 3 T8 5 SN NYNYY 2001.12.202306995.0002630.7000000.00 4001.11.2020(Anaes.) 5001.12.2023Prostatectomy, radical, involving total excision of the prostate, sparing of 5001.12.2023nerves around the prostate (where clinically indicated): (a) complicated by: 5001.12.2023(i) previous radiation therapy (including brachytherapy) on the prostate; or 5001.12.2023(ii) previous ablative procedures on the prostate; and (b) with bladder neck 5001.12.2023reconstruction; other than a service associated with a service to which item 5001.12.202330390, 30627, 35551, 36502 or 37375 applies (Anaes.) (Assist.) 1037214 01.11.2020 3 T8 5 SN NYNYY 2001.12.202308495.0003195.4000000.00 4001.11.2020(Anaes.) 5001.12.2023Prostatectomy, radical, involving total excision of the prostate, sparing of 5001.12.2023nerves around the prostate (where clinically indicated): (a) complicated by: 5001.12.2023(i) previous radiation therapy (including brachytherapy) on the prostate; or 5001.12.2023(ii) previous ablative procedures on the prostate; and (b) with bladder neck 5001.12.2023reconstruction and pelvic lymphadenectomy; other than a service associated 5001.12.2023with a service to which item 30390, 30627, 35551, 36502 or 37375 applies 5001.12.2023(Anaes.) (Assist.) 1037215 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301220.0000458.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Prostate, biopsy of, endoscopic, with or without cystoscopy (Anaes.) 1037216 01.11.2020 3 T8 5 SN NYNNY 2001.12.202300655.0000154.6000000.00 4001.11.2020(Anaes.) 5001.12.2023Prostate or prostatic bed, needle biopsy of, by the transrectal route, using 5001.12.2023prostatic ultrasound guidance and obtaining one or more prostatic specimens, 5001.12.2023being a service associated with a service to which item 55603 applies (Anaes.) 1037217 01.07.2011 3 T8 5 SN NYNNY 2001.12.202300405.0000152.2000000.00 4001.07.2011(Anaes.) 5001.12.2023Prostate, implantation of radio-opaque fiducial markers into the prostate 5001.12.2023gland or prostate surgical bed, under ultrasound guidance, being an item 5001.12.2023associated with a service to which item 55603 applies (Anaes.) 1037218 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300405.0000152.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Prostate, injection into, one or more, excluding insertion of fiduciary 5001.12.2023markers (Anaes.) 1037219 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300985.0000371.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostate or prostatic bed, needle biopsy of, by the transperineal route, using 5001.12.2023prostatic ultrasound guidance and obtaining one or more prostatic specimens, 5001.12.2023being a service associated with a service to which item 55600 or 55603 applies 5001.12.2023(Anaes.) 1037220 26.05.2002 3 T8 5 SN NYNYY 2001.12.202303105.0001149.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Prostate, radioactive seed implantation of, urological component, using 5001.12.2023transrectal ultrasound guidance: (a) for a patient with: (i) localised 5001.12.2023prostatic malignancy at clinical stages T1 (clinically inapparent tumour not 5001.12.2023palpable or visible by imaging) or T2 (tumour confined within prostate); and 5001.12.2023(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 5001.12.20233); and (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at 5001.12.2023the time of diagnosis; and (b) performed by a urologist at an approved site in 5001.12.2023association with a radiation oncologist; and (c) being a service associated 5001.12.2023with: (i) services to which items 15338 and 55603 apply; and (ii) a service to 5001.12.2023which item 60506 or 60509 applies (Anaes.) 1037221 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Prostatic abscess, endoscopic drainage of (Anaes.) 1037223 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300585.0000227.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PROSTATIC COIL, insertion of, under ultrasound control (Anaes.) 1037224 01.05.2003 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4001.05.2003(Anaes.) 5001.12.2023Prostate, diathermy or cauterisation,other than a service associated with a 5001.12.2023service to which item 37201, 37202, 37203, 37206, 37207, 37208 or 37215 5001.12.2023applies (Anaes.) 1037226 01.05.2020 3 T8 5 SNS NYNNY 2001.12.202300852.0000309.2000000.00 4001.05.2020(Anaes.) 5001.12.2023Prostate or prostatic bed, needle biopsy of, using prostatic magnetic 5001.12.2023resonance imaging techniques and obtaining 1 or more prostatic specimens. 5001.12.2023(Anaes.) (Anaes.) 1037227 01.11.2006 3 T8 5 SN NYNNY 2001.12.202303105.0000622.8000000.00 4001.11.2006(Anaes.) 5001.12.2023PROSTATE, transperineal insertion of catheters into, for high dose rate 5001.12.2023brachytherapy using ultrasound guidance including any associated cystoscopy. 5001.12.2023The procedure must be performed at an approved site in association with a 5001.12.2023radiation oncologist, and be associated with a service to which item 15331 or 5001.12.202315332 applies. (Anaes.) 1037230 01.05.2006 3 T8 5 SN NYNNY 2001.12.202303385.0001147.0500000.00 4001.05.2006(Anaes.) 5001.12.2023Prostate, ablation by electrocautery or high-energy transurethral microwave 5001.12.2023thermotherapy, with or without cystoscopy and with or without urethroscopy 5001.12.2023(Anaes.) 1037233 01.05.2006 3 T8 5 SN NYNNY 2001.12.202301625.0000614.3500000.00 4001.05.2006(Anaes.) 5001.12.2023Prostate, ablation by electrocautery or high-energy transurethral microwave 5001.12.2023thermotherapy, with or without cystoscopy and with or without urethroscopy, 5001.12.2023continuation, within 10 days, of a urological procedure of the prostate that 5001.12.2023had to be discontinued for medical reasons (Anaes.) 1037245 01.03.2013 3 T8 5 SN NYNYY 2001.12.202303885.0001389.2500000.00 4001.03.2013(Anaes.) 5001.12.2023Prostate, endoscopic enucleation of, for the treatment of benign prostatic 5001.12.2023hyperplasia: (a) with morcellation, including mechanical morcellation or by an 5001.12.2023endoscopic technique; and (b) with or without cystoscopy; and (c) with or 5001.12.2023without urethroscopy; and other than a service associated with a service to 5001.12.2023which item 36827, 36854, 37008, 37201, 37202, 37203, 37206, 37207, 37208, 5001.12.202337303, 37321 or 37324 applies (Anaes.) 1037300 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300136.0000051.3000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRAL SOUNDS, passage of, as an independent procedure (Anaes.) 1037303 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300215.0000081.5500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRAL STRICTURE, dilatation of (Anaes.) 1037306 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRA, repair of rupture of distal section (Anaes.) (Assist.) 1037309 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRA, repair of rupture of prostatic or membranous segment (Anaes.) 5001.12.2023(Assist.) 1037318 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Urethroscopy, with or without cystoscopy, with one or more of biopsy, 5001.12.2023diathermy, visual laser destruction of urethral calculi or removal of foreign 5001.12.2023body or calculi (Anaes.) 1037321 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300270.0000102.7000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRAL MEATOTOMY, EXTERNAL (Anaes.) 1037324 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Urethrotomy or urethrostomy, internal or external (Anaes.) (Assist.) 1037327 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROTOMY, optical, for urethral stricture (Anaes.) (Assist.) 1037330 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301895.0000715.2500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRECTOMY, partial or complete, for removal of tumour (Anaes.) (Assist.) 1037333 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301625.0000614.3500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROVAGINAL FISTULA, closure of (Anaes.) (Assist.) 1037336 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRORECTAL FISTULA, closure of (Anaes.) (Assist.) 1037338 01.05.2016 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4001.05.2016(Anaes.) 5001.12.2023Urethral synthetic male sling system, division or removal of, for urethral 5001.12.2023obstruction, sling erosion, pain or infection, following previous surgery for 5001.12.2023urinary incontinence, other than a service associated with a service to which 5001.12.2023item 37340 or 37341 applies (Anaes.) (Assist.) 1037339 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300705.0000264.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Periurethral or transurethral injection of urethral bulking agents for the 5001.12.2023treatment of urinary incontinence, including cystoscopy and urethroscopy, 5001.12.2023other than a service associated with a service to which item 18375 or 18379 5001.12.2023applies (Anaes.) 1037340 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Urethral synthetic sling, division or removal of, for urethral obstruction, 5001.12.2023sling erosion, pain or infection following previous surgery for urinary 5001.12.2023incontinence, vaginal approach, other than a service associated with a service 5001.12.2023to which item 37341 or 37344 applies (Anaes.) (Assist.) 1037341 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Urethral sling, division or removal of, for urethral obstruction, sling 5001.12.2023erosion, pain or infection following previous surgery for urinary 5001.12.2023incontinence, suprapubic, combined suprapubic and vaginal or combined 5001.12.2023suprapubic and perineal approach, other than a service associated with a 5001.12.2023service to which item 37340 or 37344 applies (Anaes.) (Assist.) 1037342 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROPLASTYsingle stage operation (Anaes.) (Assist.) 1037343 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304075.0001531.2000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROPLASTY, single stage operation, transpubic approach via separate 5001.12.2023incisions above and below the symphysis pubis, excluding laparotomy, 5001.12.2023symphysectomy and suprapubic cystotomy, with or without re-routing of the 5001.12.2023urethra around the crura (Anaes.) (Assist.) 1037344 01.11.2020 3 T8 5 SN NYNNY 2001.12.202302670.0001003.1000000.00 4001.11.2020(Anaes.) 5001.12.2023Urethral autologous fascial sling (or other biological sling), division or 5001.12.2023removal of, for urethral obstruction, sling erosion, pain or infection 5001.12.2023following previous surgery for urinary incontinence, vaginal approach, other 5001.12.2023than a service to which 37340 or 37341 applies (Anaes.) (Assist.) 1037345 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROPLASTY2 stage operationfirst stage (Anaes.) (Assist.) 1037348 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROPLASTY2 stage operationsecond stage (Anaes.) (Assist.) 1037351 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023URETHROPLASTY, not being a service to which another item in this Group applies 5001.12.2023(Anaes.) (Assist.) 1037354 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, meatotomy and hemicircumcision (Anaes.) (Assist.) 1037369 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300540.0000205.4000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRA, excision of prolapse of (Anaes.) 1037372 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Urethral diverticulum, excision of (Anaes.) (Assist.) 1037375 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303385.0001274.5000000.00 4026.05.2002(Anaes.) 5001.12.2023URETHRAL SPHINCTER, reconstruction by bladder tubularisation technique or 5001.12.2023similar procedure (Anaes.) (Assist.) 1037381 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTIFICIAL URINARY SPHINCTER, insertion of cuff, perineal approach (Anaes.) 5001.12.2023(Assist.) 1037384 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303385.0001274.5000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTIFICIAL URINARY SPHINCTER, insertion of cuff, abdominal approach (Anaes.) 5001.12.2023(Assist.) 1037387 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTIFICIAL URINARY SPHINCTER, insertion of pressure regulating balloon and 5001.12.2023pump (Anaes.) (Assist.) 1037388 01.11.2020 3 T8 5 SN NYNNY 2001.12.202300270.0000107.8500000.00 5001.12.2023Artificial urinary sphincter, sterile, percutaneous adjustment of filling 5001.12.2023volume 1037390 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ARTIFICIAL URINARY SPHINCTER, revision or removal of, with or without 5001.12.2023replacement (Anaes.) (Assist.) 1037393 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300680.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PRIAPISM, decompression by glanular stab cavernosospongiosum shunt or penile 5001.12.2023aspiration with or without lavage (Anaes.) 1037396 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023PRIAPISM, shunt operation for, not being a service to which item 37393 applies 5001.12.2023(Anaes.) (Assist.) 1037402 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, partial amputation of (Anaes.) (Assist.) 1037405 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, complete or radical amputation of (Anaes.) (Assist.) 1037408 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301355.0000513.3000000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, repair of laceration of cavernous tissue, or fracture involving 5001.12.2023cavernous tissue (Anaes.) (Assist.) 1037411 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, repair of avulsion (Anaes.) (Assist.) 1037415 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300136.0000051.3000000.00 5001.12.2023Penis, injection of, for the investigation and treatment of erectile 5001.12.2023dysfunction. Applicable not more than twice in a 36month period 1037417 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301625.0000614.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Penis, correction of chordee by plication techniques including Nesbits 5001.12.2023corporoplasty (Anaes.) (Assist.) 1037418 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302170.0000816.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Penis, correction of chordee with incision or excision of fibrous plaque or 5001.12.2023plaques, with or without mobilisation of one or both of the neuro-vascular 5001.12.2023bundle and urethra (Anaes.) (Assist.) 1037423 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Penis, lengthening by translocation of corpora, in conjunction with partial 5001.12.2023penectomy or penile epispadias secondary repair, either as primary or 5001.12.2023secondary procedures (Anaes.) (Assist.) 1037426 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302845.0001072.7000000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, artificial erection device, insertion of, into 1 or both corpora 5001.12.2023(Anaes.) (Assist.) 1037429 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300950.0000355.7500000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, artificial erection device, insertion of pump and pressure regulating 5001.12.2023reservoir (Anaes.) (Assist.) 1037432 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001017.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, artificial erection device, complete or partial revision or removal of 5001.12.2023components, with or without replacement (Anaes.) (Assist.) 1037435 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300270.0000102.7000000.00 4026.05.2002(Anaes.) 5001.12.2023PENIS, frenuloplasty as an independent procedure (Anaes.) 1037438 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Scrotum, partial excision of, for histologically proven malignancy or 5001.12.2023infection (Anaes.) (Assist.) 1037601 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023SPERMATOCELE OR EPIDIDYMAL CYST, excision of, 1 or more of, on 1 side (Anaes.) 1037604 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300805.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Exploration of scrotal contents, with or without fixation and with or without 5001.12.2023biopsy, unilateral or bilateral, other than a service associated with sperm 5001.12.2023harvesting for IVF (Anaes.) 1037605 01.05.2007 3 T8 5 SN NYNNY 2001.12.202301270.0000411.0500000.00 4001.05.2007(Anaes.) 5001.12.2023Transcutaneous sperm retrieval, unilateral, from either the testis or the 5001.12.2023epididymis, for the purposes ofintracytoplasmic sperm injection, for male 5001.12.2023factor infertility, excluding a service to which item 13218 applies. (Anaes.) 1037606 01.05.2007 3 T8 5 SN NYNYY 2001.12.202301885.0000610.4000000.00 4001.05.2007(Anaes.) 5001.12.2023Open surgical sperm retrieval, unilateral, including the exploration of 5001.12.2023scrotal contents, with our without biopsy, for the purposes of 5001.12.2023intracytoplasmic sperm injection, for male factor infertility, performed in a 5001.12.2023hospital, excluding a service to which item 13218 or 37604 applies. (Anaes.) 1037607 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304065.0001526.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral retroperitoneal lymph node dissection, for testicular tumour, other 5001.12.2023than a service associated with a service to which item 30390 or 30627 applies 5001.12.2023(Anaes.) (Assist.) 1037610 26.05.2002 3 T8 5 SN NYNNY 2001.12.202306090.0002296.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral retroperitoneal lymph node dissection, for testicular tumour, 5001.12.2023following previous similar retroperitoneal dissection, retroperitoneal 5001.12.2023radiation therapy or chemotherapy, other than a service associated with a 5001.12.2023service to which item 30390 or 30627 applies (Anaes.) (Assist.) 1037613 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023EPIDIDYMECTOMY (Anaes.) 1037616 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, 5001.12.2023not being a service associated with sperm harvesting for IVF (Anaes.) 5001.12.2023(Assist.) 1037619 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300815.0000304.4500000.00 4026.05.2002(Anaes.) 5001.12.2023VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, not being a service 5001.12.2023associated with sperm harvesting for IVF (Anaes.) (Assist.) 1037623 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300675.0000253.0500000.00 4026.05.2002(Anaes.) 5001.12.2023VASOTOMY OR VASECTOMY, unilateral or bilateral NOTE:Strict legal requirements 5001.12.2023apply in relation to sterilisation procedures on minors.Medicare benefits are 5001.12.2023not payable for services not rendered in accordance with relevant Commonwealth 5001.12.2023and State and Territory law.Observe the explanatory note before submitting a 5001.12.2023claim. (Anaes.) 1037800 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301525.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023PATENT URACHUS, excision of, on a patient 10 years of age or over. (Anaes.) 5001.12.2023(Assist.) 1037803 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301525.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 5001.12.2023applies, on a patient 10 years of age or over. (Anaes.) (Assist.) 1037812 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301625.0000611.9500000.00 4026.05.2002(Anaes.) 5001.12.2023IMPALPABLE TESTIS, exploration of groin for, not being a service associated 5001.12.2023with a service to which items 37803, 37806 and 37809 applies, on a patient 10 5001.12.2023years of age or over. (Anaes.) (Assist.) 1037815 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300275.0000102.1000000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, examination under anaesthesia with erection test on a patient 10 5001.12.2023years of age or over. (Anaes.) 1037818 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301450.0000540.9500000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a patient 10 5001.12.2023years of age or over (Anaes.) (Assist.) 1037821 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302440.0000917.0000000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, distal, 1 stage repair, on a patient 10 years of age or over. 5001.12.2023(Anaes.) (Assist.) 1037824 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303390.0001275.0000000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, proximal, 1 stage repair, on a patient 10 years of age or over 5001.12.2023(Anaes.) (Assist.) 1037827 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301570.0000587.3500000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, staged repair, first stage, on a patient 10 years of age or over 5001.12.2023(Anaes.) (Assist.) 1037830 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302030.0000761.0000000.00 4026.05.2002(Anaes.) 5001.12.2023HYPOSPADIAS, staged repair, second stage, on a patient 10 years of age or over 5001.12.2023(Anaes.) (Assist.) 1037833 26.05.2002 3 T8 5 SN NYNNY 2001.12.202300970.0000363.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Hypospadias, repair of urethral fistula, on apatient 10 years of age or over 5001.12.2023(Anaes.) (Assist.) 1037836 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302035.0000764.9500000.00 4026.05.2002(Anaes.) 5001.12.2023EPISPADIAS, staged repair, first stage (Anaes.) (Assist.) 1037839 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302305.0000866.8500000.00 4026.05.2002(Anaes.) 5001.12.2023EPISPADIAS, staged repair, second stage (Anaes.) (Assist.) 1037842 26.05.2002 3 T8 5 SN NYNNY 2001.12.202304475.0001683.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Exstrophy of bladder or epispadias, primary or secondary repair with or 5001.12.2023without bladder neck tightening, with or without ureteric reimplantation 5001.12.2023(Anaes.) (Assist.) 1037845 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302035.0000764.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Congenital disorder of sexual differentiation with urogenital sinus, external 5001.12.2023genitoplasty, with or without endoscopy (Anaes.) (Assist.) 1037848 26.05.2002 3 T8 5 SN NYNNY 2001.12.202303660.0001377.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Congenital disorder of sexual differentiation with urogenital sinus, external 5001.12.2023genitoplasty with endoscopy and vaginoplasty (Anaes.) (Assist.) 1037851 26.05.2002 3 T8 5 SN NYNNY 2001.12.202302710.0001020.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Congenital disorder of sexual differentiation, vaginoplasty for, with or 5001.12.2023without endoscopy (Anaes.) (Assist.) 1037854 26.05.2002 3 T8 5 SN NYNNY 2001.12.202301085.0000403.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Urethral valve, destruction of, including cystoscopy and urethroscopy (Anaes.) 1038200 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301160.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Right heart catheterisation with any one or more of the following: (a) 5001.12.2023fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output 5001.12.2023measurement by any method; (e) shunt detection; (f) exercise stress test; 5001.12.2023other than a service associated with a service to which item 38203, 38206, 5001.12.202338244, 38247, 38248, 38249, 38251, 38252, 38254 or 38368 applies (Anaes.) 1038203 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301450.0000585.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Left heart catheterisation by percutaneous arterial puncture, arteriotomy or 5001.12.2023percutaneous left ventricular puncture, with any one or more of the following: 5001.12.2023(a) fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output 5001.12.2023measurements by any method; (e) shunt detection; (f) exercise stress test; 5001.12.2023other than a service associated with a service to which item 38200, 38206, 5001.12.202338244, 38247, 38248, 38249, 38251, 38252 or 38254 applies (Anaes.) 1038206 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301755.0000707.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Right heart catheterisation with left heart catheterisation via the right 5001.12.2023heart or by another procedure, with any one or more of the following: (a) 5001.12.2023fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output 5001.12.2023measurements by any method; (e) shunt detection; (f) exercise stress test; 5001.12.2023other than a service associated with a service to which item 38200, 38203, 5001.12.202338244, 38247, 38248, 38249, 38251, 38252 or 38254 applies (Anaes.) 1038209 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301980.0000908.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CARDIAC ELECTROPHYSIOLOGICAL STUDYup to and including 3 catheter investigation 5001.12.2023of any 1 or more ofsyncope, atrioventricular conduction, sinus node function 5001.12.2023or simple ventricular tachycardia studies, not being a service associated with 5001.12.2023a service to which item 38212 or 38213 applies (Anaes.) 1038212 26.05.2002 3 T8 6 SN NYNNY 2001.12.202303110.0001510.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac electrophysiological study for: (a) the investigation of 5001.12.2023supraventricular tachycardia involving 4 or more catheters; or (b) complex 5001.12.2023tachycardia inductions; or (c) multiple catheter mapping; or (d) acute 5001.12.2023intravenous antiarrhythmic drug testing with pre and post drug inductions; or 5001.12.2023(e) catheter ablation to intentionally induce complete atrioventricular block; 5001.12.2023or (f) intraoperative mapping; other than a service associated with a service 5001.12.2023to which item 38209 or 38213 applies (Anaes.) 1038213 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301980.0000449.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac electrophysiological study, performed either: (a) during insertion of 5001.12.2023implantable defibrillator; or (b) for defibrillation threshold testing at a 5001.12.2023different time to implantation; other than a service associated with a service 5001.12.2023to which item 38209 or 38212 applies (Anaes.) 1038241 01.11.2006 3 T8 6 SN NYNNY 2001.12.202301255.0000516.9000000.00 4001.11.2006(Anaes.) 5001.12.2023Use of a coronary pressure wire, if the service is: (a) performed during 5001.12.2023selective coronary angiography, percutaneous angioplasty or transluminal 5001.12.2023insertion of one or more stents; and (b) to measure fractional flow reserve, 5001.12.2023non-hyperaemic pressure ratios or coronary flow reserve in intermediate 5001.12.2023coronary artery or graft lesions (stenosis of 50 to 70%); and (c) to determine 5001.12.2023whether revascularisation is appropriate, if previous functional imaging: (i) 5001.12.2023has not been performed; or (ii) has been performed but the results are 5001.12.2023inconclusive or do not apply to the vessel being interrogated; and (d) 5001.12.2023performed on one or more coronary vascular territories (Anaes.) 1038244 01.07.2021 3 T8 6 SN NYNNY 2001.12.202303245.0000973.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome)the service only applies if the patient meets 5001.12.2023the requirements of the descriptor and the requirements of Note: TR.8.2 and 5001.12.2023TR.8.5 Selective coronary angiography: (a) for a patient who is eligible for 5001.12.2023the service under clause 5.10.17A; and (b) with placement of one or more 5001.12.2023catheters and injection of opaque material into native coronary arteries; and 5001.12.2023(c) with or without left heart catheterisation, left ventriculography or 5001.12.2023aortography; and (d) including all associated imaging; other than a service 5001.12.2023associated with a service to which 38200, 38203, 38206, 38247, 38248, 38249, 5001.12.202338251 or 38252 applies (Anaes.) 1038247 01.07.2021 3 T8 6 SN NYNNY 2001.12.202304985.0001559.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome - graft) the service only applies if the 5001.12.2023patient meets the requirements of the descriptor and the requirements of Note: 5001.12.2023TR.8.2 and TR.8.5 Selective coronary and graft angiography: (a) for a patient 5001.12.2023who is eligible for the service under clause 5.10.17A; and (b) with placement 5001.12.2023of one or more catheters and injection of opaque material into the native 5001.12.2023coronary arteries; and (c) if free coronary grafts attached to the aorta or 5001.12.2023direct internal mammary artery grafts are presentwith placement of one or more 5001.12.2023catheters and injection of opaque material into those grafts (irrespective of 5001.12.2023the number of grafts); and (d) with or without left heart catheterisation, 5001.12.2023left ventriculography or aortography; and (e) including all associated 5001.12.2023imaging; other than a service associated with a service to which item 38200, 5001.12.202338203, 38206, 38244, 38248, 38249, 38251 or 38252 applies (Anaes.) 1038248 01.07.2021 3 T8 6 SN NYNNY 2001.12.202303245.0000973.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stable coronary syndrome) the service only applies if the patient meets 5001.12.2023the requirements of the descriptor and the of Note: TR.8.3 and TR.8.5 5001.12.2023Selective coronary angiography: (a) for a patient who is eligible for the 5001.12.2023service under clause 5.10.17B; and (b) as part of the management of the 5001.12.2023patient; and (c) with placement of catheters and injection of opaque material 5001.12.2023into native coronary arteries; and (d) with or without left heart 5001.12.2023catheterisation, left ventriculography or aortography; and (e) including all 5001.12.2023associated imaging; other than a service associated with a service to which 5001.12.2023item 38200, 38203, 38206, 38244, 38247, 38249, 38251 or 38252 5001.12.2023appliesapplicable each 3 months (Anaes.) 1038249 01.07.2021 3 T8 6 SN NYNNY 2001.12.202304985.0001559.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stable coronary syndrome - graft) the service only applies if the 5001.12.2023patient meets the requirements of the descriptor and the requirements of Note: 5001.12.2023TR.8.3 and TR.8.5 Selective coronary and graft angiography: (a) for a patient 5001.12.2023who is eligible for the service under clause 5.10.17B; and (b) as part of the 5001.12.2023management of the patient; and (c) with placement of one or more catheters and 5001.12.2023injection of opaque material into native coronary arteries; and (d) if free 5001.12.2023coronary grafts attached to the aorta or direct internal mammary artery grafts 5001.12.2023are presentwith placement of one or more catheters and injection of opaque 5001.12.2023material into those grafts (irrespective of the number of grafts);and (e) with 5001.12.2023or without left heart catheterisation, left ventriculography or aortography; 5001.12.2023and (f) including all associated imaging; other than a service associated with 5001.12.2023a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38251 or 5001.12.202338252 appliesapplicable once each 3 months (Anaes.) 1038251 01.07.2021 3 T8 6 SN NYNNY 2001.12.202303245.0000973.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (pre-operative assessment) the service only applies if the patient meets 5001.12.2023the requirements of the descriptor and the requirements of Note: TR.8.5 5001.12.2023Selective coronary angiography: (a) for a symptomatic patient with valvular or 5001.12.2023other non-coronary structural heart disease; and (b) as part of the management 5001.12.2023of the patient for: (i) pre-operative assessment for planning non-coronary 5001.12.2023cardiac surgery, including by transcatheter approaches; or (ii) evaluation of 5001.12.2023valvular heart disease or other non-coronary structural heart disease where 5001.12.2023clinical impression is discordant with non-invasive assessment; and (c) with 5001.12.2023placement of catheters and injection of opaque material into native coronary 5001.12.2023arteries; and (d) with or without left heart catheterisation, left 5001.12.2023ventriculography or aortography; and (e) including all associated imaging; 5001.12.2023other than a service associated with a service to which item 38200, 38203, 5001.12.202338206, 38244, 38247, 38248, 38249 or 38252 appliesapplicable once each 12 5001.12.2023months (Anaes.) 1038252 01.07.2021 3 T8 6 SN NYNNY 2001.12.202304985.0001559.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (pre-operative assessment - graft) the service only applies if the 5001.12.2023patient meets the requirements of the descriptor and the requirements of Note: 5001.12.2023TR.8.5 Selective coronary and graft angiography: (a) for a symptomatic patient 5001.12.2023with valvular or other non-coronary structural heart disease; and (b) as part 5001.12.2023of the management of the patient for: (i) pre-operative assessment for 5001.12.2023planning non-coronary cardiac surgery, including by transcatheter approaches; 5001.12.2023or (ii) evaluation of valvular heart disease or other non-coronary structural 5001.12.2023heart disease where clinical impression is discordant with non-invasive 5001.12.2023assessment; and (c) with placement of one or more catheters and injection of 5001.12.2023opaque material into the native coronary arteries; and (d) if free coronary 5001.12.2023grafts attached to the aorta or direct internal mammary artery grafts are 5001.12.2023presentwith placement of one or more catheters and injection of opaque 5001.12.2023material into those grafts (irrespective of the number of grafts); and (e) 5001.12.2023with or without left heart catheterisation, left ventriculography or 5001.12.2023aortography; and (f) including all associated imaging; other than a service 5001.12.2023associated with a service to which item 38200, 38203, 38206, 38244, 38247, 5001.12.202338248, 38249 or 38251 appliesapplicable once each 12 months (Anaes.) 1038254 01.07.2021 3 T8 6 SN NYNNY 2001.12.202301160.0000490.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Right heart catheterisation: (a) performed at the same time as a service to 5001.12.2023which item 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 5001.12.202338311, 38313 or 38314 applies; and (b) including any of the following (if 5001.12.2023performed): (i) fluoroscopy; (ii) oximetry; (iii) dye dilution curves; (iv) 5001.12.2023cardiac output measurement; (v) shunt detection; (vi) exercise stress test 5001.12.2023(Anaes.) 1038256 26.05.2002 3 T8 6 SN NYNNY 2001.12.202300685.0000294.1500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of (Anaes.) 1038270 26.05.2002 3 T8 6 SN NYNNY 2001.12.202302510.0001004.1500000.00 4026.05.2002(Anaes.) 5001.12.2023BALLOON VALVULOPLASTY OR ISOLATED ATRIAL SEPTOSTOMY, including cardiac 5001.12.2023catheterisations before and after balloon dilatation (Anaes.) (Assist.) 1038272 01.11.2005 3 T8 6 SN NYNNY 2001.12.202302510.0001004.1500000.00 4001.11.2005(Anaes.) 5001.12.2023Atrial septal defect or patent foramen closure: (a) for congenital heart 5001.12.2023disease in a patient with documented evidence of right heart overload or 5001.12.2023paradoxical embolism; and (b) using a septal occluder or similar device, by 5001.12.2023transcatheter approach; and (c) including right or left heart catheterisation 5001.12.2023(or both); other than a service associated with a service to which item 38200, 5001.12.202338203, 38206 or 38254 applies (Anaes.) (Assist.) 1038273 01.07.2014 3 T8 6 SN NYNNY 2001.12.202302510.0001004.1500000.00 4001.07.2014(Anaes.) 5001.12.2023Patent ductus arteriosus, transcatheter closure of, including cardiac 5001.12.2023catheterisation and any imaging associated with the service (Anaes.) (Assist.) 1038274 01.07.2014 3 T8 6 SN NYNNY 2001.12.202301130.0000822.6000000.00 4001.07.2014(Anaes.) 5001.12.2023Ventricular septal defect, transcatheter closure of, with cardiac 5001.12.2023catheterisation, excluding imaging (H) (Anaes.) (Assist.) 1038275 26.05.2002 3 T8 6 SN NYNNY 2001.12.202300820.0000328.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MYOCARDIAL BIOPSY, by cardiac catheterisation (Anaes.) 1038276 01.11.2017 3 T8 6 SNS NYNYY 2001.12.202302510.0001004.1500000.00 4001.11.2017(Anaes.) 5001.12.2023Transcatheter occlusion of left atrial appendage, and cardiac catheterisation 5001.12.2023performed by the same practitioner, for stroke prevention in a patient who has 5001.12.2023nonvalvular atrial fibrillation, if: (a) the patient is at increased risk of 5001.12.2023thromboembolism demonstrated by: (i) a prior stroke (whether of an ischaemic 5001.12.2023or unknown type), transient ischaemic attack or noncentral nervous system 5001.12.2023systemic embolism; or (ii) at least 2 of the following risk factors: (A) an 5001.12.2023age of 65 years or more; (B) hypertension; (C) diabetes mellitus; (D) heart 5001.12.2023failure or left ventricular ejection fraction of 35% or less (or both); (E) 5001.12.2023vascular disease (prior myocardial infarction, peripheral artery disease or 5001.12.2023aortic plaque); and (b) the patient has an absolute and permanent 5001.12.2023contraindication to oral anticoagulation (confirmed by written documentation 5001.12.2023that is provided by a medical practitioner, independent of the practitioner 5001.12.2023rendering the service); and (c) the service is not associated with a service 5001.12.2023to which item 38200, 38203, 38206 or 38254 applies (H) (Anaes.) (Assist.) 1038285 01.11.2004 3 T8 6 SN NYNNY 2001.12.202300315.0000169.8000000.00 4001.11.2004(Anaes.) 5001.12.2023Insertion of implantable ECG loop recorder, by a specialist or consultant 5001.12.2023physician, for the diagnosis of a primary disorder, including initial 5001.12.2023programming and testing, if: (a) the patient has recurrent unexplained syncope 5001.12.2023and does not have a structural heart defect associated with a high risk of 5001.12.2023sudden cardiac death; and (b) a diagnosis has not been achieved through all 5001.12.2023other available cardiac investigations; and (c) a neurogenic cause is not 5001.12.2023suspected (Anaes.) 1038286 01.11.2004 3 T8 6 SN NYNNY 2001.12.202300285.0000152.9500000.00 4001.11.2004(Anaes.) 5001.12.2023Removal of implantable ECG loop recorder (Anaes.) 1038287 26.05.2002 3 T8 6 SN NYNNY 2001.12.202306160.0002309.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ABLATION OF ARRHYTHMIA CIRCUIT OR FOCUS or isolation procedure involving 1 5001.12.2023atrial chamber (Anaes.) (Assist.) 1038288 01.05.2018 3 T8 6 SN NYNNY 2001.12.202300395.0000212.3500000.00 4001.05.2018(Anaes.) 5001.12.2023Implantable loop recorder, insertion of, for diagnosis of atrial fibrillation, 5001.12.2023if: (a) the patient to whom the service is provided has been diagnosed as 5001.12.2023having had an embolic stroke of undetermined source; and (b) the bases of the 5001.12.2023diagnosis included the following: (i) the medical history of the patient; (ii) 5001.12.2023physical examination; (iii) brain and carotid imaging; (iv) cardiac imaging; 5001.12.2023(v) surface ECG testing including 24hour Holter monitoring; and (c) atrial 5001.12.2023fibrillation is suspected; and (d) the patient: (i) does not have a permanent 5001.12.2023indication for oral anticoagulants; or (ii) does not have a permanent oral 5001.12.2023anticoagulants contraindication; including initial programming and testing 5001.12.2023(Anaes.) 1038290 26.05.2002 3 T8 6 SN NYNNY 2001.12.202307845.0002941.0500000.00 4026.05.2002(Anaes.) 5001.12.2023ABLATION OF ARRHYTHMIA CIRCUITS OR FOCI, or isolation procedure involving both 5001.12.2023atrial chambers and including curative procedures for atrial fibrillation 5001.12.2023(Anaes.) (Assist.) 1038293 26.05.2002 3 T8 6 SN NYNNY 2001.12.202308420.0003156.8500000.00 4026.05.2002(Anaes.) 5001.12.2023VENTRICULAR ARRHYTHMIA with mapping and ablation, including all associated 5001.12.2023electrophysiological studies performed on the same day (Anaes.) (Assist.) 1038307 01.07.2021 3 T8 6 SN NYNNY 2001.12.202306190.0001951.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome -1 coronary territory with selective coronary 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has not been 5001.12.2023completed in the previous 3 months; and (b) including selective coronary 5001.12.2023angiography and all associated imaging, catheter and contrast; and (c) 5001.12.2023including either or both: (i) percutaneous angioplasty; (ii) transluminal 5001.12.2023insertion of one or more stents; and (d) performed on one coronary vascular 5001.12.2023territory; and (e) excluding aftercare; other than a service associated with a 5001.12.2023service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 5001.12.202338252, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 5001.12.202338323 applies (Anaes.) (Assist.) 1038308 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307090.0002244.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Note:(acute coronary syndrome -2 coronary territories with selective coronary 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has not been 5001.12.2023completed in the previous 3 months; and (b) including selective coronary 5001.12.2023angiography and all associated imaging, catheter and contrast; and (c) 5001.12.2023including either or both: (i) percutaneous angioplasty; and (ii) transluminal 5001.12.2023insertion of one or more stents; and (d) performed on 2 coronary vascular 5001.12.2023territories; and (e) excluding aftercare; other than a service associated with 5001.12.2023a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 5001.12.202338251, 38252, 38307, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 5001.12.202338322 or 38323 applies (Anaes.) (Assist.) 1038309 01.11.2005 3 T8 6 SN NYNNY 2001.12.202304180.0001323.0500000.00 4001.11.2005(Anaes.) 5001.12.2023Percutaneous transluminal rotational atherectomy of one or more coronary 5001.12.2023arteries, including all associated imaging, if: (a) the target stenosis within 5001.12.2023at least one coronary artery is heavily calcified and balloon angioplasty with 5001.12.2023or without stenting is not feasible without rotational artherectomy; and (b) 5001.12.2023the service is performed in conjunction with a service to which item 38307, 5001.12.202338308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 5001.12.2023applies Applicable only once on each occasion the service is performed 5001.12.2023(Anaes.) (Assist.) 1038310 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307990.0002538.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome -3 coronary territories with selective coronary 5001.12.2023angiography)the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has not been 5001.12.2023completed in the previous 3 months; and (b) including selective coronary 5001.12.2023angiography and all associated imaging, catheter and contrast; and (c) 5001.12.2023including either or both: (i) percutaneous angioplasty; and (ii) transluminal 5001.12.2023insertion of one or more stents; and (d) performed on 3 coronary vascular 5001.12.2023territories; and (e) excluding aftercare; other than a service associated with 5001.12.2023a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 5001.12.202338251, 38252, 38307, 38308, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 5001.12.202338322 or 38323 applies (Anaes.) (Assist.) 1038311 01.07.2021 3 T8 6 SN NYNNY 2001.12.202306190.0001951.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-1 coronary territory with selective 5001.12.2023angiography)the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C 5001.12.2023for the service and a service to which item 38314 applies; and (ii) for whom 5001.12.2023selective coronary angiography has not been completed in the previous 3 5001.12.2023months; and (b) including selective coronary angiography and all associated 5001.12.2023imaging, catheter and contrast; and (c) including either or both: (i) 5001.12.2023percutaneous angioplasty; and (ii) transluminal insertion of one or more 5001.12.2023stents; and (d) performed on one coronary vascular territory; and (e) 5001.12.2023excluding aftercare; other than a service associated with a service to which 5001.12.2023item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 5001.12.202338308, 38310, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies 5001.12.2023(Anaes.) (Assist.) 1038313 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307090.0002244.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-2 coronary territories with selective 5001.12.2023angiography)the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C 5001.12.2023for the service and a service to which item 38314 applies; and (ii) for whom 5001.12.2023selective coronary angiography has not been completed in the previous 3 5001.12.2023months; and (b) including selective coronary angiography and all associated 5001.12.2023imaging, catheter and contrast; and (c) including either or both: (i) 5001.12.2023percutaneous angioplasty; and (ii) transluminal insertion of one or more 5001.12.2023stents; and (d) performed on 2 coronary vascular territories; and (e) 5001.12.2023excluding aftercare; other than a service associated with a service to which 5001.12.2023item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 5001.12.202338308, 38310, 38311, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies 5001.12.2023(Anaes.) (Assist.) 1038314 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307990.0002538.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-3 coronary territory with selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17C; and (ii) for whom selective coronary angiography has not been 5001.12.2023completed in the previous 3 months; and (b) including selective coronary 5001.12.2023angiography and all associated imaging, catheter and contrast; and (c) 5001.12.2023including either or both: (i) percutaneous angioplasty; and (ii) transluminal 5001.12.2023insertion of one or more stents; and (d) performed on 3 coronary vascular 5001.12.2023territories; and (e) excluding aftercare; other than a service associated with 5001.12.2023a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 5001.12.202338251, 38252, 38307, 38308, 38310, 38311, 38313, 38316, 38317, 38319, 38320, 5001.12.202338322 or 38323 applies (Anaes.) (Assist.) 1038316 01.07.2021 3 T8 6 SN NYNNY 2001.12.202305230.0001744.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome -1 coronary territory without selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has been 5001.12.2023completed in the previous 3 months; and (b) including any associated coronary 5001.12.2023angiography; and (c) including either or both: (i) percutaneous angioplasty; 5001.12.2023and (ii) transluminal insertion of one or more stents; and (d) performed on 5001.12.2023one coronary vascular territory; and (e) excluding aftercare; other than a 5001.12.2023service associated with a service to which item 38200, 38203, 38206, 38244, 5001.12.202338247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 5001.12.202338317, 38319, 38320, 38322 or 38323 applies (Anaes.) (Assist.) 1038317 01.07.2021 3 T8 6 SN NYNNY 2001.12.202306645.0002209.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome -2 coronary territories without selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has been 5001.12.2023completed in the previous 3 months; and (b) including any associated coronary 5001.12.2023angiography; and (c) including either or both: (i) percutaneous angioplasty; 5001.12.2023and (ii) transluminal insertion of one or more stents; and (d) performed on 2 5001.12.2023coronary vascular territories; and (e) excluding aftercare; other than a 5001.12.2023service associated with a service to which item 38200, 38203, 38206, 38244, 5001.12.202338247, 38248, 38249, 38251, 38252, 38307, 3808, 38310, 38311, 38313, 38314, 5001.12.202338316, 38319, 38320, 38322 or 38323 applies (Anaes.) (Assist.) 1038319 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307550.0002503.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (acute coronary syndrome -3 coronary territories without selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17A; and (ii) for whom selective coronary angiography has been 5001.12.2023completed in the previous 3 months; and (b) including any associated coronary 5001.12.2023angiography; and (c) including either or both: (i) percutaneous angioplasty; 5001.12.2023and (ii) transluminal insertion of one or more stents; and (d) performed on 3 5001.12.2023coronary vascular territories; and (e) excluding aftercare; other than a 5001.12.2023service associated with a service to which item 38200, 38203, 38206, 38244, 5001.12.202338247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 5001.12.202338316, 38317, 38320, 38322 or 38323 applies (Anaes.) (Assist.) 1038320 01.07.2021 3 T8 6 SN NYNNY 2001.12.202305230.0001744.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-1 coronary territory without selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C 5001.12.2023for the service and a service to which item 38323 applies; and (ii) for whom 5001.12.2023selective coronary angiography has been completed in the previous 3 months; 5001.12.2023and (b) including any associated coronary angiography; and (c) including 5001.12.2023either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion 5001.12.2023of one or more stents; and (d) performed on one coronary vascular territory; 5001.12.2023and (e) excluding aftercare; other than a service associated with a service to 5001.12.2023which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 5001.12.202338307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38322 or 38323 5001.12.2023applies (Anaes.) (Assist.) 1038322 01.07.2021 3 T8 6 SN NYNNY 2001.12.202306645.0002209.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-2 coronary territories with selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C 5001.12.2023for the service and a service to which item 38323 applies; and (ii) for whom 5001.12.2023selective coronary angiography has been completed in the previous 3 months; 5001.12.2023and (b) including any associated coronary angiography; and (c) including 5001.12.2023either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion 5001.12.2023of one or more stents; and (d) performed on 2 coronary vascular territories; 5001.12.2023and (e) excluding aftercare; other than a service associated with a service to 5001.12.2023which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 5001.12.202338307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320 or 38323 5001.12.2023applies (Anaes.) (Assist.) 1038323 01.07.2021 3 T8 6 SN NYNNY 2001.12.202307550.0002503.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Note: (stablemulti-vessel disease-3 coronary territories with selective 5001.12.2023angiography) the service only applies if the patient meets the requirements of 5001.12.2023the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous 5001.12.2023coronary intervention: (a) for a patient: (i) eligible for the service under 5001.12.2023clause 5.10.17C; and (ii) for whom selective coronary angiography has been 5001.12.2023completed in the previous 3 months; and (b) including any associated coronary 5001.12.2023angiography; and (c) including either or both: (i) percutaneous angioplasty; 5001.12.2023and (ii) transluminal insertion of one or more stents; and (d) performed on 3 5001.12.2023coronary vascular territories; and (e) excluding aftercare; other than a 5001.12.2023service associated with a service to which item 38200, 38203, 38206, 38244, 5001.12.202338247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 5001.12.202338316, 38317, 38319, 38320 or 38322 applies (Anaes.) (Assist.) 1038350 01.11.2005 3 T8 6 SN NYNNY 2001.12.202301640.0000703.0000000.00 4001.11.2005(Anaes.) 5001.12.2023SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or 5001.12.2023replacement of, including cardiac electrophysiological services where used for 5001.12.2023pacemaker implantation (Anaes.) 1038353 01.11.2005 3 T8 6 SN NYNNY 2001.12.202300655.0000281.1500000.00 4001.11.2005(Anaes.) 5001.12.2023PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of, not for 5001.12.2023cardiac resynchronisation therapy, including cardiac electrophysiological 5001.12.2023services where used for pacemaker implantation (Anaes.) 1038356 01.11.2005 3 T8 6 SN NYNNY 2001.12.202302150.0000921.6500000.00 4001.11.2005(Anaes.) 5001.12.2023DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or 5001.12.2023replacement of, including cardiac electrophysiological services where used for 5001.12.2023pacemaker implantation (Anaes.) 1038358 01.11.2005 3 T8 6 SN NYNNY 2001.12.202308110.0003156.8500000.00 4001.11.2005(Anaes.) 5001.12.2023Extraction of one or more chronically implanted transvenous pacing or 5001.12.2023defibrillator leads, by percutaneous method, with locking stylets and snares, 5001.12.2023with extraction sheaths (if any), if: (a) the leads have been in place for 5001.12.2023more than 6 months and require removal; and (b) the service is performed: (i) 5001.12.2023in association with a service to which item 61109 or 60509 applies; and (ii) 5001.12.2023by a specialist or consultant physician who has undertaken the training to 5001.12.2023perform the service; and (iii) in a facility where cardiothoracic surgery is 5001.12.2023available and a thoracotomy can be performed immediately and without transfer; 5001.12.2023and (c) if the service is performed by an interventional cardiologista 5001.12.2023cardiothoracic surgeon is in attendance during the service (H) (Anaes.) 5001.12.2023(Assist.) 1038359 01.11.2005 3 T8 6 SN NYNNY 2001.12.202300435.0000147.0500000.00 4001.11.2005(Anaes.) 5001.12.2023PERICARDIUM, paracentesis of (excluding aftercare) (Anaes.) 1038362 01.11.2005 3 T8 6 SN NYNNY 2001.12.202301130.0000423.6500000.00 4001.11.2005(Anaes.) 5001.12.2023INTRA-AORTIC BALLOON PUMP, percutaneous insertion of (Anaes.) 1038365 01.05.2006 3 T8 6 SN NYNNY 2001.12.202300845.0000281.1500000.00 4001.05.2006(Anaes.) 5001.12.2023Insertion, removal or replacement of permanent cardiac synchronisation device, 5001.12.2023if the patient: (a) has all of the following: (i) chronic heart failure, 5001.12.2023classified as New York Heart Association class III or IV (despite optimised 5001.12.2023medical therapy); (ii) left ventricular ejection fraction of less than 35%; 5001.12.2023(iii) QRS duration of greater than or equal to 130 ms; or (b) has all of the 5001.12.2023following: (i) chronic heart failure, classified as New York Heart Association 5001.12.2023class II (despite optimised medical therapy); (ii) left ventricular ejection 5001.12.2023fraction of less than 35%; (iii) QRS duration of greater than or equal to 150 5001.12.2023ms; other than a service associated with a service to which item 38212 5001.12.2023applies(H) (Anaes.) (Assist.) 1038368 01.05.2006 3 T8 6 SN NYNNY 2001.12.202304950.0001347.9000000.00 4001.05.2006(Anaes.) 5001.12.2023Insertion, removal or replacement of permanent transvenous left ventricular 5001.12.2023electrode, through the coronary sinus, for the purpose of cardiac 5001.12.2023resynchronisation therapy, including right heart catheterisation and any 5001.12.2023associated venograms, if the patient: (a) has all of the following: (i) 5001.12.2023chronic heart failure, classified as New York Heart Association class III or 5001.12.2023IV (despite optimised medical therapy); (ii) left ventricular ejection 5001.12.2023fraction of less than 35%; (iii) QRS duration of greater than or equal to 130 5001.12.2023ms; or (b) has all of the following: (i) chronic heart failure, classified as 5001.12.2023New York Heart Association class II (despite optimised medical therapy); (ii) 5001.12.2023left ventricular ejection fraction of less than 35%; (iii) QRS duration of 5001.12.2023greater than or equal to 150 ms; other than a service associated with a 5001.12.2023service to which item 35200, 38200 or 38212 applies (H) (Anaes.) (Assist.) 1038372 01.11.2023 3 T8 6 SN YNNYN 2001.12.202302289.0000830.3000000.00 4001.11.2023(Anaes.) 5001.12.2023Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous 5001.12.2023insertion of, for the treatment of bradycardia, including cardiac 5001.12.2023electrophysiological services (other than a service associated with a service 5001.12.2023to which item 38350 applies) (H) (Anaes.) 1038373 01.11.2023 3 T8 6 SN YNNYN 2001.12.202302289.0000830.3000000.00 4001.11.2023(Anaes.) 5001.12.2023Leadless permanent cardiac pacemaker, singlechamber ventricular, percutaneous 5001.12.2023retrieval and replacement of, including cardiac electrophysiological services, 5001.12.2023during the same percutaneous procedure, if: (a) the service is performed: (i) 5001.12.2023by a specialist or consultant physician who has undertaken training to perform 5001.12.2023the service; and (ii) in a facility where cardiothoracic surgery is available 5001.12.2023and a thoracotomy can be performed immediately and without transfer; and (b) 5001.12.2023if the service is performed by an interventional cardiologist at least 4 weeks 5001.12.2023after the leadless permanent cardiac pacemaker was inserteda cardiothoracic 5001.12.2023surgeon is in attendance during the service; other than a service associated 5001.12.2023with a service to which item 38350 applies (H) (Anaes.) 1038374 01.11.2023 3 T8 6 SN YNNYN 2001.12.202302289.0000830.3000000.00 4001.11.2023(Anaes.) 5001.12.2023Leadless permanent cardiac pacemaker, singlechamber ventricular, percutaneous 5001.12.2023retrieval of, if: (a) the service is performed: (i) by a specialist or 5001.12.2023consultant physician who has undertaken training to perform the service; and 5001.12.2023(ii) in a facility where cardiothoracic surgery is available and a thoracotomy 5001.12.2023can be performed immediately and without transfer; and (b) if the service is 5001.12.2023performed by an interventional cardiologist at least 4 weeks after the 5001.12.2023leadless permanent cardiac pacemaker was inserteda cardiothoracic surgeon is 5001.12.2023in attendance during the service (H) (Anaes.) 1038375 01.11.2023 3 T8 6 SN YNNYN 2001.12.202308566.0003107.1500000.00 4001.11.2023(Anaes.) 5001.12.2023Leadless permanent cardiac pacemaker, single-chamber ventricular, explantation 5001.12.2023of, by open surgical approach (H) (Anaes.) (Assist.) 1038416 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202301840.0000620.1000000.00 4001.03.2021(Anaes.) 5001.12.2023Endoscopic ultrasound guided fine needle aspiration biopsy or biopsies 5001.12.2023(endoscopy with ultrasound imaging) to obtain one or more specimens from 5001.12.2023either or both of the following: (a) mediastinal masses; (b) locoregional 5001.12.2023nodes to stage non-small cell lung carcinoma; other than a service associated 5001.12.2023with a service to which an item in Subgroup 1 of this Group, or item 38417 or 5001.12.202355054, applies (Anaes.) 1038417 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202301840.0000620.1000000.00 4001.03.2021(Anaes.) 5001.12.2023Endobronchial ultrasound guided biopsy or biopsies (bronchoscopy with 5001.12.2023ultrasound imaging, with or without associated fluoroscopic imaging) to obtain 5001.12.2023one or more specimens by: (a) transbronchial biopsy or biopsies of peripheral 5001.12.2023lung lesions; or (b) fine needle aspirations of one or more mediastinal 5001.12.2023masses; or (c) fine needle aspirations of locoregional nodes to stage 5001.12.2023non-small cell lung carcinoma; other than a service associated with a service 5001.12.2023to which an item in Subgroup 1 of this Group, item 38416, 38420 or 38423, or 5001.12.2023an item in Subgroup I5 of Group I3, applies (Anaes.) 1038419 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202300515.0000195.9500000.00 4001.03.2021(Anaes.) 5001.12.2023Bronchoscopy, as an independent procedure (Anaes.) 1038420 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202300690.0000258.7500000.00 4001.03.2021(Anaes.) 5001.12.2023Bronchoscopy with one or more endobronchial biopsies or other diagnostic or 5001.12.2023therapeutic procedures (Anaes.) 1038422 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202301000.0000404.7500000.00 4001.03.2021(Anaes.) 5001.12.2023Bronchus, removal of foreign body in (Anaes.) (Assist.) 1038423 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202300760.0000282.8500000.00 4001.03.2021(Anaes.) 5001.12.2023Fibreoptic bronchoscopy with one or more transbronchial lung biopsies, with or 5001.12.2023without bronchial or broncho-alveolar lavage, with or without the use of 5001.12.2023interventional imaging (Anaes.) (Assist.) 1038425 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202301795.0000665.1000000.00 4001.03.2021(Anaes.) 5001.12.2023Endoscopic laser resection of endobronchial tumours for relief of obstruction 5001.12.2023including any associated endoscopic procedures (Anaes.) (Assist.) 1038426 01.03.2021 3 T8 6 SNS NYNNY 2001.12.202301225.0000499.0000000.00 4001.03.2021(Anaes.) 5001.12.2023Trachea or bronchus, dilatation of stricture and endoscopic insertion of stent 5001.12.2023(Anaes.) (Assist.) 1038428 01.11.2021 3 T8 6 SNS NYNYY 2001.12.202300670.0000271.3500000.00 4001.11.2021(Anaes.) 5001.12.2023Bronchoscopy withtreatment of tracheal stricture (Anaes.) 1038429 01.03.2023 3 T8 6 SN YYNYN 2001.12.202305055.0001894.2000000.00 4001.03.2023(Anaes.) 5001.12.2023Tracheal excision and repair of, without cardiopulmonary bypass (H) (Anaes.) 5001.12.2023(Assist.) 1038431 01.03.2023 3 T8 6 SN YYNYN 2001.12.202307075.0002562.1000000.00 4001.03.2023(Anaes.) 5001.12.2023Tracheal excision and repair of, with cardiopulmonary bypass (H) (Anaes.) 5001.12.2023(Assist.) 1038461 01.07.2021 3 T8 6 DN NYNYY 2001.12.202304346.0001576.4500000.00 4001.07.2021(Anaes.) 5001.12.2023TMVr, by transvenous or transeptal techniques, for permanent coaptation of 5001.12.2023mitral valve leaflets using one or more Mitraclips, including intraoperative 5001.12.2023diagnostic imaging, if: (a) the patient has each of the following risk 5001.12.2023factors: (i) moderate to severe, or severe, symptomatic degenerative (primary) 5001.12.2023mitral valve regurgitation (grade 3+ or 4+); (ii) left ventricular ejection 5001.12.2023fraction of 20% or more; (iii) symptoms of mild, moderate or severe chronic 5001.12.2023heart failure (New York Heart Association class II, III or IV); and (b) as a 5001.12.2023result of a TMVr suitability case conference, the patient has been: (i) 5001.12.2023assessed as having an unacceptably high risk for surgical mitral valve 5001.12.2023replacement; and (ii) recommended as being suitable for the service; and (c) 5001.12.2023the service is performed: (i) by a cardiothoracic surgeon, or an 5001.12.2023interventional cardiologist, accredited by the TMVr accreditation committee to 5001.12.2023perform the service; and (ii) via transfemoral venous delivery, unless 5001.12.2023transfemoral venous delivery is contraindicated or not feasible; and (iii) in 5001.12.2023a hospital that is accredited by the TMVr accreditation committee as a 5001.12.2023suitable hospital for the service; and (d) a service to which this item, or 5001.12.2023item 38463, applies has not been provided to the patient in the previous 5 5001.12.2023years (H) (Anaes.) (Assist.) 1038463 01.07.2021 3 T8 6 DN NYNYY 2001.12.202304346.0001576.4500000.00 4001.07.2021(Anaes.) 5001.12.2023TMVr, by transvenous or transeptal techniques, for permanent coaptation of 5001.12.2023mitral valve leaflets using one or more Mitraclips, including intraoperative 5001.12.2023diagnostic imaging, if: (a) the patient has each of the following risk 5001.12.2023factors: (i) moderate to severe, or severe, symptomatic functional (secondary) 5001.12.2023mitral valve regurgitation (grade 3+ or 4+); (ii) left ventricular ejection 5001.12.2023fraction of 20% to 50%; (iii) left ventricular end systolic diameter of not 5001.12.2023more than 70mm; (iv) symptoms of mild, moderate or severe chronic heart 5001.12.2023failure (New York Heart Association class II, III or IV) that persist despite 5001.12.2023maximally tolerated guideline directed medical therapy; and (b) as a result of 5001.12.2023a TMVr suitability case conference, the patient has been: (i) assessed as 5001.12.2023having an unacceptably high risk for surgical mitral valve replacement; and 5001.12.2023(ii) recommended as being suitable for the service; and (c) the service is 5001.12.2023performed: (i) by a cardiothoracic surgeon, or an interventional cardiologist, 5001.12.2023accredited by the TMVr accreditation committee to perform the service; and 5001.12.2023(ii) via transfemoral venous delivery, unless transfemoral venous delivery is 5001.12.2023contraindicated or not feasible; and (iii) in a hospital that is accredited by 5001.12.2023the TMVr accreditation committee as a suitable hospital for the service; and 5001.12.2023(d) a service to which this item, or item 38461, applies has not been provided 5001.12.2023to the patient in the previous 5 years (H) (Anaes.) (Assist.) 1038467 01.07.2021 3 T8 6 SN NYNYY 2001.12.202303265.0001054.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Insertion, removal or replacement of permanent myocardial electrode, by open 5001.12.2023surgical approach, other than a service associated with a service to which 5001.12.2023item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies 5001.12.2023(H) (Anaes.) (Assist.) 1038471 01.07.2021 3 T8 6 SN NYNNY 2001.12.202303090.0001158.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Insertion of implantable defibrillator, including insertion of patches for the 5001.12.2023insertion of one or more transvenous endocardial leads, if the patient has one 5001.12.2023of the following: (a) a history of haemodynamically significant ventricular 5001.12.2023arrhythmias in the presence of structural heart disease; (b) documented 5001.12.2023high-risk genetic cardiac disease; (c) ischaemic heart disease, with a left 5001.12.2023ventricular ejection fraction of less than 30% at least one month after 5001.12.2023experiencing a myocardial infarction and while on optimised medical therapy; 5001.12.2023(d) chronic heart failure, classified as New York Heart Association class II 5001.12.2023or III, with a left ventricular ejection fraction of less than 35% (despite 5001.12.2023optimised medical therapy); other than a service to which item 38212 applies 5001.12.2023(H) (Anaes.) (Assist.) 1038472 01.07.2021 3 T8 6 SN NYNNY 2001.12.202300845.0000316.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Insertion, replacement or removal of implantable defibrillator generator, if 5001.12.2023the patient has one of the following: (a) a history of haemodynamically 5001.12.2023significant ventricular arrhythmias in the presence of structural heart 5001.12.2023disease; (b) documented high-risk genetic cardiac disease; (c) ischaemic heart 5001.12.2023disease, with a left ventricular ejection fraction of less than 30% at least 5001.12.2023one month after experiencing a myocardial infarction and while on optimised 5001.12.2023medical therapy; (d) chronic heart failure, classified as New York Heart 5001.12.2023Association class II or III, with a left ventricular ejection fraction of less 5001.12.2023than 35% (despite optimised medical therapy); other than a service to which 5001.12.2023item 38212 applies (H) (Anaes.) (Assist.) 1038474 01.07.2021 3 T8 6 SN NYNYY 2001.12.202306430.0002387.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair, augmentation or replacement of branch pulmonary arteriesleft or right 5001.12.2023(or both), with cardiopulmonary bypass, for congenital heart disease, other 5001.12.2023than a service associated with a service to which item 11704, 11705, 11707, 5001.12.202311714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038477 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306605.0002205.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Valve annuloplasty with insertion of ring, other than: (a) a service to which 5001.12.2023item 38516 or 38517 applies; or (b) a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038484 01.07.2021 3 T8 6 SN NYNYY 2001.12.202306725.0002234.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Aortic or pulmonary valve replacement with bioprosthesis or mechanical 5001.12.2023prosthesis, including retrograde cardioplegia (if performed), other than a 5001.12.2023service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038485 26.05.2002 3 T8 6 SN NYNNY 2001.12.202302695.0000899.3500000.00 4026.05.2002(Anaes.) 5001.12.2023MITRAL ANNULUS, reconstruction of, after decalcification, when performed in 5001.12.2023association with valve surgery (Anaes.) (Assist.) 1038487 26.05.2002 3 T8 6 SN NYNNY 2001.12.202305670.0001894.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MITRAL VALVE, open valvotomy of (Anaes.) (Assist.) 1038490 26.05.2002 3 T8 6 SN NYNNY 2001.12.202301830.0000610.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction and re-implantation of sub-valvular structures, if performed in 5001.12.2023conjunction with a service to which item 38499 applies (H) (Anaes.) (Assist.) 1038493 26.05.2002 3 T8 6 SN NYNNY 2001.12.202305960.0002154.7000000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATIVE MANAGEMENT of acute infective endocarditis, in association with 5001.12.2023heart valve surgery (Anaes.) (Assist.) 1038499 01.07.2021 3 T8 6 SN NYNYY 2001.12.202306725.0002234.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Mitral or tricuspid valve replacement with bioprothesis or mechanical 5001.12.2023prosthesis, including retrograde cardioplegia (if performed), other than a 5001.12.2023service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038502 01.07.2021 3 T8 6 SN NYNYY 2001.12.202306980.0002593.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Coronary artery bypass, including cardiopulmonary bypass, with or without 5001.12.2023retrograde cardioplegia, with or without vein grafts, and including at least 5001.12.2023one of the following: (a) harvesting of left internal mammary artery and vein 5001.12.2023graft material; (b) harvesting of left internal mammary artery; (c) harvesting 5001.12.2023of vein graft material; other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies(H) (Anaes.) (Assist.) 1038508 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305865.0002111.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or reconstruction of left ventricular aneurysm, including plication, 5001.12.2023resection and primary and patch repairs, other than a service associated with 5001.12.2023a service to which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 5001.12.2023or 45503 applies (H) (Anaes.) (Assist.) 1038509 26.05.2002 3 T8 6 SN NYNYY 2001.12.202307015.0002629.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Repair of ischaemic ventricular septal rupture,, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038510 01.07.2021 3 T8 6 SN NYNNY 2001.12.202301830.0000686.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Artery harvesting (other than of the left internal mammary), for coronary 5001.12.2023artery bypass, if: (a) more than one arterial graft is required; and (b) the 5001.12.2023service is performed in conjunction withcoronary artery bypass surgery 5001.12.2023performed by any medical practitioner (H) (Anaes.) (Assist.) 1038511 01.07.2021 3 T8 6 SN NYNNY 2001.12.202301760.0000660.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Coronary artery bypass, with the aid of tissue stabilisers, if the service is 5001.12.2023performed: (a) without cardiopulmonary bypass; and (b) in conjunction with a 5001.12.2023service to which item 38502 applies (H) (Anaes.) (Assist.) 1038512 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306165.0002309.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Division of accessory pathway, isolation procedure, procedure on 5001.12.2023atrioventricular node or perinodal tissues involving one atrial chamber only, 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038513 01.07.2021 3 T8 6 SN NYNYY 2001.12.202302935.0001100.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Creation of Ygraft, Tgraft and grafttograft extensions, with microarterial or 5001.12.2023microvenous anastomosis using microsurgical techniques, if: (a) the service is 5001.12.2023for one or more anastomoses; and (b) the service is performed in conjunction 5001.12.2023with a service to which item 38502 applies (H) (Anaes.) (Assist.) 1038514 01.03.2022 3 T8 6 DNS NYNNY 2001.12.202304346.0001576.4500000.00 4001.03.2022(Anaes.) 5001.12.2023TAVI, for the treatment of symptomatic severe aortic stenosis, performed via 5001.12.2023transfemoral delivery, unless transfemoral delivery is contraindicated or not 5001.12.2023feasible, if: the TAVI patient is at intermediate risk for surgery; and the 5001.12.2023service: is performed by a TAVI practitioner in a TAVI Hospital; and includes 5001.12.2023all intraoperative diagnostic imaging that the TAVI Practitioner performs upon 5001.12.2023the TAVI Patient; not being a service which has been rendered within 5 years 5001.12.2023of a service to which this item or item 38495or 38522 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038515 26.05.2002 3 T8 6 SN NYNYY 2001.12.202307850.0002941.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Division of accessory pathway, isolation procedure, procedure on 5001.12.2023atrioventricular node or perinodal tissues involving both atrial chambers and 5001.12.2023including curative surgery for atrial fibrillation, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038516 01.07.2021 3 T8 6 SN NYNYY 2001.12.202308250.0002750.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Simple valve repair: (a) with or without annuloplasty; and (b) including 5001.12.2023quadrangular resection, cleft closure or alfieri; and (c) including retrograde 5001.12.2023cardioplegia (if performed); other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038517 01.07.2021 3 T8 6 SN NYNYY 2001.12.202310155.0003385.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Complex valve repair: (a) with or without annuloplasty; and (b) including 5001.12.2023retrograde cardioplegia (if performed); and (c) including one of the 5001.12.2023following: (i) neochords; (ii) chordal transfer; (iii) patch augmentation; 5001.12.2023(iv) multiple leaflets; other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 5001.12.2023applies(H) (Anaes.) (Assist.) 1038518 26.05.2002 3 T8 6 SN NYNYY 2001.12.202308425.0003156.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Ventricular arrhythmia with mapping and muscle ablation, with or without 5001.12.2023aneurysmeotomy, other than a service associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038519 01.07.2021 3 T8 6 SN NYNYY 2001.12.202303505.0001163.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Valve explant of a previous prosthesis, if performed during open cardiac 5001.12.2023surgery, not being a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038522 01.07.2022 3 T8 6 DNS NYNNY 2001.12.202304720.0001576.4500000.00 4001.07.2022(Anaes.) 5001.12.2023TAVI, for the treatment of symptomatic severe native calcific aortic 5001.12.2023stenosis,performed via transfemoral delivery, unless transfemoral delivery is 5001.12.2023contraindicated or not feasible,if: the TAVI Patient is at low risk for 5001.12.2023surgery; and the service: is performed by a TAVI Practitioner in a TAVI 5001.12.2023Hospital; and includes all intraoperative diagnostic imaging that the TAVI 5001.12.2023Practitioner performs upon the TAVI Patient; not being a service which has 5001.12.2023been rendered within 5 years of a service to which this item or item 38495 or 5001.12.202338514 applies (H) (Anaes.) (Assist.) 1038523 01.07.2022 3 T8 6 DNS NYNNY 2001.12.202300845.0000286.5500000.00 4001.07.2022(Anaes.) 5001.12.2023Percutaneous transcatheter delivery of dual-filter cerebral embolic protection 5001.12.2023system during a TAVI procedure, for the reduction of postoperative embolic 5001.12.2023ischaemic strokes, if: the service is performed upon a TAVI Patient in a TAVI 5001.12.2023Hospital; and where the service is performed by the practitioner performing 5001.12.2023the TAVI procedure, the service includes all intraoperative diagnostic imaging 5001.12.2023that the TAVI Practitioner performs upon the TAVI Patient (H) (Anaes.) 5001.12.2023(Assist.) 1038550 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306830.0002472.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or replacement of ascending thoracic aorta: (a) including: (i) 5001.12.2023cardiopulmonary bypass; and (ii) retrograde cardioplegia (if performed); and 5001.12.2023(b) not including valve replacement or repair or implantation of coronary 5001.12.2023arteries; other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038553 26.05.2002 3 T8 6 SN NYNYY 2001.12.202308585.0003113.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or replacement of ascending thoracic aorta: (a) including: (i) aortic 5001.12.2023valve replacement or repair; and (i) cardiopulmonary bypass; and (ii) 5001.12.2023retrograde cardioplegia (if performed); and (b) not including implantation of 5001.12.2023coronary arteries; other than a service associated with a service to which 5001.12.2023item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies 5001.12.2023(H) (Anaes.) (Assist.) 1038554 01.07.2021 3 T8 6 SN NYNYY 2001.12.202312450.0004481.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Valve sparing aortic root surgery, with reimplantation of aortic valve and 5001.12.2023coronary arteries and replacement of the ascending aorta, including 5001.12.2023cardiopulmonary bypass, and including retrograde cardioplegia (if performed), 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038555 01.07.2021 3 T8 6 SN NYNYY 2001.12.202309815.0002750.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Simple replacement or repair of aortic arch, performed in conjunction with a 5001.12.2023service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, 5001.12.2023including: (a) deep hypothermic circulatory arrest; and (b) peripheral 5001.12.2023cannulation for cardiopulmonary bypass; and (c) antegrade or retrograde 5001.12.2023cerebral perfusion (if performed); other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38603, 38816, 5001.12.202338828 or 45503 applies (H) (Anaes.) (Assist.) 1038556 26.05.2002 3 T8 6 SN NYNYY 2001.12.202309315.0003417.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or replacement of ascending thoracic aorta, including: (a) aortic valve 5001.12.2023replacement or repair; and (b) implantation of coronary arteries; and (c) 5001.12.2023cardiopulmonary bypass; and (d) retrograde cardioplegia (if performed); other 5001.12.2023than a service associated with a service to which item 11704, 11705, 11707, 5001.12.202311714, 18260, 33824, 38603, 38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038557 01.07.2021 3 T8 6 SN NYNYY 2001.12.202313090.0004760.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Complex replacement or repair of aortic arch, performed in conjunction with a 5001.12.2023service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, 5001.12.2023including: (a) debranching and reimplantation of head and neck vessels; and 5001.12.2023(b) deep hypothermic circulatory arrest; and (c) peripheral cannulation for 5001.12.2023cardiopulmonary bypass; and (d) antegrade or retrograde cerebral perfusion (if 5001.12.2023performed); other than a service associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038558 01.07.2021 3 T8 6 SN NYNYY 2001.12.202314940.0005377.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Aortic repair involving augmentation of hypoplastic or interrupted aortic 5001.12.2023arch, if: (a) the patient is a neonate; and (b) the service includes: (i) the 5001.12.2023use of antegrade cerebral perfusion or deep hypothermic circulatory arrest and 5001.12.2023associated myocardial preservation; and (ii) retrograde cardioplegia; other 5001.12.2023than a service associated with a service to which item 11704, 11705, 11707, 5001.12.202311714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038568 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305590.0002050.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or replacement of descending thoracic aorta, without shunt or 5001.12.2023cardiopulmonary bypass, by open exposure, percutaneous or endovascular means, 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824,38816, 38828or 45503 applies (H) (Anaes.) (Assist.) 1038571 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306435.0002337.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair or replacement of descending thoracic aorta, with shunt or 5001.12.2023cardiopulmonary bypass, other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038572 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305840.0002187.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Operative management of acute rupture or dissection, if the service: (a) is 5001.12.2023performed in conjunction with a service to which item 38550, 38553, 38554, 5001.12.202338555, 38556, 38557, 38558, 38568, 38571, 38706 or 38709 applies; and (b) is 5001.12.2023not associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824, 38603, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038600 26.05.2002 3 T8 6 SN NYNNY 2001.12.202304500.0001686.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CENTRAL CANNULATION for cardiopulmonary bypass excluding post-operative 5001.12.2023management, not being a service associated with a service to which another 5001.12.2023item in this Subgroup applies (Anaes.) (Assist.) 1038603 26.05.2002 3 T8 6 SN NYNNY 2001.12.202302815.0001054.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Peripheral cannulation for cardiopulmonary bypass, excluding post-operative 5001.12.2023management, other than a service: (a) in which peripheral cannulation is used 5001.12.2023in preference to central cannulation for valve or coronary bypass procedures; 5001.12.2023or (b) associated with a service to which item 38555 or 38572 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038609 26.05.2002 3 T8 6 SN NYNYY 2001.12.202301415.0000527.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Insertion of intra-aortic balloon pump, by arteriotomy, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824,38816, 38828 or 45503 applies(H) (Anaes.) (Assist.) 1038612 26.05.2002 3 T8 6 SN NYNYY 2001.12.202301585.0000591.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of intra-aortic balloon pump, with closure of artery by direct suture, 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824, 338816, 38828 or 45503 applies(H) (Anaes.) 5001.12.2023(Assist.) 1038615 26.05.2002 3 T8 6 SN NYNYY 2001.12.202304500.0001686.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Insertion of a left or right ventricular assist device, for use as: (a) a 5001.12.2023bridge to cardiac transplantation in patients with refractory heart failure 5001.12.2023who are: (i)currently on a heart transplant waiting list, or (ii)expected to 5001.12.2023be suitable candidates for cardiac transplantation following a period of 5001.12.2023support on the ventricularassist device; or (b) acute post cardiotomy support 5001.12.2023for failure to wean from cardiopulmonary transplantation; or 5001.12.2023(c)cardio-respiratory support for acute cardiac failure which is likely to 5001.12.2023recover with short term support of less than 6weeks; other than a service 5001.12.2023associated with a service to which: (d) item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies; or (e) another item in this 5001.12.2023Schedule applies if the service described in the item is for the use of a 5001.12.2023ventricular assist device as destination therapy in the management of a 5001.12.2023patient with heart failure who is not expected to be a suitable candidate for 5001.12.2023cardiac transplantation (H) (Anaes.) (Assist.) 1038618 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305610.0002101.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Insertion of a left and right ventricular assist device, for use as: (a)a 5001.12.2023bridge to cardiac transplantation in patients with refractory heart failure 5001.12.2023who are: (i)currently on a heart transplant waiting list, or (ii)expected to 5001.12.2023be suitable candidates for cardiac transplantation following a period of 5001.12.2023support on the ventricular assist device; or (b)acute post cardiotomy support 5001.12.2023for failure to wean from cardiopulmonary transplantation; or 5001.12.2023(c)cardio-respiratory support for acute cardiac failure which is likely to 5001.12.2023recover with short term support of less than 6 weeks; other than a service 5001.12.2023associated with a service to which: (d) item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies; or (e) another item in this 5001.12.2023Schedule applies if the service described in the item is for the use of a 5001.12.2023ventricular assist device as destination therapy in the management of a 5001.12.2023patient with heart failure who is not expected to be a suitable candidate for 5001.12.2023cardiac transplantation (H) (Anaes.) (Assist.) 1038621 26.05.2002 3 T8 6 SN NYNYY 2001.12.202302240.0000839.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Left or right ventricular assist device, removal of, as an independent 5001.12.2023procedure, other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824, 38627,38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038624 26.05.2002 3 T8 6 SN NYNYY 2001.12.202302515.0000942.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Left and right ventricular assist device, removal of, as an independent 5001.12.2023procedure, other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824, 38627, 38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038627 26.05.2002 3 T8 6 SN NYNYY 2001.12.202302010.0000737.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Extra-corporeal membrane oxygenation, bypass or ventricular assist device 5001.12.2023cannulae, adjustment and re-positioning of, by open operation, in patients 5001.12.2023supported by these devices, other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824, 38627, 38816, 38828 or 5001.12.202345503 applies (H) (Anaes.) (Assist.) 1038637 26.05.2002 3 T8 6 SN NYNYY 2001.12.202301630.0000610.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Patent diseased coronary artery bypass vein graft or grafts, dissection, 5001.12.2023disconnection and oversewing of, other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 5001.12.202345503 applies (H) (Anaes.) (Assist.) 1038653 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306000.0002211.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Open heart surgery, other than a service: (a) to which another item in this 5001.12.2023Group applies; or (b) associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824,38816, 38828or 45503 applies (H) (Anaes.) (Assist.) 1038670 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305605.0002101.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac tumour, excision of, involving the wall of the atrium or inter-atrial 5001.12.2023septum, without patch or conduit reconstruction, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038673 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306310.0002365.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac tumour, excision of, involving the wall of the atrium or inter-atrial 5001.12.2023septum, requiring reconstruction with patch or conduit, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038677 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305905.0002212.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac tumour arising from ventricular myocardium, partial thickness excision 5001.12.2023of, other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038680 26.05.2002 3 T8 6 SN NYNYY 2001.12.202307005.0002624.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Cardiac tumour arising from ventricular myocardium, full thickness excision of 5001.12.2023including repair or reconstruction, other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 5001.12.2023or 45503 applies (H) (Anaes.) (Assist.) 1038700 26.05.2002 3 T8 6 SN NYNYY 2001.12.202303135.0001174.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Patent ductus arteriosus, shunt, collateral or other single large vessel, 5001.12.2023division or ligation of, without cardiopulmonary bypass, for congenital heart 5001.12.2023disease, other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038703 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305675.0002125.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Patent ductus arteriosus, shunt, collateral or other single large vessel, 5001.12.2023division or ligation of, with cardiopulmonary bypass, for congenital heart 5001.12.2023disease, other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038706 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305345.0002005.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Aorta, anastomosis or repair of, without cardiopulmonary bypass, for 5001.12.2023congenital heart disease, other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038709 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306325.0002364.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Anastomosis or repair of aorta, with cardiopulmonary bypass, for congenital 5001.12.2023heart disease, other than a service associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038715 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305010.0001878.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Main Pulmonary Artery, banding, debanding or repair of, without 5001.12.2023cardiopulmonary bypass, for congenital heart disease, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038718 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306365.0002375.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Banding, debanding or repair of main pulmonary artery, with cardiopulmonary 5001.12.2023bypass, for congenital heart disease, other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 5001.12.2023or 45503 applies(H) (Anaes.) (Assist.) 1038721 26.05.2002 3 T8 6 SN NYNYY 2001.12.202304395.0001646.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Vena Cava, anastomosis or repair of, without cardiopulmonary bypass, for 5001.12.2023congenital heart disease, other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038724 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306435.0002395.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Vena cava, anastomosis or repair of, with cardiopulmonary bypass, for 5001.12.2023congenital heart disease, other than a service associated with a service to 5001.12.2023which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 5001.12.2023applies (H) (Anaes.) (Assist.) 1038727 26.05.2002 3 T8 6 SN NYNYY 2001.12.202304400.0001646.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Anastomosis or repair of intrathoracic vessels, without cardiopulmonary 5001.12.2023bypass, performed as a primary procedure, other than a service to which item 5001.12.202311704, 11705, 11707, 11714, 18260, 33824,38700, 38703, 38706, 38709, 38715, 5001.12.202338718, 38721, 38724, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038730 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Anastomosis or repair of intrathoracic vessels, with cardiopulmonary bypass, 5001.12.2023performed as a primary procedure, other than a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824, 38700, 38703, 38706, 38709, 38715, 38718, 5001.12.202338721, 38724, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038733 26.05.2002 3 T8 6 SN NYNYY 2001.12.202304395.0001646.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Systemic pulmonary or Cavo-pulmonary shunt, creation of, without 5001.12.2023cardiopulmonary bypass, for congenital heart disease, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824, 38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038736 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Systemic pulmonary or Cavo-pulmonary shunt, creation of, with cardiopulmonary 5001.12.2023bypass, for congenital heart disease, other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 5001.12.202345503 applies (H) (Anaes.) (Assist.) 1038739 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305780.0002154.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Atrial septectomy, with or without cardiopulmonary bypass, for congenital 5001.12.2023heart disease, other than a service associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038742 26.05.2002 3 T8 6 SN NYNYY 2001.12.202305650.0002117.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Atrial septal defect, closure by open exposure and direct suture or patch, for 5001.12.2023congenital heart disease in a patient with documented evidence of right heart 5001.12.2023overload or paradoxical embolism, other than a service associated with a 5001.12.2023service to which item 11704, 11705, 11707, 11714, 18260, 33824,38816, 38828 or 5001.12.202345503 applies (H) (Anaes.) (Assist.) 1038745 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Intra-atrial baffle, insertion of, for congenital heart disease, other than a 5001.12.2023service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038748 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Ventricular septectomy, for congenital heart disease, other than a service 5001.12.2023associated with a service to which item 11704, 11705, 11707, 11714, 18260, 5001.12.202333824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038751 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Ventricular septal defect, closure by direct suture or patch, other than a 5001.12.2023service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828or 45503 applies (H) (Anaes.) (Assist.) 1038754 26.05.2002 3 T8 6 SN NYNYY 2001.12.202307850.0002941.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Intraventricular baffle or conduit, insertion of, for congenital heart 5001.12.2023disease, other than a service associated with a service to which item 11704, 5001.12.202311705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038757 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Extracardiac conduit, insertion of, for congenital heart disease, other than a 5001.12.2023service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038760 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Extracardiac conduit, replacement of, for congenital heart disease, other than 5001.12.2023a service associated with a service to which item 11704, 11705, 11707, 11714, 5001.12.202318260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038764 01.07.2021 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Ventricular myectomy, for relief of right or left ventricular obstruction, 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038766 26.05.2002 3 T8 6 SN NYNYY 2001.12.202306270.0002349.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Ventricular augmentation, right or left, for congenital heart disease, other 5001.12.2023than a service associated with a service to which item 11704, 11705, 11707, 5001.12.202311714, 18260, 33824,38816, 38828 or 45503 applies (H) (Anaes.) (Assist.) 1038800 01.11.2005 3 T8 6 SN NYNNY 2001.12.202300128.0000042.3500000.00 5001.12.2023THORACIC CAVITY, aspiration of, for diagnostic purposes, not being a service 5001.12.2023associated with a service to which item 38803 applies 1038803 01.11.2005 3 T8 6 SN NYNNY 2001.12.202300225.0000084.6500000.00 5001.12.2023THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with 5001.12.2023or without diagnostic sample 1038812 01.11.2005 3 T8 6 SN NYNNY 2001.12.202300665.0000230.2500000.00 4001.11.2005(Anaes.) 5001.12.2023PERCUTANEOUS NEEDLE BIOPSY of lung (Anaes.) 1038815 01.03.2023 3 T8 6 SN YYNYN 2001.12.202300755.0000274.8500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracoscopy, with or without division of pleural adhesions, with or without 5001.12.2023biopsy, including insertion of intercostal catheter where necessary, other 5001.12.2023than a service associated with a service to which item 18258, 18260, 38816 or 5001.12.202338828 applies (H) (Anaes.) (Assist.) 1038816 01.03.2023 3 T8 6 SNS YYNYN 2001.12.202302815.0001054.9500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy, exploratory, with or without biopsy, including insertion of an 5001.12.2023intercostal catheter where necessary, other than a service associated with a 5001.12.2023service to which item 18258, 18260, 38815 or 38828 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038817 01.03.2023 3 T8 6 SNS YYNYN 2001.12.202304465.0001658.3500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy, thoracoscopy or sternotomy, by any procedure: (a) including any 5001.12.2023division of adhesions if the time taken to divide the adhesions exceeds 30 5001.12.2023minutes; and (b) other than a service associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 18258, 18260, 33824, 38815, 38816, 38818, 38828 or 5001.12.202345503 applies (H) (Anaes.) (Assist.) 1038818 01.03.2023 3 T8 6 SNS YYNYN 2001.12.202302815.0001054.9500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy, thoracoscopy or median sternotomy for post operative bleeding, 5001.12.2023other than a service associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 18258, 18260, 33824, 38815, 38816, 38817, 38828 or 45503 applies 5001.12.2023(H) (Anaes.) (Assist.) 1038820 01.03.2023 3 T8 6 SNS YYNYN 2001.12.202303370.0001262.7500000.00 4001.03.2023(Anaes.) 5001.12.2023Lung, wedge resection of, other than a service associated with a service to 5001.12.2023which item 18258, 18260, 38815, 38816, 38820, 38821 or 38828 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038821 01.03.2023 3 T8 6 SN YYNYN 2001.12.202305055.0001894.1000000.00 4001.03.2023(Anaes.) 5001.12.2023Lung, wedge resection of, 2 or more wedges, other than a service associated 5001.12.2023with a service to which item 18258, 18260, 38815, 38816, 38820 or 38828 5001.12.2023applies (H) (Anaes.) (Assist.) 1038822 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304500.0001686.2500000.00 4001.03.2023(Anaes.) 5001.12.2023Pneumonectomy, lobectomy, bilobectomy or segmentectomy, other than a service 5001.12.2023associated with a service to which item 18258, 18260, 38815, 38816, 38823, 5001.12.202338824 or 38828 applies (H) (Anaes.) (Assist.) 1038823 01.03.2023 3 T8 6 SN YYNYN 2001.12.202305600.0002083.5000000.00 4001.03.2023(Anaes.) 5001.12.2023Radical lobectomy, pneumonectomy, bilobectomy, segmentectomy or formal 5001.12.2023mediastinal node dissection (greater than 4 nodes), other than a service 5001.12.2023associated with a service to which item 18258, 18260, 38815, 38816, 38822, 5001.12.202338824 or 38828 applies (H) (Anaes.) (Assist.) 1038824 01.03.2023 3 T8 6 SN YYNYN 2001.12.202307000.0002604.3500000.00 4001.03.2023(Anaes.) 5001.12.2023Segmentectomy, lobectomy, bilobectomy or pneumonectomy, including resection of 5001.12.2023chest wall, diaphragm, pericardium, and formal mediastinal node dissection 5001.12.2023(greater than 4 nodes), other than a service associated with a service to 5001.12.2023which item 18258, 18260, 38815, 38816, 38822, 38823 or 38828 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038828 01.03.2023 3 T8 6 SN YYNYN 2001.12.202300435.0000147.0500000.00 4001.03.2023(Anaes.) 5001.12.2023Intercostal drain, insertion of: (a) not involving resection of rib; and (b) 5001.12.2023excluding aftercare; and (c) other than a service associated with a service to 5001.12.2023which item 38815, 38816, 38829, 38830, 38831, 38832, 38833 or 38834 applies 5001.12.2023(Anaes.) 1038829 01.03.2023 3 T8 6 SN YYNYN 2001.12.202300500.0000181.1500000.00 4001.03.2023(Anaes.) 5001.12.2023Intercostal drain, insertion of, with pleurodesis: (a) not involving resection 5001.12.2023of rib; and (b) excluding aftercare; and (c) other than a service associated 5001.12.2023with a service to which item 38815, 38816, 38828, 38830, 38831, 38832, 38833 5001.12.2023or 38834 applies (Anaes.) 1038830 01.03.2023 3 T8 6 SN YYNYN 2001.12.202301265.0000439.6000000.00 4001.03.2023(Anaes.) 5001.12.2023Empyema, radical operation for, involving resection of rib, other than a 5001.12.2023service associated with a service to which item 38828, 38829, 38831, 38832, 5001.12.202338833 or 38834 applies (H) (Anaes.) (Assist.) 1038831 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304220.0001582.3500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracoscopy or thoracotomy and drainage of paraneumonic effusion and empyema, 5001.12.2023exploratory, with or without biopsy, other than a service associated with a 5001.12.2023service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 38832, 5001.12.202338833 or 38834 applies (H) (Anaes.) (Assist.) 1038832 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304500.0001686.2500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy or thoracoscopy, with pulmonary decortication, other than a 5001.12.2023service associated with a service to which item 18258, 18260, 38815, 38816, 5001.12.202338828, 38829, 38830, 38831, 38833 or 38834 applies (H) (Anaes.) (Assist.) 1038833 01.03.2023 3 T8 6 SN YYNYN 2001.12.202302815.0001054.9500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy or thoracoscopy, with pleurectomy or pleurodesis, other than a 5001.12.2023service associated with a service to which item 18258, 18260, 38815, 38816, 5001.12.202338828, 38829, 38830, 38831, 38832 or 38834 applies (H) (Anaes.) (Assist.) 1038834 01.03.2023 3 T8 6 SN YYNYN 2001.12.202310505.0003906.6500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy and radical extra pleural pneumonectomy or radical lung preserving 5001.12.2023decortication and pleurectomy for malignancy, other than a service associated 5001.12.2023with a service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 5001.12.202338831, 38832 or 38833 applies (H) (Anaes.) (Assist.) 1038837 01.03.2023 3 T8 6 SN YYNYN 2001.12.202301120.0000399.6000000.00 4001.03.2023(Anaes.) 5001.12.2023Mediastinum, cervical exploration of, with or without biopsy, other than a 5001.12.2023service associated with a service to which item 18258, 18260, 38815, 38816 or 5001.12.202338828 applies (H) (Anaes.) (Assist.) 1038838 01.03.2023 3 T8 6 SN YYNYN 2001.12.202303475.0001302.6500000.00 4001.03.2023(Anaes.) 5001.12.2023Thoracotomy or thoracoscopy or sternotomy, for removal of thymus or 5001.12.2023mediastinal tumour, other than a service associated with a service to which 5001.12.2023item 18258, 18260, 38815, 38816 or 38828 applies (H) (Anaes.) (Assist.) 1038839 01.03.2023 3 T8 6 SN YYNYN 2001.12.202301685.0000631.5000000.00 4001.03.2023(Anaes.) 5001.12.2023Pericardium, subxiphoid open surgical drainage of, other than a service 5001.12.2023associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 5001.12.202338840 applies (H) (Anaes.) (Assist.) 1038840 01.03.2023 3 T8 6 SN YYNYN 2001.12.202302685.0000942.9000000.00 4001.03.2023(Anaes.) 5001.12.2023Pericardium, transthoracic (thoracotomy or thoracoscopy) open surgical 5001.12.2023drainage of, other than a service associated with a service to which item 5001.12.202318258, 18260, 38815, 38816, 38828 or 38839 applies (H) (Anaes.) (Assist.) 1038841 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304660.0001686.2500000.00 4001.03.2023(Anaes.) 5001.12.2023Pericardiectomy via sternotomy or thoracoscopy or anterolateral thoracotomy 5001.12.2023without cardiopulmonary bypass, other than a service associated with a service 5001.12.2023to which item 18258, 18260, 38815, 38816 or 38828 applies (H) (Anaes.) 5001.12.2023(Assist.) 1038842 01.03.2023 3 T8 6 SN YYNYN 2001.12.202306515.0002359.0500000.00 4001.03.2023(Anaes.) 5001.12.2023Pericardiectomy via sternotomy or anterolateral thoracotomy with 5001.12.2023cardiopulmonary bypass, other than a service associated with a service to 5001.12.2023which item 18258, 18260, 38815, 38816 or 38828 applies (H) (Anaes.) (Assist.) 1038845 01.03.2023 3 T8 6 SN YYNYN 2001.12.202300835.0000303.1500000.00 4001.03.2023(Anaes.) 5001.12.2023Sternal wire or wires, removal of, other than a service associated with a 5001.12.2023service to which item 18258, 18260, 38815, 38816 or 38828 applies (H) (Anaes.) 1038846 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304355.0001574.3000000.00 4001.03.2023(Anaes.) 5001.12.2023Pectus excavatum or pectus carinatum, repair or radical correction of, other 5001.12.2023than a service associated with a service to which item 18258, 18260, 38815, 5001.12.202338816, 38828, 38847, 38848 or 38849 applies (H) (Anaes.) (Assist.) 1038847 01.03.2023 3 T8 6 SN YYNYN 2001.12.202302310.0000839.1000000.00 4001.03.2023(Anaes.) 5001.12.2023Pectus excavatum, repair of, with implantation of subcutaneous prosthesis, 5001.12.2023other than a service associated with a service to which item 18258, 18260, 5001.12.202338815, 38816, 38828, 38846, 38848 or 38849 applies (H) (Anaes.) (Assist.) 1038848 01.03.2023 3 T8 6 SN YYNYN 2001.12.202303480.0001259.4000000.00 4001.03.2023(Anaes.) 5001.12.2023Pectus excavatum, repair of, with insertion of a concave bar, by any method, 5001.12.2023other than a service associated with a service to which item 18258, 18260, 5001.12.202338815, 38816, 38828, 38846 or 38847 applies (H) (Anaes.) (Assist.) 1038849 01.03.2023 3 T8 6 SN YYNYN 2001.12.202301740.0000629.6500000.00 4001.03.2023(Anaes.) 5001.12.2023Pectus excavatum, removal of a concave bar, by any method, not being a service 5001.12.2023associated with a service to which item 18258, 18260, 38815, 38816, 38828, 5001.12.202338846 or 38847 applies (H) (Anaes.) (Assist.) 1038850 01.03.2023 3 T8 6 SN YYNYN 2001.12.202300990.0000359.3000000.00 4001.03.2023(Anaes.) 5001.12.2023Sternotomy wound, debridement of, not involving reopening of the mediastinum, 5001.12.2023other than a service associated with a service to which item 18258, 18260, 5001.12.202338815, 38816, 38828 or 38851 applies (H) (Anaes.) 1038851 01.03.2023 3 T8 6 SN YYNYN 2001.12.202301080.0000390.5500000.00 4001.03.2023(Anaes.) 5001.12.2023Sternotomy wound, debridement of, involving curettage of infected bone, with 5001.12.2023or without removal of wires, but not involving reopening of the mediastinum, 5001.12.2023other than a service associated with a service to which item 18258, 18260, 5001.12.202338815, 38816, 38828 or 38850 applies (H) (Anaes.) 1038852 01.03.2023 3 T8 6 SN YYNYN 2001.12.202302910.0001054.5000000.00 4001.03.2023(Anaes.) 5001.12.2023Sternum, reoperation on, for dehiscence or infection involving reopening of 5001.12.2023the mediastinum, with or without rewiring, other than a service associated 5001.12.2023with a service to which item 18258, 18260, 38815, 38816, 38828 or 38853 5001.12.2023applies (H) (Anaes.) (Assist.) 1038853 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304565.0001653.1500000.00 4001.03.2023(Anaes.) 5001.12.2023Sternum and mediastinum, reoperation for infection of, involving muscle 5001.12.2023advancement flaps and/or greater omentum, other than a service associated with 5001.12.2023a service to which item 18258, 18260, 38815, 38816, 38828 or 38852 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038857 01.03.2023 3 T8 6 SN YYNYN 2001.12.202305370.0001998.0000000.00 4001.03.2023(Anaes.) 5001.12.2023Chest wall resection, sternum and/or ribs without reconstruction, other than a 5001.12.2023service associated with a service to which item 18258, 18260, 38815, 38816, 5001.12.202338824, 38828 or 38858 applies (H) (Anaes.) (Assist.) 1038858 01.03.2023 3 T8 6 SN YYNYN 2001.12.202307000.0002604.3500000.00 4001.03.2023(Anaes.) 5001.12.2023Chest wall resection, sternum and / or ribs with reconstruction, other than a 5001.12.2023service associated with a service to which item 18258, 18260, 38815, 38816, 5001.12.202338824, 38828 or 38857 applies (H) (Anaes.) (Assist.) 1038859 01.03.2023 3 T8 6 SN YYNYN 2001.12.202302815.0001054.9500000.00 4001.03.2023(Anaes.) 5001.12.2023Plating of multiple ribs for flail segment, other than a service associated 5001.12.2023with a service to which item 18258, 18260, 33815, 38816 or 38828 applies (H) 5001.12.2023(Anaes.) (Assist.) 1038864 01.03.2023 3 T8 6 SN YYNYN 2001.12.202304660.0001686.2500000.00 4001.03.2023(Anaes.) 5001.12.2023Intrathoracic operations on heart, lungs, great vessels, bronchial tree, 5001.12.2023oesophagus or mediastinum, or on more than one of those organs, not being a 5001.12.2023service to which another item in this Group applies, other than a service 5001.12.2023associated with a service to which item 18258, 18260 or 38828 applies (H) 5001.12.2023(Anaes.) (Assist.) 1039000 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300228.0000082.8500000.00 4026.05.2002(Anaes.) 5001.12.2023LUMBAR PUNCTURE (Anaes.) 1039007 01.11.2020 3 T8 7 SN NYNNY 2001.12.202300575.0000175.4500000.00 4001.11.2020(Anaes.) 5001.12.2023Procedure to obtain access to intracranial space (including subdural space, 5001.12.2023ventricle or basal cistern), percutaneously or by burr-hole (Anaes.) 1039013 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300360.0000120.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Injection of one or more zygo-apophyseal or costo-transverse joints with one 5001.12.2023or more of contrast media, local anaesthetic or corticosteroid under image 5001.12.2023guidance (Anaes.) 1039014 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300379.0000137.4500000.00 4001.03.2022(Anaes.) 5001.12.2023Medial branch block of one or more primary posterior rami, injection of an 5001.12.2023anaesthetic agent under image guidance (Anaes.) 1039015 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301245.0000413.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial parenchymal pressure monitoring device, insertion ofincluding 5001.12.2023burr hole (excluding after care) (Anaes.) 1039018 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302895.0000909.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Cerebrospinal reservoir, ventricular reservoir or external ventricular drain, 5001.12.2023insertion of, with or without stereotaxy (Anaes.) (Assist.) 1039100 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300870.0000261.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Injection of primary branch of trigeminal nerve (ophthalmic, maxillary or 5001.12.2023mandibular branches) with alcohol, cortisone, phenol, or similar neurolytic 5001.12.2023substance, under image guidance (Anaes.) 1039109 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305195.0001560.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Trigeminal gangliotomy by radiofrequency, balloon or glycerol, including 5001.12.2023stereotaxy (Anaes.) (Assist.) 1039110 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300813.0000295.0000000.00 4001.03.2022(Anaes.) 5001.12.2023Left lumbar percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe, or cryoprobe, using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039111 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300813.0000295.0000000.00 4001.03.2022(Anaes.) 5001.12.2023Right lumbar percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe, or cryoprobe, using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039113 01.11.2020 3 T8 7 SN NYNNY 2001.12.202307655.0002617.5500000.00 4001.11.2020(Anaes.) 5001.12.2023Cranial nerve, neurectomy or intracranial decompression of, using 5001.12.2023microsurgical techniques, including stereotaxy and cranioplasty (Anaes.) 5001.12.2023(Assist.) 1039116 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300904.0000327.8500000.00 4001.03.2022(Anaes.) 5001.12.2023Left thoracic percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe or cryoprobe using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039117 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300904.0000327.8500000.00 4001.03.2022(Anaes.) 5001.12.2023Right thoracic percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe, or cryoprobe, using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039118 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301270.0000360.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Left cervical percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe, or cryoprobe, using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039119 01.03.2022 3 T8 7 SN NYNNY 2001.12.202300994.0000360.6000000.00 4001.03.2022(Anaes.) 5001.12.2023Right cervical percutaneous zygapophyseal joint denervation by radio-frequency 5001.12.2023probe, or cryoprobe, using radiological imaging control Applicable to one or 5001.12.2023more services provided in a single attendance, for not more than 3 attendances 5001.12.2023in a 12 month period (Anaes.) 1039121 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302605.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS CORDOTOMY (Anaes.) (Assist.) 1039124 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305345.0001779.6000000.00 4026.05.2002(Anaes.) 5001.12.2023CORDOTOMY OR MYELOTOMY, partial or total laminectomy for, or operation for 5001.12.2023dorsal root entry zone (Drez) lesion (Anaes.) (Assist.) 1039125 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301085.0000328.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Spinal catheter, insertion or replacement of, and connection to a subcutaneous 5001.12.2023implanted infusion pump, for the management of chronic pain, including cancer 5001.12.2023pain (H) (Anaes.) (Assist.) 1039126 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301315.0000398.3000000.00 4026.05.2002(Anaes.) 5001.12.2023All of the following:(a) infusion pump, subcutaneous implantation or 5001.12.2023replacement of;(b) connection of the pump to a spinal catheter;(c) filling of 5001.12.2023reservoir with a therapeutic agent or agents;with or without programming the 5001.12.2023pump, for the management of chronic pain, including cancer pain (H) (Anaes.) 5001.12.2023(Assist.) 1039127 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302170.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Subcutaneous reservoir and spinal catheter, insertion of, for the management 5001.12.2023of chronic pain, including cancer pain (H) (Anaes.) 1039128 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302400.0000726.3500000.00 4026.05.2002(Anaes.) 5001.12.2023All of the following:(a) infusion pump, subcutaneous implantation of;(b) 5001.12.2023spinal catheter, insertion of;(c) connection of pump to catheter;(d) filling 5001.12.2023of reservoir with a therapeutic agent or agents;with or without programming 5001.12.2023the pump, for the management of chronic pain, including cancer pain (H) 5001.12.2023(Anaes.) (Assist.) 1039129 01.03.2022 3 T8 7 SN NYNNY 2001.12.202301841.0000667.8000000.00 4001.03.2022(Anaes.) 5001.12.2023Peripheral lead or leads, percutaneous placement of, including intraoperative 5001.12.2023test stimulation, for the management of chronic neuropathic pain (H) (Anaes.) 5001.12.2023(Assist.) 1039130 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302220.0000742.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Epidural lead or leads, percutaneous placement of, including intraoperative 5001.12.2023test stimulation, for the management of chronic neuropathic pain or pain from 5001.12.2023refractory angina pectoris (H) (Anaes.) (Assist.) 1039131 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300465.0000140.7000000.00 5001.12.2023Epidural or peripheral nerve electrodes (management, adjustment, or 5001.12.2023reprogramming of neurostimulator), with a medical practitioner attending, for 5001.12.2023the management of chronic neuropathic pain or pain from refractory angina 5001.12.2023pectoriseach day 1039133 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300575.0000175.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Either:(a) subcutaneously implanted infusion pump, removal of; or(b) spinal 5001.12.2023catheter, removal or repositioning of;for the management of chronic pain, 5001.12.2023including cancer pain (H) (Anaes.) 1039134 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301240.0000374.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Neurostimulator or receiver, subcutaneous placement of, including placement 5001.12.2023and connection of extension wires to epidural or peripheral nerve electrodes, 5001.12.2023for the management of chronic neuropathic pain or pain from refractory angina 5001.12.2023pectoris (H) (Anaes.) (Assist.) 1039135 01.11.2004 3 T8 7 SN NYNNY 2001.12.202300575.0000175.4500000.00 4001.11.2004(Anaes.) 5001.12.2023Neurostimulator or receiver that was inserted for the management of chronic 5001.12.2023neuropathic pain or pain from refractory angina pectoris, open surgical 5001.12.2023removal of, performed in the operating theatre of a hospital (H) (Anaes.) 5001.12.2023(Assist.) 1039136 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300580.0000175.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Epidural or peripheral nerve lead that was implanted for the management of 5001.12.2023chronic neuropathic pain or pain from refractory angina pectoris, open 5001.12.2023surgical removal of, performed in the operating theatre of a hospital (H) 5001.12.2023(Anaes.) (Assist.) 1039137 01.11.2004 3 T8 7 SN NYNNY 2001.12.202302205.0000666.3500000.00 4001.11.2004(Anaes.) 5001.12.2023Epidural or peripheral nerve lead that was implanted for the management of 5001.12.2023chronic neuropathic pain or pain from refractory angina pectoris, open 5001.12.2023surgical repositioning of, to correct displacement or unsatisfactory 5001.12.2023positioning, including intraoperative test stimulation, other than a service 5001.12.2023to which item 39130, 39138 or 39139 applies (H) (Anaes.) (Assist.) 1039138 01.11.2004 3 T8 7 SN NYNNY 2001.12.202302220.0000742.0000000.00 4001.11.2004(Anaes.) 5001.12.2023Peripheral nerve lead or leads, surgical placement of, including 5001.12.2023intraoperative test stimulation, for the management of chronic neuropathic 5001.12.2023pain where the leads are intended to remain in situ long term (H) (Anaes.) 5001.12.2023(Assist.) 1039139 26.05.2002 3 T8 7 SN NYNNY 2001.12.202303925.0000996.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Epidural lead, surgical placement of one or more of by partial or total 5001.12.2023laminectomy, including intraoperative test stimulation, for the management of 5001.12.2023chronic neuropathic pain or pain from refractory angina pectoris (H) (Anaes.) 5001.12.2023(Assist.) 1039140 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301080.0000322.3500000.00 4026.05.2002(Anaes.) 5001.12.2023EPIDURAL CATHETER, insertion of, under imaging control, with epidurogram and 5001.12.2023epidural therapeutic injection for lysis of adhesions (Anaes.) 1039141 01.11.2022 3 T8 7 SN NYNNY 2001.12.202300388.0000140.7000000.00 5001.12.2023Epidural or peripheral nerve electrodes (management, adjustment, or 5001.12.2023reprogramming of neurostimulator), with a medical practitioner attending 5001.12.2023remotely by video conference, for the management of chronic neuropathic pain 5001.12.2023or pain from refractory angina pectoriseach day 1039300 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301150.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve, digital or cutaneous, primary repair of, using microsurgical 5001.12.2023techniques, other than a service associated with a service to which item 39330 5001.12.2023appliesapplicable once per nerve (H) (Anaes.) (Assist.) 1039303 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301585.0000513.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve, digital or cutaneous, delayed repair of, using microsurgical 5001.12.2023techniques, including either or both of the following (if performed): (a) 5001.12.2023neurolysis; (b) transposition of nerve to facilitate repair; other than a 5001.12.2023service associated with a service to which item 30023 appliesapplicable once 5001.12.2023per nerve (H) (Anaes.) (Assist.) 1039306 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302455.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve trunk, primary repair of, using microsurgical techniques, other than a 5001.12.2023service associated with a service to which item 39330 applies (H) (Anaes.) 5001.12.2023(Assist.) 1039307 01.07.2021 3 T8 7 SN NYNNY 2001.12.202303005.0000907.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Reconstruction of nerve trunk using biological or synthetic nerve conduit, 5001.12.2023using microsurgical techniques, other than a service associated with a service 5001.12.2023to which item 39330 applies (Anaes.) (Assist.) 1039309 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302605.0000786.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve trunk, delayed repair of, using microsurgical techniques, including 5001.12.2023either or both of the following (if performed): (a) neurolysis; (b) 5001.12.2023transposition of nerve or nerve transfer to facilitate repair; other than a 5001.12.2023service associated with a service to which item 30023 or 39321 applies (H) 5001.12.2023(Anaes.) (Assist.) 1039312 26.05.2002 3 T8 7 SN NYNYY 2001.12.202301435.0000438.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve trunk, internal (interfascicular), neurolysis of, using microsurgical 5001.12.2023techniques, other than a service associated with a service to which item 30023 5001.12.2023applies (H) (Anaes.) (Assist.) 1039315 26.05.2002 3 T8 7 SN NYNNY 2001.12.202303755.0001133.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve trunk, nerve graft to, by cable graft, using microsurgical techniques, 5001.12.2023including any of the following (if performed): (a) harvesting of nerve graft; 5001.12.2023(b) proximal and distal anastomosis of nerve graft; (c) transposition of nerve 5001.12.2023to facilitate grafting; (d) neurolysis; other than a service associated with a 5001.12.2023service to which item 30023 or 39330 applies (H) (Anaes.) (Assist.) 1039318 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302305.0000703.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Nerve, digital or cutaneous, nerve graft to, using microsurgical techniques, 5001.12.2023including either or both of the following (if performed): (a) harvesting of 5001.12.2023nerve graft from separate donor site; (b) proximal and distal anastomosis of 5001.12.2023nerve graft; other than a service associated with a service to which item 5001.12.202339330 applies (H) (Anaes.) (Assist.) 1039319 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301585.0000513.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Reconstruction of digital or cutaneous nerve using biological or synthetic 5001.12.2023nerve conduit, using microsurgical techniques, other than a service associated 5001.12.2023with a service to which item 39330 applies (Anaes.) (Assist.) 1039321 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301735.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Transposition of nerve, excluding the ulnar nerve at the elbow, other than a 5001.12.2023service associated with a service to which item 39330 applies (H) (Anaes.) 5001.12.2023(Assist.) 1039323 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300990.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Percutaneous denervation (excluding medial branch nerve) by cryotherapy or 5001.12.2023radiofrequency probe, other than a service to which another item applies, 5001.12.2023applicable not more than 6 times for a given nerve in a 12 month period 5001.12.2023(Anaes.) 1039324 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301020.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Neurectomy or removal of tumour or neuroma from superficial peripheral nerve 5001.12.2023(Anaes.) (Assist.) 1039327 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301735.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral or cranial 5001.12.2023nerve, by open operation, not being a service to which item 41575, 41576, 5001.12.202341578 or 41579 applies (Anaes.) (Assist.) 1039328 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301735.0000521.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Neurectomy, neurotomy or removal of tumour from deep peripheral nerve, by open 5001.12.2023operation, for upper limb surgery (H) (Anaes.) (Assist.) 1039329 01.07.2021 3 T8 7 SN NYNYY 2001.12.202301300.0000389.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Extensive neurolysis of radial, median or ulnar nerve trunk nerve in the 5001.12.2023forearm or arm, other than a service associated with a service to which item 5001.12.202330023, 39303, 39309, 39312, 39315, 39318, 39324 or 39327 applies (Anaes.) 5001.12.2023(Assist.) 1039330 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301020.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Neurolysis by open operation without transposition, other than a service 5001.12.2023associated with a service to which item 30023, 39321, 39328, 39329, 39332, 5001.12.202339336, 39339, 39342, 39345, 49774 or 49775 applies (H) (Anaes.) (Assist.) 1039331 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301530.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Carpal tunnel release, including division of transverse carpal ligament or 5001.12.2023release of median nerve, by any method, including either or both of the 5001.12.2023following (if performed): (a) synovectomy; (b) neurolysis Other than a service 5001.12.2023associated with a service to which item 30023 or 46339 applies (Anaes.) 5001.12.2023(Assist.) 1039332 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301530.0000457.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of carpal tunnel release, including division of transverse carpal 5001.12.2023ligament or release of median nerve, by any method, including either or both 5001.12.2023of the following (if performed): (a) synovectomy; (b) neurolysis; other than a 5001.12.2023service associated with a service to which item 30023 or 46339 applies. 5001.12.2023(Anaes.) (Assist.) 1039336 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301020.0000304.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Ulnar nerve decompression at elbow or wrist (cubital tunnel or Guyon's canal) 5001.12.2023without transposition, by any method, including neurolysis (if performed), 5001.12.2023other than a service associated with a service to which item 30023 applies 5001.12.2023(Anaes.) (Assist.) 1039339 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301530.0000457.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of ulnar nerve decompression at elbow (cubital tunnel) without 5001.12.2023transposition, by any method, including neurolysis (if performed), other than 5001.12.2023a service associated with a service to which item 30023 applies (Anaes.) 5001.12.2023(Assist.) 1039342 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301995.0000599.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Ulnar nerve decompression at elbow (cubital tunnel), including any of the 5001.12.2023following (if performed): (a) associated transposition; (b) subcutaneous or 5001.12.2023submuscular transposition of the nerve; (c) medial epicondylectomy; (d) 5001.12.2023ostetomy and reconstruction of the flexor origin; (e) neurolysis; other than a 5001.12.2023service associated with a service to which item 30023 applies (Anaes.) 5001.12.2023(Assist.) 1039345 01.07.2021 3 T8 7 SN NYNNY 2001.12.202301020.0000304.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Localised decompression of radial, median or ulnar nerve, or branches of, in 5001.12.2023the forearm for compressive neuropathy, including neurolysis (if performed), 5001.12.2023other than a service associated with a service to which item 30023 applies 5001.12.2023(Anaes.) (Assist.) 1039503 26.05.2002 3 T8 7 SN NYNNY 2001.12.202303475.0001051.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Facio-hypoglossal nerve or facio-accessory nerve, anastomosis of (Anaes.) 5001.12.2023(Assist.) 1039604 01.11.2020 3 T8 7 SN NYNNY 2001.12.202306485.0001974.1500000.00 4001.11.2020(Anaes.) 5001.12.2023Any of the following procedures for intracranial haemorrhage or swelling:(a) 5001.12.2023craniotomy, craniectomy or burr-holes for removal of intracranial haemorrhage, 5001.12.2023including stereotaxy;(b) craniotomy or craniectomy for brain swelling, stroke, 5001.12.2023or raised intracranial pressure, including for subtemporal decompression, 5001.12.2023including stereotaxy; or(c) post-operative re-opening, including for swelling 5001.12.2023or post-operative cerebrospinal fluid leak. (Anaes.) (Assist.) 1039610 01.11.2020 3 T8 7 SN NYNNY 2001.12.202303755.0001051.2000000.00 4001.11.2020(Anaes.) 5001.12.2023Fractured skull, without brain laceration or dural penetration, repair of 5001.12.2023(Anaes.) (Assist.) 1039612 26.05.2002 3 T8 7 SN NYNNY 2001.12.202304325.0001233.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Fractured skull, with brain laceration or dural penetration but without 5001.12.2023cerebrospinal fluid, rhinorrhoea or otorrhoea, repair of (Anaes.) (Assist.) 1039615 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306935.0002104.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Fractured skull, after trauma, with cerebrospinal fluid rhinorrhoea or 5001.12.2023otorrhoea, repair of, including stereotaxy and dermofat graft (Anaes.) 5001.12.2023(Assist.) 1039638 01.11.2020 3 T8 7 SN NYNNY 2001.12.202315480.0004685.8000000.00 4001.11.2020(Anaes.) 5001.12.2023Anterior or middle cranial fossa or cavernous sinus, tumour or vascular 5001.12.2023lesion, removal or radical excision of, including stereotaxy and 5001.12.2023cranioplastyconjoint surgery, principal surgeon (Anaes.) (Assist.) 1039639 01.11.2020 3 T8 7 SN NYNNY 2001.12.202312365.0003744.5000000.00 5001.12.2023Anterior or middle cranial fossa or cavernous sinus, tumour or vascular 5001.12.2023lesion, removal or radical excision of, including stereotaxy and 5001.12.2023cranioplastyconjoint surgery, cosurgeon (Assist.) 1039641 01.11.2020 3 T8 7 SN NYNNY 2001.12.202316325.0004942.4000000.00 4001.11.2020(Anaes.) 5001.12.2023Anterior or middle cranial fossa or cavernous sinus, tumour or vascular 5001.12.2023lesion, removal or radical excision of, including stereotaxy and cranioplasty 5001.12.2023- one surgeon (Anaes.) (Assist.) 1039651 01.11.2020 3 T8 7 SN NYNNY 2001.12.202318810.0006097.7000000.00 4001.11.2020(Anaes.) 5001.12.2023Petro-clival, clival or foramen magnum tumour or vascular lesion, removal or 5001.12.2023radical excision of, including stereotaxy and cranioplasty - one surgeon 5001.12.2023(Anaes.) (Assist.) 1039654 26.05.2002 3 T8 7 SN NYNNY 2001.12.202315480.0004685.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Petro-clival, clival or foramen magnum tumour or vascular lesion, removal or 5001.12.2023radical excision of, including stereotaxy and cranioplastyconjoint surgery, 5001.12.2023principal surgeon (Anaes.) (Assist.) 1039656 26.05.2002 3 T8 7 SN NYNNY 2001.12.202312365.0003744.5000000.00 5001.12.2023Petro clival, clival or foramen magnum tumour or vascular lesion, removal or 5001.12.2023radical excision of, including stereotaxy and cranioplastyconjoint surgery, co 5001.12.2023surgeon (Assist.) 1039700 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306635.0001994.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Skull tumour, benign or malignant, excision of, including stereotaxy and 5001.12.2023cranioplasty (Anaes.) (Assist.) 1039703 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305265.0001601.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial tumour, cyst or other brain tissue, either or both of: (a) burr 5001.12.2023hole and biopsy of; (b) drainage of; including stereotaxy (Anaes.) (Assist.) 1039710 01.11.2020 3 T8 7 SN NYNNY 2001.12.202308810.0002667.4500000.00 4001.11.2020(Anaes.) 5001.12.2023Intracranial tumour, one or more, biopsy, drainage, decompression or removal 5001.12.2023of, through a single craniotomy, including stereotaxy and cranioplasty 5001.12.2023(Anaes.) (Assist.) 1039712 26.05.2002 3 T8 7 SN NYNNY 2001.12.202310245.0004074.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Transcranial tumour removal or biopsy of one or more of any of the following: 5001.12.2023(a) meningioma; (b) pinealoma; (c) cranio pharyngioma; (d) pituitary tumour; 5001.12.2023(e) intraventricular lesion; (f) brain stem lesion; (g) any other intracranial 5001.12.2023tumour; by any means (with or without endoscopy), through a single craniotomy, 5001.12.2023including stereotaxy and cranioplasty (Anaes.) (Assist.) 1039715 26.05.2002 3 T8 7 SN NYNNY 2001.12.202309825.0002973.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Pituitary tumour, removal of, by transphenoidal approach, including stereotaxy 5001.12.2023and dermis, dermofat or fascia grafting, other than a service associated with 5001.12.2023a service to which item 40600 applies (Anaes.) (Assist.) 1039718 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305910.0001796.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Arachnoidal cyst, craniotomy for, including stereotaxy and neuroendoscopy 5001.12.2023(Anaes.) (Assist.) 1039720 01.11.2020 3 T8 7 SN NYNNY 2001.12.202309375.0003811.6000000.00 4001.11.2020(Anaes.) 5001.12.2023Awake craniotomy for functional neurosurgery (Anaes.) (Assist.) 1039801 01.11.2020 3 T8 7 SN NYNNY 2001.12.202318810.0006097.7000000.00 4001.11.2020(Anaes.) 5001.12.2023Aneurysm, clipping, proximal ligation, or reinforcement of sac, including 5001.12.2023stereotaxy and cranioplasty (Anaes.) (Assist.) 1039803 26.05.2002 3 T8 7 SN NYNNY 2001.12.202318810.0006097.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial arteriovenous malformation or fistula, treatment through a 5001.12.2023craniotomy, including stereotaxy, cranioplasty and all angiography (Anaes.) 5001.12.2023(Assist.) 1039815 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306645.0002011.2500000.00 4026.05.2002(Anaes.) 5001.12.2023CAROTID-CAVERNOUS FISTULA, obliteration of - combined cervical and 5001.12.2023intracranial procedure (Anaes.) (Assist.) 1039818 26.05.2002 3 T8 7 SN NYNNY 2001.12.202308810.0002669.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial vascular bypass using indirect techniques, including stereotaxy 5001.12.2023(Anaes.) (Assist.) 1039821 26.05.2002 3 T8 7 SN NYNNY 2001.12.202309960.0003803.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial vascular bypass using direct anastomosis techniques, including 5001.12.2023stereotaxy (Anaes.) (Assist.) 1039900 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305260.0001601.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial infection, treated by burr hole, including stereotaxy, other than 5001.12.2023a service associated with a service to which item 40600 applies (Anaes.) 5001.12.2023(Assist.) 1039903 26.05.2002 3 T8 7 SN NYNNY 2001.12.202307940.0002404.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial infection, treated by craniotomy, including stereotaxy, other 5001.12.2023than a service associated with a service to which item 40600 applies (Anaes.) 5001.12.2023(Assist.) 1039906 26.05.2002 3 T8 7 SN NYNNY 2001.12.202302885.0000877.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteomyelitis of skull or removal of infected bone flap, craniectomy for, 5001.12.2023other than a service associated with a service to which item 40600 applies 5001.12.2023(Anaes.) (Assist.) 1040004 01.11.2020 3 T8 7 SN NYNNY 2001.12.202305770.0001821.0500000.00 4001.11.2020(Anaes.) 5001.12.2023Ventricular, lumbar or cisternal shunt diversion, insertion or revision of, 5001.12.2023including stereotaxy (Anaes.) (Assist.) 1040012 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306205.0001883.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Endoscopic ventriculostomy for treatment of cerebrospinal fluid circulation 5001.12.2023disorders, including stereotaxy (Anaes.) (Assist.) 1040018 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300575.0000175.4500000.00 4026.05.2002(Anaes.) 5001.12.2023LUMBAR CEREBROSPINAL FLUID DRAIN, insertion of (Anaes.) 1040104 01.11.2020 3 T8 7 SN NYNYY 2001.12.202303120.0001117.4500000.00 4001.11.2020(Anaes.) 5001.12.2023Spinal myelomeningocele or spinal meningocele, excision and closure of, other 5001.12.2023than a service associated with a service to which item 40600 applies (Anaes.) 5001.12.2023(Assist.) 1040106 26.05.2002 3 T8 7 SN NYNNY 2001.12.202307875.0002652.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Chiari malformation, decompression or reconstruction of, including 5001.12.2023laminectomy, dermofat graft and stereotaxy, other than a service associated 5001.12.2023with a service to which item 40600 applies (Anaes.) (Assist.) 1040109 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306790.0002059.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Encephalocoele or cranial meningocele, excision and closure of, including 5001.12.2023stereotaxy and dermofat graft (Anaes.) (Assist.) 1040112 26.05.2002 3 T8 7 SN NYNNY 2001.12.202308075.0002630.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Tethered cord, release of, including lipomeningocele or diastematomyelia, 5001.12.2023multiple levels, including laminectomy and rhizolysis, other than a service 5001.12.2023associated with a service to which item 40600 applies (Anaes.) (Assist.) 1040119 01.11.2020 3 T8 7 SN NYNYY 2001.12.202303475.0001051.2000000.00 4001.11.2020(Anaes.) 5001.12.2023Craniostenosis, operation for, other than a service associated with a service 5001.12.2023to which item 40600 applies (Anaes.) (Assist.) 1040600 26.05.2002 3 T8 7 SN NYNYY 2001.12.202303475.0001051.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Cranioplasty, reconstructive, other than a service associated with a service 5001.12.2023to which item 39113, 39638, 39639, 39641, 39651, 39654, 39656, 39700, 39710, 5001.12.202339712, 39715, 39801, 39803, 40703 or 41887 applies(H) (Anaes.) (Assist.) 1040700 26.05.2002 3 T8 7 SN NYNNY 2001.12.202308525.0002578.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Corpus callosotomy, for epilepsy, including stereotaxy (Anaes.) (Assist.) 1040701 01.11.2017 3 T8 7 SN NYNNY 2001.12.202301440.0000374.8500000.00 4001.11.2017(Anaes.) 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023subcutaneous placement of electrical pulse generator, for: (a) management of 5001.12.2023refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy 5001.12.2023not suitable for resective epilepsy surgery (Anaes.) (Assist.) 1040702 01.11.2017 3 T8 7 SN NYNNY 2001.12.202300675.0000175.4500000.00 4001.11.2017(Anaes.) 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023surgical repositioning or removal of electrical pulse generator inserted for: 5001.12.2023(a) management of refractory generalised epilepsy; or (b) treatment of 5001.12.2023refractory focal epilepsy not suitable for resective epilepsy surgery (Anaes.) 5001.12.2023(Assist.) 1040703 26.05.2002 3 T8 7 SN NYNNY 2001.12.202308810.0002667.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Corticectomy, topectomy or partial lobectomy, for epilepsy, including 5001.12.2023stereotaxy and cranioplasty (Anaes.) (Assist.) 1040704 01.11.2017 3 T8 7 SN NYNNY 2001.12.202302850.0000742.0000000.00 4001.11.2017(Anaes.) 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023surgical placement of lead, including connection of lead to left vagus nerve 5001.12.2023and intra-operative test stimulation, for: (a) management of refractory 5001.12.2023generalised epilepsy; or (b) treatment of refractory focal epilepsy not 5001.12.2023suitable for resective epilepsy surgery (Anaes.) (Assist.) 1040705 01.11.2017 3 T8 7 SN NYNNY 2001.12.202302560.0000666.3500000.00 4001.11.2017(Anaes.) 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023surgical repositioning or removal of lead attached to left vagus nerve for: 5001.12.2023(a) management of refractory generalised epilepsy; or (b) treatment of 5001.12.2023refractory focal epilepsy not suitable for resective epilepsy surgery (Anaes.) 5001.12.2023(Assist.) 1040706 26.05.2002 3 T8 7 SN NYNNY 2001.12.202309375.0003811.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Hemispherectomy or functional hemispherectomy, for intractable epilepsy, 5001.12.2023including stereotaxy (Anaes.) (Assist.) 1040707 01.11.2017 3 T8 7 SN NYNNY 2001.12.202300800.0000208.8000000.00 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023electrical analysis and programming of vagus nerve stimulation therapy device 5001.12.2023using external wand, for: (a) management of refractory generalised epilepsy; 5001.12.2023or (b) treatment of refractory focal epilepsy not suitable for resective 5001.12.2023epilepsy surgery 1040708 01.11.2017 3 T8 7 SN NYNNY 2001.12.202301440.0000374.8500000.00 4001.11.2017(Anaes.) 5001.12.2023Vagus nerve stimulation therapy through stimulation of the left vagus nerve, 5001.12.2023surgical replacement of battery in electrical pulse generator inserted for: 5001.12.2023(a) management of refractory generalised epilepsy; or (b) treating refractory 5001.12.2023focal epilepsy not suitable for resective epilepsy surgery (Anaes.) (Assist.) 1040709 26.05.2002 3 T8 7 SN NYNNY 2001.12.202305260.0001601.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial electrode placement by burr hole, including stereotaxy (Anaes.) 5001.12.2023(Assist.) 1040712 26.05.2002 3 T8 7 SN NYNNY 2001.12.202309375.0003811.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial electrode placement by craniotomy, single or multiple, including 5001.12.2023stereotactic EEG, including stereotaxy (Anaes.) (Assist.) 1040801 26.05.2002 3 T8 7 SN NYNNY 2001.12.202306340.0001921.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Functional stereotactic procedure including computer assisted anatomical 5001.12.2023localisation, physiological localisation, and lesion production, by any 5001.12.2023method, in the basal ganglia, brain stem or deep white matter tracts, other 5001.12.2023than a service associated with deep brain stimulation for Parkinsons disease, 5001.12.2023essential tremor or dystonia (Anaes.) (Assist.) 1040803 26.05.2002 3 T8 7 SN NYNYY 2001.12.202304325.0001316.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Intracranial stereotactic procedure by any method, other than: (a) a service 5001.12.2023to which item 40801 applies; or (b) a service associated with a service to 5001.12.2023which item 39018, 39109, 39113, 39604, 39615, 39638, 39639, 39641, 39651, 5001.12.202339654, 39656, 39700, 39703, 39710, 39712, 39715, 39718, 39720, 39801, 39803, 5001.12.202339818, 39821, 39900, 39903, 40004, 40012, 40106, 40109, 40700, 40703, 40706, 5001.12.202340709 or 40712 applies (Anaes.) (Assist.) 1040850 26.05.2002 3 T8 7 SN NYNNY 2001.12.202308185.0002492.5000000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) functional stereotactic procedure 5001.12.2023including computer assisted anatomical localisation, physiological 5001.12.2023localisation including twist drill, burr hole craniotomy or craniectomy and 5001.12.2023insertion of electrodes for the treatment of: Parkinson's disease where the 5001.12.2023patient's response to medical therapy is not sustained and is accompanied by 5001.12.2023unacceptable motor fluctuations; or Essential tremor or dystonia where the 5001.12.2023patient's symptoms cause severe disability (Anaes.) (Assist.) 1040851 05.05.2003 3 T8 7 SN NYNNY 2001.12.202314325.0004362.1500000.00 4005.05.2003(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (bilateral) functional stereotactic procedure including 5001.12.2023computer assisted anatomical localisation, physiological localisation 5001.12.2023including twist drill, burr hole craniotomy or craniectomy and insertion of 5001.12.2023electrodes for the treatment of: Parkinson's disease where the patient's 5001.12.2023response to medical therapy is not sustained and is accompanied by 5001.12.2023unacceptable motor fluctuations; or Essential tremor or dystonia where the 5001.12.2023patient's symptoms cause severe disability. (Anaes.) (Assist.) 1040852 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301230.0000374.8500000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) subcutaneous placement of neurostimulator 5001.12.2023receiver or pulse generator for the treatment of: Parkinson's disease where 5001.12.2023the patient's response to medical therapy is not sustained and is accompanied 5001.12.2023by unacceptable motor fluctuations; or Essential tremor or dystonia where the 5001.12.2023patient's symptoms cause severe disability. (Anaes.) (Assist.) 1040854 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301905.0000579.4000000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) revision or removal of brain electrode for 5001.12.2023the treatment of: Parkinson's disease where the patient's response to medical 5001.12.2023therapy is not sustained and is accompanied by unacceptable motor 5001.12.2023fluctuations; or Essential tremor or dystonia where the patient's symptoms 5001.12.2023cause severe disability. (Anaes.) 1040856 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300925.0000281.1500000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) removal or replacement of neurostimulator 5001.12.2023receiver or pulse generator for the treatment of: Parkinson's disease where 5001.12.2023the patient's response to medical therapy is not sustained and is accompanied 5001.12.2023by unacceptable motor fluctuations; or Essential tremor or dystonia where the 5001.12.2023patient's symptoms cause severe disability. (Anaes.) 1040858 26.05.2002 3 T8 7 SN NYNNY 2001.12.202301905.0000579.4000000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) placement, removal or replacement of 5001.12.2023extension leadfor the treatment of: Parkinson's disease where the patient's 5001.12.2023response to medical therapy is not sustained and is accompanied by 5001.12.2023unacceptable motor fluctuations; or Essential tremor or dystonia where the 5001.12.2023patient's symptoms cause severe disability. (Anaes.) 1040860 26.05.2002 3 T8 7 SN NYNNY 2001.12.202307310.0002226.4000000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) target localisation incorporating 5001.12.2023anatomical and physiological techniques, including intra-operative clinical 5001.12.2023evaluation, for the insertion of a single neurostimulation wire for the 5001.12.2023treatment of: Parkinson's disease where the patient's response to medical 5001.12.2023therapy is not sustained and is accompanied by unacceptable motor 5001.12.2023fluctuations; or Essential tremor or dystonia where the patient's symptoms 5001.12.2023cause severe disability. (Anaes.) 1040862 26.05.2002 3 T8 7 SN NYNNY 2001.12.202300685.0000208.8000000.00 4026.05.2002(Anaes.) 5001.12.2023DEEP BRAIN STIMULATION (unilateral) electronic analysis and programming of 5001.12.2023neurostimulator pulse generator for the treatment of: Parkinson's disease 5001.12.2023where the patient's response to medical therapy is not sustained and is 5001.12.2023accompanied by unacceptable motor fluctuations; or Essential tremor or 5001.12.2023dystonia where the patient's symptoms cause severe disability. (Anaes.) 1040863 01.11.2022 3 T8 7 SN NYNNY 2001.12.202300576.0000208.8000000.00 5001.12.2023Deep brain stimulation (unilateral), remote electronic analysis and 5001.12.2023programming of neurostimulator pulse generator for the treatment of: (a) 5001.12.2023Parkinsons disease, if the patients response to medical therapy is not 5001.12.2023sustained and is accompanied by unacceptable motor fluctuations; or (b) 5001.12.2023essential tremor or dystonia, if the patients symptoms cause severe disability 5001.12.2023Applicable not more than 8 times in any 12 month period 1040905 01.05.2004 3 T8 7 SN NYNNY 2001.12.202302165.0000662.3000000.00 4001.05.2004(Anaes.) 5001.12.2023Craniotomy, performed by a neurosurgeon in conjunction with the correction of 5001.12.2023craniofacial abnormalities (Anaes.) (Assist.) 1041500 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300225.0000090.7500000.00 4026.05.2002(Anaes.) 5001.12.2023EAR, foreign body (other than ventilating tube) in, removal of, other than by 5001.12.2023simple syringing (Anaes.) 1041501 01.11.2019 3 T8 8 SN NYNNY 2001.12.202300545.0000204.2500000.00 5001.12.2023Examination of glottal cycles and vibratory characteristics of the vocal folds 5001.12.2023by a specialist in the practice of the specialists specialty of otolaryngology 5001.12.2023using videostroboscopy, including capturing audio, video, frequency and 5001.12.2023intensity, for confirmation of diagnosis , or for confirmation of treatment 5001.12.2023effectiveness where there is failure to progress or respond as expected, for: 5001.12.2023dysphonia where non stroboscopic techniques of the visualising the larynx have 5001.12.2023failed to identify any frank abnormality of the vocal folds; or benign or 5001.12.2023malignant vocal fold lesions; or premalignant or malignant laryngeal lesions; 5001.12.2023or vocal fold motion impairment or glottal insufficiency; or evaluation of 5001.12.2023vocal fold function after treatment or phonosurgery other than a service 5001.12.2023associated with a service to which item 41764 applies or with a services 5001.12.2023associated with the administration of a general anaesthetic 1041503 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300690.0000262.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Ear, foreign body in (other than ventilating tube), removal of, involving 5001.12.2023incision of external auditory canal, other than a service associated with a 5001.12.2023service to which another item in this Subgroup applies (Anaes.) 1041506 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300455.0000158.5500000.00 4026.05.2002(Anaes.) 5001.12.2023AURAL POLYP, removal of (Anaes.) 1041509 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300470.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023External auditory meatus, surgical removal of keratosis obturans from, 5001.12.2023performed under general anaesthesia, other than: (a) a service to which 5001.12.2023another item in this Subgroup applies; or (b) a service associated with a 5001.12.2023service to which item 41647 applies (H) (Anaes.) 1041512 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301715.0000644.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, 5001.12.2023not being a service to which item 41515 applies (Anaes.) (Assist.) 1041515 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301120.0000423.2500000.00 4026.05.2002(Anaes.) 5001.12.2023MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, 5001.12.2023being a service associated with a service to which item 41530, 41548, 41557, 5001.12.202341560 or 41563 applies (Anaes.) (Assist.) 1041518 26.05.2002 3 T8 8 SN NYNNY 2001.12.202302730.0001022.2500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL AUDITORY MEATUS, removal of EXOSTOSES IN (Anaes.) (Assist.) 1041521 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302875.0001088.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Correction of auditory canal stenosis, including meatoplasty, with or without 5001.12.2023grafting, other than a service associated with a service to which an item in 5001.12.2023Subgroup 18 applies(H) (Anaes.) (Assist.) 1041524 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300830.0000314.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of external auditory canal(H) (Anaes.) (Assist.) 1041527 26.05.2002 3 T8 18 SN NYNYY 2001.12.202301783.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Myringoplasty, by transcanal approach, other than a service associated with a 5001.12.2023service to which another item in this Subgroup applies (H) (Anaes.) (Assist.) 1041530 26.05.2002 3 T8 18 SN NYNYY 2001.12.202302905.0001053.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Myringoplasty, post-aural or endaural approach, with or without mastoid 5001.12.2023inspection, other than a service associated with a service to which another 5001.12.2023item in this Subgroup applies(H) (Anaes.) 1041533 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303472.0001259.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Atticotomy without reconstruction of the bony defect, with or without 5001.12.2023myringoplasty,other than a service associated with a service to which another 5001.12.2023item in this Subgroup applies(H) (Anaes.) (Assist.) 1041536 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303890.0001410.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Atticotomy with reconstruction of the bony defect, with or without 5001.12.2023myringoplasty,other than a service associated with a service to which another 5001.12.2023item in this Subgroup applies(H) (Anaes.) (Assist.) 1041539 26.05.2002 3 T8 8 SN NYNYY 2001.12.202303050.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Ossicular chain reconstruction, other than a service associated with a service 5001.12.2023to which item 41611 applies(H) (Anaes.) (Assist.) 1041542 26.05.2002 3 T8 8 SN NYNYY 2001.12.202303340.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Ossicular chain reconstruction and myringoplasty, other than a service 5001.12.2023associated with a service to which item 41611 applies(H) (Anaes.) (Assist.) 1041545 26.05.2002 3 T8 18 SN NYNYY 2001.12.202301582.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy (cortical),other than a service associated with a service to 5001.12.2023which another item in this Subgroup applies(H) (Anaes.) (Assist.) 1041548 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301890.0000761.3500000.00 4026.05.2002(Anaes.) 5001.12.2023OBLITERATION OF THE MASTOID CAVITY (Anaes.) (Assist.) 1041551 26.05.2002 3 T8 18 SN NYNYY 2001.12.202304834.0001753.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy, intact wall technique, with myringoplasty,other than a service 5001.12.2023associated with a service to which another item in this Subgroup applies(H) 5001.12.2023(Anaes.) (Assist.) 1041554 26.05.2002 3 T8 18 SN NYNYY 2001.12.202305696.0002066.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy, intact wall technique, with myringoplasty and ossicular chain 5001.12.2023reconstruction,other than a service associated with a service to which item 5001.12.202341603 or another item in this Subgroup applies(H) (Anaes.) (Assist.) 1041557 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303307.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy (radical or modified radical),other than a service associated 5001.12.2023with a service to which another item in this Subgroup applies(H) (Anaes.) 5001.12.2023(Assist.) 1041560 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303624.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy (radical or modified radical) and myringoplasty,other than a 5001.12.2023service associated with a service to which another item in this Subgroup 5001.12.2023applies(H) (Anaes.) 1041563 26.05.2002 3 T8 18 SN NYNYY 2001.12.202304486.0001627.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy (radical or modified radical), myringoplasty and ossicular chain 5001.12.2023reconstruction,other than a service associated with a service to which another 5001.12.2023item in this Subgroup applies (H) (Anaes.) (Assist.) 1041564 26.05.2002 3 T8 18 SN NYNYY 2001.12.202305802.0002104.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Mastoidectomy (radical or modified radical), obliteration of the mastoid 5001.12.2023cavity, blind sac closure of external auditory canal and obliteration of 5001.12.2023eustachian tube,other than a service associated with a service to which 5001.12.2023another item in this Subgroup applies (H) (Anaes.) (Assist.) 1041566 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303307.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of mastoidectomy(radical, modified radical or intact wall), including 5001.12.2023myringoplasty,other than a service associated with a service to which another 5001.12.2023item in this Subgroup applies (H) (Anaes.) (Assist.) 1041569 26.05.2002 3 T8 8 SN NYNYY 2001.12.202303340.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Decompression of facial nervein its mastoid portion,other than a service 5001.12.2023associated with a service to which item 41617 applies(H) (Anaes.) (Assist.) 1041572 26.05.2002 3 T8 8 SN NYNNY 2001.12.202303050.0001137.2500000.00 4026.05.2002(Anaes.) 5001.12.2023LABYRINTHOTOMY OR DESTRUCTION OF LABYRINTH (Anaes.) (Assist.) 1041575 26.05.2002 3 T8 8 SN NYNNY 2001.12.202306895.0002680.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CEREBELLOPONTINE ANGLE TUMOUR, removal of by 2 surgeons operating conjointly, 5001.12.2023by transmastoid, translabyrinthine or retromastoid approachtransmastoid, 5001.12.2023translabyrinthine or retromastoid procedure (including aftercare) (Anaes.) 5001.12.2023(Assist.) 1041576 26.05.2002 3 T8 8 SN NYNNY 2001.12.202310345.0004021.5500000.00 4026.05.2002(Anaes.) 5001.12.2023CEREBELLO - PONTINE ANGLE TUMOUR, removal of, by transmastoid, 5001.12.2023translabyrinthine or retromastoid approach - intracranial procedure (including 5001.12.2023aftercare) not being a service to which item 41578 or 41579 applies (Anaes.) 5001.12.2023(Assist.) 1041578 26.05.2002 3 T8 8 SN NYNNY 2001.12.202306895.0002680.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CEREBELLOPONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine 5001.12.2023or retromastoid approach, (intracranial procedure) - conjoint surgery, 5001.12.2023principal surgeon (Anaes.) (Assist.) 1041579 26.05.2002 3 T8 8 SN NYNNY 2001.12.202305175.0002010.7000000.00 5001.12.2023CEREBELLO-PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine 5001.12.2023or retromastoid approach, (intracranial procedure) - conjoint surgery, 5001.12.2023co-surgeon (Assist.) 1041581 26.05.2002 3 T8 8 SN NYNNY 2001.12.202307935.0003083.6500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and 5001.12.2023radical excision of (Anaes.) (Assist.) 1041584 26.05.2002 3 T8 8 SN NYNNY 2001.12.202305445.0002116.2500000.00 4026.05.2002(Anaes.) 5001.12.2023PARTIAL TEMPORAL BONE RESECTION for removal of tumour involving mastoidectomy 5001.12.2023with or without decompression of facial nerve (Anaes.) (Assist.) 1041587 26.05.2002 3 T8 8 SN NYNNY 2001.12.202307420.0002882.3000000.00 4026.05.2002(Anaes.) 5001.12.2023TOTAL TEMPORAL BONE RESECTION for removal of tumour (Anaes.) (Assist.) 1041590 26.05.2002 3 T8 8 SN NYNNY 2001.12.202303340.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOLYMPHATIC SAC, TRANSMASTOID DECOMPRESSION with or without drainage of 5001.12.2023(Anaes.) (Assist.) 1041593 26.05.2002 3 T8 8 SN NYNNY 2001.12.202304410.0001713.2000000.00 4026.05.2002(Anaes.) 5001.12.2023TRANSLABYRINTHINE VESTIBULAR NERVE SECTION (Anaes.) (Assist.) 1041596 26.05.2002 3 T8 8 SN NYNNY 2001.12.202304930.0001914.7000000.00 4026.05.2002(Anaes.) 5001.12.2023RETROLABYRINTHINE VESTIBULAR NERVE SECTION or COCHLEAR NERVE SECTION, or BOTH 5001.12.2023(Anaes.) (Assist.) 1041599 26.05.2002 3 T8 8 SN NYNNY 2001.12.202304930.0001914.7000000.00 4026.05.2002(Anaes.) 5001.12.2023INTERNAL AUDITORY MEATUS, exploration by middle cranial fossa approach with 5001.12.2023cranial nerve decompression (Anaes.) (Assist.) 1041603 01.11.2006 3 T8 8 SN NYNYY 2001.12.202302125.0000657.3000000.00 4001.11.2006(Anaes.) 5001.12.2023Osseo-integration procedure-implantation of bone conduction hearing system 5001.12.2023device, in a patient: (a) With a permanent or long-term hearing loss; and (b) 5001.12.2023Unable to utilise conventional air or bone conduction hearing aid for medical 5001.12.2023or audiological reasons; and (c) With bone conduction thresholds that accord 5001.12.2023with recognised criteria for the implantable bone conduction hearing device 5001.12.2023being inserted. other than a service associated with a service to which item 5001.12.202341554, 45794 or 45797 applies (Anaes.) 1041608 26.05.2002 3 T8 8 SN NYNNY 2001.12.202303050.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023STAPEDECTOMY (Anaes.) (Assist.) 1041611 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302035.0000771.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Stapes mobilisation, other than a service associated with a service to which 5001.12.2023item 41539, 41542, or an item in Subgroup 18, applies(H) (Anaes.) (Assist.) 1041614 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302920.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Round window surgery including repair of cochleotomy, other than a service 5001.12.2023associated with a service to which item 41617 applies (Anaes.) (Assist.) 1041615 26.05.2002 3 T8 8 SN NYNNY 2001.12.202303180.0001199.6500000.00 4026.05.2002(Anaes.) 5001.12.2023OVAL WINDOW SURGERY, including repair of fistula, not being a service 5001.12.2023associated with a service to which any other item in this Group applies 5001.12.2023(Anaes.) (Assist.) 1041617 26.05.2002 3 T8 8 SN NYNYY 2001.12.202305510.0002086.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Cochlear implant, insertion of, including mastoidectomy, cochleotomy and 5001.12.2023exposure of facial nerve where required, other than a service associated with 5001.12.2023a service to which item 41569 or 41614 applies(H) (Anaes.) (Assist.) 1041618 01.05.2017 3 T8 8 SN NYNNY 2001.12.202305510.0002066.0000000.00 4001.05.2017(Anaes.) 5001.12.2023Middle ear implant, partially implantable, insertion of, via mastoidectomy, 5001.12.2023for patients with:(a) stable sensorineural hearing loss; and (b) outer ear 5001.12.2023pathology that prevents the use of a conventional hearing aid; and (c) a PTA4 5001.12.2023of less than 80 dBHL; and (d) bilateral, symmetrical hearing loss with PTA 5001.12.2023thresholds in both ears within 20 dBHL (0.54kHz) of each other; and (e) speech 5001.12.2023perception discrimination of at least 65% correct for word lists with 5001.12.2023appropriately amplified sound; and (f) a normal middle ear; and (g) normal 5001.12.2023tympanometry; and (h) on audiometry, an airbone gap of less than 10 dBHL 5001.12.2023(0.54kHz) across all frequencies; and (i) no other inner ear disorders 5001.12.2023(Anaes.) (Assist.) 1041620 26.05.2002 3 T8 8 SN NYNNY 2001.12.202302325.0000907.6000000.00 4026.05.2002(Anaes.) 5001.12.2023GLOMUS TUMOUR, transtympanic removal of (Anaes.) (Assist.) 1041623 26.05.2002 3 T8 8 SN NYNNY 2001.12.202303340.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023GLOMUS TUMOUR, transmastoid removal of, including mastoidectomy (Anaes.) 5001.12.2023(Assist.) 1041626 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300450.0000158.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Incision of tympanic membrane, or installation of therapeutic agent, to the 5001.12.2023middle ear through an intact drum: (a) not including local anaesthetic; and 5001.12.2023(b) excluding aftercare; and (c) other than a service associated with a 5001.12.2023service to which item 41632 applies (Anaes.) 1041629 26.05.2002 3 T8 18 SN NYNYY 2001.12.202301582.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Middle ear, exploration of,other than a service associated with a service to 5001.12.2023which another item in this Subgroup applies (H) (Anaes.) (Assist.) 1041632 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300690.0000262.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Middle ear, insertion of tube fordrainage of (including myringotomy), other 5001.12.2023than a service associated with a service to which item 41626 applies (Anaes.) 1041635 26.05.2002 3 T8 18 SN NYNYY 2001.12.202303472.0001259.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, 5001.12.2023with or without myringoplasty, other than a service associated with a service 5001.12.2023to which another item in this Subgroup applies (H) (Anaes.) (Assist.) 1041638 26.05.2002 3 T8 18 SN NYNYY 2001.12.202304334.0001572.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, 5001.12.2023with or without myringoplasty with ossicular chain reconstruction other than a 5001.12.2023service associated with a service to which another item in this Subgroup 5001.12.2023applies (H) (Anaes.) (Assist.) 1041641 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300136.0000052.2000000.00 4026.05.2002(Anaes.) 5001.12.2023PERFORATION OF TYMPANUM, cauterisation or diathermy of (Anaes.) 1041644 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300415.0000157.3000000.00 4026.05.2002(Anaes.) 5001.12.2023EXCISION OF RIM OF EARDRUM PERFORATION, not being a service associated with 5001.12.2023myringoplasty (Anaes.) 1041647 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300310.0000120.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Micro inspection of tympanic membrane and auditory canal, requiring use of 5001.12.2023operating microscope or endoscope, including any removal of wax, with or 5001.12.2023without general anaesthesia, other than a service associated with a service to 5001.12.2023which item 41509 applies. Not applicable for the removal of uncomplicated wax 5001.12.2023in the absence of other disorders of the ear (Anaes.) 1041650 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300310.0000120.9500000.00 4026.05.2002(Anaes.) 5001.12.2023TYMPANIC MEMBRANE, microinspection of 1 or both ears under general 5001.12.2023anaesthesia, not being a service associated with a service to which another 5001.12.2023item in this Group applies (Anaes.) 1041656 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300385.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or 5001.12.2023without cauterisation and with or without anterior pack (excluding aftercare) 5001.12.2023(Anaes.) 1041659 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300225.0000085.3500000.00 4026.05.2002(Anaes.) 5001.12.2023NOSE, removal of FOREIGN BODY IN, other than by simple probing (Anaes.) 1041662 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300230.0000090.7500000.00 5001.12.2023Nasal polyp or polypi (simple), removal of, other than a service associated 5001.12.2023with a service to which item 41702, 41703 or 41705 applies on the same side 1041668 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300690.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Nasal polyp or polypi,removal of (Anaes.) 1041671 26.05.2002 3 T8 21 SN NYNYY 2001.12.202301592.0000577.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Septal surgery, including septoplasty, septal reconstruction, septectomy, 5001.12.2023closure of septal perforation or other modifications of the septum, not 5001.12.2023including cauterisation, by any approach, other than a service associated with 5001.12.2023a service to which item 41689, 41692 or 41693 applies (H) (Anaes.) (Assist.) 1041674 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300380.0000110.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Cauterisation (other than by chemical means) or cauterisation by chemical 5001.12.2023means when performed under general anaesthesia or diathermy of septum or 5001.12.2023turbinatesone or more of these procedures (including any consultation on the 5001.12.2023same occasion) other than a service associated with another operation on the 5001.12.2023nose (Anaes.) 1041677 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300290.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by cauterisation 5001.12.2023or nasal cavity packing or both (Anaes.) 1041683 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300340.0000129.0500000.00 4026.05.2002(Anaes.) 5001.12.2023DIVISION OF NASAL ADHESIONS, with or without stenting not being a service 5001.12.2023associated with any other operation on the nose and not performed during the 5001.12.2023postoperative period of a nasal operation (Anaes.) 1041686 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300230.0000079.2000000.00 4026.05.2002(Anaes.) 5001.12.2023DISLOCATION OF TURBINATE OR TURBINATES, 1 or both sides, not being a service 5001.12.2023associated with a service to which another item in this Group applies (Anaes.) 1041689 26.05.2002 3 T8 21 SN NYNYY 2001.12.202300621.0000225.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Turbinate reduction, partial or total, unilateral or bilateral, other than a 5001.12.2023service associated with a service to which item 41671, 41692 or 41693 applies 5001.12.2023(Anaes.) 1041692 26.05.2002 3 T8 21 SN NYNYY 2001.12.202300810.0000293.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Turbinate, submucous resection with removal of bone, unilateral or bilateral, 5001.12.2023other than a service associated with a service to which item 41671, 41689 or 5001.12.202341693 applies (H) (Anaes.) 1041693 01.03.2023 3 T8 21 SN YYNYN 2001.12.202302250.0000844.3000000.00 4001.03.2023(Anaes.) 5001.12.2023Septal surgery with submucous resection of turbinates, unilateral or 5001.12.2023bilateral, other than a service associated with a service to which item 41671, 5001.12.202341689, 41692 or 41764 applies (H) (Anaes.) (Assist.) 1041698 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300093.0000035.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Maxillary antrum, proof puncture and lavage of, other than a service 5001.12.2023associated with a service to which item 41702, 41703, 41705, 41710, 41734 or 5001.12.202341737 applies on the same side (Anaes.) 1041701 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300290.0000101.1500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia 5001.12.2023(requiring admission to hospital) not being a service associated with a 5001.12.2023service to which another item in this Group applies (Anaes.) 1041702 01.03.2023 3 T8 19 SNS YYNYN 2001.12.202301855.0000751.1000000.00 4001.03.2023(Anaes.) 5001.12.2023Functional sinus surgery of the ostiomeatal unit, including ethmoid, 5001.12.2023unilateral, other than a service associated with a service to which item 5001.12.202341662, 41698, 41703, 41705, 41710 or 41764 applies on the same side(H) 5001.12.2023(Anaes.) (Assist.) 1041703 01.03.2023 3 T8 19 SNS YYNYN 2001.12.202302865.0001110.4000000.00 4001.03.2023(Anaes.) 5001.12.2023Functional sinus surgery, complete dissection of all 5 sinuses and creation of 5001.12.2023single sinus cavity, unilateral, other than a service associated with a 5001.12.2023service to which item 41662, 41698, 41702, 41705, 41710, 41734, 41737, 41752 5001.12.2023or 41764 applies on the same side (H) (Anaes.) (Assist.) 1041704 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300084.0000040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ANTRUM, LAVAGE OFeach attendance at which the procedure is 5001.12.2023performed, including any associated consultation (Anaes.) 1041705 01.03.2023 3 T8 19 SNS YYNYN 2001.12.202305045.0001806.7500000.00 4001.03.2023(Anaes.) 5001.12.2023Functional sinus surgery, complete dissection of all 5 sinuses to create a 5001.12.2023single sinus cavity, with extended drilling of frontal sinuses, unilateral, 5001.12.2023other than a service associated with a service to which item 41662, 41698, 5001.12.202341702, 41703, 41710, 41734, 41737, 41752 or 41764 applies on the same side(H) 5001.12.2023(Anaes.) (Assist.) 1041707 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301220.0000493.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Maxillaryor sphenopalatine artery, ligation of (H) (Anaes.) (Assist.) 1041710 26.05.2002 3 T8 20 SN NYNYY 2001.12.202301074.0000389.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Antrostomyby any approach, other than a service associated with a service to 5001.12.2023which item 41702, 41703, 41705 or 41698 applies on the same side (H) (Anaes.) 5001.12.2023(Assist.) 1041713 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301890.0000667.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Vidian neurectomy or exposure of vidian canal (H) (Anaes.) (Assist.) 1041719 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300340.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Antrum, drainage of, through tooth socket, other than a service associated 5001.12.2023with a service to which item 41722 applies (Anaes.) 1041722 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301715.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Oroantral fistula, plastic closure of,other than a service associated with a 5001.12.2023service to which item 41719 or 45009 applies (Anaes.) (Assist.) 1041725 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301305.0000493.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Ligation of ethmoidal artery or arteries, anterior, posterior or both, by any 5001.12.2023approach (unilateral) (H) (Anaes.) (Assist.) 1041728 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302610.0000987.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of sinonasal or nasopharyngeal tumour, excluding inflammatory nasal 5001.12.2023polyps, by any approach (H) (Anaes.) (Assist.) 1041734 26.05.2002 3 T8 20 SN NYNYY 2001.12.202303077.0001116.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Endoscopic Lothrop procedure or radical external frontal sinusotomy with 5001.12.2023osteoplastic flap, unilateral, other than a service associated with a service 5001.12.2023to which item 41698, 41703, 41705 or 41764 applies on the same side(H) 5001.12.2023(Anaes.) (Assist.) 1041737 26.05.2002 3 T8 20 SN NYNYY 2001.12.202301467.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Frontal sinus, unilateral, intranasal operation on, including complete 5001.12.2023dissection of frontal recess and exposure of frontal sinus ostium (excludes 5001.12.2023simple probing, dilatation or irrigation of frontal sinus), other than a 5001.12.2023service associated with a service to which item 41698, 41703, 41705 or 41764 5001.12.2023applies on the same side(H) (Anaes.) (Assist.) 1041740 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300174.0000064.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Frontal sinus, catheterisation of, other than a service associated with a 5001.12.2023service to which item 41749 applies on the same side (H) (Anaes.) 1041743 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301075.0000371.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Frontal sinus, trephine of, other than a service associated with a service to 5001.12.2023which item 41749 applieson the same side (H) (Anaes.) (Assist.) 1041746 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302470.0000855.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Paranasal sinus, radical obliteration of, including any graft harvest (Anaes.) 5001.12.2023(Assist.) 1041749 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301800.0000667.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Paranasal sinus, external operation on, unilateral, other than a service 5001.12.2023associated with a service to which item 41740 or 41743 applies on the same 5001.12.2023side (H) (Anaes.) (Assist.) 1041752 26.05.2002 3 T8 20 SN NYNYY 2001.12.202300897.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Sphenoidal sinus, unilateral, intranasal operation on, other than a service 5001.12.2023associated with a service to which item 41703 or 41705 applies on the same 5001.12.2023side(H) (Anaes.) (Assist.) 1041755 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300128.0000051.1500000.00 4026.05.2002(Anaes.) 5001.12.2023EUSTACHIAN TUBE, catheterisation of (Anaes.) 1041764 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300355.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Nasendoscopy or sinoscopy or fibreoptic examination of nasopharynx and larynx, 5001.12.2023one or more of these procedures, unilateral or bilateral examination, other 5001.12.2023than a service associated with a service to which item 41693, 41702, 41703, 5001.12.202341705, 41734 or 41737 applies (Anaes.) 1041770 26.05.2002 3 T8 8 SN NYNNY 2001.12.202302035.0000771.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PHARYNGEAL POUCH, removal of, with or without cricopharyngeal myotomy (Anaes.) 5001.12.2023(Assist.) 1041776 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301690.0000645.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Cricopharyngeal myotomyby any approach, including open inversion of pharyngeal 5001.12.2023pouch or endoscopic repair of pharyngeal pouch(H) (Anaes.) (Assist.) 1041779 26.05.2002 3 T8 8 SN NYNNY 2001.12.202302035.0000771.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PHARYNGOTOMY (lateral), with or without total excision of tongue (Anaes.) 5001.12.2023(Assist.) 1041785 26.05.2002 3 T8 8 SN NYNYY 2001.12.202303335.0001255.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Partial pharyngectomy, by any approach, with or without partial glossectomy 5001.12.2023(H) (Anaes.) (Assist.) 1041786 26.05.2002 3 T8 8 SN NYNNY 2001.12.202302255.0000811.2500000.00 4026.05.2002(Anaes.) 5001.12.2023UVULOPALATOPHARYNGOPLASTY, with or without tonsillectomy, by any means 5001.12.2023(Anaes.) (Assist.) 1041793 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301075.0000408.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Tonsils or tonsils and adenoids, removal of, in a patient 12 years of age or 5001.12.2023over (including any examination of the postnasal space and nasopharynx and the 5001.12.2023infiltration of local anaesthetic), not being a service to which item 41764 5001.12.2023applies (Anaes.) 1041797 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300455.0000158.5500000.00 4026.05.2002(Anaes.) 5001.12.2023TONSILS OR TONSILS AND ADENOIDS, ARREST OF HAEMORRHAGE requiring general 5001.12.2023anaesthesia, following removal of (Anaes.) 1041801 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300455.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Adenoids, removal of (including any examination of the postnasal space and 5001.12.2023nasopharynx and the infiltration of local anaesthetic), not being a service to 5001.12.2023which item 41764 applies (Anaes.) 1041804 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300255.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of lingual tonsil (H) (Anaes.) 1041807 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300205.0000077.1000000.00 4026.05.2002(Anaes.) 5001.12.2023PERITONSILLAR ABSCESS (quinsy), incision of (Anaes.) 1041810 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300102.0000039.2000000.00 4026.05.2002(Anaes.) 5001.12.2023UVULOTOMY or UVULECTOMY (Anaes.) 1041813 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301015.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023VALLECULAR OR PHARYNGEAL CYSTS, removal of (Anaes.) (Assist.) 1041822 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300555.0000211.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophagoscopy, with rigid oesophagoscope, with or without biopsy, other than 5001.12.2023a service associated with a service to which item 30473 or 30478 applies (H) 5001.12.2023(Anaes.) 1041825 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301015.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of a foreign body from the pharynx, larynx or oesophagus, by any 5001.12.2023means, other than a service associated with a service to which item 30478 5001.12.2023applies (H) (Anaes.) (Assist.) 1041828 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300160.0000057.5000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL STRICTURE, dilatation of, without oesophagoscopy (Anaes.) 1041831 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301085.0000392.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Oesophagus, endoscopic pneumatic dilatation of,for treatment of achalasia 5001.12.2023(Anaes.) (Assist.) 1041832 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300670.0000251.5000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGUS, balloon dilatation of, using interventional imaging techniques 5001.12.2023(Anaes.) 1041834 26.05.2002 3 T8 8 SN NYNYY 2001.12.202304920.0001741.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Total laryngectomy, including cricopharyngeal myotomy and tracheo oesophageal 5001.12.2023puncture (H) (Anaes.) (Assist.) 1041837 26.05.2002 3 T8 8 SN NYNYY 2001.12.202303590.0001360.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Complete vertical hemi laryngectomy, involving removal of true and false vocal 5001.12.2023cords, including tracheostomy. Applicable only once per provider per patient 5001.12.2023per lifetime (H) (Anaes.) (Assist.) 1041840 26.05.2002 3 T8 8 SN NYNYY 2001.12.202304415.0001672.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Total supraglottic laryngectomy, involving removal of ventricular folds, 5001.12.2023epiglottis and aryepiglottic folds including tracheostomy. Applicable only 5001.12.2023once per provider per patient per lifetime(H) (Anaes.) (Assist.) 1041843 26.05.2002 3 T8 8 SN NYNNY 2001.12.202304065.0001471.0000000.00 4026.05.2002(Anaes.) 5001.12.2023LARYNGOPHARYNGECTOMY or PRIMARY RESTORATION OF ALIMENTARY CONTINUITY after 5001.12.2023laryngopharyngectomy USING STOMACH OR BOWEL (Anaes.) (Assist.) 1041855 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300915.0000317.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Microlaryngoscopy, by any approach, with or without biopsy(H) (Anaes.) 5001.12.2023(Assist.) 1041861 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301755.0000665.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Microlaryngoscopy with complete removal of benign or malignant lesions of the 5001.12.2023larynx, including papillomata, by any approach or technique, unilateral, other 5001.12.2023than a service associated with a service to which item 41870 applies on the 5001.12.2023same side (H) (Anaes.) (Assist.) 1041867 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301785.0000675.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Microlaryngoscopy, with partial or complete arytenoidectomy or arytenoid 5001.12.2023repositioning(H) (Anaes.) (Assist.) 1041870 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301295.0000500.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Laryngeal augmentation or modification by injection techniques, other than a 5001.12.2023service associated with a service to which item 41879 applies or item 41861 5001.12.2023applies on the same side (Anaes.) (Assist.) 1041873 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301715.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Larynx, fractured, operation for(H) (Anaes.) (Assist.) 1041876 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301715.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023LARYNX, external operation on, OR LARYNGOFISSURE with or without cordectomy 5001.12.2023(Anaes.) (Assist.) 1041879 26.05.2002 3 T8 8 SN NYNYY 2001.12.202302765.0001048.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Tracheoplasty, laryngoplasty or thyroplasty, not by injection techniques, 5001.12.2023including tracheostomy, other than a service associated with a service to 5001.12.2023which item 41870 applies(H) (Anaes.) (Assist.) 1041880 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300760.0000279.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Tracheostomyby a percutaneous technique(H) (Anaes.) 1041881 26.05.2002 3 T8 8 SN NYNYY 2001.12.202301205.0000442.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Tracheostomyby open exposure of the trachea(H) (Anaes.) (Assist.) 1041884 26.05.2002 3 T8 8 SN NYNYY 2001.12.202300270.0000100.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Cricothyrostomy(H) (Anaes.) 1041885 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300865.0000316.9000000.00 4026.05.2002(Anaes.) 5001.12.2023TRACHE-OESOPHAGEAL FISTULA, formation of, as a secondary procedure following 5001.12.2023laryngectomy, including associated endoscopic procedures (Anaes.) (Assist.) 1041886 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300515.0000195.9500000.00 4026.05.2002(Anaes.) 5001.12.2023TRACHEA, removal of foreign body in (Anaes.) 1041887 01.03.2023 3 T8 8 SNS YYNYN 2001.12.202309825.0002973.6500000.00 4001.03.2023(Anaes.) 5001.12.2023Pituitary tumour, removal of, by trans-sphenoidal approach, including 5001.12.2023stereotaxy and dermis, dermofat or fascia grafting, as part of conjoint 5001.12.2023surgery, other than a service associated with a service to which item 40600 5001.12.2023applies(H) (Anaes.) (Assist.) 1041888 01.03.2023 3 T8 8 SNS YYNYN 2001.12.202306935.0002104.5500000.00 4001.03.2023(Anaes.) 5001.12.2023Fractured skull, after trauma only, or spontaneous defects with cerebrospinal 5001.12.2023fluid rhinorrhoea or otorrhoea, repair of, including stereotaxy and dermofat 5001.12.2023graft(H) (Anaes.) (Assist.) 1041890 01.03.2023 3 T8 8 SNS YYNYN 2001.12.202303585.0001407.1000000.00 4001.03.2023(Anaes.) 5001.12.2023Orbit, decompression of, by fenestration of 2 or more walls, or by the removal 5001.12.2023of intraorbital peribulbar and retrobulbar fat from each quadrant of the 5001.12.2023orbit, one eye by endonasal approach(H) (Anaes.) (Assist.) 1041907 26.05.2002 3 T8 8 SN NYNNY 2001.12.202300355.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL SEPTUM BUTTON, insertion of (Anaes.) 1041910 26.05.2002 3 T8 8 SN NYNNY 2001.12.202301140.0000429.5500000.00 4026.05.2002(Anaes.) 5001.12.2023DUCT OF MAJOR SALIVARY GLAND, transposition of (Anaes.) (Assist.) 1042503 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300335.0000112.8000000.00 4026.05.2002(Anaes.) 5001.12.2023OPHTHALMOLOGICAL EXAMINATION under general anaesthesia, not being a service 5001.12.2023associated with a service to which another item in this Group applies (Anaes.) 1042504 01.05.2020 3 T8 9 SNS NYNNY 2001.12.202301855.0000331.0500000.00 4001.05.2020(Anaes.) 5001.12.2023Glaucoma, implantation of a micro-bypass surgery stent system into the 5001.12.2023trabecular meshwork, if: (a) conservative therapies have failed, are likely to 5001.12.2023fail, or are contraindicated; and (b) the service is performed by a specialist 5001.12.2023with training that is recognised by the Conjoint Committee for the Recognition 5001.12.2023of Training in Micro-Bypass Glaucoma Surgery (Anaes.) 1042505 01.11.2018 3 T8 9 SN NYNNY 2001.12.202301855.0000331.0500000.00 4001.11.2018(Anaes.) 5001.12.2023Complete removal from the eye of a trans-trabecular drainage device or 5001.12.2023devices, with or without replacement, following device related medical 5001.12.2023complications necessitating complete removal. (Anaes.) 1042506 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301525.0000529.7000000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, ENUCLEATION OF, with or without sphere implant (Anaes.) (Assist.) 1042509 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301890.0000670.4500000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, ENUCLEATION OF, with insertion of integrated implant (Anaes.) (Assist.) 1042510 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302105.0000772.7500000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, enucleation of, with insertion of hydroxy apatite implant or similar 5001.12.2023coralline implant (Anaes.) (Assist.) 1042512 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301525.0000529.7000000.00 4026.05.2002(Anaes.) 5001.12.2023GLOBE, EVISCERATION OF (Anaes.) (Assist.) 1042515 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301670.0000670.4500000.00 4026.05.2002(Anaes.) 5001.12.2023GLOBE, EVISCERATION OF, AND INSERTION OF INTRASCLERAL BALL OR CARTILAGE 5001.12.2023(Anaes.) (Assist.) 1042518 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301075.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ANOPHTHALMIC ORBIT, INSERTION OF CARTILAGE OR ARTIFICIAL IMPLANT as a delayed 5001.12.2023procedure, or REMOVAL OF IMPLANT FROM SOCKET, or PLACEMENT OF A MOTILITY 5001.12.2023INTEGRATING PEG by drilling into an existing orbital implant (Anaes.) 5001.12.2023(Assist.) 1042521 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303445.0001324.4000000.00 4026.05.2002(Anaes.) 5001.12.2023ANOPHTHALMIC SOCKET, treatment of, by insertion of a wired-in conformer, 5001.12.2023integrated implant or dermofat graft, as a secondary procedure (Anaes.) 5001.12.2023(Assist.) 1042524 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300670.0000225.1500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, SKIN GRAFT TO, as a delayed procedure (Anaes.) 1042527 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301335.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023CONTRACTED SOCKET, RECONSTRUCTION INCLUDING MUCOUS MEMBRANE GRAFTING AND STENT 5001.12.2023MOULD (Anaes.) (Assist.) 1042530 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301890.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, EXPLORATION with or without biopsy, requiring REMOVAL OF BONE (Anaes.) 5001.12.2023(Assist.) 1042533 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301130.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, EXPLORATION OF, with drainage or biopsy not requiring removal of bone 5001.12.2023(Anaes.) (Assist.) 1042536 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302685.0000918.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, EXENTERATION OF, with or without skin graft and with or without 5001.12.2023temporalis muscle transplant (Anaes.) (Assist.) 1042539 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303840.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, EXPLORATION OF, with removal of tumour or foreign body, requiring 5001.12.2023removal of bone (Anaes.) (Assist.) 1042542 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301595.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, exploration of anterior aspect with removal of tumour or foreign body 5001.12.2023(Anaes.) (Assist.) 1042543 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302800.0000972.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, exploration of retrobulbar aspect with removal of tumour or foreign 5001.12.2023body (Anaes.) (Assist.) 1042545 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303585.0001407.1000000.00 4026.05.2002(Anaes.) 5001.12.2023ORBIT, decompression of, for dysthyroid eye disease, by fenestrationof 2 or 5001.12.2023more walls, or by the removal of intraorbital peribulbar and retrobulbar fat 5001.12.2023from each quadrant of the orbit, 1 eye (Anaes.) (Assist.) 1042548 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303220.0000835.8500000.00 4026.05.2002(Anaes.) 5001.12.2023OPTIC NERVE MENINGES, incision of (Anaes.) (Assist.) 1042551 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302035.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, PENETRATING WOUND OR RUPTURE OF, not involving intraocular structures 5001.12.2023repair involving suture of cornea or sclera, or both, not being a service to 5001.12.2023which item 42632 applies (Anaes.) (Assist.) 1042554 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302395.0000811.2500000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration or prolapse of uveal 5001.12.2023tissue repair (Anaes.) (Assist.) 1042557 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303340.0001133.9500000.00 4026.05.2002(Anaes.) 5001.12.2023EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration of lens or vitreous 5001.12.2023repair (Anaes.) (Assist.) 1042563 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301740.0000571.2500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR FOREIGN BODY, removal from anterior segment (Anaes.) (Assist.) 1042569 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303340.0001133.9500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR FOREIGN BODY, removal from posterior segment (Anaes.) (Assist.) 1042572 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300320.0000129.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ORBITAL ABSCESS OR CYST, drainage of (Anaes.) 1042573 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300680.0000250.3500000.00 4026.05.2002(Anaes.) 5001.12.2023DERMOID, periorbital, excision of, on a patient 10 years of age or over 5001.12.2023(Anaes.) 1042574 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301450.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023DERMOID, orbital, excision of (Anaes.) (Assist.) 1042575 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300270.0000091.0500000.00 4026.05.2002(Anaes.) 5001.12.2023TARSAL CYST, extirpation of (Anaes.) 1042581 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300335.0000129.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ECTROPION OR ENTROPION, tarsal cauterisation of (Anaes.) 1042584 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300870.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023TARSORRHAPHY (Anaes.) (Assist.) 1042587 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300146.0000057.2500000.00 4026.05.2002(Anaes.) 5001.12.2023TRICHIASIS (due to causes other than trachoma), treatment of by cryotherapy, 5001.12.2023laser or electrolysis - each eyelid (Anaes.) 1042588 01.11.2018 3 T8 9 SN NYNNY 2001.12.202300146.0000057.2500000.00 4001.11.2018(Anaes.) 5001.12.2023TRICHIASIS (due to trachoma), treatment of by cryotherapy, laser or 5001.12.2023electrolysis - each eyelid (Anaes.) 1042590 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301075.0000372.4500000.00 4026.05.2002(Anaes.) 5001.12.2023CANTHOPLASTY, medial or lateral (Anaes.) (Assist.) 1042593 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300670.0000225.1500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL GLAND, excision of palpebral lobe (Anaes.) 1042596 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301595.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL SAC, excision of, or operation on (Anaes.) (Assist.) 1042599 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301725.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL CANALICULAR SYSTEM, establishment of patency by closed operation 5001.12.2023using silicone tubes or similar, 1 eye (Anaes.) (Assist.) 1042602 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302035.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL CANALICULAR SYSTEM, establishment of patency by open operation, 1 eye 5001.12.2023(Anaes.) (Assist.) 1042605 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301450.0000513.0500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL CANALICULUS, immediate repair of (Anaes.) (Assist.) 1042608 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300870.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023LACRIMAL DRAINAGE by insertion of glass tube, as an independent procedure 5001.12.2023(Anaes.) (Assist.) 1042610 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300290.0000105.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL 5001.12.2023PASSAGES, probing for obstruction, unilateral, with or without lavage - under 5001.12.2023general anaesthesia (Anaes.) 1042611 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300465.0000158.9000000.00 4026.05.2002(Anaes.) 5001.12.2023NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL 5001.12.2023PASSAGES, probing for obstruction, bilateral, with or without lavage - under 5001.12.2023general anaesthesia (Anaes.) 1042614 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300152.0000053.1500000.00 5001.12.2023NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL 5001.12.2023PASSAGES, probing to establish patency of the lacrimal passage and/or site of 5001.12.2023obstruction, unilateral, including lavage, not being a service associated with 5001.12.2023a service to which item 42610 applies (excluding aftercare) 1042615 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300215.0000079.5000000.00 5001.12.2023NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL 5001.12.2023PASSAGES, probing to establish patency of the lacrimal passage and/or site of 5001.12.2023obstruction, bilateral, including lavage, not being a service associated with 5001.12.2023a service to which item 42611 applies (excluding aftercare) 1042617 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300350.0000150.7500000.00 4026.05.2002(Anaes.) 5001.12.2023PUNCTUM SNIP operation (Anaes.) 1042620 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300245.0000058.0000000.00 4026.05.2002(Anaes.) 5001.12.2023PUNCTUM, occlusion of, by use of a plug (Anaes.) 1042622 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300250.0000091.0500000.00 4026.05.2002(Anaes.) 5001.12.2023PUNCTUM, permanent occlusion of, by use of electrical cautery (Anaes.) 1042623 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302790.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023DACRYOCYSTORHINOSTOMY (Anaes.) (Assist.) 1042626 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303175.0001241.7000000.00 4026.05.2002(Anaes.) 5001.12.2023DACRYOCYSTORHINOSTOMY where a previous dacryocystorhinostomy has been 5001.12.2023performed (Anaes.) (Assist.) 1042629 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302945.0000935.3000000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVORHINOSTOMY including dacryocystorhinostomy and fashioning of 5001.12.2023conjunctival flaps (Anaes.) (Assist.) 1042632 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300320.0000129.2000000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVAL PERITOMY OR REPAIR OF CORNEAL LACERATION by conjunctival flap 5001.12.2023(Anaes.) 1042635 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301860.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEAL PERFORATIONS, sealing of, with tissue adhesive (Anaes.) (Assist.) 1042638 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301205.0000413.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVAL GRAFT OVER CORNEA (Anaes.) (Assist.) 1042641 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301290.0000538.0000000.00 4026.05.2002(Anaes.) 5001.12.2023AUTOCONJUNCTIVAL TRANSPLANT, or mucous membrane graft (Anaes.) (Assist.) 1042644 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300230.0000079.4000000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEA OR SCLERA, complete removal of embedded foreign body from - not more 5001.12.2023than once on the same day by the same practitioner (excluding aftercare) 5001.12.2023(Anaes.) 1042647 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300670.0000225.1500000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEAL SCARS, removal of, by partial keratectomy, not being a service 5001.12.2023associated with a service to which item 42686 applies (Anaes.) 1042650 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300230.0000079.4000000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEA, epithelial debridement for corneal ulcer or corneal erosion (excluding 5001.12.2023aftercare) (Anaes.) 1042651 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300510.0000177.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEA, epithelial debridement for eliminating band keratopathy (Anaes.) 1042652 01.05.2018 3 T8 9 SN NYNNY 2001.12.202302625.0001320.8500000.00 4001.05.2018(Anaes.) 5001.12.2023Corneal collagen cross linking, on a patient with a corneal ectatic disorder, 5001.12.2023with evidence of progressionper eye (Anaes.) 1042653 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303995.0001439.4000000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEA transplantation of (Anaes.) (Assist.) 1042656 26.05.2002 3 T8 9 SN NYNNY 2001.12.202304425.0001837.6000000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEA, transplantation of, second and subsequent procedures (Anaes.) 5001.12.2023(Assist.) 1042662 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302295.0000993.1500000.00 4026.05.2002(Anaes.) 5001.12.2023SCLERA, transplantation of, full thickness, including collection of donor 5001.12.2023material (Anaes.) (Assist.) 1042665 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301725.0000662.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SCLERA, transplantation of, superficial or lamellar, including collection of 5001.12.2023donor material (Anaes.) (Assist.) 1042667 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300440.0000156.2000000.00 5001.12.2023RUNNING CORNEAL SUTURE, manipulation of, performed within 4 months of corneal 5001.12.2023grafting, to reduce astigmatism where a reduction of 2 dioptres of astigmatism 5001.12.2023is obtained, including any associated consultation 1042668 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300230.0000082.8500000.00 4026.05.2002(Anaes.) 5001.12.2023CORNEAL SUTURES, removal of, not earlier than 6 weeks after operation 5001.12.2023requiring use of slit lamp or operating microscope (Anaes.) 1042672 01.11.2003 3 T8 9 SN NYNNY 2001.12.202302395.0000993.1500000.00 4001.11.2003(Anaes.) 5001.12.2023CORNEAL INCISONS, to correct corneal astigmatism of more than 11/2 dioptres 5001.12.2023following anterior segment surgery, including appropriate measurements and 5001.12.2023calculations, performed as an independent procedure (Anaes.) (Assist.) 1042673 01.11.2003 3 T8 9 SN NYNNY 2001.12.202301305.0000496.4500000.00 4001.11.2003(Anaes.) 5001.12.2023ADDITIONAL CORNEAL INCISIONS, to correct corneal astigmatism of more than 11/2 5001.12.2023dioptres, including appropriate measurements and calculations, performed in 5001.12.2023conjunction with other anterior segment surgery (Anaes.) (Assist.) 1042676 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300360.0000127.3500000.00 5001.12.2023CONJUNCTIVA, biopsy of, as an independent procedure 1042677 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300166.0000067.1000000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVA, CAUTERY OF, INCLUDING TREATMENT OF PANNUSeach attendance at which 5001.12.2023treatment is given including any associated consultation (Anaes.) 1042680 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300870.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVA, cryotherapy to, for melanotic lesions or similar using CO² 5001.12.2023or N²0 (Anaes.) 1042683 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300355.0000132.5000000.00 4026.05.2002(Anaes.) 5001.12.2023CONJUNCTIVAL CYSTS, removal of, requiring admission to hospital or approved 5001.12.2023day-hospital facility (Anaes.) 1042686 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300800.0000301.2000000.00 4026.05.2002(Anaes.) 5001.12.2023PTERYGIUM, removal of (Anaes.) 1042689 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300335.0000129.2000000.00 4026.05.2002(Anaes.) 5001.12.2023PINGUECULA, removal of, not being a service associated with the fitting of 5001.12.2023contact lenses (Anaes.) 1042692 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300870.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023LIMBIC TUMOUR, removal of, excluding Pterygium (Anaes.) (Assist.) 1042695 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301330.0000496.4500000.00 4026.05.2002(Anaes.) 5001.12.2023LIMBIC TUMOUR, excision of, requiring keratectomy or sclerectomy, excluding 5001.12.2023Pterygium (Anaes.) (Assist.) 1042698 26.05.2002 3 T8 9 DN NYNNY 2001.12.202303680.0000654.6000000.00 4026.05.2002(Anaes.) 5001.12.2023LENS EXTRACTION, excluding surgery performed for the correction of refractive 5001.12.2023error except for anisometropia greater than 3 dioptres following the removal 5001.12.2023of cataract in the first eye (Anaes.) 1042701 26.05.2002 3 T8 9 DN NYNNY 2001.12.202302035.0000365.0500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR LENS, insertion of, excluding surgery performed for the correction 5001.12.2023of refractive errorexcept for anisometropia greater than 3 dioptres following 5001.12.2023the removal of cataract in the first eye (Anaes.) 1042702 26.05.2002 3 T8 9 DN NYNNY 2001.12.202304695.0000837.2000000.00 4026.05.2002(Anaes.) 5001.12.2023LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed 5001.12.2023for the correction of refractive error except for anisometropia greater than 3 5001.12.2023dioptres following the removal of cataract in the first eye (Anaes.) 1042703 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301525.0000629.6000000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR LENS or IRIS PROSTHESIS insertion of, into the posterior chamber 5001.12.2023with fixation to the iris or sclera (Anaes.) (Assist.) 1042704 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301235.0000513.0500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR LENS, REMOVAL or REPOSITIONING of by open operation, not being a 5001.12.2023service associated with a service to which item 42701 applies (Anaes.) 1042705 01.05.2017 3 T8 9 SN NYNNY 2001.12.202302765.0001002.9000000.00 4001.05.2017(Anaes.) 5001.12.2023LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed 5001.12.2023for the correction of refractive errorexcept for anisometropia greater than 3 5001.12.2023dioptres following the removal of cataract in the first eye, performed in 5001.12.2023association with insertion of a trans-trabecular drainage device or devices, 5001.12.2023in a patient diagnosed with open angle glaucoma who is not adequately 5001.12.2023responsive to topical anti-glaucoma medications or who is intolerant of 5001.12.2023anti-glaucoma medication. (Anaes.) 1042707 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302140.0000877.3500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR LENS, REMOVAL of and REPLACEMENT with a different lens, excluding 5001.12.2023surgery performed for the correction of refractive error except for 5001.12.2023anisometropia greater than 3 dioptres following the removal of cataract in the 5001.12.2023first eye (Anaes.) 1042710 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302405.0000993.1500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAOCULAR LENS, removal of, and replacement with a lens inserted into the 5001.12.2023posterior chamber and fixated to the iris or sclera (Anaes.) (Assist.) 1042713 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301005.0000413.8500000.00 4026.05.2002(Anaes.) 5001.12.2023IRIS SUTURING, McCannell technique or similar, for fixation of intraocular 5001.12.2023lens or repair of iris defect (Anaes.) (Assist.) 1042716 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303700.0001316.1000000.00 4026.05.2002(Anaes.) 5001.12.2023CATARACT, JUVENILE, removal of, including subsequent needlings (Anaes.) 5001.12.2023(Assist.) 1042719 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301670.0000571.2500000.00 4026.05.2002(Anaes.) 5001.12.2023REMOVAL OF VITREOUS, and/or CAPSULAR or LENS MATERIAL, via a limbal 5001.12.2023approach,not being a service associated with a service to which item 42698, 5001.12.202342702, 42716, 42725 or 42731 applies (Anaes.) (Assist.) 1042725 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303995.0001473.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Vitrectomy via pars plana sclerotomy, including one or more of the 5001.12.2023following:(a) removal of vitreous; (b) division of vitreous bands; (c) removal 5001.12.2023of epiretinal membranes; (d) capsulotomy (Anaes.) (Assist.) 1042731 26.05.2002 3 T8 9 SN NYNNY 2001.12.202304520.0001671.9500000.00 4026.05.2002(Anaes.) 5001.12.2023LIMBAL OR PARS PLANA LENSECTOMY combined with vitrectomy, not being a service 5001.12.2023associated with items 42698, 42702, 42719, or 42725 (Anaes.) (Assist.) 1042734 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301000.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Capsulotomy, other than by laser, and other than a service associated with a 5001.12.2023service to which item 42725 or 42731 applies (Anaes.) (Assist.) 1042738 01.03.2012 3 T8 9 SN NYNNY 2001.12.202301005.0000331.0500000.00 5001.12.2023PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the 5001.12.2023injection of therapeutic substances, or the removal of aqueous or vitreous 5001.12.2023humours for diagnostic or therapeutic purposes, 1 or more of, as an 5001.12.2023independent procedure. 1042739 01.03.2012 3 T8 9 SN NYNNY 2001.12.202301005.0000331.0500000.00 4001.03.2012(Anaes.) 5001.12.2023PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the 5001.12.2023injection of therapeutic substances, or the removal of aqueous or vitreous 5001.12.2023humours for diagnostic or therapeutic purposes,one or more of, as an 5001.12.2023independent procedure, for a patient requiring the administration of 5001.12.2023anaesthetic by an anaesthetist. (Anaes.) 1042740 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301005.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023INTRAVITREAL INJECTION OF THERAPEUTIC SUBSTANCES, or the removal of vitreous 5001.12.2023humour for diagnostic purposes, 1 or more of, as a procedure associated with 5001.12.2023other intraocular surgery. (Anaes.) 1042741 01.07.2008 3 T8 9 SN NYNNY 2001.12.202301005.0000331.0500000.00 4001.07.2008(Anaes.) 5001.12.2023Posterior juxtascleral depot injection of a therapeutic substance, for the 5001.12.2023treatment of subfoveal choroidal neovascularisation due to age-related macular 5001.12.2023degeneration, 1 or more of (Anaes.) 1042743 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302035.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023ANTERIOR CHAMBER, IRRIGATION OF BLOOD FROM, as an independent procedure 5001.12.2023(Anaes.) (Assist.) 1042744 01.11.2005 3 T8 9 SN NYNNY 2001.12.202300910.0000330.8500000.00 4001.11.2005(Anaes.) 5001.12.2023Needle revision of glaucoma filtration bleb, following glaucoma filtering 5001.12.2023procedure (Anaes.) 1042746 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302975.0001051.2000000.00 4026.05.2002(Anaes.) 5001.12.2023GLAUCOMA, filtering operation for, where conservative therapies have failed, 5001.12.2023are likely to fail, or are contraindicated (Anaes.) (Assist.) 1042749 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303690.0001316.1000000.00 4026.05.2002(Anaes.) 5001.12.2023GLAUCOMA, filtering operation for, where previous filtering operation has been 5001.12.2023performed (Anaes.) (Assist.) 1042752 26.05.2002 3 T8 9 SN NYNNY 2001.12.202304130.0001473.2500000.00 4026.05.2002(Anaes.) 5001.12.2023GLAUCOMA, insertion of drainage device incorporating an extraocular reservoir 5001.12.2023for, such as a Molteno device (Anaes.) (Assist.) 1042755 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300515.0000182.1000000.00 4026.05.2002(Anaes.) 5001.12.2023GLAUCOMA, removal of drainage device incorporating an extraocular reservoir 5001.12.2023for, such as a Molteno device (Anaes.) 1042758 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302180.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Goniotomy for the treatment of primary congenital glaucoma, excluding the 5001.12.2023minimally invasive implantation of glaucoma drainage devices (Anaes.) 5001.12.2023(Assist.) 1042761 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301670.0000571.2500000.00 4026.05.2002(Anaes.) 5001.12.2023DIVISION OF ANTERIOR OR POSTERIOR SYNECHIAE, as an independent procedure, 5001.12.2023other than by laser (Anaes.) (Assist.) 1042764 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301450.0000571.2500000.00 4026.05.2002(Anaes.) 5001.12.2023IRIDECTOMY (including excision of tumour of iris) OR IRIDOTOMY, as an 5001.12.2023independent procedure, other than by laser (Anaes.) (Assist.) 1042767 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303340.0001200.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, INVOLVING CILIARY BODY OR CILIARY BODY AND IRIS, excision of (Anaes.) 5001.12.2023(Assist.) 1042770 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300915.0000324.4500000.00 4026.05.2002(Anaes.) 5001.12.2023CYCLODESTRUCTIVE procedures for the treatment of intractable glaucoma, 5001.12.2023treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year 5001.12.2023period (Anaes.) (Assist.) 1042773 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302395.0000993.1500000.00 4026.05.2002(Anaes.) 5001.12.2023DETACHED RETINA, pneumatic retinopexy for, not being a service associated with 5001.12.2023a service to which item 42776 applies (Anaes.) (Assist.) 1042776 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303630.0001473.2500000.00 4026.05.2002(Anaes.) 5001.12.2023DETACHED RETINA, buckling or resection operation for (Anaes.) (Assist.) 1042779 26.05.2002 3 T8 9 SN NYNNY 2001.12.202303635.0001837.6000000.00 4026.05.2002(Anaes.) 5001.12.2023DETACHED RETINA, revision of scleral buckling operation for (Anaes.) (Assist.) 1042782 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301205.0000496.4500000.00 4026.05.2002(Anaes.) 5001.12.2023LASER TRABECULOPLASTY, for the treatment of glaucoma. Each treatment to 1 eye, 5001.12.2023to a maximum of 4 treatments to that eye in a 2 year period (Anaes.) (Assist.) 1042785 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300950.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023LASER IRIDOTOMY - each treatment episode to 1 eye, to a maximum of 3 5001.12.2023treatments to that eye in a 2 year period (Anaes.) (Assist.) 1042788 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300950.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Laser capsulotomyeach treatment episode to one eye, to a maximum of 2 5001.12.2023treatments to that eye in a 2 year periodother than a service associated with 5001.12.2023a service to which item 42702 applies (Anaes.) (Assist.) 1042791 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300950.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding 5001.12.2023vitreolysis in the posterior vitreous cavityeach treatment to one eye, to a 5001.12.2023maximum of 3 treatments to that eye in a 2 year period (Anaes.) (Assist.) 1042794 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300176.0000074.5500000.00 4026.05.2002(Anaes.) 5001.12.2023DIVISION OF SUTURE BY LASER following glaucoma filtration surgery, each 5001.12.2023treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year 5001.12.2023period (Anaes.) 1042801 01.11.2006 3 T8 9 SN NYNNY 2001.12.202303185.0001155.4500000.00 4001.11.2006(Anaes.) 5001.12.2023EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment 5001.12.2023of choroidal melanomas, insertion of (Anaes.) (Assist.) 1042802 01.11.2006 3 T8 9 SN NYNNY 2001.12.202301590.0000577.5000000.00 4001.11.2006(Anaes.) 5001.12.2023EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment 5001.12.2023of choroidal melanomas, removal of (Anaes.) (Assist.) 1042805 01.11.2005 3 T8 9 SN NYNNY 2001.12.202301775.0000645.5500000.00 4001.11.2005(Anaes.) 5001.12.2023TANTALUM MARKERS, surgical insertion to the sclera to localise the tumour base 5001.12.2023to assist in planning of radiotherapy of choroidal melanomas, 1 or more 5001.12.2023(Anaes.) (Assist.) 1042806 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300950.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023IRIS TUMOUR, laser photocoagulation of (Anaes.) (Assist.) 1042807 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301100.0000391.6000000.00 5001.12.2023PHOTOMYDRIASIS, laser 1042808 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301100.0000391.6000000.00 5001.12.2023Laser peripheral iridoplasty 1042809 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301305.0000496.4500000.00 4026.05.2002(Anaes.) 5001.12.2023RETINA, photocoagulation of, not being a service associated with photodynamic 5001.12.2023therapy with verteporfin (Anaes.) (Assist.) 1042810 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301710.0000624.8500000.00 4026.05.2002(Anaes.) 5001.12.2023PHOTOTHERAPEUTIC KERATECTOMY, by laser, for corneal scarring or disease, 5001.12.2023excluding surgery for refractive error (Anaes.) 1042811 01.11.2005 3 T8 9 SN NYNNY 2001.12.202301365.0000496.4500000.00 4001.11.2005(Anaes.) 5001.12.2023TRANSPUPILLARY THERMOTHERAPY, for treatment of choroidal and retinal tumours 5001.12.2023or vascular malformations (Anaes.) 1042812 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300535.0000182.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of scleral buckling material, from an eye having undergone previous 5001.12.2023scleral buckling surgery (Anaes.) 1042815 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301735.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023VITREOUS CAVITY, removal of silicone oil or other liquid vitreous substitutes 5001.12.2023from, during a procedure other than that in which the vitreous substitute is 5001.12.2023inserted (Anaes.) (Assist.) 1042818 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301595.0000645.5500000.00 4026.05.2002(Anaes.) 5001.12.2023RETINA, CRYOTHERAPY TO, as an independent procedure, or when performed in 5001.12.2023conjunction with item 42809 or 42770 (Anaes.) 1042821 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300270.0000099.5000000.00 4026.05.2002(Anaes.) 5001.12.2023OCULAR TRANSILLUMINATION, for the diagnosis and measurement of intraocular 5001.12.2023tumours (Anaes.) 1042824 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300205.0000076.9000000.00 5001.12.2023RETROBULBAR INJECTION OF ALCOHOL OR OTHER DRUG, as an independent procedure 1042833 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301890.0000645.5500000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 5001.12.2023OR 2 MUSCLES on a patient aged 15 years or over (Anaes.) (Assist.) 1042836 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302225.0000802.8500000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 5001.12.2023OR 2 MUSCLES, on a patient aged 14 years or under, or where the patient has 5001.12.2023had previous squint, retinal or extra ocular operations on the eye or eyes, or 5001.12.2023on a patient with concurrent thyroid eye disease (Anaes.) (Assist.) 1042839 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302180.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 5001.12.2023OR MORE MUSCLES on a patient aged 15 years or over (Anaes.) (Assist.) 1042842 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302660.0000960.1500000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 5001.12.2023or MORE MUSCLES, on a patient aged 14 years or under, or where the patient has 5001.12.2023had previous squint, retinal or extra ocular operations on the eye or eyes, or 5001.12.2023on a patient with concurrent thyroid eye disease (Anaes.) (Assist.) 1042845 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300555.0000208.5000000.00 4026.05.2002(Anaes.) 5001.12.2023READJUSTMENT OF ADJUSTABLE SUTURES, 1 or both eyes, as an independent 5001.12.2023procedure following an operation for correction of squint (Anaes.) 1042848 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302180.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a 5001.12.2023patient aged 15 years or over (Anaes.) (Assist.) 1042851 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302180.0000960.1500000.00 4026.05.2002(Anaes.) 5001.12.2023SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a 5001.12.2023patient aged 14 years or under, or where the patient has had previous squint, 5001.12.2023retinal or extra ocular operations on the eye or eyes, or on a patient with 5001.12.2023concurrent thyroid eye disease (Anaes.) (Assist.) 1042854 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301090.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023RUPTURED MEDIAL PALPEBRAL LIGAMENT or ruptured EXTRAOCULAR MUSCLE, repair of 5001.12.2023(Anaes.) (Assist.) 1042857 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301205.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023RESUTURING OF WOUND FOLLOWING INTRAOCULAR PROCEDURES with or without excision 5001.12.2023of prolapsed iris (Anaes.) (Assist.) 1042860 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302580.0000993.1500000.00 4026.05.2002(Anaes.) 5001.12.2023EYELID (upper or lower), scleral or Goretex or other non-autogenous graft to, 5001.12.2023with recession of the lid retractors (Anaes.) (Assist.) 1042863 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302445.0000852.6000000.00 4026.05.2002(Anaes.) 5001.12.2023EYELID, recession of (Anaes.) (Assist.) 1042866 26.05.2002 3 T8 9 SN NYNNY 2001.12.202302170.0000827.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ENTROPION or TARSAL ECTROPION, repair of, by tightening, shortening or repair 5001.12.2023of inferior retractors by open operation across the entire width of the eyelid 5001.12.2023(Anaes.) (Assist.) 1042869 26.05.2002 3 T8 9 SN NYNNY 2001.12.202301520.0000604.3000000.00 4026.05.2002(Anaes.) 5001.12.2023EYELID closure in facial nerve paralysis, insertion of foreign implant for 5001.12.2023(Anaes.) (Assist.) 1042872 26.05.2002 3 T8 9 SN NYNNY 2001.12.202300735.0000264.9000000.00 4026.05.2002(Anaes.) 5001.12.2023EYEBROW, elevation of, by skin excision, to correct for a reduced field of 5001.12.2023vision caused by paretic, involutional, or traumatic eyebrow descent/ptosis to 5001.12.2023a position below the superior orbital rim (Anaes.) 1043021 01.08.2007 3 T8 9 DN NYNNY 2001.12.202302020.0000500.9000000.00 5001.12.2023Photodynamic therapy, one eye, including the infusion of Verteporfin 5001.12.2023continuously through a peripheral vein, using a non-thermal laser at a 5001.12.2023wavelength of 689nm, for the treatment of choroidal neovascularisation. 1043022 01.08.2007 3 T8 9 DN NYNNY 2001.12.202302215.0000601.1500000.00 5001.12.2023Photodynamic therapy, both eyes, including the infusion of Verteporfin 5001.12.2023continuously through a peripheral vein, using a non-thermal laser at a 5001.12.2023wavelength of 689nm, for the treatment of choroidal neovascularisation. 1043023 01.08.2007 3 T8 9 DN NYNNY 2001.12.202300550.0000097.3500000.00 5001.12.2023Infusion of Verteporfin for discontinued photodynamic therapy, where a session 5001.12.2023of therapy which would have been provided under item 43021 or 43022 has been 5001.12.2023discontinued on medical grounds. 1043521 26.05.2002 3 T8 10 SN NYNNY 2001.12.202301320.0000511.3500000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATION ON SKULL (Anaes.) (Assist.) 1043527 01.07.2021 3 T8 10 SN NYNNY 2001.12.202301015.0000392.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Operation on sternum, clavicle, rib, metacarpus, carpus, phalanx, metatarsus, 5001.12.2023tarsus, mandible or maxilla (other than alveolar margins), by open or 5001.12.2023arthroscopic means, for septic arthritis or osteomyelitisone approach, 5001.12.2023inclusive of the adjoining joint (H) (Anaes.) (Assist.) 1043530 01.07.2021 3 T8 10 SN NYNNY 2001.12.202301015.0000392.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Operation on scapula, ulna, radius, tibia, fibula, humerus or femur, by open 5001.12.2023or arthroscopic means, for septic arthritis or osteomyelitisone approach, 5001.12.2023inclusive of the adjoining joint (Anaes.) (Assist.) 1043533 01.07.2021 3 T8 10 SN NYNNY 2001.12.202301715.0000646.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Operation on spine or pelvic bones, by open or arthroscopic means, for septic 5001.12.2023arthritis or osteomyelitisone approach, inclusive of the adjoining joint 5001.12.2023(Anaes.) (Assist.) 1043801 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302775.0001053.7500000.00 4026.05.2002(Anaes.) 5001.12.2023INTESTINAL MALROTATION with or without volvulus, laparotomy for, not involving 5001.12.2023bowel resection (Anaes.) (Assist.) 1043804 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302955.0001121.9000000.00 4026.05.2002(Anaes.) 5001.12.2023INTESTINAL MALROTATION with or without volvulus, laparotomy for, with bowel 5001.12.2023resection and anastomosis, with or without formation of stoma (Anaes.) 5001.12.2023(Assist.) 1043807 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303220.0001223.9500000.00 4026.05.2002(Anaes.) 5001.12.2023DUODENAL ATRESIA or STENOSIS, duodenoduodenostomy or duodenojejunostomy for 5001.12.2023(Anaes.) (Assist.) 1043810 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303760.0001427.9500000.00 4026.05.2002(Anaes.) 5001.12.2023JEJUNAL ATRESIA, bowel resection and anastomosis for, with or without tapering 5001.12.2023(Anaes.) (Assist.) 1043813 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303760.0001427.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MECONIUM ILEUS, laparotomy for, complicated by 1 or more of associated 5001.12.2023volvulus, atresia, intesinal perforation with or without meconium peritonitis 5001.12.2023(Anaes.) (Assist.) 1043816 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303490.0001325.9000000.00 4026.05.2002(Anaes.) 5001.12.2023ILEAL ATRESIA, COLONIC ATRESIA OR MECONIUM ILEUS not being a service 5001.12.2023associated with a service to which item 43813 applies, laparotomy for (Anaes.) 5001.12.2023(Assist.) 1043819 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302820.0001071.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Agangliosis Coli, laparotomy for, with or without frozen section biopsies and 5001.12.2023formation of stoma (Anaes.) (Assist.) 1043822 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302820.0001071.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ANORECTAL MALFORMATION, laparotomy and colostomy for (Anaes.) (Assist.) 1043825 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303220.0001223.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NEONATAL ALIMENTARY OBSTRUCTION, laparotomy for, not being a service to which 5001.12.2023any other item in this Subgroup applies (Anaes.) (Assist.) 1043828 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303560.0001352.2500000.00 4026.05.2002(Anaes.) 5001.12.2023ACUTE NEONATAL NECROTISING ENTEROCOLITIS, laparotomy for, with resection, 5001.12.2023including any anastomoses or stoma formation (Anaes.) (Assist.) 1043831 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302775.0001053.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ACUTE NEONATAL NECROTISING ENTEROCOLITIS where no definitive procedure is 5001.12.2023possible, laparotomy for (Anaes.) (Assist.) 1043834 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303220.0001223.9500000.00 4026.05.2002(Anaes.) 5001.12.2023BOWEL RESECTION for necrotising enterocolitis stricture or strictures, 5001.12.2023including any anastomoses or stoma formation (Anaes.) (Assist.) 1043837 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304025.0001529.9000000.00 4026.05.2002(Anaes.) 5001.12.2023CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, 5001.12.2023with diagnosis confirmed in the first 24 hours of life (Anaes.) (Assist.) 1043840 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303490.0001325.9000000.00 4026.05.2002(Anaes.) 5001.12.2023CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, 5001.12.2023diagnosed after the first day of life and before 20 days of age (Anaes.) 5001.12.2023(Assist.) 1043843 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305370.0002040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), 5001.12.2023complete correction of, not being a service to which item 43846 applies 5001.12.2023(Anaes.) (Assist.) 1043846 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305770.0002192.9000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), 5001.12.2023complete correction of, in infant of birth weight less than 1500 grams 5001.12.2023(Anaes.) (Assist.) 1043849 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301475.0000561.0000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA, gastrostomy for (Anaes.) (Assist.) 1043852 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304700.0001784.8500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA, thoracotomy for, and division of tracheo-oesophageal 5001.12.2023fistula without anastomosis (Anaes.) (Assist.) 1043855 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304965.0001887.0500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA, delayed primary anastomosis for (Anaes.) (Assist.) 1043858 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301745.0000662.9500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA, cervical oesophagostomy for (Anaes.) (Assist.) 1043861 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304830.0001836.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CONGENITAL CYSTADENOMATOID MALFORMATION OR CONGENITAL LOBAR EMPHYSEMA, 5001.12.2023thoracotomy and lung resection for (Anaes.) (Assist.) 1043864 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303625.0001377.0000000.00 4026.05.2002(Anaes.) 5001.12.2023GASTROSCHISIS, operation for (Anaes.) (Assist.) 1043867 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302015.0000764.9500000.00 4026.05.2002(Anaes.) 5001.12.2023GASTROSCHISIS or Exomphalos, secondary operation for, with removal of silo 5001.12.2023(Anaes.) (Assist.) 1043870 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302820.0001071.0000000.00 4026.05.2002(Anaes.) 5001.12.2023EXOMPHALOS containing small bowel only, operation for (Anaes.) (Assist.) 1043873 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303760.0001427.9500000.00 4026.05.2002(Anaes.) 5001.12.2023EXOMPHALOS containing small bowel and other viscera, operation for (Anaes.) 5001.12.2023(Assist.) 1043876 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303220.0001223.9500000.00 4026.05.2002(Anaes.) 5001.12.2023SACROCOCCYGEAL TERATOMA, excision of, by posterior approach (Anaes.) (Assist.) 1043879 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303760.0001427.9500000.00 4026.05.2002(Anaes.) 5001.12.2023SACROCOCCYGEAL TERATOMA, excision of, by combined posterior and abdominal 5001.12.2023approach (Anaes.) (Assist.) 1043882 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304830.0001836.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Cloacal exstrophy, operation for (H) (Anaes.) (Assist.) 1043900 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303180.0001223.9500000.00 4026.05.2002(Anaes.) 5001.12.2023TRACHEO-OESOPHAGEAL FISTULA without atresia, division and repair of (Anaes.) 5001.12.2023(Assist.) 1043903 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305300.0002040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGEAL ATRESIA or CORROSIVE OESOPHAGEAL STRICTURE, oesophageal 5001.12.2023replacement for, utilizing gastric tube, jejunum or colon (Anaes.) (Assist.) 1043906 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304640.0001784.8500000.00 4026.05.2002(Anaes.) 5001.12.2023OESOPHAGUS, resection of congenital, anastomic or corrosive stricture and 5001.12.2023anastomosis, not being a service to which item 43903 applies (Anaes.) 5001.12.2023(Assist.) 1043909 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304640.0001784.8500000.00 4026.05.2002(Anaes.) 5001.12.2023TRACHEOMALACIA, aortopexy for (Anaes.) (Assist.) 1043912 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304380.0001686.2500000.00 4026.05.2002(Anaes.) 5001.12.2023THORACOTOMY and excision of 1 or more of bronchogenic or enterogenous cyst or 5001.12.2023mediastinal teratoma (Anaes.) (Assist.) 1043915 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303315.0001275.0000000.00 4026.05.2002(Anaes.) 5001.12.2023EVENTRATION, plication of diaphragm for (Anaes.) (Assist.) 1043930 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301420.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023HYPERTROPHIC PYLORIC STENOSIS, pyloromyotomy for (Anaes.) (Assist.) 1043933 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301500.0000573.9500000.00 4026.05.2002(Anaes.) 5001.12.2023IDIOPATHIC INTUSSUSCEPTION, laparotomy and manipulative reduction of (Anaes.) 5001.12.2023(Assist.) 1043936 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302800.0001071.0000000.00 4026.05.2002(Anaes.) 5001.12.2023INTUSSUSCEPTION, laparotomy and resection with anastomosis (Anaes.) (Assist.) 1043939 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302135.0000815.9500000.00 4026.05.2002(Anaes.) 5001.12.2023VENTRAL HERNIA following neonatal closure of exomphalos or gastroschisis, 5001.12.2023repair of (Anaes.) (Assist.) 1043942 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300665.0000255.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ABDOMINAL WALL VITELLO INTESTINAL REMNANT, excision of (Anaes.) 1043945 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302800.0001071.0000000.00 4026.05.2002(Anaes.) 5001.12.2023PATENT VITELLO INTESTINAL DUCT, excision of (Anaes.) (Assist.) 1043948 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300400.0000153.1000000.00 4026.05.2002(Anaes.) 5001.12.2023UMBILICAL GRANULOMA, excision of, under general anaesthesia (Anaes.) 1043951 26.05.2002 3 T8 11 SN NYNNY 2001.12.202302510.0000959.0500000.00 4026.05.2002(Anaes.) 5001.12.2023GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and 5001.12.2023fundoplication for, without gastrostomy (Anaes.) (Assist.) 1043954 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303070.0001173.1000000.00 4026.05.2002(Anaes.) 5001.12.2023GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and 5001.12.2023fundoplication for, with gastrostomy (Anaes.) (Assist.) 1043957 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303335.0001275.0000000.00 4026.05.2002(Anaes.) 5001.12.2023GASTRO-OESOPHAGEAL REFLUX, LAPAROTOMY AND FUNDOPLICATION for, with or without 5001.12.2023hiatus hernia, in child with neurological disease, with gastrostomy (Anaes.) 5001.12.2023(Assist.) 1043960 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301175.0000448.5500000.00 4026.05.2002(Anaes.) 5001.12.2023ANORECTAL MALFORMATION, perineal anoplasty of (Anaes.) (Assist.) 1043963 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304670.0001784.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of (Anaes.) 5001.12.2023(Assist.) 1043966 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305335.0002040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of, with laparotomy 5001.12.2023(Anaes.) (Assist.) 1043969 26.05.2002 3 T8 11 SN NYNNY 2001.12.202307335.0002805.0000000.00 4026.05.2002(Anaes.) 5001.12.2023PERSISTENT CLOACA, total correction of, with genital repair using posterior 5001.12.2023sagittal approach, with or without laparotomy (Anaes.) (Assist.) 1043972 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305335.0002040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLEDOCHAL CYST, resection of, with 1 duct anastomosis (Anaes.) (Assist.) 1043975 26.05.2002 3 T8 11 SN NYNNY 2001.12.202306270.0002397.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CHOLEDOCHAL CYST, resection of, with 2 duct anastomoses (Anaes.) (Assist.) 1043978 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305335.0002040.0000000.00 4026.05.2002(Anaes.) 5001.12.2023BILIARY ATRESIA, portoenterostomy for (Anaes.) (Assist.) 1043981 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301465.0000561.0000000.00 4026.05.2002(Anaes.) 5001.12.2023NEPHROBLASTOMA, NEUROBLASTOMA OR OTHER MALIGNANT TUMOUR, laparotomy 5001.12.2023(exploratory), including associated biopsies, where no other intra-abdominal 5001.12.2023procedure is performed (Anaes.) (Assist.) 1043984 26.05.2002 3 T8 11 SN NYNNY 2001.12.202303735.0001427.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NEPHROBLASTOMA, radical nephrectomy for (Anaes.) (Assist.) 1043987 26.05.2002 3 T8 11 SN NYNNY 2001.12.202304135.0001581.0500000.00 4026.05.2002(Anaes.) 5001.12.2023NEUROBLASTOMA, radical excision of (Anaes.) (Assist.) 1043990 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305070.0001938.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Aganglionosis Coli, definitive resection with pull-through anastomosis, with 5001.12.2023or without frozen section biopsies, when aganglionic segment extends to 5001.12.2023sigmoid colon (Anaes.) (Assist.) 1043993 26.05.2002 3 T8 11 SN NYNNY 2001.12.202305470.0002091.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Aganglionosis Coli, definitive resection with pull-through anastomosis, with 5001.12.2023or without frozen section biopsies, when aganglionic segment extends into 5001.12.2023descending or transverse colon with or without resiting of stoma (Anaes.) 5001.12.2023(Assist.) 1043996 26.05.2002 3 T8 11 SN NYNNY 2001.12.202306135.0002346.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Aganglionosis Coli, total colectomy for total colonic aganglionosis with 5001.12.2023ileoanal pull-through, with or without side to side ileocolic anastomosis 5001.12.2023(Anaes.) (Assist.) 1043999 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300765.0000293.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Aganglionosis Coli, anal sphincterotomy as an independent procedure for 5001.12.2023(Anaes.) (Assist.) 1044102 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300740.0000282.8500000.00 4026.05.2002(Anaes.) 5001.12.2023RECTUM, examination of, on a patient 2 years of age or over, under general 5001.12.2023anaesthesia with full thickness biopsy or removal of polyp or similar lesion 5001.12.2023(Anaes.) (Assist.) 1044105 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300130.0000049.6000000.00 4026.05.2002(Anaes.) 5001.12.2023RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a patient 2 years 5001.12.2023of age or over, under general anaesthesia (Anaes.) 1044130 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301335.0000509.9500000.00 4026.05.2002(Anaes.) 5001.12.2023LYMPHADENECTOMY, for atypical mycobacterial infection or other granulomatous 5001.12.2023disease (Anaes.) (Assist.) 1044133 26.05.2002 3 T8 11 SN NYNNY 2001.12.202301060.0000404.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TORTICOLLIS, open division of sternomastoid muscle for (Anaes.) (Assist.) 1044136 26.05.2002 3 T8 11 SN NYNNY 2001.12.202300490.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023INGROWN TOE NAIL, operation for, under general anaesthesia (Anaes.) 1044325 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300870.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of hand, transcarpal (H) (Anaes.) (Assist.) 1044328 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301015.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of hand, proximal to wrist radiocarpal joint, through forearm (H) 5001.12.2023(Anaes.) (Assist.) 1044331 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301715.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023AMPUTATION AT SHOULDER (Anaes.) (Assist.) 1044334 26.05.2002 3 T8 12 SN NYNNY 2001.12.202303410.0001314.5500000.00 4026.05.2002(Anaes.) 5001.12.2023INTERSCAPULOTHORACIC AMPUTATION (Anaes.) (Assist.) 1044338 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300465.0000158.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of one digit of one foot, distal to metatarsal head, including any 5001.12.2023of the following (if performed): (a) resection of bone or joint; (b) excision 5001.12.2023of neuroma; (c) skin cover with homodigital flaps (H) (Anaes.) (Assist.) 1044342 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300695.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of 2 digits of one foot, distal to metatarsal head, including any 5001.12.2023of the following (if performed): (a) resection of bone or joint; (b) excision 5001.12.2023of neuroma; (c) skin cover with homodigital flaps (H) (Anaes.) (Assist.) 1044346 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300930.0000279.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of 3 digits of one foot, distal to metatarsal head, including any 5001.12.2023of the following (if performed): (a) resection of bone or joint; (b) excision 5001.12.2023of neuroma; (c) skin cover with homodigital flaps (H) (Anaes.) (Assist.) 1044350 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301160.0000317.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of 4 digits of one foot, distal to metatarsal head, including any 5001.12.2023of the following (if performed): (a) resection of bone or joint; (b) excision 5001.12.2023of neuroma; (c) skin cover with homodigital flaps (H) (Anaes.) (Assist.) 1044354 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301395.0000363.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of 5 digits of one foot, distal to metatarsal head, including any 5001.12.2023of the following (if performed): (a) resection of bone or joint; (b) excision 5001.12.2023of neuroma; (c) skin cover with homodigital flaps (H) (Anaes.) (Assist.) 1044358 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300695.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of one ray of one foot, proximal to the metatarsal head, including 5001.12.2023any of the following (if performed): (a) resection of bone; (b) excision of 5001.12.2023neuromas; (c) skin cover or recontouring with homodigital flaps (H) (Anaes.) 5001.12.2023(Assist.) 1044359 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300950.0000290.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of one or more toes of one foot, or amputation at midfoot or 5001.12.2023hindfoot of one foot, for diabetic or other microvascular disease; (a) 5001.12.2023including any of the following (if performed): (i) resection of bone; (ii) 5001.12.2023excision of neuromas; (iii) excision of one or more bones of the foot; (iv) 5001.12.2023treatment of underlying infection; (v) skin cover or recontouring with 5001.12.2023homodigital flaps; and (b) excluding aftercare; applicable only once per foot 5001.12.2023per occasion on which the service is performed (H) (Anaes.) (Assist.) 1044361 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301255.0000480.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of foot, at ankle or hindfoot, including any of the following (if 5001.12.2023performed): (a) resection of bone; (b) excision of neuromas; (c) skin cover; 5001.12.2023(H) (Anaes.) (Assist.) 1044364 26.05.2002 3 T8 12 SN NYNNY 2001.12.202300870.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of foot, transtarsal, including any of the following (if 5001.12.2023performed): (a) resection of bone; (b) excision of neuromas; (c) skin cover; 5001.12.2023(H) (Anaes.) (Assist.) 1044367 26.05.2002 3 T8 12 SN NYNNY 2001.12.202301495.0000574.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation through thigh, at knee or below knee (H) (Anaes.) (Assist.) 1044370 26.05.2002 3 T8 12 SN NYNNY 2001.12.202302105.0000792.7500000.00 4026.05.2002(Anaes.) 5001.12.2023AMPUTATION AT HIP (Anaes.) (Assist.) 1044373 26.05.2002 3 T8 12 SN NYNNY 2001.12.202304285.0001627.2500000.00 4026.05.2002(Anaes.) 5001.12.2023HINDQUARTER, amputation of (Anaes.) (Assist.) 1044376 26.05.2002 3 T8 12 SD NNNNY 3001.12.202375% of the original amputation fee 4026.05.2002(Anaes.) 5001.12.2023Amputation stump, reamputation of, to provide adequate skin and muscle cover 5001.12.2023(Anaes.) (Assist.) 1045000 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301875.0000595.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage local muscle flap repair, on eyelid, nose, lip, neck, hand, 5001.12.2023thumb, finger or genitals not in association with any of items 31356 to 31383 5001.12.2023(Anaes.) 1045003 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302085.0000662.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage local myocutaneous flap repair to one defect, simple and small 5001.12.2023not in association with any of items 31356 to 31383 (Anaes.) 1045006 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303595.0001142.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage large myocutaneous flap repair to one defect (pectoralis major, 5001.12.2023latissimus dorsi, or similar large muscle), other than a service associated 5001.12.2023with a service to which any of items 45524 to 45542 apply (H) (Anaes.) 5001.12.2023(Assist.) 1045009 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301135.0000417.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage localmuscle flap repair to 1 defect, simple and small,other than 5001.12.2023a service associated with a service to which item 30278, 30281 or 41722 5001.12.2023applies (H) (Anaes.) (Assist.) 1045012 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301920.0000856.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage large muscle flap repair to one defect (pectoralis major, 5001.12.2023gastrocnemius, gracilis or similar large muscle), other than a service 5001.12.2023associated with a service to which any of items 45524 to 45542 apply (H) 5001.12.2023(Anaes.) (Assist.) 1045015 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301045.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE OR MYOCUTANEOUS FLAP, delay of (Anaes.) 1045018 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301785.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Dermis, dermofat or fascia graft (other than transfer of fat by injection): 5001.12.2023(a) if the service is not associated with neurosurgical services for spinal 5001.12.2023disorders mentioned in any of items 51011 to 51171; and (b) other than a 5001.12.2023service associated with a service to which item 39615, 39715, 40106 or 40109 5001.12.2023applies (Anaes.) (Assist.) 1045019 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301330.0000436.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Full face chemical peel for severely sundamaged skin, if: (a) the damage 5001.12.2023affects at least 75% of the facial skin surface area; and (b) the damage 5001.12.2023involves photo-damage (dermatoheliosis); and (c) the photo-damage involves: 5001.12.2023(i) a solar keratosis load exceeding 30 individual lesions; or (ii) solar 5001.12.2023lentigines; or (iii) freckling, yellowing or leathering of the skin; or (iv) 5001.12.2023solar kertoses which have proven refractory to, or recurred following, medical 5001.12.2023therapies; and (d) at least medium depth peeling agents are used; and (e) the 5001.12.2023chemical peel is performed in the operating theatre of a hospital by a medical 5001.12.2023practitioner recognised as a specialist in the specialty of dermatology or 5001.12.2023plastic surgery. Applicable once only in any 12 month period (Anaes.) 1045021 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300535.0000195.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Abrasive therapy for severely disfiguring scarring of face resulting from 5001.12.2023trauma, burns or acne, if sufficient photographic evidence demonstrating the 5001.12.2023clinical need for the service is included in patient noteslimited to one claim 5001.12.2023per patient per episode (Anaes.) 1045025 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300535.0000195.2000000.00 4026.05.2002(Anaes.) 5001.12.2023CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) 5001.12.2023resurfacing of the face or neck for severely disfiguring scarring resulting 5001.12.2023from trauma, burns or acne - limited to 1 aesthetic area (Anaes.) 1045026 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301200.0000438.7000000.00 4026.05.2002(Anaes.) 5001.12.2023CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) 5001.12.2023resurfacing of the face or neck for severely disfiguring scarring resulting 5001.12.2023from trauma, burns or acne - more than 1 aesthetic area (Anaes.) 1045027 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300415.0000132.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly, cauterisation of or injection into, if undertaken in the 5001.12.2023operating theatre of a hospital (Anaes.) 1045030 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300400.0000149.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly, of skin, mucous membrane and/or subcutaneous tissue, small, 5001.12.2023excision and suture of (Anaes.) 1045033 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300835.0000270.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly, large or involving deeper tissue including facial muscle, 5001.12.2023excision and suture of (Anaes.) (Assist.) 1045035 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302345.0000772.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly, large, deep, and involving major neurovascular structures, 5001.12.2023excision of, including dissection of muscles, nerves or major vessels (H) 5001.12.2023(Anaes.) (Assist.) 1045036 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303910.0001241.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly, of neck, deep and involving major neurovascular structures, 5001.12.2023excision of, including dissection of cranial nerves and major vessels (H) 5001.12.2023(Anaes.) (Assist.) 1045045 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301070.0000339.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Vascular anomaly on eyelid, nose, lip, ear, neck, hand, thumb, finger or 5001.12.2023genitals, excision of (Anaes.) 1045048 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302585.0000852.6000000.00 4026.05.2002(Anaes.) 5001.12.2023LYMPHOEDEMATOUS tissue or lymphangiectasis, of lower leg and foot, or thigh, 5001.12.2023or upper arm, or forearm and hand, major excision of (Anaes.) (Assist.) 1045051 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301595.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Contour reconstruction by open repair of contour defects, due to deformity, 5001.12.2023if: (a) contour reconstructive surgery is indicated because the deformity is 5001.12.2023secondary to congenital absence of tissue or has arisen from trauma (other 5001.12.2023than trauma from previous cosmetic surgery); and (b) insertion of a 5001.12.2023non-biological implant is required, other than one or more of the following: 5001.12.2023(i) insertion of a non-biological implant that is a component of another 5001.12.2023service specified in Group T8; (ii) injection of liquid or semisolid material; 5001.12.2023(iii) an oral and maxillofacial implant service to which item 52321 applies; 5001.12.2023(iv) a service to insert mesh; and (c) photographic and/or diagnostic imaging 5001.12.2023evidence demonstrating the clinical need for this service is documented in the 5001.12.2023patient notes (Anaes.) (Assist.) 1045054 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300725.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Limb or chest, decompression escharotomy of (including all incisions), for 5001.12.2023acute compartment syndrome secondary to burn (H) (Anaes.) (Assist.) 1045200 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300935.0000313.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage local flap, if indicated to repair one defect, simple and small, 5001.12.2023excluding flap for male pattern baldness and excluding H-flap or double 5001.12.2023advancement flap not in association with any of items 31356 to 31383 (Anaes.) 1045201 01.11.2016 3 T8 13 SN NYNYY 2001.12.202301380.0000455.6000000.00 4001.11.2016(Anaes.) 5001.12.2023Muscle, myocutaneous or skin flap, where clinically indicated to repair one 5001.12.2023surgical excision made in the removal of a malignant or non-malignant skin 5001.12.2023lesion (only in association with items 31000, 31001, 31002, 31003, 31004, 5001.12.202331005, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373, 31376, 5001.12.202331378, 31380 or 31383)-may be claimed only once per defect (Anaes.) 1045202 01.11.2016 3 T8 13 SN NYNNY 2001.12.202301380.0000455.6000000.00 4001.11.2016(Anaes.) 5001.12.2023Muscle, myocutaneous or skin flap, where clinically indicated to repair one 5001.12.2023surgical excision made in the removal of a malignant or non-malignant skin 5001.12.2023lesion in a patient, if the clinical relevance of the procedure is clearly 5001.12.2023annotated in the patient's record and either: (a) item 45201 applies and 5001.12.2023additional flap repair is required for the same defect; or (b) item 45201 does 5001.12.2023not apply and either: (i) the patient has severe pre-existing scarring, severe 5001.12.2023skin atrophy or sclerodermoid changes; or (ii) the repair is contiguous with a 5001.12.2023free margin (Anaes.) 1045203 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301405.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage local flap, if indicated to repair one defect, complicated or 5001.12.2023large, excluding flap for male pattern baldness and excluding H-flap or double 5001.12.2023advancement flap not in association with any of items 31356 to 31383 (Anaes.) 5001.12.2023(Assist.) 1045206 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301330.0000422.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Single stage local flap if indicated to repair one defect, on eyelid, nose, 5001.12.2023lip, ear, neck, hand, thumb, finger or genitals and excluding H-flap or double 5001.12.2023advancement flap not in association with any of items 31356 to 31383 (Anaes.) 1045207 01.11.2006 3 T8 13 SN NYNYY 2001.12.202301325.0000422.2000000.00 4001.11.2006(Anaes.) 5001.12.2023H-flap or double advancement flap if indicated to repair one defect, on 5001.12.2023eyelid, eyebrow or forehead not in association with any of items 31356 to 5001.12.202331383 (Anaes.) 1045209 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301785.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Pedicled flap repair (forehead, cross arm, cross leg, abdominal or similar), 5001.12.2023first stage of a multistage procedure (Anaes.) (Assist.) 1045212 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300885.0000258.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Pedicled flap repair (forehead, cross arm, cross leg, abdominal or similar), 5001.12.2023subsequent stage of a multistage procedure (Anaes.) (Assist.) 1045221 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300970.0000287.9500000.00 4026.05.2002(Anaes.) 5001.12.2023DIRECT FLAP REPAIR, small (cross finger or similar), first stage (Anaes.) 1045224 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300435.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023DIRECT FLAP REPAIR, small (cross finger or similar), second stage (Anaes.) 1045227 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301705.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023INDIRECT FLAP OR TUBED PEDICLE, formation of (Anaes.) (Assist.) 1045230 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300935.0000245.1500000.00 4026.05.2002(Anaes.) 5001.12.2023DIRECT OR INDIRECT FLAP OR TUBED PEDICLE, delay of (Anaes.) 1045233 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301870.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023INDIRECT FLAP OR TUBED PEDICLE, preparation of intermediate or final site and 5001.12.2023attachment to the site (Anaes.) (Assist.) 1045239 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300870.0000287.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Direct, indirect, free or local flap, revision of, by incision and suture 5001.12.2023and/or liposuction, applicable once per flap, not being a service associated 5001.12.2023with a service to which item 45497 applies (Anaes.) 1045440 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300863.0000313.0000000.00 4001.07.2023(Anaes.) 5001.12.2023Split thickness skin graft to a small defect that is:(a) less than 40 mm in 5001.12.2023diameter: (i) on areas below the knee; or(ii) distal to the ulnar styloid; 5001.12.2023or(iii) on the genital area; or(iv) on areas above the clavicle; or (b) less 5001.12.2023than 80 mm in diameter on any other part of the body (Anaes.) (Assist.) 1045443 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301780.0000645.5500000.00 4001.07.2023(Anaes.) 5001.12.2023Split thickness skin graft to a large defect that is:(a) 40 mm or more in 5001.12.2023diameter: (i) on areas below the knee; or(ii) distal to the ulnar styloid; 5001.12.2023or(iii) on the genital area; or(iv) on areas above the clavicle; or (b) 80 mm 5001.12.2023or more in diameter on any other part of the body (Anaes.) (Assist.) 1045451 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301570.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Full thickness skin graft to one defect, with an average diameter of 5 mm or 5001.12.2023more (Anaes.) (Assist.) 1045496 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301375.0000458.0000000.00 4026.05.2002(Anaes.) 5001.12.2023FLAP, free tissue transfer using microvascular techniques - revision of, by 5001.12.2023open operation (Anaes.) 1045497 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301070.0000348.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Flap, free tissue transfer using microvascular techniques or any autologous 5001.12.2023breast reconstruction, revision of, by liposuction, other than a service 5001.12.2023associated with a service to which item 45239 applies (H) (Anaes.) 1045500 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303525.0001200.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Microvascular repair using microsurgical techniques, with restoration of 5001.12.2023continuity of artery or vein of distal extremity or digit; cannot be claimed 5001.12.2023by the same provider for both artery and vein (H) (Anaes.) (Assist.) 1045501 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305660.0001953.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Microvascular anastomosis of artery or vein using microsurgical techniques, 5001.12.2023for replantation or revascularisation of limb or digit, if the limb or digit 5001.12.2023is devitalised and the repair is critical for restoration of blood supply, 5001.12.2023other than a service associated with a service to which item 45564, 45565, 5001.12.202345567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies (H) (Anaes.) 5001.12.2023(Assist.) 1045502 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305665.0002930.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Microvascular anastomoses of artery and vein using microsurgical techniques, 5001.12.2023for replantation or revascularisation of limb or digit, if the limb or digit 5001.12.2023is devitalised and the repair is critical for restoration of blood supply, 5001.12.2023including anastomoses of all required vessels for that extremity or digit, 5001.12.2023unless a micro-arterial or micro-venous graft is being used, other than a 5001.12.2023service associated with a service to which item 45564, 45565, 45567, 46060, 5001.12.202346062, 46064, 46066, 46068, 46070 or 46072 applies (H) (Anaes.) (Assist.) 1045503 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305975.0002234.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Micro-arterial or micro-venous graft using microsurgical techniques, if the 5001.12.2023graft is critical for restoration of blood supply, including harvest of graft 5001.12.2023and suturing of all related anastomoses (not to be claimed in the context of 5001.12.2023cardiac surgery) (H) (Anaes.) (Assist.) 1045504 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305660.0001953.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Microvascular anastomosis of artery, vein or veins, using microsurgical 5001.12.2023techniques, for free transfer of tissue, including setting in of free flap, 5001.12.2023other than:(a) a service for the purpose of breast reconstruction; or(b) a 5001.12.2023service associated with a service to which item 45564, 45565, 45567, 46060, 5001.12.202346062, 46064, 46066, 46068, 46070 or 46072 applies(H) (Anaes.) (Assist.) 1045505 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305660.0002958.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Microvascular anastomoses of artery and vein or veins, using microsurgical 5001.12.2023techniques, for free transfer of tissue, including setting in of free flap, 5001.12.2023other than:(a) a service for the purpose of breast reconstruction; or(b) a 5001.12.2023service associated with a service to which item 45564, 45565, 45567, 46060, 5001.12.202346062, 46064, 46066, 46068, 46070 or 46072 applies(H) (Anaes.) (Assist.) 1045507 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304963.0001800.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Microvascular repair using microsurgical techniques, with restoration of 5001.12.2023continuity of artery and vein of distal extremity or digit, including 5001.12.2023anastomoses of all required vessels for that extremity or digit, other than a 5001.12.2023service associated with a service to which item 45564, 45565 or 45567 applies 5001.12.2023(H) (Anaes.) (Assist.) 1045510 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300667.0000242.0500000.00 4001.07.2023(Anaes.) 5001.12.2023Scar, of face or neck, not more than 3 cm in length, revision of, if:(a) 5001.12.2023undertaken in the operating theatre of a hospital; or(b) performed by a 5001.12.2023specialist in the practice of the specialists specialty (Anaes.) 1045512 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300950.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023SCAR, of face or neck, more than 3 cm in length, revision of, where undertaken 5001.12.2023in the operating theatre of a hospital, or where performed by a specialist in 5001.12.2023the practice of his or her specialty (Anaes.) 1045515 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300650.0000205.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Scar, other than on face or neck, not more than 7 cm in length, revision of, 5001.12.2023if:(a) the service is:(i) undertaken in the operating theatre of a hospital; 5001.12.2023or(ii) performed by a specialist in the practice of the specialists specialty; 5001.12.2023and(b) the service is not performed in conjunction with the insertion of 5001.12.2023breast implants for cosmetic purposes; and(c) the incision made for revision 5001.12.2023of the scar is not used as an approach for another procedure (including a non 5001.12.2023rebatable procedure); and(d) sufficient photographic evidence demonstrating 5001.12.2023the clinical need for the service is included in patient notes (Anaes.) 1045518 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300780.0000248.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Scar, other than on face or neck, more than 7 cm in length, revision of, 5001.12.2023if:(a) the service is:(i) undertaken in the operating theatre of a hospital; 5001.12.2023or(ii) performed by a specialist in the practice of the specialists specialty; 5001.12.2023and(b) the service is not performed in conjunction with the insertion of 5001.12.2023breast implants for cosmetic purposes; and(c) the incision made for revision 5001.12.2023of the scar is not used as an approach for another procedure (including a non 5001.12.2023rebatable procedure); and(d) sufficient photographic evidence demonstrating 5001.12.2023the clinical need for the service is included in patient notes (Anaes.) 1045520 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303115.0000991.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Reduction mammaplasty (unilateral) with surgical repositioning of nipple,in 5001.12.2023the context of breast cancer or developmental abnormality of the breast, other 5001.12.2023than a service associated with a service to which item 31512, 31513 or 31514 5001.12.2023applies on the same side (H) (Anaes.) (Assist.) 1045522 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302185.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Reduction mammaplasty (unilateral) without surgical repositioning of the 5001.12.2023nipple:(a) excluding the treatment of gynaecomastia; and(b) not with insertion 5001.12.2023of any prosthesis;other than a service associated with a service to which item 5001.12.202331512, 31513 or 31514 applies on the same side (H) (Anaes.) (Assist.) 1045524 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302270.0000816.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Mammaplasty, augmentation (unilateral) in the context of: (a) breast cancer; 5001.12.2023or (b) developmental abnormality of the breast, if there is a difference in 5001.12.2023breast volume, as demonstrated by an appropriate volumetric measurement 5001.12.2023technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in 5001.12.2023tubular breasts or in breasts with abnormally high inframammary folds. 5001.12.2023Applicable only once per occasion on which the service is provided, other than 5001.12.2023a service associated with a service to which item 45006 or 45012 applies (H) 5001.12.2023(Anaes.) (Assist.) 1045527 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302275.0001179.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Breast reconstruction (unilateral), following mastectomy, using a permanent 5001.12.2023prosthesis, other than a service associated with a service to which item 45006 5001.12.2023or 45012 applies (H) (Anaes.) (Assist.) 1045528 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303415.0001224.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Mammaplasty, augmentation, bilateral (other than a service to which item 45527 5001.12.2023applies), if: (a) reconstructive surgery is indicated because of: (i) 5001.12.2023developmental malformation of breast tissue (excluding hypomastia); or (ii) 5001.12.2023disease of or trauma to the breast (other than trauma resulting from previous 5001.12.2023elective cosmetic surgery); or (iii) amastia secondary to a congenital 5001.12.2023endocrine disorder; and (b) photographic or diagnostic imaging evidence 5001.12.2023demonstrating the clinical need for this service is documented in the patient 5001.12.2023notes other than a service associated with a service to which item 45006 or 5001.12.202345012 applies (H) (Anaes.) (Assist.) 1045529 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305689.0002063.3500000.00 4001.07.2023(Anaes.) 5001.12.2023Breast reconstruction (bilateral), following mastectomy, using permanent 5001.12.2023prostheses, other than a service associated with a service to which item 45006 5001.12.2023or 45012 applies (H) (Anaes.) (Assist.) 1045530 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303355.0001210.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous (unilateral), using a large 5001.12.2023muscle or myocutaneous flap, isolated on its vascular pedicle, excluding 5001.12.2023repair of muscular aponeurotic layer, other than a service associated with a 5001.12.2023service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45006 or 45012 5001.12.2023applies (H) (Anaes.) (Assist.) 1045531 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305838.0002117.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous (bilateral), using a large 5001.12.2023muscle or myocutaneous flap, isolated on its vascular pedicle, excluding 5001.12.2023repair of muscular aponeurotic layer, other than a service associated with a 5001.12.2023service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45006 or 45012 5001.12.2023applies (H) (Anaes.) (Assist.) 1045532 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300822.0000298.1500000.00 4001.07.2023(Anaes.) 5001.12.2023Revision of post-mastectomy breast reconstruction, other than a service 5001.12.2023associated with a service to which item 45006 or 45012 applies (H) (Anaes.) 5001.12.2023(Assist.) 1045537 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302387.0000865.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Perforator flap, such as a thoracodorsal artery perforator (TDAP) flap or a 5001.12.2023lateral intercostal artery perforator (LICAP) flap, or similar, raising on a 5001.12.2023named source vessel, for reconstruction of a partial mastectomy defect, other 5001.12.2023than a service associated with a service to which item 45006 or 45012 applies 5001.12.2023(H) (Anaes.) (Assist.) 1045538 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302731.0000990.6500000.00 4001.07.2023(Anaes.) 5001.12.2023Perforator flap, such as a deep inferior epigastric perforator (DIEP) flap or 5001.12.2023similar, raising in preparation for microsurgical transfer of a free flap for 5001.12.2023post mastectomy breast reconstruction, other than a service associated with a 5001.12.2023service to which item 45006 or 45012 applies (H) (Anaes.) (Assist.) 1045539 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303275.0001587.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Breast reconstruction (unilateral), following mastectomy, using tissue 5001.12.2023expansioninsertion of tissue expansion unit and all attendances for subsequent 5001.12.2023expansion injections, other than a service associated with a service to which 5001.12.2023item 45006 or 45012 applies (H) (Anaes.) (Assist.) 1045540 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307658.0002777.6000000.00 4001.07.2023(Anaes.) 5001.12.2023Breast reconstruction (bilateral), following mastectomy, using tissue 5001.12.2023expansioninsertion of tissue expansion unit and all attendances for subsequent 5001.12.2023expansion injections, other than a service associated with a service to which 5001.12.2023item 45006 or 45012 applies (H) (Anaes.) (Assist.) 1045541 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303258.0001181.5500000.00 4001.07.2023(Anaes.) 5001.12.2023Breast reconstruction (bilateral), following mastectomy, using tissue 5001.12.2023expansionremoval of tissue expansion unit and insertion of permanent 5001.12.2023prosthesis, other than a service associated with a service to which item 45006 5001.12.2023or 45012 applies (H) (Anaes.) (Assist.) 1045542 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301870.0000675.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Breast reconstruction (unilateral), following mastectomy, using tissue 5001.12.2023expansionremoval of tissue expansion unit and insertion of permanent 5001.12.2023prosthesis, other than a service associated with a service to which item 45006 5001.12.2023or 45012 applies (H) (Anaes.) (Assist.) 1045545 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302185.0000685.2500000.00 4026.05.2002(Anaes.) 5001.12.2023NIPPLE OR AREOLA or both, reconstruction of, by any surgical technique 5001.12.2023(Anaes.) (Assist.) 1045546 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300690.0000217.8000000.00 5001.12.2023NIPPLE OR AREOLA or both, intradermal colouration of, following breast 5001.12.2023reconstruction after mastectomy or for congenital absence of nipple 1045547 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302123.0000769.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Revision of breast prosthesis pocket, if:(a) breast prosthesis or tissue 5001.12.2023expander has been placed for the purpose of breast reconstruction in the 5001.12.2023context of breast cancer or for developmental breast abnormality; and(b) the 5001.12.2023prosthesis or tissue expander has migrated or rotated from its intended 5001.12.2023position or orientation; and(c) the existing prosthesis is used(H) (Anaes.) 5001.12.2023(Assist.) 1045548 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300965.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023BREAST PROSTHESIS, removal of, as an independent procedure (Anaes.) 1045551 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301540.0000488.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Breast prosthesis, removal of, with excision of at least half of the fibrous 5001.12.2023capsule, not with insertion of any prosthesis. The excised specimen must be 5001.12.2023sent for histopathology and the volume removed must be documented in the 5001.12.2023histopathology report (Anaes.) (Assist.) 1045553 01.11.2006 3 T8 13 SN NYNNY 2001.12.202302040.0000629.1500000.00 4001.11.2006(Anaes.) 5001.12.2023Breast prosthesis, removal of and replacement with another prosthesis, 5001.12.2023following medical complications (for rupture, migration of prosthetic material 5001.12.2023or symptomatic capsular contracture), if: (a) either: (i) it is demonstrated 5001.12.2023by intra-operative photographs post-removal that removal alone would cause 5001.12.2023unacceptable deformity; or (ii) the original implant was inserted in the 5001.12.2023context of breast cancer or developmental abnormality; and (b) photographic 5001.12.2023and/or diagnostic imaging evidence demonstrating the clinical need for this 5001.12.2023service is documented in the patient notes (Anaes.) (Assist.) 1045554 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302425.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Breast prosthesis, removal and replacement with another prosthesis, following 5001.12.2023medical complications (for rupture, migration of prosthetic material or 5001.12.2023symptomatic capsular contracture), including excision of at least half of the 5001.12.2023fibrous capsule or formation of a new pocket, or both, if: (a) either: (i) it 5001.12.2023is demonstrated by intra-operative photographs post-removal that removal alone 5001.12.2023would cause unacceptable deformity; or (ii) the original implant was inserted 5001.12.2023in the context of breast cancer or developmental abnormality; and (b) the 5001.12.2023excised specimen is sent for histopathology and the volume removed is 5001.12.2023documented in the histopathology report; and (c) photographic and/or 5001.12.2023diagnostic imaging evidence demonstrating the clinical need for this service 5001.12.2023is documented in the patient notes (Anaes.) (Assist.) 1045556 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302645.0000843.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Breast ptosis, correction of (unilateral), in the context of breast cancer or 5001.12.2023developmental abnormality, if photographic evidence (including anterior, left 5001.12.2023lateral and right lateral views) and/or diagnostic imaging evidence 5001.12.2023demonstrating the clinical need for this service is documented in the patient 5001.12.2023notes Applicable only once per occasion on which the service is provided, 5001.12.2023other than a service associated with a service to which item 31512, 31513 or 5001.12.202331514 applies on the same side (H) (Anaes.) (Assist.) 1045558 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303970.0001264.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Correction of bilateral breast ptosis by mastopexy, if: (a) at least twothirds 5001.12.2023of the breast tissue, including the nipple, lies inferior to the inframammary 5001.12.2023fold where the nipple is located at the most dependent, inferior part of the 5001.12.2023breast contour; and (b) photographic evidence (including anterior, left 5001.12.2023lateral and right lateral views), with a marker at the level of the 5001.12.2023inframammary fold, demonstrating the clinical need for this service, is 5001.12.2023documented in the patient notes Applicable only once per lifetime, other than 5001.12.2023a service associated with a service to which item 31512, 31513 or 31514 5001.12.2023applies (H) (Anaes.) (Assist.) 1045560 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301570.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023HAIR TRANSPLANTATION for the treatment of alopecia of congenital or traumatic 5001.12.2023origin or due to disease, excluding male pattern baldness, not being a service 5001.12.2023to which another item in this Group applies (Anaes.) 1045561 01.05.2007 3 T8 13 SN NYNYY 2001.12.202305795.0001953.4000000.00 4001.05.2007(Anaes.) 5001.12.2023Microvascular anastomosis of artery and/or vein, if considered necessary to 5001.12.2023salvage a vascularly compromised pedicled or free flap, either during the 5001.12.2023primary procedure or at a subsequent return to theatre (H) (Anaes.) (Assist.) 1045562 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303790.0001210.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Free transfer of tissue (microvascular free flap) for non-breast defect 5001.12.2023involving raising of tissue on vascular pedicle, including direct repair of 5001.12.2023secondary cutaneous defect (if performed), other than a service associated 5001.12.2023with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 5001.12.202346068, 46070 or 46072 applies (Anaes.) (Assist.) 1045563 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303790.0001210.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Neurovascular island flap for restoration of essential sensation in the digits 5001.12.2023or sole of the foot, or for genital reconstruction, including:(a) direct 5001.12.2023repair of secondary cutaneous defect (if performed); and(b) formal dissection 5001.12.2023of the neurovascular pedicle;other than a service performed on simple V-Y 5001.12.2023flaps or other standard flaps, such as rotation or keystone (Anaes.) (Assist.) 1045564 26.05.2002 3 T8 13 SN NYNYY 2001.12.202308795.0002802.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Free transfer of tissue (reconstructive surgery) for the repair of major 5001.12.2023tissue defect of the head and neck or other non-breast defect, using 5001.12.2023microvascular techniques, all necessary elements of the operation including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels; and(b) raising 5001.12.2023of tissue on a vascular pedicle; and(c) preparation of recipient vessels; 5001.12.2023and(d) transfer of tissue; and(e) insetting of tissue at recipient site; 5001.12.2023and(f) direct repair of secondary cutaneous defect, if performed;other than a 5001.12.2023service associated with a service to which item 30166, 30169, 30175, 30176, 5001.12.202330177, 30179, 45501, 45502, 45504, 45505, 45507, 45562 or 45567 5001.12.2023appliesconjoint surgery, principal specialist surgeon (H) (Anaes.) (Assist.) 1045565 26.05.2002 3 T8 13 SN NYNYY 2001.12.202306595.0002102.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Free transfer of tissue (reconstructive surgery) for the repair of major 5001.12.2023tissue defect of the head and neck or other non-breast defect, using 5001.12.2023microvascular techniques, all necessary elements of the operation including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels; and(b) raising 5001.12.2023of tissue on a vascular pedicle; and(c) preparation of recipient vessels; 5001.12.2023and(d) transfer of tissue; and(e) insetting of tissue at recipient site; 5001.12.2023and(f) direct repair of secondary cutaneous defect, if performed;other than a 5001.12.2023service associated with a service to which item 30166, 30169, 30175, 30176, 5001.12.202330177, 30179, 45501, 45502, 45504, 45505, 45507, 45562 or 45567 5001.12.2023appliesconjoint surgery, conjoint specialist surgeon (H) (Anaes.) (Assist.) 1045566 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303275.0001179.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Insertion of a temporary prosthetic tissue expander which requires subsequent 5001.12.2023removal, including all attendances for subsequent expansion injections, other 5001.12.2023than a service for breast or post-mastectomy tissue expansion (H) (Anaes.) 5001.12.2023(Assist.) 1045567 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308912.0003232.6500000.00 4001.07.2023(Anaes.) 5001.12.2023Free transfer of tissue (reconstructive surgery) for the repair of major 5001.12.2023tissue defect of the head and neck or other non-breast defect, using 5001.12.2023microvascular techniques, all necessary elements of the operation including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels; and(b) raising 5001.12.2023of tissue on a vascular pedicle; and(c) preparation of recipient vessels; 5001.12.2023and(d) transfer of tissue; and(e) insetting of tissue at recipient site; 5001.12.2023and(f) direct repair of secondary cutaneous defect, if performed;other than a 5001.12.2023service associated with a service to which item 30166, 30169, 30175, 30176, 5001.12.202330177, 30179, 45501, 45502, 45504, 45505, 45507, 45562, 45564 or 45565 5001.12.2023appliessingle surgeon (H) (Anaes.) (Assist.) 1045568 01.11.2003 3 T8 13 SN NYNYY 2001.12.202301540.0000488.4000000.00 4001.11.2003(Anaes.) 5001.12.2023Tissue expander, removal of, including complete excision of fibrous capsule if 5001.12.2023performed (H) (Anaes.) (Assist.) 1045571 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303141.0001139.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Closure of abdomen with reconstruction of umbilicus, with or without 5001.12.2023lipectomy, to be used following the harvest of an autologous flap, being a 5001.12.2023service associated with a service to which item 45530, 45531, 45562, 45564, 5001.12.202345565, 45567, 46080, 46082, 46084, 46086, 46088 or 46090 applies, including 5001.12.2023repair of the musculoaponeurotic layer of the abdomen (including insertion of 5001.12.2023prosthetic mesh if used) (H) (Anaes.) (Assist.) 1045572 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301015.0000321.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Intra-operative tissue expansion using a prosthetic tissue expander, performed 5001.12.2023under general anaesthetic or intravenous sedation during an operation, if 5001.12.2023combined with a service to which another item in Group T8 applies (including 5001.12.2023expansion injections), not to be used for breast tissue expansion (Anaes.) 1045575 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302420.0000792.7500000.00 4026.05.2002(Anaes.) 5001.12.2023FACIAL NERVE PARALYSIS, free fascia graft for (Anaes.) (Assist.) 1045578 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302820.0000918.0500000.00 4026.05.2002(Anaes.) 5001.12.2023FACIAL NERVE PARALYSIS, muscle transfer for (Anaes.) (Assist.) 1045581 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300965.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Facial nerve paralysis, excision of tissue for (Anaes.) 1045584 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302190.0000695.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Liposuction (suction assisted lipolysis) to one regional area (one limb or 5001.12.2023trunk), for treatment of post traumatic pseudolipoma, if photographic and/or 5001.12.2023diagnostic imaging evidence demonstrating the clinical need for this service 5001.12.2023is documented in the patient notes (Anaes.) 1045587 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302640.0000980.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Meloplasty for correction of facial asymmetry if: (a) the asymmetry is 5001.12.2023secondary to trauma (including previous surgery), a congenital condition or a 5001.12.2023medical condition (such as facial nerve palsy); and (b) the meloplasty is 5001.12.2023limited to one side of the face (Anaes.) (Assist.) 1045588 26.05.2002 3 T8 13 SN NYNNY 2001.12.202303950.0001470.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Meloplasty (excluding browlifts and chinlift platysmaplasties), bilateral, if: 5001.12.2023(a) surgery is indicated to correct a functional impairment due to a 5001.12.2023congenital condition, disease (excluding post-acne scarring) or trauma (other 5001.12.2023than trauma resulting from previous elective cosmetic surgery); and (b) 5001.12.2023photographic and/or diagnostic imaging evidence demonstrating the clinical 5001.12.2023need for this service is documented in the patient notes (Anaes.) (Assist.) 1045590 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301435.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Orbital cavity, reconstruction of wall or floor, with or without bone graft, 5001.12.2023cartilage graft or foreign implant, other than a service associated with a 5001.12.2023service to which item 45594 applies on the same side (H) (Anaes.) (Assist.) 1045592 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302583.0000936.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Orbital cavity, reconstruction of wall and floor with bone graft, cartilage 5001.12.2023graft or foreign implant, other than a service associated with a service to 5001.12.2023which item 45594 applies on the same side (H) (Anaes.) (Assist.) 1045594 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301211.0000439.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Orbital cavity, exploration of wall or floor without bone graft, cartilage 5001.12.2023graft or foreign implant, other than a service associated with a service to 5001.12.2023which item 45590 or 45592 applies on the same side (H) (Anaes.) (Assist.) 1045596 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302770.0000991.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Hemimaxillectomy (H) (Anaes.) (Assist.) 1045597 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303760.0001326.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Total maxillectomy (bilateral) (H) (Anaes.) (Assist.) 1045599 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302185.0001030.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Mandible, total resection of, other than a service associated with a service 5001.12.2023to which item 45608 applies (H) (Anaes.) (Assist.) 1045602 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302265.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, including lower border, OR MAXILLA, sub-total resection of (Anaes.) 5001.12.2023(Assist.) 1045605 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301870.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE OR MAXILLA, segmental resection of, for tumours or cysts (Anaes.) 5001.12.2023(Assist.) 1045608 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302505.0000910.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Mandible, segmental mandibular or maxilla reconstruction with bone graft, not 5001.12.2023being a service associated with a service to which item 45599 applies (H) 5001.12.2023(Anaes.) (Assist.) 1045609 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302511.0000910.6500000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible, maxilla or skull base, reconstruction of, using bony free flap, all 5001.12.2023osteotomies, shaping, inset and fixation by any means, including all necessary 5001.12.20233 dimensional planning, if performed in conjunction with one or more services 5001.12.2023covered by items 46060 to 46068 (H) (Anaes.) (Assist.) 1045611 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301785.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Mandible, condylectomy of (H) (Anaes.) (Assist.) 1045614 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301805.0000918.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Eyelid, reconstruction of a defect (greater than one quarter of the length of 5001.12.2023the lid) involving all 3 layers of the eyelid, if unable to be closed by 5001.12.2023direct suture or wedge excision, including all flaps and grafts that may be 5001.12.2023required (Anaes.) (Assist.) 1045617 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300700.0000258.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Upper eyelid, reduction of, if: (a) the reduction is for any of the following: 5001.12.2023(i) history of a demonstrated visual impairment; (ii) intertriginous 5001.12.2023inflammation of the eyelid; (iii) herniation of orbital fat in exophthalmos; 5001.12.2023(iv) facial nerve palsy; (v) posttraumatic scarring; (vi) the restoration of 5001.12.2023symmetry of contralateral upper eyelid in respect of one of the conditions 5001.12.2023mentioned in subparagraphs(i) to (v); and (b) photographic and/or diagnostic 5001.12.2023imaging evidence demonstrating the clinical need for this service is 5001.12.2023documented in the patient notes (Anaes.) 1045620 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300970.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Lower eyelid, reduction of, if: (a) the reduction is for: (i) herniation of 5001.12.2023orbital fat in exophthalmos, facial nerve palsy or post-traumatic scarring; or 5001.12.2023(ii) the restoration of symmetry of the contralateral lower eyelid in respect 5001.12.2023of one of these conditions; and (b) photographic and/or diagnostic imaging 5001.12.2023evidence demonstrating the clinical need for this service is documented in the 5001.12.2023patient notes (Anaes.) 1045623 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302590.0000795.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Ptosis of upper eyelid (unilateral), correction of, by: (a) sutured elevation 5001.12.2023of the tarsal plate on the eyelid retractors (Mullers or levator muscle or 5001.12.2023levator aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; 5001.12.2023Not applicable to a service for repair of mechanical ptosis to which item 5001.12.202345617 applies (Anaes.) (Assist.) 1045624 26.05.2002 3 T8 13 SN NYNNY 2001.12.202303125.0001031.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Ptosis of upper eyelid, correction of, by: (a) sutured elevation of the tarsal 5001.12.2023plate on the eyelid retractors (Mullers or levator muscle or levator 5001.12.2023aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; if a 5001.12.2023previous ptosis surgery has been performed on that side (Anaes.) (Assist.) 1045625 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300875.0000206.4500000.00 4026.05.2002(Anaes.) 5001.12.2023PTOSIS of eyelid, correction of eyelid height by revision of levator sutures 5001.12.2023within one week of primary repair by levator resection or advancement, 5001.12.2023performed in the operating theatre of a hospital (Anaes.) 1045626 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300970.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Ectropion or entropion, not caused by trachoma, correction of (unilateral) 5001.12.2023(Anaes.) 1045627 01.11.2019 3 T8 13 SNS NYNNY 2001.12.202300970.0000358.9000000.00 4001.11.2019(Anaes.) 5001.12.2023Ectropion or entropion, caused by trachoma, correction of (unilateral) 5001.12.2023(Anaes.) 1045629 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301570.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SYMBLEPHARON, grafting for (Anaes.) (Assist.) 1045632 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301720.0000563.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinoplasty, partial, involving correction of one or both lateral cartilages, 5001.12.2023one or both alar cartilages or one or both lateral cartilages and alar 5001.12.2023cartilages, if: (a) the indication for surgery is: (i) airway obstruction and 5001.12.2023the patient has a self reported NOSE Scale score of greater than 45; or (ii) 5001.12.2023significant acquired, congenital or developmental deformity; and (b) 5001.12.2023photographic and/or NOSE Scale evidence demonstrating the clinical need for 5001.12.2023this service is documented in the patient notes (Anaes.) 1045635 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302035.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinoplasty, partial, involving correction of bony vault only, if: (a) the 5001.12.2023indication for surgery is: (i) airway obstruction and the patient has a 5001.12.2023selfreported NOSE Scale score of greater than 45; or (ii) significant 5001.12.2023acquired, congenital or developmental deformity; and (b) photographic and/or 5001.12.2023NOSE Scale evidence demonstrating the clinical need for this service is 5001.12.2023documented in the patient notes (Anaes.) 1045641 26.05.2002 3 T8 13 SN NYNNY 2001.12.202303605.0001173.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinoplasty, total, including correction of all bony and cartilaginous 5001.12.2023elements of the external nose, with or without autogenous cartilage or bone 5001.12.2023graft from a local site (nasal), if: (a) the indication for surgery is: (i) 5001.12.2023airway obstruction and the patient has a selfreported NOSE Scale score of 5001.12.2023greater than 45; or (ii) significant acquired, congenital or developmental 5001.12.2023deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the 5001.12.2023clinical need for this service is documented in the patient notes (Anaes.) 1045644 26.05.2002 3 T8 13 SN NYNYY 2001.12.202304225.0001408.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinoplasty, total, including correction of all bony and cartilaginous 5001.12.2023elements of the external nose involving autogenous bone or cartilage graft 5001.12.2023obtained from distant donor site, including obtaining of graft, if: (a) the 5001.12.2023indication for surgery is: (i) airway obstruction and the patient has a 5001.12.2023selfreported NOSE Scale score of greater than 45; or (ii) significant 5001.12.2023acquired, congenital or developmental deformity; and (b) photographic and/or 5001.12.2023NOSE Scale evidence demonstrating the clinical need for this service is 5001.12.2023documented in the patient notes; other than a service associated with a 5001.12.2023service to which item 45718 applies (H) (Anaes.) (Assist.) 1045645 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300710.0000246.1000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOANAL ATRESIA, repair of by puncture and dilatation (Anaes.) 1045646 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302865.0000991.1000000.00 4026.05.2002(Anaes.) 5001.12.2023CHOANAL ATRESIA - correction by open operation with bone removal (Anaes.) 5001.12.2023(Assist.) 1045650 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300470.0000162.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinoplasty, revision of, if: (a) the indication for surgery is: (i) airway 5001.12.2023obstruction and the patient has a self-reported NOSE Scale score of greater 5001.12.2023than 45; or (ii) significant acquired, congenital or developmental deformity; 5001.12.2023and (b) photographic and/or NOSE Scale evidence demonstrating the clinical 5001.12.2023need for this service is documented in the patient notes (Anaes.) 1045652 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301055.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Rhinophyma of a moderate or severe degree, carbon dioxide laser or erbium 5001.12.2023laser excision - ablation of (Anaes.) 1045653 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301055.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023RHINOPHYMA, shaving of (Anaes.) 1045656 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302270.0000552.8000000.00 4026.05.2002(Anaes.) 5001.12.2023COMPOSITE GRAFT (Chondrocutaneous or chondromucosal) to nose, ear or eyelid 5001.12.2023(Anaes.) (Assist.) 1045658 01.03.2021 3 T8 13 SNS NYNNY 2001.12.202301620.0000573.8000000.00 4001.03.2021(Anaes.) 5001.12.2023Correction of a congenital deformity of the ear if: (a)the congenital 5001.12.2023deformity is not related to a prominent ear; and (b) the deformity has been 5001.12.2023clinically diagnosed as a constricted ear, Stahl's ear, or a similar 5001.12.2023congenital deformity; and (c) photographic evidence demonstrating the clinical 5001.12.2023need for this service is documented in the patient notes. (Anaes.) (Assist.) 1045659 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301620.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Correction of a congenital deformity of the ear if: (a) the patient is less 5001.12.2023than 18 years of age; and (b) the deformity is characterised by an absence of 5001.12.2023the antihelical fold and/or large scapha and/or large concha; and (c) 5001.12.2023photographic evidence demonstrating the clinical need for this service is 5001.12.2023documented in the patient notes (Anaes.) (Assist.) 1045660 26.05.2002 3 T8 13 SN NYNYY 2001.12.202309270.0003168.6000000.00 4026.05.2002(Anaes.) 5001.12.2023External ear, complex total reconstruction of, using costal cartilage grafts 5001.12.2023to form a framework, including the harvesting and sculpturing of the cartilage 5001.12.2023and its insertion, for congenital absence, microtia or post-traumatic loss of 5001.12.2023entire or substantial portion of pinna (first stage) - performed by a 5001.12.2023specialist in the practice of the specialists specialty (H) (Anaes.) (Assist.) 1045661 26.05.2002 3 T8 13 SN NYNYY 2001.12.202304120.0001408.2500000.00 4026.05.2002(Anaes.) 5001.12.2023External ear, complex total reconstruction of,elevation of costal cartilage 5001.12.2023framework using cartilage previously stored in abdominal wall, including the 5001.12.2023use of local skin and fascia flaps and skin graft to cover cartilage (second 5001.12.2023stage) - performed by a specialist in the practice of the specialists 5001.12.2023specialty (H) (Anaes.) (Assist.) 1045665 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301105.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Lip, eyelid or ear, full thickness wedge excision of, with repair by direct 5001.12.2023sutures, excluding eyelid wedge when performed in conjunction with a cosmetic 5001.12.2023eyelid procedure (Anaes.) 1045668 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301100.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023VERMILIONECTOMY, by surgical excision (Anaes.) 1045669 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301100.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Vermilionectomy for biopsy-confirmed cellular atypia, using carbon dioxide 5001.12.2023laser or erbium laser excision - ablation (Anaes.) 1045671 26.05.2002 3 T8 13 SN NYNYY 2001.12.202303220.0000918.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Lip or eyelid reconstruction, single stage or first stage of a two-stage flap 5001.12.2023reconstruction of a defect involving all 3 layers of tissue, if the flap is 5001.12.2023switched from the opposing lip or eyelid respectively (Anaes.) (Assist.) 1045674 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300970.0000267.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Lip or eyelid reconstruction, second stage of a two-stage flap reconstruction, 5001.12.2023division of the pedicle and inset of flap and closure of the donor (Anaes.) 1045675 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301535.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MACROCHEILIA or macroglossia, operation for (Anaes.) (Assist.) 1045676 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301830.0000633.2500000.00 4026.05.2002(Anaes.) 5001.12.2023MACROSTOMIA, operation for (Anaes.) (Assist.) 1045677 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301920.0000628.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Cleft lip, unilateralprimary repair of nasolabial complex, one stage, without 5001.12.2023anterior palate repair (H) (Anaes.) (Assist.) 1045680 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302190.0000819.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Cleft lip, unilateralprimary repair of nasolabial complex, one stage, with 5001.12.2023anterior palate repair (H) (Anaes.) (Assist.) 1045683 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302590.0000910.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Cleft lip, bilateralprimary repair of nasolabial complex, one stage, without 5001.12.2023anterior palate repair (H) (Anaes.) (Assist.) 1045686 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302875.0001074.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Cleft lip, bilateralprimary repair of nasolabial complex, one stage, with 5001.12.2023anterior palate repair (H) (Anaes.) (Assist.) 1045689 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300850.0000288.1500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, lip adhesion procedure, unilateral or bilateral (Anaes.) (Assist.) 1045692 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300800.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, partial revision, including minor flap revision alignment and 5001.12.2023adjustment, including revision of minor whistle deformity if performed 5001.12.2023(Anaes.) 1045695 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301520.0000538.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, total revision, including major flap revision, muscle 5001.12.2023reconstruction and revision of major whistle deformity (Anaes.) (Assist.) 1045698 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301485.0000504.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, primary columella lengthening procedure, bilateral (Anaes.) 1045701 26.05.2002 3 T8 13 SN NYNNY 2001.12.202303405.0000910.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first 5001.12.2023stage (Anaes.) (Assist.) 1045704 26.05.2002 3 T8 13 SN NYNNY 2001.12.202300975.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second 5001.12.2023stage (Anaes.) 1045707 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302340.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, primary repair (Anaes.) (Assist.) 1045710 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301405.0000538.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, secondary repair, closure of fistula using local flaps (Anaes.) 1045713 26.05.2002 3 T8 13 SN NYNNY 2001.12.202301770.0000612.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, secondary repair, lengthening procedure (Anaes.) (Assist.) 1045714 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302485.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Oro-nasal fistula, repair of, including a local flap for closure (H) (Anaes.) 5001.12.2023(Assist.) 1045716 26.05.2002 3 T8 13 SN NYNNY 2001.12.202302505.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for 5001.12.2023(Anaes.) 1045717 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303569.0001294.4000000.00 4001.07.2023(Anaes.) 5001.12.2023Alveolar cleft (congenital), unilateral, bone grafting of, including local 5001.12.2023flap closure of associated oro-nasal fistulae and ridge augmentation, other 5001.12.2023than a service associated with a service to which item 45718 applies (H) 5001.12.2023(Anaes.) (Assist.) 1045718 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303883.0001408.2500000.00 4001.07.2023(Anaes.) 5001.12.2023Face, contour restoration of one region, for the correction of deformity using 5001.12.2023autogenous bone or cartilage, if the deformity:(a) is secondary to congenital 5001.12.2023absence of tissue; or(b) has arisen from:(i) trauma (other than from previous 5001.12.2023cosmetic surgery); or(ii) a diagnosed pathological process;other than a 5001.12.2023service associated with a service to which item 45644 or 45717 (alveolar bone 5001.12.2023grafting) applies (H) (Anaes.) (Assist.) 1045761 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302235.0000824.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Genioplasty, including transposition of nerves and vessels and bone grafts 5001.12.2023taken from the same site, if:(a) the deformity: (i) is secondary to congenital 5001.12.2023absence of tissue; or(ii) has arisen from trauma (other than from previous 5001.12.2023cosmetic surgery) or a diagnosed pathological process; and (b) the service is 5001.12.2023required for maintaining lip competency; and(c) sufficient photographic 5001.12.2023evidence demonstrating the clinical need for the service is included in 5001.12.2023patient notes(H) (Anaes.) (Assist.) 1045767 26.05.2002 3 T8 13 SN NYNYY 2001.12.202307565.0002764.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Hypertelorism,correction of,using intracranial approach (H) (Anaes.) (Assist.) 1045773 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305260.0001929.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Syndromic orbital dystopia, such as Treacher Collins Syndrome, bilateral 5001.12.2023facial or periorbital reconstruction, with bone grafts from a distant site (H) 5001.12.2023(Anaes.) (Assist.) 1045776 26.05.2002 3 T8 13 SN NYNNY 2001.12.202305260.0001929.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 5001.12.2023orbit, intracranial (Anaes.) (Assist.) 1045779 26.05.2002 3 T8 13 SN NYNNY 2001.12.202303875.0001418.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 5001.12.2023orbit, extracranial (Anaes.) (Assist.) 1045782 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302955.0001084.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Fronto-orbital advancement (H) (Anaes.) (Assist.) 1045785 26.05.2002 3 T8 13 SN NYNYY 2001.12.202305010.0001836.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Cranial vault reconstruction for single suture synostosis (H) (Anaes.) 5001.12.2023(Assist.) 1045788 26.05.2002 3 T8 13 SN NYNYY 2001.12.202304940.0001815.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Glenoid fossa, construction of, from bone and cartilage graft, and creation of 5001.12.2023condyle and ascending ramus of mandible, in hemifacial microsomia, not 5001.12.2023including harvesting of graft material (H) (Anaes.) (Assist.) 1045791 26.05.2002 3 T8 13 SN NYNYY 2001.12.202302690.0000980.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Absent condyle and ascending ramus in craniofacial microsomia, construction 5001.12.2023of, not including harvesting of graft material (H) (Anaes.) (Assist.) 1045794 26.05.2002 3 T8 13 SN NYNYY 2001.12.202301745.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Osseointegration procedure, first stage, implantation of fixture, following 5001.12.2023congenital absence, tumour or trauma, other than a service associated with a 5001.12.2023service to which item 41603 applies (Anaes.) 1045797 26.05.2002 3 T8 13 SN NYNYY 2001.12.202300650.0000205.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Osseointegration procedure, second stage, fixation of transcutaneous abutment, 5001.12.2023following congenital absence, tumour or trauma, other than a service 5001.12.2023associated with a service to which item 41603 applies (Anaes.) 1045801 01.11.2004 3 T8 13 SN NYNYY 2001.12.202300435.0000148.5500000.00 4001.11.2004(Anaes.) 5001.12.2023Tumour, cyst, ulcer or scar (other than a scar removed during the surgical 5001.12.2023approach at an operation), in the oral cavity, removal from mucosa or 5001.12.2023submucosal tissues, if the removal is by surgical excision and suture (Anaes.) 1045807 01.11.2004 3 T8 13 SN NYNNY 2001.12.202300850.0000271.3500000.00 4001.11.2004(Anaes.) 5001.12.2023TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment 5001.12.2023unless it has been established by radiological examination that there is a 5001.12.2023minimum of 5mm separation between the cyst lining and tooth structure or where 5001.12.2023a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR 5001.12.2023(other than a scar removed during the surgical approach at an operation), in 5001.12.2023the oral and maxillofacial region, removal of, not being a service to which 5001.12.2023another item in this Subgroup applies, involving muscle, bone, or other deep 5001.12.2023tissue (Anaes.) 1045809 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301280.0000408.9500000.00 4001.11.2004(Anaes.) 5001.12.2023TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth 5001.12.2023fragment unless it has been established by radiological examination that there 5001.12.2023is a minimum of 5mm separation between the cyst lining and tooth structure or 5001.12.2023where a tumour or cyst has been proven by positive histopathology), in the 5001.12.2023oral and maxillofacial region, removal of, requiring wide excision, not being 5001.12.2023a service to which another item in this Subgroup applies (Anaes.) (Assist.) 1045811 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301730.0000552.8000000.00 4001.11.2004(Anaes.) 5001.12.2023TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue 5001.12.2023(including muscle, fascia and connective tissue), extensive excision of, 5001.12.2023without skin or mucosal graft (Anaes.) (Assist.) 1045813 01.11.2004 3 T8 13 SN NYNNY 2001.12.202302025.0000646.7500000.00 4001.11.2004(Anaes.) 5001.12.2023TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue 5001.12.2023(including muscle, fascia and connective tissue), extensive excision of, with 5001.12.2023skin or mucosal graft (Anaes.) (Assist.) 1045815 01.11.2004 3 T8 13 SN NYNYY 2001.12.202301081.0000392.2500000.00 4001.11.2004(Anaes.) 5001.12.2023Operation on:(a) mandible or maxilla (other than alveolar margins) for chronic 5001.12.2023osteomyelitis with radiological and laboratory evidence of osteomyelitis; 5001.12.2023or(b) mandible or maxilla for necrosis of the jaw from any cause including 5001.12.2023medication or radiation that requires debridement of the alveolar bone or 5001.12.2023beyond (Anaes.) (Assist.) 1045823 01.11.2004 3 T8 13 SN NYNYY 2001.12.202300375.0000119.8500000.00 4001.11.2004(Anaes.) 5001.12.2023Arch bars or similar, one or more, that were inserted for dental fixation 5001.12.2023purposes to the maxilla or mandible, removal of, requiring general 5001.12.2023anaesthesia, if the service is undertaken in the operating theatre of a 5001.12.2023hospital (H) (Anaes.) 1045825 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301165.0000372.4500000.00 4001.11.2004(Anaes.) 5001.12.2023MANDIBULAR OR PALATAL EXOSTOSIS, excision of (Anaes.) (Assist.) 1045827 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301115.0000355.9500000.00 4001.11.2004(Anaes.) 5001.12.2023MYLOHYOID RIDGE, reduction of (Anaes.) (Assist.) 1045829 01.11.2004 3 T8 13 SN NYNNY 2001.12.202300850.0000271.5500000.00 4001.11.2004(Anaes.) 5001.12.2023MAXILLARY TUBEROSITY, reduction of (Anaes.) 1045831 01.11.2004 3 T8 13 SN NYNYY 2001.12.202301115.0000355.9500000.00 4001.11.2004(Anaes.) 5001.12.2023Papillary hyperplasia of the palate, surgical reduction ofcannot be claimed 5001.12.2023more than once per occasion of service (Anaes.) (Assist.) 1045837 01.11.2004 3 T8 13 SN NYNNY 2001.12.202302020.0000645.5500000.00 4001.11.2004(Anaes.) 5001.12.2023VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or 5001.12.2023mucosal graft when performed - unilateral or bilateral (Anaes.) (Assist.) 1045841 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301630.0000521.4000000.00 4001.11.2004(Anaes.) 5001.12.2023ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral 5001.12.2023(Anaes.) (Assist.) 1045845 01.11.2004 3 T8 13 SN NYNYY 2001.12.202301745.0000554.6500000.00 4001.11.2004(Anaes.) 5001.12.2023Osseo-integration procedure, intra-oral implantation of titanium or similar 5001.12.2023fixture to facilitate restoration of the dentition following:(a) resection of 5001.12.2023part of the maxilla or mandible for a benign or a malignant tumour; or(b) 5001.12.2023segmental loss from trauma or congenital absence of a segment of the maxilla 5001.12.2023or mandible (multiple adjacent teeth)Fixture must be placed at site of the 5001.12.2023missing segment following appropriate reconstructive procedures (Anaes.) 1045847 01.11.2004 3 T8 13 SN NYNYY 2001.12.202300566.0000205.3000000.00 4001.11.2004(Anaes.) 5001.12.2023Osseo-integration procedure, fixation of transmucosal abutment to fixtures 5001.12.2023that are placed following:(a) resection of part of the maxilla or mandible for 5001.12.2023a benign or a malignant tumour; or(b) segmental loss from trauma or congenital 5001.12.2023absence of a segment of the maxilla or mandible (multiple adjacent 5001.12.2023teeth)Fixture must be placed at site of the missing segment following 5001.12.2023appropriate reconstructive procedures (Anaes.) 1045849 01.11.2004 3 T8 13 SN NYNYY 2001.12.202302000.0000639.4000000.00 4001.11.2004(Anaes.) 5001.12.2023Maxillary sinus, allograft, bone graft or both, to floor of maxillary sinus 5001.12.2023following elevation of mucosal lining (sinus lift procedure), unilateral 5001.12.2023(Anaes.) (Assist.) 1045851 01.11.2004 3 T8 13 SN NYNYY 2001.12.202300490.0000157.4500000.00 4001.11.2004(Anaes.) 5001.12.2023Temporomandibular joint, manipulation of, as an independent procedure 5001.12.2023performed in the operating theatre of a hospital, other than a service 5001.12.2023associated with a service to which any other item in this Group applies (H) 5001.12.2023(Anaes.) 1045855 01.11.2004 3 T8 13 SN NYNYY 2001.12.202301410.0000319.8000000.00 4001.11.2004(Anaes.) 5001.12.2023Temporomandibular joint, arthroscopy of, with or without biopsy, other than a 5001.12.2023service associated with another arthroscopic procedure of that joint (Anaes.) 5001.12.2023(Assist.) 1045857 01.11.2004 3 T8 13 SN NYNYY 2001.12.202302250.0000719.6500000.00 4001.11.2004(Anaes.) 5001.12.2023Temporomandibular joint, arthroscopy of, removal of loose bodies, debridement, 5001.12.2023or lysis and lavage or biopsy (including repositioning of meniscus where 5001.12.2023indicated)one or more such procedures of that joint, other than a service 5001.12.2023associated with any other arthroscopic or open procedure of the 5001.12.2023temporomandibular joint (Anaes.) (Assist.) 1045865 01.11.2004 3 T8 13 SN NYNNY 2001.12.202301000.0000319.8000000.00 4001.11.2004(Anaes.) 5001.12.2023ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 5001.12.2023cannuli into the appropriate joint space(s) (Anaes.) (Assist.) 1045871 01.11.2004 3 T8 13 SN NYNNY 2001.12.202304610.0001473.2500000.00 4001.11.2004(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular 5001.12.2023and condylar head surgery, with or without microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1045873 01.11.2004 3 T8 13 SN NYNYY 2001.12.202305180.0001655.5000000.00 4001.11.2004(Anaes.) 5001.12.2023Temporomandibular joint, surgery of, involving procedures to which item 45871 5001.12.2023applies and also involving the use of tissue flaps, or cartilage graft, or 5001.12.2023allograft implants, with or without microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1045874 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303999.0001450.5500000.00 4001.07.2023(Anaes.) 5001.12.2023Temporomandibular joint, including condylar head and glenoid fossa, total 5001.12.2023alloplastic replacement (H) (Anaes.) (Assist.) 1045882 01.11.2007 3 T8 13 SN NYNNY 2001.12.202300118.0000047.3500000.00 5001.12.2023The treatment of a premalignant lesion of the oral mucosa by a treatment using 5001.12.2023cryotherapy, diathermy or carbon dioxide laser. 1045888 01.11.2007 3 T8 13 SN NYNNY 2001.12.202300875.0000455.2000000.00 4001.11.2007(Anaes.) 5001.12.2023FOREIGN BODY, in the oral and maxillofacial region, deep, removal of using 5001.12.2023interventional imaging techniques (Anaes.) (Assist.) 1045891 01.11.2007 3 T8 13 SN NYNNY 2001.12.202302085.0000663.2000000.00 4001.11.2007(Anaes.) 5001.12.2023SINGLE-STAGE LOCAL FLAP where indicated, repair to 1 defect, using temporalis 5001.12.2023muscle (Anaes.) (Assist.) 1045894 01.11.2007 3 T8 13 SN NYNYY 2001.12.202300700.0000225.3000000.00 4001.11.2007(Anaes.) 5001.12.2023Grafting (mucosa or split skin), in the oral cavity of a mucosal defect 5001.12.2023(Anaes.) 1045939 01.11.2007 3 T8 13 SN NYNNY 2001.12.202301180.0000492.1000000.00 4001.11.2007(Anaes.) 5001.12.2023PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief 5001.12.2023(Anaes.) (Assist.) 1046050 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302387.0000865.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Perforator flap, raising on a named source vessel, for pedicled transfer for 5001.12.2023head or neck or other non-breast reconstruction (H) (Anaes.) (Assist.) 1046052 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300753.0000273.2500000.00 4001.07.2023(Anaes.) 5001.12.2023Perforator Flap, such as anterolateral thigh flap or similar, raising in 5001.12.2023preparation for microsurgical transfer of a free flap for head or neck or 5001.12.2023other non-breast reconstruction (H) (Anaes.) (Assist.) 1046060 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308078.0002930.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Free transfer of tissue with a vascularised bone component (including 5001.12.2023chimeric/composite flap), for the repair of major defect of the head or neck 5001.12.2023or other non-breast defect, all necessary elements of the operation, including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels using 5001.12.2023microvascular techniques; and(b) harvesting of flap (including osteotomies); 5001.12.2023and(c) raising of tissue on a vascular pedicle; and(d) preparation of 5001.12.2023recipient vessels; and(e) transfer of tissue, including fixation of bony 5001.12.2023element and inset of tissue at recipient site; and(f) direct repair of 5001.12.2023secondary cutaneous defect, if performed;other than the following:(g) bony 5001.12.2023reshaping for purposes of reconstruction of maxilla, mandible or skull 5001.12.2023base;(h) a service associated with a service to which item 30166, 30169, 5001.12.202330175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesSingle 5001.12.2023surgeon (H) (Anaes.) (Assist.) 1046062 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307727.0002802.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Free transfer of tissue with a vascularised bone component (including 5001.12.2023chimeric/composite flap), for the repair of major defect of the head or neck 5001.12.2023or other non-breast defect, all necessary elements of the operation, including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels using 5001.12.2023microvascular techniques; and(b) harvesting of flap (including osteotomies); 5001.12.2023and(c) raising of tissue on a vascular pedicle; and(d) preparation of 5001.12.2023recipient vessels; and(e) transfer of tissue, including fixation of bony 5001.12.2023element and inset of tissue at recipient site; and(f) direct repair of 5001.12.2023secondary cutaneous defect, if performed;other than the following:(g) bony 5001.12.2023reshaping for purposes of reconstruction of maxilla, mandible or skull 5001.12.2023base;(h) a service associated with a service to which item 30166, 30169, 5001.12.202330175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 5001.12.2023appliesConjoint surgery, principal specialist surgeon (H) (Anaes.) (Assist.) 1046064 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305796.0002102.1500000.00 4001.07.2023(Anaes.) 5001.12.2023Free transfer of tissue with a vascularised bone component (including 5001.12.2023chimeric/composite flap), for the repair of major defect of the head or neck 5001.12.2023or other non-breast defect, all necessary elements of the operation, including 5001.12.2023(but not limited to):(a) anastomoses of all required vessels using 5001.12.2023microvascular techniques; and(b) harvesting of flap (including osteotomies); 5001.12.2023and(c) raising of tissue on a vascular pedicle; and(d) preparation of 5001.12.2023recipient vessels; and(e) transfer of tissue, including fixation of bony 5001.12.2023element and inset of tissue at recipient site; and(f) direct repair of 5001.12.2023secondary cutaneous defect, if performed;other than the following:(g) bony 5001.12.2023reshaping for purposes of reconstruction of maxilla, mandible or skull 5001.12.2023base;(h) a service associated with a service to which item 30166, 30169, 5001.12.202330175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 5001.12.2023appliesConjoint surgery, conjoint specialist surgeon (H) (Anaes.) (Assist.) 1046066 01.07.2023 3 T8 13 SN YYNYN 2001.12.202311591.0004204.0500000.00 4001.07.2023(Anaes.) 5001.12.2023Double free flap, including one free transfer of tissue with a vascularized 5001.12.2023bone component, for the repair of major defect of the head or neck or other 5001.12.2023non-breast defect, all necessary elements of the operation, including (but not 5001.12.2023limited to):(a) anastomoses of all required vessels using microvascular 5001.12.2023techniques; and(b) harvesting of flap (including osteotomies); and(c) raising 5001.12.2023of tissue on a vascular pedicle; and(d) preparation of recipient vessels; 5001.12.2023and(e) transfer of tissue, including fixation of bony element and inset of 5001.12.2023tissue at recipient site; and(f) direct repair of secondary cutaneous defect, 5001.12.2023if performed;other than the following:(g) bony reshaping for purposes of 5001.12.2023reconstruction of maxilla, mandible or skull base;(h) a service associated 5001.12.2023with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 5001.12.202345502, 45504, 45505 or 45562 appliesConjoint surgery, principal specialist 5001.12.2023surgeon (H) (Anaes.) (Assist.) 1046068 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308694.0003153.2500000.00 4001.07.2023(Anaes.) 5001.12.2023Double free flap, including one free transfer of tissue with a vascularized 5001.12.2023bone component, for the repair of major defect of the head or neck or other 5001.12.2023non-breast defect, all necessary elements of the operation, including (but not 5001.12.2023limited to):(a) anastomoses of all required vessels using microvascular 5001.12.2023techniques; and(b) harvesting of flap (including osteotomies); and(c) raising 5001.12.2023of tissue on a vascular pedicle; and(d) preparation of recipient vessels; 5001.12.2023and(e) transfer of tissue, including fixation of bony element and inset of 5001.12.2023tissue at recipient site; and(f) direct repair of secondary cutaneous defect, 5001.12.2023if performed;other than the following:(g) bony reshaping for purposes of 5001.12.2023reconstruction of maxilla, mandible or skull base;(h) a service associated 5001.12.2023with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 5001.12.202345502, 45504, 45505 or 45562 appliesConjoint surgery, conjoint specialist 5001.12.2023surgeon (H) (Anaes.) (Assist.) 1046070 01.07.2023 3 T8 13 SN YYNYN 2001.12.202311591.0004204.0500000.00 4001.07.2023(Anaes.) 5001.12.2023Double free flap, including 2 free transfers of tissue (reconstructive 5001.12.2023surgery) for the repair of major tissue defect, involving anastomoses of all 5001.12.2023required vessels using microvascular techniques, all necessary elements of the 5001.12.2023operation, including (but not limited to):(a) raising each flap of tissue on a 5001.12.2023separate vascular pedicle; and(b) preparation of recipient vessels; and(c) 5001.12.2023transfer of tissue; and(d) inset of tissue at recipient site; and(e) direct 5001.12.2023repair of secondary cutaneous defect, if performed;other than a service:(f) 5001.12.2023performed in the context of breast reconstruction; or(g) associated with a 5001.12.2023service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 5001.12.202345504, 45505 or 45562 appliesConjoint surgery, principal specialist surgeon 5001.12.2023(H) (Anaes.) (Assist.) 1046072 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308694.0003153.2500000.00 4001.07.2023(Anaes.) 5001.12.2023Double free flap, including 2 free transfers of tissue (reconstructive 5001.12.2023surgery) for the repair of major tissue defect, involving anastomoses of all 5001.12.2023required vessels using microvascular techniques, all necessary elements of the 5001.12.2023operation including (but not limited to):(a) raising each flap of tissue on a 5001.12.2023separate vascular pedicle; and(b) preparation of recipient vessels; and(c) 5001.12.2023transfer of tissue; and(d) inset of tissue at recipient site; and(e) direct 5001.12.2023repair of secondary cutaneous defect, if performed;other than a service:(f) 5001.12.2023performed in the context of breast reconstruction; or(g) associated with a 5001.12.2023service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 5001.12.202345504, 45505 or 45562 appliesConjoint surgery, conjoint specialist surgeon (H) 5001.12.2023(Anaes.) (Assist.) 1046080 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308912.0003232.6500000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, single surgeon (unilateral) 5001.12.2023using a myocutaneous or perforator flap, by microsurgical transfer:(a) 5001.12.2023including anastomosis of artery and one or more veins (including repair of 5001.12.2023secondary skin defect); but(b) excluding repair of muscular aponeurotic 5001.12.2023layer;other than a service associated with a service to which item 30166, 5001.12.202330169, 30175, 30177 or 30179 applies (H) (Anaes.) (Assist.) 1046082 01.07.2023 3 T8 13 SN YYNYN 2001.12.202315597.0005657.1500000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, single surgeon (bilateral) 5001.12.2023using a myocutaneous or perforator flap, by microsurgical transfer:(a) 5001.12.2023including anastomoses of arteries and veins (including repair of secondary 5001.12.2023skin defect); but(b) excluding repair of muscular aponeurotic layer;other than 5001.12.2023a service associated with a service to which item 30166, 30169, 30175, 30177 5001.12.2023or 30179 applies (H) (Anaes.) (Assist.) 1046084 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307727.0002802.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, conjoint surgery 5001.12.2023(unilateral) using a myocutaneous or perforator flap, by microsurgical 5001.12.2023transfer:(a) including anastomosis of artery and one or more veins (including 5001.12.2023repair of secondary skin defect); but(b) excluding repair of muscular 5001.12.2023aponeurotic layer;other than a service associated with a service to which item 5001.12.202330166, 30169, 30175, 30177 or 30179 appliesconjoint surgery, principal 5001.12.2023specialist surgeon (H) (Anaes.) (Assist.) 1046086 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305796.0002102.1500000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, conjoint surgery 5001.12.2023(unilateral) using a myocutaneous or perforator flap, by microsurgical 5001.12.2023transfer:(a) including anastomosis of artery and one or more veins (including 5001.12.2023repair of secondary skin defect); but(b) excluding repair of muscular 5001.12.2023aponeurotic layer;other than a service associated with a service to which item 5001.12.202330166, 30169, 30175, 30177 or 30179 appliesconjoint surgery, conjoint 5001.12.2023specialist surgeon (H) (Anaes.) (Assist.) 1046088 01.07.2023 3 T8 13 SN YYNYN 2001.12.202313522.0004904.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, conjoint surgery 5001.12.2023(bilateral) using a myocutaneous or perforator flap, by microsurgical 5001.12.2023transfer:(a) including anastomosis of artery and one or more veins (including 5001.12.2023repair of secondary skin defect); but(b) excluding repair of muscular 5001.12.2023aponeurotic layer;other than a service associated with a service to which item 5001.12.202330166, 30169, 30175, 30177 or 30179 appliesconjoint surgery, principal 5001.12.2023specialist surgeon (H) (Anaes.) (Assist.) 1046090 01.07.2023 3 T8 13 SN YYNYN 2001.12.202310142.0003678.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Post-mastectomy breast reconstruction, autologous, conjoint surgery 5001.12.2023(bilateral) using a myocutaneous or perforator flap, by microsurgical 5001.12.2023transfer:(a) including anastomoses of arteries and veins (including repair of 5001.12.2023secondary skin defect); but(b) excluding repair of muscular aponeurotic 5001.12.2023layer;other than a service associated with a service to which item 30166, 5001.12.202330169, 30175, 30177 or 30179 appliesconjoint surgery, conjoint specialist 5001.12.2023surgeon (H) (Anaes.) (Assist.) 1046092 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301232.0000446.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Lower pole coverage of reconstructive breast prosthesis, following mastectomy, 5001.12.2023using muscle or fascia turnover flap or autologous dermal flaps, if the 5001.12.2023service is performed in combination with a service to which item 31522, 31523, 5001.12.202331528, 31529, 45527, 45539 or 45542 applies (Anaes.) (Assist.) 1046094 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300910.0000330.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Lower pole coverage or complete implant coverage of reconstructive breast 5001.12.2023prosthesis, following mastectomy, using allograft or synthetic products 5001.12.2023(Anaes.) (Assist.) 1046100 01.07.2023 3 T8 13 SD NNNYY 3001.12.202340% of the fee for the co-claimed service - performed in conjunction with a 3001.12.2023service (the co-claimed service) to which any of items 46101 to 46135 (other 3001.12.2023than item 46112 or 46124) apply. 5001.12.2023Excision of burnt tissue, or definitive burn wound closure, if:(a) the area of 5001.12.2023burn excised involves more than 1% of hands, face or anterior neck; and(b) the 5001.12.2023service is performed in conjunction with a service (the co-claimed service) to 5001.12.2023which any of items 46101 to 46135 (other than item 46112 or 46124) apply;other 5001.12.2023than a service to which item 46136 applies 1046101 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301024.0000371.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves not more than 5001.12.20231% of the total body surface (Anaes.) (Assist.) 1046102 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301626.0000589.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves more than 1% 5001.12.2023but less than 3% of the total body surface (H) (Anaes.) (Assist.) 1046103 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301783.0000646.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 3% or more but 5001.12.2023less than 10% of the total body surface (H) (Anaes.) (Assist.) 1046104 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302721.0000986.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 10% or more but 5001.12.2023less than 20% of the total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046105 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303659.0001327.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 20% or more but 5001.12.2023less than 30% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046106 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304599.0001668.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 30% or more but 5001.12.2023less than 40% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046107 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305537.0002008.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 40% or more but 5001.12.2023less than 50% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046108 01.07.2023 3 T8 13 SN YYNYN 2001.12.202306474.0002348.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 50% or more but 5001.12.2023less than 60% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046109 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307412.0002688.6000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 60% or more but 5001.12.2023less than 70% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046110 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308446.0003063.3000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 70% or more but 5001.12.2023less than 80% of total body surface, excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046111 01.07.2023 3 T8 13 SN YYNYN 2001.12.202309458.0003430.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves 80% or more of 5001.12.2023total body surface, excluding aftercare (H) (Anaes.) (Assist.) 1046112 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305221.0001893.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Excision of burnt tissue, if the area of burn excised involves whole of face 5001.12.2023(excluding ears)may be claimed with any one of items 46101 to 46111, based on 5001.12.2023the percentage total body surface (excluding the face), other than a service 5001.12.2023associated with a service to which item 46100 applies and excluding aftercare 5001.12.2023(H) (Anaes.) (Assist.) 1046113 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301024.0000371.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, or closure of skin defect secondary to burns 5001.12.2023contracture release, if the defect area is not more than 1% of total body 5001.12.2023surface and if the service:(a) is performed at the same time as the procedure 5001.12.2023for the primary burn wound excision or contracture release; and(b) involves: 5001.12.2023(i) autologous skin grafting for definitive closure; or(ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound 5001.12.2023(Anaes.) (Assist.) 1046114 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301626.0000589.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, or closure of skin defect secondary to burns 5001.12.2023contracture release, if the defect area is more than 1% but not more than 3% 5001.12.2023of total body surface and if the service:(a) is performed at the same time as 5001.12.2023the procedure for the primary burn wound excision or contracture release; 5001.12.2023and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) 5001.12.2023allogenic skin grafting, or biosynthetic skin substitutes, to temporize the 5001.12.2023excised wound (H) (Anaes.) (Assist.) 1046115 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301783.0000646.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure or closure of skin defect secondary to burns 5001.12.2023contracture release, if the defect area is more than 3% but not more than 10% 5001.12.2023of total body surface and if the service:(a) is performed at the same time as 5001.12.2023the procedure for the primary burn wound excision or contracture release; 5001.12.2023and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) 5001.12.2023allogenic skin grafting, or biosynthetic skin substitutes, to temporize the 5001.12.2023excised wound (H) (Anaes.) (Assist.) 1046116 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302721.0000986.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure or closure of skin defect secondary to burns 5001.12.2023contracture release, if the defect area is more than 10% but less than 20% of 5001.12.2023total body surface and if the service:(a) is performed at the same time as the 5001.12.2023procedure for the primary burn wound excision or contracture release; and(b) 5001.12.2023involves: (i) autologous skin grafting for definitive closure; or(ii) 5001.12.2023allogenic skin grafting, or biosynthetic skin substitutes, to temporize the 5001.12.2023excised wound; excluding aftercare (H) (Anaes.) (Assist.) 1046117 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303659.0001327.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 20% or more but less than 5001.12.202330% of total body surface and if the service:(a) is performed at the same time 5001.12.2023as the procedure for the primary burn wound excision; and(b) involves: (i) 5001.12.2023autologous skin grafting for definitive closure; or(ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046118 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304599.0001668.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 30% or more but less than 5001.12.202340% of total body surface and if the service:(a) is performed at the same time 5001.12.2023as the procedure for the primary burn wound excision; and(b) involves: (i) 5001.12.2023autologous skin grafting for definitive closure; or(ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046119 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305537.0002008.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 40% or more but less than 5001.12.202350% of total body surface and if the service:(a) is performed at the same time 5001.12.2023as the procedure for the primary burn wound excision; and(b) involves: (i) 5001.12.2023autologous skin grafting for definitive closure; or(ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046120 01.07.2023 3 T8 13 SN YYNYN 2001.12.202306474.0002348.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 50% or more but less than 5001.12.202360% of total body surface and if the service: (a) is performed at the same 5001.12.2023time as the procedure for the primary burn wound excision; and (b) involves: 5001.12.2023(i) autologous skin grafting for definitive closure; or (ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046121 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307412.0002688.6000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 60% or more but less than 5001.12.202370% of total body surface and if the service:(a) is performed at the same time 5001.12.2023as the procedure for the primary burn wound excision; and(b) involves: (i) 5001.12.2023autologous skin grafting for definitive closure; or(ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046122 01.07.2023 3 T8 13 SN YYNYN 2001.12.202308446.0003063.3000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 70% or more but less than 5001.12.202380% of total body surface and if the service: (a) is performed at the same 5001.12.2023time as the procedure for the primary burn wound excision; and (b) involves: 5001.12.2023(i) autologous skin grafting for definitive closure; or (ii) allogenic skin 5001.12.2023grafting, or biosynthetic skin substitutes, to temporize the excised wound; 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046123 01.07.2023 3 T8 13 SN YYNYN 2001.12.202309458.0003430.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure, if the defect area is 80% or more of total body 5001.12.2023surface and if the service:(a) is performed at the same time as the procedure 5001.12.2023for the primary burn wound excision; and(b) involves: (i) autologous skin 5001.12.2023grafting for definitive closure; or(ii) allogenic skin grafting, or 5001.12.2023biosynthetic skin substitutes, to temporize the excised wound; excluding 5001.12.2023aftercare (H) (Anaes.) (Assist.) 1046124 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305221.0001893.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Excised burn wound closure of whole of face, if the service:(a) is performed 5001.12.2023at the same time as the procedure for the primary burn wound excision; and(b) 5001.12.2023involves: (i) autologous skin grafting for definitive closure; or(ii) 5001.12.2023allogenic skin grafting, or biosynthetic skin substitutes, to temporize the 5001.12.2023excised wound; excluding aftercare, other than a service associated with a 5001.12.2023service to which item 46100 applies (H) (Anaes.) (Assist.) 1046125 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301024.0000371.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Non-excisional debridement of superficial or mid-dermal partial thickness 5001.12.2023burns, if the area of burn involves less than 1% of total body surface, and 5001.12.2023application of skin substitute (skin allograft or biosynthetic epidermal 5001.12.2023replacements) (Anaes.) (Assist.) 1046126 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301626.0000589.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Non-excisional debridement of superficial or mid-dermal partial thickness 5001.12.2023burns, if the area of burn involves 1% or more but less than 3% of total body 5001.12.2023surface, and application of skin substitute (skin allograft or biosynthetic 5001.12.2023epidermal replacements) (Anaes.) (Assist.) 1046127 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302252.0000816.9500000.00 4001.07.2023(Anaes.) 5001.12.2023Non-excisional debridement of superficial or mid-dermal partial thickness 5001.12.2023burns, if the area of burn involves 3% or more but less than 10% of total body 5001.12.2023surface, and application of skin substitute (skin allograft or biosynthetic 5001.12.2023epidermal replacements) (H) (Anaes.) (Assist.) 1046128 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304129.0001497.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Non-excisional debridement of superficial or mid-dermal partial thickness 5001.12.2023burns, if the area of burn involves 10% or more but less than 30% of total 5001.12.2023body surface, and application of skin substitute (skin allograft or 5001.12.2023biosynthetic epidermal replacements), excluding aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1046129 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307556.0002740.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Non-excisional debridement of superficial or mid-dermal partial thickness 5001.12.2023burns, if the area of burn involves 30% or more of total body surface, and 5001.12.2023application of skin substitute (skin allograft or biosynthetic epidermal 5001.12.2023replacements), excluding aftercare (H) (Anaes.) (Assist.) 1046130 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301024.0000371.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis or secondary to release of burns scar contracture, if 5001.12.2023the defect area involves less than 1% of total body surface, using autologous 5001.12.2023tissue (split skin graft or other) following previous procedure using 5001.12.2023non-autologous temporary wound closure or simple dressings (Anaes.) (Assist.) 1046131 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301626.0000589.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis or secondary to release of burns scar contracture, if 5001.12.2023the defect area involves 1% or more but less than 3% of total body surface, 5001.12.2023using autologous tissue (split skin graft or other) following previous 5001.12.2023procedure using non-autologous temporary wound closure or simple dressings (H) 5001.12.2023(Anaes.) (Assist.) 1046132 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301783.0000646.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis or secondary to release of burns scar contracture, if 5001.12.2023the defect area involves 3% or more but less than 10% of total body surface, 5001.12.2023using autologous tissue (split skin graft or other) following previous 5001.12.2023procedure using non-autologous temporary wound closure or simple dressings (H) 5001.12.2023(Anaes.) (Assist.) 1046133 01.07.2023 3 T8 13 SN YYNYN 2001.12.202302721.0000986.8500000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis or secondary to release of burns scar contracture, if 5001.12.2023the defect area involves 10% or more but less than 20% of total body surface, 5001.12.2023using autologous tissue (split skin graft or other) following previous 5001.12.2023procedure using non-autologous temporary wound closure or simple dressings, 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046134 01.07.2023 3 T8 13 SN YYNYN 2001.12.202306021.0002184.0000000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis, if the defect area involves 20% or more but less than 5001.12.202330% of total body surface, using autologous tissue (split skin graft or other) 5001.12.2023following previous procedure using non-autologous temporary wound closure, 5001.12.2023excluding aftercare (H) (Anaes.) (Assist.) 1046135 01.07.2023 3 T8 13 SN YYNYN 2001.12.202309458.0003430.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis, if the defect area involves 30% or more of total body 5001.12.2023surface, using autologous tissue (split skin graft or other) following 5001.12.2023previous procedure using non-autologous temporary wound closure, excluding 5001.12.2023aftercare (H) (Anaes.) (Assist.) 1046136 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305221.0001893.9000000.00 4001.07.2023(Anaes.) 5001.12.2023Definitive burn wound closure, or closure of skin defect secondary to 5001.12.2023necrotising fasciitis, of whole of face, using autologous tissue (split skin 5001.12.2023graft or other) following previous procedure using non-autologous temporary 5001.12.2023wound closure, excluding aftercare, other than a service associated with a 5001.12.2023service to which item 46100 applies (H) (Anaes.) (Assist.) 1046140 01.07.2023 3 T8 13 SN YYNYN 2001.12.202300781.0000283.3500000.00 4001.07.2023(Anaes.) 5001.12.2023Burns contracture, release of, by excision or incision of scar, if the defect 5001.12.2023resulting from surgery is less than 1% of total body surface, including direct 5001.12.2023repair if performed (Anaes.) (Assist.) 1046141 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301172.0000425.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Burns contracture, release of, by excision or incision of scar, if the defect 5001.12.2023resulting from surgery is 1% or more but less than 3% of total body surface 5001.12.2023(H) (Anaes.) (Assist.) 1046142 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301406.0000510.0000000.00 4001.07.2023(Anaes.) 5001.12.2023Burns contracture, release of, by excision or incision of scar, if the defect 5001.12.2023resulting from surgery is 3% or more but less than 10% of total body surface 5001.12.2023(H) (Anaes.) (Assist.) 1046143 01.07.2023 3 T8 13 SN YYNYN 2001.12.202301823.0000661.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Burns contracture, release of, by excision or incision of scar, if the defect 5001.12.2023resulting from surgery is 10% or more but less than 20% of total body surface 5001.12.2023(H) (Anaes.) (Assist.) 1046150 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304035.0001463.7000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible or maxilla, procedure for advancement, retrusion or alteration of 5001.12.2023tilt, by osteotomy in standard planes, including fixation by any means 5001.12.2023(including application of distractors if used)one service per patient on the 5001.12.2023same occasion (H) (Anaes.) (Assist.) 1046151 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304400.0001595.9500000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or 5001.12.2023alteration of tilt, or combination of these, by osteotomies in standard 5001.12.2023planes, including fixation by any means (including application of distractors 5001.12.2023if used)conjoint surgery, principal specialist surgeon, one service per 5001.12.2023patient on the same occasion (H) (Anaes.) (Assist.) 1046152 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303300.0001196.9500000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or 5001.12.2023alteration of tilt, or combination of these, by osteotomies in standard 5001.12.2023planes, including fixation by any means (including application of distractors 5001.12.2023if used)conjoint surgery, conjoint specialist surgeon, one service per patient 5001.12.2023on the same occasion (H) (Anaes.) (Assist.) 1046153 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305500.0001994.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or 5001.12.2023alteration of tilt, or combination of these, by osteotomies in standard 5001.12.2023planes, including fixation by any means (including application of distractors 5001.12.2023if used)single surgeon, one service per patient on the same occasion (H) 5001.12.2023(Anaes.) (Assist.) 1046154 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304606.0001670.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Maxilla, procedure for reshaping arch of, by complex segmental osteotomies, 5001.12.2023including fixation by any means (including application of distractors if 5001.12.2023used), one service per patient on the same occasion (H) (Anaes.) (Assist.) 1046155 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304606.0001670.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible, procedure for reshaping arch of, by complex segmental osteotomies, 5001.12.2023including genioplasty (if performed) and fixation by any means (including 5001.12.2023application of distractors if used), one service per patient on the same 5001.12.2023occasion (H) (Anaes.) (Assist.) 1046156 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305258.0001907.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for any combination of arch 5001.12.2023reshaping, advancement, retrusion or tilting of, involving complex segmental 5001.12.2023osteotomies, with or without standard osteotomies, including genioplasty (if 5001.12.2023performed) and fixation by any means (including application of distractors if 5001.12.2023used)conjoint surgery, principal specialist surgeon, one service per patient 5001.12.2023on the same occasion (H) (Anaes.) (Assist.) 1046157 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303943.0001430.3000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for any combination of arch 5001.12.2023reshaping, advancement, retrusion or tilting of, involving complex segmental 5001.12.2023osteotomies, with or without standard osteotomies, including genioplasty (if 5001.12.2023performed) and fixation by any means (including application of distractors if 5001.12.2023used)conjoint surgery, conjoint specialist surgeon, one service per patient on 5001.12.2023the same occasion (H) (Anaes.) (Assist.) 1046158 01.07.2023 3 T8 13 SN YYNYN 2001.12.202306572.0002383.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Mandible and maxilla (bimaxillary), procedure for any combination of arch 5001.12.2023reshaping, advancement, retrusion or tilting of, involving complex segmental 5001.12.2023osteotomies, with or without standard osteotomies, including genioplasty (if 5001.12.2023performed) and fixation by any means (including application of distractors if 5001.12.2023used)single surgeon, one service per patient on the same occasion (H) (Anaes.) 5001.12.2023(Assist.) 1046159 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305815.0002109.0500000.00 4001.07.2023(Anaes.) 5001.12.2023Midfacial osteotomies, Le Fort II or Le Fort IIIconjoint surgery, principal 5001.12.2023specialist surgeon (H) (Anaes.) (Assist.) 1046160 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304361.0001581.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Midfacial osteotomies, Le Fort II or Le Fort IIIconjoint surgery, conjoint 5001.12.2023specialist surgeon (H) (Anaes.) (Assist.) 1046161 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307268.0002636.2500000.00 4001.07.2023(Anaes.) 5001.12.2023Midfacial osteotomies, Le Fort II or Le Fort IIIsingle surgeon (H) (Anaes.) 5001.12.2023(Assist.) 1046170 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303035.0001100.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Decompression of thoracic outlet, primary, for thoracic outlet syndrome, using 5001.12.2023any approach, including (if performed) division of scalene muscles, cervical 5001.12.2023rib and/or first rib resection (H) (Anaes.) (Assist.) 1046171 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305159.0001871.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Decompression of thoracic outlet, repeat (revision) procedure, for thoracic 5001.12.2023outlet syndrome, using any approach, including (if performed) division of 5001.12.2023scalene muscles, cervical rib and/or first rib resection (H) (Anaes.) 5001.12.2023(Assist.) 1046172 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307587.0002751.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Removal or debulking of brachial plexus tumour, involving intraneural 5001.12.2023dissection, either supraclavicular or infraclavicular dissection (H) (Anaes.) 5001.12.2023(Assist.) 1046173 01.07.2023 3 T8 13 SN YYNYN 2001.12.202310621.0003852.4500000.00 4001.07.2023(Anaes.) 5001.12.2023Removal or debulking of brachial plexus tumour, involving intraneural 5001.12.2023dissection, both supraclavicular and infraclavicular dissection (H) (Anaes.) 5001.12.2023(Assist.) 1046174 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307587.0002751.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Exploration of the brachial plexus, either supraclavicular or infraclavicular, 5001.12.2023including any neurolyses performed and intraoperative neurophysiological 5001.12.2023recordings, but excluding reconstruction of elements(H) (Anaes.) (Assist.) 1046175 01.07.2023 3 T8 13 SN YYNYN 2001.12.202312139.0004402.8000000.00 4001.07.2023(Anaes.) 5001.12.2023Exploration of the brachial plexus, both supraclavicular and infraclavicular, 5001.12.2023including any neurolyses performed and intraoperative neurophysiological 5001.12.2023recordings, but excluding reconstruction of elements(H) (Anaes.) (Assist.) 1046176 01.07.2023 3 T8 13 SN YYNYN 2001.12.202303035.0001100.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Exploration of the brachial plexus, posterior subscapular approach, all 5001.12.2023necessary elements of the operation including (but not limited to):(a) 5001.12.2023resection of the first rib and/or second rib; and(b) vertebral laminectomies 5001.12.2023or facetectomies, if performed; and(c) any neurolyses performed; and(d) 5001.12.2023intraoperative neurophysiological recordings;excluding the following:(e) 5001.12.2023reconstruction of elements of the plexus;(f) spinal instrumentation(H) 5001.12.2023(Anaes.) (Assist.) 1046177 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305159.0001871.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, single cord or trunk, by any 5001.12.2023appropriate method, single surgeon (H) (Anaes.) (Assist.) 1046178 01.07.2023 3 T8 13 SN YYNYN 2001.12.202305159.0001871.2000000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, single cord or trunk, by any 5001.12.2023appropriate method, conjoint surgery, principal surgeon (H) (Anaes.) (Assist.) 1046179 01.07.2023 3 T8 13 SN YYNYN 2001.12.202304294.0001557.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, single cord or trunk, by any 5001.12.2023appropriate method, conjoint surgery, conjoint surgeon (H) (Anaes.) (Assist.) 1046180 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307587.0002751.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, more than a single cord or 5001.12.2023trunk, but less than the whole plexus, by any appropriate method, single 5001.12.2023surgeon (H) (Anaes.) (Assist.) 1046181 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307587.0002751.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, more than a single cord or 5001.12.2023trunk, but less than the whole plexus, by any appropriate method, conjoint 5001.12.2023surgery, principal surgeon (H) (Anaes.) (Assist.) 1046182 01.07.2023 3 T8 13 SN YYNYN 2001.12.202306327.0002294.9500000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, more than a single cord or 5001.12.2023trunk, but less than the whole plexus, by any appropriate method, conjoint 5001.12.2023surgery, conjoint surgeon (H) (Anaes.) (Assist.) 1046183 01.07.2023 3 T8 13 SN YYNYN 2001.12.202309104.0003302.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, whole plexus, by any 5001.12.2023appropriate method, single surgeon (H) (Anaes.) (Assist.) 1046184 01.07.2023 3 T8 13 SN YYNYN 2001.12.202309104.0003302.1000000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, whole plexus, by any 5001.12.2023appropriate method, conjoint surgery, principal surgeon (H) (Anaes.) (Assist.) 1046185 01.07.2023 3 T8 13 SN YYNYN 2001.12.202307587.0002751.7500000.00 4001.07.2023(Anaes.) 5001.12.2023Reconstruction of deficit of the brachial plexus, whole plexus, by any 5001.12.2023appropriate method, conjoint surgery, conjoint surgeon (H) (Anaes.) (Assist.) 1046300 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301485.0000446.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis of interphalangeal or metacarpophalangeal joint of hand, including 5001.12.2023either or both of the following (if performed): (a) joint debridement; (b) 5001.12.2023synovectomy one joint (H) (Anaes.) (Assist.) 1046303 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301910.0000579.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis of carpometacarpal joint of hand, including either or both of the 5001.12.2023following (if performed): (a) joint debridement; (b) synovectomy one joint (H) 5001.12.2023(Anaes.) (Assist.) 1046308 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301970.0000579.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Volar plate or soft tissue interposition arthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including either or both of the following 5001.12.2023(if performed): (a) realignment procedures; (b) tendon transfer one joint 5001.12.2023(Anaes.) (Assist.) 1046309 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301945.0000579.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) ligament reconstruction; (b) ligament realignment; (c) 5001.12.2023synovectomy; (d) tendon transfer one joint (H) (Anaes.) (Assist.) 1046312 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302415.0000745.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) ligament reconstruction; (b) ligament realignment; (c) 5001.12.2023synovectomy; (d) tendon transfer 2 joints of one hand (H) (Anaes.) (Assist.) 1046315 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303220.0000993.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) ligament reconstruction; (b) ligament realignment; (c) 5001.12.2023synovectomy; (d) tendon transfer 3 joints of one hand (H) (Anaes.) (Assist.) 1046318 26.05.2002 3 T8 14 SN NYNNY 2001.12.202304030.0001241.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) ligament reconstruction; (b) ligament realignment; (c) 5001.12.2023synovectomy; (d) tendon transfer 4 joints of one hand (H) (Anaes.) (Assist.) 1046321 26.05.2002 3 T8 14 SN NYNNY 2001.12.202304835.0001490.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) ligament reconstruction; (b) ligament realignment; (c) 5001.12.2023synovectomy; (d) tendon transfer; 5 joints of one hand (H) (Anaes.) (Assist.) 1046322 01.07.2021 3 T8 14 SN NYNNY 2001.12.202302920.0000869.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of prosthetic replacement arthroplasty or hemiarthroplasty of 5001.12.2023interphalangeal or metacarpal joint of hand, including any of the following 5001.12.2023(if performed): (a) bone grafting; (b) ligament reconstruction; (c) ligament 5001.12.2023realignment; (d) synovectomy; (e) tendon or ligament reconstruction; (f) 5001.12.2023tendon transfer; one joint (H) (Anaes.) (Assist.) 1046324 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303435.0001014.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Trapezium replacement arthroplasty or prosthetic interpositional replacement 5001.12.2023of carpometacarpal joint of thumb, including either or both of the following 5001.12.2023(if performed): (a) ligament and tendon transfers; (b) rebalancing procedures 5001.12.2023(H) (Anaes.) (Assist.) 1046325 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303435.0001014.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Excisional arthroplasty of carpometacarpal joint of thumb, with excision of 5001.12.2023adjacent trapezoid, including either or both of the following (if performed): 5001.12.2023(a) ligament and tendon transfers; (b) realignment procedures (H) (Anaes.) 5001.12.2023(Assist.) 1046330 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301280.0000380.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Ligamentous or capsular repair or reconstruction of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand, including any of the following (if 5001.12.2023performed): (a) arthrotomy; (b) joint stabilisation; (c) synovectomy; one 5001.12.2023joint (H) (Anaes.) (Assist.) 1046333 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302090.0000620.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Ligamentous or capsular repair or reconstruction of interphalangeal or 5001.12.2023metacarpophalangeal joint of hand with graft, using graft or implant, 5001.12.2023including any of the following (if performed): (a) arthrotomy; (b) harvest of 5001.12.2023graft; (c) joint stabilisation; (d) synovectomy; other than a service 5001.12.2023associated with a service to which item 48245, 48248, 48251, 48254 or 48257 5001.12.2023applyone joint (H) (Anaes.) (Assist.) 1046335 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301710.0000513.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Synovectomy of digital extensor tendons of hand, distal to wrist, for 5001.12.2023diagnosed inflammatory arthritis, including any of the following (if 5001.12.2023performed): (a) reconstruction of extensor retinaculum; (b) removal of tendon 5001.12.2023nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with a 5001.12.2023service to which item 30023, 39331 or 39330 appliesapplicable only once per 5001.12.2023occasion on which the service is performed (Anaes.) (Assist.) 1046336 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300975.0000289.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy of interphalangeal, metacarpophalangeal or carpometacarpal joint 5001.12.2023of hand, including any of the following (if performed): (a) capsulectomy; (b) 5001.12.2023debridement; (c) ligament or tendon realignment (or both); other than a 5001.12.2023service combined with a service to which item 46495 appliesone joint (Anaes.) 5001.12.2023(Assist.) 1046339 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301710.0000513.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy of digital flexor tendons at wrist level, for diagnosed 5001.12.2023inflammatory arthritis, including either or both of the following (if 5001.12.2023performed): (a) tenolysis; (b) release of median nerve and carpal tunnel; 5001.12.2023other than a service associated with a service to which item 30023, 39331 or 5001.12.202339330 appliesapplicable only once per occasion on which the service is 5001.12.2023performed (H) (Anaes.) (Assist.) 1046340 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301455.0000436.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Synovectomy of wrist flexor or extensor tendons of hand or wrist, for 5001.12.2023diagnosed inflammatory tenosynovitis, including any of the following (if 5001.12.2023performed): (a) reconstruction of flexor or extensor retinaculum; (b) removal 5001.12.2023of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service 5001.12.2023associated with a service to which item 30023, 39331 or 39330 appliesone or 5001.12.2023more compartments (H) (Anaes.) (Assist.) 1046341 01.07.2021 3 T8 14 SN NYNNY 2001.12.202300905.0000279.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Synovectomy of wrist flexor or extensor tendons of hand or wrist, for 5001.12.2023non-inflammatory tenosynovitis or post traumatic synovitis, including any of 5001.12.2023the following (if performed): (a) reconstruction of flexor or extensor 5001.12.2023retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; 5001.12.2023other than a service associated with a service to which item 30023, 39331 or 5001.12.202339330 appliesone or more compartments (H) (Anaes.) (Assist.) 1046342 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301710.0000513.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy of distal radioulnar or carpometacarpal joint of handone or more 5001.12.2023joints (H) (Anaes.) (Assist.) 1046345 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302090.0000620.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Resection arthroplasty of distal radioulnar joint of hand, partial or 5001.12.2023complete, including any of the following (if performed): (a) ligament or 5001.12.2023tendon reconstruction; (b) joint stabilisation; (c) synovectomy (H) (Anaes.) 5001.12.2023(Assist.) 1046348 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300930.0000269.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of 5001.12.2023the following (if performed): (a) removal of intratendinous nodules; (b) 5001.12.2023tenolysis; (c) tenoplasty; other than a service associated with a service to 5001.12.2023which item 30023 or 46363 appliesone ray (H) (Anaes.) (Assist.) 1046351 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301395.0000401.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of 5001.12.2023the following (if performed): (a) removal of intratendinous nodules; (b) 5001.12.2023tenolysis; (c) tenoplasty; other than a service associated with a service to 5001.12.2023which item 30023 or 46363 applies2 rays of one hand (H) (Anaes.) (Assist.) 1046354 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301860.0000538.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of 5001.12.2023the following (if performed): (a) removal of intratendinous nodules; (b) 5001.12.2023tenolysis; (c) tenoplasty; other than a service associated with a service to 5001.12.2023which item 30023 or 46363 applies3 rays of one hand (H) (Anaes.) (Assist.) 1046357 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302325.0000670.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of 5001.12.2023the following (if performed): (a) removal of intratendinous nodules; (b) 5001.12.2023tenolysis; (c) tenoplasty; other than a service associated with a service to 5001.12.2023which item 30023 or 46363 applies4 rays of one hand (H) (Anaes.) (Assist.) 1046360 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302790.0000807.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of 5001.12.2023the following (if performed): (a) removal of intratendinous nodules; (b) 5001.12.2023tenolysis; (c) tenoplasty; other than a service associated with a service to 5001.12.2023which item 30023 or 46363 applies5 rays of one hand (H) (Anaes.) (Assist.) 1046363 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300780.0000231.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Trigger finger release, for stenosing tenosynoviti, including either or both 5001.12.2023of the following (if performed): (a) synovectomy; (b) synovial biopsy; one ray 5001.12.2023(Anaes.) (Assist.) 1046364 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301710.0000513.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Digital sympathectomy of hand, using microsurgical techniques, other than a 5001.12.2023service associated with a service to which item 30023 or 46363 appliesone 5001.12.2023digit or palmer arch (or both) or radial or ulnar artery (or both) (Anaes.) 5001.12.2023(Assist.) 1046365 01.07.2021 3 T8 14 SN NYNNY 2001.12.202300975.0000289.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of rheumatoid nodules of hand one lesion (Anaes.) (Assist.) 1046367 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301490.0000437.6500000.00 4001.07.2021(Anaes.) 5001.12.2023De Quervain's release, including any of the following (if performed): (a) 5001.12.2023synovectomy of extensor pollicis brevis; (b) synovectomy of abductor pollicis 5001.12.2023longus tendons; (c) retinaculum reconstruction; other than a service 5001.12.2023associated with a service to which item 46339 applies (Anaes.) (Assist.) 1046370 01.07.2021 3 T8 14 SN NYNNY 2001.12.202300475.0000140.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Percutaneous fasciotomy for Dupuytrens contracture, by needle or chemical 5001.12.2023method, including either or both of the following (if performed): (a) 5001.12.2023immediate or delayed manipulation; (b) local or regional nerve block; one ray 5001.12.2023(Anaes.) (Assist.) 1046372 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301575.0000471.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for Dupuytrens contracture, including dissection of nerves (if 5001.12.2023performed)one ray (H) (Anaes.) (Assist.) 1046375 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301875.0000558.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for Dupuytrens contracture, including dissection of nerves (if 5001.12.2023performed)2 rays (H) (Anaes.) (Assist.) 1046378 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302485.0000745.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for Dupuytrens contracture, including dissection of nerves (if 5001.12.2023performed)3 rays (H) (Anaes.) (Assist.) 1046379 01.07.2021 3 T8 14 SN NYNNY 2001.12.202303140.0000938.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Fasciectomy for Dupuytrens contracture, including dissection of nerves (if 5001.12.2023performed)4 rays (H) (Anaes.) (Assist.) 1046380 01.07.2021 3 T8 14 SN NYNNY 2001.12.202303955.0001182.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Fasciectomy for Dupuytrens contracture, including dissection of nerves (if 5001.12.2023performed)5 rays (H) (Anaes.) (Assist.) 1046381 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301100.0000331.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Release of interphalangeal joint of hand, by open procedure, when performed in 5001.12.2023conjunction with an operation for Dupuytrens contractureone joint (H) (Anaes.) 5001.12.2023(Assist.) 1046384 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301100.0000331.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Z-plasty or similar local flap procedure, when performed in conjunction with 5001.12.2023an operation for Dupuytrens contracture, including raising, transfer 5001.12.2023in-setting and suturing of both components (flaps)one Z-plasty or local flap 5001.12.2023procedure (H) (Anaes.) (Assist.) 1046387 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302265.0000683.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for recurrence of Dupuytrens contracture, including either or both 5001.12.2023of the following (if performed): (a) dissection of nerves; (b) neurolysis; 5001.12.2023other than a service associated with a service to which item 30023 appliesone 5001.12.2023ray (H) (Anaes.) (Assist.) 1046390 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303055.0000910.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for recurrence of Dupuytrens contracture, including either or both 5001.12.2023of the following (if performed): (a) dissection of nerves; (b) neurolysis; 5001.12.2023other than a service associated with a service to which item 30023 applies2 5001.12.2023rays (H) (Anaes.) (Assist.) 1046393 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303530.0001055.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Fasciectomy for recurrence of Dupuytrens contracture, including either or both 5001.12.2023of the following (if performed): (a) dissection of nerves; (b) neurolysis; 5001.12.2023other than a service associated with a service to which item 30023 applies3 5001.12.2023rays (H) (Anaes.) (Assist.) 1046394 01.07.2021 3 T8 14 SN NYNNY 2001.12.202304385.0001315.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Fasciectomy for recurrence of Dupuytrens contracture, including either or both 5001.12.2023of the following (if performed): (a) dissection of nerves; (b) neurolysis; 5001.12.2023other than a service associated with a service to which item 30023 applies4 5001.12.2023rays (H) (Anaes.) (Assist.) 1046395 01.07.2021 3 T8 14 SN NYNNY 2001.12.202305465.0001639.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Fasciectomy for recurrence of Dupuytrens contracture, including either or both 5001.12.2023of the following (if performed): (a) dissection of nerves; (b) neurolysis; 5001.12.2023other than a service associated with a service to which item 30023 applies5 5001.12.2023rays (H) (Anaes.) (Assist.) 1046399 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301915.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of phalanx or metacarpal of hand, with internal fixationone bone (H) 5001.12.2023(Anaes.) (Assist.) 1046401 01.07.2021 3 T8 14 SN NYNNY 2001.12.202302265.0000457.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Operative treatment of non-union of phalanx or metacarpal of hand, including 5001.12.2023internal fixation (if performed) (Anaes.) (Assist.) 1046408 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302560.0000761.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of tendon of hand or wrist, by tendon graft, including either 5001.12.2023or both of the following (if performed): (a) harvest of graft; (b) tenolysis; 5001.12.2023other than a service associated with a service to which item 30023 applies (H) 5001.12.2023(Anaes.) (Assist.) 1046411 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301550.0000447.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of complete flexor tendon pulley of hand or wrist, with graft, 5001.12.2023including harvest of graft (if performed)one pulley (H) (Anaes.) (Assist.) 1046414 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301945.0000579.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Insertion of artificial tendon prosthesis in preparation for grafting of 5001.12.2023tendon of hand or wrist, including tenolysis (if performed), other than a 5001.12.2023service associated with a service to which item 30023 applies (Anaes.) 5001.12.2023(Assist.) 1046417 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301860.0000538.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Transfer of tendon of hand or wrist, for restoration of hand or digit motion, 5001.12.2023including harvest of donor motor unit (if performed)one transfer (H) (Anaes.) 5001.12.2023(Assist.) 1046420 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300775.0000225.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Primary repair of extensor tendon of hand or wristone tendon (Anaes.) 5001.12.2023(Assist.) 1046423 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301240.0000360.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Delayed repair of extensor tendon of hand or wrist, including tenolysis (if 5001.12.2023performed), other than a service associated with a service to which item 30023 5001.12.2023applies (Anaes.) (Assist.) 1046426 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301250.0000372.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Primary repair of flexor tendon of hand or wrist, proximal to A1 pulley, other 5001.12.2023than a service to repair a tendon of a digit if 2 tendons of the same digit 5001.12.2023have been repaired during the same procedureone tendon (H) (Anaes.) (Assist.) 1046432 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301975.0000621.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Primary repair of flexor tendon of hand or wrist, distal to A1 pulley, other 5001.12.2023than a service to repair a tendon of a digit if 2 tendons of the same digit 5001.12.2023have been repaired during the same procedureone tendon (H) (Anaes.) (Assist.) 1046434 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301750.0000535.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Delayed repair of flexor tendon of hand or wrist, including tenolysis (if 5001.12.2023performed), other than a service associated with a service to which item 30023 5001.12.2023applies (Anaes.) (Assist.) 1046438 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300500.0000149.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Closed pin fixation of mallet finger (Anaes.) 1046441 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301240.0000360.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Open reduction of mallet finger, including any of the following (if 5001.12.2023performed): (a) joint release; (b) pin fixation; (c) tenolysis (Anaes.) 5001.12.2023(Assist.) 1046442 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301040.0000309.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MALLET FINGER with intra articular fracture involving more than one third of 5001.12.2023base of terminal phalanx - open reduction (Anaes.) (Assist.) 1046444 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301790.0000538.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of Boutonniere or swan neck deformity of hand, including either 5001.12.2023or both of the following (if performed): (a) tendon graft harvest; (b) tendon 5001.12.2023transfer one joint (H) (Anaes.) (Assist.) 1046450 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300775.0000248.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Tenolysis of extensor tendon of hand or wrist, following tendon injury or 5001.12.2023graft, other than a service: (a) for acute, traumatic injury; or (b) 5001.12.2023associated with a service to which item 30023 applies one ray (H) (Anaes.) 1046453 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301390.0000413.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Tenolysis of flexor tendon of hand or wrist, following tendon injury, repair 5001.12.2023or graft, other than a service: (a) for acute, traumatic injury; or (b) 5001.12.2023associated with a service to which item 30023 applies (H) (Anaes.) (Assist.) 1046456 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300370.0000107.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Percutaneous tenotomy of digit of hand (Anaes.) 1046464 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300835.0000248.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of a supernumerary complete digit of hand (H) (Anaes.) (Assist.) 1046465 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300830.0000248.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of digit of hand, distal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) resection of bone; (c) 5001.12.2023skin cover with local flaps one ray (H) (Anaes.) (Assist.) 1046468 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301440.0000434.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of digit of hand, distal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) resection of bone; (c) 5001.12.2023skin cover with local flaps 2 rays (H) (Anaes.) (Assist.) 1046471 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302090.0000620.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of digit of hand, distal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) resection of bone; (c) 5001.12.2023skin cover with local flaps 3 rays (H) (Anaes.) (Assist.) 1046474 26.05.2002 3 T8 14 SN NYNNY 2001.12.202302700.0000807.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of digit of hand, distal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) resection of bone; (c) 5001.12.2023skin cover with local flaps 4 rays (H) (Anaes.) (Assist.) 1046477 26.05.2002 3 T8 14 SN NYNNY 2001.12.202303310.0000993.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of digit of hand, distal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) resection of bone; (c) 5001.12.2023skin cover with local flaps 5 rays (H) (Anaes.) (Assist.) 1046480 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301385.0000413.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of ray of hand, proximal to metacarpal head, including any of the 5001.12.2023following (if performed): (a) excision of neuroma; (b) recontouring; (c) 5001.12.2023resection of bone; (d) skin cover with local flaps one ray (H) (Anaes.) 5001.12.2023(Assist.) 1046483 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301100.0000331.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of amputation stump of hand to provide adequate cover, including any 5001.12.2023of the following (if performed): (a) bone shortening; (b) excision of nail bed 5001.12.2023remnants; (c) excision of neuroma (H) (Anaes.) (Assist.) 1046486 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300830.0000248.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Accurate reconstruction of acute nail bed laceration using magnification (H) 5001.12.2023(Anaes.) 1046489 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300975.0000289.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Secondary reconstruction of nail bed deformity using magnification, including 5001.12.2023removal of nail (if performed), other than a service associated with a service 5001.12.2023to which item 46513 or 45451 applies (H) (Anaes.) (Assist.) 1046492 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301335.0000397.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Surgical correction of contracture of joint of hand, flexor or extensor 5001.12.2023tendon, involving tissues deeper than skin and subcutaneous tissueone joint 5001.12.2023(H) (Anaes.) (Assist.) 1046493 01.07.2021 3 T8 14 SN NYNNY 2001.12.202301035.0000362.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Resection of boss of metacarpal base of hand, including either or both of the 5001.12.2023following (if performed): (a) excision of ganglion; (b) synovectomy (Anaes.) 5001.12.2023(Assist.) 1046495 26.05.2002 3 T8 14 SN NYNYY 2001.12.202300745.0000223.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Complete excision of one or more ganglia or mucous cysts of interphalangeal, 5001.12.2023metacarpophalangeal or carpometacarpal joint of hand, including any of the 5001.12.2023following (if performed): (a) arthrotomy; (b) osteophyte resections (c) 5001.12.2023synovectomy other than a service associated with a service to which item 30107 5001.12.2023or 46336 appliesone joint (H) (Anaes.) (Assist.) 1046498 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300815.0000242.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of ganglion of flexor tendon sheath of hand, including any of the 5001.12.2023following (if performed): (a) flexor tenosynovectomy; (b) sheath excision; (c) 5001.12.2023skin closure by any method other than a service associated with a service to 5001.12.2023which item 30107 or 46363 applies (Anaes.) (Assist.) 1046500 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300975.0000289.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of ganglion of dorsal wrist joint of hand, including any of the 5001.12.2023following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or 5001.12.2023both); (c) synovectomy other than a service associated with a service to which 5001.12.2023item 30107 applies (Anaes.) (Assist.) 1046501 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301215.0000362.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of ganglion of volar wrist joint of hand, including any of the 5001.12.2023following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or 5001.12.2023both); (c) synovectomy; other than a service associated with a service to 5001.12.2023which item 30107 or 46325 applies (Anaes.) (Assist.) 1046502 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301460.0000434.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of recurrent ganglion of dorsal wrist joint of hand, including any of 5001.12.2023the following (if performed): (a) arthrotomy; (b) capsular or ligament repair 5001.12.2023(or both); (c) synovectomy (Anaes.) (Assist.) 1046503 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301400.0000416.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of recurrent ganglion of volar wrist joint of hand, including any of 5001.12.2023the following (if performed): (a) arthrotomy; (b) capsular or ligament repair 5001.12.2023(or both); (c) synovectomy; other than a service associated with a service to 5001.12.2023which item 30107 applies (Anaes.) (Assist.) 1046504 26.05.2002 3 T8 14 SN NYNNY 2001.12.202304060.0001216.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Neurovascular island flap, heterodigital, for pulp re-innervation and soft 5001.12.2023tissue cover (Anaes.) (Assist.) 1046507 26.05.2002 3 T8 14 SN NYNNY 2001.12.202305545.0001651.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Transposition or transfer of digit or ray on vascular pedicle of hand, 5001.12.2023including any of the following (if performed): (a) nerve transfer; (b) skin 5001.12.2023closure, by any means; (c) rebalancing procedures (H) (Anaes.) (Assist.) 1046510 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301295.0000386.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Surgical reduction of enlarged elements resulting from macrodactyly, including 5001.12.2023any of the following (if performed): (a) nerve transfer; (b) skin closure, by 5001.12.2023any means; (c) rebalancing procedures one digit (H) (Anaes.) (Assist.) 1046513 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300210.0000062.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of nail of finger or thumbone nail (Anaes.) 1046519 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300520.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Drainage of midpalmar, thenar or hypothenar spaces or dorsum of hand, 5001.12.2023excluding aftercare (Anaes.) (Assist.) 1046522 26.05.2002 3 T8 14 SN NYNNY 2001.12.202301555.0000463.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Open operation and drainage of infection for flexor tendon sheath of finger or 5001.12.2023thumb, including either or both of the following (if performed): (a) 5001.12.2023synovectomy; (b) tenolysis; other than a service associated with a service to 5001.12.2023which item 30023 appliesone digit (H) (Anaes.) (Assist.) 1046525 26.05.2002 3 T8 14 SN NYNYY 2001.12.202300210.0000062.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Incision for pulp space infection of hand: (a) other than a service: (i) to 5001.12.2023which another item in this Group applies; or (ii) associated with a service to 5001.12.2023which item 30023 applies; and (b) excluding aftercare (H) (Anaes.) 1046528 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300625.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Wedge resection for ingrowing nail of finger or thumb: (a) including each of 5001.12.2023the following: (i) excision and partial ablation of germinal matrix; (ii) 5001.12.2023removal of segment of nail; (iii) removal of ungual fold; and (b) including 5001.12.2023phenolisation (if performed) (Anaes.) 1046531 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300315.0000093.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Partial resection of ingrowing nail of finger or thumb,including phenolisation 5001.12.2023(Anaes.) 1046534 26.05.2002 3 T8 14 SN NYNNY 2001.12.202300870.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Complete ablation of nail germinal matrix (H) (Anaes.) (Assist.) 1047000 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300166.0000077.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Mandible, treatment of dislocation of, by closed reduction, requiring general 5001.12.2023anaesthesia or intravenous sedation, if performed in the operating theatre of 5001.12.2023a hospital (H) (Anaes.) 1047003 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300198.0000093.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of clavicle, by closed reduction (Anaes.) 1047007 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301250.0000388.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of acromioclavicular or sternoclavicular joint dislocation (acute or 5001.12.2023chronic), by open, mini-open or arthroscopic technique, including either or 5001.12.2023both of the following (if performed): (a) ligament augmentation; (b) tendon 5001.12.2023transfers (Anaes.) (Assist.) 1047009 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300400.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of shoulder, requiring general anaesthesia, other 5001.12.2023than a service to which item 47012 applies (Anaes.) 1047012 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300795.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of shoulder, requiring general anaesthesia, by open 5001.12.2023reduction (H) (Anaes.) (Assist.) 1047015 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300198.0000093.3500000.00 5001.12.2023Treatment of dislocation of shoulder, not requiring general anaesthesia 1047018 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300470.0000217.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of elbow, by closed reduction (Anaes.) 1047021 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300625.0000290.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of elbow, by open reduction (H) (Anaes.) (Assist.) 1047024 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300465.0000217.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of distal or proximal radioulnar joint, by closed 5001.12.2023reduction, other than a service associated with a service to which another 5001.12.2023item in this Schedule applies if the service describedin the other item is for 5001.12.2023the purpose of treating fracture or dislocation in the same region (Anaes.) 1047027 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302305.0000715.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of distal or proximal radioulnar joint, by open 5001.12.2023reduction, including either or both of the following (if performed): (a) 5001.12.2023styloid fracture; (b) triangular fibrocartilage complex repair; other than a 5001.12.2023service associated with a service to which another item in this Schedule 5001.12.2023applies if the service described in the other item is for the purpose of 5001.12.2023treating fracture or dislocation in the same region (Anaes.) (Assist.) 1047030 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300470.0000217.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of carpus, carpus on radius and ulna or 5001.12.2023carpometacarpal joint, by closed reduction (Anaes.) 1047033 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302305.0000715.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of carpus, carpus on radius and ulna or 5001.12.2023carpometacarpal joint, by open reduction, including ligament repair (if 5001.12.2023performed) (Anaes.) (Assist.) 1047042 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300265.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of interphalangeal or metacarpophalangeal joint, by 5001.12.2023closed reduction (Anaes.) 1047045 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300995.0000463.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of interphalangeal or metacarpophalangeal joint, by 5001.12.2023open reduction, including any of the following (if performed): (a) arthrotomy; 5001.12.2023(b) capsule repair; (c) ligament repair; (d) volar plate repair (Anaes.) 5001.12.2023(Assist.) 1047047 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300770.0000357.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of dislocation of prosthetic hip, by closed reduction (Anaes.) 5001.12.2023(Assist.) 1047049 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301035.0000476.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of dislocation of prosthetic hip, by open reduction (Anaes.) 5001.12.2023(Assist.) 1047052 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301000.0000464.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of dislocation of native hip, by closed reduction (Anaes.) (Assist.) 1047053 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301345.0000619.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of dislocation of native hip, by open reduction, with internal 5001.12.2023fixation (if performed) (Anaes.) (Assist.) 1047054 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300770.0000357.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of knee, by closed reduction, including application 5001.12.2023of external fixator (if performed) (Anaes.) (Assist.) 1047057 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300300.0000139.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of patella, by closed reduction (Anaes.) 1047060 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300400.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of patella, by open reduction (Anaes.) (Assist.) 1047063 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300600.0000279.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of ankle or tarsus, by closed reduction (Anaes.) 5001.12.2023(Assist.) 1047066 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300800.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of ankle or tarsus, by open reduction, including any 5001.12.2023of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) 5001.12.2023removal of loose fragments or intervening soft tissue; (d) washout of joint 5001.12.2023(H) (Anaes.) (Assist.) 1047069 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300166.0000077.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of dislocation of toe, byclosed reductionone toe (Anaes.) 1047301 01.05.2016 3 T8 15 SN NYNNY 2001.12.202300305.0000095.5500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of middle or proximal phalanx, by closed reduction, 5001.12.2023requiring anaesthesiaone bone (Anaes.) 1047304 01.05.2016 3 T8 15 SN NYNNY 2001.12.202300350.0000108.8500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of metacarpal, by closed reduction, requiring 5001.12.2023anaesthesiaonebone (H) (Anaes.) 1047307 01.05.2016 3 T8 15 SN NYNNY 2001.12.202300705.0000220.1500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of phalanx or metacarpal, by closed reduction, including 5001.12.2023percutaneous Kwire fixation (if performed)one bone (H) (Anaes.) (Assist.) 1047310 01.05.2016 3 T8 15 SN NYNNY 2001.12.202301165.0000363.2500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of phalanx or metacarpal, by open reduction, with 5001.12.2023internal fixation (H) (Anaes.) (Assist.) 1047313 01.05.2016 3 T8 15 SN NYNNY 2001.12.202301135.0000352.2500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of intra-articular fracture of phalanx or metacarpal, by closed 5001.12.2023reduction, including: (a) percutaneous K-wire fixation; and (b) external or 5001.12.2023dynamic fixation (if performed) (H) (Anaes.) (Assist.) 1047316 01.05.2016 3 T8 15 SN NYNYY 2001.12.202302250.0000698.9500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of intraarticular fracture of phalanx or metacarpal, by open 5001.12.2023reduction with fixation, other than a service provided on the same occasion as 5001.12.2023a service to which item 47319 applies (H) (Anaes.) (Assist.) 1047319 01.05.2016 3 T8 15 SN NYNYY 2001.12.202302305.0000715.4500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of intra-articular fracture of proximal end of middle phalanx, by 5001.12.2023open reduction, with fixation, other than a service provided on the same 5001.12.2023occasion as a service to which item 47316 applies (H) (Anaes.) (Assist.) 1047348 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300335.0000103.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of carpus (excluding scaphoid), by cast immobilisation, 5001.12.2023other than a service associated with a service to which item 47351 applies 5001.12.2023(Anaes.) 1047351 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300835.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of carpus (excluding scaphoid), by open reduction, with 5001.12.2023internal fixation (Anaes.) (Assist.) 1047354 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300595.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of carpal scaphoid, by cast immobilisation, other than a 5001.12.2023service associated with a service to which item 47357 applies (Anaes.) 1047357 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301340.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of carpal scaphoid, by open reduction, with internal or 5001.12.2023percutaneous fixation (Anaes.) (Assist.) 1047361 01.05.2016 3 T8 15 SN NYNYY 2001.12.202300465.0000145.0500000.00 5001.12.2023Treatment of fracture of distal end of radius or ulna (or both), by cast 5001.12.2023immobilisation, other than a service associated with a service to which item 5001.12.202347362, 47364, 47367, 47370 or 47373 applies 1047362 01.05.2016 3 T8 15 SN NYNYY 2001.12.202300700.0000217.5000000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of distal end of radius or ulna (or both), by closed 5001.12.2023reduction, requiring general or major regional anaesthesia, but excluding 5001.12.2023local infiltration, other than a service associated with a service to which 5001.12.2023item 47361, 47364, 47367, 47370 or 47373 applies (Anaes.) 1047364 01.05.2016 3 T8 15 SN NYNYY 2001.12.202300995.0000308.2000000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of distal end of radius or ulna (not involving joint 5001.12.2023surface), by open reduction with fixation, other than a service associated 5001.12.2023with a service to which item 47361 or 47362 applies (H) (Anaes.) (Assist.) 1047367 01.05.2016 3 T8 15 SN NYNYY 2001.12.202300795.0000246.1000000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of fracture of distal end of radius, by closed reduction with 5001.12.2023percutaneous fixation, other than a service associated with a service to which 5001.12.2023item 47361 or 47362 applies (H) (Anaes.) (Assist.) 1047370 01.05.2016 3 T8 15 SN NYNYY 2001.12.202301440.0000446.8500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of intraarticular fracture of distal end of radius, by open 5001.12.2023reduction with fixation, other than a service associated with a service to 5001.12.2023which item 47361 or 47362 applies (H) (Anaes.) (Assist.) 1047373 01.05.2016 3 T8 15 SN NYNYY 2001.12.202301030.0000319.2500000.00 4001.05.2016(Anaes.) 5001.12.2023Treatment of intraarticular fracture of distal end of ulna, by open reduction 5001.12.2023with fixation, other than a service associated with a service to which item 5001.12.202347361 or 47362 applies (H) (Anaes.) (Assist.) 1047381 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300905.0000279.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of shaft of radius or ulna, by closed reduction (H) 5001.12.2023(Anaes.) 1047384 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301210.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of shaft of radius or ulna, by open reduction with 5001.12.2023internal fixation (H) (Anaes.) (Assist.) 1047385 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301030.0000321.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of: (a) fracture of shaft of radius or ulna; and (b) dislocation of 5001.12.2023distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or 5001.12.2023Monteggia injury); by closed reduction (H) (Anaes.) (Assist.) 1047386 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of: (a) fracture of shaft of radius or ulna; and (b) dislocation of 5001.12.2023distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or 5001.12.2023Monteggia injury); by open reduction, with internal fixation, including 5001.12.2023reduction of dislocation (if performed) (H) (Anaes.) (Assist.) 1047387 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300965.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of distal or shaft of radius or ulna (or both), by cast 5001.12.2023immobilisation, other than a service to which item 47390 or 47393 applies 5001.12.2023(Anaes.) (Assist.) 1047390 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301440.0000450.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of shafts of radius and ulna, by closed reduction (H) 5001.12.2023(Anaes.) 1047393 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301930.0000601.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of shafts of radius and ulna, by open reduction, with 5001.12.2023internal fixation (H) (Anaes.) (Assist.) 1047396 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300670.0000207.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of olecranon, by closed reduction (Anaes.) 1047399 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301340.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of olecranon, by open reduction (H) (Anaes.) (Assist.) 1047402 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301000.0000310.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of olecranon, with excision of olecranon fragment and 5001.12.2023reimplantation of tendon (Anaes.) (Assist.) 1047405 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300670.0000207.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of head or neck of radius, by closed reduction (Anaes.) 1047408 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301340.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of head or neck of radius, by open reduction, including 5001.12.2023internal fixation and excision (if performed) (H) (Anaes.) (Assist.) 1047411 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300400.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of tuberosity of humerus, other than a service to which 5001.12.2023item 47417 applies (Anaes.) 1047414 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300805.0000248.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of tuberosity of humerus, by open reduction (Anaes.) 1047417 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300935.0000290.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of tuberosity of humerus and associated dislocation of 5001.12.2023shoulder, by closed reduction (Anaes.) (Assist.) 1047420 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301825.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of tuberosity of humerus and associated dislocation of 5001.12.2023shoulder, by open reduction (H) (Anaes.) (Assist.) 1047423 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300770.0000238.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of fracture of, other than a service to which 5001.12.2023item 47426, 47429 or 47432 applies (Anaes.) 1047426 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301160.0000357.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of fracture of, by closed reduction (H) (Anaes.) 1047429 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301545.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of fracture of, by open reduction (H) (Anaes.) 5001.12.2023(Assist.) 1047432 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301930.0000595.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of intraarticular fracture of, by open reduction 5001.12.2023(H) (Anaes.) (Assist.) 1047435 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301465.0000455.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of fracture of, and associated dislocation of 5001.12.2023shoulder, by closed reduction (Anaes.) (Assist.) 1047438 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302340.0000725.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of fracture of, and associated dislocation of 5001.12.2023shoulder, by open reduction (H) (Anaes.) (Assist.) 1047441 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302905.0000906.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, proximal, treatment of intra-articular fracture of, and associated 5001.12.2023dislocation of shoulder, by open reduction (H) (Anaes.) (Assist.) 1047444 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300800.0000248.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, shaft of, treatment of fracture of, other than a service to which 5001.12.2023item 47447 or 47450 applies (Anaes.) 1047447 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301210.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, shaft of, treatment of fracture of, by closed reduction (H) (Anaes.) 1047450 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301595.0000497.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, shaft of, treatment of fracture of, by internal or external fixation 5001.12.2023(H) (Anaes.) (Assist.) 1047451 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301930.0000599.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, shaft of, treatment of fracture of, by intramedullary fixation (H) 5001.12.2023(Anaes.) (Assist.) 1047453 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300935.0000290.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, distal, (supracondylar or condylar), treatment of fracture of, other 5001.12.2023than a service to which item 47456 or 47459 applies (Anaes.) (Assist.) 1047456 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301390.0000435.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, distal (supracondylar or condylar), treatment of fracture of, by 5001.12.2023closed reduction (H) (Anaes.) (Assist.) 1047459 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301880.0000580.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Humerus, distal (supracondylar or condylar), treatment of fracture of, by open 5001.12.2023reduction (H) (Anaes.) (Assist.) 1047462 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300400.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Clavicle, treatment of fracture of, other than a service to which item 47465 5001.12.2023applies (Anaes.) 1047465 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301825.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Clavicle, treatment of fracture of, by open reduction (Anaes.) (Assist.) 1047466 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300395.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Sternum, treatment of fracture of, other than a service to which item 47467 5001.12.2023applies (Anaes.) 1047467 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300805.0000248.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Sternum, treatment of fracture of, by open reduction (H) (Anaes.) 1047468 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301545.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023SCAPULA, neck or glenoid region of, treatment of fracture of, by open 5001.12.2023reduction (Anaes.) (Assist.) 1047471 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300152.0000047.3500000.00 5001.12.2023RIBS (one or more), treatment of fracture of - each attendance 1047474 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300670.0000207.1500000.00 5001.12.2023PELVIC RING, treatment of fracture of, not involving disruption of pelvic ring 5001.12.2023or acetabulum 1047477 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300835.0000259.2000000.00 5001.12.2023PELVIC RING, treatment of fracture of, with disruption of pelvic ring or 5001.12.2023acetabulum 1047480 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023PELVIC RING, treatment of fracture of, requiring traction (H) (Anaes.) 5001.12.2023(Assist.) 1047483 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023PELVIC RING, treatment of fracture of, requiring control by external fixation 5001.12.2023(H) (Anaes.) (Assist.) 1047486 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of anterior pelvic ring or sacroiliac joint disruption 5001.12.2023(or both), by open reduction, with internal fixation (H) (Anaes.) (Assist.) 1047489 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305010.0001554.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of posterior pelvic ring or sacroiliac joint disruption 5001.12.2023(or both), by open reduction, with internal fixation (H) (Anaes.) (Assist.) 1047491 01.07.2021 3 T8 15 SNS NYNNY 2001.12.202305510.0001709.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Combined anterior and posterior pelvic ring disruption, including sacroiliac 5001.12.2023joint disruption, treatment of fracture by open reduction and internal 5001.12.2023fixation of both anterior and posterior ring segments (H) (Anaes.) (Assist.) 1047495 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of acetabulum and associated dislocation of hip, 5001.12.2023including the application and management of traction (if performed), excluding 5001.12.2023aftercare (Anaes.) (Assist.) 1047498 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302495.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of isolated posterior wall fracture of acetabulumand associated 5001.12.2023dislocation of hip, by open reduction, with internal fixation, including the 5001.12.2023application and management of traction (if performed) (H) (Anaes.) (Assist.) 1047501 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of anterior or posterior column fracture of acetabulum, by open 5001.12.2023reduction, with internal fixation, including any of the following (if 5001.12.2023performed): (a) capsular stabilisation; (b) capsulotomy; (c) osteotomy (H) 5001.12.2023(Anaes.) (Assist.) 1047511 01.07.2021 3 T8 15 SN NYNNY 2001.12.202305010.0001554.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of combined column T-Type, transverse, anterior column or posterior 5001.12.2023hemitransverse fractures of acetabulum, by open reduction, with internal 5001.12.2023fixation, performed through single or dual approach (including fixation of the 5001.12.2023posterior wall fracture), including any of the following (if performed): (a) 5001.12.2023capsular stabilisation; (b) capsulotomy; (c) osteotomy (H) (Anaes.) (Assist.) 1047514 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302915.0000906.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of posterior wall fracture of acetabulum and associated femoral head 5001.12.2023fracture, by open reduction, with internal fixation (H) (Anaes.) (Assist.) 1047516 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301535.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023FEMUR, treatment of fracture of, by closed reduction or traction (Anaes.) 5001.12.2023(Assist.) 1047519 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303070.0000953.4000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMUR, treatment of trochanteric or subcapital fracture of, by internal 5001.12.2023fixation (H) (Anaes.) (Assist.) 1047528 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023FEMUR, treatment of fracture of, by internal fixation or external fixation (H) 5001.12.2023(Anaes.) (Assist.) 1047531 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303405.0001056.9500000.00 4026.05.2002(Anaes.) 5001.12.2023FEMUR, treatment of fracture of shaft, by intramedullary fixation and cross 5001.12.2023fixation (H) (Anaes.) (Assist.) 1047534 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303840.0001191.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Femur, condylar region of, treatment of intraarticular (Tshaped condylar) 5001.12.2023fracture of, requiring internal fixation, with or without internal fixation of 5001.12.2023one or more osteochondral fragments (H) (Anaes.) (Assist.) 1047537 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301535.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Femur, condylar region of, treatment of fracture of, requiring internal 5001.12.2023fixation of one or more osteochondral fragments, other than a service 5001.12.2023associated with a service to which item 47534 applies (Anaes.) (Assist.) 1047540 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300770.0000238.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Hip spica or shoulder spica, application of, as an independent procedure 5001.12.2023(Anaes.) 1047543 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300800.0000248.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, plateau of, treatment of medial or lateral fracture of, other than a 5001.12.2023service to which item 47546 or 47549 applies (Anaes.) 1047546 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301210.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, plateau of, treatment of medial or lateral fracture of, by closed 5001.12.2023reduction (Anaes.) 1047549 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301915.0000592.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of medial or lateral fracture of plateau of tibia, by open 5001.12.2023reduction, with internal fixation, including any of the following (if 5001.12.2023performed): (a) arthroscopy; (b) arthrotomy; (c) meniscal repair (H) (Anaes.) 5001.12.2023(Assist.) 1047552 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301340.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, plateau of, treatment of both medial and lateral fractures of, other 5001.12.2023than a service to which item 47555 or 47558 applies (Anaes.) (Assist.) 1047555 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, plateau of, treatment of both medial and lateral fractures of, by 5001.12.2023closed reduction (H) (Anaes.) 1047558 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303580.0001098.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of medial and lateral fractures of tibia, by open reduction, with 5001.12.2023internal fixation, including any of the following (if performed): (a) 5001.12.2023arthroscopy; (b) arthrotomy; (c) meniscal repair (H) (Anaes.) (Assist.) 1047559 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302720.0000841.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of medial or lateral (or both) fracture of plateau of tibia, with 5001.12.2023application of a bridging external fixator to the plateau (Anaes.) (Assist.) 1047561 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300965.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of shaft of tibia, by cast immobilisation, other than a 5001.12.2023service to which item 47570 or 47573 applies (Anaes.) 1047565 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302525.0000784.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, shaft of, treatment of fracture of, by internal fixation or external 5001.12.2023fixation (H) (Anaes.) (Assist.) 1047566 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303215.0000999.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, shaft of, treatment of fracture of, by intramedullary fixation and 5001.12.2023cross fixation (H) (Anaes.) (Assist.) 1047568 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301440.0000450.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Closed reduction of proximal tibia, distal tibia or shaft of tibia, with or 5001.12.2023without treatment of fibular fracture (Anaes.) (Assist.) 1047570 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301930.0000601.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, shaft of, treatment of fracture of, by open reduction, with or without 5001.12.2023treatment of fibular fracture (Anaes.) (Assist.) 1047573 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302420.0000751.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of proximal or distal intra-articular fracture of shaft of tibia, by 5001.12.2023open reduction, with or without treatment of fibular fracture, including any 5001.12.2023of the following (if performed): (a) arthroscopy; (b) arthrotomy; (c) capsule 5001.12.2023repair; (d) removal of intervening soft tissue; (e) removal of loose 5001.12.2023fragments; (f) washout of joint; other than a service associated with a 5001.12.2023service to which another item in this Schedule applies if the service 5001.12.2023describedin the other item is for the purpose of treating a medial malleolus 5001.12.2023fractureof the distal tibia (H) (Anaes.) (Assist.) 1047579 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300570.0000176.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of patella, other than a service to which item 47582 or 5001.12.202347585 applies (Anaes.) 1047582 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301515.0000466.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of patella, with internal fixation, including bone 5001.12.2023grafting (if performed), other than a service associated with a service to 5001.12.2023which item 47579 or 47585 applies (H) (Anaes.) (Assist.) 1047585 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301570.0000482.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of proximal or distal fracture of patella, by open reduction, with 5001.12.2023internal fixation, including any of the following (if performed): (a) 5001.12.2023arthrotomy; (b) excision of patellar pole, with reattachment of tendon; (c) 5001.12.2023removal of loose fragments; (d) repair of quadriceps or patellar tendon (or 5001.12.2023both); (e) stabilisation of patello-femoral joint (H) (Anaes.) (Assist.) 1047588 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Knee joint, treatment of fracture of, by internal fixation of intraarticular 5001.12.2023fractures of femoral condylar or tibial articular surfaces and requiring 5001.12.2023repair or reconstruction of one or more ligaments (H) (Anaes.) (Assist.) 1047591 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305675.0001761.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Knee joint, treatment of fracture of, by internal fixation of intraarticular 5001.12.2023fractures of femoral condylar and tibial articular surfaces and requiring 5001.12.2023repair or reconstruction of one or more ligaments (H) (Anaes.) (Assist.) 1047592 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301165.0000358.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair or reconstruction (or both) of acute traumatic chondral injury to the 5001.12.2023distal femoral or proximal tibial articular surfaces of the knee, when 5001.12.2023chondral or osteochondral implants or transfers are utilised (H) (Anaes.) 5001.12.2023(Assist.) 1047593 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302850.0000878.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Repair or reconstruction (or both) of acute traumatic chondral injury to the 5001.12.2023distal femoral and proximal tibial articular surfaces of the knee, using 5001.12.2023chondral or osteochondral implants or transfers (H) (Anaes.) (Assist.) 1047595 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300575.0000177.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of fracture of ankle joint, hindfoot, midfoot, metatarsals or toes, 5001.12.2023by non-surgical managementone leg (Anaes.) 1047597 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301160.0000357.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of ankle joint, by closed reduction (Anaes.) (Assist.) 1047600 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of ankle joint: (a) by internal fixation of the 5001.12.2023malleolus, fibula or diastasis; and (b) including any of the following (if 5001.12.2023performed): (i) arthrotomy; (ii) capsule repair; (iii) removal of loose 5001.12.2023fragments or intervening soft tissue; (iv) washout of joint (H) (Anaes.) 5001.12.2023(Assist.) 1047603 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302525.0000784.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of ankle joint: (a) by internal fixation of 2 or more of 5001.12.2023the malleolus, fibula, diastasis and medial tissue interposition; and (b) 5001.12.2023including any of the following (if performed): (i) arthrotomy; (ii) capsule 5001.12.2023repair; (iii) removal of loose fragments or intervening soft tissue; (iv) 5001.12.2023washout of joint (H) (Anaes.) (Assist.) 1047612 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301440.0000450.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of intra-articular fracture of hindfoot, by closed reduction, with 5001.12.2023or without dislocationone foot (Anaes.) (Assist.) 1047615 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of hindfoot, by open reduction, with or without 5001.12.2023dislocation, including any of the following (if performed): (a) arthrotomy; 5001.12.2023(b) capsule repair; (c) removal of loose fragments or intervening soft tissue; 5001.12.2023(d) washout of joint one foot (Anaes.) (Assist.) 1047618 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302085.0000647.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of intra-articular fracture of hindfoot, by open reduction, with or 5001.12.2023without dislocation,including any of the following (if performed): (a) 5001.12.2023arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening 5001.12.2023soft tissue; (d) washout of joint one foot(H) (Anaes.) (Assist.) 1047621 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301440.0000450.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of intra-articular fracture of midfoot, by closed reduction, with or 5001.12.2023without dislocationone foot (Anaes.) (Assist.) 1047624 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of tarso-metatarsal, by open reduction, with or without 5001.12.2023dislocation, including any of the following (if performed): (a) arthrotomy; 5001.12.2023(b) capsule or ligament repair; (c) removal of loose fragments or intervening 5001.12.2023soft tissue; (d) washout of joint one joint (H) (Anaes.) (Assist.) 1047630 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301210.0000372.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of cuneiform, by open reduction, with or without 5001.12.2023dislocation, including any of the following (if performed): (a) arthrotomy; 5001.12.2023(b) capsule or ligament repair; (c) removal of loose fragments or intervening 5001.12.2023soft tissue; (d) washout of joint one bone (Anaes.) (Assist.) 1047637 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300690.0000211.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of fractures of metatarsal, by closed reductionone or more 5001.12.2023metatarsals of one foot (Anaes.) (Assist.) 1047639 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300805.0000248.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of metatarsal, by open reduction, including removal of 5001.12.2023loose fragments or intervening soft tissue (if performed)one metatarsal 5001.12.2023(Anaes.) (Assist.) 1047648 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301055.0000331.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of metatarsal, by open reduction, including removal of 5001.12.2023loose fragments or intervening soft tissue (if performed)2 metatarsals of one 5001.12.2023foot (H) (Anaes.) (Assist.) 1047657 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of metatarsal, by open reduction, including removal of 5001.12.2023loose fragments or intervening soft tissue (if performed)3 or more metatarsals 5001.12.2023of one foot (H) (Anaes.) (Assist.) 1047663 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300500.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture of phalanx of toe, by closed reductionone toe (Anaes.) 1047666 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300835.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture or dislocation of phalanx of great toe, by open 5001.12.2023reduction, including any of the following (if performed): (a) arthrotomy; (b) 5001.12.2023capsule repair; (c) removal of loose fragments; (d) removal of intervening 5001.12.2023soft tissue; (e) washout of joint one great toe (Anaes.) 1047672 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300400.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture or dislocation of phalanx of toe, by open reduction, 5001.12.2023including any of the following (if performed): (a) arthrotomy; (b) capsule 5001.12.2023repair; (c) removal of loose fragments; (d) removal of intervening soft 5001.12.2023tissue; (e) washout of joint one toe (other than great toe) of one foot 5001.12.2023(Anaes.) 1047678 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300595.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of fracture or dislocation of phalanx of toe, by open reduction, 5001.12.2023including any of the following (if performed): (a) arthrotomy; (b) capsule 5001.12.2023repair; (c) removal of loose fragments; (d) removal of intervening soft 5001.12.2023tissue; (e) washout of joint 2 or more toes (other than great toe) of one foot 5001.12.2023(Anaes.) 1047735 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300805.0000047.4000000.00 5001.12.2023Nasal bones, treatment of fracture of, other than a service to which item 5001.12.202347738 or 47741 applieseach attendance 1047738 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301205.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Nasal bones, treatment of fracture of, by reduction (Anaes.) 1047741 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301650.0000528.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Nasal bones, treatment of fracture of, by open reduction involving osteotomies 5001.12.2023(H) (Anaes.) (Assist.) 1047753 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301440.0000447.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Maxilla or mandible, treatment of fracture of, requiring splinting, wiring of 5001.12.2023teeth, circumosseous fixation or external fixation (H) (Anaes.) (Assist.) 1047762 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300845.0000262.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Zygomatic arch, treatment of fracture of, requiring surgical reduction by a 5001.12.2023temporal, intra-oral or other approach, other than a service associated with a 5001.12.2023service to which another item in this Group applies (Anaes.) 1047765 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301390.0000494.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Zygomaticomaxillary complex/malar, treatment of fracture of, requiring 5001.12.2023surgical reduction and involving internal or external fixation at one or more 5001.12.2023sites (H) (Anaes.) (Assist.) 1047766 01.07.2023 3 T8 15 SN YYNYN 2001.12.202301824.0000661.5000000.00 4001.07.2023(Anaes.) 5001.12.2023Naso-orbital-ethmoidal complex, treatment of fracture of, requiring surgical 5001.12.2023reduction and involving internal or external fixation at one or more sites (H) 5001.12.2023(Anaes.) (Assist.) 1047786 26.05.2002 3 T8 15 SN NYNYY 2001.12.202302545.0000791.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Maxilla, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation involvingone or more plates (H) (Anaes.) (Assist.) 1047789 26.05.2002 3 T8 15 SN NYNYY 2001.12.202302545.0000791.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Mandible, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation involving one or more plates (H) (Anaes.) (Assist.) 1047790 01.11.2022 3 T8 15 SNS NYNNY 2001.12.202301080.0000310.7500000.00 4001.11.2022(Anaes.) 5001.12.2023Tendon, large, lengthening of, as an independent procedure (Anaes.) (Assist.) 1047791 01.11.2022 3 T8 15 SNS NYNNY 2001.12.202300990.0000290.1500000.00 4001.11.2022(Anaes.) 5001.12.2023Tenosynovectomy, not being a service associated with a service to which 5001.12.2023another item in this Group applies (Anaes.) (Assist.) 1047792 01.11.2022 3 T8 15 SNS NYNNY 2001.12.202301670.0000518.1000000.00 4001.11.2022(Anaes.) 5001.12.2023Joint stabilisation procedure of acromioclavicular joint or scapulothoracic 5001.12.2023joint, including any of the following (if performed): (a) arthrotomy; (b) 5001.12.2023osteotomy, with or without fixation; (c) local tendon transfer; (d) local 5001.12.2023tendon lengthening or release; (e) ligament repair; (f) joint debridement; not 5001.12.2023being a service associated with a service to which another item in this Group 5001.12.2023applies (Anaes.) (Assist.) 1047900 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300635.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Injection into, or aspiration of, unicameral bone cyst (Anaes.) 1047903 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300880.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Epicondylitis, open operation for (Anaes.) 1047904 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300210.0000062.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Digital nail of toe, removal of, not being a service to which item 47906 5001.12.2023applies (Anaes.) 1047906 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300425.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Digital nail of toe, removal of, in the operating theatre of a hospital(H) 5001.12.2023(Anaes.) 1047915 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300640.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Wedge resection for ingrowing nail of toe: (a) including each of the 5001.12.2023following: (i) removal of segment of nail; (ii) removal of ungual fold; (iii) 5001.12.2023excision and partial ablation of germinal matrix and portion of nail bed; and 5001.12.2023(b) including phenolisation (if performed) (Anaes.) (Assist.) 1047916 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300320.0000093.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Partial resection for ingrowing nail of toe, including phenolisation (Anaes.) 1047918 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300880.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Complete ablation of nail germinal matrix: (a) including each of the 5001.12.2023following: (i) removal of segment of nail; (ii) removal of ungual fold; (iii) 5001.12.2023excision and ablation of germinal matrix and portion of nail bed; and (b) 5001.12.2023including phenolisation (if performed) (Anaes.) (Assist.) 1047921 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300425.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Orthopaedic pin or wire, insertion of, as an independent procedure (Anaes.) 1047924 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300142.0000041.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of one or more buried wires, pins or screws (inserted for internal 5001.12.2023fixation purposes), with incision, other than a service associated with a 5001.12.2023service to which item 47927 or 47929 appliesone bone (Anaes.) 1047927 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300530.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of one or more buried wires, pins or screws (inserted for internal 5001.12.2023fixation purposes)one bone (H) (Anaes.) 1047929 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301425.0000414.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Removal of fixation elements (including plate, rod or nail and associated 5001.12.2023wires, pins, screws or external fixation), other than a service associated 5001.12.2023with a service to which item 47924 or 47927 appliesone bone (H) (Anaes.) 5001.12.2023(Assist.) 1047953 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301635.0000476.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of distal biceps brachii tendon, by any method, performed as an 5001.12.2023independent procedure (Anaes.) (Assist.) 1047954 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301420.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Repair of traumatic tear or rupture of tendon, other than a service associated 5001.12.2023with: (a) a service to which item 39330 applies; or (b) a service to which 5001.12.2023another item in this Schedule applies if the service described in the other 5001.12.2023item is for the purpose of repairing peripheral nerve items in the same region 5001.12.2023(Anaes.) (Assist.) 1047955 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302180.0000717.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of gluteal or rectus femoris tendon, by open or arthroscopic means, 5001.12.2023when performed as an independent procedure, including either or both of the 5001.12.2023following (if performed): (a) bursectomy; (b) preparation of greater 5001.12.2023trochanter; other than a service associated with a service to which another 5001.12.2023item in this Schedule applies if the service described in the other item is 5001.12.2023for the purpose of performing a procedure on the hip (H) (Anaes.) (Assist.) 1047956 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303300.0001075.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of proximal hamstring tendon, performed as an independent procedure, 5001.12.2023other than a service associated with a service to which another item in this 5001.12.2023Schedule applies if the service described in the other item is for the purpose 5001.12.2023of performing a procedure on the hip (H) (Anaes.) (Assist.) 1047960 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300495.0000145.0500000.00 4026.05.2002(Anaes.) 5001.12.2023TENOTOMY, SUBCUTANEOUS, not being a service to which another item in this 5001.12.2023Group applies (Anaes.) 1047964 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300810.0000238.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Iliopsoas tenotomy, by open or arthroscopic means, when performed as an 5001.12.2023independent procedure, other than a service associated with a service to which 5001.12.2023another item in this Schedule applies if the service describedin the other 5001.12.2023item is for the purpose of performing a procedure on the hip (H) (Anaes.) 5001.12.2023(Assist.) 1047967 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302005.0000476.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Restoration of shoulder or elbow function by major muscle tendon transfer, 5001.12.2023including associated dissection of neurovascular pedicle, excluding 5001.12.2023micro-anastomosis and biceps tenodesisone transfer (H) (Anaes.) (Assist.) 1047975 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301385.0000406.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Forearm or calf, decompression fasciotomy of, for acute compartment syndrome, 5001.12.2023requiring excision of muscle and deep tissue(H) (Anaes.) (Assist.) 1047978 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300840.0000246.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Forearm or calf, decompression fasciotomy of, for chronic compartment 5001.12.2023syndrome, requiring excision of muscle and deep tissue(H) (Anaes.) 1047981 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300565.0000165.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Forearm, calf or interosseous muscle space of hand, decompression fasciotomy 5001.12.2023of, other than a service to which another item in this Group applies (Anaes.) 1047982 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301345.0000401.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Forage (Drill decompression), of neck or head of femur, or both (H) (Anaes.) 5001.12.2023(Assist.) 1047983 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303070.0000953.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of slipped capital femoral epiphysis, by internal fixation (H) 5001.12.2023(Anaes.) (Assist.) 1047984 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303070.0000953.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Open subcapital realignment of slipped capital femoral epiphysis, other than a 5001.12.2023service associated with a service to which item 48427 applies (H) (Anaes.) 5001.12.2023(Assist.) 1048245 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301120.0000344.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Harvesting and insertion of bone graft (autograft) via separate incisions and 5001.12.2023at separate surgical fields (H) (Anaes.) (Assist.) 1048248 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301735.0000533.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Harvesting and insertion of bone graft (autograft) via separate incisions, 5001.12.2023including internal fixation of the graft or fusion fixation (or both) (H) 5001.12.2023(Anaes.) (Assist.) 1048251 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301425.0000438.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Harvesting and insertion of osteochondral graft (autograft) via separate 5001.12.2023incisions at the same joint or joint complex (H) (Anaes.) (Assist.) 1048254 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303240.0001005.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Harvesting and insertion of pedicled bone flap (autograft), including internal 5001.12.2023fixation of the bone flap (if performed), other than a service associated with 5001.12.2023a service to which item 45562, 45504 or 45505 applies (H) (Anaes.) (Assist.) 1048257 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301425.0000438.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Preparation and insertion of metallic, cortical or other graft substitute 5001.12.2023(allograft), where substitute is structural cortico-cancellous bone or 5001.12.2023structural bone (or both), including internal fixation (if performed) (H) 5001.12.2023(Anaes.) (Assist.) 1048400 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of phalanx or metatarsal of foot, for correction of deformity, 5001.12.2023excision of accessory bone or sesamoid bone, including any of the following 5001.12.2023(if performed): (a) removal of bone; (b) excision of surrounding osteophytes; 5001.12.2023(c) synovectomy; (d) joint release; one bone (H) (Anaes.) (Assist.) 1048403 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301835.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of phalanx or metatarsal of first toe of foot, for correction of 5001.12.2023deformity, with internal fixation, including any of the following (if 5001.12.2023performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) 5001.12.2023synovectomy; (d) joint release; one bone (H) (Anaes.) (Assist.) 1048406 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), 5001.12.2023rib, tarsus or carpus, for correction of deformity, including any of the 5001.12.2023following (if performed): (a) removal of bone; (b) excision of surrounding 5001.12.2023osteophytes; (c) synovectomy; (d) joint release; one bone (H) (Anaes.) 5001.12.2023(Assist.) 1048409 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301835.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), 5001.12.2023rib, tarsus or carpus, for correction of deformity, with internal fixation, 5001.12.2023including any of the following (if performed): (a) removal of bone; (b) 5001.12.2023excision of surrounding osteophytes; (c) synovectomy; (d) joint release; one 5001.12.2023bone (H) (Anaes.) (Assist.) 1048412 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302235.0000694.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of humerus, without internal fixation (H) (Anaes.) (Assist.) 1048415 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302840.0000880.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of humerus, with internal fixation (H) (Anaes.) (Assist.) 1048419 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302235.0000694.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy of distal tibia, for correction of deformity, without internal or 5001.12.2023external fixation, including any of the following (if performed): (a) excision 5001.12.2023of surrounding osteophytes; (b) release of joint; (c) removal of bone; (d) 5001.12.2023synovectomy; one bone (H) (Anaes.) (Assist.) 1048420 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302840.0000880.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy of distal tibia, for correction of deformity, with internal or 5001.12.2023external fixation by any method, including any of the following (if 5001.12.2023performed): (a) excision of surrounding osteophytes; (b) release of joint; (c) 5001.12.2023removal of bone; (d) synovectomy; one bone (H) (Anaes.) (Assist.) 1048421 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303290.0001011.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of proximal tibia, to alter lower limb alignment or rotation (or 5001.12.2023both), with internal or external fixation (or both) (H) (Anaes.) (Assist.) 1048422 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303240.0001005.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy of distal femur, to alter lower limb alignment or rotation (or 5001.12.2023both), with internal or external fixation (or both) (H) (Anaes.) (Assist.) 1048423 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy of pelvis, in a patient aged 18 years or over, including any of the 5001.12.2023following (if performed): (a) associated intra-articular procedures; (b) bone 5001.12.2023grafting; (c) internal fixation (H) (Anaes.) (Assist.) 1048424 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of pelvis, in a patient aged less than 18 years, with application of 5001.12.2023hip spica, including internal fixation (if performed), other than a service to 5001.12.2023which item 48245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1048426 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303240.0001005.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy of femur, in a patient aged 18 years or over, including either or 5001.12.2023both of the following (if performed): (a) bone grafting; (b) internal fixation 5001.12.2023(H) (Anaes.) (Assist.) 1048427 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303240.0001005.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Osteotomy of femur, in a patient aged less than 18 years, including internal 5001.12.2023fixation (if performed), other than a service associated with a service to 5001.12.2023which item 48245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1048430 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300970.0000295.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of one or more osteophytes of the foot or ankle, or simple removal of 5001.12.2023bunion, including any of the following (if performed): (a) capsulotomy; (b) 5001.12.2023excision of surrounding osteophytes; (c) release of ligaments; (d) removal of 5001.12.2023one or more associated bursae or ganglia; (e) removal of bone; (f) 5001.12.2023synovectomy; each incision (H) (Anaes.) (Assist.) 1048433 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303825.0001176.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of non-union or malunion, with preservation of the joint, for ankle 5001.12.2023or hindfoot fracture, with internal or external fixation by any method, 5001.12.2023including any of the following (if performed): (a) arthrotomy; (b) 5001.12.2023debridement; (c) excision of surrounding osteophytes; (d) osteotomy; (e) 5001.12.2023release of joint; (f) removal of bone; (g) removal of hardware; (h) 5001.12.2023synovectomy; one bone (H) (Anaes.) (Assist.) 1048435 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of non-union or malunion, with preservation of the joint, for 5001.12.2023midfoot or forefoot fracture, with internal or external fixation by any 5001.12.2023method, including any of the following (if performed): (a) arthrotomy; (b) 5001.12.2023debridement; (c) excision of surrounding osteophytes; (d) osteotomy; (e) 5001.12.2023release of joint; (f) removal of bone; (g) removal of hardware; (h) 5001.12.2023synovectomy; one bone (H) (Anaes.) (Assist.) 1048507 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301310.0000403.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Epiphysiodesis of a long bone, in a patient less than 18 years of age (H) 5001.12.2023(Anaes.) (Assist.) 1048509 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Hemiepiphysiodesis, partial growth plate arrest using internal fixation, in a 5001.12.2023patient less than 18 years of age (H) (Anaes.) (Assist.) 1048512 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303170.0000984.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Epiphysiolysis, release of focal growth plate closure, in a patient less than 5001.12.202318 years of age (H) (Anaes.) (Assist.) 1048900 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301000.0000310.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, excision of coracoacromial ligament or removal of calcium deposit 5001.12.2023from cuff or both (Anaes.) (Assist.) 1048903 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, decompression of subacromial space by acromioplasty, excision of 5001.12.2023coracoacromial ligament and distal clavicle, or any combination (H) (Anaes.) 5001.12.2023(Assist.) 1048906 26.05.2002 3 T8 15 SN NYNYY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, repair of rotator cuff, including excision of coracoacromial 5001.12.2023ligament or removal of calcium deposit from cuff, or bothother than a service 5001.12.2023associated with a service to which item 48900 applies (H) (Anaes.) (Assist.) 1048909 26.05.2002 3 T8 15 SN NYNYY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, repair of rotator cuff, including decompression of subacromial space 5001.12.2023by acromioplasty, excision of coracoacromial ligament and distal clavicle, or 5001.12.2023any combination, other than a service associated with a service to which item 5001.12.202348903 applies (H) (Anaes.) (Assist.) 1048915 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, hemiarthroplasty of (H) (Anaes.) (Assist.) 1048918 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305345.0001658.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Anatomic or reverse total shoulder replacement, including any of the following 5001.12.2023(if performed): (a) associated rotator cuff repair; (b) biceps tenodesis; (c) 5001.12.2023tuberosity osteotomy; other than a service associated with a service to which 5001.12.2023another item in this Schedule applies if the service describedin the other 5001.12.2023item is for the purpose ofperforming a procedure on the shoulder region by 5001.12.2023open or arthroscopic means (H) (Anaes.) (Assist.) 1048921 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305510.0001709.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, total replacement arthroplasty, revision of (H) (Anaes.) (Assist.) 1048924 26.05.2002 3 T8 15 SN NYNNY 2001.12.202306345.0001969.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of total shoulder replacement, including either or both of the 5001.12.2023following (if performed): (a) bone graft to humerus; (b) bone graft to scapula 5001.12.2023(H) (Anaes.) (Assist.) 1048927 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301300.0000403.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder prosthesis, removal of (H) (Anaes.) (Assist.) 1048939 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303840.0001191.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Shoulder, arthrodesis of, with synovectomy if performed (H) (Anaes.) (Assist.) 1048942 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305010.0001554.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis of shoulder, with bone grafting or internal fixation, including 5001.12.2023either or both of the following (if performed): (a) removal of prosthesis; (b) 5001.12.2023synovectomy; other than a service associated with a service to which item 5001.12.202348245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1048945 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023SHOULDER, diagnostic arthroscopy of (including biopsy) - not being a service 5001.12.2023associated with any other arthroscopic procedure of the shoulder region (H) 5001.12.2023(Anaes.) (Assist.) 1048948 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of 5001.12.2023loose bodies; decompression of calcium deposit; debridement of labrum, 5001.12.2023synovium or rotator cuff; or chondroplasty - not being a service associated 5001.12.2023with any other arthroscopic procedure of the shoulder region(H) (Anaes.) 5001.12.2023(Assist.) 1048951 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303170.0000984.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SHOULDER, arthroscopic division of coraco-acromial ligament including 5001.12.2023acromioplasty - not being a service associated with any other arthroscopic 5001.12.2023procedure of the shoulder region(H) (Anaes.) (Assist.) 1048954 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy of shoulder, performed as an independent procedure, including 5001.12.2023release of contracture (if performed), other than a service associated with a 5001.12.2023service to which another item in this Schedule applies if the service 5001.12.2023described in the other item is for the purpose of performing a procedure on 5001.12.2023the shoulder region by arthroscopic means (H) (Anaes.) (Assist.) 1048958 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303840.0001191.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Joint stabilisation procedure for multi-directional instability of shoulder, 5001.12.2023anterior or posterior repair, by open or arthroscopic means, including labral 5001.12.2023repair or reattachment (if performed), excluding bone grafting and removal of 5001.12.2023hardware, other than a service associated with a service to which another item 5001.12.2023in this Schedule applies if the service describedin the other item is for the 5001.12.2023purpose of performing a procedure on the shoulder region by arthroscopic means 5001.12.2023(H) (Anaes.) (Assist.) 1048960 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SHOULDER, reconstruction or repair of, including repair of rotator cuff by 5001.12.2023arthroscopic, arthroscopic assisted or mini open means; arthroscopic 5001.12.2023acromioplasty; or resection of acromioclavicular joint by separate approach 5001.12.2023when performed - not being a service associated with any other procedure of 5001.12.2023the shoulder region(H) (Anaes.) (Assist.) 1048972 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301635.0000476.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Tenodesis of biceps, by open or arthroscopic means, performed as an 5001.12.2023independent procedure (H) (Anaes.) (Assist.) 1048980 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302840.0000880.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of heterotopic ossification, myositis ossificans or post-traumatic 5001.12.2023ossification in the shoulder girdle (H) (Anaes.) (Assist.) 1048983 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302080.0000645.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of heterotopic ossification, myositis ossificans or post-traumatic 5001.12.2023ossification in the elbow (H) (Anaes.) (Assist.) 1048986 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302840.0000880.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of heterotopic ossification, myositis ossificans or post-traumatic 5001.12.2023ossification in the forearm (H) (Anaes.) (Assist.) 1049100 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ELBOW, arthrotomy of, involving 1 or more of lavage, removal of loose body or 5001.12.2023division of contracture(H) (Anaes.) (Assist.) 1049104 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301895.0000582.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of one or more ligaments of the elbow, for acute instabilitywithin 6 5001.12.2023weeks after the time of injury (H) (Anaes.) (Assist.) 1049105 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302780.0000854.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of one or more ligaments of the elbow, for chronic instability, 5001.12.2023including harvesting of tendon graft6 weeks or more after the time of injury 5001.12.2023(H) (Anaes.) (Assist.) 1049106 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023ELBOW, arthrodesis of, with synovectomy if performed (Anaes.) (Assist.) 1049109 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302505.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023ELBOW, total synovectomy of(H) (Anaes.) (Assist.) 1049112 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302505.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Radial head replacement of elbow, other than a service associated with a 5001.12.2023service to which item 49115 applies (H) (Anaes.) (Assist.) 1049115 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304005.0001243.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Total or hemi humeral arthroplasty of elbow, excluding isolated radial head 5001.12.2023replacement and ligament stabilisation procedures, other than a service 5001.12.2023associated with a service to which item 49112 applies (H) (Anaes.) (Assist.) 1049116 01.11.2006 3 T8 15 SN NYNNY 2001.12.202305285.0001641.2500000.00 4001.11.2006(Anaes.) 5001.12.2023ELBOW, total replacement arthroplasty of, revision procedure, including 5001.12.2023removal of prosthesis(H) (Anaes.) (Assist.) 1049117 01.11.2006 3 T8 15 SN NYNNY 2001.12.202306340.0001969.5500000.00 4001.11.2006(Anaes.) 5001.12.2023Revision of total replacement arthroplasty of elbow, including bone grafting 5001.12.2023and removal of prosthesis (H) (Anaes.) (Assist.) 1049118 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023ELBOW, diagnostic arthroscopy of, including biopsy and lavage, not being a 5001.12.2023service associated with any other arthroscopic procedure of the elbow(H) 5001.12.2023(Anaes.) (Assist.) 1049121 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Surgery of the elbow, by arthroscopic means, including any of the following 5001.12.2023(if performed): (a) chondroplasty; (b) drilling of defect; (c) osteoplasty; 5001.12.2023(d) removal of loose bodies; (e) release of contracture or adhesions; (f) 5001.12.2023treatment of epicondylitis; other than a service associated witha service to 5001.12.2023which another item in this Schedule applies if the service described in the 5001.12.2023other item is for the purpose of an arthroscopic procedure of the elbow (H) 5001.12.2023(Anaes.) (Assist.) 1049124 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301035.0000408.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of olecranon bursa, including bony prominence, other than a service 5001.12.2023associated with a service to which another item in this Schedule applies if 5001.12.2023the service describedin the other item is for the purpose of an arthroscopic 5001.12.2023procedure of the elbow (Anaes.) (Assist.) 1049200 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302905.0000901.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Wrist, arthrodesis of, with synovectomy if performed, with or without internal 5001.12.2023fixation of the radiocarpal joint (H) (Anaes.) (Assist.) 1049203 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302775.0000853.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Limited fusion of wrist, with or without bone graft, including each of the 5001.12.2023following: (a) ligament or tendon transfers; (b) partial or total excision of 5001.12.2023one or more carpal bones; (c) rebalancing procedures; (d) synovectomy (H) 5001.12.2023(Anaes.) (Assist.) 1049206 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302005.0000621.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Proximal row carpectomy of wrist, including either or both of the following 5001.12.2023(if performed): (a) styloidectomy; (b) synovectomy (H) (Anaes.) (Assist.) 1049209 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Prosthetic replacement of wrist or distal radioulnar joint, including either 5001.12.2023or both of the following (if performed): (a) ligament realignment; (b) tendon 5001.12.2023realignment (H) (Anaes.) (Assist.) 1049210 01.11.2006 3 T8 15 SN NYNNY 2001.12.202303520.0001094.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Revision of total replacement arthroplasty of wrist or distal radioulnar 5001.12.2023joint, including any of the following (if performed): (a) ligament 5001.12.2023rebalancing; (b) removal of prosthesis; (c) tendon rebalancing (H) (Anaes.) 5001.12.2023(Assist.) 1049212 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300835.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrotomy of wrist or distal radioulnar joint, including any of the following 5001.12.2023(if performed): (a) joint debridement; (b) removal of loose bodies; (c) 5001.12.2023synovectomy (H) (Anaes.) (Assist.) 1049213 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303115.0000927.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Sauve-Kapandji procedure of distal radioulnar joint, including any of the 5001.12.2023following (if performed): a) radioulnar fusion; b) osteotomy; c) soft tissue 5001.12.2023reconstruction (Anaes.) (Assist.) 1049215 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302305.0000715.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of single or multiple ligaments or capsules of wrist, including 5001.12.2023any of the following (if performed): (a) arthrotomy; (b) ligament harvesting 5001.12.2023and grafting; (c) synovectomy; (d) tendon harvesting and grafting; (e) 5001.12.2023insertion of synthetic ligament substitute (H) (Anaes.) (Assist.) 1049218 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Wrist, diagnostic arthroscopy of, including radiocarpal or midcarpal joints, 5001.12.2023or both (including biopsy)other than a service associated with another 5001.12.2023arthroscopic procedure of the wrist joint(H) (Anaes.) (Assist.) 1049219 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Diagnosis of carpometacarpal of thumb or joint of digit, by arthroscopic 5001.12.2023means, including biopsy (if performed) (H) (Anaes.) (Assist.) 1049220 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302160.0000673.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of carpometacarpal of thumb or joint of digit, by arthroscopic 5001.12.2023meansone joint (H) (Anaes.) (Assist.) 1049221 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of wrist, by arthroscopic means, including any of the following (if 5001.12.2023performed): (a) drilling of defect; (b) removal of loose bodies; (c) release 5001.12.2023of adhesions; (d) synovectomy; (e) debridement; (f) resection of dorsal or 5001.12.2023volar ganglia; other than a service associated with a service to which another 5001.12.2023item in this Schedule applies if the service describedin the other item is for 5001.12.2023the purpose of performing an arthroscopic procedure of the wrist joint (H) 5001.12.2023(Anaes.) (Assist.) 1049224 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302505.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Osteoplasty of wrist, by arthroscopic means, including either or both of the 5001.12.2023following (if performed): (a) excision of the distal ulna; (b) total 5001.12.2023synovectomy; other than a service associated with a service to which another 5001.12.2023item in this Schedule applies if the service described in the other item is 5001.12.2023for the purpose of performing an arthroscopic procedure of the wrist joint2 or 5001.12.2023more distinct areas (H) (Anaes.) (Assist.) 1049227 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302505.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of wrist by one of the following: (a) pinning of osteochondral 5001.12.2023fragment, by arthroscopic means; (b) stabilisation procedure for ligamentous 5001.12.2023disruption; (c) partial wrist fusion or carpectomy, by arthroscopic means; (d) 5001.12.2023fracture management; other than a service associated with a service to which 5001.12.2023another item in this Schedule applies if the service describedin the other 5001.12.2023item is for the purpose of performing an arthroscopic procedure of the wrist 5001.12.2023joint (H) (Anaes.) (Assist.) 1049230 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303435.0001014.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Total, hemi or interpositional prosthetic replacement of carpal bone of wrist, 5001.12.2023for trauma or emergency, including all of the following: (a) ligament and 5001.12.2023tendon rebalancing procedures; (b) limited wrist fusions; (c) limited bone 5001.12.2023grafting (H) (Anaes.) (Assist.) 1049233 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301390.0000426.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional arthroplasty of single (or part of) carpal bone of wrist, when 5001.12.2023transfers of ligaments or tendons, or rebalancing procedures, are not 5001.12.2023required, including all of the following: (a) radial styloidectomy; (b) ulnar 5001.12.2023styloidectomy; (c) proximal hamate; (d) partial scaphoid; other than a service 5001.12.2023associated with a service to which another item in this Schedule applies if 5001.12.2023the service describedin the other item is for the purpose of performing a 5001.12.2023distal radial ulnar joint reconstruction, a proximal row carpectomy or another 5001.12.2023wrist procedureapplicable once for a single operation (H) (Anaes.) (Assist.) 1049236 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302075.0000643.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of soft tissue of distal radioulnar joint, with or without 5001.12.2023ligament or tendon grafting, including either or both of the following (if 5001.12.2023performed): (a) graft harvest; (b) triangular fibrocartilage complex repair or 5001.12.2023reconstruction (H) (Anaes.) (Assist.) 1049239 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301030.0000320.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of pisiform or hook of hamate, including release of ulnar nerve (if 5001.12.2023performed) (H) (Anaes.) (Assist.) 1049300 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301835.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Sacro-iliac jointarthrodesis of(H) (Anaes.) (Assist.) 1049303 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301935.0000601.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrotomy of hip, by open procedure, including any of the following (if 5001.12.2023performed): (a) lavage; (b) drainage; (c) biopsy (H) (Anaes.) (Assist.) 1049306 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303840.0001191.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Hip, arthrodesis of, with synovectomy if performed(H) (Anaes.) (Assist.) 1049309 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrectomy or excision arthroplasty (Girdlestone) of hip, other than a 5001.12.2023service performed: (a) for the purpose of implant removal; or (b) as stage 1 5001.12.2023of a 2-stage procedure (H) (Anaes.) (Assist.) 1049315 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303005.0000932.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Hip, arthroplasty of, unipolar or bipolar(H) (Anaes.) (Assist.) 1049318 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Total arthroplasty of hip, including minor bone grafting (if performed), other 5001.12.2023than a service associated with a service to which item 48245, 48248, 48251, 5001.12.202348254 or 48257 applies (H) (Anaes.) (Assist.) 1049319 26.05.2002 3 T8 15 SN NYNNY 2001.12.202308170.0002548.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral total arthroplasty of hip, including minor bone grafting (if 5001.12.2023performed), other than a service associated with a service to which item 5001.12.202348245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1049321 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305675.0001761.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Total arthroplasty of hip, with internal fixation, including either or both of 5001.12.2023the following (if performed): (a) structural bone graft; (b) insertion of 5001.12.2023synthetic substitutes or metal augments; other than a service associated with 5001.12.2023a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H) 5001.12.2023(Anaes.) (Assist.) 1049360 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301220.0000378.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Diagnostic arthroscopy of hip, other than a service associated with a service 5001.12.2023to which another item in this Schedule applies if the service describedin the 5001.12.2023other item is for the purpose of performing a procedure of the hip joint by 5001.12.2023arthroscopic means (H) (Anaes.) (Assist.) 1049363 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301470.0000455.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of hip, by arthroscopic means, with synovial biopsy, including any 5001.12.2023procedures to treat bone or soft tissue in the same area (if performed), other 5001.12.2023than a service associated with a service to which another item in this 5001.12.2023Schedule applies if the service described in the other item is for the purpose 5001.12.2023of performing: (a) a procedure of the hip joint by arthroscopic means; or (b) 5001.12.2023surgery for femoroacetabular impingement (H) (Anaes.) (Assist.) 1049366 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of hip, by arthroscopic means, including any procedures to treat 5001.12.2023bone or soft tissue in the same area (if performed), other than a service 5001.12.2023associated with a service to which another item in this Schedule applies if 5001.12.2023the service described in the other item is for the purpose of performing: (a) 5001.12.2023a procedure of the hip joint by arthroscopic means; or (b) surgery for 5001.12.2023femoroacetabular impingement (H) (Anaes.) (Assist.) 1049372 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303275.0001015.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with exchange of head or liner (or both) (H) 5001.12.2023(Anaes.) (Assist.) 1049374 01.07.2021 3 T8 15 SN NYNNY 2001.12.202306080.0001885.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with exchange of head and acetabular shell or 5001.12.2023cup, including minor bone grafting (if performed) (H) (Anaes.) (Assist.) 1049376 01.07.2021 3 T8 15 SN NYNNY 2001.12.202307480.0002320.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with exchange of head and acetabular shell or 5001.12.2023cup, including major bone grafting (if performed) (H) (Anaes.) (Assist.) 1049378 01.07.2021 3 T8 15 SN NYNNY 2001.12.202306545.0002030.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with revision of femoral component (if there is 5001.12.2023no requirement for femoral osteotomy), including minor bone grafting (if 5001.12.2023performed) (H) (Anaes.) (Assist.) 1049380 01.07.2021 3 T8 15 SN NYNNY 2001.12.202307945.0002465.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with revision of femoral and acetabular 5001.12.2023components (if femoral osteotomy is not required), including minor bone 5001.12.2023grafting (if performed) (H) (Anaes.) (Assist.) 1049382 01.07.2021 3 T8 15 SN NYNNY 2001.12.202310285.0003191.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with revision of femoral and acetabular 5001.12.2023components (if femoral osteotomy is not required), including major bone 5001.12.2023grafting (H) (Anaes.) (Assist.) 1049384 01.07.2021 3 T8 15 SN NYNNY 2001.12.202312155.0003771.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, for pelvic discontinuity, with revision of 5001.12.2023acetabular component (H) (Anaes.) (Assist.) 1049386 01.07.2021 3 T8 15 SN NYNNY 2001.12.202308415.0002610.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, with revision of femoral component with femoral 5001.12.2023osteotomy, including minor bone grafting (if performed) (H) (Anaes.) (Assist.) 1049388 01.07.2021 3 T8 15 SN NYNNY 2001.12.202309820.0003046.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) revision of both of the 5001.12.2023following: (i) femoral component with femoral osteotomy; (ii) acetabular 5001.12.2023component; and (b) minor bone grafting (if performed) (H) (Anaes.) (Assist.) 1049390 01.07.2021 3 T8 15 SN NYNNY 2001.12.202311685.0003626.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) revision of both of the 5001.12.2023following: (i) femoral component with femoral osteotomy; (ii) acetabular 5001.12.2023component; and (b) major bone grafting (H) (Anaes.) (Assist.) 1049392 01.07.2021 3 T8 15 SN NYNNY 2001.12.202316365.0005076.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) either: (i) revision of femoral 5001.12.2023component with femoral osteotomy; or (ii) proximal femoral replacement; and 5001.12.2023(b) revision of acetabular component for pelvic discontinuity (H) (Anaes.) 5001.12.2023(Assist.) 1049394 01.07.2021 3 T8 15 SN NYNNY 2001.12.202314025.0004351.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) replacement of proximal femur; 5001.12.2023and (b) revision of the acetabular component; and (c) bone grafting (if 5001.12.2023performed) (H) (Anaes.) (Assist.) 1049396 01.07.2021 3 T8 15 SN NYNNY 2001.12.202309350.0002901.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) removal of prosthesis as stage 1 5001.12.2023of a 2-stage revision arthroplasty or as a definitive stage procedure; and (b) 5001.12.2023insertion of temporary prosthesis (if performed) (H) (Anaes.) (Assist.) 1049398 01.07.2021 3 T8 15 SN NYNNY 2001.12.202307015.0002175.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision arthroplasty of hip, including: (a) revision of femoral component for 5001.12.2023periprosthetic fracture; and (b) internal fixation; and (c) bone grafting (if 5001.12.2023performed) (H) (Anaes.) (Assist.) 1049500 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301335.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Knee, arthrotomy of, involving one or more of capsular release, biopsy or 5001.12.2023lavage, or removal of loose body or foreign body(H) (Anaes.) (Assist.) 1049503 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301740.0000538.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrotomy of knee, including one of the following: (a) meniscal surgery; (b) 5001.12.2023repair of collateral or cruciate ligament; (c) patellectomy; (d) single 5001.12.2023transfer of ligament or tendon; (e) repair or replacement of chondral or 5001.12.2023osteochondral surface (excluding prosthetic replacement); other than a service 5001.12.2023associated with a service to which another item in this Group applies (H) 5001.12.2023(Anaes.) (Assist.) 1049506 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302635.0000808.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrotomy of knee, including 2 or more of the following: (a) meniscal 5001.12.2023surgery; (b) repair of collateral or cruciate ligament; (c) patellectomy; (d) 5001.12.2023single transfer of ligament or tendon; (e) repair or replacement of chondral 5001.12.2023or osteochondral surface (excluding prosthetic replacement); other than a 5001.12.2023service associated with a service to which another item in this Group applies 5001.12.2023(H) (Anaes.) (Assist.) 1049509 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302675.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Total synovectomy of knee, by open procedure, other than a service performed 5001.12.2023in association with a service to which another item in this Schedule applies 5001.12.2023if the service described in the other item is for the purpose of performing an 5001.12.2023arthroplasty (H) (Anaes.) (Assist.) 1049512 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Primary or revision arthrodesis of knee, including arthrodesis (H) (Anaes.) 5001.12.2023(Assist.) 1049515 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303005.0000932.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of cemented or uncemented knee prosthesis, performed as the first 5001.12.2023stage of a 2-stage procedure; including: (a) removal of associated cement; and 5001.12.2023(b) insertion of spacer (if required) (H) (Anaes.) (Assist.) 1049516 01.07.2021 3 T8 15 SN NYNNY 2001.12.202307505.0002323.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Bilateral unicompartmental arthroplasty of femur and proximal tibia of knee 5001.12.2023(H) (Anaes.) (Assist.) 1049517 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304290.0001327.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Unicompartmental arthroplasty of femur and proximal tibia of knee (H) (Anaes.) 5001.12.2023(Assist.) 1049518 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Total replacement arthroplasty of knee, including either or both of the 5001.12.2023following (if performed): (a) revision of patello-femoral joint replacement to 5001.12.2023total knee replacement; (b) patellar resurfacing; other than a service 5001.12.2023associated with a service to which item 48245, 48248, 48251, 48254 or 48257 5001.12.2023applies (H) (Anaes.) (Assist.) 1049519 26.05.2002 3 T8 15 SN NYNNY 2001.12.202308170.0002548.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral total replacement arthroplasty of knee, including patellar 5001.12.2023resurfacing, other than a service associated with a service to which item 5001.12.202348245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1049521 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305675.0001761.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Complex primary arthroplasty of knee, with revision of components to femur or 5001.12.2023tibia, including either or both of the following (if performed): (a) ligament 5001.12.2023reconstruction; (b) patellar resurfacing; other than a service associated with 5001.12.2023a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H) 5001.12.2023(Anaes.) (Assist.) 1049524 26.05.2002 3 T8 15 SN NYNNY 2001.12.202306680.0002072.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Complex primary arthroplasty of knee, with revision of components to femur and 5001.12.2023tibia, including either or both of the following (if performed): (a) ligament 5001.12.2023reconstruction; (b) patellar resurfacing; other than a service associated with 5001.12.2023a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H) 5001.12.2023(Anaes.) (Assist.) 1049525 01.07.2021 3 T8 15 SN NYNNY 2001.12.202305675.0001761.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of uni-compartmental arthroplasty of the knee, with femoral or tibial 5001.12.2023components (or both) with uni-compartmental implants, other than a service 5001.12.2023associated with a service to which: (a) item 48245, 48248, 48251, 48254 or 5001.12.202348257 applies; or (b) another item in this Group applies if the service 5001.12.2023describedin the other item is for the purpose of performing surgery on a knee 5001.12.2023(H) (Anaes.) (Assist.) 1049527 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Minor revision of total or partial replacement of knee, including either or 5001.12.2023both of the following: (a) exchange of polyethylene component (including uni); 5001.12.2023(b) insertion of patellar component; other than a service associated with a 5001.12.2023service to which item 48245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) 5001.12.2023(Assist.) 1049530 26.05.2002 3 T8 15 SN NYNNY 2001.12.202307015.0002176.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of total or partial replacement of knee, with exchange of femoral or 5001.12.2023tibial component: (a) excluding revision of unicompartmental with 5001.12.2023unicompartmental implants; and (b) including patellar resurfacing (if 5001.12.2023performed); other than a service associated with a service to which item 5001.12.202348245, 48248, 48251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1049533 26.05.2002 3 T8 15 SN NYNNY 2001.12.202309100.0002798.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of total or partial replacement of knee, with exchange of femoral and 5001.12.2023tibial components, excluding revision of unicompartmental with 5001.12.2023unicompartmental implants, including patellar resurfacing (if performed), 5001.12.2023other than a service associated with a service to which item 48245, 48248, 5001.12.202348251, 48254 or 48257 applies (H) (Anaes.) (Assist.) 1049534 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302585.0000800.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Replacement of patella and trochlea of patello-femoral joint of knee, 5001.12.2023performed as a primary procedure (H) (Anaes.) (Assist.) 1049536 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Either: (a) repair of cruciate ligaments of knee; or (b) repair or 5001.12.2023reconstruction of collateral ligaments of knee; by open or arthroscopic means, 5001.12.2023including either or both of the following (if performed): (c) graft harvest; 5001.12.2023(d) intraarticular knee surgery; other than a service associated with a 5001.12.2023service to which another item of this Schedule applies if the service 5001.12.2023described in the other item is for the purpose of performing a procedure on 5001.12.2023the knee by arthroscopic means (H) (Anaes.) (Assist.) 1049542 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of anterior or posterior cruciate ligament of knee, by open or 5001.12.2023arthroscopic means, including any of the following (if performed): (a) graft 5001.12.2023harvest; (b) donor site repair; (c) meniscal repair; (d) collateral ligament 5001.12.2023repair; (e) extra-articular tenodesis; (f) any other associated 5001.12.2023intra-articular surgery; other than a service associated with a service to 5001.12.2023which another item of this Schedule applies if the service described in the 5001.12.2023other item is for the purpose of performing a procedure on the knee by 5001.12.2023arthroscopic means (H) (Anaes.) (Assist.) 1049544 01.07.2021 3 T8 15 SN NYNNY 2001.12.202305445.0001688.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Reconstruction of 2 or more cruciate or collateral ligaments of knee, by open 5001.12.2023or arthroscopic means, including any of the following (if performed): (a) 5001.12.2023ligament repair; (b) graft harvest donor site repair; (c) meniscal repair; (d) 5001.12.2023any other associated intra-articular surgery; other than a service associated 5001.12.2023with a service to which another item of this Schedule applies if the service 5001.12.2023described in the other item is for the purpose of performing a procedure on 5001.12.2023the knee by arthroscopic means (H) (Anaes.) (Assist.) 1049548 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303395.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Knee, revision of patello-femoral stabilisation(H) (Anaes.) (Assist.) 1049551 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304740.0001450.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Knee, revision of procedures to which item 49536 or 49542 applies (H) (Anaes.) 5001.12.2023(Assist.) 1049554 26.05.2002 3 T8 15 SN NYNNY 2001.12.202306680.0002072.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of total replacement of knee, by anatomic specific allograft of tibia 5001.12.2023or femur, other than a service to which item 48245, 48248, 48251, 48254 or 5001.12.202348257 applies (H) (Anaes.) (Assist.) 1049564 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303290.0001011.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Stabilisation of patellofemoral joint of knee, by combined open and 5001.12.2023arthroscopic means, including either or both of the following (if performed): 5001.12.2023(a) medial soft tissue reconstruction and tendon transfer; (b) tibial 5001.12.2023tuberosity transfer with bone graft and internal fixation; other than a 5001.12.2023service associated a service to which another item of this Schedule applies if 5001.12.2023the service describedin the other item is for the purpose of performing a 5001.12.2023procedure on the knee by arthroscopic means (H) (Anaes.) (Assist.) 1049565 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304720.0001451.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Reconstruction of patellofemoral joint of knee, by combined open and 5001.12.2023arthroscopic means, including: (a) both of the following: (i) medial soft 5001.12.2023tissue reconstruction; (ii) tibial tuberosity transfer; and (b) any of the 5001.12.2023following (if performed): (i) bone graft; (ii) internal fixation; (iii) 5001.12.2023trochleoplasty; other than a service associated a service to which another 5001.12.2023item of this Schedule applies if the service describedin the other item is for 5001.12.2023the purpose of performing a procedure on the knee by arthroscopic means (H) 5001.12.2023(Anaes.) (Assist.) 1049569 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302675.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Knee, mobilisation for post-traumatic stiffness, by multiple muscle or tendon 5001.12.2023release (quadricepsplasty)(H) (Anaes.) (Assist.) 1049570 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Diagnosis of knee, by arthroscopic means, when the pre-procedure diagnosis is 5001.12.2023undetermined, including either or both of the following (if performed): (a) 5001.12.2023biopsy; (b) lavage (H) (Anaes.) (Assist.) 1049572 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000731.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Partial meniscectomy of knee, by arthroscopic means, for atraumatic meniscus 5001.12.2023tear, other than a service to which another item of this Schedule applies if 5001.12.2023the service described in the other item is for the purpose of treating 5001.12.2023osteoarthritis (H) (Anaes.) (Assist.) 1049574 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000731.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Removal of loose bodies of knee, by arthroscopic meansone or more bodies (H) 5001.12.2023(Anaes.) (Assist.) 1049576 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000731.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Repair of chondral lesion of knee, by arthroscopic means, including either or 5001.12.2023both of the following (if performed): (a) microfracture; (b) microdrilling; 5001.12.2023other than a service performed in combination with a service to which another 5001.12.2023item of this Schedule applies if the servicedescribedin the other item is for 5001.12.2023the purpose of performing chondral or osteochondral grafts (H) (Anaes.) 5001.12.2023(Assist.) 1049578 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000731.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Release of soft tissue, lateral release or osteoplasty of knee, by 5001.12.2023arthroscopic means, other than a service performed in combination with a 5001.12.2023service to which another item of this Schedule applies if the service 5001.12.2023describedin the other item is for the purpose of stabilising the 5001.12.2023patellofemoral joint of the knee (H) (Anaes.) (Assist.) 1049580 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000731.1500000.00 4001.07.2021(Anaes.) 5001.12.2023Partial meniscectomy of knee, by arthroscopic means, for traumatic meniscus 5001.12.2023tear (H) (Anaes.) (Assist.) 1049582 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303115.0000853.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Meniscal repair of knee, by arthroscopic means (H) (Anaes.) (Assist.) 1049584 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303115.0000853.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Chondral, osteochondral or meniscal graft of knee, by arthroscopic means (H) 5001.12.2023(Anaes.) (Assist.) 1049586 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303115.0000853.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Synovectomy of knee, by arthroscopic means, for neoplasia or inflammatory 5001.12.2023arthropathy, other than a service to which another item of this Schedule 5001.12.2023applies if the service describedin the other item is for the purpose of 5001.12.2023treating uncomplicated osteoarthritis (Anaes.) (Assist.) 1049590 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301035.0000408.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of ganglion, cyst or bursa of knee, by open or arthroscopic means, 5001.12.2023performed as an independent procedure, other than a service associated with a 5001.12.2023service to which another item in this Group applies (Anaes.) (Assist.) 1049703 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Surgery of ankle joint, by arthroscopic means, including any of the following 5001.12.2023(if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) 5001.12.2023synovectomy; (d) excision of joint osteophytes; other than a service 5001.12.2023associated with a service to which another item in this Group applies if the 5001.12.2023service describedin the other item is for the purpose of performing a 5001.12.2023procedure on the ankle by arthroscopic means (H) (Anaes.) (Assist.) 1049706 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrotomy of joint of ankle, including removal of loose bodies and joint 5001.12.2023debridement, including release of joint contracture (if performed) (H) 5001.12.2023(Anaes.) (Assist.) 1049709 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302505.0000777.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Stabilisation of ligament of ankle or subtalar joint (or both), including any 5001.12.2023of the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) joint debridement; one ligament complex, each incision (H) 5001.12.2023(Anaes.) (Assist.) 1049712 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001036.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis of ankle, by open or arthroscopic means, with internal or external 5001.12.2023fixation by any method, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at 5001.12.2023joint (H) (Anaes.) (Assist.) 1049715 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304675.0001243.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Total replacement of ankle, with prosthetic replacement of ankle joint, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) joint 5001.12.2023release; (c) synovectomy; (d) removal of osteophytes at joint (H) (Anaes.) 5001.12.2023(Assist.) 1049716 01.11.2006 3 T8 15 SN NYNNY 2001.12.202305285.0001641.2500000.00 4001.11.2006(Anaes.) 5001.12.2023Revision of total ankle replacement: (a) including either: (i) exchange of 5001.12.2023tibial or talar components (or both) and plastic inserts; or (ii) removal of 5001.12.2023tibial or talar components (or both) and plastic inserts; and (b) including 5001.12.2023any of the following (if performed): (i) insertion of cement spacer for 5001.12.2023infection; (ii) capsulotomy; (iii) joint release; (iv) neurolysis; (v) 5001.12.2023debridement of cysts; (vi) synovectomy; (vii) joint debridement other than a 5001.12.2023service associated with a service to which 30023 applies. (H) (Anaes.) 5001.12.2023(Assist.) 1049717 01.11.2006 3 T8 15 SN NYNNY 2001.12.202306340.0001969.5500000.00 4001.11.2006(Anaes.) 5001.12.2023Revision of total ankle replacement: (a) including either: (i) exchange of 5001.12.2023tibial and talar components; or (ii) removal of tibial and talar components 5001.12.2023and conversion to ankle arthrodesis; and (b) including both of the following 5001.12.2023(iii) internal or external fixation, by any means; (iv) major bone grafting; 5001.12.2023and (c) including any of the following (if performed): (i) capsulotomy; (ii) 5001.12.2023joint release; (iii) neurolysis; (iv) debridement and extensive grafting of 5001.12.2023cysts; (v) synovectomy; (vi) joint debridement; other than a service 5001.12.2023associated with a service to which item 30023, 48245, 48248, 48251, 48254 or 5001.12.202348257 applies (H) (Anaes.) (Assist.) 1049718 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301335.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Primary repair of major tendon of ankle, by any method, including either or 5001.12.2023both of the following (if performed): (a) synovial biopsy; (b) synovectomy one 5001.12.2023tendon (H) (Anaes.) (Assist.) 1049724 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302340.0000725.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Reconstruction of major tendon of ankle, by any method, including any of the 5001.12.2023following (if performed): (a) synovial biopsy; (b) synovectomy; (c) adjacent 5001.12.2023tendon transfer; (d) turn down flaps; other than a service associated with a 5001.12.2023service to which item 49718 applies (H) (Anaes.) (Assist.) 1049727 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301000.0000310.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Lengthening of major tendon of ankle, including either or both of the 5001.12.2023following (if performed): (a) synovial biopsy; (b) synovectomy (H) (Anaes.) 5001.12.2023(Assist.) 1049728 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301900.0000621.6000000.00 4001.11.2006(Anaes.) 5001.12.2023Lengthening of Achilles tendon, by any method, with gastro-soleus lengthening 5001.12.2023for the correction of equinous deformity, including either or both of the 5001.12.2023following (if performed): (a) synovial biopsy; (b) synovectomy; other than a 5001.12.2023service associated with a service to which item 49727 applies (H) (Anaes.) 5001.12.2023(Assist.) 1049730 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302160.0000673.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Surgery of joint of hindfoot (other than ankle) or first metatarsophalangeal 5001.12.2023joint, by arthroscopic means, including any of the following (if performed): 5001.12.2023(a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) 5001.12.2023excision of joint osteophytes; other than a service associated with a service 5001.12.2023to which anotheritem of this Schedule applies if the service describedin the 5001.12.2023other item is for the purpose of performing a procedure on the ankle by 5001.12.2023arthroscopic meansone joint (H) (Anaes.) (Assist.) 1049732 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302160.0000673.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Endoscopy of large tendons of foot, including any of the following (if 5001.12.2023performed): (a) debridement of tendon and sheath; (b) removal of loose bodies; 5001.12.2023(c) synovectomy; (d) excision of tendon impingement; other than a service 5001.12.2023associated with a service to which item 49718 or 49724 applies (H) (Anaes.) 5001.12.2023(Assist.) 1049734 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301170.0000362.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrotomy of hindfoot, midfoot or metatarsophalangeal joint, including: (a) 5001.12.2023removal of loose bodies; and (b) either or both of the following: (i) joint 5001.12.2023debridement; (ii) release of joint contracture; each incision (H) (Anaes.) 5001.12.2023(Assist.) 1049736 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302205.0000725.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Transfer of major tendon of foot and ankle, including: (a) split or whole 5001.12.2023transfer to contralateral side of foot; and (b) passage of posterior or 5001.12.2023anterior tendon to, or through, interosseous membrane; and (c) any of the 5001.12.2023following (if performed): (i) synovial biopsy; (ii) synovectomy; (iii) tendon 5001.12.2023lengthening; (iv) insetting of tendon (H) (Anaes.) (Assist.) 1049738 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of ligament of talonavicular or metatarsophalangeal joint, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) joint 5001.12.2023release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement (H) 5001.12.2023(Anaes.) (Assist.) 1049740 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304010.0001554.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of arthrodesis of ankle, by open or arthroscopic means, with internal 5001.12.2023or external fixation by any method, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal 5001.12.2023of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) 5001.12.2023osteotomy of non-union or malunion; other than a service associated with a 5001.12.2023service to which 30023 applies (H) (Anaes.) (Assist.) 1049742 01.07.2021 3 T8 15 SN NYNNY 2001.12.202305425.0001467.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of extended ankle and hindfoot, by open or arthroscopic means, 5001.12.2023with internal or external fixation by any method, including any of the 5001.12.2023following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; 5001.12.2023(d) removal of osteophytes at joint (H) (Anaes.) (Assist.) 1049744 01.07.2021 3 T8 15 SN NYNNY 2001.12.202308135.0002201.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of arthrodesis of extended ankle and hindfoot, by open or 5001.12.2023arthroscopic means, with internal or external fixation by any method, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) joint 5001.12.2023release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of 5001.12.2023hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a 5001.12.2023service associated with a service to which 30023 applies (H) (Anaes.) 5001.12.2023(Assist.) 1049760 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301265.0000388.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthroereisis of subtalar joint, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) synovectomy; (c) joint debridement (H) 5001.12.2023(Anaes.) (Assist.) 1049761 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301835.0000569.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsal, including any of the 5001.12.2023following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; 5001.12.2023(d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local 5001.12.2023tendon lengthening or release; (g) ligament repair; (h) joint debridement; one 5001.12.2023metatarsal (H) (Anaes.) (Assist.) 1049762 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302040.0000632.4500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 2 metatarsals (H) (Anaes.) (Assist.) 1049763 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302240.0000695.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 3 metatarsals (H) (Anaes.) (Assist.) 1049764 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302440.0000757.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 4 metatarsals (H) (Anaes.) (Assist.) 1049765 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000820.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 5 metatarsals (H) (Anaes.) (Assist.) 1049766 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302845.0000882.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 6 metatarsals (H) (Anaes.) (Assist.) 1049767 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303045.0000945.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 7 metatarsals (H) (Anaes.) (Assist.) 1049768 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303245.0001007.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of metatarsophalangeal joint at metatarsals, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) osteotomy, with or without fixation; (e) local tendon 5001.12.2023transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) 5001.12.2023joint debridement; 8 metatarsals (H) (Anaes.) (Assist.) 1049769 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303695.0000997.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Unilateral correction of hallux valgus or varus deformity, by osteotomy of 5001.12.2023first metatarsal and proximal phalanx of first toe, with internal fixation of 5001.12.2023both bones, including any of the following (if performed): (a) exostectomy; 5001.12.2023(b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or 5001.12.2023tendon release or transfer (H) (Anaes.) (Assist.) 1049770 01.07.2021 3 T8 15 SN NYNNY 2001.12.202305370.0001657.8500000.00 4001.07.2021(Anaes.) 5001.12.2023Bilateral correction of hallux valgus or varus deformity, by osteotomy of 5001.12.2023first metatarsal and proximal phalanx of first toe, with internal fixation of 5001.12.2023both bones, including any of the following (if performed): (a) exostectomy; 5001.12.2023(b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or 5001.12.2023tendon release or transfer (H) (Anaes.) (Assist.) 1049771 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301035.0000408.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Synovectomy of major tendon of ankle, for extensive synovitis by any method, 5001.12.2023including any of the following (if performed): (a) tenolysis; (b) debridement 5001.12.2023of ligament or tendon (or both); (c) release of ligament or tendon (or both); 5001.12.2023(d) excision of tubercule or osteophyte; (e) reconstruction of tendon 5001.12.2023retinaculum; (f) neurolysis; other than a service associated with a service to 5001.12.2023which item 30023 applieseach incision (H) (Anaes.) (Assist.) 1049772 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300920.0000360.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Excision of rheumatoid nodules or gouty tophi, excluding aftercare, including 5001.12.2023any of the following (if performed): (a) capsulotomy; (b) debridement of 5001.12.2023ligament or tendon (or both); (c) release of ligament or tendon (or both); (d) 5001.12.2023excision of tubercle or osteophyte; each incision (H) (Anaes.) (Assist.) 1049773 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301445.0000447.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of excision of intermetatarsal or digital neuroma, including any of 5001.12.2023the following (if performed): (a) release of tissues; (b) excision of bursae; 5001.12.2023(c) neurolysis; other than a service associated with a service to which item 5001.12.202330023 appliesone web space (H) (Anaes.) (Assist.) 1049774 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301020.0000304.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Release of tarsal tunnel, including any of the following (if performed): (a) 5001.12.2023release of ligaments; (b) synovectomy; (c) neurolysis; other than a service 5001.12.2023associated with a service to which item 30023 appliesone foot (H) (Anaes.) 5001.12.2023(Assist.) 1049775 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301375.0000411.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of release of tarsal tunnel, including any of the following (if 5001.12.2023performed): (a) release of ligaments; (b) synovectomy; (c) neurolysis; other 5001.12.2023than a service associated with a service to which item 30023 appliesone foot 5001.12.2023(H) (Anaes.) (Assist.) 1049776 01.07.2021 3 T8 15 SN NYNYY 2001.12.202304170.0001293.7500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of arthrodesis of joint of hindfoot, by open or arthroscopic means, 5001.12.2023with internal or external fixation by any method, including any of the 5001.12.2023following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; 5001.12.2023(d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; 5001.12.2023(g) osteotomy of nonunion or malunion; other than a service associated with a 5001.12.2023service to which item 30023 appliesmay only be claimed once per joint (H) 5001.12.2023(Anaes.) (Assist.) 1049777 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302470.0000766.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of joint of midfoot, by open or arthroscopic means, with internal 5001.12.2023or external fixation by any method, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal 5001.12.2023of osteophytes at joint; one joint (H) (Anaes.) (Assist.) 1049778 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303705.0001149.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal 5001.12.2023or external fixation by any method, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal 5001.12.2023of osteophytes at joints; 2 joints (H) (Anaes.) (Assist.) 1049779 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304320.0001340.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal 5001.12.2023or external fixation by any method, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal 5001.12.2023of osteophytes at joints; 3 joints (H) (Anaes.) (Assist.) 1049780 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304935.0001532.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal 5001.12.2023or external fixation by any method, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal 5001.12.2023of osteophytes at joints; 4 joints (H) (Anaes.) (Assist.) 1049781 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303705.0001149.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of arthrodesis of joint of midfoot, with internal or external 5001.12.2023fixation by any method, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) removal of ostephytes at 5001.12.2023joint; (e) removal of hardware; (f) osteotomy of non-union or malunion; one 5001.12.2023joint (H) (Anaes.) (Assist.) 1049782 01.07.2021 3 T8 15 SN NYNYY 2001.12.202302005.0000622.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of total ankle replacement, including: (a) bone grafting of 5001.12.2023perioperative cysts to the tibia or talus (or both); and (b) retention of 5001.12.2023implants; and (c) any of the following (if performed): (i) capsulotomy; (ii) 5001.12.2023joint release; (iii) neurolysis; (iv) debridement and grafting of cysts; (v) 5001.12.2023synovectomy; (vi) joint debridement; other than a service associated with a 5001.12.2023service to which item 30023 applies (H) (Anaes.) (Assist.) 1049783 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302715.0000834.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 3 joints (H) (Anaes.) (Assist.) 1049784 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303100.0000953.8000000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 4 joints (H) (Anaes.) (Assist.) 1049785 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303490.0001072.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 5 joints (H) (Anaes.) (Assist.) 1049786 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303875.0001192.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 6 joints (H) (Anaes.) (Assist.) 1049787 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304260.0001311.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 7 joints (H) (Anaes.) (Assist.) 1049788 01.07.2021 3 T8 15 SN NYNNY 2001.12.202304650.0001430.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joints, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 8 joints (H) (Anaes.) (Assist.) 1049789 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303965.0001230.3000000.00 4001.07.2021(Anaes.) 5001.12.2023Bilateral arthrodesis of first metatarsophalangeal joint, by open or 5001.12.2023arthroscopic means, with internal or external fixation by any method, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) joint 5001.12.2023release; (c) synovectomy; (d) removal of osteophytes at joint (H) (Anaes.) 5001.12.2023(Assist.) 1049790 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303445.0001068.6000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of arthrodesis of first metatarsophalangeal joint, including any of 5001.12.2023the following (if performed): (a) capsulotomy; (b) joint release; (c) 5001.12.2023synovectomy; (d) removal of exostosis at joint; (e) removal of hardware; (f) 5001.12.2023osteotomy of non-union or malunion (H) (Anaes.) (Assist.) 1049791 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301560.0000484.5000000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis of hallux interphalangeal or lesser metatarsophalangeal joint, 5001.12.2023with internal or external fixation by any method, including any of the 5001.12.2023following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; 5001.12.2023(d) removal of osteophytes at joint (H) (Anaes.) (Assist.) 1049792 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301760.0000544.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; one or 2 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049793 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302050.0000634.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 3 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049794 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302345.0000725.5500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 4 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049795 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302640.0000816.2500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 5 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049796 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302930.0000906.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 6 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049797 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303225.0000997.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 7 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049798 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303520.0001088.3500000.00 4001.07.2021(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023joint (or both) of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) 5001.12.2023synovectomy; (e) removal of osteophytes at joints; 8 toes (H) (Anaes.) 5001.12.2023(Assist.) 1049800 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300470.0000145.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Primary repair of flexor or extensor tendon of foot, including either or both 5001.12.2023of the following (if performed): (a) synovial biopsy; (b) synovectomy; one toe 5001.12.2023(Anaes.) (Assist.) 1049803 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300600.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Secondary repair of flexor or extensor tendon of foot, including either or 5001.12.2023both of the following (if performed): (a) synovial biopsy; (b) synovectomy; 5001.12.2023one toe (Anaes.) (Assist.) 1049806 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300470.0000145.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Subcutaneous tenotomy of foot, by small percutaneous incisionsone or more 5001.12.2023tendons (Anaes.) 1049809 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300770.0000238.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Open tenotomy or lengthening of foot, by open incision, with or without 5001.12.2023tenoplasty, including either or both of the following (if performed): (a) 5001.12.2023synovial biopsy; (b) synovectomy; one toe (Anaes.) (Assist.) 1049812 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301535.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Advancement of tendon or ligament transfer of foot, including: (a) side to 5001.12.2023side transfer, harvesting and transfer for ligament or minor foot tendon 5001.12.2023reconstruction; and (b) either or both of the following (if performed): (i) 5001.12.2023synovial biopsy; (ii) synovectomy; one major tendon or toe (H) (Anaes.) 5001.12.2023(Assist.) 1049814 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303520.0001088.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Reconstruction of major tendon of ankle, by any method, including: (a) 5001.12.2023osteotomy of hindfoot, with internal fixation; and (b) lengthening of major 5001.12.2023tendon of ankle; and (c) any of the following (if performed): (i) synovial 5001.12.2023biopsy; (ii) synovectomy; (iii) adjacent tendon transfer; (iv) turn down 5001.12.2023flaps; other than a service associated with a service to which item 49718 5001.12.2023applies (H) (Anaes.) (Assist.) 1049815 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304865.0001509.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Triple arthrodesis of hindfoot joints, with internal or external fixation by 5001.12.2023any method, including any of the following (if performed): (a) capsulotomy; 5001.12.2023(b) joint release; (c) synovectomy; (d) removal of osteophytes at joints (H) 5001.12.2023(Anaes.) (Assist.) 1049818 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300970.0000300.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Release of plantar fascia, including excision of calcaneal spur (if performed) 5001.12.2023(H) (Anaes.) (Assist.) 1049821 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301535.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joint, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement one joint (H) (Anaes.) (Assist.) 1049824 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302690.0000834.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Excisional or interpositional arthroplasty of metatarsophalangeal or 5001.12.2023tarsometatarsal joint, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; 5001.12.2023(e) joint debridement; 2 joints (H) (Anaes.) (Assist.) 1049827 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral correction of hallux valgus or varus deformity of the foot, by 5001.12.2023local tendon transfer, including any of the following (if performed): (a) 5001.12.2023exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) 5001.12.2023capsule or tendon release or transfer (H) (Anaes.) (Assist.) 1049830 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302920.0000906.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral correction of hallux valgus or varus deformity of the foot, by local 5001.12.2023tendon transfer, including any of the following (if performed): (a) 5001.12.2023exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) 5001.12.2023capsule or tendon release or transfer (H) (Anaes.) (Assist.) 1049833 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301835.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral correction of hallux valgus or varus deformity of the foot, by 5001.12.2023osteotomy of first metatarsal, without internal fixation, including any of the 5001.12.2023following (if performed): (a) exostectomy; (b) removal of bursae; (c) 5001.12.2023synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H) 5001.12.2023(Anaes.) (Assist.) 1049836 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303170.0000984.5000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral correction of hallux valgus or varus deformity of the foot by 5001.12.2023osteotomy of first metatarsal, without internal fixation, including any of the 5001.12.2023following (if performed): (a) exostectomy; (b) removal of bursae; (c) 5001.12.2023synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H) 5001.12.2023(Anaes.) (Assist.) 1049837 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302315.0000712.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral correction of hallux valgus or varus deformity of the foot, by 5001.12.2023osteotomy of first metatarsal, with internal fixation, including any of the 5001.12.2023following (if performed): (a) exostectomy; (b) removal of bursae; (c) 5001.12.2023synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H) 5001.12.2023(Anaes.) (Assist.) 1049838 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303995.0001230.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral correction of hallux valgus or varus deformity of the foot by 5001.12.2023osteotomy of first metatarsal, with internal fixation or arthrodesis of first 5001.12.2023metatarsophalangeal joint, including any of the following (if performed): (a) 5001.12.2023exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) 5001.12.2023capsule or tendon release or transfer (H) (Anaes.) (Assist.) 1049839 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301835.0000569.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Total replacement of first metatarsophalangeal joint, with replacement of both 5001.12.2023joint surfaces, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) synovectomy; (c) joint debridement (H) (Anaes.) (Assist.) 1049845 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302295.0000712.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral arthrodesis of first metatarsophalangeal joint, by open or 5001.12.2023arthroscopic means, with internal or external fixation by any method, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) joint 5001.12.2023release; (c) synovectomy; (d) removal of osteophytes at joints (H) (Anaes.) 5001.12.2023(Assist.) 1049851 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301535.0000476.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal 5001.12.2023(or both) joints of lesser toe, including any of the following (if performed): 5001.12.2023(a) internal fixation, by any method; (b) capsulotomy; (c) tendon lengthening; 5001.12.2023(d) joint release; (e) synovectomy; (f) removal of osteophytes at joints; one 5001.12.2023toe (H) (Anaes.) (Assist.) 1049854 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301335.0000414.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Radical plantar fasciotomy or fasciectomy, with extensive incision into foot 5001.12.2023and excision of fascia, including excision of calcaneal spur (if performed), 5001.12.2023other than a service associated with a service to which 49818 applies (H) 5001.12.2023(Anaes.) (Assist.) 1049857 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301235.0000383.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Hemi joint replacement of first or lesser metatarsophalangeal joint, including 5001.12.2023any of the following (if performed): (a) capsulotomy; (b) synovectomy; (c) 5001.12.2023joint debridement (H) (Anaes.) (Assist.) 1049860 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301165.0000358.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy of metatarsophalangeal joints, including any of the following (if 5001.12.2023performed): (a) capsulotomy; (b) debridement; (c) release of ligament or 5001.12.2023tendon (or both); one or more joints on one foot (H) (Anaes.) (Assist.) 1049866 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301070.0000331.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of intermetatarsal or digital neuroma, including any of the following 5001.12.2023(if performed): (a) release of metatarsal or digital ligament; (b) excision of 5001.12.2023bursae; (c) neurolysis; other than a service associated with a service to 5001.12.2023which item 30023 appliesone web space (H) (Anaes.) (Assist.) 1049878 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300200.0000062.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Talipes equinovarus, calcaneo valgus or metatarsus varus, treatment by cast, 5001.12.2023splint or manipulationeach attendance (Anaes.) 1049881 01.07.2021 3 T8 15 SN NYNYY 2001.12.202300635.0000242.0500000.00 4001.07.2021(Anaes.) 5001.12.2023Complete excision of one or more ganglia or bursae: (a) including excision of 5001.12.2023bony prominence or mucinous cyst of interphalangeal or metatarsophalangeal 5001.12.2023joint and surrounding tissues; and (b) including any of the following (if 5001.12.2023performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; 5001.12.2023(iv) neurolysis; (v) skin closure, by any local method; other than a service 5001.12.2023associated with a service to which item 30023 applieseach incision (H) 5001.12.2023(Anaes.) (Assist.) 1049884 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301035.0000408.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Complete excision of one or more ganglia or bursae: (a) including excision of 5001.12.2023bony prominence or mucinous cyst of ankle, hindoot or midfoot joint and 5001.12.2023surrounding tissues; and (b) including any of the following (if performed): 5001.12.2023(i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) 5001.12.2023neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any method; 5001.12.2023other than a service associated with a service to which item 30023 applieseach 5001.12.2023incision (H) (Anaes.) (Assist.) 1049887 01.07.2021 3 T8 15 SN NYNYY 2001.12.202300860.0000326.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of complete excision of one or more ganglia or bursae: (a) including 5001.12.2023excision of bony prominence or mucinous cyst of interphalangeal or 5001.12.2023metatarsophalangeal joint and surrounding tissues; and (b) including any of 5001.12.2023the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) 5001.12.2023osteophyte resections; (iv) neurolysis; (v) skin closure, by any method; other 5001.12.2023than a service associated with a service to which item 30023 or 49881 5001.12.2023applieseach incision (H) (Anaes.) (Assist.) 1049890 01.07.2021 3 T8 15 SN NYNYY 2001.12.202301400.0000552.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of complete excision of one or more ganglia or bursae: (a) including 5001.12.2023excision of bony prominence or mucinous cyst of ankle, hindoot or midfoot 5001.12.2023joint and surrounding tissues; and (b) including any of the following (if 5001.12.2023performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; 5001.12.2023(iv) neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any 5001.12.2023method; other than a service associated with a service to which item 30023 or 5001.12.202349884 applieseach incision (H) (Anaes.) (Assist.) 1050107 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301670.0000518.1000000.00 4001.07.2021(Anaes.) 5001.12.2023Stabilisation of joint of hip, by open means, including any of the following 5001.12.2023(if performed): (a) repair of capsule; (b) labrum; (c) capsulorraphy; (d) 5001.12.2023repair of ligament; (e) internal fixation; other than a service associated 5001.12.2023with a service to which another item in this Group applies (H) (Anaes.) 5001.12.2023(Assist.) 1050112 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301270.0000397.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Cicatricial flexion or extension contraction of joint, correction of, 5001.12.2023involving tissues deeper than skin and subcutaneous tissue, other than a 5001.12.2023service to which another item in this Group applies (H) (Anaes.) (Assist.) 1050115 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300495.0000157.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Manipulation of one or more joints, excluding spine, other than a service 5001.12.2023associated with a service to which another item in this Group applies (H) 5001.12.2023(Anaes.) 1050118 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302780.0000862.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Arthrodesis of joint of hindfoot, by any method, with internal or external 5001.12.2023fixation by any method, including any of the following (if performed): (a) 5001.12.2023capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at 5001.12.2023joints; one joint (H) (Anaes.) (Assist.) 1050130 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301100.0000343.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Joint or joints, application of external fixator to, other than for treatment 5001.12.2023of fractures (H) (Anaes.) (Assist.) 1050200 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300670.0000207.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Core needle biopsy of aggressive or potentially malignant bone or soft tissue 5001.12.2023tumour, excluding aftercare (Anaes.) 1050201 01.11.2004 3 T8 15 SN NYNNY 2001.12.202301695.0000362.6500000.00 4001.11.2004(Anaes.) 5001.12.2023Incisional biopsy of aggressive or potentially malignant bone or soft tissue 5001.12.2023tumour, excluding aftercare (Anaes.) (Assist.) 1050203 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301470.0000455.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Intralesional or marginal excision of bone or soft tissue tumour (Anaes.) 5001.12.2023(Assist.) 1050206 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Intralesional or marginal excision of bone tumour, with at least one of the 5001.12.2023following: (a) autograft; (b) allograft; (c) cementation (H) (Anaes.) 5001.12.2023(Assist.) 1050209 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Intralesional or marginal excision of bone tumour, with at least 2 of the 5001.12.2023following: (a) autograft; (b) allograft; (c) cementation (H) (Anaes.) 5001.12.2023(Assist.) 1050212 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304840.0001813.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Wide excision of malignant or aggressive bone or soft tissue tumour (or both), 5001.12.2023affecting a limb, trunk or scapula (H) (Anaes.) (Assist.) 1050215 26.05.2002 3 T8 15 SN NYNNY 2001.12.202306345.0002279.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Wide excision of malignant or aggressive bone or soft tissue tumour (or both), 5001.12.2023with intercalary reconstruction of bone by prosthesis, allograft or autograft 5001.12.2023(H) (Anaes.) (Assist.) 1050218 26.05.2002 3 T8 15 SN NYNNY 2001.12.202308250.0003005.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Wide excision of malignant or aggressive bone or soft tissue tumour (or both), 5001.12.2023with reconstruction, replacement or arthrodesis of adjacent joint, by 5001.12.2023prosthesis, allograft or autograft (H) (Anaes.) (Assist.) 1050221 26.05.2002 3 T8 15 SN NYNNY 2001.12.202307345.0002797.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Wide excision of malignant or aggressive bone or soft tissue tumour (or both) 5001.12.2023of pelvis, sacrum or spine, without reconstruction (H) (Anaes.) (Assist.) 1050224 26.05.2002 3 T8 15 SN NYNNY 2001.12.202308680.0003108.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Wide excision of malignant or aggressive bone or soft tissue tumour (or both) 5001.12.2023of pelvis, sacrum or spine, with reconstruction of bone defect, or one or more 5001.12.2023joints, by any technique (Anaes.) (Assist.) 1050233 26.05.2002 3 T8 15 SN NYNNY 2001.12.202306680.0002383.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of malignant or aggressive bone or soft tissue tumour (or both) by 5001.12.2023hindquarter or forequarter amputation(H) (Anaes.) (Assist.) 1050236 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305010.0001865.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of malignant or aggressive bone or soft tissue tumour (or both), by 5001.12.2023hip disarticulation, shoulder disarticulation or amputation through the 5001.12.2023proximal one third of the femur (H) (Anaes.) (Assist.) 1050239 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001243.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of malignant or aggressive bone or soft tissue tumour (or both), by 5001.12.2023amputation, other than a service associated with a service to which item 50233 5001.12.2023or 50236 applies (H) (Anaes.) (Assist.) 1050242 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303005.0000932.6500000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of endoprosthetic replacement, if item 50218 or 50224, or an item 5001.12.2023that describes a service substantially similar to either of those items, 5001.12.2023applied to the initial procedure: (a) including any of the following: (i) 5001.12.2023rebushing; (ii) patella resurfacing; (iii) polyethylene exchange or similar; 5001.12.2023and (b) excluding removal of prosthetic from bone (H) (Anaes.) (Assist.) 1050245 01.07.2021 3 T8 15 SN NYNNY 2001.12.202309010.0002798.0000000.00 4001.07.2021(Anaes.) 5001.12.2023Revision of reconstructive procedure, if item 50215, 50218 or 50224, or an 5001.12.2023item that describes a service substantially similar to any of those items, 5001.12.2023applied to the initial procedure, by any technique or combination of 5001.12.2023techniques (H) (Anaes.) (Assist.) 1050300 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303875.0001274.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Gradual correction of joint deformity, with application of external fixator 5001.12.2023(H) (Anaes.) (Assist.) 1050303 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305290.0001739.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Limb lengthening, by gradual distraction, with application of external fixator 5001.12.2023or intra-medullary device (H) (Anaes.) (Assist.) 1050306 26.05.2002 3 T8 15 SN NYNNY 2001.12.202308260.0002716.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Bipolar limb lengthening: (a) with application of external fixator or 5001.12.2023intra-medullary device; and (b) by any of the following: (i) gradual 5001.12.2023distraction; (ii) bone transport; (iii) fixator extension, to correct for an 5001.12.2023adjacent joint deformity (H) (Anaes.) (Assist.) 1050309 26.05.2002 3 T8 15 SN NYNYY 2001.12.202301020.0000335.8000000.00 4026.05.2002(Anaes.) 5001.12.2023Ring fixator or similar device, adjustment of, with or without insertion or 5001.12.2023removal of fixation pins, performed under general anaesthesia, other than a 5001.12.2023service to which item 50303 or 50306 applies (H) (Anaes.) (Assist.) 1050310 01.07.2021 3 T8 15 SN NYNNY 2001.12.202300110.0000048.0500000.00 5001.12.2023Major adjustment of ring fixator or similar device, other than a service 5001.12.2023associated with a service to which item 50303, 50306, or 50309 applies 1050312 26.05.2002 3 T8 15 SN NYNYY 2001.12.202303020.0000827.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Synovectomy or debridement, and microfracture, of ankle joint for 5001.12.2023osteochondral large defect greater than 1.5cm2, by arthroscopic or open means, 5001.12.2023including any of the following (if performed): (a) capsulotomy; (b) 5001.12.2023debridement or release of ligament; (c) debridement or release of tendon; 5001.12.2023other than a service associated with a service to which any of the following 5001.12.2023apply: (d) item 49703; (e) another item in this Schedule if the service 5001.12.2023described in the other item is for the purpose of performing an arthroscopic 5001.12.2023procedure of the ankle (H) (Anaes.) (Assist.) 1050321 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303110.0001022.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Release of soft tissue of talipes equinovarus, by open means (H) (Anaes.) 5001.12.2023(Assist.) 1050324 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304615.0001457.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Revision of release of soft tissue of talipes equinovarus, by open means (H) 5001.12.2023(Anaes.) (Assist.) 1050330 26.05.2002 3 T8 15 SN NYNYY 2001.12.202300765.0000251.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Postoperative manipulation, and change of plaster, of vertical, congenital 5001.12.2023talipes equinovarus or talus, other than a service to which item 50321 or 5001.12.202350324 applies (H) (Anaes.) 1050333 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302065.0000678.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Excision of tarsal coalition, with interposition of muscle, fat graft or 5001.12.2023similar graft, including any of the following (if performed): (a) capsulotomy; 5001.12.2023(b) synovectomy; (c) excision of osteophytes; one coalition (H) (Anaes.) 5001.12.2023(Assist.) 1050335 01.07.2021 3 T8 15 SN NYNNY 2001.12.202302065.0000678.9000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of vertical, congenital talus, by percutaneous or open stabilisation 5001.12.2023of talonavicular joint and Achilles tenotomy (H) (Anaes.) (Assist.) 1050336 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303085.0001014.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Talus, vertical, congenital, combined anterior and posterior reconstruction 5001.12.2023(H) (Anaes.) (Assist.) 1050339 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301995.0000649.9500000.00 4026.05.2002(Anaes.) 5001.12.2023Tibialis anterior or tibialis posterior tendon transfer (split or whole) (H) 5001.12.2023(Anaes.) (Assist.) 1050345 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301160.0000381.5500000.00 4026.05.2002(Anaes.) 5001.12.2023Hyperextension deformity of toe, release incorporating VY plasty of skin, 5001.12.2023lengthening of extensor tendons and release of capsule contracture (H) 5001.12.2023(Anaes.) (Assist.) 1050348 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300765.0000251.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Knee, deformity of, postoperative manipulation and change of plaster, 5001.12.2023performed under general anaesthesia (H) (Anaes.) 1050351 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305355.0001758.1000000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of developmental dislocation of hip, by open reduction, including 5001.12.2023application of hip spica (H) (Anaes.) (Assist.) 1050352 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300200.0000062.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Treatment of developmental dysplasia of hip, including supervision of initial 5001.12.2023application of splint, harness or cast, other than a service to which another 5001.12.2023item in this Group applies (Anaes.) 1050354 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304385.0001442.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Resection and fixation of congenital pseudarthrosis of tibia (Anaes.) 5001.12.2023(Assist.) 1050357 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301880.0000618.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Transfer of tendon of rectus femoris or medial or lateral hamstring (H) 5001.12.2023(Anaes.) (Assist.) 1050360 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302180.0000717.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Combined medial and lateral hamstring tendon transfer (H) (Anaes.) (Assist.) 1050369 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302180.0000717.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral posterior release of knee contracture, with multiple tendon 5001.12.2023lengthening or tenotomies, including release of joint capsule (if performed), 5001.12.2023other than a service associated with a service to which another item of this 5001.12.2023Schedule applies if the service describedin the other item is for the purpose 5001.12.2023of knee replacement (H) (Anaes.) (Assist.) 1050372 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303830.0001259.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral posterior release of knee contracture, with multiple tendon 5001.12.2023lengthening or tenotomies, including release of joint capsule (if performed), 5001.12.2023other than a service associated with a service to which another item of this 5001.12.2023Schedule applies if the service described in the other item is for the purpose 5001.12.2023of knee replacement (H) (Anaes.) (Assist.) 1050375 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301670.0000549.3500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral medial release of hip contracture, with lengthening or division of 5001.12.2023the adductors and psoas, including division of obturator nerve (if performed) 5001.12.2023(H) (Anaes.) (Assist.) 1050378 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302925.0000961.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral medial release of hip contracture, with lengthening or division of 5001.12.2023adductors and psoas, including division of obturator nerve (if performed) (H) 5001.12.2023(Anaes.) (Assist.) 1050381 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302180.0000717.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Unilateral anterior release of hip contracture, with lengthening or division 5001.12.2023of hip flexors and psoas, including division of joint capsule (if performed) 5001.12.2023(H) (Anaes.) (Assist.) 1050384 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303830.0001259.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Bilateral anterior release of hip contracture, with lengthening or division of 5001.12.2023hip flexors and psoas, including division of joint capsule (if performed) (H) 5001.12.2023(Anaes.) (Assist.) 1050390 26.05.2002 3 T8 15 SN NYNNY 2001.12.202300765.0000251.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Application of cast under general anaesthesia, for patient with perthes, 5001.12.2023cerebral palsy, or other neuromuscular conditions, affecting hips or knees (H) 5001.12.2023(Anaes.) 1050393 26.05.2002 3 T8 15 SN NYNNY 2001.12.202302830.0000930.8500000.00 4026.05.2002(Anaes.) 5001.12.2023Acetabular shelf procedure, other than a service associated with a service to 5001.12.2023which another item of this Schedule applies if the service in the other item 5001.12.2023is for the purpose of performing arthroplasty on the hip (H) (Anaes.) 5001.12.2023(Assist.) 1050394 26.05.2002 3 T8 15 SN NYNNY 2001.12.202309295.0003057.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Multiple peri-acetabular osteotomy, including internal fixation (if performed) 5001.12.2023(H) (Anaes.) (Assist.) 1050395 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303270.0001005.2000000.00 4001.07.2021(Anaes.) 5001.12.2023Osteotomy and distillation of greater trochanter, with internal fixation (H) 5001.12.2023(Anaes.) (Assist.) 1050396 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301555.0000511.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Amputation of congenital abnormalities or duplication of digits of the hand or 5001.12.2023foot, including any of the following (if performed): (a) splitting of phalanx 5001.12.2023or phalanges; (b) ligament reconstruction; (c) joint reconstruction (H) 5001.12.2023(Anaes.) (Assist.) 1050399 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303085.0001014.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Forearm, radial aplasia or dysplasia (radial club hand), centralisation or 5001.12.2023radialisation of (H) (Anaes.) (Assist.) 1050411 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304385.0001442.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Lower limb deficiency, treatment of congenital deficiency of the femur by 5001.12.2023resection of the distal femur and proximal tibia followed by knee fusion 5001.12.2023(Anaes.) (Assist.) 1050414 26.05.2002 3 T8 15 SN NYNNY 2001.12.202305915.0001945.6500000.00 4026.05.2002(Anaes.) 5001.12.2023Lower limb deficiency, treatment of congenital deficiency of the femur by 5001.12.2023resection of the distal femur and proximal tibia followed by knee fusion and 5001.12.2023rotationplasty (Anaes.) (Assist.) 1050417 26.05.2002 3 T8 15 SN NYNNY 2001.12.202304385.0001442.0000000.00 4026.05.2002(Anaes.) 5001.12.2023Lower limb deficiency, treatment of congenital deficiency of the tibia by 5001.12.2023reconstruction of the knee, involving transfer of fibula or tibia, and repair 5001.12.2023of quadriceps mechanism (Anaes.) (Assist.) 1050420 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303620.0001190.2500000.00 4026.05.2002(Anaes.) 5001.12.2023Patella, congenital dislocation of, reconstruction of the quadriceps (H) 5001.12.2023(Anaes.) (Assist.) 1050423 26.05.2002 3 T8 15 SN NYNNY 2001.12.202303340.0001098.7000000.00 4026.05.2002(Anaes.) 5001.12.2023Tibia, fibula or both, congenital deficiency of, transfer of the fibula to 5001.12.2023tibia, with internal fixation (Anaes.) (Assist.) 1050426 26.05.2002 3 T8 15 SN NYNNY 2001.12.202301555.0000511.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Removal of one or more lesions from bone, for osteochondroma occurring 5001.12.2023solitary or in association with hereditary multiple exotoses, with 5001.12.2023histological examinationone approach (H) (Anaes.) (Assist.) 1050428 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303115.0000853.7000000.00 4001.07.2021(Anaes.) 5001.12.2023Percutaneous drilling of osteochondritis dessicans or other osteochondral 5001.12.2023lesion, for a patient: (a) with open growth plates; or (b) less than 18 years 5001.12.2023of age (H) (Anaes.) (Assist.) 1050450 01.11.2006 3 T8 15 SN NYNNY 2001.12.202304125.0001350.5000000.00 4001.11.2006(Anaes.) 5001.12.2023Unilateral single event multilevel surgery, for a patient less than 18 years 5001.12.2023of age with hemiplegic cerebral palsy, comprising 3 or more of the following: 5001.12.2023(a) lengthening of a contracted muscle tendon unit or units by tendon 5001.12.2023lengthening, muscle recession, fractional lengthening or intramuscular 5001.12.2023lengthening; (b) correction of muscle imbalance by transfer of a tendon or 5001.12.2023tendons; (c) correction of femoral torsion by rotational osteotomy of the 5001.12.2023femur; (d) correction of tibial torsion by rotational osteotomy of the tibia; 5001.12.2023(e) correction of joint instability by varus derotation osteotomy of the 5001.12.2023femur, subtalar arthrodesis with synovectomy if performed, or os calcis 5001.12.2023lengthening; conjoint surgery, principal specialist surgeon, including 5001.12.2023fluoroscopy and aftercare (H) (Anaes.) (Assist.) 1050451 01.11.2006 3 T8 15 SN NYNNY 2001.12.202304125.0001350.5000000.00 4001.11.2006(Anaes.) 5001.12.2023Unilateral single event multilevel surgery, for a patient less than 18 years 5001.12.2023of age with hemiplegic cerebral palsy, comprising 3 or more of the following: 5001.12.2023(a) lengthening of a contracted muscle tendon unit or units by tendon 5001.12.2023lengthening, muscle recession, fractional lengthening or intramuscular 5001.12.2023lengthening; (b) correction of muscle imbalance by transfer of a tendon or 5001.12.2023tendons; (c) correction of femoral torsion by rotational osteotomy of the 5001.12.2023femur; (d) correction of tibial torsion by rotational osteotomy of the tibia; 5001.12.2023(e) correction of joint instability by varus derotation osteotomy of the 5001.12.2023femur, subtalar arthrodesis with synovectomy if performed, or os calcis 5001.12.2023lengthening; conjoint surgery, conjoint specialist surgeon, including 5001.12.2023fluoroscopy and excluding aftercare (H) (Anaes.) (Assist.) 1050455 01.11.2006 3 T8 15 SN NYNNY 2001.12.202304670.0001529.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises: (a) lengthening of a 5001.12.2023contracted muscle tendon unit or units by tendon lengthening, muscle 5001.12.2023recession, fractional lengthening or intramuscular lengthening; and (b) 5001.12.2023correction of muscle imbalance by transfer of a tendon or tendons; conjoint 5001.12.2023surgery, principal specialist surgeon, including fluoroscopy and aftercare (H) 5001.12.2023(Anaes.) (Assist.) 1050456 01.11.2006 3 T8 15 SN NYNNY 2001.12.202304670.0001529.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises: (a) lengthening of a 5001.12.2023contracted muscle tendon unit or units by tendon lengthening, muscle 5001.12.2023recession, fractional lengthening or intramuscular lengthening; and (b) 5001.12.2023correction of muscle imbalance by transfer of a tendon or tendons; conjoint 5001.12.2023surgery, conjoint specialist surgeon, including fluoroscopy and excluding 5001.12.2023aftercare (H) (Anaes.) (Assist.) 1050460 01.11.2006 3 T8 15 SN NYNNY 2001.12.202306975.0002283.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery 5001.12.2023and bilateral femoral osteotomies, with: (a) lengthening of a contracted 5001.12.2023muscle tendon unit or units by tendon lengthening, muscle recession, 5001.12.2023fractional lengthening or intramuscular lengthening; and (b) correction of 5001.12.2023muscle imbalance by transfer of a tendon or tendons; and (c) correction of 5001.12.2023torsional abnormality of the femur by rotational osteotomy and internal 5001.12.2023fixation; conjoint surgery, principal specialist surgeon, including 5001.12.2023fluoroscopy and aftercare (H) (Anaes.) (Assist.) 1050461 01.11.2006 3 T8 15 SN NYNNY 2001.12.202306975.0002283.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery 5001.12.2023and bilateral femoral osteotomies, with: (a) lengthening of a contracted 5001.12.2023muscle tendon unit or units by tendon lengthening, muscle recession, 5001.12.2023fractional lengthening or intramuscular lengthening; and (b) correction of 5001.12.2023muscle imbalance by transfer of a tendon or tendons; and (c) correction of 5001.12.2023torsional abnormality of the femur by rotational osteotomy and internal 5001.12.2023fixation; conjoint surgery, conjoint specialist surgeon, including fluoroscopy 5001.12.2023and excluding aftercare (H) (Anaes.) (Assist.) 1050465 01.11.2006 3 T8 15 SN NYNNY 2001.12.202309820.0003216.0500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises bilateral soft tissue 5001.12.2023surgery, bilateral femoral osteotomies and bilateral tibial osteotomies, with: 5001.12.2023(a) lengthening of a contracted muscle tendon unit or units by tendon 5001.12.2023lengthening, muscle recession, fractional lengthening or intramuscular 5001.12.2023lengthening; and (b) correction of muscle imbalance by transfer of a tendon or 5001.12.2023tendons; and (c) correction of abnormal torsion of the femur by rotational 5001.12.2023osteotomy with internal fixation; and (d) correction of abnormal torsion of 5001.12.2023the tibia by rotational osteotomy with internal fixation; conjoint surgery, 5001.12.2023principal specialist surgeon, including fluoroscopy and aftercare (H) (Anaes.) 5001.12.2023(Assist.) 1050466 01.11.2006 3 T8 15 SN NYNNY 2001.12.202309820.0003216.0500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with diplegic cerebral palsy, that comprises bilateral soft tissue 5001.12.2023surgery, bilateral femoral osteotomies and bilateral tibial osteotomies, with: 5001.12.2023(a) lengthening of a contracted muscle tendon unit or units by tendon 5001.12.2023lengthening, muscle recession, fractional lengthening or intramuscular 5001.12.2023lengthening; and (b) correction of muscle imbalance by transfer of a tendon or 5001.12.2023tendons; and (c) correction of abnormal torsion of the femur by rotational 5001.12.2023osteotomy with internal fixation; and (d) correction of abnormal torsion of 5001.12.2023the tibia by rotational osteotomy with internal fixation; conjoint surgery, 5001.12.2023conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H) 5001.12.2023(Anaes.) (Assist.) 1050470 01.11.2006 3 T8 15 SN NYNNY 2001.12.202312455.0004078.7500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with cerebral palsy, that comprises bilateral soft tissue surgery, 5001.12.2023bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot 5001.12.2023stabilisation, with: (a) lengthening of a contracted muscle tendon unit or 5001.12.2023units by tendon lengthening, muscle recession, fractional lengthening or 5001.12.2023intramuscular lengthening; and (b) correction of muscle imbalance by transfer 5001.12.2023of a tendon or tendons; and (c) correction of abnormal torsion of the femur by 5001.12.2023rotational osteotomy with internal fixation; and (d) correction of abnormal 5001.12.2023torsion of the tibia by rotational osteotomy with internal fixation; and (e) 5001.12.2023correction of bilateral pes valgus by os calcis lengthening or subtalar 5001.12.2023fusion; conjoint surgery, principal specialist surgeon, including fluoroscopy 5001.12.2023and aftercare (H) (Anaes.) (Assist.) 1050471 01.11.2006 3 T8 15 SN NYNNY 2001.12.202312455.0004078.7500000.00 4001.11.2006(Anaes.) 5001.12.2023Bilateral single event multilevel surgery, for a patient less than 18 years of 5001.12.2023age with cerebral palsy, that comprises bilateral soft tissue surgery, 5001.12.2023bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot 5001.12.2023stabilisation, with: (a) lengthening of a contracted muscle tendon unit or 5001.12.2023units by tendon lengthening, muscle recession, fractional lengthening or 5001.12.2023intramuscular lengthening; and (b) correction of muscle imbalance by transfer 5001.12.2023of a tendon or tendons; and (c) correction of abnormal torsion of the femur by 5001.12.2023rotational osteotomy with internal fixation; and (d) correction of abnormal 5001.12.2023torsion of the tibia by rotational osteotomy with internal fixation; and (e) 5001.12.2023correction of bilateral pes valgus by os calcis lengthening or subtalar 5001.12.2023fusion; conjoint surgery, conjoint specialist surgeon, including fluoroscopy 5001.12.2023and excluding aftercare (H) (Anaes.) (Assist.) 1050475 01.11.2006 3 T8 15 SN NYNNY 2001.12.202314370.0004706.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Single event multilevel surgery, for a patient less than 18 years of age with 5001.12.2023diplegic cerebral palsy, for the correction of crouch gait, including: (a) 5001.12.2023lengthening of a contracted muscle tendon unit or units by tendon lengthening, 5001.12.2023muscle recession, fractional lengthening or intramuscular lengthening; and (b) 5001.12.2023correction of muscle imbalance by transfer of a tendon or tendons; and (c) 5001.12.2023correction of flexion deformity at the knee by extension osteotomy of the 5001.12.2023distal femur including internal fixation; and (d) correction of patella alta 5001.12.2023and quadriceps insufficiency by patella tendon shortening or reconstruction; 5001.12.2023and (e) correction of tibial torsion by rotational osteotomy of the tibia with 5001.12.2023internal fixation; and (f) correction of foot instability by os calcis 5001.12.2023lengthening or subtalar fusion; conjoint surgery, principal specialist 5001.12.2023surgeon, including fluoroscopy and aftercare (H) (Anaes.) (Assist.) 1050476 01.11.2006 3 T8 15 SN NYNNY 2001.12.202314370.0004706.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Single event multilevel surgery, for a patient less than 18 years of age with 5001.12.2023diplegic cerebral palsy, for the correction of crouch gait including: (a) 5001.12.2023lengthening of a contracted muscle tendon unit or units by tendon lengthening, 5001.12.2023muscle recession, fractional lengthening or intramuscular lengthening; and (b) 5001.12.2023correction of muscle imbalance by transfer of a tendon or tendons; and (c) 5001.12.2023correction of flexion deformity at the knee by extension osteotomy of the 5001.12.2023distal femur including internal fixation; and (d) correction of patella alta 5001.12.2023and quadriceps insufficiency by patella tendon shortening or reconstruction; 5001.12.2023and (e) correction of tibial torsion by rotational osteotomy of the tibia with 5001.12.2023internal fixation; and (f) correction of foot instability by os calcis 5001.12.2023lengthening or subtalar fusion; conjoint surgery, conjoint specialist surgeon, 5001.12.2023including fluoroscopy and excluding aftercare (H) (Anaes.) (Assist.) 1050508 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301600.0000435.0000000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of distal end of radius or ulna (or both), by closed 5001.12.2023reduction, for a patient with open growth plates (Anaes.) 1050512 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302135.0000580.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of distal end of radius or ulna (or both), by open or 5001.12.2023closed reduction, with internal fixation, for a patient with open growth 5001.12.2023plates (H) (Anaes.) (Assist.) 1050524 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301735.0000449.7000000.00 4001.11.2006(Anaes.) 5001.12.2023Radius or ulna, shaft of, with open growth plate, treatment of fracture of, in 5001.12.2023conjunction with dislocation of distal radioulnar joint or proximal 5001.12.2023radiohumeral joint (Galeazzi or Monteggia injury), by closed reduction (H) 5001.12.2023(Anaes.) (Assist.) 1050528 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302670.0000725.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Radius or ulna, shaft of, with open growth plate, treatment of fracture of, in 5001.12.2023conjunction with dislocation of distal radioulnar joint or proximal 5001.12.2023radiohumeral joint (Galeazzi or Monteggia injury), by reduction with or 5001.12.2023without internal fixation by open or percutaneous means (H) (Anaes.) (Assist.) 1050532 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302320.0000631.1000000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of shafts of radius or ulna (or both), by closed 5001.12.2023reduction, for a patient with open growth plate (H) (Anaes.) 1050536 01.11.2006 3 T8 15 SN NYNNY 2001.12.202303095.0000841.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of shafts of radius or ulna (or both), by open or closed 5001.12.2023reduction, with internal fixation, for a patient with open growth plate (H) 5001.12.2023(Anaes.) (Assist.) 1050540 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302135.0000580.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Olecranon, with open growth plate, treatment of fracture of, by open reduction 5001.12.2023(H) (Anaes.) (Assist.) 1050544 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301065.0000290.1500000.00 4001.11.2006(Anaes.) 5001.12.2023Radius, with open growth plate, treatment of fracture of head or neck of, by 5001.12.2023closed reduction of (Anaes.) 1050548 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302135.0000580.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Radius, with open growth plate, treatment of fracture of head or neck of, by 5001.12.2023reduction with or without internal fixation by open or percutaneous means (H) 5001.12.2023(Anaes.) (Assist.) 1050552 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301840.0000500.5500000.00 4001.11.2006(Anaes.) 5001.12.2023Humerus, proximal, with open growth plate, treatment of fracture of, by closed 5001.12.2023reduction (H) (Anaes.) 1050556 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302455.0000667.2500000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of proximal humerus, by open or closed reduction, with 5001.12.2023internal fixation, for a patient with open growth plate (H) (Anaes.) (Assist.) 1050560 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301920.0000522.2000000.00 4001.11.2006(Anaes.) 5001.12.2023Humerus, shaft of, with open growth plate, treatment of fracture of, by closed 5001.12.2023reduction (H) (Anaes.) 1050564 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302560.0000696.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of shaft of humerus, by open or closed reduction, with 5001.12.2023internal or external fixation, for a patient with open growth plate (H) 5001.12.2023(Anaes.) (Assist.) 1050568 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302240.0000609.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Humerus, with open growth plate, supracondylar or condylar, treatment of 5001.12.2023fracture of, by closed reduction (H) (Anaes.) 1050572 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302990.0000812.4500000.00 4001.11.2006(Anaes.) 5001.12.2023Humerus, with open growth plate, supracondylar or condylar, treatment of 5001.12.2023fracture of, by reduction with or without internal fixation by open or 5001.12.2023percutaneous means (H) (Anaes.) (Assist.) 1050576 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302455.0000667.2500000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of fracture of femur, by closed reduction or traction, including 5001.12.2023application of hip spica (if performed), for a patient with open growth plate 5001.12.2023(Anaes.) (Assist.) 1050580 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302560.0000696.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Tibia, with open growth plate, plateau or condyles, medial or lateral, 5001.12.2023treatment of fracture of, by reduction with or without internal fixation by 5001.12.2023open or percutaneous means (H) (Anaes.) (Assist.) 1050584 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302455.0000667.2500000.00 4001.11.2006(Anaes.) 5001.12.2023Tibia, distal, with open growth plate, treatment of fracture of, by reduction 5001.12.2023with or without internal fixation by open or percutaneous means (H) (Anaes.) 5001.12.2023(Assist.) 1050588 01.11.2006 3 T8 15 SN NYNNY 2001.12.202303200.0000870.3500000.00 4001.11.2006(Anaes.) 5001.12.2023Tibia and fibula, with open growth plates, treatment of fracture of, by 5001.12.2023internal fixation (H) (Anaes.) (Assist.) 1050592 01.07.2021 3 T8 15 SN NYNNY 2001.12.202303405.0001056.9500000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of fracture of shaft of femur, by open or closed reduction, with 5001.12.2023internal or external fixation, for a patient with open growth plate (H) 5001.12.2023(Anaes.) (Assist.) 1050596 01.07.2021 3 T8 15 SN NYNNY 2001.12.202301065.0000330.4000000.00 4001.07.2021(Anaes.) 5001.12.2023Treatment of fracture of shaft of tibia, by open or closed reduction, 5001.12.2023including casting, for a patient with open growth plate (H) (Anaes.) (Assist.) 1050600 01.11.2006 3 T8 15 SN NYNNY 2001.12.202301775.0000478.5000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis or kyphosis, in a child, manipulation of deformity and application 5001.12.2023of a localiser cast, under general anaesthesia, in a hospital (H) (Anaes.) 5001.12.2023(Assist.) 1050604 01.11.2006 3 T8 15 SN NYNNY 2001.12.202307530.0002030.7500000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis or kyphosis, in a child or adolescent, spinal fusion for (without 5001.12.2023instrumentation) (H) (Anaes.) (Assist.) 1050608 01.11.2006 3 T8 15 SN NYNNY 2001.12.202313985.0003772.0500000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis or kyphosis, in a child or adolescent, treatment by segmental 5001.12.2023instrumentation and fusion of the spine, other than a service to which any of 5001.12.2023items 51011 to 51171 apply (H) (Anaes.) (Assist.) 1050612 01.11.2006 3 T8 15 SN NYNNY 2001.12.202319890.0005365.4000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis or kyphosis, in a child or adolescent, with spinal deformity, 5001.12.2023treatment by segmental instrumentation, utilising separate anterior and 5001.12.2023posterior approaches, other than a service to which any of items 51011 to 5001.12.202351171 apply (H) (Anaes.) (Assist.) 1050616 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302525.0000681.7000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, re-exploration for adjustment or removal 5001.12.2023of segmental instrumentation used for correction of spine deformity (H) 5001.12.2023(Anaes.) (Assist.) 1050620 01.11.2006 3 T8 15 SN NYNNY 2001.12.202313985.0003772.0500000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, revision of failed scoliosis surgery, 5001.12.2023involving more than one of osteotomy, fusion, removal of instrumentation or 5001.12.2023instrumentation, other than a service to which any of items 51011 to 51171 5001.12.2023apply (H) (Anaes.) (Assist.) 1050624 01.11.2006 3 T8 15 SN NYNNY 2001.12.202313985.0003772.0500000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, anterior correction of, with fusion and 5001.12.2023segmental fixation (Dwyer, Zielke or similar) - not more than 4 levels (H) 5001.12.2023(Anaes.) (Assist.) 1050628 01.11.2006 3 T8 15 SN NYNNY 2001.12.202317275.0004659.5500000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, anterior correction of, with fusion and 5001.12.2023segmental fixation (Dwyer, Zielke or similar)more than 4 levels (H) (Anaes.) 5001.12.2023(Assist.) 1050632 01.11.2006 3 T8 15 SN NYNYY 2001.12.202314520.0003917.1000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis or kyphosis, in a child or adolescent, requiring segmental 5001.12.2023instrumentation and fusion of the spine down to and including the pelvis or 5001.12.2023sacrum, other than a service to which any of items 51011 to 51171 apply (H) 5001.12.2023(Anaes.) (Assist.) 1050636 01.11.2006 3 T8 15 SN NYNYY 2001.12.202316135.0004352.3000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, requiring anterior decompression of the 5001.12.2023spinal cord with vertebral resection and instrumentation in the presence of 5001.12.2023spinal cord involvement, other than a service to which any of items 51011 to 5001.12.202351171 apply (H) (Anaes.) (Assist.) 1050640 01.11.2006 3 T8 15 SN NYNYY 2001.12.202308920.0002405.9000000.00 4001.11.2006(Anaes.) 5001.12.2023Scoliosis, in a child or adolescent, congenital, resection and fusion of 5001.12.2023abnormal vertebra via an anterior or posterior approach, other than a service 5001.12.2023to which any of items 51011 to 51171 apply (H) (Anaes.) (Assist.) 1050644 01.11.2006 3 T8 15 SN NYNNY 2001.12.202308605.0002321.3000000.00 4001.11.2006(Anaes.) 5001.12.2023Spine, bone graft to, for a child or adolescent, associated with surgery for 5001.12.2023correction of scoliosis or kyphosis or both (H) (Anaes.) (Assist.) 1050654 01.11.2006 3 T8 15 SN NYNNY 2001.12.202302010.0000546.6000000.00 4001.11.2006(Anaes.) 5001.12.2023Treatment of hip dysplasia or dislocation, for a patient under the age of 18 5001.12.2023years, by examination or closed reduction (or both), with or without 5001.12.2023arthrography of the hip under anaesthesia, and with application or 5001.12.2023reapplication of a hip spica (H) (Anaes.) (Assist.) 1050950 01.05.2004 3 T8 16 SN NYNYY 2001.12.202302635.0000899.3500000.00 4001.05.2004(Anaes.) 5001.12.2023Unresectable primary malignant tumour of the liver, destruction of, by 5001.12.2023percutaneous ablation (including any associated imaging services), other than 5001.12.2023a service associated with a service to which item 30419 or 50952 applies 5001.12.2023(Anaes.) 1050952 01.05.2004 3 T8 16 SN NYNYY 2001.12.202302635.0000899.3500000.00 4001.05.2004(Anaes.) 5001.12.2023Unresectable primary malignant tumour of the liver, destruction of, by open or 5001.12.2023laparoscopic ablation (including any associated imaging services), if a 5001.12.2023multidisciplinary team has assessed that percutaneous ablation cannot be 5001.12.2023performed or is not practical because of one or more of the following clinical 5001.12.2023circumstances:(a) percutaneous access cannot be achieved;(b) vital organs or 5001.12.2023tissues are at risk of damage from the percutaneousablationprocedure;(c) 5001.12.2023resection of one part of the liver is possible, however there is at least one 5001.12.2023primary liver tumour in an unresectable portion of the liver that is suitable 5001.12.2023for ablation;other than a service associated with a service to which item 5001.12.202330419 or 50950 applies (Anaes.) 1051011 01.11.2018 3 T8 17 SN NYNNY 2001.12.202306800.0001580.0500000.00 4001.11.2018(Anaes.) 5001.12.2023Direct spinal decompression or exposure (via a partial or a total laminectomy 5001.12.2023or a partial vertebrectomy), or a posterior spinal release, one motion 5001.12.2023segment, not being a service associated with a service to which item 51012, 5001.12.202351013, 51014 or 51015 applies (H) (Anaes.) (Assist.) 1051012 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307870.0002106.5000000.00 4001.11.2018(Anaes.) 5001.12.2023Direct spinal decompression or exposure (via a partial or a total laminectomy 5001.12.2023or a partial vertebrectomy), or a posterior spinal release, 2 motion segments, 5001.12.2023not being a service associated with a service to which item 51011, 51013, 5001.12.202351014 or 51015 applies (H) (Anaes.) (Assist.) 1051013 01.11.2018 3 T8 17 SN NYNNY 2001.12.202309835.0002633.2000000.00 4001.11.2018(Anaes.) 5001.12.2023Direct spinal decompression or exposure (via a partial or a total laminectomy 5001.12.2023or a partial vertebrectomy), or a posterior spinal release, 3 motion segments, 5001.12.2023not being a service associated with a service to which item 51011, 51012, 5001.12.202351014 or 51015 applies (H) (Anaes.) (Assist.) 1051014 01.11.2018 3 T8 17 SN NYNNY 2001.12.202311800.0003159.8000000.00 4001.11.2018(Anaes.) 5001.12.2023Direct spinal decompression or exposure (via a partial or a total laminectomy 5001.12.2023or a partial vertebrectomy), or a posterior spinal release, 4 motion segments, 5001.12.2023not being a service associated with a service to which item 51011, 51012, 5001.12.202351013 or 51015 applies (H) (Anaes.) (Assist.) 1051015 01.11.2018 3 T8 17 SN NYNNY 2001.12.202313765.0003686.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Direct spinal decompression or exposure (via a partial or a total laminectomy 5001.12.2023or a partial vertebrectomy), or a posterior spinal release, more than 4 motion 5001.12.2023segments, not being a service associated with a service to which item 51011, 5001.12.202351012, 51013 or 51014 applies (H) (Anaes.) (Assist.) 1051020 01.11.2018 3 T8 17 SN NYNYY 2001.12.202302235.0000842.5500000.00 4001.11.2018(Anaes.) 5001.12.2023Simple fixation of part of one vertebra (not motion segment) including pars 5001.12.2023interarticularis, spinous process or pedicle, or simple interspinous wiring 5001.12.2023between 2 adjacent vertebral levels, not being a service associated with: (a) 5001.12.2023interspinous dynamic stabilisation devices; or (b) a service to which item 5001.12.202351021, 51022, 51023, 51024, 51025 or 51026 applies (Anaes.) (Assist.) 1051021 01.11.2018 3 T8 17 SN NYNNY 2001.12.202304075.0001410.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, one motion segment, not 5001.12.2023being a service associated with a service to which item 51020, 51022, 51023, 5001.12.202351024, 51025 or 51026 applies (Anaes.) (Assist.) 1051022 01.11.2018 3 T8 17 SN NYNNY 2001.12.202305070.0001754.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, 2 motion segments, not 5001.12.2023being a service associated with a service to which item 51020, 51021, 51023, 5001.12.202351024, 51025 or 51026 applies (Anaes.) (Assist.) 1051023 01.11.2018 3 T8 17 SN NYNNY 2001.12.202306035.0002087.6500000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, 3 or 4 motion segments, 5001.12.2023not being a service associated with a service to which item 51020, 51021, 5001.12.202351022, 51024, 51025 or 51026 applies (Anaes.) (Assist.) 1051024 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307245.0002410.1000000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, 5 or 6 motion segments, 5001.12.2023not being a service associated with a service to which item 51020, 51021, 5001.12.202351022, 51023, 51025 or 51026 applies (Anaes.) (Assist.) 1051025 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307766.0002816.9000000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, 7 to 12 motion segments, 5001.12.2023not being a service associated with a service to which item 51020, 51021, 5001.12.202351022, 51023, 51024 or 51026 applies (Anaes.) (Assist.) 1051026 01.11.2018 3 T8 17 SN NYNNY 2001.12.202309090.0003084.1000000.00 4001.11.2018(Anaes.) 5001.12.2023Fixation of motion segment with vertebral body screw, pedicle screw or hook 5001.12.2023instrumentation including sublaminar tapes or wires, more than 12 motion 5001.12.2023segments, not being a service associated with a service to which item 51020, 5001.12.202351021, 51022, 51023, 51024 or 51025 applies (Anaes.) (Assist.) 1051031 01.11.2018 3 T8 17 SN NYNNY 2001.12.202303340.0001036.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, one motion segment, not 5001.12.2023being a service associated with a service to which item 51032, 51033, 51034, 5001.12.202351035 or 51036 applies (Anaes.) (Assist.) 1051032 01.11.2018 3 T8 17 SN NYNNY 2001.12.202304005.0001243.5500000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, 2 motion segments, not 5001.12.2023being a service associated with a service to which item 51031, 51033, 51034, 5001.12.202351035 or 51036 applies (Anaes.) (Assist.) 1051033 01.11.2018 3 T8 17 SN NYNNY 2001.12.202304675.0001450.8000000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, 3 motion segments, not 5001.12.2023being a service associated with a service to which item 51031, 51032, 51034, 5001.12.202351035 or 51036 applies (Anaes.) (Assist.) 1051034 01.11.2018 3 T8 17 SN NYNNY 2001.12.202305010.0001554.4000000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, 4 to 7 motion segments, 5001.12.2023not being a service associated with a service to which item 51031, 51032, 5001.12.202351033, 51035 or 51036 applies (Anaes.) (Assist.) 1051035 01.11.2018 3 T8 17 SN NYNNY 2001.12.202305345.0001658.0500000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, 8 to 11 motion segments, 5001.12.2023not being a service associated with a service to which item 51031, 51032, 5001.12.202351033, 51034 or 51036 applies (Anaes.) (Assist.) 1051036 01.11.2018 3 T8 17 SN NYNNY 2001.12.202305675.0001761.6500000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, posterior and/or posterolateral bone graft to, 12 or more motion 5001.12.2023segments, not being a service associated with a service to which item 51031, 5001.12.202351032, 51033, 51034 or 51035 applies (Anaes.) (Assist.) 1051041 01.11.2018 3 T8 17 SN NYNNY 2001.12.202303840.0001191.7000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior column (anterior, direct lateral or posterior 5001.12.2023interbody), one motion segment, not being a service associated with a service 5001.12.2023to which item 51042, 51043, 51044 or 51045 applies (Anaes.) (Assist.) 1051042 01.11.2018 3 T8 17 SN NYNNY 2001.12.202305375.0001668.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior column (anterior, direct lateral or posterior 5001.12.2023interbody), 2 motion segments, not being a service associated with a service 5001.12.2023to which item 51041, 51043, 51044 or 51045 applies (Anaes.) (Assist.) 1051043 01.11.2018 3 T8 17 SN NYNNY 2001.12.202306725.0002085.6000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior column (anterior, direct lateral or posterior 5001.12.2023interbody), 3 motion segments, not being a service associated with a service 5001.12.2023to which item 51041, 51042, 51044 or 51045 applies (Anaes.) (Assist.) 1051044 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307300.0002264.3000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior column (anterior, direct lateral or posterior 5001.12.2023interbody), 4 motion segments, not being a service associated with a service 5001.12.2023to which item 51041, 51042, 51043 or 51045 applies (Anaes.) (Assist.) 1051045 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307685.0002383.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior column (anterior, direct lateral or posterior 5001.12.2023interbody), 5 or more motion segments, not being a service associated with a 5001.12.2023service to which item 51041, 51042, 51043 or 51044 applies (Anaes.) (Assist.) 1051051 01.11.2018 3 T8 17 SN NYNYY 2001.12.202308620.0002036.3000000.00 4001.11.2018(Anaes.) 5001.12.2023Pedicle subtraction osteotomy, one vertebra, not being a service associated 5001.12.2023with a service to which item 51052, 51053, 51054, 51055, 51056, 51057, 51058 5001.12.2023or 51059 applies (Anaes.) (Assist.) 1051052 01.11.2018 3 T8 17 SN NYNYY 2001.12.202310485.0002476.6000000.00 4001.11.2018(Anaes.) 5001.12.2023Pedicle subtraction osteotomy, 2 vertebrae, not being a service associated 5001.12.2023with a service to which item 51051, 51053, 51054, 51055, 51056, 51057, 51058 5001.12.2023or 51059 applies (Anaes.) (Assist.) 1051053 01.11.2018 3 T8 17 SN NYNYY 2001.12.202311930.0002817.7500000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral column resection osteotomy performed through single posterior 5001.12.2023approach, one vertebra, not being a service associated with a service to which 5001.12.2023item 51051, 51052, 51054, 51055, 51056, 51057, 51058 or 51059 applies (Anaes.) 5001.12.2023(Assist.) 1051054 01.11.2018 3 T8 17 SN NYNYY 2001.12.202306360.0001502.4000000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal 5001.12.2023excision is defined as removal of more than 50% of the vertebral body), one 5001.12.2023vertebra, not being a service associated with: (a) anterior column fusion when 5001.12.2023at the same motion segment; or (b) a service to which item 51051, 51052, 5001.12.202351053, 51055, 51056, 51057, 51058 or 51059 applies (Anaes.) (Assist.) 1051055 01.11.2018 3 T8 17 SN NYNYY 2001.12.202309540.0002253.6500000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal 5001.12.2023excision is defined as removal of more than 50% of the vertebral body), 2 5001.12.2023vertebrae, not being a service associated with: (a) anterior column fusion 5001.12.2023when at the same motion segment; or (b) a service to which item 51051, 51052, 5001.12.202351053, 51054, 51056, 51057, 51058 or 51059 applies (Anaes.) (Assist.) 1051056 01.11.2018 3 T8 17 SN NYNYY 2001.12.202311135.0002629.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal 5001.12.2023excision is defined as removal of more than 50% of the vertebral body), 3 or 5001.12.2023more vertebrae, not being a service associated with: (a) anterior column 5001.12.2023fusion when at the same motion segment; or (b) a service to which item 51051, 5001.12.202351052, 51053, 51054, 51055, 51057, 51058 or 51059 applies (Anaes.) (Assist.) 1051057 01.11.2018 3 T8 17 SN NYNYY 2001.12.202307345.0002641.7000000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, en bloc excision of (complete spondylectomy), one vertebra, 5001.12.2023not being a service associated with: (a) anterior column fusion when at the 5001.12.2023same motion segment; or (b) a service to which item 51051, 51052, 51053, 5001.12.202351054, 51055, 51056, 51058 or 51059 applies (Anaes.) (Assist.) 1051058 01.11.2018 3 T8 17 SN NYNYY 2001.12.202308270.0002972.4000000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, en bloc excision of (complete spondylectomy), 2 vertebrae, not 5001.12.2023being a service associated with: (a) anterior column fusion when at the same 5001.12.2023motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 5001.12.202351055, 51056, 51057 or 51059 applies (Anaes.) (Assist.) 1051059 01.11.2018 3 T8 17 SN NYNYY 2001.12.202310100.0003632.3500000.00 4001.11.2018(Anaes.) 5001.12.2023Vertebral body, en bloc excision of (complete spondylectomy), 3 or more 5001.12.2023vertebrae, not being a service associated with: (a) anterior column fusion 5001.12.2023when at the same motion segment; or (b) a service to which item 51051, 51052, 5001.12.202351053, 51054, 51055, 51056, 51057 or 51058 applies (Anaes.) (Assist.) 1051061 01.11.2018 3 T8 17 SN NYNNY 2001.12.202309585.0003120.1000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at one 5001.12.2023motion segment, posterior and/or posterolateral bone graft, and anterior 5001.12.2023column fusion, not being a service associated with a service to which item 5001.12.202351062, 51063, 51064, 51065 or 51066 applies (Anaes.) (Assist.) 1051062 01.11.2018 3 T8 17 SN NYNNY 2001.12.202312455.0004044.3500000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at 2 5001.12.2023motion segments, posterior and/or posterolateral bone graft, and anterior 5001.12.2023column fusion, not being a service associated with a service to which item 5001.12.202351061, 51063, 51064, 51065 or 51066 applies (Anaes.) (Assist.) 1051063 01.11.2018 3 T8 17 SN NYNNY 2001.12.202315095.0004898.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at 3 5001.12.2023motion segments, posterior and/or posterolateral bone graft, and anterior 5001.12.2023column fusion, not being a service associated with a service to which item 5001.12.202351061, 51062, 51064, 51065 or 51066 applies (Anaes.) (Assist.) 1051064 01.11.2018 3 T8 17 SN NYNNY 2001.12.202317435.0005451.6000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at 4 5001.12.2023to 7 motion segments, posterior and/or posterolateral bone graft, and anterior 5001.12.2023column fusion, not being a service associated with a service to which item 5001.12.202351061, 51062, 51063, 51065 or 51066 applies (Anaes.) (Assist.) 1051065 01.11.2018 3 T8 17 SN NYNNY 2001.12.202318825.0006029.5000000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at 8 5001.12.2023to 11 motion segments, posterior and/or posterolateral bone graft, and 5001.12.2023anterior column fusion, not being a service associated with a service to which 5001.12.2023item 51061, 51062, 51063, 51064 or 51066 applies (Anaes.) (Assist.) 1051066 01.11.2018 3 T8 17 SN NYNNY 2001.12.202319615.0006348.3500000.00 4001.11.2018(Anaes.) 5001.12.2023Spinal fusion, anterior and posterior, including spinal instrumentation at 12 5001.12.2023or more motion segments, posterior and/or posterolateral bone graft, and 5001.12.2023anterior column fusion not being a service associated with a service to which 5001.12.2023item 51061, 51062, 51063, 51064 or 51065 applies (Anaes.) (Assist.) 1051071 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307655.0002751.7500000.00 4001.11.2018(Anaes.) 5001.12.2023Removal of intradural lesion, or primary extradural tumour or lesion, where 5001.12.2023the pathology is confirmed by histology - not including removal of synovial or 5001.12.2023juxtafacet cyst and not being a service associated with a service to which 5001.12.2023item 51072 or 51073 applies (H) (Anaes.) (Assist.) 1051072 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307960.0002861.8500000.00 4001.11.2018(Anaes.) 5001.12.2023Craniocervical junction lesion, transoral approach for, not being a service 5001.12.2023associated with a service to which item 51071 or 51073 applies (Anaes.) 5001.12.2023(Assist.) 1051073 01.11.2018 3 T8 17 SN NYNNY 2001.12.202310100.0003632.3500000.00 4001.11.2018(Anaes.) 5001.12.2023Removal of intramedullary tumour or arteriovenous malformation, not being a 5001.12.2023service associated with a service to which item 51071 or 51072 applies 5001.12.2023(Anaes.) (Assist.) 1051102 01.11.2018 3 T8 17 SN NYNNY 2001.12.202303700.0001302.6500000.00 4001.11.2018(Anaes.) 5001.12.2023Thoracoplasty in combination with thoracic scoliosis correction3 or more ribs 5001.12.2023(Anaes.) (Assist.) 1051103 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307570.0002289.2000000.00 4001.11.2018(Anaes.) 5001.12.2023Odontoid screw fixation (Anaes.) (Assist.) 1051110 01.11.2018 3 T8 17 SN NYNNY 2001.12.202302670.0000829.1000000.00 4001.11.2018(Anaes.) 5001.12.2023Spine, treatment of fracture, dislocation or fracture dislocation, with 5001.12.2023immobilisation by calipers or halo, not including application of skull tongs 5001.12.2023or calipers as part of operative positioning (Anaes.) 1051111 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301135.0000352.4000000.00 4001.11.2018(Anaes.) 5001.12.2023Skull calipers or halo, insertion of, as an independent procedure (Anaes.) 1051112 01.11.2018 3 T8 17 SN NYNNY 2001.12.202300770.0000238.3000000.00 4001.11.2018(Anaes.) 5001.12.2023Plaster jacket, application of, as an independent procedure (Anaes.) 1051113 01.11.2018 3 T8 17 SN NYNNY 2001.12.202300850.0000264.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Halo, application of, in addition to spinal fusion for scoliosis, or other 5001.12.2023conditions (Anaes.) 1051114 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301505.0000466.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Halo thoracic orthosisapplication of both halo and thoracic jacket (Anaes.) 1051115 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301505.0000466.4500000.00 4001.11.2018(Anaes.) 5001.12.2023Halo femoral traction, as an independent procedure (Anaes.) 1051120 01.11.2018 3 T8 17 SN NYNNY 2001.12.202300835.0000259.2000000.00 4001.11.2018(Anaes.) 5001.12.2023Bone graft, harvesting of autogenous graft, via separate incision or via 5001.12.2023subcutaneous approach, in conjunction with spinal fusion, other than for the 5001.12.2023purposes of bone graft obtained from the cervical, thoracic, lumbar or sacral 5001.12.2023spine (Anaes.) 1051130 01.11.2018 3 T8 17 SN NYNYY 2001.12.202306540.0001974.2500000.00 4001.11.2018(Anaes.) 5001.12.2023Lumbar artificial intervertebral total disc replacement, at one motion segment 5001.12.2023only, including removal of disc and marginal osteophytes: (a) for a patient 5001.12.2023who: (i) has not had prior spinal fusion surgery at the same lumbar level; and 5001.12.2023(ii) does not have vertebral osteoporosis; and (iii) has failed conservative 5001.12.2023therapy; and (b) not being a service associated with a service to which item 5001.12.202351011, 51012, 51013, 51014 or 51015 applies (Anaes.) (Assist.) 1051131 01.11.2018 3 T8 17 SN NYNNY 2001.12.202306540.0001191.7000000.00 4001.11.2018(Anaes.) 5001.12.2023Cervical artificial intervertebral total disc replacement, at one motion 5001.12.2023segment only, including removal of disc and marginal osteophytes, for a 5001.12.2023patient who: (a) has not had prior spinal surgery at the same cervical level; 5001.12.2023and (b) is skeletally mature; and (c) has symptomatic degenerative disc 5001.12.2023disease with radiculopathy; and (d) does not have vertebral osteoporosis; and 5001.12.2023(e) has failed conservative therapy (Anaes.) (Assist.) 1051140 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301570.0000487.0000000.00 4001.11.2018(Anaes.) 5001.12.2023Previous spinal fusion, re-exploration for, involving adjustment or removal of 5001.12.2023instrumentation up to 3 motion segments, not being a service associated with a 5001.12.2023service to which item 51141 applies (Anaes.) (Assist.) 1051141 01.11.2018 3 T8 17 SN NYNNY 2001.12.202302905.0000901.0000000.00 4001.11.2018(Anaes.) 5001.12.2023Previous spinal fusion, re-exploration for, involving adjustment or removal of 5001.12.2023instrumentation more than 3 motion segments, not being a service associated 5001.12.2023with a service to which item 51140 applies (Anaes.) (Assist.) 1051145 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301035.0000487.0000000.00 4001.11.2018(Anaes.) 5001.12.2023Wound debridement or excision for post operative infection or haematoma 5001.12.2023following spinal surgery (Anaes.) (Assist.) 1051150 01.11.2018 3 T8 17 SN NYNNY 2001.12.202301260.0000490.3000000.00 4001.11.2018(Anaes.) 5001.12.2023Coccyx, excision of (Anaes.) (Assist.) 1051160 01.11.2018 3 T8 17 SN NYNNY 2001.12.202303595.0001265.8000000.00 4001.11.2018(Anaes.) 5001.12.2023Anterior exposure of thoracic or lumbar spine, one motion segment, not being a 5001.12.2023service to which item 51165 applies (Anaes.) (Assist.) 1051165 01.11.2018 3 T8 17 SN NYNNY 2001.12.202304535.0001596.0500000.00 4001.11.2018(Anaes.) 5001.12.2023Anterior exposure of thoracic or lumbar spine, more than one motion segment, 5001.12.2023not being a service to which item 51160 applies (Anaes.) (Assist.) 1051170 01.11.2018 3 T8 17 SN NYNNY 2001.12.202307955.0002404.6000000.00 4001.11.2018(Anaes.) 5001.12.2023Syringomyelia or hydromyelia, craniotomy for, with or without duraplasty, 5001.12.2023intradural dissection, plugging of obex or local cerebrospinal fluid shunt 5001.12.2023(Anaes.) (Assist.) 1051171 01.11.2018 3 T8 17 SN NYNNY 2001.12.202303345.0001009.7500000.00 4001.11.2018(Anaes.) 5001.12.2023Syringomyelia or hydromyelia, treatment by direct cerebrospinal fluid shunt 5001.12.2023(for example, syringosubarachnoid shunt, syringopleural shunt or 5001.12.2023syringoperitoneal shunt) (Anaes.) (Assist.) 1051300 26.05.2002 3 T9 SN NYNYY 2001.12.202300275.0000095.0000000.00 5001.12.2023Assistance at any operation mentioned in an item in Group T8 that includes 5001.12.2023(Assist.) for which the fee does not exceed $614.55 or at a series or 5001.12.2023combination of operations mentioned in an item in Group T8 that include 5001.12.2023(Assist.) for which the aggregate fee does not exceed $614.55 1051303 26.05.2002 3 T9 SD NYNYY 3001.12.2023one fifth of the established fee for the operation or combination of 3001.12.2023operations 5001.12.2023Assistance at any operation mentioned in an item in Group T8 that includes 5001.12.2023(Assist.) for which the fee exceeds $614.55 or at a series or combination of 5001.12.2023operations mentioned in an item in Group T8 that include (Assist.) for which 5001.12.2023the aggregate fee exceeds $614.55 1051309 26.05.2002 3 T9 SD NNNNY 3001.12.2023one fifth of the established fee for the operation or combination of 3001.12.2023operations (the fee for item 16520 being the Schedule fee for the Caesarean 3001.12.2023section component in the calculation of the established fee) 5001.12.2023Assistance at a series or combination of operations that include (Assist.) and 5001.12.2023assistance at a birth involving Caesarean section 1051312 26.05.2002 3 T9 SD NNNNY 3001.12.2023one fifth of the established fee for the procedure or combination of 3001.12.2023procedures 5001.12.2023Assistance at any interventional obstetric procedure covered by items 16606, 5001.12.202316609, 16612, 16615 and 16627 1051315 26.05.2002 3 T9 SN NYNNY 2001.12.202300827.0000299.8500000.00 5001.12.2023Assistance at cataract and intraocular lens surgery covered by item 42698, 5001.12.202342701, 42702, 42704 or 42707, when performed in association with services 5001.12.2023covered by item 42551 to 42569, 42653, 42656, 42725, 42746, 42749, 42752, 5001.12.202342776 or 42779 1051318 26.05.2002 3 T9 SN NYNNY 2001.12.202300546.0000197.9000000.00 5001.12.2023Assistance at cataract and intraocular lens surgery where patient has: -total 5001.12.2023loss of vision, including no potential for central vision, in the fellow eye; 5001.12.2023or -previous significant surgical complication in the fellow eye; or -pseudo 5001.12.2023exfoliation, subluxed lens, iridodonesis, phacodonesis, retinal detachment, 5001.12.2023corneal scarring, pre-existing uveitis, bound down miosed pupil, 5001.12.2023nanophthalmos, spherophakia, Marfan's syndrome, homocysteinuria or previous 5001.12.2023blunt trauma causing intraocular damage 1051700 26.05.2002 4 O1 SN NYNNY 2001.12.202300205.0000094.1000000.00 5001.12.2023APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR 5001.12.2023RESIDENTIAL AGED CARE FACILITY Professional attendance (other than a second or 5001.12.2023subsequent attendance in a single course of treatment) by an approved dental 5001.12.2023practitioner, at consulting rooms, hospital or residential aged care facility 5001.12.2023where the patient is referred to him or her 1051703 26.05.2002 4 O1 SN NYNNY 2001.12.202300110.0000047.3500000.00 5001.12.2023Professional attendance by an approved dental practitioner, each attendance 5001.12.2023subsequent to the first in a single course of treatment at consulting rooms, 5001.12.2023hospital or residential aged care facility where the patient is referred to 5001.12.2023him or her 1051800 26.05.2002 4 O2 SN NYNYY 2001.12.202300275.0000095.0000000.00 5001.12.2023Assistance by an approved dental practitioner in the practice of oral and 5001.12.2023maxillofacial surgery at any operation mentioned in an item that includes 5001.12.2023(Assist.) for which the fee does not exceed $614.55 or at a series or 5001.12.2023combination of operations mentioned in an item in Groups O3 to O9 that include 5001.12.2023(Assist.) for which the aggregate fee does not exceed $614.55 1051803 26.05.2002 4 O2 SD NYNYY 3001.12.2023one fifth of the established fee for the operation or combination of 3001.12.2023operations 5001.12.2023Assistance by an approved dental practitioner in the practice of oral and 5001.12.2023maxillofacial surgery at any operation mentioned in an item that includes 5001.12.2023(Assist.) for which the fee exceeds $614.55 or at a series or combination of 5001.12.2023operations mentioned in an item that include (Assist.) if the aggregate fee 5001.12.2023exceeds $614.55 1051900 26.05.2002 4 O3 SN NYNNY 2001.12.202301035.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023WOUND OF SOFT TISSUE, deep or extensively contaminated, debridement of, under 5001.12.2023general anaesthesia or regional or field nerve block, including suturing of 5001.12.2023that wound when performed (Anaes.) (Assist.) 1051902 26.05.2002 4 O3 SN NYNNY 2001.12.202300210.0000081.4000000.00 4026.05.2002(Anaes.) 5001.12.2023WOUNDS, DRESSING OF, under general anaesthesia, with or without removal of 5001.12.2023sutures, not being a service associated with a service to which another item 5001.12.2023in Groups O3 to O9 applies (Anaes.) 1051904 26.05.2002 4 O3 SN NYNNY 2001.12.202301320.0000500.6500000.00 4026.05.2002(Anaes.) 5001.12.2023LIPECTOMY - wedge excision of skin or fat - 1 EXCISION (Anaes.) (Assist.) 1051906 26.05.2002 4 O3 SN NYNNY 2001.12.202301980.0000761.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LIPECTOMY- wedge excision of skin or fat - 2 OR MORE EXCISIONS (Anaes.) 5001.12.2023(Assist.) 1052000 26.05.2002 4 O3 SN NYNNY 2001.12.202300235.0000090.7500000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on 5001.12.2023face or neck, small (NOT MORE THAN 7 CM LONG), superficial (Anaes.) 1052003 26.05.2002 4 O3 SN NYNNY 2001.12.202300355.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on 5001.12.2023face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue 5001.12.2023(Anaes.) 1052006 26.05.2002 4 O3 SN NYNNY 2001.12.202300355.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on 5001.12.2023face or neck, large (MORE THAN 7 CM LONG), superficial (Anaes.) 1052009 26.05.2002 4 O3 SN NYNNY 2001.12.202300605.0000204.2500000.00 4026.05.2002(Anaes.) 5001.12.2023SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on 5001.12.2023face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue (Anaes.) 1052010 26.05.2002 4 O3 SN NYNNY 2001.12.202300825.0000279.5500000.00 4026.05.2002(Anaes.) 5001.12.2023FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with 5001.12.2023accurate apposition of each layer of tissue (Anaes.) (Assist.) 1052012 26.05.2002 4 O3 SN NYNNY 2001.12.202300071.0000025.9000000.00 4026.05.2002(Anaes.) 5001.12.2023SUPERFICIAL FOREIGN BODY,removal of, as an independent procedure (Anaes.) 1052015 26.05.2002 4 O3 SN NYNNY 2001.12.202300320.0000120.9500000.00 4026.05.2002(Anaes.) 5001.12.2023SUBCUTANEOUS FOREIGN BODY,removal of, requiring incision and suture, as an 5001.12.2023independent procedure (Anaes.) 1052018 26.05.2002 4 O3 SN NYNNY 2001.12.202300890.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE,removal of, as an 5001.12.2023independent procedure (Anaes.) (Assist.) 1052021 26.05.2002 4 O3 SN NYNNY 2001.12.202300102.0000032.3500000.00 4026.05.2002(Anaes.) 5001.12.2023ASPIRATION BIOPSY of 1 or MORE JAW CYSTS as an independent procedure to obtain 5001.12.2023material for diagnostic purposes and not being a service associated with an 5001.12.2023operative procedure on the same day (Anaes.) 1052024 26.05.2002 4 O3 SN NYNNY 2001.12.202300220.0000057.5000000.00 4026.05.2002(Anaes.) 5001.12.2023BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure (Anaes.) 1052025 26.05.2002 4 O3 SN NYNNN 2001.12.202300550.0000202.4000000.00 4026.05.2002(Anaes.) 5001.12.2023LYMPH NODE OF NECK, biopsy of (Anaes.) 1052027 26.05.2002 4 O3 SN NYNNY 2001.12.202300565.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent 5001.12.2023procedure and not being a service to which item 52025 applies (Anaes.) 1052030 26.05.2002 4 O3 SN NYNNY 2001.12.202300265.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023SINUS, excision of, involving superficial tissue only (Anaes.) 1052033 26.05.2002 4 O3 SN NYNNY 2001.12.202300600.0000202.4000000.00 4026.05.2002(Anaes.) 5001.12.2023SINUS, excision of, involving muscle and deep tissue (Anaes.) 1052034 26.05.2002 4 O3 SN NYNNY 2001.12.202300118.0000047.3500000.00 5001.12.2023PREMALIGNANT LESIONS of the oral mucous, treatment by cryotherapy, diathermy 5001.12.2023or carbon dioxide laser 1052035 26.05.2002 4 O3 SN NYNNY 2001.12.202301535.0000524.0000000.00 4026.05.2002(Anaes.) 5001.12.2023ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions of the oral 5001.12.2023cavity (Anaes.) 1052036 26.05.2002 4 O3 SN NYNNY 2001.12.202300435.0000139.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical 5001.12.2023approach at an operation), up to 3 cm in diameter, removal from cutaneous or 5001.12.2023subcutaneous tissue or from mucous membrane, where the removal is by surgical 5001.12.2023excision and suture, not being a service to which item 52039 applies (Anaes.) 1052039 26.05.2002 4 O3 SN NYNNY 2001.12.202301125.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the 5001.12.2023surgical approach at an operation), up to 3 cm in diameter, removal from 5001.12.2023cutaneous or subcutaneous tissue or from mucous membrane, where the removal is 5001.12.2023by surgical excision and suture, and the procedure is performed on more than 3 5001.12.2023but not more than 10 lesions (Anaes.) (Assist.) 1052042 26.05.2002 4 O3 SN NYNNY 2001.12.202300595.0000189.8500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical 5001.12.2023approach at an operation), more than 3 cm in diameter, removal from cutaneous 5001.12.2023or subcutaneous tissue or from mucous membrane (Anaes.) 1052045 26.05.2002 4 O3 SN NYNNY 2001.12.202300850.0000271.3500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment 5001.12.2023unless it has been established by radiological examination that there is a 5001.12.2023minimum of 5mm separation between the cyst lining and tooth structure or where 5001.12.2023a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR 5001.12.2023(other than a scar removed during the surgical approach at an operation), 5001.12.2023removal of, not being a service to which another item in Groups O3 to O9 5001.12.2023applies, involving muscle, bone, or other deep tissue (Anaes.) 1052048 26.05.2002 4 O3 SN NYNNY 2001.12.202301280.0000408.9500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth 5001.12.2023fragment unless it has been established by radiological examination that there 5001.12.2023is a minimum of 5mm separation between the cyst lining and tooth structure or 5001.12.2023where a tumour or cyst has been proven by positive histopathology), removal 5001.12.2023of, requiring wide excision, not being a service to which another item in 5001.12.2023Groups O3 to O9 applies (Anaes.) (Assist.) 1052051 26.05.2002 4 O3 SN NYNNY 2001.12.202301730.0000552.8000000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, removal of, from soft tissue (including muscle, fascia and connective 5001.12.2023tissue), extensive excision of, without skin or mucosal graft (Anaes.) 5001.12.2023(Assist.) 1052054 26.05.2002 4 O3 SN NYNNY 2001.12.202302025.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TUMOUR, removal of, from soft tissue (including muscle, fascia and connective 5001.12.2023tissue), extensive excision of, with skin or mucosal graft (Anaes.) (Assist.) 1052055 26.05.2002 4 O3 SN NYNNY 2001.12.202300074.0000030.1000000.00 5001.12.2023HAEMATOMA, SMALL ABSCESS OR CELLULITIS, not requiring admission to a hospital, 5001.12.2023INCISION WITH DRAINAGE OF (excluding after care) 1052056 26.05.2002 4 O3 SN NYNNY 2001.12.202300074.0000030.1000000.00 4026.05.2002(Anaes.) 5001.12.2023HAEMATOMA, aspiration of (Anaes.) 1052057 26.05.2002 4 O3 SN NYNNY 2001.12.202300480.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, 5001.12.2023requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding 5001.12.2023aftercare) (Anaes.) 1052058 26.05.2002 4 O3 SN NYNNY 2001.12.202300770.0000261.5000000.00 4026.05.2002(Anaes.) 5001.12.2023PERCUTANEOUS DRAINAGE OF DEEP ABSCESS, usinginterventional imaging techniques 5001.12.2023- but not including imaging (Anaes.) 1052059 26.05.2002 4 O3 SN NYNNY 2001.12.202300865.0000294.6500000.00 4026.05.2002(Anaes.) 5001.12.2023ABSCESS, DRAINAGE TUBE, exchange of using interventional imaging techniques - 5001.12.2023but not including imaging (Anaes.) 1052060 26.05.2002 4 O3 SN NYNNY 2001.12.202300490.0000208.5000000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, excision of (Anaes.) 1052061 26.05.2002 4 O3 SN NYNNY 2001.12.202300720.0000246.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, RUPTURED, repair of (limited), not associated with external wound 5001.12.2023(Anaes.) 1052062 26.05.2002 4 O3 SN NYNNY 2001.12.202300960.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023MUSCLE, RUPTURED, repair of (extensive), not associated with external wound 5001.12.2023(Anaes.) (Assist.) 1052063 26.05.2002 4 O3 SN NYNNY 2001.12.202301035.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023BONE TUMOUR, INNOCENT, excision of, not being a service to which another item 5001.12.2023in Groups O3 to O9 applies (Anaes.) (Assist.) 1052064 26.05.2002 4 O3 SN NYNNY 2001.12.202300635.0000186.5500000.00 4026.05.2002(Anaes.) 5001.12.2023BONE CYST, injection into or aspiration of (Anaes.) 1052066 26.05.2002 4 O3 SN NYNNY 2001.12.202301120.0000490.3000000.00 4026.05.2002(Anaes.) 5001.12.2023SUBMANDIBULAR GLAND, extirpation of (Anaes.) (Assist.) 1052069 26.05.2002 4 O3 SN NYNNY 2001.12.202300635.0000218.5500000.00 4026.05.2002(Anaes.) 5001.12.2023SUBLINGUAL GLAND, extirpation of (Anaes.) 1052072 26.05.2002 4 O3 SN NYNNY 2001.12.202300192.0000064.7500000.00 4026.05.2002(Anaes.) 5001.12.2023SALIVARY GLAND, DILATATION OR DIATHERMY of duct (Anaes.) 1052073 26.05.2002 4 O3 SN NYNNY 2001.12.202300490.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023SALIVARY GLAND, repair of CUTANEOUS FISTULA OF (Anaes.) 1052075 26.05.2002 4 O3 SN NYNNY 2001.12.202300480.0000164.8500000.00 4026.05.2002(Anaes.) 5001.12.2023SALIVARY GLAND, removal of CALCULUS from duct or meatotomy or 5001.12.2023marsupialisation, 1 or more such procedures (Anaes.) 1052078 26.05.2002 4 O3 SN NYNNY 2001.12.202300960.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023TONGUE, partial excision of (Anaes.) (Assist.) 1052081 26.05.2002 4 O3 SN NYNNY 2001.12.202300148.0000051.1500000.00 4026.05.2002(Anaes.) 5001.12.2023TONGUE TIE, division or excision of frenulum (Anaes.) 1052084 26.05.2002 4 O3 SN NYNNY 2001.12.202300375.0000131.5000000.00 4026.05.2002(Anaes.) 5001.12.2023TONGUE TIE, MANDIBULAR FRENULUM OR MAXILLARY FRENULUM, division or excision of 5001.12.2023frenulum, in a patient aged not less than 2 years (Anaes.) 1052087 26.05.2002 4 O3 SN NYNNY 2001.12.202300635.0000225.3000000.00 4026.05.2002(Anaes.) 5001.12.2023RANULA OR MUCOUS CYST OF MOUTH, removal of (Anaes.) 1052090 26.05.2002 4 O3 SN NYNNY 2001.12.202301010.0000392.2500000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for chronic 5001.12.2023osteomyelitis - 1 bone or in combination with adjoining bones (Anaes.) 5001.12.2023(Assist.) 1052092 26.05.2002 4 O3 SN NYNNY 2001.12.202301320.0000511.3500000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATION on SKULL for OSTEOMYELITIS (Anaes.) (Assist.) 1052094 26.05.2002 4 O3 SN NYNNN 2001.12.202301574.0000646.7000000.00 4026.05.2002(Anaes.) 5001.12.2023OPERATION ON ANY COMBINATION OF ADJOINING BONES, being bones referred to in 5001.12.2023item 52092 (Anaes.) (Assist.) 1052095 26.05.2002 4 O3 SN NYNNN 2001.12.202301250.0000419.2000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE GROWTH STIMULATOR, insertion of (Anaes.) (Assist.) 1052096 26.05.2002 4 O3 SN NYNNY 2001.12.202300425.0000124.2000000.00 4026.05.2002(Anaes.) 5001.12.2023ORTHOPAEDIC PIN OR WIRE, insertion of, into maxilla or mandible or zygoma, as 5001.12.2023an independent procedure (Anaes.) 1052097 26.05.2002 4 O3 SN NYNNN 2001.12.202300530.0000176.2000000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL FIXATION, removal of, in the operating theatre of a hospital (Anaes.) 1052098 26.05.2002 4 O3 SN NYNNY 2001.12.202300533.0000207.1500000.00 4026.05.2002(Anaes.) 5001.12.2023EXTERNAL FIXATION, removal of, in conjunction with operations involving 5001.12.2023internal fixation or bone grafting or both (Anaes.) 1052099 26.05.2002 4 O3 SN NYNNY 2001.12.202300142.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal 5001.12.2023fixation purposes into maxilla or mandible or zygoma, removal of, requiring 5001.12.2023anaesthesia, incision, dissection and suturing, per bone, not being a service 5001.12.2023associated with a service to which item 52102 or 52105 applies (Anaes.) 1052102 26.05.2002 4 O3 SN NYNNY 2001.12.202300530.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal 5001.12.2023fixation purposes into maxilla or mandible or zygoma, removal of, requiring 5001.12.2023anaesthesia, incision, dissection and suturing, where undertaken in the 5001.12.2023operating theatre of a hospital, per bone (Anaes.) 1052105 26.05.2002 4 O3 SN NYNNN 2001.12.202300875.0000290.1500000.00 4026.05.2002(Anaes.) 5001.12.2023PLATE, 1 or more of, and associated screw and wire which were inserted for 5001.12.2023internal fixation purposes into maxilla or mandible or zygoma, removal of, 5001.12.2023requiring anaesthesia, incision, dissection and suturing, per bone, not being 5001.12.2023a service associated with a service to which item 52099 or 52102 applies 5001.12.2023(Anaes.) (Assist.) 1052106 26.05.2002 4 O3 SN NYNNY 2001.12.202300375.0000119.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the 5001.12.2023maxilla or mandible, removal of, requiring general anaesthesia where 5001.12.2023undertaken in the operating theatre of a hospital (Anaes.) 1052108 26.05.2002 4 O3 SN NYNNY 2001.12.202301105.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023LIP, full thickness wedge excision of, with repair by direct sutures (Anaes.) 5001.12.2023(Assist.) 1052111 26.05.2002 4 O3 SN NYNNY 2001.12.202301100.0000358.9000000.00 4026.05.2002(Anaes.) 5001.12.2023VERMILIONECTOMY (Anaes.) (Assist.) 1052114 26.05.2002 4 O3 SN NYNNY 2001.12.202301870.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, segmental resection of, for tumours or cysts (Anaes.) 5001.12.2023(Assist.) 1052117 26.05.2002 4 O3 SN NYNNY 2001.12.202302265.0000769.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, including lower border, or MAXILLA, sub-total resection of (Anaes.) 5001.12.2023(Assist.) 1052120 26.05.2002 4 O3 SN NYNNY 2001.12.202302345.0000910.6500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, hemimandiblectomy of, including condylectomy where performed 5001.12.2023(Anaes.) (Assist.) 1052122 26.05.2002 4 O3 SN NYNNY 2001.12.202302505.0000910.6500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, hemi-mandibular reconstruction of, OR MAXILLA, reconstruction of, 5001.12.2023with BONE GRAFT, PLATE, TRAY OR ALLOPLAST, not being a service associated with 5001.12.2023a service to which item 52123 applies (Anaes.) (Assist.) 1052123 26.05.2002 4 O3 SN NYNNY 2001.12.202302185.0001030.9000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, total resection of both sides, including condylectomies where 5001.12.2023performed (Anaes.) (Assist.) 1052126 26.05.2002 4 O3 SN NYNNY 2001.12.202302770.0000991.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, total resection of (Anaes.) (Assist.) 1052129 26.05.2002 4 O3 SN NYNNY 2001.12.202303760.0001326.7500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, total resection of both maxillae (Anaes.) (Assist.) 1052130 26.05.2002 4 O3 SN NYNNN 2001.12.202301395.0000487.0000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE GRAFT, not being a service to which another item in Groups O3 to O9 5001.12.2023applies (Anaes.) (Assist.) 1052131 26.05.2002 4 O3 SN NYNNN 2001.12.202301930.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE GRAFT WITH INTERNAL FIXATION, not being a service to which an item in the 5001.12.2023range (a)51900 to 52186; or (b)52303 to 53460 applies (Anaes.) (Assist.) 1052132 26.05.2002 4 O3 SN NYNNY 2001.12.202300760.0000274.0500000.00 4026.05.2002(Anaes.) 5001.12.2023TRACHEOSTOMY (Anaes.) 1052133 26.05.2002 4 O3 SN NYNNY 2001.12.202300270.0000100.2000000.00 4026.05.2002(Anaes.) 5001.12.2023CRICOTHYROSTOMY by direct stab or Seldinger technique, using Minitrach or 5001.12.2023similar device (Anaes.) 1052135 26.05.2002 4 O3 SN NYNNY 2001.12.202300460.0000158.9000000.00 4026.05.2002(Anaes.) 5001.12.2023POST-OPERATIVE or POST-NASAL HAEMORRHAGE, or both, control of, where 5001.12.2023undertaken in the operating theatre of a hospital (Anaes.) 1052138 26.05.2002 4 O3 SN NYNNY 2001.12.202301220.0000493.7000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ARTERY, ligation of (Anaes.) (Assist.) 1052141 26.05.2002 4 O3 SN NYNNY 2001.12.202301180.0000488.4000000.00 4026.05.2002(Anaes.) 5001.12.2023FACIAL, MANDIBULAR or LINGUAL ARTERY or VEIN or ARTERY and VEIN, ligation of, 5001.12.2023not being a service to which item 52138 applies (Anaes.) (Assist.) 1052144 26.05.2002 4 O3 SN NYNNY 2001.12.202300875.0000455.2000000.00 4026.05.2002(Anaes.) 5001.12.2023FOREIGN BODY, deep, removal of using interventional imaging techniques 5001.12.2023(Anaes.) (Assist.) 1052147 26.05.2002 4 O3 SN NYNNY 2001.12.202301140.0000429.5500000.00 4026.05.2002(Anaes.) 5001.12.2023DUCT OF MAJOR SALIVARY GLAND, transposition of (Anaes.) (Assist.) 1052148 26.05.2002 4 O3 SN NYNNY 2001.12.202302280.0000759.3000000.00 4026.05.2002(Anaes.) 5001.12.2023PAROTID DUCT, repair of, using micro-surgical techniques (Anaes.) (Assist.) 1052158 26.05.2002 4 O3 SN NYNNY 2001.12.202303540.0001222.5000000.00 4026.05.2002(Anaes.) 5001.12.2023SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling (Anaes.) 5001.12.2023(Assist.) 1052180 26.05.2002 4 O3 SN NYNNY 2001.12.202300670.0000207.1500000.00 4026.05.2002(Anaes.) 5001.12.2023MALIGNANT DISEASE AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE 5001.12.2023TUMOUR, biopsy of (not including aftercare) (Anaes.) 1052182 26.05.2002 4 O3 SN NYNNY 2001.12.202301470.0000455.9500000.00 4026.05.2002(Anaes.) 5001.12.2023BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR, lesional or marginal excision of 5001.12.2023(Anaes.) (Assist.) 1052184 26.05.2002 4 O3 SN NYNNY 2001.12.202302170.0000673.6000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE TUMOUR, lesional or marginal excision of, combined with any 1 of: liquid 5001.12.2023nitrogen freezing, autograft, allograft or cementation (Anaes.) (Assist.) 1052186 26.05.2002 4 O3 SN NYNNY 2001.12.202302670.0000829.1000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE TUMOUR, lesional or marginal excision of, combined with any 2 or more of: 5001.12.2023liquid nitrogen freezing, autograft, allograft or cementation (Anaes.) 5001.12.2023(Assist.) 1052300 26.05.2002 4 O4 SN NYNNY 2001.12.202300935.0000313.0000000.00 4026.05.2002(Anaes.) 5001.12.2023SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with skin or 5001.12.2023mucosa (Anaes.) (Assist.) 1052303 26.05.2002 4 O4 SN NYNNY 2001.12.202301405.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with buccal pad 5001.12.2023of fat (Anaes.) (Assist.) 1052306 26.05.2002 4 O4 SN NYNNY 2001.12.202302085.0000663.2000000.00 4026.05.2002(Anaes.) 5001.12.2023SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, using temporalis 5001.12.2023muscle (Anaes.) (Assist.) 1052309 26.05.2002 4 O4 SN NYNNY 2001.12.202300700.0000225.3000000.00 4026.05.2002(Anaes.) 5001.12.2023FREE GRAFTING (mucosa or split skin) of a granulating area (Anaes.) 1052312 26.05.2002 4 O4 SN NYNNY 2001.12.202300935.0000313.0000000.00 4026.05.2002(Anaes.) 5001.12.2023FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect, including 5001.12.2023elective dissection (Anaes.) (Assist.) 1052315 26.05.2002 4 O4 SN NYNNY 2001.12.202301570.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin) (Anaes.) (Assist.) 1052318 26.05.2002 4 O4 SN NYNNN 2001.12.202300445.0000155.4000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE GRAFT, harvesting of, via separate incision, being a service associated 5001.12.2023with a service to which another item in Groups O3 to O9 applies - Autogenous - 5001.12.2023small quantity (Anaes.) 1052319 26.05.2002 4 O4 SN NYNNN 2001.12.202300740.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023BONE GRAFT, harvesting of, via separate incision, being a service associated 5001.12.2023with a service to which another item in Groups O3 to O9 applies - Autogenous - 5001.12.2023large quantity (Anaes.) 1052321 26.05.2002 4 O4 SN NYNNY 2001.12.202301595.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of, for CONTOUR RECONSTRUCTION of 5001.12.2023pathological deformity, not being a service associated with a service to which 5001.12.2023item 52624 applies (Anaes.) (Assist.) 1052324 26.05.2002 4 O4 SN NYNNY 2001.12.202301785.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023DIRECT FLAP REPAIR, using tongue, first stage (Anaes.) (Assist.) 1052327 26.05.2002 4 O4 SN NYNNY 2001.12.202300885.0000258.7500000.00 4026.05.2002(Anaes.) 5001.12.2023DIRECT FLAP REPAIR, using tongue, second stage (Anaes.) 1052330 26.05.2002 4 O4 SN NYNNY 2001.12.202302485.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023PALATAL DEFECT (oro-nasal fistula), plastic closure of, including services to 5001.12.2023which item 52300, 52303, 52306 or 52324 applies (Anaes.) (Assist.) 1052333 26.05.2002 4 O4 SN NYNNY 2001.12.202302340.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, primary repair (Anaes.) (Assist.) 1052336 26.05.2002 4 O4 SN NYNNY 2001.12.202301405.0000538.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, secondary repair, closure of fistula using local flaps (Anaes.) 5001.12.2023(Assist.) 1052337 26.05.2002 4 O4 SN NYNNY 2001.12.202303895.0001176.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ALVEOLAR CLEFT (congenital) unilateral, grafting of, including plastic closure 5001.12.2023of associated oro-nasal fistulae and ridge augmentation (Anaes.) (Assist.) 1052339 26.05.2002 4 O4 SN NYNNY 2001.12.202301770.0000612.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT PALATE, secondary repair, lengthening procedure (Anaes.) (Assist.) 1052342 26.05.2002 4 O4 SN NYNNY 2001.12.202302905.0001064.1500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including 5001.12.2023transposition of nerves and vessels and bone grafts taken from the same site 5001.12.2023(Anaes.) (Assist.) 1052345 26.05.2002 4 O4 SN NYNNY 2001.12.202303530.0001200.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including 5001.12.2023transposition of nerves and vessels and bone grafts taken from the same site 5001.12.2023and stabilisation with fixation by wires, screws, plates or pins, or any 5001.12.2023combination (Anaes.) (Assist.) 1052348 26.05.2002 4 O4 SN NYNNY 2001.12.202303705.0001356.1500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, bilateral osteotomy or osteectomy of, including 5001.12.2023transposition of nerves and vessels and bone grafts taken from the same site 5001.12.2023(Anaes.) (Assist.) 1052351 26.05.2002 4 O4 SN NYNNY 2001.12.202304480.0001523.0500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, bilateral osteotomy of osteectomy of, including 5001.12.2023transposition of nerves and vessels and bone grafts taken from the same site 5001.12.2023and stabilisation with fixation by wires, screws, plates or pins, or any 5001.12.2023combination (Anaes.) (Assist.) 1052354 26.05.2002 4 O4 SN NYNNY 2001.12.202304190.0001544.0000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such 5001.12.2023procedures on the 1 jaw, including transposition of nerves and vessels and 5001.12.2023bone grafts taken from the same site (Anaes.) (Assist.) 1052357 26.05.2002 4 O4 SN NYNNY 2001.12.202305115.0001738.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such 5001.12.2023procedures on the 1 jaw, including transposition of nerves and vessels and 5001.12.2023bone grafts taken from the same site and stabilisation with fixation by wires, 5001.12.2023screws, plates or pins, or any combination (Anaes.) (Assist.) 1052360 26.05.2002 4 O4 SN NYNNY 2001.12.202304840.0001773.2500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such 5001.12.2023procedures of each jaw, including transposition of nerves and vessels and bone 5001.12.2023grafts taken from the same site (Anaes.) (Assist.) 1052363 26.05.2002 4 O4 SN NYNNY 2001.12.202305870.0001994.8000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such 5001.12.2023procedures of each jaw, including transposition of nerves and vessels and bone 5001.12.2023grafts taken from the same site and stabilisation with fixation by wires, 5001.12.2023screws, plates or pins, or any combination (Anaes.) (Assist.) 1052366 26.05.2002 4 O4 SN NYNNY 2001.12.202305310.0001950.7500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, 5001.12.2023involving 3 or more such procedures of 1 jaw and 2 such procedures of the 5001.12.2023other jaw, including genioplasty when performed and transposition of nerves 5001.12.2023and vessels and bone grafts taken from the same site (Anaes.) (Assist.) 1052369 26.05.2002 4 O4 SN NYNNY 2001.12.202306455.0002193.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, 5001.12.2023involving 3 or more such procedures of 1 jaw and 2 such procedures of the 5001.12.2023other jaw, including genioplasty when performed and transposition of nerves 5001.12.2023and vessels and bone grafts taken from the same site and stabilisation with 5001.12.2023fixation by wires, screws, plates or pins, or any combination (Anaes.) 5001.12.2023(Assist.) 1052372 26.05.2002 4 O4 SN NYNNY 2001.12.202305810.0002128.3000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, 5001.12.2023involving 3 or more such procedures of each jaw, including genioplasty when 5001.12.2023performed and transposition of nerves and vessels and bone grafts taken from 5001.12.2023the same site (Anaes.) (Assist.) 1052375 26.05.2002 4 O4 SN NYNNY 2001.12.202307015.0002383.8000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, 5001.12.2023involving 3 or more such procedures of each jaw, including genioplasty when 5001.12.2023performed and transposition of nerves and vessels and bone grafts taken from 5001.12.2023the same site and stabilisation with fixation by wires, screws, plates or 5001.12.2023pins, or any combination (H) (Anaes.) (Assist.) 1052378 26.05.2002 4 O4 SN NYNNY 2001.12.202302235.0000824.0500000.00 4026.05.2002(Anaes.) 5001.12.2023GENIOPLASTY including transposition of nerves and vessels and bone grafts 5001.12.2023taken from the same site (Anaes.) (Assist.) 1052379 26.05.2002 4 O4 SN NYNNY 2001.12.202304225.0001408.2500000.00 4026.05.2002(Anaes.) 5001.12.2023FACE, contour reconstruction of 1 region, using autogenous bone or cartilage 5001.12.2023graft (Anaes.) (Assist.) 1052380 26.05.2002 4 O4 SN NYNNY 2001.12.202306955.0002397.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified 5001.12.2023Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of 5001.12.2023the midface including transposition of nerves and vessels and bone grafts 5001.12.2023taken from the same site (Anaes.) (Assist.) 1052382 26.05.2002 4 O4 SN NYNNY 2001.12.202308335.0002874.6500000.00 4026.05.2002(Anaes.) 5001.12.2023MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified 5001.12.2023Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of 5001.12.2023the midface including transposition of nerves and vessels and bone grafts 5001.12.2023taken from the same site and stabilisation with fixation by wires, screws, 5001.12.2023plates or pins, or any combination (Anaes.) (Assist.) 1052420 26.05.2002 4 O4 SN NYNNY 2001.12.202300835.0000265.4000000.00 5001.12.2023MANDIBLE, fixation by intermaxillary wiring, excluding wiring for obesity 1052424 26.05.2002 4 O4 SN NYNNY 2001.12.202301785.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) 5001.12.2023(Anaes.) (Assist.) 1052430 26.05.2002 4 O4 SN NYNNY 2001.12.202303525.0001200.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MICROVASCULAR REPAIR OF, using microsurgical techniques, with restoration of 5001.12.2023continuity of artery or vein of distal extremity or digit (Anaes.) (Assist.) 1052440 26.05.2002 4 O4 SN NYNNY 2001.12.202301920.0000595.8000000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, unilateral - primary repair, 1 stage, without anterior palate 5001.12.2023repair (Anaes.) (Assist.) 1052442 26.05.2002 4 O4 SN NYNNY 2001.12.202302190.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, unilateral - primary repair, 1 stage, with anterior palate repair 5001.12.2023(Anaes.) (Assist.) 1052444 26.05.2002 4 O4 SN NYNNY 2001.12.202302590.0000827.5500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, bilateral - primary repair, 1 stage, without anterior palate repair 5001.12.2023(Anaes.) (Assist.) 1052446 26.05.2002 4 O4 SN NYNNY 2001.12.202302875.0000976.9500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, bilateral - primary repair, 1 stage, with anterior palate repair 5001.12.2023(Anaes.) (Assist.) 1052450 26.05.2002 4 O4 SN NYNNY 2001.12.202300800.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, partial revision, including minor flap revision alignment and 5001.12.2023adjustment, including revision of minor whistle deformity if performed 5001.12.2023(Anaes.) 1052452 26.05.2002 4 O4 SN NYNNY 2001.12.202301520.0000538.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP, total revision, including major flap revision, muscle 5001.12.2023reconstruction and revision of major whistle deformity (Anaes.) (Assist.) 1052456 26.05.2002 4 O4 SN NYNNY 2001.12.202303405.0000910.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first 5001.12.2023stage (Anaes.) (Assist.) 1052458 26.05.2002 4 O4 SN NYNNY 2001.12.202300975.0000331.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second 5001.12.2023stage (Anaes.) 1052460 26.05.2002 4 O4 SN NYNNY 2001.12.202302216.0000860.6500000.00 4026.05.2002(Anaes.) 5001.12.2023VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for 5001.12.2023(Anaes.) 1052480 26.05.2002 4 O4 SN NYNNY 2001.12.202302270.0000552.8000000.00 4026.05.2002(Anaes.) 5001.12.2023COMPOSITE GRAFT (Chondro-cutaneous or chondro-mucosal) to nose, ear or eyelid 5001.12.2023(Anaes.) (Assist.) 1052482 26.05.2002 4 O4 SN NYNNY 2001.12.202301535.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MACROCHEILIA or macroglossia, operation for (Anaes.) (Assist.) 1052484 26.05.2002 4 O4 SN NYNNY 2001.12.202301830.0000633.2500000.00 4026.05.2002(Anaes.) 5001.12.2023MACROSTOMIA, operation for (Anaes.) (Assist.) 1052600 26.05.2002 4 O5 SN NYNNY 2001.12.202301165.0000372.4500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBULAR OR PALATAL EXOSTOSIS, excision of (Anaes.) (Assist.) 1052603 26.05.2002 4 O5 SN NYNNY 2001.12.202301115.0000355.9500000.00 4026.05.2002(Anaes.) 5001.12.2023MYLOHYOID RIDGE, reduction of (Anaes.) (Assist.) 1052606 26.05.2002 4 O5 SN NYNNY 2001.12.202300850.0000271.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY TUBEROSITY, reduction of (Anaes.) 1052609 26.05.2002 4 O5 SN NYNNY 2001.12.202301115.0000355.9500000.00 4026.05.2002(Anaes.) 5001.12.2023PAPILLARY HYPERPLASIA OF THE PALATE, removal of - less than 5 lesions (Anaes.) 5001.12.2023(Assist.) 1052612 26.05.2002 4 O5 SN NYNNY 2001.12.202301400.0000446.9000000.00 4026.05.2002(Anaes.) 5001.12.2023PAPILLARY HYPERPLASIA OF THE PALATE, removal of - 5 to 20 lesions (Anaes.) 5001.12.2023(Assist.) 1052615 26.05.2002 4 O5 SN NYNNY 2001.12.202301735.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023PAPILLARY HYPERPLASIA OF THE PALATE, removal of - more than 20 lesions 5001.12.2023(Anaes.) (Assist.) 1052618 26.05.2002 4 O5 SN NYNNY 2001.12.202302020.0000645.5500000.00 4026.05.2002(Anaes.) 5001.12.2023VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or 5001.12.2023mucosal graft when performed - unilateral or bilateral (Anaes.) (Assist.) 1052621 26.05.2002 4 O5 SN NYNNY 2001.12.202302020.0000645.5500000.00 4026.05.2002(Anaes.) 5001.12.2023FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision 5001.12.2023of muscle and skin or mucosal graft when performed - unilateral (Anaes.) 5001.12.2023(Assist.) 1052624 26.05.2002 4 O5 SN NYNNY 2001.12.202301630.0000521.4000000.00 4026.05.2002(Anaes.) 5001.12.2023ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral 5001.12.2023(Anaes.) (Assist.) 1052626 26.05.2002 4 O5 SN NYNNY 2001.12.202301000.0000319.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ALVEOLAR RIDGE AUGMENTATION - unilateral, insertion of tissue expanding device 5001.12.2023into maxillary or mandibular alveolar ridge region for (Anaes.) (Assist.) 1052627 26.05.2002 4 O5 SN NYNNY 2001.12.202301745.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial 5001.12.2023surgery, extra oral implantation of titanium fixture (Anaes.) (Assist.) 1052630 26.05.2002 4 O5 SN NYNNY 2001.12.202300650.0000205.3000000.00 4026.05.2002(Anaes.) 5001.12.2023OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial 5001.12.2023surgery, fixation of transcutaneous abutment (Anaes.) 1052633 26.05.2002 4 O5 SN NYNNY 2001.12.202301745.0000554.6500000.00 4026.05.2002(Anaes.) 5001.12.2023OSSEO-INTEGRATION PROCEDURE - intra-oral implantation of titanium fixture to 5001.12.2023facilitate restoration of the dentition following resection of part of the 5001.12.2023maxilla or mandible for benign or malignant tumours (Anaes.) 1052636 26.05.2002 4 O5 SN NYNNY 2001.12.202300650.0000205.3000000.00 4026.05.2002(Anaes.) 5001.12.2023OSSEO-INTEGRATION PROCEDURE - fixation of transmucosal abutment to fixtures 5001.12.2023placed following resection of part of the maxilla or mandible for benign or 5001.12.2023malignant tumours (Anaes.) 1052800 26.05.2002 4 O6 SN NYNNY 2001.12.202301020.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023NEUROLYSIS BY OPEN OPERATION, without transposition, not being a service 5001.12.2023associated with a service to which item 52803 applies (Anaes.) (Assist.) 1052803 26.05.2002 4 O6 SN NYNNY 2001.12.202301435.0000438.7000000.00 4026.05.2002(Anaes.) 5001.12.2023NERVE TRUNK, internal (interfascicular), NEUROLYSIS of, using microsurgical 5001.12.2023techniques (Anaes.) (Assist.) 1052806 26.05.2002 4 O6 SN NYNNY 2001.12.202301020.0000304.6500000.00 4026.05.2002(Anaes.) 5001.12.2023NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve 5001.12.2023(Anaes.) (Assist.) 1052809 26.05.2002 4 O6 SN NYNNY 2001.12.202301735.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve (Anaes.) 5001.12.2023(Assist.) 1052812 26.05.2002 4 O6 SN NYNNY 2001.12.202302455.0000744.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NERVE TRUNK, PRIMARY repair of, using microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1052815 26.05.2002 4 O6 SN NYNNY 2001.12.202302605.0000786.3500000.00 4026.05.2002(Anaes.) 5001.12.2023NERVE TRUNK, SECONDARY repair of, using microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1052818 26.05.2002 4 O6 SN NYNNY 2001.12.202301735.0000521.5000000.00 4026.05.2002(Anaes.) 5001.12.2023NERVE, TRANSPOSITION OF (Anaes.) (Assist.) 1052821 26.05.2002 4 O6 SN NYNNY 2001.12.202303755.0001133.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NERVE GRAFT TO NERVE TRUNK, (cable graft) including harvesting of nerve graft 5001.12.2023using microsurgical techniques (Anaes.) (Assist.) 1052824 26.05.2002 4 O6 SN NYNNY 2001.12.202301180.0000488.4000000.00 4026.05.2002(Anaes.) 5001.12.2023PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief 5001.12.2023(Anaes.) (Assist.) 1052826 26.05.2002 4 O6 SN NYNNY 2001.12.202300870.0000261.5000000.00 4026.05.2002(Anaes.) 5001.12.2023INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, 5001.12.2023phenol, or similar substance (Anaes.) 1052828 26.05.2002 4 O6 SN NYNNY 2001.12.202301150.0000389.0000000.00 4026.05.2002(Anaes.) 5001.12.2023CUTANEOUS NERVE,primary repair of, using microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1052830 26.05.2002 4 O6 SN NYNNY 2001.12.202301585.0000513.0500000.00 4026.05.2002(Anaes.) 5001.12.2023CUTANEOUS NERVE,secondary repair of, using microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1052832 26.05.2002 4 O6 SN NYNNY 2001.12.202302305.0000703.6500000.00 4026.05.2002(Anaes.) 5001.12.2023CUTANEOUS NERVE, nerve graft to, using microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1053000 26.05.2002 4 O7 SN NYNNY 2001.12.202300093.0000035.8500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF (Anaes.) 1053003 26.05.2002 4 O7 SN NYNNY 2001.12.202300290.0000101.1500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia 5001.12.2023(requiring admission to hospital) not being a service associated with a 5001.12.2023service to which another item in Groups O3 to O9 applies (Anaes.) 1053004 26.05.2002 4 O7 SN NYNNY 2001.12.202300084.0000039.2000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY ANTRUM, LAVAGE OF - each attendance at which the procedure is 5001.12.2023performed, including any associated consultation (Anaes.) 1053006 26.05.2002 4 O7 SN NYNNY 2001.12.202301478.0000573.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ANTROSTOMY (RADICAL) (Anaes.) (Assist.) 1053009 26.05.2002 4 O7 SN NYNNY 2001.12.202300838.0000325.4500000.00 4026.05.2002(Anaes.) 5001.12.2023ANTRUM, intranasal operation on, or removal of foreign body from (Anaes.) 5001.12.2023(Assist.) 1053012 26.05.2002 4 O7 SN NYNNY 2001.12.202300340.0000129.4000000.00 4026.05.2002(Anaes.) 5001.12.2023ANTRUM, drainage of, through tooth socket (Anaes.) 1053015 26.05.2002 4 O7 SN NYNNY 2001.12.202301715.0000646.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ORO-ANTRAL FISTULA, plastic closure of (Anaes.) (Assist.) 1053016 26.05.2002 4 O7 SN NYNNY 2001.12.202301370.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL SEPTUM, septoplasty, submucous resection or closure of septal 5001.12.2023perforation (Anaes.) (Assist.) 1053017 26.05.2002 4 O7 SN NYNNY 2001.12.202301709.0000663.6000000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL SEPTUM, reconstruction of (Anaes.) (Assist.) 1053019 26.05.2002 4 O7 SN NYNNY 2001.12.202302000.0000639.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLARY SINUS, BONE GRAFT to floor of maxillary sinus following elevation of 5001.12.2023mucosal lining (sinus lift procedure), (unilateral) (Anaes.) (Assist.) 1053052 26.05.2002 4 O7 SN NYNNY 2001.12.202300348.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023POST-NASAL SPACE, direct examination of, with or without biopsy (Anaes.) 1053054 26.05.2002 4 O7 SN NYNNY 2001.12.202300355.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX one or more 5001.12.2023of these procedures (Anaes.) 1053056 26.05.2002 4 O7 SN NYNNN 2001.12.202300220.0000079.2000000.00 4026.05.2002(Anaes.) 5001.12.2023EXAMINATION OF NASAL CAVITY or POST-NASAL SPACE, or NASAL CAVITY AND 5001.12.2023POST-NASAL SPACE, UNDER GENERAL ANAESTHESIA, not being a service associated 5001.12.2023with a service to which another item in this Group applies (Anaes.) 1053058 26.05.2002 4 O7 SN NYNNY 2001.12.202300385.0000135.1500000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or 5001.12.2023without cauterisation and with or without anterior pack (excluding aftercare) 5001.12.2023(Anaes.) 1053060 26.05.2002 4 O7 SN NYNNY 2001.12.202300380.0000110.6000000.00 4026.05.2002(Anaes.) 5001.12.2023CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical 5001.12.2023means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, 5001.12.2023TURBINATES FOR OBSTRUCTION OR HAEMORRHAGE SECONDARY TO SURGERY (OR TRAUMA) - 1 5001.12.2023or more of these procedures (including any consultation on the same occasion) 5001.12.2023not being a service associated with any other operation on the nose (Anaes.) 1053062 26.05.2002 4 O7 SN NYNNY 2001.12.202300290.0000099.1000000.00 4026.05.2002(Anaes.) 5001.12.2023POST SURGICAL NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by 5001.12.2023cauterisation or nasal cavity packing or both (Anaes.) 1053064 26.05.2002 4 O7 SN NYNNY 2001.12.202300462.0000179.3500000.00 4026.05.2002(Anaes.) 5001.12.2023CRYOTHERAPY TO NOSE in the treatment of nasal haemorrhage (Anaes.) 1053068 26.05.2002 4 O7 SN NYNNY 2001.12.202300387.0000150.2500000.00 4026.05.2002(Anaes.) 5001.12.2023TURBINECTOMY or TURBINECTOMIES, partial or total, unilateral (Anaes.) 1053070 26.05.2002 4 O7 SN NYNNY 2001.12.202300505.0000195.9500000.00 4026.05.2002(Anaes.) 5001.12.2023TURBINATES, submucous resection of, unilateral (Anaes.) 1053200 26.05.2002 4 O8 SN NYNNY 2001.12.202300166.0000077.8500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of a dislocation of, not requiring open reduction (Anaes.) 1053203 26.05.2002 4 O8 SN NYNNY 2001.12.202300330.0000130.6500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of a dislocation of, requiring open reduction (Anaes.) 1053206 26.05.2002 4 O8 SN NYNNY 2001.12.202300490.0000157.4500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre 5001.12.2023of a hospital, not being a service associated with a service to which another 5001.12.2023item in Groups O3 to O9 applies (Anaes.) 1053209 26.05.2002 4 O8 SN NYNNY 2001.12.202304940.0001815.2000000.00 4026.05.2002(Anaes.) 5001.12.2023GLENOID FOSSA, ZYGOMATIC ARCH and TEMPORAL BONE, reconstruction of (Obwegeser 5001.12.2023technique) (Anaes.) (Assist.) 1053212 26.05.2002 4 O8 SN NYNNY 2001.12.202302690.0000980.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ABSENT CONDYLE and ASCENDING RAMUS in hemifacial microsomia, construction of, 5001.12.2023not including harvesting of graft material (Anaes.) (Assist.) 1053215 26.05.2002 4 O8 SN NYNNY 2001.12.202301410.0000449.9000000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, arthroscopy of, with or without biopsy, not being a 5001.12.2023service associated with any other arthroscopic procedure of that joint 5001.12.2023(Anaes.) (Assist.) 1053218 26.05.2002 4 O8 SN NYNNY 2001.12.202302250.0000719.6500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, 5001.12.2023or treatment of adhesions - 1 or more such procedures (Anaes.) (Assist.) 1053220 26.05.2002 4 O8 SN NYNNY 2001.12.202301170.0000362.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, arthrotomy of, not being a service to which another 5001.12.2023item in this Group applies (Anaes.) (Assist.) 1053221 26.05.2002 4 O8 SN NYNNY 2001.12.202303005.0000960.1500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without 5001.12.2023microsurgical techniques (Anaes.) (Assist.) 1053224 26.05.2002 4 O8 SN NYNNY 2001.12.202303330.0001064.3500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, open surgical exploration of, with condylectomy or 5001.12.2023condylotomy, with or without microsurgical techniques (Anaes.) (Assist.) 1053225 26.05.2002 4 O8 SN NYNNY 2001.12.202301000.0000319.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 5001.12.2023cannuli into the appropriate joint space(s) (Anaes.) (Assist.) 1053226 26.05.2002 4 O8 SN NYNNY 2001.12.202301100.0000343.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, synovectomy of, not being a service to which another 5001.12.2023item in this Group applies (Anaes.) (Assist.) 1053227 26.05.2002 4 O8 SN NYNNY 2001.12.202304095.0001307.8500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without 5001.12.2023meniscus or capsular surgery, including meniscectomy when performed, with or 5001.12.2023without microsurgical techniques (Anaes.) (Assist.) 1053230 26.05.2002 4 O8 SN NYNNY 2001.12.202304610.0001473.2500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular 5001.12.2023and condylar head surgery, with or without microsurgical techniques (Anaes.) 5001.12.2023(Assist.) 1053233 26.05.2002 4 O8 SN NYNNY 2001.12.202305180.0001655.5000000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 5001.12.202353224, 53226, 53227 and 53230 apply and also involving the use of tissue 5001.12.2023flaps, or cartilage graft, or allograft implants, with or without 5001.12.2023microsurgical techniques (Anaes.) (Assist.) 1053236 26.05.2002 4 O8 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, stabilisation of, involving 1 or more of: repair of 5001.12.2023capsule, repair of ligament or internal fixation, not being a service to which 5001.12.2023another item in this Group applies (Anaes.) (Assist.) 1053239 26.05.2002 4 O8 SN NYNNY 2001.12.202301670.0000518.1000000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT, arthrodesis of, not being a service to which another 5001.12.2023item in this Group applies (Anaes.) (Assist.) 1053242 26.05.2002 4 O8 SN NYNNY 2001.12.202301100.0000343.7500000.00 4026.05.2002(Anaes.) 5001.12.2023TEMPOROMANDIBULAR JOINT OR JOINTS, application of external fixator to, other 5001.12.2023than for treatment of fractures (Anaes.) (Assist.) 1053400 26.05.2002 4 O9 SN NYNNY 2001.12.202300455.0000142.1500000.00 5001.12.2023MAXILLA, unilateral or bilateral, treatment of fracture of, not requiring 5001.12.2023splinting 1053403 26.05.2002 4 O9 SN NYNNY 2001.12.202300560.0000173.7500000.00 5001.12.2023MANDIBLE, treatment of fracture of, not requiring splinting 1053406 26.05.2002 4 O9 SN NYNNY 2001.12.202301440.0000447.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of fracture of, requiring splinting, wiring of teeth, 5001.12.2023circumosseous fixation or external fixation (Anaes.) (Assist.) 1053409 26.05.2002 4 O9 SN NYNNY 2001.12.202301440.0000447.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of fracture of, requiringsplinting, wiring of teeth, 5001.12.2023circumosseous fixation or external fixation (Anaes.) (Assist.) 1053410 26.05.2002 4 O9 SN NYNNY 2001.12.202300305.0000094.2500000.00 5001.12.2023ZYGOMATIC BONE, treatment of fracture of, not requiring surgical reduction 1053411 26.05.2002 4 O9 SN NYNNY 2001.12.202300845.0000262.8500000.00 4026.05.2002(Anaes.) 5001.12.2023ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction by a 5001.12.2023temporal, intra-oral or other approach (Anaes.) 1053412 26.05.2002 4 O9 SN NYNNY 2001.12.202301390.0000431.6000000.00 4026.05.2002(Anaes.) 5001.12.2023ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and 5001.12.2023involving internal or external fixation at 1 site (Anaes.) (Assist.) 1053413 26.05.2002 4 O9 SN NYNNY 2001.12.202301700.0000528.7500000.00 4026.05.2002(Anaes.) 5001.12.2023ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and 5001.12.2023involving internal or external fixation or both at 2 sites (Anaes.) (Assist.) 1053414 26.05.2002 4 O9 SN NYNNY 2001.12.202301955.0000607.4000000.00 4026.05.2002(Anaes.) 5001.12.2023ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and 5001.12.2023involving internal or external fixation or both at 3 sites (Anaes.) (Assist.) 1053415 26.05.2002 4 O9 SN NYNNY 2001.12.202301545.0000479.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of fracture of, requiring open reduction (Anaes.) (Assist.) 1053416 26.05.2002 4 O9 SN NYNNY 2001.12.202301545.0000479.5500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of fracture of, requiring open reduction (Anaes.) 5001.12.2023(Assist.) 1053418 26.05.2002 4 O9 SN NYNNY 2001.12.202302005.0000623.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation not involving plate(s) (Anaes.) (Assist.) 1053419 26.05.2002 4 O9 SN NYNNY 2001.12.202302005.0000623.4000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation not involving plate(s) (Anaes.) (Assist.) 1053422 26.05.2002 4 O9 SN NYNNY 2001.12.202302545.0000791.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation involving plate(s) (Anaes.) (Assist.) 1053423 26.05.2002 4 O9 SN NYNNY 2001.12.202302545.0000791.1000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of fracture of, requiring open reduction and internal 5001.12.2023fixation involving plate(s) (Anaes.) (Assist.) 1053424 26.05.2002 4 O9 SN NYNNY 2001.12.202302185.0000678.7000000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of a complicated fracture of, involving viscera, blood 5001.12.2023vessels or nerves, requiring open reduction not involving plate(s) (Anaes.) 5001.12.2023(Assist.) 1053425 26.05.2002 4 O9 SN NYNNY 2001.12.202302185.0000678.7000000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of a complicated fracture of, involving viscera, blood 5001.12.2023vessels or nerves, requiring open reduction not involving plate(s) (Anaes.) 5001.12.2023(Assist.) 1053427 26.05.2002 4 O9 SN NYNNY 2001.12.202302980.0000927.0500000.00 4026.05.2002(Anaes.) 5001.12.2023MAXILLA, treatment of a complicated fracture of, involving viscera, blood 5001.12.2023vessels or nerves, requiring open reduction involving the use of plate(s) 5001.12.2023(Anaes.) (Assist.) 1053429 26.05.2002 4 O9 SN NYNNY 2001.12.202302980.0000927.0500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of a complicated fracture of, involving viscera, blood 5001.12.2023vessels or nerves, requiring open reduction involving the use of plate(s) 5001.12.2023(Anaes.) (Assist.) 1053439 26.05.2002 4 O9 SN NYNNY 2001.12.202300845.0000262.8500000.00 4026.05.2002(Anaes.) 5001.12.2023MANDIBLE, treatment of a closed fracture of, involving a joint surface 5001.12.2023(Anaes.) 1053453 26.05.2002 4 O9 SN NYNNY 2001.12.202301435.0000531.9500000.00 4026.05.2002(Anaes.) 5001.12.2023ORBITAL CAVITY, reconstruction of a wall or floor with or without foreign 5001.12.2023implant (Anaes.) (Assist.) 1053455 26.05.2002 4 O9 SN NYNNY 2001.12.202301685.0000624.8000000.00 4026.05.2002(Anaes.) 5001.12.2023ORBITAL CAVITY, bone or cartilage graft to orbital wall or floor including 5001.12.2023reduction of prolapsed or entrapped orbital contents (Anaes.) (Assist.) 1053458 26.05.2002 4 O9 SN NYNNY 2001.12.202300122.0000047.4000000.00 5001.12.2023NASAL BONES, treatment of fracture of, not being a service to which item 53459 5001.12.2023or 53460 applies 1053459 26.05.2002 4 O9 SN NYNNY 2001.12.202301205.0000259.2000000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL BONES, treatment of fracture of, by reduction (Anaes.) 1053460 26.05.2002 4 O9 SN NYNNY 2001.12.202301650.0000528.7500000.00 4026.05.2002(Anaes.) 5001.12.2023NASAL BONES, treatment of fractures of, by open reduction involving 5001.12.2023osteotomies (Anaes.) (Assist.) 1053700 26.05.2002 4 O11 SN NYNNY 2001.12.202300354.0000137.4500000.00 5001.12.2023(Note. Where an anaesthetic combines a regional nerve block with a general 5001.12.2023anaesthetic for an operative procedure, benefits will be paid only under the 5001.12.2023anaesthetic item relevant to the operation. The items in this Group are to be 5001.12.2023used in the practice of oral and maxillofacial surgery and are not to be used 5001.12.2023for dental procedures (eg. restorative dentistry or dental extraction.)) 5001.12.2023TRIGEMINAL NERVE, primary division of, injection of an anaesthetic agent 1053702 26.05.2002 4 O11 SN NYNNY 2001.12.202300177.0000068.8500000.00 5001.12.2023TRIGEMINAL NERVE, peripheral branch of, injection of an anaesthetic agent 1053704 26.05.2002 4 O11 SN NYNNY 2001.12.202300107.0000041.4500000.00 5001.12.2023FACIAL NERVE, injection of an anaesthetic agent 1053706 26.05.2002 4 O11 SN NYNNY 2001.12.202300354.0000137.4500000.00 5001.12.2023NERVE BRANCH, destruction by a neurolytic agent, not being a service to which 5001.12.2023any other item in this Group applies 1055028 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Head, ultrasound scan of (R) 1055029 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Head, ultrasound scan of (NR) 1055030 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Orbital contents, ultrasound scan of (R) 1055031 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Orbital contents, ultrasound scan of (NR) 1055032 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Neck, one or more structures of, ultrasound scan of (R) 1055033 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Neck, one or more structures of, ultrasound scan of (NR) 1055036 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300228.0000120.5000000.00 5001.12.2023Abdomen, ultrasound scan of (including scan of urinary tract when performed), 5001.12.2023for morphological assessment, if: (a) the service is not solely a transrectal 5001.12.2023ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder 5001.12.2023base;(iii) urethra; and(b) within 24 hours of the service, a service mentioned 5001.12.2023in item 55038 is not performed on the same patient by the providing 5001.12.2023practitioner (R) 1055037 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Abdomen, ultrasound scan of (including scan of urinary tract when performed), 5001.12.2023for morphological assessment, if the service is not solely a transrectal 5001.12.2023ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder 5001.12.2023base;(iii) urethra (NR) 1055038 26.05.2002 5 I1 1 SN NYNYN 2001.12.202300224.0000118.2500000.00 5001.12.2023Urinary tract, ultrasound scan of, if: (a) the service is not solely a 5001.12.2023transrectal ultrasonic examination of any of the following: (i) prostate 5001.12.2023gland; (ii) bladder base; (iii) urethra; and (b) within 24 hours of the 5001.12.2023service, a service mentioned in item 55036 or 55065 is not performed on the 5001.12.2023same patient by the providing practitioner (R) 1055039 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Urinary tract, ultrasound scan of, if the service is not solely a transrectal 5001.12.2023ultrasonic examination of any of the following: (a) prostate gland; (b) 5001.12.2023bladder base; (c) urethra (NR) 1055048 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.6500000.00 5001.12.2023Scrotum, ultrasound scan of (R) 1055049 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Scrotum, ultrasound scan of (NR) 1055054 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Ultrasonic cross-sectional echography, in conjunction with a surgical 5001.12.2023procedure (other than a procedure to which item 55848 or 55850 applies) using 5001.12.2023interventional techniques, not being a service associated with a service to 5001.12.2023which any other item in this Group applies (R) 1055065 01.07.2014 5 I1 1 SN NYNNN 2001.12.202300201.0000106.4500000.00 5001.12.2023Pelvis, ultrasound scan of, by any or all approaches, if:(a) the service is 5001.12.2023not solelya service to which an item (other thanitem 55736 or 55739) in 5001.12.2023Subgroup 5 of this Group applies ora transrectal ultrasonic examination of any 5001.12.2023of the following: prostate gland; bladder base; urethra; and (b) within 24 5001.12.2023hours of the service, a service mentioned in item 55038 is not performed on 5001.12.2023the same patient by the providing practitioner (R) 1055066 01.05.2020 5 I1 1 SN NYNNN 2001.12.202300447.0000236.4000000.00 5001.12.2023Breasts, both, ultrasound scan, in conjunction with a surgical procedure using 5001.12.2023interventional techniques, if:(a) the request for the scan indicates that an 5001.12.2023ultrasound guided breast intervention be performed; and(b) the service is not 5001.12.2023performed in conjunction with any other item in this Group (R) 1055068 01.07.2014 5 I1 1 SN NYNNN 2001.12.202300072.0000037.8500000.00 5001.12.2023Pelvis, ultrasound scan of, by any or all approaches, if the service is not 5001.12.2023solely a service to which an item (other than item 55736 or 55739) in Subgroup 5001.12.20235 of this Group applies or a transrectal ultrasonic examination of any of the 5001.12.2023following:(i) prostate gland;(ii) bladder base;(iii) urethra (NR) 1055070 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300201.0000106.4500000.00 5001.12.2023Breast, one, ultrasound scan of (R) 1055071 01.05.2020 5 I1 1 SN NYNNN 2001.12.202300425.0000224.6000000.00 5001.12.2023Breast, one, ultrasound scan, in conjunction with a surgical procedure using 5001.12.2023interventional techniques, if:(a) the request for the scan indicates that an 5001.12.2023ultrasound guided breast intervention be performed; and(b) the service is not 5001.12.2023performed in conjunction with any other item in this group (R) 1055073 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300070.0000036.8500000.00 5001.12.2023Breast, one, ultrasound scan of (NR) 1055076 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Breasts, both, ultrasound scan of, including an ultrasound scan for post 5001.12.2023mastectomy surveillance (R) 1055079 26.05.2002 5 I1 1 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Breasts, both, ultrasound scan of, including an ultrasound scan for post 5001.12.2023mastectomy surveillance (NR) 1055084 01.05.2004 5 I1 1 SN NYNNN 2001.12.202300201.0000106.4500000.00 5001.12.2023Urinary bladder, ultrasound scan of, by any or all approaches, if within 24 5001.12.2023hours of the service, a service mentioned in item 11917, 55036, 55038, 55065, 5001.12.202355600 or 55603 is not performed on the same patient by the providing 5001.12.2023practitioner (R) 1055085 01.05.2004 5 I1 1 SN NYNNN 2001.12.202300070.0000036.8500000.00 5001.12.2023Urinary bladder, ultrasound scan of, by any or all approaches, if within 24 5001.12.2023hours of the service, a service mentioned in item 11917, 55037, 55039, 55068, 5001.12.202355600 or 55603 is not performed on the same patient by the providing 5001.12.2023practitioner (NR) 1055118 26.05.2002 5 I1 2 SN NYNNN 2001.12.202300564.0000298.4500000.00 4026.05.2002(Anaes.) 5001.12.2023Heart, two-dimensional or three-dimensional real time transoesophageal 5001.12.2023examination of, from at least 2 levels, and in more than one plane at each 5001.12.2023level, if: (a) the service includes: (i) real time colour flow mapping and, if 5001.12.2023indicated, pulsed wave Doppler examination; and (ii) recordings on digital 5001.12.2023media; and (b) the service is not an intra-operative service; and (c) not 5001.12.2023being a service associated with a service to which an item in Subgroup 3 5001.12.2023applies.(R) (Anaes.) 1055126 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Initial real time 5001.12.2023transthoracic echocardiographic examination of the heart with real time colour 5001.12.2023flow mapping from at least 3 acoustic windows, with recordings on digital 5001.12.2023media, if the service: (a) is for the investigation of any of the following: 5001.12.2023(i) symptoms or signs of cardiac failure; (ii) suspected or known ventricular 5001.12.2023hypertrophy or dysfunction; (iii) pulmonary hypertension; (iv) valvular, 5001.12.2023aortic, pericardial, thrombotic or embolic disease; (v) heart tumour; (vi) 5001.12.2023symptoms or signs of congenital heart disease; (vii) other rare indications; 5001.12.2023and (b) is not associated with a service to which: (i) another item in this 5001.12.2023Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) 5001.12.2023an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item 5001.12.2023in Subgroup 3 applies Applicable not more than once in a 24 month period (R) 1055127 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Repeat serial real time 5001.12.2023transthoracic echocardiographic examination of the heart with real time colour 5001.12.2023flow mapping from at least 3 acoustic windows, with recordings on digital 5001.12.2023media, if the service: (a) is for the investigation of known valvular 5001.12.2023dysfunction; and (b) is requested by a specialist or consultant physician; and 5001.12.2023(c) is not associated with a service to which: (i) another item in this 5001.12.2023Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) 5001.12.2023an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item 5001.12.2023in Subgroup 3 applies (R) 1055128 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Repeat serial real time 5001.12.2023transthoracic echocardiographic examination of the heart with real time colour 5001.12.2023flow mapping from at least 3 acoustic windows, with recordings on digital 5001.12.2023media, if the service: (a) is for the investigation of known valvular 5001.12.2023dysfunction; and (b) is requested by a medical practitioner (other than a 5001.12.2023specialist or consultant physician) at, or from, a practice located in a 5001.12.2023Modified Monash 3, 4, 5, 6 or 7 area; and (c) is not associated with a service 5001.12.2023to which: (i) another item in this Subgroup applies (except items 55137, 5001.12.202355141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except 5001.12.2023items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R) 1055129 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Repeat serial real time 5001.12.2023transthoracic echocardiographic examination of the heart with real time colour 5001.12.2023flow mapping from at least 3 acoustic windows, with recordings on digital 5001.12.2023media, if: (a) valvular dysfunction is not the primary issue for the patient 5001.12.2023(although it may be a secondary issue); and (b) the service is for the 5001.12.2023investigation of any of the following: (i) symptoms or signs of cardiac 5001.12.2023failure; (ii) suspected or known ventricular hypertrophy or dysfunction; (iii) 5001.12.2023pulmonary hypertension; (iv) aortic, thrombotic, embolic disease or 5001.12.2023pericardial disease (excluding isolated pericardial effusion or pericarditis); 5001.12.2023(v) heart tumour; (vi) structural heart disease; (vii) other rare indications; 5001.12.2023and (c) the service is requested by a specialist or consultant physician; and 5001.12.2023(d) the service is not associated with a service to which: (i) another item in 5001.12.2023this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or 5001.12.2023(ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an 5001.12.2023item in Subgroup 3 applies (R) 1055130 26.05.2002 5 I1 2 SN NYNNN 2001.12.202300348.0000184.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Intraoperative two-dimensional or three-dimensional real time transoesophageal 5001.12.2023echocardiography, if the service: (a) includes Doppler techniques with colour 5001.12.2023flow mapping and recordings on digital media; and (b) is performed during 5001.12.2023cardiac surgery; and (c) incorporates sequential assessment of cardiac 5001.12.2023function before and after the surgical procedure; and (d) is not associated 5001.12.2023with a service to which item 55135, or an item in Subgroup 3, applies (R) 5001.12.2023(Anaes.) 1055132 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Serial real time transthoracic 5001.12.2023echocardiographic examination of the heart with real time colour flow mapping 5001.12.2023from at least 4 acoustic windows, with recordings on digital media, if the 5001.12.2023service: (a) is for the investigation of a patient who: (i) is under 17 years 5001.12.2023of age; or (ii) has complex congenital heart disease; and (b) is performed by 5001.12.2023a specialist or consultant physician practising in the speciality of 5001.12.2023cardiology; and (c) is not associated with a service to which: (i) another 5001.12.2023item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 5001.12.202355146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); 5001.12.2023or (iii) an item in Subgroup 3 applies (R) 1055133 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300425.0000224.9500000.00 5001.12.2023Note: the service only applies if the patient meets one or more of the 5001.12.2023following and the requirements of Note: IR.1.2 Frequent repetition serial real 5001.12.2023time transthoracic echocardiographic examination of the heart with real time 5001.12.2023colour flow mapping from at least 3 acoustic windows, with recordings on 5001.12.2023digital media, if the service: (a) is for the investigation of a patient who: 5001.12.2023(i) has an isolated pericardial effusion or pericarditis; or (ii) has a normal 5001.12.2023baseline study, and has commenced medication for noncardiac purposes that has 5001.12.2023cardiotoxic side effects and is a pharmaceutical benefit (within the meaning 5001.12.2023of PartVII of the National Health Act 1953) for the writing of a prescription 5001.12.2023for the supply of which under that Part an echocardiogram is required; and (b) 5001.12.2023is not associated with a service to which: (i) another item in this Subgroup 5001.12.2023applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item 5001.12.2023in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in 5001.12.2023Subgroup 3 applies (R) 1055134 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets one or more of the 5001.12.2023following and the requirements of Note: IR.1.2 Repeat real time transthoracic 5001.12.2023echocardiographic examination of the heart with real time colour flow mapping 5001.12.2023from at least 3 acoustic windows, with recordings on digital media, for the 5001.12.2023investigation of rare cardiac pathologies, if the service: (a) is requested by 5001.12.2023a specialist or consultant physician; and (b) is not associated with a service 5001.12.2023to which: (i) another item in this Subgroup applies (except items 55137, 5001.12.202355141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except 5001.12.2023items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R) 1055135 01.05.2004 5 I1 2 SN NYNNN 2001.12.202300724.0000383.1000000.00 4001.05.2004(Anaes.) 5001.12.2023Intraoperative two-dimensional or three-dimensional real time transoesophageal 5001.12.2023echocardiography, if the service: (a) is provided on the same day as a service 5001.12.2023to which item 38477, 38484, 38499, 38516 or 38517 applies; and (b) includes 5001.12.2023Doppler techniques with colour flow mapping and recordings on digital media; 5001.12.2023and (c) is performed during cardiac valve surgery (replacement or repair); and 5001.12.2023(d) incorporates sequential assessment of cardiac function and valve 5001.12.2023competence before and after the surgical procedure; and (e) is not associated 5001.12.2023with a service to which item 55130, or an item in Subgroup 3, applies (R) 5001.12.2023(Anaes.) 1055137 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300473.0000249.9500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.1.2 Serial real time transthoracic 5001.12.2023echocardiographic examination of the heart with real time colour flow mapping 5001.12.2023from at least 4 acoustic windows, with recordings on digital media, if the 5001.12.2023service: (a) is for the investigation of a fetus with suspected or confirmed: 5001.12.2023(i) complex congenital heart disease; or (ii) functional heart disease; or 5001.12.2023(iii) fetal cardiac arrhythmia; or (iv) cardiac structural abnormality 5001.12.2023requiring confirmation; and (b) is performed by a specialist or consultant 5001.12.2023physician practising in the speciality of cardiology with advanced training 5001.12.2023and expertise in fetal cardiac imaging; and (c) is not associated with a 5001.12.2023service to which: (i) an item in Subgroup 2 applies (except items 55118 and 5001.12.202355130); or (ii) an item in Subgroup 3 applies (R) 1055141 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300842.0000445.5500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.0.1 and IR.1.2and does not apply 5001.12.2023to a service provided to a patient if, in the previous 24 months, a service 5001.12.2023associated with a service to which item 55143, 55145 or 55146 applies has been 5001.12.2023provided to the patient. Exercise stress echocardiography focused study, other 5001.12.2023than a service associated with a service to which: (a) item 11704, 11705, 5001.12.202311707, 11714, 11729 or 11730 applies; or (b) an item in Subgroup 3 applies 5001.12.2023Applicable not more than once in a 24 month period (R) 1055143 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300842.0000445.5500000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 Repeat 5001.12.2023pharmacological or exercise stress echocardiography if: (a) a service to which 5001.12.2023item 55141, 55145, 55146, or this item, applies has been performed on the 5001.12.2023patient in the previous 24 months; and (b) the patient has symptoms of 5001.12.2023ischaemia that have evolved and are not adequately controlled with optimal 5001.12.2023medical therapy; and (c) the service is requested by a specialist or a 5001.12.2023consultant physician; and (d) the service is not associated with a service to 5001.12.2023which: (i) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (ii) an 5001.12.2023item in Subgroup 3 applies Applicable not more than once in a 12 month period 5001.12.2023(R) 1055145 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300976.0000516.4000000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.0.1 and IR.1.2 Pharmacological 5001.12.2023stress echocardiography, other than a service associated with a service to 5001.12.2023which: (a) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (b) an 5001.12.2023item in Subgroup 3 applies Applicable not more than once in a 24 month period 5001.12.2023(R) Note: this item does not apply to a service provided to a patient if, in 5001.12.2023the previous 24 months, a service associated with a service to which item 5001.12.202355141, 55143 or 55146 applies has been provided to the patient. 1055146 01.08.2020 5 I1 7 SN NYNYN 2001.12.202300976.0000516.4000000.00 5001.12.2023Note: the service only applies if the patient meets the requirements of the 5001.12.2023descriptor and the requirements of Note: IR.0.1 and IR.1.2 Pharmacological 5001.12.2023stress echocardiography if: (a) a service to which item 55141 applies has been 5001.12.2023performed on the patient in the previous 4 weeks, and the test has failed due 5001.12.2023to an inadequate heart rate response; and (b) the service is not associated 5001.12.2023with a service to which: (i) item 11704, 11705, 11707, 11714, 11729 or 11730 5001.12.2023applies; or (ii) an item in Subgroup 3 applies Applicable not more than once 5001.12.2023in a 24 month period (R) Note: this item does not apply to a service provided 5001.12.2023to a patient if, in the previous 24 months, a service associated with a 5001.12.2023service to which item 55143 or 55145 applies has been provided to the patient. 1055208 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300344.0000183.6500000.00 5001.12.2023DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurement by spectral analysis of cavernosal artery of the penis 5001.12.2023following intracavernosal administration of a vasoactive agent, performed 5001.12.2023during the period of pharmacological activity of the injected agent to confirm 5001.12.2023a diagnosis of vascular aetiology for impotence (R). Note: This item is only 5001.12.2023available for services rendered by Dr Christopher McMahon, provider number 5001.12.2023045449 of Australian Centre for Sexual Health, Berry Road Medical Centre, St 5001.12.2023Leonards NSW 2065. 1055211 26.05.2002 5 I1 3 DN NYNNN 2001.12.202300344.0000183.6500000.00 5001.12.2023DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurement by spectral analysis of cavernosal tissue of the penis to 5001.12.2023confirm a diagnosis and, where indicated, assess the progress and management 5001.12.2023of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; 5001.12.2023or (d) arteriovenous malformations (R) Note: This items is only available for 5001.12.2023Dr Christopher McMahon, provider number 045449 of Australian Centre for Sexual 5001.12.2023Health, Berry Road Medical Centre, St Leonards NSW 2065 1055238 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of arteries or 5001.12.2023bypass grafts in the lower limb or of arteries and bypass grafts in the lower 5001.12.2023limb, below the inguinal ligament, not being a service associated with any of 5001.12.2023the following:(a) a service to which an item in Subgroup 4 applies;(b) a 5001.12.2023service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 5001.12.202355888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R) 1055244 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of veins in the 5001.12.2023lower limb, below the inguinal ligament, for acute venous thrombosis, not 5001.12.2023being a service associated with any of the following:(a) a service to which 5001.12.2023item 55246 applies;(b) a service to which an item in Subgroup 4 applies;(c) a 5001.12.2023service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 5001.12.202355888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R) 1055246 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of veins in the 5001.12.2023lower limb, below the inguinal ligament, for chronic venous disease, not being 5001.12.2023a service associated with any of the following:(a) a service to which item 5001.12.202355244 applies;(b) a service to which an item in Subgroup 4 applies;(c) a 5001.12.2023service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 5001.12.202355888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R) 1055248 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of arteries or 5001.12.2023bypass grafts in the upper limb or of arteries and bypass grafts in the upper 5001.12.2023limb, not being a service associated with a service to which an item in 5001.12.2023Subgroup 4 applies (R) 1055252 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of veins in the 5001.12.2023upper limb, not being a service associatedwith a service to which an item in 5001.12.2023Subgroup 4 applies (R). 1055274 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, bilateral, involving B mode ultrasound imaging and integrated 5001.12.2023Doppler flow measurements by spectral analysis of extra cranial bilateral 5001.12.2023carotid and vertebral vessels, with or without subclavian and innominate 5001.12.2023vessels, with or without oculoplethysmography or peri orbital Doppler 5001.12.2023examination, not being a service associated witha service to which an item in 5001.12.2023Subgroup 4 applies (R). 1055276 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements by spectral analysis of intraabdominal, aorta and iliac 5001.12.2023arteries or inferior vena cava and iliac veins or of intraabdominal, aorta and 5001.12.2023iliac arteries and inferior vena cava and iliac veins, excluding pregnancy 5001.12.2023related studies, not being a service associated witha service to which an item 5001.12.2023in Subgroup 4 applies (R) 1055278 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements by spectral analysis of renal or visceral vessels or of 5001.12.2023renal and visceral vessels, including aorta, inferior vena cava and iliac 5001.12.2023vessels as required excluding pregnancy related studies, not being a service 5001.12.2023associated witha service to which an item in Subgroup 4 applies (R) 1055280 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements by spectral analysis of intra cranial vessels, not being a 5001.12.2023service associated witha service to which an item in Subgroup 4 applies (R) 1055282 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements:(a) by spectral analysis of cavernosal artery of the penis 5001.12.2023following intracavernosal administration of a vasoactive agent; and(b) 5001.12.2023performed during the period of pharmacological activity of the injected agent, 5001.12.2023to confirm a diagnosis of vascular aetiology for impotence; and(c) if a 5001.12.2023specialist in diagnostic radiology, nuclear medicine, urology, general surgery 5001.12.2023(sub specialising in vascular surgery) or a consultant physician in nuclear 5001.12.2023medicine attends the patient in person at the practice location where the 5001.12.2023service is performed, immediately before or for a period during the 5001.12.2023performance of the service; and(d) if the specialist or consultant physician 5001.12.2023interprets the results and prepares a report, not being a service associated 5001.12.2023with a service to which an item in Subgroup 4 applies (R) 1055284 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements:(a) by spectral analysis of cavernosal tissue of the penis 5001.12.2023to confirm a diagnosis; and(b) if indicated, assess the progress and 5001.12.2023management of:(i) priapism; or(ii) fibrosis of any type; or(iii) fracture of 5001.12.2023the tunica; or(iv) arteriovenous malformations; and(c) if a specialist in 5001.12.2023diagnostic radiology, nuclear medicine, urology, general surgery (sub 5001.12.2023specialising in vascular surgery) or a consultant physician in nuclear 5001.12.2023medicine attends the patient in person at the practice location where the 5001.12.2023service is performed, immediately before or for a period during the 5001.12.2023performance of the service; and(d) if the specialist or consultant physician 5001.12.2023interprets the results and prepares a report, not being a service associated 5001.12.2023with a service to which an item in Subgroup 4 applies (R) 1055292 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of surgically 5001.12.2023created arteriovenous fistula or surgically created arteriovenous access 5001.12.2023grafts in the upper or lower limbs, not being a service associated with a 5001.12.2023service to which an item in Subgroup 4 applies (R) 1055294 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300347.0000183.6500000.00 5001.12.2023Duplex scanning involving B mode ultrasound imaging and integrated Doppler 5001.12.2023flow measurements by spectral analysis of arteries or veins, or both, 5001.12.2023including any associated skin marking, for mapping of bypass conduit before 5001.12.2023vascular surgery, not being a service associated with any of the following:(a) 5001.12.2023a service to which an item in Subgroup 3 or 4 applies; (b) a service to which 5001.12.2023item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 5001.12.202355890, 55891, 55892, 55893, 55894 or 55895 applies (R) 1055296 26.05.2002 5 I1 3 SN NYNNN 2001.12.202300227.0000120.2500000.00 5001.12.2023Duplex scanning, unilateral, involving B mode ultrasound imaging and 5001.12.2023integrated Doppler flow spectral analysis and marking of veins in the lower 5001.12.2023limbs below the inguinal ligament before varicose vein surgery, including any 5001.12.2023associated skin marking, not being a service associated with any of the 5001.12.2023following:(a) a service to which an item in Subgroup 3 or 4 applies;(b) a 5001.12.2023service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 5001.12.202355888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R) 1055600 26.05.2002 5 I1 4 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Prostate, bladder base and urethra, ultrasound scan of, if performed:(a) 5001.12.2023personally by a medical practitioner (not being the medical practitioner who 5001.12.2023assessed the patient as specified in paragraph (c)) using one or more 5001.12.2023transducer probes that can obtain both axial and sagittal scans in 2 planes at 5001.12.2023right angles; and(b) after a digital rectal examination of the prostate by 5001.12.2023that medical practitioner; and(c) on a patient who has been assessed by:(i) a 5001.12.2023specialist in urology, radiation oncology or medical oncology; or(ii) a 5001.12.2023consultant physician in medical oncology; who has:(iii) examined the patient 5001.12.2023in the 60 days before the scan; and(iv) recommended the scan for the 5001.12.2023management of the patients current prostatic disease(R) 1055603 26.05.2002 5 I1 4 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Prostate, bladder base and urethra, ultrasound scan of, if performed:(a) 5001.12.2023personally by a medical practitioner who made the assessment mentioned in 5001.12.2023paragraph (c) using one or more transducer probes that can obtain both axial 5001.12.2023and sagittal scans in 2 planes at right angles; and(b) after a digital rectal 5001.12.2023examination of the prostate by that medical practitioner; and(c) on a patient 5001.12.2023who has been assessed by:(i) a specialist in urology, radiation oncology or 5001.12.2023medical oncology; or(ii) a consultant physician in medical oncology; who 5001.12.2023has:(iii) examined the patient in the 60 days before the scan; and(iv) 5001.12.2023recommended the scan for the management of the patients current prostatic 5001.12.2023disease(R) 1055700 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300123.0000065.0000000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, ultrasound (the 5001.12.2023current ultrasound) scan of, by any or all approaches, for determining the 5001.12.2023gestation, location, viability or number of fetuses, if: (a) the dating of the 5001.12.2023pregnancy (as confirmed by the current ultrasound) is less than 12 weeks of 5001.12.2023gestation; and (b) the current ultrasound is not performed on the same patient 5001.12.2023within 24 hours of a service mentioned in item 55704, 55705, 55707, 55708, 5001.12.202355740, 55741, 55742 or 55743 (R) 1055703 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300072.0000037.8500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, ultrasound (the 5001.12.2023current ultrasound) scan of, by any or all approaches, for determining the 5001.12.2023gestation, location, viability or number of fetuses, if: (a) the dating of the 5001.12.2023pregnancy (as confirmed by the current ultrasound) is less than 12 weeks of 5001.12.2023gestation; and (b) the current ultrasound is not performed on the same patient 5001.12.2023within 24 hours of a service mentioned in item 55704, 55705, 55707, 55708, 5001.12.202355740, 55741, 55742 or 55743 (NR) 1055704 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300143.0000075.8500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, for determining the structure, gestation, location, 5001.12.2023viability or number of fetuses, if: (a) the dating of the pregnancy (as 5001.12.2023confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (b) 5001.12.2023the current ultrasound is not performed on the same patient within 24 hours of 5001.12.2023a service mentioned in another item in this Subgroup (R) 1055705 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300072.0000037.8500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, for determining the structure, gestation, location, 5001.12.2023viability or number of fetuses, if: (a) the dating of the pregnancy (as 5001.12.2023confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (b) 5001.12.2023the current ultrasound is not performed on the same patient within 24 hours of 5001.12.2023a service mentioned in another item in this Subgroup (NR) 1055706 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300205.0000108.3500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) the dating for the pregnancy (as confirmed by the current ultrasound) is 5001.12.202317 to 22 weeks of gestation; and (b) the current ultrasound: (i) is not 5001.12.2023performed in the same pregnancy as item 55709; and (ii) is not performed on 5001.12.2023the same patient within 24 hours of a service mentioned in item 55757 or 55758 5001.12.2023(R) 1055707 01.11.2005 5 I1 5 SN NYNNN 2001.12.202300143.0000075.8500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if:(a) the pregnancy (as confirmed by the current 5001.12.2023ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and(b) 5001.12.2023nuchal translucency measurement is performed to assess the risk of fetal 5001.12.2023abnormality; and(c) the current ultrasound is not performed on the same 5001.12.2023patient within 24 hours of a service mentioned in another item in this 5001.12.2023Subgroup (R) 1055708 01.11.2005 5 I1 5 SN NYNNN 2001.12.202300072.0000037.8500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if:(a) the pregnancy (as confirmed by the current 5001.12.2023ultrasound) is dated by a crown rump length of 45 to 84 mm; and(b) nuchal 5001.12.2023translucency measurement is performed to assess the risk of fetal abnormality; 5001.12.2023and(c) the current ultrasound is not performed on the same patient within 24 5001.12.2023hours of a service mentioned in another item in this Subgroup (NR) 1055709 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300078.0000041.1000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 5001.12.2023to 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed 5001.12.2023in the same pregnancy as item 55706; and (ii) is not performed on the same 5001.12.2023patient within 24 hours of a service mentioned in item 55757 or 55758 (NR) 1055712 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300236.0000124.5500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) the current ultrasound is requested by a medical practitioner who: (i) is 5001.12.2023a Member or a Fellow of the Royal Australian and New Zealand College of 5001.12.2023Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) 5001.12.2023has a qualification recognised by the Royal Australian and New Zealand College 5001.12.2023of Obstetricians and Gynaecologists as being equivalent to a Diploma of 5001.12.2023Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; 5001.12.2023and (b) the dating of the pregnancy (as confirmed by the current ultrasound) 5001.12.2023is 17 to 22 weeks of gestation; and (c) further examination is clinically 5001.12.2023indicated after performance, in the same pregnancy, of a scan mentioned in 5001.12.2023item 55706 or 55709; and (d) the current ultrasound is not performed on the 5001.12.2023same patient within 24 hours of a service mentioned in item 55757 or 55758 (R) 1055715 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300082.0000043.3000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, 5001.12.2023performed by or on behalf of a medical practitioner who is a Member or a 5001.12.2023Fellow of the Royal Australian and New Zealand College of Obstetricians and 5001.12.2023Gynaecologists, if: (a) the dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is 17 to 22 weeks of gestation; and (b) further 5001.12.2023examination is clinically indicated after performance, in the same pregnancy, 5001.12.2023of a scan mentioned in item 55706 or 55709; and (c) the current ultrasound is 5001.12.2023not performed on the same patient within 24 hours of a service mentioned in 5001.12.2023item 55757 or 55758 (NR) 1055718 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300205.0000108.3500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) the dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is after 22 weeks of gestation; and (b) the current 5001.12.2023ultrasound: (i) is not performed in the same pregnancy as item 55723; and (ii) 5001.12.2023is not performed on the same patient within 24 hours of a service mentioned in 5001.12.2023item 55757 or 55758 (R) 1055721 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300236.0000124.5500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) the current ultrasound is requested by a medical 5001.12.2023practitioner who: (i) is a Member or a Fellow of the Royal Australian and New 5001.12.2023Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of 5001.12.2023Obstetrics; or(iii) has a qualification recognised by the Royal Australian and 5001.12.2023New Zealand College of Obstetricians and Gynaecologists as being equivalent to 5001.12.2023a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan 5001.12.2023hospital; and (b) the dating of the pregnancy (as confirmed by the current 5001.12.2023ultrasound) is after 22 weeks of gestation; and (c) further examination is 5001.12.2023clinically indicated in the same pregnancy to which item 55718 or 55723 5001.12.2023applies; and (d) the current ultrasound is not performed on the same patient 5001.12.2023within 24 hours of a service mentioned in item 55757 or 55758 (R) 1055723 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300078.0000041.1000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) the dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is after 22 weeks of gestation; and (b) the current 5001.12.2023ultrasound: (i) is not performed in the same pregnancy as item 55718; and (ii) 5001.12.2023is not performed on the same patient within 24 hours of a service mentioned in 5001.12.2023item 55757 or 55758 (NR) 1055725 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300082.0000043.3000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, performed by or on behalf of a medical practitioner who is 5001.12.2023a Member or a Fellow of the Royal Australian and New Zealand College of 5001.12.2023Obstetricians and Gynaecologists, if: (a) the dating of the pregnancy (as 5001.12.2023confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) 5001.12.2023further examination is clinically indicated in the same pregnancy to which 5001.12.2023item 55718 or 55723 applies; and (c) the current ultrasound is not performed 5001.12.2023on the same patient within 24 hours of a service mentioned in item 55757 or 5001.12.202355758 (NR) 1055729 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300056.0000029.5000000.00 5001.12.2023Duplex scanning, if:(a) the service involves:(i) B mode ultrasound imaging and 5001.12.2023integrated Doppler flow measurements by spectral analysis of the umbilical 5001.12.2023artery; and(ii) measured assessment of amniotic fluid volume after the 24th 5001.12.2023week of gestation; and(b) there is reason to suspect intrauterine growth 5001.12.2023retardation or a significant risk of fetal death;examination and report (R) 1055736 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300260.0000137.6000000.00 5001.12.2023Pelvis, ultrasound scan of, in association with saline infusion of the 5001.12.2023endometrial cavity, by any or all approaches, if a previous transvaginal 5001.12.2023ultrasound has revealed an abnormality of the uterus or fallopian tube (R) 1055739 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300117.0000061.7500000.00 5001.12.2023Pelvis, ultrasound scan of, in association with saline infusion of the 5001.12.2023endometrial cavity, by any or all approaches, if a previous transvaginal 5001.12.2023ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) 1055740 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300217.0000112.7500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, for determining the structure, gestation, location, 5001.12.2023viability or number of fetuses, if: (a) an ultrasound of the same pregnancy 5001.12.2023confirms a multiple pregnancy; and (b) the dating of the pregnancy (as 5001.12.2023confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (c) 5001.12.2023the current ultrasound is not performed on the same patient within 24 hours of 5001.12.2023a service mentioned in another item in this Subgroup (R) 1055741 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300108.0000056.3500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, for determining the structure, gestation, location, 5001.12.2023viability or number of fetuses, if: (a) an ultrasound of the same pregnancy 5001.12.2023confirms a multiple pregnancy; and (b) the dating of the pregnancy (as 5001.12.2023confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (c) 5001.12.2023the current ultrasound is not performed on the same patient within 24 hours of 5001.12.2023a service mentioned in another item in this Subgroup (NR) 1055742 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300217.0000112.7500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) an ultrasound of the same pregnancy confirms a 5001.12.2023multiple pregnancy; and (b) the pregnancy (as confirmed by the current 5001.12.2023ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and (c) 5001.12.2023nuchal translucency measurement is performed to assess the risk of fetal 5001.12.2023abnormality; and (d) the current ultrasound is not performed on the same 5001.12.2023patient within 24 hours of a service mentioned in another item in this 5001.12.2023Subgroup (R) 1055743 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300108.0000056.3500000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) an ultrasound of the same pregnancy confirms a 5001.12.2023multiple pregnancy; and (b) the pregnancy (as confirmed by the current 5001.12.2023ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and (c) 5001.12.2023nuchal translucency measurement is performed to assess the risk of fetal 5001.12.2023abnormality; and (d) the current ultrasound is not performed on the same 5001.12.2023patient within 24 hours of a service mentioned in another item in this 5001.12.2023Subgroup (NR) 1055757 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300103.0000053.6500000.00 5001.12.2023Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical 5001.12.2023length assessment for risk of preterm labour, by any or all approaches, if: 5001.12.2023(a) the dating of the pregnancy (as confirmed by the current ultrasound) is 5001.12.2023between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) 5001.12.2023the patient has a history indicating highrisk of preterm labour or birth or 5001.12.2023second trimester fetal loss; (ii) the patient has symptoms suggestive of 5001.12.2023threatened preterm labour or second trimester fetal loss; (iii) the patients 5001.12.2023cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; 5001.12.2023and (c) the current ultrasound is not performed on the same patient within 24 5001.12.2023hours of a service mentioned in another item in this Subgroup (R) 1055758 01.11.2022 5 I1 5 SN NYNNN 2001.12.202300039.0000020.4000000.00 5001.12.2023Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical 5001.12.2023length assessment for risk of preterm labour, by any or all approaches, if: 5001.12.2023(a) the dating of the pregnancy (as confirmed by the current ultrasound) is 5001.12.2023between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) 5001.12.2023the patient has a history indicating highrisk of preterm labour or birth or 5001.12.2023second trimester fetal loss; (ii) the patient has symptoms suggestive of 5001.12.2023threatened preterm labour or second trimester fetal loss; (iii) the patients 5001.12.2023cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; 5001.12.2023and (c) the current ultrasound is not performed on the same patient within 24 5001.12.2023hours of a service mentioned in another item in this Subgroup (NR) 1055759 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300307.0000162.4500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) 5001.12.2023the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 5001.12.202322 weeks gestation; and (c) the service mentioned in item 55706, 55709, 55712, 5001.12.202355715 or 55762 is not performed in conjunction with the current ultrasound 5001.12.2023during the same pregnancy; and (d) the current ultrasound is not performed on 5001.12.2023the same patient within 24 hours of a service mentioned in item 55757 or 55758 5001.12.2023(R) 1055762 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300123.0000065.0000000.00 5001.12.2023Pelvis or abdomen, pregnancyrelated or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) 5001.12.2023the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 5001.12.202322 weeks gestation; and (c) the service mentioned in item 55706, 55709, 55712, 5001.12.202355715 or 55759 is not performed in conjunction with the current ultrasound 5001.12.2023during the same pregnancy; and (d) the current ultrasound is not performed on 5001.12.2023the same patient within 24 hours of a service mentioned in item 55757 or 55758 5001.12.2023(NR) 1055764 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300328.0000173.3000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, if: 5001.12.2023(a) the service is requested by a medical practitioner who: (i) is a Member or 5001.12.2023Fellow of the Royal Australian and New Zealand College of Obstetricians and 5001.12.2023Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a 5001.12.2023qualification recognised by the Royal Australian and New Zealand College of 5001.12.2023Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; 5001.12.2023or(iv) has obstetric privileges at a non metropolitan hospital; and (b) an 5001.12.2023ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the 5001.12.2023dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 5001.12.2023weeks gestation; and (d) further examination is clinically indicated in the 5001.12.2023same pregnancy in which item 55759 or 55762 has been performed; and (e) the 5001.12.2023service mentioned in item 55706, 55709, 55712 or 55715 is not performed in 5001.12.2023conjunction with the current ultrasound during the same pregnancy; and (f) the 5001.12.2023current ultrasound is not performed on the same patient within 24 hours of a 5001.12.2023service mentioned in item 55757 or 55758 (R) 1055766 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300133.0000070.4000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, with measurement of all parameters for dating purposes, 5001.12.2023performed by or on behalf of a medical practitioner, who is a Member or Fellow 5001.12.2023of the Royal Australian and New Zealand College of Obstetricians and 5001.12.2023Gynaecologists, if: (a) an ultrasound of the same pregnancy confirms a 5001.12.2023multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is 17 to 22 weeks of gestation; and (c) further 5001.12.2023examination is clinically indicated in the same pregnancy in which item 55759 5001.12.2023or 55762 has been performed; and (d) the service mentioned in item 55706, 5001.12.202355709, 55712 or 55715 is not performed in conjunction with the current 5001.12.2023ultrasound during the same pregnancy; and (e) the current ultrasound is not 5001.12.2023performed on the same patient within 24 hours of a service mentioned in item 5001.12.202355757 or 55758 (NR) 1055768 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300307.0000162.4500000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is after 22 weeks of gestation; and (b)an ultrasound 5001.12.2023confirms a multiple pregnancy; and (c) the service is not performed in the 5001.12.2023same pregnancy as item 55770; and (d) the service mentioned in item 55718, 5001.12.202355721, 55723 or 55725 is not performed in conjunction with the current 5001.12.2023ultrasound during the same pregnancy; and (e) the current ultrasound is not 5001.12.2023performed on the same patient within 24 hours of a service mentioned in item 5001.12.202355757 or 55758 (R) 1055770 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300123.0000065.0000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) dating of the pregnancy (as confirmed by the 5001.12.2023current ultrasound) is after 22 weeks of gestation; and (b)an ultrasound 5001.12.2023confirms a multiple pregnancy; and (c) the service is not performed in the 5001.12.2023same pregnancy as item 55768; and (d) the service mentioned in item 55718, 5001.12.202355721, 55723 or 55725 is not performed in conjunction with the current 5001.12.2023ultrasound during the same pregnancy; and (e) the current ultrasound is not 5001.12.2023performed on the same patient within 24 hours of a service mentioned in item 5001.12.202355757 or 55758 (NR) 1055772 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300328.0000173.3000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, if: (a) dating of the pregnancy as confirmed by the current 5001.12.2023ultrasound is after 22 weeks of gestation; and (b) the service is requested by 5001.12.2023a medical practitioner who: (i) is a Member or Fellow of the Royal Australian 5001.12.2023and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a 5001.12.2023Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal 5001.12.2023Australian and New Zealand College of Obstetricians and Gynaecologists as 5001.12.2023equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a 5001.12.2023non metropolitan hospital; and (c) further examination is clinically indicated 5001.12.2023in the same pregnancy to which item 55768 or 55770 has been performed; and (d) 5001.12.2023the pregnancy as confirmed by an ultrasound is a multiple pregnancy; and (e) 5001.12.2023the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in 5001.12.2023conjunction with the current ultrasound during the same pregnancy; and (f) the 5001.12.2023current ultrasound is not performed on the same patient within 24 hours of a 5001.12.2023service mentioned in item 55757 or 55758 (R) 1055774 26.05.2002 5 I1 5 SN NYNNN 2001.12.202300133.0000070.4000000.00 5001.12.2023Pelvis or abdomen, pregnancy related or pregnancy complication, fetal 5001.12.2023development and anatomy, ultrasound (the current ultrasound) scan of, by any 5001.12.2023or all approaches, performed by or on behalf of a medical practitioner who is 5001.12.2023a Member or a Fellow of the Royal Australian and New Zealand College of 5001.12.2023Obstetricians and Gynaecologists, if: (a) dating of the pregnancy as confirmed 5001.12.2023by the current ultrasound is after 22 weeks of gestation; and (b) further 5001.12.2023examination is clinically indicated in the same pregnancy to which item 55768 5001.12.2023or 55770 has been performed; and (c) the pregnancy as confirmed by an 5001.12.2023ultrasound is a multiple pregnancy; and (d) the service mentioned in item 5001.12.202355718, 55721, 55723 or 55725 is not performed in conjunction with the current 5001.12.2023ultrasound during the same pregnancy; and (e) the current ultrasound is not 5001.12.2023performed on the same patient within 24 hours of a service mentioned in item 5001.12.202355757 or 55758 (NR) 1055812 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Chest or abdominal wall, one or more areas, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55070, 55073, 5001.12.202355076 or 55079 (R) 1055814 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Chest or abdominal wall, one or more areas, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55070, 55073, 5001.12.202355076 or 55079 (NR) 1055844 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300179.0000094.6000000.00 5001.12.2023Assessment of a mass associated with the skin or subcutaneous structures, not 5001.12.2023being a part of the musculoskeletal system, one or more areas, ultrasound scan 5001.12.2023of (R) 1055846 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Assessment of a mass associated with the skin or subcutaneous structures, not 5001.12.2023being a part of the musculoskeletal system, one or more areas, ultrasound scan 5001.12.2023of (NR) 1055848 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300280.0000148.0000000.00 5001.12.2023Musculoskeletal ultrasound, in conjunction with a surgical procedure using 5001.12.2023interventional techniques, not being a service associated with a service to 5001.12.2023which any other item in this group applies, and not performed in conjunction 5001.12.2023with a service mentioned in item 55054 (R) 1055850 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300369.0000195.3500000.00 5001.12.2023Musculoskeletal ultrasound, in conjunction with a surgical procedure using 5001.12.2023interventional techniques, inclusive of a diagnostic musculoskeletal 5001.12.2023ultrasound service, if:(a) the medical practitioner or nurse practitioner has 5001.12.2023indicated on a request for a musculoskeletal ultrasound that an ultrasound 5001.12.2023guided intervention be performed if clinically indicated; and(b) the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55054 or any 5001.12.2023other item in this Subgroup (R) 1055854 26.05.2002 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Paediatric spine, spinal cord and overlying subcutaneous tissues, ultrasound 5001.12.2023scan of (NR) 1055856 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Hand or wrist or both, left or right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55858 (R) 1055857 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Hand or wrist, or both, left or right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with item 55859 (NR) 1055858 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Hand or wrist, or both, left and right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55856 (R) 1055859 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Hand or wrist, or both, left and right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55857 (NR) 1055860 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Forearm or elbow, or both, left or right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55862 (R) 1055861 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Forearm or elbow, or both, left or right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55863 (NR) 1055862 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Forearm or elbow, or both, left and right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with a service mentioned in item 55860 (R) 1055863 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Forearm or elbow, or both, left and right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55861 (NR) 1055864 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Shoulder or upper arm, or both, left or right, ultrasound scan of, if:(a) the 5001.12.2023service is used for the assessment of one or more of the following suspected 5001.12.2023or known conditions:(i) an injury to a muscle, tendon or muscle/tendon 5001.12.2023junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, 5001.12.2023subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) 5001.12.2023capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult 5001.12.2023fracture;(vii) acromioclavicular joint pathology; and(b) the service is not 5001.12.2023performed in conjunction with a service mentioned in item 55866 (R) 1055865 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Shoulder or upper arm, or both, left or right, ultrasound scan of, if:(a) the 5001.12.2023service is used for the assessment of one or more of the following suspected 5001.12.2023or known conditions:(i) an injury to a muscle, tendon or muscle/tendon 5001.12.2023junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, 5001.12.2023subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) 5001.12.2023capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult 5001.12.2023fracture;(vii) acromioclavicular joint pathology; and(b) the service is not 5001.12.2023performed in conjunction with a service mentioned in item 55867 (NR) 1055866 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Shoulder or upper arm, or both, left and right, ultrasound scan of, if:(a) the 5001.12.2023service is used for the assessment of one or more of the following suspected 5001.12.2023or known conditions:(i) an injury to a muscle, tendon or muscle/tendon 5001.12.2023junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, 5001.12.2023subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) 5001.12.2023capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult 5001.12.2023fracture;(vii) acromioclavicular joint pathology; and(b) the service is not 5001.12.2023performed in conjunction with a service mentioned in item 55864 (R) 1055867 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Shoulder or upper arm, or both, left and right, ultrasound scan of, if:(a) the 5001.12.2023service is used for the assessment of one or more of the following suspected 5001.12.2023or known conditions:(i) an injury to a muscle, tendon or muscle/tendon 5001.12.2023junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, 5001.12.2023subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) 5001.12.2023capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult 5001.12.2023fracture;(vii) acromioclavicular joint pathology; and(b) the service is not 5001.12.2023performed in conjunction with a service mentioned in item 55865 (NR) 1055868 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Hip or groin, or both, left or right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55870 (R) 1055869 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Hip or groin, or both, left or right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55871 (NR) 1055870 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Hip or groin, or both, left and right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55868 (R) 1055871 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Hip or groin, or both, left and right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with a service mentioned in item 55869 (NR) 1055872 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Paediatric hip examination for dysplasia, left or right, ultrasound scan of, 5001.12.2023if the service is not performed in conjunction with item 55874 (R) 1055874 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Paediatric hip examination for dysplasia, left and right, ultrasound scan of, 5001.12.2023if the service is not performed in conjunction with item 55872 (R) 1055876 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Buttock or thigh, or both, left or right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55878 (R) 1055877 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Buttock or thigh or both, left or right, ultrasound scan of, if the service is 5001.12.2023not performed in conjunction with item 55879 (NR) 1055878 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Buttock or thigh, or both, left and right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55876 (R) 1055879 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Buttock or thigh, or both, left and right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55877 (NR) 1055880 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Knee, left or right, ultrasound scan of, if: (a) the service is used for the 5001.12.2023assessment of one or more of the following suspected or known conditions:(i) 5001.12.2023abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, 5001.12.2023popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve 5001.12.2023or nerve sheath tumour;(iv) an injury of collateral ligaments; and (b) the 5001.12.2023service is not performed in conjunction with item 55882 (R) 1055881 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Knee, left or right, ultrasound scan of, if:(a) the service is used for the 5001.12.2023assessment of one or more of the following suspected or known conditions: (i) 5001.12.2023abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, 5001.12.2023popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve 5001.12.2023or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the 5001.12.2023service is not performed in conjunction with item 55883 (NR) 1055882 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Knee, left and right, ultrasound scan of, if:(a) the service is used for the 5001.12.2023assessment of one or more of the following suspected or known conditions:(i) 5001.12.2023abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, 5001.12.2023popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve 5001.12.2023or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the 5001.12.2023service is not performed in conjunction with a service mentioned in item 55880 5001.12.2023(R) 1055883 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Knee, left and right, ultrasound scan of, if:(a) the service is used for the 5001.12.2023assessment of one or more of the following suspected or known conditions: (i) 5001.12.2023abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, 5001.12.2023popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve 5001.12.2023or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the 5001.12.2023service is not performed in conjunction with item 55881 (NR) 1055884 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Lower leg, left or right, ultrasound scan of, if the service is not performed 5001.12.2023in conjunction with item 55886 (R) 1055885 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Lower leg, left or right, ultrasound scan of, if the service is not performed 5001.12.2023in conjunction with item 55887 (NR) 1055886 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Lower leg, left and right, ultrasound scan of, if the service is not performed 5001.12.2023in conjunction with item 55884 (R) 1055887 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Lower leg, left and right, ultrasound scan of, if the service is not performed 5001.12.2023in conjunction with item 55885 (NR) 1055888 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Ankle or hind foot, or both, left or right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55890 (R) 1055889 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Ankle or hind foot, or both, left or right, ultrasound scan of, if the service 5001.12.2023is not performed in conjunction with item 55891 (NR) 1055890 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Ankle or hind foot, or both, left and right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55888 (R) 1055891 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Ankle or hind foot, or both, left and right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55889 (NR) 1055892 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300224.0000118.2500000.00 5001.12.2023Mid foot or fore foot, or both, left or right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55894 (R) 1055893 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300078.0000040.9500000.00 5001.12.2023Mid foot or fore foot, or both, left or right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55895 (NR) 1055894 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300248.0000131.2000000.00 5001.12.2023Mid foot or fore foot, or both, left and right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55892 (R) 1055895 01.05.2020 5 I1 6 SN NYNNN 2001.12.202300086.0000045.5500000.00 5001.12.2023Mid foot or fore foot, or both, left and right, ultrasound scan of, if the 5001.12.2023service is not performed in conjunction with item 55893 (NR) 1056001 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300400.0000211.3500000.00 5001.12.2023Computed tomographyscan of brain without intravenous contrast medium, not 5001.12.2023being a service to which item 57001 applies (R) (Anaes.) 1056007 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300512.0000270.8500000.00 5001.12.2023Computed tomographyscan of brain with intravenous contrast medium and with any 5001.12.2023scans of the brain before intravenous contrast injection, when performed, not 5001.12.2023being a service to which item 57007 applies (R) (Anaes.) 1056010 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300516.0000273.1500000.00 5001.12.2023Computed tomographyscan of pituitary fossa with or without intravenous 5001.12.2023contrast medium and with or without brain scan when performed (R) (Anaes.) 1056013 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300512.0000270.8500000.00 5001.12.2023COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast 5001.12.2023medium and with or without brain scan when undertaken (R) (Anaes.) 1056016 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300594.0000314.1500000.00 5001.12.2023Computed tomographyscan of petrous bones in axial and coronal planes in 1 mm 5001.12.2023or 2 mm sections, with or without intravenous contrast medium, with or without 5001.12.2023scan of brain (R) (Anaes.) 1056022 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300461.0000243.7500000.00 5001.12.2023Computed tomographyscan of facial bones, para nasal sinuses or both without 5001.12.2023intravenous contrast medium (R) (Anaes.) 1056028 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300690.0000364.8500000.00 5001.12.2023Computed tomographyscan of facial bones, para nasal sinuses or both with 5001.12.2023intravenous contrast medium and with any scans of the facial bones, para nasal 5001.12.2023sinuses or both before intravenous contrast injection, when performed (R) 5001.12.2023(Anaes.) 1056030 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300461.0000243.7500000.00 5001.12.2023Computed tomographyscan of facial bones, para nasal sinuses or both, with scan 5001.12.2023of brain, without intravenous contrast medium (R) (Anaes.) 1056036 26.05.2002 5 I2 1 SN NYNNN 2001.12.202300690.0000364.8500000.00 5001.12.2023Computed tomographyscan of facial bones, para nasal sinuses or both, with scan 5001.12.2023of brain, with intravenous contrast medium, if:(a) a scan without intravenous 5001.12.2023contrast medium has been performed; and(b) the service is required because the 5001.12.2023result of the scan mentioned in paragraph (a) is abnormal (R) (Anaes.) 1056101 26.05.2002 5 I2 2 SN NYNNN 2001.12.202300471.0000249.1500000.00 5001.12.2023Computed tomographyscan of soft tissues of neck, including larynx, pharynx, 5001.12.2023upper oesophagus and salivary glands (not associated with cervical spine) 5001.12.2023without intravenous contrast medium, not being a service to which item 56801 5001.12.2023applies (R) (Anaes.) 1056107 26.05.2002 5 I2 2 SN NYNNN 2001.12.202300696.0000368.3500000.00 5001.12.2023Computed tomographyscan of soft tissues of neck, including larynx, pharynx, 5001.12.2023upper oesophagus and salivary glands (not associated with cervical spine)with 5001.12.2023intravenous contrast medium and with any scans of soft tissues of neck, 5001.12.2023including larynx, pharynx, upper oesophagus and salivary glands (not 5001.12.2023associated with cervical spine) before intravenous contrast injection, when 5001.12.2023undertaken, not being a service associated with a service to which item 56807 5001.12.2023applies (R) (Anaes.) 1056219 26.05.2002 5 I2 3 SN NYNYN 2001.12.202300668.0000353.4000000.00 4026.05.2002(Anaes.) 5001.12.2023Computed tomographyscan of spine, one or more regions with intrathecal 5001.12.2023contrast medium, including the preparation for intrathecal injection of 5001.12.2023contrast medium and any associated plain X rays, not being a service to which 5001.12.2023item 59724 applies (R) (Anaes.) 1056220 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300492.0000260.0500000.00 5001.12.2023Computed tomographyscan of spine, cervical region, without intravenous 5001.12.2023contrast medium (R) (Anaes.) 1056221 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300492.0000260.0500000.00 5001.12.2023Computed tomographyscan of spine, thoracic region, without intravenous 5001.12.2023contrast medium (R) (Anaes.) 1056223 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300492.0000260.0500000.00 5001.12.2023Computed tomographyscan of spine, lumbosacral region, without intravenous 5001.12.2023contrast medium (R) (Anaes.) 1056224 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300720.0000380.6500000.00 5001.12.2023Computed tomographyscan of spine, cervical region, with intravenous contrast 5001.12.2023medium and with any scans of the cervical region of the spine before 5001.12.2023intravenous contrast injection when undertaken (R) (Anaes.) 1056225 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300720.0000380.6500000.00 5001.12.2023Computed tomographyscan of spine, thoracic region, with intravenous contrast 5001.12.2023medium and with any scans of the thoracic region of the spine before 5001.12.2023intravenous contrast injection when undertaken (R) (Anaes.) 1056226 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300720.0000380.6500000.00 5001.12.2023Computed tomographyscan of spine, lumbosacral region, with intravenous 5001.12.2023contrast medium and with any scans of the lumbosacral region of the spine 5001.12.2023prior to intravenous contrast injection when undertaken (R) (Anaes.) 1056233 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300492.0000260.0500000.00 5001.12.2023NOTE:An account issued or a patient assignment form must show the item numbers 5001.12.2023of the examinations performed under this item Computed tomographyscan of 5001.12.2023spine, 2 examinations of the kind referred to in items 56220, 56221 and 56223, 5001.12.2023without intravenous contrast medium (R) (Anaes.) 1056234 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300720.0000380.6500000.00 5001.12.2023NOTE:An account issued or a patient assignment form must show the item numbers 5001.12.2023of the examinations performed under this item Computed tomographyscan of 5001.12.2023spine, 2 examinations of the kind referred to in items 56224, 56225 and 56226, 5001.12.2023with intravenous contrast medium and with any scans of these regions of the 5001.12.2023spine before intravenous contrast injection when undertaken (R) (Anaes.) 1056237 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300492.0000260.0500000.00 5001.12.2023Computed tomographyscan of spine, 3 regions cervical, thoracic and 5001.12.2023lumbosacral, without intravenous contrast medium (R) (Anaes.) 1056238 26.05.2002 5 I2 3 SN NYNNN 2001.12.202300720.0000380.6500000.00 5001.12.2023Computed tomographyscan of spine, 3 regions, cervical, thoracic and 5001.12.2023lumbosacral, with intravenous contrast medium and with any scans of these 5001.12.2023regions of the spine before intravenous contrast injection when undertaken (R) 5001.12.2023(Anaes.) 1056301 26.05.2002 5 I2 4 SN NYNNN 2001.12.202300604.0000319.6000000.00 5001.12.2023Computed tomographyscan of chest, including lungs, mediastinum, chest wall and 5001.12.2023pleura, with or without scans of the upper abdomen, without intravenous 5001.12.2023contrast medium, not being a service to which item 56801 or 57001 applies and 5001.12.2023not including a study performed to exclude coronary artery calcification or 5001.12.2023image the coronary arteries (R) (Anaes.) 1056307 26.05.2002 5 I2 4 SN NYNNN 2001.12.202300819.0000433.3500000.00 5001.12.2023Computed tomographyscan of chest, including lungs, mediastinum, chest wall and 5001.12.2023pleura, with or without scans of the upper abdomen, with intravenous contrast 5001.12.2023medium and with any scans of the chest, including lungs, mediastinum, chest 5001.12.2023wall or pleura and upper abdomen before intravenous contrast injection, when 5001.12.2023undertaken, not being a service to which item 56807 or 57007 applies and not 5001.12.2023including a study performed to exclude coronary artery calcification or image 5001.12.2023the coronary arteries (R) (Anaes.) 1056401 26.05.2002 5 I2 5 SN NYNNN 2001.12.202300512.0000270.8500000.00 5001.12.2023Computed tomographyscan of upper abdomen only (diaphragm to iliac crest) 5001.12.2023without intravenous contrast medium, not being a service to which item 56301, 5001.12.202356501, 56801 or 57001 applies (R) (Anaes.) 1056407 26.05.2002 5 I2 5 SN NYNNN 2001.12.202300737.0000390.0500000.00 5001.12.2023Computed tomographyscan of upper abdomen only (diaphragm to iliac crest), with 5001.12.2023intravenous contrast medium, and with any scans of upper abdomen (diaphragm to 5001.12.2023iliac crest) before intravenous contrast injection, when undertaken, not being 5001.12.2023a service to which item 56307, 56507, 56807 or 57007 applies (R) (Anaes.) 1056409 26.05.2002 5 I2 5 SN NYNNN 2001.12.202300512.0000270.8500000.00 5001.12.2023Computed tomographyscan of pelvis only (iliac crest to pubic symphysis) 5001.12.2023without intravenous contrast medium not being a service associated with a 5001.12.2023service to which item 56401 applies (R) (Anaes.) 1056412 26.05.2002 5 I2 5 SN NYNNN 2001.12.202300737.0000390.0500000.00 5001.12.2023Computed tomographyscan of pelvis only (iliac crest to pubic symphysis), with 5001.12.2023intravenous contrast medium and with any scans of pelvis (iliac crest to pubic 5001.12.2023symphysis) before intravenous contrast injection, when undertaken, not being a 5001.12.2023service to which item 56407 applies (R) (Anaes.) 1056501 26.05.2002 5 I2 6 SN NYNNN 2001.12.202300789.0000417.0000000.00 5001.12.2023Computed tomographyscan of upper abdomen and pelvis without intravenous 5001.12.2023contrast medium, not for the purposes of virtual colonoscopy and not being a 5001.12.2023service to which item 56801 or 57001 applies(R) (Anaes.) 1056507 26.05.2002 5 I2 6 SN NYNNN 2001.12.202300984.0000520.1000000.00 5001.12.2023Computed tomographyscan of upper abdomen and pelvis with intravenous contrast 5001.12.2023medium and with any scans of upper abdomen and pelvis before intravenous 5001.12.2023contrast injection, when performed, not for the purposes of virtual 5001.12.2023colonoscopy and not being a service to which item 56807 or 57007 applies (R) 5001.12.2023(Anaes.) 1056553 01.09.2015 5 I2 6 SN NYNNN 2001.12.202301065.0000563.3500000.00 4001.09.2015(Anaes.) 5001.12.2023Computed tomographyscan of colon for exclusion or diagnosis of colorectal 5001.12.2023neoplasia in a symptomatic or high risk patient if:(a) one or more of the 5001.12.2023following applies:(i) the patient has had an incomplete colonoscopy in the 3 5001.12.2023months before the scan;(ii) there is a high grade colonic obstruction;(iii) 5001.12.2023the service is requested by a specialist or consultant physician who performs 5001.12.2023colonoscopies in the practice of the specialists or consultant physicians 5001.12.2023speciality; and(b) the service is not a service to which item 56301, 56307, 5001.12.202356401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies(R) 5001.12.2023(Anaes.) 1056620 01.11.2018 5 I2 7 SN NYNNN 2001.12.202300451.0000238.3500000.00 5001.12.2023Computed tomographyscan of knee, without intravenous contrast medium, not 5001.12.2023being a service to which item 56622 or 56629 applies (R) (Anaes.) 1056622 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300451.0000238.3500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of lower limb, left or right or both, one region 5001.12.2023(other than knee), or more than one region (which may include knee), without 5001.12.2023intravenous contrast medium, not being a service to which item 56620 applies 5001.12.2023(R) (Anaes.) (Anaes.) 1056623 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300685.0000362.5500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of lower limb, left or right or both, one region 5001.12.2023(other than knee), or more than one region (which may include knee), with 5001.12.2023intravenous contrast medium and with any scans of the lower limb before 5001.12.2023intravenous contrast injection, when performed, not being a service to which 5001.12.2023item 56626 applies (R) (Anaes.) (Anaes.) 1056626 01.11.2018 5 I2 7 SN NYNNN 2001.12.202300685.0000362.5500000.00 5001.12.2023Computed tomographyscan of knee, with intravenous contrast medium and with any 5001.12.2023scans of the knee before intravenous contrast injection, when performed, not 5001.12.2023being a service to which items 56623 or 56630 apply (R) (Anaes.) 1056627 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300451.0000238.3500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of upper limb, left or right or both, any one region, 5001.12.2023or more than one region, without intravenous contrast medium (R) (Anaes.) 5001.12.2023(Anaes.) 1056628 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300685.0000362.5500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of upper limb, left or right or both, any one region, 5001.12.2023or more than one region, with intravenous contrast medium and with any scans 5001.12.2023of the upper limb before intravenous contrast injection, when performed (R) 5001.12.2023(Anaes.) (Anaes.) 1056629 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300451.0000238.3500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of upper limb and lower limb, left or right or both, 5001.12.2023any one region (other than knee), or more than one region (which may include 5001.12.2023knee) without intravenous contrast medium not being a service to which item 5001.12.202356620 applies (R) (Anaes.) (Anaes.) 1056630 01.05.2020 5 I2 7 SN NYNNN 2001.12.202300685.0000362.5500000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyscan of upper limb and lower limb, left or right or both, 5001.12.2023any one region (other than knee), or more than one region (which may include 5001.12.2023knee) with intravenous contrast medium with any scans of the limbs before 5001.12.2023intravenous contrast injection, when performed, not being a service to which 5001.12.2023item 56626 applies (R) (Anaes.) 1056801 26.05.2002 5 I2 8 SN NYNNN 2001.12.202300956.0000505.4500000.00 5001.12.2023Computed tomographyscan of chest, abdomen and pelvis with or without scans of 5001.12.2023soft tissues of neck without intravenous contrast medium, not including a 5001.12.2023study performed to exclude coronary artery calcification or image the coronary 5001.12.2023arteries (R) (Anaes.) 1056807 26.05.2002 5 I2 8 SN NYNNN 2001.12.202301147.0000606.7000000.00 5001.12.2023Computed tomographyscan of chest, abdomen and pelvis with or without scans of 5001.12.2023soft tissues of neck with intravenous contrast medium and with any scans of 5001.12.2023chest, abdomen and pelvis with or without scans of soft tissue of neck before 5001.12.2023intravenous contrast injection, when performed, not including a study 5001.12.2023performed to exclude coronary artery calcification or image the coronary 5001.12.2023arteries (R) (Anaes.) 1057001 26.05.2002 5 I2 9 SN NYNNN 2001.12.202300956.0000505.5500000.00 5001.12.2023Computed tomographyscan of brain and chest with or without scans of upper 5001.12.2023abdomen without intravenous contrast medium, not including a study performed 5001.12.2023to exclude coronary artery calcification or image the coronary arteries (R) 5001.12.2023(Anaes.) 1057007 26.05.2002 5 I2 9 SN NYNNN 2001.12.202301163.0000615.0500000.00 5001.12.2023Computed tomographyscan of brain and chest with or without scans of upper 5001.12.2023abdomen with intravenous contrast medium and with any scans of brain and chest 5001.12.2023and upper abdomen before intravenous contrast injection, when performed, not 5001.12.2023including a study performed to exclude coronary artery calcification or image 5001.12.2023the coronary arteries (R) (Anaes.) 1057201 26.05.2002 5 I2 10 SN NYNNN 2001.12.202300318.0000168.1500000.00 5001.12.2023Computed tomographypelvimetry (R) (Anaes.) 1057341 26.05.2002 5 I2 11 SN NYNNN 2001.12.202300963.0000509.2000000.00 5001.12.2023Computed tomography, in conjunction with a surgical procedure using 5001.12.2023interventional techniques (R) (Anaes.) 1057352 01.05.2020 5 I2 12 SN NYNNN 2001.12.202301045.0000552.5000000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyangiography with intravenous contrast medium of any or all, 5001.12.2023or any part, of: (a) the arch of the aorta; or (b) the carotid arteries; or 5001.12.2023(c) the vertebral arteries and their branches (head and neck); including any 5001.12.2023scans performed before intravenous contrast injectionone or more data 5001.12.2023acquisitions, including image editing, and maximum intensity projections or 3 5001.12.2023dimensional surface shaded display, with hardcopy or digital recording of 5001.12.2023multiple projections, if: (d) either: (i) the service is requested by a 5001.12.2023specialist or consultant physician; or (ii) the service is requested by a 5001.12.2023medical practitioner (other than a specialist or consultant physician) and the 5001.12.2023request indicates that the patients case has been discussed with a specialist 5001.12.2023or consultant physician; and (e) the service is not a service to which another 5001.12.2023item in this group applies; and (f) the service is performed for the exclusion 5001.12.2023of arterial stenosis, occlusion, aneurysm or embolism; and (g) the service is 5001.12.2023not a study performed to image the coronary arteries (R) (Anaes.) 1057353 01.05.2020 5 I2 12 SN NYNNN 2001.12.202301045.0000552.5000000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyangiography with intravenous contrast medium of any or all, 5001.12.2023or any part, of: (a) the ascending and descending aorta; or (b) the common 5001.12.2023iliac and abdominal branches including upper limbs (chest, abdomen and upper 5001.12.2023limbs); including any scans performed before intravenous contrast injectionone 5001.12.2023or more data acquisitions, including image editing, and maximum intensity 5001.12.2023projections or 3 dimensional surface shaded display, with hardcopy or digital 5001.12.2023recording of multiple projections, if: (c) either: (i) the service is 5001.12.2023requested by a specialist or consultant physician; or (ii) the service is 5001.12.2023requested by a medical practitioner (other than a specialist or consultant 5001.12.2023physician) and the request indicates that the patients case has been discussed 5001.12.2023with a specialist or consultant physician; and (d) the service is not a 5001.12.2023service to which another item in this group applies; and (e) the service is 5001.12.2023performed for the exclusion of arterial stenosis, occlusion, aneurysm or 5001.12.2023embolism; and (f) the service is not a study performed to image the coronary 5001.12.2023arteries (R) (Anaes.) 1057354 01.05.2020 5 I2 12 SN NYNNN 2001.12.202301045.0000552.5000000.00 4001.05.2020(Anaes.) 5001.12.2023Computed tomographyangiography with intravenous contrast medium of any or all, 5001.12.2023or any part, of: (a) the descending aorta; or (b) the pelvic vessels 5001.12.2023(aortoiliac segment) and lower limbs; including any scans performed before 5001.12.2023intravenous contrast injectionone or more data acquisitions, including image 5001.12.2023editing, and maximum intensity projections or 3 dimensional surface shaded 5001.12.2023display, with hardcopy or digital recording of multiple projections, if: (c) 5001.12.2023either: (i) the service is requested by a specialist or consultant physician; 5001.12.2023or (ii) the service is requested by a medical practitioner (other than a 5001.12.2023specialist or consultant physician) and the request indicates that the 5001.12.2023patients case has been discussed with a specialist or consultant physician; 5001.12.2023and (d) the service is not a service to which another item in this group 5001.12.2023applies; and (e) the service is performed for the exclusion of arterial 5001.12.2023stenosis, occlusion, aneurysm or embolism; and (f) the service is not a study 5001.12.2023performed to image the coronary arteries (R) (Anaes.) 1057357 01.11.2020 5 I2 12 SN NYNNN 2001.12.202301045.0000552.5000000.00 4001.11.2020(Anaes.) 5001.12.2023Computed tomographyangiography with intravenous contrast medium of any or all, 5001.12.2023or any part, of the pulmonary arteries and their branches, including any scans 5001.12.2023performed before intravenous contrast injectionone or more data acquisitions, 5001.12.2023including image editing, and maximum intensity projections or 3 dimensional 5001.12.2023surface shaded display, with hardcopy or digital recording of multiple 5001.12.2023projections, if: the service is not a service to which another item in this 5001.12.2023group applies; and the service is not a study performed to image the coronary 5001.12.2023arteries; and the service is:(i) performed for the exclusion of pulmonary 5001.12.2023arterial stenosis, occlusion, aneurysm or embolism and is requested by a 5001.12.2023specialist or consultant physician; or(ii) performed for the exclusion of 5001.12.2023pulmonary arterial stenosis, occlusion or aneurysm and is requested by a 5001.12.2023medical practitioner (other than a specialist or consultant physician) and the 5001.12.2023request indicates that the patients case has been discussed with a specialist 5001.12.2023or consultant physician; or (iii) for the exclusion of pulmonary embolism and 5001.12.2023is requested be a medical practitioner (other than a specialist or consultant 5001.12.2023physician) (R) (Anaes.) 1057360 01.07.2011 5 I2 12 SN NYNNN 2001.12.202301434.0000758.3000000.00 4001.07.2011(Anaes.) 5001.12.2023Computed tomography of the coronary arteries performed on a minimum of a 64 5001.12.2023slice (or equivalent) scanner if: (a) the request is made by a specialist or 5001.12.2023consultant physician; and (b) the patient has stable or acute symptoms 5001.12.2023consistent with coronary ischaemia; and (c) the patient is at low to 5001.12.2023intermediate risk of an acute coronary event, including having no significant 5001.12.2023cardiac biomarker elevation and no electrocardiogram changes indicating acute 5001.12.2023ischaemia (R) Note: See explanatory note IN.2.2 for claiming restrictions for 5001.12.2023this item. (Anaes.) 1057362 01.11.2014 5 I2 13 SN NYNNN 2001.12.202300232.0000122.6000000.00 5001.12.2023Cone beam computed tomographydental and temporo mandibular joint imaging 5001.12.2023(without contrast medium) for diagnosis and management of any of the 5001.12.2023following:(a) mandibular and dento alveolar fractures;(b) dental implant 5001.12.2023planning;(c) orthodontics;(d) endodontic conditions;(e) periodontal 5001.12.2023conditions;(f) temporo mandibular joint conditionsApplicable once per patient 5001.12.2023per day, not being for a service to which any of items 57960 to 57969 apply, 5001.12.2023and not being a service associated with another service in Group I2 (R) 5001.12.2023(Anaes.) 1057506 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300061.0000032.2000000.00 5001.12.2023Hand, wrist, forearm, elbow or humerus (NR) 1057509 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300081.0000043.0500000.00 5001.12.2023Hand, wrist, forearm, elbow or humerus (R) 1057512 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300083.0000043.8000000.00 5001.12.2023Hand and wrist, or hand, wrist and forearm, or forearm and elbow, or elbow and 5001.12.2023humerus (NR) 1057515 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300111.0000058.5000000.00 5001.12.2023Hand and wrist, or hand, wrist and forearm, or forearm and elbow, or elbow and 5001.12.2023humerus (R) 1057518 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300067.0000035.2500000.00 5001.12.2023Foot, ankle, leg or femur (NR) 1057521 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300089.0000047.0500000.00 5001.12.2023Foot, ankle, leg or femur (R) 1057522 01.11.2018 5 I3 1 SN NYNNN 2001.12.202300067.0000035.2500000.00 5001.12.2023Knee (NR) 1057523 01.11.2018 5 I3 1 SN NYNNN 2001.12.202300089.0000047.0500000.00 5001.12.2023Knee (R) 1057524 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300101.0000053.5000000.00 5001.12.2023Foot and ankle, or ankle and leg, or leg and knee, or knee and femur (NR) 1057527 26.05.2002 5 I3 1 SN NYNNN 2001.12.202300135.0000071.2500000.00 5001.12.2023Foot and ankle, or ankle and leg, or leg and knee, or knee and femur (R) 1057541 01.11.2019 5 I3 18 SN NYNNN 2001.12.202300151.0000079.7500000.00 5001.12.2023Fee for a service rendered using first eligible x-ray procedure carried out 5001.12.2023during attendance at residential aged care facility, where the service has 5001.12.2023been requested by a medical practitioner who has attended the patient in 5001.12.2023person and the request identifies one or more of the following indications: 5001.12.2023the patient has experienced a fall and one or more of the following items 5001.12.2023apply to the service 57509, 57515, 57521, 57527,57703, 57709,57712, 57715, 5001.12.202358521, 58524, 58527; or pneumonia or heart failure is suspected and item 58503 5001.12.2023applies to the service; or acute abdomen or bowel obstruction is suspected and 5001.12.2023item 58903applies to the service. This call-out fee can be claimed once only 5001.12.2023per visit at a residential aged care facility irrespective of the number of 5001.12.2023patients attended. NOTE: If the service is bulked billed 95% of the fee is 5001.12.2023payable. The multiple services rule does not apply to this item. (R) 1057700 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300083.0000043.8000000.00 5001.12.2023Shoulder or scapula (NR) 1057703 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300111.0000058.5000000.00 5001.12.2023Shoulder or scapula (R) 1057706 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300067.0000035.2500000.00 5001.12.2023Clavicle (NR) 1057709 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300089.0000047.0500000.00 5001.12.2023Clavicle (R) 1057712 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Hip joint (R) 1057715 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300125.0000066.0000000.00 5001.12.2023Pelvic girdle (R) 1057721 26.05.2002 5 I3 2 SN NYNNN 2001.12.202300203.0000107.5500000.00 5001.12.2023Femur, internal fixation of neck or intertrochanteric (pertrochanteric) 5001.12.2023fracture (R) 1057901 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300132.0000069.8500000.00 5001.12.2023Skull, not in association with item 57902 (R) 1057902 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300132.0000069.8500000.00 5001.12.2023Cephalometry, not in association with item 57901 (R) 1057905 01.05.2020 5 I3 3 SN NYNNN 2001.12.202300132.0000069.8500000.00 5001.12.2023Mastoids or petrous temporal bones (R) 1057907 01.05.2020 5 I3 3 SN NYNNN 2001.12.202300097.0000051.2500000.00 5001.12.2023Sinuses or facial bones orbit, maxilla or malar, any or all (R) 1057915 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Mandible, not by orthopantomography technique (R) 1057918 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Salivary calculus (R) 1057921 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Nose (R) 1057924 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Eye (R) 1057927 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300102.0000053.7500000.00 5001.12.2023Temporo mandibular joints (R) 1057930 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300067.0000035.7000000.00 5001.12.2023Teethsingle area (R) 1057933 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300160.0000084.7500000.00 5001.12.2023Teeth - full mouth(R) 1057939 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300132.0000069.8500000.00 5001.12.2023Palato pharyngeal studies with fluoroscopic screening (R) 1057942 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300102.0000053.7500000.00 5001.12.2023Palato pharyngeal studies without fluoroscopic screening (R) 1057945 26.05.2002 5 I3 3 SN NYNNN 2001.12.202300089.0000047.0500000.00 5001.12.2023Larynx, lateral airways and soft tissues of the neck, not being a service 5001.12.2023associated with a service to which item 57939 or 57942 applies (R) 1057960 01.11.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.4000000.00 5001.12.2023Orthopantomography for diagnosis or management (or both) of trauma, infection, 5001.12.2023tumour or a congenital or surgical condition of the teeth or maxillofacial 5001.12.2023region (R) 1057963 01.11.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.4000000.00 5001.12.2023Orthopantomography for diagnosis or management (or both) of any of the 5001.12.2023following conditions, if the signs and symptoms of the condition is 5001.12.2023present:(a) impacted teeth;(b) caries;(c) periodontal pathology;(d) periapical 5001.12.2023pathology (R) 1057966 01.11.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.4000000.00 5001.12.2023Orthopantomography for diagnosis or management (or both) of missing or crowded 5001.12.2023teeth, or developmental anomalies of the teeth or jaws (R) 1057969 01.11.2002 5 I3 3 SN NYNNN 2001.12.202300097.0000051.4000000.00 5001.12.2023Orthopantomography for diagnosis or management (or both) of temporo mandibular 5001.12.2023joint arthroses or dysfunction (R) 1058100 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300138.0000072.7000000.00 5001.12.2023Spinecervical (R) 1058103 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300113.0000059.7000000.00 5001.12.2023Spinethoracic (R) 1058106 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300158.0000083.4000000.00 5001.12.2023Spinelumbosacral (R) 1058108 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300225.0000119.1500000.00 5001.12.2023Spine4 regions, cervical, thoracic, lumbosacral and sacrococcygeal (R) 1058109 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300096.0000050.9000000.00 5001.12.2023Spinesacrococcygeal (R) 1058112 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300199.0000105.3500000.00 5001.12.2023NOTE:An account issued or a patient assignment form must show the item numbers 5001.12.2023of the examinations performed under this item Spine2 examinations of the kind 5001.12.2023mentioned in items 58100, 58103, 58106 and 58109 (R) 1058115 26.05.2002 5 I3 4 SN NYNNN 2001.12.202300225.0000119.1500000.00 5001.12.2023NOTE:An account issued or a patient assignment form must show the item numbers 5001.12.2023of the examinations performed under this item Spine3 examinations of the kind 5001.12.2023mentioned in items 58100, 58103, 58106 and 58109 (R) 1058120 01.01.2010 5 I3 4 SN NYNNN 2001.12.202300225.0000119.1500000.00 5001.12.2023Spine4 regions, cervical, thoracic, lumbosacral and sacrococcygeal, if the 5001.12.2023service to which item 58120 or 58121 applies has not been performed on the 5001.12.2023same patient within the same calendar year (R) 1058121 01.01.2010 5 I3 4 SN NYNNN 2001.12.202300225.0000119.1500000.00 5001.12.2023NOTE:An account issued or a patient assignment form must show the item numbers 5001.12.2023of the examinations performed under this item Spine3 examinations of the kind 5001.12.2023mentioned in items 58100, 58103, 58106 and 58109, if the service to which item 5001.12.202358120 or 58121 applies has not been performed on the same patient within the 5001.12.2023same calendar year (R) 1058300 26.05.2002 5 I3 5 SN NYNNN 2001.12.202300082.0000043.4000000.00 5001.12.2023Bone age study (R) 1058306 26.05.2002 5 I3 5 SN NYNNN 2001.12.202300183.0000096.8500000.00 5001.12.2023Skeletal survey (R) 1058500 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300072.0000038.3000000.00 5001.12.2023Chest (lung fields) by direct radiography (NR) 1058503 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300097.0000051.0500000.00 5001.12.2023Chest (lung fields) by direct radiography (R) 1058506 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300125.0000065.8500000.00 5001.12.2023Chest (lung fields) by direct radiography with fluoroscopic screening (R) 1058509 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300081.0000043.0500000.00 5001.12.2023Thoracic inlet or trachea (R) 1058521 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300089.0000047.0500000.00 5001.12.2023Left ribs, right ribs or sternum (R) 1058524 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300116.0000061.2000000.00 5001.12.2023Left and right ribs, left ribs and sternum, or right ribs and sternum (R) 1058527 26.05.2002 5 I3 6 SN NYNNN 2001.12.202300142.0000075.2000000.00 5001.12.2023Left ribs, right ribs and sternum (R) 1058700 26.05.2002 5 I3 7 SN NYNNN 2001.12.202300094.0000049.8500000.00 5001.12.2023Plain renal only (R) 1058706 26.05.2002 5 I3 7 SN NYNNN 2001.12.202300323.0000171.0500000.00 5001.12.2023Intravenous pyelography, with or without preliminary plain films and with or 5001.12.2023without tomography (R) 1058715 26.05.2002 5 I3 7 SN NYNNN 2001.12.202300310.0000164.2000000.00 5001.12.2023Antegrade or retrograde pyelography with or without preliminary plain films 5001.12.2023and with preparation and contrast injection, one side (R) 1058718 26.05.2002 5 I3 7 SN NYNNN 2001.12.202300258.0000136.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Retrograde cystography or retrograde urethrography with or without preliminary 5001.12.2023plain films and with preparation and contrast injection (R) (Anaes.) 1058721 26.05.2002 5 I3 7 SN NYNNN 2001.12.202300283.0000149.7500000.00 4026.05.2002(Anaes.) 5001.12.2023Retrograde micturating cysto urethrography, with preparation and contrast 5001.12.2023injection (R) (Anaes.) 1058900 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300073.0000038.7500000.00 5001.12.2023Plain abdominal only, not being a service associated with a service to which 5001.12.2023item 58909, 58912 or 58915 applies (NR) 1058903 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300098.0000051.6000000.00 5001.12.2023Plain abdominal only, not being a service associated with a service to which 5001.12.2023item 58909, 58912 or 58915 applies (R) 1058909 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300184.0000097.4000000.00 5001.12.2023Barium or other opaque meal of one or more of pharynx, oesophagus, stomach or 5001.12.2023duodenum, with or without preliminary plain films of pharynx, chest or 5001.12.2023duodenum, not being a service associated with a service to which item 57939, 5001.12.202357942 or 57945 applies (R) 1058912 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300226.0000119.4500000.00 5001.12.2023Barium or other opaque meal of oesophagus, stomach, duodenum and follow 5001.12.2023through to colon, with or without screening of chest and with or without 5001.12.2023preliminary plain film (R) 1058915 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300162.0000085.5500000.00 5001.12.2023Barium or other opaque meal, small bowel series only, with or without 5001.12.2023preliminary plain film (R) 1058916 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300284.0000150.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Small bowel enema, barium or other opaque study of the small bowel, including 5001.12.2023duodenal intubation, with or without preliminary plain films, not being a 5001.12.2023service associated with a service to which item 30488 applies (R) (Anaes.) 1058921 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300277.0000146.5500000.00 5001.12.2023Opaque enema, with or without air contrast study and with or without 5001.12.2023preliminary plain films (R) 1058927 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300157.0000082.8000000.00 5001.12.2023Cholegraphy direct, with or without preliminary plain films and with 5001.12.2023preparation and contrast injection, not being a service associated with a 5001.12.2023service to which item 30439 applies (R) 1058933 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300421.0000222.7500000.00 5001.12.2023Cholegraphy, percutaneous transhepatic, with or without preliminary plain 5001.12.2023films and with preparation and contrast injection (R) 1058936 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300401.0000212.3000000.00 5001.12.2023Cholegraphy, drip infusion, with or without preliminary plain films, with 5001.12.2023preparation and contrast injection and with or without tomography (R) 1058939 26.05.2002 5 I3 8 SN NYNNN 2001.12.202300285.0000150.9000000.00 5001.12.2023Defaecogram (R) 1059103 26.05.2002 5 I3 9 SN NYNNN 2001.12.202300044.0000023.0500000.00 5001.12.2023Localisation of foreign body, if provided in conjunction with a service 5001.12.2023described in Subgroups 1 to 12 of Group I3 (R) 1059300 26.05.2002 5 I3 10 SN NYNNN 2001.12.202300183.0000096.9500000.00 5001.12.2023Mammography of both breasts if there is reason to suspect the presence of 5001.12.2023malignancy because of:(a) the past occurrence of breast malignancy in the 5001.12.2023patient; or(b) significant history of breast or ovarian malignancy in the 5001.12.2023patients family; or(c) symptoms or indications of breast disease found on 5001.12.2023examination of the patient by a medical practitioner (R) (Note: These items 5001.12.2023are intended for use in the investigation of a clinical abnormality of the 5001.12.2023breast/s and NOT for individual, group or opportunistic screening of 5001.12.2023asymptomatic patients) 1059302 01.11.2018 5 I3 10 SN NYNNN 2001.12.202300414.0000218.8500000.00 5001.12.2023Three dimensional tomosynthesis of both breasts, if there is reason to suspect 5001.12.2023the presence of malignancy because of: a) the past occurrence of breast 5001.12.2023malignancy in the patient; or b) significant history of breast or ovarian 5001.12.2023malignancy in the patients family; or c) symptoms or indications of breast 5001.12.2023disease found on examination of the patient by a medical practitioner Not 5001.12.2023being a service to which item 59300 applies (R) 1059303 26.05.2002 5 I3 10 SN NYNNN 2001.12.202300111.0000058.4500000.00 5001.12.2023Mammography of one breast if: (a) the service is specifically requested for a 5001.12.2023unilateral mammogram; and(b) there is reason to suspect the presence of 5001.12.2023malignancy because of:(i) the past occurrence of breast malignancy in the 5001.12.2023patient; or(ii) significant history of breast or ovarian malignancy in the 5001.12.2023patients family; or(iii) symptoms or indications of breast disease found on 5001.12.2023examination of the patient by a medical practitioner (R) 1059305 01.11.2018 5 I3 10 SN NYNNN 2001.12.202300234.0000123.4500000.00 5001.12.2023Three dimensional tomosynthesis of one breast, if there is reason to suspect 5001.12.2023the presence of malignancy because of: a) the past occurrence of breast 5001.12.2023malignancy in the patient; or b) significant history of breast or ovarian 5001.12.2023malignancy in the patients family; or c) symptoms or indications of breast 5001.12.2023disease found on examination of the patient by a medical practitioner Not 5001.12.2023being a service to which item 59303 applies (R) 1059312 26.05.2002 5 I3 10 SN NYNNN 2001.12.202300178.0000094.2500000.00 5001.12.2023Radiographic examination of both breasts, in conjunction with a surgical 5001.12.2023procedure on each breast, using interventional techniques (R) 1059314 26.05.2002 5 I3 10 SN NYNNN 2001.12.202300108.0000056.9000000.00 5001.12.2023Radiographic examination of one breast, in conjunction with a surgical 5001.12.2023procedure using interventional techniques (R) 1059318 26.05.2002 5 I3 10 SN NYNNN 2001.12.202300096.0000050.9500000.00 5001.12.2023Radiographic examination of excised breast tissue to confirm satisfactory 5001.12.2023excision of one or more lesions in one breast or both following pre-operative 5001.12.2023localisation in conjunction with a service under item 31536 (R) 1059700 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300198.0000104.6000000.00 4026.05.2002(Anaes.) 5001.12.2023Discography, each disc, with or without preliminary plain films and with 5001.12.2023preparation and contrast injection (R) (Anaes.) (Anaes.) 1059703 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300156.0000082.2500000.00 5001.12.2023Dacryocystography, one side, with or without preliminary plain film and with 5001.12.2023preparation and contrast injection (R) 1059712 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300233.0000123.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Hysterosalpingography, with or without preliminary plain films and with 5001.12.2023preparation and contrast injection (R)(Anaes.) (Anaes.) 1059718 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300276.0000145.9000000.00 4026.05.2002(Anaes.) 5001.12.2023Phlebography, one side, with or without preliminary plain films and with 5001.12.2023preparation and contrast injection (R) (Anaes.) (Anaes.) 1059724 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300464.0000245.3000000.00 4026.05.2002(Anaes.) 5001.12.2023Myelography, one or more regions, with or without preliminary plain films and 5001.12.2023with preparation and contrast injection, not being a service associated with a 5001.12.2023service to which item 56219 applies (R)(Anaes.) (Anaes.) 1059733 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300221.0000116.7000000.00 5001.12.2023Sialography, one side, with preparation and contrast injection, not being a 5001.12.2023service associated with a service to which item 57918 applies (R) 1059739 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300151.0000079.8500000.00 5001.12.2023Sinogram or fistulogram, one or more regions, with or without preliminary 5001.12.2023plain films and with preparation and contrast injection (R) 1059751 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300285.0000150.7500000.00 5001.12.2023Arthrography, each joint, excluding the facet (zygapophyseal) joints of the 5001.12.2023spine, single or double contrast study, with or without preliminary plain 5001.12.2023films and with preparation and contrast injection (R) 1059754 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300449.0000237.6500000.00 5001.12.2023Lymphangiography, one or both sides, with preliminary plain films and 5001.12.2023follow-up radiography and with preparation and contrast injection (R) 1059763 26.05.2002 5 I3 12 SN NYNNN 2001.12.202300274.0000145.0000000.00 5001.12.2023Air insufflation during videofluoroscopic imaging including associated 5001.12.2023consultation (R) 1059970 26.05.2002 5 I3 13 SN NYNNN 2001.12.202300345.0000182.3000000.00 5001.12.2023Angiography or digital subtraction angiography, or both, with fluoroscopy and 5001.12.2023image acquisition, using a mobile image intensifier, including any preliminary 5001.12.2023plain films, preparation and contrast injectionone or more regions (R) 5001.12.2023(Anaes.) 1060000 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of head and neck with or without 5001.12.2023arch aortography1 to 3 data acquisition runs (R) (Anaes.) 1060003 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of head and neck with or without 5001.12.2023arch aortography4 to 6 data acquisition runs (R) (Anaes.) 1060006 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of head and neck with or without 5001.12.2023arch aortography7 to 9 data acquisition runs (R) (Anaes.) 1060009 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of head and neck with or without 5001.12.2023arch aortography10 or more data acquisition runs (R) (Anaes.) 1060012 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of thorax1 to 3 data acquisition 5001.12.2023runs (R) (Anaes.) 1060015 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of thorax4 to 6 data acquisition 5001.12.2023runs (R) (Anaes.) 1060018 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of thorax7 to 9 data acquisition 5001.12.2023runs (R) (Anaes.) 1060021 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of thorax10 or more data 5001.12.2023acquisition runs (R) (Anaes.) 1060024 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of abdomen1 to 3 data acquisition 5001.12.2023runs (R) (Anaes.) 1060027 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of abdomen4 to 6 data acquisition 5001.12.2023runs (R) (Anaes.) 1060030 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of abdomen7 to 9 data acquisition 5001.12.2023runs (R) (Anaes.) 1060033 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of abdomen10 or more data 5001.12.2023acquisition runs (R) (Anaes.) 1060036 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of upper limb or limbs1 to 3 data 5001.12.2023acquisition runs (R) (Anaes.) 1060039 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of upper limb or limbs4 to 6 data 5001.12.2023acquisition runs (R) (Anaes.) 1060042 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of upper limb or limbs7 to 9 data 5001.12.2023acquisition runs (R) (Anaes.) 1060045 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of upper limb or limbs10 or more 5001.12.2023data acquisition runs (R) (Anaes.) 1060048 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of lower limb or limbs1 to 3 data 5001.12.2023acquisition runs (R) (Anaes.) 1060051 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of lower limb or limbs4 to 6 data 5001.12.2023acquisition runs (R) (Anaes.) 1060054 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of lower limb or limbs7 to 9 data 5001.12.2023acquisition runs (R) (Anaes.) 1060057 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of lower limb or limbs10 or more 5001.12.2023data acquisition runs (R) (Anaes.) 1060060 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301155.0000611.0500000.00 5001.12.2023Digital subtraction angiography, examination of aorta and lower limb or limbs1 5001.12.2023to 3 data acquisition runs (R) (Anaes.) 1060063 26.05.2002 5 I3 13 SN NYNNN 2001.12.202301694.0000896.0500000.00 5001.12.2023Digital subtraction angiography, examination of aorta and lower limb or limbs4 5001.12.2023to 6 data acquisition runs (R) (Anaes.) 1060066 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302409.0001274.1500000.00 5001.12.2023Digital subtraction angiography, examination of aorta and lower limb or limbs7 5001.12.2023to 9 data acquisition runs (R) (Anaes.) 1060069 26.05.2002 5 I3 13 SN NYNNN 2001.12.202302819.0001491.0000000.00 5001.12.2023Digital subtraction angiography, examination of aorta and lower limb or 5001.12.2023limbs10 or more data acquisition runs (R) (Anaes.) 1060072 26.05.2002 5 I3 13 SN NYNNN 2001.12.202300099.0000052.1000000.00 5001.12.2023Selective arteriography or selective venography by digital subtraction 5001.12.2023angiography techniqueone vessel (NR) (Anaes.) 1060075 26.05.2002 5 I3 13 SN NYNNN 2001.12.202300197.0000104.1500000.00 5001.12.2023Selective arteriography or selective venography by digital subtraction 5001.12.2023angiography technique2 vessels (NR) (Anaes.) 1060078 26.05.2002 5 I3 13 SN NYNNN 2001.12.202300295.0000156.2500000.00 5001.12.2023Selective arteriography or selective venography by digital subtraction 5001.12.2023angiography technique3 or more vessels (NR) (Anaes.) 1060500 26.05.2002 5 I3 15 SN NYNNN 2001.12.202300089.0000047.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Fluoroscopy, with general anaesthesia (not being a service associated with a 5001.12.2023radiographic examination) (R) (Anaes.) 1060503 26.05.2002 5 I3 15 SN NYNNN 2001.12.202300061.0000032.2000000.00 5001.12.2023Fluoroscopy, without general anaesthesia (not being a service associated with 5001.12.2023a radiographic examination) (R) 1060506 26.05.2002 5 I3 15 SN NYNNN 2001.12.202300131.0000069.1000000.00 5001.12.2023Fluoroscopy using a mobile image intensifier, in conjunction with a surgical 5001.12.2023procedure lasting less than 1 hour, not being a service associated with a 5001.12.2023service to which another item in this Group applies (R) 1060509 26.05.2002 5 I3 15 SN NYNNN 2001.12.202300203.0000107.1500000.00 5001.12.2023Fluoroscopy using a mobile image intensifier, in conjunction with a surgical 5001.12.2023procedure lasting 1 hour or more, not being a service associated with a 5001.12.2023service to which another item in this Group applies (R) 1060918 26.05.2002 5 I3 16 SN NYNYN 2001.12.202300097.0000051.0500000.00 4026.05.2002(Anaes.) 5001.12.2023Arteriography (peripheral) or phlebographyone vessel, when used in association 5001.12.2023with a service to which item 59970 applies, not being a service associated 5001.12.2023with a service to which any of items 60000 to 60078 apply (NR) (Anaes.) 1060927 26.05.2002 5 I3 16 SN NYNNN 2001.12.202300078.0000041.1500000.00 4026.05.2002(Anaes.) 5001.12.2023Selective arteriogram or phlebogram, when used in association with a service 5001.12.2023to which item 59970 applies, not being a service associated with a service to 5001.12.2023which any of items 60000 to 60078 apply (NR) (Anaes.) 1061109 26.05.2002 5 I3 17 SN NYNNN 2001.12.202300530.0000280.5000000.00 5001.12.2023Fluoroscopy in an angiography suite with image intensification, in conjunction 5001.12.2023with a surgical procedure using interventional techniques, not being a service 5001.12.2023associated with a service to which another item in this Group applies (R) 1061310 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300735.0000367.3000000.00 5001.12.2023Myocardial infarct avid study (R) 1061313 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300607.0000303.3500000.00 5001.12.2023Gated cardiac blood pool study, (equilibrium) (R) 1061314 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300840.0000420.0000000.00 5001.12.2023Gated cardiac blood pool study, with or without intervention, and first pass 5001.12.2023blood flow or cardiac shunt study (R) 1061321 01.08.2020 5 I4 1 SN NYNYN 2001.12.202300658.0000329.0000000.00 5001.12.2023Single rest myocardial perfusion study for the assessment of the extent and 5001.12.2023severity of viable and nonviable myocardium, with single photon emission 5001.12.2023tomography, with or without planar imaging, if: (a) the patient has left 5001.12.2023ventricular systolic dysfunction and probable or confirmed coronary artery 5001.12.2023disease; and (b) the service uses a single rest technetium99m (Tc99m) 5001.12.2023protocol; and (c) the service is requested by a specialist or a consultant 5001.12.2023physician; and (d) the service is not associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 11729, 11730, 61325, 61329, 61345, 61398 or 61406 5001.12.2023applies; and (e) if the patient is 17 years or oldera service to which this 5001.12.2023item, or item 61325, 61329, 61345, 61398 or 61406 applies has not been 5001.12.2023provided to the patient in the previous 24 months (R) 1061324 01.08.2020 5 I4 1 SN NYNYN 2001.12.202301306.0000653.0500000.00 5001.12.2023Single stress myocardial perfusion study, with single photon emission 5001.12.2023tomography, with or without planar imaging, if: (a) the patient has symptoms 5001.12.2023of cardiac ischaemia; and (b) at least one of the following applies: (i) the 5001.12.2023patient has body habitus or other physical conditions (including heart rhythm 5001.12.2023disturbance) to the extent that a stress echocardiography would not provide 5001.12.2023adequate information; (ii) the patient is unable to exercise to the extent 5001.12.2023required for a stress echocardiography to provide adequate information; (iii) 5001.12.2023the patient has had a failed stress echocardiography provided in a service to 5001.12.2023which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes 5001.12.2023resting ECG, continuous ECG monitoring during exercise (with recording), blood 5001.12.2023pressure monitoring and the recording of other parameters (including heart 5001.12.2023rate); and (d) the service is requested by a specialist or consultant 5001.12.2023physician; and (e) the service is not associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345, 61357, 5001.12.202361394, 61398, 61406 or 61414 applies; and (f) if the patient is 17 years or 5001.12.2023oldera service to which this item, or item 61329, 61345, 61357, 61394, 61398, 5001.12.202361406, 61410 or 61414, applies has not been provided to the patient in the 5001.12.2023previous 24 months (R) 1061325 01.08.2020 5 I4 1 SN NYNYN 2001.12.202300658.0000329.0000000.00 5001.12.2023Single rest myocardial perfusion study for the assessment of the extent and 5001.12.2023severity of viable and nonviable myocardium, with single photon emission 5001.12.2023tomography, with or without planar imaging, if: (a) the patient has left 5001.12.2023ventricular systolic dysfunction and probable or confirmed coronary artery 5001.12.2023disease; and (b) the service uses: (i) an initial rest study followed by a 5001.12.2023redistribution study on the same day; and (ii) a thallous chloride201 (Tl201) 5001.12.2023protocol; and (c) the service is requested by a specialist or a consultant 5001.12.2023physician; and (d) the service is not associated with a service to which item 5001.12.202311704, 11705, 11707, 11714, 11729, 11730, 61321, 61329, 61345, 61398 or 61406 5001.12.2023applies; and (e) if the patient is 17 years or older: (i) a service to which 5001.12.2023item 61321, 61329, 61345, 61398 or 61406 applies has not been provided to the 5001.12.2023patient in the previous 24 months; and (ii) the service is applicable only 5001.12.2023twice each 24 months (R) 1061328 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300455.0000227.6500000.00 5001.12.2023Lung perfusion study (R) 1061329 01.08.2020 5 I4 1 SN NYNYN 2001.12.202301964.0000982.0500000.00 5001.12.2023Combined stress and rest, stress and reinjection or rest and redistribution 5001.12.2023myocardial perfusion study, including delayed imaging or reinjection protocol 5001.12.2023on a subsequent occasion, with single photon emission tomography, with or 5001.12.2023without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; 5001.12.2023and (b) at least one of the following applies: (i) the patient has body 5001.12.2023habitus or other physical conditions (including heart rhythm disturbance) to 5001.12.2023the extent that a stress echocardiography would not provide adequate 5001.12.2023information; (ii) the patient is unable to exercise to the extent required for 5001.12.2023a stress echocardiography to provide adequate information; (iii) the patient 5001.12.2023has had a failed stress echocardiography provided in a service to which item 5001.12.202355141, 55143, 55145 or 55146 applies; and (c) the service includes resting 5001.12.2023electrocardiograph, continuous electrocardiograph monitoring during exercise 5001.12.2023(with recording), blood pressure monitoring and the recording of other 5001.12.2023parameters (including heart rate); and (d) the service is requested by a 5001.12.2023medical practitioner (other than a specialist or consultant physician); and 5001.12.2023(e) the service is not associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 11729, 11730, 61321, 61324, 61325, 61345, 61357, 61394, 61398, 5001.12.202361406 or 61414 applies; and (f) if the patient is 17 years or oldera service 5001.12.2023to which this item, or item 61321, 61324, 61325, 61345, 61357, 61394, 61398, 5001.12.202361406 or 61414, applies has not been provided to the patient in the previous 5001.12.202324 months (R) 1061333 14.09.2019 5 I4 2 DN NNNNN 2001.12.202300887.0000443.3500000.00 5001.12.2023Lung ventilation study using Galligas and lung perfusion study using 5001.12.2023gallium-68 macro aggregated albumin (68Ga-MAA), with PET, if the service is 5001.12.2023performed because the service to which item 61348 applies cannot be performed 5001.12.2023due to unavailability of technetium-99m (R) 1061336 14.09.2019 5 I4 2 DN NNNNN 2001.12.202301210.0000605.0500000.00 5001.12.2023Cerebral study, with PET, if the service is performed because the service to 5001.12.2023which item 61402 applies cannot be performed due to unavailability of 5001.12.2023technetium-99m (R) 1061340 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300506.0000253.0000000.00 5001.12.2023Lung ventilation study using aerosol, technegas or xenon gas (R) 1061341 14.09.2019 5 I4 2 DN NNNNN 2001.12.202301201.0000600.7000000.00 5001.12.2023Bone study whole body with PET, with delayed imaging when undertaken, if the 5001.12.2023service is performed because the services to which item 61421 or 61425 apply 5001.12.2023cannot be performed due to unavailability of technetium-99m (R) 1061345 01.08.2020 5 I4 1 SN NYNYN 2001.12.202301964.0000982.0500000.00 5001.12.2023Combined stress and rest, stress and reinjection or rest and redistribution 5001.12.2023myocardial perfusion study, including delayed imaging or reinjection protocol 5001.12.2023on a subsequent occasion, with single photon emission tomography, with or 5001.12.2023without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; 5001.12.2023and (b) at least one of the following applies: (i) the patient has body 5001.12.2023habitus or other physical conditions (including heart rhythm disturbance) to 5001.12.2023the extent that a stress echocardiography would not provide adequate 5001.12.2023information; (ii) the patient is unable to exercise to the extent required for 5001.12.2023a stress echocardiography to provide adequate information; (iii) the patient 5001.12.2023has had a failed stress echocardiography provided in a service to which item 5001.12.202355141, 55143, 55145 or 55146 applies; and (c) the service includes resting 5001.12.2023electrocardiograph, continuous electrocardiograph monitoring during exercise 5001.12.2023(with recording), blood pressure monitoring and the recording of other 5001.12.2023parameters (including heart rate); and (d) the service is requested by a 5001.12.2023specialist or consultant physician; and (e) the service is not associated with 5001.12.2023a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 5001.12.202361324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414 applies (R); and (f) 5001.12.2023if the patient is 17 years or oldera service to which this item, or item 5001.12.202361321, 61324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414, applies has 5001.12.2023not been provided to the patient in the previous 24 months (R) 1061348 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300887.0000443.3500000.00 5001.12.2023Lung perfusion study and lung ventilation study using aerosol, technegas or 5001.12.2023xenon gas (R) 1061349 01.08.2020 5 I4 1 SN NYNYN 2001.12.202301964.0000982.0500000.00 5001.12.2023Repeat combined stress and rest, stress and reinjection or rest and 5001.12.2023redistribution myocardial perfusion study, including delayed imaging or 5001.12.2023reinjection protocol on a subsequent occasion, with single photon emission 5001.12.2023tomography, with or without planar imaging, if: (a) both: (i) a service has 5001.12.2023been provided to the patient in the previous 24 months to which this item, or 5001.12.2023item 61324, 61329, 61345, 61357, 61394, 61398, 61406, 61410 or 61414 applies; 5001.12.2023and (ii) the patient has subsequently undergone a revascularisation procedure; 5001.12.2023and (b) the patient has one or more symptoms of cardiac ischaemia that have 5001.12.2023evolved and are not adequately controlled with optimal medical therapy; and 5001.12.2023(c) at least one of the following applies: (i) the patient has body habitus or 5001.12.2023other physical conditions (including heart rhythm disturbance) to the extent 5001.12.2023that a stress echocardiography would not provide adequate information; (ii) 5001.12.2023the patient is unable to exercise to the extent required for a stress 5001.12.2023echocardiography to provide adequate information; (iii) the patient has had a 5001.12.2023failed stress echocardiography provided in a service to which item 55141, 5001.12.202355143, 55145 or 55146 applies; and (d) the service is requested by a 5001.12.2023specialist or a consultant physician; and (e) the service is not associated 5001.12.2023with a service to which item 11704, 11705, 11707, 11714, 11729, 11730 or 61410 5001.12.2023applies; and (f) if the patient is 17 years or oldera service to which this 5001.12.2023item, or item 61410, applies has not been provided to the patient in the 5001.12.2023previous 12 months (R) 1061353 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300773.0000386.6000000.00 5001.12.2023Liver and spleen study (colloid) (R) 1061356 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300786.0000392.8000000.00 5001.12.2023Red blood cell spleen or liver study (R) 1061357 01.08.2020 5 I4 1 SN NYNYN 2001.12.202301306.0000653.0500000.00 5001.12.2023Single stress myocardial perfusion study, with single photon emission 5001.12.2023tomography, with or without planar imaging, if: (a) the patient has symptoms 5001.12.2023of cardiac ischaemia; and (b) at least one of the following applies: (i) the 5001.12.2023patient has body habitus or other physical conditions (including heart rhythm 5001.12.2023disturbance) to the extent that a stress echocardiography would not provide 5001.12.2023adequate information; (ii) the patient is unable to exercise to the extent 5001.12.2023required for a stress echocardiography to provide adequate information; (iii) 5001.12.2023the patient has had a failed stress echocardiography provided in a service to 5001.12.2023which items 55141, 55143, 55145 or 55146 applies; and (c) the service includes 5001.12.2023resting electrocardiograph, continuous electrocardiograph monitoring during 5001.12.2023exercise (with recording), blood pressure monitoring and the recording of 5001.12.2023other parameters (including heart rate); and (d) the service is requested by a 5001.12.2023medical practitioner (other than a specialist or consultant physician); and 5001.12.2023(e) the service is not associated with a service to which item 11704, 11705, 5001.12.202311707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61394, 61398, 5001.12.202361406 or 61414 applies; and (f) if the patient is 17 years or oldera service 5001.12.2023to which this item, or item 61324, 61329, 61345, 61394, 61398, 61406, or 5001.12.202361414, applies has not been provided to the patient in the previous 24 months 5001.12.2023(R) 1061360 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300807.0000403.3500000.00 5001.12.2023Hepatobiliary study, including morphine administration or pre-treatment with a 5001.12.2023cholagogue when performed (R) 1061361 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300923.0000461.4000000.00 5001.12.2023Hepatobiliary study with formal quantification following baseline imaging, 5001.12.2023using a cholagogue (R) 1061364 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300994.0000496.9500000.00 5001.12.2023Bowel haemorrhage study (R) 1061368 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300446.0000223.1000000.00 5001.12.2023Meckels diverticulum study (R) 1061369 26.05.2002 5 I4 1 SN NNNNN 2001.12.202304032.0002015.7500000.00 5001.12.2023Indium-labelled octreotide study (including single photon emission tomography 5001.12.2023when undertaken), if:(a) a gastro-entero-pancreatic endocrine tumour is 5001.12.2023suspected on the basis of biochemical evidence with negative or equivocal 5001.12.2023conventional imaging; or(b) both:(i) a surgically amenable 5001.12.2023gastro-entero-pancreatic endocrine tumour has been identified on the basis of 5001.12.2023conventional techniques; and(ii) the study is to exclude additional disease 5001.12.2023sites (R) 1061372 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300446.0000223.1000000.00 5001.12.2023Salivary study (R) 1061373 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300979.0000489.7000000.00 5001.12.2023Gastro-oesophageal reflux study, including delayed imaging on a separate 5001.12.2023occasion when performed (R) 1061376 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300287.0000143.3500000.00 5001.12.2023Oesophageal clearance study (R) 1061381 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301149.0000574.3500000.00 5001.12.2023Gastric emptying study, using single tracer (R) 1061383 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301250.0000624.9500000.00 5001.12.2023Combined solid and liquid gastric emptying study using dual isotope technique 5001.12.2023or the same isotope on separate days (R) 1061384 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301375.0000687.7000000.00 5001.12.2023Radionuclide colonic transit study (R) 1061386 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300665.0000332.5000000.00 5001.12.2023Renal study, including perfusion and renogram images and computer analysis or 5001.12.2023cortical study with planar imaging (R) 1061387 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300862.0000430.7500000.00 5001.12.2023Renal cortical study, with single photon emission tomography and planar 5001.12.2023quantification (R) 1061389 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300741.0000370.5500000.00 5001.12.2023Single renal study with pre-procedural administration of a diuretic or 5001.12.2023angiotensin converting enzyme (ACE) inhibitor (R) 1061390 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300820.0000409.9500000.00 5001.12.2023Renal study with diuretic administration after a baseline study (R) 1061393 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301211.0000605.5000000.00 5001.12.2023Combined examination involving a renal study following angiotensin converting 5001.12.2023enzyme (ACE) inhibitor provocation and a baseline study, in either order and 5001.12.2023related to a single referral episode (R) 1061397 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300494.0000246.8500000.00 5001.12.2023Cystoureterogram (R) 1061402 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301210.0000605.0500000.00 5001.12.2023Cerebral perfusion study, with single photon emission tomography and with 5001.12.2023planar imaging when performed (R) 1061409 26.05.2002 5 I4 1 SN NNNYN 2001.12.202301747.0000873.5000000.00 5001.12.2023Cerebro-spinal fluid transport study using technetium 99m, with imaging on 2 5001.12.2023or more separate occasions (R) 1061413 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300452.0000225.9500000.00 5001.12.2023Cerebro spinal fluid shunt patency study (R) 1061421 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300960.0000479.8000000.00 5001.12.2023Bone studywhole body, with, when undertaken, blood flow, blood pool and 5001.12.2023delayed imaging on a separate occasion (R) 1061425 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301201.0000600.7000000.00 5001.12.2023Bone studywhole body and single photon emission tomography, with, when 5001.12.2023undertaken, blood flow, blood pool and delayed imaging on a separate occasion 5001.12.2023(R) 1061426 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301110.0000554.8000000.00 5001.12.2023Whole body study using iodine (R) 1061429 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301086.0000543.0000000.00 5001.12.2023Whole body study using gallium (R) 1061430 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301319.0000659.4500000.00 5001.12.2023Whole body study using gallium, with single photon emission tomography (R) 1061433 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300994.0000496.9500000.00 5001.12.2023Whole body study using cells labelled with technetium (R) 1061434 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301231.0000615.4000000.00 5001.12.2023Whole body study using cells labelled with technetium, with single photon 5001.12.2023emission tomography (R) 1061438 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301346.0000672.9500000.00 5001.12.2023Whole body study using thallium (R) 1061441 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300979.0000489.7000000.00 5001.12.2023Bone marrow studywhole body using technetium labelled bone marrow agents (R) 1061442 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301505.0000752.3500000.00 5001.12.2023Whole body study, using galliumwith single photon emission tomography of 2 or 5001.12.2023more body regions acquired separately (R) 1061445 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300574.0000286.8000000.00 5001.12.2023Bone marrow studylocalised using technetium labelled agent (R) 1061446 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300667.0000333.5500000.00 5001.12.2023Regional scintigraphic study, using an approved bone scanning agent,including 5001.12.2023when undertaken, blood flow imaging, blood pool imagingand repeat imaging on a 5001.12.2023separate occasion (R) 1061449 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300912.0000456.2000000.00 5001.12.2023Regional scintigraphic study, using an approved bone scanning agentand single 5001.12.2023photon emission tomography, including when undertaken, blood flow imaging, 5001.12.2023blood pool imagingand repeat imaging on a separate occasion (R) 1061450 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300795.0000397.5500000.00 5001.12.2023Localised study using gallium (R) 1061453 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301029.0000514.7000000.00 5001.12.2023Localised study using gallium, with single photon emission tomography (R) 1061454 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300696.0000348.1000000.00 5001.12.2023Localised study using cells labelled with technetium (R) 1061457 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300941.0000470.4500000.00 5001.12.2023Localised study using cells labelled with technetium, with single photon 5001.12.2023emission tomography (R) 1061461 26.05.2002 5 I4 1 SN NNNNN 2001.12.202301056.0000527.8500000.00 5001.12.2023Localised study using thallium (R) 1061462 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300258.0000129.0000000.00 5001.12.2023Repeat planar and single photon emission tomography imaging, or repeat planar 5001.12.2023imaging or single photon emission tomography imaging on an occasion subsequent 5001.12.2023to the performance of item 61364, 61426, 61429, 61430, 61442, 61450, 61453, 5001.12.202361469 or 61485, if there is no additional administration of 5001.12.2023radiopharmaceutical and if the previous radionuclide scan was abnormal or 5001.12.2023equivocal (R) 1061466 01.07.2023 5 I4 1 SN YNNYN 2001.12.202309382.0004690.9000000.00 5001.12.2023Cerebro-spinal fluid transport study using indium-111, with imaging on 2 or 5001.12.2023more separate occasions (R) 1061469 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300696.0000348.1000000.00 5001.12.2023Lymphoscintigraphy (R) 1061470 01.07.2023 5 I4 1 DN YNNYN 2001.12.202302252.0001126.0000000.00 5001.12.2023Whole body or localised study using thallium-201, or single rest myocardial 5001.12.2023perfusion study using thallium-201, if all of the following apply: (a) The 5001.12.2023service is bulk billed; (b) The service is performed in conjunction with a 5001.12.2023service described in items 61438, 61461 or 61325. 1061473 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300351.0000175.4000000.00 5001.12.2023Thyroid study (R) 1061477 08.11.2022 5 I4 1 DN YNNYN 2001.12.202301480.0000740.0000000.00 5001.12.2023Whole body or localised study using gallium, if all of the following apply: 5001.12.2023(a) the service is bulk-billed; (b) the service is performed in conjunction 5001.12.2023with a service described in items 61429, 61430, 61442, 61450 or 61453 1061480 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300774.0000386.8500000.00 5001.12.2023Parathyroid study (R) 1061485 26.05.2002 5 I4 1 SN NYNNN 2001.12.202301998.0003364.0000000.00 5001.12.2023Adrenal study, with single photon emission tomography (R) 1061495 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300446.0000223.1000000.00 5001.12.2023Tear duct study (R) 1061499 26.05.2002 5 I4 1 SN NNNNN 2001.12.202300506.0000253.0000000.00 5001.12.2023Particle perfusion study (infra arterial) or Le Veen shunt study (R) 1061505 01.05.2007 5 I4 3 SN NNNNN 2001.12.202300200.0000100.0000000.00 5001.12.2023CT scan performed at the same time and covering the same body area as single 5001.12.2023photon emission tomography or positron emission tomography for the purpose of 5001.12.2023anatomic localisation or attenuation correction if no separate diagnostic CT 5001.12.2023report is issued and performed in association with a service to which an item 5001.12.2023in Subgroup 1 or 2 of Group I4 applies (R) 1061523 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, performed for evaluation of a solitary pulmonary 5001.12.2023nodule where the lesion is considered unsuitable for transthoracic fine needle 5001.12.2023aspiration biopsy, or for which an attempt at pathological characterisation 5001.12.2023has failed.(R) 1061524 01.11.2019 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Whole body FDG PET study, performed for the staging of locally advanced (Stage 5001.12.2023III) breast cancer, for a patient who is considered suitable for active 5001.12.2023therapy (R) (Anaes.) 1061525 01.11.2019 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 4001.11.2019(Anaes.) 5001.12.2023Whole body FDG PET study, performed for the evaluation of suspected metastatic 5001.12.2023or suspected locally or regionally recurrent breast carcinoma, for a patient 5001.12.2023who is considered suitable for active therapy (R) (Anaes.) 1061527 01.08.2022 5 I4 2 DN NNNNN 2001.12.202301505.0000752.3500000.00 5001.12.2023Whole body study using PET, if the service is performed because the services 5001.12.2023to which items 61429, 61430, 61442, 61450 or 61453 apply cannot be performed 5001.12.2023due to unavailability of gallium-67 (R) 1061529 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, performed for the staging of proven non-small cell 5001.12.2023lung cancer, where curative surgery or radiotherapy is planned (R) 1061538 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301802.0000901.0000000.00 5001.12.2023FDG PET study of the brain for evaluation of suspected residual or recurrent 5001.12.2023malignant brain tumour based on anatomical imaging findings, after definitive 5001.12.2023therapy (or during ongoing chemotherapy) in patients who are considered 5001.12.2023suitable for further active therapy. (R) 1061541 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, following initial therapy, for the evaluation of 5001.12.2023suspected residual, metastatic or recurrent colorectal carcinoma in patients 5001.12.2023considered suitable for active therapy (R) 1061553 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301998.0000999.0000000.00 5001.12.2023Whole body FDG PET study, following initial therapy, performed for the 5001.12.2023evaluation of suspected metastatic or recurrent malignant melanoma in patients 5001.12.2023considered suitable for active therapy (R) 1061559 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301836.0000918.0000000.00 5001.12.2023FDG PET study of the brain, performed for the evaluation of refractory 5001.12.2023epilepsy which is being evaluated for surgery (R) 1061563 01.07.2022 5 I4 2 SN NNNNY 2001.12.202302600.0001300.0000000.00 5001.12.2023Whole body prostate-specific membrane antigen PET study performed for the 5001.12.2023initial staging of intermediate to high-risk prostate adenocarcinoma, for a 5001.12.2023previously untreated patient who is considered suitable for locoregional 5001.12.2023therapy with curative intent Applicable once per lifetime (R) 1061564 01.07.2022 5 I4 2 SN NNNNY 2001.12.202302600.0001300.0000000.00 5001.12.2023Whole body prostate-specific membrane antigen PET study performed for the 5001.12.2023restaging of recurrent prostate adenocarcinoma, for a patient who:(a) has 5001.12.2023undergone prior locoregional therapy; and(b) is considered suitable for 5001.12.2023further locoregional therapy to determine appropriate therapeutic pathways and 5001.12.2023timing of treatment initiation Applicable twice per lifetime (R) 1061565 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, following initial therapy, performed for the 5001.12.2023evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in 5001.12.2023patients considered suitable for active therapy. (R) 1061571 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, for the further primary staging ofpatients with 5001.12.2023histologically proven carcinoma of the uterine cervix, at FIGO stage IB2 or 5001.12.2023greater by conventional staging, prior to planned radical radiation therapy or 5001.12.2023combined modality therapy with curative intent. (R) 1061575 01.07.2011 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, for the further staging of patients with confirmed 5001.12.2023local recurrence of carcinoma of the uterine cervix considered suitable for 5001.12.2023salvage pelvic chemoradiotherapy or pelvic exenteration with curative intent. 5001.12.2023(R) 1061577 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study, performed for the staging of proven oesophageal or 5001.12.2023GEJ carcinoma, in patients considered suitable for active therapy (R). 1061598 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study performed for the staging of biopsy-proven newly 5001.12.2023diagnosed or recurrent head and neck cancer (R). 1061604 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study performed for the evaluation of patients with 5001.12.2023suspected residual head and neck cancer after definitive treatment, and who 5001.12.2023are suitable for active therapy (R). 1061610 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study performed for the evaluation of metastatic squamous 5001.12.2023cell carcinoma of unknown primary site involving cervical nodes (R). 1061612 01.11.2022 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study for the initial staging of eligible cancer types, for 5001.12.2023a patient who is considered suitable for active therapy, if: (a) the eligible 5001.12.2023cancer type is: (i) a rare or uncommon cancer (less than 12 cases per 100,000 5001.12.2023persons per year); and (ii) a typically FDGavid cancer; and (b) there is at 5001.12.2023least a 10% likelihood that the PET study result will inform a significant 5001.12.2023change in management for the patient Applicable once per cancer diagnosis (R) 1061620 01.07.2011 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study for the initial staging of newly diagnosed or 5001.12.2023previously untreated Hodgkin or non-Hodgkin lymphoma (R) 1061622 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study to assess response to first line therapy either 5001.12.2023during treatment or within three months of completing definitive first line 5001.12.2023treatment for Hodgkin or non-Hodgkin lymphoma (R) 1061628 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study for restaging following confirmation of recurrence of 5001.12.2023Hodgkin or non-Hodgkin lymphoma (R) 1061632 01.07.2011 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body FDG PET study to assess response to second-line chemotherapy 5001.12.2023ifhaemopoietic stem cell transplantation is being considered for Hodgkin or 5001.12.2023non-Hodgkin lymphoma (R) 1061640 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301998.0000999.0000000.00 5001.12.2023Whole body FDG PET study for initial staging of patients with biopsy-proven 5001.12.2023bone or soft tissue sarcoma (excluding gastrointestinal stromal tumour) 5001.12.2023considered by conventional staging to be potentially curable. (R) 1061644 01.04.2022 5 I4 2 DN NNNYN 2001.12.202300658.0000329.0000000.00 5001.12.2023Single rest myocardial perfusion study for the assessment of the extent and 5001.12.2023severity of nonviable myocardium, with PET, if: (a) the service is performed 5001.12.2023because the service to which item 61325 applies cannot be performed due to 5001.12.2023unavailability of thallous chloride 201 (Tl-201); and (b) the patient has left 5001.12.2023ventricular systolic dysfunction and probable or confirmed coronary artery 5001.12.2023disease; and (c) the service is performed in conjunction with a rest 5001.12.2023myocardial perfusion study using technetium-99m; and (d) the service is 5001.12.2023requested by a specialist or a consultant physician; and (e) the service is 5001.12.2023not associated with a service to which item 11704, 11705, 11707, 11714, 11729 5001.12.2023or 11730 applies; and (f) this service and item 61325 are applicable only 5001.12.2023twice each 24 months (R) 1061646 26.05.2002 5 I4 2 SN NNNNN 2001.12.202301998.0000999.0000000.00 5001.12.2023Whole body FDG PET study for the evaluation of patients with suspected 5001.12.2023residual or recurrent sarcoma (excluding gastrointestinal stromal tumour) 5001.12.2023after the initial course of definitive therapy to determine suitability for 5001.12.2023subsequent therapy with curative intent. (R) 1061647 01.05.2018 5 I4 2 SN NNNNN 2001.12.202301906.0000953.0000000.00 5001.12.2023Whole body 68Ga DOTA peptide PET study, if:(a) a gastro entero pancreatic 5001.12.2023neuroendocrine tumour is suspected on the basis of biochemical evidence with 5001.12.2023negative or equivocal conventional imaging; or(b) both:(i) a surgically 5001.12.2023amenable gastro entero pancreatic neuroendocrine tumour has been identified on 5001.12.2023the basis of conventional techniques; and(ii) the study is for excluding 5001.12.2023additional disease sites (R) 1061650 01.06.2004 5 I4 1 SN NNNNN 2001.12.202301757.0000878.7000000.00 5001.12.2023LeukoScan study of the long bones and feet for suspected osteomyelitis, if:(a) 5001.12.2023the patient does not have access to ex vivo white blood cell scanning; and(b) 5001.12.2023the patient is not being investigated for other sites of infection (R) 1063001 01.08.2004 5 I5 1 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for tumour of the brain or 5001.12.2023meninges (R) (Anaes.) (Contrast) (Anaes.) 1063004 01.08.2004 5 I5 1 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for inflammation of brain or 5001.12.2023meninges (R) (Anaes.) (Contrast) (Anaes.) 1063007 01.08.2004 5 I5 1 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for skull base or orbital tumour 5001.12.2023(R) (Anaes.) (Contrast) (Anaes.) 1063010 01.08.2004 5 I5 1 SN NYNNY 2001.12.202300355.0000355.4500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for stereotactic scan of brain, 5001.12.2023with fiducials in place, for the sole purpose of allowing planning for 5001.12.2023stereotactic neurosurgery (R) (Anaes.) (Contrast) (Anaes.) 1063040 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300355.0000355.4500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for acoustic neuroma (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063043 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for pituitary tumour (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063046 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for toxic or metabolic or 5001.12.2023ischaemic encephalopathy (R) (Anaes.) (Contrast) (Anaes.) 1063049 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for demyelinating disease of the 5001.12.2023brain (R) (Anaes.) (Contrast) (Anaes.) 1063052 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for congenital malformation of 5001.12.2023the brain or meninges (R) (Anaes.) (Contrast) (Anaes.) 1063055 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for venous sinus thrombosis (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063058 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for head trauma (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063061 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for epilepsy (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063064 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for stroke (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063067 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for carotid or vertebral artery 5001.12.2023dissection (R) (Anaes.) (Contrast) (Anaes.) 1063070 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for intracranial aneurysm (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063073 01.08.2004 5 I5 2 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head (including MRA, if performed) for intracranial arteriovenous 5001.12.2023malformation (R) (Anaes.) (Contrast) (Anaes.) 1063101 01.08.2004 5 I5 3 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRI and MRA of extracranial or intracranial circulation (or both)scan of head 5001.12.2023and neck vessels for stroke (R) (Anaes.) (Contrast) (Anaes.) 1063111 01.08.2004 5 I5 4 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head and cervical spine (including MRA, if performed) for tumour of 5001.12.2023the central nervous system or meninges (R) (Anaes.) (Contrast) (Anaes.) 1063114 01.08.2004 5 I5 4 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head and cervical spine (including MRA, if performed) for 5001.12.2023inflammation of the central nervous system or meninges (R) (Anaes.) (Contrast) 5001.12.2023(Anaes.) 1063125 01.08.2004 5 I5 5 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head and cervical spine (including MRA, if performed) for 5001.12.2023demyelinating disease of the central nervous system (R) (Anaes.) (Contrast) 5001.12.2023(Anaes.) 1063128 01.08.2004 5 I5 5 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head and cervical spine (including MRA, if performed) for 5001.12.2023congenital malformation of the central nervous system or meninges (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063131 01.08.2004 5 I5 5 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of head and cervical spine (including MRA, if performed) for syrinx 5001.12.2023(congenital or acquired) (R) (Anaes.) (Contrast) (Anaes.) 1063151 01.08.2004 5 I5 6 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for infection (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063154 01.08.2004 5 I5 6 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for tumour (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063161 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for demyelinating 5001.12.2023disease (R) (Anaes.) (Contrast) (Anaes.) 1063164 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for congenital 5001.12.2023malformation of the spinal cord or the cauda equina or the meninges (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063167 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for myelopathy (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063170 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for syrinx 5001.12.2023(congenital or acquired) (R) (Anaes.) (Contrast) (Anaes.) 1063173 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for cervical 5001.12.2023radiculopathy (R) (Anaes.) (Contrast) (Anaes.) 1063176 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for sciatica (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063179 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for spinal canal 5001.12.2023stenosis (R) (Anaes.) (Contrast) (Anaes.) 1063182 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for previous spinal 5001.12.2023surgery (R) (Anaes.) (Contrast) (Anaes.) 1063185 01.08.2004 5 I5 7 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of one region or 2 contiguous regions of the spine for trauma (R) 5001.12.2023(Anaes.) (Anaes.) 1063201 01.08.2004 5 I5 8 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for infection 5001.12.2023(R) (Anaes.) (Contrast) (Anaes.) 1063204 01.08.2004 5 I5 8 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for tumour 5001.12.2023(R) (Anaes.) (Contrast) (Anaes.) 1063219 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for 5001.12.2023demyelinating disease (R) (Anaes.) (Contrast) (Anaes.) 1063222 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for 5001.12.2023congenital malformation of the spinal cord or the cauda equina or the meninges 5001.12.2023(R) (Anaes.) (Contrast) (Anaes.) 1063225 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for 5001.12.2023myelopathy (R) (Anaes.) (Contrast) (Anaes.) 1063228 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for syrinx 5001.12.2023(congenital or acquired) (R) (Anaes.) (Contrast) (Anaes.) 1063231 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for cervical 5001.12.2023radiculopathy (R) (Anaes.) (Contrast) (Anaes.) 1063234 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for sciatica 5001.12.2023(R) (Anaes.) (Contrast) (Anaes.) 1063237 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for spinal 5001.12.2023canal stenosis (R) (Anaes.) (Contrast) (Anaes.) 1063240 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for previous 5001.12.2023spinal surgery (R) (Anaes.) (Contrast) (Anaes.) 1063243 01.08.2004 5 I5 9 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of 3 contiguous or 2 non contiguous regions of the spine for trauma 5001.12.2023(R) (Anaes.) (Anaes.) 1063271 01.08.2004 5 I5 10 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cervical spine and brachial plexus for tumour (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063274 01.08.2004 5 I5 10 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cervical spine and brachial plexus for trauma (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063277 01.08.2004 5 I5 10 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cervical spine and brachial plexus for cervical radiculopathy (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063280 01.08.2004 5 I5 10 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cervical spine and brachial plexus for previous surgery (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063301 01.08.2004 5 I5 11 SN NYNNY 2001.12.202300403.0000402.8500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for tumour arising in bone or 5001.12.2023musculoskeletal system, excluding tumours arising in breast, prostate or 5001.12.2023rectum (R) (Anaes.) (Contrast) (Anaes.) 1063304 01.08.2004 5 I5 11 SN NYNNY 2001.12.202300403.0000402.8500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for infection arising in bone or 5001.12.2023musculoskeletal system, excluding infection arising in breast, prostate or 5001.12.2023rectum (R) (Anaes.) (Contrast) (Anaes.) 1063307 01.08.2004 5 I5 11 SN NYNNY 2001.12.202300403.0000402.8500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for osteonecrosis (R) (Anaes.) (Contrast) 5001.12.2023(Anaes.) 1063322 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of hip or its supporting 5001.12.2023structures (R) (Anaes.) (Contrast) (Anaes.) 1063325 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of shoulder or its 5001.12.2023supporting structures (R) (Anaes.) (Contrast) (Anaes.) 1063328 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of knee or its supporting 5001.12.2023structures (R) (Anaes.) (Contrast) (Anaes.) 1063331 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of ankle or foot (or both) 5001.12.2023or its supporting structures (R) (Anaes.) (Contrast) (Anaes.) 1063334 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300355.0000355.4500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of one or both 5001.12.2023temporomandibular joints or their supporting structures (R) (Anaes.) 5001.12.2023(Contrast) (Anaes.) 1063337 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of wrist or hand (or both) 5001.12.2023or its supporting structures (R) (Anaes.) (Contrast) (Anaes.) 1063340 01.08.2004 5 I5 12 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for derangement of elbow or its supporting 5001.12.2023structures (R) (Anaes.) (Contrast) (Anaes.) 1063361 01.08.2004 5 I5 13 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of musculoskeletal system for Gaucher disease (R) (Anaes.) (Anaes.) 1063385 01.08.2004 5 I5 14 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cardiovascular system for congenital disease of the heart or a 5001.12.2023great vessel (R) (Anaes.) (Contrast) (Anaes.) 1063388 01.08.2004 5 I5 14 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cardiovascular system for tumour of the heart or a great vessel (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063391 01.08.2004 5 I5 14 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of cardiovascular system for abnormality of thoracic aorta (R) 5001.12.2023(Anaes.) (Contrast) (Anaes.) 1063395 01.05.2018 5 I5 14 SN NYNNY 2001.12.202300905.0000904.7000000.00 4001.05.2018(Anaes.) 5001.12.2023MRIscan of cardiovascular system for assessment of myocardial structure and 5001.12.2023function involving:(a) dedicated right ventricular views; and(b) 3D volumetric 5001.12.2023assessment of the right ventricle; and(c) reporting of end diastolic and end 5001.12.2023systolic volumes, ejection fraction and BSA indexed values;if the request for 5001.12.2023the scan indicates that:(d) the patient presented with symptoms consistent 5001.12.2023with arrhythmogenic right ventricular cardiomyopathy (ARVC); or(e) 5001.12.2023investigative findings in relation to the patient are consistent with ARVC(R) 5001.12.2023(Contrast) (Anaes.) 1063397 01.05.2018 5 I5 14 SN NYNNY 2001.12.202300905.0000904.7000000.00 4001.05.2018(Anaes.) 5001.12.2023MRIscan of cardiovascular system for assessment of myocardial structure and 5001.12.2023function involving: (a) dedicated right ventricular views; and(b) 3D 5001.12.2023volumetric assessment of the right ventricle; and(c) reporting of end 5001.12.2023diastolic and end systolic volumes, ejection fraction and BSA indexed 5001.12.2023values;if the request for the scan indicates that the patient:(d) is 5001.12.2023asymptomatic; and(e) has one or more first degree relatives diagnosed with 5001.12.2023confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC)(R) (Contrast) 5001.12.2023(Anaes.) 1063399 01.01.2022 5 I5 14 DN NYNNN 2001.12.202301710.0000904.7000000.00 4001.01.2022(Anaes.) 5001.12.2023MRIscan of cardiovascular system for the assessment of myocardial structure 5001.12.2023and function, if the service is requested by a consultant physician who has 5001.12.2023assessed the patient, and the request for the scan indicates: the patient has 5001.12.2023suspected myocarditis after receiving a mRNA COVID-19 vaccine; and the patient 5001.12.2023had symptom onset within 21 days of a mRNA COVID-19 vaccine administration; 5001.12.2023and the results from the following examinations are inconclusive to form a 5001.12.2023diagnosis of myocarditis:(i)echocardiogram; and(ii) troponin; and(iii)chest 5001.12.2023X-ray. Applicable not more than once in a patients lifetime (R) (Contrast) 5001.12.2023(Anaes.) 1063401 01.08.2004 5 I5 15 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRAif the request for the scan specifically identifies the clinical indication 5001.12.2023for the scanscan of cardiovascular system for vascular abnormality in a 5001.12.2023patient with a previous anaphylactic reaction to an iodinated contrast medium 5001.12.2023(R) (Contrast) (Anaes.) 1063404 01.08.2004 5 I5 15 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRAif the request for the scan specifically identifies the clinical indication 5001.12.2023for the scanscan of cardiovascular system for obstruction of the superior vena 5001.12.2023cava, inferior vena cava or a major pelvic vein (R) (Contrast) (Anaes.) 1063416 01.08.2004 5 I5 16 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRAscan of person under the age of 16 for the vasculature of limbs prior to 5001.12.2023limb or digit transfer surgery in congenital limb deficiency syndrome (R) 5001.12.2023(Contrast) (Anaes.) 1063425 01.08.2004 5 I5 17 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of person under the age of 16 for post inflammatory or post traumatic 5001.12.2023physeal fusion (R) (Anaes.) 1063428 01.08.2004 5 I5 17 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of person under the age of 16 for Gaucher disease (R) (Anaes.) 1063440 01.08.2004 5 I5 18 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of person under the age of 16 for pelvic or abdominal mass (R) 5001.12.2023(Contrast) (Anaes.) 1063443 01.08.2004 5 I5 18 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of person under the age of 16 for mediastinal mass (R) (Contrast) 5001.12.2023(Anaes.) 1063446 01.08.2004 5 I5 18 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of person under the age of 16 for congenital uterine or anorectal 5001.12.2023abnormality (R) (Contrast) (Anaes.) 1063454 01.05.2019 5 I5 20 DN NYNNY 2001.12.202301269.0001269.4000000.00 4001.05.2019(Anaes.) 5001.12.2023MRI scan of the pelvis or abdomen, for a patient who is pregnant, if: (a) the 5001.12.2023pregnancy is at, or after, 18 weeks gestation; and (b) fetal abnormality is 5001.12.2023suspected; and (c) an ultrasound has been performed and is provided by, or on 5001.12.2023behalf of, or at the request of, a specialist who is practising in the 5001.12.2023specialty of obstetrics; and (d) the diagnosisof fetal abnormality as a result 5001.12.2023of the ultrasound is indeterminate or requires further examination; and (e) 5001.12.2023the MRI service is requested by a specialist practising in the specialty of 5001.12.2023obstetrics(R) (Contrast) (Anaes.) 1063461 01.08.2004 5 I5 19 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of the body for adrenal mass in a patient with a malignancy that is 5001.12.2023otherwise resectable (R) (Anaes.) 1063464 01.02.2009 5 I5 19 SN NYNYY 2001.12.202300730.0000729.9500000.00 4001.02.2009(Anaes.) 5001.12.2023MRI scan of both breasts for the detection of cancer in a patient, if: (a) a 5001.12.2023dedicated breast coil is used; and (b) the request for the scan identifies 5001.12.2023that the patient is asymptomatic and is younger than 60 years of age; and (c) 5001.12.2023the request for the scan identifies that the patient is at high risk of 5001.12.2023developing breast cancer due to one or more of the following: (i) genetic 5001.12.2023testing has identified the presence of a high risk breast cancer gene mutation 5001.12.2023in the patient or in a first degree relative of the patient; (ii) both: (A) 5001.12.2023one of the patients first or second degree relatives was diagnosed with breast 5001.12.2023cancer at age 45 years or younger; and (B) another first or second degree 5001.12.2023relative on the same side of the patients family was diagnosed with bone or 5001.12.2023soft tissue sarcoma at age 45 years or younger; (iii) the patient has a 5001.12.2023personal history of breast cancer before the age of 50 years; (iv) the patient 5001.12.2023has a personal history of mantle radiation therapy; (v) the patient has a 5001.12.2023lifetime risk estimation greater than 30% or a 10 year absolute risk 5001.12.2023estimation greater than 5% using a clinically relevant risk evaluation 5001.12.2023algorithm; and (d) the service is not performed in conjunction with item 55076 5001.12.2023or 55079 Applicable not more than once in a 12 month period (R) (Contrast) 5001.12.2023(Anaes.) 1063467 01.02.2009 5 I5 19 SN NYNNY 2001.12.202300730.0000729.9500000.00 4001.02.2009(Anaes.) 5001.12.2023MRIscan of both breasts for the detection of cancer, if:(a) a dedicated breast 5001.12.2023coil is used; and(b) the person has had an abnormality detected as a result of 5001.12.2023a service mentioned in item 63464 performed in the previous 12 months (R) 5001.12.2023(Anaes.) 1063470 01.08.2004 5 I5 20 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of the pelvis for the staging of histologically diagnosed cervical 5001.12.2023cancer at FIGO stage 1B or greater, if the request for scan identifies that: 5001.12.2023(a) a histological diagnosis of carcinoma of the cervix has been made; and(b) 5001.12.2023the patient has been diagnosed with cervical cancer at FIGO stage 1B or 5001.12.2023greater (R) (Contrast) (Anaes.) 1063473 01.08.2004 5 I5 20 SN NYNNY 2001.12.202300664.0000663.5000000.00 4001.08.2004(Anaes.) 5001.12.2023MRIscan of the pelvis and upper abdomen, in a single examination, for the 5001.12.2023staging of histologically diagnosed cervical cancer at FIGO stage 1B or 5001.12.2023greater, if the request for the scan identifies that: (a) a histological 5001.12.2023diagnosis of carcinoma of the cervix has been made; and(b) the patient has 5001.12.2023been diagnosed with cervical cancer at FIGO stage 1B or greater (R) (Contrast) 5001.12.2023(Anaes.) 1063476 01.07.2009 5 I5 20 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.07.2009(Anaes.) 5001.12.2023MRIscan of the pelvis for the initial staging of rectal cancer, if: (a) a 5001.12.2023phased array body coil is used; and(b) the request for the scan identifies 5001.12.2023that the indication is for the initial staging of rectal cancer (including 5001.12.2023cancer of the rectosigmoid and anorectum) (R) (Contrast) (Anaes.) 1063482 01.01.2006 5 I5 21 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.01.2006(Anaes.) 5001.12.2023MRIscan of pancreas and biliary tree for suspected biliary or pancreatic 5001.12.2023pathology (R) (Anaes.) 1063487 01.11.2016 5 I5 19 SN NYNNY 2001.12.202300730.0000729.9500000.00 5001.12.2023MRIscan of both breasts, if:(a) a dedicated breast coil is used; and(b) the 5001.12.2023request for the scan identifies that:(i) the patient has been diagnosed with 5001.12.2023metastatic cancer restricted to the regional lymph nodes; and(ii) clinical 5001.12.2023examination and conventional imaging have failed to identify the primary 5001.12.2023cancer (R) (Anaes.) 1063489 01.11.2016 5 I5 19 SN NYNNY 2001.12.202301066.0001066.3000000.00 4001.11.2016(Anaes.) 5001.12.2023MRIscan of one breast, performed in conjunction with a biopsy procedure on 5001.12.2023that breast and an ultrasound scan of that breast, if: (a) the request for the 5001.12.2023MRI scan identifies that the patient has a suspicious lesion seen on MRI but 5001.12.2023not on conventional imaging; and (b) the ultrasound scan is performed 5001.12.2023immediately before the MRI scan and confirms that the lesion is not amenable 5001.12.2023to biopsy guided by conventional imaging; and (c) a dedicated breast coil is 5001.12.2023used (R) (Anaes.) 1063491 01.08.2004 5 I5 22 SN NYNNY 2001.12.202300047.0000047.4000000.00 5001.12.2023NOTE: Benefits in Subgroup 22 are only payable for modifying items where 5001.12.2023claimed simultaneously with MRI services. Modifiers for sedation and 5001.12.2023anaesthesia may not be claimed for the same service. MRI or MRA service to 5001.12.2023which an item in this Group (other than an item in this Subgroup) applies if: 5001.12.2023(a) the service is performed on a person in accordance with clause 2.5.1; 5001.12.2023and(b) the item for the service includes in its description (Contrast); and(c) 5001.12.2023the service is performed using a contrast agent 1063494 01.08.2004 5 I5 22 SN NYNNY 2001.12.202300047.0000047.4000000.00 5001.12.2023MRI or MRA service to which an item in this Group (other than an item in this 5001.12.2023Subgroup) applies if: (a) the service is performed on a person in accordance 5001.12.2023with clause 2.5.1; and(b) the service is performed using intravenous or intra 5001.12.2023muscular sedation 1063496 01.05.2019 5 I5 22 SN NYNNY 2001.12.202300264.0000264.4500000.00 5001.12.2023NOTE: Benefits in Subgroup 22 are only payable for modifying items where 5001.12.2023claimed simultaneously with MRI services. Modifiers for sedation and 5001.12.2023anaesthesia may not be claimed for the same service. MRI service to which item 5001.12.202363545 or 63546 applies if: (a) the service is performed on a person under the 5001.12.2023supervision of an eligible provider; and(b) the service is performed using an 5001.12.2023hepatobiliary specific contrast agent 1063497 01.08.2004 5 I5 22 SN NYNNY 2001.12.202300166.0000165.9000000.00 5001.12.2023MRI or MRA service to which an item in this Group (other than an item in this 5001.12.2023Subgroup) applies if: (a) the service is performed on a person in accordance 5001.12.2023with clause 2.5.1; and(b) the service is performed under anaesthetic in the 5001.12.2023presence of a medical practitioner who is qualified to perform an anaesthetic 1063498 12.03.2012 5 I5 22 SN NYNYY 2001.12.202300047.0000047.4000000.00 5001.12.2023MRI service to which item 63501, 63502, 63504 or 63505 applies, if the service 5001.12.2023is performed on a person using intravenous or intra muscular sedation 1063499 12.03.2012 5 I5 22 SN NYNYY 2001.12.202300166.0000165.9000000.00 5001.12.2023MRI service to which item 63501, 63502, 63504 or 63505 applies, if the service 5001.12.2023is performed on a person under anaesthetic in the presence of a medical 5001.12.2023practitioner who is qualified to perform an anaesthetic 1063501 12.03.2012 5 I5 32 SN NYNYY 2001.12.202300529.0000528.9500000.00 5001.12.2023MRIscan of one or both breasts for the evaluation of implant integrity, if: 5001.12.2023(a) a dedicated breast coil is used; and (b) the request for the scan 5001.12.2023identifies that the patient: (i) has or is suspected of having a silicone 5001.12.2023breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the 5001.12.2023result of the scan confirms a loss of integrity of the implant (R) 1063502 12.03.2012 5 I5 32 SN NYNYY 2001.12.202300529.0000528.9500000.00 5001.12.2023MRIscan of one or both breasts for the evaluation of implant integrity, if: 5001.12.2023(a) a dedicated breast coil is used; and (b) the request for the scan 5001.12.2023identifies that the patient: (i) has or is suspected of having a silicone 5001.12.2023breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the 5001.12.2023result of the scan does not demonstrate a loss of integrity of the implant (R) 1063507 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of head for a patient under 16 years if the service is for:(a) an 5001.12.2023unexplained seizure; or(b) an unexplained headache if significant pathology is 5001.12.2023suspected; or(c) paranasal sinus pathology that has not responded to 5001.12.2023conservative therapy (R) (Contrast) (Anaes.) 1063510 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of spine following radiographic examination for a patient under 16 5001.12.2023years if the service is for: (a) significant trauma; or(b) unexplained neck or 5001.12.2023back pain with associated neurological signs; or(c) unexplained back pain if 5001.12.2023significant pathology is suspected (R) (Contrast) (Anaes.) 1063513 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of knee for internal joint derangement for a patient under 16 years 5001.12.2023(R) (Contrast) (Anaes.) 1063516 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of hip following radiographic examination for a patient under 16 years 5001.12.2023if any of the following is suspected: (a) septic arthritis;(b) slipped capital 5001.12.2023femoral epiphysis;(c) Perthes disease (R) (Contrast) (Anaes.) 1063519 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of elbow following radiographic examination for a patient under 16 5001.12.2023years if a significant fracture or avulsion injury, which would change the way 5001.12.2023in which the patient is managed, is suspected (R) (Contrast) (Anaes.) 1063522 01.11.2012 5 I5 33 SN NYNNY 2001.12.202300474.0000473.9000000.00 4001.11.2012(Anaes.) 5001.12.2023MRIscan of wrist following radiographic examination for a patient under 16 5001.12.2023years if a scaphoid fracture is suspected (R) (Contrast) (Anaes.) 1063531 01.11.2019 5 I5 19 SN NYNNY 2001.12.202300730.0000729.9500000.00 4001.11.2019(Anaes.) 5001.12.2023MRIscan of both breasts, if: (a) a dedicated breast coil is used; and(b) the 5001.12.2023request for the scan identifies that:(i) the patient has a breast lesion; 5001.12.2023and(ii) the results of conventional imaging are inconclusive for the presence 5001.12.2023of breast cancer; and(iii) biopsy has not been possible (R) (Contrast) 5001.12.2023(Anaes.) 1063533 01.11.2019 5 I5 19 SN NYNNY 2001.12.202300730.0000729.9500000.00 4001.11.2019(Anaes.) 5001.12.2023MRIscan of both breasts, if: (a) a dedicated breast coil is used; and(b) the 5001.12.2023request for the scan identifies that:(i) the patient has been diagnosed with a 5001.12.2023breast cancer; and(ii) there is a discrepancy between the clinical assessment 5001.12.2023and the conventional imaging assessment of the extent of the malignancy; 5001.12.2023and(c) the results of breast MRI imaging may alter treatment planning (R) 5001.12.2023(Contrast) (Anaes.) 1063541 01.07.2018 5 I5 19 SN NYNNY 2001.12.202300476.0000476.0000000.00 4001.07.2018(Anaes.) 5001.12.2023Multiparametric MRIscan of the prostate for the detection of cancer, requested 5001.12.2023by a specialist in the speciality of urology, radiation oncology or medical 5001.12.2023oncology: (a) if the request for the scan identifies that the patient is 5001.12.2023suspected of developing prostate cancer: (i) on the basis of a digital rectal 5001.12.2023examination; or (ii) in the circumstances mentioned in clause2.5.9A; and (b) 5001.12.2023using a standardised image acquisition protocol involving: (i) T2weighted 5001.12.2023imaging; and (ii) diffusionweighted imaging; and (iii) (unless 5001.12.2023contraindicated) dynamic contrast enhancement (R) Note:See explanatory note 5001.12.2023IN.5.1 forthe meaning of Clause 2.5.9 in the descriptor for this item and the 5001.12.2023claiming limitations. (Anaes.) 1063543 01.07.2018 5 I5 19 SN NYNNY 2001.12.202300476.0000476.0000000.00 4001.07.2018(Anaes.) 5001.12.2023Multiparametric MRIscan of the prostate for the assessment of cancer, 5001.12.2023requested by a specialist in the speciality of urology, radiation oncology or 5001.12.2023medical oncology: (a) if the request for the scan identifies that the patient: 5001.12.2023(i) is under active surveillance following a confirmed diagnosis of prostate 5001.12.2023cancer by biopsy histopathology; and (ii) is not undergoing, or planning to 5001.12.2023undergo, treatment for prostate cancer; and (b) using a standardised image 5001.12.2023acquisition protocol involving: (i) T2weighted imaging; and (ii) 5001.12.2023diffusionweighted imaging; and (iii) (unless contraindicated) dynamic contrast 5001.12.2023enhancement (R) Note: See explanatory note IN.5.2 for claiming restrictions 5001.12.2023for this item. (Anaes.) 1063545 01.05.2019 5 I5 21 SN NYNYY 2001.12.202300582.0000581.8000000.00 4001.05.2019(Anaes.) 5001.12.2023MRI - multiphase scans of liver (including delayed imaging, if performed) with 5001.12.2023a contrast agent, for characterisation, or staging where surgical resection or 5001.12.2023interventional techniques are under consideration, if: (a) the patient has a 5001.12.2023confirmed extrahepatic primary malignancy (other than hepatocellular 5001.12.2023carcinoma); and (b) computed tomography is negative or inconclusive for 5001.12.2023hepatic metastatic disease; and (c) the identification of liver metastases 5001.12.2023would change the patients treatment planning Applicable not more than once in 5001.12.2023a 12 month period (R) (Contrast) (Anaes.) 1063546 01.05.2019 5 I5 21 SN NYNNY 2001.12.202300582.0000581.8000000.00 4001.05.2019(Anaes.) 5001.12.2023MRI multiphase scans of the liver (including delayed imaging, if performed) 5001.12.2023with a contrast agent, for diagnosis or staging, if: (a) the patient has:(i) 5001.12.2023known or suspected hepatocellular carcinoma; and(ii) chronic liver disease 5001.12.2023that has been confirmed by a specialist or consultant physician; and(b) the 5001.12.2023patients liver function has been identified as Child Pugh class A or B; and(c) 5001.12.2023the patient has an identified hepatic lesion over 10 mm in diameter.For any 5001.12.2023particular patientapplicable not more than once in a 12 month period (R) 5001.12.2023(Contrast) (Anaes.) 1063547 01.05.2018 5 I5 19 SN NYNNY 2001.12.202300730.0000729.9500000.00 4001.05.2018(Anaes.) 5001.12.2023MRIscan of both breasts for the detection of cancer, if: (a) a dedicated 5001.12.2023breast coil is used; and(b) the request for the scan identifies that:(i) the 5001.12.2023patient has a breast implant in situ; and(ii) anaplastic large cell lymphoma 5001.12.2023has been diagnosed(R) (Contrast) (Anaes.) 1063549 01.11.2022 5 I5 20 SN NYNNN 2001.12.202303658.0001904.1000000.00 4001.11.2022(Anaes.) 5001.12.2023MRI scan of the pelvis or abdomen, for a patient with a multiple pregnancy, 5001.12.2023if: (a) the multiple pregnancy is at, or after, 18 weeks gestation; and (b) 5001.12.2023fetal abnormality is suspected; and (c) an ultrasound has been performed and 5001.12.2023is provided by, or on behalf of, or at the request of, a specialist who is 5001.12.2023practising in the specialty of obstetrics; and (d) the diagnosis of fetal 5001.12.2023abnormality as a result of the ultrasound is indeterminate or requires further 5001.12.2023examination; and (e) the MRI service is requested by a specialist practising 5001.12.2023in the specialty of obstetrics (R) (Contrast) (Anaes.) 1063551 01.11.2013 5 I5 34 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2013(Anaes.) 5001.12.2023MRI - scan of head for a patient 16 years or older, after a request by a 5001.12.2023medical practitioner (other than a specialist or consultant physician), for 5001.12.2023any of the following: (a) unexplained seizure(s);(b) unexplained chronic 5001.12.2023headache with suspected intracranial pathology (R) (Contrast) (Anaes.) 1063554 01.11.2013 5 I5 34 SN NYNNY 2001.12.202300379.0000379.1500000.00 4001.11.2013(Anaes.) 5001.12.2023MRI - scan of spine for a patient 16 years or older, after referral by a 5001.12.2023medical practitioner (other than a specialist or consultant physician), for 5001.12.2023suspected cervical radiculopathy (R) (Contrast) (Anaes.) 1063557 01.11.2013 5 I5 34 SN NYNNY 2001.12.202300521.0000521.3500000.00 4001.11.2013(Anaes.) 5001.12.2023MRI - scan of spine for a patient 16 years or older, after referral by a 5001.12.2023medical practitioner (other than a specialist or consultant physician), for 5001.12.2023suspected cervical spinal trauma (R) (Contrast) (Anaes.) 1063560 01.11.2013 5 I5 34 SN NYNNY 2001.12.202300427.0000426.5000000.00 4001.11.2013(Anaes.) 5001.12.2023MRI - scan of knee following acute knee trauma, after referral by a medical 5001.12.2023practitioner (other than a specialist or consultant physician), for a patient 5001.12.202316 to 49 years with: (a) inability to extend the knee suggesting the 5001.12.2023possibility of acute meniscal tear; or(b) clinical findings suggesting acute 5001.12.2023anterior cruciate ligament tear (R) (Contrast) (Anaes.) 1063563 01.11.2022 5 I5 20 SN NYNNN 2001.12.202300819.0000426.5000000.00 4001.11.2022(Anaes.) 5001.12.2023MRI scan of the pelvis or abdomen, if the request for the scan identifies that 5001.12.2023the investigation is for: (a) subfertility that requires one or more of the 5001.12.2023following: (i) an investigation of suspected Mullerian duct anomaly seen in 5001.12.2023pelvic ultrasound or hysterosalpingogram; (ii) an assessment of uterine mass 5001.12.2023identified on pelvic ultrasound before consideration of surgery; (iii) an 5001.12.2023investigation of recurrent implantation failure in IVF (2 or more embryo 5001.12.2023transfer cycles without viable pregnancy); or (b) surgical planning of a 5001.12.2023patient with known or suspected deep endometriosis involving the bowel, 5001.12.2023bladder or ureter (or any combination of the bowel, bladder or ureter), where 5001.12.2023the results of pelvic ultrasound are inconclusive Applicable not more than 5001.12.2023once in a 2 year period (R) (Contrast) (Anaes.) 1063564 01.03.2023 5 I5 19 DN YYNYN 2001.12.202303124.0001561.7500000.00 4001.03.2023(Anaes.) 5001.12.2023Note: the requirements for services provided under item 63564 are detailed 5001.12.2023under note IN.5.4 MRI whole body scan for the early detection of cancer: 5001.12.2023a)requested by a specialist or consultant physician in consultation with a 5001.12.2023clinical geneticist in a familial cancer or genetic clinic; and b)the request 5001.12.2023identifies that the patient has a high risk of developing cancer malignancy 5001.12.2023due to heritableTP53- related cancer (hTP53rc) syndrome (R) (Anaes.) 1064992 01.01.2022 5 I6 SN NYNNN 2001.12.202300023.0000012.2000000.00 5001.12.2023A diagnostic imaging service to which an item in this table (other than this 5001.12.2023item or item 64990, 64991, 64993, 64994 or 64995) applies if: (a) the service 5001.12.2023is an unreferred service; and (b) the service is provided to a person who is 5001.12.2023under the age of 16 or is a Commonwealth concession card holder; and (c) the 5001.12.2023person is not an admitted patient of a hospital; and (d) the service is 5001.12.2023bulk-billed in respect of the fees for: (i)this item; and (ii) the other item 5001.12.2023in this Schedule applying to the service; and (e) the service is provided at, 5001.12.2023or from, a practice location in: (i) a Modified Monash 3 are; or (ii) a 5001.12.2023Modified Monash 4 area 1064993 01.01.2022 5 I6 SN NYNNN 2001.12.202300025.0000012.9500000.00 5001.12.2023A diagnostic imaging service to which an item in this table (other than this 5001.12.2023item or item 64990, 64991, 64992, 64994 or 64995) applies if: (a) the service 5001.12.2023is an unreferred service; and (b) the service is provided to a person who is 5001.12.2023under the age of 16 or is a Commonwealth concession card holder; and (c) the 5001.12.2023person is not an admitted patient of a hospital; and (d) the service is 5001.12.2023bulk-billed in respect of the fees for: (i)this item; and (ii) the other item 5001.12.2023in this Schedule applying to the service; and (e) the service is provided at, 5001.12.2023or from, a practice location in a Modified Monash 5 area 1064994 01.01.2022 5 I6 SN NYNNN 2001.12.202300026.0000013.7500000.00 5001.12.2023A diagnostic imaging service to which an item in this table (other than this 5001.12.2023item or item 64990, 64991, 64992, 64993 or 64995) applies if: (a) the service 5001.12.2023is an unreferred service; and (b) the service is provided to a person who is 5001.12.2023under the age of 16 or is a Commonwealth concession card holder; and (c) the 5001.12.2023person is not an admitted patient of a hospital; and (d) the service is 5001.12.2023bulk-billed in respect of the fees for: (i)this item; and (ii) the other item 5001.12.2023in this Schedule applying to the service; and (e)the service is provided at, 5001.12.2023or from, a practice location in a Modified Monash 6 area 1064995 01.01.2022 5 I6 SN NYNNN 2001.12.202300029.0000015.0500000.00 5001.12.2023A diagnostic imaging service to which an item in this table (other than this 5001.12.2023item or item 64990, 64991, 64992, 64993 or 64994) applies if: (a) the service 5001.12.2023is an unreferred service; and (b) the service is provided to a person who is 5001.12.2023under the age of 16 or is a Commonwealth concession card holder; and (c) the 5001.12.2023person is not an admitted patient of a hospital; and (d) the service is 5001.12.2023bulk-billed in respect of the fees for: (i)this item; and (ii)the other item 5001.12.2023in this Schedule applying to the service; and (e) the service is provided at, 5001.12.2023or from, a practice location in a Modified Monash 7 area 1065060 26.05.2002 6 P1 SN NNNNY 2001.12.202300025.0000007.8500000.00 5001.12.2023Haemoglobin, erythrocyte sedimentation rate, blood viscosity - 1 or more tests 1065066 26.05.2002 6 P1 SN NNNNY 2001.12.202300033.0000010.4000000.00 5001.12.2023Examination of: (a)a blood film by special stains to demonstrate Heinz bodies, 5001.12.2023parasites or iron; or (b)a blood film by enzyme cytochemistry for neutrophil 5001.12.2023alkaline phosphatase, alpha-naphthyl acetate esterase or chloroacetate 5001.12.2023esterase; or (c)a blood film using any other special staining methods 5001.12.2023including periodic acid Schiff and Sudan Black; or (d)a urinary sediment for 5001.12.2023haemosiderin including a service described in item 65072 1065070 26.05.2002 6 P1 SN NNNNY 2001.12.202300053.0000016.9500000.00 5001.12.2023Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red 5001.12.2023cell index or indices, platelet count, leucocyte count and manual or 5001.12.2023instrument generated differential count - not being a service where 5001.12.2023haemoglobin only is requested - one or more instrument generated sets of 5001.12.2023results from a single sample; and (if performed) (a) a morphological 5001.12.2023assessment of a blood film; (b) any service in item 65060 or 65072 1065072 26.05.2002 6 P1 SN NNNNY 2001.12.202300032.0000010.2000000.00 5001.12.2023Examination for reticulocytes including a reticulocyte count by any method - 1 5001.12.2023or more tests 1065075 26.05.2002 6 P1 SN NNNNY 2001.12.202300164.0000051.9500000.00 5001.12.2023Haemolysis or metabolic enzymes - assessment by: (a)erythrocyte autohaemolysis 5001.12.2023test; or (b)erythrocyte osmotic fragility test; or (c)sugar water test; or 5001.12.2023(d)G-6-P D (qualitative or quantitative) test; or (e)pyruvate kinase 5001.12.2023(qualitative or quantitative) test; or (f)acid haemolysis test; or (g) 5001.12.2023quantitation of muramidase in serum or urine; or (h) Donath Landsteiner 5001.12.2023antibody test; or (i) other erythrocyte metabolic enzyme tests 1 or more tests 1065078 26.05.2002 6 P1 SN NNNNY 2001.12.202300285.0000090.2000000.00 5001.12.2023Tests for the diagnosis of thalassaemia consisting of haemoglobin 5001.12.2023electrophoresis or chromatography and at least 2 of: (a)examination for HbH; 5001.12.2023or (b)quantitation of HbA2; or (c)quantitation of HbF; including (if 5001.12.2023performed) any service described in item 65060 or 65070 1065079 01.05.2007 6 P1 SN NNNNY 2001.12.202300285.0000090.2000000.00 5001.12.2023Tests described in item 65078 if rendered by a receiving APP - 1 or more tests 5001.12.2023(Item is subject to rule 18) 1065081 26.05.2002 6 P1 SN NNNNY 2001.12.202300305.0000096.6000000.00 5001.12.2023Tests for the investigation of haemoglobinopathy consisting of haemoglobin 5001.12.2023electrophoresis or chromatography and at least 1 of: (a)heat denaturation 5001.12.2023test; or (b)isopropanol precipitation test; or (c)tests for the presence of 5001.12.2023haemoglobin S; or (d)quantitation of any haemoglobin fraction (including S, C, 5001.12.2023D, E); including (if performed) any service described in item 65060, 65070 or 5001.12.202365078 1065082 01.05.2007 6 P1 SN NNNNY 2001.12.202300305.0000096.6000000.00 5001.12.2023Tests described in item 65081 if rendered by a receiving APP - 1 or more tests 5001.12.2023(Item is subject to rule 18) 1065084 26.05.2002 6 P1 SN NNNNY 2001.12.202300535.0000165.8500000.00 5001.12.2023Bone marrow trephine biopsy - histopathological examination of sections of 5001.12.2023bone marrow and examination of aspirated material (including clot sections 5001.12.2023where necessary), including (if performed): any test described in item 65060, 5001.12.202365066 or 65070 1065087 26.05.2002 6 P1 SN NNNNY 2001.12.202300275.0000083.1000000.00 5001.12.2023Bone marrow - examination of aspirated material (including clot sections where 5001.12.2023necessary), including (if performed): any test described in item 65060, 65066 5001.12.2023or 65070 1065090 26.05.2002 6 P1 SN NNNNY 2001.12.202300035.0000011.1500000.00 5001.12.2023Blood grouping (including back-grouping if performed) - ABO and Rh (D antigen) 1065093 26.05.2002 6 P1 SN NNNNY 2001.12.202300069.0000022.0000000.00 5001.12.2023Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or 5001.12.2023any other blood group system - 1 or more systems, including item 65090 (if 5001.12.2023performed) 1065096 26.05.2002 6 P1 SN NNNNY 2001.12.202300128.0000041.0000000.00 5001.12.2023Blood grouping (including back-grouping if performed), and examination of 5001.12.2023serum for Rh and other blood group antibodies, including: (a)identification 5001.12.2023and quantitation of any antibodies detected; and (b)(if performed) any test 5001.12.2023described in item 65060 or 65070 1065099 26.05.2002 6 P1 SN NNNNY 2001.12.202300350.0000108.9000000.00 5001.12.2023Compatibility tests by crossmatch - all tests performed on any1 day for up to 5001.12.20236 units, including: (a)direct testing of donor red cells from each unit 5001.12.2023against the serum of the patient by one or more accepted crossmatching 5001.12.2023techniques; and (b) all grouping checks of the patient and donor; and 5001.12.2023(c)examination for antibodies, and if necessary identification of any 5001.12.2023antibodies detected; and (d)(if performed) any tests described in item 65060, 5001.12.202365070, 65090 or 65096 (Item is subject to rule 5) 1065102 26.05.2002 6 P1 SN NNNNY 2001.12.202300525.0000164.6000000.00 5001.12.2023Compatibility tests by crossmatch - all tests performed on any1 day in excess 5001.12.2023of 6 units, including: (a) direct testing of donor red cells from each unit 5001.12.2023against serum of the patient by one or more accepted crossmatching techniques; 5001.12.2023and (b) all grouping checks of the patient and donor; and (c)examination for 5001.12.2023antibodies, and if necessary identification of any antibodies detected; and 5001.12.2023(d)(if performed) any tests described in item 65060, 65070, 65090, 65096, 5001.12.202365099 or 65105 (Item is subject to rule 5) 1065105 26.05.2002 6 P1 SN NNNNY 2001.12.202300350.0000108.9000000.00 5001.12.2023Compatibility testing using at least a 3 cell panel and issue of red cells for 5001.12.2023transfusion - all tests performed on any one day for up to 6 units, including: 5001.12.2023(a) all grouping checks of the patient and donor; and (b) examination for 5001.12.2023antibodies and, if necessary, identification of any antibodies detected; and 5001.12.2023(c) (if performed) any tests described in item 65060, 65070, 65090 or 65096 5001.12.2023(Item is subject to rule 5) 1065108 26.05.2002 6 P1 SN NNNNY 2001.12.202300525.0000164.6000000.00 5001.12.2023Compatibility testing using at least a 3 cell panel and issue of red cells for 5001.12.2023transfusion - all tests performed on any one day in excess of 6 units, 5001.12.2023including: (a)all grouping checks of the patient and donor; and (b)examination 5001.12.2023for antibodies and, if necessary, identification of any antibodies detected; 5001.12.2023and (c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 5001.12.202365099 or 65105 (Item is subject to rule 5) 1065109 01.05.2007 6 P1 SN NNNNY 2001.12.202300041.0000012.9000000.00 5001.12.2023Release of fresh frozen plasma or cryoprecipitate for the use in a patient for 5001.12.2023the correction of a coagulopathy - 1 release. 1065110 01.05.2007 6 P1 SN NNNNY 2001.12.202300041.0000012.9000000.00 5001.12.2023Release of compatible fresh platelets for the use in a patient for platelet 5001.12.2023support as prophylaxis to minimize bleeding or during active bleeding - 1 5001.12.2023release. 1065111 26.05.2002 6 P1 SN NNNNY 2001.12.202300073.0000023.2000000.00 5001.12.2023Examination of serum for blood group antibodies (including identification and, 5001.12.2023if necessary, quantitation of any antibodies detected) 1065114 26.05.2002 6 P1 SN NNNNY 2001.12.202300029.0000009.1000000.00 5001.12.20231 or more of the following tests: (a)direct Coombs (antiglobulin) test; 5001.12.2023(b)qualitative or quantitative test for cold agglutinins or heterophil 5001.12.2023antibodies 1065117 26.05.2002 6 P1 SN NNNNY 2001.12.202300064.0000020.2500000.00 5001.12.20231 or more of the following tests: (a)Spectroscopic examination of blood for 5001.12.2023chemically altered haemoglobins; (b)detection of methaemalbumin (Schumm's 5001.12.2023test) 1065120 26.05.2002 6 P1 SN NNNNY 2001.12.202300044.0000013.7000000.00 5001.12.2023Prothrombin time (including INR where appropriate), activated partial 5001.12.2023thromboplastin time, thrombin time (including test for the presence of 5001.12.2023heparin), test for factor XIII deficiency (qualitative), Echis test, Stypven 5001.12.2023test, reptilase time, fibrinogen, or 1 of fibrinogen degradation products, 5001.12.2023fibrin monomer or D-dimer - 1 test 1065123 26.05.2002 6 P1 SN NNNNY 2001.12.202300064.0000020.3500000.00 5001.12.20232 tests described in item 65120 1065126 26.05.2002 6 P1 SN NNNNY 2001.12.202300088.0000027.8500000.00 5001.12.20233 tests described in item 65120 1065129 26.05.2002 6 P1 SN NNNNY 2001.12.202300112.0000035.5000000.00 5001.12.20234 or more tests described in item 65120 1065137 26.05.2002 6 P1 SN NNNNY 2001.12.202300080.0000025.3500000.00 5001.12.2023Test for the presence of lupus anticoagulant not being a service associated 5001.12.2023with any service to which items 65175, 65176, 65177, 65178 and 65179 apply 1065142 26.05.2002 6 P1 SN NNNNY 2001.12.202300080.0000025.3500000.00 5001.12.2023Confirmation or clarification of an abnormal or indeterminate result from a 5001.12.2023test described in item 65175, by testing a specimen collected on a different 5001.12.2023day - 1 or more tests 1065144 26.05.2002 6 P1 SN NNNNY 2001.12.202300178.0000056.5500000.00 5001.12.2023Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or other 5001.12.2023substances; or heparin, low molecular weight heparins, heparinoid or other 5001.12.2023drugs - 1 or more tests 1065147 26.05.2002 6 P1 SN NNNNY 2001.12.202300120.0000037.9000000.00 5001.12.2023Quantitation of anti-Xa activity when monitoring is required for a patient 5001.12.2023receiving a low molecular weight heparin or heparinoid - 1 test 1065150 26.05.2002 6 P1 SN NNNNY 2001.12.202300225.0000070.9000000.00 5001.12.2023Quantitation of von Willebrand factor antigen, von Willebrand factor activity 5001.12.2023(ristocetin cofactor assay), von Willebrand factor collagen binding activity, 5001.12.2023factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, 5001.12.2023factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating 5001.12.2023coagulation factor inhibitors other than by Bethesda assay - 1 test (Item is 5001.12.2023subject to rule 6 ) 1065153 26.05.2002 6 P1 SN NNNNY 2001.12.202300445.0000141.8500000.00 5001.12.20232 tests described in item 65150 (Item is subject to rule 6 ) 1065156 26.05.2002 6 P1 SN NNNNY 2001.12.202300670.0000212.7500000.00 5001.12.20233 or more tests described in item 65150 (Item is subject to rule 6 ) 1065157 01.05.2007 6 P1 SN NNNNY 2001.12.202300225.0000070.9000000.00 5001.12.2023A test described in item 65150, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1065158 01.05.2007 6 P1 SN NNNNY 2001.12.202300225.0000070.9000000.00 5001.12.2023Tests described in item 65150, other than that described in 65157, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 2 tests (Item is subject to 5001.12.2023rule 6 and 18) 1065159 26.05.2002 6 P1 SN NNNNY 2001.12.202300225.0000070.9000000.00 5001.12.2023Quantitation of circulating coagulation factor inhibitors by Bethesda assay - 5001.12.20231 test 1065162 26.05.2002 6 P1 SN NNNNY 2001.12.202300033.0000010.4500000.00 5001.12.2023Examination of a maternal blood film for the presence of fetal red blood cells 5001.12.2023(Kleihauer test) 1065165 26.05.2002 6 P1 SN NNNNY 2001.12.202300108.0000034.4500000.00 5001.12.2023Detection and quantitation of fetal red blood cells in the maternal 5001.12.2023circulation by detection of red cell antigens using flow cytometric methods 5001.12.2023including (if performed) any test described in item 65070 or 65162 1065166 01.05.2007 6 P1 SN NNNNY 2001.12.202300108.0000034.4500000.00 5001.12.2023A test described in item 65165 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1065171 26.05.2002 6 P1 SN NNNNY 2001.12.202300080.0000025.3500000.00 5001.12.2023Test for the presence of antithrombin III deficiency, protein C deficiency, 5001.12.2023protein S deficiency or activated protein C resistance in a first degree 5001.12.2023relative of a person who has a proven defect of any of the above - 1 or more 5001.12.2023tests 1065175 01.05.2007 6 P1 SN NNNNY 2001.12.202300080.0000025.3500000.00 5001.12.2023Test for the presence of antithrombin III deficiency, protein C deficiency, 5001.12.2023protein S deficiency, lupus anticoagulant, activated protein C resistance - 5001.12.2023where the request for the test(s) specifically identifies that the patient has 5001.12.2023a history of venous thromboembolism - quantitation by 1 or more techniques - 1 5001.12.2023test (Item is subject to Rule 6) 1065176 01.05.2007 6 P1 SN NNNNY 2001.12.202300154.0000048.6500000.00 5001.12.20232 tests described in item 65175 (Item is subject to rule 6) 1065177 01.05.2007 6 P1 SN NNNNY 2001.12.202300225.0000071.9500000.00 5001.12.20233 tests described in item 65175 (Item is subject to rule 6) 1065178 01.05.2007 6 P1 SN NNNNY 2001.12.202300300.0000095.2000000.00 5001.12.20234 tests described in item 65175 (Item is subject to rule 6) 1065179 01.05.2007 6 P1 SN NNNNY 2001.12.202300375.0000118.5000000.00 5001.12.20235 tests described in item 65175 (Item is subject to rule 6) 1065180 01.05.2007 6 P1 SN NNNNY 2001.12.202300080.0000025.3500000.00 5001.12.2023A test described in item 65175, if rendered by a receiving APA, where no tests 5001.12.2023in the item have been rendered by the referring APA - 1 test (Item is subject 5001.12.2023to rule6 and 18) 1065181 01.05.2007 6 P1 SN NNNYY 2001.12.202300073.0000023.3000000.00 5001.12.2023A test described in item 65175, if rendered by a receiving APP, if one or more 5001.12.2023tests described in the item have been rendered by the referring APP - one test 5001.12.2023(Item is subject to rule 6 and 18) 1066500 26.05.2002 6 P2 SN NNNNY 2001.12.202300031.0000009.7000000.00 5001.12.2023Quantitation in serum, plasma, urine or other body fluid (except amniotic 5001.12.2023fluid), by any method except reagent tablet or reagent strip (with or without 5001.12.2023reflectance meter) of: acid phosphatase, alanine aminotransferase, albumin, 5001.12.2023alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, 5001.12.2023bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, 5001.12.2023calcium (total or corrected for albumin), chloride, creatine kinase, 5001.12.2023creatinine, gamma glutamyl transferase, globulin, glucose, lactate 5001.12.2023dehydrogenase, lipase, magnesium, phosphate, potassium, sodium, total protein, 5001.12.2023total cholesterol, triglycerides, urate or urea - 1 test 1066503 26.05.2002 6 P2 SN NNNNY 2001.12.202300037.0000011.6500000.00 5001.12.20232 tests described in item 66500 1066506 26.05.2002 6 P2 SN NNNNY 2001.12.202300043.0000013.6500000.00 5001.12.20233 tests described in item 66500 1066509 26.05.2002 6 P2 SN NNNNY 2001.12.202300050.0000015.6500000.00 5001.12.20234 tests described in item 66500 1066512 26.05.2002 6 P2 SN NNNNY 2001.12.202300056.0000017.7000000.00 5001.12.20235 or more tests described in item 66500 1066517 01.11.2007 6 P2 SN NNNNY 2001.12.202300062.0000019.6500000.00 5001.12.2023Quantitation of bile acids in blood in pregnancy. Applicable not more than 3 5001.12.2023times in a pregnancy. 1066518 26.05.2002 6 P2 SN NNNNY 2001.12.202300063.0000020.0500000.00 5001.12.2023Investigation of cardiac or skeletal muscle damage by quantitative measurement 5001.12.2023of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 1 5001.12.2023specimen in a 24 hour period 1066519 26.05.2002 6 P2 SN NNNNY 2001.12.202300128.0000040.1500000.00 5001.12.2023Investigation of cardiac or skeletal muscle damage by quantitative measurement 5001.12.2023of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 2 5001.12.2023or more specimens in a 24 hour period 1066536 26.05.2002 6 P2 SN NNNNY 2001.12.202300037.0000011.0500000.00 5001.12.2023Quantitation of HDL cholesterol 1066539 26.05.2002 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Electrophoresis of serum for demonstration of lipoprotein subclasses, if the 5001.12.2023cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the 5001.12.2023diagnosis of types III and IV hyperlipidaemia - (Item is subject to rule 25) 1066542 26.05.2002 6 P2 SN NNNNY 2001.12.202300060.0000018.9500000.00 5001.12.2023Oral glucose tolerance test for the diagnosis of diabetes mellitus that 5001.12.2023includes: (a)administration of glucose; and (b)at least 2 measurements of 5001.12.2023blood glucose; and (c)(if performed) any test described in item 66695 1066560 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1000000.00 5001.12.2023Microalbumin - quantitation in urine 1066563 26.05.2002 6 P2 SN NNNNY 2001.12.202300078.0000024.7000000.00 5001.12.2023Osmolality, estimation by osmometer, in serum or in urine - 1 or more tests 1066566 26.05.2002 6 P2 SN NNNNY 2001.12.202300106.0000033.7000000.00 5001.12.2023Quantitation of: (a)blood gases (including pO2, oxygen saturation and pCO2) ; 5001.12.2023and (b)bicarbonate and pH; including any other measurement (eg. haemoglobin, 5001.12.2023lactate, potassium or ionised calcium) or calculation performed on the same 5001.12.2023specimen - 1 or more tests on 1 specimen 1066569 26.05.2002 6 P2 SN NNNNY 2001.12.202300134.0000042.6000000.00 5001.12.2023Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5001.12.20232 specimens performed within any 1 day 1066572 26.05.2002 6 P2 SN NNNNY 2001.12.202300162.0000051.5500000.00 5001.12.2023Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5001.12.20233 specimens performed within any 1 day 1066575 26.05.2002 6 P2 SN NNNNY 2001.12.202300190.0000060.4500000.00 5001.12.2023Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5001.12.20234 specimens performed within any 1 day 1066578 26.05.2002 6 P2 SN NNNNY 2001.12.202300220.0000069.3500000.00 5001.12.2023Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5001.12.20235 specimens performed within any 1 day 1066581 26.05.2002 6 P2 SN NNNNY 2001.12.202300245.0000078.2500000.00 5001.12.2023Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5001.12.20236 or more specimens performed within any 1 day 1066584 26.05.2002 6 P2 SN NNNNY 2001.12.202300031.0000009.7000000.00 5001.12.2023Quantitation of ionised calcium (except if performed as part of item 66566) - 5001.12.20231 test 1066585 01.11.2023 6 P2 SN YNNYN 2001.12.202300132.0000058.5000000.00 5001.12.2023Quantification of laboratorybased BNP or NTproBNP testing in a patient with 5001.12.2023systemic sclerosis (scleroderma) to assess risk of pulmonary arterial 5001.12.2023hypertension Maximum of 2 tests in a 12 month period 1066587 26.05.2002 6 P2 SN NNNNY 2001.12.202300150.0000047.5500000.00 5001.12.2023Urine acidification test for the diagnosis of renal tubular acidosis including 5001.12.2023the administration of an acid load, and pH measurements on 4 or more urine 5001.12.2023specimens and at least 1 blood specimen 1066590 26.05.2002 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Calculus, analysis of 1 or more 1066593 26.05.2002 6 P2 SN NNNNY 2001.12.202300060.0000018.0000000.00 5001.12.2023Ferritin - quantitation, except if requested as part of iron studies 1066596 26.05.2002 6 P2 SN NNNNY 2001.12.202300108.0000032.5500000.00 5001.12.2023Iron studies, consisting of quantitation of: (a)serum iron; and (b)transferrin 5001.12.2023or iron binding capacity; and (c)ferritin 1066605 26.05.2002 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Vitamins - quantitation of vitamins B1, B2, B3, B6 or Cin blood, urine or 5001.12.2023other body fluid - 1 or more tests 1066606 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023A test described in item 66605 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18 and 25) 1066607 01.05.2009 6 P2 SN NNNNY 2001.12.202300235.0000075.7500000.00 5001.12.2023Vitamins - quantitation of vitamins A or E in blood, urine or other body fluid 5001.12.2023- 1 or more tests within a 6 month period 1066610 01.07.2011 6 P2 SN NNNNY 2001.12.202300235.0000075.7500000.00 5001.12.2023A test described in item 66607 if rendered by a receiving APP - 1 or more 5001.12.2023tests 1066623 26.05.2002 6 P2 SN NNNNY 2001.12.202300130.0000041.5000000.00 5001.12.2023All qualitative and quantitative tests on blood, urine or other body fluid 5001.12.2023for: (a)a drug or drugs of abuse (including illegal drugs and legally 5001.12.2023available drugs taken other than in appropriate dosage); or (b)ingested or 5001.12.2023absorbed toxic chemicals; including a service described in item 66800, 66803, 5001.12.202366806, 66812 or 66815 (if performed), but excluding: (c)the surveillance of 5001.12.2023sports people and athletes for performance improving substances; and (d)the 5001.12.2023monitoring of patients participating in a drug abuse treatment program 1066626 26.05.2002 6 P2 SN NNNNY 2001.12.202300076.0000024.1000000.00 5001.12.2023Detection or quantitation or both (not including the detection of nicotine and 5001.12.2023metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a 5001.12.2023therapeutic drug, on a sample collected from a patient participating in a drug 5001.12.2023abuse treatment program; but excluding the surveillance of sports people and 5001.12.2023athletes for performance improving substances; including all tests on blood, 5001.12.2023urine or other body fluid (Item is subject to rule 25) 1066629 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1000000.00 5001.12.2023Beta-2-microglobulin - quantitation in serum, urine or other body fluids - 1 5001.12.2023or more tests 1066632 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1000000.00 5001.12.2023Caeruloplasmin, haptoglobins, or prealbumin - quantitation in serum, urine or 5001.12.2023other body fluids - 1 or more tests 1066635 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1000000.00 5001.12.2023Alpha-1-antitrypsin - quantitation in serum, urine or other body fluid - 1 or 5001.12.2023more tests 1066638 26.05.2002 6 P2 SN NNNNY 2001.12.202300092.0000049.0500000.00 5001.12.2023Isoelectric focussing or similar methods for determination of 5001.12.2023alpha-1-antitrypsin phenotype in serum - 1 or more tests 1066639 01.05.2007 6 P2 SN NNNNY 2001.12.202300092.0000029.2000000.00 5001.12.2023A test described in item 66638 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066641 26.05.2002 6 P2 SN NNNNY 2001.12.202300092.0000029.2000000.00 5001.12.2023Electrophoresis of serum or other body fluid to demonstrate: (a)the isoenzymes 5001.12.2023of lactate dehydrogenase; or (b)the isoenzymes of alkaline phosphatase; 5001.12.2023including the preliminary quantitation of total relevant enzyme activity - 1 5001.12.2023or more tests 1066642 01.05.2007 6 P2 SN NNNNY 2001.12.202300092.0000029.2000000.00 5001.12.2023A test described in item 66641 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066644 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1500000.00 5001.12.2023C-1 esterase inhibitor - quantitation 1066647 26.05.2002 6 P2 SN NNNNY 2001.12.202300142.0000045.1000000.00 5001.12.2023C-1 esterase inhibitor - functional assay 1066650 26.05.2002 6 P2 SN NNNNY 2001.12.202300077.0000024.3500000.00 5001.12.2023Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 5001.12.2023antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic 5001.12.2023antigen (CEA), human chorionic gonadotrophin (HCG), neuron specific enolase 5001.12.2023(NSE), thyroglobulin in serum or other body fluid, in the monitoring of 5001.12.2023malignancy or in the detection or monitoring of hepatic tumours, gestational 5001.12.2023trophoblastic disease or germ cell tumour - quantitation - 1 test (Item is 5001.12.2023subject to rule 6) 1066651 01.05.2007 6 P2 SN NNNNY 2001.12.202300077.0000024.3500000.00 5001.12.2023A test described in item 66650 if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1066652 01.05.2007 6 P2 SN NNNNY 2001.12.202300064.0000020.3000000.00 5001.12.2023A test described in item 66650 if rendered by a receiving APP - other than 5001.12.2023that described in 66651, if rendered by a receiving APP, 1 test (Item is 5001.12.2023subject to rule 6 and 18) 1066653 26.05.2002 6 P2 SN NNNNY 2001.12.202300140.0000044.6000000.00 5001.12.20232 or more tests described in item 66650 (Item is subject to rule 6) 1066654 01.11.2023 6 P2 SN YNNYN 2001.12.202300045.0000020.1500000.00 5001.12.2023Prostate specific antigen quantitation in the monitoring of high-risk patients 5001.12.2023For any particular patient, applicable not more than once in 11 months 1066655 26.05.2002 6 P2 SN NYNYY 2001.12.202300064.0000020.1500000.00 5001.12.2023Prostate specific antigenquantitation For any particular patient, applicable 5001.12.2023not more than once in 23 months 1066656 26.05.2002 6 P2 SN NYNYY 2001.12.202300064.0000020.1500000.00 5001.12.2023Prostate specific antigen (PSA) quantitation in the monitoring of previously 5001.12.2023diagnosed prostatic disease (includingprostate cancer, prostatitis or a 5001.12.2023premalignant condition such as atypical small acinar proliferation) 1066659 26.05.2002 6 P2 SN NYNYY 2001.12.202300118.0000037.3000000.00 5001.12.2023Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA 5001.12.2023and any derived index, including, if performed, a test described in item 5001.12.202366656, in the follow up of a PSA result under item 66654 or 66655 that lies 5001.12.2023at: (a) more than 2.0 ug/L but less than or equal to 5.5 ug/L for patients 5001.12.2023with a family history of prostate cancer; or (b) more than 3.0 ug/L but less 5001.12.2023than or equal to 5.5 ug/L for patients who are at least 50 years of age but 5001.12.2023under 70 years of age; or (c) more than 5.5 ug/L but less than or equal to 5001.12.202310.0 ug/L for patients who are at least 70 years of age For any particular 5001.12.2023patient, applicable not more than once in 11 months 1066660 01.05.2009 6 P2 SN NYNYY 2001.12.202300118.0000037.3000000.00 5001.12.2023Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA 5001.12.2023and any derived index, in the monitoring of previously diagnosed prostatic 5001.12.2023disease, including, if performed, a test described in item 66656, if the 5001.12.2023current PSA level lies at: (a) more than 2.0 ug/L but less than or equal to 5001.12.20235.5 ug/L for patients with a family history of prostate cancer; or (b) more 5001.12.2023than 3.0 ug/L but less than or equal to 5.5 ug/L for patients who are at least 5001.12.202350 years of age but under 70 years of age; or (c) more than 5.5 ug/L but less 5001.12.2023than or equal to 10.0 ug/L for patients who are at least 70 years of age For 5001.12.2023any particular patient, applicable not more than 4 times in 11 months 1066662 26.05.2002 6 P2 SN NNNNY 2001.12.202300250.0000079.9500000.00 5001.12.2023Quantitation of hormone receptors on proven primary breast or ovarian 5001.12.2023carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent 5001.12.2023lesion in the breast - 1 or more tests 1066663 01.05.2007 6 P2 SN NNNNY 2001.12.202300250.0000079.9500000.00 5001.12.2023A test described in item 66662 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066665 26.05.2002 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Lead quantitation in blood or urine (other than for occupational health 5001.12.2023screening purposes) to a maximum of 3 tests in a 6 month period - each test 1066666 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023A test described in item 66665 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066667 26.05.2002 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Quantitation of serum zinc in a patient receiving intravenous alimentation - 5001.12.2023each test 1066671 26.05.2002 6 P2 SN NNNNY 2001.12.202300116.0000036.9000000.00 5001.12.2023Quantitation of serum aluminium in a patient in a renal dialysis program - 5001.12.2023each test 1066674 26.05.2002 6 P2 SN NNNNY 2001.12.202300126.0000039.9500000.00 5001.12.2023Quantitation of: (a)faecal fat; or (b)breath hydrogen in response to loading 5001.12.2023with disaccharides; 1 or more tests within a 28 day period 1066677 26.05.2002 6 P2 SN NNNNY 2001.12.202300035.0000011.1500000.00 5001.12.2023Test for tryptic activity in faeces in the investigation of diarrhoea of 5001.12.2023longer than 4 weeks duration in children under 6 years old 1066680 26.05.2002 6 P2 SN NNNNY 2001.12.202300235.0000074.4500000.00 5001.12.2023Quantitation of disaccharidases and other enzymes in intestinal tissue - 1 or 5001.12.2023more tests 1066683 26.05.2002 6 P2 SN NNNNY 2001.12.202300235.0000074.4500000.00 5001.12.2023Enzymes - quantitation in solid tissue or tissues other than blood elements or 5001.12.2023intestinal tissue - 1 or more tests 1066686 26.05.2002 6 P2 SN NNNNY 2001.12.202300160.0000050.6500000.00 5001.12.2023Performance of 1 or more of the following procedures: (a)growth hormone 5001.12.2023suppression by glucose loading; (b)growth hormone stimulation by exercise; 5001.12.2023(c)dexamethasone suppression test; (d)sweat collection by iontophoresis for 5001.12.2023chloride analysis; (e)pharmacological stimulation of growth hormone 1066695 26.05.2002 6 P2 SN NNNNY 2001.12.202300100.0000030.5000000.00 5001.12.2023Quantitation in blood or urine of hormones and hormone binding proteins - 5001.12.2023ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, DHEAS, 5001.12.202311-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, 5001.12.2023hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, 5001.12.2023prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), 5001.12.2023free or total testosterone, urine steroid fraction or fractions, vasoactive 5001.12.2023intestinal peptide,- 1 test (Item is subject to rule 6) 1066696 01.05.2007 6 P2 SN NNNNY 2001.12.202300100.0000030.5000000.00 5001.12.2023A test described in item 66695, if rendered by a receiving APP - where no 5001.12.2023tests in the item have been rendered by the referring APP (Item is subject to 5001.12.2023rule 6 and 18) 1066697 01.05.2007 6 P2 SN NNNNY 2001.12.202300043.0000013.2000000.00 5001.12.2023Tests described in item 66695, other than that described in 66696, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 4 tests (Item is subject to 5001.12.2023rule 6 and 18) 1066698 26.05.2002 6 P2 SN NNNNY 2001.12.202300140.0000043.7000000.00 5001.12.20232 tests described in item 66695 (Item is subject to rule 6) 1066701 26.05.2002 6 P2 SN NNNNY 2001.12.202300182.0000056.9000000.00 5001.12.20233 tests described in item 66695 (Item is subject to rule 6) 1066704 26.05.2002 6 P2 SN NNNNY 2001.12.202300225.0000070.1500000.00 5001.12.20234 tests described in item 66695 (This fee applies where 1 laboratory, or more 5001.12.2023than 1 laboratory belonging to the same APA, performs the only 4 tests 5001.12.2023specified on the request form or performs 4 tests and refers the rest to the 5001.12.2023laboratory of a separate APA) (Item is subject to rule 6) 1066707 26.05.2002 6 P2 SN NNNNY 2001.12.202300265.0000083.3500000.00 5001.12.20235 or more tests described in item 66695 (Item is subject to rule 6) 1066711 01.11.2005 6 P2 SN NNNNY 2001.12.202300099.0000030.1500000.00 5001.12.2023Quantitation in saliva of cortisol in: (a)the investigation of Cushing's 5001.12.2023syndrome; or (b)the management of children with congenital adrenal hyperplasia 5001.12.2023(Item is subject to rule 6) 1066712 01.11.2005 6 P2 SN NNNNY 2001.12.202300142.0000043.0500000.00 5001.12.2023Two tests described in item 66711 (Item is subject to rule 6) 1066714 01.05.2007 6 P2 SN NNNNY 2001.12.202300099.0000030.1500000.00 5001.12.2023A test described in item 66711, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP (Item is subject to rule 6 5001.12.2023and 18) 1066715 01.05.2007 6 P2 SN NNNNY 2001.12.202300043.0000012.8500000.00 5001.12.2023Tests described in item 66711, other than that described in 66714, if rendered 5001.12.2023by a receiving APP, each test to a maximum of 1 test (Item is subject to rule 5001.12.20236 and 18) 1066716 26.05.2002 6 P2 SN NNNNY 2001.12.202300098.0000025.0500000.00 5001.12.2023TSH quantitation 1066719 26.05.2002 6 P2 SN NNNNY 2001.12.202300128.0000034.8000000.00 5001.12.2023Thyroid function tests (comprising the service described in item 66716 and 5001.12.2023either or bothof a test for free thyroxine and a test for free T3) for a 5001.12.2023patient, if: (a)the patient has a level of TSH that is outside the normal 5001.12.2023reference range for the particular method of assay used to determine the 5001.12.2023level; or (b)the request from the requesting medical practitioner indicates 5001.12.2023that the tests are performed: (i)for the purpose of monitoring thyroid disease 5001.12.2023in the patient; or (ii)to investigate the sick euthyroid syndrome if the 5001.12.2023patient is an admitted patient; or (iii)to investigate dementia or psychiatric 5001.12.2023illness of the patient; or (iv)to investigate amenorrhoea or infertility of 5001.12.2023the patient; or (c)the request from the requesting medical practitioner 5001.12.2023indicates that themedical practitionersuspects the patient has a pituitary 5001.12.2023dysfunction; or (d)the request from the requesting medical practitioner 5001.12.2023indicates that thepatient is on drugs that interfere with thyroid hormone 5001.12.2023metabolism or function 1066722 26.05.2002 6 P2 SN NNNNY 2001.12.202300138.0000037.9000000.00 5001.12.2023TSH quantitation described in item 66716 and 1 test described in item 66695 5001.12.2023(This fee applies where 1 laboratory, or more than 1 laboratory belonging to 5001.12.2023the same APA, performs the only 2 tests specified on the request form or 5001.12.2023performs 2 tests and refers the rest to the laboratory of a separate APA) 5001.12.2023(Item is subject to rule 6) 1066723 01.05.2007 6 P2 SN NNNNY 2001.12.202300138.0000037.9000000.00 5001.12.2023Tests described in item 66722, that is, TSH quantitation and 1 test described 5001.12.2023in 66695, if rendered by a receiving APP, where no tests in the item have been 5001.12.2023rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) 1066724 01.05.2007 6 P2 SN NNNNY 2001.12.202300048.0000013.1500000.00 5001.12.2023Tests described in item 66722, if rendered by a receiving APP, other than that 5001.12.2023described in 66723. It is to include a quantitation of TSH - each test to a 5001.12.2023maximum of 4 tests described in item 66695 (Item is subject to rule 6 and 18) 1066725 26.05.2002 6 P2 SN NNNNY 2001.12.202300180.0000051.0500000.00 5001.12.2023TSH quantitation described in item 66716 and 2 tests described in item 66695 5001.12.2023(This fee applies where 1 laboratory, or more than 1 laboratory belonging to 5001.12.2023the same APA, performs the only 3 tests specified on the request form or 5001.12.2023performs 3 tests and refers the rest to the laboratory of a separate APA) 5001.12.2023(Item is subject to rule 6) 1066728 26.05.2002 6 P2 SN NNNNY 2001.12.202300220.0000064.2000000.00 5001.12.2023TSH quantitation described in item 66716 and 3 tests described in item 66695 5001.12.2023(This fee applies where 1 laboratory, or more than 1 laboratory belonging to 5001.12.2023the same APA, performs the only 4 tests specified on the request form or 5001.12.2023performs 4 tests and refers the rest to the laboratory of a separate APA) 5001.12.2023(Item is subject to rule 6) 1066731 26.05.2002 6 P2 SN NNNNY 2001.12.202300265.0000077.4000000.00 5001.12.2023TSH quantitation described in item 66716 and 4 tests described in item 66695 5001.12.2023(This fee applies where 1 laboratory, or more than 1 laboratory belonging to 5001.12.2023the same APA, performs the only 5 tests specified on the request form or 5001.12.2023performs 5 tests and refers the rest to the laboratory of a separate APA) 5001.12.2023(Item is subject to rule 6) 1066734 26.05.2002 6 P2 SN NNNNY 2001.12.202300305.0000090.5500000.00 5001.12.2023TSH quantitation described in item 66716 and 5 tests described in item 66695 5001.12.2023(This fee applies where 1 laboratory, or more than 1 laboratory belonging to 5001.12.2023the same APA, performs 6 or more tests specified on the request form) (Item is 5001.12.2023subject to rule 6) 1066743 26.05.2002 6 P2 SN NNNNY 2001.12.202300064.0000020.1000000.00 5001.12.2023Quantitation of alpha-fetoprotein in serum or other body fluids during 5001.12.2023pregnancy except if requested as part of items 66750 or 66751 1066749 26.05.2002 6 P2 SN NNNNY 2001.12.202300104.0000032.9500000.00 5001.12.2023Amniotic fluid, spectrophotometric examination of, and quantitation of: 5001.12.2023(a)lecithin/sphingomyelin ratio; or (b)palmitic acid, phosphatidylglycerol or 5001.12.2023lamellar body phospholipid; or (c)bilirubin, including correction for 5001.12.2023haemoglobin 1 or more tests 1066750 01.05.2003 6 P2 SN NNNNY 2001.12.202300122.0000039.7500000.00 5001.12.2023Quantitation, in pregnancy, of any2 of the following to detect foetal 5001.12.2023abnormality- total human chorionic gonadotrophin (total HCG), free alpha human 5001.12.2023chorionic gonadotrophin (free alpha HCG), free beta human chorionic 5001.12.2023gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), 5001.12.2023unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - including (if 5001.12.2023performed) a service described initem 73527or 73529 - Applicable not more than 5001.12.2023once in a pregnancy 1066751 01.05.2003 6 P2 SN NNNNY 2001.12.202300174.0000055.2500000.00 5001.12.2023Quantitation, in pregnancy, of any three or more tests described in 66750 5001.12.2023(Item is subject to rule 25) 1066752 26.05.2002 6 P2 SN NNNNY 2001.12.202300078.0000024.7000000.00 5001.12.2023Quantitation of acetoacetate, beta-hydroxybutyrate, citrate, oxalate, total 5001.12.2023free fatty acids, cysteine, homocysteine, cystine, lactate, pyruvate or other 5001.12.2023amino acids and hydroxyproline (except if performed as part of item 66773 or 5001.12.202366776) - 1 test 1066755 26.05.2002 6 P2 SN NNNNY 2001.12.202300122.0000038.8500000.00 5001.12.20232 or more tests described in item 66752 1066756 01.05.2007 6 P2 SN NNNNY 2001.12.202300325.0000098.3000000.00 5001.12.2023Quantitation of 10 or more amino acids for the diagnosis of inborn errors of 5001.12.2023metabolism - up to 4 tests in a 12 month period on specimens of plasma, CSF 5001.12.2023and urine. 1066757 01.05.2007 6 P2 SN NNNNY 2001.12.202300325.0000098.3000000.00 5001.12.2023Quantitation of 10 or more amino acids for monitoring of previously diagnosed 5001.12.2023inborn errors of metabolism in 1 tissue type. 1066758 26.05.2002 6 P2 SN NNNNY 2001.12.202300078.0000024.7000000.00 5001.12.2023Quantitation of angiotensin converting enzyme, or cholinesterase - 1 or more 5001.12.2023tests 1066761 26.05.2002 6 P2 SN NNNNY 2001.12.202300042.0000013.1500000.00 5001.12.2023Test for reducing substances in faeces by any method (except reagent strip or 5001.12.2023dipstick) 1066764 26.05.2002 6 P2 SN NNNNY 2001.12.202300028.0000008.9000000.00 5001.12.2023Examination for faecal occult blood (including tests for haemoglobin and its 5001.12.2023derivatives in the faeces except by reagent strip or dip stick methods) with a 5001.12.2023maximum of 3 examinations on specimens collected on separate days in a 28 day 5001.12.2023period 1066767 26.05.2002 6 P2 SN NNNNY 2001.12.202300056.0000017.8500000.00 5001.12.20232 examinations described in item 66764 performed on separately collected and 5001.12.2023identified specimens 1066770 26.05.2002 6 P2 SN NNNNY 2001.12.202300084.0000026.7000000.00 5001.12.20233 examinations described in item 66764 performed on separately collected and 5001.12.2023identified specimens 1066773 26.05.2002 6 P2 SN NNNNY 2001.12.202300078.0000024.6500000.00 5001.12.2023Quantitation of products of collagen breakdown or formation for the monitoring 5001.12.2023of patients with proven low bone mineral density, and if performed, a service 5001.12.2023described in item 66752 - 1 or more tests (Low bone densitometry is defined in 5001.12.2023the explanatory notes to Category 2 - Diagnostic Procedures and Investigations 5001.12.2023of the Medicare Benefits Schedule) 1066776 26.05.2002 6 P2 SN NNNNY 2001.12.202300078.0000024.6500000.00 5001.12.2023Quantitation of products of collagen breakdown or formation for the monitoring 5001.12.2023of patients with metabolic bone disease or Paget's disease of bone, and if 5001.12.2023performed, a service described in item 66752 - 1 or more tests 1066779 26.05.2002 6 P2 SN NNNNY 2001.12.202300126.0000039.9500000.00 5001.12.2023Adrenaline, noradrenaline, dopamine, histamine, hydroxyindoleacetic acid 5001.12.2023(5HIAA), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), 5001.12.2023metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid 5001.12.2023(PAA) or serotoninquantitation - 1 or more tests 1066780 01.05.2007 6 P2 SN NNNNY 2001.12.202300126.0000039.9500000.00 5001.12.2023A test described in item 66779 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066782 26.05.2002 6 P2 SN NNNNY 2001.12.202300042.0000013.1500000.00 5001.12.2023Porphyrins or porphyrins precursors - detection in plasma, red cells, urine or 5001.12.2023faeces - 1 or more tests 1066783 01.05.2007 6 P2 SN NNNNY 2001.12.202300042.0000013.1500000.00 5001.12.2023A test described in item 66782 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066785 26.05.2002 6 P2 SN NNNNY 2001.12.202300126.0000039.9500000.00 5001.12.2023Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine 5001.12.2023or faeces - 1 test (Item is subject to rule 6) 1066788 26.05.2002 6 P2 SN NNNNY 2001.12.202300210.0000065.8500000.00 5001.12.2023Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine 5001.12.2023or faeces - 2 or more tests (Item is subject to rule 6) 1066789 01.05.2007 6 P2 SN NNNNY 2001.12.202300126.0000039.9500000.00 5001.12.2023A test described in item 66785 if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1066790 01.05.2007 6 P2 SN NNNNY 2001.12.202300081.0000025.9000000.00 5001.12.2023A test described in item 66785 other than that described in 66789, if rendered 5001.12.2023by a receiving APP - to a maximum of 1 test (Item is subject to rule 6 and 18) 1066791 26.05.2002 6 P2 SN NNNNY 2001.12.202300235.0000074.4500000.00 5001.12.2023Porphyrin biosynthetic enzymes - measurement of activity in blood cells or 5001.12.2023other tissues - 1 or more tests 1066792 01.05.2007 6 P2 SN NNNNY 2001.12.202300235.0000074.4500000.00 5001.12.2023A test described in item 66791 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1066800 01.11.2003 6 P2 SN NNNNY 2001.12.202300057.0000018.1500000.00 5001.12.2023Quantitation in blood, urine or other body fluid by any method (except reagent 5001.12.2023tablet or reagent strip) of any of the following being used therapeutically by 5001.12.2023the patient from whom the specimen was taken: amikacin, carbamazepine, 5001.12.2023digoxin, disopyramide, ethanol, ethosuximide, gentamicin, lithium, lignocaine, 5001.12.2023netilmicin, paracetamol, phenobarbitone, primidone, phenytoin, procainamide, 5001.12.2023quinidine, salicylate, theophylline, tobramycin, valproate or vancomycin - 1 5001.12.2023test (Item to be subject to rule 6) 1066803 01.11.2003 6 P2 SN NNNNY 2001.12.202300097.0000030.5000000.00 5001.12.20232 tests described in item 66800 (Item is subject to rule 6) 1066804 01.05.2007 6 P2 SN NNNNY 2001.12.202300057.0000018.1500000.00 5001.12.2023A test described in item 66800 if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1066805 01.05.2007 6 P2 SN NNNNY 2001.12.202300040.0000012.3500000.00 5001.12.2023A test described in item 66800 other than that described in 66804, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 2 tests (Item is subject to 5001.12.2023rule 6 and 18) 1066806 01.11.2003 6 P2 SN NNNNY 2001.12.202300136.0000041.8500000.00 5001.12.20233 tests described in item 66800 (Item is subject to rule 6) 1066812 01.11.2003 6 P2 SN NNNNY 2001.12.202300110.0000034.8000000.00 5001.12.2023Quantitation, not elsewhere described in this Table by any method or methods, 5001.12.2023in blood, urine or other body fluid, of a drug being used therapeutically by 5001.12.2023the patient from whom the specimen was taken - 1 test (This fee applies where 5001.12.20231 laboratory performs the only test specified on the request form or performs 5001.12.20231 test and refers the rest to the laboratory of a separate APA) (Item is 5001.12.2023subject to rule 6) 1066815 01.11.2003 6 P2 SN NNNNY 2001.12.202300188.0000059.5500000.00 5001.12.20232 tests described in item 66812 (This fee applies where 1 laboratory, or more 5001.12.2023than 1 laboratory belonging to the same APA, performs the only 2 tests 5001.12.2023specified on the request form or performs 2 tests and refers the rest to the 5001.12.2023laboratory of a separate APA) (Item is subject to rule 6) 1066816 01.05.2007 6 P2 SN NNNNY 2001.12.202300188.0000034.8000000.00 5001.12.2023A test described in item 66812 if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1066817 01.05.2007 6 P2 SN NNNNY 2001.12.202300134.0000024.7500000.00 5001.12.2023A test described in item 66812, other than that described in 66816, if 5001.12.2023rendered by a receiving APP - to a maximum of 1 test (Item is subject to rule 5001.12.20236 and 18) 1066819 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Quantitation of copper, manganese, selenium, or zinc (except if item 66667 5001.12.2023applies), in blood, urine or other body fluid - 1 test. (Item is subject to 5001.12.2023rule 6, 22 and 25) 1066820 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023A test described in item 66819 if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6, 18, 22 and 25) 1066821 01.05.2007 6 P2 SN NNNNY 2001.12.202300068.0000021.8000000.00 5001.12.2023A test described in item 66819 other than that described in 66820 if rendered 5001.12.2023by a receiving APP to a maximum of 1 test (Item is subject to rule 6, 18,22 5001.12.2023and 25) 1066822 01.05.2007 6 P2 SN NNNNY 2001.12.202300164.0000052.4500000.00 5001.12.2023Quantitation of copper, manganese, selenium, or zinc (except if item 66667 5001.12.2023applies), in blood, urine or other body fluid - 2 or more tests. (Item is 5001.12.2023subject to rule 6, 22 and 25) 1066825 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, 5001.12.2023cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or 5001.12.2023other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 5001.12.2023month period (Item is subject to rule 6, 22 and 25) 1066826 01.05.2007 6 P2 SN NNNNY 2001.12.202300096.0000030.6000000.00 5001.12.2023A test described in item 66825 if rendered by a receiving APP where no tests 5001.12.2023have been rendered by the referring APP - 1 test (Item is subject to rules 6, 5001.12.202318, 22 and 25 ) 1066827 01.05.2007 6 P2 SN NNNNY 2001.12.202300068.0000021.8000000.00 5001.12.2023A test described in item 66825, other than that described in 66826, if 5001.12.2023rendered by a receiving APP to a maximum of 1 test (Item is subject to rules 5001.12.20236, 18, 22 and 25) 1066828 01.05.2007 6 P2 SN NNNNY 2001.12.202300164.0000052.4500000.00 5001.12.2023Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, 5001.12.2023cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or 5001.12.2023other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item 5001.12.2023in a 6 month period (Item is subject to rule 6, 22 and 25) 1066830 01.07.2008 6 P2 SN NNNNY 2001.12.202300194.0000058.5000000.00 5001.12.2023Quantitation of BNP or NT-proBNP for the diagnosis of heart failure in 5001.12.2023patients presenting with dyspnoea to a hospital Emergency Department (Item is 5001.12.2023subject to rule 25) 1066831 01.11.2008 6 P2 SN NNNNY 2001.12.202300096.0000030.9500000.00 5001.12.2023Quantitation of copper or iron in liver tissue biopsy 1066832 01.11.2008 6 P2 SN NNNNY 2001.12.202300096.0000030.9500000.00 5001.12.2023A test described in item 66831 if rendered by a receiving APP (Item is subject 5001.12.2023to rule 18A and 22) 1066833 01.11.2014 6 P2 SN NNNNY 2001.12.202300134.0000030.0500000.00 5001.12.202325-hydroxyvitamin D, quantification in serum, for the investigation of a 5001.12.2023patient who: (a)has signs or symptoms of osteoporosis or osteomalacia; or 5001.12.2023(b)has increased alkaline phosphatase and otherwise normal liver function 5001.12.2023tests; or (c)has hyperparathyroidism, hypo- or hypercalcaemia, or 5001.12.2023hypophosphataemia; or (d)is suffering from malabsorption (for example, because 5001.12.2023the patient has cystic fibrosis, short bowel syndrome, inflammatory bowel 5001.12.2023disease or untreated coeliac disease, or has had bariatric surgery); or (e) 5001.12.2023has deeply pigmented skin, or chronic and severe lack of sun exposure for 5001.12.2023cultural, medical, occupational or residential reasons; or (f)is taking 5001.12.2023medication known to decrease 25OH-D levels (for example, anticonvulsants); or 5001.12.2023(g)has chronic renal failure or is a renal transplant recipient; or (h)is less 5001.12.2023than 16 years of age and has signs or symptoms of rickets; or (i)is an infant 5001.12.2023whose mother has established vitamin D deficiency; or (j)is a exclusively 5001.12.2023breastfed baby and has at least one other risk factor mentioned in a paragraph 5001.12.2023in this item; or (k)has a sibling who is less than 16 years of age and has 5001.12.2023vitamin D deficiency 1066834 01.11.2014 6 P2 SN NNNNY 2001.12.202300134.0000030.0500000.00 5001.12.2023A test described in item 66833 if rendered by a receiving APP (Item is subject 5001.12.2023to Rule 18) 1066835 01.11.2014 6 P2 SN NNNNY 2001.12.202300134.0000039.0500000.00 5001.12.20231, 25-dihydroxyvitamin D - quantification in serum, if the request for the 5001.12.2023test is made by, or on advice of, the specialist or consultant physician 5001.12.2023managing the treatment of the patient 1066836 01.11.2014 6 P2 SN NNNNY 2001.12.202300134.0000039.0500000.00 5001.12.20231, 25-dihydroxyvitamin D-quantification in serum, if: (a)the patient has 5001.12.2023hypercalcaemia; and (b)the request for the test is made by a general 5001.12.2023practitioner managing the treatment of the patient 1066837 01.11.2014 6 P2 SN NNNNY 2001.12.202300134.0000039.0500000.00 5001.12.2023A test described in item 66835 or 66836 if rendered by a receiving APP (Item 5001.12.2023is subject to Rule 18) 1066838 01.11.2014 6 P2 SN NNNNY 2001.12.202300078.0000023.6000000.00 5001.12.2023Serum vitamin B12 test (Item is subject to Rule 25) 1066839 01.11.2014 6 P2 SN NNNNY 2001.12.202300142.0000042.9500000.00 5001.12.2023Quantification of vitamin B12 markers such as holoTranscobalamin or 5001.12.2023methylmalonic acid, where initial serum vitamin B12 result is low or equivocal 1066840 01.11.2014 6 P2 SN NNNNY 2001.12.202300078.0000023.6000000.00 5001.12.2023Serum folate test and, if required, red cell folate test for a patient at risk 5001.12.2023of folate deficiency, including patients with malabsorption conditions, 5001.12.2023macrocytic anaemia or coeliac disease 1066841 01.11.2014 6 P2 SN NNNNY 2001.12.202300053.0000016.8000000.00 5001.12.2023Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of 5001.12.2023diabetes in asymptomatic patients at high risk.(Item is subject to rule 25) 1066900 01.05.2009 6 P2 SN NNNNY 2001.12.202300240.0000077.6500000.00 5001.12.2023CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, including the 5001.12.2023measurement of exhaled 13CO2 or 14CO2 (except if item 12533 applies) for 5001.12.2023either:- (a)the confirmation of Helicobacter pylori colonisation OR (b)the 5001.12.2023monitoring of the success of eradication of Helicobacter pylori. 1069300 26.05.2002 6 P3 SN NNNNY 2001.12.202300039.0000012.5000000.00 5001.12.2023Microscopy of wet film material other than blood, from 1 or more sites, 5001.12.2023obtained directly from a patient (not cultures) including: (a)differential 5001.12.2023cell count (if performed); or (b)examination for dermatophytes; or (c)dark 5001.12.2023ground illumination; or (d)stained preparation or preparations using any 5001.12.2023relevant stain or stains; 1 or more tests 1069303 26.05.2002 6 P3 SN NNNNY 2001.12.202300069.0000022.0000000.00 5001.12.2023Culture and (if performed) microscopy to detect pathogenic micro-organisms 5001.12.2023from nasal swabs, throat swabs, eye swabs and ear swabs (excluding swabs taken 5001.12.2023for epidemiological surveillance), including (if performed): (a)pathogen 5001.12.2023identification and antibiotic susceptibility testing; or (b)a service 5001.12.2023described in item 69300; specimens from 1 or more sites 1069306 26.05.2002 6 P3 SN NNNNY 2001.12.202300106.0000033.7500000.00 5001.12.2023Microscopy and culture to detect pathogenic micro-organisms from skin or other 5001.12.2023superficial sites, including (if performed): (a)pathogen identification and 5001.12.2023antibiotic susceptibility testing; or (b)a service described in items 69300, 5001.12.202369303, 69312, 69318; 1 or more tests on 1 or more specimens 1069309 26.05.2002 6 P3 SN NNNNY 2001.12.202300150.0000048.1500000.00 5001.12.2023Microscopy and culture to detect dermatophytes and other fungi causing 5001.12.2023cutaneous disease from skin scrapings, skin biopsies, hair and nails 5001.12.2023(excluding swab specimens) and including (if performed): (a)the detection of 5001.12.2023antigens not elsewhere specified in this Schedule; or (b)a service described 5001.12.2023in items 69300, 69303, 69306, 69312, 69318; 1 or more tests on 1 or more 5001.12.2023specimens 1069312 26.05.2002 6 P3 SN NNNNY 2001.12.202300106.0000033.7500000.00 5001.12.2023Microscopy and culture to detect pathogenic micro-organisms from urethra, 5001.12.2023vagina, cervix or rectum (except for faecal pathogens), including (if 5001.12.2023performed): (a)pathogen identification and antibiotic susceptibility testing; 5001.12.2023or (b) a service described in items 69300, 69303, 69306 and 69318; 1 or more 5001.12.2023tests on 1 or more specimens 1069316 01.05.2007 6 P3 SN NNNNY 2001.12.202300089.0000028.6500000.00 5001.12.2023Detection of Chlamydia trachomatis by any method - 1 test (Item is subject to 5001.12.2023rule 26) 1069317 01.05.2007 6 P3 SN NNNNY 2001.12.202300112.0000035.8500000.00 5001.12.20231 test described in item 69494 and a test described in 69316.(Item is subject 5001.12.2023to rule 26) 1069318 26.05.2002 6 P3 SN NNNNY 2001.12.202300100.0000033.7500000.00 5001.12.2023Microscopy and culture to detect pathogenic micro-organisms from specimens of 5001.12.2023sputum (except when part of items 69324, 69327 and 69330), including (if 5001.12.2023performed): (a) pathogen identification and antibiotic susceptibility testing; 5001.12.2023or (b)a service described in items 69300, 69303, 69306 and 69312; 1 or more 5001.12.2023tests on 1 or more specimens 1069319 01.05.2007 6 P3 SN NNNNY 2001.12.202300134.0000042.9500000.00 5001.12.20232 tests described in item 69494 and a test described in 69316. (Item is 5001.12.2023subject to rule 26) 1069321 26.05.2002 6 P3 SN NNNNY 2001.12.202300150.0000048.1500000.00 5001.12.2023Microscopy and culture of post-operative wounds, aspirates of body cavities, 5001.12.2023synovial fluid, CSF or operative or biopsy specimens, for the presence of 5001.12.2023pathogenic micro-organisms involving aerobic and anaerobic cultures and the 5001.12.2023use of different culture media, and including (if performed): (a)pathogen 5001.12.2023identification and antibiotic susceptibility testing; or (b)a service 5001.12.2023described in item 69300, 69303, 69306, 69312 or 69318; specimens from 1 or 5001.12.2023more sites 1069324 26.05.2002 6 P3 SN NNNNY 2001.12.202300134.0000043.0000000.00 5001.12.2023Microscopy (with appropriate stains) and culture for mycobacteria - 1 specimen 5001.12.2023of sputum, urine, or other body fluid or 1 operative or biopsy specimen, 5001.12.2023including (if performed): (a)microscopy and culture of other bacterial 5001.12.2023pathogens isolated as a result of this procedure; or (b)pathogen 5001.12.2023identification and antibiotic susceptibility testing; including a service 5001.12.2023described in item 69300 1069325 01.05.2007 6 P3 SN NNNNY 2001.12.202300134.0000043.0000000.00 5001.12.2023A test described in item 69324 if rendered by a receiving APP (Item is subject 5001.12.2023to rule 18) 1069327 26.05.2002 6 P3 SN NNNNY 2001.12.202300265.0000085.0000000.00 5001.12.2023Microscopy (with appropriate stains) and culture for mycobacteria - 2 5001.12.2023specimens of sputum, urine, or other body fluid or 2 operative or biopsy 5001.12.2023specimens, including (if performed): (a)microscopy and culture of other 5001.12.2023bacterial pathogens isolated as a result of this procedure; or (b)pathogen 5001.12.2023identification and antibiotic susceptibility testing; including a service 5001.12.2023mentioned in item 69300 1069328 01.05.2007 6 P3 SN NNNNY 2001.12.202300265.0000085.0000000.00 5001.12.2023A test described in item 69327 if rendered by a receiving APP (Item is subject 5001.12.2023to rule 18) 1069330 26.05.2002 6 P3 SN NNNNY 2001.12.202300400.0000128.0000000.00 5001.12.2023Microscopy (with appropriate stains) and culture for mycobacteria - 3 5001.12.2023specimens of sputum, urine, or other body fluid or 3 operative or biopsy 5001.12.2023specimens, including (if performed): (a)microscopy and culture of other 5001.12.2023bacterial pathogens isolated as a result of this procedure; or (b)pathogen 5001.12.2023identification and antibiotic susceptibility testing; including a service 5001.12.2023mentioned in item 69300 1069331 01.05.2007 6 P3 SN NNNNY 2001.12.202300400.0000128.0000000.00 5001.12.2023A test described in item 69330 if rendered by a receiving APP (Item is subject 5001.12.2023to rule 18) 1069333 26.05.2002 6 P3 SN NNNNY 2001.12.202300064.0000020.5500000.00 5001.12.2023Urine examination (including serial examinations) by any means other than 5001.12.2023simple culture by dip slide, including: (a)cell count; and (b)culture; and 5001.12.2023(c)colony count; and (d)(if performed) stained preparations; and (e)(if 5001.12.2023performed) identification of cultured pathogens; and (f)(if performed) 5001.12.2023antibiotic susceptibility testing; and (g)(if performed) examination for pH, 5001.12.2023specific gravity, blood, protein, urobilinogen, sugar, acetone or bile salts 1069336 26.05.2002 6 P3 SN NNNNY 2001.12.202300108.0000033.4500000.00 5001.12.2023Microscopy of faeces for ova, cysts and parasites that must include a 5001.12.2023concentration technique, and the use of fixed stains or antigen detection for 5001.12.2023cryptosporidia and giardia - including (if performed) a service described in 5001.12.2023item 69300 - 1 of this item in any 7 day period 1069339 26.05.2002 6 P3 SN NNNNY 2001.12.202300060.0000019.1000000.00 5001.12.2023Microscopy of faeces for ova, cysts and parasites using concentration 5001.12.2023techniques examined subsequent to item 69336 on a separately collected and 5001.12.2023identified specimen collected within 7 days of the examination described in 5001.12.202369336 - 1 examination in any 7 day period 1069345 26.05.2002 6 P3 SN NNNNY 2001.12.202300164.0000052.9000000.00 5001.12.2023Culture and (if performed) microscopy without concentration techniques of 5001.12.2023faeces for faecal pathogens, using at least 2 selective or enrichment media 5001.12.2023and culture in at least 2 different atmospheres including (if performed): 5001.12.2023(a)pathogen identification and antibiotic susceptibility testing; and (b)the 5001.12.2023detection of clostridial toxins; and (c)a service described in item 69300; - 1 5001.12.2023examination in any 7 day period 1069354 26.05.2002 6 P3 SN NNNNY 2001.12.202300096.0000030.7500000.00 5001.12.2023Blood culture for pathogenic micro-organisms (other than viruses), including 5001.12.2023sub-cultures and (if performed): (a)identification of any cultured 5001.12.2023pathogen;and (b)necessary antibiotic susceptibility testing; to a maximum of 3 5001.12.2023sets of cultures - 1 set of cultures 1069357 26.05.2002 6 P3 SN NNNNY 2001.12.202300192.0000061.4500000.00 5001.12.20232 sets of cultures described in item 69354 1069360 26.05.2002 6 P3 SN NNNNY 2001.12.202300285.0000092.2000000.00 5001.12.20233 sets of cultures described in item 69354 1069363 26.05.2002 6 P3 SN NNNNY 2001.12.202300080.0000028.6500000.00 5001.12.2023Detection of Clostridium difficile or Clostridium difficile toxin (except if a 5001.12.2023service described in item 69345 has been performed) - one or more tests 1069378 26.05.2002 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a 5001.12.2023HIV sero-positive patient not on antiretroviral therapy - 1 or more tests 1069379 01.05.2007 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023A test described in item 69378 if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1069380 01.07.2011 6 P3 SN NNNNY 2001.12.202302370.0000770.3000000.00 5001.12.2023Genotypic testing for HIV antiretroviral resistance in a patient with 5001.12.2023confirmed HIV infection if the patient's viral load is greater than 1,000 5001.12.2023copies per ml at any of the following times: (a)at presentation; or (b)before 5001.12.2023antiretroviral therapy: or (c)when treatment with combination antiretroviral 5001.12.2023agents fails; maximum of 2 tests in a 12 month period 1069381 26.05.2002 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023Quantitation of HIV viral RNA load in plasma or serum in the monitoring of 5001.12.2023antiretroviral therapy in a HIV sero-positive patient - 1 or more tests on 1 5001.12.2023or more specimens 1069382 26.05.2002 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV 5001.12.2023sero-positive patient - 1 or more tests on 1 or more specimens 1069383 01.05.2007 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023A test described in item 69381 if rendered by a receiving APP - 1 or more 5001.12.2023tests on 1 or more specimens (Item is subject to rule 18) 1069384 26.05.2002 6 P3 SN NNNNY 2001.12.202300049.0000015.6500000.00 5001.12.2023Quantitation of 1 antibody to microbial antigens not elsewhere described in 5001.12.2023the Schedule - 1 test (This fee applies where a laboratory performs the only 5001.12.2023antibody test specified on the request form or performs 1 test and refers the 5001.12.2023rest to the laboratory of a separate APA) (Item is subject to rule 6) 1069387 26.05.2002 6 P3 SN NNNNY 2001.12.202300089.0000029.0000000.00 5001.12.20232 tests described in item 69384 (This fee applies where 1 laboratory, or more 5001.12.2023than 1 laboratory belonging to the same APA, performs the only 2 estimations 5001.12.2023specified on the request form or performs 2 of the antibody estimations 5001.12.2023specified on the request form and refers the remainder to the laboratory of a 5001.12.2023separate APA) (Item is subject to rule 6) 1069390 26.05.2002 6 P3 SN NNNNY 2001.12.202300134.0000042.3500000.00 5001.12.20233 tests described in item 69384 (This fee applies where 1 laboratory, or more 5001.12.2023than 1 laboratory belonging to the same APA, performs the only 3 estimations 5001.12.2023specified on the request form or performs 3 of the antibody estimations 5001.12.2023specified on the request form and refers the remainder to the laboratory of a 5001.12.2023separate APA) (Item is subject to rule 6) 1069393 26.05.2002 6 P3 SN NNNNY 2001.12.202300178.0000055.7000000.00 5001.12.20234 tests described in item 69384 (This fee applies where 1 laboratory, or more 5001.12.2023than 1 laboratory belonging to the same APA, performs the only 4 estimations 5001.12.2023specified on the request form or performs 4 of the antibody estimations 5001.12.2023specified on the request form and refers the remainder to the laboratory of a 5001.12.2023separate APA) (Item is subject to rule 6) 1069396 26.05.2002 6 P3 SN NNNNY 2001.12.202300225.0000069.1000000.00 5001.12.20235 or more tests described in item 69384 (This fee applies where 1 laboratory, 5001.12.2023or more than 1 laboratory belonging to the same APA, performs the only 5 5001.12.2023estimations specified on the request form or performs 5 of the antibody tests 5001.12.2023specified on the request form and refers the remainder to the laboratory of a 5001.12.2023separate APA) (Item is subject to rule 6) 1069400 01.05.2007 6 P3 SN NNNNY 2001.12.202300049.0000015.6500000.00 5001.12.2023A test described in item 69384, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rules 6 and 18) 1069401 01.05.2007 6 P3 SN NNNNY 2001.12.202300044.0000013.3500000.00 5001.12.2023A test described in item 69384, other than that described in 69400, if 5001.12.2023rendered by a receiving APP - each test to a maximum of 4 tests (Item is 5001.12.2023subject to rule 6, 18 and 18A) 1069405 26.05.2002 6 P3 SN NNNNY 2001.12.202300049.0000015.6500000.00 5001.12.2023Microbiological serology during a pregnancy (except in the investigation of a 5001.12.2023clinically apparent intercurrent microbial illness or close contact with a 5001.12.2023patient suffering from parvovirus infection or varicella during that 5001.12.2023pregnancy) including: (a)the determination of 1 of the following - rubella 5001.12.2023immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis 5001.12.2023C antibody, HIV antibody and (b)(if performed) a service described in 1 or 5001.12.2023more of items 69384, 69475, 69478 and 69481 1069408 26.05.2002 6 P3 SN NNNNY 2001.12.202300087.0000029.0000000.00 5001.12.2023Microbiological serology during a pregnancy (except in the investigation of a 5001.12.2023clinically apparent intercurrent microbial illness or close contact with a 5001.12.2023patient suffering from parvovirus infection or varicella during that 5001.12.2023pregnancy) including: (a)the determination of 2 of the following - rubella 5001.12.2023immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis 5001.12.2023C antibody, HIV antibody and (b)(if performed) a service described in 1 or 5001.12.2023more of items 69384, 69475, 69478 and 69481 1069411 26.05.2002 6 P3 SN NNNNY 2001.12.202300122.0000042.3500000.00 5001.12.2023Microbiological serology during a pregnancy (except in the investigation of a 5001.12.2023clinically apparent intercurrent microbial illness or close contact with a 5001.12.2023patient suffering from parvovirus infection or varicella during that 5001.12.2023pregnancy) including: (a)the determination of 3 of the following - rubella 5001.12.2023immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis 5001.12.2023C antibody, HIV antibody and (b)(if performed) a service described in 1 or 5001.12.2023more of items 69384, 69475, 69478 and 69481 1069413 01.11.2003 6 P3 SN NNNNY 2001.12.202300156.0000055.7000000.00 5001.12.2023Microbiological serology during a pregnancy (except in the investigation of a 5001.12.2023clinically apparent intercurrent microbial illness or close contact with a 5001.12.2023patient suffering from parvovirus infection or varicella during that 5001.12.2023pregnancy) including: (a)the determination of 4 of the following - rubella 5001.12.2023immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis 5001.12.2023C antibody, HIV antibody and (b)(if performed) a service described in 1 or 5001.12.2023more of items 69384, 69475, 69478 and 69481 1069445 26.05.2002 6 P3 SN NNNNY 2001.12.202300285.0000092.2000000.00 5001.12.2023Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy 5001.12.2023for chronic HCV hepatitis (including a service described in item 69499) - 1 5001.12.2023test. To a maximum of 4 of this item in a 12 month period (Item is subject to 5001.12.2023rule 25) 1069451 01.05.2007 6 P3 SN NNNNY 2001.12.202300285.0000092.2000000.00 5001.12.2023A test described in item 69445 if rendered by a receiving APP - 1 test. (Item 5001.12.2023is subject to rule 18 and 25) 1069471 26.05.2002 6 P3 SN NNNNY 2001.12.202300110.0000034.9000000.00 5001.12.2023Test of cellmediated immune response in blood for the detection of latent 5001.12.2023tuberculosis by interferon gamma release assay (IGRA) in the following people: 5001.12.2023(a) a person who has been exposed to a confirmed case of active tuberculosis; 5001.12.2023(b) a person who is infected with human immunodeficiency virus; (c) a person 5001.12.2023who is to commence, or has commenced, tumour necrosis factor (TNF) inhibitor 5001.12.2023therapy; (d) a person who is to commence, or has commenced, renal dialysis; 5001.12.2023(e) a person with silicosis; (f) a person who is, or is about to become, 5001.12.2023immunosuppressed because of a disease, or a medical treatment, not mentioned 5001.12.2023in paragraphs(a) to (e) 1069472 26.05.2002 6 P3 SN NNNNY 2001.12.202300049.0000015.6500000.00 5001.12.2023Detection of antibodies to Epstein Barr Virus using specific serology - 1 test 1069474 26.05.2002 6 P3 SN NNNNY 2001.12.202300090.0000028.6500000.00 5001.12.2023Detection of antibodies to Epstein Barr Virus using specific serology - 2 or 5001.12.2023more tests 1069475 01.11.2002 6 P3 SN NNNNY 2001.12.202300049.0000015.6500000.00 5001.12.2023One test for hepatitis antigen or antibodies to determine immune status or 5001.12.2023viral carriage following exposure or vaccination to Hepatitis A, Hepatitis B, 5001.12.2023Hepatitis C or Hepatitis D (Item subject to rule 11) 1069478 01.11.2002 6 P3 SN NNNNY 2001.12.202300091.0000029.2500000.00 5001.12.20232 tests described in 69475 (Item subject to rule 11) 1069481 01.11.2002 6 P3 SN NNNNY 2001.12.202300126.0000040.5500000.00 5001.12.2023Investigation of infectious causes of acute or chronic hepatitis - 3 tests for 5001.12.2023hepatitis antibodies or antigens, (Item subject to rule 11) 1069482 01.07.2008 6 P3 SN NNNNY 2001.12.202300470.0000152.1000000.00 5001.12.2023Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface 5001.12.2023antigen positive and have chronic hepatitis B, but are not receiving antiviral 5001.12.2023therapy - 1 test (Item is subject to rule 25) 1069483 01.07.2008 6 P3 SN NNNNY 2001.12.202300470.0000152.1000000.00 5001.12.2023Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface 5001.12.2023antigen positive and who have chronic hepatitis B and are receiving antiviral 5001.12.2023therapy - 1 test (Item is subject to rule 25) 1069484 01.11.2002 6 P3 SN NNNNY 2001.12.202300053.0000017.1000000.00 5001.12.2023Supplementary testing for Hepatitis B surface antigen or Hepatitis C antibody 5001.12.2023using a different assay on the specimen which yielded a reactive result on 5001.12.2023initial testing (Item is subject to rule 18) 1069488 01.05.2007 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023Quantitation of HCV RNA load in plasma or serum in: (a) the pre-treatment 5001.12.2023evaluation,of a patient with chronic HCV hepatitis, for antiviral therapy;or 5001.12.2023(b) the assessment of efficacy of antiviral therapy for such a patient 5001.12.2023(including a service in item 69499 or 69445) (Item is subject to rule 18 and 5001.12.202325) 1069489 01.05.2007 6 P3 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023A test described in item 69488 if rendered by a receiving APP (Item is subject 5001.12.2023to rule 18 and 25) 1069491 01.05.2007 6 P3 SN NNNNY 2001.12.202300635.0000204.8000000.00 5001.12.2023Nucleic acid amplification and determination of Hepatitis C virus (HCV) 5001.12.2023genotype if the patient is HCV RNA positive and is being evaluated for 5001.12.2023antiviral therapy of chronic HCV hepatitis. To a maximum of 1 of this item in 5001.12.2023a 12 month period 1069492 01.05.2007 6 P3 SN NNNNY 2001.12.202300635.0000204.8000000.00 5001.12.2023A test described in item 69491 if rendered by a receiving APP - 1 test(Item is 5001.12.2023subject to rule 18 and 25) 1069494 01.05.2007 6 P3 SN NNNNY 2001.12.202300080.0000028.6500000.00 5001.12.2023Detection of a virus or microbial antigen or microbial nucleic acid (not 5001.12.2023elsewhere specified) 1 test (Item is subject to rule 6 and 26) 1069495 01.05.2007 6 P3 SN NNNNY 2001.12.202300104.0000035.8500000.00 5001.12.20232 tests described in 69494 (Item is subject to rule 6 and 26) 1069496 01.05.2007 6 P3 SN NNNNY 2001.12.202300134.0000043.0500000.00 5001.12.20233 or more tests described in 69494 (Item is subject to rule 6 and 26) 1069497 01.05.2007 6 P3 SN NNNNY 2001.12.202300080.0000028.6500000.00 5001.12.2023A test described in item 69494, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6, 18 and 26) 1069498 01.05.2007 6 P3 SN NNNNY 2001.12.202300020.0000007.2000000.00 5001.12.2023A test described in item 69494, other than that described in 69497, if 5001.12.2023rendered by a receiving APP - each test to a maximum of 2 tests (Item is 5001.12.2023subject to rule 6, 18 and 26) 1069499 01.05.2007 6 P3 SN NNNNY 2001.12.202300285.0000092.2000000.00 5001.12.2023Detection of Hepatitis C viral RNA if at least 1 of the following criteria is 5001.12.2023satisfied: (a)the patient is Hepatitis C seropositive; (b)the patient's 5001.12.2023serological status is uncertain after testing; (c)the test is performed for 5001.12.2023the purpose of: (i)determining the Hepatitis C status of an immunosuppressed 5001.12.2023or immunocompromised patient; or (ii)the detection of acute Hepatitis C prior 5001.12.2023to seroconversion where considered necessary for the clinical management of 5001.12.2023the patient; To a maximum of 1 of this item in a 12 month period (Item is 5001.12.2023subject to rule 19 and 25) 1069500 01.05.2007 6 P3 SN NNNNY 2001.12.202300285.0000092.2000000.00 5001.12.2023A test described in item 69499 if rendered by a receiving APP - 1 test (Item 5001.12.2023is subject to rule 18,19 and 25) 1069505 01.07.2023 6 P3 SN YNNYN 2001.12.202300338.0000150.0000000.00 5001.12.2023Sequencing and analysis of the genome of mycobacterium tuberculosis complex 5001.12.2023from an isolate or nucleic acid extract: (a) to speciate the organism: (i) at 5001.12.2023the time of a patients initial diagnosis and commencement of initial empiric 5001.12.2023therapy; or (ii) following recurrence of a patients symptoms or a patients 5001.12.2023failure to respond to treatment within the expected timeframe; and (b) for the 5001.12.2023purpose of: (i) genomewide determination of the antimicrobial resistance 5001.12.2023markers (resistome) of the isolate; and (ii) individualising the patients 5001.12.2023treatment Applicable once at initial diagnosis and once per episode of disease 5001.12.2023recurrence 1069506 01.10.2022 6 P3 DN NNNYN 2001.12.202300079.0000034.9000000.00 5001.12.2023Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient 5001.12.2023in a recognised hospital; or (b) the person receives a bulk-billed service 5001.12.2023from a prescribed laboratory 1069507 01.10.2022 6 P3 DN NNNYN 2001.12.202300085.0000037.8500000.00 5001.12.2023Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella 5001.12.2023species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate 5001.12.2023and/or lower respiratory tract sample, including a service described in 69506, 5001.12.2023if: (a) the person is a private patient in a recognised hospital; or (b) the 5001.12.2023person receives a bulk-billed service from a prescribed laboratory 2 to 4 5001.12.2023tests 1069508 01.10.2022 6 P3 DN NNNNN 2001.12.202300092.0000040.8500000.00 5001.12.20235 to 8 tests described in 69507 1069509 01.10.2022 6 P3 DN NNNNN 2001.12.202300099.0000043.8000000.00 5001.12.20239 to 12 tests described in 69507 1069510 01.10.2022 6 P3 DN NNNNN 2001.12.202300105.0000046.7500000.00 5001.12.202313 or more tests described in item 69507 1069511 01.10.2022 6 P3 DN NNNYN 2001.12.202300155.0000068.8500000.00 5001.12.2023Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient 5001.12.2023in a hospital other than a recognised hospital; or (b) the person receives a 5001.12.2023bulk-billed service not covered by item 69506 1069512 01.10.2022 6 P3 DN NNNYN 2001.12.202300168.0000074.7500000.00 5001.12.2023Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella 5001.12.2023species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate 5001.12.2023and/or lower respiratory tract sample, including a service described in 69511, 5001.12.2023if: (a) the person is a private patient in a hospital other than a recognised 5001.12.2023hospital; or (b) the person receives a bulk-billed service not covered by item 5001.12.202369507 2 to 4 tests 1069513 01.10.2022 6 P3 DN NNNNN 2001.12.202300181.0000080.6500000.00 5001.12.20235 to 8 tests described in 69512 1069514 01.10.2022 6 P3 DN NNNNN 2001.12.202300195.0000086.5500000.00 5001.12.20239 to 12 tests described in 69512 1069515 01.10.2022 6 P3 DN NNNNN 2001.12.202300208.0000092.4500000.00 5001.12.202313 or more tests described in item 69512 1071057 26.05.2002 6 P4 SN NNNNY 2001.12.202300112.0000032.9000000.00 5001.12.2023Electrophoresis, quantitative and qualitative, of serum, urine or other body 5001.12.2023fluid all collected within a 28 day period, to demonstrate: (a)protein 5001.12.2023classes; or (b)presence and amount of paraprotein; including the preliminary 5001.12.2023quantitation of total protein, albumin and globulin - 1 specimen type 1071058 26.05.2002 6 P4 SN NNNNY 2001.12.202300160.0000050.5000000.00 5001.12.2023Examination as described in item 71057 of 2 or more specimen types 1071059 26.05.2002 6 P4 SN NNNNY 2001.12.202300092.0000035.6500000.00 5001.12.2023Immunofixation or immunoelectrophoresis or isoelectric focusing of: (a)urine 5001.12.2023for detection of Bence Jones proteins; or (b)serum, plasma or other body 5001.12.2023fluid; and characterisation of a paraprotein or cryoglobulin- examination of 1 5001.12.2023specimen type (eg. serum, urine or CSF) 1071060 26.05.2002 6 P4 SN NNNNY 2001.12.202300138.0000044.0500000.00 5001.12.2023Examination as described in item 71059 of 2 or more specimen types 1071062 26.05.2002 6 P4 SN NNNNY 2001.12.202300138.0000044.0500000.00 5001.12.2023Electrophoresis and immunofixation or immunoelectrophoresis or isoelectric 5001.12.2023focussing of CSF for the detection of oligoclonal bands and including if 5001.12.2023required electrophoresis of the patient's serum for comparison purposes - 1 or 5001.12.2023more tests 1071064 26.05.2002 6 P4 SN NNNNY 2001.12.202300065.0000020.7500000.00 5001.12.2023Detection and quantitation of cryoglobulins or cryofibrinogen - 1 or more 5001.12.2023tests 1071066 01.11.2002 6 P4 SN NNNNY 2001.12.202300046.0000014.5500000.00 5001.12.2023Quantitation of total immunoglobulin A by any method in serum, urine or other 5001.12.2023body fluid - 1 test 1071068 01.11.2002 6 P4 SN NNNNY 2001.12.202300046.0000014.5500000.00 5001.12.2023Quantitation of total immunoglobulin G by any method in serum, urine or other 5001.12.2023body fluid - 1 test 1071069 26.05.2002 6 P4 SN NNNNY 2001.12.202300075.0000022.7500000.00 5001.12.20232 tests described in items 71066, 71068, 71072 or 71074 1071071 26.05.2002 6 P4 SN NNNNY 2001.12.202300102.0000030.9500000.00 5001.12.20233 or more tests described in items 71066, 71068, 71072 or 71074 1071072 01.11.2002 6 P4 SN NNNNY 2001.12.202300046.0000014.5500000.00 5001.12.2023Quantitation of total immunoglobulin M by any method in serum, urine or other 5001.12.2023body fluid - 1 test 1071073 26.05.2002 6 P4 SN NNNNY 2001.12.202300335.0000106.1500000.00 5001.12.2023Quantitation of all 4 immunoglobulin G subclasses 1071074 01.11.2002 6 P4 SN NNNNY 2001.12.202300046.0000014.5500000.00 5001.12.2023Quantitation of total immunoglobulin D by any method in serum, urine or other 5001.12.2023body fluid - 1 test 1071075 26.05.2002 6 P4 SN NNNNY 2001.12.202300085.0000023.0000000.00 5001.12.2023Quantitation of immunoglobulin E (total), 1 test. (Item is subject to rule 25) 1071076 01.05.2007 6 P4 SN NNNNY 2001.12.202300335.0000106.1500000.00 5001.12.2023A test described in item 71073 if rendered by a receiving APP - 1 test (Item 5001.12.2023is subject to rule 18) 1071077 26.05.2002 6 P4 SN NNNNY 2001.12.202300085.0000027.0500000.00 5001.12.2023Quantitation of immunoglobulin E (total) in the follow up of a patient with 5001.12.2023proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency 5001.12.2023or proven allergic bronchopulmonary aspergillosis, 1 test. (Item is subject to 5001.12.2023rule 25) 1071079 26.05.2002 6 P4 SN NNNNY 2001.12.202300085.0000026.8000000.00 5001.12.2023Detection of specific immunoglobulin E antibodies to single or multiple 5001.12.2023potential allergens, 1 test (Item is subject to rule 25) 1071081 26.05.2002 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023Quantitation of total haemolytic complement 1071083 26.05.2002 6 P4 SN NNNNY 2001.12.202300064.0000020.1500000.00 5001.12.2023Quantitation of complement components C3 and C4 or properdin factor B - 1 test 1071085 26.05.2002 6 P4 SN NNNNY 2001.12.202300091.0000028.9500000.00 5001.12.20232 tests described in item 71083 1071087 26.05.2002 6 P4 SN NNNNY 2001.12.202300118.0000037.7000000.00 5001.12.20233 or more tests described in item 71083 1071089 26.05.2002 6 P4 SN NNNNY 2001.12.202300092.0000029.1500000.00 5001.12.2023Quantitation of complement components or breakdown products of complement 5001.12.2023proteins not elsewhere described in an item in this Schedule - 1 test (Item is 5001.12.2023subject to rule 6) 1071090 01.05.2007 6 P4 SN NNNNY 2001.12.202300092.0000029.1500000.00 5001.12.2023A test described in item 71089, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1071091 26.05.2002 6 P4 SN NNNNY 2001.12.202300166.0000052.8500000.00 5001.12.20232 tests described in item 71089 (Item is subject to rule 6) 1071092 01.05.2007 6 P4 SN NNNNY 2001.12.202300074.0000023.7000000.00 5001.12.2023Tests described in item 71089, other than that described in 71090, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 2 tests (Item is subject to 5001.12.2023rule 6 and 18) 1071093 26.05.2002 6 P4 SN NNNNY 2001.12.202300240.0000076.4500000.00 5001.12.20233 or more tests described in item 71089 (Item is subject to rule 6) 1071095 26.05.2002 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023Quantitation of serum or plasma eosinophil cationic protein, or both, to a 5001.12.2023maximum of 3 assays in 1 year, for monitoring the response to therapy in 5001.12.2023corticosteroid treated asthma, in a child aged less than 12 years 1071096 01.05.2007 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023A test described in item 71095 if rendered by a receiving APP. (Item is 5001.12.2023subject to rule 18) 1071097 26.05.2002 6 P4 SN NNNNY 2001.12.202300080.0000024.4500000.00 5001.12.2023Antinuclear antibodies - detection in serum or other body fluids, including 5001.12.2023quantitation if required 1071099 26.05.2002 6 P4 SN NNNNY 2001.12.202300084.0000026.5000000.00 5001.12.2023Double-stranded DNA antibodies - quantitation by 1 or more methods other than 5001.12.2023the Crithidia method 1071101 26.05.2002 6 P4 SN NNNNY 2001.12.202300055.0000017.4000000.00 5001.12.2023Antibodies to 1 or more extractable nuclear antigens - detection in serum or 5001.12.2023other body fluids 1071103 26.05.2002 6 P4 SN NNNNY 2001.12.202300164.0000052.0500000.00 5001.12.2023Characterisation of an antibody detected in a service described in item 71101 5001.12.2023(including that service) 1071106 26.05.2002 6 P4 SN NNNNY 2001.12.202300036.0000011.3000000.00 5001.12.2023Rheumatoid factor - detection by any technique in serum or other body fluids, 5001.12.2023including quantitation if required 1071119 26.05.2002 6 P4 SN NNNNY 2001.12.202300055.0000017.3500000.00 5001.12.2023Antibodies to tissue antigens not elsewhere specified in this Table - 5001.12.2023detection, including quantitation if required, of 1 antibody 1071121 26.05.2002 6 P4 SN NNNNY 2001.12.202300065.0000020.8000000.00 5001.12.2023Detection of 2 antibodies specified in item 71119 1071123 26.05.2002 6 P4 SN NNNNY 2001.12.202300076.0000024.2500000.00 5001.12.2023Detection of 3 antibodies specified in item 71119 1071125 26.05.2002 6 P4 SN NNNNY 2001.12.202300087.0000027.6500000.00 5001.12.2023Detection of 4 or more antibodies specified in item 71119 1071127 26.05.2002 6 P4 SN NNNNY 2001.12.202300555.0000176.3500000.00 5001.12.2023Functional tests for lymphocytes - quantitation other than by microscopy of: 5001.12.2023(a)proliferation induced by 1 or more mitogens; or (b)proliferation induced by 5001.12.20231 or more antigens; or (c)estimation of 1 or more mixed lymphocyte reactions; 5001.12.2023including a test described in item 65066 or 65070 (if performed), 1 of this 5001.12.2023item to a maximum of 2 in a 12 month period 1071129 26.05.2002 6 P4 SN NNNNY 2001.12.202300685.0000217.8500000.00 5001.12.20232 tests described in item 71127 1071131 26.05.2002 6 P4 SN NNNNY 2001.12.202300815.0000259.3500000.00 5001.12.20233 or more tests described in item 71127 1071133 01.11.2002 6 P4 SN NNNNY 2001.12.202300033.0000010.4000000.00 5001.12.2023Investigation of recurrent infection by qualitative assessment for the 5001.12.2023presence of defects in oxidative pathways in neutrophils by the nitroblue 5001.12.2023tetrazolium (NBT) reduction test 1071134 01.11.2002 6 P4 SN NNNNY 2001.12.202300330.0000104.0500000.00 5001.12.2023Investigation of recurrent infection by quantitative assessment of oxidative 5001.12.2023pathways by flow cytometric techniques, including a test described in 71133 5001.12.2023(if performed) 1071135 26.05.2002 6 P4 SN NNNNY 2001.12.202300655.0000207.9500000.00 5001.12.2023Quantitation of neutrophil function, comprising at least 2 of the following: 5001.12.2023(a)chemotaxis; (b)phagocytosis; (c)oxidative metabolism; (d)bactericidal 5001.12.2023activity; including any test described in items 65066, 65070, 71133 or 71134 5001.12.2023(if performed), 1 of this item to a maximum of 2 in a 12 month period 1071137 26.05.2002 6 P4 SN NNNNY 2001.12.202300095.0000030.2500000.00 5001.12.2023Quantitation of cell-mediated immunity by multiple antigen delayed type 5001.12.2023hypersensitivity intradermal skin testing using a minimum of 7 antigens, 1 of 5001.12.2023this item to a maximum of 2 in a 12 month period 1071139 26.05.2002 6 P4 SN NNNNY 2001.12.202300330.0000104.0500000.00 5001.12.2023Characterisation of 3 or more leucocyte surface antigens by immunofluorescence 5001.12.2023or immunoenzyme techniques to assess lymphoid or myeloid cell populations, 5001.12.2023including a total lymphocyte count or total leucocyte count by any method, on 5001.12.20231 or more specimens of blood, CSF or serous fluid 1071141 26.05.2002 6 P4 SN NNNNY 2001.12.202300620.0000197.3500000.00 5001.12.2023Characterisation of 3 or more leucocyte surface antigens by immunofluorescence 5001.12.2023or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 5001.12.2023or more disaggregated tissue specimens 1071143 26.05.2002 6 P4 SN NNNNY 2001.12.202300820.0000260.0000000.00 5001.12.2023Characterisation of 6 or more leucocyte surface antigens by immunofluorescence 5001.12.2023or immunoenzyme techniques to assess lymphoid or myeloid cell populations for 5001.12.2023the diagnosis(but not monitoring) of an immunological or haematological 5001.12.2023malignancy, including a service described in 1 or both of items 71139 and 5001.12.202371141 (if performed), on a specimen of blood, CSF, serous fluid or 5001.12.2023disaggregated tissue 1071145 26.05.2002 6 P4 SN NNNNY 2001.12.202301340.0000424.5000000.00 5001.12.2023Characterisation of 6 or more leucocyte surface antigens by immunofluorescence 5001.12.2023or immunoenzyme techniques to assess lymphoid or myeloid cell populations for 5001.12.2023the diagnosis (but not monitoring) of an immunological or haematological 5001.12.2023malignancy, including a service described in 1 or more of items 71139, 71141 5001.12.2023and 71143 (if performed), on 2 or more specimens of disaggregated tissues or 1 5001.12.2023specimen of disaggregated tissue and 1 or more specimens of blood, CSF or 5001.12.2023serous fluid 1071146 01.05.2004 6 P4 SN NNNNY 2001.12.202300340.0000104.0500000.00 5001.12.2023Enumeration of CD34+ cells, only for the purposes of autologous or directed 5001.12.2023allogeneic haemopoietic stem cell transplantation, including a total white 5001.12.2023cell count on the pherisis collection 1071147 26.05.2002 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023HLA-B27 typing (Item is subject to rule 27) 1071148 01.05.2007 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023A test described in item 71147 if rendered by a receiving APP. (Item is 5001.12.2023subject to rule 18 and 27) 1071149 26.05.2002 6 P4 SN NNNNY 2001.12.202300340.0000108.2500000.00 5001.12.2023Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any 5001.12.2023separation of leucocytes), including (if performed) a service described in 5001.12.2023item 71147 1071151 26.05.2002 6 P4 SN NNNNY 2001.12.202300375.0000118.8500000.00 5001.12.2023Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any 5001.12.2023separation of leucocytes) - phenotyping or genotyping of 2 or more antigens 1071153 26.05.2002 6 P4 SN NNNNY 2001.12.202300108.0000034.5500000.00 5001.12.2023Investigations in the assessment or diagnosis of systemic inflammatory disease 5001.12.2023or vasculitis - antineutrophil cytoplasmic antibody immunofluorescence (ANCA 5001.12.2023test), antineutrophil proteinase 3 antibody (PR-3 ANCA test), 5001.12.2023antimyeloperoxidase antibody (MPO ANCA test) or antiglomerular basement 5001.12.2023membrane antibody (GBM test) - detection of 1 antibody (Item is subject to 5001.12.2023rule 6 and 23) 1071154 01.05.2007 6 P4 SN NNNNY 2001.12.202300108.0000034.5500000.00 5001.12.2023A test described in item 71153, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test. (Item is subject 5001.12.2023to rule 6, 18 and 23) 1071155 26.05.2002 6 P4 SN NNNNY 2001.12.202300148.0000047.4500000.00 5001.12.2023Detection of 2 antibodies described in item 71153 (Item is subject to rule 6 5001.12.2023and 23) 1071156 01.05.2007 6 P4 SN NNNNY 2001.12.202300040.0000012.8500000.00 5001.12.2023Tests described in item 71153, other than that described in 71154, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 3 tests (Item is subject to 5001.12.2023rule 6, 18 and 23) 1071157 26.05.2002 6 P4 SN NNNNY 2001.12.202300190.0000060.3000000.00 5001.12.2023Detection of 3 antibodies described in item 71153 (Item is subject to rule 6 5001.12.2023and 23) 1071159 26.05.2002 6 P4 SN NNNNY 2001.12.202300230.0000073.1500000.00 5001.12.2023Detection of 4 or more antibodies described in item 71153 (Item is subject to 5001.12.2023rule 6 and 23) 1071163 01.11.2003 6 P4 SN NNNNY 2001.12.202300079.0000024.7500000.00 5001.12.2023Detection of one of the following antibodies (of 1 or more class or isotype) 5001.12.2023in the assessment or diagnosis of coeliac disease or other gluten 5001.12.2023hypersensitivity syndromes and including a service described in item 71066 (if 5001.12.2023performed): a)Antibodies to gliadin; or b)Antibodies to endomysium; or 5001.12.2023c)Antibodies to tissue transglutaminase; - 1 test 1071164 01.11.2003 6 P4 SN NNNNY 2001.12.202300128.0000039.9000000.00 5001.12.2023Two or more tests described in 71163 and including a service described in 5001.12.202371066 (if performed) 1071165 01.05.2007 6 P4 SN NNNNY 2001.12.202300108.0000034.5500000.00 5001.12.2023Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, heart, 5001.12.2023histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, 5001.12.2023neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin 5001.12.2023basement membrane and intercellular substance, thyroglobulin, thyroid 5001.12.2023microsome or thyroid stimulating hormone receptor) - detection, including 5001.12.2023quantitation if required, of 1 antibody (Item is subject to rule 6) 1071166 01.05.2007 6 P4 SN NNNNY 2001.12.202300150.0000047.4500000.00 5001.12.2023Detection of 2 antibodies described in item 71165 (Item is subject to rule 6) 1071167 01.05.2007 6 P4 SN NNNNY 2001.12.202300190.0000060.3000000.00 5001.12.2023Detection of 3 antibodies described in item 71165 (Item is subject to rule 6) 1071168 01.05.2007 6 P4 SN NNNNY 2001.12.202300230.0000073.1500000.00 5001.12.2023Detection of 4 or more antibodies described in item 71165 (Item is subject to 5001.12.2023rule 6) 1071169 01.05.2007 6 P4 SN NNNNY 2001.12.202300108.0000034.5500000.00 5001.12.2023A test described in item 71165, if rendered by a receiving APP, where no tests 5001.12.2023in the item have been rendered by the referring APP - 1 test (Item is subject 5001.12.2023to rule 6 and 18) 1071170 01.05.2007 6 P4 SN NNNNY 2001.12.202300041.0000012.8500000.00 5001.12.2023Tests described in item 71165, other than that described in 71169, if rendered 5001.12.2023by a receiving APP - each test to a maximum of 3 tests (Item is subject to 5001.12.2023rule 6 and 18) 1071180 01.11.2007 6 P4 SN NNNNY 2001.12.202300108.0000034.5500000.00 5001.12.2023Antibody to cardiolipin or beta-2 glycoprotein I - detection, including 5001.12.2023quantitation if required; one antibody specificity (IgG or IgM) 1071183 01.11.2007 6 P4 SN NNNNY 2001.12.202300148.0000047.4500000.00 5001.12.2023Detection of two antibodies described in item 71180 1071186 01.11.2007 6 P4 SN NNNNY 2001.12.202300190.0000060.3000000.00 5001.12.2023Detection of three or more antibodies described in item 71180 1071189 01.11.2007 6 P4 SN NNNNY 2001.12.202300049.0000015.5000000.00 5001.12.2023Detection of specific IgG antibodies to 1 or more respiratory disease 5001.12.2023allergens not elsewhere specified. 1071192 01.11.2007 6 P4 SN NNNNY 2001.12.202300090.0000028.3500000.00 5001.12.20232 items described in item 71189. 1071195 01.11.2007 6 P4 SN NNNNY 2001.12.202300126.0000040.0500000.00 5001.12.20233 or more items described in item 71189. 1071198 01.11.2007 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023Estimation of serum tryptase for the evaluation of unexplained acute 5001.12.2023hypotension or suspected anaphylactic event, assessment of risk in stinging 5001.12.2023insect anaphylaxis, exclusion of mastocytosis, monitoring of known 5001.12.2023mastocytosis. 1071200 01.11.2007 6 P4 SN NNNNY 2001.12.202300112.0000059.6000000.00 5001.12.2023Detection and quantitation, if present, of free kappa and lambda light chains 5001.12.2023in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma 5001.12.2023cell dyscrasias. 1071202 01.11.2023 6 P4 SN YNNYN 2001.12.202301238.0000550.0000000.00 5001.12.2023Measurable residual disease (MRD) testing by flow cytometry, performed on bone 5001.12.2023marrow from a patient diagnosed with acute lymphoblastic leukaemia, for the 5001.12.2023purpose of determining baseline MRD, or facilitating the determination of MRD 5001.12.2023following combination chemotherapy or after salvage therapy, requested by a 5001.12.2023specialist or consultant physician practising as a haematologist or oncologist 1071203 01.11.2007 6 P4 SN NNNNY 2001.12.202300128.0000040.5500000.00 5001.12.2023Determination of HLAB5701 status by flow cytometry or cytotoxity assay prior 5001.12.2023to the initiation of Abacavir therapy including item 73323 if performed. 1072813 26.05.2002 6 P5 SN NNNNY 2001.12.202300250.0000071.5000000.00 5001.12.2023Examination of complexity level 2 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 or more separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072814 01.11.2018 6 P5 DN NNNYY 2001.12.202300220.0000074.5000000.00 5001.12.2023Immunohistochemical examination by immunoperoxidase or other labelled antibody 5001.12.2023techniques using the programmed cell death ligand 1 (PDL1) antibody of tumour 5001.12.2023material from a patient diagnosed with: (a) nonsmall cell lung cancer; or (b) 5001.12.2023recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or 5001.12.2023larynx; or (c) locally recurrent unresectable or metastatic triple-negative 5001.12.2023breast cancer. 1072816 26.05.2002 6 P5 SN NNNNY 2001.12.202300270.0000086.3500000.00 5001.12.2023Examination of complexity level 3 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 separately identified 5001.12.2023specimen (Item is subject to rule 13) 1072817 26.05.2002 6 P5 SN NNNNY 2001.12.202300300.0000096.8000000.00 5001.12.2023Examination of complexity level 3 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 2 to 4 separately identified 5001.12.2023specimens (Item is subject to rule 13) 1072818 01.11.2002 6 P5 SN NNNNY 2001.12.202300335.0000107.0500000.00 5001.12.2023Examination of complexity level 3 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 5 or more separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072823 26.05.2002 6 P5 SN NNNNY 2001.12.202300305.0000097.1500000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 separately identified 5001.12.2023specimen (Item is subject to rule 13) 1072824 26.05.2002 6 P5 SN NNNNY 2001.12.202300440.0000141.3500000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 2 to 4 separately identified 5001.12.2023specimens (Item is subject to rule 13) 1072825 26.05.2002 6 P5 SN NNNNY 2001.12.202300560.0000180.2500000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 5 to 7 separately identified 5001.12.2023specimens (Item is subject to rule 13) 1072826 01.11.2002 6 P5 SN NNNNY 2001.12.202300610.0000194.6000000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 8 to 11 separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072827 01.11.2008 6 P5 SN NNNNY 2001.12.202300655.0000208.9500000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 12 to 17 separately 5001.12.2023identified specimens (Item is subject to Rule 13) 1072828 01.11.2008 6 P5 SN NNNNY 2001.12.202300700.0000223.3000000.00 5001.12.2023Examination of complexity level 4 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions -18 or more separately 5001.12.2023identified specimens (Item is subject to Rule 13) 1072830 26.05.2002 6 P5 SN NNNNY 2001.12.202300850.0000274.1500000.00 5001.12.2023Examination of complexity level 5 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 or more separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072836 26.05.2002 6 P5 SN NNNNY 2001.12.202301310.0000417.2000000.00 5001.12.2023Examination of complexity level 6 biopsy material with 1 or more tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 or more separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072838 01.11.2007 6 P5 SN NNNNY 2001.12.202301470.0000466.8500000.00 5001.12.2023Examination of complexicity level 7 biopsy material with multiple tissue 5001.12.2023blocks, including specimen dissection, all tissue processing, staining, light 5001.12.2023microscopy and professional opinion or opinions - 1 or more separately 5001.12.2023identified specimens. (Item is subject to rule 13) 1072844 26.05.2002 6 P5 SN NNNNY 2001.12.202300096.0000030.7500000.00 5001.12.2023Enzyme histochemistry of skeletal muscle for investigation of primary 5001.12.2023degenerative or metabolic muscle diseases or of muscle abnormalities secondary 5001.12.2023to disease of the central or peripheral nervous system - 1 or more tests 1072846 26.05.2002 6 P5 SN NNNNY 2001.12.202300186.0000059.6000000.00 5001.12.2023Immunohistochemical examination of biopsy material by immunofluorescence, 5001.12.2023immunoperoxidase or other labelled antibody techniques with multiple antigenic 5001.12.2023specificities per specimen - 1 to 3 antibodies except those listed in 72848 5001.12.2023(Item is subject to rule 13) 1072847 26.05.2002 6 P5 SN NNNNY 2001.12.202300280.0000089.4000000.00 5001.12.2023Immunohistochemical examination of biopsy material by immunofluorescence, 5001.12.2023immunoperoxidase or other labelled antibody techniques with multiple antigenic 5001.12.2023specificities per specimen - 4-6 antibodies (Item is subject to rule 13) 1072848 01.11.2003 6 P5 SN NNNNY 2001.12.202300235.0000074.5000000.00 5001.12.2023Immunohistochemical examination of biopsy material by immunofluorescence, 5001.12.2023immunoperoxidase or other labelled antibody techniques with multiple antigenic 5001.12.2023specificities per specimen - 1 to 3 of the following antibodies - oestrogen, 5001.12.2023progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) 1072849 01.11.2008 6 P5 SN NNNNY 2001.12.202300325.0000104.3000000.00 5001.12.2023Immunohistochemical examination of biopsy material by immunofluorescence, 5001.12.2023immunoperoxidase or other labelled antibody techniques with multiple antigenic 5001.12.2023specificities per specimen - 7-10 antibodies (Item is subject to rule 13) 1072850 01.11.2008 6 P5 SN NNNNY 2001.12.202300375.0000119.2000000.00 5001.12.2023Immunohistochemical examination of biopsy material by immunofluorescence, 5001.12.2023immunoperoxidase or other labelled antibody techniques with multiple antigenic 5001.12.2023specificities per specimen - 11 or more antibodies (Item is subject to rule 5001.12.202313) 1072851 26.05.2002 6 P5 SN NNNNY 2001.12.202301675.0000565.0000000.00 5001.12.2023Electron microscopic examination of biopsy material - 1 separately identified 5001.12.2023specimen (Item is subject to rule 13) 1072852 26.05.2002 6 P5 SN NNNNY 2001.12.202302235.0000753.0000000.00 5001.12.2023Electron microscopic examination of biopsy material - 2 or more separately 5001.12.2023identified specimens (Item is subject to rule 13) 1072855 26.05.2002 6 P5 SN NNNNY 2001.12.202300575.0000184.3500000.00 5001.12.2023Intraoperative consultation and examination of biopsy material by frozen 5001.12.2023section or tissue imprint or smear - 1 separately identified specimen (Item is 5001.12.2023subject to rule 13) 1072856 26.05.2002 6 P5 SN NNNNY 2001.12.202300765.0000245.8000000.00 5001.12.2023Intraoperative consultation and examination of biopsy material by frozen 5001.12.2023section or tissue imprint or smear - 2 to 4 separately identified specimens 5001.12.2023(Item is subject to rule 13) 1072857 01.11.2003 6 P5 SN NNNNY 2001.12.202300900.0000286.7500000.00 5001.12.2023Intraoperative consultation and examination of biopsy material by frozen 5001.12.2023section or tissue imprint or smear - 5 or more separately identified specimens 5001.12.2023(Item is subject to rule 13) 1072860 01.05.2019 6 P5 SN NNNYY 2001.12.202300270.0000085.0000000.00 5001.12.2023Retrieval and review of one or more archived formalin fixed paraffin embedded 5001.12.2023blocks to determine the appropriate samples for the purpose of conducting 5001.12.2023genetic testing, other than: (a) a service associated with a service to which 5001.12.2023item 72858 or 72859 applies; or (b) a service associated with, and rendered in 5001.12.2023the same patient episode as, a service to which an item in Group P5, P6, P10 5001.12.2023or P11 applies Applicable not more than once in a patient episode 1073043 26.05.2002 6 P6 SN NNNNY 2001.12.202300063.0000022.8500000.00 5001.12.2023Cytology (including serial examinations) of nipple discharge or smears from 5001.12.2023skin, lip, mouth, nose or anus for detection of precancerous or cancerous 5001.12.2023changes1 or more tests 1073045 26.05.2002 6 P6 SN NNNNY 2001.12.202300144.0000048.6000000.00 5001.12.2023Cytology (including serial examinations) for malignancy (other than an 5001.12.2023examination mentioned in item 73076); and including any Group P5 service, if 5001.12.2023performed on: (a)specimens resulting from washings or brushings from sites not 5001.12.2023specified in item 73043; or (b)a single specimen of sputum or urine; or (c)1 5001.12.2023or more specimens of other body fluids; 1 or more tests 1073047 26.05.2002 6 P6 SN NNNNY 2001.12.202300285.0000094.7000000.00 5001.12.2023Cytology of a series of 3 sputum or urine specimens for malignant cells 1073049 26.05.2002 6 P6 SN NNNNY 2001.12.202300210.0000068.1500000.00 5001.12.2023Cytology of material obtained directly from a patient by fine needle 5001.12.2023aspiration of solid tissue or tissues - 1 identified site 1073051 26.05.2002 6 P6 SN NNNNY 2001.12.202300525.0000170.3500000.00 5001.12.2023Cytology of material obtained directly from a patient at one identified site 5001.12.2023by fine needle aspiration of solid tissue or tissues if a recognized 5001.12.2023pathologist: (a)performs the aspiration; or (b)attends the aspiration and 5001.12.2023performs cytological examination during the attendance 1073059 26.05.2002 6 P6 SN NNNNY 2001.12.202300134.0000043.0000000.00 5001.12.2023Immunocytochemical examination of material obtained by procedures described in 5001.12.2023items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the 5001.12.2023characterisation of a malignancy by immunofluorescence, immunoperoxidase or 5001.12.2023other labelled antibody techniques with multiple antigenic specificities per 5001.12.2023specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to 5001.12.2023rule 13) 1073060 26.05.2002 6 P6 SN NNNNY 2001.12.202300178.0000057.3500000.00 5001.12.2023Immunocytochemical examination of material obtained by procedures described in 5001.12.2023items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067for the 5001.12.2023characterisation of a malignancy by immunofluorescence, immunoperoxidase or 5001.12.2023other labelled antibody techniques with multiple antigenic specificities per 5001.12.2023specimen - 4 to 6antibodies (Item is subject to rule 13) 1073061 01.11.2003 6 P6 SN NNNNY 2001.12.202300160.0000051.2000000.00 5001.12.2023Immunocytochemical examination of material obtained by procedures described in 5001.12.2023items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the 5001.12.2023characterisation of a malignancy by immunofluorescence, immunoperoxidase or 5001.12.2023other labelled antibody techniques with multiple antigenic specificities per 5001.12.2023specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and 5001.12.2023c-erb-B2 (HER2) (Item is subject to rule 13) 1073062 01.05.2009 6 P6 SN NNNNY 2001.12.202300270.0000089.0000000.00 5001.12.2023Cytology of material obtained directly from a patient by fine needle 5001.12.2023aspiration of solid tissue or tissues - 2 or more separately identified sites. 1073063 01.05.2009 6 P6 SN NNNNY 2001.12.202300300.0000099.3500000.00 5001.12.2023Cytology of material obtained directly from a patient at one identified site 5001.12.2023by fine needle aspiration of solid tissue or tissues if an employee of an 5001.12.2023approved pathology authority attends the aspiration for confirmation of sample 5001.12.2023adequacy 1073064 01.05.2009 6 P6 SN NNNNY 2001.12.202300225.0000071.7000000.00 5001.12.2023Immunocytochemical examination of material obtained by procedures described in 5001.12.2023items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the 5001.12.2023characterisation of a malignancy by immunofluorescence, immunoperoxidase or 5001.12.2023other labelled antibody techniques with multiple antigenic specificities per 5001.12.2023specimen - 7 to 10 antibodies (Item is subject to rule 13) 1073065 01.05.2009 6 P6 SN NNNNY 2001.12.202300265.0000086.0000000.00 5001.12.2023Immunocytochemical examination of material obtained by procedures described in 5001.12.2023items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the 5001.12.2023characterisation of a malignancy by immunofluorescence, immunoperoxidase or 5001.12.2023other labelled antibody techniques with multiple antigenic specificities per 5001.12.2023specimen - 11 or more antibodies (Item is subject to rule 13) 1073066 01.07.2011 6 P6 SN NNNNY 2001.12.202300675.0000221.4500000.00 5001.12.2023Cytology of material obtained directly from a patient at 2 or more separately 5001.12.2023identified sites by fine needle aspiration of solid tissue or tissues if a 5001.12.2023recognized pathologist: (a)performs the aspiration; or (b) attends the 5001.12.2023aspiration and performs cytological examination during the attendance 1073067 01.07.2011 6 P6 SN NNNNY 2001.12.202300395.0000129.1500000.00 5001.12.2023Cytology of material obtained directly from a patient at 2 or more separately 5001.12.2023identified sites by fine needle aspiration of solid tissue or tissues if an 5001.12.2023employee of an approved pathology authority attends the aspiration for 5001.12.2023confirmation of sample adequacy 1073070 01.12.2017 6 P6 SN NNNNY 2001.12.202300124.0000035.0000000.00 5001.12.202373070 A test, including partial genotyping, for oncogenic human papillomavirus 5001.12.2023that may be associated with cervical precancer or cancer: (a) performed on a 5001.12.2023liquid based cervical specimen; and (b) for an asymptomatic patient who is at 5001.12.2023least 24 years and 9 months of age For any particular patient, once only in a 5001.12.202357 month period 1073287 26.05.2002 6 P7 SN NNNNY 2001.12.202301130.0000394.5500000.00 5001.12.2023The study of the whole of every chromosome by cytogenetic or other techniques, 5001.12.2023performed on 1 or more of any tissue or fluid except blood (including a 5001.12.2023service mentioned in item 73293, if performed) - 1 or more tests 1073289 26.05.2002 6 P7 SN NNNNY 2001.12.202301030.0000358.9500000.00 5001.12.2023The study of the whole of every chromosome by cytogenetic or other techniques, 5001.12.2023performed on blood (including a service mentioned in item 73293, if performed) 5001.12.2023- 1 or more tests 1073290 01.05.2010 6 P7 SN NNNNY 2001.12.202301130.0000394.5500000.00 5001.12.2023The study of the whole of each chromosome by cytogenetic or other techniques, 5001.12.2023performed on blood or bone marrow, in the diagnosis and monitoringof 5001.12.2023haematological malignancy (including a service in items 73287 or 73289, if 5001.12.2023performed). - 1 or more tests. 1073291 01.05.2010 6 P7 SN NNNNY 2001.12.202300660.0000230.9500000.00 5001.12.2023Analysis of one or more chromosome regions for specific constitutional genetic 5001.12.2023abnormalities of blood or fresh tissue in a)diagnostic studies of a person 5001.12.2023with developmental delay, intellectual disability, autism, or at least two 5001.12.2023congenital abnormalities, in whom cytogenetic studies (item 73287 or 73289) 5001.12.2023are either normal or have not been performed; or b)studies of a relative for 5001.12.2023an abnormality previously identified in such an affected person. - 1 or more 5001.12.2023tests. 1073292 01.05.2010 6 P7 SN NNNNY 2001.12.202301690.0000589.9000000.00 5001.12.2023Analysis of chromosomes by genome-wide micro-array including targeted 5001.12.2023assessment of specific regions for constitutional genetic abnormalities in 5001.12.2023diagnostic studies of a person with developmental delay, intellectual 5001.12.2023disability, autism, or at least two congenital abnormalities (including a 5001.12.2023service in items 73287, 73289 or 73291, if performed) - 1 or more tests. 1073293 01.05.2010 6 P7 SN NNNNY 2001.12.202300660.0000230.9500000.00 5001.12.2023Analysis of one or more regions on all chromosomes for specific constitutional 5001.12.2023genetic abnormalities of fresh tissue in diagnostic studies of the products of 5001.12.2023conception, including exclusion of maternal cell contamination. - 1 or more 5001.12.2023tests. 1073294 01.05.2010 6 P7 SN NNNNY 2001.12.202300660.0000230.9500000.00 5001.12.2023Analysis of the PMP22 gene for constitutional genetic abnormalities causing 5001.12.2023peripheral neuropathy, either as: a)diagnostic studies of an affected person; 5001.12.2023or b)studies of a relative for an abnormality previously identified in an 5001.12.2023affected person - 1 or more tests. 1073301 01.08.2020 6 P7 DN NNNNY 2001.12.202303530.0001200.0000000.00 5001.12.2023A test of tumour tissue from a patient with advanced (FIGO III-IV), high grade 5001.12.2023serous or high grade epithelial ovarian, fallopian tube or primary peritoneal 5001.12.2023cancer, requested by a specialist or consultant physician, to determine 5001.12.2023eligibility relating to BRCA status for access to treatment with a poly 5001.12.2023(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor under 5001.12.2023thePharmaceutical Benefits Scheme (PBS) Applicable once per primary tumour 5001.12.2023diagnosis 1073302 01.08.2020 6 P7 DN NNNNY 2001.12.202301180.0000400.0000000.00 5001.12.2023Characterisation of germline gene variants including copy number variants, in 5001.12.2023BRCA1 or BRCA2 genes, in a patient who has had a pathogenic or likely 5001.12.2023pathogenic variant identified in either gene by tumour testing and who has not 5001.12.2023previously received a service to which items 73295, 73296 or 73297 applies, 5001.12.2023requested by a specialist or consultant physician. Applicable once per primary 5001.12.2023tumour diagnosis 1073303 01.04.2022 6 P7 DN NNNNN 2001.12.202302250.0001000.0000000.00 5001.12.2023A test of tumour tissue from a patient with metastatic castration-resistant 5001.12.2023prostate cancer, including subsequent characterisation of germline gene 5001.12.2023variants should tumour tissue testing undertaken during the same service be 5001.12.2023inconclusive, requested by a specialist or consultant physician, to determine 5001.12.2023eligibility relating to BRCA status for access to olaparib under the 5001.12.2023Pharmaceutical Benefits Scheme. Applicable once per primary tumour diagnosis 1073304 01.04.2022 6 P7 DN NNNNN 2001.12.202302250.0001000.0000000.00 5001.12.2023Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene 5001.12.2023variants, in a patient with metastatic castrationresistant prostate cancer, 5001.12.2023for whom testing of tumour tissue is not clinically feasible, requested by a 5001.12.2023specialist or consultant physician, to determine eligibility for olaparib 5001.12.2023under the Pharmaceutical Benefits Scheme. Applicable once per lifetime 1073305 01.05.2003 6 P7 SN NNNNY 2001.12.202300640.0000202.6500000.00 5001.12.2023Detection of mutation of the FMR1 gene by Southern Blot analysis where the 5001.12.2023results in item 73300 are inconclusive 1073306 01.11.2023 6 P7 SN YNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Gene expression profiling testing using EndoPredict, for the purpose of 5001.12.2023profiling gene expression in formalinfixed, paraffinembedded primary breast 5001.12.2023cancer tissue from core needle biopsy or surgical tumour sample to estimate 5001.12.2023the risk of distant recurrence of breast cancer within 10 years, if: (a) the 5001.12.2023sample is from a new primary breast cancer, which is suitable for adjuvant 5001.12.2023chemotherapy; and (b) the sample has been determined to be oestrogen receptor 5001.12.2023positive and HER2 negative by IHC and ISH respectively on surgically removed 5001.12.2023tumour; and (c) the sample is axillary node negative or positive (up to 3 5001.12.2023nodes) with a tumour size of at least 1 cm and no more than 5 cm determined by 5001.12.2023histopathology on surgically removed tumour; and (d) the sample has no 5001.12.2023evidence of distal metastasis; and (e) pretesting of intermediate risk of 5001.12.2023distant metastases has shown that the tumour is defined by at least one of the 5001.12.2023following characteristics: (i) histopathological grade 2 or 3; (ii) one to 3 5001.12.2023lymph nodes involved in metastatic disease (including micrometastases but not 5001.12.2023isolated tumour cells); and (f) the service is not administered for the 5001.12.2023purpose of altering treatment decisions Applicable once per new primary breast 5001.12.2023cancer diagnosis for any particular patient 1073308 01.05.2006 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023Characterisation of the genotype of a patient for Factor V Leiden gene 5001.12.2023mutation, or detection of the other relevant mutations in the investigation of 5001.12.2023proven venous thrombosis or pulmonary embolism - 1 or more tests 1073309 01.05.2007 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023A test described in item 73308, if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1073310 01.11.2023 6 P7 SN YNNYN 2001.12.202303488.0001550.0000000.00 5001.12.2023Measurable residual disease (MRD) testing by next-generation sequencing, 5001.12.2023performed on bone marrow (or a peripheral blood sample if bone marrow cannot 5001.12.2023be collected) from a patient diagnosed with acute lymphoblastic leukaemia, for 5001.12.2023the purpose of determining baseline MRD, or facilitating the determination of 5001.12.2023MRD following combination chemotherapy or after salvage therapy, requested by 5001.12.2023a specialist or consultant physician practising as a haematologist or 5001.12.2023oncologist 1073311 01.05.2006 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023Characterisation of the genotype of a person who is a first degree relative of 5001.12.2023a person who has proven to have 1 or more abnormal genotypes under item 73308 5001.12.2023- 1 or more tests 1073312 01.05.2007 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023A test described in item 73311, if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1073314 01.05.2006 6 P7 SN NNNNY 2001.12.202300690.0000230.9500000.00 5001.12.2023Characterisation of gene rearrangement or the identification of mutations 5001.12.2023within a known gene rearrangement, in the diagnosis and monitoring of patients 5001.12.2023with laboratory evidence of: (a)acute myeloid leukaemia; or (b)acute 5001.12.2023promyelocytic leukaemia; or (c)acute lymphoid leukaemia; or (d)chronic myeloid 5001.12.2023leukaemia; 1073315 01.05.2007 6 P7 SN NNNNY 2001.12.202300690.0000230.9500000.00 5001.12.2023A test described in item 73314, if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18) 1073317 01.05.2006 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023Detection of the C282Y genetic mutation of the HFE gene and, if performed, 5001.12.2023detection of other mutations for haemochromatosis where: (a)the patient has an 5001.12.2023elevated transferrin saturation or elevated serum ferritin on testing of 5001.12.2023repeated specimens; or (b)the patient has a first degree relative with 5001.12.2023haemochromatosis; or (c)the patient has a first degree relative with 5001.12.2023homozygosity for the C282Y genetic mutation, or with compound heterozygosity 5001.12.2023for recognised genetic mutations for haemochromatosis (Item is subject to rule 5001.12.202320) 1073318 01.05.2007 6 P7 SN NNNNY 2001.12.202300110.0000036.4500000.00 5001.12.2023A test described in item 73317, if rendered by a receiving APP - 1 or more 5001.12.2023tests (Item is subject to rule 18 and 20) 1073320 01.05.2006 6 P7 SN NNNNY 2001.12.202300122.0000040.5500000.00 5001.12.2023Detection of HLA-B27 by nucleic acid amplification includes a service 5001.12.2023described in 71147 unless the service in item 73320 is rendered as a 5001.12.2023pathologist determinable service. (Item is subject to rule 27) 1073321 01.05.2007 6 P7 SN NNNNY 2001.12.202300122.0000040.5500000.00 5001.12.2023A test described in item 73320, if rendered by a receiving APP - 1 or more 5001.12.2023tests. (Item is subject to rule 18 and 27) 1073323 01.11.2007 6 P7 SN NNNNY 2001.12.202300122.0000040.5500000.00 5001.12.2023Determination of HLAB5701 status by molecular techniques prior to the 5001.12.2023initiation of Abacavir therapy including item 71203 if performed. 1073324 01.11.2008 6 P7 SN NNNNY 2001.12.202300122.0000040.9500000.00 5001.12.2023A test described in item 73323 if rendered by a receiving APP 1 or more tests 5001.12.2023(Item is subject to Rule 18) 1073325 01.07.2011 6 P7 SN NNNNY 2001.12.202300220.0000090.0000000.00 5001.12.2023Determination of JAK2 V617F variant allele frequency in the diagnostic workup 5001.12.2023by, or on behalf of, a specialist or consultant physician, for a patient with 5001.12.2023clinical and laboratory evidence of a myeloproliferative neoplasm 1073326 01.07.2011 6 P7 SN NNNNY 2001.12.202300685.0000230.9500000.00 5001.12.2023Characterisation of the gene rearrangement FIP1L1-PDGFRA in the diagnostic 5001.12.2023work-up and management of a patient with laboratory evidence of: a)mast cell 5001.12.2023disease; or b)idiopathic hypereosinophilic syndrome; or c)chronic eosinophilic 5001.12.2023leukaemia;. 1 or more tests 1073327 01.07.2011 6 P7 SN NNNNY 2001.12.202300154.0000051.9500000.00 5001.12.2023Detection of genetic polymorphisms in the Thiopurine S-methyltransferase gene 5001.12.2023for the prevention of dose-related toxicity during treatment with thiopurine 5001.12.2023drugs; including (if performed) any service described in item 65075. 1 or more 5001.12.2023tests 1073332 01.05.2012 6 P7 SN NNNNY 2001.12.202300950.0000315.4000000.00 5001.12.2023An in situ hybridization (ISH) test of tumour tissue from a patient with 5001.12.2023breast cancer requested by, or on the advice of, a specialist or consultant 5001.12.2023physician who manages the treatment of the patient to determine if the 5001.12.2023requirements relating to human epidermal growth factor receptor 2 (HER2) gene 5001.12.2023amplification for access to trastuzumab under the Pharmaceutical Benefits 5001.12.2023Scheme (PBS) or the Herceptin Program are fulfilled. 1073333 01.11.2012 6 P7 SN NNNYY 2001.12.202301765.0000600.0000000.00 5001.12.2023Detection of germline mutations of the von HippelLindau (VHL) gene: (a) in a 5001.12.2023patient who has a clinical diagnosis of VHL syndrome and: (i) a family history 5001.12.2023of VHL syndrome and one of the following: (A) haemangioblastoma (retinal or 5001.12.2023central nervous system); (B) phaeochromocytoma; (C) renal cell carcinoma; or 5001.12.2023(ii) 2 or more haemangioblastomas; or (iii) one haemangioblastoma and a tumour 5001.12.2023or a cyst of: (A) the adrenal gland; or (B) the kidney; or (C) the pancreas; 5001.12.2023or (D) the epididymis; or (E) a broad ligament (other than epididymal and 5001.12.2023single renal cysts, which are common in the general population); or (b) in a 5001.12.2023patient presenting with one or more of the following clinical features 5001.12.2023suggestive of VHL syndrome: (i) haemangiblastomas of the brain, spinal cord, 5001.12.2023or retina; (ii) phaeochromocytoma; (iii) functional extraadrenal paraganglioma 1073334 01.11.2012 6 P7 SN NNNNY 2001.12.202301000.0000340.0000000.00 5001.12.2023Detection of germline mutations of the von Hippel-Lindau (VHL) gene in 5001.12.2023biological relatives of a patient with a known mutation in the VHL gene 1073335 01.11.2012 6 P7 SN NNNNY 2001.12.202301385.0000470.0000000.00 5001.12.2023Detection of somatic mutations of the von Hippel-Lindau (VHL) gene in a 5001.12.2023patient with: (a)2 or more tumours comprising: (i)2 or more 5001.12.2023haemangioblastomas, or (ii)one haemangioblastoma and a tumour of: (A)the 5001.12.2023adrenal gland; or (B)the kidney; or (C)the pancreas; or (D)the epididymis; and 5001.12.2023(b)no germline mutations of the VHL gene identified by genetic testing 1073336 01.12.2013 6 P7 SN NNNNN 2001.12.202300520.0000230.9500000.00 5001.12.2023A test of tumour tissue from a patient withstage III or stage IV metastatic 5001.12.2023cutaneous melanoma, requested by, or on behalf of, a specialist or consultant 5001.12.2023physician, to determine if the requirements relating to BRAF V600 mutation 5001.12.2023status for access to dabrafenib,vemurafenib or encorafenibunder the 5001.12.2023Pharmaceutical Benefits Scheme are fulfilled. 1073337 01.01.2014 6 P7 DN NYNYN 2001.12.202300894.0000397.3500000.00 5001.12.2023A test of tumour tissue from a patient with a new diagnosis of nonsmall cell 5001.12.2023lung cancer, shown to have non-squamous histology or histology not otherwise 5001.12.2023specified, requested by, or on behalf of, a specialist or consultant 5001.12.2023physician, if the test is: (a) to determine if requirements relating to 5001.12.2023epidermal growth factor receptor (EGFR) gene status for access to an 5001.12.2023immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are 5001.12.2023fulfilled; and (b) not associated with a service to which item 73437 or 73438 5001.12.2023applies 1073338 01.04.2014 6 P7 SN NNNNN 2001.12.202300816.0000362.6000000.00 5001.12.2023A test of tumour tissue from a patient with metastatic colorectal cancer 5001.12.2023(stage IV), requested by a specialist or consultant physician, to determine 5001.12.2023if: (a) requirements relating to rat sarcoma oncogene (RAS) gene variant 5001.12.2023status for access to cetuximab or panitumumab under the Pharmaceutical 5001.12.2023Benefits Scheme are fulfilled, if: the test is conducted for all clinically 5001.12.2023relevant mutations on KRAS exons 2, 3 and 4 and NRAS exons 2, 3, and 4; or a 5001.12.2023clinically-relevant RAS variant is detected; and, in cases where no RAS 5001.12.2023variant is detected (b) the requirements relating to BRAF V600 gene variant 5001.12.2023status for access to encorafenib under the Pharmaceutical Benefits Scheme are 5001.12.2023fulfilled. 1073339 01.11.2014 6 P7 SN NNNNY 2001.12.202301175.0000400.0000000.00 5001.12.2023Detection of germline mutations in the RET gene in patients with a suspected 5001.12.2023clinical diagnosis of multiple endocrine neoplasia type 2 (MEN2) requested by 5001.12.2023a specialist or consultant physician who manages the treatment of the patient. 5001.12.2023One test.(Item issubject to rule 25) 1073340 01.11.2014 6 P7 SN NNNNY 2001.12.202300590.0000200.0000000.00 5001.12.2023Detection of a known mutation in the RET gene in an asymptomatic relative of a 5001.12.2023patient with a documented pathogenic germline RET mutation requested by a 5001.12.2023specialist or consultant physician who manages the treatment of the patient. 5001.12.2023One test.(Item is subject to rule 25) 1073341 01.07.2015 6 P7 DN NYNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient 5001.12.2023with a new diagnosis of locally advanced or metastatic non-small cell lung 5001.12.2023cancer, which is of non-squamous histology or histology not otherwise 5001.12.2023specified, with documented evidence of anaplastic lymphoma kinase (ALK) 5001.12.2023immunoreactivity by immunohistochemical (IHC) examination giving a staining 5001.12.2023intensity score > 0, and with documented absence of activating mutations of 5001.12.2023the epidermal growth factor receptor (EGFR) gene, requested by a specialist or 5001.12.2023consultant physician, if the test is: (a) to determine if requirements 5001.12.2023relating to ALK gene rearrangement status for access to an immunotherapy 5001.12.2023listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled; and (b) 5001.12.2023not associated with a service to which item 73437 or 73439 applies 1073343 01.09.2017 6 P7 SN NYNYN 2001.12.202301327.0000589.9000000.00 5001.12.2023Detection of 17p chromosomal deletions by fluorescence in situ hybridisation 5001.12.2023or genome wide microarray, in a patient with chronic lymphocytic leukaemia or 5001.12.2023small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node 5001.12.2023sample, requested by a specialist or consultant physician For any particular 5001.12.2023patient: (a) at initial diagnosis; or (b) at disease relapse; or (c) on 5001.12.2023disease progression; but only where initiation of, or change in, therapy is 5001.12.2023anticipated 1073344 01.01.2019 6 P7 DN NYNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient 5001.12.2023with a new diagnosis of locally advanced or metastatic non-small cell lung 5001.12.2023cancer, which is of non-squamous histology or histology not otherwise 5001.12.2023specified, with documented evidence of ROS proto-oncogene 1 (ROS1) 5001.12.2023immunoreactivity by immunohistochemical (IHC) examination giving a staining 5001.12.2023intensity score of 2+ or 3+; and with documented absence of both activating 5001.12.2023mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic 5001.12.2023lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or 5001.12.2023consultant physician, if the test is: (a) to determine if requirements 5001.12.2023relating to ROS1 gene arrangement status for access to an immunotherapy listed 5001.12.2023under the Pharmaceutical Benefits Scheme (PBS) are fulfilled: and (b) not 5001.12.2023associated with a service to which item 73437 or 73439 applies 1073351 01.02.2019 6 P7 SN NNNNN 2001.12.202300894.0000397.3500000.00 5001.12.2023A test of tumour tissue that is derived from a new sample from a patient with 5001.12.2023locally advanced (Stage IIIb) or metastatic (Stage IV) non-small cell lung 5001.12.2023cancer (NSCLC), who has progressed on or after treatment with an epidermal 5001.12.2023growth factor receptor tyrosine kinase inhibitor (EGFR TKI). The test is to be 5001.12.2023requested by a specialist or consultant physician, to determine if the 5001.12.2023requirements relating to EGFR T790M gene status for access to osimertinib 5001.12.2023under the Pharmaceutical Benefits Scheme are fulfilled. 1073392 01.07.2022 6 P7 SN NNNNN 2001.12.202302700.0001200.0000000.00 5001.12.2023Characterisation of pathogenic or likely pathogenic germline gene variants, 5001.12.2023requested by a specialist or consultant physician: (a) in at least the 5001.12.2023following genes: (i) MYBPC3; (ii) MYH7; (iii) TNNI3; (iv) TNNT2; (v) TPM1; 5001.12.2023(vi) ACTC1; (vii) MYL2; (viii) MYL3; (ix) PRKAG2; (x) LAMP2; (xi) GLA; (xii) 5001.12.2023LMNA; (xiii) SCN5A; (xiv) TTN; (xv) RBM20; (xvi) PLN; (xvii) DSP; (xviii) 5001.12.2023DSC2; (xix) DSG2; (xx) JUP; (xxi) PKP2; (xxii) TMEM43; and (b) for a patient 5001.12.2023for whom clinical history, family history or laboratory findings suggest there 5001.12.2023is a high probability of one or more of the following heritable 5001.12.2023cardiomyopathies in the patient: (i) hypertrophic cardiomyopathy; (ii) dilated 5001.12.2023cardiomyopathy; (iii) arrhythmogenic cardiomyopathy Applicable once per 5001.12.2023lifetime 1073393 01.07.2022 6 P7 SN NNNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Characterisation of one or more pathogenic or likely pathogenic germline gene 5001.12.2023variants, requested by a specialist or consultant physician, if: (a) a service 5001.12.2023described in item 73392 has not previously been performed for the patient; and 5001.12.2023(b) the patient is a first-degree biological relative (or a second-degree 5001.12.2023biological relative if a first-degree biological relative is unavailable) of a 5001.12.2023person who has a pathogenic or likely pathogenic germline gene variant that is 5001.12.2023confirmed by laboratory findings; and (c) the service is performed for the 5001.12.2023purpose of assessing present or future risk of any of the following heritable 5001.12.2023cardiomyopathies in the patient: (i) hypertrophic cardiomyopathy; (ii) dilated 5001.12.2023cardiomyopathy; (iii) arrhythmogenic cardiomyopathy Applicable once per 5001.12.2023variant per lifetime 1073394 01.07.2022 6 P7 SN NNNNN 2001.12.202302700.0001200.0000000.00 5001.12.2023Characterisation of one or more recessive pathogenic or likely pathogenic 5001.12.2023germline genes, requested by a specialist or consultant physician, for the 5001.12.2023purpose of determining the reproductive risk of heritable cardiomyopathy in a 5001.12.2023patient: (a) who is a reproductive partner of a known carrier of a pathogenic 5001.12.2023or likely pathogenic germline gene that is confirmed by laboratory findings ; 5001.12.2023and (b) for whom carrier status of a pathogenic or likely pathogenic germline 5001.12.2023gene is unknown; and (c) who has a clinical history, family history or 5001.12.2023laboratory findings suggesting there is a low probability of heritable 5001.12.2023cardiomyopathy Applicable once per gene per lifetime 1073395 01.07.2022 6 P7 SN NNNYN 2001.12.202301125.0000500.0000000.00 5001.12.2023Reanalysis of whole exome or genome data that is obtained in performing a 5001.12.2023service to which item 73392 applies, for characterisation of previously 5001.12.2023unreported germline gene variants related to the clinical phenotype, if: (a) 5001.12.2023the re-analysis is requested by a consultant physician practising as a 5001.12.2023clinical geneticist or a cardiologist; and (b) the patient is strongly 5001.12.2023suspected of having a heritable cardiomyopathy; and (c) the re-analysis is 5001.12.2023performed at least 18 months after a service to which item 73392 or this item 5001.12.2023applies is performed for the patient Applicable twice per lifetime 1073396 01.07.2022 6 P7 SN NNNNN 2001.12.202300203.0000090.0000000.00 5001.12.2023Characterisation of variants in the JAK2 exon 12 in the diagnostic workup of a 5001.12.2023patient with clinical and laboratory evidence of polycythaemia vera, requested 5001.12.2023by a specialist or consultant physician 1073397 01.07.2022 6 P7 SN NNNNN 2001.12.202300450.0000200.0000000.00 5001.12.2023Characterisation of variants in both the CALR and MPL genes in the diagnostic 5001.12.2023workup of a patient with clinical and laboratory evidence of essential 5001.12.2023thrombocythaemia or primary myelofibrosis, requested by a specialist or 5001.12.2023consultant physician 1073398 01.07.2022 6 P7 SN NNNNN 2001.12.202300945.0000420.0000000.00 5001.12.2023Characterisation of variants in at least 8 genes, which must include all of 5001.12.2023the following genes: (a) JAK2 (including exons 12 and 14); (b) CALR; (c) MPL; 5001.12.2023in the diagnostic workup of a patient with clinical and laboratory evidence of 5001.12.2023polycythaemia vera or essential thrombocythaemia, requested by a specialist or 5001.12.2023consultant physician Applicable to one test per diagnostic episode 1073399 01.07.2022 6 P7 SN NNNNN 2001.12.202301575.0000700.0000000.00 5001.12.2023Characterisation of variants in at least 20 genes, which must include all of 5001.12.2023the following genes: (a) JAK2 (including exons 12 and 14); (b) CALR; (c) MPL; 5001.12.2023in the diagnostic workup of a patient, with clinical and laboratory evidence 5001.12.2023of primary myelofibrosis, who is eligible for a stem cell transplant, 5001.12.2023requested by a specialist or consultant physician Applicable to one test per 5001.12.2023diagnostic episode 1073401 01.07.2022 6 P7 SN NNNNN 2001.12.202304725.0002100.0000000.00 5001.12.2023Characterisation, by whole exome or genome sequencing and analysis, of 5001.12.2023germline gene variants in one or more of the genes implicated in heritable 5001.12.2023cystic kidney disease, if: (a) the service is requested by a consultant 5001.12.2023physician practising as: (i) a clinical geneticist; or (ii) a specialist 5001.12.2023nephrologist; and (b) the patient has a renal abnormality and is strongly 5001.12.2023suspected of having a monogenic condition Applicable once per lifetime 1073402 01.07.2022 6 P7 SN NNNNN 2001.12.202304725.0002100.0000000.00 5001.12.2023Characterisation, by whole exome or genome sequencing and analysis, of 5001.12.2023germline gene variants in one or more of the genes implicated in heritable 5001.12.2023kidney disease, if: (a) the service is requested by a consultant physician 5001.12.2023practising as: (i) a clinical geneticist; or (ii) a specialist nephrologist; 5001.12.2023and (b) the patient has chronic kidney disease (other than cystic disease or 5001.12.2023Alport syndrome) and is strongly suspected of having a monogenic condition 5001.12.2023Applicable once per lifetime 1073403 01.07.2022 6 P7 SN NNNNN 2001.12.202301125.0000500.0000000.00 5001.12.2023Reanalysis of genetic data obtained in performing a service to which item 5001.12.202373401 or 73402 applies, for characterisation of previously unreported germline 5001.12.2023gene variants related to the clinical phenotype, if: (a) the re-analysis is 5001.12.2023requested by a consultant physician practising as a clinical geneticist or a 5001.12.2023specialist paediatrician; and (b) the patient has a strong clinical suspicion 5001.12.2023of a monogenic condition; and (c) a service to which item 73401, 73402 or this 5001.12.2023item applies has not been performed for the patient in the previous 18 months 5001.12.2023Applicable twice per lifetime 1073404 01.07.2022 6 P7 SN NNNNN 2001.12.202300900.0000400.0000000.00 5001.12.2023Detection of a single gene variant in a patient, if: (a) the service is 5001.12.2023requested by: (i) a clinical geneticist; or (ii) a specialist or consultant 5001.12.2023physician providing professional genetic counselling services; and (b) the 5001.12.2023patient has a first-degree relative with a known monogenic cause of kidney 5001.12.2023disease; and (c) a service described in item 73401, 73402, or 73403 has 5001.12.2023identified the causative variant for the disease for the relative Applicable 5001.12.2023once per variant per lifetime 1073405 01.07.2022 6 P7 SN NNNNN 2001.12.202302700.0001200.0000000.00 5001.12.2023Detection of one or more variants of a single gene known to cause heritable 5001.12.2023kidney disease, for the purpose of reproductive decision making, if: (a) the 5001.12.2023detection is requested by a consultant physician practising as: (i) a clinical 5001.12.2023geneticist; or (ii) a specialist nephrologist; and (b) the patient is the 5001.12.2023reproductive partner of an individual known to be a carrier of a pathogenic 5001.12.2023variant that causes heritable kidney disease that has a recessive mode of 5001.12.2023inheritance; and (c) a service described in item 73401, 73402, 73403 or 73404 5001.12.2023has identified the causative gene for the patients partner; and (d) the 5001.12.2023detection test methodology has sufficient diagnostic range and sensitivity to 5001.12.2023detect at least 95% of pathogenic variants likely to be present in the patient 1073406 01.07.2022 6 P7 SN NNNNN 2001.12.202300900.0000400.0000000.00 5001.12.2023Testing of a pregnant patient, for the purpose of determining whether 5001.12.2023monogenic variants are present in the fetus, if: (a) the service is requested 5001.12.2023by a consultant physician practising as: (i) a clinical geneticist; or (ii) a 5001.12.2023specialist nephrologist; and (b) the patient or the patients reproductive 5001.12.2023partner (or both) are known to be affected by, or are carriers of, a known 5001.12.2023pathogenic variant that causes heritable kidney disease; and (c) the fetus is 5001.12.2023at risk, of at least 25%, of inheriting a monogenic variant known to cause 5001.12.2023kidney disease 1073410 01.07.2022 6 P7 SN NNNNN 2001.12.202300225.0000100.0000000.00 5001.12.2023Deletion testing of HBA1 and HBA2 for: (a) the diagnosis of alpha thalassaemia 5001.12.2023in a patient of reproductive age: (i) who has abnormal red cell indices; and 5001.12.2023(ii) for whom thalassaemia screening was suggestive of thalassaemia; and (iii) 5001.12.2023who does not have a concurrent iron deficiency (or who, irrespective of iron 5001.12.2023status, is pregnant); and (iv) who has no historic normal cell indices; or (b) 5001.12.2023the determination of carrier status in a person: (i) who is a reproductive 5001.12.2023partner of a person of childbearing potential with diagnosed alpha 5001.12.2023thalassaemia; and (ii) who has abnormal red cell indices; and (iii) who does 5001.12.2023not have a concurrent iron deficiency (See para PN.7.5 of explanatory notes to 5001.12.2023this Category) 1073411 01.07.2022 6 P7 SN NNNNN 2001.12.202300900.0000400.0000000.00 5001.12.2023Sequencing of HBA1 or HBA2, if the results of deletion testing described in 5001.12.2023item 73410 were inconclusive and a less common or rare variant is suspected, 5001.12.2023either: (a) for the diagnosis of alpha thalassaemia in a patient of 5001.12.2023reproductive age; or (b) for the determination of carrier status in a 5001.12.2023reproductive partner of a person of childbearing potential with diagnosed 5001.12.2023alpha thalassaemia Applicable once per gene per lifetime 1073412 01.07.2022 6 P7 SN NNNNN 2001.12.202300563.0000250.0000000.00 5001.12.2023Deletion testing of HBA1 and HBA2, if the results of deletion testing 5001.12.2023described in item 73410 were inconclusive and a large deletion variant is 5001.12.2023suspected, either: (a) for the diagnosis of alpha thalassaemia in a patient of 5001.12.2023reproductive age; or (b) for the determination of carrier status in a 5001.12.2023reproductive partner of a person of childbearing potential with diagnosed 5001.12.2023alpha thalassaemia 1073413 01.07.2022 6 P7 SN NNNNN 2001.12.202300563.0000250.0000000.00 5001.12.2023Nondeletion testing of HBA1 and HBA2 using techniques other than sequencing, 5001.12.2023if the results of deletion testing described in item 73410 were inconclusive, 5001.12.2023either: (a) for the diagnosis of alpha thalassaemia in a patient of 5001.12.2023reproductive age ; or (b) for the determination of carrier status in a 5001.12.2023reproductive partner of a person of childbearing potential with diagnosed 5001.12.2023alpha thalassaemia 1073416 01.07.2022 6 P7 SN NNNNN 2001.12.202302700.0001200.0000000.00 5001.12.2023Detection of germline gene variants, including copy number variation, 5001.12.2023requested by a specialist or consultant physician: (a) in at least the 5001.12.2023following genes: (i) KCNQ1; (ii) KCNH2; (iii) SCN5A; (iv) KCNE1; (v) KCNE2; 5001.12.2023(vi) KCNJ2; (vii) CACNA1C; (viii) RYR2; (ix) CASQ2; (x) CAV3; (xi) SCN4B; 5001.12.2023(xii) AKAP9; (xiii) SNTA1; (xiv) KCNJ5; (xv) ALG10; (xvi) CALM1; (xvii) CALM2; 5001.12.2023(xviii) ANK2; (xix) TECRL; (xx) TRDN; and (b) for a patient for whom clinical 5001.12.2023or family history criteria is suggestive of inherited cardiac arrhythmias or 5001.12.2023channelopathies that place the patient at greater than 10% risk of having a 5001.12.2023pathogenic variant Applicable once per lifetime 1073417 01.07.2022 6 P7 SN NNNNN 2001.12.202300900.0000400.0000000.00 5001.12.2023Characterisation of one or more pathogenic or likely pathogenic germline gene 5001.12.2023variants, requested by a specialist or consultant physician, if: (a) the 5001.12.2023patient is a first-degree or seconddegree biological relative of a person with 5001.12.2023a pathogenic or likely pathogenic germline gene variant that is confirmed by 5001.12.2023laboratory findings; and (b) the service is performed for the purpose of 5001.12.2023assessing present or future risk of a cardiac arrhythmia or channelopathy; and 5001.12.2023(c) a service to which item 73416 applies has not previously been performed 5001.12.2023for the patient Applicable once per variant per lifetime 1073418 01.07.202201.12.20226 P7 SN NYNYY 2001.12.202302700.0001200.0000000.00 5001.12.2023Characterisation of one or more recessive pathogenic or likely pathogenic 5001.12.2023germline genes, requested by a specialist or consultant physician, for the 5001.12.2023purpose of determining the reproductive risk of cardiac arrhythmia or 5001.12.2023channelopathy in a patient: (a) who is a reproductive partner of a person who 5001.12.2023is a known carrier of a pathogenic or likely pathogenic germline gene variant 5001.12.2023of a gene confirmed by laboratory findings; and (b) for whom a service to 5001.12.2023which item 73416 applies has not previously been performed; and (c) for whom 5001.12.2023carrier status of a pathogenic or likely pathogenic germline gene variant is 5001.12.2023unknown; and (d) who has a clinical history, family history or laboratory 5001.12.2023findings suggesting there is a low probability of cardiac arrhythmia or 5001.12.2023channelopathy Applicable once per gene per lifetime 1073419 01.07.2022 6 P7 SN NNNNN 2001.12.202301125.0000500.0000000.00 5001.12.2023Reanalysis of whole exome or genome data that was obtained in performing a 5001.12.2023service to which item 73416 applies, for characterisation of previously 5001.12.2023unreported germline gene variants related to the clinical phenotype, if: (a) 5001.12.2023the re-analysis is requested by a consultant physician practising as a 5001.12.2023clinical geneticist or a cardiologist; and (b) the patient is strongly 5001.12.2023suspected of having inheritable cardiac arrhythmia or channelopathies; and (c) 5001.12.2023the service is performed at least 18 months after a service to which item 5001.12.202373416 or this item applies was performed for the patient Applicable twice per 5001.12.2023lifetime 1073420 01.07.2022 6 P7 SN NNNNN 2001.12.202300126.0000056.0000000.00 5001.12.2023Noninvasive prenatal testing of blood from an RhD negative pregnant patient 5001.12.2023for the detection of the RHD gene from fetal DNA circulating in maternal blood 1073421 01.07.2022 6 P7 SN NNNNN 2001.12.202301238.0000550.0000000.00 5001.12.2023Noninvasive prenatal testing of blood from an RhD negative pregnant patient 5001.12.2023(in a singleton pregnancy) for the detection of the RHD gene from fetal DNA 5001.12.2023circulating in maternal blood, if the patient is alloimmunised with immune 5001.12.2023Anti-D 1073422 01.11.2022 6 P7 SN NNNNN 2001.12.202302700.0001200.0000000.00 5001.12.2023Characterisation of a gene variant or gene variants using a gene panel, in a 5001.12.2023patient presenting with clinical signs and symptoms suggestive of a genetic 5001.12.2023neuromuscular disorder (other than signs and symptoms associated with variants 5001.12.2023that are not detected by massively parallel sequencing), if the service is 5001.12.2023requested: (a) by a specialist or consultant physician; and (b) after 5001.12.2023exclusion of nongenetic causes Applicable once per lifetime 1073423 01.11.2022 6 P7 SN NNNNN 2001.12.202301125.0000500.0000000.00 5001.12.2023Detection of a single identified gene variant, in a biological relative of a 5001.12.2023person with a germline gene variant for a neuromuscular disorder identified by 5001.12.2023a service described in item 73422, 73425 or 73426, if the service is requested 5001.12.2023by a specialist or consultant physician Applicable once per variant 1073424 01.11.2022 6 P7 SN NNNNN 2001.12.202303600.0001600.0000000.00 5001.12.2023Prenatal detection of an actionable pathogenic familial gene variant or gene 5001.12.2023variants (including maternal cell contamination assessment), requested by a 5001.12.2023specialist or consultant physician, for a genetic neuromuscular disorder 5001.12.2023previously identified in an index person in the patients family as a result of 5001.12.2023a service described in item 73422 Applicable once per pregnancy 1073425 01.11.2022 6 P7 SN NNNNN 2001.12.202304050.0001800.0000000.00 5001.12.2023Prenatal detection of unknown gene variants (including maternal cell 5001.12.2023contamination assessment) using a gene panel, if: (a) the service is 5001.12.2023requested: (i) by a specialist or consultant physician, for a suspected 5001.12.2023genetic neuromuscular disorder; and (ii) after exclusion of nongenetic causes; 5001.12.2023and (b) the service is performed using a sample from the fetus; and (c) the 5001.12.2023service is not performed in conjunction with a service to which item 73426 5001.12.2023applies Applicable once per pregnancy 1073426 01.11.2022 6 P7 SN NNNNN 2001.12.202305400.0002400.0000000.00 5001.12.2023Prenatal detection of unknown gene variants (including maternal cell 5001.12.2023contamination assessment) using a gene panel, if: (a) the service is 5001.12.2023requested: (i) by a specialist or consultant physician; and (ii) for a 5001.12.2023suspected genetic neuromuscular disorder; and (iii) after exclusion of 5001.12.2023nongenetic causes; and (b) the request states that singleton testing is 5001.12.2023inappropriate; and (c) the service is performed using a sample from the fetus 5001.12.2023and a sample from each of the fetuss biological parents; and (d) the service 5001.12.2023is not performed in conjunction with a service to which item 73425 applies 5001.12.2023Applicable once per pregnancy 1073427 01.11.2022 6 P7 SN NNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Single gene testing for the characterisation of a germline gene variant or 5001.12.2023germline gene variants: (a) if requested by a specialist or consultant 5001.12.2023physician; and (b) within the same gene in which the patients reproductive 5001.12.2023partner has a documented pathogenic germline recessive gene variant for a 5001.12.2023neuromuscular disorder identified by a service described in: (i) item 73422, 5001.12.202373425 or 73426; or (ii) item 73434, if the patient has been provided a service 5001.12.2023described in item 73434 and that service has not identified a relevant variant 5001.12.2023Applicable once per gene 1073428 01.11.2022 6 P7 SN NNNNN 2001.12.202301125.0000500.0000000.00 5001.12.2023Reanalysis of whole genome or exome data obtained in performing a service 5001.12.2023described in item 73422, 73425 or 73426, for characterisation of previously 5001.12.2023unreported gene variants related to the clinical phenotype, if the reanalysis 5001.12.2023is requested by: (a) a consultant physician practicing as a clinical 5001.12.2023geneticist; or (b) a consultant physician practising as a specialist 5001.12.2023paediatrician, following consultation with a clinical geneticist Applicable 5001.12.2023twice per lifetime 1073429 01.07.2023 6 P7 SN YNNYN 2001.12.202301998.0000887.9000000.00 5001.12.2023Genetic testing (including characterisation of single nucleotide variants, 5001.12.2023structural variants, fusions and copy number alterations) in a single gene 5001.12.2023panel, requested by a specialist or consultant physician, for a patient with 5001.12.2023clinical or laboratory evidence of a glioma, glioneuronal tumour or 5001.12.2023glioblastoma, to aid diagnosis and classification of the relevant tumour, 5001.12.2023including assessments of at least the following kinds: (a) IDH1, IDH2variant 5001.12.2023testing; (b) 1p/19qcodeletion assessment; (c) H3F3Avariant status; (d) 5001.12.2023TERTpromoter variant status; (e) EGFRamplification; (f) CDKN2A/Bdeletion; (g) 5001.12.2023BRAFvariants Applicable to one test per diagnostic episode 1073430 01.07.2022 6 P7 DN NNNNN 2001.12.202300900.0000400.0000000.00 5001.12.2023Fluorescence in-situ hybridisation (FISH) test of tumour tissue from a patient 5001.12.2023with locally advanced or metastatic solid tumour, if: (a) the tumour is at 5001.12.2023risk of being caused by a neurotrophic receptor tyrosine kinase (NTRK) gene 5001.12.2023fusion as determined by either: (i) occurring in a child less than 18 years of 5001.12.2023age; or (ii) being mammary analogue secretory carcinoma of the salivary gland; 5001.12.2023or (iii) being secretory breast carcinoma; and (b) the test is requested by a 5001.12.2023specialist or consultant physician to determine if requirements relating to 5001.12.2023NTRK gene fusion status for access to a tropomyosin receptor kinase (Trk) 5001.12.2023inhibitor under the Pharmaceutical Benefits Scheme are fulfilled This item 5001.12.2023cannot be claimed if item 73433 has been claimed for the same patient during 5001.12.2023the same cancer diagnosis Applicable only once per cancer diagnosis 1073431 01.07.2022 6 P7 DN NNNNN 2001.12.202301199.0000533.0000000.00 5001.12.2023Two tests described in item 73430 1073432 01.07.2022 6 P7 DN NNNNN 2001.12.202301501.0000667.0000000.00 5001.12.2023Three or more tests described in item 73430 1073433 01.07.2022 6 P7 DN NNNNN 2001.12.202302250.0001000.0000000.00 5001.12.2023Next generation sequencing (NGS) test for neurotrophic receptor tyrosine 5001.12.2023kinase (NTRK1, NTRK2, NTRK3) fusions by RNA or DNA in tumour tissue from a 5001.12.2023patient with locally advanced or metastatic solid tumour, if: (a) the tumour 5001.12.2023is at risk of being caused by an NTRK gene fusion as determined by either: (i) 5001.12.2023occurring in a child less than 18 years of age; or (ii) being mammary analogue 5001.12.2023secretory carcinoma of the salivary gland; or (iii) being secretory breast 5001.12.2023carcinoma; (b) the test is requested by a specialist or consultant physician 5001.12.2023to determine if requirements relating to NTRK gene fusion status for access to 5001.12.2023a tropomyosin receptor kinase (Trk) inhibitor under the Pharmaceutical 5001.12.2023Benefits Scheme are fulfilled This item cannot be claimed if item 73430 has 5001.12.2023been claimed for the same patient during the same cancer diagnosis Applicable 5001.12.2023only once per cancer diagnosis 1073434 01.07.2023 6 P7 SN YNNYN 2001.12.202300882.0000392.0000000.00 5001.12.2023Detection of pathogenic or likely pathogenic gene variants, requested by a 5001.12.2023specialist or consultant physician, for any of the following: (a) a patient 5001.12.2023with a suspected neuromuscular disorder; (b) a relative of a patient with a 5001.12.2023pathogenic or likely pathogenic germline gene variant associated with a 5001.12.2023neuromuscular disorder (confirmed by laboratory findings); (c) the 5001.12.2023reproductive partner of a patient with a recessive pathogenic or likely 5001.12.2023pathogenic germline gene variant associated with a neuromuscular disorder 5001.12.2023(confirmed by laboratory findings) Applicable once per gene per lifetime 1073435 01.07.2023 6 P7 SN YNNYN 2001.12.202302250.0001000.0000000.00 5001.12.2023Detection of pathogenic or likely pathogenic DUX4 gene variants, requested by 5001.12.2023a specialist or consultant physician, for: (a) a patient with a suspected 5001.12.2023neuromuscular disorder; or (b) a relative of a patient with a pathogenic or 5001.12.2023likely pathogenic germline gene variant associated with a neuromuscular 5001.12.2023disorder (confirmed by laboratory findings) Applicable once per gene per 5001.12.2023lifetime 1073436 01.11.2022 6 P7 DN NYNYN 2001.12.202300894.0000397.3500000.00 5001.12.2023A test of tumour tissue from a patient with a new diagnosis of locally 5001.12.2023advanced or metastatic non-small cell lung cancer requested by, or on behalf 5001.12.2023of, a specialist or consultant physician, if the test is: (a) to determine if 5001.12.2023the requirements relating to MET proto-oncogene, receptor tyrosine kinase 5001.12.2023(MET) exon 14 skipping alterations (METex14sk) status for access to an 5001.12.2023immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are 5001.12.2023fulfilled: and (b) not associated with a service to which item 73437 or 73438 5001.12.2023applies 1073437 01.11.2023 6 P7 DN YNNYN 2001.12.202302806.0001247.0000000.00 5001.12.2023A nucleic acid-based multi-gene panel test of tumour tissue from a patient 5001.12.2023with a new diagnosis of non-small cell lung cancer requested by, or on behalf 5001.12.2023of, a specialist or consultant physician,if the test is: (a) to detect 5001.12.2023variants in at least EGFR, BRAF, KRAS and MET exon 14 to determine access to 5001.12.2023specific therapies relevant to these variants listed on the Pharmaceutical 5001.12.2023Benefits Scheme (PBS); and (b) to detect the fusion status of at least ALK, 5001.12.2023ROS1, RET, NTRK1, NTRK2 and NTRK3; and (i) to determine access to specific 5001.12.2023therapies relevant to these variants listed on the PBS; or (ii) determine if 5001.12.2023the requirements relating to EGFR, ALK and ROS1 status for access 5001.12.2023immunotherapies listed on the PBS are fulfilled; and (c) not associated with a 5001.12.2023service to which item 73438, 73439, 73337, 73341, 73344, 73436 or 73351 5001.12.2023applies 1073438 01.11.2023 6 P7 DN YNNYN 2001.12.202301535.0000682.3500000.00 5001.12.2023A DNA-based multi-gene panel test of tumour tissue from a patient with a new 5001.12.2023diagnosis of non-small cell lung cancer requested by, or on behalf of, a 5001.12.2023specialist or consultant physician, if the test is: (a) to detect variants in 5001.12.2023at least EGFR, BRAF, KRAS and MET exon 14; and (b) to determine access to 5001.12.2023specific therapies relevant to these variants listed on the Pharmaceutical 5001.12.2023Benefits Scheme (PBS); or (c) to determine if the requirements relating to 5001.12.2023EGFR status for access to immunotherapies listed on the PBS are fulfilled; and 5001.12.2023(d) not associated with a service to which item 73437, 73337, 73436 or 73351 5001.12.2023applies 1073439 01.11.2023 6 P7 DN YNNYN 2001.12.202301535.0000682.3500000.00 5001.12.2023A nucleic acid-based multi-gene panel test of tumour tissue from a patient 5001.12.2023with a new diagnosis of non-small cell lung cancer and with documented absence 5001.12.2023of activating variants of the EGFR gene, KRAS, BRAF and MET exon14, requested 5001.12.2023by, or on behalf of, a specialist or consultant physician, if the test is: (a) 5001.12.2023to determine the fusion status of at least ALK, ROS1, RET, NTRK1, NTRK2, and 5001.12.2023NTRK3 to determine access to specific therapies relevant to these variants 5001.12.2023listed on the Pharmaceutical Benefits Scheme (PBS) are fulfilled; or (b) to 5001.12.2023determine if the requirements relating to ALK and ROS1 status for access to 5001.12.2023immunotherapies listed on the PBS are fulfilled; and (c) not associated with a 5001.12.2023service to which item 73437, 73341, 73344 or 73351 applies 1073440 01.11.2023 6 P7 SN YNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Genomic testing and copy number variant analysis of genes known to be 5001.12.2023causative or likely causative of childhood hearing loss in a patient, if:(a) 5001.12.2023the testing and analysis is requested by a specialist or consultant physician; 5001.12.2023and(b) the patient has congenital or childhood onset hearing loss that 5001.12.2023presented before the patient was 18 years of age and is permanent moderate, 5001.12.2023severe, or profound (>40 dB in the worst ear over 3 frequencies) and 5001.12.2023classified as sensorineural, auditory neuropathy or mixed; and(c) the patient 5001.12.2023is not eligible for a service to which item 73358 or 73359 applies; and(d) the 5001.12.2023testing and analysis is not associated with a service to which item 73441 5001.12.2023applies Applicable once per lifetime 1073441 01.11.2023 6 P7 SN YNNYN 2001.12.202304725.0002100.0000000.00 5001.12.2023Genomic testing and copy number variant analysis of relevant genes known to be 5001.12.2023causative or likely causative of childhood hearing loss in a patient, if:(a) 5001.12.2023the testing and analysis is requested by a specialist or consultant physician; 5001.12.2023and(b) the patient has congenital or childhood onset hearing loss that 5001.12.2023presented before the patient was 18 years of age and is permanent bilateral 5001.12.2023moderate, severe, or profound (>40 dB in the worst ear over 3 frequencies) 5001.12.2023and classified as sensorineural, auditory neuropathy or mixed; and(c) the 5001.12.2023testing and analysis is performed using a sample from the patient and a sample 5001.12.2023from each of the patients biological parents; and(d) the patient is not 5001.12.2023eligible for a service to which item 73358 or 73359 applies; and(e) the 5001.12.2023testing and analysis is not associated with a service to which item 73440 5001.12.2023applies Applicable once per lifetime 1073442 01.11.2023 6 P7 SN YNNYN 2001.12.202301125.0000500.0000000.00 5001.12.2023Re-analysis of whole exome or genome data obtained under a service to which 5001.12.2023item 73440 or 73441 applies, for characterisation of previously unreported 5001.12.2023germline gene variants for childhood hearing loss in a patient, if:(a) the 5001.12.2023re-analysis is requested by a specialist or consultant physician; and(b) the 5001.12.2023re-analysis is performed at least 24 months after:(i) the service to which 5001.12.2023items 73440 or 73441 applies has been provided to the patient; or(ii) a 5001.12.2023service to which this item applies is performed for the patient Applicable 5001.12.2023twice per lifetime 1073443 01.11.2023 6 P7 SN YNNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Characterisation of one or more familial germline gene variants known to be 5001.12.2023causative or likely causative of childhood hearing loss in a person, if:(a) 5001.12.2023the person tested is a biological relative of a patient with a germline gene 5001.12.2023variant known to be causative or likely causative of hearing loss confirmed by 5001.12.2023laboratory findings; and(b) the result of a previous proband testing is made 5001.12.2023available to the laboratory undertaking the characterisation 1073444 01.11.2023 6 P7 SN YNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Characterisation of all germline variants in one or more genes known to cause 5001.12.2023hearing loss in a person, if:(a) the characterisation is requested by a 5001.12.2023specialist or consultant physician; and(b) the characterisation is for the 5001.12.2023reproductive partner of a patient with a pathogenic or likely pathogenic 5001.12.2023recessive germline gene variant known to cause hearing loss confirmed by 5001.12.2023laboratory findings; and(c) the result of the patients previous testing is 5001.12.2023made available to the laboratory undertaking the characterisation 1073445 01.11.2023 6 P7 SN YNNYN 2001.12.202302475.0001100.0000000.00 5001.12.2023Characterisation of a variant or variants in a panel of at least 25 genes 5001.12.2023using DNA and RNA, requested by a specialist or consultant physician, to 5001.12.2023determine the diagnosis, prognosis and/or management of a patient presenting 5001.12.2023with a clinically suspected haematological malignancy of myeloid origin 5001.12.2023Applicable once per diagnostic episode, at diagnosis, disease progression or 5001.12.2023relapse 1073446 01.11.2023 6 P7 SN YNNYN 2001.12.202302475.0001100.0000000.00 5001.12.2023Characterisation of a variant or variants in a panel of at least 25 genes 5001.12.2023using DNA and RNA, requested by a specialist or consultant physician, to 5001.12.2023determine the diagnosis, prognosis and/or management of a patient presenting 5001.12.2023with a clinically suspected haematological malignancy of lymphoid origin 5001.12.2023Applicable once per diagnostic episode, at diagnosis, disease progression or 5001.12.2023relapse 1073447 01.11.2023 6 P7 SN YNNYN 2001.12.202302088.0000927.9000000.00 5001.12.2023Characterisation of a variant or variants in a panel of at least 25 genes 5001.12.2023using DNA, requested by a specialist or consultant physician, to determine the 5001.12.2023diagnosis, prognosis and/or management of a patient presenting with a 5001.12.2023clinically suspected haematological malignancy of myeloid origin Applicable 5001.12.2023once per diagnostic episode, at diagnosis, disease progression or relapse 1073448 01.11.2023 6 P7 SN YNNYN 2001.12.202302088.0000927.9000000.00 5001.12.2023Characterisation of a variant or variants in a panel of at least 25 genes 5001.12.2023using DNA, requested by a specialist or consultant physician, to determine the 5001.12.2023diagnosis, prognosis and/or management of a patient presenting with a 5001.12.2023clinically suspected haematological malignancy of lymphoid origin Applicable 5001.12.2023once per diagnostic episode, at diagnosis, disease progression or relapse 1073451 01.11.2023 6 P7 SN YNNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Testing of a patient who is pregnant, or planning pregnancy, to identify 5001.12.2023carrier status for pathogenic or likely pathogenic variants in the following 5001.12.2023genes, for the purpose of determining reproductive risk of cystic fibrosis, 5001.12.2023spinal muscular atrophy or fragile X syndrome: CFTR; SMN1; FMR1 One test per 5001.12.2023lifetime. 1073452 01.11.2023 6 P7 SN YNNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Testing of the reproductive partner of a patient who has been found to be a 5001.12.2023carrier of a pathogenic or likely pathogenic variant in the CFTR or SMN1 gene 5001.12.2023identified by testing under item 73451, for the purpose of determining the 5001.12.2023couples reproductive risk of cystic fibrosis or spinal muscular atrophy One 5001.12.2023test per condition per lifetime 1073453 01.11.2023 6 P7 SN YNNYN 2001.12.202300956.0000425.0000000.00 5001.12.2023Characterisation of germline pathogenic or likely pathogenic gene variants: 5001.12.2023(a) in at least the following genes: (i) ASPA; (ii) BLM; (iii) CFTR; (iv) 5001.12.2023ELP1; (v) FANCA; (vi) FANCC; (vii) FANCG; (viii) FMR1; (ix) G6PC1; (x) GBA1; 5001.12.2023(xi) HEXA; (xii) MCOLN1; (xiii) SLC37A4; (xiv) SMN1; (xv) SMPD1; and (b) in a 5001.12.2023patient of reproductive age who is of Ashkenazi Jewish descent for the purpose 5001.12.2023of ascertaining the patients carrier status for the following: (i) Bloom 5001.12.2023syndrome (ii) Canavan disease (iii) Cystic fibrosis (iv) Familial dysautonomia 5001.12.2023(v) Fanconi anaemia type C (vi) Fragile-X syndrome (vii) Gaucher disease 5001.12.2023(viii) Glycogen storage disease type I (ix) Mucolipidosis type IV (x) 5001.12.2023Niemann-Pick disease type A 7 (xi) Spinal muscular atrophy (xii) Tay-Sachs 5001.12.2023disease Applicable once per lifetime 1073454 01.11.2023 6 P7 SN YNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Whole gene sequencing of a gene or genes described in item 73453, in a patient 5001.12.2023who is the reproductive partner of an individual who is affected by, or is a 5001.12.2023known genetic carrier of, one or more conditions described in item 73453 5001.12.2023(other than cystic fibrosis, fragileX syndrome or spinal muscular atrophy), 5001.12.2023for the purpose of determining the couples combined reproductive risk of the 5001.12.2023conditions, if: (a) the patient is not eligible for a service to which item 5001.12.202373453 applies; and (b) the patient has not received a service to which item 5001.12.202373453 applies; and (c) the patient has not received a service to which this 5001.12.2023item applies for the purpose of determining the patients reproductive risk 5001.12.2023with the patients current reproductive partner Applicable once per couple per 5001.12.2023lifetime 1073455 01.11.2023 6 P7 SN YNNYN 2001.12.202303600.0001600.0000000.00 5001.12.2023Testing of a pregnant patient, if at least one prospective parent is known to 5001.12.2023be affected by, or is a genetic carrier of, one or more conditions described 5001.12.2023in item 73453, for the purpose of determining whether a familial variant or 5001.12.2023variants are present in the fetus, if: (a) the testing is requested by a 5001.12.2023specialist or consultant physician; and (b) there is at least a 25% risk of 5001.12.2023the fetus inheriting a condition described in paragraph(b) of item 73453 1073456 01.11.2023 6 P7 SN YNNYN 2001.12.202304725.0002100.0000000.00 5001.12.2023Characterisation by whole genome sequencing, or by either or both whole exome 5001.12.2023sequencing and mitochondrial DNA sequencing, of germline variants present in 5001.12.2023nuclear DNA and in mitochondrial DNA of a patient with a strong suspicion of a 5001.12.2023mitochondrial disease, if: (a) the characterisation is requested by a 5001.12.2023specialist or consultant physician; and (b) the characterisation is requested 5001.12.2023because of the onset of one or more clinical features indicative of 5001.12.2023mitochondrial disease, including at least one or more of the following: (i) 5001.12.2023meeting the clinical criteria of a probable indicator of mitochondrial disease 5001.12.2023on a relevant scoring system; (ii) evident mitochondrial dysfunction or 5001.12.2023decompensation; (iii) unexplained hypotonia or weakness, profound 5001.12.2023hypoglycaemia orfailure to thrive in the presence of a metabolic acidosis; 5001.12.2023(iv) unexplained single or multi-organ dysfunction or fulminant failure 5001.12.2023(including, but not limited to, neuropathies, myopathies, hepatopathy, 5001.12.2023pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, 5001.12.2023developmental delays or cognitive regression, or progressive encephalopathy 5001.12.2023orprogressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac 5001.12.2023arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) 5001.12.2023stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, 5001.12.2023seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) 5001.12.2023hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) 5001.12.2023family history of mitochondrial disease, or any of the above; and (c) the 5001.12.2023service is not a service associated with a service to which item 73358, 73359 5001.12.2023or 73457 applies Applicable only once per lifetime 1073457 01.11.2023 6 P7 SN YNNYN 2001.12.202307425.0003300.0000000.00 5001.12.2023Characterisation by whole genome sequencing, or either or both whole exome 5001.12.2023sequencing and mitochondrial DNA sequencing, of germline variants present in 5001.12.2023nuclear DNA and in mitochondrial DNA, of a patient with a strong suspicion of 5001.12.2023a mitochondrial disease, if: (a) the characterisation is performed using a 5001.12.2023sample from the patient and a sample from each of the patients biological 5001.12.2023parents; and (b) the request for the characterisation states that singleton 5001.12.2023testing is inappropriate; and (c) the characterisation is requested by a 5001.12.2023specialist or consultant physician; and (d) the characterisation is requested 5001.12.2023because of the onset of one or more clinical features indicative of 5001.12.2023mitochondrial disease, including at least one or more of the following: (i) 5001.12.2023meeting the clinical criteria of a probable indicator of mitochondrial disease 5001.12.2023on a relevant scoring system; (ii) evident mitochondrial dysfunction or 5001.12.2023decompensation; (iii) unexplained hypotonia or weakness, profound 5001.12.2023hypoglycaemia or failure to thrive in the presence of a metabolic acidosis; 5001.12.2023(iv) unexplained single or multi-organ dysfunction or fulminant failure 5001.12.2023(including, but not limited to, neuropathies, myopathies, hepatopathy, 5001.12.2023pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, 5001.12.2023developmental delays or cognitive regression, or progressive encephalopathy or 5001.12.2023progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; 5001.12.2023(vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like 5001.12.2023episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, 5001.12.2023muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, 5001.12.2023diabetes, unexplained short stature, or endocrinopathy; (xii) family history 5001.12.2023of mitochondrial disease; and (e) the service is not a service associated with 5001.12.2023a service to which item 73358, 73359 or 73456 applies Applicable only once per 5001.12.2023lifetime 1073458 01.11.2023 6 P7 SN YNNYN 2001.12.202301125.0000500.0000000.00 5001.12.2023Re-analysis of whole genome or whole exome or mitochondrial DNA data obtained 5001.12.2023in performing a service to which item 73456 or 73457 applies, for 5001.12.2023characterisation of previously unreported germline variants related to the 5001.12.2023clinical phenotype, if: (a) the re-analysis is requested by a specialist or 5001.12.2023consultant physician; and (b) the patient is strongly suspected of having a 5001.12.2023monogenic mitochondrial disease; and (c) the re-analysis is performed at least 5001.12.202324 months after: (i) the service to which item 73456 or 73457 applies; or (ii) 5001.12.2023a service to which this item applies Applicable twice per lifetime 1073459 01.11.2023 6 P7 SN YNNYN 2001.12.202303600.0001600.0000000.00 5001.12.2023Testing for diagnostic purposes of a pregnant patient, for detection in the 5001.12.2023fetus of a gene variant or variants present in the parents, if: (a) the gene 5001.12.2023variant or variants are: (i) a variant or variants in the mitochondrial genome 5001.12.2023identified in the oocyte donating parent; or (ii) autosomal recessive variants 5001.12.2023identified in both biological parents within the same gene; or (iii) an 5001.12.2023autosomal dominant or X-linked variant identified in either biological parent; 5001.12.2023or (iv) identified in a biological sibling of the fetus; and (b) the causative 5001.12.2023variant or variants for the condition of the fetus first-degree relative have 5001.12.2023been confirmed by laboratory findings; and (c) the detection is requested by a 5001.12.2023specialist or consultant physician; and (d) the service is not a service 5001.12.2023associated with a service to which item 73361, 73362, 73363 or 73462 applies 1073460 01.11.2023 6 P7 SN YNNYN 2001.12.202301013.0000450.0000000.00 5001.12.2023Characterisation of mitochondrial DNA deletion or variant for diagnostic 5001.12.2023purposes in a patient suspected to have mitochondrial disease, if: (a) the 5001.12.2023characterisation is requested by the specialist or consultant physician 5001.12.2023managing the patients treatment; and (b) the patient displays onset of one or 5001.12.2023more clinical features indicative of mitochondrial disease, including at least 5001.12.2023one or more of the following: (i) meeting the clinical criteria of a probable 5001.12.2023indicator of mitochondrial disease on a relevant scoring system; (ii) evident 5001.12.2023mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or 5001.12.2023weakness, profound hypoglycaemia or failure to thrive in the presence of a 5001.12.2023metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or 5001.12.2023fulminant failure (including, but not limited to, neuropathies, myopathies, 5001.12.2023hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or 5001.12.2023atypical seizures, developmental delays or cognitive regression, or 5001.12.2023progressive encephalopathy or progressive encephalomyopathy; (vi) 5001.12.2023cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless 5001.12.2023visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; 5001.12.2023(ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) 5001.12.2023external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short 5001.12.2023stature, or endocrinopathy; (xii) family history of mitochondrial disease; and 5001.12.2023(c) the service is performed following a service to which items 73292, 73358, 5001.12.202373359,73456 or 73457 applies for the same patient if the results were 5001.12.2023non-informativeApplicable 3 times per lifetime 1073461 01.11.2023 6 P7 SN YNNYN 2001.12.202302700.0001200.0000000.00 5001.12.2023Whole gene testing of a person for the characterisation of all germline gene 5001.12.2023variants within the same gene in which the persons reproductive partner has a 5001.12.2023pathogenic or likely pathogenic germline recessive gene variant for 5001.12.2023mitochondrial disease, if: (a) the partners germline recessive gene variant is 5001.12.2023confirmed by laboratory findings; and (b) the characterisation is requested by 5001.12.2023a specialist or consultant physician 1073462 01.11.2023 6 P7 SN YNNYN 2001.12.202300900.0000400.0000000.00 5001.12.2023Testing of a person for the detection of a single gene variant, if: (a) the 5001.12.2023person tested has a biological relative with a known pathogenic or likely 5001.12.2023pathogenic mitochondrial disease variant confirmed by laboratory findings; and 5001.12.2023(b) the testing is requested by a specialist or consultant physician; and (c) 5001.12.2023the service is not a service associated with a service to which item 73361, 5001.12.202373362 or 73363 applies 1073521 26.05.2002 6 P8 SN NNNNY 2001.12.202300031.0000009.7000000.00 5001.12.2023Semen examination for presence of spermatozoa or examination of cervical mucus 5001.12.2023for spermatozoa (Huhner's test) 1073523 26.05.2002 6 P8 SN NNNNY 2001.12.202300132.0000041.7500000.00 5001.12.2023Semen examination (other than post-vasectomy semen examination), including: 5001.12.2023(a)measurement of volume, sperm count and motility; and (b)examination of 5001.12.2023stained preparations; and (c)morphology; and (if performed) (d)differential 5001.12.2023count and 1 or more chemical tests; (Item is subject to rule 25) 1073525 26.05.2002 6 P8 SN NNNNY 2001.12.202300089.0000028.3500000.00 5001.12.2023Sperm antibodies - sperm-penetrating ability - 1 or more tests 1073527 26.05.2002 6 P8 SN NNNNY 2001.12.202300032.0000010.0000000.00 5001.12.2023Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more 5001.12.2023methods for diagnosis of pregnancy - 1 or more tests 1073529 26.05.2002 6 P8 SN NNNNY 2001.12.202300090.0000028.6500000.00 5001.12.2023Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more 5001.12.2023methods (except by latex, membrane, strip or other pregnancy test kit) for 5001.12.2023diagnosis of threatened abortion, or follow up of abortion or diagnosis of 5001.12.2023ectopic pregnancy, including any services performed in item 73527 - 1 test 1073801 26.05.2002 6 P9 SN NNNNY 2001.12.202300022.0000006.9000000.00 5001.12.2023Semen examination for presence of spermatozoa 1073802 26.05.2002 6 P9 SN NNNNY 2001.12.202300014.0000004.5500000.00 5001.12.2023Leucocyte count, erythrocyte sedimentation rate, examination of blood film 5001.12.2023(including differential leucocyte count), haemoglobin, haematocrit or 5001.12.2023erythrocyte count - 1 test 1073803 26.05.2002 6 P9 SN NNNNY 2001.12.202300020.0000006.3500000.00 5001.12.20232 tests described in item 73802 1073804 26.05.2002 6 P9 SN NNNNY 2001.12.202300026.0000008.1500000.00 5001.12.20233 or more tests described in item 73802 1073805 26.05.2002 6 P9 SN NNNNY 2001.12.202300014.0000004.5500000.00 5001.12.2023Microscopy of urine, excluding dipstick testing. 1073806 26.05.2002 6 P9 SN NNNNY 2001.12.202300032.0000010.1500000.00 5001.12.2023Pregnancy test by 1 or more immunochemical methods 1073807 26.05.2002 6 P9 SN NNNNY 2001.12.202300022.0000006.9000000.00 5001.12.2023Microscopy for wet film other than urine, including any relevant stain 1073808 26.05.2002 6 P9 SN NNNNY 2001.12.202300027.0000008.6500000.00 5001.12.2023Microscopy of Gram-stained film, including (if performed) a service described 5001.12.2023in item 73805 or 73807 1073809 26.05.2002 6 P9 SN NNNNN 2001.12.202300007.0000002.3500000.00 5001.12.2023Chemical tests for occult blood in faeces by reagent stick, strip, tablet or 5001.12.2023similar method 1073810 26.05.2002 6 P9 SN NNNNY 2001.12.202300022.0000006.9000000.00 5001.12.2023Microscopy for fungi in skin, hair or nails - 1 or more sites 1073811 26.05.2002 6 P9 SN NNNNY 2001.12.202300035.0000011.2000000.00 5001.12.2023Mantoux test 1073828 01.11.2011 6 P9 DN NNNNN 2001.12.202300016.0000006.9000000.00 5001.12.2023Semen examination for presence of spermatozoa by a participating nurse 5001.12.2023practitioner 1073829 01.11.2011 6 P9 DN NNNNN 2001.12.202300010.0000004.5500000.00 5001.12.2023Leucocyte count, erythrocyte sedimentation rate, examination of blood film 5001.12.2023(including differential leucocyte count), haemoglobin, haematocrit or 5001.12.2023erythrocyte count by a participating nurse practitioner- 1 test 1073830 01.11.2011 6 P9 DN NNNNN 2001.12.202300014.0000006.3500000.00 5001.12.20232 tests described in item 73829 by a participating nurse practitioner 1073831 01.11.2011 6 P9 DN NNNNN 2001.12.202300018.0000008.1500000.00 5001.12.20233 or more tests described in item 73829 by a participating nurse practitioner 1073832 01.11.2011 6 P9 DN NNNNN 2001.12.202300010.0000004.5500000.00 5001.12.2023Microscopy of urine,excluding dipstick testingby a participating nurse 5001.12.2023practitioner. 1073833 01.11.2011 6 P9 DN NNNNN 2001.12.202300023.0000010.1500000.00 5001.12.2023Pregnancy test by 1 or more immunochemical methods by a participating nurse 5001.12.2023practitioner 1073834 01.11.2011 6 P9 DN NNNNN 2001.12.202300016.0000006.9000000.00 5001.12.2023Microscopy for wet film other than urine, including any relevant stain by a 5001.12.2023participating nurse practitioner 1073835 01.11.2011 6 P9 DN NNNNN 2001.12.202300019.0000008.6500000.00 5001.12.2023Microscopy of Gram-stained film, including (if performed) a service described 5001.12.2023in item 73832 or 73834 by a participating nurse practitioner 1073836 01.11.2011 6 P9 DN NNNNN 2001.12.202300005.0000002.3500000.00 5001.12.2023Chemical tests for occult blood in faeces by reagent stick, strip, tablet or 5001.12.2023similar method by a participating nurse practitioner 1073837 01.11.2011 6 P9 DN NNNNN 2001.12.202300016.0000006.9000000.00 5001.12.2023Microscopy for fungi in skin, hair or nails by a participating nurse 5001.12.2023practitioner- 1 or more sites 1073899 01.11.2015 6 P10 SN NNNNY 2001.12.202300055.0000005.9500000.00 5001.12.2023Initiation of a patient episode that consists of a service described in item 5001.12.202372858 or 72859 in circumstances other than those mentioned in item 73900 1073900 01.11.2015 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode that consists of a service described in item 5001.12.202372858 or 72859 if the service is rendered in a prescribed laboratory. 1073920 01.07.2008 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services (other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected in an approved collection centre that the APA 5001.12.2023operates in the same premises as it operates a category GX or GY pathology 5001.12.2023laboratory 1073922 01.05.2007 6 P10 SN NNNNY 2001.12.202300026.0000008.2000000.00 5001.12.2023Initiation of a patient episode that consists of a service described in item 5001.12.202373070, 73071, 73072, 73074, 73075 or 73076(in circumstances other than those 5001.12.2023described in item 73923) 1073923 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode that consists of a service described in items 5001.12.202373070, 73071, 73072, 73074, 73075 or 73076 if: (a) the person is a private 5001.12.2023patient in a recognised hospital; or (b) the person receives the service from 5001.12.2023a prescribed laboratory 1073924 01.05.2007 6 P10 SN NNNNY 2001.12.202300046.0000014.6500000.00 5001.12.2023Initiation of a patient episode that consists of 1 or more services described 5001.12.2023in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 5001.12.202372830, 72836 and 72838 (in circumstances other than those described in item 5001.12.202373925) from a person who is an in-patient of a hospital. 1073925 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode that consists of 1 or more services described 5001.12.2023in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 5001.12.202372830, 72836 and 72838 if the person is: (a)a private patient of a recognised 5001.12.2023hospital;or (b) a private patient of a hospital who receives the service or 5001.12.2023services from a prescribed laboratory. 1073926 01.05.2007 6 P10 SN NNNNY 2001.12.202300026.0000008.2000000.00 5001.12.2023Initiation of a patient episode that consists of 1 or more services described 5001.12.2023in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 5001.12.202372830, 72836 and 72838 (in circumstances other than those described in item 5001.12.202373927) from a person who is not a patient of a hospital. 1073927 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by a prescribed laboratory that consists of 1 5001.12.2023or more services described in items, 72813, 72816, 72817, 72818, 72823, 72824, 5001.12.202372825, 72826, 72827, 72828, 72830, 72836 and 72838 from a person who is not a 5001.12.2023patient of a hospital. 1073928 01.05.2007 6 P10 SN NNNNY 2001.12.202300055.0000005.9500000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or 5001.12.2023moreservices (other than those services described in items 73922, 73924 or 5001.12.202373926) if the specimen is collected in an approved collection centre. Unless 5001.12.2023item 73920 or 73929 applies 1073929 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected by an approved pathology practitioner for a 5001.12.2023prescribed laboratory or by an employee of an approved pathology authority, 5001.12.2023who conducts a prescribed laboratory, if the specimen is collected in an 5001.12.2023approved pathology collection centre 1073930 01.05.2007 6 P10 SN NNNNY 2001.12.202300055.0000005.9500000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for a service for 5001.12.20231 or more services (other than those services described in items 73922, 73924 5001.12.2023or 73926) if the specimen is collected by an approved pathology practitioner 5001.12.2023or an employee of an approved pathology authority from a person who is an 5001.12.2023in-patient of a hospital other than a recognised hospital. Unless item 73931 5001.12.2023applies 1073931 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926) 5001.12.2023if: ()the specimen is collected by an approved pathology practitioner for a 5001.12.2023prescribed laboratory or by an employee of an approved pathology authority, 5001.12.2023who conducts a prescribed laboratory, from a person who is a private patient 5001.12.2023in a hospital or () the person is a private patient in a recognised hospital 5001.12.2023and the specimen is collected by an approved pathology practitioner or an 5001.12.2023employee of an approved pathology authority 1073932 01.05.2007 6 P10 SN NNNNY 2001.12.202300034.0000010.2500000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services (other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected by an approved pathology practitioner or an 5001.12.2023employee of an approved pathology authority from a person in the place where 5001.12.2023the person was residing. Unless item 73933 applies 1073933 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected by an approved pathology practitioner for a 5001.12.2023prescribed laboratory or by an employee of an approved pathology authority, 5001.12.2023who conducts a prescribed laboratory, from a person in the place where the 5001.12.2023person is residing 1073934 01.05.2007 6 P10 SN NNNNY 2001.12.202300055.0000017.6000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services (other than those services described in items 73922, 73924 and 73926) 5001.12.2023if the specimen is collected by an approved pathology practitioner or an 5001.12.2023employee of an approved pathology authority from a person in a residential 5001.12.2023aged care home or institution. Unless 73935 applies 1073935 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected by an approved pathology practitioner or by an 5001.12.2023employee of an approved pathology authority, who conducts a prescribed 5001.12.2023laboratory, from a person in a residential aged care home or institution 1073936 01.05.2007 6 P10 SN NNNNY 2001.12.202300032.0000005.9500000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services (other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected from the person by the person. 1073937 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926), 5001.12.2023if the specimen is collected from the person by the person and if: ()the 5001.12.2023service is performed in a prescribed laboratory or ()the person is a private 5001.12.2023patient in a recognised hospital 1073938 01.05.2007 6 P10 SN NNNNY 2001.12.202300032.0000007.9500000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services (other than those services described in items 73922, 73924 or 73926) 5001.12.2023if the specimen is collected by or on behalf of the treating practitioner. 5001.12.2023Unless item 73939 applies 1073939 01.05.2007 6 P10 SN NNNNY 2001.12.202300008.0000002.4000000.00 5001.12.2023Initiation of a patient episode by collection of a specimen for 1 or more 5001.12.2023services(other than those services described in items 73922, 73924 or 73926), 5001.12.2023if the specimen is collected by or on behalf of the treating practitioner and 5001.12.2023if: ()the service is performed in a prescribed laboratory or ()the person is a 5001.12.2023private patient in a recognised hospital 1073940 01.05.2007 6 P11 SN NNNYY 2001.12.202300034.0000010.2500000.00 5001.12.2023Receipt of a specimen by an approved pathology practitioner of an approved 5001.12.2023pathology authority from another approved pathology practitioner of another 5001.12.2023approved pathology authority 1075001 26.05.2002 7 C1 SN NYNNY 2001.12.202300237.0000094.1000000.00 5001.12.2023Note: In this Group, benefit is only payable where the service has been 5001.12.2023rendered to a patient by a dental practitioner who is registered in the 5001.12.2023specialty of orthodontics, except for the services covered by Items 5001.12.202375009-75023 which may also be rendered by a medical practitioner who is a 5001.12.2023specialist in the practice of his or her specialty of oral and maxillofacial 5001.12.2023surgery. CONSULTATIONS INITIAL PROFESSIONAL ATTENDANCE in a single course of 5001.12.2023treatment by an eligible orthodontist (AO) 1075004 26.05.2002 7 C1 SN NYNNY 2001.12.202300119.0000047.3500000.00 5001.12.2023PROFESSIONAL ATTENDANCE by an eligible orthodontist subsequent to the first 5001.12.2023professional attendance by the orthodontist in a single course of treatment 5001.12.2023(AO) 1075006 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300211.0000083.8500000.00 5001.12.2023PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a 5001.12.2023service to which item 75004 applies) prior to provision of a service to which: 5001.12.2023(a)item 75030, 75033, 75034, 75036, 75037, 75039, 75045 or 75051 applies; or 5001.12.2023(b)an item in Group T8 or Groups 03 to 09 applies; in a single course of 5001.12.2023treatment 1075009 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300189.0000075.0500000.00 5001.12.2023RADIOGRAPHY ORTHODONTIC RADIOGRAPHY orthopantomography (panoramic 5001.12.2023radiography), including any consultation on the same occasion 1075012 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300299.0000118.9500000.00 5001.12.2023ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR CEPHALOMETRIC RADIOGRAPHY with 5001.12.2023cephalometric tracings OR LATERAL CEPHALOMETRIC RADIOGRAPHY with cephalometric 5001.12.2023tracings including any consultation on the same occasion 1075015 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300411.0000163.5000000.00 5001.12.2023ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, 5001.12.2023with cephalometric tracings including any consultation on the same occasion 1075018 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300524.0000208.3500000.00 5001.12.2023ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, 5001.12.2023with cephalometric tracings and orthopantomography including any consultation 5001.12.2023on the same occasion 1075021 26.05.2002 7 C1 SNAOSNYNNY 2001.12.202300642.0000255.4000000.00 5001.12.2023ORTHODONTIC RADIOGRAPHYhand-wrist studies (including growth prediction) 5001.12.2023including any consultation on the same occasion 1075023 26.05.2002 7 C1 SNAOSNYNNY 2001.12.202300129.0000051.1000000.00 5001.12.2023INTRAORAL RADIOGRAPHY - single area, periapical or bitewing film 1075024 26.05.2002 7 C1 SNAO NYNNY 2001.12.202301661.0000660.5500000.00 5001.12.2023PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING PRESURGICAL INFANT MAXILLARY 5001.12.2023ARCH REPOSITIONING including supply of appliances and all adjustments of 5001.12.2023appliances and supervision - WHERE 1 APPLIANCE IS USED 1075027 26.05.2002 7 C1 SNAO NYNNY 2001.12.202302278.0000905.7500000.00 5001.12.2023PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances 5001.12.2023and all adjustments of appliances and supervisionWHERE 2 APPLIANCES ARE USED 1075030 26.05.2002 7 C1 SNAO NYNNY 2001.12.202302028.0000806.4500000.00 5001.12.2023DENTITION TREATMENT MAXILLARY ARCH EXPANSION not being a service associated 5001.12.2023with a service to which item 75039, 75042, 75045 or 75048 applies, including 5001.12.2023supply of appliances, all adjustments of the appliances, removal of the 5001.12.2023appliances and retention 1075033 26.05.2002 7 C1 SNAO NYNNY 2001.12.202303325.0001321.9000000.00 5001.12.2023MIXED DENTITION TREATMENT - incisor alignment using fixed appliances in 5001.12.2023maxillary arch, including supply of appliances, all adjustments of appliances, 5001.12.2023removal of the appliances and retention 1075034 26.05.2002 7 C1 SNAO NYNNY 2001.12.202301692.0000672.8000000.00 5001.12.2023MIXED DENTITION TREATMENT - incisor alignment with or without lateral arch 5001.12.2023expansion using a removable appliance in the maxillary arch, including supply 5001.12.2023of appliances, associated adjustments and retention 1075036 26.05.2002 7 C1 SNAO NYNNY 2001.12.202304592.0001825.8500000.00 5001.12.2023MIXED DENTITION TREATMENT - lateral arch expansion and incisor alignment using 5001.12.2023fixed appliances in maxillary arch, including supply of appliances, all 5001.12.2023adjustments of appliances, removal of appliances and retention 1075037 26.05.2002 7 C1 SN NYNNY 2001.12.202305783.0002299.6000000.00 5001.12.2023MIXED DENTITION TREATMENT - lateral arch expansion and incisor correction - 2 5001.12.2023arch (maxillary and mandibular) using fixed appliances in both maxillary and 5001.12.2023mandibular arches, including supply of appliances, all adjustments of 5001.12.2023appliances, removal of appliances and retention 1075039 26.05.2002 7 C1 SNAO NYNNY 2001.12.202301537.0000611.2000000.00 5001.12.2023PERMANENT DENTITION TREATMENTSINGLE ARCH (mandibular or maxillary) TREATMENT 5001.12.2023(correction and alignment) using fixed appliances, including supply of 5001.12.2023appliances - initial 3 months of active treatment 1075042 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300575.0000228.4500000.00 5001.12.2023PERMANENT DENTITION TREATMENT - SINGLE ARCH (mandibular or maxillary) 5001.12.2023TREATMENT (correction and alignment) using fixed appliances, including supply 5001.12.2023of appliances - each 3 months of active treatment (including all adjustments 5001.12.2023and maintenance and removal of the appliances) after the first for a maximum 5001.12.2023of a further 33 months 1075045 26.05.2002 7 C1 SNAO NYNNY 2001.12.202303077.0001223.5000000.00 5001.12.2023PERMANENT DENTITION TREATMENT2 ARCH (mandibular and maxillary) TREATMENT 5001.12.2023(correction and alignment) using fixed appliances, including supply of 5001.12.2023appliances - initial 3 months of active treatment 1075048 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300789.0000313.7500000.00 5001.12.2023PERMANENT DENTITION TREATMENT - 2 ARCH (mandibular and maxillary) TREATMENT 5001.12.2023(correction and alignment) using fixed appliances, including supply of 5001.12.2023appliances - each subsequent 3 months of active treatment (including all 5001.12.2023adjustments and maintenance, and removal of the appliances) after the first 5001.12.2023for a maximum of a further 33 months 1075049 26.05.2002 7 C1 SNAO NYNNY 2001.12.202300924.0000367.2500000.00 5001.12.2023RETENTION, FIXED OR REMOVABLE, single arch (mandibular or maxillary) - supply 5001.12.2023of retainer and supervision of retention 1075050 26.05.2002 7 C1 SNAO NYNNY 2001.12.202301783.0000708.9000000.00 5001.12.2023RETENTION, FIXED OR REMOVABLE, 2-arch (mandibular and maxillary) - supply of 5001.12.2023retainers and supervision of retention 1075051 26.05.2002 7 C1 SNAO NYNNY 2001.12.202302737.0001088.2000000.00 5001.12.2023JAW GROWTH GUIDANCE JAW GROWTH guidance using removable or functional 5001.12.2023appliances, including supply of appliances and all adjustments to appliances 1075150 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300237.0000094.1000000.00 5001.12.2023Note:(i) In this Group, benefit is only payable where the service has been 5001.12.2023rendered to a patient who has been referred by an eligibleorthodontist. 5001.12.2023(ii)While benefit is payable for simple extractions performed by a registered 5001.12.2023dental practitioner, benefit is only payable for surgical extractions and 5001.12.2023other surgical procedures where the service is rendered by amedical 5001.12.2023practitioner who is a specialist in the practice of his or her speciality of 5001.12.2023oral and maxillofacial surgery. CONSULTATIONS INITIAL PROFESSIONAL attendance 5001.12.2023in a single course of treatment by an eligible oral and maxillofacial surgeon 5001.12.2023where the patient is referred to the surgeon by an eligible orthodontist (AOS) 1075153 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300119.0000047.3500000.00 5001.12.2023PROFESSIONAL ATTENDANCE by an eligible oral and maxillofacial surgeon 5001.12.2023subsequent to the first professional attendance by the surgeon in a single 5001.12.2023course of treatment where the patient is referred to the surgeon by an 5001.12.2023eligible orthodontist 1075156 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300211.0000083.8500000.00 5001.12.2023PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a 5001.12.2023service to which item 75153 applies) prior to provision of a service: (a)to 5001.12.2023which item 52321, 53212 or 75618 applies; or (b)to which an item in the series 5001.12.202352330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 applies; in a 5001.12.2023single course of treatment if the patient is referred by an eligible 5001.12.2023orthodontist (AOS) 1075200 26.05.2002 7 C2 SNAD NYNNY 2001.12.202300152.0000060.4500000.00 5001.12.2023SIMPLE EXTRACTIONS Removal of tooth or tooth fragment (other than treatment to 5001.12.2023which item 75400, 75403, 75406, 75409, 75412 or 75415 applies), if the patient 5001.12.2023is referred by an eligible orthodontist (AD) 1075203 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300228.0000090.7000000.00 5001.12.2023REMOVAL OF TOOTH OR TOOTH FRAGMENT under general anaesthesia, if the patient 5001.12.2023is referred by an eligible orthodontist (AD) 1075206 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300076.0000030.1000000.00 5001.12.2023Removal of each additional tooth or tooth fragment at the same attendance at 5001.12.2023which a service to which item 75200 or 75203 applies is rendered, if the 5001.12.2023patient is referred by an eligible orthodontist (AD) 1075400 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300456.0000181.3500000.00 5001.12.2023SURGICAL EXTRACTIONS Surgical removal of erupted tooth, if the patient is 5001.12.2023referred by an eligible orthodontist (AOS) 1075403 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300524.0000208.3500000.00 5001.12.2023Surgical removal of tooth with soft tissue impaction, if the patient is 5001.12.2023referred by an eligible orthodontist (AOS) 1075406 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300597.0000237.4000000.00 5001.12.2023Surgical removal of tooth with partial bone impaction, if the patient is 5001.12.2023referred by an eligible orthodontist (AOS) 1075409 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300676.0000268.8000000.00 5001.12.2023Surgical removal of tooth with complete bone impaction, if the patient is 5001.12.2023referred by an eligible orthodontist (AOS) 1075412 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300378.0000150.1500000.00 5001.12.2023Surgical removal of tooth fragment requiring incision of soft tissue only, if 5001.12.2023the patient is referred by an eligible orthodontist (AOS) 1075415 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300456.0000181.3500000.00 5001.12.2023Surgical removal of tooth fragment requiring removal of bone, if the patient 5001.12.2023is referred by an eligible orthodontist (AOS) 1075600 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300642.0000255.4000000.00 5001.12.2023OTHER SURGICAL PROCEDURES Surgical exposure, stimulation and packing of 5001.12.2023unerupted tooth, if the patient is referred by an eligible orthodontist (AOS) 1075603 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300755.0000300.2500000.00 5001.12.2023Surgical exposure of unerupted tooth for the purpose of fitting a traction 5001.12.2023device, if the patient is referred by an eligible orthodontist (AOS) 1075606 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300755.0000300.2500000.00 5001.12.2023Surgical repositioning of unerupted tooth, if the patient is referred by an 5001.12.2023eligible orthodontist (AOS) 1075609 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202301127.0000448.2000000.00 5001.12.2023Transplantation of tooth bud, if the patient is referred by an eligible 5001.12.2023orthodontist (AOS) 1075612 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202301395.0000554.6500000.00 5001.12.2023Surgical procedure for intra oral implantation of osseointegrated fixture 5001.12.2023(first stage), if the patient is referred by an eligible orthodontist (AOS) 1075615 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300516.0000205.3000000.00 5001.12.2023Surgical procedure for fixation of trans mucosal abutment (second stage of 5001.12.2023osseointegrated implant), if the patient is referred by an eligible 5001.12.2023orthodontist (AOS) 1075618 26.05.2002 7 C2 SNAOSNYNNY 2001.12.202300641.0000254.9000000.00 5001.12.2023Provision and fitting of a bite rising appliance or dental splint for the 5001.12.2023management of temporomandibular joint dysfunction syndrome, if the patient is 5001.12.2023referred by an eligible orthodontist (AOS) 1075621 26.05.2002 7 C2 SN NYNYY 2001.12.202300641.0000254.9000000.00 5001.12.2023The provision and fitting of surgical template in conjunction with 5001.12.2023orthognathic surgical procedures in association with: (a) an item in the 5001.12.2023series: (i) 46150 to 46161; or (ii) 52342 to 52375; or (b) item 52380 or 5001.12.202352382; if the patient is referred by an eligible orthodontist (AOS) 1075800 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300228.0000090.7000000.00 5001.12.2023Note:Benefit is payable for services listed in this Group where they are 5001.12.2023rendered by a registered dental practitioner CONSULTATIONS ATTENDANCE BY AN 5001.12.2023ELIGIBLE DENTAL PRACTITIONER involving consultation, preventive treatment and 5001.12.2023prophylaxis, of not less than 30 minutes' durationeach attendance to a maximum 5001.12.2023of 3 attendances in any period of 12 months 1075803 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300913.0000363.0000000.00 5001.12.2023PROSTHODONTIC PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including 5001.12.2023retainers1 TOOTH 1075806 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301071.0000425.7000000.00 5001.12.2023PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 2 5001.12.2023TEETH 1075809 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301268.0000504.1000000.00 5001.12.2023PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE. including retainers 3 5001.12.2023TEETH 1075812 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301409.0000560.0500000.00 5001.12.2023PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 4 5001.12.2023TEETH 1075815 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301719.0000683.4500000.00 5001.12.2023PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 5 5001.12.2023TO 9 TEETH 1075818 26.05.2002 7 C3 SNAD NYNNY 2001.12.202302028.0000806.4500000.00 5001.12.2023PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 10 5001.12.2023TO 12 TEETH 1075821 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301634.0000649.6500000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers 1 TOOTH 1075824 26.05.2002 7 C3 SNAD NYNNY 2001.12.202301888.0000750.5000000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers2 TEETH 1075827 26.05.2002 7 C3 SNAD NYNNY 2001.12.202302170.0000862.7000000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers 3 TEETH 1075830 26.05.2002 7 C3 SNAD NYNNY 2001.12.202302395.0000952.3000000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers 4 TEETH 1075833 26.05.2002 7 C3 SNAD NYNNY 2001.12.202302930.0001164.9500000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers 5 TO 9 TEETH 1075836 26.05.2002 7 C3 SNAD NYNNY 2001.12.202303353.0001333.0500000.00 5001.12.2023PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL 5001.12.2023DENTURE including casting and retainers 10 TO 12 TEETH 1075839 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300076.0000030.1000000.00 5001.12.2023PROVISION AND FITTING OF RETAINERS not being a service associated with a 5001.12.2023service to which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 5001.12.202375827, 75830, 75833 or 75836 applieseach retainer 1075842 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300113.0000044.8500000.00 5001.12.2023ADJUSTMENT OF PARTIAL DENTURE not being a service associated with a service to 5001.12.2023which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 75827, 5001.12.202375830, 75833 or 75836 applies 1075845 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300564.0000224.1500000.00 5001.12.2023RELINING OF PARTIAL DENTURE by laboratory process and associated fitting 1075848 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300676.0000268.8000000.00 5001.12.2023REMODELLING AND FITTING OF PARTIAL DENTURE of more than 4 teeth 1075851 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300338.0000134.4500000.00 5001.12.2023REPAIR TO CAST METAL BASE OF PARTIAL DENTURE1 or more points 1075854 26.05.2002 7 C3 SNAD NYNNY 2001.12.202300338.0000134.4500000.00 5001.12.2023ADDITION OF A TOOTH OR TEETH to a partial denture to replace extracted tooth 5001.12.2023or teeth including taking of necessary impression 1075855 01.01.2022 8 M1 1 SN NYNYY 2001.12.202300037.0000013.0000000.00 5001.12.2023A medical service to which an item in this Schedule (other than this item) 5001.12.2023applies, if:(a) the service is an unreferred service; and(b) the service is 5001.12.2023provided to a person who is:(i) under the age of 16; or(ii) a concessional 5001.12.2023beneficiary; and(c) the person is not an admitted patient of a hospital; 5001.12.2023and(d) the service is bulk-billed in relation to the fees for:(i) this item; 5001.12.2023and(ii) any other item in this Schedule applying to the service; and(e) the 5001.12.2023service is provided at, or from, a practice location in:(i) a Modified Monash 5001.12.20233 area; or(ii) a Modified Monash 4 area;other than a service associated with a 5001.12.2023service:(f) to which another item in this Group applies; or(g) that is a 5001.12.2023general practice support service; or(h) that is a MyMedicare service 1075856 01.01.2022 8 M1 1 SN NYNYY 2001.12.202300039.0000013.8500000.00 5001.12.2023A medical service to which an item in this Schedule (other than this item) 5001.12.2023applies, if:(a) the service is an unreferred service; and(b) the service is 5001.12.2023provided to a person who is:(i) under the age of 16; or(ii) a concessional 5001.12.2023beneficiary; and(c) the person is not an admitted patient of a hospital; 5001.12.2023and(d) the service is bulk-billed in relation to the fees for:(i) this item; 5001.12.2023and(ii) any other item in this Schedule applying to the service; and(e) the 5001.12.2023service is provided at, or from, a practice location in a Modified Monash 5 5001.12.2023area;other than a service associated with a service:(f) to which another item 5001.12.2023in this Group applies; or(g) that is a general practice support service; or(h) 5001.12.2023that is a MyMedicare service 1075857 01.01.2022 8 M1 1 SN NYNYN 2001.12.202300039.0000014.6000000.00 5001.12.2023A medical service to which an item in this Schedule (other than this item) 5001.12.2023applies, if:(a) the service is an unreferred service; and(b) the service is 5001.12.2023provided to a person who is:(i) under the age of 16; or(ii) a concessional 5001.12.2023beneficiary; and(c) the person is not an admitted patient of a hospital; 5001.12.2023and(d) the service is bulk-billed in relation to the fees for:(i) this item; 5001.12.2023and(ii) any other item in this Schedule applying to the service; and(e) the 5001.12.2023service is provided at, or from, a practice location in a Modified Monash 6 5001.12.2023area;other than a service associated with a service:(f) to which another item 5001.12.2023in this Group applies; or(g) that is a general practice support service; or(h) 5001.12.2023that is a MyMedicare service 1075858 01.01.2022 8 M1 1 SN NYNYY 2001.12.202300044.0000015.5500000.00 5001.12.2023A medical service to which an item in this Schedule (other than this item) 5001.12.2023applies, if:(a) the service is an unreferred service; and(b) the service is 5001.12.2023provided to a person who is:(i) under the age of 16; or(ii) a concessional 5001.12.2023beneficiary; and(c) the person is not an admitted patient of a hospital; 5001.12.2023and(d) the service is bulk-billed in relation to the fees for:(i) this item; 5001.12.2023and(ii) any other item in this Schedule applying to the service; and(e) the 5001.12.2023service is provided at, or from, a practice location in a Modified Monash 7 5001.12.2023area;other than a service associated with a service:(f) to which another item 5001.12.2023in this Group applies; or(g) that is a general practice support service; or(h) 5001.12.2023that is a MyMedicare service 1075861 01.01.2022 6 P12 SN NYNNY 2001.12.202300027.0000012.2000000.00 5001.12.2023A pathology service to which an item in this table (other than this item or 5001.12.2023item 74990, 74991, 75862, 75863 or 75864) applies if: (a)the service is an 5001.12.2023unreferred service; and (b)the service is rendered to a person who is under 5001.12.2023the age of 16 or is a concessional beneficiary; and (c)the person is not an 5001.12.2023admitted patient of a hospital; and (d)the service is bulk-billed in respect 5001.12.2023of the fees for: (i)this item; and (ii) the other item in this Schedule 5001.12.2023applying to the service; and (e) the service is rendered at, or from, a 5001.12.2023practice location in: (i) a Modified Monash 3 area; or (ii) a Modified Monash 5001.12.20234 area 1075862 01.01.2022 6 P12 SN NYNNY 2001.12.202300029.0000012.9500000.00 5001.12.2023A pathology service to which an item in this Schedule (other than this item or 5001.12.2023item 74990, 74991, 75861, 75863, or 75864) applies if: (a)the service is an 5001.12.2023unreferred service; and (b)the service is rendered to a person who is under 5001.12.2023the age of 16 or is a concessional beneficiary; and (c)the person is not an 5001.12.2023admitted patient of a hospital; and (d)the service is bulk-billed in relation 5001.12.2023to the fees for: (i)this item; and (ii)the other item in this Schedule 5001.12.2023applying to the service; and (e)the service is rendered at, or from, a 5001.12.2023practice location in a Modified Monash 5 area 1075863 01.01.2022 6 P12 SN NYNNN 2001.12.202300029.0000013.7500000.00 5001.12.2023A pathology service to which an item in this Schedule (other than this item or 5001.12.2023item 74990, 74991, 75861, 75862 or 75864) applies if: (a)the service is an 5001.12.2023unreferred service; and (b)the service is rendered to a person who is under 5001.12.2023the age of 16 or is a concessional beneficiary; and (c)the person is not an 5001.12.2023admitted patient of a hospital; and (d)the service is bulk-billed in respect 5001.12.2023of the fees for: (i)this item; and (ii) the other item in this Schedule 5001.12.2023applying to the service; and (e)the service is rendered at, or from, a 5001.12.2023practice location in a Modified Monash 6 area 1075864 01.01.2022 6 P12 SN NYNNN 2001.12.202300032.0000015.0500000.00 5001.12.2023A pathology service to which an item in this Schedule (other than this item or 5001.12.2023item 74990, 74991, 75861, 75862 or 75863) applies if: (a)the service is an 5001.12.2023unreferred service; and (b)the service is rendered to a person who is under 5001.12.2023the age of 16 or is a concessional beneficiary; and (c)the person is not an 5001.12.2023admitted patient of a hospital; and (d)the service is bulk-billed in relation 5001.12.2023to the fees for: (i) this item; and (ii) the other item in this Schedule 5001.12.2023applying to the service; and (e) the service is rendered at, or from, a 5001.12.2023practice location in a Modified Monash 7 area 1075870 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300068.0000024.2500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service;other than an attendance service associated with a service 5001.12.2023to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75871, 75872, 5001.12.202375873, 75874, 75875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies 5001.12.2023Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E 5001.12.2023general attendance items, and level B telehealth and telephone general 5001.12.2023attendance items. 1075871 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300104.0000036.9000000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service; and(d) the attendance service is provided at, or from, a 5001.12.2023practice location in a Modified Monash 2 area;other than an attendance service 5001.12.2023associated with a service to which item 10990, 10991, 10992, 75855, 75856, 5001.12.202375857, 75858, 75870, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 5001.12.202375883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with 5001.12.2023face to face level B, C, D and E general attendance items, and level B 5001.12.2023telehealth and telephone general attendance items. 1075872 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300104.0000036.9000000.00 5001.12.2023Professional attendance (the attendance service) if:(a) item 763, 766, 769, 5001.12.2023776, 788, 789, 2198, 2200, 5023, 5028, 5043, 5049, 5063, 5067, 5076, 5077, 5001.12.20235223, 5227, 5228, 5261, 5263, 5265, 5267 or 5262 applies; and(b) the 5001.12.2023attendance service is an unreferred service; and(c) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(d) the patient is not an admitted patient of a hospital; 5001.12.2023and(e) the attendance service is not provided in consulting rooms; and(f) the 5001.12.2023attendance service is provided in any of the following areas:(i) a Modified 5001.12.2023Monash 2 area;(ii) a Modified Monash 3 area;(iii) a Modified Monash 4 5001.12.2023area;(iv) a Modified Monash 5 area;(v) a Modified Monash 6 area;(vi) a 5001.12.2023Modified Monash 7 area; and(g) the attendance service is provided by, or on 5001.12.2023behalf of, a general practitioner, a medical practitioner or a prescribed 5001.12.2023medical practitioner whose practice location is not in an area mentioned in 5001.12.2023paragraph (f); and(h) the attendance service is bulk-billed in relation to the 5001.12.2023fees for:(i) this item; and(ii) an item mentioned in paragraph (a) that 5001.12.2023applies to the service 1075873 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300110.0000039.2000000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service; and(d) the attendance service is provided at, or from, a 5001.12.2023practice location in:(i) a Modified Monash 3 area; or(ii) a Modified Monash 4 5001.12.2023area;other than an attendance service associated with a service to which item 5001.12.202310990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75874, 5001.12.202375875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 5001.12.20232NOTE: this item can be claimed with face to face level B, C, D and E general 5001.12.2023attendance items, and level B telehealth and telephone general attendance 5001.12.2023items. 1075874 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300117.0000041.6500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service; and(d) the attendance service is provided at, or from, a 5001.12.2023practice location in a Modified Monash 5 area;other than an attendance service 5001.12.2023associated with a service which item 10990, 10991, 10992, 75855, 75856, 75857, 5001.12.202375858, 75870, 75871, 75872, 75873, 75875, 75876, 75880, 75881, 75882, 75883, 5001.12.202375884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to 5001.12.2023face level B, C, D and E general attendance items, and level B telehealth and 5001.12.2023telephone general attendance items. 1075875 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300124.0000043.9500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service; and(d) the attendance service is provided at, or from, a 5001.12.2023practice location in a Modified Monash 6 area;other than an attendance service 5001.12.2023associated with a service to which item 10990, 10991, 10992, 75855, 75856, 5001.12.202375857, 75858, 75870, 75871, 75872, 75873, 75874, 75876, 75880, 75881, 75882, 5001.12.202375883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with 5001.12.2023face to face level B, C, D and E general attendance items, and level B 5001.12.2023telehealth and telephone general attendance items. 1075876 01.11.2023 8 M1 2 SN YNNYN 2001.12.202300131.0000046.6500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a general 5001.12.2023practice support service is provided, if:(a) the attendance service is 5001.12.2023provided to a patient who is under the age of 16 or who is a concessional 5001.12.2023beneficiary; and(b) the patient is not an admitted patient of a hospital; 5001.12.2023and(c) the attendance service is bulk-billed in relation to the fees for:(i) 5001.12.2023this item; and(ii) the general practice support service item applying to the 5001.12.2023attendance service; and(d) the attendance service is provided at, or from, a 5001.12.2023practice location in a Modified Monash 7 area;other than an attendance service 5001.12.2023associated with a service to which item 10990, 10991, 10992, 75855, 75856, 5001.12.202375857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75880, 75881, 75882, 5001.12.202375883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with 5001.12.2023face to face level B, C, D and E general attendance items, and level B 5001.12.2023telehealth and telephone general attendance items. 1075880 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300068.0000024.2500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service;other than an attendance service associated 5001.12.2023with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 5001.12.202375870, 75871, 75872, 75873, 75874, 75875, 75876, 75881, 75882, 75883, 75884 or 5001.12.202375885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E 5001.12.2023telehealth general attendance items, and level C and D telephone general 5001.12.2023attendance items, where the patient is registered with MyMedicare. 1075881 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300104.0000036.9000000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service; and(d) the attendance service is provided 5001.12.2023at, or from, a practice location in a Modified Monash 2 area;other than an 5001.12.2023attendance service associated with a service to which item 10990, 10991, 5001.12.202310992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 5001.12.202375876, 75880, 75882, 75883, 75884 or 75885 applies Subgroup 3NOTE: this item 5001.12.2023can be claimed with level C, D, and E telehealth general attendance items, and 5001.12.2023level C and D telephone general attendance items, where the patient is 5001.12.2023registered with MyMedicare. 1075882 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300110.0000039.2000000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service; and(d) the attendance service is provided 5001.12.2023at, or from, a practice location in:(i) a Modified Monash 3 area; or(ii) a 5001.12.2023Modified Monash 4 area;other than an attendance service associated with a 5001.12.2023service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 5001.12.202375871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75883, 75884 or 75885 5001.12.2023applies Subgroup 3NOTE: this item can be claimed with level C, D, and E 5001.12.2023telehealth general attendance items, and level C and D telephone general 5001.12.2023attendance items, where the patient is registered with MyMedicare. 1075883 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300117.0000041.6500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service; and(d) the attendance service is provided 5001.12.2023at, or from, a practice location in a Modified Monash 5 area;other than an 5001.12.2023attendance service associated with a service to which item 10990, 10991, 5001.12.202310992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 5001.12.202375876, 75880, 75881, 75882, 75884 or 75885 applies Subgroup 3NOTE: this item 5001.12.2023can be claimed with level C, D, and E telehealth general attendance items, and 5001.12.2023level C and D telephone general attendance items, where the patient is 5001.12.2023registered with MyMedicare. 1075884 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300124.0000043.9500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service; and(d) the attendance service is provided 5001.12.2023at, or from, a practice location in a Modified Monash 6 area;other than an 5001.12.2023attendance service associated with a service to which item 10990, 10991, 5001.12.202310992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 5001.12.202375876, 75880, 75881, 75882, 75883 or 75885 applies Subgroup 3NOTE: this item 5001.12.2023can be claimed with level C, D, and E telehealth general attendance items, and 5001.12.2023level C and D telephone general attendance items, where the patient is 5001.12.2023registered with MyMedicare. 1075885 01.11.2023 8 M1 3 SN YNNYN 2001.12.202300131.0000046.6500000.00 5001.12.2023Professional attendance (the attendance service) by a general practitioner, a 5001.12.2023medical practitioner or a prescribed medical practitioner, at which a 5001.12.2023MyMedicare service is provided, if:(a) the attendance service is provided to a 5001.12.2023patient:(i) who is enrolled in MyMedicare at the general practice through 5001.12.2023which the attendance service is provided; and(ii) who is under the age of 16 5001.12.2023or who is a concessional beneficiary; and(b) the patient is not an admitted 5001.12.2023patient of a hospital; and(c) the attendance service is bulk-billed in 5001.12.2023relation to the fees for:(i) this item; and(ii) the MyMedicare service item 5001.12.2023applying to the attendance service; and(d) the attendance service is provided 5001.12.2023at, or from, a practice location in a Modified Monash 7 area;other than an 5001.12.2023attendance service associated with a service to which item 10990, 10991, 5001.12.202310992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 5001.12.202375876, 75880, 75881, 75882, 75883 or 75884 applies Subgroup 3NOTE: this item 5001.12.2023can be claimed with level C, D, and E telehealth general attendance items, and 5001.12.2023level C and D telephone general attendance items, where the patient is 5001.12.2023registered with MyMedicare. 1080002 01.03.2023 8 M6 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Psychological therapy health service provided in consulting rooms by an 5001.12.2023eligible clinical psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible clinical psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 30 minutes but less than 50 minutes 1080006 01.03.2023 8 M6 DN YYNYN 2001.12.202300386.0000137.2500000.00 5001.12.2023Psychological therapy health service provided at a place other than consulting 5001.12.2023rooms by an eligible clinical psychologist to a person other than the patient, 5001.12.2023if: (a) the service is part of the patients treatment; (b) the patient has 5001.12.2023been referred to the eligible clinical psychologist by a referring 5001.12.2023practitioner; and (c) the service lasts at least 30 minutes but less than 50 5001.12.2023minutes 1080012 01.03.2023 8 M6 DN YYNYN 2001.12.202300454.0000161.2000000.00 5001.12.2023Psychological therapy health service provided in consulting rooms by an 5001.12.2023eligible clinical psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible clinical psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 50 minutes 1080016 01.03.2023 8 M6 DN YYNYN 2001.12.202300531.0000188.6000000.00 5001.12.2023Psychological therapy health service provided at a place other than consulting 5001.12.2023rooms by an eligible clinical psychologist to a person other than the patient, 5001.12.2023if: (a) the service is part of the patients treatment; (b) the patient has 5001.12.2023been referred to the eligible clinical psychologist by a referring 5001.12.2023practitioner; and (c) the service lasts at least 50 minutes 1080022 01.11.2022 8 M6 DN NYNNY 2001.12.202300157.0000055.7500000.00 5001.12.2023Psychological therapy health service provided to a person as part of a group 5001.12.2023of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is 5001.12.2023referred for a course of treatment by: (i) a medical practitioner, either as 5001.12.2023part of a GP Mental Health Treatment Plan, or as part of a psychiatrist 5001.12.2023assessment and management plan; or (ii) a specialist or consultant physician 5001.12.2023specialising in the practice of his or her field of psychiatry; or (iii) a 5001.12.2023specialist or consultant physician specialising in the practice of his or her 5001.12.2023field of paediatrics; and (b) the service is provided in person; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the service is at least 90 minutes 5001.12.2023duration Further information on the requirements for this item are available 5001.12.2023in the explanatory notes to this Category. 1080023 01.11.2022 8 M6 DN NYNNY 2001.12.202300157.0000055.7500000.00 5001.12.2023Psychological therapy health service provided to a person as part of a group 5001.12.2023of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is 5001.12.2023referred by: (i) a medical practitioner, either as part of a GP Mental Health 5001.12.2023Treatment Plan, or as part of a psychiatrist assessment and management plan; 5001.12.2023or (ii) a specialist or consultant physician specialising in the practice of 5001.12.2023his or her field of psychiatry; or (iii) a specialist or consultant physician 5001.12.2023specialising in the practice of his or her field of paediatrics; and (b) the 5001.12.2023attendance is by video conference; and (c) the patient is not an admitted 5001.12.2023patient; and (d) the patient is located within a telehealth eligible area; and 5001.12.2023(e) the patient is, at the time of the attendance, at least 15 kilometres by 5001.12.2023road from the clinical psychologist; and (f) the service is at least 90 5001.12.2023minutes duration Further information on the requirements for this item are 5001.12.2023available in the explanatory notes to this Category. 1080024 01.11.2022 8 M6 DN NYNNY 2001.12.202300213.0000075.7500000.00 5001.12.2023Psychological therapy health service provided to a person as part of a group 5001.12.2023of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is 5001.12.2023referred for a course of treatment by: (i) a medical practitioner, either as 5001.12.2023part of a GP Mental Health Treatment Plan, or as part of a psychiatrist 5001.12.2023assessment and management plan; or (ii) a specialist or consultant physician 5001.12.2023specialising in the practice of his or her field of psychiatry; or (iii) a 5001.12.2023specialist or consultant physician specialising in the practice of his or her 5001.12.2023field of paediatrics; and (b) the service is provided in person; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the service is at least 120 5001.12.2023minutes duration Further information on the requirements for this item are 5001.12.2023available in the explanatory notes to this Category. 1080025 01.11.2022 8 M6 DN NYNNY 2001.12.202300213.0000075.7500000.00 5001.12.2023Psychological therapy health service provided to a person as part of a group 5001.12.2023of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is 5001.12.2023referred by: (i) a medical practitioner, either as part of a GP Mental Health 5001.12.2023Treatment Plan, or as part of a psychiatrist assessment and management plan; 5001.12.2023or (ii) a specialist or consultant physician specialising in the practice of 5001.12.2023his or her field of psychiatry; or (iii) a specialist or consultant physician 5001.12.2023specialising in the practice of his or her field of paediatrics; and (b) the 5001.12.2023attendance is by video conference; and (c) the patient is not an admitted 5001.12.2023patient; and (d) the patient is located within a telehealth eligible area; and 5001.12.2023(e) the patient is, at the time of the attendance, at least 15 kilometres by 5001.12.2023road from the clinical psychologist; and (f) the service is at least 120 5001.12.2023minutes duration Further information on the requirements for this item are 5001.12.2023available in the explanatory notes to this Category. 1080102 01.03.2023 8 M7 DN YYNYN 2001.12.202300219.0000077.8500000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible psychologist by a referring practitioner; and (c) the service 5001.12.2023lasts at least 20 minutes but less than 50 minutes 1080106 01.03.2023 8 M7 DN YYNYN 2001.12.202300298.0000105.8500000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible psychologist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible psychologist by a referring 5001.12.2023practitioner; and (c) the service lasts at least 20 minutes but less than 50 5001.12.2023minutes 1080112 01.03.2023 8 M7 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible psychologist by a referring practitioner; and (c) the service 5001.12.2023lasts at least 50 minutes 1080116 01.03.2023 8 M7 DN YYNYN 2001.12.202300388.0000137.9000000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible psychologist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible psychologist by a referring 5001.12.2023practitioner; and (c) the service lasts at least 50 minutes 1080122 01.11.2022 8 M7 DN NYNNY 2001.12.202300107.0000038.1500000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible psychologist if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 90 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080123 01.11.2022 8 M7 DN NYNNY 2001.12.202300107.0000038.1500000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 by an eligible psychologist if: (a) the person is 5001.12.2023referred by: (i) a medical practitioner, either as part of a GP Mental Health 5001.12.2023Treatment Plan, or as part of a psychiatrist assessment and management plan; 5001.12.2023or (ii) a specialist or consultant physician specialising in the practice of 5001.12.2023his or her field of psychiatry; or (iii) a specialist or consultant physician 5001.12.2023specialising in the practice of his or her field of paediatrics; and (b) the 5001.12.2023attendance is by video conference; and (c) the patient is not an admitted 5001.12.2023patient; and (d) the patient is located within a telehealth eligible area; and 5001.12.2023(e) the patient is, at the time of the attendance, at least 15 kilometres by 5001.12.2023road from the psychologist; and (f) the service is at least 90 minutes 5001.12.2023duration Further information on the requirements for this item are available 5001.12.2023in the explanatory notes to this Category. 1080127 01.11.2022 8 M7 DN NYNNY 2001.12.202300146.0000051.8500000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible psychologist if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 120 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080128 01.11.2022 8 M7 DN NYNNY 2001.12.202300146.0000051.8500000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible psychologist if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the attendance is by video conference; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the patient is located within a 5001.12.2023telehealth eligible area; and (e) the patient is, at the time of the 5001.12.2023attendance, at least 15 kilometres by road from the psychologist; and (f) the 5001.12.2023service is at least 120 minutes duration Further information on the 5001.12.2023requirements for this item are available in the explanatory notes to this 5001.12.2023Category. 1080129 01.03.2023 8 M7 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible occupational therapist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible occupational therapist by a referring practitioner; 5001.12.2023and (c) the service lasts at least 20 minutes but less than 50 minutes 1080131 01.03.2023 8 M7 DN YYNYN 2001.12.202300272.0000096.5500000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible occupational therapist to a person other 5001.12.2023than the patient, if: (a) the service is part of the patients treatment; (b) 5001.12.2023the patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 20 minutes but less 5001.12.2023than 50 minutes 1080137 01.03.2023 8 M7 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible occupational therapist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible occupational therapist by a referring practitioner; 5001.12.2023and (c) the service lasts at least 50 minutes 1080141 01.03.2023 8 M7 DN YYNYN 2001.12.202300351.0000124.7500000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible occupational therapist to a person other 5001.12.2023than the patient, if: (a) the service is part of the patients treatment; (b) 5001.12.2023the patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 50 minutes 1080147 01.11.2022 8 M7 DN NYNNY 2001.12.202300094.0000033.4000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible occupational therapist if: (a) 5001.12.2023the person is referred by: (i) a medical practitioner, either as part of a GP 5001.12.2023Mental Health Treatment Plan, or as part of a psychiatrist assessment and 5001.12.2023management plan; or (ii) a specialist or consultant physician specialising in 5001.12.2023the practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 90 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080148 01.11.2022 8 M7 DN NYNNY 2001.12.202300094.0000033.4000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible occupational therapist if: (a) 5001.12.2023the person is referred by: (i) a medical practitioner, either as part of a GP 5001.12.2023Mental Health Treatment Plan, or as part of a psychiatrist assessment and 5001.12.2023management plan; or (ii) a specialist or consultant physician specialising in 5001.12.2023the practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the attendance is by video conference; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the patient is located within a 5001.12.2023telehealth eligible area; and (e) the patient is, at the time of the 5001.12.2023attendance, at least 15 kilometres by road from the occupational therapist; 5001.12.2023and (f) the service is at least 90 minutes duration Further information on the 5001.12.2023requirements for this item are available in the explanatory notes to this 5001.12.2023Category. 1080152 01.11.2022 8 M7 DN NYNNY 2001.12.202300128.0000045.5000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible occupational therapist if: (a) 5001.12.2023the person is referred by: (i) a medical practitioner, either as part of a GP 5001.12.2023Mental Health Treatment Plan, or as part of a psychiatrist assessment and 5001.12.2023management plan; or (ii) a specialist or consultant physician specialising in 5001.12.2023the practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 120 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080153 01.11.2022 8 M7 DN NYNNY 2001.12.202300128.0000045.5000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible occupational therapist if: (a) 5001.12.2023the person is referred by: (i) a medical practitioner, either as part of a GP 5001.12.2023Mental Health Treatment Plan, or as part of a psychiatrist assessment and 5001.12.2023management plan; or (ii) a specialist or consultant physician specialising in 5001.12.2023the practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the attendance is by video conference; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the patient is located within a 5001.12.2023telehealth eligible area; and (e) the patient is, at the time of the 5001.12.2023attendance, at least 15 kilometres by road from the occupational therapist; 5001.12.2023and (f) the service is at least 120 minutes duration Further information on 5001.12.2023the requirements for this item are available in the explanatory notes to this 5001.12.2023Category. 1080154 01.03.2023 8 M7 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible social worker to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible social worker by a referring practitioner; and (c) the service 5001.12.2023lasts at least 20 minutes but less than 50 minutes 1080156 01.03.2023 8 M7 DN YYNYN 2001.12.202300272.0000096.5500000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible social worker to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible social worker by a referring 5001.12.2023practitioner; and (c) the service lasts at least 20 minutes but less than 50 5001.12.2023minutes 1080162 01.03.2023 8 M7 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Focussed psychological strategies health service provided in consulting rooms 5001.12.2023by an eligible social worker to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible social worker by a referring practitioner; and (c) the service 5001.12.2023lasts at least 50 minutes 1080166 01.03.2023 8 M7 DN YYNYN 2001.12.202300351.0000124.7500000.00 5001.12.2023Focussed psychological strategies health service provided at a place other 5001.12.2023than consulting rooms by an eligible social worker to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible social worker by a referring 5001.12.2023practitioner; and (c) the service lasts at least 50 minutes 1080172 01.11.2022 8 M7 DN NYNNY 2001.12.202300094.0000033.4000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible social worker if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 90 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080173 01.11.2022 8 M7 DN NYNNY 2001.12.202300094.0000033.4000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible social worker if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the attendance is by video conference; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the patient is located within a 5001.12.2023telehealth eligible area; and (e) the patient is, at the time of the 5001.12.2023attendance, at least 15 kilometres by road from the social worker; and (f) the 5001.12.2023service is at least 90 minutes duration Further information on the 5001.12.2023requirements for this item are available in the explanatory notes to this 5001.12.2023Category. 1080174 01.11.2022 8 M7 DN NYNNY 2001.12.202300128.0000045.5000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible social worker if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the service is provided in person; and (c) the patient is 5001.12.2023not an admitted patient; and (d) the service is at least 120 minutes duration 5001.12.2023Further information on the requirements for this item are available in the 5001.12.2023explanatory notes to this Category. 1080175 01.11.2022 8 M7 DN NYNNY 2001.12.202300128.0000045.5000000.00 5001.12.2023Focussed psychological strategies health service provided to a person as part 5001.12.2023of a group of 4 to 10 patients by an eligible social worker if: (a) the person 5001.12.2023is referred by: (i) a medical practitioner, either as part of a GP Mental 5001.12.2023Health Treatment Plan, or as part of a psychiatrist assessment and management 5001.12.2023plan; or (ii) a specialist or consultant physician specialising in the 5001.12.2023practice of his or her field of psychiatry; or (iii) a specialist or 5001.12.2023consultant physician specialising in the practice of his or her field of 5001.12.2023paediatrics; and (b) the attendance is by video conference; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the patient is located within a 5001.12.2023telehealth eligible area; and (e) the patient is, at the time of the 5001.12.2023attendance, at least 15 kilometres by road from the social worker; and (f) the 5001.12.2023service is at least 120 minutes duration Further information on the 5001.12.2023requirements for this item are available in the explanatory notes to this 5001.12.2023Category. 1080176 01.07.2023 8 M7 2 DN YYNYN 2001.12.202300151.0000053.7500000.00 5001.12.2023Attendance by an eligible allied health practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 15 minutes, but for less than 5001.12.202320 minutes 1080177 01.07.2023 8 M7 2 DN YYNYN 2001.12.202300259.0000092.2000000.00 5001.12.2023Attendance by an eligible allied health practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 20 minutes, but for less than 5001.12.202340 minutes 1080178 01.07.2023 8 M7 2 DN YYNYN 2001.12.202300432.0000153.4500000.00 5001.12.2023Attendance by an eligible allied health practitioner, as a member of a 5001.12.2023multidisciplinary case conference team, to participate in a mental health case 5001.12.2023conference if the conference lasts for at least 40 minutes 1082200 01.11.2010 8 M141 DN NYNNY 2001.12.202300020.0000010.5500000.00 5001.12.2023Professional attendance by a participating nurse practitioner for an obvious 5001.12.2023problem characterised by the straightforward nature of the task that requires 5001.12.2023a short patient history and, if required, limited examination and management. 1082205 01.11.2010 8 M141 DN NYNNY 2001.12.202300045.0000023.0500000.00 5001.12.2023Professional attendance by a participating nurse practitioner lasting less 5001.12.2023than 20 minutes and including any of the following: a)taking a history; 5001.12.2023b)undertaking clinical examination; c)arranging any necessary investigation; 5001.12.2023d)implementing a management plan; e)providing appropriate preventive health 5001.12.2023care, for 1 or more health related issues, with appropriate documentation. 1082210 01.11.2010 8 M141 DN NYNNY 2001.12.202300085.0000043.7000000.00 5001.12.2023Professional attendance by a participating nurse practitioner lasting at least 5001.12.202320 minutes and including any of the following: a)taking a detailed history; 5001.12.2023b)undertaking clinical examination; c)arranging any necessary investigation; 5001.12.2023d)implementing a management plan; e)providing appropriate preventive health 5001.12.2023care, for 1 or more health related issues, with appropriate documentation. 1082215 01.11.2010 8 M141 DN NYNNY 2001.12.202300125.0000064.5000000.00 5001.12.2023Professional attendance by a participating nurse practitioner lasting at least 5001.12.202340 minutes and including any of the following: a)taking an extensive history; 5001.12.2023b)undertaking clinical examination; c)arranging any necessary investigation; 5001.12.2023d)implementing a management plan; e)providing appropriate preventive health 5001.12.2023care, for 1 or more health related issues, with appropriate documentation. 1082300 01.11.2012 8 M15 DN NYNYY 2001.12.202300477.0000169.4500000.00 5001.12.2023Audiology health service, consisting of brain stem evoked response audiometry, 5001.12.2023performed on a patient by an eligible audiologist if: (a) the service is not 5001.12.2023for the purposes of programming either an auditory implant or the sound 5001.12.2023processors of an auditory implant; and (b) the service is performed pursuant 5001.12.2023to a written request made by a medical practitioner to assist in the 5001.12.2023diagnosis, treatment or management of ear disease or a related disorder in the 5001.12.2023patient; and (c) the service is not performed for the purpose of a hearing 5001.12.2023screening; and (d) the patient is not an admitted patient; and (e) the service 5001.12.2023is performed on the patient individually and in person; and (f) after the 5001.12.2023service, the eligible audiologist provides a copy of the results of the 5001.12.2023service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (g) a service to which item 11300 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1082301 01.03.2023 8 M15 SN YYNYN 2001.12.202300477.0000169.4500000.00 5001.12.2023Audiology health service, consisting of programming an auditory implant or the 5001.12.2023sound processor of an auditory implant, unilateral, performed on a patient by 5001.12.2023an eligible audiologist if: (a) the patient is not an admitted patient; and 5001.12.2023(b) the service is performed on the patient individually and in person; and 5001.12.2023(c) a service to which item 11302, 11342 or 11345 applies has not been 5001.12.2023performed on the patient on the same day Applicable up to a total of 4 5001.12.2023services to which this item, item 82302 or item 82304 applies on the same day 5001.12.2023This item is subject to section 9 1082302 01.03.2022 8 M15 DN NYNYY 2001.12.202300477.0000169.4500000.00 5001.12.2023Audiology health service by telehealth for programming of an auditory implant, 5001.12.2023or the sound processor of an auditory implant, unilateral, performed on a 5001.12.2023patient by an eligible audiologist if: (a) the service is not performed for 5001.12.2023the purpose of a hearing screening; and (b) a service to which item 11302, 5001.12.202311342 or 11345 applies not been performed on the patient on the same day 5001.12.2023Applicable up to a total of 4 services to which this item, item 82301 or item 5001.12.202382304 applies on the same day 1082304 01.03.2022 8 M15 DN NYNYY 2001.12.202300477.0000169.4500000.00 5001.12.2023Audiology health service by phone for programming of an auditory implant, or 5001.12.2023the sound processor of an auditory implant, unilateral, performed on a patient 5001.12.2023by an eligible audiologist if: (a) the service is not performed for the 5001.12.2023purpose of a hearing screening; and (b) a service to which item 11302, 11342 5001.12.2023or 11345 applies not been performed on the patient on the same day Applicable 5001.12.2023up to a total of 4 services to which this item, item 82301 or item 82302 5001.12.2023applies on the same day 1082306 01.11.2012 8 M15 DN NYNYY 2001.12.202300054.0000019.2500000.00 5001.12.2023Audiology health service, consisting of non-determinate audiometry performed 5001.12.2023on a patient by an eligible audiologist if: (a) the service is performed 5001.12.2023pursuant to a written request made by a medical practitioner to assist in the 5001.12.2023diagnosis, treatment or management of ear disease or a related disorder in the 5001.12.2023patient; and (b) the service is not performed for the purpose of a hearing 5001.12.2023screening; and (c) the patient is not an admitted patient; and (d) the service 5001.12.2023is performed on the patient individually and in person; and (e) after the 5001.12.2023service, the eligible audiologist provides a copy of the results of the 5001.12.2023service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (f) a service to which item 11306 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1082309 01.11.2012 8 M15 DN NYNYY 2001.12.202300065.0000023.1500000.00 5001.12.2023Audiology health service, consisting of an air conduction audiogram performed 5001.12.2023on a patient by an eligible audiologist if: (a) the service is performed 5001.12.2023pursuant to a written request made by a medical practitioner to assist in the 5001.12.2023diagnosis, treatment or management of ear disease or a related disorder in the 5001.12.2023patient; and (b) the service is not performed for the purpose of a hearing 5001.12.2023screening; and (c) the patient is not an admitted patient; and (d) the service 5001.12.2023is performed on the patient individually and in person; and (e) after the 5001.12.2023service, the eligible audiologist provides a copy of the results of the 5001.12.2023service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (f) a service to which item 11309 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1082312 01.11.2012 8 M15 DN NYNYY 2001.12.202300092.0000032.7500000.00 5001.12.2023Audiology health service, consisting of an air and bone conduction audiogram 5001.12.2023or air conduction and speech discrimination audiogram performed on a patient 5001.12.2023by an eligible audiologist if: (a) the service is performed pursuant to a 5001.12.2023written request made by a medical practitioner to assist in the diagnosis, 5001.12.2023treatment or management of ear disease or a related disorder in the patient; 5001.12.2023and (b) the service is not performed for the purpose of a hearing screening; 5001.12.2023and (c) the patient is not an admitted patient; and (d) the service is 5001.12.2023performed on the patient individually and in person; and (e) after the 5001.12.2023service, the eligible audiologist provides a copy of the results of the 5001.12.2023service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (f) a service to which item 11312 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1082315 01.11.2012 8 M15 DN NYNYY 2001.12.202300122.0000043.3000000.00 5001.12.2023Audiology health service, consisting of an air and bone conduction and speech 5001.12.2023discrimination audiogram performed on a patient by an eligible audiologist if: 5001.12.2023(a) the service is performed pursuant to a written request made by a medical 5001.12.2023practitioner to assist in the diagnosis, treatment or management of ear 5001.12.2023disease or a related disorder in the patient; and (b) the service is not 5001.12.2023performed for the purpose of a hearing screening; and (c) the patient is not 5001.12.2023an admitted patient; and (d) the service is performed on the patient 5001.12.2023individually and in person; and (e) after the service, the eligible 5001.12.2023audiologist provides a copy of the results of the service performed, together 5001.12.2023with relevant comments in writing that the eligible audiologist has on those 5001.12.2023results, to the medical practitioner who requested the service; and (f) a 5001.12.2023service to which item 11315 applies has not been performed on the patient on 5001.12.2023the same day This item is subject to sections 9 and 12 1082318 01.11.2012 8 M15 DN NYNYY 2001.12.202300151.0000053.5000000.00 5001.12.2023Audiology health service, consisting of an air and bone conduction and speech 5001.12.2023discrimination audiogram with other cochlear tests performed on a patient by 5001.12.2023an eligible audiologist if: (a) the service is performed pursuant to a written 5001.12.2023request made by a medical practitioner to assist in the diagnosis, treatment 5001.12.2023or management of ear disease or a related disorder in the patient; and (b) the 5001.12.2023service is not performed for the purpose of a hearing screening; and (c) the 5001.12.2023patient is not an admitted patient; and (d) the service is performed on the 5001.12.2023patient individually and in person; and (e) after the service, the eligible 5001.12.2023audiologist provides a copy of the results of the service performed, together 5001.12.2023with relevant comments in writing that the eligible audiologist has on those 5001.12.2023results, to the medical practitioner who requested the service; and (f) a 5001.12.2023service to which item 11318 applies has not been performed on the patient on 5001.12.2023the same day This item is subject to sections 9 and 12 1082324 01.11.2012 8 M15 DN NYNYN 2001.12.202300077.0000017.6000000.00 5001.12.2023Audiology health service, consisting of an impedance audiogram involving 5001.12.2023tympanometry and measurement of static compliance and acoustic reflex 5001.12.2023performed on a patient by an eligible audiologist if: (a) the service is 5001.12.2023performed pursuant to a written request made by a medical practitioner to 5001.12.2023assist in the diagnosis, treatment or management of ear disease or a related 5001.12.2023disorder in the patient; and (b) the service is not performed for the purpose 5001.12.2023of a hearing screening; and (c) the patient is not an admitted patient; and 5001.12.2023(d) the service is performed on the patient individually and in person; and 5001.12.2023(e) after the service, the eligible audiologist provides a copy of the results 5001.12.2023of the service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (f) a service to which item 11324 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1082332 01.11.2012 8 M15 DN NYNYY 2001.12.202300145.0000051.6000000.00 5001.12.2023Audiology health service, consisting of an oto-acoustic emission audiometry 5001.12.2023for the detection of outer hair cell functioning in the cochlear, performed by 5001.12.2023an eligible audiologist, when middle ear pathology has been excluded, if: (a) 5001.12.2023the service is performed pursuant to a written request made by a medical 5001.12.2023practitioner to assist in the diagnosis, treatment or management of ear 5001.12.2023disease or a related disorder in the patient; and (b) the service is 5001.12.2023performed: (i) on an infant or child who is at risk of permanent hearing 5001.12.2023impairment; or (ii) on a patient who is at risk of oto-toxicity due to 5001.12.2023medications or medical intervention; or (iii) on a patient at risk of noise 5001.12.2023induced hearing loss; or (iv) to assist in the diagnosis of auditory 5001.12.2023neuropathy; and (c) the patient is not an admitted patient; and (d) the 5001.12.2023service is performed on the patient individually and in person; and (e) after 5001.12.2023the service, the eligible audiologist provides a copy of the results of the 5001.12.2023service performed, together with relevant comments in writing that the 5001.12.2023eligible audiologist has on those results, to the medical practitioner who 5001.12.2023requested the service; and (f) a service to which item 11332 applies has not 5001.12.2023been performed on the patient on the same day This item is subject to sections 5001.12.20239 and 12 1090001 01.03.201901.12.20221 A351 SN NYNYY 2001.12.202300117.0000060.5500000.00 5001.12.2023For the first patient attended during one attendance by a general practitioner 5001.12.2023at one residential aged care facility on one occasion, the fee for the medical 5001.12.2023service described in whichever of items 90020, 90035, 90043, 90051 or 90054 5001.12.2023applies is the amount listed in the item plus $60.55. 1090002 01.03.201901.12.20221 A351 SN NYNYY 2001.12.202300085.0000043.9500000.00 5001.12.2023For the first patient attended during one attendance by a medical practitioner 5001.12.2023at one residential aged care facility on one occasion, the fee for the medical 5001.12.2023service described in whichever of items 90092, 90093, 90095, 90096, 90098, 5001.12.202390183, 90188, 90202, 90212 or 90215 applies is the amount listed in the item 5001.12.2023plus $43.95. 1090005 14.06.202101.12.20221 A351 DN NYNYY 2001.12.202300280.0000144.7000000.00 5001.12.2023A flag fall service to which item 93644, 93645, 93646, 93647, 93653, 93654, 5001.12.202393655, 93656, 93660 or 93661 applies. For the first patient attended during 5001.12.2023one attendance by a general practitioner or by a medical practitioner (other 5001.12.2023than a general practitioner) at: (a) one residential aged care facility, or at 5001.12.2023consulting rooms situated within such a complex, on one occasion; or(b) one 5001.12.2023residential disability setting facility, or at consulting rooms situated 5001.12.2023within such a complex, on one occasion; or (c) a persons place of residence 5001.12.2023(other than a residential aged care facility) on one occasion. 1090020 01.03.201901.12.20221 A352 SN NYNNY 2001.12.202300037.0000018.9500000.00 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023selfcontained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex if the patient is accommodated in a residential aged 5001.12.2023care facility (other than accommodation in a selfcontained unit) by a general 5001.12.2023practitioner for an obvious problem characterised by the straightforward 5001.12.2023nature of the task that requires a short patient history and, if required, 5001.12.2023limited examination and managementan attendance on one or more patients at one 5001.12.2023residential aged care facility on one occasion - each patient. 1090035 01.03.201901.12.20221 A352 SN NYNYY 2001.12.202300080.0000041.4000000.00 5001.12.2023Professional attendance by a general practitioner, on care recipients in a 5001.12.2023residential aged care facility, other than a service to which another item 5001.12.2023applies, lasting at least 6 minutes and less than 20 minutes and including any 5001.12.2023of the following that are clinically relevant:(a) taking a patient history;(b) 5001.12.2023performing a clinical examination;(c) arranging any necessary 5001.12.2023investigation;(d) implementing a management plan;(e) providing appropriate 5001.12.2023preventive health care;for one or more health-related issues, with appropriate 5001.12.2023documentationan attendance on one or more patients at one residential aged 5001.12.2023care facility on one occasioneach patient (subject to clause 2.30.1) 1090043 01.03.201901.12.20221 A352 SN NYNNY 2001.12.202300155.0000080.1000000.00 5001.12.2023Professional attendance by a general practitioner at a residential aged care 5001.12.2023facility to residents of the facility (other than a service to which another 5001.12.2023item in the table applies), lasting at least 20 minutes and including any of 5001.12.2023the following that are clinically relevant: (a) taking a detailed patient 5001.12.2023history; (b) performing a clinical examination; (c) arranging any necessary 5001.12.2023investigation; (d) implementing a management plan; (e) providing appropriate 5001.12.2023preventive health care; for one or more healthrelated issues, with appropriate 5001.12.2023documentationan attendance on one or more patients at one residential aged 5001.12.2023care facility on one occasioneach patient 1090051 01.03.201901.12.20221 A352 SN NYNNY 2001.12.202300229.0000118.0000000.00 5001.12.2023Professional attendance by a general practitioner at a residential aged care 5001.12.2023facility to residents of the facility (other than a service to which another 5001.12.2023item in the table applies), lasting at least 40 minutes and including any of 5001.12.2023the following that are clinically relevant: (a) taking an extensive patient 5001.12.2023history; (b) performing a clinical examination; (c) arranging any necessary 5001.12.2023investigation; (d) implementing a management plan; (e) providing appropriate 5001.12.2023preventive health care; for one or more healthrelated issues, with appropriate 5001.12.2023documentationan attendance on one or more patients at one residential aged 5001.12.2023care facility on one occasioneach patient 1090092 01.03.201901.12.20221 A353 SN NNNNN 2001.12.202300016.0000008.5000000.00 5001.12.2023Professional attendance (other than a service to which any other item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023selfcontained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex where the patient is accommodated in the residential 5001.12.2023aged care facility (that is not accommodation in a selfcontained unit) of not 5001.12.2023more than 5 minutes in durationan attendance on one or more patients at one 5001.12.2023residential aged care facility on one occasioneach patient, by a medical 5001.12.2023practitioner who is not a general practitioner. 1090093 01.03.201901.12.20221 A353 DN NNNNN 2001.12.202300031.0000016.0000000.00 5001.12.2023Professional attendance (other than a service to which any other item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023selfcontained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex where the patient is accommodated in the residential 5001.12.2023aged care facility (that is not accommodation in a selfcontained unit) of more 5001.12.2023than 5 minutes in duration but not more than 25 minutesan attendance on one or 5001.12.2023more patients at one residential aged care facility on one occasioneach 5001.12.2023patient, by a medical practitioner who is not a general practitioner. 1090095 01.03.201901.12.20221 A353 SN NNNNN 2001.12.202300069.0000035.5000000.00 5001.12.2023Professional attendance (other than a service to which any other item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023selfcontained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex where the patient is accommodated in the residential 5001.12.2023aged care facility (that is not accommodation in a selfcontained unit) of more 5001.12.2023than 25 minutes in duration but not more than 45 minutesan attendance on one 5001.12.2023or more patients at one residential aged care facility on one occasioneach 5001.12.2023patient, by a medical practitioner who is not a general practitioner. 1090096 01.03.201901.12.20221 A353 SN NYNYN 2001.12.202300111.0000057.5000000.00 5001.12.2023Professional attendance (other than a service to which any other item applies) 5001.12.2023at a residential agedcare facility (other than a professional attendance at a 5001.12.2023self-contained unit) or professional attendance at consulting rooms situated 5001.12.2023within such a complex, if the patient is a care recipient in the facility who 5001.12.2023is not a resident of a self-contained unit, lasting more than 45 minutes, but 5001.12.2023less than 60 minutesan attendance on one or more patients at one residential 5001.12.2023aged care facility on one occasioneach patient (subject to clause 2.30.1), by 5001.12.2023a medical practitioner who is not a general practitioner 1090183 01.03.201901.12.20221 A354 SN NYNYY 2001.12.202300029.0000015.1500000.00 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self contained unit) or professional attendance at consulting rooms within 5001.12.2023such a complex, if the patient is a care recipient in the facility who is not 5001.12.2023a resident of a self contained unit, lasting not more than 5 minutesan 5001.12.2023attendance on one or more patients at one residential aged care facility on 5001.12.2023one occasion by a prescribed medical practitioner in an eligible areaeach 5001.12.2023patient (subject to subclause 2.30.1(2)) 1090188 01.03.201901.12.20221 A354 SN NYNYY 2001.12.202300064.0000033.1000000.00 5001.12.2023Professional attendance (other than a service to which another item applies) 5001.12.2023at a residential aged care facility (other than a professional attendance at a 5001.12.2023self contained unit) or professional attendance at consulting rooms within 5001.12.2023such a complex, if the patient is a care recipient in the facility who is not 5001.12.2023a resident of a self contained unit, lasting more than 5 minutes but not more 5001.12.2023than 25 minutesan attendance on one or more patients at one residential aged 5001.12.2023care facility on one occasion by a prescribed medical practitioner in an 5001.12.2023eligible areaeach patient (subject to subclause 2.30.1(2)) 1091168 01.03.2023 8 M181 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Telehealth attendance for a psychological therapy health service provided by 5001.12.2023an eligible clinical psychologist to a person other than the patient, if: (a) 5001.12.2023the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible clinical psychologist by a referring practitioner; 5001.12.2023and (c) the service lasts at least 30 minutes but less than 50 minutes 1091171 01.03.2023 8 M181 DN YYNYN 2001.12.202300454.0000161.2000000.00 5001.12.2023Telehealth attendance for a psychological therapy health service provided by 5001.12.2023an eligible clinical psychologist to a person other than the patient, if: (a) 5001.12.2023the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible clinical psychologist by a referring practitioner; 5001.12.2023and (c) the service lasts at least 50 minutes 1091174 01.03.2023 8 M182 DN YYNYN 2001.12.202300219.0000077.8500000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible psychologist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 20 minutes but less than 50 minutes 1091177 01.03.2023 8 M182 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible psychologist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 50 minutes 1091194 01.03.2023 8 M183 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible occupational therapist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 20 minutes but less 5001.12.2023than 50 minutes 1091195 01.03.2023 8 M183 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible occupational therapist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 50 minutes 1091196 01.03.2023 8 M184 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible social worker to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible social worker by a referring practitioner and (c) the 5001.12.2023service lasts at least 20 minutes but less than 50 minutes 1091197 01.03.2023 8 M184 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Telehealth attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible social worker to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible social worker by a referring practitioner; and (c) 5001.12.2023the service lasts at least 50 minutes 1091198 01.03.2023 8 M186 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Phone attendance for a psychological therapy health service provided by an 5001.12.2023eligible clinical psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible clinical psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 30 minutes but less than 50 minutes 1091199 01.03.2023 8 M186 DN YYNYN 2001.12.202300454.0000161.2000000.00 5001.12.2023Phone attendance for a psychological therapy health service provided by an 5001.12.2023eligible clinical psychologist to a person other than the patient, if: (a) the 5001.12.2023service is part of the patients treatment; (b) the patient has been referred 5001.12.2023to the eligible clinical psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 50 minutes 1091200 01.03.2023 8 M187 DN YYNYN 2001.12.202300219.0000077.8500000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible psychologist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 20 minutes but less than 50 minutes 1091201 01.03.2023 8 M187 DN YYNYN 2001.12.202300309.0000109.8000000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible psychologist to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible psychologist by a referring practitioner; and (c) the 5001.12.2023service lasts at least 50 minutes 1091202 01.03.2023 8 M188 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible occupational therapist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 20 minutes but less 5001.12.2023than 50 minutes 1091203 01.03.2023 8 M188 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible occupational therapist to a person other than the 5001.12.2023patient, if: (a) the service is part of the patients treatment; (b) the 5001.12.2023patient has been referred to the eligible occupational therapist by a 5001.12.2023referring practitioner; and (c) the service lasts at least 50 minutes 1091204 01.03.2023 8 M189 DN YYNYN 2001.12.202300193.0000068.5500000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible social worker to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible social worker by a referring practitioner; and (c) 5001.12.2023the service lasts at least 20 minutes but less than 50 minutes 1091205 01.03.2023 8 M189 DN YYNYN 2001.12.202300272.0000096.8000000.00 5001.12.2023Phone attendance for a focussed psychological strategies health service 5001.12.2023provided by an eligible social worker to a person other than the patient, if: 5001.12.2023(a) the service is part of the patients treatment; (b) the patient has been 5001.12.2023referred to the eligible social worker by a referring practitioner; and (c) 5001.12.2023the service lasts at least 50 minutes 1091790 13.03.2020 1 A401 DN NYNNY 2001.12.202300051.0000018.9500000.00 5001.12.2023Telehealth attendance by a general practitioner for an obvious problem 5001.12.2023characterised by the straightforward nature of the task that requires a short 5001.12.2023patient history and, if required, limited management. NOTE: It is a 5001.12.2023legislative requirement thatthis service must be performed by the patients 5001.12.2023usual medical practitioner (please see Note AN.1.1 for the definition of 5001.12.2023patients usual medical practitioner as some exemptions do apply). 1091792 13.03.2020 1 A401 DN NNNNY 2001.12.202300051.0000011.0000000.00 5001.12.2023Telehealth attendance by a medical practitioner of not more than 5 minutes. 5001.12.2023NOTE: It is a legislative requirement thatthis service must be performed by 5001.12.2023the patients usual medical practitioner (please see Note AN.1.1 for the 5001.12.2023definition of patients usual medical practitioner as some exemptions do 5001.12.2023apply). 1091794 13.03.2020 1 A401 DN NYNYY 2001.12.202300029.0000015.1500000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, of not 5001.12.2023more than 5 minutes NOTE: It is a legislative requirement thatthis service 5001.12.2023must be performed by the patients usual medical practitioner (please see Note 5001.12.2023AN.1.1 for the definition of patients usual medical practitioner as some 5001.12.2023exemptions do apply). 1091800 13.03.2020 1 A401 DN NYNYY 2001.12.202300102.0000041.4000000.00 5001.12.2023Telehealth attendance by a general practitioner lasting at least 6 minutes but 5001.12.2023less than 20 minutes if the attendance includes any of the following that are 5001.12.2023clinically relevant:(a) taking a short patient history;(b) arranging any 5001.12.2023necessary investigation;(c) implementing a management plan;(d) providing 5001.12.2023appropriate preventative health care 1091801 13.03.2020 1 A401 DN NYNNY 2001.12.202300188.0000080.1000000.00 5001.12.2023Telehealth attendance by a general practitioner lasting at least 20 minutes if 5001.12.2023the attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking a detailed patient history; (b) arranging any necessary investigation; 5001.12.2023(c) implementing a management plan; (d) providing appropriate preventative 5001.12.2023health care. NOTE: It is a legislative requirement that this service must be 5001.12.2023performed by the patients usual medical practitioner (please see Note AN.1.1 5001.12.2023for the definition of patients usual medical practitioner as some exemptions 5001.12.2023do apply). 1091802 13.03.2020 1 A401 DN NYNNY 2001.12.202300285.0000118.0000000.00 5001.12.2023Telehealth attendance by a general practitioner lasting at least 40 minutes if 5001.12.2023the attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking an extensive patient history; (b) arranging any necessary 5001.12.2023investigation; (c) implementing a management plan; (d) providing appropriate 5001.12.2023preventative health care. NOTE: It is a legislative requirement that this 5001.12.2023service must be performed by the patients usual medical practitioner (please 5001.12.2023see Note AN.1.1 for the definition of patients usual medical practitioner as 5001.12.2023some exemptions do apply). 1091803 13.03.2020 1 A401 DN NNNNY 2001.12.202300102.0000021.0000000.00 5001.12.2023Telehealth attendance by a medical practitioner of more than 5 minutes in 5001.12.2023duration but not more than 25 minutes if the attendance includes any of the 5001.12.2023following that are clinically relevant: (a) taking a short patient history; 5001.12.2023(b) arranging any necessary investigation; (c) implementing a management plan; 5001.12.2023(d) providing appropriate preventative health care. NOTE: It is a legislative 5001.12.2023requirement thatthis service must be performed by the patients usual medical 5001.12.2023practitioner (please see Note AN.1.1 for the definition of patients usual 5001.12.2023medical practitioner as some exemptions do apply). 1091804 13.03.2020 1 A401 DN NNNNY 2001.12.202300188.0000038.0000000.00 5001.12.2023Telehealth attendance by a medical practitioner of more than 25 minutes in 5001.12.2023duration but not more than 45 minutes if the attendance includes any of the 5001.12.2023following that are clinically relevant: (a) taking a detailed patient history; 5001.12.2023(b) arranging any necessary investigation; (c) implementing a management plan; 5001.12.2023(d) providing appropriate preventative health care; NOTE: It is a legislative 5001.12.2023requirement thatthis service must be performed by the patients usual medical 5001.12.2023practitioner (please see Note AN.1.1 for the definition of patients usual 5001.12.2023medical practitioner as some exemptions do apply). 1091805 13.03.2020 1 A401 DN NYNYY 2001.12.202300285.0000061.0000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner) of more than 45 minutes in duration but not more than 60 minutes 5001.12.2023if the attendance includes any of the following that are clinically relevant: 5001.12.2023(a) taking an extensive patient history; (b) arranging any necessary 5001.12.2023investigation; (c) implementing a management plan; (d) providing appropriate 5001.12.2023preventative health care NOTE: It is a legislative requirement that this 5001.12.2023service must be performed by the patients usual medical practitioner (please 5001.12.2023see Note AN.1.1 for the definition of patients usual medical practitioner as 5001.12.2023some exemptions do apply). 1091806 13.03.2020 1 A401 DN NYNYY 2001.12.202300064.0000033.1000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, of 5001.12.2023more than 5 minutes in duration but not more than 25 minutes if the attendance 5001.12.2023includes any of the following that are clinically relevant: (a) taking a short 5001.12.2023patient history; (b) arranging any necessary investigation; (c) implementing a 5001.12.2023management plan; (d) providing appropriate preventative health care NOTE: It 5001.12.2023is a legislative requirement thatthis service must be performed by the 5001.12.2023patients usual medical practitioner (please see Note AN.1.1 for the definition 5001.12.2023of patients usual medical practitioner as some exemptions do apply). 1091807 13.03.2020 1 A401 DN NYNYY 2001.12.202300124.0000064.1000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, of 5001.12.2023more than 25 minutes in duration but not more than 45 minutes if the 5001.12.2023attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking a detailed patient history; (b) arranging any necessary investigation; 5001.12.2023(c) implementing a management plan; (d) providing appropriate preventative 5001.12.2023health care NOTE: It is a legislative requirement thatthis service must be 5001.12.2023performed by the patients usual medical practitioner (please see Note AN.1.1 5001.12.2023for the definition of patients usual medical practitioner as some exemptions 5001.12.2023do apply). 1091808 13.03.2020 1 A401 DN NYNYY 2001.12.202300183.0000094.4000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, of 5001.12.2023more than 45 minutes in duration but not more than 60 minutes if the 5001.12.2023attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking an extensive patient history; (b) arranging any necessary 5001.12.2023investigation; (c) implementing a management plan; (d) providing appropriate 5001.12.2023preventative health care NOTE: It is a legislative requirement thatthis 5001.12.2023service must be performed by the patients usual medical practitioner (please 5001.12.2023see Note AN.1.1 for the definition of patients usual medical practitioner as 5001.12.2023some exemptions do apply). 1091818 13.03.2020 1 A403 DN NYNNY 2001.12.202300198.0000102.1000000.00 5001.12.2023Telehealth attendance by a general practitioner, for the purpose of providing 5001.12.2023focussed psychological strategies for assessed mental disorders if: (a) the 5001.12.2023practitioner is registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialing requirements for provision of this service; and (b) the service 5001.12.2023lasts at least 30 minutes, but less than 40 minutes. 1091819 13.03.2020 1 A403 DN NYNNY 2001.12.202300283.0000146.1000000.00 5001.12.2023Telehealth attendance by a general practitioner, for the purpose of providing 5001.12.2023focussed psychological strategies for assessed mental disorders if: (a) the 5001.12.2023practitioner is registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialing requirements for provision of this service; and (b) the service 5001.12.2023lasts at least 40 minutes. 1091820 13.03.2020 1 A403 DN NYNYY 2001.12.202300158.0000081.7000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), for the purpose of 5001.12.2023providing focussed psychological strategies for assessed mental disorders if: 5001.12.2023(a) the practitioner is registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialing requirements for provision of this service; and (b) 5001.12.2023the service lasts at least 30 minutes, but less than 40 minutes 1091821 13.03.2020 1 A403 DN NYNYY 2001.12.202300226.0000116.9000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), for the purpose of 5001.12.2023providing focussed psychological strategies for assessed mental disorders if: 5001.12.2023(a) the practitioner is registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialing requirements for provision of this service; and (b) 5001.12.2023the service lasts at least 40 minutes 1091822 13.03.2020 1 A404 SN NYNNY 2001.12.202300205.0000095.6000000.00 5001.12.2023Telehealth attendance for a person by a specialist in the practice of the 5001.12.2023specialists specialty if: (a) the attendance follows referral of the patient 5001.12.2023to the specialist; and (b) the attendance was of more than 5 minutes in 5001.12.2023duration. Where the attendance was other than a second or subsequent 5001.12.2023attendance as part of a single course of treatment. 1091823 13.03.2020 1 A404 SN NYNNY 2001.12.202300110.0000048.0500000.00 5001.12.2023Telehealth attendance for a person by a specialist in the practice of the 5001.12.2023specialists specialty if: (a) the attendance follows referral of the patient 5001.12.2023to the specialist; and (b) the attendance was of more than 5 minutes in 5001.12.2023duration. Where the attendance is after the first attendance as part of a 5001.12.2023single course of treatment. 1091824 13.03.2020 1 A405 DN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Telehealth attendance for a person by a consultant physician in the practice 5001.12.2023of the consultant physicians specialty (other than psychiatry) if: (a) the 5001.12.2023attendance follows referral of the patient to the specialist; and (b) the 5001.12.2023attendance was of more than 5 minutes in duration. Where the attendance was 5001.12.2023other than a second or subsequent attendance as part of a single course of 5001.12.2023treatment. 1091825 13.03.2020 1 A405 DN NYNNY 2001.12.202300180.0000084.3500000.00 5001.12.2023Telehealth attendance for a person by a consultant physician in the practice 5001.12.2023of the consultant physicians specialty (other than psychiatry) if: (a) the 5001.12.2023attendance follows referral of the patient to the specialist; and (b) the 5001.12.2023attendance was of more than 5 minutes in duration. Where the attendance is not 5001.12.2023a minor attendance after the first as part of a single course of treatment. 1091826 13.03.2020 1 A405 DN NYNNY 2001.12.202300093.0000048.0500000.00 5001.12.2023Telehealth attendance for a person by a consultant physician in the practice 5001.12.2023of the consultant physicians specialty (other than psychiatry) if: (a) the 5001.12.2023attendance follows referral of the patient to the specialist; and (b) the 5001.12.2023attendance was of more than 5 minutes in duration. Where the attendance is a 5001.12.2023minor attendance after the first as part of a single course of treatment. 1091827 13.03.2020 1 A406 DN NYNNY 2001.12.202300108.0000048.4000000.00 5001.12.2023Telehealth attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was not more than 15 minutes 5001.12.2023duration. 1091828 13.03.2020 1 A406 DN NYNNY 2001.12.202300215.0000096.6000000.00 5001.12.2023Telehealth attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was at least 15 minutes, but 5001.12.2023not more than 30 minutes in duration. 1091829 13.03.2020 1 A406 DN NYNNY 2001.12.202300325.0000148.7000000.00 5001.12.2023Telehealth attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was at least 30 minutes, but 5001.12.2023not more than 45 minutes in duration. 1091830 13.03.2020 1 A406 DN NYNNY 2001.12.202300490.0000205.2000000.00 5001.12.2023Telehealth attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was at least 45 minutes, but 5001.12.2023not more than 75 minutes in duration. 1091831 13.03.2020 1 A406 DN NYNNY 2001.12.202300545.0000238.1500000.00 5001.12.2023Telehealth attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was at least 75 minutes in 5001.12.2023duration. 1091833 13.03.2020 1 A407 DN NYNNY 2001.12.202300110.0000048.0500000.00 5001.12.2023Phone attendance for a person by a specialist in the practice of the 5001.12.2023specialists specialty if: (a) the attendance follows referral of the patient 5001.12.2023to the specialist; and (b) the attendance was of more than 5 minutes in 5001.12.2023duration. Where the attendance is after the first attendance as part of a 5001.12.2023single course of treatment. 1091836 13.03.2020 1 A408 DN NYNNY 2001.12.202300093.0000048.0500000.00 5001.12.2023Phone attendance for a person by a consultant physician in the practice of the 5001.12.2023consultant physicians specialty (other than psychiatry) if: (a) the attendance 5001.12.2023follows referral of the patient to the specialist; and (b) the attendance was 5001.12.2023of more than 5 minutes in duration. Where the attendance is a minor attendance 5001.12.2023after the first as part of a single course of treatment. 1091837 13.03.2020 1 A409 DN NYNNY 2001.12.202300108.0000048.4000000.00 5001.12.2023Phone attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was not more than 15 minutes 5001.12.2023duration; Where the attendance is after the first attendance as part of a 5001.12.2023single course of treatment 1091838 13.03.2020 1 A409 DN NYNNY 2001.12.202300215.0000096.6000000.00 5001.12.2023Phone attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner and (b) the attendance was at least 15 minutes, but 5001.12.2023not more than 30 minutes in duration; Where the attendance is after the first 5001.12.2023attendance as part of a single course of treatment 1091839 13.03.2020 1 A409 DN NYNNY 2001.12.202300325.0000148.7000000.00 5001.12.2023Phone attendance for a person by a consultant psychiatrist; if: (a) the 5001.12.2023attendance follows a referral of the patient to the consultant psychiatrist by 5001.12.2023a referring practitioner; and (b) the attendance was at least 30 minutes, but 5001.12.2023not more than 45 minutes in duration Where the attendance is after the first 5001.12.2023attendance as part of a single course of treatment 1091842 13.03.2020 1 A4010 DN NYNNY 2001.12.202300198.0000102.1000000.00 5001.12.2023Phone attendance by a general practitioner, for the purpose of providing 5001.12.2023focussed psychological strategies for assessed mental disorders if: (a) the 5001.12.2023practitioner is registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialing requirements for provision of this service; and (b) the service 5001.12.2023lasts at least 30 minutes, but less than 40 minutes. 1091843 13.03.2020 1 A4010 DN NYNNY 2001.12.202300283.0000146.1000000.00 5001.12.2023Phone attendance by a general practitioner, for the purpose of providing 5001.12.2023focussed psychological strategies for assessed mental disorders if: (a) the 5001.12.2023practitioner is registered with the Chief Executive Medicare as meeting the 5001.12.2023credentialing requirements for provision of this service; and (b) the service 5001.12.2023lasts at least 40 minutes. 1091844 13.03.2020 1 A4010 DN NYNYY 2001.12.202300158.0000081.7000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a General 5001.12.2023Practitioner, Specialist or Consultant Physician), for the purpose of 5001.12.2023providing focussed psychological strategies for assessed mental disorders if: 5001.12.2023(a) the practitioner is registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialing requirements for provision of this service; and (b) 5001.12.2023the service lasts at least 30 minutes, but less than 40 minutes 1091845 13.03.2020 1 A4010 DN NYNYY 2001.12.202300226.0000116.9000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a General 5001.12.2023Practitioner, Specialist or Consultant Physician), for the purpose of 5001.12.2023providing focussed psychological strategies for assessed mental disorders if: 5001.12.2023(a) the practitioner is registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialing requirements for provision of this service; and (b) 5001.12.2023the service lasts at least 40 minutes 1091859 01.03.2023 1 A403 DN YYNYN 2001.12.202300198.0000102.1000000.00 5001.12.2023Telehealth attendance by a general practitioner (not including a specialist or 5001.12.2023a consultant physician), registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialling requirements for provision of this service: (a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and (b) lasting at least 30 minutes but less than 40 minutes 1091861 01.03.2023 1 A403 DN YYNYN 2001.12.202300283.0000146.1000000.00 5001.12.2023Telehealth attendance by a general practitioner (not including a specialist or 5001.12.2023a consultant physician), registered with the Chief Executive Medicare as 5001.12.2023meeting the credentialling requirements for provision of this service: (a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and (b) lasting at least 40 minutes 1091862 01.03.2023 1 A403 DN YYNYN 2001.12.202300158.0000081.6500000.00 5001.12.2023Telehealth attendance by a medical practitioner, registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies for assessed 5001.12.2023mental disorders to a person other than the patient, if the service is part of 5001.12.2023the patients treatment; and (b) lasting at least 30 minutes but less than 40 5001.12.2023minutes 1091863 01.03.2023 1 A403 DN YYNYN 2001.12.202300226.0000116.9000000.00 5001.12.2023Telehealth attendance by a medical practitioner, registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies for assessed 5001.12.2023mental disorders to a person other than the patient, if the service is part of 5001.12.2023the patients treatment; and (b) lasting at least 40 minutes 1091864 01.03.2023 1 A4010 DN YYNYN 2001.12.202300198.0000102.1000000.00 5001.12.2023Phone attendance by a general practitioner (not including a specialist or a 5001.12.2023consultant physician), registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service: (a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and (b) lasting at least 30 minutes but less than 40 minutes 1091865 01.03.2023 1 A4010 DN YYNYN 2001.12.202300283.0000146.1000000.00 5001.12.2023Phone attendance by a general practitioner (not including a specialist or a 5001.12.2023consultant physician), registered with the Chief Executive Medicare as meeting 5001.12.2023the credentialling requirements for provision of this service: (a) for 5001.12.2023providing focussed psychological strategies for assessed mental disorders to a 5001.12.2023person other than the patient, if the service is part of the patients 5001.12.2023treatment; and (b) lasting at least 40 minutes 1091866 01.03.2023 1 A4010 DN YYNYN 2001.12.202300158.0000081.6500000.00 5001.12.2023Phone attendance by a medical practitioner, registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies for assessed 5001.12.2023mental disorders to a person other than the patient, if the service is part of 5001.12.2023the patients treatment; and (b) lasting at least 30 minutes but less than 40 5001.12.2023minutes 1091867 01.03.2023 1 A4010 DN YYNYN 2001.12.202300226.0000116.9000000.00 5001.12.2023Phone attendance by a medical practitioner, registered with the Chief 5001.12.2023Executive Medicare as meeting the credentialling requirements for provision of 5001.12.2023this service: (a) for providing focussed psychological strategies for assessed 5001.12.2023mental disorders to a person other than the patient, if the service is part of 5001.12.2023the patients treatment; and (b) lasting at least 40 minutes 1091890 01.07.2021 1 A402 SN NYNNY 2001.12.202300051.0000018.9500000.00 5001.12.2023Phone attendance by a general practitioner lasting less than 6 minutes for an 5001.12.2023obvious problem characterised by the straightforward nature of the task that 5001.12.2023requires a short patient history and, if required, limited management 1091891 01.07.2021 1 A402 SN NYNNY 2001.12.202300102.0000041.4000000.00 5001.12.2023Phone attendance by a general practitioner lasting at least 6 minutes if the 5001.12.2023attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking a short patient history; (b) arranging any necessary investigation; (c) 5001.12.2023implementing a management plan; (d) providing appropriate preventative health 5001.12.2023care 1091892 01.07.2021 1 A402 SN NNNNY 2001.12.202300051.0000011.0000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician) lasting less than 6 minutes 5001.12.2023for an obvious problem characterised by the straightforward nature of the task 5001.12.2023that requires a short patient history and, if required, limited management 1091893 01.07.2021 1 A402 SN NNNNY 2001.12.202300102.0000021.0000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician) lasting at least 6 minutes 5001.12.2023if the attendance includes any of the following that are clinically relevant: 5001.12.2023(a) taking a short patient history; (b) arranging any necessary investigation; 5001.12.2023(c) implementing a management plan; (d) providing appropriate preventative 5001.12.2023health care 1091900 01.11.2023 1 A402 DN YNNYN 2001.12.202300155.0000080.1000000.00 5001.12.2023Phone attendance by a general practitioner to a patient registered under 5001.12.2023MyMedicare with the billing practice, lasting at least 20 minutes, if the 5001.12.2023attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking a short patient history; (b) arranging any necessary investigation; (c) 5001.12.2023implementing a management plan; (d) providing appropriate preventative health 5001.12.2023care; for one or more health related issues, with appropriate documentation 1091903 01.11.2023 1 A402 DN YNNYN 2001.12.202300074.0000038.0000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner) to a patient registered under MyMedicare with the billing 5001.12.2023practice, of more than 25 minutes in duration but not more than 45 minutes, if 5001.12.2023the attendance includes any of the following that are clinically relevant: (a) 5001.12.2023taking a short patient history; (b) arranging any necessary investigation; (c) 5001.12.2023implementing a management plan; (d) providing appropriate preventative health 5001.12.2023care; for one or more health related issues, with appropriate documentation 1091906 01.11.2023 1 A402 DN YNNYN 2001.12.202300124.0000064.1000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, to a 5001.12.2023patient registered under MyMedicare with the billing practice, of more than 25 5001.12.2023minutes in duration but not more than 45 minutes, if the attendance includes 5001.12.2023any of the following that are clinically relevant:(a) taking an extensive 5001.12.2023patient history;(b) arranging any necessary investigation;(c) implementing a 5001.12.2023management plan;(d) providing appropriate preventive health care;for one or 5001.12.2023more health related issues, with appropriate documentation 1091910 01.11.2023 1 A402 DN YNNYN 2001.12.202300229.0000118.0000000.00 5001.12.2023Phone attendance by a general practitioner, to a patient registered under 5001.12.2023MyMedicare with the billing practice, lasting at least 40 minutes, if the 5001.12.2023attendance includes any of the following that are clinically relevant:(a) 5001.12.2023taking an extensive patient history;(b) arranging any necessary 5001.12.2023investigation;(c) implementing a management plan;(d) providing appropriate 5001.12.2023preventive health care;for one or more health related issues, with appropriate 5001.12.2023documentation 1091913 01.11.2023 1 A402 DN YNNYN 2001.12.202300118.0000061.0000000.00 5001.12.2023Phone attendance by a medical practitioner, to a patient registered under 5001.12.2023MyMedicare with the billing practice, of more than 45 minutes in duration but 5001.12.2023not more than 60 minutes, if the attendance includes any of the following that 5001.12.2023are clinically relevant:(a) taking a detailed patient history;(b) arranging 5001.12.2023any necessary investigation;(c) implementing a management plan;(d) providing 5001.12.2023appropriate preventative health care;for one or more health related issues, 5001.12.2023with appropriate documentation 1091916 01.11.2023 1 A402 DN YNNYN 2001.12.202300183.0000094.4000000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, to a 5001.12.2023patient registered under MyMedicare with the billing practice, of more than 45 5001.12.2023minutes in duration but not more than 60 minutes, if the attendance includes 5001.12.2023any of the following that are clinically relevant:(a) taking a detailed 5001.12.2023patient history;(b) arranging any necessary investigation;(c) implementing a 5001.12.2023management plan;(d) providing appropriate preventative health care;for one or 5001.12.2023more health related issues, with appropriate documentation 1091920 01.11.2023 1 A401 DN YNNYN 2001.12.202300370.0000191.2000000.00 5001.12.2023Telehealth attendance by a general practitioner, lasting at least 60 minutes 5001.12.2023and including any of the following that are clinically relevant:(a) taking an 5001.12.2023extensive patient history;(b) arranging any necessary investigation;(c) 5001.12.2023implementing a management plan;(d) providing appropriate preventive health 5001.12.2023care;for one or more health related issues, with appropriate documentation 5001.12.2023NOTE: It is a legislative requirement that this service must be performed by 5001.12.2023the patients usual medical practitioner (please see Note AN.1.1 for the 5001.12.2023definition of patients usual medical practitioner as some exemptions do 5001.12.2023apply). 1091923 01.11.2023 1 A401 DN YNNYN 2001.12.202300191.0000098.4000000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner), of more than 60 minutes in duration and including any of the 5001.12.2023following that are clinically relevant:(a) taking an extensive patient 5001.12.2023history;(b) arranging any necessary investigation;(c) implementing a 5001.12.2023management plan;(d) providing appropriate preventive health care;for one or 5001.12.2023more health related issues, with appropriate documentation NOTE: It is a 5001.12.2023legislative requirement that this service must be performed by the patients 5001.12.2023usual medical practitioner (please see Note AN.1.1 for the definition of 5001.12.2023patients usual medical practitioner as some exemptions do apply). 1091926 01.11.2023 1 A401 DN YNNYN 2001.12.202300296.0000152.9500000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in an eligible area, of 5001.12.2023more than 60 minutes in duration and including any of the following that are 5001.12.2023clinically relevant:(a) taking an extensive patient history;(b) arranging any 5001.12.2023necessary investigation;(c) implementing a management plan;(d) providing 5001.12.2023appropriate preventive health care;for one or more health related issues, with 5001.12.2023appropriate documentation NOTE: It is a legislative requirement that this 5001.12.2023service must be performed by the patients usual medical practitioner (please 5001.12.2023see Note AN.1.1 for the definition of patients usual medical practitioner as 5001.12.2023some exemptions do apply). 1092115 30.03.202001.12.20221 A4019 DN NYNNY 2001.12.202300215.0000078.9500000.00 5001.12.2023Telehealth attendance by a general practitioner in relation to a mental 5001.12.2023disorder and of at least 20 minutes in duration, involving taking relevant 5001.12.2023history and identifying the presenting problem (to the extent not previously 5001.12.2023recorded), providing treatment and advice and, if appropriate, referral for 5001.12.2023other services or treatments, and documenting the outcomes of the 5001.12.2023consultation. 1092121 30.03.2020 1 A4019 DN NYNYY 2001.12.202300122.0000063.1500000.00 5001.12.2023Telehealth attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician), in relation to a mental 5001.12.2023disorder and of at least 20 minutes in duration, involving taking relevant 5001.12.2023history and identifying the presenting problem (to the extent not previously 5001.12.2023recorded), providing treatment and advice and, if appropriate, referral for 5001.12.2023other services or treatments, and documenting the outcomes of the consultation 1092127 30.03.202001.12.20221 A4020 DN NYNNY 2001.12.202300215.0000078.9500000.00 5001.12.2023Phone attendance by a general practitioner in relation to a mental disorder 5001.12.2023and of at least 20 minutes in duration, involving taking relevant history and 5001.12.2023identifying the presenting problem (to the extent not previously recorded), 5001.12.2023providing treatment and advice and, if appropriate, referral for other 5001.12.2023services or treatments, and documenting the outcomes of the consultation. 1092133 30.03.2020 1 A4020 DN NYNYY 2001.12.202300122.0000063.1500000.00 5001.12.2023Phone attendance by a medical practitioner (not including a general 5001.12.2023practitioner, specialist or consultant physician) in relation to a mental 5001.12.2023disorder and of at least 20 minutes in duration, involving taking relevant 5001.12.2023history and identifying the presenting problem (to the extent not previously 5001.12.2023recorded), providing treatment and advice and, if appropriate, referral for 5001.12.2023other services or treatments, and documenting the outcomes of the consultation 1092435 06.04.2020 1 A406 DN NYNNY 2001.12.202300890.0000505.7000000.00 5001.12.2023Telehealth attendance of more than 45 minutes in by a consultant physician in 5001.12.2023the practice of the consultant physicians specialty of psychiatry, if: (a) the 5001.12.2023attendance follows referral of the patient to the consultant for an assessment 5001.12.2023or management by a medical practitioner in general practice (not including a 5001.12.2023specialist or consultant physician) or a participating nurse practitioner; and 5001.12.2023(b) during the attendance, the consultant: (i) uses an outcome tool (if 5001.12.2023clinically appropriate); and (ii) carries out a mental state examination; and 5001.12.2023(iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is 5001.12.2023clinically appropriate for the patient to be managed by the referring 5001.12.2023practitioner without ongoing treatment by the consultant; and (d) within 2 5001.12.2023weeks after the attendance, the consultant: (i) prepares a written diagnosis 5001.12.2023of the patient; and (ii) prepares a written management plan for the patient 5001.12.2023that: (A) covers the next 12 months; and (B) is appropriate to the patients 5001.12.2023diagnosis; and (C) comprehensively evaluates the patients biological, 5001.12.2023psychological and social issues; and (D) addresses the patients diagnostic 5001.12.2023psychiatric issues; and (E) makes management recommendations addressing the 5001.12.2023patients biological, psychological and social issues; and (iii) gives the 5001.12.2023referring practitioner a copy of the diagnosis and the management plan; and 5001.12.2023(iv) if clinically appropriate, explains the diagnosis and management plan, 5001.12.2023and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), 5001.12.2023if the patient agrees; and (e) in the preceding 12 months, a service to which 5001.12.2023this item or item 291 of the general medical services table applies has not 5001.12.2023been provided 1092436 06.04.2020 1 A406 DN NYNNY 2001.12.202300595.0000316.1500000.00 5001.12.2023Telehealth attendance of more than 30 minutes but not more than 45 minutes in 5001.12.2023duration by a consultant physician in the practice of the consultant 5001.12.2023physicians specialty of psychiatry, if: (a) the patient is being managed by a 5001.12.2023medical practitioner or a participating nurse practitioner in accordance with 5001.12.2023a management plan prepared by the consultant in accordance with item 291 or 5001.12.202392435; and (b) the attendance follows referral of the patient to the 5001.12.2023consultant for review of the management plan by the medical practitioner or a 5001.12.2023participating nurse practitioner managing the patient; and (c) during the 5001.12.2023attendance, the consultant: (i) uses an outcome tool (if clinically 5001.12.2023appropriate); and (ii) carries out a mental state examination; and (iii) makes 5001.12.2023a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 5001.12.20232 weeks after the attendance, the consultant: (i) prepares a written diagnosis 5001.12.2023of the patient; and (ii) revises the management plan; and (iii) gives the 5001.12.2023referring practitioner a copy of the diagnosis and the revised management 5001.12.2023plan; and (iv) if clinically appropriate, explains the diagnosis and the 5001.12.2023revised management plan, and gives a copy, to: (A) the patient; and (B) the 5001.12.2023patients carer (if any), if the patient agrees; and (e) in the preceding 12 5001.12.2023months, a service to which item 291 of the general medical services table 5001.12.2023or92435 applies has been provided; and (f) in the preceding 12 months, a 5001.12.2023service to which this item, or item 293 of the general medical services table 5001.12.2023applies has not been provided 1092437 06.04.2020 1 A406 DN NYNYY 2001.12.202300485.0000290.8500000.00 5001.12.2023Telehealth attendance of more than 45 minutes in duration by a consultant 5001.12.2023physician in the practice of the consultant physicians speciality of 5001.12.2023psychiatry following referral of the patient to the consultant physician by a 5001.12.2023referring practitioner: (a) if the patient: (i) is a new patient for this 5001.12.2023consultant physician; or (ii) has not received an attendance from this 5001.12.2023consultant physician in the preceding 24 months; and (b) the patient has not 5001.12.2023received an attendance under this item, or item 91827 to 91831, 91837 to 5001.12.202391839, 92455 to 92457, or item 296, 297, 299 or300 to 346 of the general 5001.12.2023medical services table, in the preceding 24 months 1092455 20.04.2020 1 A406 DN NYNNY 2001.12.202300134.0000055.0500000.00 5001.12.2023Telehealth attendance for group psychotherapy (including any associated 5001.12.2023consultations with a patient taking place on the same occasion and relating to 5001.12.2023the condition for which group therapy is conducted): (a) of not less than 1 5001.12.2023hour in duration; and (b) given under the continuous direct supervision of a 5001.12.2023consultant physician in the practice of the consultant physicians specialty of 5001.12.2023psychiatry; and (c) involving a group of 2 to 9 unrelated patients or a family 5001.12.2023group of more than 3 patients, each of whom is referred to the consultant 5001.12.2023physician by a referring practitioner; each patient 1092456 20.04.2020 1 A406 DN NYNNY 2001.12.202300174.0000073.1000000.00 5001.12.2023Telehealth attendance for group psychotherapy (including any associated 5001.12.2023consultations with a patient taking place on the same occasion and relating to 5001.12.2023the condition for which group therapy is conducted): (a) of not less than 1 5001.12.2023hour in duration; and (b) given under the continuous direct supervision of a 5001.12.2023consultant physician in the practice of the consultant physicians specialty of 5001.12.2023psychiatry; and (c) involving a family group of 3 patients, each of whom is 5001.12.2023referred to the consultant physician by a referring practitioner; each patient 1092457 20.04.2020 1 A406 DN NYNNY 2001.12.202300260.0000108.1500000.00 5001.12.2023Telehealth attendance for group psychotherapy (including any associated 5001.12.2023consultations with a patient taking place on the same occasion and relating to 5001.12.2023the condition for which group therapy is conducted): (a) of not less than 1 5001.12.2023hour in duration; and (b) given under the continuous direct supervision of a 5001.12.2023consultant physician in the practice of the consultant physicians specialty of 5001.12.2023psychiatry; and (c) involving a family group of 2 patients, each of whom is 5001.12.2023referred to the consultant physician by a referring practitioner; each patient 1092458 06.04.2020 1 A406 DN NYNNY 2001.12.202300325.0000141.6000000.00 5001.12.2023Telehealth attendance by a consultant physician in the practice of the 5001.12.2023consultant physicians specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 20 minutes, but 5001.12.2023less than 45 minutes, in duration, in the course of initial diagnostic 5001.12.2023evaluation of a patient. . 1092459 06.04.2020 1 A406 DN NYNNY 2001.12.202300435.0000195.4500000.00 5001.12.2023Telehealth attendance by a consultant physician in the practice of the 5001.12.2023consultant physicians specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 45 minutes in 5001.12.2023duration, in the course of initial diagnostic evaluation of a patient. 1092460 06.04.2020 1 A406 DN NYNNY 2001.12.202300220.0000141.6000000.00 5001.12.2023Telehealth attendance by a consultant physician in the practice of the 5001.12.2023consultant physicians specialty of psychiatry, following referral of the 5001.12.2023patient to the consultant physician by a referring practitioner, involving an 5001.12.2023interview of a person other than the patient of not less than 20 minutes in 5001.12.2023duration, in the course of continuing management of a patientif that 5001.12.2023attendance and another attendance to which this item or item 352 of the 5001.12.2023general medical services table applies have not exceeded 4 in a calendar year 5001.12.2023for the patient 1092610 20.04.2020 1 A4035 DN NYNNY 2001.12.202300315.0000144.7500000.00 5001.12.2023Telehealth attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialist (other than a second or 5001.12.2023subsequent attendance in a single course of treatment). 1092611 20.04.2020 1 A4035 DN NYNNY 2001.12.202300112.0000048.0500000.00 5001.12.2023Telehealth attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialista minor attendance after 5001.12.2023the first in a single course of treatment. 1092612 20.04.2020 1 A4035 DN NYNNY 2001.12.202300220.0000095.6000000.00 5001.12.2023Telehealth attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialistan attendance after the 5001.12.2023first in a single course of treatment, involving arranging any necessary 5001.12.2023investigations in relation to one or more complex problems and of more than 15 5001.12.2023minutes in duration but not more than 30 minutes in duration. 1092613 20.04.2020 1 A4035 DN NYNNY 2001.12.202300305.0000132.4000000.00 5001.12.2023Telehealth attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialistan attendance after the 5001.12.2023first in a single course of treatment, involving arranging any necessary 5001.12.2023investigations in relation to one or more complex problems and of more than 30 5001.12.2023minutes in duration but not more than 45 minutes in duration. 1092614 20.04.2020 1 A4035 DN NYNNY 2001.12.202300390.0000168.6000000.00 5001.12.2023Telehealth attendance by a specialist in the practice of neurosurgery 5001.12.2023following referral of the patient to the specialistan attendance after the 5001.12.2023first in a single course of treatment, involving arranging any necessary 5001.12.2023investigations in relation to one or more complex problems and of more than 45 5001.12.2023minutes in duration. 1092618 20.04.2020 1 A4036 DN NYNNY 2001.12.202300112.0000048.0500000.00 5001.12.2023Phone attendance by a specialist in the practice of neurosurgery following 5001.12.2023referral of the patient to the specialista minor attendance after the first in 5001.12.2023a single course of treatment. 1092701 22.05.2020 1 A4037 DN NYNNY 2001.12.202300400.0000095.6000000.00 5001.12.2023Telehealth attendance by a medical practitioner in the practice of anaesthesia 5001.12.2023for a consultation on a patient undergoing advanced surgery or who has complex 5001.12.2023medical problems, involving a selective history and the formulation of a 5001.12.2023written patient management plan documented in the patient notes, and lasting 5001.12.2023more than 15 minutes (other than a service associated with a service to which 5001.12.2023any of items 2801 to 3000 of the general medical services table apply) 1093644 26.02.2021 1 A443 DN NYNYY 2001.12.202300083.0000042.9500000.00 5001.12.2023Professional attendance by a general practitioner for the purpose of assessing 5001.12.2023a patients suitability for a COVID-19 vaccine if all of the following 5001.12.2023apply:(a) one or both of the following is undertaken, where clinically 5001.12.2023relevant: (i) a short patient history; (ii) limited examination and 5001.12.2023management;(b) the service is bulk-billed;(c) the service is provided at, or 5001.12.2023from, a practice location in a Modified Monash 1 area 1093645 26.02.2021 1 A443 DN NYNYY 2001.12.202300091.0000047.1500000.00 5001.12.2023Professional attendance by a general practitioner for the purpose of assessing 5001.12.2023a patients suitability for a COVID-19 vaccine if all of the following 5001.12.2023apply:(a) one or both of the following is undertaken, where clinically 5001.12.2023relevant: (i) a short patient history; (ii) limited examination and 5001.12.2023management;(b) the service is bulk-billed;(c) the service is provided at, or 5001.12.2023from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified 5001.12.2023Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 5001.12.2023area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area 1093646 26.02.2021 1 A443 DN NYNYY 2001.12.202300067.0000034.4500000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) for the purpose of assessing a patients suitability for a 5001.12.2023COVID-19 vaccine if all of the following apply:(a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management;(b) the service is 5001.12.2023bulk-billed;(c) the service is provided at, or from, a practice location in a 5001.12.2023Modified Monash 1 area 1093647 26.02.2021 1 A443 SN NYNYY 2001.12.202300083.0000042.6000000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) for the purpose of assessing a patients suitability for a 5001.12.2023COVID-19 vaccine if all of the following apply:(a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management;(b) the service is 5001.12.2023bulk-billed;(c) the service is provided at, or from, a practice location in: 5001.12.2023(i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a 5001.12.2023Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified 5001.12.2023Monash 6 area; or (vi) a Modified Monash 7 area 1093653 26.02.2021 1 A444 DN NYNYY 2001.12.202300113.0000058.2500000.00 5001.12.2023Professional attendance by a general practitioner for the purpose of assessing 5001.12.2023a patients suitability for a COVID-19 vaccine if all of the following apply: 5001.12.2023(a) one or both of the following is undertaken, where clinically relevant: (i) 5001.12.2023a short patient history; (ii) limited examination and management; (b) the 5001.12.2023service is bulk-billed; (c) the service is provided at, or from, a practice 5001.12.2023location in a Modified Monash 1 area; (d) the service is rendered in an 5001.12.2023after-hours period 1093654 26.02.2021 1 A444 DN NYNYY 2001.12.202300121.0000062.3500000.00 5001.12.2023Professional attendance by a general practitioner for the purpose of assessing 5001.12.2023a patients suitability for a dose of a COVID-19 vaccine if all of the 5001.12.2023following apply: (a) one or both of the following is undertaken, where 5001.12.2023clinically relevant: (i) a short patient history; (ii) limited examination and 5001.12.2023management; (b) the service is bulk-billed; (c) the service is provided at, or 5001.12.2023from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified 5001.12.2023Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 5001.12.2023area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) 5001.12.2023the service is rendered in an after-hours period 1093655 26.02.2021 1 A444 DN NYNYY 2001.12.202300091.0000046.9500000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) for the purpose of assessing a patients suitability for a 5001.12.2023COVID-19 vaccine if all of the following apply: (a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management; (b) the service is 5001.12.2023bulk-billed; (c) the service is provided at, or from, a practice location in a 5001.12.2023Modified Monash 1 area; (d) the service is rendered in an after-hours period 1093656 26.02.2021 1 A444 DN NYNYY 2001.12.202300106.0000054.8000000.00 5001.12.2023Professional attendance by a medical practitioner (other than a general 5001.12.2023practitioner) for the purpose of assessing a patients suitability for a 5001.12.2023COVID-19 vaccine if all of the following apply: (a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management; (b) the service is 5001.12.2023bulk-billed; (c) the service is provided at, or from, a practice location in: 5001.12.2023(i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a 5001.12.2023Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified 5001.12.2023Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered 5001.12.2023in an after-hours period 1093660 01.01.2022 1 A446 SN NYNNY 2001.12.202300051.0000026.1500000.00 5001.12.2023Attendance by a relevant health professional on behalf of a medical 5001.12.2023practitioner for the purpose of assessing a patients suitability for a dose of 5001.12.2023a COVID-19 vaccine if all of the following apply: (a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management; (b)the service is 5001.12.2023bulk-billed; (c) the service is not provided at a practice location; and (d) 5001.12.2023the service is provided from a practice location in a Modified Monash 1 area 1093661 01.01.2022 1 A446 SN NYNNY 2001.12.202300058.0000029.8500000.00 5001.12.2023Attendance by a relevant health professional on behalf of a medical 5001.12.2023practitioner for the purpose of assessing a patients suitability for a dose of 5001.12.2023a COVID-19 vaccine if all of the following apply: (a) one or both of the 5001.12.2023following is undertaken, where clinically relevant: (i) a short patient 5001.12.2023history; (ii) limited examination and management; (b)the service is 5001.12.2023bulk-billed; (c) the service is not provided at a practice location; and (d) 5001.12.2023the service is provided from a practice location in: (i) a Modified Monash 2 5001.12.2023area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or 5001.12.2023(iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a 5001.12.2023Modified Monash 7 area 1093716 19.07.2022 1 A46 DN NYNNY 2001.12.202300182.0000094.2000000.00 5001.12.2023Phone attendance by a general practitioner lasting at least 20 minutes for the 5001.12.2023assessment and management of a person with COVID19 infection of recent onset, 5001.12.2023for the purposes of determining the patients eligibility for receiving a 5001.12.2023COVID-19 oral antiviral treatment, where the service includes any of the 5001.12.2023following that are clinically relevant: (a) taking a detailed patient 5001.12.2023history;(b) arranging any necessary investigation;(c) implementing a 5001.12.2023management plan, including follow up arrangements;(d) providing any necessary 5001.12.2023treatment, including prescribing a COVID-19 oral antiviral treatment;(e) 5001.12.2023providing appropriate preventive health care for one or more related issues; 5001.12.2023with appropriate documentation 1093717 19.07.2022 1 A46 DN NNNNN 2001.12.202300087.0000044.7000000.00 5001.12.2023Phone attendance by a medical practitioner (other than a general practitioner) 5001.12.2023lasting at least 25 minutes for the assessment and management of a person with 5001.12.2023COVID19 infection of recent onset, for the purposes of determining the 5001.12.2023patients eligibility for receiving a COVID-19 oral antiviral treatment, where 5001.12.2023the service includes any of the following that are clinically relevant: (a) 5001.12.2023taking a detailed patient history;(b) arranging any necessary 5001.12.2023investigation;(c) implementing a management plan, including follow up 5001.12.2023arrangements;(d) providing any necessary treatment, including prescribing a 5001.12.2023COVID-19 oral antiviral treatment;(e)providing appropriate preventive health 5001.12.2023care for one or more related issues; with appropriate documentation